22	22	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
oxacalcitriol	oxacalcitriol	NOUN	NNS	I-Chemical
suppresses	suppress	VERB	VBZ	O
secondary	secondary	ADJ	JJ	B-Disease
hyperparathyroidism	hyperparathyroidism	NOUN	NN	I-Disease
without	without	ADP	IN	O
inducing	induce	VERB	VBG	O
low	low	ADJ	JJ	B-Disease
bone	bone	NOUN	NN	I-Disease
turnover	turnover	NOUN	NN	I-Disease
in	in	ADP	IN	O
dogs	dog	NOUN	NNS	O
with	with	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Calcitriol	Calcitriol	PROPN	NNP	B-Chemical
therapy	therapy	NOUN	NN	O
suppresses	suppress	VERB	VBZ	O
serum	serum	ADJ	JJ	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
parathyroid	parathyroid	ADJ	JJ	O
hormone	hormone	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PTH	PTH	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
but	but	CCONJ	CC	O
has	have	VERB	VBZ	O
several	several	ADJ	JJ	O
drawbacks	drawback	NOUN	NNS	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
hypercalcemia	hypercalcemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
marked	mark	VERB	VBN	O
suppression	suppression	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
bone	bone	NOUN	NN	I-Disease
turnover	turnover	NOUN	NN	I-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
may	may	VERB	MD	O
lead	lead	VERB	VB	O
to	to	ADP	IN	O
adynamic	adynamic	ADJ	JJ	B-Disease
bone	bone	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
new	new	ADJ	JJ	O
vitamin	vitamin	NOUN	NN	B-Chemical
D	d	NOUN	NN	I-Chemical
analogue	analogue	NOUN	NN	O
,	,	PUNCT	,	O
22	22	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
oxacalcitriol	oxacalcitriol	NOUN	NNS	I-Chemical
(	(	PUNCT	-LRB-	O
OCT	OCT	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
shown	show	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
promising	promising	ADJ	JJ	O
characteristics	characteristic	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
undertaken	undertake	VERB	VBN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
OCT	OCT	PROPN	NNP	B-Chemical
on	on	ADP	IN	O
serum	serum	ADJ	JJ	O
PTH	PTH	PROPN	NNP	O
levels	level	NOUN	NNS	O
and	and	CCONJ	CC	O
bone	bone	NOUN	NN	O
turnover	turnover	NOUN	NN	O
in	in	ADP	IN	O
states	state	NOUN	NNS	O
of	of	ADP	IN	O
normal	normal	ADJ	JJ	O
or	or	CCONJ	CC	O
impaired	impaired	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Sixty	sixty	NUM	CD	O
dogs	dog	NOUN	NNS	O
were	be	VERB	VBD	O
either	either	CCONJ	CC	O
nephrectomized	nephrectomized	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
Nx	Nx	PROPN	NNP	O
,	,	PUNCT	,	O
N	N	PROPN	NNP	O
=	=	SYM	SYM	O
38	38	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
sham	sham	NOUN	NN	O
-	-	PUNCT	HYPH	O
operated	operate	VERB	VBN	O
(	(	PUNCT	-LRB-	O
Sham	Sham	PROPN	NNP	O
,	,	PUNCT	,	O
N	N	PROPN	NNP	O
=	=	SYM	SYM	O
22	22	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
animals	animal	NOUN	NNS	O
received	receive	VERB	VBD	O
supplemental	supplemental	ADJ	JJ	O
phosphate	phosphate	NOUN	NN	B-Chemical
to	to	PART	TO	O
enhance	enhance	VERB	VB	O
PTH	PTH	PROPN	NNP	O
secretion	secretion	NOUN	NN	O
.	.	PUNCT	.	O

Fourteen	fourteen	NUM	CD	O
weeks	week	NOUN	NNS	O
after	after	ADP	IN	O
the	the	DET	DT	O
start	start	NOUN	NN	O
of	of	ADP	IN	O
phosphate	phosphate	NOUN	NN	B-Chemical
supplementation	supplementation	NOUN	NN	O
,	,	PUNCT	,	O
half	half	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
Nx	Nx	PROPN	NNP	O
and	and	CCONJ	CC	O
Sham	Sham	PROPN	NNP	O
dogs	dog	NOUN	NNS	O
received	receive	VERB	VBD	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
OCT	OCT	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
three	three	NUM	CD	O
times	time	NOUN	NNS	O
per	per	ADP	IN	O
week	week	NOUN	NN	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
half	half	NOUN	NN	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
vehicle	vehicle	NOUN	NN	O
for	for	ADP	IN	O
60	60	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

Thereafter	thereafter	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
modalities	modality	NOUN	NNS	O
for	for	ADP	IN	O
a	a	DET	DT	O
subset	subset	NOUN	NN	O
of	of	ADP	IN	O
animals	animal	NOUN	NNS	O
were	be	VERB	VBD	O
crossed	cross	VERB	VBN	O
over	over	PART	RP	O
for	for	ADP	IN	O
an	an	DET	DT	O
additional	additional	ADJ	JJ	O
eight	eight	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Biochemical	biochemical	ADJ	JJ	O
and	and	CCONJ	CC	O
hormonal	hormonal	ADJ	JJ	O
indices	index	NOUN	NNS	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
bone	bone	NOUN	NN	O
metabolism	metabolism	NOUN	NN	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
throughout	throughout	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
bone	bone	NOUN	NN	O
biopsies	biopsy	NOUN	NNS	O
were	be	VERB	VBD	O
done	do	VERB	VBN	O
at	at	ADP	IN	O
baseline	baseline	NOUN	NN	O
,	,	PUNCT	,	O
60	60	NUM	CD	O
weeks	week	NOUN	NNS	O
after	after	ADP	IN	O
OCT	OCT	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
vehicle	vehicle	NOUN	NN	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
at	at	ADP	IN	O
the	the	DET	DT	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
crossover	crossover	NOUN	NN	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
Nx	Nx	PROPN	NNP	O
dogs	dog	NOUN	NNS	O
,	,	PUNCT	,	O
OCT	OCT	PROPN	NNP	B-Chemical
significantly	significantly	ADV	RB	O
decreased	decrease	VERB	VBD	O
serum	serum	ADJ	JJ	O
PTH	PTH	PROPN	NNP	O
levels	level	NOUN	NNS	O
soon	soon	ADV	RB	O
after	after	ADP	IN	O
the	the	DET	DT	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
insufficiency	insufficiency	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
long	long	ADV	RB	O
-	-	PUNCT	HYPH	O
standing	stand	VERB	VBG	O
secondary	secondary	ADJ	JJ	B-Disease
hyperparathyroidism	hyperparathyroidism	NOUN	NN	I-Disease
,	,	PUNCT	,	O
OCT	OCT	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
stabilized	stabilize	VERB	VBD	O
serum	serum	NOUN	NN	O
PTH	PTH	PROPN	NNP	O
levels	level	NOUN	NNS	O
during	during	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Serum	Serum	PROPN	NNP	O
PTH	PTH	PROPN	NNP	O
levels	level	NOUN	NNS	O
rose	rise	VERB	VBD	O
thereafter	thereafter	ADV	RB	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
rise	rise	NOUN	NN	O
was	be	VERB	VBD	O
less	less	ADV	RBR	O
pronounced	pronounce	VERB	VBN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
baseline	baseline	NOUN	NN	O
than	than	ADP	IN	O
the	the	DET	DT	O
rise	rise	NOUN	NN	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
Nx	Nx	PROPN	NNP	O
control	control	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
effects	effect	NOUN	NNS	O
were	be	VERB	VBD	O
accompanied	accompany	VERB	VBN	O
by	by	ADP	IN	O
episodes	episode	NOUN	NNS	O
of	of	ADP	IN	O
hypercalcemia	hypercalcemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
hyperphosphatemia	hyperphosphatemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
animals	animal	NOUN	NNS	O
with	with	ADP	IN	O
normal	normal	ADJ	JJ	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
,	,	PUNCT	,	O
OCT	OCT	PROPN	NNP	B-Chemical
induced	induce	VERB	VBD	O
a	a	DET	DT	O
transient	transient	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
serum	serum	ADJ	JJ	O
PTH	PTH	PROPN	NNP	O
levels	level	NOUN	NNS	O
at	at	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
sustained	sustain	VERB	VBN	O
with	with	ADP	IN	O
lowering	lower	VERB	VBG	O
of	of	ADP	IN	O
the	the	DET	DT	O
doses	dose	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
Nx	Nx	PROPN	NNP	O
dogs	dog	NOUN	NNS	O
,	,	PUNCT	,	O
OCT	OCT	PROPN	NNP	B-Chemical
reversed	reverse	VERB	VBD	O
abnormal	abnormal	ADJ	JJ	O
bone	bone	NOUN	NN	O
formation	formation	NOUN	NN	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
woven	weave	VERB	VBN	B-Disease
osteoid	osteoid	VERB	VB	I-Disease
and	and	CCONJ	CC	O
fibrosis	fibrosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
alter	alter	VERB	VB	O
the	the	DET	DT	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
bone	bone	NOUN	NN	O
turnover	turnover	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
OCT	OCT	PROPN	NNP	B-Chemical
improved	improve	VERB	VBD	O
mineralization	mineralization	NOUN	NN	O
lag	lag	NOUN	NN	O
time	time	NOUN	NN	O
,	,	PUNCT	,	O
(	(	PUNCT	-LRB-	O
that	that	ADV	RB	O
is	is	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
rate	rate	NOUN	NN	O
at	at	ADP	IN	O
which	which	DET	WDT	O
osteoid	osteoid	NOUN	NN	O
mineralizes	mineralize	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
both	both	DET	DT	O
Nx	Nx	PROPN	NNP	O
and	and	CCONJ	CC	O
Sham	Sham	PROPN	NNP	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
These	these	DET	DT	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
even	even	ADV	RB	O
though	though	ADP	IN	O
OCT	OCT	PROPN	NNP	B-Chemical
does	do	VERB	VBZ	O
not	not	ADV	RB	O
completely	completely	ADV	RB	O
prevent	prevent	VERB	VB	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
hypercalcemia	hypercalcemia	NOUN	NN	B-Disease
in	in	ADP	IN	O
experimental	experimental	ADJ	JJ	O
dogs	dog	NOUN	NNS	O
with	with	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
insufficiency	insufficiency	NOUN	NN	I-Disease
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
be	be	VERB	VB	O
of	of	ADP	IN	O
use	use	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
secondary	secondary	ADJ	JJ	B-Disease
hyperparathyroidism	hyperparathyroidism	NOUN	NN	I-Disease
because	because	ADP	IN	O
it	-PRON-	PRON	PRP	O
does	do	VERB	VBZ	O
not	not	ADV	RB	O
induce	induce	VERB	VB	O
low	low	ADJ	JJ	B-Disease
bone	bone	NOUN	NN	I-Disease
turnover	turnover	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
therefore	therefore	ADV	RB	O
,	,	PUNCT	,	O
does	do	VERB	VBZ	O
not	not	ADV	RB	O
increase	increase	VERB	VB	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
adynamic	adynamic	ADJ	JJ	B-Disease
bone	bone	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Hypotension	Hypotension	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
bradycardia	bradycardia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
asystole	asystole	ADV	RB	B-Disease
after	after	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
intravenous	intravenous	ADJ	JJ	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
in	in	ADP	IN	O
a	a	DET	DT	O
monitored	monitor	VERB	VBN	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
bradycardia	bradycardia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
asystole	asystole	ADV	RB	B-Disease
after	after	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
in	in	ADP	IN	O
a	a	DET	DT	O
73	73	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
underwent	undergo	VERB	VBD	O
electrocardiographic	electrocardiographic	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
ECG	ECG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
monitoring	monitor	VERB	VBG	O
throughout	throughout	ADP	IN	O
the	the	DET	DT	O
episode	episode	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
ischemic	ischemic	ADJ	JJ	B-Disease
cardiac	cardiac	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
9	9	NUM	CD	O
years	year	NOUN	NNS	O
earlier	earlier	ADV	RBR	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
admitted	admit	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
pulmonary	pulmonary	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
renal	renal	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
with	with	ADP	IN	O
hemoptysis	hemoptysis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
rapidly	rapidly	ADV	RB	O
progressive	progressive	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
hypoxemia	hypoxemia	NOUN	NN	B-Disease
that	that	DET	WDT	O
required	require	VERB	VBD	O
mechanical	mechanical	ADJ	JJ	O
ventilation	ventilation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
intensive	intensive	ADJ	JJ	O
care	care	NOUN	NN	O
unit	unit	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
receiving	receive	VERB	VBG	O
advanced	advanced	ADJ	JJ	O
cardiopulmonary	cardiopulmonary	ADJ	JJ	O
resuscitation	resuscitation	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
recovered	recover	VERB	VBD	O
cardiac	cardiac	ADJ	JJ	O
rhythm	rhythm	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
ECG	ECG	PROPN	NNP	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
junctional	junctional	ADJ	JJ	O
rhythm	rhythm	NOUN	NN	O
without	without	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmia	arrhythmia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
reviews	review	VERB	VBZ	O
the	the	DET	DT	O
current	current	ADJ	JJ	O
proposed	propose	VERB	VBN	O
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
sudden	sudden	ADJ	JJ	B-Disease
death	death	NOUN	NN	I-Disease
after	after	ADP	IN	O
a	a	DET	DT	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
IVMP	IVMP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
mechanisms	mechanism	NOUN	NNS	O
are	be	VERB	VBP	O
not	not	ADV	RB	O
well	well	ADV	RB	O
understood	understand	VERB	VBN	O
because	because	ADP	IN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
most	most	ADJ	JJS	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
monitored	monitor	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
moment	moment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
event	event	NOUN	NN	O
.	.	PUNCT	.	O

Rapid	rapid	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
and	and	CCONJ	CC	O
underlying	underlie	VERB	VBG	O
cardiac	cardiac	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
were	be	VERB	VBD	O
important	important	ADJ	JJ	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
case	case	NOUN	NN	O
reported	report	VERB	VBN	O
here	here	ADV	RB	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
authors	author	NOUN	NNS	O
discount	discount	VERB	VBP	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmia	arrhythmia	NOUN	NN	I-Disease
as	as	ADP	IN	O
the	the	DET	DT	O
main	main	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
.	.	PUNCT	.	O

Worsening	worsen	VERB	VBG	O
of	of	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
by	by	ADP	IN	O
motor	motor	NOUN	NN	O
and	and	CCONJ	CC	O
mental	mental	ADJ	JJ	O
tasks	task	NOUN	NNS	O
.	.	PUNCT	.	O

Ten	ten	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
with	with	ADP	IN	O
disabling	disable	VERB	VBG	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
were	be	VERB	VBD	O
included	include	VERB	VBN	O
in	in	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
mental	mental	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
mental	mental	ADJ	JJ	O
calculation	calculation	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
motor	motor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
flexion	flexion	NOUN	NN	O
/	/	SYM	SYM	O
extension	extension	NOUN	NN	O
of	of	ADP	IN	O
right	right	ADJ	JJ	O
fingers	finger	NOUN	NNS	O
,	,	PUNCT	,	O
flexion	flexion	NOUN	NN	O
/	/	SYM	SYM	O
extension	extension	NOUN	NN	O
of	of	ADP	IN	O
left	left	ADJ	JJ	O
fingers	finger	NOUN	NNS	O
,	,	PUNCT	,	O
flexion	flexion	NOUN	NN	O
/	/	SYM	SYM	O
extension	extension	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
neck	neck	NOUN	NN	O
,	,	PUNCT	,	O
speaking	speak	VERB	VBG	O
aloud	aloud	ADV	RB	O
)	)	PUNCT	-RRB-	O
tasks	task	NOUN	NNS	O
on	on	ADP	IN	O
the	the	DET	DT	O
worsening	worsening	NOUN	NN	O
of	of	ADP	IN	O
peak	peak	NOUN	NN	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
following	follow	VERB	VBG	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
score	score	NOUN	NN	O
at	at	ADP	IN	O
rest	rest	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
aggravation	aggravation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
dyskinesia	dyskinesia	ADJ	JJ	B-Disease
score	score	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
during	during	ADP	IN	O
speaking	speak	VERB	VBG	O
aloud	aloud	ADV	RB	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
movements	movement	NOUN	NNS	O
of	of	ADP	IN	O
right	right	NOUN	NN	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
left	leave	VERB	VBD	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
,	,	PUNCT	,	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
fingers	finger	NOUN	NNS	O
,	,	PUNCT	,	O
movements	movement	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
neck	neck	NOUN	NN	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
mental	mental	ADJ	JJ	O
calculation	calculation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
activation	activation	NOUN	NN	O
tasks	task	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
"	"	PUNCT	``	O
speaking	speak	VERB	VBG	O
aloud	aloud	ADV	RB	O
"	"	PUNCT	''	O
could	could	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
objective	objective	ADJ	JJ	O
assessment	assessment	NOUN	NN	O
of	of	ADP	IN	O
dyskinesia	dyskinesia	ADJ	JJ	B-Disease
severity	severity	NOUN	NN	O
.	.	PUNCT	.	O

Urine	Urine	PROPN	NNP	O
N	n	NOUN	NN	O
-	-	PUNCT	HYPH	O
acetyl	acetyl	NOUN	NN	O
-	-	PUNCT	HYPH	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
D	d	NOUN	NN	O
-	-	PUNCT	HYPH	O
glucosaminidase	glucosaminidase	NOUN	NN	O
-	-	PUNCT	HYPH	O
-	-	PUNCT	HYPH	O
a	a	DET	DT	O
marker	marker	NOUN	NN	O
of	of	ADP	IN	O
tubular	tubular	ADJ	JJ	O
damage	damage	NOUN	NN	O
?	?	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Although	although	ADP	IN	O
an	an	DET	DT	O
indicator	indicator	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
tubular	tubular	ADJ	JJ	I-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
,	,	PUNCT	,	O
an	an	DET	DT	O
increased	increased	ADJ	JJ	O
urinary	urinary	ADJ	JJ	O
N	n	NOUN	NN	O
-	-	PUNCT	HYPH	O
acetyl	acetyl	NOUN	NN	O
-	-	PUNCT	HYPH	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
D	d	NOUN	NN	O
-	-	PUNCT	HYPH	O
glucosaminidase	glucosaminidase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
NAG	NAG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
activity	activity	NOUN	NN	O
might	may	VERB	MD	O
reflect	reflect	VERB	VB	O
increased	increase	VERB	VBN	O
lysosomal	lysosomal	ADJ	JJ	O
activity	activity	NOUN	NN	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
tubular	tubular	ADJ	JJ	O
cells	cell	NOUN	NNS	O
.	.	PUNCT	.	O

METHODS	METHODS	PROPN	NNP	O
:	:	PUNCT	:	O
Puromycin	Puromycin	PROPN	NNP	B-Chemical
aminonucleoside	aminonucleoside	ADP	IN	I-Chemical
(	(	PUNCT	-LRB-	O
PAN	PAN	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
to	to	ADP	IN	O
Sprague	Sprague	PROPN	NNP	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
to	to	PART	TO	O
induce	induce	VERB	VB	O
proteinuria	proteinuria	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Total	total	ADJ	JJ	O
protein	protein	NOUN	NN	O
,	,	PUNCT	,	O
albumin	albumin	NOUN	NN	O
,	,	PUNCT	,	O
NAG	NAG	PROPN	NNP	O
activity	activity	NOUN	NN	O
and	and	CCONJ	CC	O
protein	protein	NOUN	NN	O
electrophoretic	electrophoretic	ADJ	JJ	O
pattern	pattern	NOUN	NN	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
in	in	ADP	IN	O
daily	daily	ADJ	JJ	O
urine	urine	NOUN	NN	O
samples	sample	NOUN	NNS	O
for	for	ADP	IN	O
33	33	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
morphological	morphological	ADJ	JJ	O
appearance	appearance	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
kidneys	kidney	NOUN	NNS	O
was	be	VERB	VBD	O
examined	examine	VERB	VBN	O
on	on	ADP	IN	O
days	day	NOUN	NNS	O
three	three	NUM	CD	O
,	,	PUNCT	,	O
four	four	NUM	CD	O
,	,	PUNCT	,	O
six	six	NUM	CD	O
,	,	PUNCT	,	O
eight	eight	NUM	CD	O
and	and	CCONJ	CC	O
thirty	thirty	NUM	CD	O
three	three	NUM	CD	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
NAG	NAG	PROPN	NNP	O
isoenzyme	isoenzyme	NOUN	NN	O
patterns	pattern	NOUN	NNS	O
on	on	ADP	IN	O
days	day	NOUN	NNS	O
zero	zero	NUM	CD	O
,	,	PUNCT	,	O
four	four	NUM	CD	O
,	,	PUNCT	,	O
eight	eight	NUM	CD	O
and	and	CCONJ	CC	O
thirty	thirty	NUM	CD	O
three	three	NUM	CD	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Following	follow	VERB	VBG	O
intravenous	intravenous	ADJ	JJ	O
PAN	PAN	PROPN	NNP	B-Chemical
urine	urine	NOUN	NN	O
volume	volume	NOUN	NN	O
and	and	CCONJ	CC	O
urine	urine	NOUN	NN	O
NAG	NAG	PROPN	NNP	O
activity	activity	NOUN	NN	O
increased	increase	VERB	VBD	O
significantly	significantly	ADV	RB	O
by	by	ADP	IN	O
day	day	NOUN	NN	O
two	two	NUM	CD	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
returned	return	VERB	VBD	O
to	to	ADP	IN	O
normal	normal	ADJ	JJ	O
by	by	ADP	IN	O
day	day	NOUN	NN	O
four	four	NUM	CD	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
day	day	NOUN	NN	O
four	four	NUM	CD	O
all	all	DET	DT	O
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
exhibited	exhibit	VERB	VBD	O
a	a	DET	DT	O
marked	marked	ADJ	JJ	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
urine	urine	NOUN	NN	O
albumin	albumin	NOUN	NN	O
,	,	PUNCT	,	O
total	total	ADJ	JJ	O
protein	protein	NOUN	NN	O
excretion	excretion	NOUN	NN	O
and	and	CCONJ	CC	O
NAG	NAG	PROPN	NNP	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Electrophoresis	electrophoresis	NOUN	NN	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
generalised	generalised	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
middle	middle	ADJ	JJ	O
and	and	CCONJ	CC	O
high	high	ADJ	JJ	O
molecular	molecular	ADJ	JJ	O
weight	weight	NOUN	NN	O
urine	urine	NOUN	NN	O
proteins	protein	NOUN	NNS	O
from	from	ADP	IN	O
day	day	NOUN	NN	O
four	four	NUM	CD	O
onwards	onwards	ADV	RB	O
.	.	PUNCT	.	O

Protein	protein	NOUN	NN	O
droplets	droplet	NOUN	NNS	O
first	first	ADV	RB	O
appeared	appear	VERB	VBD	O
prominent	prominent	ADJ	JJ	O
in	in	ADP	IN	O
tubular	tubular	ADJ	JJ	O
cells	cell	NOUN	NNS	O
on	on	ADP	IN	O
day	day	NOUN	NN	O
four	four	NUM	CD	O
.	.	PUNCT	.	O

Peak	peak	NOUN	NN	O
urine	urine	NOUN	NN	O
NAG	NAG	PROPN	NNP	O
activity	activity	NOUN	NN	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
NAG	NAG	PROPN	NNP	O
isoenzyme	isoenzyme	NOUN	NN	O
pattern	pattern	NOUN	NN	O
coincided	coincide	VERB	VBD	O
with	with	ADP	IN	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
peak	peak	NOUN	NN	O
proteinuria	proteinuria	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
the	the	DET	DT	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
intracellular	intracellular	ADJ	JJ	O
protein	protein	NOUN	NN	O
and	and	CCONJ	CC	O
NAG	NAG	PROPN	NNP	O
droplets	droplet	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
day	day	NOUN	NN	O
six	six	NUM	CD	O
onwards	onwards	ADV	RB	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
This	this	DET	DT	O
animal	animal	NOUN	NN	O
model	model	NOUN	NN	O
demonstrates	demonstrate	VERB	VBZ	O
that	that	ADP	IN	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
lysosomal	lysosomal	ADJ	JJ	O
turnover	turnover	NOUN	NN	O
and	and	CCONJ	CC	O
hence	hence	ADV	RB	O
urine	urine	NOUN	NN	O
NAG	NAG	PROPN	NNP	O
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
occurs	occur	VERB	VBZ	O
when	when	ADV	WRB	O
increased	increase	VERB	VBN	O
protein	protein	NOUN	NN	O
is	be	VERB	VBZ	O
presented	present	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
tubular	tubular	ADJ	JJ	O
cells	cell	NOUN	NNS	O
.	.	PUNCT	.	O

Urine	Urine	PROPN	NNP	O
NAG	NAG	PROPN	NNP	O
activity	activity	NOUN	NN	O
is	be	VERB	VBZ	O
thus	thus	ADV	RB	O
a	a	DET	DT	O
measure	measure	NOUN	NN	O
of	of	ADP	IN	O
altered	altered	ADJ	JJ	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
renal	renal	ADJ	JJ	O
tubules	tubule	NOUN	NNS	O
and	and	CCONJ	CC	O
not	not	ADV	RB	O
simply	simply	ADV	RB	O
an	an	DET	DT	O
indicator	indicator	NOUN	NN	O
of	of	ADP	IN	O
damage	damage	NOUN	NN	O
.	.	PUNCT	.	O

Cauda	Cauda	PROPN	NNP	B-Disease
equina	equina	VERB	VBD	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
after	after	ADP	IN	O
spinal	spinal	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
with	with	ADP	IN	O
hyperbaric	hyperbaric	ADJ	JJ	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
lignocaine	lignocaine	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
a	a	DET	DT	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
six	six	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
cauda	cauda	NOUN	NN	B-Disease
equina	equina	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
reported	report	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
Swedish	Swedish	PROPN	NNP	O
Pharmaceutical	Pharmaceutical	PROPN	NNP	O
Insurance	Insurance	PROPN	NNP	O
1993	1993	NUM	CD	O
-	-	SYM	SYM	O
1997	1997	NUM	CD	O
.	.	PUNCT	.	O

Six	six	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
cauda	cauda	NOUN	NN	B-Disease
equina	equina	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
with	with	ADP	IN	O
varying	vary	VERB	VBG	O
severity	severity	NOUN	NN	O
were	be	VERB	VBD	O
reported	report	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
Swedish	Swedish	PROPN	NNP	O
Pharmaceutical	Pharmaceutical	PROPN	NNP	O
Insurance	Insurance	PROPN	NNP	O
during	during	ADP	IN	O
the	the	DET	DT	O
period	period	NOUN	NN	O
1993	1993	NUM	CD	O
-	-	SYM	SYM	O
1997	1997	NUM	CD	O
.	.	PUNCT	.	O

All	all	DET	DT	O
were	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
spinal	spinal	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
using	use	VERB	VBG	O
hyperbaric	hyperbaric	ADJ	JJ	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
lignocaine	lignocaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Five	five	NUM	CD	O
cases	case	NOUN	NNS	O
had	have	VERB	VBD	O
single	single	ADJ	JJ	O
-	-	PUNCT	HYPH	O
shot	shot	NOUN	NN	O
spinal	spinal	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
and	and	CCONJ	CC	O
one	one	PRON	PRP	O
had	have	VERB	VBD	O
a	a	DET	DT	O
repeat	repeat	NOUN	NN	O
spinal	spinal	NOUN	NN	O
anaesthetic	anaesthetic	ADJ	JJ	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
inadequate	inadequate	ADJ	JJ	O
block	block	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
hyperbaric	hyperbaric	ADJ	JJ	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
lignocaine	lignocaine	NOUN	NN	B-Chemical
administered	administer	VERB	VBD	O
ranged	range	VERB	VBN	O
from	from	ADP	IN	O
60	60	NUM	CD	O
to	to	ADP	IN	O
120	120	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O

Three	three	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
cases	case	NOUN	NNS	O
were	be	VERB	VBD	O
most	most	ADV	RBS	O
likely	likely	ADV	RB	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
direct	direct	ADJ	JJ	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
hyperbaric	hyperbaric	ADJ	JJ	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
lignocaine	lignocaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
3	3	NUM	CD	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
direct	direct	ADJ	JJ	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
was	be	VERB	VBD	O
also	also	ADV	RB	O
probable	probable	ADJ	JJ	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
unfortunately	unfortunately	ADV	RB	O
radiological	radiological	ADJ	JJ	O
investigations	investigation	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
done	do	VERB	VBN	O
to	to	PART	TO	O
definitely	definitely	ADV	RB	O
exclude	exclude	VERB	VB	O
a	a	DET	DT	O
compressive	compressive	ADJ	JJ	O
aetiology	aetiology	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
cases	case	NOUN	NNS	O
sustained	sustain	VERB	VBD	O
permanent	permanent	ADJ	JJ	O
neurological	neurological	ADJ	JJ	B-Disease
deficits	deficit	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
recommend	recommend	VERB	VBP	O
that	that	DET	DT	O
hyperbaric	hyperbaric	ADJ	JJ	O
lignocaine	lignocaine	NOUN	NN	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
administered	administer	VERB	VBN	O
in	in	ADP	IN	O
concentrations	concentration	NOUN	NNS	O
not	not	ADV	RB	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
at	at	ADP	IN	O
a	a	DET	DT	O
total	total	ADJ	JJ	O
dose	dose	NOUN	NN	O
preferably	preferably	ADV	RB	O
not	not	ADV	RB	O
exceeding	exceed	VERB	VBG	O
60	60	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O

Systemic	systemic	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
following	follow	VERB	VBG	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
sirolimus	sirolimus	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
formerly	formerly	ADV	RB	O
rapamycin	rapamycin	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
psoriasis	psoriasis	NOUN	NN	B-Disease
:	:	PUNCT	:	O
association	association	NOUN	NN	O
of	of	ADP	IN	O
capillary	capillary	ADJ	JJ	B-Disease
leak	leak	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
with	with	ADP	IN	O
apoptosis	apoptosis	NOUN	NN	O
of	of	ADP	IN	O
lesional	lesional	ADJ	JJ	O
lymphocytes	lymphocyte	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Sirolimus	Sirolimus	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
formerly	formerly	ADV	RB	O
rapamycin	rapamycin	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
immunosuppressive	immunosuppressive	ADJ	JJ	O
agent	agent	NOUN	NN	O
that	that	DET	WDT	O
interferes	interfere	VERB	VBZ	O
with	with	ADP	IN	O
T	T	PROPN	NNP	O
-	-	PUNCT	HYPH	O
cell	cell	NOUN	NN	O
activation	activation	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
2	2	NUM	CD	O
individuals	individual	NOUN	NNS	O
with	with	ADP	IN	O
psoriasis	psoriasis	NOUN	NN	B-Disease
developed	develop	VERB	VBD	O
a	a	DET	DT	O
capillary	capillary	ADJ	JJ	B-Disease
leak	leak	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
oral	oral	ADJ	JJ	O
sirolimus	sirolimus	NOUN	NN	B-Chemical
lesional	lesional	ADJ	JJ	O
skin	skin	NOUN	NN	O
cells	cell	NOUN	NNS	O
and	and	CCONJ	CC	O
activated	activate	VERB	VBN	O
peripheral	peripheral	ADJ	JJ	O
blood	blood	NOUN	NN	O
cells	cell	NOUN	NNS	O
were	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
for	for	ADP	IN	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
apoptosis	apoptosis	NOUN	NN	O
.	.	PUNCT	.	O

OBSERVATIONS	observation	NOUN	NNS	O
:	:	PUNCT	:	O
A	a	DET	DT	O
keratome	keratome	NOUN	NN	O
skin	skin	NOUN	NN	O
specimen	speciman	NOUN	NNS	O
from	from	ADP	IN	O
1	1	NUM	CD	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
sirolimus	sirolimus	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
capillary	capillary	ADJ	JJ	B-Disease
leak	leak	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
had	have	VERB	VBD	O
a	a	DET	DT	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
-	-	PUNCT	:	O
fold	fold	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
percentage	percentage	NOUN	NN	O
of	of	ADP	IN	O
apoptotic	apoptotic	ADJ	JJ	O
cells	cell	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
to	to	ADP	IN	O
48	48	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
unaffected	unaffected	ADJ	JJ	O
sirolimus	sirolimus	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
psoriasis	psoriasis	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
21	21	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Activated	activate	VERB	VBN	O
peripheral	peripheral	ADJ	JJ	O
blood	blood	NOUN	NN	O
T	t	NOUN	NN	O
cells	cell	VERB	VBZ	O
from	from	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
psoriasis	psoriasis	NOUN	NN	B-Disease
tended	tend	VERB	VBD	O
to	to	PART	TO	O
exhibit	exhibit	VERB	VB	O
greater	great	ADJ	JJR	O
spontaneous	spontaneous	ADJ	JJ	O
or	or	CCONJ	CC	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
apoptosis	apoptosis	NOUN	NN	O
than	than	ADP	IN	O
did	do	VERB	VBD	O
normal	normal	ADJ	JJ	O
T	T	PROPN	NNP	O
cells	cell	NOUN	NNS	O
,	,	PUNCT	,	O
particularly	particularly	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
sirolimus	sirolimus	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Severe	severe	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
sirolimus	sirolimus	NOUN	NN	B-Chemical
include	include	VERB	VBP	O
fever	fever	NOUN	NN	B-Disease
,	,	PUNCT	,	O
anemia	anemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
capillary	capillary	ADJ	JJ	B-Disease
leak	leak	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

These	these	DET	DT	O
symptoms	symptom	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
the	the	DET	DT	O
result	result	NOUN	NN	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
apoptosis	apoptosis	NOUN	NN	O
of	of	ADP	IN	O
lesional	lesional	ADJ	JJ	O
leukocytes	leukocyte	NOUN	NNS	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
activated	activate	VERB	VBN	O
T	T	PROPN	NNP	O
lymphocytes	lymphocyte	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
possibly	possibly	ADV	RB	O
release	release	VERB	VB	O
of	of	ADP	IN	O
inflammatory	inflammatory	ADJ	JJ	O
mediators	mediator	NOUN	NNS	O
.	.	PUNCT	.	O

Because	because	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
psoriasis	psoriasis	NOUN	NN	B-Disease
may	may	VERB	MD	O
develop	develop	VERB	VB	O
capillary	capillary	ADJ	JJ	B-Disease
leak	leak	NOUN	NN	I-Disease
from	from	ADP	IN	O
various	various	ADJ	JJ	O
systemic	systemic	ADJ	JJ	O
therapies	therapy	NOUN	NNS	O
,	,	PUNCT	,	O
clinical	clinical	ADJ	JJ	O
monitoring	monitoring	NOUN	NN	O
is	be	VERB	VBZ	O
advisable	advisable	ADJ	JJ	O
for	for	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
inflammatory	inflammatory	ADJ	JJ	B-Disease
diseases	disease	NOUN	NNS	I-Disease
who	who	PRON	WP	O
are	be	VERB	VBP	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
immune	immune	ADJ	JJ	O
modulators	modulator	NOUN	NNS	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
maintenance	maintenance	NOUN	NN	O
therapy	therapy	NOUN	NN	O
on	on	ADP	IN	O
thyroid	thyroid	NOUN	NN	O
and	and	CCONJ	CC	O
parathyroid	parathyroid	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

OBJECTIVES	objectives	NOUN	NN	O
:	:	PUNCT	:	O
To	to	PART	TO	O
assess	assess	VERB	VB	O
changes	change	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
maintenance	maintenance	NOUN	NN	O
therapy	therapy	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
thyroid	thyroid	NOUN	NN	O
,	,	PUNCT	,	O
parathyroid	parathyroid	NOUN	NN	O
and	and	CCONJ	CC	O
ion	ion	NOUN	NN	O
alterations	alteration	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
with	with	ADP	IN	O
respect	respect	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
sex	sex	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
family	family	NOUN	NN	O
history	history	NOUN	NN	O
(	(	PUNCT	-LRB-	O
whether	whether	ADP	IN	O
or	or	CCONJ	CC	O
not	not	ADV	RB	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
a	a	DET	DT	O
first	first	ADJ	JJ	O
-	-	PUNCT	HYPH	O
degree	degree	NOUN	NN	O
relative	relative	NOUN	NN	O
with	with	ADP	IN	O
thyroid	thyroid	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
Prospective	prospective	ADJ	JJ	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

SETTING	set	VERB	VBG	O
:	:	PUNCT	:	O
Affective	Affective	PROPN	NNP	O
Disorders	Disorders	PROPN	NNPS	O
Clinic	Clinic	PROPN	NNP	O
at	at	ADP	IN	O
St	St	PROPN	NNP	O
.	.	PUNCT	.	O

Mary	Mary	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	PROPN	NNP	O
Hospital	Hospital	PROPN	NNP	O
,	,	PUNCT	,	O
Montreal	Montreal	PROPN	NNP	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
:	:	PUNCT	:	O
One	one	NUM	CD	O
hundred	hundred	NUM	CD	O
and	and	CCONJ	CC	O
one	one	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
28	28	NUM	CD	O
men	man	NOUN	NNS	O
and	and	CCONJ	CC	O
73	73	NUM	CD	O
women	woman	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
bipolar	bipolar	ADJ	JJ	B-Disease
disorder	disorder	NOUN	NN	I-Disease
receiving	receiving	NOUN	NN	O
lithium	lithium	NOUN	NN	B-Chemical
maintenance	maintenance	NOUN	NN	O
therapy	therapy	NOUN	NN	O
ranging	range	VERB	VBG	O
from	from	ADP	IN	O
1	1	NUM	CD	O
year	year	NOUN	NN	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
to	to	ADP	IN	O
32	32	NUM	CD	O
years	year	NOUN	NNS	O
'	'	PART	POS	O
duration	duration	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
consisted	consist	VERB	VBD	O
of	of	ADP	IN	O
82	82	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
no	no	DET	DT	O
psychiatric	psychiatric	ADJ	JJ	B-Disease
or	or	CCONJ	CC	O
endocrinological	endocrinological	ADJ	JJ	O
diagnoses	diagnosis	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
hospital	hospital	NOUN	NN	O
'	'	PUNCT	''	O
s	s	VERB	VBZ	O
out	out	ADV	RB	O
-	-	PUNCT	HYPH	O
patient	patient	ADJ	JJ	O
clinics	clinic	NOUN	NNS	O
.	.	PUNCT	.	O

OUTCOME	OUTCOME	PROPN	NNP	O
MEASURES	MEASURES	PROPN	NNP	O
:	:	PUNCT	:	O
Laboratory	laboratory	NOUN	NN	O
analyses	analysis	NOUN	NNS	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
magnesium	magnesium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
thyroid	thyroid	NOUN	NN	O
-	-	PUNCT	HYPH	O
stimulating	stimulate	VERB	VBG	O
hormone	hormone	NOUN	NN	O
levels	level	NOUN	NNS	O
performed	perform	VERB	VBN	O
before	before	ADP	IN	O
beginning	begin	VERB	VBG	O
lithium	lithium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
and	and	CCONJ	CC	O
at	at	ADP	IN	O
biannual	biannual	ADJ	JJ	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Hypothyroidism	hypothyroidism	NOUN	NN	B-Disease
developed	develop	VERB	VBD	O
in	in	ADP	IN	O
40	40	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
excluding	exclude	VERB	VBG	O
8	8	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
hypothyroid	hypothyroid	ADJ	JJ	B-Disease
at	at	ADP	IN	O
baseline	baseline	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
having	have	VERB	VBG	O
first	first	ADJ	JJ	O
-	-	PUNCT	HYPH	O
degree	degree	NOUN	NN	O
relatives	relative	NOUN	NNS	O
affected	affect	VERB	VBN	O
by	by	ADP	IN	O
thyroid	thyroid	NOUN	NN	B-Disease
illness	illness	NOUN	NN	I-Disease
had	have	VERB	VBD	O
accelerated	accelerate	VERB	VBN	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
hypothyroidism	hypothyroidism	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
years	year	NOUN	NNS	O
after	after	ADP	IN	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
)	)	PUNCT	-RRB-	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
patients	patient	NOUN	NNS	O
without	without	ADP	IN	O
a	a	DET	DT	O
family	family	NOUN	NN	O
history	history	NOUN	NN	O
(	(	PUNCT	-LRB-	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
years	year	NOUN	NNS	O
after	after	ADP	IN	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Women	woman	NOUN	NNS	O
over	over	ADP	IN	O
60	60	NUM	CD	O
years	year	NOUN	NNS	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
were	be	VERB	VBD	O
more	more	ADV	RBR	O
often	often	ADV	RB	O
affected	affect	VERB	VBN	O
by	by	ADP	IN	O
hypothyroidism	hypothyroidism	NOUN	NN	B-Disease
than	than	ADP	IN	O
women	woman	NOUN	NNS	O
under	under	ADP	IN	O
60	60	NUM	CD	O
years	year	NOUN	NNS	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
(	(	PUNCT	-LRB-	O
34	34	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
versus	versus	ADP	IN	O
31	31	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Magnesium	magnesium	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
on	on	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
were	be	VERB	VBD	O
unchanged	unchanged	ADJ	JJ	O
from	from	ADP	IN	O
baseline	baseline	NOUN	NN	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
calcium	calcium	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
higher	high	ADJ	JJR	O
than	than	ADP	IN	O
either	either	CCONJ	CC	O
baseline	baseline	NOUN	NN	O
levels	level	NOUN	NNS	O
or	or	CCONJ	CC	O
control	control	NOUN	NN	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
lithium	lithium	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
counteracted	counteract	VERB	VBD	O
the	the	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
plasma	plasma	NOUN	NN	O
calcium	calcium	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
aging	age	VERB	VBG	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Familial	familial	ADJ	JJ	O
thyroid	thyroid	NOUN	NN	B-Disease
illness	illness	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
risk	risk	NOUN	NN	O
factor	factor	NOUN	NN	O
for	for	ADP	IN	O
hypothyroidism	hypothyroidism	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
hypercalcemia	hypercalcemia	NOUN	NN	B-Disease
during	during	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Severe	severe	ADJ	JJ	O
immune	immune	ADJ	JJ	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
prophylactic	prophylactic	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
cefotetan	cefotetan	NOUN	NN	B-Chemical
in	in	ADP	IN	O
obstetric	obstetric	ADJ	JJ	O
and	and	CCONJ	CC	O
gynecologic	gynecologic	ADJ	JJ	O
procedures	procedure	NOUN	NNS	O
.	.	PUNCT	.	O

Second	second	ADJ	JJ	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
third	third	ADJ	JJ	O
-	-	PUNCT	HYPH	O
generation	generation	NOUN	NN	O
cephalosporins	cephalosporin	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
cefotetan	cefotetan	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
are	be	VERB	VBP	O
increasingly	increasingly	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
,	,	PUNCT	,	O
sometimes	sometimes	ADV	RB	O
fatal	fatal	ADJ	JJ	O
immune	immune	ADJ	JJ	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
noticed	notice	VERB	VBD	O
that	that	ADP	IN	O
10	10	NUM	CD	O
of	of	ADP	IN	O
our	-PRON-	DET	PRP$	O
35	35	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
cefotetan	cefotetan	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemias	anemia	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
received	receive	VERB	VBN	O
cefotetan	cefotetan	NOUN	NN	B-Chemical
prophylactically	prophylactically	ADV	RB	O
for	for	ADP	IN	O
obstetric	obstetric	ADJ	JJ	O
and	and	CCONJ	CC	O
gynecologic	gynecologic	ADJ	JJ	O
procedures	procedure	NOUN	NNS	O
.	.	PUNCT	.	O

Eight	eight	NUM	CD	O
of	of	ADP	IN	O
these	these	DET	DT	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
immune	immune	ADJ	JJ	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
are	be	VERB	VBP	O
described	describe	VERB	VBN	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
nonsteroidal	nonsteroidal	ADJ	JJ	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
on	on	ADP	IN	O
hemostasis	hemostasis	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
aneurysmal	aneurysmal	ADJ	JJ	B-Disease
subarachnoid	subarachnoid	NOUN	NN	I-Disease
hemorrhage	hemorrhage	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Platelet	platelet	ADJ	JJ	O
function	function	NOUN	NN	O
is	be	VERB	VBZ	O
impaired	impair	VERB	VBN	O
by	by	ADP	IN	O
nonsteroidal	nonsteroidal	ADJ	JJ	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
NSAIDs	nsaid	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
prominent	prominent	ADJ	JJ	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
properties	property	NOUN	NNS	O
.	.	PUNCT	.	O

Their	-PRON-	DET	PRP$	O
safety	safety	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
intracranial	intracranial	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
is	be	VERB	VBZ	O
under	under	ADP	IN	O
debate	debate	NOUN	NN	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
aneurysmal	aneurysmal	ADJ	JJ	B-Disease
subarachnoid	subarachnoid	NOUN	NN	I-Disease
hemorrhage	hemorrhage	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
SAH	SAH	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
randomized	randomize	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
either	either	CCONJ	CC	O
ketoprofen	ketoprofen	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
,	,	PUNCT	,	O
three	three	NUM	CD	O
times	time	NOUN	NNS	O
a	a	DET	DT	O
day	day	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ketoprofen	ketoprofen	PROPN	NNP	B-Chemical
group	group	NOUN	NN	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
a	a	DET	DT	O
weak	weak	ADJ	JJ	O
NSAID	NSAID	PROPN	NNP	O
,	,	PUNCT	,	O
acetaminophen	acetaminophen	ADV	RB	B-Chemical
,	,	PUNCT	,	O
1	1	NUM	CD	O
g	g	NOUN	NN	O
,	,	PUNCT	,	O
three	three	NUM	CD	O
times	time	NOUN	NNS	O
a	a	DET	DT	O
day	day	NOUN	NN	O
(	(	PUNCT	-LRB-	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
starting	start	VERB	VBG	O
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
the	the	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
aneurysmal	aneurysmal	ADJ	JJ	B-Disease
SAH	SAH	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
was	be	VERB	VBD	O
continued	continue	VERB	VBN	O
for	for	ADP	IN	O
3	3	NUM	CD	O
days	day	NOUN	NNS	O
postoperatively	postoperatively	ADV	RB	O
.	.	PUNCT	.	O

Test	test	NOUN	NN	O
blood	blood	NOUN	NN	O
samples	sample	NOUN	NNS	O
were	be	VERB	VBD	O
taken	take	VERB	VBN	O
before	before	ADP	IN	O
treatment	treatment	NOUN	NN	O
and	and	CCONJ	CC	O
surgery	surgery	NOUN	NN	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
on	on	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
,	,	PUNCT	,	O
third	third	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
fifth	fifth	ADJ	JJ	O
postoperative	postoperative	ADJ	JJ	O
mornings	morning	NOUN	NNS	O
.	.	PUNCT	.	O

Maximal	maximal	ADJ	JJ	O
platelet	platelet	NOUN	NN	B-Disease
aggregation	aggregation	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
6	6	NUM	CD	O
microM	microM	PROPN	NNP	O
of	of	ADP	IN	O
adenosine	adenosine	NOUN	NN	B-Chemical
diphosphate	diphosphate	NOUN	NN	I-Chemical
decreased	decrease	VERB	VBD	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
ketoprofen	ketoprofen	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Aggregation	aggregation	NOUN	NN	O
was	be	VERB	VBD	O
lower	low	ADJ	JJR	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
ketoprofen	ketoprofen	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
just	just	ADV	RB	O
before	before	ADP	IN	O
surgery	surgery	NOUN	NN	O
and	and	CCONJ	CC	O
on	on	ADP	IN	O
the	the	DET	DT	O
third	third	ADJ	JJ	O
postoperative	postoperative	ADJ	JJ	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
maximal	maximal	ADJ	JJ	O
platelet	platelet	NOUN	NN	B-Disease
aggregation	aggregation	NOUN	NN	I-Disease
increased	increase	VERB	VBD	O
in	in	ADP	IN	O
the	the	DET	DT	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
third	third	ADJ	JJ	O
postoperative	postoperative	ADJ	JJ	O
day	day	NOUN	NN	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
pretreatment	pretreatment	ADJ	JJ	O
platelet	platelet	NOUN	NN	B-Disease
aggregation	aggregation	NOUN	NN	I-Disease
results	result	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
patient	patient	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ketoprofen	ketoprofen	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
developed	develop	VERB	VBD	O
a	a	DET	DT	O
postoperative	postoperative	ADJ	JJ	O
intracranial	intracranial	ADJ	JJ	O
hematoma	hematoma	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Coagulation	coagulation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
prothrombin	prothrombin	NOUN	NN	O
time	time	NOUN	NN	O
[	[	PUNCT	-LRB-	O
PT	PT	PROPN	NNP	O
]	]	PUNCT	-RRB-	O
,	,	PUNCT	,	O
activated	activate	VERB	VBD	O
partial	partial	ADJ	JJ	O
thromboplastin	thromboplastin	NOUN	NN	O
time	time	NOUN	NN	O
[	[	PUNCT	-LRB-	O
APPT	APPT	PROPN	NNP	O
]	]	PUNCT	-RRB-	O
,	,	PUNCT	,	O
fibrinogen	fibrinogen	NOUN	NN	O
concentration	concentration	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
antithrombin	antithrombin	NOUN	NN	O
III	III	PROPN	NNP	O
[	[	PUNCT	-LRB-	O
AT	at	ADP	IN	O
III	III	PROPN	NNP	O
]	]	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
comparable	comparable	ADJ	JJ	O
between	between	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Ketoprofen	Ketoprofen	PROPN	NNP	B-Chemical
but	but	CCONJ	CC	O
not	not	ADV	RB	O
acetaminophen	acetaminophen	ADV	RB	B-Chemical
impaired	impair	VERB	VBN	O
platelet	platelet	NOUN	NN	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
SAH	SAH	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

If	if	ADP	IN	O
ketoprofen	ketoprofen	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
used	use	VERB	VBN	O
before	before	ADP	IN	O
surgery	surgery	NOUN	NN	O
on	on	ADP	IN	O
cerebral	cerebral	ADJ	JJ	O
artery	artery	NOUN	NN	B-Disease
aneurysms	aneurysm	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
pose	pose	VERB	VB	O
an	an	DET	DT	O
additional	additional	ADJ	JJ	O
risk	risk	NOUN	NN	O
factor	factor	NOUN	NN	O
for	for	ADP	IN	O
hemorrhage	hemorrhage	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
synthase	synthase	NOUN	NN	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
lead	lead	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
recently	recently	ADV	RB	O
showed	show	VERB	VBD	O
elevated	elevated	ADJ	JJ	O
reactive	reactive	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
species	specie	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
ROS	ROS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
reduced	reduce	VERB	VBD	O
urinary	urinary	ADJ	JJ	O
excretion	excretion	NOUN	NN	O
of	of	ADP	IN	O
NO	no	DET	DT	B-Chemical
metabolites	metabolite	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
NOx	NOx	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBD	O
NO	no	DET	DT	B-Chemical
sequestration	sequestration	NOUN	NN	O
as	as	ADP	IN	O
nitrotyrosine	nitrotyrosine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
various	various	ADJ	JJ	O
tissues	tissue	NOUN	NNS	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
lead	lead	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
designed	design	VERB	VBN	O
to	to	PART	TO	O
discern	discern	VERB	VB	O
whether	whether	ADP	IN	O
the	the	DET	DT	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
urinary	urinary	ADJ	JJ	O
NOx	NOx	NOUN	NNS	O
in	in	ADP	IN	O
lead	lead	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypertension	hypertension	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
part	part	NOUN	NN	O
,	,	PUNCT	,	O
due	due	ADP	IN	O
to	to	ADP	IN	O
depressed	depressed	ADJ	JJ	O
NO	no	DET	DT	B-Chemical
synthase	synthase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
NOS	NOS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

Male	Male	PROPN	NNP	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
assigned	assign	VERB	VBN	O
to	to	ADP	IN	O
a	a	DET	DT	O
lead	lead	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
given	give	VERB	VBN	O
lead	lead	NOUN	NN	B-Chemical
acetate	acetate	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
100	100	NUM	CD	O
ppm	ppm	NOUN	NNS	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
drinking	drinking	NOUN	NN	O
water	water	NOUN	NN	O
and	and	CCONJ	CC	O
regular	regular	ADJ	JJ	O
rat	rat	NOUN	NN	O
chow	chow	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
group	group	NOUN	NN	O
given	give	VERB	VBN	O
lead	lead	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
vitamin	vitamin	NOUN	NN	B-Chemical
E	e	NOUN	NN	I-Chemical
-	-	ADJ	JJ	O
fortified	fortified	ADJ	JJ	O
chow	chow	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
a	a	DET	DT	O
normal	normal	ADJ	JJ	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
given	give	VERB	VBN	O
either	either	CCONJ	CC	O
regular	regular	ADJ	JJ	O
food	food	NOUN	NN	O
and	and	CCONJ	CC	O
water	water	NOUN	NN	O
or	or	CCONJ	CC	O
vitamin	vitamin	NOUN	NN	B-Chemical
E	e	NOUN	NN	I-Chemical
-	-	ADJ	JJ	O
fortified	fortify	VERB	VBN	O
food	food	NOUN	NN	O
for	for	ADP	IN	O
12	12	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

Tail	tail	NOUN	NN	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
,	,	PUNCT	,	O
urinary	urinary	ADJ	JJ	O
NOx	NOx	NOUN	NNS	O
excretion	excretion	NOUN	NN	O
,	,	PUNCT	,	O
plasma	plasma	NOUN	NN	O
malondialdehyde	malondialdehyde	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
MDA	MDA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
endothelial	endothelial	ADJ	JJ	O
and	and	CCONJ	CC	O
inducible	inducible	ADJ	JJ	O
NOS	NOS	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
eNOS	eNOS	PROPN	NNP	O
and	and	CCONJ	CC	O
iNOS	iNOS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
isotypes	isotype	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
aorta	aorta	NOUN	NNS	O
and	and	CCONJ	CC	O
kidney	kidney	NOUN	NN	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
lead	lead	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
group	group	NOUN	NN	O
exhibited	exhibit	VERB	VBD	O
a	a	DET	DT	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
plasma	plasma	VERB	VB	O
MDA	MDA	PROPN	NNP	B-Chemical
concentration	concentration	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
fall	fall	NOUN	NN	O
in	in	ADP	IN	O
urinary	urinary	ADJ	JJ	O
NOx	NOx	NOUN	NNS	O
excretion	excretion	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
paradoxical	paradoxical	ADJ	JJ	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
vascular	vascular	ADJ	JJ	O
and	and	CCONJ	CC	O
renal	renal	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
eNOS	eNOS	PROPN	NNP	O
and	and	CCONJ	CC	O
iNOS	iNOS	PROPN	NNP	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

Vitamin	vitamin	NOUN	NN	B-Chemical
E	e	NOUN	NN	I-Chemical
supplementation	supplementation	NOUN	NN	O
ameliorated	ameliorate	VERB	VBD	O
hypertension	hypertension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
lowered	lower	VERB	VBN	O
plasma	plasma	NOUN	NN	O
MDA	MDA	PROPN	NNP	B-Chemical
concentration	concentration	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
raised	raise	VERB	VBD	O
urinary	urinary	ADJ	JJ	O
NOx	NOx	NOUN	NNS	O
excretion	excretion	NOUN	NN	O
while	while	ADP	IN	O
significantly	significantly	ADV	RB	O
lowering	lower	VERB	VBG	O
vascular	vascular	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
renal	renal	ADJ	JJ	O
,	,	PUNCT	,	O
tissue	tissue	VERB	VB	O
eNOS	eNOS	PROPN	NNP	O
and	and	CCONJ	CC	O
iNOS	iNOS	PROPN	NNP	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

Vitamin	vitamin	NOUN	NN	B-Chemical
E	e	NOUN	NN	I-Chemical
supplementation	supplementation	NOUN	NN	O
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
either	either	DET	DT	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
,	,	PUNCT	,	O
plasma	plasma	VERB	VB	O
MDA	MDA	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
NOS	NOS	PROPN	NNP	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
study	study	NOUN	NN	O
also	also	ADV	RB	O
revealed	reveal	VERB	VBD	O
significant	significant	ADJ	JJ	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
NOS	NOS	PROPN	NNP	O
enzymatic	enzymatic	ADJ	JJ	O
activity	activity	NOUN	NN	O
by	by	ADP	IN	O
lead	lead	NOUN	NN	B-Chemical
in	in	ADP	IN	O
cell	cell	NOUN	NN	O
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
preparations	preparation	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
lead	lead	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
in	in	ADP	IN	O
this	this	DET	DT	O
model	model	NOUN	NN	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
compensatory	compensatory	ADJ	JJ	O
upregulation	upregulation	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
and	and	CCONJ	CC	O
vascular	vascular	ADJ	JJ	O
eNOS	eNOS	PROPN	NNP	O
and	and	CCONJ	CC	O
iNOS	iNOS	PROPN	NNP	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
part	part	NOUN	NN	O
,	,	PUNCT	,	O
due	due	ADP	IN	O
to	to	ADP	IN	O
ROS	ROS	PROPN	NNP	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
NO	no	DET	DT	B-Chemical
inactivation	inactivation	NOUN	NN	O
,	,	PUNCT	,	O
lead	lead	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
NOS	NOS	PROPN	NNP	O
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
perhaps	perhaps	ADV	RB	O
stimulatory	stimulatory	ADJ	JJ	O
actions	action	NOUN	NNS	O
of	of	ADP	IN	O
increased	increase	VERB	VBN	O
shear	shear	ADJ	JJ	O
stress	stress	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Glyceryl	glyceryl	NOUN	NN	B-Chemical
trinitrate	trinitrate	NOUN	NN	I-Chemical
induces	induce	VERB	VBZ	O
attacks	attack	NOUN	NNS	O
of	of	ADP	IN	O
migraine	migraine	NOUN	NN	B-Disease
without	without	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
in	in	ADP	IN	O
sufferers	sufferer	NOUN	NNS	O
of	of	ADP	IN	O
migraine	migraine	NOUN	NN	B-Disease
with	with	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Migraine	migraine	NOUN	NN	B-Disease
with	with	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
migraine	migraine	NOUN	NN	B-Disease
without	without	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
have	have	VERB	VBP	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
pain	pain	NOUN	NN	B-Disease
phase	phase	NOUN	NN	O
,	,	PUNCT	,	O
thus	thus	ADV	RB	O
indicating	indicate	VERB	VBG	O
that	that	DET	DT	O
migraine	migraine	NOUN	NN	B-Disease
with	with	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
migraine	migraine	NOUN	NN	B-Disease
without	without	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
share	share	VERB	VB	O
a	a	DET	DT	O
common	common	ADJ	JJ	O
pathway	pathway	NOUN	NN	O
of	of	ADP	IN	O
nociception	nociception	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
recent	recent	ADJ	JJ	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
increasing	increase	VERB	VBG	O
evidence	evidence	NOUN	NN	O
has	have	VERB	VBZ	O
suggested	suggest	VERB	VBN	O
that	that	ADP	IN	O
the	the	DET	DT	O
messenger	messenger	NOUN	NN	O
molecule	molecule	NOUN	NN	O
nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NO	no	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
migraine	migraine	NOUN	NN	B-Disease
without	without	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
clarify	clarify	VERB	VB	O
whether	whether	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
is	be	VERB	VBZ	O
true	true	ADJ	JJ	O
for	for	ADP	IN	O
migraine	migraine	NOUN	NN	B-Disease
with	with	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
we	-PRON-	PRON	PRP	O
examined	examine	VERB	VBD	O
the	the	DET	DT	O
headache	headache	NOUN	NN	B-Disease
response	response	NOUN	NN	O
to	to	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
glyceryl	glyceryl	NOUN	NN	B-Chemical
trinitrate	trinitrate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
GTN	GTN	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
for	for	ADP	IN	O
20	20	NUM	CD	O
min	min	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
12	12	NUM	CD	O
sufferers	sufferer	NOUN	NNS	O
of	of	ADP	IN	O
migraine	migraine	NOUN	NN	B-Disease
with	with	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
specific	specific	ADJ	JJ	O
aim	aim	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
elucidate	elucidate	VERB	VB	O
whether	whether	ADP	IN	O
an	an	DET	DT	O
aura	aura	NOUN	NN	O
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
an	an	DET	DT	O
attack	attack	NOUN	NN	O
of	of	ADP	IN	O
migraine	migraine	NOUN	NN	B-Disease
without	without	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
could	could	VERB	MD	O
be	be	VERB	VB	O
induced	induce	VERB	VBN	O
.	.	PUNCT	.	O

Fourteen	fourteen	NUM	CD	O
healthy	healthy	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
served	serve	VERB	VBD	O
as	as	ADP	IN	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

Aura	aura	NOUN	NN	O
symptoms	symptom	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
elicited	elicit	VERB	VBN	O
in	in	ADP	IN	O
any	any	DET	DT	O
subject	subject	NOUN	NN	O
.	.	PUNCT	.	O

Headache	Headache	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
more	more	ADV	RBR	O
severe	severe	ADJ	JJ	O
in	in	ADP	IN	O
migraineurs	migraineur	NOUN	NNS	B-Disease
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
controls	control	NOUN	NNS	O
during	during	ADP	IN	O
and	and	CCONJ	CC	O
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
GTN	GTN	PROPN	NNP	B-Chemical
infusion	infusion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
037	037	NUM	CD	O
)	)	PUNCT	-RRB-	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
during	during	ADP	IN	O
the	the	DET	DT	O
following	follow	VERB	VBG	O
11	11	NUM	CD	O
h	h	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
008	008	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
controls	control	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
GTN	GTN	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
headache	headache	NOUN	NN	B-Disease
gradually	gradually	ADV	RB	O
disappeared	disappear	VERB	VBD	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
in	in	ADP	IN	O
migraineurs	migraineur	NOUN	NNS	B-Disease
peak	peak	NOUN	NN	O
headache	headache	NOUN	NN	B-Disease
intensity	intensity	NOUN	NN	O
occurred	occur	VERB	VBD	O
at	at	ADP	IN	O
a	a	DET	DT	O
mean	mean	ADJ	JJ	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
240	240	NUM	CD	O
min	min	NOUN	NN	O
post	post	ADJ	JJ	O
-	-	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
this	this	DET	DT	O
time	time	NOUN	NN	O
the	the	DET	DT	O
induced	induced	ADJ	JJ	O
headache	headache	NOUN	NN	B-Disease
in	in	ADP	IN	O
6	6	NUM	CD	O
of	of	ADP	IN	O
12	12	NUM	CD	O
migraineurs	migraineur	NOUN	NNS	B-Disease
fulfilled	fulfil	VERB	VBD	O
the	the	DET	DT	O
diagnostic	diagnostic	ADJ	JJ	O
criteria	criterion	NOUN	NNS	O
for	for	ADP	IN	O
migraine	migraine	NOUN	NN	B-Disease
without	without	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
International	International	PROPN	NNP	O
Headache	Headache	PROPN	NNP	B-Disease
Society	Society	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
therefore	therefore	ADV	RB	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
NO	no	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pain	pain	NOUN	NN	B-Disease
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
migraine	migraine	NOUN	NN	B-Disease
with	with	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Since	since	ADP	IN	O
cortical	cortical	ADJ	JJ	O
spreading	spread	VERB	VBG	O
depression	depression	NOUN	NN	B-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
shown	show	VERB	VBN	O
to	to	PART	TO	O
liberate	liberate	VERB	VB	O
NO	NO	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
animals	animal	NOUN	NNS	O
,	,	PUNCT	,	O
this	this	DET	DT	O
finding	finding	NOUN	NN	O
may	may	VERB	MD	O
help	help	VERB	VB	O
our	-PRON-	DET	PRP$	O
understanding	understanding	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
coupling	coupling	NOUN	NN	O
between	between	ADP	IN	O
cortical	cortical	NOUN	NN	O
spreading	spread	VERB	VBG	O
depression	depression	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
headache	headache	NOUN	NN	B-Disease
in	in	ADP	IN	O
migraine	migraine	NOUN	NN	B-Disease
with	with	ADP	IN	I-Disease
aura	aura	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Rapid	rapid	ADJ	JJ	O
reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
threatening	threaten	VERB	VBG	O
diltiazem	diltiazem	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
tetany	tetany	NOUN	NN	B-Disease
with	with	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
tetany	tetany	ADJ	JJ	B-Disease
with	with	ADP	IN	O
sudden	sudden	ADJ	JJ	O
respiratory	respiratory	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
after	after	ADP	IN	O
the	the	DET	DT	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
diltiazem	diltiazem	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
rapidly	rapidly	ADV	RB	O
resolved	resolve	VERB	VBD	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	VERB	VBZ	O
tetany	tetany	ADJ	JJ	B-Disease
with	with	ADP	IN	O
prompt	prompt	ADJ	JJ	O
recovery	recovery	NOUN	NN	O
of	of	ADP	IN	O
respiratory	respiratory	ADJ	JJ	O
function	function	NOUN	NN	O
,	,	PUNCT	,	O
averting	avert	VERB	VBG	O
the	the	DET	DT	O
need	need	NOUN	NN	O
for	for	ADP	IN	O
more	more	ADV	RBR	O
aggressive	aggressive	ADJ	JJ	O
airway	airway	NOUN	NN	O
management	management	NOUN	NN	O
and	and	CCONJ	CC	O
ventilatory	ventilatory	NOUN	NN	O
support	support	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
emergency	emergency	NOUN	NN	O
physician	physician	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
that	that	ADP	IN	O
life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
threatening	threaten	VERB	VBG	O
tetany	tetany	NOUN	NN	B-Disease
may	may	VERB	MD	O
accompany	accompany	VERB	VB	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
diltiazem	diltiazem	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
that	that	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
rapid	rapid	ADJ	JJ	O
and	and	CCONJ	CC	O
effective	effective	ADJ	JJ	O
remedy	remedy	NOUN	NN	O
.	.	PUNCT	.	O

Predictors	predictor	NOUN	NNS	O
of	of	ADP	IN	O
decreased	decrease	VERB	VBN	B-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
during	during	ADP	IN	O
angiotensin	angiotensin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
converting	convert	VERB	VBG	O
enzyme	enzyme	ADJ	JJ	O
inhibitor	inhibitor	NOUN	NN	O
therapy	therapy	NOUN	NN	O
:	:	PUNCT	:	O
results	result	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
studies	study	NOUN	NNS	O
of	of	ADP	IN	O
left	left	ADJ	JJ	B-Disease
ventricular	ventricular	ADJ	JJ	I-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
SOLVD	SOLVD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Although	although	ADP	IN	O
angiotensin	angiotensin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
converting	convert	VERB	VBG	O
enzyme	enzyme	ADJ	JJ	O
inhibitor	inhibitor	NOUN	NN	O
therapy	therapy	NOUN	NN	O
reduces	reduce	VERB	VBZ	O
mortality	mortality	NOUN	NN	O
rates	rate	NOUN	NNS	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
congestive	congestive	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
CHF	CHF	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
also	also	ADV	RB	O
cause	cause	VERB	VB	O
decreased	decrease	VERB	VBN	B-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Little	little	ADJ	JJ	O
information	information	NOUN	NN	O
is	be	VERB	VBZ	O
available	available	ADJ	JJ	O
to	to	PART	TO	O
predict	predict	VERB	VB	O
which	which	DET	WDT	O
patients	patient	NOUN	NNS	O
are	be	VERB	VBP	O
at	at	ADP	IN	O
highest	high	ADJ	JJS	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
this	this	DET	DT	O
complication	complication	NOUN	NN	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
quantify	quantify	VERB	VB	O
specific	specific	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
predictors	predictor	NOUN	NNS	O
of	of	ADP	IN	O
reduction	reduction	NOUN	NN	B-Disease
in	in	ADP	IN	I-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
CHF	CHF	PROPN	NNP	B-Disease
who	who	PRON	WP	O
are	be	VERB	VBP	O
prescribed	prescribe	VERB	VBN	O
angiotensin	angiotensin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
converting	convert	VERB	VBG	O
enzyme	enzyme	ADJ	JJ	O
inhibitor	inhibitor	NOUN	NN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

METHOD	method	NOUN	NN	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
analyzed	analyze	VERB	VBD	O
data	datum	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
Studies	Studies	PROPN	NNPS	O
of	of	ADP	IN	O
Left	Left	PROPN	NNP	B-Disease
Ventricular	Ventricular	PROPN	NNP	I-Disease
Dysfunction	Dysfunction	PROPN	NNP	I-Disease
(	(	PUNCT	-LRB-	O
SOLVD	SOLVD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
enalapril	enalapril	NOUN	NN	B-Chemical
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
CHF	CHF	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
3379	3379	NUM	CD	O
patients	patient	NOUN	NNS	O
randomly	randomly	ADV	RB	O
assigned	assign	VERB	VBN	O
to	to	PART	TO	O
enalapril	enalapril	VERB	VB	B-Chemical
with	with	ADP	IN	O
a	a	DET	DT	O
median	median	ADJ	JJ	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
of	of	ADP	IN	O
974	974	NUM	CD	O
days	day	NOUN	NNS	O
and	and	CCONJ	CC	O
3379	3379	NUM	CD	O
patients	patient	NOUN	NNS	O
randomly	randomly	ADV	RB	O
assigned	assign	VERB	VBN	O
to	to	PART	TO	O
placebo	placebo	VERB	VB	O
with	with	ADP	IN	O
a	a	DET	DT	O
mean	mean	ADJ	JJ	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
of	of	ADP	IN	O
967	967	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Decreased	decrease	VERB	VBN	B-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
was	be	VERB	VBD	O
defined	define	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
>	>	X	XX	O
/	/	SYM	SYM	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
dL	dl	NOUN	NN	O
(	(	PUNCT	-LRB-	O
44	44	NUM	CD	O
micromol	micromol	NOUN	NN	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
)	)	PUNCT	-RRB-	O
from	from	ADP	IN	O
baseline	baseline	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
used	use	VERB	VBD	O
time	time	NOUN	NN	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
event	event	NOUN	NN	O
analysis	analysis	NOUN	NN	O
to	to	PART	TO	O
identify	identify	VERB	VB	O
potential	potential	ADJ	JJ	O
predictors	predictor	NOUN	NNS	O
of	of	ADP	IN	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
including	include	VERB	VBG	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
baseline	baseline	NOUN	NN	O
ejection	ejection	NOUN	NN	O
fraction	fraction	NOUN	NN	O
,	,	PUNCT	,	O
baseline	baseline	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
low	low	ADJ	JJ	O
systolic	systolic	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
(	(	PUNCT	-LRB-	O
<	<	X	XX	O
100	100	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
hypertension	hypertension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
diabetes	diabetes	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
antiplatelet	antiplatelet	NOUN	NN	O
,	,	PUNCT	,	O
diuretic	diuretic	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
blocker	blocker	NOUN	NN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Patients	patient	NOUN	NNS	O
randomly	randomly	ADV	RB	O
assigned	assign	VERB	VBD	O
to	to	PART	TO	O
enalapril	enalapril	VERB	VB	B-Chemical
had	have	VERB	VBD	O
a	a	DET	DT	O
33	33	NUM	CD	O
%	%	NOUN	NN	O
greater	great	ADJ	JJR	O
likelihood	likelihood	NOUN	NN	O
of	of	ADP	IN	O
decreased	decrease	VERB	VBN	B-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
than	than	ADP	IN	O
controls	control	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	X	XX	O
.	.	PUNCT	.	O
003	003	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

By	by	ADP	IN	O
multivariate	multivariate	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
and	and	CCONJ	CC	O
enalapril	enalapril	ADJ	JJ	B-Chemical
groups	group	NOUN	NNS	O
older	old	ADJ	JJR	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
diuretic	diuretic	ADJ	JJ	B-Chemical
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
diabetes	diabete	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
decreased	decrease	VERB	VBN	B-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
blocker	blocker	NOUN	NN	O
therapy	therapy	NOUN	NN	O
and	and	CCONJ	CC	O
higher	high	ADJ	JJR	O
ejection	ejection	NOUN	NN	O
fraction	fraction	NOUN	NN	O
were	be	VERB	VBD	O
renoprotective	renoprotective	ADJ	JJ	O
.	.	PUNCT	.	O

Older	old	ADJ	JJR	O
age	age	NOUN	NN	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
greater	great	ADJ	JJR	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
developing	develop	VERB	VBG	O
decreased	decrease	VERB	VBN	B-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
significantly	significantly	ADV	RB	O
more	more	ADV	RBR	O
so	so	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
enalapril	enalapril	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
enalapril	enalapril	VERB	VB	B-Chemical
:	:	PUNCT	:	O
risk	risk	NOUN	NN	O
ratio	ratio	NOUN	NN	O
[	[	PUNCT	-LRB-	O
RR	RR	PROPN	NNP	O
]	]	PUNCT	-RRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
42	42	NUM	CD	O
per	per	ADP	IN	O
10	10	NUM	CD	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
[	[	PUNCT	-LRB-	O
CI	CI	PROPN	NNP	O
]	]	PUNCT	-RRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
32	32	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
52	52	NUM	CD	O
with	with	ADP	IN	O
enalapril	enalapril	NOUN	NN	B-Chemical
;	;	PUNCT	:	O
placebo	placebo	NOUN	NN	O
:	:	PUNCT	:	O
RR	RR	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
18	18	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
12	12	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Diuretic	diuretic	ADJ	JJ	B-Chemical
therapy	therapy	NOUN	NN	O
was	be	VERB	VBD	O
likewise	likewise	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
greater	great	ADJ	JJR	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
decreased	decrease	VERB	VBN	B-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
enalapril	enalapril	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
RR	RR	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
89	89	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
70	70	NUM	CD	O
-	-	SYM	SYM	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
08	08	NUM	CD	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
RR	RR	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
35	35	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
09	09	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
66	66	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Conversely	conversely	ADV	RB	O
,	,	PUNCT	,	O
enalapril	enalapril	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
a	a	DET	DT	O
relative	relative	ADJ	JJ	O
renoprotective	renoprotective	ADJ	JJ	O
effect	effect	NOUN	NN	O
(	(	PUNCT	-LRB-	O
RR	RR	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
33	33	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
13	13	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
53	53	NUM	CD	O
)	)	PUNCT	-RRB-	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
RR	RR	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
96	96	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
57	57	NUM	CD	O
-	-	SYM	SYM	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
44	44	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
diabetes	diabete	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
lower	low	ADJ	JJR	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
impairment	impairment	NOUN	NN	I-Disease
was	be	VERB	VBD	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
with	with	ADP	IN	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
blocker	blocker	NOUN	NN	O
therapy	therapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
RR	RR	PROPN	NNP	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
70	70	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
57	57	NUM	CD	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
85	85	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
higher	high	ADJ	JJR	O
baseline	baseline	NOUN	NN	O
ejection	ejection	NOUN	NN	O
fraction	fraction	NOUN	NN	O
(	(	PUNCT	-LRB-	O
RR	RR	PROPN	NNP	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
93	93	NUM	CD	O
per	per	ADP	IN	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
increment	increment	NOUN	NN	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
91	91	NUM	CD	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
96	96	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Enalapril	Enalapril	PROPN	NNP	B-Chemical
use	use	NOUN	NN	O
caused	cause	VERB	VBD	O
a	a	DET	DT	O
33	33	NUM	CD	O
%	%	NOUN	NN	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
decreased	decrease	VERB	VBN	B-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
CHF	CHF	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Diuretic	diuretic	ADJ	JJ	B-Chemical
use	use	NOUN	NN	O
and	and	CCONJ	CC	O
advanced	advanced	ADJ	JJ	O
age	age	NOUN	NN	O
increased	increase	VERB	VBD	O
this	this	DET	DT	O
risk	risk	NOUN	NN	O
.	.	PUNCT	.	O

Diabetes	diabete	NOUN	NNS	B-Disease
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
impairment	impairment	NOUN	NN	I-Disease
in	in	ADP	IN	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
CHF	CHF	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
this	this	DET	DT	O
risk	risk	NOUN	NN	O
was	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
enalapril	enalapril	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

beta	beta	NOUN	NN	O
-	-	PUNCT	:	O
Blocker	blocker	NOUN	NN	O
therapy	therapy	NOUN	NN	O
and	and	CCONJ	CC	O
higher	high	ADJ	JJR	O
ejection	ejection	NOUN	NN	O
fraction	fraction	NOUN	NN	O
were	be	VERB	VBD	O
renoprotective	renoprotective	ADJ	JJ	O
in	in	ADP	IN	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
regardless	regardless	ADV	RB	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Hypomania	Hypomania	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
syndrome	syndrome	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
olanzapine	olanzapine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
female	female	ADJ	JJ	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
not	not	ADV	RB	O
otherwise	otherwise	ADV	RB	O
specified	specify	VERB	VBN	O
psychotic	psychotic	ADJ	JJ	B-Disease
disorder	disorder	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
DSM	DSM	PROPN	NNP	O
-	-	PUNCT	HYPH	O
IV	IV	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
hypomania	hypomania	NOUN	NN	B-Disease
shortly	shortly	ADV	RB	O
after	after	ADP	IN	O
the	the	DET	DT	O
introduction	introduction	NOUN	NN	O
of	of	ADP	IN	O
olanzapine	olanzapine	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Acetazolamide	acetazolamide	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
Gerstmann	Gerstmann	PROPN	NNP	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	O
confusion	confusion	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
acetazolamide	acetazolamide	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
well	well	ADV	RB	O
known	know	VERB	VBN	O
adverse	adverse	ADJ	JJ	O
drug	drug	NOUN	NN	O
reaction	reaction	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
impairment	impairment	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
acetazolamide	acetazolamide	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
Gerstmann	Gerstmann	PROPN	NNP	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
normal	normal	ADJ	JJ	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
,	,	PUNCT	,	O
to	to	PART	TO	O
highlight	highlight	VERB	VB	O
predisposing	predispose	VERB	VBG	O
factors	factor	NOUN	NNS	O
that	that	DET	WDT	O
are	be	VERB	VBP	O
frequently	frequently	ADV	RB	O
overlooked	overlook	VERB	VBN	O
.	.	PUNCT	.	O

Vasopressin	vasopressin	VERB	VB	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
milrinone	milrinone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
in	in	ADP	IN	O
severe	severe	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
phosphodiesterase	phosphodiesterase	NOUN	NN	O
inhibitors	inhibitor	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
milrinone	milrinone	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
frequently	frequently	ADV	RB	O
restricted	restrict	VERB	VBN	O
because	because	ADP	IN	O
they	-PRON-	PRON	PRP	O
cause	cause	VERB	VBP	O
vasodilation	vasodilation	NOUN	NN	O
and	and	CCONJ	CC	O
hypotension	hypotension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
decompensated	decompensated	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
with	with	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
milrinone	milrinone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
low	low	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
vasopressin	vasopressin	NOUN	NN	B-Chemical
restored	restore	VERB	VBN	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
without	without	ADP	IN	O
inhibiting	inhibit	VERB	VBG	O
the	the	DET	DT	O
inotropic	inotropic	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
milrinone	milrinone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
by	by	ADP	IN	O
conversion	conversion	NOUN	NN	O
to	to	PART	TO	O
cyclosporine	cyclosporine	VERB	VB	B-Chemical
in	in	ADP	IN	O
liver	liver	NOUN	NN	O
transplant	transplant	NOUN	NN	O
recipients	recipient	NOUN	NNS	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
tacrolimus	tacrolimus	ADJ	JJ	B-Chemical
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
persist	persist	VERB	VBP	O
despite	despite	ADP	IN	O
dose	dose	NOUN	NN	O
reduction	reduction	NOUN	NN	O
,	,	PUNCT	,	O
conversion	conversion	NOUN	NN	O
to	to	PART	TO	O
cyclosporine	cyclosporine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
based	base	VERB	VBN	O
immunosuppression	immunosuppression	NOUN	NN	O
(	(	PUNCT	-LRB-	O
CyA	CyA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
necessary	necessary	ADJ	JJ	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
characterized	characterize	VERB	VBD	O
tacrolimus	tacrolimus	VERB	VBP	B-Chemical
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
that	that	DET	WDT	O
warranted	warrant	VERB	VBD	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
outcomes	outcome	NOUN	NNS	O
after	after	ADP	IN	O
conversion	conversion	NOUN	NN	O
.	.	PUNCT	.	O

Of	of	ADP	IN	O
388	388	NUM	CD	O
liver	liver	NOUN	NN	O
recipients	recipient	NOUN	NNS	O
who	who	PRON	WP	O
received	receive	VERB	VBD	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
as	as	ADP	IN	O
primary	primary	ADJ	JJ	O
immunosuppression	immunosuppression	NOUN	NN	O
,	,	PUNCT	,	O
70	70	NUM	CD	O
required	require	VERB	VBN	O
conversion	conversion	NOUN	NN	O
to	to	ADP	IN	O
CyA	CyA	PROPN	NNP	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
recorded	record	VERB	VBD	O
indication	indication	NOUN	NN	O
for	for	ADP	IN	O
conversion	conversion	NOUN	NN	O
,	,	PUNCT	,	O
whether	whether	ADP	IN	O
conversion	conversion	NOUN	NN	O
was	be	VERB	VBD	O
early	early	ADJ	JJ	O
or	or	CCONJ	CC	O
late	late	ADJ	JJ	O
after	after	ADP	IN	O
transplantation	transplantation	NOUN	NN	O
,	,	PUNCT	,	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
and	and	CCONJ	CC	O
trough	trough	VERB	VB	O
blood	blood	NOUN	NN	O
level	level	NOUN	NN	O
at	at	ADP	IN	O
conversion	conversion	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
rejection	rejection	NOUN	NN	O
after	after	ADP	IN	O
conversion	conversion	NOUN	NN	O
.	.	PUNCT	.	O

Conversion	conversion	NOUN	NN	O
was	be	VERB	VBD	O
early	early	ADJ	JJ	O
in	in	ADP	IN	O
29	29	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
41	41	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
late	late	ADV	RB	O
in	in	ADP	IN	O
41	41	NUM	CD	O
(	(	PUNCT	-LRB-	O
58	58	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Indications	indication	NOUN	NNS	O
for	for	ADP	IN	O
early	early	ADJ	JJ	O
conversion	conversion	NOUN	NN	O
were	be	VERB	VBD	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
(	(	PUNCT	-LRB-	B-Disease
insulin	insulin	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	I-Disease
dependent	dependent	ADJ	JJ	I-Disease
)	)	PUNCT	-RRB-	I-Disease
diabetes	diabetes	NOUN	NN	I-Disease
mellitus	mellitus	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
IDDM	IDDM	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
gastrointestinal	gastrointestinal	ADJ	JJ	B-Disease
(	(	PUNCT	-LRB-	I-Disease
GI	GI	PROPN	NNP	I-Disease
)	)	PUNCT	-RRB-	I-Disease
toxicity	toxicity	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
for	for	ADP	IN	O
late	late	ADJ	JJ	O
conversion	conversion	NOUN	NN	O
were	be	VERB	VBD	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
15	15	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
IDDM	IDDM	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
GI	GI	PROPN	NNP	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
post	post	ADJ	JJ	B-Disease
-	-	ADJ	JJ	I-Disease
transplant	transplant	ADJ	JJ	I-Disease
lmphoproliferate	lmphoproliferate	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
PTLD	PTLD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
pruritus	pruritus	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

All	all	DET	DT	O
early	early	ADJ	JJ	O
-	-	PUNCT	HYPH	O
conversion	conversion	NOUN	NN	O
patients	patient	NOUN	NNS	O
showed	show	VERB	VBD	O
improvement	improvement	NOUN	NN	O
/	/	SYM	SYM	O
resolution	resolution	NOUN	NN	O
of	of	ADP	IN	O
symptoms	symptom	NOUN	NNS	O
.	.	PUNCT	.	O

Among	among	ADP	IN	O
late	late	ADJ	JJ	O
-	-	PUNCT	HYPH	O
conversion	conversion	NOUN	NN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
37	37	NUM	CD	O
(	(	PUNCT	-LRB-	O
90	90	NUM	CD	O
.	.	NOUN	NN	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
improvement	improvement	NOUN	NN	O
/	/	SYM	SYM	O
resolution	resolution	NOUN	NN	O
;	;	PUNCT	:	O
in	in	ADP	IN	O
4	4	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
persisted	persist	VERB	VBD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
overall	overall	ADJ	JJ	O
rejection	rejection	NOUN	NN	O
rate	rate	NOUN	NN	O
was	be	VERB	VBD	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

Sixty	sixty	NUM	CD	O
-	-	PUNCT	HYPH	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
88	88	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
are	be	VERB	VBP	O
alive	alive	ADJ	JJ	O
with	with	ADP	IN	O
functioning	function	VERB	VBG	O
grafts	graft	NOUN	NNS	O
686	686	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
362	362	NUM	CD	O
days	day	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
range	range	NOUN	NN	O
,	,	PUNCT	,	O
154	154	NUM	CD	O
-	-	SYM	SYM	O
1433	1433	NUM	CD	O
days	day	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
after	after	ADP	IN	O
conversion	conversion	NOUN	NN	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
tacrolimus	tacrolimus	ADJ	JJ	B-Chemical
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
are	be	VERB	VBP	O
unresponsive	unresponsive	ADJ	JJ	O
to	to	PART	TO	O
dose	dose	VERB	VB	O
reduction	reduction	NOUN	NN	O
,	,	PUNCT	,	O
conversion	conversion	NOUN	NN	O
to	to	ADP	IN	O
CyA	CyA	PROPN	NNP	O
can	can	VERB	MD	O
be	be	VERB	VB	O
accomplished	accomplish	VERB	VBN	O
safely	safely	ADV	RB	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
no	no	DET	DT	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
rejection	rejection	NOUN	NN	O
and	and	CCONJ	CC	O
excellent	excellent	ADJ	JJ	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
outcome	outcome	NOUN	NN	O
.	.	PUNCT	.	O

Ocular	ocular	ADJ	JJ	O
manifestations	manifestation	NOUN	NNS	O
of	of	ADP	IN	O
juvenile	juvenile	NOUN	NN	B-Disease
rheumatoid	rheumatoid	ADJ	JJ	I-Disease
arthritis	arthritis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
followed	follow	VERB	VBD	O
210	210	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
juvenile	juvenile	NOUN	NN	B-Disease
rheumatoid	rheumatoid	ADJ	JJ	I-Disease
arthritis	arthritis	NOUN	NN	I-Disease
closely	closely	ADV	RB	O
for	for	ADP	IN	O
eleven	eleven	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

Thirty	thirty	NUM	CD	O
-	-	PUNCT	HYPH	O
six	six	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
210	210	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
17	17	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
developed	develop	VERB	VBN	O
iridocyclitis	iridocyclitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Iridocyclitis	Iridocyclitis	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
seen	see	VERB	VBN	O
most	most	ADV	RBS	O
frequently	frequently	ADV	RB	O
in	in	ADP	IN	O
young	young	ADJ	JJ	O
female	female	ADJ	JJ	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
to	to	PART	TO	O
4	4	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
the	the	DET	DT	O
monoarticular	monoarticular	NOUN	NN	O
or	or	CCONJ	CC	O
pauciatricular	pauciatricular	ADJ	JJ	O
form	form	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
arthritis	arthritis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
uveitis	uveitis	ADJ	JJ	B-Disease
after	after	ADP	IN	O
16	16	NUM	CD	O
years	year	NOUN	NNS	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
61	61	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
a	a	DET	DT	O
noncontributory	noncontributory	ADJ	JJ	O
ocular	ocular	ADJ	JJ	O
history	history	NOUN	NN	O
on	on	ADP	IN	O
entry	entry	NOUN	NN	O
,	,	PUNCT	,	O
42	42	NUM	CD	O
%	%	NOUN	NN	O
had	have	VERB	VBD	O
active	active	ADJ	JJ	O
uveitis	uveitis	NOUN	NN	B-Disease
on	on	ADP	IN	O
entry	entry	NOUN	NN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
approach	approach	NOUN	NN	O
was	be	VERB	VBD	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
detecting	detect	VERB	VBG	O
uveitis	uveitis	ADJ	JJ	B-Disease
in	in	ADP	IN	O
new	new	ADJ	JJ	O
cases	case	NOUN	NNS	O
and	and	CCONJ	CC	O
exacerbations	exacerbation	NOUN	NNS	O
of	of	ADP	IN	O
uveitis	uveitis	NOUN	NN	B-Disease
in	in	ADP	IN	O
established	establish	VERB	VBN	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

Forty	forty	NUM	CD	O
-	-	PUNCT	HYPH	O
four	four	NUM	CD	O
percent	percent	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
uveitis	uveitis	PROPN	NNP	B-Disease
had	have	VERB	VBD	O
one	one	NUM	CD	O
or	or	CCONJ	CC	O
more	more	ADV	RBR	O
identifiable	identifiable	ADJ	JJ	O
signs	sign	NOUN	NNS	O
or	or	CCONJ	CC	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
red	red	ADJ	JJ	O
eye	eye	NOUN	NN	O
,	,	PUNCT	,	O
ocular	ocular	ADJ	JJ	B-Disease
pain	pain	NOUN	NN	I-Disease
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	B-Disease
visual	visual	ADJ	JJ	I-Disease
acuity	acuity	NOUN	NN	I-Disease
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
photophobia	photophobia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
in	in	ADP	IN	O
order	order	NOUN	NN	O
of	of	ADP	IN	O
decreasing	decrease	VERB	VBG	O
frequency	frequency	NOUN	NN	O
.	.	PUNCT	.	O

Even	even	ADV	RB	O
after	after	ADP	IN	O
early	early	ADJ	JJ	O
detection	detection	NOUN	NN	O
and	and	CCONJ	CC	O
prompt	prompt	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
41	41	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
uveitis	uveitis	NOUN	NN	B-Disease
did	do	VERB	VBD	O
not	not	ADV	RB	O
respond	respond	VERB	VB	O
to	to	ADP	IN	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
six	six	NUM	CD	O
months	month	NOUN	NNS	O
of	of	ADP	IN	O
intensive	intensive	ADJ	JJ	O
topical	topical	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
corticosteroids	corticosteroid	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
mydriatics	mydriatic	NOUN	NNS	O
.	.	PUNCT	.	O

Despite	despite	ADP	IN	O
this	this	DET	DT	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
dramatic	dramatic	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
blinding	blind	VERB	VBG	O
complications	complication	NOUN	NNS	O
of	of	ADP	IN	O
uveitis	uveitis	ADJ	JJ	B-Disease
cited	cite	VERB	VBN	O
in	in	ADP	IN	O
earlier	early	ADJ	JJR	O
studies	study	NOUN	NNS	O
.	.	PUNCT	.	O

Cataract	cataract	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
band	band	NOUN	NN	B-Disease
keratopathy	keratopathy	NOUN	NN	I-Disease
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
only	only	ADV	RB	O
22	22	NUM	CD	O
and	and	CCONJ	CC	O
13	13	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
our	-PRON-	DET	PRP$	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
used	use	VERB	VBD	O
chloroquine	chloroquine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
hydroxychloroquine	hydroxychloroquine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
173	173	NUM	CD	O
of	of	ADP	IN	O
210	210	NUM	CD	O
cases	case	NOUN	NNS	O
and	and	CCONJ	CC	O
found	find	VERB	VBD	O
only	only	ADV	RB	O
one	one	NUM	CD	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
chorioretinopathy	chorioretinopathy	ADJ	JJ	B-Disease
attributable	attributable	ADJ	JJ	O
to	to	ADP	IN	O
these	these	DET	DT	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

Systemically	systemically	ADV	RB	O
administered	administer	VERB	VBN	O
corticosteroids	corticosteroid	NOUN	NNS	B-Chemical
were	be	VERB	VBD	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
75	75	NUM	CD	O
of	of	ADP	IN	O
210	210	NUM	CD	O
cases	case	NOUN	NNS	O
;	;	PUNCT	:	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
posterior	posterior	ADJ	JJ	O
subcapsular	subcapsular	ADJ	JJ	O
cataracts	cataract	NOUN	NNS	B-Disease
was	be	VERB	VBD	O
found	find	VERB	VBN	O
.	.	PUNCT	.	O

Typical	typical	ADJ	JJ	O
keratoconjunctivitis	keratoconjunctivitis	NOUN	NN	B-Disease
sicca	sicca	NOUN	NN	O
developed	develop	VERB	VBD	O
in	in	ADP	IN	O
three	three	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
uveitis	uveitis	ADJ	JJ	B-Disease
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
association	association	NOUN	NN	O
with	with	ADP	IN	O
uveitis	uveitis	ADJ	JJ	B-Disease
and	and	CCONJ	CC	O
JRA	JRA	PROPN	NNP	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
noted	note	VERB	VBN	O
previously	previously	ADV	RB	O
.	.	PUNCT	.	O

Surgical	surgical	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
cataracts	cataract	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
band	band	NOUN	NN	B-Disease
keratopathy	keratopathy	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
glaucoma	glaucoma	NOUN	NN	B-Disease
achieved	achieve	VERB	VBN	O
uniformly	uniformly	ADV	RB	O
discouraging	discouraging	ADJ	JJ	O
results	result	NOUN	NNS	O
.	.	PUNCT	.	O

Cyclophosphamide	Cyclophosphamide	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cystitis	cystitis	NOUN	NN	B-Disease
in	in	ADP	IN	O
freely	freely	ADV	RB	O
-	-	PUNCT	HYPH	O
moving	move	VERB	VBG	O
conscious	conscious	ADJ	JJ	O
rats	rat	NOUN	NNS	O
:	:	PUNCT	:	O
behavioral	behavioral	ADJ	JJ	O
approach	approach	NOUN	NN	O
to	to	ADP	IN	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
visceral	visceral	ADJ	JJ	B-Disease
pain	pain	NOUN	NN	I-Disease
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
develop	develop	VERB	VB	O
a	a	DET	DT	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
visceral	visceral	ADJ	JJ	B-Disease
pain	pain	NOUN	NN	I-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
using	use	VERB	VBG	O
a	a	DET	DT	O
behavioral	behavioral	ADJ	JJ	O
approach	approach	NOUN	NN	O
.	.	PUNCT	.	O

Cyclophosphamide	Cyclophosphamide	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
CP	CP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
an	an	DET	DT	O
antitumoral	antitumoral	ADJ	JJ	O
agent	agent	NOUN	NN	O
known	know	VERB	VBN	O
to	to	PART	TO	O
produce	produce	VERB	VB	O
toxic	toxic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
the	the	DET	DT	O
bladder	bladder	NOUN	NN	O
wall	wall	NOUN	NN	O
through	through	ADP	IN	O
its	-PRON-	DET	PRP$	O
main	main	ADJ	JJ	O
toxic	toxic	ADJ	JJ	O
metabolite	metabolite	NOUN	NN	O
acrolein	acrolein	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
induce	induce	VERB	VB	O
cystitis	cystitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

MATERIALS	material	NOUN	NNS	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
CP	CP	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
50	50	NUM	CD	O
,	,	PUNCT	,	O
100	100	NUM	CD	O
and	and	CCONJ	CC	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O

i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
to	to	ADP	IN	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
their	-PRON-	DET	PRP$	O
behavior	behavior	NOUN	NN	O
observed	observe	VERB	VBD	O
and	and	CCONJ	CC	O
scored	score	VERB	VBD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
to	to	PART	TO	O
4	4	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
CP	CP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
behavioral	behavioral	ADJ	JJ	O
modifications	modification	NOUN	NNS	O
were	be	VERB	VBD	O
tested	test	VERB	VBN	O
administered	administer	VERB	VBD	O
alone	alone	ADV	RB	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
naloxone	naloxone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O
s	s	PUNCT	LS	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
90	90	NUM	CD	O
minutes	minute	NOUN	NNS	O
after	after	ADP	IN	O
CP	CP	PROPN	NNP	B-Chemical
injection	injection	NOUN	NN	O
,	,	PUNCT	,	O
that	that	ADV	RB	O
is	is	ADV	RB	O
,	,	PUNCT	,	O
at	at	ADP	IN	O
the	the	DET	DT	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
bladder	bladder	NOUN	NN	O
was	be	VERB	VBD	O
removed	remove	VERB	VBN	O
in	in	ADP	IN	O
some	some	DET	DT	O
rats	rat	NOUN	NNS	O
for	for	ADP	IN	O
histological	histological	ADJ	JJ	O
examination	examination	NOUN	NN	O
.	.	PUNCT	.	O

Finally	finally	ADV	RB	O
,	,	PUNCT	,	O
to	to	PART	TO	O
show	show	VERB	VB	O
that	that	ADP	IN	O
the	the	DET	DT	O
bladder	bladder	NOUN	NN	O
is	be	VERB	VBZ	O
essential	essential	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
CP	CP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
behavioral	behavioral	ADJ	JJ	O
modifications	modification	NOUN	NNS	O
,	,	PUNCT	,	O
female	female	ADJ	JJ	O
rats	rat	NOUN	NNS	O
also	also	ADV	RB	O
received	receive	VERB	VBD	O
CP	CP	PROPN	NNP	B-Chemical
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O

i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
and	and	CCONJ	CC	O
of	of	ADP	IN	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
by	by	ADP	IN	O
the	the	DET	DT	O
intravesical	intravesical	ADJ	JJ	O
route	route	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
acrolein	acrolein	VERB	VB	B-Chemical
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
by	by	ADP	IN	O
the	the	DET	DT	O
intravesical	intravesical	ADJ	JJ	O
route	route	NOUN	NN	O
and	and	CCONJ	CC	O
of	of	ADP	IN	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O

i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
CP	cp	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
-	-	PUNCT	:	O
relatedly	relatedly	ADV	RB	O
induced	induce	VERB	VBN	O
marked	mark	VERB	VBN	O
behavioral	behavioral	ADJ	JJ	O
modifications	modification	NOUN	NNS	O
in	in	ADP	IN	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
:	:	PUNCT	:	O
breathing	breathing	NOUN	NN	O
rate	rate	NOUN	NN	O
decrease	decrease	NOUN	NN	O
,	,	PUNCT	,	O
closing	closing	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
eyes	eye	NOUN	NNS	O
and	and	CCONJ	CC	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
specific	specific	ADJ	JJ	O
postures	posture	NOUN	NNS	O
.	.	PUNCT	.	O

Morphine	morphine	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
-	-	PUNCT	:	O
dependently	dependently	ADV	RB	O
reversed	reverse	VERB	VBD	O
these	these	DET	DT	O
behavioral	behavioral	ADJ	JJ	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O
produced	produce	VERB	VBD	O
a	a	DET	DT	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
almost	almost	ADV	RB	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
behavioral	behavioral	ADJ	JJ	O
score	score	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
CP	CP	PROPN	NNP	B-Chemical
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
effect	effect	NOUN	NN	O
was	be	VERB	VBD	O
completely	completely	ADV	RB	O
prevented	prevent	VERB	VBN	O
by	by	ADP	IN	O
pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
naloxone	naloxone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

At	at	ADP	IN	O
the	the	DET	DT	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
histological	histological	ADJ	JJ	O
modifications	modification	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
bladder	bladder	NOUN	NN	O
wall	wall	NOUN	NN	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
chorionic	chorionic	NOUN	NN	O
and	and	CCONJ	CC	O
muscle	muscle	NOUN	NN	O
layer	layer	NOUN	NN	O
edema	edema	NOUN	NN	B-Disease
,	,	PUNCT	,	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
female	female	ADJ	JJ	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
CP	CP	PROPN	NNP	B-Chemical
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O

i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
produced	produce	VERB	VBD	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
marked	mark	VERB	VBN	O
behavioral	behavioral	ADJ	JJ	O
modifications	modification	NOUN	NNS	O
as	as	ADP	IN	O
those	those	DET	DT	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Administered	administer	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
intravesically	intravesically	ADV	RB	O
,	,	PUNCT	,	O
CP	CP	PROPN	NNP	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
produce	produce	VERB	VB	O
any	any	DET	DT	O
behavioral	behavioral	ADJ	JJ	O
effects	effect	NOUN	NNS	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
acrolein	acrolein	VERB	VBP	B-Chemical
at	at	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
intravesically	intravesically	ADV	RB	O
induced	induce	VERB	VBN	O
behavioral	behavioral	ADJ	JJ	O
modifications	modification	NOUN	NNS	O
identical	identical	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
under	under	ADP	IN	O
CP	CP	PROPN	NNP	B-Chemical
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O

i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
maximal	maximal	NOUN	NN	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

Conversely	conversely	ADV	RB	O
,	,	PUNCT	,	O
acrolein	acrolein	NOUN	NN	B-Chemical
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O

i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
produce	produce	VERB	VB	O
any	any	DET	DT	O
behavioral	behavioral	ADJ	JJ	O
effects	effect	NOUN	NNS	O
at	at	ADV	RB	O
all	all	ADV	RB	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Overall	overall	ADV	RB	O
,	,	PUNCT	,	O
these	these	DET	DT	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
this	this	DET	DT	O
experimental	experimental	ADJ	JJ	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
CP	CP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cystitis	cystitis	NOUN	NN	B-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
an	an	DET	DT	O
interesting	interesting	ADJ	JJ	O
new	new	ADJ	JJ	O
behavioral	behavioral	ADJ	JJ	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
inflammatory	inflammatory	ADJ	JJ	O
visceral	visceral	ADJ	JJ	B-Disease
pain	pain	NOUN	NN	I-Disease
,	,	PUNCT	,	O
allowing	allow	VERB	VBG	O
a	a	DET	DT	O
better	well	ADJ	JJR	O
understanding	understanding	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
painful	painful	ADJ	JJ	B-Disease
syndromes	syndrome	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
thus	thus	ADV	RB	O
a	a	DET	DT	O
better	better	ADV	RBR	O
therapeutic	therapeutic	ADJ	JJ	O
approach	approach	NOUN	NN	O
to	to	ADP	IN	O
them	-PRON-	PRON	PRP	O
.	.	PUNCT	.	O

Prednisolone	Prednisolone	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
muscle	muscle	NOUN	NN	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
caused	cause	VERB	VBN	O
more	more	ADJ	JJR	O
by	by	ADP	IN	O
atrophy	atrophy	NOUN	NN	B-Disease
than	than	ADP	IN	O
by	by	ADP	IN	O
altered	alter	VERB	VBN	O
acetylcholine	acetylcholine	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

Large	large	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
glucocorticoids	glucocorticoid	NOUN	NNS	O
can	can	VERB	MD	O
alter	alter	VERB	VB	O
muscle	muscle	NOUN	NN	O
physiology	physiology	NOUN	NN	O
and	and	CCONJ	CC	O
susceptibility	susceptibility	NOUN	NN	O
to	to	ADP	IN	O
neuromuscular	neuromuscular	ADJ	JJ	O
blocking	block	VERB	VBG	O
drugs	drug	NOUN	NNS	O
by	by	ADP	IN	O
mechanisms	mechanism	NOUN	NNS	O
not	not	ADV	RB	O
clearly	clearly	ADV	RB	O
understood	understand	VERB	VBN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
moderate	moderate	ADJ	JJ	O
and	and	CCONJ	CC	O
large	large	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
prednisolone	prednisolone	NOUN	NN	B-Chemical
on	on	ADP	IN	O
muscle	muscle	NOUN	NN	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
pharmacology	pharmacology	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
their	-PRON-	DET	PRP$	O
relationship	relationship	NOUN	NN	O
to	to	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
muscle	muscle	NOUN	NN	O
size	size	NOUN	NN	O
and	and	CCONJ	CC	O
acetylcholine	acetylcholine	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
AChR	AChR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

With	with	ADP	IN	O
institutional	institutional	ADJ	JJ	O
approval	approval	NOUN	NN	O
,	,	PUNCT	,	O
35	35	NUM	CD	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
allocated	allocate	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
daily	daily	ADJ	JJ	O
subcutaneous	subcutaneous	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
prednisolone	prednisolone	ADJ	JJ	B-Chemical
(	(	PUNCT	-LRB-	O
P10	P10	PROPN	NNP	O
group	group	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
prednisolone	prednisolone	ADJ	JJ	B-Chemical
(	(	PUNCT	-LRB-	O
P100	p100	NOUN	NN	O
group	group	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
an	an	DET	DT	O
equal	equal	ADJ	JJ	O
volume	volume	NOUN	NN	O
of	of	ADP	IN	O
saline	saline	NOUN	NN	O
(	(	PUNCT	-LRB-	O
S	S	PROPN	NNP	O
group	group	NOUN	NN	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
fourth	fourth	ADJ	JJ	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
rats	rat	NOUN	NNS	O
was	be	VERB	VBD	O
pair	pair	NOUN	NN	O
fed	feed	VERB	VBN	O
(	(	PUNCT	-LRB-	O
food	food	NOUN	NN	O
restricted	restrict	VERB	VBN	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
the	the	DET	DT	O
P100	P100	PROPN	NNP	O
rats	rat	NOUN	NNS	O
for	for	ADP	IN	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
FR	FR	PROPN	NNP	O
group	group	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
Day	day	NOUN	NN	O
8	8	NUM	CD	O
,	,	PUNCT	,	O
the	the	DET	DT	O
nerve	nerve	NOUN	NN	O
-	-	PUNCT	HYPH	O
evoked	evoke	VERB	VBN	O
peak	peak	NOUN	NN	O
twitch	twitch	NOUN	NN	O
tensions	tension	NOUN	NNS	O
,	,	PUNCT	,	O
tetanic	tetanic	ADJ	JJ	B-Disease
tensions	tension	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
fatigability	fatigability	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
response	response	NOUN	NN	O
curves	curve	NOUN	NNS	O
of	of	ADP	IN	O
d	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
tubocurarine	tubocurarine	NOUN	NN	I-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
tibialis	tibialis	NOUN	NN	O
cranialis	cranialis	NOUN	NN	O
muscle	muscle	NOUN	NN	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
and	and	CCONJ	CC	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
muscle	muscle	NOUN	NN	O
mass	mass	NOUN	NN	O
or	or	CCONJ	CC	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
AChRs	AChRs	PROPN	NNP	O
.	.	PUNCT	.	O

Rate	rate	NOUN	NN	O
of	of	ADP	IN	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
gain	gain	NOUN	NN	O
was	be	VERB	VBD	O
depressed	depress	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
P100	P100	PROPN	NNP	O
,	,	PUNCT	,	O
FR	FR	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
P10	P10	PROPN	NNP	O
groups	group	NOUN	NNS	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
S	S	PROPN	NNP	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Tibialis	Tibialis	PROPN	NNP	O
muscle	muscle	NOUN	NN	O
mass	mass	NOUN	NN	O
was	be	VERB	VBD	O
smaller	small	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
P100	P100	PROPN	NNP	O
group	group	NOUN	NN	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
P10	P10	PROPN	NNP	O
or	or	CCONJ	CC	O
S	S	PROPN	NNP	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
evoked	evoked	ADJ	JJ	O
peak	peak	NOUN	NN	O
twitch	twitch	NOUN	NN	O
and	and	CCONJ	CC	O
tetanic	tetanic	ADJ	JJ	B-Disease
tensions	tension	NOUN	NNS	O
were	be	VERB	VBD	O
less	less	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
P100	P100	PROPN	NNP	O
group	group	NOUN	NN	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
P10	P10	PROPN	NNP	O
or	or	CCONJ	CC	O
S	S	PROPN	NNP	O
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
tension	tension	NOUN	NN	O
per	per	ADP	IN	O
milligram	milligram	NOUN	NN	O
of	of	ADP	IN	O
muscle	muscle	NOUN	NN	O
mass	mass	NOUN	NN	O
was	be	VERB	VBD	O
greater	great	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
P100	P100	PROPN	NNP	O
group	group	NOUN	NN	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
S	S	PROPN	NNP	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
effective	effective	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
d	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
tubocurarine	tubocurarine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
tibialis	tibialis	NOUN	NN	O
muscle	muscle	NOUN	NN	O
was	be	VERB	VBD	O
smaller	small	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
P10	P10	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
33	33	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
4	4	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
S	S	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
61	61	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
the	the	DET	DT	O
P100	P100	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
71	71	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
9	9	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

AChR	AChR	PROPN	NNP	O
expression	expression	NOUN	NN	O
was	be	VERB	VBD	O
less	less	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
P10	P10	PROPN	NNP	O
group	group	NOUN	NN	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
S	S	PROPN	NNP	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
evoked	evoked	ADJ	JJ	O
tensions	tension	NOUN	NNS	O
correlated	correlate	VERB	VBD	O
with	with	ADP	IN	O
muscle	muscle	NOUN	NN	O
mass	mass	NOUN	NN	O
(	(	PUNCT	-LRB-	O
r	r	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
=	=	VERB	VBZ	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
32	32	NUM	CD	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
not	not	ADV	RB	O
with	with	ADP	IN	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
AChR	AChR	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
effective	effective	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
d	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
tubocurarine	tubocurarine	NOUN	NN	I-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
correlate	correlate	VERB	VB	O
with	with	ADP	IN	O
muscle	muscle	NOUN	NN	O
mass	mass	NOUN	NN	O
or	or	CCONJ	CC	O
AChR	AChR	PROPN	NNP	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
neuromuscular	neuromuscular	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
after	after	ADP	IN	O
prednisolone	prednisolone	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
derives	derive	VERB	VBZ	O
primarily	primarily	ADV	RB	O
from	from	ADP	IN	O
muscle	muscle	NOUN	NN	B-Disease
atrophy	atrophy	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
derives	derive	VERB	VBZ	O
less	less	ADV	RBR	O
so	so	ADV	RB	O
from	from	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
AChR	AChR	PROPN	NNP	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

IMPLICATIONS	implications	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
mechanisms	mechanism	NOUN	NNS	O
by	by	ADP	IN	O
which	which	DET	WDT	O
chronic	chronic	ADJ	JJ	O
glucocorticoid	glucocorticoid	NOUN	NN	O
therapy	therapy	NOUN	NN	O
alters	alter	NOUN	NNS	O
neuromuscular	neuromuscular	ADJ	JJ	O
physiology	physiology	NOUN	NN	O
and	and	CCONJ	CC	O
pharmacology	pharmacology	NOUN	NN	O
are	be	VERB	VBP	O
unclear	unclear	ADJ	JJ	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
observed	observed	ADJ	JJ	O
effects	effect	NOUN	NNS	O
are	be	VERB	VBP	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
and	and	CCONJ	CC	O
derive	derive	VERB	VBP	O
primarily	primarily	ADV	RB	O
from	from	ADP	IN	O
muscle	muscle	NOUN	NN	B-Disease
atrophy	atrophy	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
derive	derive	VERB	VB	O
less	less	ADJ	JJR	O
from	from	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
acetylcholine	acetylcholine	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

Apomorphine	apomorphine	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
an	an	DET	DT	O
underutilized	underutilize	VERB	VBN	O
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Apomorphine	Apomorphine	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
dopaminergic	dopaminergic	ADJ	JJ	O
drug	drug	NOUN	NN	O
ever	ever	ADV	RB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
treat	treat	VERB	VB	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

While	while	ADP	IN	O
powerful	powerful	ADJ	JJ	O
antiparkinsonian	antiparkinsonian	ADJ	JJ	O
effects	effect	NOUN	NNS	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
observed	observe	VERB	VBN	O
as	as	ADV	RB	O
early	early	ADV	RB	O
as	as	ADP	IN	O
1951	1951	NUM	CD	O
,	,	PUNCT	,	O
the	the	DET	DT	O
potential	potential	NOUN	NN	O
of	of	ADP	IN	O
treating	treat	VERB	VBG	O
fluctuating	fluctuate	VERB	VBG	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
by	by	ADP	IN	O
subcutaneous	subcutaneous	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
only	only	ADV	RB	O
recently	recently	ADV	RB	O
become	become	VERB	VBN	O
the	the	DET	DT	O
subject	subject	NOUN	NN	O
of	of	ADP	IN	O
systematic	systematic	ADJ	JJ	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
small	small	ADJ	JJ	O
scale	scale	NOUN	NN	O
clinical	clinical	ADJ	JJ	O
trials	trial	NOUN	NNS	O
have	have	VERB	VBP	O
unequivocally	unequivocally	ADV	RB	O
shown	show	VERB	VBN	O
that	that	ADP	IN	O
intermittent	intermittent	ADJ	JJ	O
subcutaneous	subcutaneous	ADJ	JJ	O
apomorphine	apomorphine	ADJ	JJ	B-Chemical
injections	injection	NOUN	NNS	O
produce	produce	VERB	VBP	O
antiparkinsonian	antiparkinsonian	ADJ	JJ	O
benefit	benefit	NOUN	NN	O
close	close	ADV	RB	O
if	if	ADP	IN	O
not	not	ADV	RB	O
identical	identical	ADJ	JJ	O
to	to	ADP	IN	O
that	that	DET	DT	O
seen	see	VERB	VBN	O
with	with	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
that	that	ADP	IN	O
apomorphine	apomorphine	ADJ	JJ	B-Chemical
rescue	rescue	NOUN	NN	O
injections	injection	NOUN	NNS	O
can	can	VERB	MD	O
reliably	reliably	ADV	RB	O
revert	revert	VERB	VB	O
off	off	PART	RP	O
-	-	PUNCT	HYPH	O
periods	period	NOUN	NNS	O
even	even	ADV	RB	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
complex	complex	ADJ	JJ	O
on	on	ADP	IN	O
-	-	PUNCT	HYPH	O
off	off	PART	RP	O
motor	motor	NOUN	NN	O
swings	swing	NOUN	NNS	O
.	.	PUNCT	.	O

Continuous	continuous	ADJ	JJ	O
subcutaneous	subcutaneous	ADJ	JJ	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
infusions	infusion	NOUN	NNS	O
can	can	VERB	MD	O
reduce	reduce	VERB	VB	O
daily	daily	ADV	RB	O
off	off	ADP	IN	O
-	-	PUNCT	HYPH	O
time	time	NOUN	NN	O
by	by	ADP	IN	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
in	in	ADP	IN	O
this	this	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
a	a	DET	DT	O
stronger	strong	ADJ	JJR	O
effect	effect	NOUN	NN	O
than	than	ADP	IN	O
that	that	DET	DT	O
generally	generally	ADV	RB	O
seen	see	VERB	VBN	O
with	with	ADP	IN	O
add	add	VERB	VB	O
-	-	PUNCT	HYPH	O
on	on	PART	RP	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
oral	oral	ADJ	JJ	O
dopamine	dopamine	NOUN	NN	B-Chemical
agonists	agonist	NOUN	NNS	O
or	or	CCONJ	CC	O
COMT	COMT	PROPN	NNP	O
inhibitors	inhibitor	NOUN	NNS	O
.	.	PUNCT	.	O

Extended	extend	VERB	VBN	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
studies	study	NOUN	NNS	O
of	of	ADP	IN	O
up	up	ADP	IN	O
to	to	PART	TO	O
8	8	NUM	CD	O
years	year	NOUN	NNS	O
have	have	VERB	VBP	O
demonstrated	demonstrate	VERB	VBN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
persistence	persistence	NOUN	NN	O
of	of	ADP	IN	O
apomorphine	apomorphine	ADJ	JJ	B-Chemical
efficacy	efficacy	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
is	be	VERB	VBZ	O
convincing	convince	VERB	VBG	O
clinical	clinical	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
that	that	DET	DT	O
monotherapy	monotherapy	NOUN	NN	O
with	with	ADP	IN	O
continuous	continuous	ADJ	JJ	O
subcutaneous	subcutaneous	ADJ	JJ	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
infusions	infusion	NOUN	NNS	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
marked	marked	ADJ	JJ	O
reductions	reduction	NOUN	NNS	O
of	of	ADP	IN	O
preexisting	preexist	VERB	VBG	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
main	main	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
subcutaneous	subcutaneous	ADJ	JJ	O
apomorphine	apomorphine	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
are	be	VERB	VBP	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
cutaneous	cutaneous	ADJ	JJ	O
tolerability	tolerability	NOUN	NN	O
problems	problem	NOUN	NNS	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
sedation	sedation	NOUN	NN	O
and	and	CCONJ	CC	O
psychiatric	psychiatric	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	O
play	play	VERB	VBP	O
a	a	DET	DT	O
lesser	less	ADJ	JJR	O
role	role	NOUN	NN	O
.	.	PUNCT	.	O

Given	give	VERB	VBN	O
the	the	DET	DT	O
marked	marked	ADJ	JJ	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
subcutaneous	subcutaneous	ADJ	JJ	O
apomorphine	apomorphine	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
in	in	ADP	IN	O
fluctuating	fluctuate	VERB	VBG	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
this	this	DET	DT	O
approach	approach	NOUN	NN	O
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
deserve	deserve	VERB	VB	O
more	more	ADV	RBR	O
widespread	widespread	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
use	use	NOUN	NN	O
.	.	PUNCT	.	O

Probing	probe	VERB	VBG	O
peripheral	peripheral	ADJ	JJ	O
and	and	CCONJ	CC	O
central	central	ADJ	JJ	O
cholinergic	cholinergic	NOUN	NN	O
system	system	NOUN	NN	O
responses	response	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
pharmacological	pharmacological	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
drugs	drug	NOUN	NNS	O
that	that	DET	WDT	O
act	act	VERB	VBP	O
on	on	ADP	IN	O
the	the	DET	DT	O
cholinergic	cholinergic	NOUN	NN	O
system	system	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
iris	iris	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
used	use	VERB	VBN	O
to	to	PART	TO	O
predict	predict	VERB	VB	O
deficits	deficit	NOUN	NNS	O
in	in	ADP	IN	O
central	central	ADJ	JJ	O
cholinergic	cholinergic	NOUN	NN	O
functioning	functioning	NOUN	NN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
diseases	disease	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
Alzheimer	Alzheimer	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
yet	yet	CCONJ	CC	O
correlations	correlation	NOUN	NNS	O
between	between	ADP	IN	O
central	central	ADJ	JJ	O
and	and	CCONJ	CC	O
peripheral	peripheral	ADJ	JJ	O
responses	response	NOUN	NNS	O
have	have	VERB	VBP	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
properly	properly	ADV	RB	O
studied	study	VERB	VBN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
assessed	assess	VERB	VBD	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
normal	normal	ADJ	JJ	O
aging	aging	NOUN	NN	O
on	on	ADP	IN	O
(	(	PUNCT	-LRB-	O
1	1	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
the	the	DET	DT	O
tropicamide	tropicamide	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
pupil	pupil	NOUN	NN	O
diameter	diameter	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
the	the	DET	DT	O
reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
effect	effect	NOUN	NN	O
with	with	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Scopolamine	Scopolamine	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
used	use	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
positive	positive	ADJ	JJ	O
control	control	NOUN	NN	O
to	to	PART	TO	O
detect	detect	VERB	VB	O
age	age	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
central	central	ADJ	JJ	O
cholinergic	cholinergic	NOUN	NN	O
functioning	functioning	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
elderly	elderly	ADJ	JJ	O
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
Randomized	randomize	VERB	VBN	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
controlled	control	VERB	VBN	O
trial	trial	NOUN	NN	O
.	.	PUNCT	.	O

PARTICIPANTS	participant	NOUN	NNS	O
:	:	PUNCT	:	O
Ten	ten	NUM	CD	O
healthy	healthy	ADJ	JJ	O
elderly	elderly	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
mean	mean	ADJ	JJ	O
age	age	NOUN	NN	O
70	70	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
9	9	NUM	CD	O
young	young	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
mean	mean	ADJ	JJ	O
age	age	NOUN	NN	O
33	33	NUM	CD	O
)	)	PUNCT	-RRB-	O
volunteers	volunteer	NOUN	NNS	O
.	.	PUNCT	.	O

INTERVENTIONS	intervention	NOUN	NNS	O
:	:	PUNCT	:	O
Pupil	pupil	NOUN	NN	O
diameter	diameter	NOUN	NN	O
was	be	VERB	VBD	O
monitored	monitor	VERB	VBN	O
using	use	VERB	VBG	O
a	a	DET	DT	O
computerized	computerized	ADJ	JJ	O
infrared	infrared	ADJ	JJ	O
pupillometer	pupillometer	NOUN	NN	O
over	over	ADP	IN	O
4	4	NUM	CD	O
hours	hour	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
study	study	NOUN	NN	O
involved	involve	VERB	VBD	O
4	4	NUM	CD	O
sessions	session	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
1	1	NUM	CD	O
session	session	NOUN	NN	O
,	,	PUNCT	,	O
tropicamide	tropicamide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
microL	microL	PROPN	NNP	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
to	to	ADP	IN	O
one	one	NUM	CD	O
eye	eye	NOUN	NN	O
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
another	another	DET	DT	O
session	session	NOUN	NN	O
,	,	PUNCT	,	O
tropicamide	tropicamide	VERB	VB	B-Chemical
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
microL	microL	PROPN	NNP	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
to	to	ADP	IN	O
both	both	DET	DT	O
eyes	eye	NOUN	NNS	O
,	,	PUNCT	,	O
followed	follow	VERB	VBD	O
23	23	NUM	CD	O
minutes	minute	NOUN	NNS	O
later	later	ADV	RB	O
by	by	ADP	IN	O
the	the	DET	DT	O
application	application	NOUN	NN	O
of	of	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
microL	microL	PROPN	NNP	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
one	one	NUM	CD	O
eye	eye	NOUN	NN	O
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
.	.	PUNCT	.	O

All	all	DET	DT	O
eye	eye	NOUN	NN	O
drops	drop	NOUN	NNS	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
randomized	randomized	ADJ	JJ	O
order	order	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
2	2	NUM	CD	O
separate	separate	ADJ	JJ	O
sessions	session	NOUN	NNS	O
,	,	PUNCT	,	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
,	,	PUNCT	,	O
intravenously	intravenously	ADV	RB	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
word	word	NOUN	NN	O
recall	recall	NOUN	NN	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
using	use	VERB	VBG	O
the	the	DET	DT	O
Buschke	Buschke	PROPN	NNP	O
Selective	Selective	PROPN	NNP	O
Reminding	Reminding	PROPN	NNP	O
Test	test	NOUN	NN	O
over	over	ADP	IN	O
2	2	NUM	CD	O
hours	hour	NOUN	NNS	O
.	.	PUNCT	.	O

OUTCOME	OUTCOME	PROPN	NNP	O
MEASURES	MEASURES	PROPN	NNP	O
:	:	PUNCT	:	O
Pupil	pupil	NOUN	NN	O
size	size	NOUN	NN	O
at	at	ADP	IN	O
time	time	NOUN	NN	O
points	point	NOUN	NNS	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
tropicamide	tropicamide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
;	;	PUNCT	:	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
impairment	impairment	NOUN	NN	B-Disease
in	in	ADP	IN	I-Disease
word	word	NOUN	NN	I-Disease
recall	recall	NOUN	NN	I-Disease
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
There	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
difference	difference	NOUN	NN	O
between	between	ADP	IN	O
elderly	elderly	ADJ	JJ	O
and	and	CCONJ	CC	O
young	young	ADJ	JJ	O
volunteers	volunteer	NOUN	NNS	O
in	in	ADP	IN	O
pupillary	pupillary	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	PART	TO	O
tropicamide	tropicamide	VERB	VB	B-Chemical
at	at	ADP	IN	O
any	any	DET	DT	O
time	time	NOUN	NN	O
point	point	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
>	>	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
elderly	elderly	ADJ	JJ	O
group	group	NOUN	NN	O
had	have	VERB	VBD	O
a	a	DET	DT	O
significantly	significantly	ADV	RB	O
greater	great	ADJ	JJR	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
net	net	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
pupil	pupil	NOUN	NN	O
size	size	NOUN	NN	O
85	85	NUM	CD	O
,	,	PUNCT	,	O
125	125	NUM	CD	O
,	,	PUNCT	,	O
165	165	NUM	CD	O
and	and	CCONJ	CC	O
215	215	NUM	CD	O
minutes	minute	NOUN	NNS	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
young	young	ADJ	JJ	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
young	young	ADJ	JJ	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
elderly	elderly	ADJ	JJ	O
group	group	NOUN	NN	O
had	have	VERB	VBD	O
greater	great	ADJ	JJR	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
impairment	impairment	NOUN	NN	B-Disease
in	in	ADP	IN	I-Disease
word	word	NOUN	NN	I-Disease
recall	recall	NOUN	NN	I-Disease
60	60	NUM	CD	O
,	,	PUNCT	,	O
90	90	NUM	CD	O
and	and	CCONJ	CC	O
120	120	NUM	CD	O
minutes	minute	NOUN	NNS	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
There	there	ADV	EX	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
age	age	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
pupillary	pupillary	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	PART	TO	O
pilocarpine	pilocarpine	VERB	VB	B-Chemical
that	that	DET	DT	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
found	find	VERB	VBN	O
with	with	ADP	IN	O
tropicamide	tropicamide	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
useful	useful	ADJ	JJ	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
variations	variation	NOUN	NNS	O
in	in	ADP	IN	O
central	central	ADJ	JJ	O
cholinergic	cholinergic	NOUN	NN	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Pain	pain	NOUN	NN	B-Disease
responses	response	NOUN	NNS	O
in	in	ADP	IN	O
methadone	methadone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
maintained	maintain	VERB	VBN	O
opioid	opioid	NOUN	NN	O
abusers	abuser	NOUN	NNS	O
.	.	PUNCT	.	O

Providing	provide	VERB	VBG	O
pain	pain	NOUN	NN	B-Disease
management	management	NOUN	NN	O
for	for	ADP	IN	O
known	know	VERB	VBN	O
opioid	opioid	NOUN	NN	O
abusers	abuser	NOUN	NNS	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
challenging	challenging	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
task	task	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
part	part	NOUN	NN	O
because	because	ADP	IN	O
little	little	ADJ	JJ	O
is	be	VERB	VBZ	O
known	know	VERB	VBN	O
about	about	ADP	IN	O
their	-PRON-	DET	PRP$	O
pain	pain	NOUN	NN	B-Disease
experience	experience	NOUN	NN	O
and	and	CCONJ	CC	O
analgesic	analgesic	ADJ	JJ	O
requirements	requirement	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
designed	design	VERB	VBN	O
to	to	PART	TO	O
describe	describe	VERB	VB	O
pain	pain	NOUN	NN	B-Disease
tolerance	tolerance	NOUN	NN	O
and	and	CCONJ	CC	O
analgesic	analgesic	ADJ	JJ	O
response	response	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
sample	sample	NOUN	NN	O
of	of	ADP	IN	O
opioid	opioid	NOUN	NN	B-Disease
addicts	addict	NOUN	NNS	I-Disease
stabilized	stabilize	VERB	VBN	O
in	in	ADP	IN	O
methadone	methadone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
maintenance	maintenance	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MM	MM	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
60	60	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
comparison	comparison	NOUN	NN	O
to	to	ADP	IN	O
matched	match	VERB	VBN	O
nondependent	nondependent	ADJ	JJ	O
control	control	NOUN	NN	O
subjects	subject	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
60	60	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

By	by	ADP	IN	O
using	use	VERB	VBG	O
a	a	DET	DT	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
,	,	PUNCT	,	O
two	two	NUM	CD	O
-	-	PUNCT	HYPH	O
way	way	NOUN	NN	O
factorial	factorial	ADJ	JJ	O
design	design	NOUN	NN	O
,	,	PUNCT	,	O
tolerance	tolerance	NOUN	NN	O
to	to	ADP	IN	O
cold	cold	ADJ	JJ	O
-	-	PUNCT	HYPH	O
pressor	pressor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
CP	CP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
pain	pain	NOUN	NN	B-Disease
was	be	VERB	VBD	O
examined	examine	VERB	VBN	O
,	,	PUNCT	,	O
both	both	CCONJ	CC	O
before	before	ADP	IN	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
oral	oral	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
therapeutic	therapeutic	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
common	common	ADJ	JJ	O
opioid	opioid	NOUN	NN	O
(	(	PUNCT	-LRB-	O
hydromorphone	hydromorphone	NOUN	NN	B-Chemical
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
nonsteroidal	nonsteroidal	ADJ	JJ	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
ketorolac	ketorolac	NOUN	NN	B-Chemical
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
analgesic	analgesic	ADJ	JJ	O
agents	agent	NOUN	NNS	O
.	.	PUNCT	.	O

Results	result	NOUN	NNS	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
MM	MM	PROPN	NNP	O
individuals	individual	NOUN	NNS	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
less	less	ADV	RBR	O
tolerant	tolerant	ADJ	JJ	O
of	of	ADP	IN	O
CP	CP	PROPN	NNP	O
pain	pain	NOUN	NN	B-Disease
than	than	ADP	IN	O
control	control	NOUN	NN	O
subjects	subject	NOUN	NNS	O
,	,	PUNCT	,	O
replicating	replicate	VERB	VBG	O
previous	previous	ADJ	JJ	O
work	work	NOUN	NN	O
.	.	PUNCT	.	O

Analgesic	analgesic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
were	be	VERB	VBD	O
significant	significant	ADJ	JJ	O
neither	neither	CCONJ	CC	O
for	for	ADP	IN	O
medication	medication	NOUN	NN	O
nor	nor	CCONJ	CC	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
MM	MM	PROPN	NNP	O
opioid	opioid	VERB	VBP	O
abusers	abuser	NOUN	NNS	O
represent	represent	VERB	VBP	O
a	a	DET	DT	O
pain	pain	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
intolerant	intolerant	ADJ	JJ	I-Disease
subset	subset	NOUN	NN	O
of	of	ADP	IN	O
clinical	clinical	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Their	-PRON-	DET	PRP$	O
complaints	complaint	NOUN	NNS	O
of	of	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
should	should	VERB	MD	O
be	be	VERB	VB	O
evaluated	evaluate	VERB	VBN	O
seriously	seriously	ADV	RB	O
and	and	CCONJ	CC	O
managed	manage	VERB	VBN	O
aggressively	aggressively	ADV	RB	O
.	.	PUNCT	.	O

High	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
may	may	VERB	MD	O
do	do	VERB	VB	O
more	more	ADJ	JJR	O
harm	harm	NOUN	NN	O
for	for	ADP	IN	O
spinal	spinal	ADJ	JJ	B-Disease
cord	cord	NOUN	NN	I-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Because	because	ADP	IN	O
of	of	ADP	IN	O
the	the	DET	DT	O
National	National	PROPN	NNP	O
Acute	Acute	PROPN	NNP	O
Spinal	Spinal	PROPN	NNP	B-Disease
Cord	Cord	PROPN	NNP	I-Disease
Injury	Injury	PROPN	NNP	I-Disease
Studies	Studies	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
NASCIS	NASCIS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
became	become	VERB	VBD	O
the	the	DET	DT	O
standard	standard	NOUN	NN	O
of	of	ADP	IN	O
care	care	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
acute	acute	ADJ	JJ	O
spinal	spinal	ADJ	JJ	B-Disease
cord	cord	NOUN	NN	I-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
NASCIS	NASCIS	PROPN	NNP	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
mention	mention	NOUN	NN	O
regarding	regard	VERB	VBG	O
the	the	DET	DT	O
possibility	possibility	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
corticosteroid	corticosteroid	NOUN	NN	B-Chemical
myopathy	myopathy	NOUN	NN	B-Disease
that	that	DET	WDT	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
may	may	VERB	MD	O
cause	cause	VERB	VB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
dosage	dosage	NOUN	NN	O
of	of	ADP	IN	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
recommended	recommend	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
NASCIS	NASCIS	PROPN	NNP	O
3	3	NUM	CD	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
highest	high	ADJ	JJS	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
steroids	steroid	NOUN	NNS	B-Chemical
ever	ever	ADV	RB	O
being	be	VERB	VBG	O
used	use	VERB	VBN	O
during	during	ADP	IN	O
a	a	DET	DT	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
day	day	NOUN	NN	O
period	period	NOUN	NN	O
for	for	ADP	IN	O
any	any	DET	DT	O
clinical	clinical	ADJ	JJ	O
condition	condition	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
hypothesize	hypothesize	VERB	VBP	O
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
cause	cause	VERB	VB	O
some	some	DET	DT	O
damage	damage	NOUN	NN	B-Disease
to	to	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
muscle	muscle	NOUN	NN	I-Disease
of	of	ADP	IN	O
spinal	spinal	ADJ	JJ	B-Disease
cord	cord	NOUN	NN	I-Disease
injury	injury	NOUN	NN	I-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Further	further	ADV	RB	O
,	,	PUNCT	,	O
steroid	steroid	VERB	VB	B-Chemical
myopathy	myopathy	ADJ	JJ	B-Disease
recovers	recover	NOUN	NNS	O
naturally	naturally	ADV	RB	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
neurological	neurological	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
shown	show	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
NASCIS	NASCIS	PROPN	NNP	O
may	may	VERB	MD	O
be	be	VERB	VB	O
just	just	ADV	RB	O
a	a	DET	DT	O
recording	recording	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
natural	natural	ADJ	JJ	O
motor	motor	NOUN	NN	O
recovery	recovery	NOUN	NN	O
from	from	ADP	IN	O
the	the	DET	DT	O
steroid	steroid	NOUN	NN	B-Chemical
myopathy	myopathy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
instead	instead	ADV	RB	O
of	of	ADP	IN	O
any	any	DET	DT	O
protection	protection	NOUN	NN	O
that	that	ADP	IN	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
offers	offer	VERB	VBZ	O
to	to	ADP	IN	O
the	the	DET	DT	O
spinal	spinal	ADJ	JJ	B-Disease
cord	cord	NOUN	NN	I-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

To	to	ADP	IN	O
our	-PRON-	DET	PRP$	O
knowledge	knowledge	NOUN	NN	O
,	,	PUNCT	,	O
this	this	DET	DT	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
discussion	discussion	NOUN	NN	O
considering	consider	VERB	VBG	O
the	the	DET	DT	O
possibility	possibility	NOUN	NN	O
that	that	ADP	IN	O
the	the	DET	DT	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
recommended	recommend	VERB	VBN	O
by	by	ADP	IN	O
NASCIS	NASCIS	PROPN	NNP	O
may	may	VERB	MD	O
cause	cause	VERB	VB	O
acute	acute	ADJ	JJ	O
corticosteroid	corticosteroid	ADJ	JJ	B-Chemical
myopathy	myopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Conversion	conversion	NOUN	NN	O
to	to	PART	TO	O
rapamycin	rapamycin	VERB	VB	B-Chemical
immunosuppression	immunosuppression	NOUN	NN	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
transplant	transplant	NOUN	NN	O
recipients	recipient	NOUN	NNS	O
:	:	PUNCT	:	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
initial	initial	ADJ	JJ	O
experience	experience	NOUN	NN	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
is	be	VERB	VBZ	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
RAPA	RAPA	PROPN	NNP	B-Chemical
conversion	conversion	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
cyclosporine	cyclosporine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
CsA	CsA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Tac	Tac	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Twenty	twenty	NUM	CD	O
renal	renal	ADJ	JJ	O
transplant	transplant	NOUN	NN	O
recipients	recipient	NOUN	NNS	O
were	be	VERB	VBD	O
switched	switch	VERB	VBN	O
to	to	ADP	IN	O
fixed	fix	VERB	VBN	O
dose	dose	NOUN	NN	O
rapamycin	rapamycin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
RAPA	RAPA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
0	0	NUM	CD	O
to	to	ADP	IN	O
204	204	NUM	CD	O
months	month	NOUN	NNS	O
posttransplant	posttransplant	ADJ	JJ	O
.	.	PUNCT	.	O

Drug	drug	NOUN	NN	O
monitoring	monitoring	NOUN	NN	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
initially	initially	ADV	RB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
adjust	adjust	VERB	VB	O
doses	dose	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
indications	indication	NOUN	NNS	O
for	for	ADP	IN	O
switch	switch	NOUN	NN	O
were	be	VERB	VBD	O
chronic	chronic	ADJ	JJ	O
CsA	CsA	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
Tac	Tac	PROPN	NNP	B-Chemical
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
acute	acute	ADJ	JJ	O
CsA	CsA	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
Tac	Tac	PROPN	NNP	B-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
severe	severe	ADJ	JJ	O
facial	facial	ADJ	JJ	B-Disease
dysmorphism	dysmorphism	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
posttransplant	posttransplant	ADJ	JJ	B-Disease
lymphoproliferative	lymphoproliferative	ADJ	JJ	I-Disease
disorder	disorder	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
PTLD	PTLD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
remission	remission	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O

Follow	follow	VERB	VB	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
is	be	VERB	VBZ	O
7	7	NUM	CD	O
to	to	PART	TO	O
24	24	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
the	the	DET	DT	O
12	12	NUM	CD	O
patients	patient	NOUN	NNS	O
switched	switch	VERB	VBN	O
because	because	ADP	IN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
[	[	PUNCT	-LRB-	O
233	233	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
34	34	NUM	CD	O
to	to	ADP	IN	O
210	210	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
56	56	NUM	CD	O
micromol	micromol	NOUN	NN	O
/	/	SYM	SYM	O
liter	liter	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
6	6	NUM	CD	O
months	month	NOUN	NNS	O
]	]	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Facial	facial	ADJ	JJ	B-Disease
dysmorphism	dysmorphism	NOUN	NN	I-Disease
improved	improve	VERB	VBD	O
in	in	ADP	IN	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

No	no	DET	DT	O
relapse	relapse	NOUN	NN	O
of	of	ADP	IN	O
PTLD	PTLD	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

Five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
pneumonia	pneumonia	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
two	two	NUM	CD	O
Pneumocystis	Pneumocystis	PROPN	NNP	B-Disease
carinii	carinii	NOUN	NN	I-Disease
pneumonia	pneumonia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
one	one	NUM	CD	O
infectious	infectious	ADJ	JJ	B-Disease
mononucleosis	mononucleosis	NOUN	NN	I-Disease
with	with	ADP	IN	O
polyclonal	polyclonal	ADJ	JJ	O
PTLD	PTLD	PROPN	NNP	B-Disease
lung	lung	NOUN	NN	O
infiltrate	infiltrate	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
two	two	NUM	CD	O
had	have	VERB	VBD	O
bronchiolitis	bronchiolitis	NOUN	NN	B-Disease
obliterans	obliteran	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
deaths	death	NOUN	NNS	O
.	.	PUNCT	.	O

RAPA	RAPA	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
in	in	ADP	IN	O
four	four	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
because	because	ADP	IN	O
of	of	ADP	IN	O
pneumonia	pneumonia	NOUN	NN	B-Disease
in	in	ADP	IN	O
two	two	NUM	CD	O
,	,	PUNCT	,	O
PTLD	PTLD	NOUN	NNS	B-Disease
in	in	ADP	IN	O
one	one	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
oral	oral	ADJ	JJ	O
aphtous	aphtous	ADJ	JJ	B-Disease
ulcers	ulcer	NOUN	NNS	I-Disease
in	in	ADP	IN	O
one	one	NUM	CD	O
.	.	PUNCT	.	O

RAPA	RAPA	PROPN	NNP	B-Chemical
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
high	high	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
>	>	X	XX	O
15	15	NUM	CD	O
ng	ng	ADP	IN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
7	7	NUM	CD	O
of	of	ADP	IN	O
13	13	NUM	CD	O
(	(	PUNCT	-LRB-	O
54	54	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
RAPA	RAPA	PROPN	NNP	B-Chemical
conversion	conversion	NOUN	NN	O
provides	provide	VERB	VBZ	O
adequate	adequate	ADJ	JJ	O
immunosuppression	immunosuppression	NOUN	NN	O
to	to	PART	TO	O
enable	enable	VERB	VB	O
CsA	CsA	PROPN	NNP	B-Chemical
withdrawal	withdrawal	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
converting	convert	VERB	VBG	O
patients	patient	NOUN	NNS	O
to	to	ADP	IN	O
RAPA	RAPA	PROPN	NNP	B-Chemical
drug	drug	NOUN	NN	O
levels	level	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
monitored	monitor	VERB	VBN	O
to	to	PART	TO	O
avoid	avoid	VERB	VB	O
over	over	ADP	IN	O
-	-	PUNCT	HYPH	O
immunosuppression	immunosuppression	NOUN	NN	O
and	and	CCONJ	CC	O
adequate	adequate	ADJ	JJ	O
antiviral	antiviral	NOUN	NN	O
and	and	CCONJ	CC	O
Pneumocystis	Pneumocystis	PROPN	NNP	B-Disease
carinii	carinii	NOUN	NN	I-Disease
pneumonia	pneumonia	NOUN	NN	I-Disease
prophylaxis	prophylaxis	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
given	give	VERB	VBN	O
.	.	PUNCT	.	O

Electro	electro	NOUN	NN	O
-	-	PUNCT	HYPH	O
oculography	oculography	NOUN	NN	O
,	,	PUNCT	,	O
electroretinography	electroretinography	NOUN	NN	O
,	,	PUNCT	,	O
visual	visual	ADJ	JJ	O
evoked	evoke	VERB	VBN	O
potentials	potential	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
multifocal	multifocal	ADJ	JJ	O
electroretinography	electroretinography	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
vigabatrin	vigabatrin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
attributed	attribute	VERB	VBN	O
visual	visual	ADJ	JJ	B-Disease
field	field	NOUN	NN	I-Disease
constriction	constriction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
Symptomatic	symptomatic	ADJ	JJ	O
visual	visual	ADJ	JJ	B-Disease
field	field	NOUN	NN	I-Disease
constriction	constriction	NOUN	NN	I-Disease
thought	think	VERB	VBD	O
to	to	PART	TO	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
vigabatrin	vigabatrin	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
current	current	ADJ	JJ	O
study	study	NOUN	NN	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
visual	visual	ADJ	JJ	O
fields	field	NOUN	NNS	O
and	and	CCONJ	CC	O
visual	visual	ADJ	JJ	O
electrophysiology	electrophysiology	NOUN	NN	O
of	of	ADP	IN	O
eight	eight	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
known	know	VERB	VBN	O
vigabatrin	vigabatrin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
attributed	attribute	VERB	VBN	O
visual	visual	ADJ	JJ	B-Disease
field	field	NOUN	NN	I-Disease
loss	loss	NOUN	NN	I-Disease
,	,	PUNCT	,	O
three	three	NUM	CD	O
of	of	ADP	IN	O
whom	whom	PRON	WP	O
were	be	VERB	VBD	O
reported	report	VERB	VBN	O
previously	previously	ADV	RB	O
.	.	PUNCT	.	O

Six	six	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
no	no	ADV	RB	O
longer	longer	ADV	RBR	O
receiving	receive	VERB	VBG	O
vigabatrin	vigabatrin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
central	central	ADJ	JJ	O
and	and	CCONJ	CC	O
peripheral	peripheral	ADJ	JJ	O
fields	field	NOUN	NNS	O
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
Humphrey	Humphrey	PROPN	NNP	O
Visual	Visual	PROPN	NNP	O
Field	Field	PROPN	NNP	O
Analyzer	Analyzer	PROPN	NNP	O
.	.	PUNCT	.	O

Full	full	ADJ	JJ	O
visual	visual	ADJ	JJ	O
electrophysiology	electrophysiology	NOUN	NN	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
flash	flash	NOUN	NN	O
electroretinography	electroretinography	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ERG	ERG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
pattern	pattern	NOUN	NN	O
electroretinography	electroretinography	NOUN	NN	O
,	,	PUNCT	,	O
multifocal	multifocal	ADJ	JJ	O
ERG	ERG	PROPN	NNP	O
using	use	VERB	VBG	O
the	the	DET	DT	O
VERIS	VERIS	PROPN	NNP	O
system	system	NOUN	NN	O
,	,	PUNCT	,	O
electro	electro	NOUN	NN	O
-	-	PUNCT	HYPH	O
oculography	oculography	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
flash	flash	NOUN	NN	O
and	and	CCONJ	CC	O
pattern	pattern	VERB	VB	O
visual	visual	ADJ	JJ	O
evoked	evoke	VERB	VBN	O
potentials	potential	NOUN	NNS	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
undertaken	undertake	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Seven	seven	NUM	CD	O
patients	patient	NOUN	NNS	O
showed	show	VERB	VBD	O
marked	mark	VERB	VBN	O
visual	visual	ADJ	JJ	B-Disease
field	field	NOUN	NN	I-Disease
constriction	constriction	NOUN	NN	I-Disease
with	with	ADP	IN	O
some	some	DET	DT	O
sparing	sparing	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
temporal	temporal	ADJ	JJ	O
visual	visual	ADJ	JJ	O
field	field	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
eighth	eighth	ADJ	JJ	O
exhibited	exhibit	VERB	VBN	O
concentric	concentric	ADJ	JJ	O
constriction	constriction	NOUN	NN	O
.	.	PUNCT	.	O

Most	Most	ADJ	JJS	O
electrophysiological	electrophysiological	ADJ	JJ	O
responses	response	NOUN	NNS	O
were	be	VERB	VBD	O
usually	usually	ADV	RB	O
just	just	ADV	RB	O
within	within	ADP	IN	O
normal	normal	ADJ	JJ	O
limits	limit	NOUN	NNS	O
;	;	PUNCT	:	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
subnormal	subnormal	ADJ	JJ	O
Arden	Arden	PROPN	NNP	O
electro	electro	NOUN	NN	O
-	-	PUNCT	HYPH	O
oculography	oculography	NOUN	NN	O
indices	index	NOUN	NNS	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
showed	show	VERB	VBD	O
an	an	DET	DT	O
abnormally	abnormally	ADV	RB	O
delayed	delay	VERB	VBN	O
photopic	photopic	NOUN	NN	O
b	b	PUNCT	LS	O
wave	wave	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
showed	show	VERB	VBD	O
delayed	delay	VERB	VBN	O
30	30	NUM	CD	O
-	-	SYM	SYM	O
Hz	hz	NOUN	NN	O
flicker	flicker	NOUN	NN	O
b	b	NOUN	NN	O
waves	wave	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
seven	seven	NUM	CD	O
patients	patient	NOUN	NNS	O
showed	show	VERB	VBD	O
delayed	delay	VERB	VBN	O
oscillatory	oscillatory	ADJ	JJ	O
potentials	potential	NOUN	NNS	O
.	.	PUNCT	.	O

Multifocal	multifocal	ADJ	JJ	O
ERG	ERG	PROPN	NNP	O
showed	show	VERB	VBD	O
abnormalities	abnormality	NOUN	NNS	O
that	that	ADP	IN	O
sometimes	sometimes	ADV	RB	O
correlated	correlate	VERB	VBD	O
with	with	ADP	IN	O
the	the	DET	DT	O
visual	visual	ADJ	JJ	O
field	field	NOUN	NN	O
appearance	appearance	NOUN	NN	O
and	and	CCONJ	CC	O
confirmed	confirm	VERB	VBD	O
that	that	ADP	IN	O
the	the	DET	DT	O
deficit	deficit	NOUN	NN	O
occurs	occur	VERB	VBZ	O
at	at	ADP	IN	O
the	the	DET	DT	O
retinal	retinal	ADJ	JJ	O
level	level	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Marked	mark	VERB	VBN	O
visual	visual	ADJ	JJ	B-Disease
field	field	NOUN	NN	I-Disease
constriction	constriction	NOUN	NN	I-Disease
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
vigabatrin	vigabatrin	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
field	field	NOUN	NN	O
defects	defect	NOUN	NNS	O
and	and	CCONJ	CC	O
some	some	DET	DT	O
electrophysiological	electrophysiological	ADJ	JJ	O
abnormalities	abnormality	NOUN	NNS	O
persist	persist	VERB	VBP	O
when	when	ADV	WRB	O
vigabatrin	vigabatrin	ADJ	JJ	B-Chemical
therapy	therapy	NOUN	NN	O
is	be	VERB	VBZ	O
withdrawn	withdraw	VERB	VBN	O
.	.	PUNCT	.	O

Myocardial	myocardial	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
due	due	ADJ	JJ	O
to	to	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
spasm	spasm	NOUN	NNS	I-Disease
during	during	ADP	IN	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
stress	stress	NOUN	NN	O
echocardiography	echocardiography	NOUN	NN	O
.	.	PUNCT	.	O

Dobutamine	dobutamine	NOUN	NN	B-Chemical
stress	stress	NOUN	NN	O
echocardiography	echocardiography	NOUN	NN	O
(	(	PUNCT	-LRB-	O
DSE	DSE	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
useful	useful	ADJ	JJ	O
and	and	CCONJ	CC	O
safe	safe	ADJ	JJ	O
provocation	provocation	NOUN	NN	O
test	test	NOUN	NN	O
for	for	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Until	until	ADP	IN	O
now	now	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
test	test	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
focused	focus	VERB	VBN	O
only	only	ADV	RB	O
on	on	ADP	IN	O
the	the	DET	DT	O
organic	organic	ADJ	JJ	O
lesion	lesion	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
coronary	coronary	ADJ	JJ	O
artery	artery	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
positive	positive	ADJ	JJ	O
DSE	DSE	PROPN	NNP	O
has	have	VERB	VBZ	O
indicated	indicate	VERB	VBN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
significant	significant	ADJ	JJ	O
fixed	fix	VERB	VBN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
stenosis	stenosis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
is	be	VERB	VBZ	O
to	to	PART	TO	O
examine	examine	VERB	VB	O
whether	whether	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
spasm	spasm	NOUN	NNS	I-Disease
is	be	VERB	VBZ	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
performed	perform	VERB	VBD	O
DSE	DSE	PROPN	NNP	O
on	on	ADP	IN	O
51	51	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
spastic	spastic	ADJ	JJ	I-Disease
angina	angina	NOUN	NN	I-Disease
but	but	CCONJ	CC	O
without	without	ADP	IN	O
significant	significant	ADJ	JJ	O
fixed	fix	VERB	VBN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
stenosis	stenosis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
anginal	anginal	ADJ	JJ	B-Disease
attacks	attack	NOUN	NNS	O
at	at	ADP	IN	O
rest	rest	NOUN	NN	O
with	with	ADP	IN	O
ST	ST	PROPN	NNP	O
elevation	elevation	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
electrocardiogram	electrocardiogram	NOUN	NN	O
(	(	PUNCT	-LRB-	O
variant	variant	ADJ	JJ	B-Disease
angina	angina	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Coronary	coronary	ADJ	JJ	O
spasm	spasm	NOUN	NNS	O
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
intracoronary	intracoronary	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
acetylcholine	acetylcholine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
no	no	DET	DT	O
fixed	fix	VERB	VBN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
stenosis	stenosis	NOUN	NN	I-Disease
was	be	VERB	VBD	O
documented	document	VERB	VBN	O
on	on	ADP	IN	O
angiograms	angiogram	NOUN	NNS	O
in	in	ADP	IN	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

DSE	DSE	PROPN	NNP	O
was	be	VERB	VBD	O
performed	perform	VERB	VBN	O
with	with	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
infusion	infusion	NOUN	NN	O
with	with	ADP	IN	O
an	an	DET	DT	O
incremental	incremental	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
,	,	PUNCT	,	O
20	20	NUM	CD	O
,	,	PUNCT	,	O
30	30	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
40	40	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
every	every	DET	DT	O
5	5	NUM	CD	O
minutes	minute	NOUN	NNS	O
.	.	PUNCT	.	O

Of	of	ADP	IN	O
the	the	DET	DT	O
51	51	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
7	7	NUM	CD	O
patients	patient	NOUN	NNS	O
showed	show	VERB	VBD	O
asynergy	asynergy	ADV	RB	O
with	with	ADP	IN	O
ST	ST	PROPN	NNP	O
elevation	elevation	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
7	7	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
13	13	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
chest	chest	NOUN	NN	B-Disease
pain	pain	NOUN	NN	I-Disease
during	during	ADP	IN	O
asynergy	asynergy	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
both	both	DET	DT	O
chest	chest	NOUN	NN	B-Disease
pain	pain	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
electrocardiographic	electrocardiographic	ADJ	JJ	O
changes	change	NOUN	NNS	O
were	be	VERB	VBD	O
preceded	precede	VERB	VBN	O
by	by	ADP	IN	O
asynergy	asynergy	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
can	can	VERB	MD	O
provoke	provoke	VERB	VB	O
coronary	coronary	ADJ	JJ	B-Disease
spasm	spasm	NOUN	NNS	I-Disease
in	in	ADP	IN	O
some	some	DET	DT	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
spastic	spastic	ADJ	JJ	I-Disease
angina	angina	NOUN	NN	I-Disease
.	.	PUNCT	.	O

When	when	ADV	WRB	O
DSE	DSE	PROPN	NNP	O
is	be	VERB	VBZ	O
performed	perform	VERB	VBN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
not	not	ADV	RB	O
only	only	ADV	RB	O
fixed	fix	VERB	VBN	O
coronary	coronary	ADJ	JJ	B-Disease
stenosis	stenosis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
also	also	ADV	RB	O
coronary	coronary	ADJ	JJ	B-Disease
spasm	spasm	NOUN	NNS	I-Disease
should	should	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
genesis	genesis	NOUN	NN	O
of	of	ADP	IN	O
asynergy	asynergy	NOUN	NN	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
intravenous	intravenous	ADJ	JJ	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
plus	plus	CCONJ	CC	O
glucagon	glucagon	NOUN	NN	O
on	on	ADP	IN	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
myocardial	myocardial	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

STUDY	study	NOUN	NN	O
OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
on	on	ADP	IN	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
stress	stress	NOUN	NN	O
testing	testing	NOUN	NN	O
with	with	ADP	IN	O
technetium	technetium	NOUN	NN	B-Chemical
-	-	PUNCT	:	I-Chemical
99m	99m	NOUN	NNS	I-Chemical
sestamibi	sestamibi	VERB	VBP	I-Chemical
single	single	ADJ	JJ	O
-	-	PUNCT	HYPH	O
photon	photon	NOUN	NN	O
emission	emission	NOUN	NN	O
computed	compute	VERB	VBD	O
tomography	tomography	NOUN	NN	O
imaging	image	VERB	VBG	O
and	and	CCONJ	CC	O
ST	ST	PROPN	NNP	O
-	-	PUNCT	HYPH	O
segment	segment	NOUN	NN	O
monitoring	monitoring	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
impact	impact	NOUN	NN	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
glucagon	glucagon	NOUN	NN	O
on	on	ADP	IN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
'	'	PUNCT	''	O
s	s	PART	POS	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
Randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
trial	trial	NOUN	NN	O
.	.	PUNCT	.	O

SETTING	setting	NOUN	NN	O
:	:	PUNCT	:	O
Community	community	NOUN	NN	O
hospital	hospital	NOUN	NN	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
:	:	PUNCT	:	O
Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
known	know	VERB	VBN	O
reversible	reversible	ADJ	JJ	O
perfusion	perfusion	NOUN	NN	O
defects	defect	NOUN	NNS	O
.	.	PUNCT	.	O

INTERVENTION	intervention	NOUN	NN	O
:	:	PUNCT	:	O
Patients	patient	NOUN	NNS	O
underwent	undergo	VERB	VBD	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
stress	stress	NOUN	NN	O
tests	test	NOUN	NNS	O
per	per	ADP	IN	O
standard	standard	ADJ	JJ	O
protocol	protocol	NOUN	NN	O
.	.	PUNCT	.	O

Before	before	ADP	IN	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
begun	begin	VERB	VBN	O
,	,	PUNCT	,	O
no	no	DET	DT	O
therapy	therapy	NOUN	NN	O
was	be	VERB	VBD	O
given	give	VERB	VBN	O
during	during	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
visit	visit	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
randomized	randomize	VERB	VBN	O
on	on	ADP	IN	O
subsequent	subsequent	ADJ	JJ	O
visits	visit	NOUN	NNS	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
plus	plus	CCONJ	CC	O
glucagon	glucagon	ADJ	JJ	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O

Metoprolol	Metoprolol	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
dosed	dose	VERB	VBN	O
to	to	PART	TO	O
achieve	achieve	VERB	VB	O
a	a	DET	DT	O
resting	rest	VERB	VBG	O
predobutamine	predobutamine	NOUN	NN	B-Chemical
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
below	below	ADP	IN	O
65	65	NUM	CD	O
beats	beat	NOUN	NNS	O
/	/	SYM	SYM	O
minute	minute	NOUN	NN	O
or	or	CCONJ	CC	O
a	a	DET	DT	O
total	total	ADJ	JJ	O
intravenous	intravenous	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O

MEASUREMENTS	measurement	NOUN	NNS	O
AND	and	CCONJ	CC	O
MAIN	main	ADJ	JJ	O
RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Metoprolol	Metoprolol	PROPN	NNP	B-Chemical
reduced	reduce	VERB	VBD	O
maximum	maximum	ADJ	JJ	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
31	31	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
summed	sum	VERB	VBN	O
stress	stress	NOUN	NN	O
scores	score	VERB	VBZ	O
29	29	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
summed	sum	VERB	VBN	O
difference	difference	NOUN	NN	O
scores	score	VERB	VBZ	O
43	43	NUM	CD	O
%	%	NOUN	NN	O
versus	versus	ADP	IN	O
control	control	NOUN	NN	O
.	.	PUNCT	.	O

Metoprolol	Metoprolol	PROPN	NNP	B-Chemical
plus	plus	CCONJ	CC	O
glucagon	glucagon	NOUN	NN	O
also	also	ADV	RB	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
maximum	maximum	ADJ	JJ	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
29	29	NUM	CD	O
%	%	NOUN	NN	O
versus	versus	ADP	IN	O
control	control	NOUN	NN	O
.	.	PUNCT	.	O

Summed	sum	VERB	VBN	O
stress	stress	NOUN	NN	O
and	and	CCONJ	CC	O
summed	sum	VERB	VBN	O
difference	difference	NOUN	NN	O
scores	score	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBN	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
they	-PRON-	PRON	PRP	O
were	be	VERB	VBD	O
18	18	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
lower	low	ADJ	JJR	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
than	than	ADP	IN	O
control	control	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
any	any	DET	DT	O
parameter	parameter	NOUN	NN	O
between	between	ADP	IN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
glucagon	glucagon	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
During	during	ADP	IN	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
stress	stress	NOUN	NN	O
testing	testing	NOUN	NN	O
,	,	PUNCT	,	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
attenuates	attenuate	NOUN	NNS	O
or	or	CCONJ	CC	O
eliminates	eliminate	VERB	VBZ	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Glucagon	Glucagon	PROPN	NNP	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
somewhat	somewhat	ADV	RB	O
effective	effective	ADJ	JJ	O
,	,	PUNCT	,	O
does	do	VERB	VBZ	O
not	not	ADV	RB	O
correct	correct	VERB	VB	O
this	this	DET	DT	O
effect	effect	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
extent	extent	NOUN	NN	O
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
can	can	VERB	MD	O
be	be	VERB	VB	O
administered	administer	VERB	VBN	O
clinically	clinically	ADV	RB	O
.	.	PUNCT	.	O

Evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
functional	functional	ADJ	JJ	O
somatotopy	somatotopy	NOUN	NN	O
in	in	ADP	IN	O
GPi	GPi	NOUN	NNS	O
from	from	ADP	IN	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
pallidotomy	pallidotomy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
objective	objective	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
explore	explore	VERB	VB	O
the	the	DET	DT	O
functional	functional	ADJ	JJ	O
anatomy	anatomy	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
globus	globus	ADJ	JJ	O
pallidus	pallidus	NOUN	NN	O
internus	internus	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GPi	GPi	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
by	by	ADP	IN	O
studying	study	VERB	VBG	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
unilateral	unilateral	ADJ	JJ	O
pallidotomy	pallidotomy	NOUN	NN	O
on	on	ADP	IN	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
'	'	PUNCT	``	O
off	off	PART	RP	O
'	'	PUNCT	``	O
signs	sign	NOUN	NNS	O
and	and	CCONJ	CC	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
(	(	PUNCT	-LRB-	O
LID	LID	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
found	find	VERB	VBD	O
significant	significant	ADJ	JJ	O
positive	positive	ADJ	JJ	O
correlations	correlation	NOUN	NNS	O
between	between	ADP	IN	O
the	the	DET	DT	O
preoperative	preoperative	ADJ	JJ	O
levodopa	levodopa	ADJ	JJ	B-Chemical
responsiveness	responsiveness	NOUN	NN	O
of	of	ADP	IN	O
motor	motor	NOUN	NN	O
signs	sign	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
levodopa	levodopa	ADJ	JJ	B-Chemical
responsiveness	responsiveness	NOUN	NN	O
of	of	ADP	IN	O
scores	score	NOUN	NNS	O
in	in	ADP	IN	O
timed	time	VERB	VBN	O
tests	test	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
Core	Core	PROPN	NNP	O
Assessment	Assessment	PROPN	NNP	O
Program	Program	PROPN	NNP	O
for	for	ADP	IN	O
Intracerebral	Intracerebral	PROPN	NNP	O
Transplantations	Transplantations	PROPN	NNPS	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
contralateral	contralateral	ADJ	JJ	O
limbs	limb	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
scores	score	NOUN	NNS	O
after	after	ADP	IN	O
surgery	surgery	NOUN	NN	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
correlation	correlation	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
LID	LID	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
also	also	ADV	RB	O
found	find	VERB	VBD	O
a	a	DET	DT	O
highly	highly	ADV	RB	O
significant	significant	ADJ	JJ	O
correlation	correlation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
:	:	PUNCT	:	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0001	0001	NUM	CD	O
,	,	PUNCT	,	O
r	r	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
between	between	ADP	IN	O
the	the	DET	DT	O
volume	volume	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ventral	ventral	ADJ	JJ	O
lesion	lesion	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
GPi	GPi	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
LID	LID	PROPN	NNP	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
contralateral	contralateral	ADJ	JJ	O
limbs	limb	NOUN	NNS	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
correlation	correlation	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
ventral	ventral	ADJ	JJ	O
volume	volume	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
'	'	PUNCT	``	O
off	off	PART	RP	O
'	'	PUNCT	``	O
signs	sign	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
volumes	volume	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
total	total	ADJ	JJ	O
lesion	lesion	NOUN	NN	O
cylinder	cylinder	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
dorsal	dorsal	ADJ	JJ	O
lesion	lesion	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
correlate	correlate	VERB	VB	O
with	with	ADP	IN	O
the	the	DET	DT	O
outcome	outcome	NOUN	NN	O
of	of	ADP	IN	O
either	either	CCONJ	CC	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
or	or	CCONJ	CC	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
'	'	PUNCT	''	O
off	off	PART	RP	O
'	'	PUNCT	``	O
signs	sign	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
differential	differential	ADJ	JJ	O
predictive	predictive	ADJ	JJ	O
value	value	NOUN	NN	O
of	of	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
responsiveness	responsiveness	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
outcome	outcome	NOUN	NN	O
of	of	ADP	IN	O
parkinsonian	parkinsonian	NOUN	NN	B-Disease
'	'	PUNCT	``	O
off	off	PART	RP	O
'	'	PUNCT	``	O
signs	sign	NOUN	NNS	O
and	and	CCONJ	CC	O
LID	LID	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
the	the	DET	DT	O
different	different	ADJ	JJ	O
correlations	correlation	NOUN	NNS	O
of	of	ADP	IN	O
ventral	ventral	ADJ	JJ	O
lesion	lesion	NOUN	NN	O
volume	volume	NOUN	NN	O
with	with	ADP	IN	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
'	'	PUNCT	''	O
off	off	PART	RP	O
'	'	PUNCT	''	O
signs	sign	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	DET	DT	O
different	different	ADJ	JJ	O
anatomical	anatomical	ADJ	JJ	O
or	or	CCONJ	CC	O
pathophysiological	pathophysiological	ADJ	JJ	O
substrates	substrate	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
generation	generation	NOUN	NN	O
of	of	ADP	IN	O
parkinsonian	parkinsonian	NOUN	NN	B-Disease
'	'	PUNCT	``	O
off	off	PART	RP	O
'	'	PUNCT	``	O
signs	sign	NOUN	NNS	O
and	and	CCONJ	CC	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Whereas	whereas	ADP	IN	O
cells	cell	NOUN	NNS	O
in	in	ADP	IN	O
a	a	DET	DT	O
wider	wide	ADJ	JJR	O
area	area	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
GPi	GPi	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
parkinsonism	parkinsonism	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
ventral	ventral	ADJ	JJ	O
GPi	GPi	NOUN	NNS	O
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
crucial	crucial	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
manifestation	manifestation	NOUN	NN	O
of	of	ADP	IN	O
LID	LID	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
our	-PRON-	DET	PRP$	O
observations	observation	NOUN	NNS	O
are	be	VERB	VBP	O
additional	additional	ADJ	JJ	O
proof	proof	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
functional	functional	ADJ	JJ	O
somatotopy	somatotopy	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
systems	system	NOUN	NNS	O
within	within	ADP	IN	O
the	the	DET	DT	O
GPi	GPi	NOUN	NNS	O
that	that	DET	WDT	O
mediate	mediate	VERB	VBP	O
parkinsonism	parkinsonism	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
along	along	ADP	IN	O
the	the	DET	DT	O
dorsoventral	dorsoventral	ADJ	JJ	O
trajectory	trajectory	NOUN	NN	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
pallidotomy	pallidotomy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
outcome	outcome	NOUN	NN	O
of	of	ADP	IN	O
pallidotomy	pallidotomy	NOUN	NN	O
in	in	ADP	IN	O
which	which	DET	WDT	O
the	the	DET	DT	O
lesion	lesion	NOUN	NN	O
involves	involve	VERB	VBZ	O
the	the	DET	DT	O
ventral	ventral	ADJ	JJ	O
and	and	CCONJ	CC	O
dorsal	dorsal	ADJ	JJ	O
GPi	GPi	NOUN	NNS	O
could	could	VERB	MD	O
be	be	VERB	VB	O
the	the	DET	DT	O
net	net	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
alteration	alteration	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
pathways	pathway	NOUN	NNS	O
which	which	DET	WDT	O
mediate	mediate	VERB	VBP	O
different	different	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
hence	hence	ADV	RB	O
could	could	VERB	MD	O
be	be	VERB	VB	O
variable	variable	ADJ	JJ	O
.	.	PUNCT	.	O

Screening	screen	VERB	VBG	O
for	for	ADP	IN	O
stimulant	stimulant	ADJ	JJ	O
use	use	NOUN	NN	O
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
emergency	emergency	NOUN	NN	O
department	department	NOUN	NN	O
seizure	seizure	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
objective	objective	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
prevalence	prevalence	NOUN	NN	O
of	of	ADP	IN	O
positive	positive	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
drug	drug	NOUN	NN	O
screening	screen	VERB	VBG	O
for	for	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
emergency	emergency	NOUN	NN	O
department	department	NOUN	NN	O
seizure	seizure	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
This	this	DET	DT	O
prospective	prospective	ADJ	JJ	O
study	study	NOUN	NN	O
evaluated	evaluate	VERB	VBD	O
consecutive	consecutive	ADJ	JJ	O
eligible	eligible	ADJ	JJ	O
seizure	seizure	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
a	a	DET	DT	O
plasma	plasma	NOUN	NN	O
sample	sample	NOUN	NN	O
collected	collect	VERB	VBN	O
as	as	ADP	IN	O
part	part	NOUN	NN	O
of	of	ADP	IN	O
their	-PRON-	DET	PRP$	O
clinical	clinical	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
.	.	PUNCT	.	O

Plasma	Plasma	PROPN	NNP	O
was	be	VERB	VBD	O
tested	test	VERB	VBN	O
for	for	ADP	IN	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
cocaine	cocaine	NOUN	NN	B-Chemical
metabolite	metabolite	NOUN	NN	O
benzoylecgonine	benzoylecgonine	NOUN	NN	B-Chemical
using	use	VERB	VBG	O
enzyme	enzyme	ADJ	JJ	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
immunoassay	immunoassay	NOUN	NN	O
methodology	methodology	NOUN	NN	O
.	.	PUNCT	.	O

Plasma	plasma	NOUN	NN	O
samples	sample	NOUN	NNS	O
with	with	ADP	IN	O
benzoylecgonine	benzoylecgonine	NOUN	NN	B-Chemical
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
150	150	NUM	CD	O
ng	ng	NOUN	NNS	O
/	/	SYM	SYM	O
mL	ml	NOUN	NN	O
or	or	CCONJ	CC	O
an	an	DET	DT	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
500	500	NUM	CD	O
ng	ng	ADP	IN	O
/	/	SYM	SYM	O
mL	mL	PROPN	NNP	O
were	be	VERB	VBD	O
defined	define	VERB	VBN	O
as	as	ADP	IN	O
positive	positive	ADJ	JJ	O
.	.	PUNCT	.	O

Patient	patient	ADJ	JJ	O
demographics	demographic	NOUN	NNS	O
,	,	PUNCT	,	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
underlying	underlie	VERB	VBG	O
drug	drug	NOUN	NN	O
or	or	CCONJ	CC	O
alcohol	alcohol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
seizure	seizure	NOUN	NN	B-Disease
disorder	disorder	NOUN	NN	O
,	,	PUNCT	,	O
estimated	estimate	VERB	VBN	O
time	time	NOUN	NN	O
from	from	ADP	IN	O
seizure	seizure	NOUN	NN	B-Disease
to	to	PART	TO	O
sample	sample	NOUN	NN	O
collection	collection	NOUN	NN	O
,	,	PUNCT	,	O
history	history	NOUN	NN	O
or	or	CCONJ	CC	O
suspicion	suspicion	NOUN	NN	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Disease
or	or	CCONJ	CC	I-Disease
amphetamine	amphetamine	NOUN	NN	I-Disease
abuse	abuse	NOUN	NN	I-Disease
,	,	PUNCT	,	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
clinical	clinical	ADJ	JJ	O
urine	urine	NOUN	NN	O
testing	testing	NOUN	NN	O
for	for	ADP	IN	O
drugs	drug	NOUN	NNS	O
of	of	ADP	IN	O
abuse	abuse	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
assay	assay	ADJ	JJ	O
results	result	NOUN	NNS	O
were	be	VERB	VBD	O
recorded	record	VERB	VBN	O
without	without	ADP	IN	O
patient	patient	ADJ	JJ	O
identifiers	identifier	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Fourteen	fourteen	NUM	CD	O
of	of	ADP	IN	O
248	248	NUM	CD	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
-	-	PUNCT	HYPH	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
plasma	plasma	NOUN	NN	O
samples	sample	NOUN	NNS	O
were	be	VERB	VBD	O
positive	positive	ADJ	JJ	O
by	by	ADP	IN	O
immunoassay	immunoassay	NOUN	NN	O
testing	testing	NOUN	NN	O
for	for	ADP	IN	O
benzoylecgonine	benzoylecgonine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
no	no	DET	DT	O
samples	sample	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
0	0	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
positive	positive	ADJ	JJ	O
for	for	ADP	IN	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Positive	positive	ADJ	JJ	O
test	test	NOUN	NN	O
results	result	NOUN	NNS	O
were	be	VERB	VBD	O
more	more	ADV	RBR	O
common	common	ADJ	JJ	O
in	in	ADP	IN	O
patient	patient	ADJ	JJ	O
visits	visit	NOUN	NNS	O
where	where	ADV	WRB	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
history	history	NOUN	NN	O
or	or	CCONJ	CC	O
suspicion	suspicion	NOUN	NN	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Disease
or	or	CCONJ	CC	I-Disease
amphetamine	amphetamine	NOUN	NN	I-Disease
abuse	abuse	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0005	0005	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
During	during	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
routine	routine	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
screening	screen	VERB	VBG	O
for	for	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
amphetamines	amphetamine	NOUN	NNS	B-Chemical
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
seizure	seizure	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
a	a	DET	DT	O
low	low	ADJ	JJ	O
yield	yield	NOUN	NN	O
.	.	PUNCT	.	O

As	as	ADP	IN	O
a	a	DET	DT	O
result	result	NOUN	NN	O
,	,	PUNCT	,	O
routine	routine	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
screening	screening	NOUN	NN	O
would	would	VERB	MD	O
yield	yield	VERB	VB	O
few	few	ADJ	JJ	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
stimulant	stimulant	ADJ	JJ	O
drug	drug	NOUN	NN	O
in	in	ADP	IN	O
which	which	DET	WDT	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
neither	neither	CCONJ	CC	O
a	a	DET	DT	O
history	history	NOUN	NN	O
nor	nor	CCONJ	CC	O
suspicion	suspicion	NOUN	NN	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	B-Disease
abuse	abuse	NOUN	NN	I-Disease
in	in	ADP	IN	O
this	this	DET	DT	O
population	population	NOUN	NN	O
.	.	PUNCT	.	O

Contribution	contribution	NOUN	NN	O
of	of	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
valproate	valproate	NOUN	NN	I-Chemical
to	to	ADP	IN	O
the	the	DET	DT	O
syndrome	syndrome	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
inappropriate	inappropriate	ADJ	JJ	I-Disease
secretion	secretion	NOUN	NN	I-Disease
of	of	ADP	IN	I-Disease
antidiuretic	antidiuretic	ADJ	JJ	I-Disease
hormone	hormone	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
the	the	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
62	62	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
who	who	PRON	WP	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
sodium	sodium	NOUN	NN	B-Chemical
valproate	valproate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
VPA	VPA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
who	who	PRON	WP	O
subsequently	subsequently	ADV	RB	O
developed	develop	VERB	VBD	O
the	the	DET	DT	O
syndrome	syndrome	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
inappropriate	inappropriate	ADJ	JJ	I-Disease
secretion	secretion	NOUN	NN	I-Disease
of	of	ADP	IN	I-Disease
antidiuretic	antidiuretic	ADJ	JJ	I-Disease
hormone	hormone	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
SIADH	SIADH	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
taking	take	VERB	VBG	O
VPA	VPA	PROPN	NNP	B-Chemical
for	for	ADP	IN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
idiopathic	idiopathic	ADJ	JJ	O
generalized	generalize	VERB	VBN	O
tonic	tonic	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
clonic	clonic	NOUN	NN	I-Disease
convulsions	convulsion	NOUN	NNS	I-Disease
since	since	ADP	IN	O
he	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
56	56	NUM	CD	O
years	year	NOUN	NNS	O
old	old	ADJ	JJ	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
substituting	substitute	VERB	VBG	O
VPA	VPA	PROPN	NNP	B-Chemical
with	with	ADP	IN	O
zonisamide	zonisamide	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
serum	serum	ADJ	JJ	O
sodium	sodium	NOUN	NN	B-Chemical
level	level	NOUN	NN	O
returned	return	VERB	VBD	O
to	to	ADP	IN	O
normal	normal	ADJ	JJ	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
consider	consider	VERB	VBP	O
this	this	DET	DT	O
episode	episode	NOUN	NN	O
of	of	ADP	IN	O
SIADH	SIADH	PROPN	NNP	B-Disease
to	to	PART	TO	O
be	be	VERB	VB	O
the	the	DET	DT	O
result	result	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
combination	combination	NOUN	NN	O
of	of	ADP	IN	O
factors	factor	NOUN	NNS	O
including	include	VERB	VBG	O
a	a	DET	DT	O
weakness	weakness	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
central	central	ADJ	JJ	I-Disease
nervous	nervous	ADJ	JJ	I-Disease
system	system	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
VPA	VPA	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Association	association	NOUN	NN	O
of	of	ADP	IN	O
nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
production	production	NOUN	NN	O
and	and	CCONJ	CC	O
apoptosis	apoptosis	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
experimental	experimental	ADJ	JJ	O
nephropathy	nephropathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
recent	recent	ADJ	JJ	O
studies	study	NOUN	NNS	O
increased	increase	VERB	VBD	O
amounts	amount	NOUN	NNS	O
of	of	ADP	IN	O
nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NO	no	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
apoptosis	apoptosis	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
various	various	ADJ	JJ	O
pathological	pathological	ADJ	JJ	O
conditions	condition	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
have	have	VERB	VBP	O
studied	study	VERB	VBN	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
NO	no	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
association	association	NOUN	NN	O
with	with	ADP	IN	O
apoptosis	apoptosis	NOUN	NN	O
in	in	ADP	IN	O
an	an	DET	DT	O
experimental	experimental	ADJ	JJ	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
adriamycin	adriamycin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
ADR	ADR	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
alteration	alteration	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
NO	no	DET	DT	B-Chemical
pathway	pathway	NOUN	NN	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
measuring	measure	VERB	VBG	O
nitrite	nitrite	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
in	in	ADP	IN	O
serum	serum	NOUN	NN	O
/	/	SYM	SYM	O
urine	urine	NOUN	NN	O
and	and	CCONJ	CC	O
by	by	ADP	IN	O
evaluating	evaluate	VERB	VBG	O
the	the	DET	DT	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
vascular	vascular	ADJ	JJ	O
reactivity	reactivity	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
isolated	isolate	VERB	VBN	O
perfused	perfused	ADJ	JJ	O
rat	rat	NOUN	NN	O
kidney	kidney	NOUN	NN	O
(	(	PUNCT	-LRB-	O
IPRK	IPRK	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
system	system	NOUN	NN	O
.	.	PUNCT	.	O

Rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
stratified	stratify	VERB	VBN	O
into	into	ADP	IN	O
control	control	NOUN	NN	O
groups	group	NOUN	NNS	O
and	and	CCONJ	CC	O
ADR	ADR	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephropathy	nephropathy	ADJ	JJ	B-Disease
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
were	be	VERB	VBD	O
then	then	ADV	RB	O
divided	divide	VERB	VBN	O
into	into	ADP	IN	O
:	:	PUNCT	:	O
group	group	NOUN	NN	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
animals	animal	NOUN	NNS	O
receiving	receive	VERB	VBG	O
saline	saline	NOUN	NN	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
group	group	NOUN	NN	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
animals	animal	NOUN	NNS	O
receiving	receive	VERB	VBG	O
aminoguanidine	aminoguanidine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
AG	AG	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
specific	specific	ADJ	JJ	O
inhibitor	inhibitor	NOUN	NN	O
of	of	ADP	IN	O
inducible	inducible	ADJ	JJ	O
-	-	PUNCT	HYPH	O
NO	no	NOUN	NN	B-Chemical
synthase	synthase	NOUN	NN	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
day	day	NOUN	NN	O
21	21	NUM	CD	O
,	,	PUNCT	,	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
sacrificed	sacrifice	VERB	VBN	O
after	after	ADP	IN	O
obtaining	obtain	VERB	VBG	O
material	material	NOUN	NN	O
for	for	ADP	IN	O
biochemical	biochemical	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Histopathological	histopathological	ADJ	JJ	O
examination	examination	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
kidneys	kidney	NOUN	NNS	O
of	of	ADP	IN	O
rats	rat	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
ADR	ADR	PROPN	NNP	B-Chemical
revealed	reveal	VERB	VBD	O
focal	focal	ADJ	JJ	O
areas	area	NOUN	NNS	O
of	of	ADP	IN	O
mesangial	mesangial	ADJ	JJ	B-Disease
proliferation	proliferation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
mild	mild	ADJ	JJ	O
tubulointerstitial	tubulointerstitial	ADJ	JJ	B-Disease
inflammation	inflammation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

They	-PRON-	PRON	PRP	O
also	also	ADV	RB	O
had	have	VERB	VBD	O
significantly	significantly	ADV	RB	O
higher	high	ADJ	JJR	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
proteinuria	proteinuria	NOUN	NN	B-Disease
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
control	control	NOUN	NN	O
and	and	CCONJ	CC	O
treatment	treatment	NOUN	NN	O
groups	group	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Urine	urine	ADJ	JJ	O
nitrite	nitrite	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ADR	ADR	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
nephropathy	nephropathy	NOUN	NN	B-Disease
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
IPRK	IPRK	PROPN	NNP	O
phenylephrine	phenylephrine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
acetylcholine	acetylcholine	NOUN	NN	B-Chemical
related	related	ADJ	JJ	O
responses	response	NOUN	NNS	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
impaired	impair	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ADR	ADR	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
nephropathy	nephropathy	NOUN	NN	B-Disease
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Apoptosis	apoptosis	NOUN	NN	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
detected	detect	VERB	VBN	O
in	in	ADP	IN	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
ADR	ADR	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
nephropathy	nephropathy	NOUN	NN	B-Disease
group	group	NOUN	NN	O
,	,	PUNCT	,	O
numerous	numerous	ADJ	JJ	O
apoptotic	apoptotic	ADJ	JJ	O
cells	cell	NOUN	NNS	O
were	be	VERB	VBD	O
identified	identify	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
tubulointerstitial	tubulointerstitial	ADJ	JJ	O
areas	area	NOUN	NNS	O
.	.	PUNCT	.	O

Double	double	ADJ	JJ	O
staining	staining	NOUN	NN	O
revealed	reveal	VERB	VBD	O
numerous	numerous	ADJ	JJ	O
interstitial	interstitial	ADJ	JJ	O
apoptotic	apoptotic	ADJ	JJ	O
cells	cell	NOUN	NNS	O
to	to	PART	TO	O
stain	stain	VERB	VB	O
for	for	ADP	IN	O
ED1	ED1	PROPN	NNP	O
,	,	PUNCT	,	O
a	a	DET	DT	O
marker	marker	NOUN	NN	O
for	for	ADP	IN	O
monocytes	monocyte	NOUN	NNS	O
/	/	SYM	SYM	O
macrophages	macrophage	NOUN	NNS	O
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
AG	AG	PROPN	NNP	B-Chemical
prevented	prevent	VERB	VBD	O
the	the	DET	DT	O
impairment	impairment	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
vascular	vascular	ADJ	JJ	O
bed	bed	NOUN	NN	O
responses	response	NOUN	NNS	O
and	and	CCONJ	CC	O
reduced	reduce	VERB	VBD	O
both	both	DET	DT	O
urine	urine	ADJ	JJ	O
nitrite	nitrite	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
and	and	CCONJ	CC	O
apoptosis	apoptosis	NOUN	NN	O
to	to	PART	TO	O
control	control	VERB	VB	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
interactions	interaction	NOUN	NNS	O
between	between	ADP	IN	O
NO	no	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
apoptosis	apoptosis	NOUN	NN	O
are	be	VERB	VBP	O
important	important	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
pathogenesis	pathogenesis	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ADR	ADR	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrosis	nephrosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Dual	dual	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
melatonin	melatonin	NOUN	NN	B-Chemical
on	on	ADP	IN	O
barbiturate	barbiturate	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
narcosis	narcosis	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Melatonin	Melatonin	PROPN	NNP	B-Chemical
affects	affect	VERB	VBZ	O
the	the	DET	DT	O
circadian	circadian	ADJ	JJ	O
sleep	sleep	NOUN	NN	O
/	/	SYM	SYM	O
wake	wake	NOUN	NN	O
cycle	cycle	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
clear	clear	ADJ	JJ	O
whether	whether	ADP	IN	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
influence	influence	VERB	VB	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
narcosis	narcosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Sodium	sodium	NOUN	NN	B-Chemical
thiopenthal	thiopenthal	NOUN	NN	I-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
intraperitoneally	intraperitoneally	ADV	RB	O
into	into	ADP	IN	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
pre	pre	VERB	VBN	O
-	-	VERB	VBN	O
treated	treated	ADJ	JJ	O
with	with	ADP	IN	O
melatonin	melatonin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
and	and	CCONJ	CC	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Melatonin	Melatonin	PROPN	NNP	B-Chemical
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
affected	affect	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
dual	dual	ADJ	JJ	O
manner	manner	NOUN	NN	O
barbiturate	barbiturate	NOUN	NN	B-Chemical
narcosis	narcosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
no	no	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
effect	effect	NOUN	NN	O
correlation	correlation	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
particular	particular	ADJ	JJ	O
,	,	PUNCT	,	O
low	low	ADJ	JJ	O
doses	dose	NOUN	NNS	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
latency	latency	NOUN	NN	O
to	to	ADP	IN	O
and	and	CCONJ	CC	O
prolonged	prolong	VERB	VBD	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
barbiturate	barbiturate	NOUN	NN	B-Chemical
narcosis	narcosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
highest	high	ADJ	JJS	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
melatonin	melatonin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
caused	cause	VERB	VBD	O
a	a	DET	DT	O
paradoxical	paradoxical	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
latency	latency	NOUN	NN	O
and	and	CCONJ	CC	O
produced	produce	VERB	VBD	O
a	a	DET	DT	O
sustained	sustained	ADJ	JJ	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
narcosis	narcosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
mortality	mortality	NOUN	NN	O
rate	rate	NOUN	NN	O
.	.	PUNCT	.	O

Melatonin	Melatonin	PROPN	NNP	B-Chemical
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
and	and	CCONJ	CC	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
influenced	influence	VERB	VBD	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
the	the	DET	DT	O
latency	latency	NOUN	NN	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
or	or	CCONJ	CC	O
diazepam	diazepam	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
narcosis	narcosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
dual	dual	ADJ	JJ	O
action	action	NOUN	NN	O
of	of	ADP	IN	O
melatonin	melatonin	NOUN	NN	B-Chemical
on	on	ADP	IN	O
pharmacological	pharmacological	ADJ	JJ	O
narcosis	narcosis	NOUN	NN	B-Disease
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
specific	specific	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
barbiturate	barbiturate	NOUN	NN	B-Chemical
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
action	action	NOUN	NN	O
.	.	PUNCT	.	O

Reduced	reduce	VERB	VBN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
preserved	preserve	VERB	VBD	O
antitumor	antitumor	CCONJ	CC	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
liposome	liposome	NOUN	NN	O
-	-	PUNCT	HYPH	O
encapsulated	encapsulate	VERB	VBN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
conventional	conventional	ADJ	JJ	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
a	a	DET	DT	O
randomized	randomized	ADJ	JJ	O
,	,	PUNCT	,	O
multicenter	multicenter	NOUN	NN	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
metastatic	metastatic	ADJ	JJ	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
determine	determine	VERB	VB	O
whether	whether	ADP	IN	O
Myocet	Myocet	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
liposome	liposome	ADV	RB	O
-	-	PUNCT	HYPH	O
encapsulated	encapsulate	VERB	VBN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
;	;	PUNCT	:	O
The	the	DET	DT	O
Liposome	Liposome	PROPN	NNP	O
Company	Company	PROPN	NNP	O
,	,	PUNCT	,	O
Elan	Elan	PROPN	NNP	O
Corporation	Corporation	PROPN	NNP	O
,	,	PUNCT	,	O
Princeton	Princeton	PROPN	NNP	O
,	,	PUNCT	,	O
NJ	NJ	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
significantly	significantly	ADV	RB	O
reduces	reduce	VERB	VBZ	O
doxorubicin	doxorubicin	ADJ	JJ	B-Chemical
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
while	while	ADP	IN	O
providing	provide	VERB	VBG	O
comparable	comparable	ADJ	JJ	O
antitumor	antitumor	CCONJ	CC	O
efficacy	efficacy	NOUN	NN	O
in	in	ADP	IN	O
first	first	ADJ	JJ	O
-	-	PUNCT	HYPH	O
line	line	NOUN	NN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
metastatic	metastatic	ADJ	JJ	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
MBC	MBC	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Two	two	NUM	CD	O
hundred	hundred	NUM	CD	O
ninety	ninety	NUM	CD	O
-	-	PUNCT	HYPH	O
seven	seven	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
MBC	MBC	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
no	no	DET	DT	O
prior	prior	ADJ	JJ	O
chemotherapy	chemotherapy	NOUN	NN	O
for	for	ADP	IN	O
metastatic	metastatic	ADJ	JJ	O
disease	disease	NOUN	NN	O
were	be	VERB	VBD	O
randomized	randomize	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
either	either	CCONJ	CC	O
60	60	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m	m	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
Myocet	Myocet	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
M	M	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
conventional	conventional	ADJ	JJ	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
A	a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
600	600	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m	m	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
C	C	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
every	every	DET	DT	O
3	3	NUM	CD	O
weeks	week	NOUN	NNS	O
until	until	ADP	IN	O
disease	disease	NOUN	NN	O
progression	progression	NOUN	NN	O
or	or	CCONJ	CC	O
unacceptable	unacceptable	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Cardiotoxicity	Cardiotoxicity	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
defined	define	VERB	VBN	O
by	by	ADP	IN	O
reductions	reduction	NOUN	NNS	O
in	in	ADP	IN	O
left	left	ADJ	JJ	O
-	-	PUNCT	HYPH	O
ventricular	ventricular	ADJ	JJ	O
ejection	ejection	NOUN	NN	O
fraction	fraction	NOUN	NN	O
,	,	PUNCT	,	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
serial	serial	ADJ	JJ	O
multigated	multigate	VERB	VBN	O
radionuclide	radionuclide	ADJ	JJ	O
angiography	angiography	ADJ	JJ	O
scans	scan	NOUN	NNS	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
congestive	congestive	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
CHF	CHF	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Antitumor	Antitumor	PROPN	NNP	O
efficacy	efficacy	NOUN	NN	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
objective	objective	ADJ	JJ	O
tumor	tumor	NOUN	NN	B-Disease
response	response	NOUN	NN	O
rates	rate	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
World	World	PROPN	NNP	O
Health	Health	PROPN	NNP	O
Organization	Organization	PROPN	NNP	O
criteria	criterion	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
time	time	NOUN	NN	O
to	to	ADP	IN	O
progression	progression	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
survival	survival	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Six	six	NUM	CD	O
percent	percent	NOUN	NN	O
of	of	ADP	IN	O
MC	MC	PROPN	NNP	O
patients	patient	NOUN	NNS	O
versus	versus	ADP	IN	O
21	21	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
including	include	VERB	VBG	O
five	five	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
CHF	CHF	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
AC	AC	PROPN	NNP	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	X	XX	O
.	.	PUNCT	.	O
0002	0002	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Median	median	ADJ	JJ	O
cumulative	cumulative	ADJ	JJ	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
at	at	ADP	IN	O
onset	onset	NOUN	NN	O
was	be	VERB	VBD	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
220	220	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m	m	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
MC	MC	PROPN	NNP	O
versus	versus	ADP	IN	O
480	480	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m	m	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
AC	AC	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	X	XX	O
.	.	PUNCT	.	O
0001	0001	NUM	CD	O
,	,	PUNCT	,	O
hazard	hazard	NOUN	NN	O
ratio	ratio	NOUN	NN	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
04	04	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

MC	MC	PROPN	NNP	O
patients	patient	NOUN	NNS	O
also	also	ADV	RB	O
experienced	experience	VERB	VBD	O
less	less	ADJ	JJR	O
grade	grade	NOUN	NN	O
4	4	NUM	CD	O
neutropenia	neutropenia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Antitumor	Antitumor	PROPN	NNP	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
MC	MC	PROPN	NNP	O
versus	versus	ADP	IN	O
AC	AC	PROPN	NNP	O
was	be	VERB	VBD	O
comparable	comparable	ADJ	JJ	O
:	:	PUNCT	:	O
objective	objective	ADJ	JJ	O
response	response	NOUN	NN	O
rates	rate	NOUN	NNS	O
,	,	PUNCT	,	O
43	43	NUM	CD	O
%	%	NOUN	NN	O
versus	versus	ADP	IN	O
43	43	NUM	CD	O
%	%	NOUN	NN	O
;	;	PUNCT	,	O
median	median	ADJ	JJ	O
time	time	NOUN	NN	O
to	to	ADP	IN	O
progression	progression	NOUN	NN	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
versus	versus	ADP	IN	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
months	month	NOUN	NNS	O
;	;	PUNCT	:	O
median	median	ADJ	JJ	O
time	time	NOUN	NN	O
to	to	ADP	IN	O
treatment	treatment	NOUN	NN	O
failure	failure	NOUN	NN	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
versus	versus	ADP	IN	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
months	month	NOUN	NNS	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
median	median	ADJ	JJ	O
survival	survival	NOUN	NN	O
,	,	PUNCT	,	O
19	19	NUM	CD	O
versus	versus	ADP	IN	O
16	16	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Myocet	Myocet	PROPN	NNP	B-Chemical
improves	improve	VERB	VBZ	O
the	the	DET	DT	O
therapeutic	therapeutic	ADJ	JJ	O
index	index	NOUN	NN	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
by	by	ADP	IN	O
significantly	significantly	ADV	RB	O
reducing	reduce	VERB	VBG	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
grade	grade	NOUN	NN	O
4	4	NUM	CD	O
neutropenia	neutropenia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
provides	provide	VERB	VBZ	O
comparable	comparable	ADJ	JJ	O
antitumor	antitumor	CCONJ	CC	O
efficacy	efficacy	NOUN	NN	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
as	as	ADP	IN	O
first	first	ADJ	JJ	O
-	-	PUNCT	HYPH	O
line	line	NOUN	NN	O
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
MBC	MBC	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
nitrergic	nitrergic	ADJ	JJ	O
system	system	NOUN	NN	O
in	in	ADP	IN	O
lidocaine	lidocaine	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsion	convulsion	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
mouse	mouse	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
nitro	nitro	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
L	l	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
arginine	arginine	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
ester	ester	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
NAME	NAME	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
a	a	DET	DT	O
nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NO	no	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
synthase	synthase	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
and	and	CCONJ	CC	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
arginine	arginine	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
NO	no	DET	DT	B-Chemical
precursor	precursor	NOUN	NN	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
on	on	ADP	IN	O
lidocaine	lidocaine	ADV	RBR	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
experiment	experiment	NOUN	NN	O
,	,	PUNCT	,	O
four	four	NUM	CD	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
mice	mouse	NOUN	NNS	O
received	receive	VERB	VBD	O
physiological	physiological	ADJ	JJ	O
saline	saline	NOUN	NN	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
arginine	arginine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
300	300	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
NAME	NAME	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
diazepam	diazepam	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Thirty	thirty	NUM	CD	O
minutes	minute	NOUN	NNS	O
after	after	ADP	IN	O
these	these	DET	DT	O
injections	injection	NOUN	NNS	O
,	,	PUNCT	,	O
all	all	DET	DT	O
mice	mouse	NOUN	NNS	O
received	receive	VERB	VBD	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
second	second	ADJ	JJ	O
experiment	experiment	NOUN	NN	O
,	,	PUNCT	,	O
four	four	NUM	CD	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
mice	mouse	NOUN	NNS	O
received	receive	VERB	VBD	O
similar	similar	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
experiment	experiment	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
after	after	ADP	IN	O
these	these	DET	DT	O
injections	injection	NOUN	NNS	O
,	,	PUNCT	,	O
all	all	DET	DT	O
mice	mouse	NOUN	NNS	O
received	receive	VERB	VBD	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
80	80	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
NAME	name	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
diazepam	diazepam	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
significantly	significantly	ADV	RB	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
arginine	arginine	NOUN	NN	I-Chemical
treatment	treatment	NOUN	NN	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
80	80	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
significantly	significantly	ADV	RB	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
may	may	VERB	MD	O
suggest	suggest	VERB	VB	O
that	that	ADP	IN	O
NO	no	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
proconvulsant	proconvulsant	ADJ	JJ	O
mediator	mediator	NOUN	NN	O
in	in	ADP	IN	O
lidocaine	lidocaine	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Erythropoietin	erythropoietin	NOUN	NN	O
restores	restore	VERB	VBZ	O
the	the	DET	DT	O
anemia	anemia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
cytotoxicity	cytotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
rat	rat	NOUN	NN	O
tumors	tumor	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
examine	examine	VERB	VB	O
the	the	DET	DT	O
impact	impact	NOUN	NN	O
of	of	ADP	IN	O
anemia	anemia	NOUN	NN	B-Disease
prevention	prevention	NOUN	NN	O
by	by	ADP	IN	O
recombinant	recombinant	ADJ	JJ	O
human	human	ADJ	JJ	O
erythropoietin	erythropoietin	NOUN	NN	O
(	(	PUNCT	-LRB-	O
rHuEPO	rhuepo	NOUN	NN	O
)	)	PUNCT	-RRB-	O
treatment	treatment	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
cytotoxicity	cytotoxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
solid	solid	ADJ	JJ	O
experimental	experimental	ADJ	JJ	O
tumors	tumor	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Anemia	Anemia	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
using	use	VERB	VBG	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
a	a	DET	DT	O
long	long	ADV	RB	O
-	-	PUNCT	HYPH	O
lasting	last	VERB	VBG	O
reduction	reduction	NOUN	NN	O
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
the	the	DET	DT	O
hemoglobin	hemoglobin	NOUN	NN	O
concentration	concentration	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
a	a	DET	DT	O
second	second	ADJ	JJ	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
anemia	anemia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
prevented	prevent	VERB	VBN	O
by	by	ADP	IN	O
rHuEPO	rhuepo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1000	1000	NUM	CD	O
IU	IU	PROPN	NNP	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
administered	administer	VERB	VBD	O
s	s	PRON	PRP	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
three	three	NUM	CD	O
times	time	NOUN	NNS	O
/	/	SYM	SYM	O
week	week	NOUN	NN	O
starting	start	VERB	VBG	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
before	before	ADP	IN	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
application	application	NOUN	NN	O
.	.	PUNCT	.	O

Four	four	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
carboplatin	carboplatin	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
tumors	tumor	NOUN	NNS	B-Disease
(	(	PUNCT	-LRB-	O
DS	DS	PROPN	NNP	O
-	-	PUNCT	HYPH	O
sarcoma	sarcoma	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
implanted	implant	VERB	VBN	O
s	s	PART	POS	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
onto	onto	ADP	IN	O
the	the	DET	DT	O
hind	hind	NOUN	NN	O
food	food	NOUN	NN	O
dorsum	dorsum	NOUN	NN	O
.	.	PUNCT	.	O

Neither	neither	DET	DT	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
nor	nor	CCONJ	CC	O
rHuEPO	rhuepo	NOUN	NN	O
treatment	treatment	NOUN	NN	O
influenced	influence	VERB	VBN	O
tumor	tumor	NOUN	NN	B-Disease
growth	growth	NOUN	NN	O
rate	rate	NOUN	NN	O
per	per	ADP	IN	O
se	se	X	FW	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
tumors	tumor	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
60	60	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
5	5	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
implantation	implantation	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
growth	growth	NOUN	NN	O
delay	delay	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
subsequent	subsequent	ADJ	JJ	O
regrowth	regrowth	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
tumors	tumor	NOUN	NNS	B-Disease
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
anemia	anemia	NOUN	NN	B-Disease
group	group	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
growth	growth	NOUN	NN	O
delay	delay	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
shorter	short	ADJ	JJR	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
nonanemic	nonanemic	ADJ	JJ	O
controls	control	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
13	13	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
days	day	NOUN	NNS	O
versus	versus	ADP	IN	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
days	day	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
group	group	NOUN	NN	O
where	where	ADV	WRB	O
anemia	anemia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
prevented	prevent	VERB	VBN	O
by	by	ADP	IN	O
rHuEPO	rhuepo	NOUN	NN	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
growth	growth	NOUN	NN	O
delay	delay	NOUN	NN	O
was	be	VERB	VBD	O
comparable	comparable	ADJ	JJ	O
with	with	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
nonanemic	nonanemic	ADJ	JJ	O
controls	control	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
13	13	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
days	day	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	DET	DT	O
chemotherapy	chemotherapy	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
anemia	anemia	NOUN	NN	B-Disease
reduces	reduce	VERB	VBZ	O
cytotoxicity	cytotoxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
tumors	tumor	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
correction	correction	NOUN	NN	O
of	of	ADP	IN	O
anemia	anemia	NOUN	NN	B-Disease
by	by	ADP	IN	O
rHuEPO	rhuepo	NOUN	NN	O
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
epoetin	epoetin	NOUN	NN	O
alpha	alpha	NOUN	NN	O
)	)	PUNCT	-RRB-	O
increases	increase	VERB	VBZ	O
the	the	DET	DT	O
sensitivity	sensitivity	NOUN	NN	O
,	,	PUNCT	,	O
probably	probably	ADV	RB	O
as	as	ADP	IN	O
a	a	DET	DT	O
result	result	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
improved	improve	VERB	VBN	O
oxygen	oxygen	NOUN	NN	B-Chemical
supply	supply	NOUN	NN	O
to	to	PART	TO	O
tumor	tumor	NOUN	NN	B-Disease
tissue	tissue	NOUN	NN	O
.	.	PUNCT	.	O

Fatal	Fatal	PROPN	NNP	O
haemorrhagic	haemorrhagic	ADJ	JJ	B-Disease
myocarditis	myocarditis	NOUN	NN	I-Disease
secondary	secondary	ADJ	JJ	O
to	to	PART	TO	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Haemorrhagic	haemorrhagic	ADJ	JJ	B-Disease
myocarditis	myocarditis	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
rare	rare	ADJ	JJ	O
but	but	CCONJ	CC	O
important	important	ADJ	JJ	O
complication	complication	NOUN	NN	O
of	of	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Echocardiographic	echocardiographic	ADJ	JJ	O
identification	identification	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
disorder	disorder	NOUN	NN	O
can	can	VERB	MD	O
be	be	VERB	VB	O
made	make	VERB	VBN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
believe	believe	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
ultrasound	ultrasound	NOUN	NN	O
features	feature	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
disorder	disorder	NOUN	NN	O
have	have	VERB	VBP	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
previously	previously	ADV	RB	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
verapamil	verapamil	NOUN	NN	B-Chemical
on	on	ADP	IN	O
atrial	atrial	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
electrophysiological	electrophysiological	ADJ	JJ	O
determinants	determinant	NOUN	NNS	O
in	in	ADP	IN	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Atrial	atrial	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
remodeling	remodeling	NOUN	NN	O
promotes	promote	VERB	VBZ	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
and	and	CCONJ	CC	O
maintenance	maintenance	NOUN	NN	O
of	of	ADP	IN	O
atrial	atrial	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
AF	AF	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
decreases	decrease	VERB	VBZ	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
type	type	NOUN	NN	O
Ca	ca	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
+	+	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
current	current	ADJ	JJ	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
is	be	VERB	VBZ	O
also	also	ADV	RB	O
a	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
suggestion	suggestion	NOUN	NN	O
that	that	DET	WDT	O
acute	acute	ADJ	JJ	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
type	type	NOUN	NN	O
Ca	ca	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
channel	channel	NOUN	NN	O
blockade	blockade	NOUN	NN	O
can	can	VERB	MD	O
promote	promote	VERB	VB	O
AF	AF	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
an	an	DET	DT	O
AF	AF	PROPN	NNP	B-Disease
promoting	promote	VERB	VBG	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
Ca	Ca	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
+	+	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
channel	channel	NOUN	NN	O
inhibition	inhibition	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
To	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
potential	potential	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
AF	AF	PROPN	NNP	B-Disease
promotion	promotion	NOUN	NN	O
by	by	ADP	IN	O
Ca	Ca	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
+	+	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
channel	channel	NOUN	NN	O
blockers	blocker	NOUN	NNS	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
administered	administer	VERB	VBD	O
verapamil	verapamil	NOUN	NN	B-Chemical
to	to	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
chloralose	chloralose	ADJ	JJ	B-Chemical
anesthetized	anesthetized	ADJ	JJ	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

Diltiazem	Diltiazem	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
used	use	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
comparison	comparison	NOUN	NN	O
drug	drug	NOUN	NN	O
and	and	CCONJ	CC	O
autonomic	autonomic	ADJ	JJ	O
blockade	blockade	NOUN	NN	O
with	with	ADP	IN	O
atropine	atropine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
nadolol	nadolol	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
applied	apply	VERB	VBN	O
in	in	ADP	IN	O
some	some	DET	DT	O
experiments	experiment	NOUN	NNS	O
.	.	PUNCT	.	O

Epicardial	epicardial	ADJ	JJ	O
mapping	mapping	NOUN	NN	O
with	with	ADP	IN	O
240	240	NUM	CD	O
epicardial	epicardial	ADJ	JJ	O
electrodes	electrode	NOUN	NNS	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
activation	activation	NOUN	NN	O
during	during	ADP	IN	O
AF	AF	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Verapamil	Verapamil	PROPN	NNP	B-Chemical
caused	cause	VERB	VBD	O
AF	AF	PROPN	NNP	B-Disease
promotion	promotion	NOUN	NN	O
in	in	ADP	IN	O
six	six	NUM	CD	O
dogs	dog	NOUN	NNS	O
,	,	PUNCT	,	O
increasing	increase	VERB	VBG	O
mean	mean	ADJ	JJ	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
AF	AF	PROPN	NNP	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
burst	burst	NOUN	NN	O
pacing	pacing	NOUN	NN	O
,	,	PUNCT	,	O
from	from	ADP	IN	O
8	8	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
4	4	NUM	CD	O
s	s	NOUN	NN	O
(	(	PUNCT	-LRB-	O
mean	mean	ADJ	JJ	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
S	s	NOUN	NN	O
.	.	PUNCT	.	O
E	e	NOUN	NN	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
95	95	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
39	39	NUM	CD	O
s	s	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
vs	vs	NOUN	NN	O
.	.	PUNCT	.	O
control	control	NOUN	NN	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
a	a	DET	DT	O
loading	loading	NOUN	NN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
and	and	CCONJ	CC	O
228	228	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
101	101	NUM	CD	O
s	s	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0005	0005	NUM	CD	O
vs	vs	NOUN	NN	O
.	.	PUNCT	.	O
control	control	NOUN	NN	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O

Underlying	underlie	VERB	VBG	O
electrophysiological	electrophysiological	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
in	in	ADP	IN	O
detail	detail	NOUN	NN	O
in	in	ADP	IN	O
five	five	NUM	CD	O
additional	additional	ADJ	JJ	O
dogs	dog	NOUN	NNS	O
under	under	ADP	IN	O
control	control	NOUN	NN	O
conditions	condition	NOUN	NNS	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
higher	high	ADJ	JJR	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
verapamil	verapamil	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
these	these	DET	DT	O
experiments	experiment	NOUN	NNS	O
,	,	PUNCT	,	O
verapamil	verapamil	NOUN	NN	B-Chemical
shortened	shorten	VERB	VBN	O
mean	mean	ADJ	JJ	O
effective	effective	ADJ	JJ	O
refractory	refractory	ADJ	JJ	O
period	period	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ERP	ERP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
from	from	ADP	IN	O
122	122	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
to	to	ADP	IN	O
114	114	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
4	4	NUM	CD	O
ms	ms	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
02	02	NUM	CD	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
a	a	DET	DT	O
cycle	cycle	NOUN	NN	O
length	length	NOUN	NN	O
of	of	ADP	IN	O
300	300	NUM	CD	O
ms	m	NOUN	NNS	O
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
ERP	ERP	PROPN	NNP	O
heterogeneity	heterogeneity	NOUN	NN	O
(	(	PUNCT	-LRB-	O
from	from	ADP	IN	O
15	15	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
to	to	ADP	IN	O
10	10	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
heterogeneously	heterogeneously	ADV	RB	O
accelerated	accelerate	VERB	VBD	O
atrial	atrial	ADJ	JJ	O
conduction	conduction	NOUN	NN	O
and	and	CCONJ	CC	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
cycle	cycle	NOUN	NN	O
length	length	NOUN	NN	O
of	of	ADP	IN	O
AF	AF	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
94	94	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
4	4	NUM	CD	O
to	to	ADP	IN	O
84	84	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
ms	ms	NOUN	NN	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
005	005	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Diltiazem	Diltiazem	PROPN	NNP	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
affect	affect	VERB	VB	O
ERP	ERP	PROPN	NNP	O
,	,	PUNCT	,	O
AF	AF	PROPN	NNP	B-Disease
cycle	cycle	NOUN	NN	O
length	length	NOUN	NN	O
or	or	CCONJ	CC	O
AF	AF	PROPN	NNP	B-Disease
duration	duration	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
produced	produce	VERB	VBD	O
conduction	conduction	NOUN	NN	O
acceleration	acceleration	NOUN	NN	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
that	that	DET	DT	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
verapamil	verapamil	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
5	5	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
autonomic	autonomic	ADJ	JJ	O
blockade	blockade	NOUN	NN	O
,	,	PUNCT	,	O
verapamil	verapamil	NOUN	NN	B-Chemical
failed	fail	VERB	VBD	O
to	to	PART	TO	O
promote	promote	VERB	VB	O
AF	AF	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
increased	increase	VERB	VBD	O
,	,	PUNCT	,	O
rather	rather	ADV	RB	O
than	than	ADP	IN	O
decreasing	decrease	VERB	VBG	O
,	,	PUNCT	,	O
refractoriness	refractoriness	NOUN	NN	O
.	.	PUNCT	.	O

Neither	neither	DET	DT	O
verapamil	verapamil	NOUN	NN	B-Chemical
nor	nor	CCONJ	CC	O
diltiazem	diltiazem	ADJ	JJ	B-Chemical
affected	affected	ADJ	JJ	O
atrial	atrial	ADJ	JJ	O
conduction	conduction	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
autonomic	autonomic	ADJ	JJ	O
blockade	blockade	NOUN	NN	O
.	.	PUNCT	.	O

Epicardial	epicardial	ADJ	JJ	O
mapping	mapping	NOUN	NN	O
suggested	suggest	VERB	VBD	O
that	that	ADP	IN	O
verapamil	verapamil	NOUN	NN	B-Chemical
promoted	promote	VERB	VBN	O
AF	AF	PROPN	NNP	B-Disease
by	by	ADP	IN	O
increasing	increase	VERB	VBG	O
the	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
simultaneous	simultaneous	ADJ	JJ	O
wavefronts	wavefront	NOUN	NNS	O
reflected	reflect	VERB	VBN	O
by	by	ADP	IN	O
separate	separate	ADJ	JJ	O
zones	zone	NOUN	NNS	O
of	of	ADP	IN	O
reactivation	reactivation	NOUN	NN	O
in	in	ADP	IN	O
each	each	DET	DT	O
cycle	cycle	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Verapamil	Verapamil	PROPN	NNP	B-Chemical
promotes	promote	VERB	VBZ	O
AF	AF	PROPN	NNP	B-Disease
in	in	ADP	IN	O
normal	normal	ADJ	JJ	O
dogs	dog	NOUN	NNS	O
by	by	ADP	IN	O
promoting	promote	VERB	VBG	O
multiple	multiple	ADJ	JJ	O
circuit	circuit	NOUN	NN	O
reentry	reentry	NOUN	NN	O
,	,	PUNCT	,	O
an	an	DET	DT	O
effect	effect	NOUN	NN	O
dependent	dependent	ADJ	JJ	O
on	on	ADP	IN	O
intact	intact	ADJ	JJ	O
autonomic	autonomic	ADJ	JJ	O
tone	tone	NOUN	NN	O
and	and	CCONJ	CC	O
not	not	ADV	RB	O
shared	share	VERB	VBN	O
by	by	ADP	IN	O
diltiazem	diltiazem	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

Calcitonin	calcitonin	ADJ	JJ	O
gene	gene	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
peptide	peptide	NOUN	NN	O
levels	level	NOUN	NNS	O
during	during	ADP	IN	O
nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
headache	headache	NOUN	NN	B-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	O
tension	tension	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
type	type	NOUN	NN	I-Disease
headache	headache	NOUN	NN	I-Disease
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
proposed	propose	VERB	VBN	O
that	that	ADP	IN	O
nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NO	NO	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
induced	induced	ADJ	JJ	O
headache	headache	NOUN	NN	B-Disease
in	in	ADP	IN	O
primary	primary	ADJ	JJ	B-Disease
headaches	headache	NOUN	NNS	I-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
release	release	NOUN	NN	O
of	of	ADP	IN	O
calcitonin	calcitonin	ADJ	JJ	O
gene	gene	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
peptide	peptide	NOUN	NN	O
(	(	PUNCT	-LRB-	O
CGRP	CGRP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
we	-PRON-	PRON	PRP	O
aimed	aim	VERB	VBD	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
plasma	plasma	NOUN	NN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
CGRP	CGRP	NOUN	NNS	O
during	during	ADP	IN	O
headache	headache	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
NO	no	DET	DT	B-Chemical
donor	donor	NOUN	NN	O
glyceryl	glyceryl	NOUN	NN	B-Chemical
trinitrate	trinitrate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
GTN	GTN	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
16	16	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	O
tension	tension	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
type	type	NOUN	NN	I-Disease
headache	headache	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
16	16	NUM	CD	O
healthy	healthy	ADJ	JJ	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
subjects	subject	NOUN	NNS	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
allocated	allocate	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
GTN	GTN	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
over	over	ADP	IN	O
20	20	NUM	CD	O
min	min	NOUN	NN	O
on	on	ADP	IN	O
two	two	NUM	CD	O
headache	headache	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Blood	blood	NOUN	NN	O
samples	sample	NOUN	NNS	O
were	be	VERB	VBD	O
collected	collect	VERB	VBN	O
at	at	ADP	IN	O
baseline	baseline	NOUN	NN	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
,	,	PUNCT	,	O
20	20	NUM	CD	O
and	and	CCONJ	CC	O
60	60	NUM	CD	O
min	min	NOUN	NN	O
after	after	ADP	IN	O
start	start	NOUN	NN	O
of	of	ADP	IN	O
infusion	infusion	NOUN	NN	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
patients	patient	NOUN	NNS	O
and	and	CCONJ	CC	O
controls	control	NOUN	NNS	O
developed	develop	VERB	VBD	O
significantly	significantly	ADV	RB	O
stronger	strong	ADJ	JJR	O
immediate	immediate	ADJ	JJ	O
headache	headache	NOUN	NN	B-Disease
on	on	ADP	IN	O
the	the	DET	DT	O
GTN	GTN	PROPN	NNP	B-Chemical
day	day	NOUN	NN	O
than	than	ADP	IN	O
on	on	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
day	day	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
headache	headache	NOUN	NN	B-Disease
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
more	more	ADV	RBR	O
pronounced	pronounced	ADJ	JJ	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
than	than	ADP	IN	O
in	in	ADP	IN	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
difference	difference	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
area	area	NOUN	NN	O
under	under	ADP	IN	O
the	the	DET	DT	O
CGRP	CGRP	PROPN	NNP	O
curve	curve	NOUN	NN	O
(	(	PUNCT	-LRB-	O
AUCCGRP	AUCCGRP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
GTN	GTN	PROPN	NNP	B-Chemical
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
placebo	placebo	NOUN	NN	O
day	day	NOUN	NN	O
in	in	ADP	IN	O
either	either	DET	DT	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
65	65	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
controls	control	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
48	48	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
AUCCGRP	auccgrp	NOUN	NN	O
recorded	record	VERB	VBD	O
on	on	ADP	IN	O
the	the	DET	DT	O
GTN	GTN	PROPN	NNP	B-Chemical
day	day	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
differ	differ	VERB	VB	O
between	between	ADP	IN	O
patients	patient	NOUN	NNS	O
and	and	CCONJ	CC	O
controls	control	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
36	36	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
and	and	CCONJ	CC	O
controls	control	NOUN	NNS	O
,	,	PUNCT	,	O
CGRP	CGRP	PROPN	NNP	O
levels	level	NOUN	NNS	O
changed	change	VERB	VBD	O
significantly	significantly	ADV	RB	O
over	over	ADP	IN	O
time	time	NOUN	NN	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
GTN	GTN	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
days	day	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
indicates	indicate	VERB	VBZ	O
that	that	ADP	IN	O
NO	no	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
immediate	immediate	ADJ	JJ	O
headache	headache	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
not	not	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
release	release	NOUN	NN	O
of	of	ADP	IN	O
CGRP	CGRP	PROPN	NNP	O
.	.	PUNCT	.	O

Fluconazole	fluconazole	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
torsade	torsade	NOUN	NN	B-Disease
de	de	X	FW	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
present	present	VERB	VB	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
fluconazole	fluconazole	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
torsade	torsade	NOUN	NN	B-Disease
de	de	X	FW	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
TDP	TDP	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
discuss	discuss	VERB	VB	O
fluconazole	fluconazole	NOUN	NN	B-Chemical
'	'	PUNCT	''	O
s	s	PART	POS	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
causing	cause	VERB	VBG	O
TDP	tdp	NOUN	NN	B-Disease
.	.	PUNCT	.	O

CASE	case	NOUN	NN	O
SUMMARY	summary	NOUN	NN	O
:	:	PUNCT	:	O
A	a	DET	DT	O
68	68	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
white	white	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
Candida	Candida	PROPN	NNP	O
glabrata	glabrata	NOUN	NN	O
isolated	isolate	VERB	VBD	O
from	from	ADP	IN	O
a	a	DET	DT	O
presacral	presacral	ADJ	JJ	O
abscess	abscess	NOUN	NN	O
developed	develop	VERB	VBD	O
TDP	tdp	NOUN	NN	B-Disease
eight	eight	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
commencing	commence	VERB	VBG	O
oral	oral	ADJ	JJ	O
fluconazole	fluconazole	NOUN	NN	B-Chemical
The	the	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
no	no	DET	DT	O
other	other	ADJ	JJ	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
for	for	ADP	IN	O
TDP	TDP	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
including	include	VERB	VBG	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
cardiomyopathy	cardiomyopathy	ADJ	JJ	B-Disease
,	,	PUNCT	,	O
congestive	congestive	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
electrolyte	electrolyte	NOUN	NN	O
abnormalities	abnormality	NOUN	NNS	O
There	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
temporal	temporal	ADJ	JJ	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
fluconazole	fluconazole	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
TDP	tdp	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
TDP	tdp	NOUN	NN	B-Disease
resolved	resolve	VERB	VBD	O
when	when	ADV	WRB	O
fluconazole	fluconazole	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
;	;	PUNCT	:	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
continued	continue	VERB	VBD	O
to	to	PART	TO	O
have	have	VERB	VB	O
premature	premature	ADJ	JJ	B-Disease
ventricular	ventricular	ADJ	JJ	I-Disease
contractions	contraction	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
nonsustained	nonsustaine	VERB	VBD	O
ventricular	ventricular	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
NSVT	NSVT	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
until	until	ADP	IN	O
six	six	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
drug	drug	NOUN	NN	O
cessation	cessation	NOUN	NN	O
DISCUSSION	discussion	NOUN	NN	O
:	:	PUNCT	:	O
Use	use	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
Naranjo	Naranjo	PROPN	NNP	O
probability	probability	NOUN	NN	O
scale	scale	NOUN	NN	O
indicates	indicate	VERB	VBZ	O
a	a	DET	DT	O
probable	probable	ADJ	JJ	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
fluconazole	fluconazole	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
TDP	TDP	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
possible	possible	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
is	be	VERB	VBZ	O
depression	depression	NOUN	NN	B-Disease
of	of	ADP	IN	O
rapidly	rapidly	ADV	RB	O
activating	activate	VERB	VBG	O
delayed	delay	VERB	VBN	O
rectifier	rectifi	ADJ	JJR	O
potassium	potassium	NOUN	NN	B-Chemical
currents	current	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
our	-PRON-	DET	PRP$	O
patient	patient	NOUN	NN	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
other	other	ADJ	JJ	O
etiology	etiology	NOUN	NN	O
identified	identify	VERB	VBD	O
that	that	DET	WDT	O
could	could	VERB	MD	O
explain	explain	VERB	VB	O
QT	QT	PROPN	NNP	B-Disease
prolongation	prolongation	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
TDP	tdp	NOUN	NN	B-Disease
The	the	DET	DT	O
complete	complete	ADJ	JJ	O
disappearance	disappearance	NOUN	NN	O
of	of	ADP	IN	O
NSVT	NSVT	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
premature	premature	ADJ	JJ	B-Disease
ventricular	ventricular	ADJ	JJ	I-Disease
contractions	contraction	NOUN	NNS	I-Disease
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
normalization	normalization	NOUN	NN	O
of	of	ADP	IN	O
QT	QT	PROPN	NNP	O
interval	interval	NOUN	NN	O
after	after	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
was	be	VERB	VBD	O
stopped	stop	VERB	VBN	O
strongly	strongly	ADV	RB	O
suggests	suggest	VERB	VBZ	O
fluconazole	fluconazole	NOUN	NN	B-Chemical
as	as	ADP	IN	O
the	the	DET	DT	O
etiology	etiology	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Clinicians	clinician	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
that	that	DET	DT	O
fluconazole	fluconazole	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
even	even	ADV	RB	O
at	at	ADP	IN	O
low	low	ADJ	JJ	O
doses	dose	NOUN	NNS	O
,	,	PUNCT	,	O
may	may	VERB	MD	O
cause	cause	VERB	VB	O
prolongation	prolongation	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
QT	QT	PROPN	NNP	I-Disease
interval	interval	NOUN	NN	I-Disease
,	,	PUNCT	,	O
leading	lead	VERB	VBG	O
to	to	ADP	IN	O
TDP	TDP	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Serial	serial	ADJ	JJ	O
electrocardiographic	electrocardiographic	ADJ	JJ	O
monitoring	monitoring	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
when	when	ADV	WRB	O
fluconazole	fluconazole	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
administered	administer	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
are	be	VERB	VBP	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Cutaneous	cutaneous	ADJ	JJ	B-Disease
leucocytoclastic	leucocytoclastic	ADJ	JJ	I-Disease
vasculitis	vasculitis	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
oxacillin	oxacillin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
67	67	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
who	who	PRON	WP	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
oxacillin	oxacillin	NOUN	NN	B-Chemical
for	for	ADP	IN	O
one	one	NUM	CD	O
week	week	NOUN	NN	O
because	because	ADP	IN	O
of	of	ADP	IN	O
Staphylococcus	Staphylococcus	PROPN	NNP	B-Disease
aureus	aureus	NOUN	NN	I-Disease
bacteremia	bacteremia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
developed	develop	VERB	VBN	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
diffuse	diffuse	NOUN	NN	O
,	,	PUNCT	,	O
symmetric	symmetric	ADJ	JJ	O
,	,	PUNCT	,	O
palpable	palpable	ADJ	JJ	O
purpuric	purpuric	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
on	on	ADP	IN	O
his	-PRON-	DET	PRP$	O
feet	foot	NOUN	NNS	O
.	.	PUNCT	.	O

Necrotic	necrotic	ADJ	JJ	B-Disease
blisters	blister	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
noted	note	VERB	VBN	O
on	on	ADP	IN	O
his	-PRON-	DET	PRP$	O
fingers	finger	NOUN	NNS	O
.	.	PUNCT	.	O

Skin	skin	NOUN	NN	O
biopsies	biopsy	NOUN	NNS	O
showed	show	VERB	VBD	O
findings	finding	NOUN	NNS	O
diagnostic	diagnostic	ADJ	JJ	O
of	of	ADP	IN	O
leucocytoclastic	leucocytoclastic	ADJ	JJ	B-Disease
vasculitis	vasculitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Oxacillin	Oxacillin	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
and	and	CCONJ	CC	O
patient	patient	ADJ	JJ	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
corticosteroids	corticosteroid	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
rash	rash	NOUN	NN	B-Disease
disappeared	disappear	VERB	VBD	O
after	after	ADP	IN	O
three	three	NUM	CD	O
weeks	week	NOUN	NNS	O
and	and	CCONJ	CC	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
returned	return	VERB	VBD	O
to	to	ADP	IN	O
normal	normal	ADJ	JJ	O
.	.	PUNCT	.	O

Leucocytoclastic	leucocytoclastic	ADJ	JJ	B-Disease
vasculitis	vasculitis	NOUN	NN	I-Disease
presents	present	VERB	VBZ	O
as	as	ADP	IN	O
palpable	palpable	ADJ	JJ	O
purpura	purpura	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
lower	low	ADJ	JJR	O
extremities	extremity	NOUN	NNS	O
often	often	ADV	RB	O
accompanied	accompany	VERB	VBN	O
by	by	ADP	IN	O
abdominal	abdominal	ADJ	JJ	B-Disease
pain	pain	NOUN	NN	I-Disease
,	,	PUNCT	,	O
arthralgia	arthralgia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
renal	renal	ADJ	JJ	B-Disease
involvement	involvement	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Etiologic	etiologic	ADJ	JJ	O
factors	factor	NOUN	NNS	O
or	or	CCONJ	CC	O
associated	associate	VERB	VBN	O
disorders	disorder	NOUN	NNS	O
include	include	VERB	VBP	O
infections	infection	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
medications	medication	NOUN	NNS	O
,	,	PUNCT	,	O
collagen	collagen	NOUN	NN	B-Disease
vascular	vascular	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
neoplasia	neoplasia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
half	half	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cases	case	NOUN	NNS	O
no	no	DET	DT	O
etiologic	etiologic	ADJ	JJ	O
factor	factor	NOUN	NN	O
is	be	VERB	VBZ	O
identified	identify	VERB	VBN	O
.	.	PUNCT	.	O

Usually	usually	ADV	RB	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
self	self	NOUN	NN	O
-	-	PUNCT	HYPH	O
limited	limit	VERB	VBN	O
disorder	disorder	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
corticosteroid	corticosteroid	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
needed	need	VERB	VBN	O
in	in	ADP	IN	O
life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
threatening	threaten	VERB	VBG	O
cases	case	NOUN	NNS	O
since	since	ADP	IN	O
early	early	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
corticosteroids	corticosteroid	NOUN	NNS	B-Chemical
in	in	ADP	IN	O
severe	severe	ADJ	JJ	O
cases	case	NOUN	NNS	O
can	can	VERB	MD	O
prevent	prevent	VERB	VB	O
complications	complication	NOUN	NNS	O
.	.	PUNCT	.	O

Oxacillin	Oxacillin	PROPN	NNP	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
included	include	VERB	VBN	O
among	among	ADP	IN	O
the	the	DET	DT	O
drugs	drug	NOUN	NNS	O
that	that	DET	WDT	O
can	can	VERB	MD	O
cause	cause	VERB	VB	O
leucocytoclastic	leucocytoclastic	ADJ	JJ	B-Disease
vasculitis	vasculitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
renal	renal	ADJ	JJ	O
pathology	pathology	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
diabetes	diabetes	NOUN	NN	B-Disease
insipidus	insipidus	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
diabetes	diabetes	NOUN	NN	B-Disease
insipidus	insipidus	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
necropsy	necropsy	ADJ	JJ	O
microscopy	microscopy	NOUN	NN	O
shoed	shoed	NOUN	NN	O
unique	unique	ADJ	JJ	O
and	and	CCONJ	CC	O
extensive	extensive	ADJ	JJ	O
damage	damage	NOUN	NN	O
to	to	ADP	IN	O
cells	cell	NOUN	NNS	O
lining	line	VERB	VBG	O
the	the	DET	DT	O
distal	distal	ADJ	JJ	O
nephron	nephron	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
suggested	suggest	VERB	VBN	O
that	that	ADP	IN	O
these	these	DET	DT	O
changes	change	NOUN	NNS	O
represent	represent	VERB	VBP	O
a	a	DET	DT	O
specific	specific	ADJ	JJ	O
toxic	toxic	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
reported	report	VERB	VBN	O
here	here	ADV	RB	O
for	for	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
time	time	NOUN	NN	O
in	in	ADP	IN	O
man	man	NOUN	NN	O
.	.	PUNCT	.	O

Cholestatic	cholestatic	ADJ	JJ	B-Disease
jaundice	jaundice	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
metformin	metformin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
cholestatic	cholestatic	ADJ	JJ	B-Disease
jaundice	jaundice	NOUN	NN	I-Disease
shortly	shortly	ADV	RB	O
after	after	ADP	IN	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
metformin	metformin	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Ultrasound	Ultrasound	PROPN	NNP	O
of	of	ADP	IN	O
the	the	DET	DT	O
liver	liver	NOUN	NN	O
and	and	CCONJ	CC	O
abdominal	abdominal	ADJ	JJ	O
CT	CT	PROPN	NNP	O
were	be	VERB	VBD	O
normal	normal	ADJ	JJ	O
.	.	PUNCT	.	O

An	an	DET	DT	O
ERCP	ERCP	PROPN	NNP	O
showed	show	VERB	VBD	O
normal	normal	ADJ	JJ	O
biliary	biliary	ADJ	JJ	O
anatomy	anatomy	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
percutaneous	percutaneous	ADJ	JJ	O
liver	liver	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
was	be	VERB	VBD	O
obtained	obtain	VERB	VBN	O
showing	show	VERB	VBG	O
marked	marked	ADJ	JJ	O
cholestasis	cholestasis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
with	with	ADP	IN	O
portal	portal	ADJ	JJ	O
edema	edema	NOUN	NN	B-Disease
,	,	PUNCT	,	O
ductular	ductular	ADJ	JJ	O
proliferation	proliferation	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
acute	acute	ADJ	JJ	O
inflammation	inflammation	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Metformin	metformin	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
was	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	PART	POS	O
jaundice	jaundice	NOUN	NN	B-Disease
resolved	resolve	VERB	VBN	O
slowly	slowly	ADV	RB	O
over	over	ADP	IN	O
a	a	DET	DT	O
period	period	NOUN	NN	O
of	of	ADP	IN	O
several	several	ADJ	JJ	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Given	give	VERB	VBN	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
his	-PRON-	DET	PRP$	O
jaundice	jaundice	NOUN	NN	B-Disease
2	2	NUM	CD	O
wk	wk	ADV	RB	O
after	after	ADP	IN	O
the	the	DET	DT	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
metformin	metformin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
believe	believe	VERB	VBP	O
that	that	ADP	IN	O
this	this	DET	DT	O
case	case	NOUN	NN	O
represents	represent	VERB	VBZ	O
an	an	DET	DT	O
example	example	NOUN	NN	O
of	of	ADP	IN	O
metformin	metformin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
such	such	ADJ	JJ	O
case	case	NOUN	NN	O
reported	report	VERB	VBD	O
.	.	PUNCT	.	O

Systemic	systemic	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
resuscitation	resuscitation	NOUN	NN	O
in	in	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
levobupivacaine	levobupivacaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
ropivacaine	ropivacaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
infused	infuse	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
compared	compare	VERB	VBD	O
the	the	DET	DT	O
systemic	systemic	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
levobupivacaine	levobupivacaine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
ropivacaine	ropivacaine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
anesthetized	anesthetized	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
also	also	ADV	RB	O
compared	compare	VERB	VBD	O
the	the	DET	DT	O
ability	ability	NOUN	NN	O
to	to	PART	TO	O
resuscitate	resuscitate	VERB	VB	O
rats	rat	NOUN	NNS	O
after	after	ADP	IN	O
lethal	lethal	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
these	these	DET	DT	O
local	local	ADJ	JJ	O
anesthetics	anesthetic	NOUN	NNS	O
.	.	PUNCT	.	O

Bupivacaine	bupivacaine	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
levobupivacaine	levobupivacaine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
ropivacaine	ropivacaine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
infused	infuse	VERB	VBN	O
at	at	ADP	IN	O
a	a	DET	DT	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O

kg	kg	X	FW	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

min	min	X	FW	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
while	while	ADP	IN	O
electrocardiogram	electrocardiogram	NOUN	NN	O
,	,	PUNCT	,	O
electroencephalogram	electroencephalogram	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
were	be	VERB	VBD	O
continuously	continuously	ADV	RB	O
monitored	monitor	VERB	VBN	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
asystole	asystole	NOUN	NN	B-Disease
was	be	VERB	VBD	O
recorded	record	VERB	VBN	O
,	,	PUNCT	,	O
drug	drug	NOUN	NN	O
infusion	infusion	NOUN	NN	O
was	be	VERB	VBD	O
stopped	stop	VERB	VBN	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
resuscitation	resuscitation	NOUN	NN	O
sequence	sequence	NOUN	NN	O
was	be	VERB	VBD	O
begun	begin	VERB	VBN	O
.	.	PUNCT	.	O

Epinephrine	Epinephrine	PROPN	NNP	B-Chemical
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	PROPN	NNP	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
at	at	ADP	IN	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
min	min	NOUN	NN	O
intervals	interval	NOUN	NNS	O
while	while	ADP	IN	O
external	external	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
compressions	compression	NOUN	NNS	O
were	be	VERB	VBD	O
applied	apply	VERB	VBN	O
.	.	PUNCT	.	O

Resuscitation	resuscitation	NOUN	NN	O
was	be	VERB	VBD	O
considered	consider	VERB	VBN	O
successful	successful	ADJ	JJ	O
when	when	ADV	WRB	O
a	a	DET	DT	O
systolic	systolic	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
>	>	X	XX	O
or	or	CCONJ	CC	O
=	=	VERB	VBZ	O
100	100	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
was	be	VERB	VBD	O
achieved	achieve	VERB	VBN	O
within	within	ADP	IN	O
5	5	NUM	CD	O
min	min	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
cumulative	cumulative	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
levobupivacaine	levobupivacaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
ropivacaine	ropivacaine	NOUN	NN	B-Chemical
that	that	DET	WDT	O
produced	produce	VERB	VBD	O
seizures	seizure	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
and	and	CCONJ	CC	O
were	be	VERB	VBD	O
larger	large	ADJ	JJR	O
than	than	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
cumulative	cumulative	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
levobupivacaine	levobupivacaine	NOUN	NN	B-Chemical
that	that	DET	WDT	O
produced	produce	VERB	VBD	O
dysrhythmias	dysrhythmia	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
asystole	asystole	NOUN	NN	B-Disease
were	be	VERB	VBD	O
smaller	small	ADJ	JJR	O
than	than	ADP	IN	O
the	the	DET	DT	O
corresponding	correspond	VERB	VBG	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
ropivacaine	ropivacaine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
they	-PRON-	PRON	PRP	O
were	be	VERB	VBD	O
larger	large	ADJ	JJR	O
than	than	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
successful	successful	ADJ	JJ	O
resuscitations	resuscitation	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
differ	differ	VERB	VB	O
among	among	ADP	IN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
a	a	DET	DT	O
smaller	small	ADJ	JJR	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
required	require	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
Ropivacaine	Ropivacaine	PROPN	NNP	B-Chemical
group	group	NOUN	NN	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
systemic	systemic	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
levobupivacaine	levobupivacaine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
intermediate	intermediate	ADJ	JJ	O
between	between	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
ropivacaine	ropivacaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
when	when	ADV	WRB	O
administered	administer	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
rate	rate	NOUN	NN	O
and	and	CCONJ	CC	O
that	that	DET	DT	O
ropivacaine	ropivacaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
more	more	ADV	RBR	O
susceptible	susceptible	ADJ	JJ	O
to	to	ADP	IN	O
treatment	treatment	NOUN	NN	O
than	than	ADP	IN	O
that	that	DET	DT	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
levobupivacaine	levobupivacaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Amphotericin	Amphotericin	PROPN	NNP	B-Chemical
B	B	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
AIDS	AIDS	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
report	report	VERB	VB	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
multiple	multiple	ADJ	JJ	O
episodes	episode	NOUN	NNS	O
of	of	ADP	IN	O
seizure	seizure	NOUN	NN	B-Disease
activity	activity	NOUN	NN	O
in	in	ADP	IN	O
an	an	DET	DT	O
AIDS	AIDS	PROPN	NNP	B-Disease
patent	patent	NOUN	NN	O
following	follow	VERB	VBG	O
amphotericin	amphotericin	NOUN	NN	B-Chemical
B	B	PROPN	NNP	I-Chemical
infusion	infusion	NOUN	NN	O
.	.	PUNCT	.	O

CASE	case	NOUN	NN	O
SUMMARY	summary	NOUN	NN	O
:	:	PUNCT	:	O
A	a	DET	DT	O
46	46	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
African	african	ADJ	JJ	O
-	-	PUNCT	HYPH	O
American	american	ADJ	JJ	O
man	man	NOUN	NN	O
experienced	experience	VERB	VBD	O
recurrent	recurrent	ADJ	JJ	O
grand	grand	ADJ	JJ	B-Disease
mal	mal	NOUN	NN	I-Disease
seizures	seizure	NOUN	NNS	I-Disease
during	during	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
amphotericin	amphotericin	PROPN	NNP	B-Chemical
B	B	PROPN	NNP	I-Chemical
,	,	PUNCT	,	O
then	then	ADV	RB	O
petit	petit	VERB	VBZ	O
mal	mal	NOUN	NN	O
seizures	seizure	NOUN	NNS	B-Disease
as	as	ADP	IN	O
the	the	DET	DT	O
infusion	infusion	NOUN	NN	O
was	be	VERB	VBD	O
stopped	stop	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
decreased	decrease	VERB	VBD	O
with	with	ADP	IN	O
time	time	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patients	patient	NOUN	NNS	O
concurrent	concurrent	ADJ	JJ	O
medications	medication	NOUN	NNS	O
included	include	VERB	VBD	O
didanosine	didanosine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
hydroxyzine	hydroxyzine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
promethazine	promethazine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
hydrocortisone	hydrocortisone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
prochlorperazine	prochlorperazine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Despite	despite	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
phenytoin	phenytoin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
lorazepam	lorazepam	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
seizures	seizure	NOUN	NNS	B-Disease
persisted	persist	VERB	VBD	O
and	and	CCONJ	CC	O
occurred	occur	VERB	VBD	O
only	only	ADV	RB	O
during	during	ADP	IN	O
amphotercin	amphotercin	NOUN	NN	B-Chemical
B	b	NOUN	NN	I-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

DISCUSSION	discussion	NOUN	NN	O
:	:	PUNCT	:	O
AIDS	aids	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
cryptococcal	cryptococcal	ADJ	JJ	B-Disease
meningitis	meningitis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
both	both	DET	DT	O
of	of	ADP	IN	O
which	which	DET	WDT	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
,	,	PUNCT	,	O
can	can	VERB	MD	O
potentially	potentially	ADV	RB	O
cause	cause	VERB	VB	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
alcohol	alcohol	NOUN	NN	B-Disease
abuse	abuse	NOUN	NN	I-Disease
;	;	PUNCT	:	O
alcohol	alcohol	NOUN	NN	B-Chemical
intake	intake	NOUN	NN	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
withdrawal	withdrawal	NOUN	NN	O
can	can	VERB	MD	O
also	also	ADV	RB	O
cause	cause	VERB	VB	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Didanosine	Didanosine	PROPN	NNP	B-Chemical
also	also	ADV	RB	O
has	have	VERB	VBZ	O
a	a	DET	DT	O
potential	potential	NOUN	NN	O
for	for	ADP	IN	O
inducing	induce	VERB	VBG	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
these	these	DET	DT	O
other	other	ADJ	JJ	O
potential	potential	ADJ	JJ	O
causes	cause	NOUN	NNS	O
of	of	ADP	IN	O
seizure	seizure	NOUN	NN	B-Disease
were	be	VERB	VBD	O
ruled	rule	VERB	VBN	O
out	out	PART	RP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
time	time	NOUN	NN	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
events	event	NOUN	NNS	O
suggested	suggest	VERB	VBD	O
that	that	ADP	IN	O
amphotericin	amphotericin	PROPN	NNP	B-Chemical
B	B	PROPN	NNP	I-Chemical
was	be	VERB	VBD	O
the	the	DET	DT	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
seizures	seizure	NOUN	NNS	B-Disease
in	in	ADP	IN	O
this	this	DET	DT	O
AIDS	AIDS	PROPN	NNP	B-Disease
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Amphotericin	Amphotericin	PROPN	NNP	B-Chemical
B	B	PROPN	NNP	I-Chemical
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
the	the	DET	DT	O
probable	probable	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

To	to	ADP	IN	O
date	date	NOUN	NN	O
,	,	PUNCT	,	O
only	only	ADV	RB	O
three	three	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
amphotericin	amphotericin	ADJ	JJ	B-Chemical
B	B	PROPN	NNP	I-Chemical
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
healthcare	healthcare	NOUN	NN	O
providers	provider	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
the	the	DET	DT	O
potential	potential	NOUN	NN	O
for	for	ADP	IN	O
this	this	DET	DT	O
rare	rare	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Sirolimus	sirolimus	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
mycophenolate	mycophenolate	NOUN	NN	B-Chemical
mofetil	mofetil	NOUN	NN	I-Chemical
for	for	ADP	IN	O
calcineurin	calcineurin	NOUN	NN	O
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
immunosuppression	immunosuppression	NOUN	NN	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
transplant	transplant	NOUN	NN	O
recipients	recipient	NOUN	NNS	O
.	.	PUNCT	.	O

Calcineurin	calcineurin	NOUN	NN	O
inhibitors	inhibitor	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
cyclosporine	cyclosporine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
available	available	ADJ	JJ	O
for	for	ADP	IN	O
almost	almost	ADV	RB	O
20	20	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
these	these	DET	DT	O
drugs	drug	NOUN	NNS	O
are	be	VERB	VBP	O
highly	highly	ADV	RB	O
effective	effective	ADJ	JJ	O
and	and	CCONJ	CC	O
represent	represent	VERB	VB	O
the	the	DET	DT	O
mainstay	mainstay	NOUN	NN	O
of	of	ADP	IN	O
transplant	transplant	NOUN	NN	O
immunosuppression	immunosuppression	NOUN	NN	O
,	,	PUNCT	,	O
they	-PRON-	PRON	PRP	O
are	be	VERB	VBP	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	O
and	and	CCONJ	CC	O
chronic	chronic	ADJ	JJ	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
occurs	occur	VERB	VBZ	O
in	in	ADP	IN	O
the	the	DET	DT	O
early	early	ADJ	JJ	O
period	period	NOUN	NN	O
after	after	ADP	IN	O
transplantation	transplantation	NOUN	NN	O
,	,	PUNCT	,	O
leads	lead	VERB	VBZ	O
to	to	ADP	IN	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
dialysis	dialysis	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
chronic	chronic	ADJ	JJ	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
may	may	VERB	MD	O
eventually	eventually	ADV	RB	O
result	result	VERB	VB	O
in	in	ADP	IN	O
graft	graft	NOUN	NN	O
loss	loss	NOUN	NN	O
.	.	PUNCT	.	O

Acute	Acute	PROPN	NNP	O
and	and	CCONJ	CC	O
chronic	chronic	ADJ	JJ	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
becoming	become	VERB	VBG	O
more	more	ADV	RBR	O
common	common	ADJ	JJ	O
as	as	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
marginal	marginal	ADJ	JJ	O
kidneys	kidney	NOUN	NNS	O
for	for	ADP	IN	O
transplantation	transplantation	NOUN	NN	O
increases	increase	NOUN	NNS	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
recently	recently	ADV	RB	O
available	available	ADJ	JJ	O
immunosuppressive	immunosuppressive	ADJ	JJ	O
agents	agent	NOUN	NNS	O
,	,	PUNCT	,	O
mycophenolate	mycophenolate	NOUN	NN	B-Chemical
mofetil	mofetil	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
sirolimus	sirolimus	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
rapamycin	rapamycin	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
have	have	VERB	VBP	O
no	no	DET	DT	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
drugs	drug	NOUN	NNS	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
agents	agent	NOUN	NNS	O
has	have	VERB	VBZ	O
led	lead	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
new	new	ADJ	JJ	O
paradigms	paradigms	NOUN	NN	O
of	of	ADP	IN	O
immunosuppressive	immunosuppressive	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
paper	paper	NOUN	NN	O
reviews	review	VERB	VBZ	O
the	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
clinical	clinical	ADJ	JJ	O
trials	trial	NOUN	NNS	O
that	that	DET	WDT	O
have	have	VERB	VBP	O
investigated	investigate	VERB	VBN	O
these	these	DET	DT	O
new	new	ADJ	JJ	O
approaches	approach	NOUN	NNS	O
to	to	ADP	IN	O
immunosuppression	immunosuppression	NOUN	NN	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
transplant	transplant	NOUN	NN	O
recipients	recipient	NOUN	NNS	O
.	.	PUNCT	.	O

Tolerability	tolerability	NOUN	NN	O
of	of	ADP	IN	O
nimesulide	nimesulide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
NSAID	NSAID	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
urticaria	urticaria	NOUN	NN	B-Disease
/	/	SYM	SYM	O
angioedema	angioedema	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Previous	previous	ADJ	JJ	O
studies	study	NOUN	NNS	O
evaluated	evaluate	VERB	VBD	O
the	the	DET	DT	O
tolerance	tolerance	NOUN	NN	O
of	of	ADP	IN	O
nimesulide	nimesulide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
in	in	ADP	IN	O
subjects	subject	NOUN	NNS	O
with	with	ADP	IN	O
cutaneous	cutaneous	ADJ	JJ	O
,	,	PUNCT	,	O
respiratory	respiratory	ADJ	JJ	O
and	and	CCONJ	CC	O
anaphylactoid	anaphylactoid	ADJ	JJ	O
reactions	reaction	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
nonsteroidal	nonsteroidal	ADJ	JJ	B-Chemical
anti	anti	ADJ	JJ	I-Chemical
-	-	ADJ	JJ	I-Chemical
inflammatory	inflammatory	ADJ	JJ	I-Chemical
drugs	drug	NOUN	NNS	I-Chemical
(	(	PUNCT	-LRB-	O
NSAIDs	nsaid	NOUN	NNS	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
we	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
tolerability	tolerability	NOUN	NN	O
and	and	CCONJ	CC	O
reliability	reliability	NOUN	NN	O
of	of	ADP	IN	O
nimesulide	nimesulide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
in	in	ADP	IN	O
a	a	DET	DT	O
very	very	ADV	RB	O
large	large	ADJ	JJ	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
an	an	DET	DT	O
exclusive	exclusive	ADJ	JJ	O
well	well	ADV	RB	O
-	-	PUNCT	HYPH	O
documented	document	VERB	VBN	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
NSAID	NSAID	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
urticaria	urticaria	NOUN	NN	B-Disease
/	/	SYM	SYM	O
angioedema	angioedema	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
evaluated	evaluate	VERB	VBD	O
whether	whether	ADP	IN	O
some	some	DET	DT	O
factors	factor	NOUN	NNS	O
have	have	VERB	VBP	O
the	the	DET	DT	O
potential	potential	NOUN	NN	O
to	to	PART	TO	O
increase	increase	VERB	VB	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
reaction	reaction	NOUN	NN	O
to	to	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
nimesulide	nimesulide	VERB	VB	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
single	single	ADJ	JJ	O
-	-	PUNCT	HYPH	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
oral	oral	ADJ	JJ	O
challenge	challenge	NOUN	NN	O
procedure	procedure	NOUN	NN	O
with	with	ADP	IN	O
nimesulide	nimesulide	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
applied	apply	VERB	VBN	O
to	to	ADP	IN	O
829	829	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
NSAID	NSAID	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
urticaria	urticaria	NOUN	NN	B-Disease
/	/	SYM	SYM	O
angioedema	angioedema	NOUN	NN	B-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
75	75	NUM	CD	O
/	/	SYM	SYM	O
829	829	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
.	.	NOUN	NN	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
patients	patient	NOUN	NNS	O
experienced	experience	VERB	VBD	O
reactions	reaction	NOUN	NNS	O
to	to	PART	TO	O
nimesulide	nimesulide	VERB	VB	B-Chemical
or	or	CCONJ	CC	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Of	of	ADP	IN	O
the	the	DET	DT	O
715	715	NUM	CD	O
patients	patient	NOUN	NNS	O
tested	test	VERB	VBN	O
with	with	ADP	IN	O
nimesulide	nimesulide	NOUN	NN	B-Chemical
62	62	NUM	CD	O
(	(	PUNCT	-LRB-	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
positive	positive	ADJ	JJ	O
test	test	NOUN	NN	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
of	of	ADP	IN	O
114	114	NUM	CD	O
subjects	subject	NOUN	NNS	O
submitted	submit	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
challenge	challenge	NOUN	NN	O
with	with	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
13	13	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
tolerate	tolerate	VERB	VB	O
this	this	DET	DT	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
18	18	NUM	CD	O
.	.	PUNCT	.	O
28	28	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	O
urticaria	urticaria	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
subjects	subject	NOUN	NNS	O
with	with	ADP	IN	O
an	an	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
NSAID	NSAID	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
urticaria	urticaria	NOUN	NN	B-Disease
/	/	SYM	SYM	O
angioedema	angioedema	NOUN	NN	B-Disease
or	or	CCONJ	CC	O
angioedema	angioedema	NOUN	NN	B-Disease
alone	alone	ADV	RB	O
(	(	PUNCT	-LRB-	O
with	with	ADP	IN	O
or	or	CCONJ	CC	O
without	without	ADP	IN	O
chronic	chronic	ADJ	JJ	O
urticaria	urticaria	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
resulted	result	VERB	VBD	O
to	to	PART	TO	O
be	be	VERB	VB	O
intolerant	intolerant	ADJ	JJ	O
to	to	ADP	IN	O
alternative	alternative	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

Taken	take	VERB	VBN	O
together	together	ADV	RB	O
,	,	PUNCT	,	O
our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
confirm	confirm	VERB	VBP	O
the	the	DET	DT	O
good	good	ADJ	JJ	O
tolerability	tolerability	NOUN	NN	O
of	of	ADP	IN	O
nimesulide	nimesulide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
experienced	experience	VERB	VBD	O
urticaria	urticaria	NOUN	NN	B-Disease
/	/	SYM	SYM	O
angioedema	angioedema	NOUN	NN	B-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
NSAIDs	nsaid	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
reaction	reaction	NOUN	NN	O
to	to	ADP	IN	O
these	these	DET	DT	O
alternative	alternative	ADJ	JJ	O
study	study	NOUN	NN	O
drugs	drug	NOUN	NNS	O
is	be	VERB	VBZ	O
statistically	statistically	ADV	RB	O
increased	increase	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	O
urticaria	urticaria	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
above	above	ADP	IN	O
all	all	DET	DT	O
,	,	PUNCT	,	O
by	by	ADP	IN	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
NSAID	NSAID	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
angioedema	angioedema	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Comparison	comparison	NOUN	NN	O
of	of	ADP	IN	O
aqueous	aqueous	ADJ	JJ	O
and	and	CCONJ	CC	O
gellan	gellan	VERB	VB	O
ophthalmic	ophthalmic	ADJ	JJ	O
timolol	timolol	NOUN	NN	B-Chemical
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
response	response	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
on	on	ADP	IN	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
glaucoma	glaucoma	NOUN	NN	B-Disease
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
Topical	topical	ADJ	JJ	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
blocker	blocker	NOUN	NN	O
treatment	treatment	NOUN	NN	O
is	be	VERB	VBZ	O
routine	routine	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
glaucoma	glaucoma	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Therapy	therapy	NOUN	NN	O
results	result	NOUN	NNS	O
in	in	ADP	IN	O
systemic	systemic	ADJ	JJ	O
absorption	absorption	NOUN	NN	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
resting	rest	VERB	VBG	O
and	and	CCONJ	CC	O
peak	peak	NOUN	NN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
has	have	VERB	VBZ	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
quantified	quantify	VERB	VBN	O
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
This	this	DET	DT	O
trial	trial	NOUN	NN	O
evaluated	evaluate	VERB	VBD	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
placebo	placebo	NOUN	NN	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
aqueous	aqueous	ADJ	JJ	O
timolol	timolol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
timolol	timolol	NOUN	NN	B-Chemical
solution	solution	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
timolol	timolol	NOUN	NN	B-Chemical
suspension	suspension	NOUN	NN	O
that	that	DET	WDT	O
forms	form	VERB	VBZ	O
a	a	DET	DT	O
gel	gel	NOUN	NN	O
on	on	ADP	IN	O
application	application	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
conjunctiva	conjunctiva	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
timolol	timolol	NOUN	NN	B-Chemical
gellan	gellan	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
the	the	DET	DT	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
currently	currently	ADV	RB	O
being	be	VERB	VBG	O
treated	treat	VERB	VBN	O
for	for	ADP	IN	O
glaucoma	glaucoma	NOUN	NN	B-Disease
to	to	PART	TO	O
quantify	quantify	VERB	VB	O
the	the	DET	DT	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
mean	mean	ADJ	JJ	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Forty	forty	NUM	CD	O
-	-	PUNCT	HYPH	O
three	three	NUM	CD	O
Caucasian	caucasian	ADJ	JJ	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
primary	primary	ADJ	JJ	O
open	open	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
angle	angle	NOUN	NN	I-Disease
glaucoma	glaucoma	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
ocular	ocular	ADJ	JJ	B-Disease
hypertension	hypertension	NOUN	NN	I-Disease
with	with	ADP	IN	O
a	a	DET	DT	O
mean	mean	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
SD	sd	NOUN	NN	O
)	)	PUNCT	-RRB-	O
age	age	NOUN	NN	O
of	of	ADP	IN	O
63	63	NUM	CD	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
years	year	NOUN	NNS	O
were	be	VERB	VBD	O
randomized	randomize	VERB	VBN	O
and	and	CCONJ	CC	O
crossed	cross	VERB	VBD	O
over	over	PART	RP	O
in	in	ADP	IN	O
a	a	DET	DT	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
masked	mask	VERB	VBN	O
manner	manner	NOUN	NN	O
to	to	ADP	IN	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
morning	morning	NOUN	NN	O
and	and	CCONJ	CC	O
evening	evening	NOUN	NN	O
in	in	ADP	IN	O
both	both	DET	DT	O
eyes	eye	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
timolol	timolol	NOUN	NN	B-Chemical
solution	solution	NOUN	NN	O
(	(	PUNCT	-LRB-	O
morning	morning	NOUN	NN	O
and	and	CCONJ	CC	O
evening	evening	NOUN	NN	O
in	in	ADP	IN	O
both	both	DET	DT	O
eyes	eye	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
timolol	timolol	NOUN	NN	B-Chemical
gellan	gellan	NOUN	NN	O
(	(	PUNCT	-LRB-	O
morning	morning	NOUN	NN	O
in	in	ADP	IN	O
both	both	DET	DT	O
eyes	eye	NOUN	NNS	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
evening	evening	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
13th	13th	ADJ	JJ	O
day	day	NOUN	NN	O
of	of	ADP	IN	O
each	each	DET	DT	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
was	be	VERB	VBD	O
recorded	record	VERB	VBN	O
continuously	continuously	ADV	RB	O
during	during	ADP	IN	O
a	a	DET	DT	O
typical	typical	ADJ	JJ	O
,	,	PUNCT	,	O
ambulant	ambulant	ADJ	JJ	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Both	both	DET	DT	O
timolol	timolol	NOUN	NN	B-Chemical
solution	solution	NOUN	NN	O
and	and	CCONJ	CC	O
timolol	timolol	NOUN	NN	B-Chemical
gellan	gellan	NOUN	NN	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
or	or	CCONJ	CC	O
=	=	NOUN	NNS	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
this	this	DET	DT	O
reduction	reduction	NOUN	NN	O
was	be	VERB	VBD	O
most	most	ADV	RBS	O
pronounced	pronounce	VERB	VBN	O
during	during	ADP	IN	O
the	the	DET	DT	O
daytime	daytime	NOUN	NN	O
(	(	PUNCT	-LRB-	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
mean	mean	ADJ	JJ	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
,	,	PUNCT	,	O
-	-	PUNCT	:	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
beats	beat	NOUN	NNS	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Timolol	Timolol	PROPN	NNP	B-Chemical
gellan	gellan	NOUN	NN	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
numerically	numerically	ADV	RB	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
smaller	small	ADJ	JJR	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
,	,	PUNCT	,	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
timolol	timolol	NOUN	NN	B-Chemical
solution	solution	NOUN	NN	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
the	the	DET	DT	O
night	night	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
12	12	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
on	on	ADP	IN	O
placebo	placebo	NOUN	NN	O
and	and	CCONJ	CC	O
timolol	timolol	NOUN	NN	B-Chemical
gellan	gellan	NOUN	NN	O
were	be	VERB	VBD	O
both	both	DET	DT	O
significantly	significantly	ADV	RB	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
on	on	ADP	IN	O
timolol	timolol	NOUN	NN	B-Chemical
solution	solution	NOUN	NN	O
;	;	PUNCT	:	O
the	the	DET	DT	O
difference	difference	NOUN	NN	O
between	between	ADP	IN	O
solution	solution	NOUN	NN	O
and	and	CCONJ	CC	O
gellan	gellan	NOUN	NN	O
treatments	treatment	NOUN	NNS	O
was	be	VERB	VBD	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	X	XX	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Both	both	DET	DT	O
timolol	timolol	NOUN	NN	B-Chemical
solution	solution	NOUN	NN	O
and	and	CCONJ	CC	O
timolol	timolol	NOUN	NN	B-Chemical
gellan	gellan	NOUN	NN	O
decrease	decrease	NOUN	NN	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
response	response	NOUN	NN	O
was	be	VERB	VBD	O
most	most	ADV	RBS	O
pronounced	pronounce	VERB	VBN	O
during	during	ADP	IN	O
the	the	DET	DT	O
active	active	ADJ	JJ	O
daytime	daytime	ADJ	JJ	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
quantify	quantify	VERB	VBP	O
the	the	DET	DT	O
modest	modest	ADJ	JJ	O
bradycardia	bradycardia	NOUN	NN	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
ophthalmic	ophthalmic	ADJ	JJ	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
blocker	blocker	NOUN	NN	O
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
typical	typical	ADJ	JJ	O
patient	patient	ADJ	JJ	O
population	population	NOUN	NN	O
on	on	ADP	IN	O
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
glaucoma	glaucoma	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Although	although	ADP	IN	O
exercise	exercise	NOUN	NN	O
performance	performance	NOUN	NN	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
assessed	assess	VERB	VBN	O
in	in	ADP	IN	O
this	this	DET	DT	O
trial	trial	NOUN	NN	O
,	,	PUNCT	,	O
reductions	reduction	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
magnitude	magnitude	NOUN	NN	O
should	should	VERB	MD	O
not	not	ADV	RB	O
have	have	VERB	VB	O
substantial	substantial	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
consequences	consequence	NOUN	NNS	O
.	.	PUNCT	.	O

Management	management	NOUN	NN	O
strategies	strategy	NOUN	NNS	O
for	for	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
hepatitis	hepatitis	PROPN	NNP	B-Disease
C	C	PROPN	NNP	I-Disease
:	:	PUNCT	:	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
economic	economic	ADJ	JJ	O
implications	implication	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVES	objectives	NOUN	NN	O
:	:	PUNCT	:	O
Recently	recently	ADV	RB	O
published	publish	VERB	VBN	O
studies	study	NOUN	NNS	O
have	have	VERB	VBP	O
demonstrated	demonstrate	VERB	VBN	O
increased	increase	VERB	VBN	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
cost	cost	NOUN	NN	O
-	-	PUNCT	HYPH	O
effectiveness	effectiveness	NOUN	NN	O
of	of	ADP	IN	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
interferon	interferon	NOUN	NN	O
and	and	CCONJ	CC	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
2b	2b	NOUN	NN	O
/	/	SYM	SYM	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
interferon	interferon	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
alpha	alpha	NOUN	NN	I-Chemical
monotherapy	monotherapy	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
C	C	PROPN	NNP	I-Disease
(	(	PUNCT	-LRB-	O
CHC	CHC	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
clinically	clinically	ADV	RB	O
important	important	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
:	:	PUNCT	:	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
RIHA	RIHA	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
objective	objective	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
direct	direct	ADJ	JJ	O
health	health	NOUN	NN	O
-	-	PUNCT	HYPH	O
care	care	NOUN	NN	O
costs	cost	NOUN	NNS	O
and	and	CCONJ	CC	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
RIHA	RIHA	PROPN	NNP	B-Disease
during	during	ADP	IN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
CHC	CHC	PROPN	NNP	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
trial	trial	NOUN	NN	O
setting	setting	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
A	a	DET	DT	O
systematic	systematic	ADJ	JJ	O
literature	literature	NOUN	NN	O
review	review	NOUN	NN	O
was	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
to	to	PART	TO	O
synthesize	synthesize	VERB	VB	O
information	information	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
and	and	CCONJ	CC	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
RIHA	RIHA	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Decision	decision	NOUN	NN	O
-	-	PUNCT	HYPH	O
analytic	analytic	ADJ	JJ	O
techniques	technique	NOUN	NNS	O
were	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
estimate	estimate	VERB	VB	O
the	the	DET	DT	O
cost	cost	NOUN	NN	O
of	of	ADP	IN	O
treating	treat	VERB	VBG	O
RIHA	RIHA	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Uncertainty	uncertainty	NOUN	NN	O
was	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
using	use	VERB	VBG	O
sensitivity	sensitivity	NOUN	NN	O
analyses	analysis	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
RIHA	RIHA	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
defined	define	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
hemoglobin	hemoglobin	NOUN	NN	O
to	to	ADP	IN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
100	100	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
,	,	PUNCT	,	O
occurs	occur	VERB	VBZ	O
in	in	ADP	IN	O
approximately	approximately	ADV	RB	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
to	to	PART	TO	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
standard	standard	NOUN	NN	O
of	of	ADP	IN	O
care	care	NOUN	NN	O
for	for	ADP	IN	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
RIHA	RIHA	PROPN	NNP	B-Disease
is	be	VERB	VBZ	O
reduction	reduction	NOUN	NN	O
or	or	CCONJ	CC	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
dosage	dosage	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
estimated	estimate	VERB	VBD	O
the	the	DET	DT	O
direct	direct	ADJ	JJ	O
cost	cost	NOUN	NN	O
of	of	ADP	IN	O
treating	treat	VERB	VBG	O
clinically	clinically	ADV	RB	O
significant	significant	ADJ	JJ	O
RIHA	RIHA	PROPN	NNP	B-Disease
to	to	PART	TO	O
be	be	VERB	VB	O
170	170	NUM	CD	O
per	per	ADP	IN	O
patient	patient	NOUN	NN	O
receiving	receive	VERB	VBG	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
per	per	ADP	IN	O
48	48	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
treatment	treatment	NOUN	NN	O
course	course	NOUN	NN	O
(	(	PUNCT	-LRB-	O
range	range	VERB	VB	O
68	68	NUM	CD	O
-	-	SYM	SYM	O
692	692	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
one	one	NUM	CD	O
-	-	PUNCT	HYPH	O
way	way	NOUN	NN	O
sensitivity	sensitivity	NOUN	NN	O
analyses	analysis	NOUN	NNS	O
ranged	range	VERB	VBD	O
from	from	ADP	IN	O
57	57	NUM	CD	O
to	to	ADP	IN	O
317	317	NUM	CD	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
comparison	comparison	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
cost	cost	NOUN	NN	O
of	of	ADP	IN	O
48	48	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
is	be	VERB	VBZ	O
16	16	NUM	CD	O
,	,	PUNCT	,	O
459	459	NUM	CD	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
direct	direct	ADJ	JJ	O
cost	cost	NOUN	NN	O
of	of	ADP	IN	O
treating	treat	VERB	VBG	O
clinically	clinically	ADV	RB	O
significant	significant	ADJ	JJ	O
RIHA	RIHA	PROPN	NNP	B-Disease
is	be	VERB	VBZ	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
170	170	NUM	CD	O
/	/	SYM	SYM	O
16	16	NUM	CD	O
,	,	PUNCT	,	O
459	459	NUM	CD	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
treatment	treatment	NOUN	NN	O
costs	cost	NOUN	NNS	O
.	.	PUNCT	.	O

Questions	question	NOUN	NNS	O
remain	remain	VERB	VBP	O
about	about	ADP	IN	O
the	the	DET	DT	O
optimal	optimal	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
RIHA	RIHA	PROPN	NNP	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
real	real	ADJ	JJ	O
-	-	PUNCT	HYPH	O
world	world	NOUN	NN	O
population	population	NOUN	NN	O
.	.	PUNCT	.	O

Despite	despite	ADP	IN	O
these	these	DET	DT	O
uncertainties	uncertainty	NOUN	NNS	O
,	,	PUNCT	,	O
this	this	DET	DT	O
initial	initial	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
direct	direct	ADJ	JJ	O
cost	cost	NOUN	NN	O
of	of	ADP	IN	O
treating	treat	VERB	VBG	O
RIHA	RIHA	PROPN	NNP	B-Disease
provides	provide	VERB	VBZ	O
an	an	DET	DT	O
estimate	estimate	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cost	cost	NOUN	NN	O
and	and	CCONJ	CC	O
management	management	NOUN	NN	O
implications	implication	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
clinically	clinically	ADV	RB	O
important	important	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Preliminary	preliminary	ADJ	JJ	O
efficacy	efficacy	NOUN	NN	O
assessment	assessment	NOUN	NN	O
of	of	ADP	IN	O
intrathecal	intrathecal	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
American	american	ADJ	JJ	O
formulation	formulation	NOUN	NN	O
of	of	ADP	IN	O
adenosine	adenosine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
humans	human	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Preclinical	preclinical	ADJ	JJ	O
studies	study	NOUN	NNS	O
of	of	ADP	IN	O
intrathecal	intrathecal	ADJ	JJ	O
adenosine	adenosine	NOUN	NN	B-Chemical
suggest	suggest	VERB	VBP	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
be	be	VERB	VB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
and	and	CCONJ	CC	I-Disease
chronic	chronic	ADJ	JJ	I-Disease
pain	pain	NOUN	NN	I-Disease
in	in	ADP	IN	O
humans	human	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
preliminary	preliminary	ADJ	JJ	O
studies	study	NOUN	NNS	O
in	in	ADP	IN	O
volunteers	volunteer	NOUN	NNS	O
and	and	CCONJ	CC	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
Swedish	swedish	ADJ	JJ	O
formulation	formulation	NOUN	NN	O
of	of	ADP	IN	O
adenosine	adenosine	NOUN	NN	B-Chemical
suggests	suggest	VERB	VBZ	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
be	be	VERB	VB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
states	state	NOUN	NNS	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	O
noxious	noxious	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
purpose	purpose	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
screen	screen	VERB	VB	O
for	for	ADP	IN	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
different	different	ADJ	JJ	O
formulation	formulation	NOUN	NN	O
of	of	ADP	IN	O
adenosine	adenosine	NOUN	NN	B-Chemical
marketed	market	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
US	US	PROPN	NNP	O
,	,	PUNCT	,	O
using	use	VERB	VBG	O
both	both	DET	DT	O
acute	acute	ADJ	JJ	O
noxious	noxious	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
and	and	CCONJ	CC	O
capsaicin	capsaicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
evoked	evoke	VERB	VBN	O
mechanical	mechanical	ADJ	JJ	O
hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Following	follow	VERB	VBG	O
Food	Food	PROPN	NNP	O
and	and	CCONJ	CC	O
Drug	Drug	PROPN	NNP	O
Administration	Administration	PROPN	NNP	O
and	and	CCONJ	CC	O
institutional	institutional	ADJ	JJ	O
review	review	NOUN	NN	O
board	board	NOUN	NN	O
approval	approval	NOUN	NN	O
and	and	CCONJ	CC	O
written	write	VERB	VBN	O
informed	informed	ADJ	JJ	O
consent	consent	NOUN	NN	O
,	,	PUNCT	,	O
65	65	NUM	CD	O
volunteers	volunteer	NOUN	NNS	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
in	in	ADP	IN	O
two	two	NUM	CD	O
trials	trial	NOUN	NNS	O
:	:	PUNCT	:	O
an	an	DET	DT	O
open	open	ADJ	JJ	O
-	-	PUNCT	HYPH	O
label	label	NOUN	NN	O
,	,	PUNCT	,	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
escalating	escalate	VERB	VBG	O
trial	trial	NOUN	NN	O
with	with	ADP	IN	O
intrathecal	intrathecal	ADJ	JJ	O
adenosine	adenosine	NOUN	NN	B-Chemical
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
-	-	SYM	SYM	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
adenosine	adenosine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O

Cerebrospinal	cerebrospinal	ADJ	JJ	O
fluid	fluid	NOUN	NN	O
was	be	VERB	VBD	O
obtained	obtain	VERB	VBN	O
for	for	ADP	IN	O
pharmacokinetic	pharmacokinetic	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
pain	pain	NOUN	NN	B-Disease
ratings	rating	NOUN	NNS	O
in	in	ADP	IN	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
acute	acute	ADJ	JJ	O
heat	heat	NOUN	NN	O
stimuli	stimulus	NOUN	NNS	O
and	and	CCONJ	CC	O
areas	area	NOUN	NNS	O
of	of	ADP	IN	O
mechanical	mechanical	ADJ	JJ	B-Disease
hyperalgesia	hyperalgesia	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
allodynia	allodynia	ADJ	JJ	B-Disease
after	after	ADP	IN	O
intradermal	intradermal	ADJ	JJ	O
capsaicin	capsaicin	NOUN	NN	B-Chemical
injection	injection	NOUN	NN	O
were	be	VERB	VBD	O
determined	determine	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Adenosine	adenosine	NOUN	NN	B-Chemical
produced	produce	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
report	report	NOUN	NN	O
to	to	ADP	IN	O
acute	acute	ADJ	JJ	O
noxious	noxious	ADJ	JJ	O
thermal	thermal	ADJ	JJ	O
or	or	CCONJ	CC	O
chemical	chemical	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
but	but	CCONJ	CC	O
reduced	reduce	VERB	VBD	O
mechanical	mechanical	ADJ	JJ	B-Disease
hyperalgesia	hyperalgesia	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
allodynia	allodynia	ADJ	JJ	B-Disease
from	from	ADP	IN	O
intradermal	intradermal	ADJ	JJ	O
capsaicin	capsaicin	NOUN	NN	B-Chemical
injection	injection	NOUN	NN	O
for	for	ADP	IN	O
at	at	ADV	RB	O
least	least	ADV	RBS	O
24	24	NUM	CD	O
h	h	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
residence	residence	NOUN	NN	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
adenosine	adenosine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
cerebrospinal	cerebrospinal	ADJ	JJ	O
fluid	fluid	NOUN	NN	O
was	be	VERB	VBD	O
short	short	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
<	<	X	XX	O
4	4	NUM	CD	O
h	h	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
These	these	DET	DT	O
results	result	NOUN	NNS	O
show	show	VERB	VBP	O
selective	selective	ADJ	JJ	O
inhibition	inhibition	NOUN	NN	O
by	by	ADP	IN	O
intrathecal	intrathecal	ADJ	JJ	O
adenosine	adenosine	NOUN	NN	B-Chemical
of	of	ADP	IN	O
hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
presumed	presume	VERB	VBN	O
to	to	PART	TO	O
reflect	reflect	VERB	VB	O
central	central	ADJ	JJ	O
sensitization	sensitization	NOUN	NN	O
in	in	ADP	IN	O
humans	human	NOUN	NNS	O
after	after	ADP	IN	O
peripheral	peripheral	ADJ	JJ	O
capsaicin	capsaicin	NOUN	NN	B-Chemical
injection	injection	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
long	long	ADV	RB	O
-	-	PUNCT	HYPH	O
lasting	last	VERB	VBG	O
effect	effect	NOUN	NN	O
is	be	VERB	VBZ	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
that	that	DET	DT	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
preliminary	preliminary	ADJ	JJ	O
reports	report	NOUN	NNS	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	O
neuropathic	neuropathic	ADJ	JJ	B-Disease
pain	pain	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
prolonged	prolong	VERB	VBN	O
residence	residence	NOUN	NN	O
of	of	ADP	IN	O
adenosine	adenosine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
cerebrospinal	cerebrospinal	ADJ	JJ	O
fluid	fluid	NOUN	NN	O
.	.	PUNCT	.	O

Delayed	delay	VERB	VBN	O
-	-	PUNCT	HYPH	O
onset	onset	NOUN	NN	O
heparin	heparin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Heparin	Heparin	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
presents	present	NOUN	NNS	O
5	5	NUM	CD	O
to	to	PART	TO	O
12	12	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
heparin	heparin	ADJ	JJ	B-Chemical
exposure	exposure	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
or	or	CCONJ	CC	O
without	without	ADP	IN	O
arterial	arterial	ADJ	JJ	B-Disease
or	or	CCONJ	CC	I-Disease
venous	venous	ADJ	JJ	I-Disease
thromboemboli	thromboemboli	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Delayed	delay	VERB	VBN	O
recognition	recognition	NOUN	NN	O
and	and	CCONJ	CC	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
contribute	contribute	VERB	VBP	O
to	to	ADP	IN	O
poor	poor	ADJ	JJ	O
patient	patient	ADJ	JJ	O
outcomes	outcome	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
describe	describe	VERB	VB	O
and	and	CCONJ	CC	O
increase	increase	VERB	VB	O
awareness	awareness	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
scenario	scenario	NOUN	NN	O
in	in	ADP	IN	O
which	which	DET	WDT	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
or	or	CCONJ	CC	O
manifestations	manifestation	NOUN	NNS	O
of	of	ADP	IN	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
are	be	VERB	VBP	O
delayed	delay	VERB	VBN	O
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
Retrospective	retrospective	ADJ	JJ	O
case	case	NOUN	NN	O
series	series	NOUN	NN	O
.	.	PUNCT	.	O

SETTING	set	VERB	VBG	O
:	:	PUNCT	:	O
Three	three	NUM	CD	O
large	large	ADJ	JJ	O
urban	urban	ADJ	JJ	O
hospitals	hospital	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
with	with	ADP	IN	O
active	active	ADJ	JJ	O
cardiovascular	cardiovascular	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
programs	program	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
:	:	PUNCT	:	O
14	14	NUM	CD	O
patients	patient	NOUN	NNS	O
seen	see	VERB	VBN	O
over	over	ADP	IN	O
a	a	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
period	period	NOUN	NN	O
in	in	ADP	IN	O
whom	whom	PRON	WP	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
became	become	VERB	VBD	O
apparent	apparent	ADJ	JJ	O
on	on	ADP	IN	O
delayed	delay	VERB	VBN	O
presentation	presentation	NOUN	NN	O
with	with	ADP	IN	O
thromboembolic	thromboembolic	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	O
.	.	PUNCT	.	O

MEASUREMENTS	measurement	NOUN	NNS	O
:	:	PUNCT	:	O
Platelet	platelet	ADJ	JJ	O
counts	count	NOUN	NNS	O
,	,	PUNCT	,	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
objectively	objectively	ADV	RB	O
determined	determine	VERB	VBN	O
thromboembolism	thromboembolism	NOUN	NN	B-Disease
,	,	PUNCT	,	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
platelet	platelet	NOUN	NN	O
factor	factor	NOUN	NN	O
4	4	NUM	CD	O
antibody	antibody	NOUN	NN	O
tests	test	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
outcomes	outcome	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Patients	patient	NOUN	NNS	O
went	go	VERB	VBD	O
home	home	ADV	RB	O
after	after	ADP	IN	O
hospitalizations	hospitalization	NOUN	NNS	O
that	that	DET	WDT	O
had	have	VERB	VBD	O
included	include	VERB	VBN	O
heparin	heparin	ADJ	JJ	B-Chemical
exposure	exposure	NOUN	NN	O
-	-	PUNCT	:	O
-	-	PUNCT	HYPH	O
in	in	ADP	IN	O
most	most	ADJ	JJS	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
no	no	DET	DT	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
recognized	recognize	VERB	VBN	O
-	-	PUNCT	:	O
-	-	PUNCT	HYPH	O
only	only	ADV	RB	O
to	to	PART	TO	O
return	return	VERB	VB	O
to	to	ADP	IN	O
the	the	DET	DT	O
hospital	hospital	NOUN	NN	O
(	(	PUNCT	-LRB-	O
median	median	NOUN	NN	O
,	,	PUNCT	,	O
day	day	NOUN	NN	O
14	14	NUM	CD	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
thromboembolic	thromboembolic	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	O
.	.	PUNCT	.	O

Thromboemboli	Thromboemboli	PROPN	NNP	B-Disease
were	be	VERB	VBD	O
venous	venous	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
7	7	NUM	CD	O
with	with	ADP	IN	O
pulmonary	pulmonary	ADJ	JJ	B-Disease
emboli	emboli	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
arterial	arterial	NOUN	NN	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
both	both	DET	DT	O
.	.	PUNCT	.	O

Platelet	platelet	ADJ	JJ	O
counts	count	NOUN	NNS	O
were	be	VERB	VBD	O
mildly	mildly	ADV	RB	O
decreased	decrease	VERB	VBN	O
in	in	ADP	IN	O
all	all	DET	DT	O
but	but	ADP	IN	O
2	2	NUM	CD	O
patients	patient	NOUN	NNS	O
on	on	ADP	IN	O
second	second	ADJ	JJ	O
presentation	presentation	NOUN	NN	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
readmission	readmission	NOUN	NN	O
,	,	PUNCT	,	O
11	11	NUM	CD	O
patients	patient	NOUN	NNS	O
received	receive	VERB	VBD	O
therapeutic	therapeutic	ADJ	JJ	O
heparin	heparin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
worsened	worsen	VERB	VBD	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
'	'	PART	POS	O
clinical	clinical	ADJ	JJ	O
condition	condition	NOUN	NN	O
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
all	all	DET	DT	O
11	11	NUM	CD	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
platelet	platelet	NOUN	NN	O
count	count	NOUN	NN	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
at	at	ADP	IN	O
readmission	readmission	NOUN	NN	O
,	,	PUNCT	,	O
143	143	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
;	;	PUNCT	:	O
mean	mean	VERB	VB	O
nadir	nadir	NOUN	NN	O
after	after	ADP	IN	O
heparin	heparin	ADJ	JJ	B-Chemical
re	re	NOUN	NN	O
-	-	NOUN	NN	O
exposure	exposure	NOUN	NN	O
,	,	PUNCT	,	O
39	39	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Results	result	NOUN	NNS	O
of	of	ADP	IN	O
serologic	serologic	ADJ	JJ	O
tests	test	NOUN	NNS	O
for	for	ADP	IN	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
antibodies	antibody	NOUN	NNS	O
were	be	VERB	VBD	O
positive	positive	ADJ	JJ	O
in	in	ADP	IN	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Subsequent	subsequent	ADJ	JJ	O
treatments	treatment	NOUN	NNS	O
included	include	VERB	VBD	O
alternative	alternative	ADJ	JJ	O
anticoagulants	anticoagulant	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
11	11	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
thrombolytic	thrombolytic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
inferior	inferior	ADJ	JJ	O
vena	vena	NOUN	NN	O
cava	cava	NOUN	NN	O
filters	filter	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
eventually	eventually	ADV	RB	O
,	,	PUNCT	,	O
warfarin	warfarin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
11	11	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
died	die	VERB	VBD	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Delayed	delayed	NOUN	NN	O
-	-	PUNCT	HYPH	O
onset	onset	NOUN	NN	O
heparin	heparin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
increasingly	increasingly	ADV	RB	O
being	be	VERB	VBG	O
recognized	recognize	VERB	VBN	O
.	.	PUNCT	.	O

To	to	PART	TO	O
avoid	avoid	VERB	VB	O
disastrous	disastrous	ADJ	JJ	O
outcomes	outcome	NOUN	NNS	O
,	,	PUNCT	,	O
physicians	physician	NOUN	NNS	O
must	must	VERB	MD	O
consider	consider	VERB	VB	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
whenever	whenever	ADV	WRB	O
a	a	DET	DT	O
recently	recently	ADV	RB	O
hospitalized	hospitalize	VERB	VBN	O
patient	patient	ADJ	JJ	O
returns	return	NOUN	NNS	O
with	with	ADP	IN	O
thromboembolism	thromboembolism	NOUN	NN	B-Disease
;	;	PUNCT	:	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
alternative	alternative	ADJ	JJ	O
anticoagulants	anticoagulant	NOUN	NNS	O
,	,	PUNCT	,	O
not	not	ADV	RB	O
heparin	heparin	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
should	should	VERB	MD	O
be	be	VERB	VB	O
initiated	initiate	VERB	VBN	O
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
with	with	ADP	IN	O
a	a	DET	DT	O
dopamine	dopamine	NOUN	NN	B-Chemical
agonist	agonist	NOUN	NN	O
in	in	ADP	IN	O
children	child	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Risperidone	Risperidone	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
potent	potent	ADJ	JJ	O
antagonist	antagonist	NOUN	NN	O
of	of	ADP	IN	O
both	both	DET	DT	O
serotonergic	serotonergic	NOUN	NN	O
(	(	PUNCT	-LRB-	O
5HT2A	5ht2a	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
dopaminergic	dopaminergic	ADJ	JJ	O
D2	D2	PROPN	NNP	O
receptors	receptor	NOUN	NNS	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
in	in	ADP	IN	O
adults	adult	NOUN	NNS	O
and	and	CCONJ	CC	O
children	child	NOUN	NNS	O
.	.	PUNCT	.	O

Chronically	chronically	ADV	RB	O
elevated	elevated	ADJ	JJ	O
prolactin	prolactin	NOUN	NN	O
levels	level	NOUN	NNS	O
in	in	ADP	IN	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
prolactinomas	prolactinoma	NOUN	NNS	B-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
arrested	arrest	VERB	VBN	O
growth	growth	NOUN	NN	O
and	and	CCONJ	CC	O
development	development	NOUN	NN	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
either	either	DET	DT	O
delayed	delay	VERB	VBN	B-Disease
puberty	puberty	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
short	short	ADJ	JJ	O
stature	stature	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
possibilities	possibility	NOUN	NNS	O
stress	stress	VERB	VBP	O
the	the	DET	DT	O
importance	importance	NOUN	NN	O
of	of	ADP	IN	O
developing	develop	VERB	VBG	O
a	a	DET	DT	O
safe	safe	ADJ	JJ	O
and	and	CCONJ	CC	O
effective	effective	ADJ	JJ	O
approach	approach	NOUN	NN	O
to	to	ADP	IN	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
in	in	ADP	IN	O
youth	youth	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
the	the	DET	DT	O
successful	successful	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
with	with	ADP	IN	O
cabergoline	cabergoline	NOUN	NN	B-Chemical
in	in	ADP	IN	O
youth	youth	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
undertook	undertake	VERB	VBD	O
a	a	DET	DT	O
retrospective	retrospective	ADJ	JJ	O
case	case	NOUN	NN	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
four	four	NUM	CD	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
cabergoline	cabergoline	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Four	four	NUM	CD	O
males	male	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
age	age	NOUN	NN	O
6	6	NUM	CD	O
-	-	SYM	SYM	O
11	11	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
Diagnostic	Diagnostic	PROPN	NNP	O
and	and	CCONJ	CC	O
Statistical	Statistical	PROPN	NNP	O
Manual	Manual	PROPN	NNP	O
of	of	ADP	IN	O
Mental	Mental	PROPN	NNP	B-Disease
Disorders	Disorders	PROPN	NNP	I-Disease
(	(	PUNCT	-LRB-	O
fourth	fourth	ADJ	JJ	O
edition	edition	NOUN	NN	O
)	)	PUNCT	-RRB-	O
bipolar	bipolar	ADJ	JJ	B-Disease
disorder	disorder	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
psychoses	psychosis	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
elevations	elevation	NOUN	NNS	O
in	in	ADP	IN	O
serum	serum	ADJ	JJ	O
prolactin	prolactin	NOUN	NN	O
levels	level	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
57	57	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
129	129	NUM	CD	O
ng	ng	NOUN	NN	O
/	/	SYM	SYM	O
mL	ml	NOUN	NN	O
,	,	PUNCT	,	O
normal	normal	ADJ	JJ	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
15	15	NUM	CD	O
ng	ng	NOUN	NN	O
/	/	SYM	SYM	O
mL	ml	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
cabergoline	cabergoline	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
dose	dose	NOUN	NN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
13	13	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
09	09	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
week	week	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
serum	serum	ADJ	JJ	O
prolactin	prolactin	NOUN	NN	O
levels	level	NOUN	NNS	O
normalized	normalize	VERB	VBN	O
in	in	ADP	IN	O
all	all	DET	DT	O
four	four	NUM	CD	O
subjects	subject	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
10	10	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
ng	ng	ADP	IN	O
/	/	SYM	SYM	O
mL	ml	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
cabergoline	cabergoline	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
to	to	ADP	IN	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
week	week	NOUN	NN	O
in	in	ADP	IN	O
three	three	NUM	CD	O
of	of	ADP	IN	O
four	four	NUM	CD	O
subjects	subject	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
cabergoline	cabergoline	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
523	523	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
129	129	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
788	788	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
162	162	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Cabergoline	Cabergoline	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
without	without	ADP	IN	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Cabergoline	Cabergoline	PROPN	NNP	B-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
useful	useful	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
in	in	ADP	IN	O
youth	youth	NOUN	NN	O
;	;	PUNCT	:	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
further	further	ADJ	JJ	O
research	research	NOUN	NN	O
is	be	VERB	VBZ	O
needed	need	VERB	VBN	O
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	O
cholestatic	cholestatic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
after	after	ADP	IN	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
report	report	VERB	VB	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
cholestatic	cholestatic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
inhalational	inhalational	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

CASE	case	NOUN	NN	O
SUMMARY	summary	NOUN	NN	O
:	:	PUNCT	:	O
A	a	DET	DT	O
70	70	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
healthy	healthy	ADJ	JJ	O
woman	woman	NOUN	NN	O
from	from	ADP	IN	O
Iraq	Iraq	PROPN	NNP	O
developed	develop	VERB	VBD	O
acute	acute	ADJ	JJ	O
cholestatic	cholestatic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
3	3	NUM	CD	O
weeks	week	NOUN	NNS	O
following	follow	VERB	VBG	O
repair	repair	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
right	right	ADJ	JJ	O
rotator	rotator	NOUN	NN	O
cuff	cuff	NOUN	NN	O
under	under	ADP	IN	O
general	general	ADJ	JJ	O
anesthesia	anesthesia	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
evidence	evidence	NOUN	NN	O
for	for	ADP	IN	O
viral	viral	ADJ	JJ	O
,	,	PUNCT	,	O
autoimmune	autoimmune	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
metabolic	metabolic	ADJ	JJ	O
causes	cause	NOUN	NNS	O
of	of	ADP	IN	O
hepatitis	hepatitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

No	no	DET	DT	O
other	other	ADJ	JJ	O
medications	medication	NOUN	NNS	O
were	be	VERB	VBD	O
involved	involve	VERB	VBN	O
except	except	ADP	IN	O
for	for	ADP	IN	O
dipyrone	dipyrone	NOUN	NN	B-Chemical
for	for	ADP	IN	O
analgesia	analgesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
alanine	alanine	NOUN	NN	B-Chemical
aminotransferase	aminotransferase	NOUN	NN	O
was	be	VERB	VBD	O
elevated	elevate	VERB	VBN	O
to	to	ADP	IN	O
a	a	DET	DT	O
peak	peak	NOUN	NN	O
concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
1533	1533	NUM	CD	O
U	U	PROPN	NNP	O
/	/	SYM	SYM	O
L	L	PROPN	NNP	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
serum	serum	ADJ	JJ	O
bilirubin	bilirubin	NOUN	NN	B-Chemical
reached	reach	VERB	VBD	O
a	a	DET	DT	O
peak	peak	NOUN	NN	O
of	of	ADP	IN	O
17	17	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
dL	dl	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
slow	slow	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
over	over	ADP	IN	O
4	4	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Accidental	accidental	ADJ	JJ	O
reexposure	reexposure	NOUN	NN	O
by	by	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
to	to	ADP	IN	O
dipyrone	dipyrone	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
uneventful	uneventful	ADJ	JJ	O
.	.	PUNCT	.	O

DISCUSSION	discussion	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
histologic	histologic	ADJ	JJ	O
picture	picture	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
case	case	NOUN	NN	O
resembles	resemble	VERB	VBZ	O
halothane	halothane	NOUN	NN	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
has	have	VERB	VBZ	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
mortality	mortality	NOUN	NN	O
rate	rate	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Isoflurane	Isoflurane	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
common	common	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
agent	agent	NOUN	NN	O
,	,	PUNCT	,	O
can	can	VERB	MD	O
cause	cause	VERB	VB	O
severe	severe	ADJ	JJ	O
cholestatic	cholestatic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Torsade	Torsade	PROPN	NNP	B-Disease
de	de	ADP	IN	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
metoclopramide	metoclopramide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
an	an	DET	DT	O
elderly	elderly	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
preexisting	preexist	VERB	VBG	O
complete	complete	ADJ	JJ	O
left	left	ADJ	JJ	B-Disease
bundle	bundle	ADJ	JJ	I-Disease
branch	branch	NOUN	NN	I-Disease
block	block	NOUN	NN	I-Disease
.	.	PUNCT	.	O

There	there	ADV	EX	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
growing	grow	VERB	VBG	O
list	list	NOUN	NN	O
of	of	ADP	IN	O
drugs	drug	NOUN	NNS	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
acquired	acquire	VERB	VBN	O
long	long	ADJ	JJ	B-Disease
QT	QT	PROPN	NNP	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
torsade	torsade	NOUN	NN	B-Disease
de	de	X	FW	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
torsadogenic	torsadogenic	ADJ	JJ	O
potential	potential	NOUN	NN	O
of	of	ADP	IN	O
metoclopramide	metoclopramide	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
commonly	commonly	ADV	RB	O
used	use	VERB	VBN	O
antiemetic	antiemetic	ADJ	JJ	O
and	and	CCONJ	CC	O
prokinetic	prokinetic	ADJ	JJ	O
drug	drug	NOUN	NN	O
,	,	PUNCT	,	O
has	have	VERB	VBZ	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
,	,	PUNCT	,	O
despite	despite	ADP	IN	O
its	-PRON-	DET	PRP$	O
chemical	chemical	NOUN	NN	O
similarity	similarity	NOUN	NN	O
to	to	ADP	IN	O
procainamide	procainamide	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
on	on	ADP	IN	O
a	a	DET	DT	O
92	92	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
preexisting	preexist	VERB	VBG	O
complete	complete	ADJ	JJ	O
left	left	ADJ	JJ	B-Disease
bundle	bundle	ADJ	JJ	I-Disease
branch	branch	NOUN	NN	I-Disease
block	block	NOUN	NN	I-Disease
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
torsade	torsade	NOUN	NN	B-Disease
de	de	ADP	IN	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
after	after	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
and	and	CCONJ	CC	O
oral	oral	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
metoclopramide	metoclopramide	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
patient	patient	NOUN	NN	O
also	also	ADV	RB	O
developed	develop	VERB	VBD	O
torsade	torsade	NOUN	NN	B-Disease
de	de	ADP	IN	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
when	when	ADV	WRB	O
cisapride	cisapride	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
erythromycin	erythromycin	ADV	RB	B-Chemical
were	be	VERB	VBD	O
given	give	VERB	VBN	O
simultaneously	simultaneously	ADV	RB	O
.	.	PUNCT	.	O

These	these	DET	DT	O
two	two	NUM	CD	O
episodes	episode	NOUN	NNS	O
were	be	VERB	VBD	O
suppressed	suppress	VERB	VBN	O
successfully	successfully	ADV	RB	O
after	after	ADP	IN	O
discontinuing	discontinue	VERB	VBG	O
the	the	DET	DT	O
offending	offend	VERB	VBG	O
drugs	drug	NOUN	NNS	O
and	and	CCONJ	CC	O
administering	administer	VERB	VBG	O
class	class	NOUN	NN	O
IB	ib	NOUN	NN	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
documentation	documentation	NOUN	NN	O
that	that	DET	WDT	O
metoclopramide	metoclopramide	VERB	VBP	B-Chemical
provokes	provoke	NOUN	NNS	O
torsade	torsade	NOUN	NN	B-Disease
de	de	X	FW	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
clinically	clinically	ADV	RB	O
.	.	PUNCT	.	O

Metoclopramide	Metoclopramide	PROPN	NNP	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
cautiously	cautiously	ADV	RB	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
torsade	torsade	NOUN	NN	B-Disease
de	de	X	FW	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Dopamine	dopamine	NOUN	NN	B-Chemical
D2	d2	NOUN	NN	O
receptor	receptor	NOUN	NN	O
signaling	signal	VERB	VBG	O
controls	control	VERB	VBZ	O
neuronal	neuronal	ADJ	JJ	O
cell	cell	NOUN	NN	O
death	death	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
muscarinic	muscarinic	ADJ	JJ	O
and	and	CCONJ	CC	O
glutamatergic	glutamatergic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

Dopamine	Dopamine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
DA	DA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
through	through	ADP	IN	O
D1	D1	PROPN	NNP	O
/	/	SYM	SYM	O
D2	d2	NOUN	NN	O
receptor	receptor	NOUN	NN	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
signaling	signaling	NOUN	NN	O
,	,	PUNCT	,	O
plays	play	VERB	VBZ	O
a	a	DET	DT	O
major	major	ADJ	JJ	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
of	of	ADP	IN	O
epileptic	epileptic	ADJ	JJ	B-Disease
seizures	seizure	NOUN	NNS	I-Disease
arising	arise	VERB	VBG	O
in	in	ADP	IN	O
the	the	DET	DT	O
limbic	limbic	ADJ	JJ	O
system	system	NOUN	NN	O
.	.	PUNCT	.	O

Excitotoxicity	excitotoxicity	NOUN	NN	B-Disease
leading	lead	VERB	VBG	O
to	to	ADP	IN	O
neuronal	neuronal	ADJ	JJ	O
cell	cell	NOUN	NN	O
death	death	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
affected	affect	VERB	VBN	O
areas	area	NOUN	NNS	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
major	major	ADJ	JJ	O
consequence	consequence	NOUN	NN	O
of	of	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
at	at	ADP	IN	O
the	the	DET	DT	O
cellular	cellular	ADJ	JJ	O
level	level	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
respect	respect	NOUN	NN	O
,	,	PUNCT	,	O
little	little	ADJ	JJ	O
is	be	VERB	VBZ	O
known	know	VERB	VBN	O
about	about	ADP	IN	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
DA	DA	PROPN	NNP	B-Chemical
receptors	receptor	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
epilepsy	epilepsy	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
neuronal	neuronal	ADJ	JJ	O
cell	cell	NOUN	NN	O
death	death	NOUN	NN	O
.	.	PUNCT	.	O

Here	here	ADV	RB	O
we	-PRON-	PRON	PRP	O
analyze	analyze	VERB	VBP	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
D2R	D2R	PROPN	NNP	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
mice	mouse	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
cholinergic	cholinergic	NOUN	NN	O
agonist	agonist	NOUN	NN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
compared	compare	VERB	VBD	O
these	these	DET	DT	O
results	result	NOUN	NNS	O
with	with	ADP	IN	O
those	those	DET	DT	O
previously	previously	ADV	RB	O
obtained	obtain	VERB	VBN	O
with	with	ADP	IN	O
kainic	kainic	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
KA	KA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
potent	potent	ADJ	JJ	O
glutamate	glutamate	ADJ	JJ	B-Chemical
agonist	agonist	NOUN	NN	O
.	.	PUNCT	.	O

Importantly	importantly	ADV	RB	O
,	,	PUNCT	,	O
D2R	D2R	PROPN	NNP	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
mice	mouse	NOUN	NNS	O
develop	develop	VERB	VBP	O
seizures	seizure	NOUN	NNS	B-Disease
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
both	both	DET	DT	O
drugs	drug	NOUN	NNS	O
that	that	DET	WDT	O
are	be	VERB	VBP	O
not	not	ADV	RB	O
epileptogenic	epileptogenic	ADJ	JJ	O
for	for	ADP	IN	O
WT	wt	NOUN	NN	O
littermates	littermate	NOUN	NNS	O
and	and	CCONJ	CC	O
show	show	VERB	VB	O
greater	great	ADJ	JJR	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
result	result	VERB	VBP	O
in	in	ADP	IN	O
a	a	DET	DT	O
more	more	ADV	RBR	O
widespread	widespread	ADJ	JJ	O
neuronal	neuronal	ADJ	JJ	O
death	death	NOUN	NN	O
in	in	ADP	IN	O
both	both	DET	DT	O
WT	WT	PROPN	NNP	O
and	and	CCONJ	CC	O
D2R	D2R	PROPN	NNP	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
brains	brain	NOUN	NNS	O
in	in	ADP	IN	O
comparison	comparison	NOUN	NN	O
to	to	ADP	IN	O
KA	KA	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
D2R	D2R	PROPN	NNP	O
lowers	lower	VERB	VBZ	O
the	the	DET	DT	O
threshold	threshold	NOUN	NN	O
for	for	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
both	both	DET	DT	O
glutamate	glutamate	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
acetylcholine	acetylcholine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
dopaminergic	dopaminergic	ADJ	JJ	O
control	control	NOUN	NN	O
of	of	ADP	IN	O
epilepsy	epilepsy	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
neurodegeneration	neurodegeneration	NOUN	NN	B-Disease
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
distinct	distinct	ADJ	JJ	O
interactions	interaction	NOUN	NNS	O
of	of	ADP	IN	O
D2R	D2R	PROPN	NNP	O
signaling	signal	VERB	VBG	O
with	with	ADP	IN	O
these	these	DET	DT	O
two	two	NUM	CD	O
neurotransmitters	neurotransmitter	NOUN	NNS	O
.	.	PUNCT	.	O

Steroid	steroid	VERB	VB	B-Chemical
structure	structure	NOUN	NN	O
and	and	CCONJ	CC	O
pharmacological	pharmacological	ADJ	JJ	O
properties	property	NOUN	NNS	O
determine	determine	VERB	VBP	O
the	the	DET	DT	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
amnesic	amnesic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
pregnenolone	pregnenolone	NOUN	NN	B-Chemical
sulphate	sulphate	NOUN	NN	I-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
passive	passive	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
task	task	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Pregnenolone	pregnenolone	NOUN	NN	B-Chemical
sulphate	sulphate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
PREGS	pregs	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
has	have	VERB	VBZ	O
generated	generate	VERB	VBN	O
interest	interest	NOUN	NN	O
as	as	ADP	IN	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
most	most	ADV	RBS	O
potent	potent	ADJ	JJ	O
memory	memory	NOUN	NN	O
-	-	PUNCT	HYPH	O
enhancing	enhance	VERB	VBG	O
neurosteroids	neurosteroid	NOUN	NNS	O
to	to	PART	TO	O
be	be	VERB	VB	O
examined	examine	VERB	VBN	O
in	in	ADP	IN	O
rodent	rodent	ADJ	JJ	O
learning	learning	NOUN	NN	O
studies	study	NOUN	NNS	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
particular	particular	ADJ	JJ	O
importance	importance	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ageing	ageing	NOUN	NN	O
process	process	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
by	by	ADP	IN	O
which	which	DET	WDT	O
this	this	DET	DT	O
endogenous	endogenous	ADJ	JJ	O
steroid	steroid	NOUN	NN	B-Chemical
enhances	enhance	NOUN	NNS	O
memory	memory	NOUN	NN	O
formation	formation	NOUN	NN	O
is	be	VERB	VBZ	O
hypothesized	hypothesize	VERB	VBN	O
to	to	PART	TO	O
involve	involve	VERB	VB	O
actions	action	NOUN	NNS	O
on	on	ADP	IN	O
glutamatergic	glutamatergic	NOUN	NN	O
and	and	CCONJ	CC	O
GABAergic	GABAergic	PROPN	NNP	O
systems	system	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
stems	stem	VERB	VBZ	O
from	from	ADP	IN	O
findings	finding	NOUN	NNS	O
that	that	DET	WDT	O
PREGS	pregs	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
potent	potent	ADJ	JJ	O
positive	positive	ADJ	JJ	O
modulator	modulator	NOUN	NN	O
of	of	ADP	IN	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
d	d	VERB	VBN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aspartate	aspartate	NOUN	NN	I-Chemical
receptors	receptor	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
NMDARs	NMDARs	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
negative	negative	ADJ	JJ	O
modulator	modulator	NOUN	NN	O
of	of	ADP	IN	O
gamma	gamma	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminobutyric	aminobutyric	ADJ	JJ	I-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
A	a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
receptors	receptor	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
GABA	GABA	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
A	a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
Rs	r	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
PREGS	pregs	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
able	able	ADJ	JJ	O
to	to	PART	TO	O
reverse	reverse	VERB	VB	O
the	the	DET	DT	O
amnesic	amnesic	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
NMDAR	NMDAR	PROPN	NNP	O
and	and	CCONJ	CC	O
GABA	GABA	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
A	a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
R	r	NOUN	NN	O
ligands	ligand	NOUN	NNS	O
.	.	PUNCT	.	O

To	to	PART	TO	O
investigate	investigate	VERB	VB	O
this	this	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
examined	examine	VERB	VBD	O
the	the	DET	DT	O
memory	memory	NOUN	NN	O
-	-	PUNCT	HYPH	O
altering	alter	VERB	VBG	O
abilities	ability	NOUN	NNS	O
of	of	ADP	IN	O
structural	structural	ADJ	JJ	O
analogs	analog	NOUN	NNS	O
of	of	ADP	IN	O
PREGS	PREGS	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
differ	differ	VERB	VBP	O
in	in	ADP	IN	O
their	-PRON-	DET	PRP$	O
modulation	modulation	NOUN	NN	O
of	of	ADP	IN	O
NMDAR	NMDAR	PROPN	NNP	O
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
GABA	GABA	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
A	a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
R	r	NOUN	NN	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
analogs	analog	NOUN	NNS	O
tested	test	VERB	VBN	O
were	be	VERB	VBD	O
:	:	PUNCT	:	O
11	11	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
ketopregnenolone	ketopregnenolone	NOUN	NN	I-Chemical
sulphate	sulphate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
an	an	DET	DT	O
agent	agent	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
inactive	inactive	ADJ	JJ	O
at	at	ADP	IN	O
GABA	GABA	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
A	a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
Rs	r	NOUN	NNS	O
and	and	CCONJ	CC	O
NMDARs	NMDARs	PROPN	NNPS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
epipregnanolone	epipregnanolone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	I-Chemical
[	[	PUNCT	-LRB-	I-Chemical
3beta	3beta	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxy	hydroxy	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
5beta	5beta	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
pregnan	pregnan	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
20	20	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
one	one	NUM	CD	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
sulphate	sulphate	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
an	an	DET	DT	O
inhibitor	inhibitor	NOUN	NN	O
of	of	ADP	IN	O
both	both	CCONJ	CC	O
GABA	GABA	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
A	a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
Rs	r	NOUN	NNS	O
and	and	CCONJ	CC	O
NMDARs	NMDARs	PROPN	NNPS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
newly	newly	ADV	RB	O
synthesized	synthesize	VERB	VBN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
PREGS	pregs	NOUN	NN	B-Chemical
enantiomer	enantiomer	NOUN	NN	O
(	(	PUNCT	-LRB-	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
identical	identical	ADJ	JJ	O
to	to	ADP	IN	O
PREGS	pregs	NOUN	NN	B-Chemical
in	in	ADP	IN	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
GABA	GABA	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
A	a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
Rs	r	NOUN	NNS	O
and	and	CCONJ	CC	O
NMDARs	NMDARs	PROPN	NNPS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
memory	memory	NOUN	NN	O
-	-	PUNCT	HYPH	O
enhancing	enhance	VERB	VBG	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
PREGS	PREGS	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
analogs	analog	NOUN	NNS	O
were	be	VERB	VBD	O
tested	test	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
passive	passive	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
task	task	NOUN	NN	O
using	use	VERB	VBG	O
the	the	DET	DT	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Both	both	DET	DT	O
PREGS	pregs	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
enantiomer	enantiomer	NOUN	NN	O
blocked	block	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
,	,	PUNCT	,	O
unlike	unlike	ADP	IN	O
PREGS	PREGS	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
11	11	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
ketopregnenolone	ketopregnenolone	NOUN	NN	I-Chemical
sulphate	sulphate	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
epipregnanolone	epipregnanolone	NOUN	NN	B-Chemical
sulphate	sulphate	NOUN	NN	I-Chemical
failed	fail	VERB	VBD	O
to	to	PART	TO	O
block	block	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
that	that	ADP	IN	O
altering	alter	VERB	VBG	O
the	the	DET	DT	O
modulation	modulation	NOUN	NN	O
of	of	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
receptors	receptor	NOUN	NNS	O
diminishes	diminish	VERB	VBZ	O
the	the	DET	DT	O
memory	memory	NOUN	NN	O
-	-	PUNCT	HYPH	O
enhancing	enhance	VERB	VBG	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
PREGS	pregs	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
enantioselectivity	enantioselectivity	NOUN	NN	O
was	be	VERB	VBD	O
demonstrated	demonstrate	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
ability	ability	NOUN	NN	O
of	of	ADP	IN	O
natural	natural	ADJ	JJ	O
PREGS	pregs	NOUN	NN	B-Chemical
to	to	PART	TO	O
be	be	VERB	VB	O
an	an	DET	DT	O
order	order	NOUN	NN	O
of	of	ADP	IN	O
magnitude	magnitude	NOUN	NN	O
more	more	ADV	RBR	O
effective	effective	ADJ	JJ	O
than	than	ADP	IN	O
its	-PRON-	DET	PRP$	O
synthetic	synthetic	ADJ	JJ	O
enantiomer	enantiomer	NOUN	NN	O
in	in	ADP	IN	O
reversing	reverse	VERB	VBG	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
identify	identify	VERB	VBP	O
a	a	DET	DT	O
novel	novel	ADJ	JJ	O
neuropharmacological	neuropharmacological	ADJ	JJ	O
site	site	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
modulation	modulation	NOUN	NN	O
of	of	ADP	IN	O
memory	memory	NOUN	NN	O
processes	process	NOUN	NNS	O
by	by	ADP	IN	O
neuroactive	neuroactive	ADJ	JJ	O
steroids	steroid	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

Activation	activation	NOUN	NN	O
of	of	ADP	IN	O
poly	poly	ADJ	JJ	B-Chemical
(	(	PUNCT	-LRB-	I-Chemical
ADP	ADP	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
ribose	ribose	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
polymerase	polymerase	NOUN	NN	O
contributes	contribute	NOUN	NNS	O
to	to	ADP	IN	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Activation	activation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
nuclear	nuclear	ADJ	JJ	O
enzyme	enzyme	ADJ	JJ	O
poly	poly	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	I-Chemical
ADP	ADP	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
ribose	ribose	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
polymerase	polymerase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PARP	PARP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
by	by	ADP	IN	O
oxidant	oxidant	ADJ	JJ	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
DNA	dna	NOUN	NN	O
damage	damage	NOUN	NN	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
pathway	pathway	NOUN	NN	O
of	of	ADP	IN	O
cell	cell	NOUN	NN	O
dysfunction	dysfunction	NOUN	NN	O
and	and	CCONJ	CC	O
tissue	tissue	NOUN	NN	O
injury	injury	NOUN	NN	O
in	in	ADP	IN	O
conditions	condition	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
.	.	PUNCT	.	O

Increased	increase	VERB	VBN	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
major	major	ADJ	JJ	O
factor	factor	NOUN	NN	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DOX	DOX	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
antitumor	antitumor	CCONJ	CC	O
anthracycline	anthracycline	ADJ	JJ	B-Chemical
antibiotic	antibiotic	ADJ	JJ	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
hypothesized	hypothesize	VERB	VBD	O
that	that	ADP	IN	O
the	the	DET	DT	O
activation	activation	NOUN	NN	O
of	of	ADP	IN	O
PARP	PARP	PROPN	NNP	O
may	may	VERB	MD	O
contribute	contribute	VERB	VB	O
to	to	ADP	IN	O
the	the	DET	DT	O
DOX	DOX	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Using	use	VERB	VBG	O
a	a	DET	DT	O
dual	dual	ADJ	JJ	O
approach	approach	NOUN	NN	O
of	of	ADP	IN	O
PARP	PARP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
suppression	suppression	NOUN	NN	O
,	,	PUNCT	,	O
by	by	ADP	IN	O
genetic	genetic	ADJ	JJ	O
deletion	deletion	NOUN	NN	O
or	or	CCONJ	CC	O
pharmacological	pharmacological	ADJ	JJ	O
inhibition	inhibition	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
phenanthridinone	phenanthridinone	NOUN	NN	O
PARP	PARP	PROPN	NNP	O
inhibitor	inhibitor	NOUN	NN	O
PJ34	PJ34	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
now	now	ADV	RB	O
demonstrate	demonstrate	VERB	VBP	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
PARP	PARP	PROPN	NNP	O
in	in	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
DOX	DOX	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

PARP	PARP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
+	+	NOUN	NN	O
/	/	SYM	SYM	O
+	+	CCONJ	CC	O
and	and	CCONJ	CC	O
PARP	PARP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
mice	mouse	NOUN	NNS	O
received	receive	VERB	VBD	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
DOX	DOX	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
25	25	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Five	five	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
DOX	DOX	PROPN	NNP	B-Chemical
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
left	leave	VERB	VBD	O
ventricular	ventricular	ADJ	JJ	O
performance	performance	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
depressed	depress	VERB	VBN	O
in	in	ADP	IN	O
PARP	PARP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
+	+	NOUN	NN	O
/	/	SYM	SYM	O
+	+	CCONJ	CC	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
only	only	ADV	RB	O
to	to	ADP	IN	O
a	a	DET	DT	O
smaller	small	ADJ	JJR	O
extent	extent	NOUN	NN	O
in	in	ADP	IN	O
PARP	PARP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
ones	one	NOUN	NNS	O
.	.	PUNCT	.	O

Similar	similar	ADJ	JJ	O
experiments	experiment	NOUN	NNS	O
were	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
in	in	ADP	IN	O
BALB	BALB	PROPN	NNP	O
/	/	SYM	SYM	O
c	c	NOUN	NN	O
mice	mouse	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
PJ34	PJ34	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
vehicle	vehicle	NOUN	NN	O
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
PJ34	PJ34	PROPN	NNP	B-Chemical
significantly	significantly	ADV	RB	O
improved	improve	VERB	VBD	O
cardiac	cardiac	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
survival	survival	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
PJ34	PJ34	PROPN	NNP	B-Chemical
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
DOX	DOX	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
serum	serum	ADJ	JJ	O
lactate	lactate	NOUN	NN	B-Chemical
dehydrogenase	dehydrogenase	NOUN	NN	O
and	and	CCONJ	CC	O
creatine	creatine	NOUN	NN	B-Chemical
kinase	kinase	NUM	CD	O
activities	activity	NOUN	NNS	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
metalloproteinase	metalloproteinase	VERB	VB	O
activation	activation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
heart	heart	NOUN	NN	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
PARP	PARP	PROPN	NNP	O
activation	activation	NOUN	NN	O
contributes	contribute	VERB	VBZ	O
to	to	ADP	IN	O
the	the	DET	DT	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
DOX	DOX	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

PARP	parp	NOUN	NN	O
inhibitors	inhibitor	NOUN	NNS	O
may	may	VERB	MD	O
exert	exert	VERB	VB	O
protective	protective	ADJ	JJ	O
effects	effect	NOUN	NNS	O
against	against	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
DOX	DOX	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Spironolactone	spironolactone	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
is	be	VERB	VBZ	O
it	-PRON-	PRON	PRP	O
a	a	DET	DT	O
novel	novel	ADJ	JJ	O
drug	drug	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
amphotericin	amphotericin	PROPN	NNP	B-Chemical
B	b	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
in	in	ADP	IN	O
cancer	cancer	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
?	?	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
Nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
the	the	DET	DT	O
major	major	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
amphotericin	amphotericin	NOUN	NN	B-Chemical
B	B	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
AmB	AmB	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
often	often	ADV	RB	O
limiting	limit	VERB	VBG	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
full	full	ADJ	JJ	O
dosage	dosage	NOUN	NN	O
.	.	PUNCT	.	O

Selective	selective	ADJ	JJ	O
distal	distal	ADJ	JJ	O
tubular	tubular	ADJ	JJ	O
epithelial	epithelial	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
profound	profound	ADJ	JJ	O
potassium	potassium	NOUN	NN	B-Chemical
wasting	wasting	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
major	major	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
AmB	AmB	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Potassium	potassium	NOUN	NN	B-Chemical
depletion	depletion	NOUN	NN	O
also	also	ADV	RB	O
potentiates	potentiate	VERB	VBZ	O
the	the	DET	DT	O
tubular	tubular	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
AmB	AmB	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
designed	design	VERB	VBN	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
ability	ability	NOUN	NN	O
of	of	ADP	IN	O
spironolactone	spironolactone	NOUN	NN	B-Chemical
to	to	PART	TO	O
reduce	reduce	VERB	VB	O
potassium	potassium	NOUN	NN	B-Chemical
requirements	requirement	NOUN	NNS	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
prevent	prevent	VERB	VB	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
in	in	ADP	IN	O
neutropenic	neutropenic	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
on	on	ADP	IN	O
AmB	amb	DET	DT	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
26	26	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
various	various	ADJ	JJ	O
hematological	hematological	ADJ	JJ	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
randomized	randomize	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
either	either	CCONJ	CC	O
intravenous	intravenous	ADJ	JJ	O
AmB	amb	CCONJ	CC	B-Chemical
alone	alone	ADJ	JJ	O
or	or	CCONJ	CC	O
AmB	amb	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
oral	oral	ADJ	JJ	O
spironolactone	spironolactone	NOUN	NN	B-Chemical
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
twice	twice	ADV	RB	O
daily	daily	ADV	RB	O
when	when	ADV	WRB	O
developing	develop	VERB	VBG	O
a	a	DET	DT	O
proven	prove	VERB	VBN	O
or	or	CCONJ	CC	O
suspected	suspect	VERB	VBN	O
fungal	fungal	ADJ	JJ	B-Disease
infection	infection	NOUN	NN	I-Disease
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
concomitant	concomitant	ADJ	JJ	O
AmB	AmB	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
spironolactone	spironolactone	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
significantly	significantly	ADV	RB	O
higher	high	ADJ	JJR	O
plasma	plasma	NOUN	NN	O
potassium	potassium	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
than	than	ADP	IN	O
those	those	DET	DT	O
receiving	receive	VERB	VBG	O
AmB	amb	CCONJ	CC	B-Chemical
alone	alone	ADV	RB	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0027	0027	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Those	those	DET	DT	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
AmB	amb	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
spironolactone	spironolactone	NOUN	NN	B-Chemical
required	require	VERB	VBD	O
significantly	significantly	ADV	RB	O
less	less	ADJ	JJR	O
potassium	potassium	NOUN	NN	B-Chemical
supplementation	supplementation	NOUN	NN	O
to	to	PART	TO	O
maintain	maintain	VERB	VB	O
their	-PRON-	DET	PRP$	O
plasma	plasma	NOUN	NN	O
potassium	potassium	NOUN	NN	B-Chemical
within	within	ADP	IN	O
the	the	DET	DT	O
normal	normal	ADJ	JJ	O
range	range	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
022	022	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
urinary	urinary	ADJ	JJ	O
potassium	potassium	NOUN	NN	B-Chemical
losses	loss	NOUN	NNS	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
less	less	ADV	RBR	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
AmB	amb	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
spironolactone	spironolactone	NOUN	NN	B-Chemical
than	than	ADP	IN	O
those	those	DET	DT	O
receiving	receive	VERB	VBG	O
AmB	amb	CCONJ	CC	B-Chemical
alone	alone	ADV	RB	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
040	040	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
This	this	DET	DT	O
study	study	NOUN	NN	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
spironolactone	spironolactone	NOUN	NN	B-Chemical
can	can	VERB	MD	O
reduce	reduce	VERB	VB	O
potassium	potassium	NOUN	NN	B-Chemical
requirements	requirement	NOUN	NNS	O
and	and	CCONJ	CC	O
prevent	prevent	VERB	VB	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
by	by	ADP	IN	O
reducing	reduce	VERB	VBG	O
urinary	urinary	ADJ	JJ	O
potassium	potassium	NOUN	NN	B-Chemical
loss	loss	NOUN	NN	O
in	in	ADP	IN	O
neutropenic	neutropenic	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
on	on	ADP	IN	O
AmB	amb	DET	DT	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Erectile	erectile	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
occurs	occur	VERB	VBZ	O
following	follow	VERB	VBG	O
substantia	substantia	ADJ	JJ	O
nigra	nigra	NOUN	NN	O
lesions	lesion	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

Erectile	erectile	ADJ	JJ	O
function	function	NOUN	NN	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
following	follow	VERB	VBG	O
uni	uni	ADJ	JJ	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
bilateral	bilateral	ADJ	JJ	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxydopamine	hydroxydopamine	NOUN	NN	I-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
substantia	substantia	ADJ	JJ	O
nigra	nigra	NOUN	NN	O
nucleus	nucleus	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
.	.	PUNCT	.	O

Behavioral	behavioral	ADJ	JJ	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
penile	penile	NOUN	NN	O
erections	erection	NOUN	NNS	O
were	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
/	/	SYM	SYM	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBN	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
/	/	SYM	SYM	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
uni	uni	NOUN	NN	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
bilateral	bilateral	ADJ	JJ	O
lesioned	lesione	VERB	VBN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

Intracavernous	intracavernous	ADJ	JJ	O
pressures	pressure	NOUN	NNS	O
,	,	PUNCT	,	O
following	follow	VERB	VBG	O
electrical	electrical	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cavernous	cavernous	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
in	in	ADP	IN	O
lesioned	lesione	VERB	VBN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

Lesions	lesion	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
substantia	substantia	NOUN	NN	O
nigra	nigra	NOUN	NN	O
were	be	VERB	VBD	O
confirmed	confirm	VERB	VBN	O
by	by	ADP	IN	O
histology	histology	NOUN	NN	O
.	.	PUNCT	.	O

Concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
metabolites	metabolite	NOUN	NNS	O
were	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
of	of	ADP	IN	O
substantia	substantia	NOUN	NN	O
nigra	nigra	NOUN	NN	O
lesioned	lesione	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Lesions	lesion	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
substantia	substantia	NOUN	NN	O
nigra	nigra	NOUN	NN	O
are	be	VERB	VBP	O
therefore	therefore	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
erectile	erectile	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
may	may	VERB	MD	O
serve	serve	VERB	VB	O
as	as	ADP	IN	O
a	a	DET	DT	O
model	model	NOUN	NN	O
to	to	PART	TO	O
study	study	VERB	VB	O
erectile	erectile	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
in	in	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Nicotine	nicotine	NOUN	NN	B-Chemical
potentiation	potentiation	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
nicotine	nicotine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
investigated	investigate	VERB	VBN	O
.	.	PUNCT	.	O

Morphine	morphine	NOUN	NN	B-Chemical
but	but	CCONJ	CC	O
not	not	ADV	RB	O
nicotine	nicotine	NOUN	NN	B-Chemical
induced	induce	VERB	VBD	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
response	response	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
potentiated	potentiate	VERB	VBN	O
by	by	ADP	IN	O
nicotine	nicotine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Intraperitoneal	intraperitoneal	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
atropine	atropine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
naloxone	naloxone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
mecamylamine	mecamylamine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
hexamethonium	hexamethonium	NOUN	NN	B-Chemical
to	to	ADP	IN	O
mice	mouse	NOUN	NNS	O
reduced	reduce	VERB	VBN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
combination	combination	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
with	with	ADP	IN	O
nicotine	nicotine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Intracerebroventricular	intracerebroventricular	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
atropine	atropine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
hexamethonium	hexamethonium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
naloxone	naloxone	NOUN	NN	B-Chemical
also	also	ADV	RB	O
decreased	decrease	VERB	VBD	O
catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
plus	plus	CCONJ	CC	O
nicotine	nicotine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Intraperitoneal	intraperitoneal	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
atropine	atropine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
intraperitoneal	intraperitoneal	ADJ	JJ	O
or	or	CCONJ	CC	O
intracerebroventricular	intracerebroventricular	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
hexamethonium	hexamethonium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
concluded	conclude	VERB	VBN	O
that	that	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
catalepsy	catalepsy	NOUN	NN	B-Disease
can	can	VERB	MD	O
be	be	VERB	VB	O
elicited	elicit	VERB	VBN	O
by	by	ADP	IN	O
opioid	opioid	NOUN	NN	O
and	and	CCONJ	CC	O
cholinergic	cholinergic	NOUN	NN	O
receptors	receptor	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
potentiation	potentiation	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
nicotine	nicotine	NOUN	NN	B-Chemical
may	may	VERB	MD	O
also	also	ADV	RB	O
be	be	VERB	VB	O
mediated	mediate	VERB	VBN	O
through	through	ADP	IN	O
cholinergic	cholinergic	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
mechanisms	mechanism	NOUN	NNS	O
.	.	PUNCT	.	O

Force	force	NOUN	NN	O
overflow	overflow	ADJ	JJ	O
and	and	CCONJ	CC	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
in	in	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
assessed	assess	VERB	VBD	O
force	force	NOUN	NN	O
coordination	coordination	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hand	hand	NOUN	NN	O
in	in	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
relationship	relationship	NOUN	NN	O
to	to	ADP	IN	O
motor	motor	NOUN	NN	O
complications	complication	NOUN	NNS	O
of	of	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
particularly	particularly	ADV	RB	O
to	to	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
(	(	PUNCT	-LRB-	O
LID	LID	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
studied	study	VERB	VBD	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
(	(	PUNCT	-LRB-	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
+	+	CCONJ	CC	O
LID	LID	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
23	23	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
without	without	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
(	(	PUNCT	-LRB-	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	O
LID	LID	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
10	10	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
age	age	NOUN	NN	O
-	-	PUNCT	HYPH	O
matched	match	VERB	VBN	O
healthy	healthy	ADJ	JJ	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
motor	motor	NOUN	NN	O
score	score	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
Unified	Unified	PROPN	NNP	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
Disease	Disease	PROPN	NNP	I-Disease
Rating	Rating	PROPN	NNP	O
Scale	Scale	PROPN	NNP	O
,	,	PUNCT	,	O
a	a	DET	DT	O
dyskinesia	dyskinesia	ADJ	JJ	B-Disease
score	score	NOUN	NN	O
and	and	CCONJ	CC	O
force	force	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
grip	grip	NOUN	NN	O
-	-	PUNCT	HYPH	O
lift	lift	NOUN	NN	O
paradigm	paradigm	NOUN	NN	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
ON	ON	PROPN	NNP	O
and	and	CCONJ	CC	O
OFF	OFF	PROPN	NNP	O
levodopa	levodopa	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
pathological	pathological	ADJ	JJ	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
forces	force	NOUN	NNS	O
was	be	VERB	VBD	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
ON	ON	PROPN	NNP	O
-	-	PUNCT	HYPH	O
state	state	NOUN	NN	O
in	in	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
+	+	CCONJ	CC	O
LID	LID	PROPN	NNP	B-Disease
only	only	ADV	RB	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
+	+	CCONJ	CC	O
LID	LID	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
force	force	NOUN	NN	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
pressing	press	VERB	VBG	O
down	down	PART	RP	O
the	the	DET	DT	O
object	object	NOUN	NN	O
before	before	ADP	IN	O
lifting	lifting	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBN	O
by	by	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
(	(	PUNCT	-LRB-	O
by	by	ADP	IN	O
61	61	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

An	an	DET	DT	O
overshooting	overshooting	NOUN	NN	O
of	of	ADP	IN	O
peak	peak	NOUN	NN	O
grip	grip	NOUN	NN	O
force	force	NOUN	NN	O
by	by	ADP	IN	O
51	51	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
of	of	ADP	IN	O
static	static	ADJ	JJ	O
grip	grip	NOUN	NN	O
force	force	NOUN	NN	O
by	by	ADP	IN	O
45	45	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ON	ON	PROPN	NNP	O
-	-	PUNCT	HYPH	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
OFF	OFF	PROPN	NNP	O
-	-	PUNCT	HYPH	O
drug	drug	NOUN	NN	O
condition	condition	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
no	no	DET	DT	O
excessive	excessive	ADJ	JJ	O
force	force	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PUNCT	HYPH	I-Disease
disease	disease	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	O
LID	lid	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Peak	peak	VERB	VB	O
grip	grip	NOUN	NN	O
force	force	NOUN	NN	O
in	in	ADP	IN	O
ON	ON	PROPN	NNP	O
-	-	PUNCT	HYPH	O
state	state	NOUN	NN	O
was	be	VERB	VBD	O
140	140	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
higher	high	ADJ	JJR	O
in	in	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
+	+	CCONJ	CC	O
LID	lid	NOUN	NN	B-Disease
than	than	ADP	IN	O
in	in	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PUNCT	HYPH	I-Disease
disease	disease	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	O
LID	lid	NOUN	NN	B-Disease
,	,	PUNCT	,	O
while	while	ADP	IN	O
static	static	ADJ	JJ	O
grip	grip	NOUN	NN	O
force	force	NOUN	NN	O
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
by	by	ADP	IN	O
138	138	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
between	between	ADP	IN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Severity	severity	NOUN	NN	O
of	of	ADP	IN	O
peak	peak	NOUN	NN	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
was	be	VERB	VBD	O
strongly	strongly	ADV	RB	O
correlated	correlate	VERB	VBN	O
with	with	ADP	IN	O
grip	grip	ADJ	JJ	O
force	force	NOUN	NN	O
in	in	ADP	IN	O
ON	ON	PROPN	NNP	O
-	-	PUNCT	HYPH	O
state	state	NOUN	NN	O
(	(	PUNCT	-LRB-	O
r	r	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
79	79	NUM	CD	O
with	with	ADP	IN	O
peak	peak	NOUN	NN	O
force	force	NOUN	NN	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

No	no	DET	DT	O
correlation	correlation	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
between	between	ADP	IN	O
forces	force	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
motor	motor	NOUN	NN	O
score	score	NOUN	NN	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
with	with	ADP	IN	O
the	the	DET	DT	O
daily	daily	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
dopaminergic	dopaminergic	ADJ	JJ	O
medication	medication	NOUN	NN	O
.	.	PUNCT	.	O

Force	force	NOUN	NN	O
excess	excess	NOUN	NN	O
was	be	VERB	VBD	O
only	only	ADV	RB	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
LID	LID	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
motor	motor	NOUN	NN	O
fluctuations	fluctuation	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
close	close	ADJ	JJ	O
relationship	relationship	NOUN	NN	O
was	be	VERB	VBD	O
seen	see	VERB	VBN	O
between	between	ADP	IN	O
the	the	DET	DT	O
overshooting	overshooting	NOUN	NN	O
of	of	ADP	IN	O
forces	force	NOUN	NNS	O
and	and	CCONJ	CC	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
ON	ON	PROPN	NNP	O
-	-	PUNCT	HYPH	O
drug	drug	NOUN	NN	O
condition	condition	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
postulate	postulate	VERB	VBP	O
that	that	ADP	IN	O
both	both	CCONJ	CC	O
LID	LID	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
grip	grip	NOUN	NN	O
force	force	NOUN	NN	O
excess	excess	ADJ	JJ	O
share	share	NOUN	NN	O
common	common	ADJ	JJ	O
pathophysiological	pathophysiological	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
motor	motor	NOUN	NN	O
fluctuations	fluctuation	NOUN	NNS	O
.	.	PUNCT	.	O

Behavioral	behavioral	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	NUM	CD	I-Chemical
on	on	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
dizocilpine	dizocilpine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
noncompetitive	noncompetitive	ADJ	JJ	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
D	d	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aspartate	aspartate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NMDA	NMDA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
on	on	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
behaviors	behavior	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
treatments	treatment	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
focuses	focus	VERB	VBZ	O
on	on	ADP	IN	O
behavioral	behavioral	ADJ	JJ	O
syndromes	syndrome	NOUN	NNS	O
that	that	DET	WDT	O
may	may	VERB	MD	O
used	use	VERB	VBN	O
as	as	ADP	IN	O
models	model	NOUN	NNS	O
for	for	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
tardive	tardive	ADJ	JJ	B-Disease
dyskinesia	dyskinesia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
response	response	NOUN	NN	O
after	after	ADP	IN	O
glutamatergic	glutamatergic	ADJ	JJ	O
blockage	blockage	NOUN	NN	O
.	.	PUNCT	.	O

Reserpine	Reserpine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
administered	administer	VERB	VBD	O
once	once	ADV	RB	O
every	every	DET	DT	O
other	other	ADJ	JJ	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
4	4	NUM	CD	O
days	day	NOUN	NNS	O
,	,	PUNCT	,	O
produced	produce	VERB	VBD	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
orofacial	orofacial	ADJ	JJ	B-Disease
dyskinesia	dyskinesia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
tongue	tongue	NOUN	NN	O
protrusion	protrusion	NOUN	NN	O
and	and	CCONJ	CC	O
vacuous	vacuous	ADJ	JJ	O
chewing	chewing	NOUN	NN	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
are	be	VERB	VBP	O
signs	sign	NOUN	NNS	O
indicative	indicative	ADJ	JJ	O
of	of	ADP	IN	O
tardive	tardive	ADJ	JJ	B-Disease
dyskinesia	dyskinesia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Reserpine	Reserpine	PROPN	NNP	B-Chemical
also	also	ADV	RB	O
produced	produce	VERB	VBD	O
tremor	tremor	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
catalepsy	catalepsy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
are	be	VERB	VBP	O
signs	sign	NOUN	NNS	O
suggestive	suggestive	ADJ	JJ	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
administered	administer	VERB	VBD	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
the	the	DET	DT	O
observation	observation	NOUN	NN	O
test	test	NOUN	NN	O
,	,	PUNCT	,	O
prevented	prevent	VERB	VBD	O
the	the	DET	DT	O
vacuous	vacuous	ADJ	JJ	O
chewing	chewing	NOUN	NN	O
movements	movement	NOUN	NNS	O
,	,	PUNCT	,	O
tongue	tongue	NOUN	NN	O
protrusions	protrusion	NOUN	NNS	O
and	and	CCONJ	CC	O
catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	NUM	CD	I-Chemical
injection	injection	NOUN	NN	O
produced	produce	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
tremor	tremor	NOUN	NN	B-Disease
in	in	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Reserpine	Reserpine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
administered	administer	VERB	VBD	O
90	90	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
the	the	DET	DT	O
test	test	NOUN	NN	O
and	and	CCONJ	CC	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
apomophine	apomophine	NOUN	NN	B-Chemical
injection	injection	NOUN	NN	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
5	5	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
the	the	DET	DT	O
test	test	NOUN	NN	O
,	,	PUNCT	,	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
produce	produce	VERB	VB	O
oral	oral	ADJ	JJ	B-Disease
dyskinesia	dyskinesia	NOUN	NN	I-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
hand	hand	NOUN	NN	O
,	,	PUNCT	,	O
reserpine	reserpine	NOUN	NN	B-Chemical
induced	induced	ADJ	JJ	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
tremor	tremor	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
catalepsy	catalepsy	NOUN	NN	B-Disease
compared	compare	VERB	VBN	O
to	to	PART	TO	O
control	control	VERB	VB	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
administration	administration	NOUN	NN	O
attenuated	attenuate	VERB	VBD	O
the	the	DET	DT	O
catalepsy	catalepsy	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
tremor	tremor	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
24	24	NUM	CD	O
h	h	NOUN	NN	O
before	before	ADP	IN	O
the	the	DET	DT	O
observation	observation	NOUN	NN	O
test	test	NOUN	NN	O
produced	produce	VERB	VBD	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
vacuous	vacuous	ADJ	JJ	O
chewing	chewing	NOUN	NN	O
movements	movement	NOUN	NNS	O
and	and	CCONJ	CC	O
tongue	tongue	NOUN	NN	O
protrusion	protrusion	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
tremor	tremor	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
catalepsy	catalepsy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
injection	injection	NOUN	NN	O
90	90	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
the	the	DET	DT	O
test	test	NOUN	NN	O
reversed	reverse	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
produces	produce	VERB	VBZ	O
different	different	ADJ	JJ	O
and	and	CCONJ	CC	O
abnormal	abnormal	ADJ	JJ	B-Disease
movements	movement	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
are	be	VERB	VBP	O
related	relate	VERB	VBN	O
to	to	PART	TO	O
dose	dose	VERB	VB	O
and	and	CCONJ	CC	O
schedule	schedule	NOUN	NN	O
employed	employ	VERB	VBN	O
and	and	CCONJ	CC	O
can	can	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
as	as	ADP	IN	O
parkinsonian	parkinsonian	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
and	and	CCONJ	CC	O
tardive	tardive	ADJ	JJ	B-Disease
dsykinesia	dsykinesia	NOUN	NN	I-Disease
signs	sign	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
glutamatergic	glutamatergic	ADJ	JJ	O
blockage	blockage	NOUN	NN	O
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
can	can	VERB	MD	O
restore	restore	VERB	VB	O
these	these	DET	DT	O
signs	sign	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
vacuous	vacuous	ADJ	JJ	O
chewing	chewing	NOUN	NN	O
movements	movement	NOUN	NNS	O
,	,	PUNCT	,	O
tongue	tongue	NOUN	NN	O
protrusions	protrusion	NOUN	NNS	O
,	,	PUNCT	,	O
catalepsy	catalepsy	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
tremor	tremor	NOUN	NN	B-Disease
according	accord	VERB	VBG	O
to	to	ADP	IN	O
the	the	DET	DT	O
employed	employ	VERB	VBN	O
model	model	NOUN	NN	O
.	.	PUNCT	.	O

Risperidone	risperidone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
,	,	PUNCT	,	O
benign	benign	ADJ	JJ	O
transient	transient	ADJ	JJ	O
visual	visual	ADJ	JJ	B-Disease
disturbances	disturbance	NOUN	NNS	I-Disease
in	in	ADP	IN	O
schizophrenic	schizophrenic	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
past	past	ADJ	JJ	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
LSD	LSD	PROPN	NNP	B-Chemical
abuse	abuse	NOUN	NN	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
schizophrenic	schizophrenic	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
a	a	DET	DT	O
prior	prior	ADJ	JJ	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
LSD	LSD	PROPN	NNP	B-Chemical
abuse	abuse	NOUN	NN	O
and	and	CCONJ	CC	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
previously	previously	ADV	RB	O
developed	develop	VERB	VBN	O
EPS	EPS	PROPN	NNP	B-Disease
with	with	ADP	IN	O
classic	classic	ADJ	JJ	O
antipsychotics	antipsychotic	NOUN	NNS	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
successfully	successfully	ADV	RB	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

They	-PRON-	PRON	PRP	O
both	both	DET	DT	O
reported	report	VERB	VBD	O
short	short	ADJ	JJ	O
episodes	episode	NOUN	NNS	O
of	of	ADP	IN	O
transient	transient	ADJ	JJ	O
visual	visual	ADJ	JJ	B-Disease
disturbances	disturbance	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
appeared	appear	VERB	VBD	O
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
starting	start	VERB	VBG	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
imagery	imagery	NOUN	NN	O
resembled	resemble	VERB	VBD	O
visual	visual	ADJ	JJ	B-Disease
disturbances	disturbance	NOUN	NNS	I-Disease
previously	previously	ADV	RB	O
experienced	experience	VERB	VBD	O
as	as	ADP	IN	O
"	"	PUNCT	``	O
flashbacks	flashback	NOUN	NNS	O
"	"	PUNCT	''	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
prior	prior	ADJ	JJ	O
LSD	LSD	PROPN	NNP	B-Chemical
consumption	consumption	NOUN	NN	O
.	.	PUNCT	.	O

Risperidone	risperidone	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
was	be	VERB	VBD	O
continued	continue	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
visual	visual	ADJ	JJ	B-Disease
disturbances	disturbance	NOUN	NNS	I-Disease
gradually	gradually	ADV	RB	O
wore	wear	VERB	VBD	O
off	off	PART	RP	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
a	a	DET	DT	O
six	six	NUM	CD	O
-	-	PUNCT	HYPH	O
month	month	NOUN	NN	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
recurrence	recurrence	NOUN	NN	O
of	of	ADP	IN	O
visual	visual	ADJ	JJ	B-Disease
disturbances	disturbance	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
phenomenon	phenomenon	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
interpreted	interpret	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
benign	benign	ADJ	JJ	O
,	,	PUNCT	,	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
and	and	CCONJ	CC	O
self	self	NOUN	NN	O
-	-	PUNCT	HYPH	O
limiting	limit	VERB	VBG	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
which	which	DET	WDT	O
does	do	VERB	VBZ	O
not	not	ADV	RB	O
contraindicate	contraindicate	VERB	VB	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
interfere	interfere	VERB	VB	O
with	with	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Conclusions	conclusion	NOUN	NNS	O
based	base	VERB	VBN	O
on	on	ADP	IN	O
two	two	NUM	CD	O
case	case	NOUN	NN	O
reports	report	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
taken	take	VERB	VBN	O
with	with	ADP	IN	O
appropriate	appropriate	ADJ	JJ	O
caution	caution	NOUN	NN	O
.	.	PUNCT	.	O

Topiramate	topiramate	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrolithiasis	nephrolithiasis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Topiramate	topiramate	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
recently	recently	ADV	RB	O
developed	develop	VERB	VBN	O
antiepileptic	antiepileptic	ADJ	JJ	O
medication	medication	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
becoming	become	VERB	VBG	O
more	more	ADV	RBR	O
widely	widely	ADV	RB	O
prescribed	prescribe	VERB	VBN	O
because	because	ADP	IN	O
of	of	ADP	IN	O
its	-PRON-	DET	PRP$	O
efficacy	efficacy	NOUN	NN	O
in	in	ADP	IN	O
treating	treat	VERB	VBG	O
refractory	refractory	NOUN	NN	B-Disease
seizures	seizure	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Urologists	urologist	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
that	that	ADP	IN	O
this	this	DET	DT	O
medication	medication	NOUN	NN	O
can	can	VERB	MD	O
cause	cause	VERB	VB	O
metabolic	metabolic	ADJ	JJ	B-Disease
acidosis	acidosis	NOUN	NN	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
carbonic	carbonic	ADJ	JJ	O
anhydrase	anhydrase	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
distal	distal	ADJ	JJ	O
tubular	tubular	ADJ	JJ	O
acidification	acidification	NOUN	NN	O
defect	defect	NOUN	NN	O
may	may	VERB	MD	O
result	result	VERB	VB	O
,	,	PUNCT	,	O
thus	thus	ADV	RB	O
impairing	impair	VERB	VBG	O
the	the	DET	DT	O
normal	normal	ADJ	JJ	O
compensatory	compensatory	NOUN	NN	O
drop	drop	NOUN	NN	O
in	in	ADP	IN	O
urine	urine	NOUN	NN	O
pH	pH	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
factors	factor	NOUN	NNS	O
can	can	VERB	MD	O
lead	lead	VERB	VB	O
to	to	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
phosphate	phosphate	NOUN	NN	I-Chemical
nephrolithiasis	nephrolithiasis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
topiramate	topiramate	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrolithiasis	nephrolithiasis	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
urologic	urologic	ADJ	JJ	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

Ketamine	ketamine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
war	war	NOUN	NN	O
/	/	SYM	SYM	O
tropical	tropical	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
(	(	PUNCT	-LRB-	O
a	a	DET	DT	O
final	final	ADJ	JJ	O
tribute	tribute	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
racemic	racemic	NOUN	NN	O
mixture	mixture	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
technique	technique	NOUN	NN	O
of	of	ADP	IN	O
continuous	continuous	ADJ	JJ	O
intravenous	intravenous	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
with	with	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
used	use	VERB	VBN	O
successfully	successfully	ADV	RB	O
during	during	ADP	IN	O
the	the	DET	DT	O
Somalia	Somalia	PROPN	NNP	O
civil	civil	ADJ	JJ	O
war	war	NOUN	NN	O
in	in	ADP	IN	O
1994	1994	NUM	CD	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
north	north	ADJ	JJ	O
Uganda	Uganda	PROPN	NNP	O
in	in	ADP	IN	O
1999	1999	NUM	CD	O
for	for	ADP	IN	O
64	64	NUM	CD	O
operations	operation	NOUN	NNS	O
in	in	ADP	IN	O
62	62	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
aged	age	VERB	VBN	O
from	from	ADP	IN	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
to	to	ADP	IN	O
70	70	NUM	CD	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
undergoing	undergo	VERB	VBG	O
limb	limb	NOUN	NN	O
and	and	CCONJ	CC	O
abdominal	abdominal	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
including	include	VERB	VBG	O
caesarian	caesarian	ADJ	JJ	O
sections	section	NOUN	NNS	O
and	and	CCONJ	CC	O
interventions	intervention	NOUN	NNS	O
in	in	ADP	IN	O
neonates	neonate	NOUN	NNS	O
.	.	PUNCT	.	O

Operations	operation	NOUN	NNS	O
lasting	last	VERB	VBG	O
up	up	PART	RP	O
to	to	ADP	IN	O
2h	2h	PRON	PRP	O
could	could	VERB	MD	O
be	be	VERB	VB	O
performed	perform	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
sophisticated	sophisticated	ADJ	JJ	O
equipment	equipment	NOUN	NN	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
pulse	pulse	NOUN	NN	O
oximeters	oximeter	NOUN	NNS	O
or	or	CCONJ	CC	O
ventilators	ventilator	NOUN	NNS	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
on	on	ADP	IN	O
spontaneous	spontaneous	ADJ	JJ	O
ventilation	ventilation	NOUN	NN	O
breathing	breathing	NOUN	NN	O
air	air	NOUN	NN	O
/	/	SYM	SYM	O
oxygen	oxygen	NOUN	NN	B-Chemical
only	only	ADV	RB	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
premedication	premedication	NOUN	NN	O
with	with	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
glycopyrrolate	glycopyrrolate	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
local	local	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
induction	induction	NOUN	NN	O
with	with	ADP	IN	O
standard	standard	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
maintenance	maintenance	NOUN	NN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
10	10	NUM	CD	O
-	-	SYM	SYM	O
20	20	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
proved	prove	VERB	VBD	O
safe	safe	ADJ	JJ	O
and	and	CCONJ	CC	O
effective	effective	ADJ	JJ	O
.	.	PUNCT	.	O

Emphasis	emphasis	NOUN	NN	O
was	be	VERB	VBD	O
placed	place	VERB	VBN	O
on	on	ADP	IN	O
bedside	bedside	NOUN	NN	O
clinical	clinical	ADJ	JJ	O
monitoring	monitoring	NOUN	NN	O
,	,	PUNCT	,	O
relying	rely	VERB	VBG	O
heavily	heavily	ADV	RB	O
on	on	ADP	IN	O
the	the	DET	DT	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
.	.	PUNCT	.	O

Diazepam	Diazepam	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
unless	unless	ADP	IN	O
contraindicated	contraindicated	ADJ	JJ	O
or	or	CCONJ	CC	O
risky	risky	ADJ	JJ	O
,	,	PUNCT	,	O
remains	remain	VERB	VBZ	O
the	the	DET	DT	O
only	only	ADJ	JJ	O
necessary	necessary	ADJ	JJ	O
complementary	complementary	ADJ	JJ	O
drug	drug	NOUN	NN	O
to	to	PART	TO	O
ketamine	ketamine	VERB	VB	B-Chemical
as	as	ADP	IN	O
it	-PRON-	PRON	PRP	O
buffers	buffer	VERB	VBZ	O
its	-PRON-	DET	PRP$	O
cardiovascular	cardiovascular	ADJ	JJ	O
response	response	NOUN	NN	O
and	and	CCONJ	CC	O
decreases	decrease	VERB	VBZ	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
and	and	CCONJ	CC	O
intensity	intensity	NOUN	NN	O
of	of	ADP	IN	O
operative	operative	ADJ	JJ	O
and	and	CCONJ	CC	O
postoperative	postoperative	ADJ	JJ	O
hallucinations	hallucination	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Local	local	ADJ	JJ	O
anaesthetic	anaesthetic	ADJ	JJ	O
blocks	block	NOUN	NNS	O
were	be	VERB	VBD	O
useful	useful	ADJ	JJ	O
in	in	ADP	IN	O
decreasing	decrease	VERB	VBG	O
the	the	DET	DT	O
requirement	requirement	NOUN	NN	O
for	for	ADP	IN	O
postoperative	postoperative	ADJ	JJ	O
analgesia	analgesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

An	an	DET	DT	O
antisialogue	antisialogue	NOUN	NN	O
was	be	VERB	VBD	O
usually	usually	ADV	RB	O
unnecessary	unnecessary	ADJ	JJ	O
in	in	ADP	IN	O
operations	operation	NOUN	NNS	O
lasting	last	VERB	VBG	O
up	up	PART	RP	O
to	to	ADP	IN	O
2	2	NUM	CD	O
h	h	NOUN	NN	O
,	,	PUNCT	,	O
glycopyrrolate	glycopyrrolate	NOUN	NN	B-Chemical
being	be	VERB	VBG	O
the	the	DET	DT	O
best	good	ADJ	JJS	O
choice	choice	NOUN	NN	O
for	for	ADP	IN	O
its	-PRON-	DET	PRP$	O
lowest	low	ADJ	JJS	O
psychotropic	psychotropic	NOUN	NN	O
and	and	CCONJ	CC	O
chronotropic	chronotropic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
in	in	ADP	IN	O
a	a	DET	DT	O
hot	hot	ADJ	JJ	O
climate	climate	NOUN	NN	O
.	.	PUNCT	.	O

Experience	experience	NOUN	NN	O
in	in	ADP	IN	O
war	war	NOUN	NN	O
/	/	SYM	SYM	O
tropical	tropical	ADJ	JJ	O
settings	setting	NOUN	NNS	O
suggests	suggest	VERB	VBZ	O
this	this	DET	DT	O
technique	technique	NOUN	NN	O
could	could	VERB	MD	O
be	be	VERB	VB	O
useful	useful	ADJ	JJ	O
in	in	ADP	IN	O
civilian	civilian	ADJ	JJ	O
contexts	contexts	NOUN	NN	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
outdoor	outdoor	ADJ	JJ	O
life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
saving	save	VERB	VBG	O
emergency	emergency	NOUN	NN	O
surgery	surgery	NOUN	NN	O
or	or	CCONJ	CC	O
in	in	ADP	IN	O
mass	mass	ADJ	JJ	O
casualties	casualty	NOUN	NNS	O
where	where	ADV	WRB	O
,	,	PUNCT	,	O
e	e	NOUN	NN	O
.	.	PUNCT	.	O
g	g	NOUN	NN	O
.	.	PUNCT	.	O
amputation	amputation	NOUN	NN	O
and	and	CCONJ	CC	O
rapid	rapid	ADJ	JJ	O
extrication	extrication	NOUN	NN	O
were	be	VERB	VBD	O
required	require	VERB	VBN	O
.	.	PUNCT	.	O

Intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
severe	severe	ADJ	JJ	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
in	in	ADP	IN	O
immunocompromised	immunocompromise	VERB	VBN	O
children	child	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Adenovirus	Adenovirus	PROPN	NNP	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
morbidity	morbidity	NOUN	NN	O
and	and	CCONJ	CC	O
mortality	mortality	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
immunocompromised	immunocompromise	VERB	VBN	O
host	host	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
in	in	ADP	IN	O
pediatrics	pediatric	NOUN	NNS	O
is	be	VERB	VBZ	O
increasing	increase	VERB	VBG	O
in	in	ADP	IN	O
association	association	NOUN	NN	O
with	with	ADP	IN	O
growing	grow	VERB	VBG	O
numbers	number	NOUN	NNS	O
of	of	ADP	IN	O
immunocompromised	immunocompromised	ADJ	JJ	O
children	child	NOUN	NNS	O
,	,	PUNCT	,	O
where	where	ADV	WRB	O
case	case	NOUN	NN	O
fatality	fatality	NOUN	NN	O
rates	rate	NOUN	NNS	O
as	as	ADV	RB	O
high	high	ADJ	JJ	O
as	as	ADP	IN	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
to	to	PART	TO	O
80	80	NUM	CD	O
%	%	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
are	be	VERB	VBP	O
no	no	DET	DT	O
approved	approve	VERB	VBN	O
antiviral	antiviral	ADJ	JJ	O
agents	agent	NOUN	NNS	O
with	with	ADP	IN	O
proven	prove	VERB	VBN	O
efficacy	efficacy	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
nor	nor	CCONJ	CC	O
are	be	VERB	VBP	O
there	there	ADV	EX	O
any	any	DET	DT	O
prospective	prospective	ADJ	JJ	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
controlled	control	VERB	VBN	O
trials	trial	NOUN	NNS	O
of	of	ADP	IN	O
potentially	potentially	ADV	RB	O
useful	useful	ADJ	JJ	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
adenovirus	adenovirus	ADJ	JJ	O
therapies	therapy	NOUN	NNS	O
.	.	PUNCT	.	O

Apparent	apparent	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
success	success	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
limited	limit	VERB	VBN	O
to	to	ADP	IN	O
a	a	DET	DT	O
few	few	ADJ	JJ	O
case	case	NOUN	NN	O
reports	report	NOUN	NNS	O
and	and	CCONJ	CC	O
small	small	ADJ	JJ	O
series	series	NOUN	NN	O
.	.	PUNCT	.	O

Experience	experience	NOUN	NN	O
is	be	VERB	VBZ	O
greatest	great	ADJ	JJS	O
with	with	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
cidofovir	cidofovir	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Ribavirin	Ribavirin	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
guanosine	guanosine	NOUN	NN	B-Chemical
analogue	analogue	NOUN	NN	O
,	,	PUNCT	,	O
has	have	VERB	VBZ	O
broad	broad	ADJ	JJ	O
antiviral	antiviral	ADJ	JJ	O
activity	activity	NOUN	NN	O
against	against	ADP	IN	O
both	both	DET	DT	O
RNA	RNA	PROPN	NNP	O
and	and	CCONJ	CC	O
DNA	dna	NOUN	NN	O
viruses	virus	NOUN	NNS	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
documented	document	VERB	VBN	O
activity	activity	NOUN	NN	O
against	against	ADP	IN	O
adenovirus	adenovirus	NOUN	NN	O
in	in	ADP	IN	O
vitro	vitro	X	FW	O
.	.	PUNCT	.	O

Ribavirin	Ribavirin	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
licensed	license	VERB	VBN	O
in	in	ADP	IN	O
aerosol	aerosol	NOUN	NN	O
form	form	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
respiratory	respiratory	ADJ	JJ	B-Disease
syncytial	syncytial	ADJ	JJ	I-Disease
virus	virus	NOUN	NN	I-Disease
infection	infection	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
orally	orally	ADV	RB	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
interferon	interferon	NOUN	NN	O
to	to	PART	TO	O
treat	treat	VERB	VB	O
hepatitis	hepatitis	PROPN	NNP	B-Disease
C	C	PROPN	NNP	I-Disease
.	.	PUNCT	.	O

Intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
choice	choice	NOUN	NN	O
for	for	ADP	IN	O
infection	infection	NOUN	NN	B-Disease
with	with	ADP	IN	I-Disease
hemorrhagic	hemorrhagic	ADJ	JJ	I-Disease
fever	fever	NOUN	NN	I-Disease
viruses	virus	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
reversible	reversible	ADJ	JJ	O
mild	mild	ADJ	JJ	O
anemia	anemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
cidofovir	cidofovir	NOUN	NN	B-Chemical
in	in	ADP	IN	O
severe	severe	ADJ	JJ	O
adenovirus	adenovirus	NOUN	NN	B-Disease
infection	infection	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
limited	limit	VERB	VBN	O
by	by	ADP	IN	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
most	most	ADV	RBS	O
significant	significant	ADJ	JJ	O
of	of	ADP	IN	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
our	-PRON-	DET	PRP$	O
experience	experience	NOUN	NN	O
with	with	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
severe	severe	ADJ	JJ	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
series	series	NOUN	NN	O
of	of	ADP	IN	O
immunocompromised	immunocompromise	VERB	VBN	O
children	child	NOUN	NNS	O
and	and	CCONJ	CC	O
review	review	VERB	VB	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

DESIGN	DESIGN	PROPN	NNP	O
/	/	SYM	SYM	O
METHODS	METHODS	PROPN	NNP	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
retrospectively	retrospectively	ADV	RB	O
reviewed	review	VERB	VBD	O
the	the	DET	DT	O
medical	medical	ADJ	JJ	O
records	record	NOUN	NNS	O
of	of	ADP	IN	O
5	5	NUM	CD	O
children	child	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
for	for	ADP	IN	O
documented	document	VERB	VBN	O
severe	severe	ADJ	JJ	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
adenovirus	adenovirus	ADJ	JJ	O
hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
after	after	ADP	IN	O
cardiac	cardiac	NOUN	NN	O
and	and	CCONJ	CC	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplants	transplant	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplant	transplant	NOUN	NN	O
patient	patient	NOUN	NN	O
also	also	ADV	RB	O
received	receive	VERB	VBD	O
intravenous	intravenous	ADJ	JJ	O
cidofovir	cidofovir	NOUN	NN	B-Chemical
for	for	ADP	IN	O
progressive	progressive	ADJ	JJ	O
disseminated	disseminate	VERB	VBN	O
disease	disease	NOUN	NN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
additional	additional	ADJ	JJ	O
3	3	NUM	CD	O
children	child	NOUN	NNS	O
developed	develop	VERB	VBD	O
adenovirus	adenovirus	NOUN	NN	B-Disease
pneumonia	pneumonia	NOUN	NN	I-Disease
;	;	PUNCT	:	O
2	2	NUM	CD	O
were	be	VERB	VBD	O
neonates	neonate	NOUN	NNS	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
of	of	ADP	IN	O
whom	whom	PRON	WP	O
had	have	VERB	VBD	O
partial	partial	ADJ	JJ	O
DiGeorge	DiGeorge	PROPN	NNP	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
remaining	remain	VERB	VBG	O
infant	infant	NOUN	NN	O
had	have	VERB	VBD	O
recently	recently	ADV	RB	O
undergone	undergo	VERB	VBN	O
a	a	DET	DT	O
cardiac	cardiac	ADJ	JJ	O
transplant	transplant	NOUN	NN	O
.	.	PUNCT	.	O

Intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
on	on	ADP	IN	O
a	a	DET	DT	O
compassionate	compassionate	ADJ	JJ	O
-	-	PUNCT	HYPH	O
use	use	NOUN	NN	O
protocol	protocol	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Complete	complete	VERB	VB	O
clinical	clinical	ADJ	JJ	O
recovery	recovery	NOUN	NN	O
followed	follow	VERB	VBD	O
later	later	ADV	RB	O
by	by	ADP	IN	O
viral	viral	ADJ	JJ	O
clearance	clearance	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
2	2	NUM	CD	O
children	child	NOUN	NNS	O
:	:	PUNCT	:	O
the	the	DET	DT	O
cardiac	cardiac	ADJ	JJ	O
transplant	transplant	NOUN	NN	O
recipient	recipient	NOUN	NN	O
with	with	ADP	IN	O
adenovirus	adenovirus	ADJ	JJ	O
hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
the	the	DET	DT	O
immunocompetent	immunocompetent	ADJ	JJ	O
neonate	neonate	NOUN	NN	O
with	with	ADP	IN	O
adenovirus	adenovirus	NOUN	NN	B-Disease
pneumonia	pneumonia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
remaining	remain	VERB	VBG	O
3	3	NUM	CD	O
children	child	NOUN	NNS	O
died	die	VERB	VBD	O
of	of	ADP	IN	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
was	be	VERB	VBD	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
.	.	PUNCT	.	O

Use	Use	PROPN	NNP	O
of	of	ADP	IN	O
cidofovir	cidofovir	NOUN	NN	B-Chemical
in	in	ADP	IN	O
1	1	NUM	CD	O
child	child	NOUN	NN	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
progressive	progressive	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
neutropenia	neutropenia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

DISCUSSION	discussion	NOUN	NN	O
:	:	PUNCT	:	O
Our	-PRON-	DET	PRP$	O
series	series	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
is	be	VERB	VBZ	O
representative	representative	ADJ	JJ	O
of	of	ADP	IN	O
the	the	DET	DT	O
spectrum	spectrum	NOUN	NN	O
of	of	ADP	IN	O
immunocompromised	immunocompromised	ADJ	JJ	O
children	child	NOUN	NNS	O
at	at	ADP	IN	O
greatest	great	ADJ	JJS	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
severe	severe	ADJ	JJ	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
namely	namely	ADV	RB	O
solid	solid	ADJ	JJ	O
-	-	PUNCT	HYPH	O
organ	organ	NOUN	NN	O
and	and	CCONJ	CC	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplant	transplant	NOUN	NN	O
recipients	recipient	NOUN	NNS	O
,	,	PUNCT	,	O
neonates	neonate	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
immunodeficiency	immunodeficiency	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Although	although	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
not	not	ADV	RB	O
effective	effective	ADJ	JJ	O
for	for	ADP	IN	O
all	all	DET	DT	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
in	in	ADP	IN	O
this	this	DET	DT	O
series	series	NOUN	NN	O
or	or	CCONJ	CC	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
,	,	PUNCT	,	O
therapy	therapy	NOUN	NN	O
is	be	VERB	VBZ	O
unlikely	unlikely	ADJ	JJ	O
to	to	PART	TO	O
be	be	VERB	VB	O
of	of	ADP	IN	O
benefit	benefit	NOUN	NN	O
if	if	ADP	IN	O
begun	begin	VERB	VBN	O
late	late	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
infection	infection	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Early	early	ADJ	JJ	O
identification	identification	NOUN	NN	O
,	,	PUNCT	,	O
eg	eg	NOUN	NN	O
by	by	ADP	IN	O
polymerase	polymerase	NOUN	NN	O
chain	chain	NOUN	NN	O
reaction	reaction	NOUN	NN	O
of	of	ADP	IN	O
those	those	DET	DT	O
patients	patient	NOUN	NNS	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
disseminated	disseminate	VERB	VBN	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
may	may	VERB	MD	O
permit	permit	VERB	VB	O
earlier	earlier	ADV	RBR	O
antiviral	antiviral	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
and	and	CCONJ	CC	O
better	well	ADJ	JJR	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
therapeutic	therapeutic	ADJ	JJ	O
response	response	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Two	two	NUM	CD	O
of	of	ADP	IN	O
5	5	NUM	CD	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
recovered	recover	VERB	VBD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
availability	availability	NOUN	NN	O
of	of	ADP	IN	O
newer	new	ADJ	JJR	O
rapid	rapid	ADJ	JJ	O
diagnostic	diagnostic	ADJ	JJ	O
techniques	technique	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
polymerase	polymerase	NOUN	NN	O
chain	chain	NOUN	NN	O
reaction	reaction	NOUN	NN	O
,	,	PUNCT	,	O
may	may	VERB	MD	O
make	make	VERB	VB	O
earlier	earlier	ADV	RBR	O
,	,	PUNCT	,	O
more	more	ADV	RBR	O
effective	effective	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
adenovirus	adenovirus	ADJ	JJ	B-Disease
infection	infection	NOUN	NN	I-Disease
possible	possible	ADJ	JJ	O
.	.	PUNCT	.	O

Given	give	VERB	VBN	O
the	the	DET	DT	O
seriousness	seriousness	NOUN	NN	O
and	and	CCONJ	CC	O
increasing	increase	VERB	VBG	O
prevalence	prevalence	NOUN	NN	O
of	of	ADP	IN	O
adenovirus	adenovirus	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
in	in	ADP	IN	O
certain	certain	ADJ	JJ	O
hosts	host	NOUN	NNS	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
children	child	NOUN	NNS	O
,	,	PUNCT	,	O
a	a	DET	DT	O
large	large	ADJ	JJ	O
,	,	PUNCT	,	O
multicenter	multicenter	NOUN	NN	O
clinical	clinical	ADJ	JJ	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
potentially	potentially	ADV	RB	O
useful	useful	ADJ	JJ	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
adenoviral	adenoviral	ADJ	JJ	O
therapies	therapy	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
clearly	clearly	ADV	RB	O
required	require	VERB	VBN	O
to	to	PART	TO	O
demonstrate	demonstrate	VERB	VB	O
the	the	DET	DT	O
most	most	ADV	RBS	O
effective	effective	ADJ	JJ	O
and	and	CCONJ	CC	O
least	least	ADJ	JJS	O
toxic	toxic	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Delayed	delay	VERB	VBN	O
asystolic	asystolic	VERB	VBP	B-Disease
cardiac	cardiac	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
after	after	ADP	IN	O
diltiazem	diltiazem	ADJ	JJ	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
;	;	PUNCT	:	O
resuscitation	resuscitation	NOUN	NN	O
with	with	ADP	IN	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
intravenous	intravenous	ADJ	JJ	O
calcium	calcium	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
51	51	NUM	CD	O
year	year	NOUN	NN	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
took	take	VERB	VBD	O
a	a	DET	DT	O
mixed	mixed	ADJ	JJ	O
overdose	overdose	NOUN	NN	B-Disease
including	include	VERB	VBG	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
g	g	NOUN	NN	O
of	of	ADP	IN	O
diltiazem	diltiazem	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
aspirin	aspirin	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
isosorbide	isosorbide	ADJ	JJ	B-Chemical
nitrate	nitrate	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
alcohol	alcohol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
initially	initially	ADV	RB	O
presented	present	VERB	VBD	O
to	to	ADP	IN	O
hospital	hospital	NOUN	NN	O
after	after	ADP	IN	O
six	six	NUM	CD	O
hours	hour	NOUN	NNS	O
with	with	ADP	IN	O
mild	mild	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
activated	activate	VERB	VBN	O
charcoal	charcoal	NOUN	NN	O
and	and	CCONJ	CC	O
intravenous	intravenous	ADJ	JJ	O
fluids	fluid	NOUN	NNS	O
.	.	PUNCT	.	O

Eighteen	eighteen	NUM	CD	O
hours	hour	NOUN	NNS	O
after	after	ADP	IN	O
the	the	DET	DT	O
overdose	overdose	NOUN	NN	B-Disease
he	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
two	two	NUM	CD	O
generalised	generalise	VERB	VBN	O
tonic	tonic	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
clonic	clonic	NOUN	NN	I-Disease
seizures	seizure	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
remained	remain	VERB	VBD	O
unresponsive	unresponsive	ADJ	JJ	O
with	with	ADP	IN	O
junctional	junctional	ADJ	JJ	O
bradycardia	bradycardia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
unrecordable	unrecordable	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
then	then	ADV	RB	O
became	become	VERB	VBD	O
asystolic	asystolic	ADJ	JJ	B-Disease
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
resuscitated	resuscitate	VERB	VBN	O
with	with	ADP	IN	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
(	(	PUNCT	-LRB-	O
13	13	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
g	g	NOUN	NN	O
)	)	PUNCT	-RRB-	O
intravenous	intravenous	ADJ	JJ	O
calcium	calcium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
required	require	VERB	VBD	O
inotropic	inotropic	ADJ	JJ	O
support	support	NOUN	NN	O
and	and	CCONJ	CC	O
temporary	temporary	ADJ	JJ	O
pacing	pacing	NOUN	NN	O
over	over	ADP	IN	O
the	the	DET	DT	O
next	next	ADJ	JJ	O
48	48	NUM	CD	O
hours	hour	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
case	case	NOUN	NN	O
suggests	suggest	VERB	VBZ	O
there	there	ADV	EX	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
role	role	NOUN	NN	O
for	for	ADP	IN	O
aggressive	aggressive	ADJ	JJ	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
intravenous	intravenous	ADJ	JJ	O
calcium	calcium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
severe	severe	ADJ	JJ	O
diltiazem	diltiazem	ADJ	JJ	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
,	,	PUNCT	,	O
particularly	particularly	ADV	RB	O
with	with	ADP	IN	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
asystole	asystole	NOUN	NN	B-Disease
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
should	should	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
early	early	ADV	RB	O
in	in	ADP	IN	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
after	after	ADP	IN	O
diltiazem	diltiazem	ADJ	JJ	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
case	case	NOUN	NN	O
also	also	ADV	RB	O
highlights	highlight	VERB	VBZ	O
the	the	DET	DT	O
problems	problem	NOUN	NNS	O
with	with	ADP	IN	O
delayed	delay	VERB	VBN	O
toxicity	toxicity	NOUN	NN	B-Disease
when	when	ADV	WRB	O
whole	whole	ADJ	JJ	O
bowel	bowel	NOUN	NN	O
irrigation	irrigation	NOUN	NN	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
administered	administer	VERB	VBN	O
.	.	PUNCT	.	O

Low	low	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
molecular	molecular	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
weight	weight	NOUN	NN	I-Chemical
heparin	heparin	NOUN	NN	I-Chemical
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
mechanical	mechanical	ADJ	JJ	O
heart	heart	NOUN	NN	O
valves	valve	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
interruption	interruption	NOUN	NN	O
of	of	ADP	IN	O
oral	oral	ADJ	JJ	O
anticoagulant	anticoagulant	NOUN	NN	O
(	(	PUNCT	-LRB-	O
OAC	OAC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
administration	administration	NOUN	NN	O
is	be	VERB	VBZ	O
sometimes	sometimes	ADV	RB	O
indicated	indicate	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
mechanical	mechanical	ADJ	JJ	O
heart	heart	NOUN	NN	O
valves	valve	NOUN	NNS	O
,	,	PUNCT	,	O
mainly	mainly	ADV	RB	O
before	before	ADP	IN	O
noncardiac	noncardiac	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
,	,	PUNCT	,	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
surgical	surgical	ADJ	JJ	O
interventions	intervention	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
pregnancy	pregnancy	NOUN	NN	O
.	.	PUNCT	.	O

Unfractionated	unfractionated	ADJ	JJ	B-Chemical
heparin	heparin	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
UH	UH	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
currently	currently	ADV	RB	O
the	the	DET	DT	O
substitute	substitute	NOUN	NN	O
for	for	ADP	IN	O
selected	select	VERB	VBN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Low	low	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
molecular	molecular	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
weight	weight	NOUN	NN	I-Chemical
heparin	heparin	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
LMWH	LMWH	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
offers	offer	VERB	VBZ	O
theoretical	theoretical	ADJ	JJ	O
advantages	advantage	NOUN	NNS	O
over	over	ADP	IN	O
UH	UH	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
currently	currently	ADV	RB	O
considered	consider	VERB	VBN	O
in	in	ADP	IN	O
clinical	clinical	ADJ	JJ	O
guidelines	guideline	NOUN	NNS	O
as	as	ADP	IN	O
an	an	DET	DT	O
alternative	alternative	NOUN	NN	O
to	to	ADP	IN	O
UH	UH	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
prosthetic	prosthetic	ADJ	JJ	O
valves	valve	NOUN	NNS	O
.	.	PUNCT	.	O

HYPOTHESIS	hypothesis	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
review	review	VERB	VB	O
the	the	DET	DT	O
data	datum	NOUN	NNS	O
accumulated	accumulate	VERB	VBN	O
so	so	ADV	RB	O
far	far	ADV	RB	O
on	on	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
LMWH	LMWH	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
this	this	DET	DT	O
patient	patient	ADJ	JJ	O
population	population	NOUN	NN	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
discuss	discuss	VERB	VB	O
its	-PRON-	DET	PRP$	O
applicability	applicability	NOUN	NN	O
in	in	ADP	IN	O
common	common	ADJ	JJ	O
practice	practice	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
For	for	ADP	IN	O
this	this	DET	DT	O
paper	paper	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
current	current	ADJ	JJ	O
medical	medical	ADJ	JJ	O
literature	literature	NOUN	NN	O
on	on	ADP	IN	O
LMWH	LMWH	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
mechanical	mechanical	ADJ	JJ	O
heart	heart	NOUN	NN	O
valves	valve	NOUN	NNS	O
was	be	VERB	VBD	O
extensively	extensively	ADV	RB	O
reviewed	review	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
There	there	ADV	EX	O
were	be	VERB	VBD	O
eight	eight	NUM	CD	O
series	series	NOUN	NN	O
and	and	CCONJ	CC	O
six	six	NUM	CD	O
case	case	NOUN	NN	O
reports	report	NOUN	NNS	O
.	.	PUNCT	.	O

None	none	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
studies	study	NOUN	NNS	O
was	be	VERB	VBD	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
only	only	ADV	RB	O
one	one	NUM	CD	O
was	be	VERB	VBD	O
prospective	prospective	ADJ	JJ	O
.	.	PUNCT	.	O

Data	datum	NOUN	NNS	O
to	to	PART	TO	O
establish	establish	VERB	VB	O
the	the	DET	DT	O
thromboembolic	thromboembolic	ADJ	JJ	B-Disease
risk	risk	NOUN	NN	O
were	be	VERB	VBD	O
incomplete	incomplete	ADJ	JJ	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
excluding	exclude	VERB	VBG	O
case	case	NOUN	NN	O
reports	report	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
following	follow	VERB	VBG	O
groups	group	NOUN	NNS	O
were	be	VERB	VBD	O
constructed	construct	VERB	VBN	O
:	:	PUNCT	:	O
(	(	PUNCT	-LRB-	O
a	a	DET	DT	O
)	)	PUNCT	-RRB-	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
after	after	ADP	IN	O
valve	valve	NOUN	NN	O
insertion	insertion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
212	212	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	,	O
(	(	PUNCT	-LRB-	O
b	b	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
,	,	PUNCT	,	O
perioperative	perioperative	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
noncardiac	noncardiac	NOUN	NN	O
)	)	PUNCT	-RRB-	O
/	/	SYM	SYM	O
periprocedural	periprocedural	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
114	114	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	,	O
(	(	PUNCT	-LRB-	O
c	c	NOUN	NN	O
)	)	PUNCT	-RRB-	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
,	,	PUNCT	,	O
due	due	ADP	IN	O
to	to	ADP	IN	O
intolerance	intolerance	NOUN	NN	O
to	to	ADP	IN	O
OAC	OAC	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
16	16	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	,	O
(	(	PUNCT	-LRB-	O
d	d	NOUN	NN	O
)	)	PUNCT	-RRB-	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
pregnancy	pregnancy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
10	10	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
thromboembolism	thromboembolism	NOUN	NN	B-Disease
was	be	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
for	for	ADP	IN	O
all	all	DET	PDT	O
the	the	DET	DT	O
studies	study	NOUN	NNS	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
20	20	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
in	in	ADP	IN	O
groups	group	NOUN	NNS	O
a	a	DET	DT	O
,	,	PUNCT	,	O
b	b	NOUN	NN	O
,	,	PUNCT	,	O
c	c	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
d	d	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
;	;	PUNCT	:	O
for	for	ADP	IN	O
hemorrhage	hemorrhage	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
overall	overall	ADJ	JJ	O
rate	rate	NOUN	NN	O
was	be	VERB	VBD	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
respective	respective	ADJ	JJ	O
groups	group	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
mechanical	mechanical	ADJ	JJ	O
heart	heart	NOUN	NN	O
valves	valve	NOUN	NNS	O
,	,	PUNCT	,	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
LMWH	lmwh	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
compares	compare	VERB	VBZ	O
favorably	favorably	ADV	RB	O
with	with	ADP	IN	O
UH	UH	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Data	datum	NOUN	NNS	O
on	on	ADP	IN	O
mid	mid	PROPN	NNP	O
-	-	NOUN	NN	O
and	and	CCONJ	CC	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
LMWH	lmwh	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
are	be	VERB	VBP	O
sparse	sparse	ADJ	JJ	O
.	.	PUNCT	.	O

Further	further	ADJ	JJ	O
randomized	randomize	VERB	VBN	O
studies	study	NOUN	NNS	O
are	be	VERB	VBP	O
needed	need	VERB	VBN	O
to	to	PART	TO	O
confirm	confirm	VERB	VB	O
the	the	DET	DT	O
safety	safety	NOUN	NN	O
and	and	CCONJ	CC	O
precise	precise	ADJ	JJ	O
indications	indication	NOUN	NNS	O
for	for	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
LMWH	LMWH	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
mechanical	mechanical	ADJ	JJ	O
heart	heart	NOUN	NN	O
valves	valve	NOUN	NNS	O
.	.	PUNCT	.	O

Cardiac	cardiac	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
after	after	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
metoclopramide	metoclopramide	NOUN	NN	B-Chemical
-	-	PUNCT	,	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
five	five	NUM	CD	O
repeated	repeat	VERB	VBN	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
metoclopramide	metoclopramide	NOUN	NN	B-Chemical
causing	cause	VERB	VBG	O
five	five	NUM	CD	O
episodes	episode	NOUN	NNS	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
where	where	ADV	WRB	O
intravenous	intravenous	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
metoclopramide	metoclopramide	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
immediately	immediately	ADV	RB	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
asystole	asystole	NOUN	NN	B-Disease
repeatedly	repeatedly	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
received	receive	VERB	VBD	O
metoclopramide	metoclopramide	NOUN	NN	B-Chemical
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
five	five	NUM	CD	O
times	time	NOUN	NNS	O
during	during	ADP	IN	O
48	48	NUM	CD	O
h	h	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
interviewing	interview	VERB	VBG	O
the	the	DET	DT	O
attending	attend	VERB	VBG	O
nurses	nurse	NOUN	NNS	O
and	and	CCONJ	CC	O
reviewing	review	VERB	VBG	O
the	the	DET	DT	O
written	write	VERB	VBN	O
documentation	documentation	NOUN	NN	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
clear	clear	ADJ	JJ	O
that	that	ADP	IN	O
every	every	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
metoclopramide	metoclopramide	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
immediately	immediately	ADV	RB	O
(	(	PUNCT	-LRB-	O
within	within	ADP	IN	O
s	s	PRON	PRP	O
)	)	PUNCT	-RRB-	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
asystole	asystole	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
asystole	asystole	NOUN	NN	B-Disease
lasted	last	VERB	VBD	O
15	15	NUM	CD	O
-	-	SYM	SYM	O
30	30	NUM	CD	O
s	s	NOUN	NN	O
on	on	ADP	IN	O
four	four	NUM	CD	O
occasions	occasion	NOUN	NNS	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
one	one	NUM	CD	O
occasion	occasion	NOUN	NN	O
it	-PRON-	PRON	PRP	O
lasted	last	VERB	VBD	O
2	2	NUM	CD	O
min	min	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
received	receive	VERB	VBD	O
atropine	atropine	NOUN	NN	B-Chemical
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
and	and	CCONJ	CC	O
chest	chest	NOUN	NN	O
compressions	compression	NOUN	NNS	O
,	,	PUNCT	,	O
before	before	ADP	IN	O
sinus	sinus	NOUN	NN	O
rhythm	rhythm	NOUN	NN	O
again	again	ADV	RB	O
took	take	VERB	VBD	O
over	over	PART	RP	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
interpret	interpret	VERB	VBP	O
this	this	DET	DT	O
as	as	ADP	IN	O
episodes	episode	NOUN	NNS	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
metoclopramide	metoclopramide	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
rapid	rapid	ADJ	JJ	O
injection	injection	NOUN	NN	O
via	via	ADP	IN	O
the	the	DET	DT	O
central	central	ADJ	JJ	O
venous	venous	ADJ	JJ	O
route	route	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
concomitant	concomitant	ADJ	JJ	O
tapering	tapering	NOUN	NN	O
of	of	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
infusion	infusion	NOUN	NN	O
might	may	VERB	MD	O
have	have	VERB	VB	O
contributed	contribute	VERB	VBN	O
in	in	ADP	IN	O
precipitating	precipitate	VERB	VBG	O
the	the	DET	DT	O
adverse	adverse	ADJ	JJ	O
drug	drug	NOUN	NN	O
reaction	reaction	NOUN	NN	O
.	.	PUNCT	.	O

Immunohistochemical	immunohistochemical	ADJ	JJ	O
study	study	NOUN	NN	O
on	on	ADP	IN	O
inducible	inducible	ADJ	JJ	O
type	type	NOUN	NN	O
of	of	ADP	IN	O
nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
iNOS	iNOS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
basic	basic	ADJ	JJ	O
fibroblast	fibroblast	NOUN	NN	O
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
bFGF	bFGF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
tumor	tumor	NOUN	NN	B-Disease
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
-	-	PUNCT	HYPH	O
beta1	beta1	NOUN	NN	O
(	(	PUNCT	-LRB-	O
TGF	TGF	PROPN	NNP	O
-	-	PUNCT	HYPH	O
beta1	beta1	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
arteritis	arteritis	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
by	by	ADP	IN	O
fenoldopam	fenoldopam	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
theophylline	theophylline	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
vasodilators	vasodilator	NOUN	NNS	O
.	.	PUNCT	.	O

Arteritis	Arteritis	PROPN	NNP	B-Disease
induced	induce	VERB	VBD	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
by	by	ADP	IN	O
vasodilators	vasodilator	NOUN	NNS	O
,	,	PUNCT	,	O
fenoldopam	fenoldopam	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
theophylline	theophylline	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
was	be	VERB	VBD	O
examined	examine	VERB	VBN	O
immunohistochemically	immunohistochemically	ADV	RB	O
for	for	ADP	IN	O
expressions	expression	NOUN	NNS	O
of	of	ADP	IN	O
inducible	inducible	ADJ	JJ	O
type	type	NOUN	NN	O
of	of	ADP	IN	O
nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
synthase	synthase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
iNOS	iNOS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
basic	basic	ADJ	JJ	O
fibroblast	fibroblast	NOUN	NN	O
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
bFGF	bFGF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
tumor	tumor	NOUN	NN	B-Disease
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
-	-	PUNCT	HYPH	O
beta1	beta1	NOUN	NN	O
(	(	PUNCT	-LRB-	O
TGF	TGF	PROPN	NNP	O
-	-	PUNCT	HYPH	O
beta1	beta1	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
administered	administer	VERB	VBN	O
fenoldopam	fenoldopam	NOUN	NN	B-Chemical
for	for	ADP	IN	O
24	24	NUM	CD	O
hours	hour	NOUN	NNS	O
by	by	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
with	with	ADP	IN	O
or	or	CCONJ	CC	O
without	without	ADP	IN	O
following	follow	VERB	VBG	O
repeated	repeat	VERB	VBN	O
daily	daily	ADJ	JJ	O
oral	oral	ADJ	JJ	O
administrations	administration	NOUN	NNS	O
of	of	ADP	IN	O
theophylline	theophylline	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Irrespective	irrespective	ADV	RB	O
of	of	ADP	IN	O
theophylline	theophylline	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
iNOS	iNOS	PROPN	NNP	O
antigens	antigen	NOUN	NNS	O
were	be	VERB	VBD	O
remarkably	remarkably	ADV	RB	O
abundant	abundant	ADJ	JJ	O
in	in	ADP	IN	O
ED	ED	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
cells	cell	NOUN	NNS	O
on	on	ADP	IN	O
day	day	NOUN	NN	O
5	5	NUM	CD	O
and	and	CCONJ	CC	O
8	8	NUM	CD	O
post	post	ADJ	JJ	O
-	-	PUNCT	HYPH	O
fenoldopam	fenoldopam	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
infusion	infusion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
DPI	DPI	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
bFGF	bFGF	NOUN	NNS	O
antigens	antigen	NOUN	NNS	O
were	be	VERB	VBD	O
remarkably	remarkably	ADV	RB	O
abundant	abundant	ADJ	JJ	O
in	in	ADP	IN	O
ED	ED	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
cells	cell	NOUN	NNS	O
on	on	ADP	IN	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
DPI	DPI	PROPN	NNP	O
;	;	PUNCT	:	O
TGF	TGF	PROPN	NNP	O
-	-	PUNCT	HYPH	O
beta1	beta1	PROPN	NNP	O
antigens	antigen	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
ED	ED	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
cells	cell	NOUN	NNS	O
on	on	ADP	IN	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
5	5	NUM	CD	O
DPI	dpi	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
peak	peak	NOUN	NN	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
iNOS	iNOS	PROPN	NNP	O
antigen	antigen	NOUN	NN	O
was	be	VERB	VBD	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
bFGF	bFGF	PROPN	NNP	O
antigen	antigen	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
bFGF	bFGF	PROPN	NNP	O
may	may	VERB	MD	O
have	have	VERB	VB	O
a	a	DET	DT	O
suppressive	suppressive	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
iNOS	iNOS	PROPN	NNP	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
rat	rat	NOUN	NN	O
arteritis	arteritis	NOUN	NN	B-Disease
models	model	NOUN	NNS	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
hand	hand	NOUN	NN	O
,	,	PUNCT	,	O
TGF	TGF	PROPN	NNP	O
-	-	PUNCT	HYPH	O
beta1	beta1	PROPN	NNP	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
considered	consider	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
a	a	DET	DT	O
suppressive	suppressive	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
iNOS	iNOS	PROPN	NNP	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
models	model	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
striatum	striatum	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
target	target	NOUN	NN	O
for	for	ADP	IN	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
rigor	rigor	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
an	an	DET	DT	O
antagonist	antagonist	NOUN	NN	O
of	of	ADP	IN	O
mGluR1	mGluR1	PROPN	NNP	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
an	an	DET	DT	O
agonist	agonist	NOUN	NN	O
of	of	ADP	IN	O
group	group	NOUN	NN	O
II	II	PROPN	NNP	O
metabotropic	metabotropic	ADJ	JJ	O
glutamate	glutamate	NOUN	NN	B-Chemical
receptors	receptor	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
find	find	VERB	VB	O
out	out	PART	RP	O
whether	whether	ADP	IN	O
the	the	DET	DT	O
metabotropic	metabotropic	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
1	1	NUM	CD	O
(	(	PUNCT	-LRB-	O
mGluR1	mGluR1	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
group	group	NOUN	NN	O
II	II	PROPN	NNP	O
mGluRs	mglurs	NUM	CD	O
,	,	PUNCT	,	O
localized	localize	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
,	,	PUNCT	,	O
are	be	VERB	VBP	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
antiparkinsonian	antiparkinsonian	ADJ	JJ	O
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
effects	effect	NOUN	NNS	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Haloperidol	Haloperidol	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
ip	ip	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
induced	induce	VERB	VBD	O
parkinsonian	parkinsonian	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
,	,	PUNCT	,	O
measured	measure	VERB	VBN	O
as	as	ADP	IN	O
an	an	DET	DT	O
increased	increase	VERB	VBN	O
resistance	resistance	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
rat	rat	NOUN	NN	O
'	'	PUNCT	``	O
s	s	PART	POS	O
hind	hind	NOUN	NN	O
foot	foot	NOUN	NN	O
to	to	ADP	IN	O
passive	passive	ADJ	JJ	O
flexion	flexion	NOUN	NN	O
and	and	CCONJ	CC	O
extension	extension	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
ankle	ankle	NOUN	NN	O
joint	joint	NOUN	NN	O
.	.	PUNCT	.	O

(	(	PUNCT	-LRB-	B-Chemical
RS	RS	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
1	1	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminoindan	aminoindan	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
1	1	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
5	5	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dicarboxylic	dicarboxylic	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
AIDA	AIDA	PROPN	NNP	B-Chemical
;	;	PUNCT	:	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
15	15	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
potent	potent	ADJ	JJ	O
and	and	CCONJ	CC	O
selective	selective	ADJ	JJ	O
mGluR1	mGluR1	PROPN	NNP	O
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
(	(	PUNCT	-LRB-	B-Chemical
2R	2r	NOUN	NN	I-Chemical
,	,	PUNCT	,	I-Chemical
4R	4R	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminopyrrolidine	aminopyrrolidine	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2	2	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	:	I-Chemical
dicarboxylate	dicarboxylate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
2R	2r	NOUN	NN	B-Chemical
,	,	PUNCT	,	I-Chemical
4R	4r	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
APDC	apdc	ADJ	JJ	I-Chemical
;	;	PUNCT	:	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
15	15	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
selective	selective	ADJ	JJ	O
group	group	NOUN	NN	O
II	II	PROPN	NNP	O
agonist	agonist	NOUN	NN	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
injected	inject	VERB	VBN	O
bilaterally	bilaterally	ADV	RB	O
into	into	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
of	of	ADP	IN	O
haloperidol	haloperidol	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

AIDA	AIDA	NOUN	NNS	B-Chemical
in	in	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
15	15	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
diminished	diminish	VERB	VBD	O
the	the	DET	DT	O
haloperidol	haloperidol	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
2R	2r	NOUN	NN	B-Chemical
,	,	PUNCT	,	I-Chemical
4R	4r	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
APDC	apdc	ADJ	JJ	I-Chemical
injections	injection	NOUN	NNS	O
were	be	VERB	VBD	O
ineffective	ineffective	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
results	result	NOUN	NNS	O
may	may	VERB	MD	O
suggest	suggest	VERB	VB	O
that	that	ADP	IN	O
the	the	DET	DT	O
blockade	blockade	NOUN	NN	O
of	of	ADP	IN	O
striatal	striatal	ADJ	JJ	O
mGluR1	mGluR1	PROPN	NNP	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
the	the	DET	DT	O
stimulation	stimulation	NOUN	NN	O
of	of	ADP	IN	O
group	group	NOUN	NN	O
II	II	PROPN	NNP	O
mGluRs	mglurs	NUM	CD	O
,	,	PUNCT	,	O
may	may	VERB	MD	O
ameliorate	ameliorate	VERB	VB	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
phase	phase	NOUN	NN	O
II	II	PROPN	NNP	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
thalidomide	thalidomide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
advanced	advanced	ADJ	JJ	O
metastatic	metastatic	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
cell	cell	NOUN	NN	I-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
.	.	PUNCT	.	O

OBJECTIVES	objectives	NOUN	NN	O
:	:	PUNCT	:	O
To	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
toxicity	toxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
thalidomide	thalidomide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
advanced	advanced	ADJ	JJ	O
metastatic	metastatic	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
cell	cell	NOUN	NN	I-Disease
cancer	cancer	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
to	to	PART	TO	O
measure	measure	VERB	VB	O
changes	change	NOUN	NNS	O
of	of	ADP	IN	O
one	one	NUM	CD	O
angiogenic	angiogenic	ADJ	JJ	O
factor	factor	NOUN	NN	O
,	,	PUNCT	,	O
vascular	vascular	ADJ	JJ	O
endothelial	endothelial	ADJ	JJ	O
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
VEGF	VEGF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
165	165	NUM	CD	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
29	29	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
enrolled	enrol	VERB	VBN	O
on	on	ADP	IN	O
a	a	DET	DT	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
thalidomide	thalidomide	NOUN	NN	B-Chemical
using	use	VERB	VBG	O
an	an	DET	DT	O
intra	intra	ADJ	JJ	O
-	-	PUNCT	HYPH	O
patient	patient	ADJ	JJ	O
dose	dose	NOUN	NN	O
escalation	escalation	NOUN	NN	O
schedule	schedule	NOUN	NN	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
began	begin	VERB	VBD	O
thalidomide	thalidomide	NOUN	NN	B-Chemical
at	at	ADP	IN	O
400	400	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
and	and	CCONJ	CC	O
escalated	escalate	VERB	VBN	O
as	as	ADP	IN	O
tolerated	tolerate	VERB	VBN	O
to	to	ADP	IN	O
1200	1200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
by	by	ADP	IN	O
day	day	NOUN	NN	O
54	54	NUM	CD	O
.	.	PUNCT	.	O

Fifty	fifty	NUM	CD	O
-	-	PUNCT	HYPH	O
nine	nine	NUM	CD	O
per	per	ADP	IN	O
cent	cent	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
had	have	VERB	VBN	O
previous	previous	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
IL	IL	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
and	and	CCONJ	CC	O
52	52	NUM	CD	O
%	%	NOUN	NN	O
were	be	VERB	VBD	O
performance	performance	NOUN	NN	O
status	status	NOUN	NN	O
2	2	NUM	CD	O
or	or	CCONJ	CC	O
3	3	NUM	CD	O
.	.	PUNCT	.	O

Systemic	systemic	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
VEGF165	vegf165	NOUN	NN	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
by	by	ADP	IN	O
dual	dual	ADJ	JJ	O
monoclonal	monoclonal	ADJ	JJ	O
ELISA	ELISA	PROPN	NNP	O
in	in	ADP	IN	O
8	8	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
24	24	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
evaluable	evaluable	ADJ	JJ	O
for	for	ADP	IN	O
response	response	NOUN	NN	O
with	with	ADP	IN	O
one	one	NUM	CD	O
partial	partial	ADJ	JJ	O
response	response	NOUN	NN	O
of	of	ADP	IN	O
11	11	NUM	CD	O
months	month	NOUN	NNS	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
hepatic	hepatic	ADJ	JJ	O
and	and	CCONJ	CC	O
pulmonary	pulmonary	ADJ	JJ	O
metastases	metastasis	NOUN	NNS	B-Disease
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
one	one	NUM	CD	O
minor	minor	ADJ	JJ	O
response	response	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
patients	patient	NOUN	NNS	O
stable	stable	ADJ	JJ	O
for	for	ADP	IN	O
over	over	ADP	IN	O
6	6	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Somnolence	somnolence	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
constipation	constipation	NOUN	NN	B-Disease
were	be	VERB	VBD	O
prominent	prominent	ADJ	JJ	O
toxicities	toxicity	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
most	most	ADJ	JJS	O
patients	patient	NOUN	NNS	O
could	could	VERB	MD	O
not	not	ADV	RB	O
tolerate	tolerate	VERB	VB	O
the	the	DET	DT	O
1200	1200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
dose	dose	NOUN	NN	O
level	level	NOUN	NN	O
.	.	PUNCT	.	O

Systemic	systemic	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
VEGF165	vegf165	NOUN	NN	O
levels	level	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
change	change	VERB	VB	O
with	with	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
These	these	DET	DT	O
results	result	NOUN	NNS	O
are	be	VERB	VBP	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
a	a	DET	DT	O
low	low	ADJ	JJ	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
thalidomide	thalidomide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
cell	cell	NOUN	NN	I-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Administration	administration	NOUN	NN	O
of	of	ADP	IN	O
doses	dose	NOUN	NNS	O
over	over	ADP	IN	O
800	800	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
was	be	VERB	VBD	O
difficult	difficult	ADJ	JJ	O
to	to	PART	TO	O
achieve	achieve	VERB	VB	O
in	in	ADP	IN	O
this	this	DET	DT	O
patient	patient	ADJ	JJ	O
population	population	NOUN	NN	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
lower	low	ADJ	JJR	O
doses	dose	NOUN	NNS	O
were	be	VERB	VBD	O
practical	practical	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
response	response	NOUN	NN	O
relationship	relationship	NOUN	NN	O
,	,	PUNCT	,	O
if	if	ADP	IN	O
any	any	DET	DT	O
,	,	PUNCT	,	O
of	of	ADP	IN	O
thalidomide	thalidomide	NOUN	NN	B-Chemical
for	for	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
cell	cell	NOUN	NN	I-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
unclear	unclear	ADJ	JJ	O
.	.	PUNCT	.	O

Can	Can	VERB	MD	O
lidocaine	lidocaine	ADV	RB	B-Chemical
reduce	reduce	VERB	VB	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
induced	induce	VERB	VBN	O
postoperative	postoperative	ADJ	JJ	B-Disease
myalgia	myalgia	NOUN	NN	I-Disease
?	?	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
undertaken	undertake	VERB	VBN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	ADJ	JJR	B-Chemical
pretreatment	pretreatment	NOUN	NN	O
on	on	ADP	IN	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
myalgia	myalgia	NOUN	NN	B-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
general	general	ADJ	JJ	O
anesthesia	anesthesia	NOUN	NN	O
for	for	ADP	IN	O
gynecological	gynecological	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
hundred	hundred	NUM	CD	O
and	and	CCONJ	CC	O
thirty	thirty	NUM	CD	O
-	-	PUNCT	HYPH	O
five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
assigned	assign	VERB	VBN	O
to	to	ADP	IN	O
one	one	NUM	CD	O
of	of	ADP	IN	O
three	three	NUM	CD	O
groups	group	NOUN	NNS	O
in	in	ADP	IN	O
a	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomized	ADJ	JJ	O
manner	manner	NOUN	NN	O
.	.	PUNCT	.	O

Group	Group	PROPN	NNP	O
PS	PS	PROPN	NNP	O
,	,	PUNCT	,	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
received	receive	VERB	VBD	O
normal	normal	ADJ	JJ	O
saline	saline	NOUN	NN	O
and	and	CCONJ	CC	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
x	x	X	XX	O
kg	kg	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
Group	Group	PROPN	NNP	O
LS	LS	PROPN	NNP	O
,	,	PUNCT	,	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
x	x	X	XX	O
kg	kg	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
x	x	X	XX	O
kg	kg	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
Group	Group	PROPN	NNP	O
PR	PR	PROPN	NNP	O
,	,	PUNCT	,	O
normal	normal	ADJ	JJ	O
saline	saline	NOUN	NN	O
and	and	CCONJ	CC	O
rocuronium	rocuronium	NOUN	NN	B-Chemical
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
mg	mg	NOUN	NN	O
x	x	X	XX	O
kg	kg	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Morphine	Morphine	PROPN	NNP	B-Chemical
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
x	x	X	XX	O
kg	kg	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
iv	iv	PRON	PRP	O
was	be	VERB	VBD	O
given	give	VERB	VBN	O
for	for	ADP	IN	O
premedication	premedication	NOUN	NN	O
and	and	CCONJ	CC	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
monitored	monitor	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
noninvasive	noninvasive	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
monitor	monitor	NOUN	NN	O
,	,	PUNCT	,	O
ECG	ECG	PROPN	NNP	O
and	and	CCONJ	CC	O
pulse	pulse	VERB	VB	O
oximetry	oximetry	NOUN	NN	O
.	.	PUNCT	.	O

Anesthesia	Anesthesia	PROPN	NNP	O
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
with	with	ADP	IN	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O
kg	kg	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
thiopental	thiopental	ADJ	JJ	B-Chemical
iv	iv	NOUN	NN	O
.	.	PUNCT	.	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Group	Group	PROPN	NNP	O
PS	PS	PROPN	NNP	O
,	,	PUNCT	,	O
LS	LS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
rocuronium	rocuronium	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Group	Group	PROPN	NNP	O
PR	PR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
tracheal	tracheal	NOUN	NN	O
intubation	intubation	NOUN	NN	O
.	.	PUNCT	.	O

Following	follow	VERB	VBG	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
agents	agent	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
fasciculation	fasciculation	NOUN	NN	B-Disease
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
visually	visually	ADV	RB	O
on	on	ADP	IN	O
a	a	DET	DT	O
four	four	NUM	CD	O
point	point	NOUN	NN	O
scale	scale	NOUN	NN	O
by	by	ADP	IN	O
one	one	NUM	CD	O
investigator	investigator	NOUN	NN	O
who	who	PRON	WP	O
was	be	VERB	VBD	O
blinded	blind	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
administered	administer	VERB	VBD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
each	each	DET	DT	O
patient	patient	NOUN	NN	O
were	be	VERB	VBD	O
monitored	monitor	VERB	VBN	O
on	on	ADP	IN	O
nine	nine	NUM	CD	O
occasions	occasion	NOUN	NNS	O
.	.	PUNCT	.	O

Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
four	four	NUM	CD	O
hours	hour	NOUN	NNS	O
later	later	ADV	RB	O
,	,	PUNCT	,	O
any	any	DET	DT	O
myalgia	myalgia	NOUN	NN	B-Disease
experienced	experience	VERB	VBD	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
according	accord	VERB	VBG	O
to	to	ADP	IN	O
a	a	DET	DT	O
structured	structured	ADJ	JJ	O
questionaire	questionaire	NOUN	NN	O
and	and	CCONJ	CC	O
graded	grade	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
four	four	NUM	CD	O
point	point	NOUN	NN	O
scale	scale	NOUN	NN	O
by	by	ADP	IN	O
one	one	NUM	CD	O
investigator	investigator	NOUN	NN	O
blinded	blind	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
intraoperative	intraoperative	ADJ	JJ	O
management	management	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	DET	DT	O
muscle	muscle	NOUN	NN	B-Disease
fasciculation	fasciculation	NOUN	NN	I-Disease
was	be	VERB	VBD	O
not	not	ADV	RB	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
Group	Group	PROPN	NNP	O
PR	PR	PROPN	NNP	O
while	while	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
Group	Group	PROPN	NNP	O
LS	LS	PROPN	NNP	O
had	have	VERB	VBD	O
a	a	DET	DT	O
lower	low	ADJ	JJR	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
muscle	muscle	NOUN	NN	B-Disease
fasciculation	fasciculation	NOUN	NN	I-Disease
than	than	ADP	IN	O
those	those	DET	DT	O
in	in	ADP	IN	O
Group	Group	PROPN	NNP	O
PS	PS	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
p	p	PROPN	NNP	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
24	24	NUM	CD	O
h	h	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
myalgia	myalgia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
in	in	ADP	IN	O
Group	Group	PROPN	NNP	O
PS	PS	PROPN	NNP	O
than	than	ADP	IN	O
in	in	ADP	IN	O
Group	Group	PROPN	NNP	O
LS	LS	PROPN	NNP	O
and	and	CCONJ	CC	O
PR	PR	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
correlation	correlation	NOUN	NN	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
found	find	VERB	VBN	O
between	between	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
myalgia	myalgia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
muscle	muscle	NOUN	NN	B-Disease
fasciculation	fasciculation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
systolic	systolic	ADJ	JJ	O
and	and	CCONJ	CC	O
diastolic	diastolic	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
significant	significant	ADJ	JJ	O
among	among	ADP	IN	O
the	the	DET	DT	O
three	three	NUM	CD	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
where	where	ADV	WRB	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
used	use	VERB	VBN	O
,	,	PUNCT	,	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
proven	prove	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
the	the	DET	DT	O
useful	useful	ADJ	JJ	O
pretreatment	pretreatment	ADJ	JJ	O
agent	agent	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
postoperative	postoperative	ADJ	JJ	B-Disease
myalgia	myalgia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Reduced	reduce	VERB	VBN	O
sodium	sodium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
density	density	NOUN	NN	O
,	,	PUNCT	,	O
altered	alter	VERB	VBD	O
voltage	voltage	NOUN	NN	O
dependence	dependence	NOUN	NN	O
of	of	ADP	IN	O
inactivation	inactivation	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBD	O
susceptibility	susceptibility	NOUN	NN	O
to	to	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
lacking	lack	VERB	VBG	O
sodium	sodium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
beta	beta	NOUN	NN	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
subunits	subunit	NOUN	NNS	O
.	.	PUNCT	.	O

Sodium	sodium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
subunits	subunit	NOUN	NNS	O
modulate	modulate	ADJ	JJ	O
channel	channel	NOUN	NN	O
gating	gating	NOUN	NN	O
,	,	PUNCT	,	O
assembly	assembly	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
cell	cell	NOUN	NN	O
surface	surface	NOUN	NN	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
heterologous	heterologous	ADJ	JJ	O
cell	cell	NOUN	NN	O
systems	system	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
generated	generate	VERB	VBD	O
beta2	beta2	NOUN	NN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
beta2	beta2	NOUN	NN	O
in	in	ADP	IN	O
control	control	NOUN	NN	O
of	of	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
density	density	NOUN	NN	O
,	,	PUNCT	,	O
localization	localization	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
.	.	PUNCT	.	O

Measurements	measurement	NOUN	NNS	O
of	of	ADP	IN	O
[	[	PUNCT	-LRB-	O
(	(	PUNCT	-LRB-	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
H	h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
saxitoxin	saxitoxin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
STX	STX	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
binding	binding	NOUN	NN	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
membrane	membrane	NOUN	NN	O
sodium	sodium	NOUN	NN	B-Chemical
channels	channel	NOUN	NNS	O
in	in	ADP	IN	O
beta2	beta2	NOUN	NN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
neurons	neuron	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
beta2	beta2	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
negative	negative	ADJ	JJ	O
shifts	shift	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
voltage	voltage	NOUN	NN	O
dependence	dependence	NOUN	NN	O
of	of	ADP	IN	O
inactivation	inactivation	NOUN	NN	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
significant	significant	ADJ	JJ	O
decreases	decrease	NOUN	NNS	O
in	in	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
current	current	ADJ	JJ	O
density	density	NOUN	NN	O
in	in	ADP	IN	O
acutely	acutely	ADV	RB	O
dissociated	dissociate	VERB	VBN	O
hippocampal	hippocampal	ADJ	JJ	O
neurons	neuron	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
integral	integral	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
compound	compound	NOUN	NN	O
action	action	NOUN	NN	O
potential	potential	NOUN	NN	O
in	in	ADP	IN	O
optic	optic	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
threshold	threshold	NOUN	NN	O
for	for	ADP	IN	O
action	action	NOUN	NN	O
potential	potential	ADJ	JJ	O
generation	generation	NOUN	NN	O
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
,	,	PUNCT	,	O
indicating	indicate	VERB	VBG	O
a	a	DET	DT	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
functional	functional	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
membrane	membrane	NOUN	NN	O
sodium	sodium	NOUN	NN	B-Chemical
channels	channel	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
conduction	conduction	NOUN	NN	O
velocity	velocity	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
number	number	NOUN	NN	O
and	and	CCONJ	CC	O
size	size	NOUN	NN	O
of	of	ADP	IN	O
axons	axon	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
optic	optic	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
specific	specific	ADJ	JJ	O
localization	localization	NOUN	NN	O
of	of	ADP	IN	O
Na	Na	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
v	v	NOUN	NN	O
)	)	PUNCT	-RRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
channels	channel	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
nodes	node	NOUN	NNS	O
of	of	ADP	IN	O
Ranvier	Ranvier	PROPN	NNP	O
were	be	VERB	VBD	O
unchanged	unchanged	ADJ	JJ	O
.	.	PUNCT	.	O

beta2	beta2	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
displayed	display	VERB	VBD	O
increased	increase	VERB	VBN	O
susceptibility	susceptibility	NOUN	NN	O
to	to	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
as	as	ADP	IN	O
indicated	indicate	VERB	VBN	O
by	by	ADP	IN	O
reduced	reduced	ADJ	JJ	O
latency	latency	NOUN	NN	O
and	and	CCONJ	CC	O
threshold	threshold	NOUN	NN	O
for	for	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
seemed	seem	VERB	VBD	O
normal	normal	ADJ	JJ	O
in	in	ADP	IN	O
other	other	ADJ	JJ	O
neurological	neurological	ADJ	JJ	O
tests	test	NOUN	NNS	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
observations	observation	NOUN	NNS	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
beta2	beta2	NOUN	NN	O
-	-	PUNCT	HYPH	O
subunits	subunit	NOUN	NNS	O
play	play	VERB	VBP	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
density	density	NOUN	NN	O
and	and	CCONJ	CC	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
and	and	CCONJ	CC	O
are	be	VERB	VBP	O
required	require	VERB	VBN	O
for	for	ADP	IN	O
normal	normal	ADJ	JJ	O
action	action	NOUN	NN	O
potential	potential	ADJ	JJ	O
generation	generation	NOUN	NN	O
and	and	CCONJ	CC	O
control	control	NOUN	NN	O
of	of	ADP	IN	O
excitability	excitability	NOUN	NN	O
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
with	with	ADP	IN	O
concurrent	concurrent	ADJ	JJ	O
bupropion	bupropion	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
carbimazole	carbimazole	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
report	report	VERB	VB	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
fatal	fatal	ADJ	JJ	O
liver	liver	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
possibly	possibly	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
concurrent	concurrent	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
carbimazole	carbimazole	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

CASE	case	NOUN	NN	O
SUMMARY	summary	NOUN	NN	O
:	:	PUNCT	:	O
A	a	DET	DT	O
41	41	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
Chinese	chinese	ADJ	JJ	O
man	man	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
hyperthyroidism	hyperthyroidism	NOUN	NN	B-Disease
had	have	VERB	VBD	O
been	be	VERB	VBN	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
carbimazole	carbimazole	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
propranolol	propranolol	NOUN	NN	B-Chemical
for	for	ADP	IN	O
the	the	DET	DT	O
past	past	ADJ	JJ	O
5	5	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
received	receive	VERB	VBD	O
a	a	DET	DT	O
10	10	NUM	CD	O
-	-	PUNCT	HYPH	O
day	day	NOUN	NN	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
as	as	ADP	IN	O
an	an	DET	DT	O
aid	aid	NOUN	NN	O
for	for	ADP	IN	O
smoking	smoking	NOUN	NN	O
cessation	cessation	NOUN	NN	O
10	10	NUM	CD	O
weeks	week	NOUN	NNS	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
presentation	presentation	NOUN	NN	O
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
developed	develop	VERB	VBD	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
with	with	ADP	IN	O
rapid	rapid	ADJ	JJ	O
deterioration	deterioration	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

Liver	liver	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
showed	show	VERB	VBD	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
nonspecific	nonspecific	ADJ	JJ	O
drug	drug	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
induced	induce	VERB	VBN	I-Disease
acute	acute	ADJ	JJ	I-Disease
liver	liver	NOUN	NN	I-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

His	-PRON-	DET	PRP$	O
condition	condition	NOUN	NN	O
was	be	VERB	VBD	O
further	further	ADV	RB	O
complicated	complicate	VERB	VBN	O
by	by	ADP	IN	O
sepsis	sepsis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
coagulopathy	coagulopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Death	death	NOUN	NN	O
resulted	result	VERB	VBD	O
19	19	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
symptoms	symptom	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
likelihood	likelihood	NOUN	NN	O
that	that	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
induced	induce	VERB	VBD	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
our	-PRON-	DET	PRP$	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
possible	possible	ADJ	JJ	O
,	,	PUNCT	,	O
based	base	VERB	VBN	O
on	on	ADP	IN	O
the	the	DET	DT	O
Naranjo	Naranjo	PROPN	NNP	O
probability	probability	NOUN	NN	O
scale	scale	NOUN	NN	O
.	.	PUNCT	.	O

DISCUSSION	discussion	NOUN	NN	O
:	:	PUNCT	:	O
Although	although	ADP	IN	O
there	there	ADV	EX	O
is	be	VERB	VBZ	O
increasing	increase	VERB	VBG	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
this	this	DET	DT	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
fatality	fatality	NOUN	NN	O
that	that	DET	WDT	O
could	could	VERB	MD	O
have	have	VERB	VB	O
resulted	result	VERB	VBN	O
from	from	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	ADJ	JJ	O
receiving	receive	VERB	VBG	O
bupropion	bupropion	NOUN	NN	B-Chemical
while	while	ADP	IN	O
on	on	ADP	IN	O
concomitant	concomitant	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
carbimazole	carbimazole	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Clinicians	clinician	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
the	the	DET	DT	O
possibility	possibility	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
insult	insult	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
given	give	VERB	VBN	O
concurrently	concurrently	ADV	RB	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
hepatotoxic	hepatotoxic	ADJ	JJ	B-Disease
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

Pyeloureteral	pyeloureteral	ADJ	JJ	O
filling	filling	NOUN	NN	O
defects	defect	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
systemic	systemic	ADJ	JJ	O
anticoagulation	anticoagulation	NOUN	NN	O
:	:	PUNCT	:	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
etiology	etiology	NOUN	NN	O
of	of	ADP	IN	O
pyeloureteritis	pyeloureteritis	NOUN	NN	B-Disease
cystica	cystica	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
long	long	ADV	RB	O
been	be	VERB	VBN	O
attributed	attribute	VERB	VBN	O
to	to	ADP	IN	O
chronic	chronic	ADJ	JJ	O
infection	infection	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
inflammation	inflammation	NOUN	NN	B-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
is	be	VERB	VBZ	O
presented	present	VERB	VBN	O
that	that	ADP	IN	O
is	be	VERB	VBZ	O
unique	unique	ADJ	JJ	O
in	in	ADP	IN	O
that	that	ADP	IN	O
the	the	DET	DT	O
acute	acute	ADJ	JJ	O
onset	onset	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
rapid	rapid	ADJ	JJ	O
resolution	resolution	NOUN	NN	O
of	of	ADP	IN	O
pyeloureteral	pyeloureteral	ADJ	JJ	O
filling	filling	NOUN	NN	O
defects	defect	NOUN	NNS	O
in	in	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
were	be	VERB	VBD	O
documented	document	VERB	VBN	O
by	by	ADP	IN	O
radiography	radiography	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
is	be	VERB	VBZ	O
no	no	DET	DT	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
antecedent	antecedent	NOUN	NN	O
or	or	CCONJ	CC	O
concurrent	concurrent	ADJ	JJ	O
infection	infection	NOUN	NN	B-Disease
in	in	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
disease	disease	NOUN	NN	O
occurred	occur	VERB	VBD	O
subsequent	subsequent	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
heparin	heparin	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
suspected	suspect	VERB	VBN	O
pelvic	pelvic	ADJ	JJ	O
thrombophlebitis	thrombophlebitis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
cleared	clear	VERB	VBD	O
rapidly	rapidly	ADV	RB	O
subsequent	subsequent	ADJ	JJ	O
to	to	ADP	IN	O
its	-PRON-	DET	PRP$	O
discontinuation	discontinuation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
resolution	resolution	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
radiographic	radiographic	ADJ	JJ	O
findings	finding	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
helpful	helpful	ADJ	JJ	O
in	in	ADP	IN	O
distinguishing	distinguish	VERB	VBG	O
between	between	ADP	IN	O
true	true	ADJ	JJ	O
pyeloureteritis	pyeloureteritis	NOUN	NN	B-Disease
cystica	cystica	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
submucosal	submucosal	NOUN	NN	B-Disease
hemorrhage	hemorrhage	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
in	in	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
risk	risk	NOUN	NN	O
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
angiography	angiography	ADV	RB	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
iodinated	iodinate	VERB	VBN	O
contrast	contrast	NOUN	NN	O
medium	medium	NOUN	NN	O
can	can	VERB	MD	O
result	result	VERB	VB	O
in	in	ADP	IN	O
nephropathy	nephropathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Whether	whether	ADP	IN	O
iso	iso	ADJ	JJ	O
-	-	PUNCT	HYPH	O
osmolar	osmolar	NOUN	NN	O
contrast	contrast	NOUN	NN	O
medium	medium	NOUN	NN	O
is	be	VERB	VBZ	O
less	less	ADV	RBR	O
nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
than	than	ADP	IN	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
osmolar	osmolar	NOUN	NN	O
contrast	contrast	NOUN	NN	O
medium	medium	NOUN	NN	O
in	in	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
risk	risk	NOUN	NN	O
patients	patient	NOUN	NNS	O
is	be	VERB	VBZ	O
uncertain	uncertain	ADJ	JJ	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
conducted	conduct	VERB	VBD	O
a	a	DET	DT	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
multicenter	multicenter	NOUN	NN	O
study	study	NOUN	NN	O
comparing	compare	VERB	VBG	O
the	the	DET	DT	O
nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
an	an	DET	DT	O
iso	iso	ADJ	JJ	O
-	-	PUNCT	HYPH	O
osmolar	osmolar	NOUN	NN	O
,	,	PUNCT	,	O
dimeric	dimeric	ADJ	JJ	O
,	,	PUNCT	,	O
nonionic	nonionic	ADJ	JJ	O
contrast	contrast	NOUN	NN	O
medium	medium	NOUN	NN	O
,	,	PUNCT	,	O
iodixanol	iodixanol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
with	with	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
a	a	DET	DT	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
osmolar	osmolar	NOUN	NN	O
,	,	PUNCT	,	O
nonionic	nonionic	ADJ	JJ	O
,	,	PUNCT	,	O
monomeric	monomeric	ADJ	JJ	O
contrast	contrast	NOUN	NN	O
medium	medium	NOUN	NN	O
,	,	PUNCT	,	O
iohexol	iohexol	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
study	study	NOUN	NN	O
involved	involve	VERB	VBD	O
129	129	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
diabetes	diabete	NOUN	NNS	B-Disease
with	with	ADP	IN	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
to	to	ADP	IN	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
who	who	PRON	WP	O
underwent	undergo	VERB	VBD	O
coronary	coronary	ADJ	JJ	O
or	or	CCONJ	CC	O
aortofemoral	aortofemoral	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
primary	primary	ADJ	JJ	O
end	end	NOUN	NN	O
point	point	NOUN	NN	O
was	be	VERB	VBD	O
the	the	DET	DT	O
peak	peak	NOUN	NN	O
increase	increase	NOUN	NN	O
from	from	ADP	IN	O
base	base	NOUN	NN	O
line	line	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
creatinine	creatinine	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
during	during	ADP	IN	O
the	the	DET	DT	O
three	three	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
angiography	angiography	NOUN	NN	O
.	.	PUNCT	.	O

Other	other	ADJ	JJ	O
end	end	NOUN	NN	O
points	point	NOUN	NNS	O
were	be	VERB	VBD	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
creatinine	creatinine	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
,	,	PUNCT	,	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
creatinine	creatinine	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
from	from	ADP	IN	O
day	day	NOUN	NN	O
0	0	NUM	CD	O
to	to	ADP	IN	O
day	day	NOUN	NN	O
7	7	NUM	CD	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
creatinine	creatinine	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
increased	increase	VERB	VBD	O
significantly	significantly	ADV	RB	O
less	less	ADV	RBR	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
received	receive	VERB	VBD	O
iodixanol	iodixanol	ADV	RB	B-Chemical
.	.	PUNCT	.	O

From	from	ADP	IN	O
day	day	NOUN	NN	O
0	0	NUM	CD	O
to	to	ADP	IN	O
day	day	NOUN	NN	O
3	3	NUM	CD	O
,	,	PUNCT	,	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
peak	peak	NOUN	NN	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
creatinine	creatinine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
13	13	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
iodixanol	iodixanol	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
55	55	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
iohexol	iohexol	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
;	;	PUNCT	:	O
the	the	DET	DT	O
increase	increase	NOUN	NN	O
with	with	ADP	IN	O
iodixanol	iodixanol	NOUN	NN	B-Chemical
minus	minus	CCONJ	CC	O
the	the	DET	DT	O
increase	increase	NOUN	NN	O
with	with	ADP	IN	O
iohexol	iohexol	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
-	-	PUNCT	HYPH	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
42	42	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
[	[	PUNCT	-LRB-	O
95	95	NUM	CD	O
percent	percent	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
-	-	PUNCT	HYPH	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
73	73	NUM	CD	O
to	to	PART	TO	O
-	-	PUNCT	HYPH	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
22	22	NUM	CD	O
]	]	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
64	64	NUM	CD	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
iodixanol	iodixanol	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
percent	percent	NOUN	NN	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
creatinine	creatinine	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
17	17	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
65	65	NUM	CD	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
iohexol	iohexol	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
26	26	NUM	CD	O
percent	percent	NOUN	NN	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
002	002	NUM	CD	O
;	;	PUNCT	:	O
odds	odd	NOUN	NNS	O
ratio	ratio	NOUN	NN	O
for	for	ADP	IN	O
such	such	DET	PDT	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
iodixanol	iodixanol	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
09	09	NUM	CD	O
[	[	PUNCT	-LRB-	O
95	95	NUM	CD	O
percent	percent	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
02	02	NUM	CD	O
to	to	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
41	41	NUM	CD	O
]	]	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

No	no	DET	DT	O
patient	patient	NOUN	NN	O
receiving	receive	VERB	VBG	O
iodixanol	iodixanol	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
10	10	NUM	CD	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
iohexol	iohexol	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
15	15	NUM	CD	O
percent	percent	NOUN	NN	O
)	)	PUNCT	-RRB-	O
did	do	VERB	VBD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
creatinine	creatinine	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
from	from	ADP	IN	O
day	day	NOUN	NN	O
0	0	NUM	CD	O
to	to	ADP	IN	O
day	day	NOUN	NN	O
7	7	NUM	CD	O
was	be	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
07	07	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
iodixanol	iodixanol	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
24	24	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
iohexol	iohexol	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
003	003	NUM	CD	O
;	;	PUNCT	:	O
value	value	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
iodixanol	iodixanol	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
minus	minus	ADP	IN	O
the	the	DET	DT	O
value	value	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
iohexol	iohexol	ADJ	JJ	B-Chemical
group	group	NOUN	NN	O
,	,	PUNCT	,	O
-	-	PUNCT	HYPH	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
17	17	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
deciliter	deciliter	NOUN	NN	O
[	[	PUNCT	-LRB-	O
95	95	NUM	CD	O
percent	percent	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
-	-	PUNCT	HYPH	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
34	34	NUM	CD	O
to	to	PART	TO	O
-	-	PUNCT	HYPH	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
07	07	NUM	CD	O
]	]	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Nephropathy	Nephropathy	PROPN	NNP	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
contrast	contrast	NOUN	NN	O
medium	medium	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
less	less	ADV	RBR	O
likely	likely	ADJ	JJ	O
to	to	PART	TO	O
develop	develop	VERB	VB	O
in	in	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
risk	risk	NOUN	NN	O
patients	patient	NOUN	NNS	O
when	when	ADV	WRB	O
iodixanol	iodixanol	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
used	use	VERB	VBN	O
rather	rather	ADV	RB	O
than	than	ADP	IN	O
a	a	DET	DT	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
osmolar	osmolar	NOUN	NN	O
,	,	PUNCT	,	O
nonionic	nonionic	ADJ	JJ	O
contrast	contrast	NOUN	NN	O
medium	medium	NOUN	NN	O
.	.	PUNCT	.	O

Protective	protective	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
edaravone	edaravone	NOUN	NN	B-Chemical
against	against	ADP	IN	O
streptomycin	streptomycin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
vestibulotoxicity	vestibulotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
guinea	guinea	NOUN	NN	O
pig	pig	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
investigated	investigate	VERB	VBD	O
alleviation	alleviation	NOUN	NN	O
of	of	ADP	IN	O
streptomycin	streptomycin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
vestibulotoxicity	vestibulotoxicity	NOUN	NN	B-Disease
by	by	ADP	IN	O
edaravone	edaravone	NOUN	NN	B-Chemical
in	in	ADP	IN	O
guinea	guinea	NOUN	NN	O
pigs	pig	NOUN	NNS	O
.	.	PUNCT	.	O

Edaravone	Edaravone	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
free	free	ADJ	JJ	O
radical	radical	ADJ	JJ	O
scavenger	scavenger	NOUN	NN	O
,	,	PUNCT	,	O
has	have	VERB	VBZ	O
potent	potent	ADJ	JJ	O
free	free	ADJ	JJ	O
radical	radical	ADJ	JJ	O
quenching	quenching	NOUN	NN	O
action	action	NOUN	NN	O
and	and	CCONJ	CC	O
is	be	VERB	VBZ	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
clinical	clinical	ADJ	JJ	O
practice	practice	NOUN	NN	O
to	to	PART	TO	O
treat	treat	VERB	VB	O
cerebral	cerebral	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Streptomycin	Streptomycin	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
inner	inner	ADJ	JJ	O
ear	ear	NOUN	NN	O
by	by	ADP	IN	O
osmotic	osmotic	ADJ	JJ	O
pump	pump	NOUN	NN	O
for	for	ADP	IN	O
24	24	NUM	CD	O
h	h	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
edaravone	edaravone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
saline	saline	NOUN	NN	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
intraperitoneally	intraperitoneally	ADV	RB	O
injected	inject	VERB	VBN	O
once	once	ADV	RB	O
a	a	DET	DT	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
observed	observe	VERB	VBD	O
horizontal	horizontal	ADJ	JJ	O
vestibulo	vestibulo	VERB	VBN	O
-	-	PUNCT	HYPH	O
ocular	ocular	ADJ	JJ	O
reflex	reflex	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
marker	marker	NOUN	NN	O
of	of	ADP	IN	O
postoperative	postoperative	ADJ	JJ	O
vestibular	vestibular	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

Animals	animal	NOUN	NNS	O
injected	inject	VERB	VBD	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
showed	show	VERB	VBD	O
statistically	statistically	ADV	RB	O
smaller	small	ADJ	JJR	O
gains	gain	NOUN	NNS	O
than	than	ADP	IN	O
those	those	DET	DT	O
injected	inject	VERB	VBN	O
with	with	ADP	IN	O
edaravone	edaravone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
edaravone	edaravone	NOUN	NN	B-Chemical
suppresses	suppress	VERB	VBZ	O
streptomycin	streptomycin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
vestibulotoxicity	vestibulotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Levodopa	Levodopa	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
oromandibular	oromandibular	ADJ	JJ	O
dystonia	dystonia	NOUN	NN	B-Disease
in	in	ADP	IN	O
progressive	progressive	ADJ	JJ	B-Disease
supranuclear	supranuclear	NOUN	NN	I-Disease
palsy	palsy	ADJ	JJ	I-Disease
.	.	PUNCT	.	O

Levodopa	Levodopa	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
multiple	multiple	ADJ	JJ	B-Disease
system	system	NOUN	NN	I-Disease
atrophy	atrophy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Cranial	cranial	ADJ	JJ	O
dystonias	dystonia	NOUN	NNS	B-Disease
are	be	VERB	VBP	O
rare	rare	ADJ	JJ	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
progressive	progressive	ADJ	JJ	B-Disease
supranuclear	supranuclear	NOUN	NN	I-Disease
palsy	palsy	ADJ	JJ	I-Disease
(	(	PUNCT	-LRB-	O
PSP	PSP	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
report	report	NOUN	NN	O
we	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
an	an	DET	DT	O
unusual	unusual	ADJ	JJ	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
reversible	reversible	ADJ	JJ	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
Oromandibular	Oromandibular	PROPN	NNP	B-Disease
dystonia	dystonia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
OMD	OMD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
a	a	DET	DT	O
PSP	PSP	PROPN	NNP	B-Disease
patient	patient	NOUN	NN	O
to	to	PART	TO	O
highlight	highlight	VERB	VB	O
the	the	DET	DT	O
importance	importance	NOUN	NN	O
of	of	ADP	IN	O
recognizing	recognize	VERB	VBG	O
this	this	DET	DT	O
drug	drug	NOUN	NN	O
related	relate	VERB	VBN	O
complication	complication	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
PSP	PSP	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
discuss	discuss	VERB	VB	O
the	the	DET	DT	O
possible	possible	ADJ	JJ	O
underlying	underlying	ADJ	JJ	O
pathophysiology	pathophysiology	NOUN	NN	O
.	.	PUNCT	.	O

Case	case	NOUN	NN	O
report	report	NOUN	NN	O
:	:	PUNCT	:	O
Dexatrim	Dexatrim	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
Phenylpropanolamine	Phenylpropanolamine	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
as	as	ADP	IN	O
a	a	DET	DT	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Phenylpropanolamine	Phenylpropanolamine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
PPA	PPA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
sympathetic	sympathetic	ADJ	JJ	O
amine	amine	NOUN	NN	B-Chemical
used	use	VERB	VBN	O
in	in	ADP	IN	O
over	over	ADP	IN	O
-	-	PUNCT	HYPH	O
the	the	DET	DT	O
-	-	PUNCT	HYPH	O
counter	counter	NOUN	NN	O
cold	cold	ADJ	JJ	O
remedies	remedy	NOUN	NNS	O
and	and	CCONJ	CC	O
weight	weight	NOUN	NN	O
-	-	PUNCT	HYPH	O
control	control	NOUN	NN	O
preparations	preparation	NOUN	NNS	O
worldwide	worldwide	ADV	RB	O
.	.	PUNCT	.	O

Its	-PRON-	DET	PRP$	O
use	use	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
episodes	episode	NOUN	NNS	O
and	and	CCONJ	CC	O
hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
strokes	stroke	NOUN	NNS	I-Disease
in	in	ADP	IN	O
younger	young	ADJ	JJR	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

Several	several	ADJ	JJ	O
reports	report	NOUN	NNS	O
have	have	VERB	VBP	O
linked	link	VERB	VBN	O
the	the	DET	DT	O
abuse	abuse	NOUN	NN	O
of	of	ADP	IN	O
PPA	PPA	PROPN	NNP	B-Chemical
with	with	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
when	when	ADV	WRB	O
overdose	overdose	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
involved	involve	VERB	VBN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
here	here	ADV	RB	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
Dexatrim	Dexatrim	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
PPA	PPA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
myocardial	myocardial	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
young	young	ADJ	JJ	O
woman	woman	NOUN	NN	O
who	who	PRON	WP	O
was	be	VERB	VBD	O
using	use	VERB	VBG	O
it	-PRON-	PRON	PRP	O
at	at	ADP	IN	O
recommended	recommend	VERB	VBN	O
doses	dose	NOUN	NNS	O
for	for	ADP	IN	O
weight	weight	NOUN	NN	O
control	control	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
review	review	VERB	VBP	O
the	the	DET	DT	O
7	7	NUM	CD	O
other	other	ADJ	JJ	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
PPA	PPA	PROPN	NNP	B-Chemical
related	relate	VERB	VBN	O
myocardial	myocardial	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
that	that	DET	WDT	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
so	so	ADV	RB	O
far	far	ADV	RB	O
.	.	PUNCT	.	O

Physicians	physician	NOUN	NNS	O
and	and	CCONJ	CC	O
patients	patient	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
alert	alert	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
potential	potential	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
risk	risk	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
PPA	PPA	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
even	even	ADV	RB	O
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
generally	generally	ADV	RB	O
considered	consider	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
safe	safe	ADJ	JJ	O
.	.	PUNCT	.	O

Differential	differential	ADJ	JJ	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
serum	serum	NOUN	NN	O
creatine	creatine	NOUN	NN	B-Chemical
kinase	kinase	NOUN	NN	O
levels	level	NOUN	NNS	O
in	in	ADP	IN	O
systemic	systemic	ADJ	JJ	B-Disease
lupus	lupus	NOUN	NN	I-Disease
erythematosus	erythematosus	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
the	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
bioptic	bioptic	ADJ	JJ	O
findings	finding	NOUN	NNS	O
for	for	ADP	IN	O
a	a	DET	DT	O
57	57	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
chloroquine	chloroquine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
myopathy	myopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Since	since	ADP	IN	O
1989	1989	NUM	CD	O
,	,	PUNCT	,	O
she	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
suffering	suffer	VERB	VBG	O
from	from	ADP	IN	O
systemic	systemic	ADJ	JJ	B-Disease
lupus	lupus	NOUN	NN	I-Disease
erythematosus	erythematosus	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
SLE	SLE	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
involvement	involvement	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
undergone	undergone	ADJ	JJ	O
periods	period	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
azathioprine	azathioprine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Additional	additional	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
chloroquine	chloroquine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
CQ	CQ	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
started	start	VERB	VBN	O
because	because	ADP	IN	O
of	of	ADP	IN	O
arthralgia	arthralgia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

At	at	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
time	time	NOUN	NN	O
,	,	PUNCT	,	O
slightly	slightly	ADV	RB	O
increased	increase	VERB	VBN	O
creatine	creatine	NOUN	NN	B-Chemical
kinase	kinase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
CK	ck	NOUN	NN	O
)	)	PUNCT	-RRB-	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
noted	note	VERB	VBN	O
.	.	PUNCT	.	O

Myositis	Myositis	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
suspected	suspect	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
steroids	steroid	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
CK	CK	PROPN	NNP	O
increase	increase	NOUN	NN	O
persisted	persist	VERB	VBD	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
she	-PRON-	PRON	PRP	O
developed	develop	VERB	VBD	O
progressive	progressive	ADJ	JJ	O
muscular	muscular	ADJ	JJ	B-Disease
weakness	weakness	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
muscular	muscular	ADJ	JJ	B-Disease
atrophy	atrophy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Routine	Routine	PROPN	NNP	O
controls	control	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
markedly	markedly	ADV	RB	O
elevated	elevate	VERB	VBN	O
CK	CK	PROPN	NNP	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
700	700	NUM	CD	O
U	u	NOUN	NN	O
/	/	SYM	SYM	O
l	l	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
neurological	neurological	ADJ	JJ	O
and	and	CCONJ	CC	O
electrophysiological	electrophysiological	ADJ	JJ	O
findings	finding	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
typical	typical	ADJ	JJ	O
of	of	ADP	IN	O
myositis	myositis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
muscle	muscle	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
deltoid	deltoid	ADJ	JJ	O
muscle	muscle	NOUN	NN	O
was	be	VERB	VBD	O
performed	perform	VERB	VBN	O
in	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
exclude	exclude	VERB	VB	O
polymyositis	polymyositis	NOUN	NN	B-Disease
or	or	CCONJ	CC	O
toxic	toxic	ADJ	JJ	O
myopathy	myopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

As	as	ADP	IN	O
it	-PRON-	PRON	PRP	O
revealed	reveal	VERB	VBD	O
chloroquine	chloroquine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
myopathy	myopathy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
medication	medication	NOUN	NN	O
was	be	VERB	VBD	O
stopped	stop	VERB	VBN	O
.	.	PUNCT	.	O

Discriminating	discriminate	VERB	VBG	O
between	between	ADP	IN	O
primary	primary	ADJ	JJ	O
SLE	SLE	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
affection	affection	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
musculoskeletal	musculoskeletal	ADJ	JJ	I-Disease
system	system	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
is	be	VERB	VBZ	O
important	important	ADJ	JJ	O
for	for	ADP	IN	O
appropriate	appropriate	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
SLE	SLE	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Seizure	Seizure	PROPN	NNP	B-Disease
associated	associate	VERB	VBD	O
with	with	ADP	IN	O
sleep	sleep	NOUN	NN	B-Disease
deprivation	deprivation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
sustained	sustain	VERB	VBN	O
-	-	PUNCT	HYPH	O
release	release	NOUN	NN	O
bupropion	bupropion	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
describes	describe	VERB	VBZ	O
a	a	DET	DT	O
generalized	generalized	ADJ	JJ	O
seizure	seizure	NOUN	NN	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
sustained	sustain	VERB	VBN	O
-	-	PUNCT	HYPH	O
release	release	NOUN	NN	O
bupropion	bupropion	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
and	and	CCONJ	CC	O
sleep	sleep	NOUN	NN	B-Disease
deprivation	deprivation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
subject	subject	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
31	31	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
female	female	ADJ	JJ	O
smoker	smoker	NOUN	NN	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
participating	participate	VERB	VBG	O
in	in	ADP	IN	O
a	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
trial	trial	NOUN	NN	O
evaluating	evaluate	VERB	VBG	O
an	an	DET	DT	O
investigational	investigational	ADJ	JJ	O
medication	medication	NOUN	NN	O
for	for	ADP	IN	O
smoking	smoking	NOUN	NN	O
cessation	cessation	NOUN	NN	O
that	that	DET	WDT	O
used	use	VERB	VBD	O
sustained	sustained	ADJ	JJ	O
-	-	PUNCT	HYPH	O
release	release	NOUN	NN	O
bupropion	bupropion	NOUN	NN	B-Chemical
as	as	ADP	IN	O
an	an	DET	DT	O
active	active	ADJ	JJ	O
control	control	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
5	5	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
subject	subject	NOUN	NN	O
experienced	experience	VERB	VBD	O
a	a	DET	DT	O
generalized	generalized	ADJ	JJ	O
tonic	tonic	NOUN	NN	O
clonic	clonic	NOUN	NN	O
seizure	seizure	NOUN	NN	B-Disease
after	after	ADP	IN	O
staying	stay	VERB	VBG	O
up	up	PART	RP	O
nearly	nearly	ADV	RB	O
all	all	DET	DT	O
night	night	NOUN	NN	O
packing	pack	VERB	VBG	O
and	and	CCONJ	CC	O
moving	move	VERB	VBG	O
to	to	ADP	IN	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
residence	residence	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
no	no	DET	DT	O
other	other	ADJ	JJ	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
for	for	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
sleep	sleep	NOUN	NN	B-Disease
deprivation	deprivation	NOUN	NN	I-Disease
may	may	VERB	MD	O
add	add	VERB	VB	O
to	to	ADP	IN	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Postoperative	postoperative	ADJ	JJ	B-Disease
myalgia	myalgia	NOUN	NN	I-Disease
after	after	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
no	no	DET	DT	O
evidence	evidence	NOUN	NN	O
for	for	ADP	IN	O
an	an	DET	DT	O
inflammatory	inflammatory	ADJ	JJ	O
origin	origin	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
common	common	ADJ	JJ	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
postoperative	postoperative	ADJ	JJ	B-Disease
myalgia	myalgia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
pathogenesis	pathogenesis	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
myalgia	myalgia	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
still	still	ADV	RB	O
unclear	unclear	ADJ	JJ	O
;	;	PUNCT	:	O
inflammation	inflammation	NOUN	NN	B-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
suggested	suggest	VERB	VBN	O
but	but	CCONJ	CC	O
without	without	ADP	IN	O
convincing	convince	VERB	VBG	O
evidence	evidence	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
designed	design	VERB	VBD	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
whether	whether	ADP	IN	O
an	an	DET	DT	O
inflammatory	inflammatory	ADJ	JJ	O
reaction	reaction	NOUN	NN	O
contributes	contribute	NOUN	NNS	O
to	to	ADP	IN	O
this	this	DET	DT	O
myalgia	myalgia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
and	and	CCONJ	CC	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
myalgia	myalgia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
determined	determine	VERB	VBN	O
in	in	ADP	IN	O
64	64	NUM	CD	O
patients	patient	NOUN	NNS	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
or	or	CCONJ	CC	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
before	before	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
32	32	NUM	CD	O
for	for	ADP	IN	O
each	each	DET	DT	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Incidence	incidence	NOUN	NN	O
and	and	CCONJ	CC	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
myalgia	myalgia	NOUN	NN	B-Disease
did	do	VERB	VBD	O
not	not	ADV	RB	O
differ	differ	VERB	VB	O
significantly	significantly	ADV	RB	O
between	between	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
:	:	PUNCT	:	O
15	15	NUM	CD	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
complained	complain	VERB	VBD	O
of	of	ADP	IN	O
myalgia	myalgia	NOUN	NN	B-Disease
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
18	18	NUM	CD	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
saline	saline	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
severe	severe	ADJ	JJ	O
myalgia	myalgia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
reported	report	VERB	VBN	O
by	by	ADP	IN	O
five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
and	and	CCONJ	CC	O
three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
(	(	PUNCT	-LRB-	O
not	not	ADV	RB	O
significant	significant	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
48	48	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
surgery	surgery	NOUN	NN	O
,	,	PUNCT	,	O
12	12	NUM	CD	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
still	still	ADV	RB	O
suffered	suffer	VERB	VBD	O
from	from	ADP	IN	O
myalgia	myalgia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
not	not	ADV	RB	O
significant	significant	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
interleukin	interleukin	NOUN	NN	O
-	-	PUNCT	HYPH	O
6	6	NUM	CD	O
(	(	PUNCT	-LRB-	O
IL	IL	PROPN	NNP	O
-	-	PUNCT	HYPH	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
as	as	ADP	IN	O
an	an	DET	DT	O
early	early	ADJ	JJ	O
marker	marker	NOUN	NN	O
of	of	ADP	IN	O
inflammation	inflammation	NOUN	NN	B-Disease
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
subgroup	subgroup	NOUN	NN	O
of	of	ADP	IN	O
10	10	NUM	CD	O
patients	patient	NOUN	NNS	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
found	find	VERB	VBD	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
IL	IL	PROPN	NNP	O
-	-	PUNCT	HYPH	O
6	6	NUM	CD	O
for	for	ADP	IN	O
only	only	ADV	RB	O
three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
only	only	ADV	RB	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
reported	report	VERB	VBD	O
myalgia	myalgia	NOUN	NN	B-Disease
;	;	PUNCT	:	O
no	no	DET	DT	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
myalgia	myalgia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
the	the	DET	DT	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
IL	IL	PROPN	NNP	O
-	-	PUNCT	HYPH	O
6	6	NUM	CD	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
is	be	VERB	VBZ	O
no	no	DET	DT	O
evidence	evidence	NOUN	NN	O
for	for	ADP	IN	O
an	an	DET	DT	O
inflammatory	inflammatory	ADJ	JJ	O
origin	origin	NOUN	NN	O
of	of	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
myalgia	myalgia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

IMPLICATIONS	implications	NOUN	NN	O
:	:	PUNCT	:	O
Administration	administration	NOUN	NN	O
of	of	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
before	before	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
not	not	ADV	RB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
decreasing	decrease	VERB	VBG	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
or	or	CCONJ	CC	O
the	the	DET	DT	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
postoperative	postoperative	ADJ	JJ	B-Disease
myalgia	myalgia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
postoperative	postoperative	ADJ	JJ	B-Disease
myalgia	myalgia	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
time	time	NOUN	NN	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
interleukin	interleukin	NOUN	NN	O
-	-	PUNCT	HYPH	O
6	6	NUM	CD	O
concentrations	concentration	NOUN	NNS	O
,	,	PUNCT	,	O
a	a	DET	DT	O
marker	marker	NOUN	NN	O
of	of	ADP	IN	O
inflammation	inflammation	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
not	not	ADV	RB	O
justified	justified	ADJ	JJ	O
to	to	PART	TO	O
prevent	prevent	VERB	VB	O
postoperative	postoperative	ADJ	JJ	B-Disease
myalgia	myalgia	NOUN	NN	I-Disease
after	after	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
lindane	lindane	NOUN	NN	B-Chemical
on	on	ADP	IN	O
hepatic	hepatic	ADJ	JJ	O
and	and	CCONJ	CC	O
brain	brain	NOUN	NN	O
cytochrome	cytochrome	DET	PDT	O
P450s	P450s	PROPN	NNP	O
and	and	CCONJ	CC	O
influence	influence	NOUN	NN	O
of	of	ADP	IN	O
P450	P450	PROPN	NNP	O
modulation	modulation	NOUN	NN	O
in	in	ADP	IN	O
lindane	lindane	NOUN	NN	B-Chemical
induced	induced	ADJ	JJ	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Oral	oral	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
lindane	lindane	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
and	and	CCONJ	CC	O
15	15	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
5	5	NUM	CD	O
days	day	NOUN	NNS	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
produce	produce	VERB	VB	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
P450	P450	PROPN	NNP	O
dependent	dependent	ADJ	JJ	O
7	7	NUM	CD	O
-	-	PUNCT	HYPH	O
ethoxyresorufin	ethoxyresorufin	NOUN	NN	O
-	-	PUNCT	HYPH	O
O	o	NOUN	NN	O
-	-	PUNCT	HYPH	O
deethylase	deethylase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
EROD	EROD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
7	7	NUM	CD	O
-	-	PUNCT	HYPH	O
pentoxyresorufin	pentoxyresorufin	NOUN	NN	O
-	-	PUNCT	HYPH	O
O	o	NOUN	NN	O
-	-	PUNCT	HYPH	O
dealkylase	dealkylase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PROD	PROD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
nitrosodimethylamine	nitrosodimethylamine	NOUN	NN	I-Chemical
demethylase	demethylase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
NDMA	NDMA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
d	d	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
rat	rat	NOUN	NN	O
brain	brain	NOUN	NN	O
and	and	CCONJ	CC	O
liver	liver	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
significant	significant	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
hepatic	hepatic	ADJ	JJ	O
and	and	CCONJ	CC	O
brain	brain	NOUN	NN	O
P450	P450	PROPN	NNP	O
monooxygenases	monooxygenase	NOUN	NNS	O
was	be	VERB	VBD	O
also	also	ADV	RB	O
observed	observe	VERB	VBN	O
when	when	ADV	WRB	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
exposure	exposure	NOUN	NN	O
of	of	ADP	IN	O
low	low	ADJ	JJ	O
dose	dose	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
lindane	lindane	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
from	from	ADP	IN	O
5	5	NUM	CD	O
days	day	NOUN	NNS	O
to	to	ADP	IN	O
15	15	NUM	CD	O
or	or	CCONJ	CC	O
21	21	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

As	as	ADP	IN	O
observed	observe	VERB	VBN	O
with	with	ADP	IN	O
different	different	ADJ	JJ	O
doses	dose	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
magnitude	magnitude	NOUN	NN	O
of	of	ADP	IN	O
induction	induction	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
P450	P450	PROPN	NNP	O
monooxygenases	monooxygenase	NOUN	NNS	O
was	be	VERB	VBD	O
several	several	ADJ	JJ	O
fold	fold	VERB	VB	O
higher	high	ADJ	JJR	O
in	in	ADP	IN	O
liver	liver	NOUN	NN	O
microsomes	microsome	NOUN	NNS	O
when	when	ADV	WRB	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
.	.	PUNCT	.	O

Western	western	ADJ	JJ	O
blotting	blotting	NOUN	NN	O
studies	study	NOUN	NNS	O
have	have	VERB	VBP	O
indicated	indicate	VERB	VBN	O
that	that	ADP	IN	O
the	the	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
P450	P450	PROPN	NNP	O
enzymes	enzyme	NOUN	NNS	O
could	could	VERB	MD	O
be	be	VERB	VB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
P450	P450	PROPN	NNP	O
1A1	1a1	NUM	CD	O
/	/	SYM	SYM	O
1A2	1a2	NUM	CD	O
,	,	PUNCT	,	O
2B1	2b1	NUM	CD	O
/	/	SYM	SYM	O
2B2	2b2	NUM	CD	O
and	and	CCONJ	CC	O
2E1	2e1	NUM	CD	O
isoenzymes	isoenzyme	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
vitro	vitro	X	FW	O
studies	study	NOUN	NNS	O
using	use	VERB	VBG	O
organic	organic	ADJ	JJ	O
inhibitors	inhibitor	NOUN	NNS	O
specific	specific	ADJ	JJ	O
for	for	ADP	IN	O
individual	individual	ADJ	JJ	O
P450	P450	PROPN	NNP	O
isoenzymes	isoenzyme	NOUN	NNS	O
and	and	CCONJ	CC	O
antibody	antibody	NOUN	NN	O
inhibition	inhibition	NOUN	NN	O
experiments	experiment	NOUN	NNS	O
have	have	VERB	VBP	O
further	further	ADV	RB	O
demonstrated	demonstrate	VERB	VBN	O
that	that	ADP	IN	O
the	the	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
PROD	PROD	PROPN	NNP	O
,	,	PUNCT	,	O
EROD	EROD	PROPN	NNP	O
and	and	CCONJ	CC	O
NDMA	NDMA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
d	d	PROPN	NNP	O
are	be	VERB	VBP	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
P450	P450	PROPN	NNP	O
2B1	2B1	PROPN	NNP	O
/	/	SYM	SYM	O
2B2	2b2	NUM	CD	O
,	,	PUNCT	,	O
1A1	1a1	NUM	CD	O
/	/	SYM	SYM	O
1A2	1a2	NUM	CD	O
and	and	CCONJ	CC	O
2E1	2e1	NUM	CD	O
isoenzymes	isoenzyme	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Induction	induction	NOUN	NN	O
studies	study	NOUN	NNS	O
have	have	VERB	VBP	O
further	further	ADV	RB	O
shown	show	VERB	VBN	O
that	that	ADP	IN	O
while	while	ADP	IN	O
pretreatment	pretreatment	NOUN	NN	O
of	of	ADP	IN	O
3	3	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methylcholanthrene	methylcholanthrene	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
MC	MC	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
an	an	DET	DT	O
inducer	inducer	NOUN	NN	O
of	of	ADP	IN	O
P4501A1	P4501A1	PROPN	NNP	O
/	/	SYM	SYM	O
1A2	1a2	NUM	CD	O
,	,	PUNCT	,	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
produce	produce	VERB	VB	O
any	any	DET	DT	O
significant	significant	ADJ	JJ	O
effect	effect	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
lindane	lindane	ADJ	JJ	B-Chemical
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
phenobarbital	phenobarbital	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
PB	PB	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
an	an	DET	DT	O
inducer	inducer	NOUN	NN	O
of	of	ADP	IN	O
P450	P450	PROPN	NNP	O
2B1	2B1	PROPN	NNP	O
/	/	SYM	SYM	O
2B2	2b2	NUM	CD	O
or	or	CCONJ	CC	O
ethanol	ethanol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
an	an	DET	DT	O
inducer	inducer	NOUN	NN	O
of	of	ADP	IN	O
P450	P450	PROPN	NNP	O
2E1	2e1	NUM	CD	O
catalysed	catalyse	VERB	VBN	O
reactions	reaction	NOUN	NNS	O
,	,	PUNCT	,	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
lindane	lindane	ADJ	JJ	B-Chemical
induced	induced	ADJ	JJ	O
convulsions	convulsion	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Similarly	similarly	ADV	RB	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
the	the	DET	DT	O
P450	P450	PROPN	NNP	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
metabolism	metabolism	NOUN	NN	O
of	of	ADP	IN	O
lindane	lindane	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
blocked	block	VERB	VBN	O
by	by	ADP	IN	O
cobalt	cobalt	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
convulsions	convulsion	NOUN	NNS	B-Disease
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
in	in	ADP	IN	O
animals	animal	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
lindane	lindane	NOUN	NN	B-Chemical
indicating	indicate	VERB	VBG	O
that	that	DET	DT	O
lindane	lindane	NOUN	NN	B-Chemical
per	per	X	FW	O
se	se	X	FW	O
or	or	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
metabolites	metabolite	NOUN	NNS	O
formed	form	VERB	VBN	O
by	by	ADP	IN	O
PB	PB	PROPN	NNP	O
or	or	CCONJ	CC	O
ethanol	ethanol	NOUN	NN	B-Chemical
inducible	inducible	ADJ	JJ	O
P450	P450	PROPN	NNP	O
isoenzymes	isoenzyme	NOUN	NNS	O
are	be	VERB	VBP	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
its	-PRON-	DET	PRP$	O
neurobehavioral	neurobehavioral	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Absolute	absolute	ADJ	JJ	O
and	and	CCONJ	CC	O
attributable	attributable	ADJ	JJ	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
venous	venous	ADJ	JJ	B-Disease
thromboembolism	thromboembolism	NOUN	NN	I-Disease
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
combined	combined	ADJ	JJ	O
cyproterone	cyproterone	NOUN	NN	B-Chemical
acetate	acetate	ADJ	JJ	I-Chemical
and	and	CCONJ	CC	O
ethinylestradiol	ethinylestradiol	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
achieve	achieve	VERB	VB	O
absolute	absolute	ADJ	JJ	O
risk	risk	NOUN	NN	O
estimates	estimate	NOUN	NNS	O
of	of	ADP	IN	O
venous	venous	ADJ	JJ	B-Disease
thromboembolism	thromboembolism	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
VTE	VTE	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
among	among	ADP	IN	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
cyproterone	cyproterone	NOUN	NN	B-Chemical
acetate	acetate	ADJ	JJ	I-Chemical
plus	plus	CCONJ	CC	O
ethinylestradiol	ethinylestradiol	NOUN	NNS	B-Chemical
(	(	PUNCT	-LRB-	O
CPA	CPA	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
EE	EE	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
among	among	ADP	IN	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
combined	combine	VERB	VBN	B-Chemical
oral	oral	ADJ	JJ	I-Chemical
contraceptives	contraceptive	NOUN	NNS	I-Chemical
(	(	PUNCT	-LRB-	O
COCs	COCs	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
From	from	ADP	IN	O
the	the	DET	DT	O
Danish	Danish	PROPN	NNP	O
National	National	PROPN	NNP	O
Register	Register	PROPN	NNP	O
of	of	ADP	IN	O
Patients	Patients	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
NRP	NRP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
1996	1996	NUM	CD	O
to	to	ADP	IN	O
1998	1998	NUM	CD	O
,	,	PUNCT	,	O
the	the	DET	DT	O
records	record	NOUN	NNS	O
of	of	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
million	million	NUM	CD	O
Danish	danish	ADJ	JJ	O
women	woman	NOUN	NNS	O
,	,	PUNCT	,	O
ages	age	VERB	VBZ	O
15	15	NUM	CD	O
to	to	PART	TO	O
44	44	NUM	CD	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
searched	search	VERB	VBN	O
for	for	ADP	IN	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
VTE	VTE	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

COC	COC	PROPN	NNP	B-Chemical
use	use	NOUN	NN	O
was	be	VERB	VBD	O
ascertained	ascertain	VERB	VBN	O
through	through	ADP	IN	O
mailed	mail	VERB	VBN	O
questionnaires	questionnaire	NOUN	NNS	O
.	.	PUNCT	.	O

Sales	sale	NOUN	NNS	O
statistics	statistic	NOUN	NNS	O
of	of	ADP	IN	O
COCs	coc	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
CPA	CPA	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
EE	EE	PROPN	NNP	B-Chemical
were	be	VERB	VBD	O
provided	provide	VERB	VBN	O
through	through	ADP	IN	O
Danish	Danish	PROPN	NNP	O
Drug	Drug	PROPN	NNP	O
Statistics	Statistics	PROPN	NNPS	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
During	during	ADP	IN	O
the	the	DET	DT	O
time	time	NOUN	NN	O
frame	frame	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
330	330	NUM	CD	O
women	woman	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
had	have	VERB	VBN	O
VTE	VTE	PROPN	NNP	B-Disease
while	while	ADP	IN	O
on	on	ADP	IN	O
COCs	coc	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

Of	of	ADP	IN	O
these	these	DET	DT	O
women	woman	NOUN	NNS	O
,	,	PUNCT	,	O
67	67	NUM	CD	O
were	be	VERB	VBD	O
on	on	ADP	IN	O
levonorgestrel	levonorgestrel	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
COCs	COCs	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Eleven	eleven	NUM	CD	O
were	be	VERB	VBD	O
on	on	ADP	IN	O
CPA	CPA	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
EE	ee	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
corresponding	correspond	VERB	VBG	O
absolute	absolute	ADJ	JJ	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
VTE	VTE	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
4	4	PUNCT	LS	O
(	(	PUNCT	-LRB-	O
range	range	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
per	per	ADP	IN	O
10	10	NUM	CD	O
000	000	NUM	CD	O
women	woman	NOUN	NNS	O
years	year	NOUN	NNS	O
among	among	ADP	IN	O
the	the	DET	DT	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
COCs	COCs	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
2	2	PUNCT	LS	O
(	(	PUNCT	-LRB-	O
range	range	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
-	-	SYM	SYM	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
per	per	ADP	IN	O
10	10	NUM	CD	O
000	000	NUM	CD	O
women	woman	NOUN	NNS	O
years	year	NOUN	NNS	O
among	among	ADP	IN	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
levonorgestrel	levonorgestrel	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
COCs	COCs	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
(	(	PUNCT	-LRB-	O
range	range	NOUN	NN	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
-	-	SYM	SYM	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
per	per	ADP	IN	O
10	10	NUM	CD	O
000	000	NUM	CD	O
women	woman	NOUN	NNS	O
years	year	NOUN	NNS	O
among	among	ADP	IN	O
the	the	DET	DT	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
CPA	CPA	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
EE	ee	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
the	the	DET	DT	O
absolute	absolute	ADJ	JJ	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
VTE	VTE	PROPN	NNP	B-Disease
among	among	ADP	IN	O
Danish	danish	ADJ	JJ	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
COCs	COCs	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
that	that	DET	DT	O
among	among	ADP	IN	O
women	woman	NOUN	NNS	O
taking	take	VERB	VBG	O
CPA	CPA	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
EE	ee	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Comparison	comparison	NOUN	NN	O
of	of	ADP	IN	O
developmental	developmental	ADJ	JJ	O
toxicology	toxicology	NOUN	NN	O
of	of	ADP	IN	O
aspirin	aspirin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
acetylsalicylic	acetylsalicylic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
using	use	VERB	VBG	O
selected	select	VERB	VBN	O
dosing	dose	VERB	VBG	O
paradigms	paradigms	NOUN	NN	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
for	for	ADP	IN	O
nonsteroidal	nonsteroidal	ADJ	JJ	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
NSAIDs	nsaid	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
a	a	DET	DT	O
low	low	ADJ	JJ	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
developmental	developmental	ADJ	JJ	B-Disease
anomalies	anomaly	NOUN	NNS	I-Disease
occurs	occur	VERB	VBZ	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
given	give	VERB	VBN	O
NSAIDs	nsaid	NOUN	NNS	O
on	on	ADP	IN	O
specific	specific	ADJ	JJ	O
days	day	NOUN	NNS	O
during	during	ADP	IN	O
organogenesis	organogenesis	NOUN	NN	O
.	.	PUNCT	.	O

Aspirin	Aspirin	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
acetylsalicylic	acetylsalicylic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
[	[	PUNCT	-LRB-	O
ASA	ASA	PROPN	NNP	B-Chemical
]	]	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
an	an	DET	DT	O
irreversible	irreversible	ADJ	JJ	O
cyclooxygenase	cyclooxygenase	NOUN	NN	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
inhibitor	inhibitor	NOUN	NN	O
,	,	PUNCT	,	O
induces	induce	VERB	VBZ	O
developmental	developmental	ADJ	JJ	B-Disease
anomalies	anomaly	NOUN	NNS	I-Disease
when	when	ADV	WRB	O
administered	administer	VERB	VBN	O
to	to	ADP	IN	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
on	on	ADP	IN	O
gestational	gestational	ADJ	JJ	O
day	day	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GD	GD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
9	9	NUM	CD	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
11	11	NUM	CD	O
(	(	PUNCT	-LRB-	O
Kimmel	Kimmel	PROPN	NNP	O
CA	CA	PROPN	NNP	O
,	,	PUNCT	,	O
Wilson	Wilson	PROPN	NNP	O
JG	JG	PROPN	NNP	O
,	,	PUNCT	,	O
Schumacher	Schumacher	PROPN	NNP	O
HJ	HJ	PROPN	NNP	O
.	.	PUNCT	.	O
Teratology	teratology	NOUN	NN	O
4	4	NUM	CD	O
:	:	PUNCT	:	O
15	15	NUM	CD	O
-	-	SYM	SYM	O
24	24	NUM	CD	O
,	,	PUNCT	,	O
1971	1971	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
are	be	VERB	VBP	O
no	no	DET	DT	O
published	publish	VERB	VBN	O
ASA	ASA	PROPN	NNP	B-Chemical
studies	study	NOUN	NNS	O
using	use	VERB	VBG	O
the	the	DET	DT	O
multiple	multiple	ADJ	JJ	O
dosing	dose	VERB	VBG	O
paradigm	paradigm	NOUN	NN	O
of	of	ADP	IN	O
GDs	gd	NOUN	NNS	O
6	6	NUM	CD	O
to	to	ADP	IN	O
17	17	NUM	CD	O
.	.	PUNCT	.	O

Objectives	objective	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
current	current	ADJ	JJ	O
study	study	NOUN	NN	O
were	be	VERB	VBD	O
to	to	PART	TO	O
compare	compare	VERB	VB	O
results	result	NOUN	NNS	O
between	between	ADP	IN	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
SD	SD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
Wistar	Wistar	PROPN	NNP	O
strains	strain	NOUN	NNS	O
when	when	ADV	WRB	O
ASA	ASA	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
administered	administer	VERB	VBN	O
on	on	ADP	IN	O
GD	GD	PROPN	NNP	O
9	9	NUM	CD	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
11	11	NUM	CD	O
;	;	PUNCT	:	O
to	to	PART	TO	O
compare	compare	VERB	VB	O
the	the	DET	DT	O
malformation	malformation	NOUN	NN	O
patterns	pattern	NOUN	NNS	O
following	follow	VERB	VBG	O
single	single	ADJ	JJ	O
and	and	CCONJ	CC	O
multiple	multiple	ADJ	JJ	O
dosings	dosing	NOUN	NNS	O
during	during	ADP	IN	O
organogenesis	organogenesis	NOUN	NN	O
in	in	ADP	IN	O
SD	SD	PROPN	NNP	O
rats	rat	NOUN	NNS	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
test	test	VERB	VB	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
that	that	ADP	IN	O
maternal	maternal	ADJ	JJ	O
gastrointestinal	gastrointestinal	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
confounds	confound	VERB	VBZ	O
the	the	DET	DT	O
detection	detection	NOUN	NN	O
of	of	ADP	IN	O
low	low	ADJ	JJ	O
incidence	incidence	NOUN	NN	O
malformations	malformation	NOUN	NNS	B-Disease
with	with	ADP	IN	O
ASA	ASA	PROPN	NNP	B-Chemical
when	when	ADV	WRB	O
a	a	DET	DT	O
multiple	multiple	ADJ	JJ	O
dosing	dose	VERB	VBG	O
paradigm	paradigm	NOUN	NN	O
is	be	VERB	VBZ	O
used	use	VERB	VBN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
ASA	ASA	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
on	on	ADP	IN	O
GD	GD	PROPN	NNP	O
9	9	NUM	CD	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
250	250	NUM	CD	O
,	,	PUNCT	,	O
500	500	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
625	625	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
500	500	NUM	CD	O
,	,	PUNCT	,	O
625	625	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
750	750	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
11	11	NUM	CD	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
500	500	NUM	CD	O
,	,	PUNCT	,	O
750	750	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
1000	1000	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
from	from	ADP	IN	O
GD	GD	PROPN	NNP	O
6	6	NUM	CD	O
to	to	ADP	IN	O
GD	GD	PROPN	NNP	O
17	17	NUM	CD	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
50	50	NUM	CD	O
,	,	PUNCT	,	O
125	125	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
250	250	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
a	a	DET	DT	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
multiple	multiple	ADJ	JJ	O
dose	dose	NOUN	NN	O
study	study	NOUN	NN	O
to	to	ADP	IN	O
SD	SD	PROPN	NNP	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Animals	animal	NOUN	NNS	O
were	be	VERB	VBD	O
killed	kill	VERB	VBN	O
on	on	ADP	IN	O
GD	GD	PROPN	NNP	O
21	21	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
fetuses	fetus	NOUN	NNS	O
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
viscerally	viscerally	ADV	RB	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
literature	literature	NOUN	NN	O
evaluation	evaluation	NOUN	NN	O
suggested	suggest	VERB	VBD	O
that	that	ADP	IN	O
NSAIDs	nsaid	NOUN	NNS	O
induce	induce	VERB	VBP	O
ventricular	ventricular	ADJ	JJ	B-Disease
septal	septal	ADJ	JJ	I-Disease
defects	defect	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
VSDs	vsd	NOUN	NNS	B-Disease
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
midline	midline	NOUN	NN	B-Disease
defects	defect	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
MDs	md	NOUN	NNS	B-Disease
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
diaphragmatic	diaphragmatic	ADJ	JJ	B-Disease
hernia	hernia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
DH	DH	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
MDs	md	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
VSDs	vsd	NOUN	NNS	B-Disease
in	in	ADP	IN	O
rabbits	rabbit	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
Cook	Cook	PROPN	NNP	O
JC	JC	PROPN	NNP	O
et	et	PROPN	NNP	O
al	al	PROPN	NNP	O
.	.	PUNCT	.	O
,	,	PUNCT	,	O
2003	2003	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
hence	hence	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
focused	focus	VERB	VBD	O
on	on	ADP	IN	O
these	these	DET	DT	O
malformations	malformation	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
even	even	ADV	RB	O
though	though	ADP	IN	O
ASA	ASA	PROPN	NNP	B-Chemical
induces	induce	VERB	VBZ	O
several	several	ADJ	JJ	O
other	other	ADJ	JJ	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
incidence	incidence	NOUN	NN	O
malformations	malformation	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
studies	study	NOUN	NNS	O
,	,	PUNCT	,	O
DH	DH	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
MD	MD	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
VSD	VSD	PROPN	NNP	B-Disease
were	be	VERB	VBD	O
induced	induce	VERB	VBN	O
on	on	ADP	IN	O
GDs	gd	NOUN	NNS	O
9	9	NUM	CD	O
and	and	CCONJ	CC	O
10	10	NUM	CD	O
.	.	PUNCT	.	O

VSD	VSD	PROPN	NNP	B-Disease
also	also	ADV	RB	O
was	be	VERB	VBD	O
noted	note	VERB	VBN	O
following	follow	VERB	VBG	O
treatment	treatment	NOUN	NN	O
on	on	ADP	IN	O
GD	GD	PROPN	NNP	O
11	11	NUM	CD	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
DH	DH	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
MD	MD	PROPN	NNP	B-Disease
were	be	VERB	VBD	O
noted	note	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
multiple	multiple	ADJ	JJ	O
dose	dose	NOUN	NN	O
study	study	NOUN	NN	O
design	design	NOUN	NN	O
only	only	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
VSD	VSD	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
noted	note	VERB	VBN	O
across	across	ADP	IN	O
all	all	DET	DT	O
dose	dose	NOUN	NN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
High	high	ADJ	JJ	O
concordance	concordance	NOUN	NN	O
in	in	ADP	IN	O
major	major	ADJ	JJ	O
developmental	developmental	ADJ	JJ	B-Disease
anomalies	anomaly	NOUN	NNS	I-Disease
between	between	ADP	IN	O
Wistar	Wistar	PROPN	NNP	O
and	and	CCONJ	CC	O
SD	SD	PROPN	NNP	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
noted	note	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
exception	exception	NOUN	NN	O
of	of	ADP	IN	O
VSD	VSD	PROPN	NNP	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
SD	sd	NOUN	NN	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
hydrocephalus	hydrocephalus	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Variations	variation	NOUN	NNS	O
and	and	CCONJ	CC	O
malformations	malformation	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
when	when	ADV	WRB	O
ASA	ASA	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
or	or	CCONJ	CC	O
during	during	ADP	IN	O
the	the	DET	DT	O
period	period	NOUN	NN	O
of	of	ADP	IN	O
organogenesis	organogenesis	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GDs	gd	NOUN	NNS	O
6	6	NUM	CD	O
to	to	ADP	IN	O
17	17	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
also	also	ADV	RB	O
evident	evident	ADJ	JJ	O
that	that	ADP	IN	O
,	,	PUNCT	,	O
by	by	ADP	IN	O
titrating	titrate	VERB	VBG	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
to	to	PART	TO	O
achieve	achieve	VERB	VB	O
a	a	DET	DT	O
maximum	maximum	ADJ	JJ	O
tolerated	tolerate	VERB	VBN	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
malformations	malformation	NOUN	NNS	B-Disease
that	that	DET	WDT	O
normally	normally	ADV	RB	O
occur	occur	VERB	VBP	O
at	at	ADP	IN	O
low	low	ADJ	JJ	O
incidence	incidence	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
reported	report	VERB	VBN	O
from	from	ADP	IN	O
previous	previous	ADJ	JJ	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
studies	study	NOUN	NNS	O
,	,	PUNCT	,	O
could	could	VERB	MD	O
also	also	ADV	RB	O
be	be	VERB	VB	O
induced	induce	VERB	VBN	O
with	with	ADP	IN	O
ASA	ASA	PROPN	NNP	B-Chemical
given	give	VERB	VBN	O
at	at	ADP	IN	O
multiple	multiple	ADJ	JJ	O
doses	dose	NOUN	NNS	O
.	.	PUNCT	.	O

Reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
central	central	ADJ	JJ	O
benzodiazepine	benzodiazepine	ADJ	JJ	B-Chemical
effects	effect	NOUN	NNS	O
by	by	ADP	IN	O
flumazenil	flumazenil	NOUN	NN	B-Chemical
after	after	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
conscious	conscious	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
with	with	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
opioids	opioid	NOUN	NNS	O
:	:	PUNCT	:	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
multicenter	multicenter	NOUN	NN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
Flumazenil	Flumazenil	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
Intravenous	Intravenous	PROPN	NNP	O
Conscious	Conscious	PROPN	NNP	O
Sedation	Sedation	PROPN	NNP	O
with	with	ADP	IN	O
Diazepam	Diazepam	PROPN	NNP	B-Chemical
Multicenter	Multicenter	PROPN	NNP	O
Study	Study	PROPN	NNP	O
Group	Group	PROPN	NNP	O
II	II	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
benzodiazepine	benzodiazepine	NOUN	NN	B-Chemical
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
flumazenil	flumazenil	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
multicenter	multicenter	NOUN	NN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Flumazenil	Flumazenil	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
76	76	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
ml	ml	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
intravenously	intravenously	ADV	RB	O
to	to	ADP	IN	O
130	130	NUM	CD	O
and	and	CCONJ	CC	O
67	67	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
given	give	VERB	VBN	O
diazepam	diazepam	NOUN	NN	B-Chemical
in	in	ADP	IN	O
conjunction	conjunction	NOUN	NN	O
with	with	ADP	IN	O
an	an	DET	DT	O
opioid	opioid	NOUN	NN	O
(	(	PUNCT	-LRB-	O
fentanyl	fentanyl	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
meperidine	meperidine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
morphine	morphine	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
the	the	DET	DT	O
induction	induction	NOUN	NN	O
and	and	CCONJ	CC	O
maintenance	maintenance	NOUN	NN	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
conscious	conscious	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
for	for	ADP	IN	O
diagnostic	diagnostic	ADJ	JJ	O
or	or	CCONJ	CC	O
therapeutic	therapeutic	ADJ	JJ	O
surgical	surgical	ADJ	JJ	O
procedures	procedure	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
group	group	NOUN	NN	O
assessable	assessable	ADJ	JJ	O
for	for	ADP	IN	O
efficacy	efficacy	NOUN	NN	O
comprised	comprise	VERB	VBN	O
122	122	NUM	CD	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
flumazenil	flumazenil	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
64	64	NUM	CD	O
patients	patient	NOUN	NNS	O
given	give	VERB	VBN	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
5	5	NUM	CD	O
minutes	minute	NOUN	NNS	O
,	,	PUNCT	,	O
80	80	NUM	CD	O
/	/	SYM	SYM	O
115	115	NUM	CD	O
(	(	PUNCT	-LRB-	O
70	70	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
flumazenil	flumazenil	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
21	21	NUM	CD	O
/	/	SYM	SYM	O
63	63	NUM	CD	O
(	(	PUNCT	-LRB-	O
33	33	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
completely	completely	ADV	RB	O
awake	awake	ADJ	JJ	O
and	and	CCONJ	CC	O
alert	alert	ADJ	JJ	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
indicated	indicate	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
score	score	NOUN	NN	O
of	of	ADP	IN	O
5	5	NUM	CD	O
on	on	ADP	IN	O
the	the	DET	DT	O
Observer	Observer	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	PART	POS	O
Assessment	Assessment	PROPN	NNP	O
of	of	ADP	IN	O
Alertness	Alertness	PROPN	NNP	O
/	/	SYM	SYM	O
Sedation	Sedation	PROPN	NNP	O
Scale	Scale	PROPN	NNP	O
.	.	PUNCT	.	O

Ninety	ninety	NUM	CD	O
-	-	PUNCT	HYPH	O
five	five	NUM	CD	O
percent	percent	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
each	each	DET	DT	O
group	group	NOUN	NN	O
who	who	PRON	WP	O
attained	attain	VERB	VBD	O
a	a	DET	DT	O
score	score	NOUN	NN	O
of	of	ADP	IN	O
5	5	NUM	CD	O
at	at	ADP	IN	O
the	the	DET	DT	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
minute	minute	NOUN	NN	O
assessment	assessment	NOUN	NN	O
showed	show	VERB	VBD	O
no	no	DET	DT	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
alertness	alertness	NOUN	NN	O
throughout	throughout	ADP	IN	O
the	the	DET	DT	O
180	180	NUM	CD	O
-	-	PUNCT	HYPH	O
minute	minute	NOUN	NN	O
assessment	assessment	NOUN	NN	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

Flumazenil	Flumazenil	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
also	also	ADV	RB	O
performed	perform	VERB	VBD	O
significantly	significantly	ADV	RB	O
better	better	ADV	RBR	O
on	on	ADP	IN	O
the	the	DET	DT	O
Finger	Finger	PROPN	NNP	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
Nose	nose	NOUN	NN	O
Test	Test	PROPN	NNP	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
recall	recall	NOUN	NN	O
of	of	ADP	IN	O
pictures	picture	NOUN	NNS	O
shown	show	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
minute	minute	NOUN	NN	O
assessment	assessment	NOUN	NN	O
.	.	PUNCT	.	O

Flumazenil	Flumazenil	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
no	no	DET	DT	O
serious	serious	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

Thirty	thirty	NUM	CD	O
-	-	PUNCT	HYPH	O
nine	nine	NUM	CD	O
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
flumazenil	flumazenil	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
17	17	NUM	CD	O
(	(	PUNCT	-LRB-	O
25	25	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
one	one	NUM	CD	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
adverse	adverse	ADJ	JJ	O
experiences	experience	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
were	be	VERB	VBD	O
nausea	nausea	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
vomiting	vomiting	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
flumazenil	flumazenil	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
and	and	CCONJ	CC	O
nausea	nausea	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
injection	injection	NOUN	NN	O
-	-	PUNCT	HYPH	O
site	site	NOUN	NN	O
pain	pain	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Flumazenil	Flumazenil	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
promptly	promptly	ADV	RB	O
reverse	reverse	VERB	VB	O
sedation	sedation	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
opioids	opioid	NOUN	NNS	O
.	.	PUNCT	.	O

Methylphenidate	methylphenidate	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
obsessive	obsessive	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
compulsive	compulsive	ADJ	JJ	I-Disease
symptoms	symptom	NOUN	NNS	I-Disease
in	in	ADP	IN	O
an	an	DET	DT	O
elderly	elderly	ADJ	JJ	O
man	man	NOUN	NN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
82	82	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
with	with	ADP	IN	O
treatment	treatment	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
resistant	resistant	ADJ	JJ	I-Disease
depression	depression	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
early	early	ADJ	JJ	O
Alzheimer	Alzheimer	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
was	be	VERB	VBD	O
started	start	VERB	VBN	O
on	on	ADP	IN	O
methylphenidate	methylphenidate	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

Significant	significant	ADJ	JJ	O
obsessive	obsessive	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
compulsive	compulsive	ADJ	JJ	I-Disease
behavior	behavior	NOUN	NN	I-Disease
ensued	ensue	VERB	VBN	O
but	but	CCONJ	CC	O
diminished	diminish	VERB	VBN	O
over	over	ADP	IN	O
several	several	ADJ	JJ	O
weeks	week	NOUN	NNS	O
when	when	ADV	WRB	O
methylphenidate	methylphenidate	ADJ	JJ	B-Chemical
was	be	VERB	VBD	O
replaced	replace	VERB	VBN	O
by	by	ADP	IN	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
no	no	DET	DT	O
prior	prior	ADJ	JJ	O
psychiatric	psychiatric	ADJ	JJ	B-Disease
history	history	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
he	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
a	a	DET	DT	O
sister	sister	NOUN	NN	O
with	with	ADP	IN	O
obsessive	obsessive	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
compulsive	compulsive	ADJ	JJ	I-Disease
disorder	disorder	NOUN	NN	I-Disease
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
appears	appear	VERB	VBZ	O
that	that	ADP	IN	O
methylphenidate	methylphenidate	ADJ	JJ	B-Chemical
precipitated	precipitate	VERB	VBD	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	PART	POS	O
pathological	pathological	ADJ	JJ	O
behavior	behavior	NOUN	NN	O
.	.	PUNCT	.	O

Ciprofloxacin	Ciprofloxacin	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
acute	acute	ADJ	JJ	O
interstitial	interstitial	ADJ	JJ	B-Disease
nephritis	nephritis	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
autoimmune	autoimmune	ADJ	JJ	B-Disease
hemolytic	hemolytic	ADJ	JJ	I-Disease
anemia	anemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Ciprofloxacin	Ciprofloxacin	PROPN	NNP	B-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
several	several	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
including	include	VERB	VBG	O
interstitial	interstitial	ADJ	JJ	B-Disease
nephritis	nephritis	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
combination	combination	NOUN	NN	O
of	of	ADP	IN	O
both	both	DET	DT	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
is	be	VERB	VBZ	O
extremely	extremely	ADV	RB	O
rare	rare	ADJ	JJ	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
report	report	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
ciprofloxacin	ciprofloxacin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
interstitial	interstitial	ADJ	JJ	B-Disease
nephritis	nephritis	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
autoimmune	autoimmune	ADJ	JJ	B-Disease
hemolytic	hemolytic	ADJ	JJ	I-Disease
anemia	anemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
improved	improve	VERB	VBN	O
after	after	ADP	IN	O
stopping	stop	VERB	VBG	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
and	and	CCONJ	CC	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
steroid	steroid	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Unfortunately	unfortunately	ADV	RB	O
,	,	PUNCT	,	O
acute	acute	ADJ	JJ	O
interstitial	interstitial	ADJ	JJ	B-Disease
nephritis	nephritis	NOUN	NN	I-Disease
was	be	VERB	VBD	O
irreversible	irreversible	ADJ	JJ	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
developed	develop	VERB	VBN	O
end	end	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
stage	stage	NOUN	NN	I-Disease
renal	renal	ADJ	JJ	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Potential	potential	ADJ	JJ	O
deleterious	deleterious	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
furosemide	furosemide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
radiocontrast	radiocontrast	NOUN	NN	O
nephropathy	nephropathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
purpose	purpose	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
furosemide	furosemide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
addition	addition	NOUN	NN	O
to	to	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
fluids	fluid	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
radiocontrast	radiocontrast	NOUN	NN	O
nephropathy	nephropathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

18	18	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
referred	refer	VERB	VBD	O
to	to	ADP	IN	O
a	a	DET	DT	O
radiocontrast	radiocontrast	NOUN	NN	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
considered	consider	VERB	VBN	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
because	because	ADP	IN	O
of	of	ADP	IN	O
preexisting	preexist	VERB	VBG	O
renal	renal	ADJ	JJ	B-Disease
insufficiency	insufficiency	NOUN	NN	I-Disease
,	,	PUNCT	,	O
were	be	VERB	VBD	O
enrolled	enrol	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
controlled	control	VERB	VBN	O
trial	trial	NOUN	NN	O
,	,	PUNCT	,	O
performed	perform	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
secondary	secondary	ADJ	JJ	O
care	care	NOUN	NN	O
center	center	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
100	100	NUM	CD	O
-	-	PUNCT	HYPH	O
bed	bed	NOUN	NN	O
private	private	ADJ	JJ	O
university	university	NOUN	NN	O
hospital	hospital	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
to	to	ADP	IN	O
fluids	fluid	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
group	group	NOUN	NN	O
received	receive	VERB	VBD	O
furosemide	furosemide	ADV	RB	B-Chemical
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
dose	dose	NOUN	NN	O
110	110	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
intravenously	intravenously	ADV	RB	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
the	the	DET	DT	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
contrast	contrast	NOUN	NN	O
material	material	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
received	receive	VERB	VBD	O
fluids	fluid	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
3	3	NUM	CD	O
liters	liter	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Radiological	radiological	ADJ	JJ	O
studies	study	NOUN	NNS	O
were	be	VERB	VBD	O
mostly	mostly	ADV	RB	O
angiographies	angiography	NOUN	NNS	O
performed	perform	VERB	VBN	O
with	with	ADP	IN	O
both	both	CCONJ	CC	O
ionic	ionic	ADJ	JJ	O
and	and	CCONJ	CC	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
ionic	ionic	ADJ	JJ	O
contrast	contrast	NOUN	NN	O
material	material	NOUN	NN	O
,	,	PUNCT	,	O
at	at	ADP	IN	O
an	an	DET	DT	O
average	average	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
245	245	NUM	CD	O
ml	ml	NOUN	NNS	O
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	B-Disease
function	function	NOUN	NN	I-Disease
significantly	significantly	ADV	RB	I-Disease
deteriorated	deteriorate	VERB	VBN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
group	group	NOUN	NN	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
furosemide	furosemide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
005	005	NUM	CD	O
by	by	ADP	IN	O
ANOVA	ANOVA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
a	a	DET	DT	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
from	from	ADP	IN	O
145	145	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
13	13	NUM	CD	O
to	to	PART	TO	O
182	182	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
16	16	NUM	CD	O
mumol	mumol	NOUN	NN	O
/	/	SYM	SYM	O
l	l	NOUN	NN	O
at	at	ADP	IN	O
24	24	NUM	CD	O
h	h	NOUN	NN	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
no	no	DET	DT	O
change	change	NOUN	NN	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
from	from	ADP	IN	O
141	141	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
6	6	NUM	CD	O
to	to	ADP	IN	O
142	142	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
mumol	mumol	NOUN	NN	O
/	/	SYM	SYM	O
l	l	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
weight	weight	NOUN	NN	B-Disease
loss	loss	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
furosemide	furosemide	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Furosemide	furosemide	ADV	RB	B-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
deleterious	deleterious	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
radiocontrast	radiocontrast	NOUN	NN	O
nephropathy	nephropathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Progestational	progestational	ADJ	JJ	O
agents	agent	NOUN	NNS	O
and	and	CCONJ	CC	O
blood	blood	NOUN	NN	B-Disease
coagulation	coagulation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

VII	VII	PROPN	NNP	O
.	.	PUNCT	.	O

Thromboembolic	thromboembolic	ADJ	JJ	B-Disease
and	and	CCONJ	CC	O
other	other	ADJ	JJ	O
complications	complication	NOUN	NNS	O
of	of	ADP	IN	O
oral	oral	ADJ	JJ	B-Chemical
contraceptive	contraceptive	ADJ	JJ	I-Chemical
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
relationship	relationship	NOUN	NN	O
to	to	ADP	IN	O
pretreatment	pretreatment	ADJ	JJ	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	B-Disease
coagulation	coagulation	NOUN	NN	I-Disease
factors	factor	NOUN	NNS	O
:	:	PUNCT	:	O
summary	summary	NOUN	NN	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
ten	ten	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
a	a	DET	DT	O
ten	ten	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
348	348	NUM	CD	O
women	woman	NOUN	NNS	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
for	for	ADP	IN	O
a	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
877	877	NUM	CD	O
patient	patient	ADJ	JJ	O
months	month	NOUN	NNS	O
in	in	ADP	IN	O
four	four	NUM	CD	O
separate	separate	ADJ	JJ	O
studies	study	NOUN	NNS	O
relating	relate	VERB	VBG	O
oral	oral	ADJ	JJ	B-Chemical
contraceptives	contraceptive	NOUN	NNS	I-Chemical
to	to	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
hematologic	hematologic	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
.	.	PUNCT	.	O

Significant	significant	ADJ	JJ	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
certain	certain	ADJ	JJ	O
factors	factor	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
blood	blood	NOUN	NN	B-Disease
coagulation	coagulation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
fibrinolysin	fibrinolysin	NOUN	NN	O
systems	system	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
factors	factor	NOUN	NNS	O
I	-PRON-	PRON	PRP	O
,	,	PUNCT	,	O
II	II	PROPN	NNP	O
,	,	PUNCT	,	O
VII	VII	PROPN	NNP	O
,	,	PUNCT	,	O
VIII	VIII	PROPN	NNP	O
,	,	PUNCT	,	O
IX	IX	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
X	x	NOUN	NN	O
and	and	CCONJ	CC	O
plasminogen	plasminogen	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treated	treated	ADJ	JJ	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Severe	severe	ADJ	JJ	O
complications	complication	NOUN	NNS	O
developed	develop	VERB	VBD	O
in	in	ADP	IN	O
four	four	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

All	all	DET	DT	O
four	four	NUM	CD	O
had	have	VERB	VBD	O
an	an	DET	DT	O
abnormal	abnormal	ADJ	JJ	O
blood	blood	NOUN	NN	B-Disease
coagulation	coagulation	NOUN	NN	I-Disease
profile	profile	NOUN	NN	O
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
"	"	PUNCT	``	O
hypercoagulability	hypercoagulability	NOUN	NN	B-Disease
"	"	PUNCT	''	O
before	before	ADP	IN	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Some	some	DET	DT	O
of	of	ADP	IN	O
these	these	DET	DT	O
findings	finding	NOUN	NNS	O
represented	represent	VERB	VBD	O
the	the	DET	DT	O
most	most	ADV	RBS	O
extreme	extreme	ADJ	JJ	O
abnormalities	abnormality	NOUN	NNS	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
entire	entire	ADJ	JJ	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
;	;	PUNCT	:	O
some	some	DET	DT	O
increased	increase	VERB	VBD	O
further	further	ADV	RB	O
during	during	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
of	of	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
a	a	DET	DT	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
before	before	ADP	IN	O
receiving	receive	VERB	VBG	O
any	any	DET	DT	O
medication	medication	NOUN	NN	O
,	,	PUNCT	,	O
shortly	shortly	ADV	RB	O
after	after	ADP	IN	O
the	the	DET	DT	O
base	base	NOUN	NN	O
-	-	PUNCT	HYPH	O
line	line	NOUN	NN	O
values	value	NOUN	NNS	O
were	be	VERB	VBD	O
obtained	obtain	VERB	VBN	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
patient	patient	NOUN	NN	O
developed	develop	VERB	VBD	O
retinopathy	retinopathy	ADJ	JJ	B-Disease
19	19	NUM	CD	O
months	month	NOUN	NNS	O
after	after	ADP	IN	O
she	-PRON-	PRON	PRP	O
began	begin	VERB	VBD	O
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
another	another	DET	DT	O
developed	develop	VERB	VBN	O
thrombophlebitis	thrombophlebitis	NOUN	NN	B-Disease
after	after	ADP	IN	O
27	27	NUM	CD	O
months	month	NOUN	NNS	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
fourth	fourth	ADJ	JJ	O
patient	patient	NOUN	NN	O
developed	develop	VERB	VBN	O
thrombophlebitis	thrombophlebitis	NOUN	NN	B-Disease
14	14	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
contraceptive	contraceptive	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
four	four	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
of	of	ADP	IN	O
the	the	DET	DT	O
A	a	NOUN	NN	O
or	or	CCONJ	CC	O
AB	AB	PROPN	NNP	O
blood	blood	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Previous	previous	ADJ	JJ	O
studies	study	NOUN	NNS	O
suggested	suggest	VERB	VBD	O
the	the	DET	DT	O
possiblility	possiblility	NOUN	NN	O
of	of	ADP	IN	O
increased	increase	VERB	VBN	O
propensity	propensity	NOUN	NN	O
for	for	ADP	IN	O
thromboembolic	thromboembolic	ADJ	JJ	B-Disease
episodes	episode	NOUN	NNS	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
possessing	possess	VERB	VBG	O
the	the	DET	DT	O
A	A	PROPN	NNP	O
antigen	antigen	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
appears	appear	VERB	VBZ	O
from	from	ADP	IN	O
these	these	DET	DT	O
data	datum	NOUN	NNS	O
that	that	DET	WDT	O
hematologic	hematologic	ADJ	JJ	O
work	work	NOUN	NN	O
-	-	PUNCT	HYPH	O
ups	up	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
useful	useful	ADJ	JJ	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
who	who	PRON	WP	O
are	be	VERB	VBP	O
about	about	ADJ	JJ	O
to	to	PART	TO	O
start	start	VERB	VB	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
oral	oral	ADJ	JJ	B-Chemical
contraceptive	contraceptive	NOUN	NN	I-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Orthostatic	orthostatic	ADJ	JJ	B-Disease
hypotension	hypotension	NOUN	NN	I-Disease
occurs	occur	VERB	VBZ	O
following	follow	VERB	VBG	O
alpha	alpha	NOUN	NN	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
blockade	blockade	NOUN	NN	O
in	in	ADP	IN	O
chronic	chronic	ADJ	JJ	O
prazosin	prazosin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
pretreated	pretreate	VERB	VBN	O
conscious	conscious	ADJ	JJ	O
spontaneously	spontaneously	ADV	RB	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

1	1	PUNCT	LS	O
.	.	PUNCT	.	O

Studies	study	NOUN	NNS	O
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
whether	whether	ADP	IN	O
chronic	chronic	ADJ	JJ	O
prazosin	prazosin	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
alters	alter	NOUN	NNS	O
the	the	DET	DT	O
alpha	alpha	NOUN	NN	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
function	function	NOUN	NN	O
for	for	ADP	IN	O
orthostatic	orthostatic	ADJ	JJ	O
control	control	NOUN	NN	O
of	of	ADP	IN	O
arterial	arterial	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
in	in	ADP	IN	O
conscious	conscious	ADJ	JJ	O
spontaneously	spontaneously	ADV	RB	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
SHR	SHR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

2	2	PUNCT	LS	O
.	.	PUNCT	.	O

Conscious	conscious	ADJ	JJ	O
SHR	SHR	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
male	male	ADJ	JJ	O
300	300	NUM	CD	O
-	-	SYM	SYM	O
350	350	NUM	CD	O
g	g	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
subjected	subject	VERB	VBN	O
to	to	ADP	IN	O
90	90	NUM	CD	O
degrees	degree	NOUN	NNS	O
head	head	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
tilts	tilt	NOUN	NNS	O
for	for	ADP	IN	O
60	60	NUM	CD	O
s	s	NOUN	NNS	O
following	follow	VERB	VBG	O
acute	acute	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
prazosin	prazosin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
rauwolscine	rauwolscine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Orthostatic	orthostatic	ADJ	JJ	B-Disease
hypotension	hypotension	NOUN	NN	I-Disease
was	be	VERB	VBD	O
determined	determine	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
average	average	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
(	(	PUNCT	-LRB-	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
mean	mean	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MAP	MAP	PROPN	NNP	O
femoral	femoral	NOUN	NN	O
)	)	PUNCT	-RRB-	O
over	over	ADP	IN	O
the	the	DET	DT	O
60	60	NUM	CD	O
-	-	PUNCT	HYPH	O
s	s	NOUN	NN	O
tilt	tilt	NOUN	NN	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
basal	basal	NOUN	NN	O
MAP	MAP	PROPN	NNP	O
of	of	ADP	IN	O
conscious	conscious	ADJ	JJ	O
SHR	SHR	PROPN	NNP	O
was	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
to	to	ADP	IN	O
a	a	DET	DT	O
similar	similar	ADJ	JJ	O
extent	extent	NOUN	NN	O
by	by	ADP	IN	O
prazosin	prazosin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
23	23	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
26	26	NUM	CD	O
%	%	NOUN	NN	O
MAP	MAP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
rauwolscine	rauwolscine	VERB	VB	B-Chemical
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
16	16	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
33	33	NUM	CD	O
%	%	NOUN	NN	O
MAP	MAP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
head	head	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
tilt	tilt	NOUN	NN	O
induced	induce	VERB	VBD	O
orthostatic	orthostatic	ADJ	JJ	B-Disease
hypotension	hypotension	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
SHR	SHR	PROPN	NNP	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
prazosin	prazosin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
16	16	NUM	CD	O
%	%	NOUN	NN	O
MAP	MAP	PROPN	NNP	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
SHR	SHR	PROPN	NNP	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
rauwolscine	rauwolscine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
+	+	SYM	SYM	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
MAP	MAP	PROPN	NNP	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

3	3	PUNCT	LS	O
.	.	PUNCT	.	O

Conscious	conscious	ADJ	JJ	O
SHR	SHR	PROPN	NNP	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
for	for	ADP	IN	O
4	4	NUM	CD	O
days	day	NOUN	NNS	O
with	with	ADP	IN	O
prazosin	prazosin	NOUN	NN	B-Chemical
at	at	ADP	IN	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
day	day	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
for	for	ADP	IN	O
chronic	chronic	ADJ	JJ	O
alpha	alpha	NOUN	NN	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
blockade	blockade	NOUN	NN	O
.	.	PUNCT	.	O

MAP	MAP	PROPN	NNP	O
in	in	ADP	IN	O
conscious	conscious	ADJ	JJ	O
SHR	SHR	PROPN	NNP	O
after	after	ADP	IN	O
chronic	chronic	ADJ	JJ	O
prazosin	prazosin	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
was	be	VERB	VBD	O
14	14	NUM	CD	O
%	%	NOUN	NN	O
lower	low	ADJ	JJR	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
untreated	untreated	ADJ	JJ	O
SHR	SHR	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Head	Head	PROPN	NNP	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
tilts	tilt	NOUN	NNS	O
in	in	ADP	IN	O
these	these	DET	DT	O
rats	rat	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
produce	produce	VERB	VB	O
orthostatic	orthostatic	ADJ	JJ	B-Disease
hypotension	hypotension	NOUN	NN	I-Disease
when	when	ADV	WRB	O
performed	perform	VERB	VBN	O
either	either	CCONJ	CC	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
or	or	CCONJ	CC	O
after	after	ADP	IN	O
acute	acute	ADJ	JJ	O
dosing	dosing	NOUN	NN	O
of	of	ADP	IN	O
prazosin	prazosin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Conversely	conversely	ADV	RB	O
,	,	PUNCT	,	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
rauwolscine	rauwolscine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
chronic	chronic	ADJ	JJ	O
prazosin	prazosin	NOUN	NN	B-Chemical
treated	treat	VERB	VBD	O
SHR	SHR	PROPN	NNP	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
basal	basal	NOUN	NN	O
MAP	MAP	PROPN	NNP	O
by	by	ADP	IN	O
12	12	NUM	CD	O
-	-	SYM	SYM	O
31	31	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
4	4	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
subsequent	subsequent	ADJ	JJ	O
tilts	tilt	NOUN	NNS	O
induced	induce	VERB	VBD	O
further	further	ADJ	JJ	O
drops	drop	NOUN	NNS	O
of	of	ADP	IN	O
MAP	MAP	PROPN	NNP	O
by	by	ADP	IN	O
19	19	NUM	CD	O
-	-	SYM	SYM	O
23	23	NUM	CD	O
%	%	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

4	4	PUNCT	LS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
pressor	pressor	NOUN	NN	O
responses	response	NOUN	NNS	O
and	and	CCONJ	CC	O
bradycardia	bradycardia	NOUN	NNS	B-Disease
to	to	ADP	IN	O
the	the	DET	DT	O
alpha	alpha	NOUN	NN	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
agonist	agonist	NOUN	NN	O
cirazoline	cirazoline	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
alpha	alpha	NOUN	NN	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
agonist	agonist	NOUN	NN	O
Abbott	Abbott	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
53693	53693	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
noradrenaline	noradrenaline	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
determined	determine	VERB	VBN	O
in	in	ADP	IN	O
conscious	conscious	ADJ	JJ	O
SHR	SHR	PROPN	NNP	O
with	with	ADP	IN	O
and	and	CCONJ	CC	O
without	without	ADP	IN	O
chronic	chronic	ADJ	JJ	O
prazosin	prazosin	NOUN	NN	B-Chemical
pretreatment	pretreatment	NOUN	NN	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
the	the	DET	DT	O
pressor	pressor	NOUN	NN	O
and	and	CCONJ	CC	O
bradycardia	bradycardia	NOUN	NN	B-Disease
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
cirazoline	cirazoline	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
abolished	abolish	VERB	VBN	O
in	in	ADP	IN	O
chronic	chronic	ADJ	JJ	O
prazosin	prazosin	NOUN	NN	B-Chemical
treated	treat	VERB	VBD	O
SHR	SHR	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
4	4	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
untreated	untreated	ADJ	JJ	O
SHR	SHR	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
4	4	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
hand	hand	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
pressor	pressor	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
Abbott	Abbott	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
53693	53693	NUM	CD	I-Chemical
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
SHR	SHR	PROPN	NNP	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
accompanying	accompany	VERB	VBG	O
bradycardia	bradycardia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
greater	great	ADJ	JJR	O
in	in	ADP	IN	O
SHR	SHR	PROPN	NNP	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	O
prazosin	prazosin	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
than	than	ADP	IN	O
without	without	ADP	IN	O
such	such	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
bradycardia	bradycardia	NOUN	NN	B-Disease
that	that	DET	WDT	O
accompanied	accompany	VERB	VBD	O
the	the	DET	DT	O
noradrenaline	noradrenaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
pressor	pressor	NOUN	NN	O
effect	effect	NOUN	NN	O
in	in	ADP	IN	O
SHR	SHR	PROPN	NNP	O
was	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
with	with	ADP	IN	O
and	and	CCONJ	CC	O
without	without	ADP	IN	O
chronic	chronic	ADJ	JJ	O
prazosin	prazosin	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
despite	despite	ADP	IN	O
a	a	DET	DT	O
47	47	NUM	CD	O
-	-	SYM	SYM	O
71	71	NUM	CD	O
%	%	NOUN	NN	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
pressor	pressor	NOUN	NN	O
effect	effect	NOUN	NN	O
in	in	ADP	IN	O
chronic	chronic	ADJ	JJ	O
alpha	alpha	NOUN	NN	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
receptor	receptor	NOUN	NN	O
blocked	block	VERB	VBN	O
SHR	SHR	PROPN	NNP	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
ABSTRACT	ABSTRACT	PROPN	NNP	O
TRUNCATED	truncated	NUM	CD	O
AT	at	ADP	IN	O
400	400	NUM	CD	O
WORDS	word	NOUN	NNS	O
)	)	PUNCT	-RRB-	O

Hemolytic	hemolytic	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
uremic	uremic	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
ingestion	ingestion	NOUN	NN	O
of	of	ADP	IN	O
quinine	quinine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Hemolytic	hemolytic	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
uremic	uremic	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
quinine	quinine	NOUN	NN	B-Chemical
ingestion	ingestion	NOUN	NN	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
newly	newly	ADV	RB	O
described	describe	VERB	VBN	O
phenomenon	phenomenon	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
just	just	ADV	RB	O
two	two	NUM	CD	O
previous	previous	ADJ	JJ	O
descriptions	description	NOUN	NNS	O
of	of	ADP	IN	O
4	4	NUM	CD	O
cases	case	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
a	a	DET	DT	O
5th	5th	ADJ	JJ	O
case	case	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
reaction	reaction	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
antibodies	antibody	NOUN	NNS	O
reactive	reactive	ADJ	JJ	O
against	against	ADP	IN	O
platelets	platelet	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
quinine	quinine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
has	have	VERB	VBZ	O
included	include	VERB	VBN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
exchange	exchange	NOUN	NN	O
,	,	PUNCT	,	O
prednisone	prednisone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
aspirin	aspirin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
dipyridamole	dipyridamole	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
patients	patient	NOUN	NNS	O
have	have	VERB	VBP	O
all	all	DET	DT	O
regained	regain	VERB	VBN	O
some	some	DET	DT	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
unclear	unclear	ADJ	JJ	O
whether	whether	ADP	IN	O
pharmacological	pharmacological	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
or	or	CCONJ	CC	O
spontaneous	spontaneous	ADJ	JJ	O
resolution	resolution	NOUN	NN	O
is	be	VERB	VBZ	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
improvement	improvement	NOUN	NN	O
.	.	PUNCT	.	O

Quinine	Quinine	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
uremic	uremic	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
probably	probably	ADV	RB	O
occurs	occur	VERB	VBZ	O
more	more	ADV	RBR	O
often	often	ADV	RB	O
than	than	ADP	IN	O
is	be	VERB	VBZ	O
recognized	recognize	VERB	VBN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
important	important	ADJ	JJ	O
to	to	PART	TO	O
recognize	recognize	VERB	VB	O
this	this	DET	DT	O
reaction	reaction	NOUN	NN	O
when	when	ADV	WRB	O
it	-PRON-	PRON	PRP	O
occurs	occur	VERB	VBZ	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
avoid	avoid	VERB	VB	O
further	further	ADJ	JJ	O
quinine	quinine	NOUN	NN	B-Chemical
exposure	exposure	NOUN	NN	O
,	,	PUNCT	,	O
since	since	ADP	IN	O
the	the	DET	DT	O
reaction	reaction	NOUN	NN	O
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
recurrent	recurrent	ADJ	JJ	O
.	.	PUNCT	.	O

Amnestic	amnestic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
propranolol	propranolol	NOUN	NN	B-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
:	:	PUNCT	:	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
elderly	elderly	ADJ	JJ	O
woman	woman	NOUN	NN	O
developed	develop	VERB	VBD	O
an	an	DET	DT	O
Alzheimer	Alzheimer	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
subacute	subacute	NOUN	NN	O
dementia	dementia	NOUN	NN	B-Disease
as	as	ADP	IN	O
a	a	DET	DT	O
result	result	NOUN	NN	O
of	of	ADP	IN	O
propranolol	propranolol	NOUN	NN	B-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
manifestations	manifestation	NOUN	NNS	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
severe	severe	ADJ	JJ	O
impairment	impairment	NOUN	NN	O
of	of	ADP	IN	O
memory	memory	NOUN	NN	O
accounted	account	VERB	VBD	O
for	for	ADP	IN	O
virtually	virtually	ADV	RB	O
all	all	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
abnormalities	abnormality	NOUN	NNS	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
is	be	VERB	VBZ	O
evidence	evidence	NOUN	NN	O
that	that	ADP	IN	O
cerebral	cerebral	ADJ	JJ	O
reactions	reaction	NOUN	NNS	O
to	to	ADP	IN	O
drug	drug	NOUN	NN	O
toxicity	toxicity	NOUN	NN	B-Disease
can	can	VERB	MD	O
exhibit	exhibit	VERB	VB	O
patterns	pattern	NOUN	NNS	O
that	that	DET	WDT	O
suggest	suggest	VERB	VBP	O
highly	highly	ADV	RB	O
selective	selective	ADJ	JJ	O
involvement	involvement	NOUN	NN	O
of	of	ADP	IN	O
functional	functional	ADJ	JJ	O
subdivisions	subdivision	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
.	.	PUNCT	.	O

Cefotetan	Cefotetan	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
immune	immune	ADJ	JJ	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Immune	Immune	PROPN	NNP	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
a	a	DET	DT	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
adsorption	adsorption	NOUN	NN	O
mechanism	mechanism	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
described	describe	VERB	VBN	O
primarily	primarily	ADV	RB	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
penicillins	penicillin	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
first	first	ADJ	JJ	O
-	-	PUNCT	HYPH	O
generation	generation	NOUN	NN	O
cephalosporins	cephalosporin	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
anemia	anemia	NOUN	NN	B-Disease
while	while	ADP	IN	O
receiving	receive	VERB	VBG	O
intravenous	intravenous	ADJ	JJ	O
cefotetan	cefotetan	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Cefotetan	cefotetan	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
antibodies	antibody	NOUN	NNS	O
were	be	VERB	VBD	O
detected	detect	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	VERB	VBZ	O
serum	serum	ADJ	JJ	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
an	an	DET	DT	O
eluate	eluate	NOUN	NN	O
prepared	prepare	VERB	VBN	O
from	from	ADP	IN	O
his	-PRON-	DET	PRP$	O
red	red	ADJ	JJ	O
blood	blood	NOUN	NN	O
cells	cell	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
eluate	eluate	NOUN	NN	O
also	also	ADV	RB	O
reacted	react	VERB	VBD	O
weakly	weakly	ADV	RB	O
with	with	ADP	IN	O
red	red	ADJ	JJ	O
blood	blood	NOUN	NN	O
cells	cell	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
cefotetan	cefotetan	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
the	the	DET	DT	O
concomitant	concomitant	ADJ	JJ	O
formation	formation	NOUN	NN	O
of	of	ADP	IN	O
warm	warm	ADJ	JJ	O
-	-	PUNCT	HYPH	O
reactive	reactive	ADJ	JJ	O
autoantibodies	autoantibody	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
observations	observation	NOUN	NNS	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
conjunction	conjunction	NOUN	NN	O
with	with	ADP	IN	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
laboratory	laboratory	NOUN	NN	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
extravascular	extravascular	ADJ	JJ	O
hemolysis	hemolysis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
are	be	VERB	VBP	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
possibly	possibly	ADV	RB	O
involving	involve	VERB	VBG	O
both	both	CCONJ	CC	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
adsorption	adsorption	NOUN	NN	O
and	and	CCONJ	CC	O
autoantibody	autoantibody	NOUN	NN	O
formation	formation	NOUN	NN	O
mechanisms	mechanism	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
case	case	NOUN	NN	O
emphasizes	emphasize	VERB	VBZ	O
the	the	DET	DT	O
need	need	NOUN	NN	O
for	for	ADP	IN	O
increased	increase	VERB	VBN	O
awareness	awareness	NOUN	NN	O
of	of	ADP	IN	O
hemolytic	hemolytic	ADJ	JJ	O
reactions	reaction	NOUN	NNS	O
to	to	ADP	IN	O
all	all	DET	DT	O
cephalosporins	cephalosporin	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

Use	use	NOUN	NN	O
of	of	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
with	with	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
for	for	ADP	IN	O
the	the	DET	DT	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

AIM	AIM	PROPN	NNP	O
:	:	PUNCT	:	O
Hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
HC	HC	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
limiting	limit	VERB	VBG	O
side	side	NOUN	NN	O
-	-	PUNCT	HYPH	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
chemotherapy	chemotherapy	NOUN	NN	O
with	with	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
IFS	IFS	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
presented	present	VERB	VBN	O
here	here	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
for	for	ADP	IN	O
the	the	DET	DT	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
IFS	IFS	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
HC	HC	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Male	Male	PROPN	NNP	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
150	150	NUM	CD	O
-	-	SYM	SYM	O
200	200	NUM	CD	O
g	g	NOUN	NN	O
;	;	PUNCT	:	O
6	6	NUM	CD	O
rats	rat	NOUN	NNS	O
per	per	ADP	IN	O
group	group	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
or	or	CCONJ	CC	O
mesna	mesna	NOUN	NN	B-Chemical
5	5	NUM	CD	O
min	min	NOUN	NN	O
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
before	before	ADV	RB	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
(	(	PUNCT	-LRB-	O
v	v	X	XX	O
.	.	PUNCT	.	O
o	o	X	XX	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
IFS	IFS	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

One	one	NUM	CD	O
,	,	PUNCT	,	O
two	two	NUM	CD	O
or	or	CCONJ	CC	O
three	three	NUM	CD	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
replaced	replace	VERB	VBN	O
with	with	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
alone	alone	ADJ	JJ	O
or	or	CCONJ	CC	O
with	with	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
plus	plus	CCONJ	CC	O
mesna	mesna	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Cystitis	Cystitis	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
24	24	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
its	-PRON-	DET	PRP$	O
induction	induction	NOUN	NN	O
by	by	ADP	IN	O
the	the	DET	DT	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
bladder	bladder	NOUN	NN	O
wet	wet	ADJ	JJ	O
weight	weight	NOUN	NN	O
and	and	CCONJ	CC	O
by	by	ADP	IN	O
macroscopic	macroscopic	ADJ	JJ	O
and	and	CCONJ	CC	O
microscopic	microscopic	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
replacement	replacement	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
last	last	ADJ	JJ	O
dose	dose	NOUN	NN	O
or	or	CCONJ	CC	O
the	the	DET	DT	O
last	last	ADJ	JJ	O
two	two	NUM	CD	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
with	with	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
bladder	bladder	NOUN	NN	O
wet	wet	ADJ	JJ	O
weight	weight	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
IFS	IFS	PROPN	NNP	B-Chemical
by	by	ADP	IN	O
84	84	NUM	CD	O
.	.	PUNCT	.	O
79	79	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
89	89	NUM	CD	O
.	.	PUNCT	.	O
13	13	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
almost	almost	ADV	RB	O
abolished	abolish	VERB	VBD	O
the	the	DET	DT	O
macroscopic	macroscopic	ADJ	JJ	O
and	and	CCONJ	CC	O
microscopic	microscopic	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
IFS	IFS	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
addition	addition	NOUN	NN	O
of	of	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
to	to	ADP	IN	O
the	the	DET	DT	O
last	last	ADJ	JJ	O
two	two	NUM	CD	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
more	more	ADV	RBR	O
efficient	efficient	ADJ	JJ	O
than	than	ADP	IN	O
three	three	NUM	CD	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
when	when	ADV	WRB	O
evaluated	evaluate	VERB	VBN	O
microscopically	microscopically	ADV	RB	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Dexamethasone	dexamethasone	NOUN	NN	B-Chemical
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
efficient	efficient	ADJ	JJ	O
in	in	ADP	IN	O
blocking	block	VERB	VBG	O
IFS	IFS	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
HC	HC	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
replacement	replacement	NOUN	NN	O
of	of	ADP	IN	O
last	last	ADJ	JJ	O
two	two	NUM	CD	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
or	or	CCONJ	CC	O
all	all	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
mesna	mesna	NOUN	NN	B-Chemical
doses	dose	VERB	VBZ	O
with	with	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
prevent	prevent	VERB	VB	O
HC	HC	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

All	all	DET	DT	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
trans	trans	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
retinoic	retinoic	ADJ	JJ	I-Chemical
acid	acid	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
erythema	erythema	NOUN	NN	B-Disease
nodosum	nodosum	NOUN	NN	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
promyelocytic	promyelocytic	ADJ	JJ	I-Disease
leukemia	leukemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Erythema	Erythema	PROPN	NNP	B-Disease
nodosum	nodosum	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
all	all	DET	DT	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
trans	trans	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
retinoic	retinoic	ADJ	JJ	I-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
ATRA	ATRA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
promyelocytic	promyelocytic	ADJ	JJ	I-Disease
leukemia	leukemia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
APL	APL	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
very	very	ADV	RB	O
rare	rare	ADJ	JJ	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
four	four	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
classic	classic	ADJ	JJ	O
APL	APL	PROPN	NNP	B-Disease
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
erythema	erythema	NOUN	NN	B-Disease
nodosum	nodosum	NOUN	NN	I-Disease
during	during	ADP	IN	O
ATRA	ATRA	PROPN	NNP	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Fever	fever	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
subsequent	subsequent	ADJ	JJ	O
multiple	multiple	ADJ	JJ	O
painful	painful	ADJ	JJ	B-Disease
erythematous	erythematous	ADJ	JJ	B-Disease
nodules	nodule	NOUN	NNS	I-Disease
over	over	ADP	IN	O
extremities	extremity	NOUN	NNS	O
developed	develop	VERB	VBN	O
on	on	ADP	IN	O
D11	D11	PROPN	NNP	O
,	,	PUNCT	,	O
D16	D16	PROPN	NNP	O
,	,	PUNCT	,	O
D17	D17	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
D19	D19	PROPN	NNP	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
after	after	ADP	IN	O
ATRA	ATRA	PROPN	NNP	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
skin	skin	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
taken	take	VERB	VBN	O
from	from	ADP	IN	O
each	each	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
erythema	erythema	NOUN	NN	B-Disease
nodosum	nodosum	NOUN	NN	I-Disease
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
received	receive	VERB	VBD	O
short	short	ADJ	JJ	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
steroids	steroid	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

Fever	fever	NOUN	NN	B-Disease
subsided	subside	VERB	VBD	O
rapidly	rapidly	ADV	RB	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
skin	skin	NOUN	NN	O
lesions	lesion	NOUN	NNS	O
regressed	regress	VERB	VBN	O
completely	completely	ADV	RB	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
achieved	achieve	VERB	VBD	O
complete	complete	ADJ	JJ	O
remission	remission	NOUN	NN	O
without	without	ADP	IN	O
withdrawal	withdrawal	NOUN	NN	O
of	of	ADP	IN	O
ATRA	ATRA	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

ATRA	ATRA	PROPN	NNP	B-Chemical
seemed	seem	VERB	VBD	O
to	to	PART	TO	O
be	be	VERB	VB	O
the	the	DET	DT	O
most	most	ADV	RBS	O
possible	possible	ADJ	JJ	O
etiology	etiology	NOUN	NN	O
of	of	ADP	IN	O
erythema	erythema	NOUN	NN	B-Disease
nodosum	nodosum	NOUN	NN	I-Disease
in	in	ADP	IN	O
our	-PRON-	DET	PRP$	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
steroid	steroid	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
very	very	ADV	RB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
ATRA	ATRA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
erythema	erythema	NOUN	NN	B-Disease
nodosum	nodosum	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
some	some	DET	DT	O
convulsants	convulsant	NOUN	NNS	O
on	on	ADP	IN	O
the	the	DET	DT	O
protective	protective	ADJ	JJ	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
loreclezole	loreclezole	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
combinations	combination	NOUN	NNS	O
with	with	ADP	IN	O
valproate	valproate	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
clonazepam	clonazepam	NOUN	NN	B-Chemical
in	in	ADP	IN	O
amygdala	amygdala	NOUN	NN	O
-	-	PUNCT	HYPH	O
kindled	kindle	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Loreclezole	Loreclezole	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
exerted	exert	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
protective	protective	ADJ	JJ	O
action	action	NOUN	NN	O
in	in	ADP	IN	O
amygdala	amygdala	NOUN	NN	O
-	-	PUNCT	HYPH	O
kindled	kindle	VERB	VBN	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
reducing	reduce	VERB	VBG	O
both	both	DET	DT	O
seizure	seizure	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
afterdischarge	afterdischarge	ADJ	JJ	O
durations	duration	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
combinations	combination	NOUN	NNS	O
of	of	ADP	IN	O
loreclezole	loreclezole	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
valproate	valproate	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
clonazepam	clonazepam	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
applied	apply	VERB	VBN	O
at	at	ADP	IN	O
their	-PRON-	DET	PRP$	O
subprotective	subprotective	ADJ	JJ	O
doses	dose	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
also	also	ADV	RB	O
exhibited	exhibit	VERB	VBD	O
antiseizure	antiseizure	NOUN	NN	O
effect	effect	NOUN	NN	O
in	in	ADP	IN	O
this	this	DET	DT	O
test	test	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
only	only	ADV	RB	O
two	two	NUM	CD	O
first	first	ADJ	JJ	O
combinations	combination	NOUN	NNS	O
occurred	occur	VERB	VBD	O
to	to	PART	TO	O
be	be	VERB	VB	O
of	of	ADP	IN	O
pharmacodynamic	pharmacodynamic	ADJ	JJ	O
nature	nature	NOUN	NN	O
.	.	PUNCT	.	O

Among	among	ADP	IN	O
several	several	ADJ	JJ	O
chemoconvulsants	chemoconvulsant	NOUN	NNS	O
,	,	PUNCT	,	O
bicuculline	bicuculline	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
D	d	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aspartic	aspartic	ADJ	JJ	I-Chemical
acid	acid	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
BAY	BAY	PROPN	NNP	B-Chemical
k	k	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
8644	8644	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
the	the	DET	DT	O
opener	opener	NOUN	NN	O
of	of	ADP	IN	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
type	type	NOUN	NN	O
calcium	calcium	NOUN	NN	B-Chemical
channels	channel	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
reversed	reverse	VERB	VBD	O
the	the	DET	DT	O
protective	protective	ADJ	JJ	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
loreclezole	loreclezole	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
valproate	valproate	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
hand	hand	NOUN	NN	O
,	,	PUNCT	,	O
bicuculline	bicuculline	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
aminophylline	aminophylline	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
BAY	BAY	PROPN	NNP	B-Chemical
k	k	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
8644	8644	NUM	CD	I-Chemical
inhibited	inhibit	VERB	VBD	O
the	the	DET	DT	O
anticonvulsive	anticonvulsive	ADJ	JJ	O
action	action	NOUN	NN	O
of	of	ADP	IN	O
loreclezole	loreclezole	NOUN	NN	B-Chemical
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
clonazepam	clonazepam	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
support	support	VERB	VBP	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
that	that	ADP	IN	O
the	the	DET	DT	O
protective	protective	ADJ	JJ	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
loreclezole	loreclezole	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
combinations	combination	NOUN	NNS	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
antiepileptics	antiepileptic	NOUN	NNS	O
may	may	VERB	MD	O
involve	involve	VERB	VB	O
potentiation	potentiation	NOUN	NN	O
of	of	ADP	IN	O
GABAergic	GABAergic	PROPN	NNP	O
neurotransmission	neurotransmission	NOUN	NN	O
and	and	CCONJ	CC	O
blockade	blockade	NOUN	NN	O
of	of	ADP	IN	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
type	type	NOUN	NN	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
channels	channel	NOUN	NNS	O
.	.	PUNCT	.	O

Mitochondrial	mitochondrial	ADJ	JJ	O
DNA	DNA	PROPN	NNP	O
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
respiratory	respiratory	ADJ	JJ	O
chain	chain	NOUN	NN	O
products	product	NOUN	NNS	O
are	be	VERB	VBP	O
defective	defective	ADJ	JJ	O
in	in	ADP	IN	O
doxorubicin	doxorubicin	ADJ	JJ	B-Chemical
nephrosis	nephrosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Doxorubicin	Doxorubicin	PROPN	NNP	B-Chemical
induces	induce	VERB	VBZ	O
a	a	DET	DT	O
self	self	NOUN	NN	O
-	-	PUNCT	HYPH	O
perpetuating	perpetuate	VERB	VBG	O
nephropathy	nephropathy	NOUN	NN	B-Disease
characterized	characterize	VERB	VBN	O
by	by	ADP	IN	O
early	early	ADJ	JJ	O
glomerular	glomerular	NOUN	NN	B-Disease
and	and	CCONJ	CC	I-Disease
late	late	ADJ	JJ	I-Disease
-	-	PUNCT	HYPH	I-Disease
onset	onset	NOUN	NN	I-Disease
tubular	tubular	ADJ	JJ	I-Disease
lesions	lesion	NOUN	NNS	I-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
potential	potential	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
mitochondrial	mitochondrial	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
lesions	lesion	NOUN	NNS	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
kg	kg	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
week	week	NOUN	NN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
7	7	NUM	CD	O
weeks	week	NOUN	NNS	O
and	and	CCONJ	CC	O
were	be	VERB	VBD	O
sacrificed	sacrifice	VERB	VBN	O
either	either	CCONJ	CC	O
1	1	NUM	CD	O
week	week	NOUN	NN	O
(	(	PUNCT	-LRB-	O
'	'	PUNCT	``	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
'	'	PUNCT	''	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
30	30	NUM	CD	O
weeks	week	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
'	'	PUNCT	``	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
'	'	PUNCT	''	O
)	)	PUNCT	-RRB-	O
following	follow	VERB	VBG	O
the	the	DET	DT	O
last	last	ADJ	JJ	O
dose	dose	NOUN	NN	O
.	.	PUNCT	.	O

Additional	additional	ADJ	JJ	O
rats	rat	NOUN	NNS	O
received	receive	VERB	VBD	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
either	either	CCONJ	CC	O
6	6	NUM	CD	O
days	day	NOUN	NNS	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
h	h	NOUN	NN	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
euthanasia	euthanasia	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
killed	kill	VERB	VBN	O
at	at	ADP	IN	O
48	48	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
.	.	PUNCT	.	O

Glomerular	glomerular	NOUN	NN	B-Disease
and	and	CCONJ	CC	I-Disease
tubular	tubular	ADJ	JJ	I-Disease
injury	injury	NOUN	NN	I-Disease
was	be	VERB	VBD	O
monitored	monitor	VERB	VBN	O
and	and	CCONJ	CC	O
correlated	correlate	VERB	VBD	O
to	to	ADP	IN	O
the	the	DET	DT	O
activity	activity	NOUN	NN	O
or	or	CCONJ	CC	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
respiratory	respiratory	ADJ	JJ	O
chain	chain	NOUN	NN	O
components	component	NOUN	NNS	O
.	.	PUNCT	.	O

Finally	finally	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
quantified	quantify	VERB	VBD	O
both	both	CCONJ	CC	O
nuclear	nuclear	ADJ	JJ	O
and	and	CCONJ	CC	O
mitochondrial	mitochondrial	ADJ	JJ	O
DNA	DNA	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
mtDNA	mtDNA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
superoxide	superoxide	ADJ	JJ	B-Chemical
production	production	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
4834	4834	NUM	CD	O
base	base	NOUN	NN	O
pair	pair	NOUN	NN	O
'	'	PUNCT	''	O
common	common	ADJ	JJ	O
'	'	PUNCT	''	O
mtDNA	mtdna	ADJ	JJ	O
deletion	deletion	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
'	'	PUNCT	``	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
'	'	PUNCT	''	O
group	group	NOUN	NN	O
had	have	VERB	VBD	O
significant	significant	ADJ	JJ	O
glomerular	glomerular	NOUN	NN	B-Disease
and	and	CCONJ	CC	I-Disease
tubular	tubular	ADJ	JJ	I-Disease
lesions	lesion	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
depressed	depressed	ADJ	JJ	O
activities	activity	NOUN	NNS	O
of	of	ADP	IN	O
mtDNA	mtDNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
encoded	encode	VERB	VBN	O
NADH	NADH	PROPN	NNP	O
dehydrogenase	dehydrogenase	NOUN	NN	O
and	and	CCONJ	CC	O
cytochrome	cytochrome	ADJ	JJ	O
-	-	PUNCT	HYPH	O
c	c	NOUN	NN	O
oxidase	oxidase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
COX	COX	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBN	O
citrate	citrate	NOUN	NN	B-Chemical
synthase	synthase	NOUN	NN	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
mtDNA	mtDNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
encoded	encode	VERB	VBN	O
COX	COX	PROPN	NNP	O
subunit	subunit	NOUN	NN	O
I	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
and	and	CCONJ	CC	O
mtDNA	mtdna	ADJ	JJ	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
'	'	PUNCT	``	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
'	'	PUNCT	''	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
were	be	VERB	VBD	O
fewer	few	ADJ	JJR	O
tubular	tubular	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
similar	similar	ADJ	JJ	O
numbers	number	NOUN	NNS	O
of	of	ADP	IN	O
glomerular	glomerular	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Among	among	ADP	IN	O
all	all	DET	DT	O
animals	animal	NOUN	NNS	O
,	,	PUNCT	,	O
glomerular	glomerular	NOUN	NN	B-Disease
and	and	CCONJ	CC	I-Disease
tubular	tubular	ADJ	JJ	I-Disease
injury	injury	NOUN	NN	I-Disease
were	be	VERB	VBD	O
inversely	inversely	ADV	RB	O
correlated	correlate	VERB	VBN	O
with	with	ADP	IN	O
mtDNA	mtdna	ADJ	JJ	O
levels	level	NOUN	NNS	O
,	,	PUNCT	,	O
mtDNA	mtDNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
encoded	encode	VERB	VBN	O
respiratory	respiratory	ADJ	JJ	O
chain	chain	NOUN	NN	O
activities	activity	NOUN	NNS	O
and	and	CCONJ	CC	O
with	with	ADP	IN	O
the	the	DET	DT	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
mtDNA	mtDNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
encoded	encode	VERB	VBN	O
respiratory	respiratory	ADJ	JJ	O
chain	chain	NOUN	NN	O
subunit	subunit	NOUN	NN	O
COX	COX	PROPN	NNP	O
-	-	PUNCT	:	O
I	-PRON-	PRON	PRP	O
.	.	PUNCT	.	O

Injury	Injury	PROPN	NNP	O
was	be	VERB	VBD	O
positively	positively	ADV	RB	O
correlated	correlate	VERB	VBN	O
with	with	ADP	IN	O
superoxide	superoxide	ADJ	JJ	B-Chemical
production	production	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
activities	activity	NOUN	NNS	O
of	of	ADP	IN	O
nucleus	nucleus	NOUN	NN	O
-	-	PUNCT	HYPH	O
encoded	encode	VERB	VBN	O
mitochondrial	mitochondrial	NOUN	NN	O
or	or	CCONJ	CC	O
cytoplasmic	cytoplasmic	ADJ	JJ	O
enzymes	enzyme	NOUN	NNS	O
.	.	PUNCT	.	O

Kidneys	kidney	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
'	'	PUNCT	``	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
'	'	PUNCT	''	O
group	group	NOUN	NN	O
showed	show	VERB	VBD	O
more	more	ADJ	JJR	O
mtDNA	mtdna	ADJ	JJ	O
deletions	deletion	NOUN	NNS	O
than	than	ADP	IN	O
in	in	ADP	IN	O
'	'	PUNCT	``	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
'	'	PUNCT	''	O
animals	animal	NOUN	NNS	O
and	and	CCONJ	CC	O
these	these	DET	DT	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
role	role	NOUN	NN	O
for	for	ADP	IN	O
quantitative	quantitative	ADJ	JJ	O
and	and	CCONJ	CC	O
qualitative	qualitative	ADJ	JJ	O
mtDNA	mtdna	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
through	through	ADP	IN	O
the	the	DET	DT	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
mtDNA	mtDNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
encoded	encode	VERB	VBN	O
respiratory	respiratory	ADJ	JJ	O
chain	chain	NOUN	NN	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
superoxide	superoxide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
renal	renal	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
randomized	randomized	ADJ	JJ	O
,	,	PUNCT	,	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
,	,	PUNCT	,	O
crossover	crossover	NOUN	NN	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
ephedrine	ephedrine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
SSRI	SSRI	PROPN	NNP	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
female	female	ADJ	JJ	O
sexual	sexual	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
objective	objective	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
whether	whether	ADP	IN	O
ephedrine	ephedrine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
an	an	DET	DT	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenergic	adrenergic	NOUN	NN	O
agonist	agonist	NOUN	NN	O
previously	previously	ADV	RB	O
shown	show	VERB	VBN	O
to	to	PART	TO	O
enhance	enhance	VERB	VB	O
genital	genital	ADJ	JJ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
,	,	PUNCT	,	O
has	have	VERB	VBZ	O
beneficial	beneficial	ADJ	JJ	O
effects	effect	NOUN	NNS	O
in	in	ADP	IN	O
reversing	reverse	VERB	VBG	O
antidepressant	antidepressant	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
sexual	sexual	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Nineteen	nineteen	NUM	CD	O
sexually	sexually	ADV	RB	B-Disease
dysfunctional	dysfunctional	ADJ	JJ	I-Disease
women	woman	NOUN	NNS	O
receiving	receive	VERB	VBG	O
either	either	CCONJ	CC	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
sertraline	sertraline	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
paroxetine	paroxetine	NOUN	NN	B-Chemical
participated	participate	VERB	VBD	O
in	in	ADP	IN	O
an	an	DET	DT	O
eight	eight	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
,	,	PUNCT	,	O
cross	cross	ADJ	JJ	O
-	-	ADJ	JJ	O
over	over	ADJ	JJ	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
ephedrine	ephedrine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
self	self	NOUN	NN	O
-	-	PUNCT	HYPH	O
report	report	NOUN	NN	O
measures	measure	NOUN	NNS	O
of	of	ADP	IN	O
sexual	sexual	ADJ	JJ	O
desire	desire	NOUN	NN	O
,	,	PUNCT	,	O
arousal	arousal	NOUN	NN	O
,	,	PUNCT	,	O
orgasm	orgasm	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
sexual	sexual	ADJ	JJ	O
satisfaction	satisfaction	NOUN	NN	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
there	there	ADV	EX	O
were	be	VERB	VBD	O
significant	significant	ADJ	JJ	O
improvements	improvement	NOUN	NNS	O
relative	relative	ADJ	JJ	O
to	to	ADP	IN	O
baseline	baseline	NOUN	NN	O
in	in	ADP	IN	O
sexual	sexual	ADJ	JJ	O
desire	desire	NOUN	NN	O
and	and	CCONJ	CC	O
orgasm	orgasm	VERB	VB	O
intensity	intensity	NOUN	NN	O
/	/	SYM	SYM	O
pleasure	pleasure	NOUN	NN	O
on	on	ADP	IN	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
ephedrine	ephedrine	NOUN	NN	B-Chemical
1	1	NUM	CD	O
-	-	PUNCT	:	O
hr	hr	INTJ	UH	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
sexual	sexual	ADJ	JJ	O
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
significant	significant	ADJ	JJ	O
improvements	improvement	NOUN	NNS	O
in	in	ADP	IN	O
these	these	DET	DT	O
measures	measure	NOUN	NNS	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
in	in	ADP	IN	O
sexual	sexual	ADJ	JJ	O
arousal	arousal	NOUN	NN	O
and	and	CCONJ	CC	O
orgasmic	orgasmic	ADJ	JJ	O
ability	ability	NOUN	NN	O
also	also	ADV	RB	O
were	be	VERB	VBD	O
noted	note	VERB	VBN	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
highlight	highlight	VERB	VBP	O
the	the	DET	DT	O
importance	importance	NOUN	NN	O
of	of	ADP	IN	O
conducting	conduct	VERB	VBG	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
trials	trial	NOUN	NNS	O
for	for	ADP	IN	O
this	this	DET	DT	O
condition	condition	NOUN	NN	O
.	.	PUNCT	.	O

Does	do	VERB	VBZ	O
hormone	hormone	NOUN	NN	O
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
have	have	VERB	VBP	O
a	a	DET	DT	O
detrimental	detrimental	ADJ	JJ	B-Disease
effect	effect	NOUN	NN	I-Disease
on	on	ADP	IN	I-Disease
memory	memory	NOUN	NN	I-Disease
and	and	CCONJ	CC	I-Disease
cognition	cognition	NOUN	NN	I-Disease
?	?	PUNCT	.	O

A	a	DET	DT	O
pilot	pilot	NOUN	NN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
pilot	pilot	NOUN	NN	O
study	study	NOUN	NN	O
examines	examine	NOUN	NNS	O
whether	whether	ADP	IN	O
hormone	hormone	NOUN	NN	O
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
affects	affect	VERB	VBZ	O
cognition	cognition	NOUN	NN	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
participating	participate	VERB	VBG	O
in	in	ADP	IN	O
a	a	DET	DT	O
randomised	randomise	VERB	VBN	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
anastrozole	anastrozole	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
tamoxifen	tamoxifen	ADV	RB	B-Chemical
alone	alone	ADV	RB	O
or	or	CCONJ	CC	O
combined	combined	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
ATAC	ATAC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
94	94	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
women	woman	NOUN	NNS	O
without	without	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
35	35	NUM	CD	O
)	)	PUNCT	-RRB-	O
completed	complete	VERB	VBD	O
a	a	DET	DT	O
battery	battery	NOUN	NN	O
of	of	ADP	IN	O
neuropsychological	neuropsychological	ADJ	JJ	O
measures	measure	NOUN	NNS	O
.	.	PUNCT	.	O

Compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
impaired	impair	VERB	VBN	O
on	on	ADP	IN	O
a	a	DET	DT	O
processing	processing	NOUN	NN	O
speed	speed	NOUN	NN	O
task	task	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
032	032	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
on	on	ADP	IN	O
a	a	DET	DT	O
measure	measure	NOUN	NN	O
of	of	ADP	IN	O
immediate	immediate	ADJ	JJ	O
verbal	verbal	ADJ	JJ	O
memory	memory	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
026	026	NUM	CD	O
)	)	PUNCT	-RRB-	O
after	after	ADP	IN	O
controlling	control	VERB	VBG	O
for	for	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
hormone	hormone	NOUN	NN	O
replacement	replacement	NOUN	NN	O
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Patient	patient	ADJ	JJ	O
group	group	NOUN	NN	O
performance	performance	NOUN	NN	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
length	length	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
or	or	CCONJ	CC	O
measures	measure	NOUN	NNS	O
of	of	ADP	IN	O
psychological	psychological	ADJ	JJ	O
morbidity	morbidity	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
showed	show	VERB	VBD	O
specific	specific	ADJ	JJ	O
impairments	impairment	NOUN	NNS	O
in	in	ADP	IN	O
processing	process	VERB	VBG	O
speed	speed	NOUN	NN	O
and	and	CCONJ	CC	O
verbal	verbal	ADJ	JJ	O
memory	memory	NOUN	NN	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
receiving	receive	VERB	VBG	O
hormonal	hormonal	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Verbal	verbal	ADJ	JJ	O
memory	memory	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
especially	especially	ADV	RB	O
sensitive	sensitive	ADJ	JJ	O
to	to	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
oestrogen	oestrogen	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
,	,	PUNCT	,	O
a	a	DET	DT	O
finding	finding	NOUN	NN	O
commonly	commonly	ADV	RB	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
studies	study	NOUN	NNS	O
of	of	ADP	IN	O
hormone	hormone	NOUN	NN	O
replacement	replacement	NOUN	NN	O
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
healthy	healthy	ADJ	JJ	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
view	view	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
increased	increase	VERB	VBN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
hormone	hormone	NOUN	NN	O
therapies	therapy	NOUN	NNS	O
in	in	ADP	IN	O
an	an	DET	DT	O
adjuvant	adjuvant	ADJ	JJ	O
and	and	CCONJ	CC	O
preventative	preventative	ADJ	JJ	O
setting	set	VERB	VBG	O
their	-PRON-	DET	PRP$	O
impact	impact	NOUN	NN	O
on	on	ADP	IN	O
cognitive	cognitive	ADJ	JJ	O
functioning	functioning	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
investigated	investigate	VERB	VBN	O
more	more	ADV	RBR	O
thoroughly	thoroughly	ADV	RB	O
.	.	PUNCT	.	O

Expression	expression	NOUN	NN	O
of	of	ADP	IN	O
p300	p300	PROPN	NNP	O
protects	protect	VERB	VBZ	O
cardiac	cardiac	ADJ	JJ	O
myocytes	myocyte	NOUN	NNS	O
from	from	ADP	IN	O
apoptosis	apoptosis	NOUN	NN	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
.	.	PUNCT	.	O

Doxorubicin	Doxorubicin	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
an	an	DET	DT	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
tumor	tumor	ADJ	JJ	B-Disease
agent	agent	NOUN	NN	O
that	that	DET	WDT	O
represses	repress	VERB	VBZ	O
cardiac	cardiac	ADJ	JJ	O
-	-	PUNCT	HYPH	O
specific	specific	ADJ	JJ	O
gene	gene	NOUN	NN	O
expression	expression	NOUN	NN	O
and	and	CCONJ	CC	O
induces	induce	VERB	VBZ	O
myocardial	myocardial	ADJ	JJ	O
cell	cell	NOUN	NN	O
apoptosis	apoptosis	NOUN	NN	O
.	.	PUNCT	.	O

Doxorubicin	Doxorubicin	PROPN	NNP	B-Chemical
depletes	deplete	VERB	VBZ	O
cardiac	cardiac	ADJ	JJ	O
p300	p300	NOUN	NNS	O
,	,	PUNCT	,	O
a	a	DET	DT	O
transcriptional	transcriptional	ADJ	JJ	O
coactivator	coactivator	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
required	require	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
maintenance	maintenance	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
differentiated	differentiated	ADJ	JJ	O
phenotype	phenotype	NOUN	NN	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
myocytes	myocyte	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
p300	p300	PROPN	NNP	O
in	in	ADP	IN	O
protection	protection	NOUN	NN	O
against	against	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
apoptosis	apoptosis	NOUN	NN	O
is	be	VERB	VBZ	O
unknown	unknown	ADJ	JJ	O
.	.	PUNCT	.	O

Transgenic	transgenic	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
overexpressing	overexpresse	VERB	VBG	O
p300	p300	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
heart	heart	NOUN	NN	O
and	and	CCONJ	CC	O
wild	wild	ADJ	JJ	O
-	-	PUNCT	HYPH	O
type	type	NOUN	NN	O
mice	mouse	NOUN	NNS	O
were	be	VERB	VBD	O
subjected	subject	VERB	VBN	O
to	to	ADP	IN	O
doxorubicin	doxorubicin	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Compared	compare	VERB	VBN	O
with	with	ADP	IN	O
wild	wild	ADJ	JJ	O
-	-	PUNCT	HYPH	O
type	type	NOUN	NN	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
transgenic	transgenic	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
exhibited	exhibit	VERB	VBD	O
higher	high	ADJ	JJR	O
survival	survival	NOUN	NN	O
rate	rate	NOUN	NN	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
more	more	ADV	RBR	O
preserved	preserve	VERB	VBN	O
left	leave	VERB	VBN	O
ventricular	ventricular	ADJ	JJ	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
sarcomeric	sarcomeric	ADJ	JJ	O
actin	actin	NOUN	NN	O
.	.	PUNCT	.	O

Doxorubicin	Doxorubicin	PROPN	NNP	B-Chemical
induced	induce	VERB	VBD	O
myocardial	myocardial	ADJ	JJ	O
cell	cell	NOUN	NN	O
apoptosis	apoptosis	NOUN	NN	O
in	in	ADP	IN	O
wild	wild	ADJ	JJ	O
-	-	PUNCT	HYPH	O
type	type	NOUN	NN	O
mice	mouse	NOUN	NNS	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
in	in	ADP	IN	O
transgenic	transgenic	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Expression	expression	NOUN	NN	O
of	of	ADP	IN	O
p300	p300	PROPN	NNP	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
cardiac	cardiac	ADJ	JJ	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
bcl	bcl	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
and	and	CCONJ	CC	O
mdm	mdm	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
that	that	DET	DT	O
of	of	ADP	IN	O
p53	p53	NOUN	NN	O
or	or	CCONJ	CC	O
other	other	ADJ	JJ	O
members	member	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
bcl	bcl	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
family	family	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
demonstrate	demonstrate	VERB	VBP	O
that	that	DET	DT	O
overexpression	overexpression	NOUN	NN	O
of	of	ADP	IN	O
p300	p300	PROPN	NNP	O
protects	protect	VERB	VBZ	O
cardiac	cardiac	ADJ	JJ	O
myocytes	myocyte	NOUN	NNS	O
from	from	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
apoptosis	apoptosis	NOUN	NN	O
and	and	CCONJ	CC	O
reduces	reduce	VERB	VBZ	O
the	the	DET	DT	O
extent	extent	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
mice	mouse	NOUN	NNS	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
.	.	PUNCT	.	O

Methimazole	Methimazole	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cholestatic	cholestatic	ADJ	JJ	B-Disease
jaundice	jaundice	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Methimazole	Methimazole	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
and	and	CCONJ	CC	O
generally	generally	ADV	RB	O
well	well	ADV	RB	O
-	-	PUNCT	HYPH	O
tolerated	tolerate	VERB	VBN	O
antithyroid	antithyroid	ADJ	JJ	O
agent	agent	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
43	43	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
had	have	VERB	VBD	O
severe	severe	ADJ	JJ	O
jaundice	jaundice	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
itching	itching	NOUN	NN	B-Disease
1	1	NUM	CD	O
month	month	NOUN	NN	O
after	after	ADP	IN	O
receiving	receive	VERB	VBG	O
methimazole	methimazole	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
tid	tid	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
propranolol	propranolol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
tid	tid	NOUN	NN	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
hyperthyroidism	hyperthyroidism	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
continued	continue	VERB	VBN	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
another	another	DET	DT	O
4	4	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
the	the	DET	DT	O
appearance	appearance	NOUN	NN	O
of	of	ADP	IN	O
jaundice	jaundice	NOUN	NN	B-Disease
until	until	ADP	IN	O
she	-PRON-	PRON	PRP	O
finished	finish	VERB	VBD	O
both	both	DET	DT	O
medications	medication	NOUN	NNS	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
seen	see	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
emergency	emergency	NOUN	NN	O
department	department	NOUN	NN	O
2	2	NUM	CD	O
weeks	week	NOUN	NNS	O
later	later	ADV	RB	O
,	,	PUNCT	,	O
she	-PRON-	PRON	PRP	O
still	still	ADV	RB	O
had	have	VERB	VBD	O
severe	severe	ADJ	JJ	O
icterus	icterus	NOUN	NN	B-Disease
,	,	PUNCT	,	O
pruritus	pruritus	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
hyperbilirubinemia	hyperbilirubinemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
formed	form	VERB	VBN	O
mainly	mainly	ADV	RB	O
of	of	ADP	IN	O
the	the	DET	DT	O
conjugated	conjugate	VERB	VBN	O
fraction	fraction	NOUN	NN	O
.	.	PUNCT	.	O

Methimazole	Methimazole	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cholestasis	cholestasis	NOUN	NN	B-Disease
was	be	VERB	VBD	O
diagnosed	diagnose	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
propranolol	propranolol	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
was	be	VERB	VBD	O
resumed	resume	VERB	VBN	O
.	.	PUNCT	.	O

Over	over	ADP	IN	O
the	the	DET	DT	O
following	following	ADJ	JJ	O
9	9	NUM	CD	O
days	day	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
symptoms	symptom	NOUN	NNS	O
improved	improve	VERB	VBD	O
and	and	CCONJ	CC	O
plasma	plasma	NOUN	NN	O
bilirubin	bilirubin	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
normal	normal	ADJ	JJ	O
after	after	ADP	IN	O
12	12	NUM	CD	O
weeks	week	NOUN	NNS	O
without	without	ADP	IN	O
methimazole	methimazole	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
rare	rare	ADJ	JJ	O
cases	case	NOUN	NNS	O
within	within	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
few	few	ADJ	JJ	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
this	this	DET	DT	O
drug	drug	NOUN	NN	O
can	can	VERB	MD	O
cause	cause	VERB	VB	O
severe	severe	ADJ	JJ	O
and	and	CCONJ	CC	O
reversible	reversible	ADJ	JJ	O
cholestatic	cholestatic	ADJ	JJ	B-Disease
jaundice	jaundice	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Physicians	physician	NOUN	NNS	O
and	and	CCONJ	CC	O
patients	patient	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
this	this	DET	DT	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
so	so	ADP	IN	O
that	that	ADP	IN	O
,	,	PUNCT	,	O
upon	upon	ADP	IN	O
occurrence	occurrence	NOUN	NN	O
,	,	PUNCT	,	O
they	-PRON-	PRON	PRP	O
can	can	VERB	MD	O
discontinue	discontinue	VERB	VB	O
methimazole	methimazole	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
and	and	CCONJ	CC	O
avoid	avoid	VERB	VB	O
unnecessary	unnecessary	ADJ	JJ	O
invasive	invasive	ADJ	JJ	O
procedures	procedure	NOUN	NNS	O
.	.	PUNCT	.	O

Atrial	atrial	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
chemotherapy	chemotherapy	NOUN	NN	O
for	for	ADP	IN	O
stage	stage	NOUN	NN	O
IIIE	IIIE	PROPN	NNP	O
diffuse	diffuse	VERB	VBP	O
large	large	ADJ	JJ	O
B	b	NOUN	NN	O
-	-	PUNCT	HYPH	O
cell	cell	NOUN	NN	O
gastric	gastric	NOUN	NN	B-Disease
lymphoma	lymphoma	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
myotonic	myotonic	ADJ	JJ	B-Disease
dystrophy	dystrophy	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
Steinert	Steinert	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
authors	author	NOUN	NNS	O
describe	describe	VERB	VBP	O
the	the	DET	DT	O
unusual	unusual	ADJ	JJ	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
diffuse	diffuse	NOUN	NN	O
B	b	NOUN	NN	O
-	-	PUNCT	HYPH	O
cell	cell	NOUN	NN	O
gastric	gastric	ADJ	JJ	B-Disease
lymphoma	lymphoma	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
myotonic	myotonic	ADJ	JJ	B-Disease
dystrophy	dystrophy	NOUN	NN	I-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
form	form	NOUN	NN	O
of	of	ADP	IN	O
adult	adult	NOUN	NN	O
muscular	muscular	ADJ	JJ	B-Disease
dystrophy	dystrophy	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
sudden	sudden	ADJ	JJ	O
atrial	atrial	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
one	one	NUM	CD	O
cycle	cycle	NOUN	NN	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
based	base	VERB	VBN	O
chemotherapy	chemotherapy	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

Atrial	atrial	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
other	other	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
are	be	VERB	VBP	O
unusual	unusual	ADJ	JJ	O
complications	complication	NOUN	NNS	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
chemotherapy	chemotherapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
cardiac	cardiac	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
intrinsically	intrinsically	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
aggressive	aggressive	ADJ	JJ	O
chemotherapy	chemotherapy	NOUN	NN	O
employed	employ	VERB	VBN	O
could	could	VERB	MD	O
function	function	VERB	VB	O
as	as	ADP	IN	O
a	a	DET	DT	O
triggering	trigger	VERB	VBG	O
factor	factor	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
predisposed	predispose	VERB	VBN	O
myocardium	myocardium	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

Hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
immune	immune	ADJ	JJ	O
reaction	reaction	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
mechanism	mechanism	NOUN	NN	O
for	for	ADP	IN	O
dilevalol	dilevalol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
hepatitis	hepatitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
assess	assess	VERB	VB	O
lymphocyte	lymphocyte	ADJ	JJ	O
reactivity	reactivity	NOUN	NN	O
to	to	PART	TO	O
dilevalol	dilevalol	VERB	VB	B-Chemical
and	and	CCONJ	CC	O
to	to	PART	TO	O
serum	serum	ADV	RB	O
containing	contain	VERB	VBG	O
putative	putative	ADJ	JJ	O
ex	ex	NOUN	NN	O
vivo	vivo	NOUN	NNS	O
dilevalol	dilevalol	VERB	VBP	B-Chemical
antigens	antigen	NOUN	NNS	O
or	or	CCONJ	CC	O
metabolites	metabolite	NOUN	NNS	O
in	in	ADP	IN	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
dilevalol	dilevalol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
liver	liver	NOUN	NN	B-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

PATIENT	PATIENT	PROPN	NNP	O
:	:	PUNCT	:	O
A	a	DET	DT	O
58	58	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
dilevalol	dilevalol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
liver	liver	NOUN	NN	B-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Peripheral	peripheral	ADJ	JJ	O
blood	blood	NOUN	NN	O
mononuclear	mononuclear	NOUN	NN	O
cells	cell	NOUN	NNS	O
collected	collect	VERB	VBN	O
from	from	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
were	be	VERB	VBD	O
cultured	culture	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
solution	solution	NOUN	NN	O
of	of	ADP	IN	O
dilevalol	dilevalol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
also	also	ADV	RB	O
with	with	ADP	IN	O
sera	sera	NOUN	NN	O
collected	collect	VERB	VBN	O
from	from	ADP	IN	O
a	a	DET	DT	O
volunteer	volunteer	NOUN	NN	O
before	before	ADP	IN	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
dilevalol	dilevalol	NOUN	NN	B-Chemical
intake	intake	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
similar	similar	ADJ	JJ	O
protocol	protocol	NOUN	NN	O
was	be	VERB	VBD	O
performed	perform	VERB	VBN	O
with	with	ADP	IN	O
lymphocytes	lymphocyte	NOUN	NNS	O
from	from	ADP	IN	O
a	a	DET	DT	O
healthy	healthy	ADJ	JJ	O
subject	subject	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
No	no	DET	DT	O
lymphocyte	lymphocyte	NOUN	NN	O
proliferation	proliferation	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
either	either	CCONJ	CC	O
in	in	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
or	or	CCONJ	CC	O
in	in	ADP	IN	O
the	the	DET	DT	O
healthy	healthy	ADJ	JJ	O
volunteer	volunteer	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
dilevalol	dilevalol	NOUN	NN	B-Chemical
solutions	solution	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
significant	significant	ADJ	JJ	O
proliferative	proliferative	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
serum	serum	ADV	RB	O
collected	collect	VERB	VBN	O
after	after	ADP	IN	O
dilevalol	dilevalol	NOUN	NN	B-Chemical
intake	intake	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
proliferative	proliferative	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
serum	serum	NOUN	NN	O
collected	collect	VERB	VBN	O
before	before	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
intake	intake	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
reactivity	reactivity	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
when	when	ADV	WRB	O
lymphocytes	lymphocyte	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
healthy	healthy	ADJ	JJ	O
subject	subject	NOUN	NN	O
were	be	VERB	VBD	O
tested	test	VERB	VBN	O
under	under	ADP	IN	O
similar	similar	ADJ	JJ	O
conditions	condition	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
methodology	methodology	NOUN	NN	O
used	use	VERB	VBD	O
allowed	allow	VERB	VBN	O
the	the	DET	DT	O
detection	detection	NOUN	NN	O
of	of	ADP	IN	O
lymphocyte	lymphocyte	ADJ	JJ	O
sensitization	sensitization	NOUN	NN	O
to	to	ADP	IN	O
sera	sera	NOUN	NN	O
containing	contain	VERB	VBG	O
ex	ex	NOUN	NN	O
vivo	vivo	NOUN	NNS	O
-	-	PUNCT	HYPH	O
prepared	prepare	VERB	VBN	O
dilevalol	dilevalol	NOUN	NN	B-Chemical
antigens	antigen	NOUN	NNS	O
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
the	the	DET	DT	O
involvement	involvement	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
immunologic	immunologic	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
in	in	ADP	IN	O
dilevalol	dilevalol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
liver	liver	NOUN	NN	B-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Increased	increase	VERB	VBN	O
expression	expression	NOUN	NN	O
and	and	CCONJ	CC	O
apical	apical	ADJ	JJ	O
targeting	targeting	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
ENaC	ENaC	PROPN	NNP	O
subunits	subunit	NOUN	NNS	O
in	in	ADP	IN	O
puromycin	puromycin	ADJ	JJ	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
often	often	ADV	RB	O
accompanied	accompany	VERB	VBN	O
by	by	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
retention	retention	NOUN	NN	O
and	and	CCONJ	CC	O
generalized	generalize	VERB	VBN	O
edema	edema	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
molecular	molecular	ADJ	JJ	O
basis	basis	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
decreased	decrease	VERB	VBN	O
renal	renal	ADJ	JJ	O
sodium	sodium	NOUN	NN	B-Chemical
excretion	excretion	NOUN	NN	O
remains	remain	VERB	VBZ	O
undefined	undefined	ADJ	JJ	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
hypothesized	hypothesize	VERB	VBD	O
that	that	ADP	IN	O
epithelial	epithelial	ADJ	JJ	O
Na	Na	PROPN	NNP	B-Chemical
channel	channel	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ENaC	ENaC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
subunit	subunit	NOUN	NN	O
dysregulation	dysregulation	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
increased	increase	VERB	VBN	O
sodium	sodium	NOUN	NN	B-Chemical
retention	retention	NOUN	NN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
experimental	experimental	ADJ	JJ	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
rats	rat	NOUN	NNS	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
puromycin	puromycin	NOUN	NN	B-Chemical
aminonucleoside	aminonucleoside	ADP	IN	I-Chemical
(	(	PUNCT	-LRB-	O
PAN	PAN	PROPN	NNP	B-Chemical
;	;	PUNCT	:	O
180	180	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
iv	iv	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
received	receive	VERB	VBD	O
only	only	ADJ	JJ	O
vehicle	vehicle	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
,	,	PUNCT	,	O
PAN	PAN	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
induced	induce	VERB	VBD	O
significant	significant	ADJ	JJ	O
proteinuria	proteinuria	NOUN	NN	B-Disease
,	,	PUNCT	,	O
hypoalbuminemia	hypoalbuminemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
urinary	urinary	ADJ	JJ	O
sodium	sodium	NOUN	NN	B-Chemical
excretion	excretion	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
extensive	extensive	ADJ	JJ	O
ascites	ascite	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
protein	protein	NOUN	NN	O
abundance	abundance	NOUN	NN	O
of	of	ADP	IN	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
ENaC	enac	NOUN	NN	O
and	and	CCONJ	CC	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
ENaC	ENaC	PROPN	NNP	O
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
inner	inner	ADJ	JJ	O
stripe	stripe	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
outer	outer	ADJ	JJ	O
medulla	medulla	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ISOM	ISOM	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
the	the	DET	DT	O
inner	inner	ADJ	JJ	O
medulla	medulla	NOUN	NN	O
(	(	PUNCT	-LRB-	O
IM	IM	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
but	but	CCONJ	CC	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
altered	alter	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
cortex	cortex	NOUN	NN	O
.	.	PUNCT	.	O

gamma	gamma	NOUN	NN	O
-	-	PUNCT	HYPH	O
ENaC	enac	ADJ	JJ	O
abundance	abundance	NOUN	NN	O
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
cortex	cortex	NOUN	NN	O
,	,	PUNCT	,	O
ISOM	ISOM	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
IM	IM	PROPN	NNP	O
.	.	PUNCT	.	O

Immunoperoxidase	Immunoperoxidase	PROPN	NNP	O
brightfield	brightfield	NOUN	NN	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
laser	laser	NOUN	NN	O
-	-	PUNCT	HYPH	O
scanning	scan	VERB	VBG	O
confocal	confocal	ADJ	JJ	O
fluorescence	fluorescence	NOUN	NN	O
microscopy	microscopy	NOUN	NN	O
demonstrated	demonstrate	VERB	VBD	O
increased	increase	VERB	VBN	O
targeting	targeting	NOUN	NN	O
of	of	ADP	IN	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
ENaC	enac	NOUN	NN	O
,	,	PUNCT	,	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
ENaC	enac	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
gamma	gamma	NOUN	NN	O
-	-	PUNCT	HYPH	O
ENaC	ENaC	PROPN	NNP	O
subunits	subunit	NOUN	NNS	O
to	to	ADP	IN	O
the	the	DET	DT	O
apical	apical	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
membrane	membrane	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
distal	distal	ADJ	JJ	O
convoluted	convoluted	ADJ	JJ	O
tubule	tubule	NOUN	NN	O
(	(	PUNCT	-LRB-	O
DCT2	DCT2	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
connecting	connect	VERB	VBG	O
tubule	tubule	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
cortical	cortical	ADJ	JJ	O
and	and	CCONJ	CC	O
medullary	medullary	ADJ	JJ	O
collecting	collect	VERB	VBG	O
duct	duct	NOUN	NN	O
segments	segment	NOUN	NNS	O
.	.	PUNCT	.	O

Immunoelectron	immunoelectron	ADJ	JJ	O
microscopy	microscopy	NOUN	NN	O
further	further	ADV	RB	O
revealed	reveal	VERB	VBD	O
an	an	DET	DT	O
increased	increase	VERB	VBN	O
labeling	labeling	NOUN	NN	O
of	of	ADP	IN	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
ENaC	enac	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
apical	apical	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
membrane	membrane	NOUN	NN	O
of	of	ADP	IN	O
cortical	cortical	ADJ	JJ	O
collecting	collect	VERB	VBG	O
duct	duct	NOUN	NN	O
principal	principal	ADJ	JJ	O
cells	cell	NOUN	NNS	O
of	of	ADP	IN	O
PAN	PAN	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
indicating	indicate	VERB	VBG	O
enhanced	enhance	VERB	VBN	O
apical	apical	ADJ	JJ	O
targeting	targeting	NOUN	NN	O
of	of	ADP	IN	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
ENaC	enac	NUM	CD	O
subunits	subunit	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
protein	protein	NOUN	NN	O
abundances	abundance	NOUN	NNS	O
of	of	ADP	IN	O
Na	Na	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
/	/	SYM	SYM	O
H	h	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
exchanger	exchanger	NOUN	NN	O
type	type	NOUN	NN	O
3	3	NUM	CD	O
(	(	PUNCT	-LRB-	O
NHE3	NHE3	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
Na	Na	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	:	O
K	K	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	:	O
2Cl	2cl	NUM	CD	B-Chemical
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
cotransporter	cotransporter	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BSC	BSC	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
thiazide	thiazide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
sensitive	sensitive	ADJ	JJ	O
Na	Na	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	:	O
Cl	cl	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
cotransporter	cotransporter	NOUN	NN	O
(	(	PUNCT	-LRB-	O
TSC	TSC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
abundance	abundance	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
alpha	alpha	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
subunit	subunit	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
Na	Na	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
K	K	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
ATPase	ATPase	PROPN	NNP	O
was	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
cortex	cortex	NOUN	NN	O
and	and	CCONJ	CC	O
ISOM	ISOM	PROPN	NNP	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
it	-PRON-	PRON	PRP	O
remained	remain	VERB	VBD	O
unchanged	unchanged	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
IM	IM	PROPN	NNP	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
increased	increase	VERB	VBN	O
or	or	CCONJ	CC	O
sustained	sustain	VERB	VBN	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
ENaC	enac	NUM	CD	O
subunits	subunit	NOUN	NNS	O
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
increased	increase	VERB	VBN	O
apical	apical	ADJ	JJ	O
targeting	targeting	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
DCT2	DCT2	PROPN	NNP	O
,	,	PUNCT	,	O
connecting	connect	VERB	VBG	O
tubule	tubule	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
collecting	collect	VERB	VBG	O
duct	duct	NOUN	NN	O
are	be	VERB	VBP	O
likely	likely	ADJ	JJ	O
to	to	PART	TO	O
play	play	VERB	VB	O
a	a	DET	DT	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
sodium	sodium	NOUN	NN	B-Chemical
retention	retention	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
PAN	PAN	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
decreased	decrease	VERB	VBN	O
abundance	abundance	NOUN	NN	O
of	of	ADP	IN	O
NHE3	NHE3	PROPN	NNP	O
,	,	PUNCT	,	O
BSC	BSC	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	PROPN	NNP	O
,	,	PUNCT	,	O
TSC	TSC	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
Na	Na	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
K	K	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
ATPase	ATPase	PROPN	NNP	O
may	may	VERB	MD	O
play	play	VERB	VB	O
a	a	DET	DT	O
compensatory	compensatory	ADJ	JJ	O
role	role	NOUN	NN	O
to	to	PART	TO	O
promote	promote	VERB	VB	O
sodium	sodium	NOUN	NN	B-Chemical
excretion	excretion	NOUN	NN	O
.	.	PUNCT	.	O

Pallidal	pallidal	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
:	:	PUNCT	:	O
an	an	DET	DT	O
alternative	alternative	NOUN	NN	O
to	to	ADP	IN	O
pallidotomy	pallidotomy	NOUN	NN	O
?	?	PUNCT	.	O

A	a	DET	DT	O
resurgence	resurgence	NOUN	NN	O
of	of	ADP	IN	O
interest	interest	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
surgical	surgical	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
PD	PD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
came	come	VERB	VBD	O
with	with	ADP	IN	O
the	the	DET	DT	O
rediscovery	rediscovery	NOUN	NN	O
of	of	ADP	IN	O
posteroventral	posteroventral	ADJ	JJ	O
pallidotomy	pallidotomy	NOUN	NN	O
by	by	ADP	IN	O
Laitinen	Laitinen	PROPN	NNP	O
in	in	ADP	IN	O
1985	1985	NUM	CD	O
.	.	PUNCT	.	O

Laitinen	laitinen	NOUN	NN	O
'	'	PUNCT	''	O
s	s	PART	POS	O
procedure	procedure	NOUN	NN	O
improved	improve	VERB	VBD	O
most	most	ADJ	JJS	O
symptoms	symptom	NOUN	NNS	O
in	in	ADP	IN	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
resistant	resistant	ADJ	JJ	O
PD	pd	NOUN	NN	B-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
engendered	engender	VERB	VBD	O
wide	wide	ADJ	JJ	O
interest	interest	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
neurosurgical	neurosurgical	ADJ	JJ	O
community	community	NOUN	NN	O
.	.	PUNCT	.	O

Another	another	DET	DT	O
lesioning	lesione	VERB	VBG	O
procedure	procedure	NOUN	NN	O
,	,	PUNCT	,	O
ventrolateral	ventrolateral	ADJ	JJ	O
thalamotomy	thalamotomy	NOUN	NN	O
,	,	PUNCT	,	O
has	have	VERB	VBZ	O
become	become	VERB	VBN	O
a	a	DET	DT	O
powerful	powerful	ADJ	JJ	O
alternative	alternative	NOUN	NN	O
to	to	PART	TO	O
stimulate	stimulate	VERB	VB	O
the	the	DET	DT	O
nucleus	nucleus	NOUN	NN	O
ventralis	ventralis	X	FW	O
intermedius	intermedius	NOUN	NN	O
,	,	PUNCT	,	O
producing	produce	VERB	VBG	O
high	high	ADJ	JJ	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
success	success	NOUN	NN	O
rates	rate	NOUN	NNS	O
and	and	CCONJ	CC	O
low	low	ADJ	JJ	O
morbidity	morbidity	NOUN	NN	O
rates	rate	NOUN	NNS	O
.	.	PUNCT	.	O

Pallidal	Pallidal	PROPN	NNP	O
stimulation	stimulation	NOUN	NN	O
has	have	VERB	VBZ	O
not	not	ADV	RB	O
met	meet	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
success	success	NOUN	NN	O
.	.	PUNCT	.	O

According	accord	VERB	VBG	O
to	to	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
pallidotomy	pallidotomy	NOUN	NN	O
improves	improve	VERB	VBZ	O
the	the	DET	DT	O
"	"	PUNCT	``	O
on	on	ADP	IN	O
"	"	PUNCT	``	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
PD	PD	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
the	the	DET	DT	O
"	"	PUNCT	``	O
off	off	ADP	IN	O
"	"	PUNCT	``	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
rigidity	rigidity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
bradykinesia	bradykinesia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
on	on	ADP	IN	O
-	-	PUNCT	HYPH	O
off	off	PART	RP	O
fluctuations	fluctuation	NOUN	NNS	O
.	.	PUNCT	.	O

Pallidal	pallidal	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
improves	improve	VERB	VBZ	O
bradykinesia	bradykinesia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
rigidity	rigidity	NOUN	NN	B-Disease
to	to	ADP	IN	O
a	a	DET	DT	O
minor	minor	ADJ	JJ	O
extent	extent	NOUN	NN	O
;	;	PUNCT	:	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
its	-PRON-	DET	PRP$	O
strength	strength	NOUN	NN	O
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
in	in	ADP	IN	O
improving	improve	VERB	VBG	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Stimulation	stimulation	NOUN	NN	O
often	often	ADV	RB	O
produces	produce	VERB	VBZ	O
an	an	DET	DT	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
hyper	hyper	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
or	or	CCONJ	CC	I-Disease
dyskinetic	dyskinetic	ADJ	JJ	I-Disease
upper	upper	ADJ	JJ	O
limbs	limb	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
increases	increase	VERB	VBZ	O
the	the	DET	DT	O
"	"	PUNCT	``	O
freezing	freezing	ADJ	JJ	O
"	"	PUNCT	''	O
phenomenon	phenomenon	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
lower	low	ADJ	JJR	O
limbs	limb	NOUN	NNS	O
at	at	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
time	time	NOUN	NN	O
.	.	PUNCT	.	O

Considering	consider	VERB	VBG	O
the	the	DET	DT	O
small	small	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
independence	independence	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
high	high	ADJ	JJ	O
costs	cost	NOUN	NNS	O
of	of	ADP	IN	O
bilateral	bilateral	ADJ	JJ	O
implants	implant	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
difficulty	difficulty	NOUN	NN	O
most	most	ADJ	JJS	O
patients	patient	NOUN	NNS	O
experience	experience	VERB	VBP	O
in	in	ADP	IN	O
handling	handle	VERB	VBG	O
the	the	DET	DT	O
devices	device	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
question	question	NOUN	NN	O
arises	arise	VERB	VBZ	O
as	as	ADP	IN	O
to	to	ADP	IN	O
whether	whether	ADP	IN	O
bilateral	bilateral	ADJ	JJ	O
pallidal	pallidal	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
real	real	ADJ	JJ	O
alternative	alternative	NOUN	NN	O
to	to	ADP	IN	O
pallidotomy	pallidotomy	NOUN	NN	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
cyclooxygenase	cyclooxygenase	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
specific	specific	ADJ	JJ	O
inhibitor	inhibitor	NOUN	NN	O
valdecoxib	valdecoxib	NOUN	NN	B-Chemical
versus	versus	ADP	IN	O
nonsteroidal	nonsteroidal	ADJ	JJ	O
antiinflammatory	antiinflammatory	ADJ	JJ	O
agents	agent	NOUN	NNS	O
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
on	on	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	O
thrombotic	thrombotic	ADJ	JJ	B-Disease
events	event	NOUN	NNS	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
arthritis	arthritis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

There	there	ADV	EX	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
concerns	concern	NOUN	NNS	O
that	that	ADP	IN	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	O
thrombotic	thrombotic	ADJ	JJ	B-Disease
events	event	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
higher	high	ADJ	JJR	O
with	with	ADP	IN	O
cyclooxygenase	cyclooxygenase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
COX	COX	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
specific	specific	ADJ	JJ	O
inhibitors	inhibitor	NOUN	NNS	O
than	than	ADP	IN	O
nonselective	nonselective	ADJ	JJ	O
nonsteroidal	nonsteroidal	ADJ	JJ	O
antiinflammatory	antiinflammatory	NOUN	NN	O
drugs	drug	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
NSAIDs	nsaid	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
evaluated	evaluate	VERB	VBD	O
cardiovascular	cardiovascular	ADJ	JJ	O
event	event	NOUN	NN	O
data	datum	NOUN	NNS	O
for	for	ADP	IN	O
valdecoxib	valdecoxib	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
COX	COX	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
specific	specific	ADJ	JJ	O
inhibitor	inhibitor	NOUN	NN	O
in	in	ADP	IN	O
approximately	approximately	ADV	RB	O
8000	8000	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
osteoarthritis	osteoarthritis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
rheumatoid	rheumatoid	VERB	VB	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
this	this	DET	DT	O
agent	agent	NOUN	NN	O
in	in	ADP	IN	O
randomized	randomize	VERB	VBN	O
clinical	clinical	ADJ	JJ	O
trials	trial	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	O
thrombotic	thrombotic	ADJ	JJ	B-Disease
events	event	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
cardiac	cardiac	ADJ	JJ	O
,	,	PUNCT	,	O
cerebrovascular	cerebrovascular	ADJ	JJ	O
and	and	CCONJ	CC	O
peripheral	peripheral	ADJ	JJ	O
vascular	vascular	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
arterial	arterial	ADJ	JJ	O
thrombotic	thrombotic	ADJ	JJ	B-Disease
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
determined	determine	VERB	VBN	O
by	by	ADP	IN	O
analyzing	analyze	VERB	VBG	O
pooled	pool	VERB	VBN	O
valdecoxib	valdecoxib	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
-	-	SYM	SYM	O
80	80	NUM	CD	O
mg	mg	NOUN	NN	O
daily	daily	ADV	RB	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
nonselective	nonselective	ADJ	JJ	O
NSAID	NSAID	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
diclofenac	diclofenac	NOUN	NN	B-Chemical
75	75	NUM	CD	O
mg	mg	NOUN	NN	O
bid	bid	NOUN	NN	O
,	,	PUNCT	,	O
ibuprofen	ibuprofen	VERB	VB	B-Chemical
800	800	NUM	CD	O
mg	mg	NOUN	NN	O
tid	tid	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
naproxen	naproxen	ADJ	JJ	B-Chemical
500	500	NUM	CD	O
mg	mg	NOUN	NN	O
bid	bid	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
data	datum	NOUN	NNS	O
from	from	ADP	IN	O
10	10	NUM	CD	O
randomized	randomize	VERB	VBN	O
osteoarthritis	osteoarthritis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
rheumatoid	rheumatoid	VERB	VB	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
trials	trial	NOUN	NNS	O
that	that	DET	WDT	O
were	be	VERB	VBD	O
6	6	NUM	CD	O
-	-	SYM	SYM	O
52	52	NUM	CD	O
weeks	week	NOUN	NNS	O
in	in	ADP	IN	O
duration	duration	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
rates	rate	NOUN	NNS	O
of	of	ADP	IN	O
events	event	NOUN	NNS	O
were	be	VERB	VBD	O
determined	determine	VERB	VBN	O
in	in	ADP	IN	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
7934	7934	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
users	user	NOUN	NNS	O
of	of	ADP	IN	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
(	(	PUNCT	-LRB-	O
<	<	X	XX	O
or	or	CCONJ	CC	O
=	=	SYM	SYM	O
325	325	NUM	CD	O
mg	mg	NOUN	NN	O
daily	daily	ADV	RB	O
)	)	PUNCT	-RRB-	O
aspirin	aspirin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
1051	1051	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
nonusers	nonuser	NOUN	NNS	O
of	of	ADP	IN	O
aspirin	aspirin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	NOUN	NNS	O
6883	6883	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Crude	crude	NOUN	NN	O
and	and	CCONJ	CC	O
exposure	exposure	NOUN	NN	O
-	-	PUNCT	HYPH	O
adjusted	adjust	VERB	VBN	O
incidences	incidence	NOUN	NNS	O
of	of	ADP	IN	O
thrombotic	thrombotic	ADJ	JJ	B-Disease
events	event	NOUN	NNS	O
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
for	for	ADP	IN	O
valdecoxib	valdecoxib	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
NSAIDs	nsaid	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
serious	serious	ADJ	JJ	O
thrombotic	thrombotic	ADJ	JJ	B-Disease
events	event	NOUN	NNS	O
was	be	VERB	VBD	O
also	also	ADV	RB	O
similar	similar	ADJ	JJ	O
for	for	ADP	IN	O
each	each	DET	DT	O
valdecoxib	valdecoxib	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
.	.	PUNCT	.	O

Thrombotic	thrombotic	ADJ	JJ	B-Disease
risk	risk	NOUN	NN	O
was	be	VERB	VBD	O
consistently	consistently	ADV	RB	O
higher	high	ADJ	JJR	O
for	for	ADP	IN	O
users	user	NOUN	NNS	O
of	of	ADP	IN	O
aspirin	aspirin	ADJ	JJ	B-Chemical
users	user	NOUN	NNS	O
than	than	ADP	IN	O
nonusers	nonuser	NOUN	NNS	O
of	of	ADP	IN	O
aspirin	aspirin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
placebo	placebo	NOUN	NN	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
;	;	PUNCT	,	O
valdecoxib	valdecoxib	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
;	;	PUNCT	:	O
NSAIDs	nsaid	NOUN	NNS	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
rates	rate	NOUN	NNS	O
of	of	ADP	IN	O
events	event	NOUN	NNS	O
in	in	ADP	IN	O
users	user	NOUN	NNS	O
of	of	ADP	IN	O
aspirin	aspirin	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
for	for	ADP	IN	O
all	all	DET	DT	O
3	3	NUM	CD	O
treatment	treatment	NOUN	NN	O
groups	group	NOUN	NNS	O
and	and	CCONJ	CC	O
across	across	ADP	IN	O
valdecoxib	valdecoxib	NOUN	NN	B-Chemical
doses	dose	NOUN	NNS	O
.	.	PUNCT	.	O

Short	Short	PROPN	NNP	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
intermediate	intermediate	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
therapeutic	therapeutic	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
or	or	CCONJ	CC	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
daily	daily	ADV	RB	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
supratherapeutic	supratherapeutic	NOUN	NN	O
(	(	PUNCT	-LRB-	O
40	40	NUM	CD	O
or	or	CCONJ	CC	O
80	80	NUM	CD	O
mg	mg	NOUN	NN	O
daily	daily	ADV	RB	O
)	)	PUNCT	-RRB-	O
valdecoxib	valdecoxib	NOUN	NN	B-Chemical
doses	dose	NOUN	NNS	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
increased	increase	VERB	VBN	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
thrombotic	thrombotic	ADJ	JJ	B-Disease
events	event	NOUN	NNS	O
relative	relative	ADJ	JJ	O
to	to	ADP	IN	O
nonselective	nonselective	ADJ	JJ	O
NSAIDs	nsaid	NOUN	NNS	O
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
in	in	ADP	IN	O
osteoarthritis	osteoarthritis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
rheumatoid	rheumatoid	VERB	VB	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
controlled	control	VERB	VBN	O
clinical	clinical	ADJ	JJ	O
trials	trial	NOUN	NNS	O
.	.	PUNCT	.	O

Hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
myocarditis	myocarditis	NOUN	NN	B-Disease
complicating	complicate	VERB	VBG	O
hypertrophic	hypertrophic	ADJ	JJ	B-Disease
cardiomyopathy	cardiomyopathy	ADJ	JJ	I-Disease
heart	heart	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
report	report	NOUN	NN	O
describes	describe	VERB	VBZ	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
eosinophilic	eosinophilic	NOUN	NN	B-Disease
myocarditis	myocarditis	NOUN	NN	I-Disease
complicating	complicate	VERB	VBG	O
hypertrophic	hypertrophic	ADJ	JJ	B-Disease
cardiomyopathy	cardiomyopathy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
47	47	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
female	female	ADJ	JJ	O
patient	patient	NOUN	NN	O
,	,	PUNCT	,	O
known	know	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
hypertrophic	hypertrophic	ADJ	JJ	B-Disease
cardiomyopathy	cardiomyopathy	NOUN	NN	I-Disease
,	,	PUNCT	,	O
was	be	VERB	VBD	O
admitted	admit	VERB	VBN	O
with	with	ADP	IN	O
biventricular	biventricular	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
managed	manage	VERB	VBD	O
aggressively	aggressively	ADV	RB	O
with	with	ADP	IN	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
infusion	infusion	NOUN	NN	O
and	and	CCONJ	CC	O
other	other	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
while	while	ADP	IN	O
being	be	VERB	VBG	O
assessed	assess	VERB	VBN	O
for	for	ADP	IN	O
heart	heart	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
transthoracic	transthoracic	NOUN	NN	O
echocardiogram	echocardiogram	NOUN	NN	O
,	,	PUNCT	,	O
she	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
moderate	moderate	ADJ	JJ	O
left	leave	VERB	VBN	B-Disease
ventricular	ventricular	ADJ	JJ	I-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
with	with	ADP	IN	O
regional	regional	ADJ	JJ	O
variability	variability	NOUN	NN	O
and	and	CCONJ	CC	O
moderate	moderate	ADJ	JJ	O
mitral	mitral	ADJ	JJ	B-Disease
regurgitation	regurgitation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
recipient	recipient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
heart	heart	NOUN	NN	O
showed	show	VERB	VBD	O
the	the	DET	DT	O
features	feature	NOUN	NNS	O
of	of	ADP	IN	O
apical	apical	ADJ	JJ	O
hypertrophic	hypertrophic	ADJ	JJ	B-Disease
cardiomyopathy	cardiomyopathy	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
myocarditis	myocarditis	NOUN	NN	B-Disease
with	with	ADP	IN	O
abundant	abundant	ADJ	JJ	O
eosinophils	eosinophil	NOUN	NNS	O
.	.	PUNCT	.	O

Myocarditis	Myocarditis	PROPN	NNP	B-Disease
is	be	VERB	VBZ	O
rare	rare	ADJ	JJ	O
and	and	CCONJ	CC	O
eosinophilic	eosinophilic	ADJ	JJ	B-Disease
myocarditis	myocarditis	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
rarer	rare	ADJ	JJR	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
likely	likely	ADJ	JJ	O
that	that	ADP	IN	O
the	the	DET	DT	O
hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
eosinophilic	eosinophilic	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
myocarditis	myocarditis	NOUN	NN	B-Disease
was	be	VERB	VBD	O
related	relate	VERB	VBN	O
to	to	PART	TO	O
dobutamine	dobutamine	VERB	VB	B-Chemical
infusion	infusion	NOUN	NN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Eosinophilic	eosinophilic	ADJ	JJ	B-Disease
myocarditis	myocarditis	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
to	to	ADP	IN	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
in	in	ADP	IN	O
explanted	explante	VERB	VBN	O
hearts	heart	NOUN	NNS	O
and	and	CCONJ	CC	O
may	may	VERB	MD	O
be	be	VERB	VB	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
multidrug	multidrug	NOUN	NN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Time	time	NOUN	NN	O
trends	trend	NOUN	NNS	O
in	in	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
hemorrhage	hemorrhage	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
annual	annual	ADJ	JJ	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
bleeding	bleeding	NOUN	NN	B-Disease
at	at	ADP	IN	O
Brigham	Brigham	PROPN	NNP	O
and	and	CCONJ	CC	O
Women	Women	PROPN	NNP	O
'	'	PART	POS	O
s	s	PROPN	NNP	O
Hospital	Hospital	PROPN	NNP	O
increased	increase	VERB	VBD	O
from	from	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
97	97	NUM	CD	O
/	/	SYM	SYM	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
000	000	NUM	CD	O
patient	patient	ADJ	JJ	O
admissions	admission	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
time	time	NOUN	NN	O
period	period	NOUN	NN	O
(	(	PUNCT	-LRB-	O
January	January	PROPN	NNP	O
1995	1995	NUM	CD	O
to	to	ADP	IN	O
October	October	PROPN	NNP	O
1998	1998	NUM	CD	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
19	19	NUM	CD	O
/	/	SYM	SYM	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
000	000	NUM	CD	O
patient	patient	ADJ	JJ	O
admissions	admission	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
second	second	ADJ	JJ	O
time	time	NOUN	NN	O
period	period	NOUN	NN	O
(	(	PUNCT	-LRB-	O
November	November	PROPN	NNP	O
1998	1998	NUM	CD	O
to	to	ADP	IN	O
August	August	PROPN	NNP	O
2002	2002	NUM	CD	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
proportion	proportion	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
major	major	ADJ	JJ	O
and	and	CCONJ	CC	O
intracranial	intracranial	ADJ	JJ	B-Disease
bleeding	bleeding	NOUN	NN	I-Disease
increased	increase	VERB	VBD	O
from	from	ADP	IN	O
20	20	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
time	time	NOUN	NN	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
to	to	ADP	IN	O
33	33	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
second	second	NOUN	NN	O
.	.	PUNCT	.	O

Yohimbine	yohimbine	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
sexual	sexual	ADJ	JJ	B-Disease
side	side	NOUN	NN	I-Disease
effects	effect	NOUN	NNS	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
serotonin	serotonin	NOUN	NN	B-Chemical
reuptake	reuptake	NOUN	NN	O
blockers	blocker	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Preclinical	preclinical	ADJ	JJ	O
and	and	CCONJ	CC	O
clinical	clinical	ADJ	JJ	O
studies	study	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
facilitates	facilitate	VERB	VBZ	O
sexual	sexual	ADJ	JJ	O
behavior	behavior	NOUN	NN	O
and	and	CCONJ	CC	O
may	may	VERB	MD	O
be	be	VERB	VB	O
helpful	helpful	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
male	male	ADJ	JJ	B-Disease
impotence	impotence	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
single	single	ADJ	JJ	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
treat	treat	VERB	VB	O
the	the	DET	DT	O
sexual	sexual	ADJ	JJ	B-Disease
side	side	NOUN	NN	I-Disease
effects	effect	NOUN	NNS	I-Disease
of	of	ADP	IN	O
clomipramine	clomipramine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
evaluated	evaluate	VERB	VBD	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
as	as	ADP	IN	O
a	a	DET	DT	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
sexual	sexual	ADJ	JJ	B-Disease
side	side	NOUN	NN	I-Disease
effects	effect	NOUN	NNS	I-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
serotonin	serotonin	NOUN	NN	B-Chemical
reuptake	reuptake	NOUN	NN	O
blockers	blocker	NOUN	NNS	O
.	.	PUNCT	.	O

METHOD	method	NOUN	NN	O
:	:	PUNCT	:	O
Six	six	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
either	either	DET	DT	O
obsessive	obsessive	ADJ	JJ	B-Disease
compulsive	compulsive	ADJ	JJ	I-Disease
disorder	disorder	NOUN	NN	I-Disease
,	,	PUNCT	,	O
trichotillomania	trichotillomania	NOUN	NN	B-Disease
,	,	PUNCT	,	O
anxiety	anxiety	NOUN	NN	B-Disease
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
affective	affective	ADJ	JJ	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
who	who	PRON	WP	O
suffered	suffer	VERB	VBD	O
sexual	sexual	ADJ	JJ	B-Disease
side	side	NOUN	NN	I-Disease
effects	effect	NOUN	NNS	I-Disease
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
serotonin	serotonin	NOUN	NN	B-Chemical
reuptake	reuptake	NOUN	NN	O
blockers	blocker	NOUN	NNS	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
a	a	DET	DT	O
p	p	NOUN	NN	O
.	.	PUNCT	.	O
r	r	NOUN	NN	O
.	.	PUNCT	.	O
n	n	ADV	RB	O
.	.	PUNCT	.	O
basis	basis	NOUN	NN	O
in	in	ADP	IN	O
an	an	DET	DT	O
open	open	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
trial	trial	NOUN	NN	O
.	.	PUNCT	.	O

Various	various	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
ideal	ideal	ADJ	JJ	O
dose	dose	NOUN	NN	O
for	for	ADP	IN	O
each	each	DET	DT	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Five	five	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
six	six	NUM	CD	O
patients	patient	NOUN	NNS	O
experienced	experience	VERB	VBD	O
improved	improve	VERB	VBN	O
sexual	sexual	ADJ	JJ	O
functioning	functioning	NOUN	NN	O
after	after	ADP	IN	O
taking	take	VERB	VBG	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

One	one	NUM	CD	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
failed	fail	VERB	VBD	O
to	to	PART	TO	O
comply	comply	VERB	VB	O
with	with	ADP	IN	O
yohimbine	yohimbine	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
had	have	VERB	VBD	O
no	no	DET	DT	O
therapeutic	therapeutic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

Side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
included	include	VERB	VBD	O
excessive	excessive	ADJ	JJ	O
sweating	sweating	NOUN	NN	O
,	,	PUNCT	,	O
increased	increase	VERB	VBN	O
anxiety	anxiety	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
wound	wound	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
feeling	feeling	NOUN	NN	O
in	in	ADP	IN	O
some	some	DET	DT	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
sexual	sexual	ADJ	JJ	B-Disease
side	side	NOUN	NN	I-Disease
effects	effect	NOUN	NNS	I-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
serotonin	serotonin	NOUN	NN	B-Chemical
reuptake	reuptake	NOUN	NN	O
blockers	blocker	NOUN	NNS	O
.	.	PUNCT	.	O

Future	future	NOUN	NN	O
controlled	control	VERB	VBN	O
studies	study	NOUN	NNS	O
are	be	VERB	VBP	O
needed	need	VERB	VBN	O
to	to	PART	TO	O
further	further	ADV	RB	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
effectiveness	effectiveness	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
of	of	ADP	IN	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
this	this	DET	DT	O
indication	indication	NOUN	NN	O
.	.	PUNCT	.	O

Hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
complicating	complicate	VERB	VBG	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

Hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
potentially	potentially	ADV	RB	O
serious	serious	ADJ	JJ	O
complication	complication	NOUN	NN	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
administered	administer	VERB	VBN	O
before	before	ADP	IN	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

As	as	ADP	IN	O
standard	standard	ADJ	JJ	O
practice	practice	NOUN	NN	O
at	at	ADP	IN	O
our	-PRON-	DET	PRP$	O
institution	institution	NOUN	NN	O
,	,	PUNCT	,	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
are	be	VERB	VBP	O
scheduled	schedule	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
a	a	DET	DT	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplant	transplant	NOUN	NN	O
are	be	VERB	VBP	O
treated	treat	VERB	VBN	O
prophylactically	prophylactically	ADV	RB	O
with	with	ADP	IN	O
forced	force	VERB	VBN	O
hydration	hydration	NOUN	NN	O
and	and	CCONJ	CC	O
bladder	bladder	NOUN	NN	O
irrigation	irrigation	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
an	an	DET	DT	O
attempt	attempt	NOUN	NN	O
to	to	PART	TO	O
obviate	obviate	VERB	VB	O
the	the	DET	DT	O
inconvenience	inconvenience	NOUN	NN	O
of	of	ADP	IN	O
bladder	bladder	NOUN	NN	O
irrigation	irrigation	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
conducted	conduct	VERB	VBD	O
a	a	DET	DT	O
feasibility	feasibility	NOUN	NN	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
uroprophylaxis	uroprophylaxis	NOUN	NN	O
with	with	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
neutralizes	neutralize	VERB	VBZ	O
the	the	DET	DT	O
hepatic	hepatic	ADJ	JJ	O
metabolite	metabolite	NOUN	NN	O
of	of	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
that	that	DET	WDT	O
causes	cause	VERB	VBZ	O
hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Of	of	ADP	IN	O
97	97	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
received	receive	VERB	VBD	O
standard	standard	ADJ	JJ	O
prophylaxis	prophylaxis	NOUN	NN	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
had	have	VERB	VBD	O
symptomatic	symptomatic	ADJ	JJ	O
hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
two	two	NUM	CD	O
of	of	ADP	IN	O
four	four	NUM	CD	O
consecutive	consecutive	ADJ	JJ	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
received	receive	VERB	VBD	O
mesna	mesna	ADJ	JJ	B-Chemical
uroprophylaxis	uroprophylaxis	ADJ	JJ	O
before	before	ADP	IN	O
allogeneic	allogeneic	ADJ	JJ	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
had	have	VERB	VBD	O
severe	severe	ADJ	JJ	O
hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
for	for	ADP	IN	O
at	at	ADV	RB	O
least	least	ADV	RBS	O
2	2	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

Because	because	ADP	IN	O
of	of	ADP	IN	O
this	this	DET	DT	O
suboptimal	suboptimal	ADJ	JJ	O
result	result	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
resumed	resume	VERB	VBD	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
bladder	bladder	NOUN	NN	O
irrigation	irrigation	NOUN	NN	O
and	and	CCONJ	CC	O
forced	force	VERB	VBN	O
hydration	hydration	NOUN	NN	O
to	to	PART	TO	O
minimize	minimize	VERB	VB	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Consensus	consensus	NOUN	NN	O
statement	statement	NOUN	NN	O
concerning	concern	VERB	VBG	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
occurring	occur	VERB	VBG	O
during	during	ADP	IN	O
haematopoietic	haematopoietic	ADJ	JJ	O
stem	stem	NOUN	NN	O
cell	cell	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
autoimmune	autoimmune	ADJ	JJ	B-Disease
diseases	disease	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
with	with	ADP	IN	O
special	special	ADJ	JJ	O
reference	reference	NOUN	NN	O
to	to	ADP	IN	O
systemic	systemic	ADJ	JJ	B-Disease
sclerosis	sclerosis	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
multiple	multiple	ADJ	JJ	B-Disease
sclerosis	sclerosis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Autologous	autologous	ADJ	JJ	O
haematopoietic	haematopoietic	ADJ	JJ	O
stem	stem	NOUN	NN	O
cell	cell	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
is	be	VERB	VBZ	O
now	now	ADV	RB	O
a	a	DET	DT	O
feasible	feasible	ADJ	JJ	O
and	and	CCONJ	CC	O
effective	effective	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
selected	select	VERB	VBN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
autoimmune	autoimmune	ADJ	JJ	B-Disease
diseases	disease	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Worldwide	worldwide	ADV	RB	O
,	,	PUNCT	,	O
over	over	ADP	IN	O
650	650	NUM	CD	O
patients	patient	NOUN	NNS	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
transplanted	transplant	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
context	context	NOUN	NN	O
of	of	ADP	IN	O
phase	phase	NOUN	NN	O
I	I	PROPN	NNP	O
and	and	CCONJ	CC	O
II	II	PROPN	NNP	O
clinical	clinical	ADJ	JJ	O
trials	trial	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
are	be	VERB	VBP	O
encouraging	encourage	VERB	VBG	O
enough	enough	ADV	RB	O
to	to	PART	TO	O
begin	begin	VERB	VB	O
randomised	randomise	VERB	VBN	O
phase	phase	NOUN	NN	O
III	iii	NUM	CD	O
trials	trial	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
predicted	predict	VERB	VBN	O
,	,	PUNCT	,	O
significant	significant	ADJ	JJ	O
transplant	transplant	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
morbidity	morbidity	NOUN	NN	O
and	and	CCONJ	CC	O
mortality	mortality	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
primarily	primarily	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
complications	complication	NOUN	NNS	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
either	either	CCONJ	CC	O
the	the	DET	DT	O
stage	stage	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
disease	disease	NOUN	NN	O
at	at	ADP	IN	O
transplant	transplant	NOUN	NN	O
or	or	CCONJ	CC	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
infections	infection	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
deaths	death	NOUN	NNS	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
low	low	ADJ	JJ	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
caution	caution	NOUN	NN	O
is	be	VERB	VBZ	O
required	require	VERB	VBN	O
when	when	ADV	WRB	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
anthracyclines	anthracycline	NOUN	NNS	B-Chemical
such	such	ADJ	JJ	O
as	as	ADP	IN	O
mitoxantrone	mitoxantrone	NOUN	NN	B-Chemical
are	be	VERB	VBP	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
underlying	underlie	VERB	VBG	O
heart	heart	NOUN	NN	B-Disease
damage	damage	NOUN	NN	I-Disease
,	,	PUNCT	,	O
for	for	ADP	IN	O
example	example	NOUN	NN	O
,	,	PUNCT	,	O
systemic	systemic	ADJ	JJ	B-Disease
sclerosis	sclerosis	NOUN	NN	I-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
November	November	PROPN	NNP	O
2002	2002	NUM	CD	O
,	,	PUNCT	,	O
a	a	DET	DT	O
meeting	meeting	NOUN	NN	O
was	be	VERB	VBD	O
held	hold	VERB	VBN	O
in	in	ADP	IN	O
Florence	Florence	PROPN	NNP	O
,	,	PUNCT	,	O
bringing	bring	VERB	VBG	O
together	together	ADV	RB	O
a	a	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
experts	expert	NOUN	NNS	O
in	in	ADP	IN	O
various	various	ADJ	JJ	O
fields	field	NOUN	NNS	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
rheumatology	rheumatology	NOUN	NN	O
,	,	PUNCT	,	O
cardiology	cardiology	NOUN	NN	O
,	,	PUNCT	,	O
neurology	neurology	NOUN	NN	O
,	,	PUNCT	,	O
pharmacology	pharmacology	NOUN	NN	O
and	and	CCONJ	CC	O
transplantation	transplantation	NOUN	NN	O
medicine	medicine	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
object	object	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
meeting	meeting	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
analyse	analyse	VERB	VB	O
existing	exist	VERB	VBG	O
data	datum	NOUN	NNS	O
,	,	PUNCT	,	O
both	both	CCONJ	CC	O
published	publish	VERB	VBN	O
or	or	CCONJ	CC	O
available	available	ADJ	JJ	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
European	European	PROPN	NNP	O
Group	Group	PROPN	NNP	O
for	for	ADP	IN	O
Blood	Blood	PROPN	NNP	O
and	and	CCONJ	CC	O
Marrow	Marrow	PROPN	NNP	O
Transplantation	Transplantation	PROPN	NNP	O
autoimmune	autoimmune	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
database	database	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
propose	propose	VERB	VB	O
a	a	DET	DT	O
safe	safe	ADJ	JJ	O
approach	approach	NOUN	NN	O
to	to	ADP	IN	O
such	such	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
full	full	ADJ	JJ	O
cardiological	cardiological	ADJ	JJ	O
assessment	assessment	NOUN	NN	O
before	before	ADP	IN	O
and	and	CCONJ	CC	O
during	during	ADP	IN	O
the	the	DET	DT	O
transplant	transplant	NOUN	NN	O
emerged	emerge	VERB	VBD	O
as	as	ADP	IN	O
the	the	DET	DT	O
major	major	ADJ	JJ	O
recommendation	recommendation	NOUN	NN	O
.	.	PUNCT	.	O

Does	do	VERB	VBZ	O
supplemental	supplemental	ADJ	JJ	O
vitamin	vitamin	NOUN	NN	B-Chemical
C	c	NOUN	NN	I-Chemical
increase	increase	VERB	VBP	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
risk	risk	NOUN	NN	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
diabetes	diabete	NOUN	NNS	B-Disease
?	?	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Vitamin	vitamin	NOUN	NN	B-Chemical
C	C	PROPN	NNP	I-Chemical
acts	act	VERB	VBZ	O
as	as	ADP	IN	O
a	a	DET	DT	O
potent	potent	ADJ	JJ	O
antioxidant	antioxidant	NOUN	NN	O
;	;	PUNCT	:	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
can	can	VERB	MD	O
also	also	ADV	RB	O
be	be	VERB	VB	O
a	a	DET	DT	O
prooxidant	prooxidant	ADJ	JJ	O
and	and	CCONJ	CC	O
glycate	glycate	ADJ	JJ	O
protein	protein	NOUN	NN	O
under	under	ADP	IN	O
certain	certain	ADJ	JJ	O
circumstances	circumstance	NOUN	NNS	O
in	in	ADP	IN	O
vitro	vitro	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
observations	observation	NOUN	NNS	O
led	lead	VERB	VBD	O
us	-PRON-	PRON	PRP	O
to	to	PART	TO	O
hypothesize	hypothesize	VERB	VB	O
that	that	ADP	IN	O
a	a	DET	DT	O
high	high	ADJ	JJ	O
intake	intake	NOUN	NN	O
of	of	ADP	IN	O
vitamin	vitamin	NOUN	NN	B-Chemical
C	c	NOUN	NN	I-Chemical
in	in	ADP	IN	O
diabetic	diabetic	ADJ	JJ	B-Disease
persons	person	NOUN	NNS	O
might	may	VERB	MD	O
promote	promote	VERB	VB	O
atherosclerosis	atherosclerosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
objective	objective	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
examine	examine	VERB	VB	O
the	the	DET	DT	O
relation	relation	NOUN	NN	O
between	between	ADP	IN	O
vitamin	vitamin	NOUN	NN	B-Chemical
C	c	NOUN	NN	I-Chemical
intake	intake	NOUN	NN	O
and	and	CCONJ	CC	O
mortality	mortality	NOUN	NN	O
from	from	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
studied	study	VERB	VBD	O
the	the	DET	DT	O
relation	relation	NOUN	NN	O
between	between	ADP	IN	O
vitamin	vitamin	NOUN	NN	B-Chemical
C	c	NOUN	NN	I-Chemical
intake	intake	NOUN	NN	O
and	and	CCONJ	CC	O
mortality	mortality	NOUN	NN	O
from	from	ADP	IN	O
total	total	ADJ	JJ	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
281	281	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
175	175	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
stroke	stroke	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
57	57	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
1923	1923	NUM	CD	O
postmenopausal	postmenopausal	NOUN	NN	O
women	woman	NOUN	NNS	O
who	who	PRON	WP	O
reported	report	VERB	VBD	O
being	be	VERB	VBG	O
diabetic	diabetic	ADJ	JJ	B-Disease
at	at	ADP	IN	O
baseline	baseline	NOUN	NN	O
.	.	PUNCT	.	O

Diet	Diet	PROPN	NNP	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
food	food	NOUN	NN	O
-	-	PUNCT	HYPH	O
frequency	frequency	NOUN	NN	O
questionnaire	questionnaire	NOUN	NN	O
at	at	ADP	IN	O
baseline	baseline	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
subjects	subject	NOUN	NNS	O
initially	initially	ADV	RB	O
free	free	ADJ	JJ	O
of	of	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
were	be	VERB	VBD	O
prospectively	prospectively	ADV	RB	O
followed	follow	VERB	VBN	O
for	for	ADP	IN	O
15	15	NUM	CD	O
y	y	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
After	after	ADP	IN	O
adjustment	adjustment	NOUN	NN	O
for	for	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
,	,	PUNCT	,	O
type	type	NOUN	NN	O
of	of	ADP	IN	O
diabetes	diabetes	NOUN	NN	B-Disease
medication	medication	NOUN	NN	O
used	use	VERB	VBN	O
,	,	PUNCT	,	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
diabetes	diabetes	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
intakes	intake	NOUN	NNS	O
of	of	ADP	IN	O
folate	folate	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
vitamin	vitamin	NOUN	NN	B-Chemical
E	e	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
beta	beta	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
carotene	carotene	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
adjusted	adjust	VERB	VBN	O
relative	relative	ADJ	JJ	O
risks	risk	NOUN	NNS	O
of	of	ADP	IN	O
total	total	ADJ	JJ	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
mortality	mortality	NOUN	NN	O
were	be	VERB	VBD	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
97	97	NUM	CD	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
11	11	NUM	CD	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
47	47	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
84	84	NUM	CD	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
for	for	ADP	IN	O
trend	trend	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
across	across	ADP	IN	O
quintiles	quintile	NOUN	NNS	O
of	of	ADP	IN	O
total	total	ADJ	JJ	O
vitamin	vitamin	NOUN	NN	B-Chemical
C	c	NOUN	NN	I-Chemical
intake	intake	NOUN	NN	O
from	from	ADP	IN	O
food	food	NOUN	NN	O
and	and	CCONJ	CC	O
supplements	supplement	NOUN	NNS	O
.	.	PUNCT	.	O

Adjusted	adjusted	ADJ	JJ	O
relative	relative	ADJ	JJ	O
risks	risk	NOUN	NNS	O
of	of	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
were	be	VERB	VBD	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
81	81	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
99	99	NUM	CD	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
26	26	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
91	91	NUM	CD	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
for	for	ADP	IN	O
trend	trend	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
of	of	ADP	IN	O
stroke	stroke	NOUN	NN	B-Disease
were	be	VERB	VBD	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
52	52	NUM	CD	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
23	23	NUM	CD	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
22	22	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
57	57	NUM	CD	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
for	for	ADP	IN	O
trend	trend	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
dietary	dietary	ADJ	JJ	O
and	and	CCONJ	CC	O
supplemental	supplemental	ADJ	JJ	O
vitamin	vitamin	NOUN	NN	B-Chemical
C	c	NOUN	NN	I-Chemical
were	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
separately	separately	ADV	RB	O
,	,	PUNCT	,	O
only	only	ADV	RB	O
supplemental	supplemental	ADJ	JJ	O
vitamin	vitamin	NOUN	NN	B-Chemical
C	c	NOUN	NN	I-Chemical
showed	show	VERB	VBD	O
a	a	DET	DT	O
positive	positive	ADJ	JJ	O
association	association	NOUN	NN	O
with	with	ADP	IN	O
mortality	mortality	NOUN	NN	O
endpoints	endpoint	NOUN	NNS	O
.	.	PUNCT	.	O

Vitamin	vitamin	NOUN	NN	B-Chemical
C	C	PROPN	NNP	I-Chemical
intake	intake	NOUN	NN	O
was	be	VERB	VBD	O
unrelated	unrelated	ADJ	JJ	O
to	to	ADP	IN	O
mortality	mortality	NOUN	NN	O
from	from	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
nondiabetic	nondiabetic	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
at	at	ADP	IN	O
baseline	baseline	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
A	a	DET	DT	O
high	high	ADJ	JJ	O
vitamin	vitamin	NOUN	NN	B-Chemical
C	c	NOUN	NN	I-Chemical
intake	intake	NOUN	NN	O
from	from	ADP	IN	O
supplements	supplement	NOUN	NNS	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
mortality	mortality	NOUN	NN	O
in	in	ADP	IN	O
postmenopausal	postmenopausal	NOUN	NN	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
diabetes	diabete	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Optical	optical	ADJ	JJ	O
coherence	coherence	NOUN	NN	O
tomography	tomography	NOUN	NN	O
can	can	VERB	MD	O
measure	measure	VERB	VB	O
axonal	axonal	ADJ	JJ	O
loss	loss	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
map	map	VERB	VB	O
and	and	CCONJ	CC	O
identify	identify	VERB	VB	O
the	the	DET	DT	O
pattern	pattern	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
,	,	PUNCT	,	O
of	of	ADP	IN	O
axonal	axonal	ADJ	JJ	B-Disease
degeneration	degeneration	NOUN	NN	I-Disease
in	in	ADP	IN	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
using	use	VERB	VBG	O
optical	optical	ADJ	JJ	O
coherence	coherence	NOUN	NN	O
tomography	tomography	NOUN	NN	O
(	(	PUNCT	-LRB-	O
OCT	OCT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Ethambutol	Ethambutol	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
an	an	DET	DT	O
antimycobacterial	antimycobacterial	ADJ	JJ	O
agent	agent	NOUN	NN	O
often	often	ADV	RB	O
used	use	VERB	VBD	O
to	to	PART	TO	O
treat	treat	VERB	VB	O
tuberculosis	tuberculosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
serious	serious	ADJ	JJ	O
complication	complication	NOUN	NN	O
of	of	ADP	IN	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
an	an	DET	DT	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
that	that	DET	WDT	O
impairs	impair	VERB	VBZ	O
visual	visual	ADJ	JJ	O
acuity	acuity	NOUN	NN	O
,	,	PUNCT	,	O
contrast	contrast	NOUN	NN	O
sensitivity	sensitivity	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
color	color	NOUN	NN	O
vision	vision	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
early	early	ADV	RB	O
on	on	ADV	RB	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
the	the	DET	DT	O
toxic	toxic	ADJ	JJ	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
mild	mild	ADJ	JJ	O
and	and	CCONJ	CC	O
partly	partly	ADV	RB	O
reversible	reversible	ADJ	JJ	O
,	,	PUNCT	,	O
the	the	DET	DT	O
funduscopic	funduscopic	ADJ	JJ	O
findings	finding	NOUN	NNS	O
are	be	VERB	VBP	O
often	often	ADV	RB	O
subtle	subtle	ADJ	JJ	O
and	and	CCONJ	CC	O
easy	easy	ADJ	JJ	O
to	to	PART	TO	O
miss	miss	VERB	VB	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Three	three	NUM	CD	O
subjects	subject	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
EMB	EMB	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
of	of	ADP	IN	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
intermediate	intermediate	ADJ	JJ	O
-	-	PUNCT	:	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
visual	visual	ADJ	JJ	B-Disease
deficits	deficit	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
administered	administer	VERB	VBN	O
a	a	DET	DT	O
full	full	ADJ	JJ	O
neuro	neuro	NOUN	NN	O
-	-	PUNCT	HYPH	O
ophthalmologic	ophthalmologic	ADJ	JJ	O
examination	examination	NOUN	NN	O
including	include	VERB	VBG	O
visual	visual	ADJ	JJ	O
acuity	acuity	NOUN	NN	O
,	,	PUNCT	,	O
color	color	NOUN	NN	O
vision	vision	NOUN	NN	O
,	,	PUNCT	,	O
contrast	contrast	NOUN	NN	O
sensitivity	sensitivity	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
fundus	fundus	NOUN	NN	O
examination	examination	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
OCT	OCT	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
OCT	OCT	PROPN	NNP	O
3000	3000	NUM	CD	O
,	,	PUNCT	,	O
Humphrey	Humphrey	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Zeiss	Zeiss	PROPN	NNP	O
,	,	PUNCT	,	O
Dublin	Dublin	PROPN	NNP	O
,	,	PUNCT	,	O
CA	CA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
performed	perform	VERB	VBN	O
on	on	ADP	IN	O
both	both	DET	DT	O
eyes	eye	NOUN	NNS	O
of	of	ADP	IN	O
each	each	DET	DT	O
subject	subject	NOUN	NN	O
using	use	VERB	VBG	O
the	the	DET	DT	O
retinal	retinal	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
fiber	fiber	NOUN	NN	O
layer	layer	NOUN	NN	O
(	(	PUNCT	-LRB-	O
RNFL	RNFL	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
analysis	analysis	NOUN	NN	O
protocol	protocol	NOUN	NN	O
.	.	PUNCT	.	O

OCT	OCT	PROPN	NNP	O
interpolates	interpolate	VERB	VBZ	O
data	datum	NOUN	NNS	O
from	from	ADP	IN	O
100	100	NUM	CD	O
points	point	NOUN	NNS	O
around	around	ADP	IN	O
the	the	DET	DT	O
optic	optic	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
to	to	PART	TO	O
effectively	effectively	ADV	RB	O
map	map	VERB	VB	O
out	out	PART	RP	O
the	the	DET	DT	O
RNFL	RNFL	PROPN	NNP	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
results	result	NOUN	NNS	O
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
calculated	calculated	ADJ	JJ	O
average	average	ADJ	JJ	O
RNFL	rnfl	NOUN	NN	O
of	of	ADP	IN	O
normal	normal	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
accumulated	accumulate	VERB	VBN	O
from	from	ADP	IN	O
four	four	NUM	CD	O
prior	prior	ADJ	JJ	O
studies	study	NOUN	NNS	O
using	use	VERB	VBG	O
OCT	OCT	PROPN	NNP	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
661	661	NUM	CD	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
all	all	DET	DT	O
subjects	subject	NOUN	NNS	O
with	with	ADP	IN	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
EMB	EMB	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
mean	mean	ADJ	JJ	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
72	72	NUM	CD	O
%	%	NOUN	NN	O
nerve	nerve	NOUN	NN	O
fiber	fiber	NOUN	NN	O
layer	layer	NOUN	NN	O
thickness	thickness	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
temporal	temporal	ADJ	JJ	O
quadrant	quadrant	NOUN	NN	O
(	(	PUNCT	-LRB-	O
patient	patient	NOUN	NN	O
A	a	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
eventual	eventual	ADJ	JJ	O
recovery	recovery	NOUN	NN	O
of	of	ADP	IN	O
visual	visual	ADJ	JJ	O
acuity	acuity	NOUN	NN	O
and	and	CCONJ	CC	O
fields	field	NOUN	NNS	O
,	,	PUNCT	,	O
58	58	NUM	CD	O
%	%	NOUN	NN	O
loss	loss	NOUN	NN	O
;	;	PUNCT	:	O
patient	patient	NOUN	NN	O
B	b	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
intermediate	intermediate	ADJ	JJ	O
visual	visual	ADJ	JJ	B-Disease
deficits	deficit	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
68	68	NUM	CD	O
%	%	NOUN	NN	O
loss	loss	NOUN	NN	O
;	;	PUNCT	:	O
patient	patient	NOUN	NN	O
C	C	PROPN	NNP	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	O
visual	visual	ADJ	JJ	B-Disease
deficits	deficit	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
90	90	NUM	CD	O
%	%	NOUN	NN	O
loss	loss	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
an	an	DET	DT	O
average	average	ADJ	JJ	O
mean	mean	ADJ	JJ	O
optic	optic	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
thickness	thickness	NOUN	NN	O
of	of	ADP	IN	O
26	26	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
16	16	NUM	CD	O
microm	microm	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
combined	combine	VERB	VBN	O
mean	mean	ADJ	JJ	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
46	46	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
fibers	fiber	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
superior	superior	ADJ	JJ	O
,	,	PUNCT	,	O
inferior	inferior	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
nasal	nasal	NOUN	NN	O
quadrants	quadrant	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
(	(	PUNCT	-LRB-	O
six	six	NUM	CD	O
)	)	PUNCT	-RRB-	O
eyes	eye	NOUN	NNS	O
of	of	ADP	IN	O
all	all	DET	DT	O
three	three	NUM	CD	O
subjects	subject	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
average	average	ADJ	JJ	O
thickness	thickness	NOUN	NN	O
of	of	ADP	IN	O
55	55	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
29	29	NUM	CD	O
microm	microm	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
both	both	DET	DT	O
sets	set	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
four	four	NUM	CD	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
eyes	eye	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
subjects	subject	NOUN	NNS	O
with	with	ADP	IN	O
persistent	persistent	ADJ	JJ	O
visual	visual	ADJ	JJ	B-Disease
deficits	deficit	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
patients	patient	NOUN	NNS	O
B	B	PROPN	NNP	O
and	and	CCONJ	CC	O
C	C	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
an	an	DET	DT	O
average	average	ADJ	JJ	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
79	79	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
nerve	nerve	NOUN	NN	O
fiber	fiber	NOUN	NN	O
thickness	thickness	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
temporal	temporal	ADJ	JJ	O
quadrant	quadrant	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
OCT	OCT	PROPN	NNP	O
results	result	VERB	VBZ	O
in	in	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
EMB	EMB	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
show	show	VERB	VBP	O
considerable	considerable	ADJ	JJ	O
loss	loss	NOUN	NN	O
especially	especially	ADV	RB	O
of	of	ADP	IN	O
the	the	DET	DT	O
temporal	temporal	ADJ	JJ	O
fibers	fiber	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
prior	prior	ADJ	JJ	O
histopathological	histopathological	ADJ	JJ	O
studies	study	NOUN	NNS	O
that	that	DET	WDT	O
show	show	VERB	VBP	O
predominant	predominant	ADJ	JJ	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
parvo	parvo	NOUN	NNS	O
-	-	PUNCT	HYPH	O
cellular	cellular	ADJ	JJ	O
axons	axon	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
or	or	CCONJ	CC	O
small	small	ADJ	JJ	O
-	-	PUNCT	HYPH	O
caliber	caliber	NOUN	NN	O
axons	axon	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
within	within	ADP	IN	O
the	the	DET	DT	O
papillo	papillo	NOUN	NN	O
-	-	PUNCT	HYPH	O
macular	macular	ADJ	JJ	O
bundle	bundle	NOUN	NN	O
in	in	ADP	IN	O
toxic	toxic	ADJ	JJ	O
or	or	CCONJ	CC	O
hereditary	hereditary	ADJ	JJ	O
optic	optic	ADJ	JJ	B-Disease
neuropathies	neuropathy	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

OCT	OCT	PROPN	NNP	O
can	can	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
valuable	valuable	ADJ	JJ	O
tool	tool	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
quantitative	quantitative	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
optic	optic	ADJ	JJ	B-Disease
neuropathies	neuropathy	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Additionally	additionally	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
terms	term	NOUN	NNS	O
of	of	ADP	IN	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
EMB	EMB	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
important	important	ADJ	JJ	O
to	to	PART	TO	O
properly	properly	ADV	RB	O
manage	manage	VERB	VB	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
dosing	dose	VERB	VBG	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
impairment	impairment	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
to	to	PART	TO	O
achieve	achieve	VERB	VB	O
proper	proper	ADJ	JJ	O
transition	transition	NOUN	NN	O
to	to	ADP	IN	O
a	a	DET	DT	O
maintenance	maintenance	NOUN	NN	O
dose	dose	NOUN	NN	O
once	once	ADV	RB	O
an	an	DET	DT	O
appropriate	appropriate	ADJ	JJ	O
loading	loading	NOUN	NN	O
dose	dose	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reached	reach	VERB	VBN	O
.	.	PUNCT	.	O

Hypoxia	hypoxia	NOUN	NN	B-Disease
in	in	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
with	with	ADP	IN	O
proteinuria	proteinuria	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
glomerular	glomerular	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Despite	despite	ADP	IN	O
the	the	DET	DT	O
increasing	increase	VERB	VBG	O
need	need	NOUN	NN	O
to	to	PART	TO	O
identify	identify	VERB	VB	O
and	and	CCONJ	CC	O
quantify	quantify	VERB	VB	O
tissue	tissue	NOUN	NN	O
oxygenation	oxygenation	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
cellular	cellular	ADJ	JJ	O
level	level	NOUN	NN	O
,	,	PUNCT	,	O
relatively	relatively	ADV	RB	O
few	few	ADJ	JJ	O
methods	method	NOUN	NNS	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
available	available	ADJ	JJ	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
developed	develop	VERB	VBD	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
hypoxia	hypoxia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
responsive	responsive	ADJ	JJ	O
reporter	reporter	NOUN	NN	O
vector	vector	NOUN	NN	O
using	use	VERB	VBG	O
a	a	DET	DT	O
hypoxia	hypoxia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
responsive	responsive	ADJ	JJ	O
element	element	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
5	5	NUM	CD	O
'	'	PUNCT	``	O
vascular	vascular	ADJ	JJ	O
endothelial	endothelial	ADJ	JJ	O
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
untranslated	untranslated	ADJ	JJ	O
region	region	NOUN	NN	O
and	and	CCONJ	CC	O
generated	generate	VERB	VBD	O
a	a	DET	DT	O
novel	novel	ADJ	JJ	O
hypoxia	hypoxia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
sensing	sense	VERB	VBG	O
transgenic	transgenic	ADJ	JJ	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
then	then	ADV	RB	O
applied	apply	VERB	VBD	O
this	this	DET	DT	O
animal	animal	NOUN	NN	O
model	model	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
detection	detection	NOUN	NN	O
of	of	ADP	IN	O
tubulointerstitial	tubulointerstitial	ADJ	JJ	O
hypoxia	hypoxia	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
diseased	diseased	ADJ	JJ	B-Disease
kidney	kidney	NOUN	NN	I-Disease
.	.	PUNCT	.	O

With	with	ADP	IN	O
this	this	DET	DT	O
model	model	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
were	be	VERB	VBD	O
able	able	ADJ	JJ	O
to	to	PART	TO	O
identify	identify	VERB	VB	O
diffuse	diffuse	VERB	VB	O
cortical	cortical	ADJ	JJ	O
hypoxia	hypoxia	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
puromycin	puromycin	ADJ	JJ	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
focal	focal	ADJ	JJ	O
and	and	CCONJ	CC	O
segmental	segmental	ADJ	JJ	O
hypoxia	hypoxia	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
remnant	remnant	ADJ	JJ	O
kidney	kidney	NOUN	NN	O
model	model	NOUN	NN	O
.	.	PUNCT	.	O

Expression	expression	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hypoxia	hypoxia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
responsive	responsive	ADJ	JJ	O
transgene	transgene	NOUN	NN	O
increased	increase	VERB	VBD	O
throughout	throughout	ADP	IN	O
the	the	DET	DT	O
observation	observation	NOUN	NN	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
reaching	reach	VERB	VBG	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
2	2	PUNCT	LS	O
-	-	PUNCT	:	O
fold	fold	VERB	VB	O
at	at	ADP	IN	O
2	2	NUM	CD	O
weeks	week	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
puromycin	puromycin	NOUN	NN	B-Chemical
aminonucleoside	aminonucleoside	ADP	IN	I-Chemical
model	model	NOUN	NN	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
-	-	NOUN	NN	O
fold	fold	VERB	VB	O
at	at	ADP	IN	O
4	4	NUM	CD	O
weeks	week	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
remnant	remnant	ADJ	JJ	O
kidney	kidney	NOUN	NN	O
model	model	NOUN	NN	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
vascular	vascular	ADJ	JJ	O
endothelial	endothelial	ADJ	JJ	O
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
mild	mild	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
,	,	PUNCT	,	O
reflecting	reflect	VERB	VBG	O
distinct	distinct	ADJ	JJ	O
behaviors	behavior	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
genes	gene	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
hypoxia	hypoxia	NOUN	NN	B-Disease
showed	show	VERB	VBD	O
a	a	DET	DT	O
positive	positive	ADJ	JJ	O
correlation	correlation	NOUN	NN	O
with	with	ADP	IN	O
microscopic	microscopic	ADJ	JJ	O
tubulointerstitial	tubulointerstitial	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
in	in	ADP	IN	O
both	both	DET	DT	O
models	model	NOUN	NNS	O
.	.	PUNCT	.	O

Finally	finally	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
identified	identify	VERB	VBD	O
the	the	DET	DT	O
localization	localization	NOUN	NN	O
of	of	ADP	IN	O
proliferating	proliferate	VERB	VBG	O
cell	cell	NOUN	NN	O
nuclear	nuclear	ADJ	JJ	O
antigen	antigen	NOUN	NN	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
,	,	PUNCT	,	O
ED	ED	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
terminal	terminal	ADJ	JJ	O
dUTP	dUTP	PROPN	NNP	O
nick	nick	ADJ	JJ	O
-	-	PUNCT	HYPH	O
end	end	NOUN	NN	O
labeled	label	VERB	VBN	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
cells	cell	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
hypoxic	hypoxic	ADJ	JJ	B-Disease
cortical	cortical	ADJ	JJ	O
area	area	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
remnant	remnant	ADJ	JJ	O
kidney	kidney	NOUN	NN	O
model	model	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
propose	propose	VERB	VBP	O
here	here	ADV	RB	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
pathological	pathological	ADJ	JJ	O
tie	tie	NOUN	NN	O
between	between	ADP	IN	O
chronic	chronic	ADJ	JJ	O
tubulointerstitial	tubulointerstitial	ADJ	JJ	O
hypoxia	hypoxia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
progressive	progressive	ADJ	JJ	O
glomerular	glomerular	ADJ	JJ	B-Disease
diseases	disease	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Adequate	adequate	ADJ	JJ	O
timing	timing	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	ADJ	JJ	B-Chemical
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
hemolysis	hemolysis	NOUN	NN	B-Disease
during	during	ADP	IN	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
of	of	ADP	IN	O
interferon	interferon	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
for	for	ADP	IN	O
chronic	chronic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
C	C	PROPN	NNP	I-Disease
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
major	major	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
of	of	ADP	IN	O
interferon	interferon	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Because	because	ADP	IN	O
of	of	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
dose	dose	NOUN	NN	O
reduction	reduction	NOUN	NN	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
common	common	ADJ	JJ	O
event	event	NOUN	NN	O
in	in	ADP	IN	O
this	this	DET	DT	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
clinical	clinical	ADJ	JJ	O
retrospective	retrospective	ADJ	JJ	O
cohort	cohort	NOUN	NN	O
study	study	NOUN	NN	O
we	-PRON-	PRON	PRP	O
have	have	VERB	VBP	O
examined	examine	VERB	VBN	O
the	the	DET	DT	O
suitable	suitable	ADJ	JJ	O
timing	timing	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	ADJ	JJ	B-Chemical
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
hemolysis	hemolysis	NOUN	NN	B-Disease
during	during	ADP	IN	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	METHODS	PROPN	NNP	O
:	:	PUNCT	:	O
Thirty	thirty	NUM	CD	O
-	-	PUNCT	HYPH	O
seven	seven	NUM	CD	O
of	of	ADP	IN	O
160	160	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
HCV	HCV	PROPN	NNP	O
-	-	PUNCT	HYPH	O
genotype	genotype	PROPN	NNP	O
1b	1b	NUM	CD	O
,	,	PUNCT	,	O
had	have	VERB	VBD	O
high	high	ADJ	JJ	O
virus	virus	NOUN	NN	O
load	load	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
received	receive	VERB	VBD	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
developed	develop	VERB	VBD	O
anemia	anemia	NOUN	NN	B-Disease
with	with	ADP	IN	O
hemoglobin	hemoglobin	NOUN	NN	O
level	level	NOUN	NN	O
<	<	X	XX	O
10	10	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
dl	dl	NOUN	NN	O
or	or	CCONJ	CC	O
anemia	anemia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
signs	sign	NOUN	NNS	O
during	during	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
that	that	DET	DT	O
,	,	PUNCT	,	O
these	these	DET	DT	O
37	37	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
one	one	NUM	CD	O
tablet	tablet	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
27	27	NUM	CD	O
of	of	ADP	IN	O
37	37	NUM	CD	O
patients	patient	NOUN	NNS	O
could	could	VERB	MD	O
continue	continue	VERB	VB	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
a	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
24	24	NUM	CD	O
weeks	week	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
A	A	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
of	of	ADP	IN	O
37	37	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
could	could	VERB	MD	O
not	not	ADV	RB	O
continue	continue	VERB	VB	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
because	because	ADP	IN	O
their	-PRON-	DET	PRP$	O
<	<	X	XX	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
dl	dl	NOUN	NN	O
hemoglobin	hemoglobin	NOUN	NN	O
values	value	NOUN	NNS	O
decreased	decrease	VERB	VBD	O
to	to	ADP	IN	O
or	or	CCONJ	CC	O
anemia	anemia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
severe	severe	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
occurred	occur	VERB	VBD	O
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
B	B	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
assessed	assess	VERB	VBD	O
the	the	DET	DT	O
final	final	ADJ	JJ	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
after	after	ADP	IN	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
groups	group	NOUN	NNS	O
A	a	NOUN	NN	O
and	and	CCONJ	CC	O
B	b	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
A	a	DET	DT	O
sustained	sustained	ADJ	JJ	O
virological	virological	ADJ	JJ	O
response	response	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SVR	SVR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
29	29	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
8	8	NUM	CD	O
/	/	SYM	SYM	O
27	27	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
group	group	NOUN	NN	O
A	A	PROPN	NNP	O
and	and	CCONJ	CC	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
/	/	SYM	SYM	O
10	10	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
group	group	NOUN	NN	O
B	B	PROPN	NNP	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

A	a	DET	DT	O
34	34	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
/	/	SYM	SYM	O
27	27	NUM	CD	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
SVR	SVR	PROPN	NNP	O
+	+	CCONJ	CC	O
biological	biological	ADJ	JJ	O
response	response	NOUN	NN	O
in	in	ADP	IN	O
group	group	NOUN	NN	O
A	A	PROPN	NNP	O
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
than	than	ADP	IN	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
/	/	SYM	SYM	O
10	10	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
group	group	NOUN	NN	O
B	B	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
051	051	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
slight	slight	ADJ	JJ	O
significance	significance	NOUN	NN	O
.	.	PUNCT	.	O

With	with	ADP	IN	O
respect	respect	NOUN	NN	O
to	to	ADP	IN	O
hemoglobin	hemoglobin	NOUN	NN	O
level	level	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	ADJ	JJ	B-Chemical
reduction	reduction	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
continuation	continuation	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
>	>	X	XX	O
or	or	CCONJ	CC	O
=	=	SYM	SYM	O
10	10	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
dl	dl	NOUN	NN	O
hemoglobin	hemoglobin	NOUN	NN	O
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
than	than	ADP	IN	O
that	that	DET	DT	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
<	<	X	XX	O
10	10	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
dl	dl	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
036	036	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
at	at	ADP	IN	O
hemoglobin	hemoglobin	NOUN	NN	O
level	level	NOUN	NN	O
>	>	X	XX	O
or	or	CCONJ	CC	O
=	=	SYM	SYM	O
10	10	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
dl	dl	NOUN	NN	O
is	be	VERB	VBZ	O
suitable	suitable	ADJ	JJ	O
in	in	ADP	IN	O
terms	term	NOUN	NNS	O
of	of	ADP	IN	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

Aging	age	VERB	VBG	O
process	process	NOUN	NN	O
of	of	ADP	IN	O
epithelial	epithelial	ADJ	JJ	O
cells	cell	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
prostate	prostate	NOUN	NN	O
lateral	lateral	ADJ	JJ	O
lobe	lobe	NOUN	NN	O
in	in	ADP	IN	O
experimental	experimental	ADJ	JJ	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
examine	examine	VERB	VB	O
the	the	DET	DT	O
influence	influence	NOUN	NN	O
of	of	ADP	IN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
HAL	HAL	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
age	age	NOUN	NN	O
related	related	ADJ	JJ	O
morphology	morphology	NOUN	NN	O
and	and	CCONJ	CC	O
function	function	NOUN	NN	O
changes	change	NOUN	NNS	O
of	of	ADP	IN	O
epithelial	epithelial	ADJ	JJ	O
cells	cell	NOUN	NNS	O
in	in	ADP	IN	O
rat	rat	NOUN	NN	O
prostate	prostate	NOUN	NN	O
lateral	lateral	ADJ	JJ	O
lobe	lobe	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
performed	perform	VERB	VBN	O
on	on	ADP	IN	O
sexually	sexually	ADV	RB	O
mature	mature	ADJ	JJ	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Serum	serum	ADJ	JJ	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
prolactin	prolactin	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PRL	PRL	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
testosterone	testosterone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
T	t	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
.	.	PUNCT	.	O

Tissue	tissue	NOUN	NN	O
sections	section	NOUN	NNS	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
with	with	ADP	IN	O
light	light	NOUN	NN	O
and	and	CCONJ	CC	O
electron	electron	NOUN	NN	O
microscopy	microscopy	NOUN	NN	O
.	.	PUNCT	.	O

Immunohistochemical	immunohistochemical	ADJ	JJ	O
reactions	reaction	NOUN	NNS	O
for	for	ADP	IN	O
Anti	Anti	PROPN	NNP	O
-	-	ADJ	JJ	O
Proliferating	proliferate	VERB	VBG	O
Cell	Cell	PROPN	NNP	O
Nuclear	Nuclear	PROPN	NNP	O
Antigen	Antigen	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
PCNA	PCNA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
rats	rat	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
experimental	experimental	ADJ	JJ	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
:	:	PUNCT	:	O
PRL	PRL	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
twice	twice	ADV	RB	O
higher	high	ADJ	JJR	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
T	T	PROPN	NNP	B-Chemical
concentration	concentration	NOUN	NN	O
was	be	VERB	VBD	O
almost	almost	ADV	RB	O
twice	twice	ADV	RB	O
lower	low	ADJ	JJR	O
than	than	ADP	IN	O
that	that	DET	DT	O
in	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Light	light	ADJ	JJ	O
microscopy	microscopy	NOUN	NN	O
visualized	visualize	VERB	VBD	O
the	the	DET	DT	O
following	following	NOUN	NN	O
:	:	PUNCT	:	O
hypertrophy	hypertrophy	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
epithelium	epithelium	NOUN	NN	O
hyperplasia	hyperplasia	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
glandular	glandular	ADJ	JJ	O
ducts	duct	NOUN	NNS	O
,	,	PUNCT	,	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
increased	increase	VERB	VBN	O
PCNA	pcna	NOUN	NN	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

Electron	Electron	PROPN	NNP	O
microscopy	microscopy	NOUN	NN	O
revealed	reveal	VERB	VBD	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
columnar	columnar	ADJ	JJ	O
epithelial	epithelial	ADJ	JJ	O
cells	cell	NOUN	NNS	O
,	,	PUNCT	,	O
concerning	concern	VERB	VBG	O
organelles	organelle	NOUN	NNS	O
,	,	PUNCT	,	O
engaged	engage	VERB	VBN	O
in	in	ADP	IN	O
protein	protein	NOUN	NN	O
synthesis	synthesis	NOUN	NN	O
and	and	CCONJ	CC	O
secretion	secretion	NOUN	NN	O
.	.	PUNCT	.	O

Relation	relation	NOUN	NN	O
of	of	ADP	IN	O
perfusion	perfusion	NOUN	NN	O
defects	defect	NOUN	NNS	O
observed	observe	VERB	VBN	O
with	with	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
contrast	contrast	NOUN	NN	O
echocardiography	echocardiography	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
stenosis	stenosis	NOUN	NN	I-Disease
:	:	PUNCT	:	O
correlation	correlation	NOUN	NN	O
with	with	ADP	IN	O
thallium	thallium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
201	201	NUM	CD	O
single	single	ADJ	JJ	O
-	-	PUNCT	HYPH	O
photon	photon	NOUN	NN	O
emission	emission	NOUN	NN	O
tomography	tomography	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
previously	previously	ADV	RB	O
shown	show	VERB	VBN	O
that	that	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
contrast	contrast	NOUN	NN	O
echocardiography	echocardiography	NOUN	NN	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
valuable	valuable	ADJ	JJ	O
technique	technique	NOUN	NN	O
for	for	ADP	IN	O
delineating	delineate	VERB	VBG	O
regions	region	NOUN	NNS	O
of	of	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
underperfusion	underperfusion	NOUN	NN	O
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
occlusion	occlusion	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
to	to	ADP	IN	O
critical	critical	ADJ	JJ	O
coronary	coronary	ADJ	JJ	B-Disease
stenoses	stenosis	NOUN	NNS	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
hyperemic	hyperemic	ADJ	JJ	B-Disease
stimulation	stimulation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
whether	whether	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
contrast	contrast	NOUN	NN	O
echocardiography	echocardiography	NOUN	NN	O
performed	perform	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
stable	stable	ADJ	JJ	O
solution	solution	NOUN	NN	O
of	of	ADP	IN	O
sonicated	sonicated	ADJ	JJ	O
albumin	albumin	NOUN	NN	O
could	could	VERB	MD	O
detect	detect	VERB	VB	O
regions	region	NOUN	NNS	O
of	of	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
underperfusion	underperfusion	NOUN	NN	O
resulting	result	VERB	VBG	O
from	from	ADP	IN	O
various	various	ADJ	JJ	O
degrees	degree	NOUN	NNS	O
of	of	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
stenosis	stenosis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
perfusion	perfusion	NOUN	NN	O
defect	defect	NOUN	NN	O
produced	produce	VERB	VBN	O
in	in	ADP	IN	O
16	16	NUM	CD	O
open	open	ADJ	JJ	O
chest	chest	NOUN	NN	O
dogs	dog	NOUN	NNS	O
was	be	VERB	VBD	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
anatomic	anatomic	ADJ	JJ	O
area	area	NOUN	NN	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
measured	measure	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
postmortem	postmortem	ADJ	JJ	O
dual	dual	ADJ	JJ	O
-	-	PUNCT	HYPH	O
perfusion	perfusion	NOUN	NN	O
technique	technique	NOUN	NN	O
and	and	CCONJ	CC	O
with	with	ADP	IN	O
thallium	thallium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
201	201	NUM	CD	O
single	single	ADJ	JJ	O
-	-	PUNCT	HYPH	O
photon	photon	NOUN	NN	O
emission	emission	NOUN	NN	O
tomography	tomography	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SPECT	SPECT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
a	a	DET	DT	O
transient	transient	NOUN	NN	O
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
-	-	PUNCT	HYPH	O
s	s	NOUN	NN	O
)	)	PUNCT	-RRB-	O
coronary	coronary	ADJ	JJ	B-Disease
occlusion	occlusion	NOUN	NN	I-Disease
,	,	PUNCT	,	O
a	a	DET	DT	O
perfusion	perfusion	NOUN	NN	O
defect	defect	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
with	with	ADP	IN	O
contrast	contrast	NOUN	NN	O
echocardiography	echocardiography	NOUN	NN	O
in	in	ADP	IN	O
14	14	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
15	15	NUM	CD	O
dogs	dog	NOUN	NNS	O
in	in	ADP	IN	O
which	which	DET	WDT	O
the	the	DET	DT	O
occlusion	occlusion	NOUN	NN	O
was	be	VERB	VBD	O
produced	produce	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
perfusion	perfusion	NOUN	NN	O
defect	defect	NOUN	NN	O
correlated	correlate	VERB	VBD	O
significantly	significantly	ADV	RB	O
with	with	ADP	IN	O
the	the	DET	DT	O
anatomic	anatomic	ADJ	JJ	O
area	area	NOUN	NN	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
(	(	PUNCT	-LRB-	O
r	r	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
74	74	NUM	CD	O
;	;	PUNCT	:	O
p	p	PUNCT	LS	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
002	002	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
dipyridamole	dipyridamole	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hyperemia	hyperemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
12	12	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
16	16	NUM	CD	O
dogs	dog	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
partial	partial	ADJ	JJ	O
coronary	coronary	ADJ	JJ	B-Disease
stenosis	stenosis	NOUN	NN	I-Disease
had	have	VERB	VBD	O
a	a	DET	DT	O
visible	visible	ADJ	JJ	O
area	area	NOUN	NN	O
of	of	ADP	IN	O
hypoperfusion	hypoperfusion	NOUN	NN	O
by	by	ADP	IN	O
contrast	contrast	NOUN	NN	O
echocardiography	echocardiography	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
four	four	NUM	CD	O
dogs	dog	NOUN	NNS	O
without	without	ADP	IN	O
a	a	DET	DT	O
perfusion	perfusion	NOUN	NN	O
defect	defect	NOUN	NN	O
had	have	VERB	VBD	O
a	a	DET	DT	O
stenosis	stenosis	NOUN	NN	O
that	that	DET	WDT	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
a	a	DET	DT	O
mild	mild	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
to	to	PART	TO	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
dipyridamole	dipyridamole	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hyperemia	hyperemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
size	size	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
perfusion	perfusion	NOUN	NN	O
defect	defect	NOUN	NN	O
during	during	ADP	IN	O
stenosis	stenosis	NOUN	NN	O
correlated	correlate	VERB	VBD	O
significantly	significantly	ADV	RB	O
with	with	ADP	IN	O
the	the	DET	DT	O
anatomic	anatomic	ADJ	JJ	O
area	area	NOUN	NN	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
(	(	PUNCT	-LRB-	O
r	r	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
61	61	NUM	CD	O
;	;	PUNCT	:	O
p	p	PUNCT	LS	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
02	02	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Thallium	Thallium	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
201	201	NUM	CD	O
SPECT	SPECT	PROPN	NNP	O
demonstrated	demonstrate	VERB	VBD	O
a	a	DET	DT	O
perfusion	perfusion	NOUN	NN	O
defect	defect	NOUN	NN	O
in	in	ADP	IN	O
all	all	DET	DT	O
14	14	NUM	CD	O
dogs	dog	NOUN	NNS	O
analyzed	analyze	VERB	VBN	O
during	during	ADP	IN	O
dipyridamole	dipyridamole	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hyperemia	hyperemia	NOUN	NN	B-Disease
;	;	PUNCT	:	O
the	the	DET	DT	O
size	size	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
perfusion	perfusion	NOUN	NN	O
defect	defect	NOUN	NN	O
correlated	correlate	VERB	VBD	O
with	with	ADP	IN	O
the	the	DET	DT	O
anatomic	anatomic	ADJ	JJ	O
area	area	NOUN	NN	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
(	(	PUNCT	-LRB-	O
r	r	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
58	58	NUM	CD	O
;	;	PUNCT	:	O
p	p	PUNCT	LS	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
with	with	ADP	IN	O
the	the	DET	DT	O
perfusion	perfusion	NOUN	NN	O
defect	defect	NOUN	NN	O
by	by	ADP	IN	O
contrast	contrast	NOUN	NN	O
echocardiography	echocardiography	NOUN	NN	O
(	(	PUNCT	-LRB-	O
r	r	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
58	58	NUM	CD	O
;	;	PUNCT	:	O
p	p	PUNCT	LS	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
myocardial	myocardial	ADJ	JJ	O
contrast	contrast	NOUN	NN	O
echocardiography	echocardiography	NOUN	NN	O
can	can	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
visualize	visualize	VERB	VB	O
and	and	CCONJ	CC	O
quantitate	quantitate	VERB	VB	O
the	the	DET	DT	O
amount	amount	NOUN	NN	O
of	of	ADP	IN	O
jeopardized	jeopardized	ADJ	JJ	O
myocardium	myocardium	NOUN	NN	O
during	during	ADP	IN	O
moderate	moderate	ADJ	JJ	O
to	to	ADP	IN	O
severe	severe	ADJ	JJ	O
degrees	degree	NOUN	NNS	O
of	of	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
stenosis	stenosis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
obtained	obtain	VERB	VBD	O
show	show	VERB	VBP	O
a	a	DET	DT	O
correlation	correlation	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
anatomic	anatomic	ADJ	JJ	O
area	area	NOUN	NN	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
that	that	DET	DT	O
obtained	obtain	VERB	VBN	O
with	with	ADP	IN	O
thallium	thallium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
201	201	NUM	CD	O
SPECT	spect	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
activation	activation	NOUN	NN	O
of	of	ADP	IN	O
spinal	spinal	ADJ	JJ	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
D	d	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aspartate	aspartate	NOUN	NN	I-Chemical
receptors	receptor	NOUN	NNS	O
may	may	VERB	MD	O
contribute	contribute	VERB	VB	O
to	to	ADP	IN	O
degeneration	degeneration	NOUN	NN	O
of	of	ADP	IN	O
spinal	spinal	ADJ	JJ	O
motor	motor	NOUN	NN	O
neurons	neuron	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
neuraxial	neuraxial	ADJ	JJ	O
morphine	morphine	NOUN	NN	B-Chemical
after	after	ADP	IN	O
a	a	DET	DT	O
noninjurious	noninjurious	ADJ	JJ	O
interval	interval	NOUN	NN	O
of	of	ADP	IN	O
spinal	spinal	ADJ	JJ	B-Disease
cord	cord	NOUN	NN	I-Disease
ischemia	ischemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
degeneration	degeneration	NOUN	NN	O
of	of	ADP	IN	O
spinal	spinal	ADJ	JJ	O
motor	motor	NOUN	NN	O
neurons	neuron	NOUN	NNS	O
and	and	CCONJ	CC	O
activation	activation	NOUN	NN	O
of	of	ADP	IN	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
d	d	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aspartate	aspartate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NMDA	NMDA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
receptors	receptor	NOUN	NNS	O
after	after	ADP	IN	O
neuraxial	neuraxial	ADJ	JJ	O
morphine	morphine	NOUN	NN	B-Chemical
following	follow	VERB	VBG	O
a	a	DET	DT	O
noninjurious	noninjurious	ADJ	JJ	O
interval	interval	NOUN	NN	O
of	of	ADP	IN	O
aortic	aortic	ADJ	JJ	B-Disease
occlusion	occlusion	NOUN	NN	I-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Spinal	spinal	ADJ	JJ	B-Disease
cord	cord	NOUN	NN	I-Disease
ischemia	ischemia	NOUN	NN	I-Disease
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
aortic	aortic	ADJ	JJ	B-Disease
occlusion	occlusion	NOUN	NN	I-Disease
for	for	ADP	IN	O
6	6	NUM	CD	O
min	min	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
balloon	balloon	NOUN	NN	O
catheter	catheter	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
a	a	DET	DT	O
microdialysis	microdialysis	NOUN	NN	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
muL	mul	NOUN	NN	O
of	of	ADP	IN	O
saline	saline	NOUN	NN	O
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
C	C	PROPN	NNP	O
;	;	PUNCT	:	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
30	30	NUM	CD	O
mug	mug	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
M	M	PROPN	NNP	O
;	;	PUNCT	:	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
injected	inject	VERB	VBN	O
intrathecally	intrathecally	ADV	RB	O
(	(	PUNCT	-LRB-	O
IT	it	NOUN	NN	O
)	)	PUNCT	-RRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
reflow	reflow	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
mug	mug	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
SM	SM	PROPN	NNP	O
;	;	PUNCT	:	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
10	10	NUM	CD	O
muL	mul	NOUN	NN	O
of	of	ADP	IN	O
saline	saline	NOUN	NN	O
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
SC	SC	PROPN	NNP	O
;	;	PUNCT	:	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
injected	inject	VERB	VBN	O
IT	IT	PROPN	NNP	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
sham	sham	ADJ	JJ	O
operation	operation	NOUN	NN	O
.	.	PUNCT	.	O

Microdialysis	microdialysis	NOUN	NN	O
samples	sample	NOUN	NNS	O
were	be	VERB	VBD	O
collected	collect	VERB	VBN	O
preischemia	preischemia	ADJ	JJ	O
,	,	PUNCT	,	O
before	before	ADP	IN	O
IT	it	NOUN	NN	O
injection	injection	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
at	at	ADP	IN	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
8	8	NUM	CD	O
,	,	PUNCT	,	O
24	24	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
48	48	NUM	CD	O
h	h	NOUN	NN	O
of	of	ADP	IN	O
reperfusion	reperfusion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
after	after	ADP	IN	O
IT	it	NOUN	NN	O
injection	injection	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Second	second	ADJ	JJ	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
IT	IT	PROPN	NNP	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
mug	mug	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
the	the	DET	DT	O
histopathologic	histopathologic	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
spinal	spinal	ADJ	JJ	O
cord	cord	NOUN	NN	O
after	after	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
spastic	spastic	ADJ	JJ	B-Disease
paraparesis	paraparesis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

After	after	ADP	IN	O
IT	IT	PROPN	NNP	O
morphine	morphine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
cerebrospinal	cerebrospinal	ADJ	JJ	O
fluid	fluid	NOUN	NN	O
(	(	PUNCT	-LRB-	O
CSF	CSF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
glutamate	glutamate	ADJ	JJ	B-Chemical
concentration	concentration	NOUN	NN	O
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
in	in	ADP	IN	O
group	group	NOUN	NN	O
M	M	PROPN	NNP	O
relative	relative	ADJ	JJ	O
to	to	ADP	IN	O
both	both	DET	DT	O
baseline	baseline	NOUN	NN	O
and	and	CCONJ	CC	O
group	group	NOUN	NN	O
C	C	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

This	this	DET	DT	O
increase	increase	NOUN	NN	O
persisted	persist	VERB	VBD	O
for	for	ADP	IN	O
8	8	NUM	CD	O
hrs	hrs	NOUN	NN	O
.	.	PUNCT	.	O

IT	IT	PROPN	NNP	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	PROPN	NNP	I-Chemical
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
dark	dark	ADV	RB	O
-	-	PUNCT	HYPH	O
stained	stain	VERB	VBN	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
motoneurons	motoneuron	NOUN	NNS	O
after	after	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
spastic	spastic	ADJ	JJ	B-Disease
paraparesis	paraparesis	NOUN	NN	I-Disease
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
saline	saline	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
IT	it	NOUN	NN	O
morphine	morphine	NOUN	NN	B-Chemical
induces	induce	VERB	VBZ	O
spastic	spastic	ADJ	JJ	B-Disease
paraparesis	paraparesis	NOUN	NN	I-Disease
with	with	ADP	IN	O
a	a	DET	DT	O
concomitant	concomitant	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
CSF	csf	NOUN	NN	O
glutamate	glutamate	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
receptor	receptor	NOUN	NN	O
activation	activation	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
opioids	opioid	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
neurotoxic	neurotoxic	ADJ	JJ	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
setting	setting	NOUN	NN	O
of	of	ADP	IN	O
spinal	spinal	ADJ	JJ	B-Disease
cord	cord	NOUN	NN	I-Disease
ischemia	ischemia	NOUN	NN	I-Disease
via	via	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
receptor	receptor	NOUN	NN	O
activation	activation	NOUN	NN	O
.	.	PUNCT	.	O

Acute	Acute	PROPN	NNP	O
low	low	ADJ	JJ	B-Disease
back	back	ADJ	JJ	I-Disease
pain	pain	NOUN	NN	I-Disease
during	during	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
a	a	DET	DT	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

Amiodarone	Amiodarone	PROPN	NNP	B-Chemical
represents	represent	VERB	VBZ	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
antiarrhythmic	antiarrhythmic	ADJ	JJ	O
drug	drug	NOUN	NN	O
for	for	ADP	IN	O
cardioversion	cardioversion	NOUN	NN	O
of	of	ADP	IN	O
recent	recent	ADJ	JJ	O
-	-	PUNCT	HYPH	O
onset	onset	NOUN	NN	O
atrial	atrial	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
AF	AF	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
maintenance	maintenance	NOUN	NN	O
of	of	ADP	IN	O
sinus	sinus	NOUN	NN	O
rhythm	rhythm	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
briefly	briefly	ADV	RB	O
describe	describe	VERB	VBP	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
suffering	suffer	VERB	VBG	O
from	from	ADP	IN	O
recent	recent	ADJ	JJ	O
-	-	PUNCT	HYPH	O
onset	onset	NOUN	NN	O
atrial	atrial	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
,	,	PUNCT	,	O
who	who	PRON	WP	O
experienced	experience	VERB	VBD	O
an	an	DET	DT	O
acute	acute	ADJ	JJ	O
devastating	devastating	ADJ	JJ	O
low	low	ADJ	JJ	B-Disease
back	back	ADJ	JJ	I-Disease
pain	pain	NOUN	NN	I-Disease
a	a	DET	DT	O
few	few	ADJ	JJ	O
minutes	minute	NOUN	NNS	O
after	after	ADP	IN	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
amiodarone	amiodarone	ADJ	JJ	B-Chemical
loading	loading	NOUN	NN	O
.	.	PUNCT	.	O

Notably	notably	ADV	RB	O
,	,	PUNCT	,	O
this	this	DET	DT	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
has	have	VERB	VBZ	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
ever	ever	ADV	RB	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
medical	medical	ADJ	JJ	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

Clinicians	clinician	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
this	this	DET	DT	O
reaction	reaction	NOUN	NN	O
since	since	ADP	IN	O
prompt	prompt	ADJ	JJ	O
termination	termination	NOUN	NN	O
of	of	ADP	IN	O
parenteral	parenteral	ADJ	JJ	O
administration	administration	NOUN	NN	O
leads	lead	VERB	VBZ	O
to	to	PART	TO	O
complete	complete	ADJ	JJ	O
resolution	resolution	NOUN	NN	O
.	.	PUNCT	.	O

Quantitative	quantitative	ADJ	JJ	O
drug	drug	NOUN	NN	O
levels	level	NOUN	NNS	O
in	in	ADP	IN	O
stimulant	stimulant	ADJ	JJ	O
psychosis	psychosis	NOUN	NN	B-Disease
:	:	PUNCT	:	O
relationship	relationship	NOUN	NN	O
to	to	ADP	IN	O
symptom	symptom	NOUN	NN	O
severity	severity	NOUN	NN	O
,	,	PUNCT	,	O
catecholamines	catecholamine	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
hyperkinesia	hyperkinesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

To	to	PART	TO	O
examine	examine	VERB	VB	O
the	the	DET	DT	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
quantitative	quantitative	ADJ	JJ	O
stimulant	stimulant	ADJ	JJ	O
drug	drug	NOUN	NN	O
levels	level	NOUN	NNS	O
,	,	PUNCT	,	O
catecholamines	catecholamine	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
psychotic	psychotic	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
nineteen	nineteen	NUM	CD	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
a	a	DET	DT	O
psychiatric	psychiatric	ADJ	JJ	B-Disease
emergency	emergency	NOUN	NN	O
service	service	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
or	or	CCONJ	CC	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
psychosis	psychosis	NOUN	NN	B-Disease
were	be	VERB	VBD	O
interviewed	interview	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
plasma	plasma	NOUN	NN	O
and	and	CCONJ	CC	O
urine	urine	NOUN	NN	O
were	be	VERB	VBD	O
collected	collect	VERB	VBN	O
for	for	ADP	IN	O
quantitative	quantitative	ADJ	JJ	O
assays	assay	NOUN	NNS	O
of	of	ADP	IN	O
stimulant	stimulant	ADJ	JJ	O
drug	drug	NOUN	NN	O
and	and	CCONJ	CC	O
catecholamine	catecholamine	NOUN	NN	B-Chemical
metabolite	metabolite	ADJ	JJ	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

Methamphetamine	Methamphetamine	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
several	several	ADJ	JJ	O
psychopathology	psychopathology	NOUN	NN	O
scores	score	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
global	global	ADJ	JJ	O
hyperkinesia	hyperkinesia	ADJ	JJ	B-Disease
rating	rating	NOUN	NN	O
.	.	PUNCT	.	O

HVA	hva	NOUN	NN	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
global	global	ADJ	JJ	O
hyperkinesia	hyperkinesia	NOUN	NN	B-Disease
but	but	CCONJ	CC	O
not	not	ADV	RB	O
to	to	ADP	IN	O
psychopathology	psychopathology	NOUN	NN	O
ratings	rating	NOUN	NNS	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
many	many	ADJ	JJ	O
other	other	ADJ	JJ	O
factors	factor	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
sensitization	sensitization	NOUN	NN	O
may	may	VERB	MD	O
play	play	VERB	VB	O
a	a	DET	DT	O
role	role	NOUN	NN	O
,	,	PUNCT	,	O
intensity	intensity	NOUN	NN	O
of	of	ADP	IN	O
stimulant	stimulant	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
psychotic	psychotic	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
stereotypies	stereotypie	NOUN	NNS	B-Disease
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
in	in	ADP	IN	O
part	part	NOUN	NN	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
.	.	PUNCT	.	O

Pheochromocytoma	pheochromocytoma	NOUN	NN	B-Disease
unmasked	unmasked	ADJ	JJ	O
by	by	ADP	IN	O
amisulpride	amisulpride	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
tiapride	tiapride	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
describe	describe	VERB	VB	O
the	the	DET	DT	O
unmasking	unmasking	NOUN	NN	O
of	of	ADP	IN	O
pheochromocytoma	pheochromocytoma	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
amisulpride	amisulpride	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
tiapride	tiapride	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

CASE	case	NOUN	NN	O
SUMMARY	summary	NOUN	NN	O
:	:	PUNCT	:	O
A	a	DET	DT	O
42	42	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
white	white	ADJ	JJ	O
man	man	NOUN	NN	O
developed	develop	VERB	VBD	O
acute	acute	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
headache	headache	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
vomiting	vomit	VERB	VBG	B-Disease
2	2	NUM	CD	O
hours	hour	NOUN	NNS	O
after	after	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
amisulpride	amisulpride	NOUN	NN	B-Chemical
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
and	and	CCONJ	CC	O
tiapride	tiapride	NOUN	NN	B-Chemical
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
drugs	drug	NOUN	NNS	O
were	be	VERB	VBD	O
immediately	immediately	ADV	RB	O
discontinued	discontinue	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
recovered	recover	VERB	VBN	O
after	after	ADP	IN	O
subsequent	subsequent	ADJ	JJ	O
nicardipine	nicardipine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
verapamil	verapamil	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Abdominal	abdominal	ADJ	JJ	O
ultrasound	ultrasound	NOUN	NN	O
showed	show	VERB	VBD	O
an	an	DET	DT	O
adrenal	adrenal	ADJ	JJ	O
mass	mass	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
postoperative	postoperative	ADJ	JJ	O
histologic	histologic	ADJ	JJ	O
examination	examination	NOUN	NN	O
confirmed	confirm	VERB	VBD	O
the	the	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
pheochromocytoma	pheochromocytoma	NOUN	NN	B-Disease
.	.	PUNCT	.	O

DISCUSSION	discussion	NOUN	NN	O
:	:	PUNCT	:	O
Drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
pheochromocytoma	pheochromocytoma	NOUN	NN	B-Disease
are	be	VERB	VBP	O
often	often	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
substituted	substitute	VERB	VBN	O
benzamide	benzamide	ADJ	JJ	B-Chemical
drugs	drug	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
underlying	underlie	VERB	VBG	O
mechanism	mechanism	NOUN	NN	O
is	be	VERB	VBZ	O
unknown	unknown	ADJ	JJ	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
our	-PRON-	DET	PRP$	O
case	case	NOUN	NN	O
,	,	PUNCT	,	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
Naranjo	Naranjo	PROPN	NNP	O
probability	probability	NOUN	NN	O
scale	scale	NOUN	NN	O
indicated	indicate	VERB	VBD	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
crisis	crisis	NOUN	NN	O
and	and	CCONJ	CC	O
amisulpride	amisulpride	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
tiapride	tiapride	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
As	as	ADP	IN	O
of	of	ADP	IN	O
March	March	PROPN	NNP	O
24	24	NUM	CD	O
,	,	PUNCT	,	O
2005	2005	NUM	CD	O
,	,	PUNCT	,	O
this	this	DET	DT	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
reported	report	VERB	VBN	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
amisulpride	amisulpride	NOUN	NN	B-Chemical
-	-	PUNCT	,	O
and	and	CCONJ	CC	O
tiapride	tiapride	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
crisis	crisis	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
pheochromocytoma	pheochromocytoma	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Physicians	physician	NOUN	NNS	O
and	and	CCONJ	CC	O
other	other	ADJ	JJ	O
healthcare	healthcare	NOUN	NN	O
professionals	professional	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
this	this	DET	DT	O
potential	potential	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
tiapride	tiapride	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
amisulpride	amisulpride	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Minor	minor	ADJ	JJ	O
neurological	neurological	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
,	,	PUNCT	,	O
cognitive	cognitive	ADJ	JJ	O
development	development	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
somatic	somatic	ADJ	JJ	O
development	development	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
age	age	NOUN	NN	O
of	of	ADP	IN	O
3	3	NUM	CD	O
to	to	PART	TO	O
7	7	NUM	CD	O
years	year	NOUN	NNS	O
after	after	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
in	in	ADP	IN	O
very	very	ADV	RB	O
-	-	PUNCT	HYPH	O
low	low	ADJ	JJ	O
birth	birth	NOUN	NN	O
-	-	PUNCT	HYPH	O
weight	weight	NOUN	NN	O
infants	infant	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
objective	objective	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
minor	minor	ADJ	JJ	O
neurological	neurological	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
,	,	PUNCT	,	O
cognitive	cognitive	ADJ	JJ	O
development	development	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
somatic	somatic	ADJ	JJ	O
development	development	NOUN	NN	O
after	after	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
very	very	ADV	RB	O
-	-	PUNCT	HYPH	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
birthweight	birthweight	ADJ	JJ	O
infants	infant	NOUN	NNS	O
.	.	PUNCT	.	O

Thirty	thirty	NUM	CD	O
-	-	PUNCT	HYPH	O
three	three	NUM	CD	O
children	child	NOUN	NNS	O
after	after	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
were	be	VERB	VBD	O
matched	match	VERB	VBN	O
to	to	ADP	IN	O
33	33	NUM	CD	O
children	child	NOUN	NNS	O
without	without	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Data	datum	NOUN	NNS	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
age	age	NOUN	NN	O
of	of	ADP	IN	O
3	3	NUM	CD	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

Dexamethasone	Dexamethasone	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
started	start	VERB	VBN	O
between	between	ADP	IN	O
the	the	DET	DT	O
7th	7th	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
28th	28th	ADJ	JJ	O
day	day	NOUN	NN	O
of	of	ADP	IN	O
life	life	NOUN	NN	O
over	over	ADP	IN	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
total	total	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
35	35	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

Exclusion	exclusion	NOUN	NN	O
criteria	criterion	NOUN	NNS	O
were	be	VERB	VBD	O
asphyxia	asphyxia	ADV	RB	B-Disease
,	,	PUNCT	,	O
malformations	malformation	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
major	major	ADJ	JJ	O
surgical	surgical	ADJ	JJ	O
interventions	intervention	NOUN	NNS	O
,	,	PUNCT	,	O
small	small	ADJ	JJ	O
for	for	ADP	IN	O
gestational	gestational	ADJ	JJ	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
intraventricular	intraventricular	ADJ	JJ	O
haemorrhage	haemorrhage	NOUN	NN	B-Disease
grades	grade	VERB	VBZ	O
III	III	PROPN	NNP	O
and	and	CCONJ	CC	O
IV	IV	PROPN	NNP	O
,	,	PUNCT	,	O
periventricular	periventricular	ADJ	JJ	B-Disease
leukomalacia	leukomalacia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
severe	severe	ADJ	JJ	O
psychomotor	psychomotor	NOUN	NN	B-Disease
retardation	retardation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Each	each	DET	DT	O
child	child	NOUN	NN	O
was	be	VERB	VBD	O
examined	examine	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
neuropediatrician	neuropediatrician	NOUN	NN	O
for	for	ADP	IN	O
minor	minor	ADJ	JJ	O
neurological	neurological	ADJ	JJ	B-Disease
dysfunctions	dysfunction	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
tested	test	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
psychologist	psychologist	NOUN	NN	O
for	for	ADP	IN	O
cognitive	cognitive	ADJ	JJ	O
development	development	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
Kaufman	Kaufman	PROPN	NNP	O
Assessment	Assessment	PROPN	NNP	O
Battery	Battery	PROPN	NNP	O
for	for	ADP	IN	O
Children	Children	PROPN	NNP	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
Draw	draw	VERB	VB	O
-	-	PUNCT	HYPH	O
a	a	DET	DT	O
-	-	PUNCT	HYPH	O
Man	man	NOUN	NN	O
Test	test	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
demographic	demographic	ADJ	JJ	O
data	datum	NOUN	NNS	O
,	,	PUNCT	,	O
growth	growth	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
socio	socio	NOUN	NN	O
-	-	PUNCT	HYPH	O
economic	economic	ADJ	JJ	O
status	status	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Fine	fine	ADJ	JJ	O
motor	motor	NOUN	NN	O
skills	skill	NOUN	NNS	O
and	and	CCONJ	CC	O
gross	gross	ADJ	JJ	O
motor	motor	NOUN	NN	O
function	function	NOUN	NN	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
better	well	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
Draw	Draw	PROPN	NNP	O
-	-	PUNCT	HYPH	O
a	a	DET	DT	O
-	-	PUNCT	HYPH	O
Man	man	NOUN	NN	O
Test	Test	PROPN	NNP	O
,	,	PUNCT	,	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
showed	show	VERB	VBD	O
better	well	ADJ	JJR	O
results	result	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
speech	speech	NOUN	NN	O
,	,	PUNCT	,	O
social	social	ADJ	JJ	O
development	development	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
Kaufman	Kaufman	PROPN	NNP	O
Assessment	Assessment	PROPN	NNP	O
Battery	Battery	PROPN	NNP	O
for	for	ADP	IN	O
Children	Children	PROPN	NNP	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
dexamethasone	dexamethasone	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
children	child	NOUN	NNS	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
minor	minor	ADJ	JJ	O
neurological	neurological	ADJ	JJ	B-Disease
dysfunctions	dysfunction	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Neurological	neurological	ADJ	JJ	O
development	development	NOUN	NN	O
was	be	VERB	VBD	O
affected	affect	VERB	VBN	O
even	even	ADV	RB	O
without	without	ADP	IN	O
neurological	neurological	ADJ	JJ	O
diagnosis	diagnosis	NOUN	NN	O
.	.	PUNCT	.	O

Further	further	ADJ	JJ	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
studies	study	NOUN	NNS	O
will	will	VERB	MD	O
be	be	VERB	VB	O
necessary	necessary	ADJ	JJ	O
to	to	PART	TO	O
fully	fully	ADV	RB	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
impact	impact	NOUN	NN	O
of	of	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
on	on	ADP	IN	O
neurological	neurological	ADJ	JJ	O
and	and	CCONJ	CC	O
cognitive	cognitive	ADJ	JJ	O
development	development	NOUN	NN	O
.	.	PUNCT	.	O

Valproic	Valproic	PROPN	NNP	B-Chemical
acid	acid	NOUN	NN	I-Chemical
I	-PRON-	PRON	PRP	O
:	:	PUNCT	:	O
time	time	NOUN	NN	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
lipid	lipid	NOUN	NN	O
peroxidation	peroxidation	NOUN	NN	O
biomarkers	biomarker	NOUN	NNS	O
,	,	PUNCT	,	O
liver	liver	NOUN	NN	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
valproic	valproic	VERB	VB	B-Chemical
acid	acid	ADJ	JJ	I-Chemical
metabolite	metabolite	NOUN	NN	O
levels	level	NOUN	NNS	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
valproic	valproic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
VPA	VPA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
antiepileptic	antiepileptic	ADJ	JJ	O
drug	drug	NOUN	NN	O
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
recently	recently	ADV	RB	O
demonstrated	demonstrate	VERB	VBN	O
by	by	ADP	IN	O
elevated	elevated	ADJ	JJ	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
15	15	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
F	f	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2t	2t	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	:	I-Chemical
isoprostane	isoprostane	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
15	15	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
F	f	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2t	2t	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	:	I-Chemical
IsoP	IsoP	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

To	to	PART	TO	O
determine	determine	VERB	VB	O
whether	whether	ADP	IN	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
temporal	temporal	ADJ	JJ	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
VPA	VPA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
and	and	CCONJ	CC	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
adult	adult	NOUN	NN	O
male	male	NOUN	NN	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
ip	ip	PRON	PRP	O
with	with	ADP	IN	O
VPA	VPA	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
500	500	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
saline	saline	NOUN	NN	O
(	(	PUNCT	-LRB-	O
vehicle	vehicle	NOUN	NN	O
)	)	PUNCT	-RRB-	O
once	once	ADV	RB	O
daily	daily	ADV	RB	O
for	for	ADP	IN	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
7	7	NUM	CD	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
determining	determine	VERB	VBG	O
plasma	plasma	NOUN	NN	O
and	and	CCONJ	CC	O
liver	liver	NOUN	NN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
15	15	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
F	f	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2t	2t	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	:	I-Chemical
IsoP	IsoP	PROPN	NNP	I-Chemical
,	,	PUNCT	,	O
lipid	lipid	NOUN	NN	B-Chemical
hydroperoxides	hydroperoxide	NOUN	NNS	I-Chemical
(	(	PUNCT	-LRB-	O
LPO	LPO	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
thiobarbituric	thiobarbituric	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
reactive	reactive	ADJ	JJ	I-Chemical
substances	substance	NOUN	NNS	I-Chemical
(	(	PUNCT	-LRB-	O
TBARs	TBARs	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Plasma	Plasma	PROPN	NNP	O
and	and	CCONJ	CC	O
liver	liver	NOUN	NN	O
15	15	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
F	f	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2t	2t	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	:	I-Chemical
IsoP	isop	CCONJ	CC	I-Chemical
were	be	VERB	VBD	O
elevated	elevate	VERB	VBN	O
and	and	CCONJ	CC	O
reached	reach	VERB	VBN	O
a	a	DET	DT	O
plateau	plateau	NOUN	NN	O
after	after	ADP	IN	O
day	day	NOUN	NN	O
2	2	NUM	CD	O
of	of	ADP	IN	O
VPA	VPA	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
compared	compare	VERB	VBN	O
to	to	PART	TO	O
control	control	VERB	VB	O
.	.	PUNCT	.	O

Liver	Liver	PROPN	NNP	O
LPO	LPO	PROPN	NNP	B-Chemical
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
elevated	elevate	VERB	VBN	O
until	until	ADP	IN	O
day	day	NOUN	NN	O
7	7	NUM	CD	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
-	-	ADV	RB	O
fold	fold	VERB	VB	O
versus	versus	ADP	IN	O
control	control	NOUN	NN	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Liver	liver	NOUN	NN	O
and	and	CCONJ	CC	O
plasma	plasma	NOUN	NN	O
TBARs	tbar	NOUN	NNS	B-Chemical
were	be	VERB	VBD	O
not	not	ADV	RB	O
increased	increase	VERB	VBN	O
until	until	ADP	IN	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
fold	fold	VERB	VB	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
control	control	NOUN	NN	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Liver	liver	NOUN	NN	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
was	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
based	base	VERB	VBN	O
on	on	ADP	IN	O
serum	serum	ADJ	JJ	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
glutathione	glutathione	VERB	VBN	B-Chemical
S	s	NOUN	NN	O
-	-	PUNCT	HYPH	O
transferase	transferase	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
GST	GST	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
by	by	ADP	IN	O
histology	histology	NOUN	NN	O
.	.	PUNCT	.	O

Serum	serum	ADJ	JJ	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
GST	gst	ADJ	JJ	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
elevated	elevate	VERB	VBN	O
by	by	ADP	IN	O
day	day	NOUN	NN	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
corresponded	correspond	VERB	VBD	O
to	to	PART	TO	O
hepatotoxicity	hepatotoxicity	VERB	VB	B-Disease
as	as	ADP	IN	O
shown	show	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
increasing	increase	VERB	VBG	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
inflammation	inflammation	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
liver	liver	NOUN	NN	O
capsule	capsule	NOUN	NN	O
,	,	PUNCT	,	O
necrosis	necrosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
steatosis	steatosis	NOUN	NN	B-Disease
throughout	throughout	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
liver	liver	NOUN	NN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
oxidation	oxidation	NOUN	NN	O
metabolites	metabolite	NOUN	NNS	O
of	of	ADP	IN	O
VPA	VPA	PROPN	NNP	B-Chemical
were	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
by	by	ADP	IN	O
day	day	NOUN	NN	O
14	14	NUM	CD	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
the	the	DET	DT	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
4	4	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
ene	ene	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
VPA	VPA	PROPN	NNP	I-Chemical
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
E	E	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
diene	diene	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
VPA	VPA	PROPN	NNP	I-Chemical
were	be	VERB	VBD	O
not	not	ADV	RB	O
elevated	elevate	VERB	VBN	O
throughout	throughout	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Overall	overall	ADV	RB	O
,	,	PUNCT	,	O
these	these	DET	DT	O
findings	finding	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
VPA	VPA	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
results	result	NOUN	NNS	O
in	in	ADP	IN	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
measured	measure	VERB	VBN	O
by	by	ADP	IN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
15	15	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
F	f	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2t	2t	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	:	I-Chemical
IsoP	IsoP	PROPN	NNP	I-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
precedes	precede	VERB	VBZ	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
necrosis	necrosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
steatosis	steatosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
elevated	elevated	ADJ	JJ	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
serum	serum	ADJ	JJ	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
GST	gst	ADJ	JJ	O
.	.	PUNCT	.	O

Assessment	assessment	NOUN	NN	O
of	of	ADP	IN	O
perinatal	perinatal	ADJ	JJ	O
hepatitis	hepatitis	NOUN	NN	B-Disease
B	B	PROPN	NNP	I-Disease
and	and	CCONJ	CC	O
rubella	rubella	NOUN	NN	B-Disease
prevention	prevention	NOUN	NN	O
in	in	ADP	IN	O
New	New	PROPN	NNP	O
Hampshire	Hampshire	PROPN	NNP	O
delivery	delivery	NOUN	NN	O
hospitals	hospital	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
current	current	ADJ	JJ	O
performance	performance	NOUN	NN	O
on	on	ADP	IN	O
recommended	recommend	VERB	VBN	O
perinatal	perinatal	ADJ	JJ	O
hepatitis	hepatitis	NOUN	NN	B-Disease
B	B	PROPN	NNP	I-Disease
and	and	CCONJ	CC	O
rubella	rubella	NOUN	NN	B-Disease
prevention	prevention	NOUN	NN	O
practices	practice	NOUN	NNS	O
in	in	ADP	IN	O
New	New	PROPN	NNP	O
Hampshire	Hampshire	PROPN	NNP	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Data	datum	NOUN	NNS	O
were	be	VERB	VBD	O
extracted	extract	VERB	VBN	O
from	from	ADP	IN	O
2021	2021	NUM	CD	O
paired	pair	VERB	VBN	O
mother	mother	NOUN	NN	O
-	-	PUNCT	HYPH	O
infant	infant	NOUN	NN	O
records	record	NOUN	NNS	O
for	for	ADP	IN	O
the	the	DET	DT	O
year	year	NOUN	NN	O
2000	2000	NUM	CD	O
birth	birth	NOUN	NN	O
cohort	cohort	NOUN	NN	O
in	in	ADP	IN	O
New	New	PROPN	NNP	O
Hampshire	Hampshire	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	VERB	VBZ	O
25	25	NUM	CD	O
delivery	delivery	NOUN	NN	O
hospitals	hospital	NOUN	NNS	O
.	.	PUNCT	.	O

Assessment	Assessment	PROPN	NNP	O
was	be	VERB	VBD	O
done	do	VERB	VBN	O
on	on	ADP	IN	O
the	the	DET	DT	O
following	follow	VERB	VBG	O
:	:	PUNCT	:	O
prenatal	prenatal	ADJ	JJ	O
screening	screening	NOUN	NN	O
for	for	ADP	IN	O
hepatitis	hepatitis	NOUN	NN	B-Disease
B	B	PROPN	NNP	I-Disease
and	and	CCONJ	CC	O
rubella	rubella	NOUN	NN	B-Disease
,	,	PUNCT	,	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hepatitis	hepatitis	PROPN	NNP	B-Disease
B	B	PROPN	NNP	I-Disease
vaccine	vaccine	NOUN	NN	O
birth	birth	NOUN	NN	O
dose	dose	NOUN	NN	O
to	to	ADP	IN	O
all	all	DET	DT	O
infants	infant	NOUN	NNS	O
,	,	PUNCT	,	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
hepatitis	hepatitis	PROPN	NNP	B-Disease
B	B	PROPN	NNP	I-Disease
immune	immune	ADJ	JJ	O
globulin	globulin	NOUN	NN	O
to	to	ADP	IN	O
infants	infant	NOUN	NNS	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
born	bear	VERB	VBN	O
to	to	PART	TO	O
hepatitis	hepatitis	VERB	VB	B-Chemical
B	B	PROPN	NNP	I-Chemical
surface	surface	NOUN	NN	I-Chemical
antigen	antigen	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
mothers	mother	NOUN	NNS	O
,	,	PUNCT	,	O
rubella	rubella	NOUN	NN	B-Disease
immunity	immunity	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
in	in	ADP	IN	O
-	-	PUNCT	HYPH	O
hospital	hospital	NOUN	NN	O
postpartum	postpartum	NOUN	NN	O
rubella	rubella	NOUN	NN	B-Disease
vaccine	vaccine	NOUN	NN	O
to	to	ADP	IN	O
rubella	rubella	NOUN	NN	B-Disease
nonimmune	nonimmune	ADJ	JJ	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Prenatal	prenatal	ADJ	JJ	O
screening	screening	NOUN	NN	O
rates	rate	NOUN	NNS	O
for	for	ADP	IN	O
hepatitis	hepatitis	NOUN	NN	B-Disease
B	B	PROPN	NNP	I-Disease
(	(	PUNCT	-LRB-	O
98	98	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
rubella	rubella	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
99	99	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
high	high	ADJ	JJ	O
.	.	PUNCT	.	O

Hepatitis	Hepatitis	PROPN	NNP	B-Disease
B	B	PROPN	NNP	I-Disease
vaccine	vaccine	NOUN	NN	O
birth	birth	NOUN	NN	O
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
to	to	ADP	IN	O
76	76	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
all	all	DET	DT	O
infants	infant	NOUN	NNS	O
.	.	PUNCT	.	O

All	all	DET	DT	O
infants	infant	NOUN	NNS	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
born	bear	VERB	VBN	O
to	to	PART	TO	O
hepatitis	hepatitis	VERB	VB	B-Chemical
B	B	PROPN	NNP	I-Chemical
surface	surface	NOUN	NN	I-Chemical
antigen	antigen	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
mothers	mother	NOUN	NNS	O
also	also	ADV	RB	O
received	receive	VERB	VBD	O
hepatitis	hepatitis	NOUN	NN	B-Disease
B	B	PROPN	NNP	I-Disease
immune	immune	ADJ	JJ	O
globulin	globulin	NOUN	NN	O
.	.	PUNCT	.	O

Multivariate	multivariate	ADJ	JJ	O
logistic	logistic	ADJ	JJ	O
regression	regression	NOUN	NN	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
the	the	DET	DT	O
month	month	NOUN	NN	O
of	of	ADP	IN	O
delivery	delivery	NOUN	NN	O
and	and	CCONJ	CC	O
infant	infant	ADJ	JJ	O
birth	birth	NOUN	NN	O
weight	weight	NOUN	NN	O
were	be	VERB	VBD	O
independent	independent	ADJ	JJ	O
predictors	predictor	NOUN	NNS	O
of	of	ADP	IN	O
hepatitis	hepatitis	NOUN	NN	B-Disease
B	B	PROPN	NNP	I-Disease
vaccination	vaccination	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
proportion	proportion	NOUN	NN	O
of	of	ADP	IN	O
infants	infant	NOUN	NNS	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
vaccinated	vaccinate	VERB	VBN	O
in	in	ADP	IN	O
January	January	PROPN	NNP	O
and	and	CCONJ	CC	O
February	February	PROPN	NNP	O
2000	2000	NUM	CD	O
(	(	PUNCT	-LRB-	O
48	48	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
67	67	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
any	any	DET	DT	O
other	other	ADJ	JJ	O
months	month	NOUN	NNS	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
the	the	DET	DT	O
proportion	proportion	NOUN	NN	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
vaccinated	vaccinate	VERB	VBN	O
in	in	ADP	IN	O
December	December	PROPN	NNP	O
2000	2000	NUM	CD	O
(	(	PUNCT	-LRB-	O
88	88	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
the	the	DET	DT	O
highest	high	ADJ	JJS	O
.	.	PUNCT	.	O

Women	woman	NOUN	NNS	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
born	bear	VERB	VBN	O
between	between	ADP	IN	O
1971	1971	NUM	CD	O
and	and	CCONJ	CC	O
1975	1975	NUM	CD	O
had	have	VERB	VBD	O
the	the	DET	DT	O
highest	high	ADJ	JJS	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
rubella	rubella	NOUN	NN	B-Disease
nonimmunity	nonimmunity	NOUN	NN	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
-	-	PUNCT	HYPH	O
hospital	hospital	NOUN	NN	O
postpartum	postpartum	NOUN	NN	O
rubella	rubella	NOUN	NN	B-Disease
vaccine	vaccine	NOUN	NN	O
administration	administration	NOUN	NN	O
was	be	VERB	VBD	O
documented	document	VERB	VBN	O
for	for	ADP	IN	O
75	75	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
nonimmune	nonimmune	NOUN	NN	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
This	this	DET	DT	O
study	study	NOUN	NN	O
documents	document	VERB	VBZ	O
good	good	ADJ	JJ	O
compliance	compliance	NOUN	NN	O
in	in	ADP	IN	O
New	New	PROPN	NNP	O
Hampshire	Hampshire	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
birthing	birth	VERB	VBG	O
hospitals	hospital	NOUN	NNS	O
with	with	ADP	IN	O
national	national	ADJ	JJ	O
guidelines	guideline	NOUN	NNS	O
for	for	ADP	IN	O
perinatal	perinatal	ADJ	JJ	O
hepatitis	hepatitis	NOUN	NN	B-Disease
B	B	PROPN	NNP	I-Disease
and	and	CCONJ	CC	O
rubella	rubella	NOUN	NN	B-Disease
prevention	prevention	NOUN	NN	O
and	and	CCONJ	CC	O
highlights	highlight	VERB	VBZ	O
potential	potential	ADJ	JJ	O
areas	area	NOUN	NNS	O
for	for	ADP	IN	O
improvement	improvement	NOUN	NN	O
.	.	PUNCT	.	O

Succinylcholine	Succinylcholine	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
masseter	masseter	NOUN	NN	B-Disease
muscle	muscle	NOUN	NN	I-Disease
rigidity	rigidity	NOUN	NN	I-Disease
during	during	ADP	IN	O
bronchoscopic	bronchoscopic	ADJ	JJ	O
removal	removal	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
tracheal	tracheal	ADJ	JJ	O
foreign	foreign	ADJ	JJ	O
body	body	NOUN	NN	O
.	.	PUNCT	.	O

Masseter	Masseter	PROPN	NNP	B-Disease
muscle	muscle	NOUN	NN	I-Disease
rigidity	rigidity	NOUN	NN	I-Disease
during	during	ADP	IN	O
general	general	ADJ	JJ	O
anesthesia	anesthesia	NOUN	NN	O
is	be	VERB	VBZ	O
considered	consider	VERB	VBN	O
an	an	DET	DT	O
early	early	ADJ	JJ	O
warning	warning	NOUN	NN	O
sign	sign	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
episode	episode	NOUN	NN	O
of	of	ADP	IN	O
malignant	malignant	ADJ	JJ	B-Disease
hyperthermia	hyperthermia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
decision	decision	NOUN	NN	O
whether	whether	ADP	IN	O
to	to	PART	TO	O
continue	continue	VERB	VB	O
or	or	CCONJ	CC	O
discontinue	discontinue	VERB	VB	O
the	the	DET	DT	O
procedure	procedure	NOUN	NN	O
depends	depend	VERB	VBZ	O
on	on	ADP	IN	O
the	the	DET	DT	O
urgency	urgency	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
surgery	surgery	NOUN	NN	O
and	and	CCONJ	CC	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
masseter	masseter	NOUN	NN	B-Disease
muscle	muscle	NOUN	NN	I-Disease
rigidity	rigidity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Here	here	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
masseter	masseter	NOUN	NN	B-Disease
muscle	muscle	NOUN	NN	I-Disease
rigidity	rigidity	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
jaw	jaw	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
steel	steel	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	O
after	after	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Sch	Sch	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
administration	administration	NOUN	NN	O
during	during	ADP	IN	O
general	general	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
management	management	NOUN	NN	O
for	for	ADP	IN	O
rigid	rigid	ADJ	JJ	O
bronchoscopic	bronchoscopic	ADJ	JJ	O
removal	removal	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
tracheal	tracheal	ADJ	JJ	O
foreign	foreign	ADJ	JJ	O
body	body	NOUN	NN	O
.	.	PUNCT	.	O

Anesthesia	Anesthesia	PROPN	NNP	O
was	be	VERB	VBD	O
continued	continue	VERB	VBN	O
uneventfully	uneventfully	ADV	RB	O
with	with	ADP	IN	O
propofol	propofol	ADJ	JJ	B-Chemical
infusion	infusion	NOUN	NN	O
while	while	ADP	IN	O
all	all	DET	DT	O
facilities	facility	NOUN	NNS	O
were	be	VERB	VBD	O
available	available	ADJ	JJ	O
to	to	PART	TO	O
detect	detect	VERB	VB	O
and	and	CCONJ	CC	O
treat	treat	VERB	VB	O
malignant	malignant	ADJ	JJ	B-Disease
hyperthermia	hyperthermia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Dexrazoxane	dexrazoxane	NOUN	NN	B-Chemical
protects	protect	VERB	VBZ	O
against	against	ADP	IN	O
myelosuppression	myelosuppression	NOUN	NN	B-Disease
from	from	ADP	IN	O
the	the	DET	DT	O
DNA	dna	NOUN	NN	O
cleavage	cleavage	NOUN	NN	O
-	-	PUNCT	HYPH	O
enhancing	enhance	VERB	VBG	O
drugs	drug	NOUN	NNS	O
etoposide	etoposide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
daunorubicin	daunorubicin	VERB	VBD	B-Chemical
but	but	CCONJ	CC	O
not	not	ADV	RB	O
doxorubicin	doxorubicin	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
anthracyclines	anthracycline	NOUN	NNS	B-Chemical
daunorubicin	daunorubicin	VERB	VBP	B-Chemical
and	and	CCONJ	CC	O
doxorubicin	doxorubicin	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
epipodophyllotoxin	epipodophyllotoxin	NOUN	NN	B-Chemical
etoposide	etoposide	NOUN	NN	B-Chemical
are	be	VERB	VBP	O
potent	potent	ADJ	JJ	O
DNA	dna	NOUN	NN	O
cleavage	cleavage	NOUN	NN	O
-	-	PUNCT	HYPH	O
enhancing	enhance	VERB	VBG	O
drugs	drug	NOUN	NNS	O
that	that	DET	WDT	O
are	be	VERB	VBP	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
clinical	clinical	ADJ	JJ	O
oncology	oncology	NOUN	NN	O
;	;	PUNCT	:	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
myelosuppression	myelosuppression	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
limit	limit	VERB	VBP	O
their	-PRON-	DET	PRP$	O
use	use	NOUN	NN	O
.	.	PUNCT	.	O

Dexrazoxane	Dexrazoxane	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
ICRF	ICRF	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
187	187	NUM	CD	I-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
recommended	recommend	VERB	VBN	O
for	for	ADP	IN	O
protection	protection	NOUN	NN	O
against	against	ADP	IN	O
anthracycline	anthracycline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

EXPERIMENTAL	EXPERIMENTAL	PROPN	NNP	O
DESIGN	DESIGN	PROPN	NNP	O
:	:	PUNCT	:	O
Because	because	ADP	IN	O
of	of	ADP	IN	O
their	-PRON-	DET	PRP$	O
widespread	widespread	ADJ	JJ	O
use	use	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
hematologic	hematologic	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
coadministration	coadministration	NOUN	NN	O
of	of	ADP	IN	O
dexrazoxane	dexrazoxane	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
these	these	DET	DT	O
three	three	NUM	CD	O
structurally	structurally	ADV	RB	O
different	different	ADJ	JJ	O
DNA	dna	NOUN	NN	O
cleavage	cleavage	NOUN	NN	O
enhancers	enhancer	NOUN	NNS	O
was	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
:	:	PUNCT	:	O
Sensitivity	sensitivity	NOUN	NN	O
of	of	ADP	IN	O
human	human	NOUN	NN	O
and	and	CCONJ	CC	O
murine	murine	ADJ	JJ	O
blood	blood	NOUN	NN	O
progenitor	progenitor	NOUN	NN	O
cells	cell	NOUN	NNS	O
to	to	PART	TO	O
etoposide	etoposide	VERB	VB	B-Chemical
,	,	PUNCT	,	O
daunorubicin	daunorubicin	VERB	VB	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
dexrazoxane	dexrazoxane	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
determined	determine	VERB	VBN	O
in	in	ADP	IN	O
granulocyte	granulocyte	NOUN	NN	O
-	-	PUNCT	HYPH	O
macrophage	macrophage	NOUN	NN	O
colony	colony	NOUN	NN	O
forming	form	VERB	VBG	O
assays	assay	NOUN	NNS	O
.	.	PUNCT	.	O

Likewise	likewise	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
,	,	PUNCT	,	O
B6D2F1	B6D2F1	ADJ	JJR	O
mice	mouse	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
etoposide	etoposide	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
daunorubicin	daunorubicin	VERB	VB	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
doxorubicin	doxorubicin	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
with	with	ADP	IN	O
or	or	CCONJ	CC	O
without	without	ADP	IN	O
dexrazoxane	dexrazoxane	NOUN	NN	B-Chemical
over	over	ADP	IN	O
a	a	DET	DT	O
wide	wide	ADJ	JJ	O
range	range	NOUN	NN	O
of	of	ADP	IN	O
doses	dose	NOUN	NNS	O
:	:	PUNCT	:	O
posttreatment	posttreatment	VERB	VB	O
,	,	PUNCT	,	O
a	a	DET	DT	O
full	full	ADJ	JJ	O
hematologic	hematologic	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
was	be	VERB	VBD	O
done	do	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Nontoxic	Nontoxic	PROPN	NNP	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
dexrazoxane	dexrazoxane	NOUN	NN	B-Chemical
reduced	reduce	VERB	VBN	O
myelosuppression	myelosuppression	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
weight	weight	NOUN	NN	B-Disease
loss	loss	NOUN	NN	I-Disease
from	from	ADP	IN	O
daunorubicin	daunorubicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
etoposide	etoposide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
and	and	CCONJ	CC	O
antagonized	antagonize	VERB	VBD	O
their	-PRON-	DET	PRP$	O
antiproliferative	antiproliferative	ADJ	JJ	O
effects	effect	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
colony	colony	NOUN	NN	O
assay	assay	NOUN	NN	O
;	;	PUNCT	:	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
dexrazoxane	dexrazoxane	VERB	VB	B-Chemical
neither	neither	CCONJ	CC	O
reduced	reduce	VERB	VBN	O
myelosuppression	myelosuppression	NOUN	NN	B-Disease
,	,	PUNCT	,	O
weight	weight	NOUN	NN	B-Disease
loss	loss	NOUN	NN	I-Disease
,	,	PUNCT	,	O
nor	nor	CCONJ	CC	O
the	the	DET	DT	O
in	in	ADP	IN	O
vitro	vitro	X	FW	O
cytotoxicity	cytotoxicity	NOUN	NN	B-Disease
from	from	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Although	although	ADP	IN	O
our	-PRON-	DET	PRP$	O
findings	finding	NOUN	NNS	O
support	support	VERB	VBP	O
the	the	DET	DT	O
observation	observation	NOUN	NN	O
that	that	ADP	IN	O
dexrazoxane	dexrazoxane	NOUN	NN	B-Chemical
reduces	reduce	VERB	VBZ	O
neither	neither	CCONJ	CC	O
hematologic	hematologic	ADJ	JJ	O
activity	activity	NOUN	NN	O
nor	nor	CCONJ	CC	O
antitumor	antitumor	ADJ	JJ	O
activity	activity	NOUN	NN	O
from	from	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
clinically	clinically	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
potent	potent	ADJ	JJ	O
antagonism	antagonism	NOUN	NN	O
of	of	ADP	IN	O
daunorubicin	daunorubicin	ADJ	JJ	B-Chemical
activity	activity	NOUN	NN	O
raises	raise	VERB	VBZ	O
concern	concern	NOUN	NN	O
;	;	PUNCT	:	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
interference	interference	NOUN	NN	O
with	with	ADP	IN	O
anticancer	anticancer	NOUN	NN	O
efficacy	efficacy	NOUN	NN	O
certainly	certainly	ADV	RB	O
would	would	VERB	MD	O
call	call	VERB	VB	O
for	for	ADP	IN	O
renewed	renew	VERB	VBN	O
attention	attention	NOUN	NN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
data	datum	NOUN	NNS	O
also	also	ADV	RB	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
significant	significant	ADJ	JJ	O
etoposide	etoposide	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
escalation	escalation	NOUN	NN	O
is	be	VERB	VBZ	O
perhaps	perhaps	ADV	RB	O
possible	possible	ADJ	JJ	O
by	by	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
dexrazoxane	dexrazoxane	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
trials	trial	NOUN	NNS	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
brain	brain	NOUN	NN	O
metastases	metastasis	NOUN	NNS	B-Disease
combining	combine	VERB	VBG	O
dexrazoxane	dexrazoxane	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
etoposide	etoposide	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
ongoing	ongoing	ADJ	JJ	O
with	with	ADP	IN	O
the	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
improving	improve	VERB	VBG	O
efficacy	efficacy	NOUN	NN	O
without	without	ADP	IN	O
aggravating	aggravate	VERB	VBG	O
hematologic	hematologic	NOUN	NN	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

If	if	ADP	IN	O
successful	successful	ADJ	JJ	O
,	,	PUNCT	,	O
this	this	DET	DT	O
represents	represent	VERB	VBZ	O
an	an	DET	DT	O
exciting	exciting	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
for	for	ADP	IN	O
pharmacologic	pharmacologic	ADJ	JJ	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
from	from	ADP	IN	O
cytotoxic	cytotoxic	NOUN	NN	O
chemotherapy	chemotherapy	NOUN	NN	O
.	.	PUNCT	.	O

Assessment	assessment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
and	and	CCONJ	CC	O
persistence	persistence	NOUN	NN	O
of	of	ADP	IN	O
amnesia	amnesia	NOUN	NN	B-Disease
during	during	ADP	IN	O
procedural	procedural	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
with	with	ADP	IN	O
propofol	propofol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

OBJECTIVES	objectives	NOUN	NN	O
:	:	PUNCT	:	O
To	to	PART	TO	O
assess	assess	VERB	VB	O
patients	patient	NOUN	NNS	O
'	'	PART	POS	O
ability	ability	NOUN	NN	O
to	to	PART	TO	O
repeat	repeat	VERB	VB	O
and	and	CCONJ	CC	O
recall	recall	NOUN	NN	O
words	word	NOUN	NNS	O
presented	present	VERB	VBN	O
to	to	ADP	IN	O
them	-PRON-	PRON	PRP	O
while	while	ADP	IN	O
undergoing	undergo	VERB	VBG	O
procedural	procedural	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
with	with	ADP	IN	O
propofol	propofol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
correlate	correlate	VERB	VB	O
their	-PRON-	DET	PRP$	O
recall	recall	NOUN	NN	O
with	with	ADP	IN	O
their	-PRON-	DET	PRP$	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
awareness	awareness	NOUN	NN	O
as	as	ADP	IN	O
measured	measure	VERB	VBN	O
by	by	ADP	IN	O
bispectral	bispectral	ADJ	JJ	O
index	index	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BIS	BIS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
monitoring	monitoring	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
This	this	DET	DT	O
was	be	VERB	VBD	O
a	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
single	single	ADJ	JJ	O
-	-	PUNCT	HYPH	O
intervention	intervention	NOUN	NN	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
consenting	consent	VERB	VBG	O
adult	adult	NOUN	NN	O
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
procedural	procedural	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
with	with	ADP	IN	O
propofol	propofol	NOUN	NN	B-Chemical
between	between	ADP	IN	O
December	December	PROPN	NNP	O
28	28	NUM	CD	O
,	,	PUNCT	,	O
2002	2002	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
October	October	PROPN	NNP	O
31	31	NUM	CD	O
,	,	PUNCT	,	O
2003	2003	NUM	CD	O
.	.	PUNCT	.	O

BIS	BIS	PROPN	NNP	O
monitoring	monitoring	NOUN	NN	O
was	be	VERB	VBD	O
initiated	initiate	VERB	VBN	O
starting	start	VERB	VBG	O
3	3	NUM	CD	O
minutes	minute	NOUN	NNS	O
before	before	ADP	IN	O
the	the	DET	DT	O
procedure	procedure	NOUN	NN	O
and	and	CCONJ	CC	O
continuing	continue	VERB	VBG	O
until	until	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
regained	regain	VERB	VBN	O
baseline	baseline	ADJ	JJ	O
mental	mental	ADJ	JJ	O
status	status	NOUN	NN	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
minute	minute	NOUN	NN	O
intervals	interval	NOUN	NNS	O
during	during	ADP	IN	O
the	the	DET	DT	O
procedural	procedural	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
,	,	PUNCT	,	O
until	until	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
regained	regain	VERB	VBD	O
baseline	baseline	ADJ	JJ	O
mental	mental	ADJ	JJ	O
status	status	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
procedure	procedure	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
word	word	NOUN	NN	O
from	from	ADP	IN	O
a	a	DET	DT	O
standardized	standardized	ADJ	JJ	O
list	list	NOUN	NN	O
was	be	VERB	VBD	O
read	read	VERB	VBN	O
aloud	aloud	ADV	RB	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
asked	ask	VERB	VBN	O
to	to	PART	TO	O
immediately	immediately	ADV	RB	O
repeat	repeat	VERB	VB	O
the	the	DET	DT	O
word	word	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
investigator	investigator	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
BIS	BIS	PROPN	NNP	O
score	score	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
time	time	NOUN	NN	O
the	the	DET	DT	O
word	word	NOUN	NN	O
was	be	VERB	VBD	O
read	read	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
ability	ability	NOUN	NN	O
to	to	PART	TO	O
repeat	repeat	VERB	VB	O
the	the	DET	DT	O
word	word	NOUN	NN	O
were	be	VERB	VBD	O
recorded	record	VERB	VBN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
the	the	DET	DT	O
procedure	procedure	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
asked	ask	VERB	VBN	O
to	to	PART	TO	O
state	state	VERB	VB	O
all	all	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
words	word	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
list	list	NOUN	NN	O
that	that	ADP	IN	O
he	-PRON-	PRON	PRP	O
or	or	CCONJ	CC	O
she	-PRON-	PRON	PRP	O
could	could	VERB	MD	O
recall	recall	VERB	VB	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
identify	identify	VERB	VB	O
the	the	DET	DT	O
last	last	ADJ	JJ	O
word	word	NOUN	NN	O
recalled	recall	VERB	VBD	O
from	from	ADP	IN	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
the	the	DET	DT	O
start	start	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
procedure	procedure	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
word	word	NOUN	NN	O
recalled	recall	VERB	VBD	O
from	from	ADP	IN	O
after	after	ADP	IN	O
the	the	DET	DT	O
procedure	procedure	NOUN	NN	O
was	be	VERB	VBD	O
completed	complete	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Seventy	seventy	NUM	CD	O
-	-	PUNCT	HYPH	O
five	five	NUM	CD	O
consenting	consent	VERB	VBG	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
enrolled	enrol	VERB	VBN	O
;	;	PUNCT	:	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
excluded	exclude	VERB	VBN	O
from	from	ADP	IN	O
data	datum	NOUN	NNS	O
analysis	analysis	NOUN	NN	O
for	for	ADP	IN	O
a	a	DET	DT	O
protocol	protocol	NOUN	NN	O
violation	violation	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
serious	serious	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
were	be	VERB	VBD	O
noted	note	VERB	VBN	O
during	during	ADP	IN	O
the	the	DET	DT	O
procedural	procedural	ADJ	JJ	O
sedations	sedation	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
standard	standard	ADJ	JJ	O
deviation	deviation	NOUN	NN	O
)	)	PUNCT	-RRB-	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
data	datum	NOUN	NNS	O
collection	collection	NOUN	NN	O
was	be	VERB	VBD	O
16	16	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
minutes	minute	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
;	;	PUNCT	:	O
range	range	VERB	VB	O
5	5	NUM	CD	O
to	to	PART	TO	O
34	34	NUM	CD	O
minutes	minute	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
initial	initial	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
preprocedure	preprocedure	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
BIS	BIS	PROPN	NNP	O
score	score	NOUN	NN	O
was	be	VERB	VBD	O
97	97	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
;	;	PUNCT	:	O
range	range	VERB	VBP	O
92	92	NUM	CD	O
to	to	ADP	IN	O
99	99	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
lowest	low	ADJ	JJS	O
BIS	BIS	PROPN	NNP	O
score	score	NOUN	NN	O
occurring	occur	VERB	VBG	O
during	during	ADP	IN	O
these	these	DET	DT	O
procedural	procedural	ADJ	JJ	O
sedations	sedation	NOUN	NNS	O
was	be	VERB	VBD	O
66	66	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
14	14	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
;	;	PUNCT	:	O
range	range	VERB	VBP	O
33	33	NUM	CD	O
to	to	PART	TO	O
91	91	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
lowest	low	ADJ	JJS	O
BIS	BIS	PROPN	NNP	O
score	score	NOUN	NN	O
corresponding	correspond	VERB	VBG	O
to	to	ADP	IN	O
the	the	DET	DT	O
ability	ability	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
to	to	PART	TO	O
immediately	immediately	ADV	RB	O
repeat	repeat	VERB	VB	O
words	word	NOUN	NNS	O
read	read	VERB	VBP	O
from	from	ADP	IN	O
the	the	DET	DT	O
list	list	NOUN	NN	O
was	be	VERB	VBD	O
77	77	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
=	=	NOUN	NNS	O
74	74	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
to	to	PART	TO	O
80	80	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
highest	high	ADJ	JJS	O
BIS	BIS	PROPN	NNP	O
score	score	NOUN	NN	O
corresponding	correspond	VERB	VBG	O
to	to	ADP	IN	O
the	the	DET	DT	O
inability	inability	NOUN	NN	B-Disease
to	to	PART	TO	I-Disease
repeat	repeat	VERB	VB	I-Disease
words	word	NOUN	NNS	I-Disease
was	be	VERB	VBD	O
81	81	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
=	=	PROPN	NNP	O
78	78	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
to	to	ADP	IN	O
84	84	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
BIS	BIS	PROPN	NNP	O
score	score	NOUN	NN	O
corresponding	correspond	VERB	VBG	O
to	to	ADP	IN	O
the	the	DET	DT	O
last	last	ADJ	JJ	O
word	word	NOUN	NN	O
recalled	recall	VERB	VBD	O
from	from	ADP	IN	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
the	the	DET	DT	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
sedation	sedation	NOUN	NN	O
was	be	VERB	VBD	O
96	96	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
;	;	PUNCT	:	O
range	range	VERB	VBP	O
84	84	NUM	CD	O
to	to	PART	TO	O
98	98	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
BIS	BIS	PROPN	NNP	O
score	score	NOUN	NN	O
corresponding	correspond	VERB	VBG	O
to	to	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
word	word	NOUN	NN	O
recalled	recall	VERB	VBD	O
after	after	ADP	IN	O
the	the	DET	DT	O
procedure	procedure	NOUN	NN	O
was	be	VERB	VBD	O
completed	complete	VERB	VBN	O
was	be	VERB	VBD	O
91	91	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
=	=	NOUN	NNS	O
88	88	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
to	to	ADP	IN	O
94	94	NUM	CD	O
.	.	PUNCT	.	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
recalled	recall	VERB	VBD	O
at	at	ADV	RB	O
least	least	ADV	RBS	O
one	one	NUM	CD	O
word	word	NOUN	NN	O
that	that	DET	WDT	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
read	read	VERB	VBN	O
to	to	ADP	IN	O
them	-PRON-	PRON	PRP	O
during	during	ADP	IN	O
the	the	DET	DT	O
protocol	protocol	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
lowest	low	ADJ	JJS	O
BIS	BIS	PROPN	NNP	O
score	score	NOUN	NN	O
for	for	ADP	IN	O
any	any	DET	DT	O
recalled	recalled	ADJ	JJ	O
word	word	NOUN	NN	O
was	be	VERB	VBD	O
91	91	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
;	;	PUNCT	:	O
range	range	VERB	VB	O
79	79	NUM	CD	O
to	to	PART	TO	O
98	98	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
no	no	DET	DT	O
words	word	NOUN	NNS	O
were	be	VERB	VBD	O
recalled	recall	VERB	VBN	O
when	when	ADV	WRB	O
the	the	DET	DT	O
corresponding	correspond	VERB	VBG	O
BIS	BIS	PROPN	NNP	O
score	score	NOUN	NN	O
was	be	VERB	VBD	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
90	90	NUM	CD	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
There	there	ADV	EX	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
range	range	NOUN	NN	O
of	of	ADP	IN	O
BIS	BIS	PROPN	NNP	O
scores	score	NOUN	NNS	O
during	during	ADP	IN	O
which	which	DET	WDT	O
sedated	sedate	VERB	VBN	O
patients	patient	NOUN	NNS	O
are	be	VERB	VBP	O
able	able	ADJ	JJ	O
to	to	PART	TO	O
repeat	repeat	VERB	VB	O
words	word	NOUN	NNS	O
read	read	VERB	VBN	O
to	to	ADP	IN	O
them	-PRON-	PRON	PRP	O
but	but	CCONJ	CC	O
are	be	VERB	VBP	O
not	not	ADV	RB	O
able	able	ADJ	JJ	O
to	to	PART	TO	O
subsequently	subsequently	ADV	RB	O
recall	recall	VERB	VB	O
these	these	DET	DT	O
words	word	NOUN	NNS	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
no	no	DET	DT	O
recall	recall	NOUN	NN	O
of	of	ADP	IN	O
words	word	NOUN	NNS	O
repeated	repeat	VERB	VBN	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
procedural	procedural	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
in	in	ADP	IN	O
BIS	BIS	PROPN	NNP	O
ranges	range	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
recall	recall	NOUN	NN	O
after	after	ADP	IN	O
procedural	procedural	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
,	,	PUNCT	,	O
suggestive	suggestive	NOUN	NN	O
of	of	ADP	IN	O
retrograde	retrograde	NOUN	NN	B-Disease
amnesia	amnesia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Amiodarone	amiodarone	ADJ	JJ	B-Chemical
pulmonary	pulmonary	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Amiodarone	Amiodarone	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
antiarrhythmic	antiarrhythmic	ADJ	JJ	O
agent	agent	NOUN	NN	O
whose	whose	DET	WP$	O
utility	utility	NOUN	NN	O
is	be	VERB	VBZ	O
limited	limit	VERB	VBN	O
by	by	ADP	IN	O
many	many	ADJ	JJ	O
side	side	NOUN	NN	O
-	-	PUNCT	HYPH	O
effects	effect	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
most	most	ADV	RBS	O
problematic	problematic	ADJ	JJ	O
being	be	VERB	VBG	O
pneumonitis	pneumonitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
pulmonary	pulmonary	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
of	of	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
thought	think	VERB	VBN	O
to	to	PART	TO	O
result	result	VERB	VB	O
from	from	ADP	IN	O
direct	direct	ADJ	JJ	O
injury	injury	NOUN	NN	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
intracellular	intracellular	ADJ	JJ	O
accumulation	accumulation	NOUN	NN	O
of	of	ADP	IN	O
phospholipid	phospholipid	NOUN	NN	O
and	and	CCONJ	CC	O
T	T	PROPN	NNP	O
cell	cell	NOUN	NN	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
pneumonitis	pneumonitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
radiographic	radiographic	ADJ	JJ	O
features	feature	NOUN	NNS	O
of	of	ADP	IN	O
amiodarone	amiodarone	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
pulmonary	pulmonary	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
are	be	VERB	VBP	O
characteristic	characteristic	ADJ	JJ	O
but	but	CCONJ	CC	O
nonspecific	nonspecific	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
depends	depend	VERB	VBZ	O
on	on	ADP	IN	O
exclusion	exclusion	NOUN	NN	O
of	of	ADP	IN	O
other	other	ADJ	JJ	O
entities	entity	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
,	,	PUNCT	,	O
infection	infection	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
malignancy	malignancy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

While	while	ADP	IN	O
withdrawal	withdrawal	NOUN	NN	O
of	of	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
leads	lead	NOUN	NNS	O
to	to	ADP	IN	O
clinical	clinical	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
majority	majority	NOUN	NN	O
of	of	ADP	IN	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
this	this	DET	DT	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
always	always	ADV	RB	O
possible	possible	ADJ	JJ	O
or	or	CCONJ	CC	O
advisable	advisable	ADJ	JJ	O
.	.	PUNCT	.	O

Dose	dose	NOUN	NN	O
reduction	reduction	NOUN	NN	O
or	or	CCONJ	CC	O
concomitant	concomitant	ADJ	JJ	O
steroid	steroid	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
may	may	VERB	MD	O
have	have	VERB	VB	O
a	a	DET	DT	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
selected	select	VERB	VBN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
prodrugs	prodrug	NOUN	NNS	O
of	of	ADP	IN	O
potent	potent	ADJ	JJ	O
and	and	CCONJ	CC	O
selective	selective	ADJ	JJ	O
GluR5	GluR5	PROPN	NNP	O
kainate	kainate	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
antagonists	antagonist	VERB	VBZ	O
actives	active	VERB	VBZ	O
in	in	ADP	IN	O
three	three	NUM	CD	O
animal	animal	NOUN	NN	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Amino	amino	ADJ	JJ	O
acids	acid	NOUN	NNS	O
5	5	NUM	CD	O
and	and	CCONJ	CC	O
7	7	NUM	CD	O
,	,	PUNCT	,	O
two	two	NUM	CD	O
potent	potent	ADJ	JJ	O
and	and	CCONJ	CC	O
selective	selective	ADJ	JJ	O
competitive	competitive	ADJ	JJ	O
GluR5	GluR5	PROPN	NNP	O
KA	KA	PROPN	NNP	B-Chemical
receptor	receptor	NOUN	NN	O
antagonists	antagonist	NOUN	NNS	O
,	,	PUNCT	,	O
exhibited	exhibit	VERB	VBN	O
high	high	ADJ	JJ	O
GluR5	GluR5	PROPN	NNP	O
receptor	receptor	NOUN	NN	O
affinity	affinity	NOUN	NN	O
over	over	ADP	IN	O
other	other	ADJ	JJ	O
glutamate	glutamate	ADJ	JJ	B-Chemical
receptors	receptor	NOUN	NNS	O
.	.	PUNCT	.	O

Their	-PRON-	DET	PRP$	O
ester	ester	NOUN	NN	O
prodrugs	prodrug	VERB	VBZ	O
6	6	NUM	CD	O
and	and	CCONJ	CC	O
8	8	NUM	CD	O
were	be	VERB	VBD	O
orally	orally	ADV	RB	O
active	active	ADJ	JJ	O
in	in	ADP	IN	O
three	three	NUM	CD	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
:	:	PUNCT	:	O
reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
formalin	formalin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
paw	paw	PRON	PRP	O
licking	lick	VERB	VBG	O
,	,	PUNCT	,	O
carrageenan	carrageenan	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
thermal	thermal	ADJ	JJ	B-Disease
hyperalgesia	hyperalgesia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
capsaicin	capsaicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
mechanical	mechanical	ADJ	JJ	B-Disease
hyperalgesia	hyperalgesia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Possible	possible	ADJ	JJ	O
azithromycin	azithromycin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
hiccups	hiccup	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
report	report	VERB	VB	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
persistent	persistent	ADJ	JJ	O
hiccups	hiccup	NOUN	NNS	B-Disease
associated	associate	VERB	VBN	O
by	by	ADP	IN	O
azithromycin	azithromycin	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

CASE	case	NOUN	NN	O
SUMMARY	summary	NOUN	NN	O
:	:	PUNCT	:	O
A	a	DET	DT	O
76	76	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
presented	present	VERB	VBN	O
with	with	ADP	IN	O
persistent	persistent	ADJ	JJ	O
hiccups	hiccup	NOUN	NNS	B-Disease
after	after	ADP	IN	O
beginning	begin	VERB	VBG	O
azithromycin	azithromycin	NOUN	NN	B-Chemical
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
pharyngitis	pharyngitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Hiccups	hiccup	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
persistent	persistent	ADJ	JJ	O
and	and	CCONJ	CC	O
exhausting	exhausting	ADJ	JJ	O
.	.	PUNCT	.	O

Discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
azithromycin	azithromycin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
baclofen	baclofen	NOUN	NNS	B-Chemical
finally	finally	ADV	RB	O
resolved	resolve	VERB	VBN	O
hiccups	hiccup	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

No	no	DET	DT	O
organic	organic	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
hiccups	hiccup	NOUN	NNS	B-Disease
was	be	VERB	VBD	O
identified	identify	VERB	VBN	O
despite	despite	ADP	IN	O
extensive	extensive	ADJ	JJ	O
investigation	investigation	NOUN	NN	O
.	.	PUNCT	.	O

DISCUSSION	discussion	NOUN	NN	O
:	:	PUNCT	:	O
Pharmacotherapeutic	pharmacotherapeutic	ADJ	JJ	O
agents	agent	NOUN	NNS	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
uncommonly	uncommonly	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
hiccups	hiccup	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Corticosteroids	corticosteroid	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
dexamethasone	dexamethasone	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
methylprednisolone	methylprednisolone	ADJ	JJ	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
benzodiazepines	benzodiazepine	NOUN	NNS	B-Chemical
(	(	PUNCT	-LRB-	O
midazolam	midazolam	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
general	general	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
the	the	DET	DT	O
specific	specific	ADJ	JJ	O
agents	agent	NOUN	NNS	O
mentioned	mention	VERB	VBD	O
most	most	ADV	RBS	O
frequently	frequently	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
as	as	ADP	IN	O
being	be	VERB	VBG	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
hiccups	hiccup	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Few	few	ADJ	JJ	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hiccups	hiccup	NOUN	NNS	B-Disease
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
related	related	ADJ	JJ	O
to	to	ADP	IN	O
macrolide	macrolide	NOUN	NN	B-Chemical
antimicrobials	antimicrobial	NOUN	NNS	O
.	.	PUNCT	.	O

Using	use	VERB	VBG	O
the	the	DET	DT	O
Naranjo	Naranjo	PROPN	NNP	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
reaction	reaction	NOUN	NN	O
probability	probability	NOUN	NN	O
scale	scale	NOUN	NN	O
this	this	DET	DT	O
event	event	NOUN	NN	O
could	could	VERB	MD	O
be	be	VERB	VB	O
classified	classify	VERB	VBN	O
as	as	ADP	IN	O
possible	possible	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
score	score	NOUN	NN	O
5	5	NUM	CD	O
points	point	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
mostly	mostly	ADV	RB	O
because	because	ADP	IN	O
of	of	ADP	IN	O
the	the	DET	DT	O
close	close	ADJ	JJ	O
temporal	temporal	ADJ	JJ	O
sequence	sequence	NOUN	NN	O
,	,	PUNCT	,	O
previous	previous	ADJ	JJ	O
reports	report	NOUN	NNS	O
on	on	ADP	IN	O
this	this	DET	DT	O
reaction	reaction	NOUN	NN	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
macrolides	macrolide	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
any	any	DET	DT	O
alternative	alternative	ADJ	JJ	O
explanation	explanation	NOUN	NN	O
for	for	ADP	IN	O
hiccups	hiccup	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
hypothesis	hypothesis	NOUN	NN	O
is	be	VERB	VBZ	O
that	that	ADP	IN	O
a	a	DET	DT	O
vagal	vagal	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
azithromycin	azithromycin	NOUN	NN	B-Chemical
could	could	VERB	MD	O
be	be	VERB	VB	O
the	the	DET	DT	O
pathogenesis	pathogenesis	NOUN	NN	O
of	of	ADP	IN	O
hiccups	hiccup	NOUN	NNS	B-Disease
in	in	ADP	IN	O
our	-PRON-	DET	PRP$	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hiccups	hiccup	NOUN	NNS	B-Disease
is	be	VERB	VBZ	O
difficult	difficult	ADJ	JJ	O
and	and	CCONJ	CC	O
often	often	ADV	RB	O
achieved	achieve	VERB	VBN	O
only	only	ADV	RB	O
by	by	ADP	IN	O
a	a	DET	DT	O
process	process	NOUN	NN	O
of	of	ADP	IN	O
elimination	elimination	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
macrolide	macrolide	NOUN	NN	B-Chemical
antimicrobials	antimicrobial	NOUN	NNS	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
hiccups	hiccup	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
vagal	vagal	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
could	could	VERB	MD	O
explain	explain	VERB	VB	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
side	side	NOUN	NN	O
-	-	PUNCT	HYPH	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Calcium	calcium	NOUN	NN	B-Chemical
carbonate	carbonate	NOUN	NN	I-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
:	:	PUNCT	:	O
the	the	DET	DT	O
updated	update	VERB	VBN	O
milk	milk	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
alkali	alkali	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
;	;	PUNCT	:	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
3	3	NUM	CD	O
cases	case	NOUN	NNS	O
and	and	CCONJ	CC	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
describe	describe	VERB	VB	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
carbonate	carbonate	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypercalcemia	hypercalcemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
gain	gain	VERB	VB	O
insights	insight	NOUN	NNS	O
into	into	ADP	IN	O
the	the	DET	DT	O
cause	cause	NOUN	NN	O
and	and	CCONJ	CC	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
milk	milk	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
alkali	alkali	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
the	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
laboratory	laboratory	NOUN	NN	O
data	datum	NOUN	NNS	O
in	in	ADP	IN	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
presented	present	VERB	VBD	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
hypercalcemia	hypercalcemia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
corrected	correct	VERB	VBN	O
serum	serum	ADJ	JJ	O
calcium	calcium	NOUN	NN	B-Chemical
>	>	X	XX	O
or	or	CCONJ	CC	O
=	=	SYM	SYM	O
14	14	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
dL	dL	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
review	review	VERB	VB	O
the	the	DET	DT	O
pertinent	pertinent	ADJ	JJ	O
literature	literature	NOUN	NN	O
on	on	ADP	IN	O
milk	milk	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
alkali	alkali	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
insufficiency	insufficiency	NOUN	NN	I-Disease
,	,	PUNCT	,	O
relative	relative	ADJ	JJ	O
metabolic	metabolic	ADJ	JJ	B-Disease
alkalosis	alkalosis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
low	low	ADJ	JJ	O
parathyroid	parathyroid	ADJ	JJ	O
hormone	hormone	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PTH	PTH	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
PTH	PTH	PROPN	NNP	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
peptide	peptide	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
1	1	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
25	25	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dihydroxyvitamin	dihydroxyvitamin	NOUN	NN	I-Chemical
D	d	NOUN	NN	I-Chemical
concentrations	concentration	NOUN	NNS	O
.	.	PUNCT	.	O

No	no	DET	DT	O
malignant	malignant	ADJ	JJ	O
lesion	lesion	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
included	include	VERB	VBD	O
aggressive	aggressive	ADJ	JJ	O
hydration	hydration	NOUN	NN	O
and	and	CCONJ	CC	O
varied	varied	ADJ	JJ	O
amounts	amount	NOUN	NNS	O
of	of	ADP	IN	O
furosemide	furosemide	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
2	2	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
the	the	DET	DT	O
higher	high	ADJ	JJR	O
serum	serum	NOUN	NN	O
calcium	calcium	NOUN	NN	B-Chemical
concentrations	concentration	NOUN	NNS	O
received	receive	VERB	VBN	O
pamidronate	pamidronate	ADJ	JJ	B-Chemical
intravenously	intravenously	ADV	RB	O
(	(	PUNCT	-LRB-	O
60	60	NUM	CD	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
caused	cause	VERB	VBD	O
severe	severe	ADJ	JJ	O
hypocalcemia	hypocalcemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Of	of	ADP	IN	O
the	the	DET	DT	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
were	be	VERB	VBD	O
ingesting	ingest	VERB	VBG	O
acceptable	acceptable	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
elemental	elemental	ADJ	JJ	O
calcium	calcium	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
g	g	NOUN	NN	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
g	g	NOUN	NN	O
daily	daily	ADV	RB	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
form	form	NOUN	NN	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
carbonate	carbonate	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
to	to	ADP	IN	O
our	-PRON-	DET	PRP$	O
highlighted	highlight	VERB	VBN	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
review	review	VERB	VBP	O
the	the	DET	DT	O
history	history	NOUN	NN	O
,	,	PUNCT	,	O
classification	classification	NOUN	NN	O
,	,	PUNCT	,	O
pathophysiologic	pathophysiologic	NOUN	NN	O
features	feature	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
milk	milk	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
alkali	alkali	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
summarize	summarize	VERB	VBP	O
the	the	DET	DT	O
cases	case	NOUN	NNS	O
reported	report	VERB	VBN	O
from	from	ADP	IN	O
early	early	ADJ	JJ	O
1995	1995	NUM	CD	O
to	to	ADP	IN	O
November	November	PROPN	NNP	O
2003	2003	NUM	CD	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Milk	milk	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
alkali	alkali	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
common	common	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
unexplained	unexplained	ADJ	JJ	O
hypercalcemia	hypercalcemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
can	can	VERB	MD	O
be	be	VERB	VB	O
precipitated	precipitate	VERB	VBN	O
by	by	ADP	IN	O
small	small	ADJ	JJ	O
amounts	amount	NOUN	NNS	O
of	of	ADP	IN	O
orally	orally	ADV	RB	O
ingested	ingest	VERB	VBN	O
calcium	calcium	NOUN	NN	B-Chemical
carbonate	carbonate	NOUN	NN	I-Chemical
in	in	ADP	IN	O
susceptible	susceptible	ADJ	JJ	O
persons	person	NOUN	NNS	O
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
hydration	hydration	NOUN	NN	O
,	,	PUNCT	,	O
furosemide	furosemide	ADV	RB	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
calcium	calcium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
vitamin	vitamin	NOUN	NN	B-Chemical
D	d	NOUN	NN	I-Chemical
source	source	NOUN	NN	O
is	be	VERB	VBZ	O
adequate	adequate	ADJ	JJ	O
.	.	PUNCT	.	O

Pamidronate	pamidronate	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
considerable	considerable	ADJ	JJ	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
hypocalcemia	hypocalcemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
even	even	ADV	RB	O
in	in	ADP	IN	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
initially	initially	ADV	RB	O
severe	severe	ADJ	JJ	O
hypercalcemia	hypercalcemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Warfarin	warfarin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
leukocytoclastic	leukocytoclastic	ADJ	JJ	B-Disease
vasculitis	vasculitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Skin	skin	NOUN	NN	O
reactions	reaction	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
oral	oral	ADJ	JJ	O
coumarin	coumarin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
derived	derive	VERB	VBN	O
anticoagulants	anticoagulant	NOUN	NNS	O
are	be	VERB	VBP	O
an	an	DET	DT	O
uncommon	uncommon	ADJ	JJ	O
occurrence	occurrence	NOUN	NN	O
.	.	PUNCT	.	O

Leukocytoclastic	leukocytoclastic	ADJ	JJ	B-Disease
vasculitis	vasculitis	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
LV	LV	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
primarily	primarily	ADV	RB	O
a	a	DET	DT	O
cutaneous	cutaneous	ADJ	JJ	B-Disease
small	small	ADJ	JJ	I-Disease
vessel	vessel	NOUN	NN	I-Disease
vasculitis	vasculitis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
though	though	ADP	IN	O
systemic	systemic	ADJ	JJ	O
involvement	involvement	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
encountered	encounter	VERB	VBN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
4	4	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
late	late	ADJ	JJ	O
-	-	PUNCT	HYPH	O
onset	onset	NOUN	NN	O
LV	LV	PROPN	NNP	B-Disease
probably	probably	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

All	all	DET	DT	O
4	4	NUM	CD	O
patients	patient	NOUN	NNS	O
presented	present	VERB	VBN	O
with	with	ADP	IN	O
skin	skin	NOUN	NN	B-Disease
eruptions	eruption	NOUN	NNS	I-Disease
that	that	DET	WDT	O
developed	develop	VERB	VBD	O
after	after	ADP	IN	O
receiving	receive	VERB	VBG	O
warfarin	warfarin	NOUN	NN	B-Chemical
for	for	ADP	IN	O
several	several	ADJ	JJ	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
skin	skin	NOUN	NN	B-Disease
lesion	lesion	NOUN	NN	I-Disease
biopsies	biopsy	NOUN	NNS	O
were	be	VERB	VBD	O
available	available	ADJ	JJ	O
in	in	ADP	IN	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
confirming	confirm	VERB	VBG	O
LV	LV	PROPN	NNP	B-Disease
Cutaneous	Cutaneous	PROPN	NNP	I-Disease
lesions	lesion	NOUN	NNS	I-Disease
resolved	resolve	VERB	VBD	O
in	in	ADP	IN	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
after	after	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
2	2	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
4	4	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
rechallenge	rechallenge	NOUN	NN	O
with	with	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
led	lead	VERB	VBD	O
to	to	ADP	IN	O
recurrence	recurrence	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
lesions	lesion	NOUN	NNS	O
.	.	PUNCT	.	O

LV	LV	PROPN	NNP	B-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
late	late	ADJ	JJ	O
-	-	PUNCT	HYPH	O
onset	onset	NOUN	NN	O
adverse	adverse	ADJ	JJ	O
reaction	reaction	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
brainstem	brainstem	NOUN	NN	O
seizures	seizure	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
behavior	behavior	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
variety	variety	NOUN	NN	O
of	of	ADP	IN	O
abnormal	abnormal	ADJ	JJ	O
sensory	sensory	ADJ	JJ	O
/	/	SYM	SYM	O
motor	motor	NOUN	NN	O
behaviors	behavior	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
electrical	electrical	ADJ	JJ	O
discharges	discharge	NOUN	NNS	O
recorded	record	VERB	VBN	O
from	from	ADP	IN	O
the	the	DET	DT	O
bilateral	bilateral	ADJ	JJ	O
brainstem	brainstem	NOUN	NN	O
were	be	VERB	VBD	O
induced	induce	VERB	VBN	O
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
WKY	wky	ADJ	JJ	O
rats	rat	NOUN	NNS	O
by	by	ADP	IN	O
mechanical	mechanical	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
electrode	electrode	NOUN	NN	O
implants	implant	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
DC	DC	PROPN	NNP	O
electrical	electrical	ADJ	JJ	O
current	current	ADJ	JJ	O
stimulations	stimulation	NOUN	NNS	O
and	and	CCONJ	CC	O
by	by	ADP	IN	O
acute	acute	ADJ	JJ	O
and	and	CCONJ	CC	O
chronic	chronic	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
electrode	electrode	NOUN	NN	O
implant	implant	NOUN	NN	O
implicated	implicate	VERB	VBD	O
one	one	NUM	CD	O
side	side	NOUN	NN	O
or	or	CCONJ	CC	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
of	of	ADP	IN	O
the	the	DET	DT	O
reticular	reticular	ADJ	JJ	O
system	system	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
brainstem	brainstem	NOUN	NN	O
but	but	CCONJ	CC	O
subjects	subject	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
incapacitated	incapacitate	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
stimulations	stimulation	NOUN	NNS	O
.	.	PUNCT	.	O

Cocaine	Cocaine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
40	40	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
injected	inject	VERB	VBN	O
subcutaneously	subcutaneously	ADV	RB	O
for	for	ADP	IN	O
an	an	DET	DT	O
acute	acute	ADJ	JJ	O
experiment	experiment	NOUN	NN	O
and	and	CCONJ	CC	O
subsequent	subsequent	ADJ	JJ	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
doses	dose	VERB	VBZ	O
twice	twice	ADV	RB	O
daily	daily	ADJ	JJ	O
for	for	ADP	IN	O
3	3	NUM	CD	O
days	day	NOUN	NNS	O
in	in	ADP	IN	O
a	a	DET	DT	O
chronic	chronic	ADJ	JJ	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Cocaine	cocaine	NOUN	NN	B-Chemical
generated	generate	VERB	VBD	O
more	more	ADV	RBR	O
abnormal	abnormal	ADJ	JJ	O
behaviors	behavior	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
brainstem	brainstem	NOUN	NN	O
perturbation	perturbation	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
the	the	DET	DT	O
electrically	electrically	ADV	RB	O
perturbated	perturbate	VERB	VBN	O
subjects	subject	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
abnormal	abnormal	ADJ	JJ	O
behaviors	behavior	NOUN	NNS	O
were	be	VERB	VBD	O
yawning	yawn	VERB	VBG	O
,	,	PUNCT	,	O
retrocollis	retrocollis	ADJ	JJ	O
,	,	PUNCT	,	O
hyperactivity	hyperactivity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
"	"	PUNCT	''	O
beating	beat	VERB	VBG	O
drum	drum	NOUN	NN	O
"	"	PUNCT	''	O
behavior	behavior	NOUN	NN	O
,	,	PUNCT	,	O
squealing	squealing	NOUN	NN	O
,	,	PUNCT	,	O
head	head	NOUN	NN	O
bobbing	bob	VERB	VBG	O
,	,	PUNCT	,	O
circling	circle	VERB	VBG	O
,	,	PUNCT	,	O
sniffing	sniffing	NOUN	NN	O
,	,	PUNCT	,	O
abnormal	abnormal	ADJ	JJ	O
posturing	posturing	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
facial	facial	ADJ	JJ	O
twitching	twitching	NOUN	NN	O
.	.	PUNCT	.	O

Shifts	shift	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
power	power	NOUN	NN	O
frequency	frequency	NOUN	NN	O
spectra	spectra	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
discharge	discharge	NOUN	NN	O
patterns	pattern	NOUN	NNS	O
were	be	VERB	VBD	O
noted	note	VERB	VBN	O
between	between	ADP	IN	O
quiet	quiet	ADJ	JJ	O
and	and	CCONJ	CC	O
pacing	pace	VERB	VBG	O
behavioral	behavioral	ADJ	JJ	O
states	state	NOUN	NNS	O
.	.	PUNCT	.	O

Hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
to	to	ADP	IN	O
various	various	ADJ	JJ	O
auditory	auditory	NOUN	NN	O
,	,	PUNCT	,	O
tactile	tactile	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
visual	visual	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
was	be	VERB	VBD	O
present	present	ADJ	JJ	O
and	and	CCONJ	CC	O
shifts	shift	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
brainstem	brainstem	NOUN	NN	O
ambient	ambient	ADJ	JJ	O
power	power	NOUN	NN	O
spectral	spectral	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
response	response	NOUN	NN	O
to	to	PART	TO	O
tactile	tactile	VERB	VB	O
stimulation	stimulation	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
brainstem	brainstem	NOUN	NN	O
generates	generate	NOUN	NNS	O
and	and	CCONJ	CC	O
propagates	propagate	VERB	VBZ	O
pathological	pathological	ADJ	JJ	O
discharges	discharge	NOUN	NNS	O
that	that	DET	WDT	O
can	can	VERB	MD	O
be	be	VERB	VB	O
elicited	elicit	VERB	VBN	O
by	by	ADP	IN	O
mechanical	mechanical	ADJ	JJ	O
and	and	CCONJ	CC	O
DC	DC	PROPN	NNP	O
electrical	electrical	ADJ	JJ	O
perturbation	perturbation	NOUN	NN	O
.	.	PUNCT	.	O

Cocaine	Cocaine	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
activate	activate	VERB	VB	O
the	the	DET	DT	O
discharge	discharge	NOUN	NN	O
system	system	NOUN	NN	O
and	and	CCONJ	CC	O
thus	thus	ADV	RB	O
induce	induce	VERB	VB	O
abnormal	abnormal	ADJ	JJ	O
behaviors	behavior	NOUN	NNS	O
that	that	DET	WDT	O
are	be	VERB	VBP	O
generated	generate	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
discharge	discharge	ADJ	JJ	O
site	site	NOUN	NN	O
and	and	CCONJ	CC	O
at	at	ADP	IN	O
distant	distant	ADJ	JJ	O
sites	site	NOUN	NNS	O
to	to	PART	TO	O
which	which	DET	WDT	O
the	the	DET	DT	O
discharge	discharge	ADJ	JJ	O
propagates	propagate	NOUN	NNS	O
.	.	PUNCT	.	O

Cognitive	cognitive	ADJ	JJ	O
functions	function	NOUN	NNS	O
may	may	VERB	MD	O
also	also	ADV	RB	O
be	be	VERB	VB	O
involved	involve	VERB	VBN	O
since	since	ADP	IN	O
dopaminergic	dopaminergic	NOUN	NN	O
and	and	CCONJ	CC	O
serotonergic	serotonergic	ADJ	JJ	O
cellular	cellular	ADJ	JJ	O
elements	element	NOUN	NNS	O
at	at	ADP	IN	O
the	the	DET	DT	O
brainstem	brainstem	NOUN	NN	O
level	level	NOUN	NN	O
are	be	VERB	VBP	O
also	also	ADV	RB	O
implicated	implicate	VERB	VBN	O
.	.	PUNCT	.	O

rTMS	rtms	NOUN	NN	O
of	of	ADP	IN	O
supplementary	supplementary	ADJ	JJ	O
motor	motor	NOUN	NN	O
area	area	NOUN	NN	O
modulates	modulate	NOUN	NNS	O
therapy	therapy	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
in	in	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
neural	neural	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
and	and	CCONJ	CC	O
circuitry	circuitry	NOUN	NN	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
are	be	VERB	VBP	O
unclear	unclear	ADJ	JJ	O
.	.	PUNCT	.	O

Using	use	VERB	VBG	O
repetitive	repetitive	ADJ	JJ	O
transcranial	transcranial	ADJ	JJ	O
magnetic	magnetic	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
rTMS	rTMS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
over	over	ADP	IN	O
the	the	DET	DT	O
supplementary	supplementary	ADJ	JJ	O
motor	motor	NOUN	NN	O
area	area	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SMA	SMA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
a	a	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
advanced	advanced	ADJ	JJ	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
authors	author	NOUN	NNS	O
investigated	investigate	VERB	VBD	O
whether	whether	ADP	IN	O
modulation	modulation	NOUN	NN	O
of	of	ADP	IN	O
SMA	SMA	PROPN	NNP	O
excitability	excitability	NOUN	NN	O
may	may	VERB	MD	O
result	result	VERB	VB	O
in	in	ADP	IN	O
a	a	DET	DT	O
modification	modification	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
dyskinetic	dyskinetic	ADJ	JJ	B-Disease
state	state	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
continuous	continuous	ADJ	JJ	O
apomorphine	apomorphine	ADJ	JJ	B-Chemical
infusion	infusion	NOUN	NN	O
.	.	PUNCT	.	O

rTMS	rtms	NOUN	NN	O
at	at	ADP	IN	O
1	1	NUM	CD	O
Hz	Hz	PROPN	NNP	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
to	to	PART	TO	O
markedly	markedly	ADV	RB	O
reduce	reduce	VERB	VB	O
drug	drug	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
induced	induce	VERB	VBN	I-Disease
dyskinesias	dyskinesia	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
5	5	NUM	CD	O
-	-	PUNCT	:	O
Hz	Hz	PROPN	NNP	O
rTMS	rtms	NOUN	NN	O
induced	induce	VERB	VBD	O
a	a	DET	DT	O
slight	slight	ADJ	JJ	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
significant	significant	ADJ	JJ	O
increase	increase	NOUN	NN	O
.	.	PUNCT	.	O

Intracavitary	intracavitary	ADJ	JJ	O
chemotherapy	chemotherapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
/	/	SYM	SYM	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
liquid	liquid	ADJ	JJ	O
crystalline	crystalline	ADJ	JJ	O
cubic	cubic	ADJ	JJ	O
phases	phase	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
recurrent	recurrent	ADJ	JJ	O
glioblastoma	glioblastoma	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
-	-	PUNCT	HYPH	O
clinical	clinical	ADJ	JJ	O
observations	observation	NOUN	NNS	O
.	.	PUNCT	.	O

Human	human	ADJ	JJ	O
malignant	malignant	ADJ	JJ	O
brain	brain	NOUN	NN	B-Disease
tumors	tumor	NOUN	NNS	I-Disease
have	have	VERB	VBP	O
a	a	DET	DT	O
poor	poor	ADJ	JJ	O
prognosis	prognosis	NOUN	NN	O
in	in	ADP	IN	O
spite	spite	NOUN	NN	O
of	of	ADP	IN	O
surgery	surgery	NOUN	NN	O
and	and	CCONJ	CC	O
radiation	radiation	NOUN	NN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Cubic	cubic	ADJ	JJ	O
phases	phase	NOUN	NNS	O
consist	consist	VERB	VBP	O
of	of	ADP	IN	O
curved	curve	VERB	VBN	O
biocontinuous	biocontinuous	ADJ	JJ	O
lipid	lipid	NOUN	NN	O
bilayers	bilayer	NOUN	NNS	O
,	,	PUNCT	,	O
separating	separate	VERB	VBG	O
two	two	NUM	CD	O
congruent	congruent	ADJ	JJ	O
networks	network	NOUN	NNS	O
of	of	ADP	IN	O
water	water	NOUN	NN	O
channels	channel	NOUN	NNS	O
.	.	PUNCT	.	O

Used	use	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
host	host	NOUN	NN	O
for	for	ADP	IN	O
cytotoxic	cytotoxic	NOUN	NN	O
drugs	drug	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
gel	gel	NOUN	NN	O
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
matrix	matrix	NOUN	NN	O
can	can	VERB	MD	O
easily	easily	ADV	RB	O
be	be	VERB	VB	O
applied	apply	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
walls	wall	NOUN	NNS	O
of	of	ADP	IN	O
a	a	DET	DT	O
surgical	surgical	ADJ	JJ	O
resection	resection	NOUN	NN	O
cavity	cavity	NOUN	NN	O
.	.	PUNCT	.	O

For	for	ADP	IN	O
human	human	ADJ	JJ	O
glioblastoma	glioblastoma	NOUN	NN	B-Disease
recurrences	recurrence	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
feasibility	feasibility	NOUN	NN	O
,	,	PUNCT	,	O
safety	safety	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
a	a	DET	DT	O
surgical	surgical	ADJ	JJ	O
intracavitary	intracavitary	ADJ	JJ	O
application	application	NOUN	NN	O
of	of	ADP	IN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
encapsulated	encapsulate	VERB	VBN	O
by	by	ADP	IN	O
liquid	liquid	ADJ	JJ	O
crystalline	crystalline	ADJ	JJ	O
cubic	cubic	ADJ	JJ	O
phases	phase	NOUN	NNS	O
are	be	VERB	VBP	O
examined	examine	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
pilot	pilot	NOUN	NN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
12	12	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
recurrence	recurrence	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
glioblastoma	glioblastoma	NOUN	NN	B-Disease
multiforme	multiforme	NOUN	NN	O
underwent	underwent	NOUN	NN	O
re	re	NOUN	NN	O
-	-	NOUN	NN	O
resection	resection	NOUN	NN	O
and	and	CCONJ	CC	O
received	receive	VERB	VBD	O
an	an	DET	DT	O
intracavitary	intracavitary	ADJ	JJ	O
application	application	NOUN	NN	O
of	of	ADP	IN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
carboplatin	carboplatin	ADJ	JJ	B-Chemical
cubic	cubic	ADJ	JJ	O
phases	phase	NOUN	NNS	O
in	in	ADP	IN	O
different	different	ADJ	JJ	O
dosages	dosage	NOUN	NNS	O
.	.	PUNCT	.	O

Six	six	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
received	receive	VERB	VBD	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
15	15	NUM	CD	O
mg	mg	NOUN	NN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
suffered	suffer	VERB	VBD	O
from	from	ADP	IN	O
moderate	moderate	ADJ	JJ	O
to	to	ADP	IN	O
severe	severe	ADJ	JJ	O
brain	brain	NOUN	NN	B-Disease
edema	edema	NOUN	NN	I-Disease
,	,	PUNCT	,	O
while	while	ADP	IN	O
the	the	DET	DT	O
remaining	remain	VERB	VBG	O
patients	patient	NOUN	NNS	O
received	receive	VERB	VBD	O
only	only	ADV	RB	O
a	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
15	15	NUM	CD	O
mg	mg	NOUN	NN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
latter	latter	ADJ	JJ	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
brain	brain	NOUN	NN	B-Disease
edema	edema	NOUN	NN	I-Disease
was	be	VERB	VBD	O
markedly	markedly	ADV	RB	O
reduced	reduce	VERB	VBN	O
and	and	CCONJ	CC	O
dealt	deal	VERB	VBD	O
medically	medically	ADV	RB	O
.	.	PUNCT	.	O

Intracavitary	intracavitary	ADJ	JJ	O
chemotherapy	chemotherapy	NOUN	NN	O
in	in	ADP	IN	O
recurrent	recurrent	ADJ	JJ	O
glioblastoma	glioblastoma	NOUN	NN	B-Disease
using	use	VERB	VBG	O
cubic	cubic	ADJ	JJ	O
phases	phase	NOUN	NNS	O
is	be	VERB	VBZ	O
feasible	feasible	ADJ	JJ	O
and	and	CCONJ	CC	O
safe	safe	ADJ	JJ	O
,	,	PUNCT	,	O
yet	yet	CCONJ	CC	O
the	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
benefit	benefit	NOUN	NN	O
remains	remain	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
examined	examine	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
phase	phase	NOUN	NN	O
II	II	PROPN	NNP	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Lamotrigine	Lamotrigine	PROPN	NNP	B-Chemical
associated	associate	VERB	VBD	O
with	with	ADP	IN	O
exacerbation	exacerbation	NOUN	NN	O
or	or	CCONJ	CC	O
de	de	X	FW	O
novo	novo	NOUN	NN	O
myoclonus	myoclonus	NOUN	NN	B-Disease
in	in	ADP	IN	O
idiopathic	idiopathic	ADJ	JJ	B-Disease
generalized	generalize	VERB	VBN	I-Disease
epilepsies	epilepsy	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
idiopathic	idiopathic	ADJ	JJ	B-Disease
generalized	generalize	VERB	VBN	I-Disease
epilepsies	epilepsy	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
IGE	IGE	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
lamotrigine	lamotrigine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
LTG	LTG	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
experienced	experience	VERB	VBN	O
exacerbation	exacerbation	NOUN	NN	O
or	or	CCONJ	CC	O
de	de	X	FW	O
novo	novo	NOUN	NN	O
appearance	appearance	NOUN	NN	O
of	of	ADP	IN	O
myoclonic	myoclonic	ADJ	JJ	B-Disease
jerks	jerk	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
MJ	MJ	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
LTG	LTG	PROPN	NNP	B-Chemical
exacerbated	exacerbate	VERB	VBD	O
MJ	MJ	PROPN	NNP	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
manner	manner	NOUN	NN	O
with	with	ADP	IN	O
early	early	ADJ	JJ	O
aggravation	aggravation	NOUN	NN	O
during	during	ADP	IN	O
titration	titration	NOUN	NN	O
.	.	PUNCT	.	O

MJ	MJ	PROPN	NNP	B-Disease
disappeared	disappear	VERB	VBD	O
when	when	ADV	WRB	O
LTG	LTG	PROPN	NNP	B-Chemical
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
by	by	ADP	IN	O
25	25	NUM	CD	O
to	to	PART	TO	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
LTG	LTG	PROPN	NNP	B-Chemical
exacerbated	exacerbate	VERB	VBD	O
MJ	MJ	PROPN	NNP	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
delayed	delay	VERB	VBN	O
but	but	CCONJ	CC	O
more	more	ADV	RBR	O
severe	severe	ADJ	JJ	O
manner	manner	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
myoclonic	myoclonic	ADJ	JJ	B-Disease
status	status	NOUN	NN	I-Disease
that	that	DET	WDT	O
only	only	ADV	RB	O
ceased	cease	VERB	VBD	O
after	after	ADP	IN	O
LTG	LTG	PROPN	NNP	B-Chemical
withdrawal	withdrawal	NOUN	NN	O
.	.	PUNCT	.	O

Absence	absence	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	O
vasoconstriction	vasoconstriction	NOUN	NN	O
after	after	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
subarachnoid	subarachnoid	NOUN	NN	B-Disease
hemorrhage	hemorrhage	NOUN	NN	I-Disease
.	.	PUNCT	.	O

INTRODUCTION	INTRODUCTION	PROPN	NNP	O
:	:	PUNCT	:	O
Cocaine	cocaine	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
neurovascular	neurovascular	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
including	include	VERB	VBG	O
arterial	arterial	ADJ	JJ	O
vasoconstriction	vasoconstriction	NOUN	NN	O
and	and	CCONJ	CC	O
vasculitis	vasculitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
are	be	VERB	VBP	O
few	few	ADJ	JJ	O
studies	study	NOUN	NNS	O
of	of	ADP	IN	O
angiographic	angiographic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
human	human	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	O
arteries	artery	NOUN	NNS	O
.	.	PUNCT	.	O

Information	information	NOUN	NN	O
on	on	ADP	IN	O
these	these	DET	DT	O
effects	effect	NOUN	NNS	O
could	could	VERB	MD	O
be	be	VERB	VB	O
obtained	obtain	VERB	VBN	O
from	from	ADP	IN	O
angiograms	angiogram	NOUN	NNS	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
subarachnoid	subarachnoid	NOUN	NN	B-Disease
hemorrhage	hemorrhage	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
SAH	SAH	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
who	who	PRON	WP	O
underwent	undergo	VERB	VBD	O
angiography	angiography	NOUN	NN	O
shortly	shortly	ADV	RB	O
after	after	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
screened	screen	VERB	VBD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
SAH	SAH	PROPN	NNP	B-Disease
retrospectively	retrospectively	ADV	RB	O
and	and	CCONJ	CC	O
identified	identify	VERB	VBD	O
those	those	DET	DT	O
with	with	ADP	IN	O
positive	positive	ADJ	JJ	O
urine	urine	NOUN	NN	O
toxicology	toxicology	NOUN	NN	O
for	for	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
metabolites	metabolite	NOUN	NNS	O
.	.	PUNCT	.	O

Quantitative	quantitative	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
diameter	diameter	NOUN	NN	O
measurements	measurement	NOUN	NNS	O
from	from	ADP	IN	O
angiograms	angiogram	NOUN	NNS	O
of	of	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
measurements	measurement	NOUN	NNS	O
from	from	ADP	IN	O
control	control	NOUN	NN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
SAH	SAH	PROPN	NNP	B-Disease
who	who	PRON	WP	O
were	be	VERB	VBD	O
matched	match	VERB	VBN	O
for	for	ADP	IN	O
factors	factor	NOUN	NNS	O
known	know	VERB	VBN	O
to	to	PART	TO	O
influence	influence	VERB	VB	O
arterial	arterial	ADJ	JJ	O
diameter	diameter	NOUN	NN	O
.	.	PUNCT	.	O

Qualitative	qualitative	ADJ	JJ	O
comparisons	comparison	NOUN	NNS	O
of	of	ADP	IN	O
small	small	ADJ	JJ	O
artery	artery	NOUN	NN	O
changes	change	NOUN	NNS	O
also	also	ADV	RB	O
were	be	VERB	VBD	O
made	make	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Thirteen	thirteen	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
positive	positive	ADJ	JJ	O
cocaine	cocaine	NOUN	NN	B-Chemical
toxicology	toxicology	NOUN	NN	O
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
26	26	NUM	CD	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
groups	group	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
diameters	diameter	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
intradural	intradural	ADJ	JJ	O
internal	internal	ADJ	JJ	O
carotid	carotid	NOUN	NN	O
,	,	PUNCT	,	O
sphenoidal	sphenoidal	NOUN	NN	O
segment	segment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
middle	middle	ADJ	JJ	O
cerebral	cerebral	NOUN	NN	O
,	,	PUNCT	,	O
precommunicating	precommunicate	VERB	VBG	O
segment	segment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
anterior	anterior	ADJ	JJ	O
cerebral	cerebral	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
basilar	basilar	ADJ	JJ	O
arteries	artery	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
p	p	X	XX	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
for	for	ADP	IN	O
all	all	DET	DT	O
comparisons	comparison	NOUN	NNS	O
,	,	PUNCT	,	O
unpaired	unpaired	ADJ	JJ	O
t	t	NOUN	NN	O
-	-	PUNCT	HYPH	O
tests	test	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
also	also	ADV	RB	O
were	be	VERB	VBD	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
groups	group	NOUN	NNS	O
when	when	ADV	WRB	O
expressing	express	VERB	VBG	O
diameters	diameter	NOUN	NNS	O
as	as	ADP	IN	O
the	the	DET	DT	O
sum	sum	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
precommunicating	precommunicate	VERB	VBG	O
segment	segment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
anterior	anterior	ADJ	JJ	O
cerebral	cerebral	NOUN	NN	O
+	+	CCONJ	CC	O
sphenoidal	sphenoidal	NOUN	NN	O
segment	segment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
middle	middle	ADJ	JJ	O
cerebral	cerebral	NOUN	NN	O
+	+	CCONJ	CC	O
supraclinoid	supraclinoid	ADJ	JJ	O
internal	internal	ADJ	JJ	O
carotid	carotid	ADJ	JJ	O
artery	artery	NOUN	NN	O
+	+	CCONJ	CC	O
basilar	basilar	ADJ	JJ	O
artery	artery	NOUN	NN	O
divided	divide	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
diameter	diameter	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
petrous	petrous	ADJ	JJ	O
internal	internal	ADJ	JJ	O
carotid	carotid	ADJ	JJ	O
artery	artery	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
,	,	PUNCT	,	O
unpaired	unpaired	ADJ	JJ	O
t	t	NOUN	NN	O
-	-	PUNCT	HYPH	O
tests	test	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Qualitative	qualitative	ADJ	JJ	O
assessments	assessment	NOUN	NNS	O
showed	show	VERB	VBD	O
two	two	NUM	CD	O
arterial	arterial	ADJ	JJ	O
irregularities	irregularity	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
distal	distal	ADJ	JJ	O
vasculature	vasculature	NOUN	NN	O
in	in	ADP	IN	O
each	each	DET	DT	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
No	no	DET	DT	O
quantitative	quantitative	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
for	for	ADP	IN	O
narrowing	narrow	VERB	VBG	O
of	of	ADP	IN	O
large	large	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	O
arteries	artery	NOUN	NNS	O
or	or	CCONJ	CC	O
qualitative	qualitative	ADJ	JJ	O
angiographic	angiographic	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
for	for	ADP	IN	O
distal	distal	ADJ	JJ	O
narrowing	narrowing	NOUN	NN	O
or	or	CCONJ	CC	O
vasculitis	vasculitis	NOUN	NN	B-Disease
could	could	VERB	MD	O
be	be	VERB	VB	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
underwent	undergo	VERB	VBD	O
angiography	angiography	ADV	RB	O
after	after	ADP	IN	O
aneurysmal	aneurysmal	ADJ	JJ	B-Disease
SAH	SAH	PROPN	NNP	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
.	.	PUNCT	.	O

Methamphetamine	Methamphetamine	PROPN	NNP	B-Chemical
causes	cause	VERB	VBZ	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
MAP	MAP	PROPN	NNP	O
kinase	kinase	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
pathways	pathway	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
brains	brain	NOUN	NNS	O
of	of	ADP	IN	O
mice	mouse	NOUN	NNS	O
that	that	DET	WDT	O
display	display	VERB	VBP	O
increased	increase	VERB	VBN	O
aggressiveness	aggressiveness	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Aggressive	aggressive	ADJ	JJ	B-Disease
behaviors	behavior	NOUN	NNS	I-Disease
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
suffer	suffer	VERB	VBP	O
from	from	ADP	IN	O
some	some	DET	DT	O
psychiatric	psychiatric	ADJ	JJ	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
are	be	VERB	VBP	O
common	common	ADJ	JJ	O
in	in	ADP	IN	O
methamphetamine	methamphetamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
METH	METH	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
abusers	abuser	NOUN	NNS	O
.	.	PUNCT	.	O

Herein	Herein	PROPN	NNP	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
that	that	ADP	IN	O
multiple	multiple	NOUN	NN	O
(	(	PUNCT	-LRB-	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
single	single	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBD	O
aggressiveness	aggressiveness	NOUN	NN	B-Disease
in	in	ADP	IN	O
male	male	ADJ	JJ	O
CD	cd	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
aggressiveness	aggressiveness	NOUN	NN	B-Disease
was	be	VERB	VBD	O
not	not	ADV	RB	O
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hyperactivity	hyperactivity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
protein	protein	NOUN	NN	O
expression	expression	NOUN	NN	O
using	use	VERB	VBG	O
antibody	antibody	NOUN	NN	O
microarrays	microarray	NOUN	NNS	O
and	and	CCONJ	CC	O
Western	western	ADJ	JJ	O
blotting	blotting	NOUN	NN	O
revealed	reveal	VERB	VBD	O
differential	differential	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
MAP	MAP	PROPN	NNP	O
kinase	kinase	NUM	CD	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
pathways	pathway	NOUN	NNS	O
after	after	ADP	IN	O
multiple	multiple	ADJ	JJ	O
and	and	CCONJ	CC	O
single	single	ADJ	JJ	O
METH	METH	PROPN	NNP	B-Chemical
injections	injection	NOUN	NNS	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
decreases	decrease	VERB	VBZ	O
in	in	ADP	IN	O
MEK1	MEK1	PROPN	NNP	O
,	,	PUNCT	,	O
Erk2p	Erk2p	PROPN	NNP	O
,	,	PUNCT	,	O
GSK3alpha	GSK3alpha	PROPN	NNP	O
,	,	PUNCT	,	O
14	14	NUM	CD	O
-	-	PUNCT	HYPH	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
3e	3e	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
MEK7	MEK7	PROPN	NNP	O
in	in	ADP	IN	O
the	the	DET	DT	O
striata	striata	NOUN	NN	O
of	of	ADP	IN	O
mice	mouse	NOUN	NNS	O
after	after	ADP	IN	O
multiple	multiple	ADJ	JJ	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

MEK1	MEK1	PROPN	NNP	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
decreased	decrease	VERB	VBN	O
also	also	ADV	RB	O
after	after	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
to	to	ADP	IN	O
a	a	DET	DT	O
much	much	ADV	RB	O
lesser	less	ADJ	JJR	O
degree	degree	NOUN	NN	O
than	than	ADP	IN	O
after	after	ADP	IN	O
multiple	multiple	ADJ	JJ	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
frontal	frontal	ADJ	JJ	O
cortex	cortex	NOUN	NN	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
GSK3alpha	GSK3alpha	PROPN	NNP	O
after	after	ADP	IN	O
multiple	multiple	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
single	single	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
MAP	MAP	PROPN	NNP	O
kinase	kinase	NUM	CD	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
pathways	pathway	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
prefronto	prefronto	NOUN	NN	O
-	-	PUNCT	HYPH	O
striatal	striatal	ADJ	JJ	O
circuitries	circuitry	NOUN	NNS	O
might	may	VERB	MD	O
be	be	VERB	VB	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
manifestation	manifestation	NOUN	NN	O
of	of	ADP	IN	O
aggressive	aggressive	ADJ	JJ	B-Disease
behaviors	behavior	NOUN	NNS	I-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Amisulpride	amisulpride	ADP	IN	B-Chemical
related	related	ADJ	JJ	O
tic	tic	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
like	like	ADJ	JJ	I-Disease
symptoms	symptom	NOUN	NNS	I-Disease
in	in	ADP	IN	O
an	an	DET	DT	O
adolescent	adolescent	NOUN	NN	O
schizophrenic	schizophrenic	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Tic	tic	NOUN	NN	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
can	can	VERB	MD	O
be	be	VERB	VB	O
effectively	effectively	ADV	RB	O
treated	treat	VERB	VBN	O
by	by	ADP	IN	O
atypical	atypical	ADJ	JJ	O
antipsychotics	antipsychotic	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
olanzapine	olanzapine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
ziprasidone	ziprasidone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
are	be	VERB	VBP	O
two	two	NUM	CD	O
case	case	NOUN	NN	O
reports	report	NOUN	NNS	O
that	that	DET	WDT	O
show	show	VERB	VBP	O
tic	tic	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
like	like	ADJ	JJ	I-Disease
symptoms	symptom	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
including	include	VERB	VBG	O
motor	motor	NOUN	NN	O
and	and	CCONJ	CC	O
phonic	phonic	ADJ	JJ	O
variants	variant	NOUN	NNS	O
,	,	PUNCT	,	O
occurring	occur	VERB	VBG	O
during	during	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
clozapine	clozapine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
present	present	VERB	VBP	O
a	a	DET	DT	O
15	15	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
girl	girl	NOUN	NN	O
schizophrenic	schizophrenic	NOUN	NN	B-Disease
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
frequent	frequent	ADJ	JJ	O
involuntary	involuntary	ADJ	JJ	B-Disease
eye	eye	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	I-Disease
blinking	blink	VERB	VBG	I-Disease
movements	movement	NOUN	NNS	I-Disease
after	after	ADP	IN	O
5	5	NUM	CD	O
months	month	NOUN	NNS	O
of	of	ADP	IN	O
amisulpride	amisulpride	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1000	1000	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
tic	tic	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
like	like	ADJ	JJ	I-Disease
symptoms	symptom	NOUN	NNS	I-Disease
resolved	resolve	VERB	VBN	O
completely	completely	ADV	RB	O
after	after	ADP	IN	O
we	-PRON-	PRON	PRP	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
amisulpride	amisulpride	NOUN	NN	B-Chemical
down	down	ADP	IN	O
to	to	ADP	IN	O
800	800	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
her	-PRON-	DET	PRP$	O
psychosis	psychosis	NOUN	NN	B-Disease
recurred	recur	VERB	VBD	O
after	after	ADP	IN	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
reduction	reduction	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
then	then	ADV	RB	O
placed	place	VERB	VBD	O
her	-PRON-	PRON	PRP	O
on	on	ADP	IN	O
an	an	DET	DT	O
additional	additional	ADJ	JJ	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
of	of	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

She	-PRON-	PRON	PRP	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
in	in	ADP	IN	O
complete	complete	ADJ	JJ	O
remission	remission	NOUN	NN	O
under	under	ADP	IN	O
the	the	DET	DT	O
combined	combine	VERB	VBN	O
medications	medication	NOUN	NNS	O
for	for	ADP	IN	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
one	one	NUM	CD	O
year	year	NOUN	NN	O
and	and	CCONJ	CC	O
maintains	maintain	VERB	VBZ	O
a	a	DET	DT	O
fair	fair	ADJ	JJ	O
role	role	NOUN	NN	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
more	more	ADV	RBR	O
tic	tic	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
like	like	ADJ	JJ	I-Disease
symptoms	symptom	NOUN	NNS	I-Disease
or	or	CCONJ	CC	O
other	other	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

Together	together	ADV	RB	O
with	with	ADP	IN	O
previously	previously	ADV	RB	O
reported	report	VERB	VBN	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
our	-PRON-	DET	PRP$	O
patient	patient	NOUN	NN	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
tic	tic	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
like	like	ADJ	JJ	I-Disease
symptoms	symptom	NOUN	NNS	I-Disease
might	may	VERB	MD	O
occur	occur	VERB	VB	O
in	in	ADP	IN	O
certain	certain	ADJ	JJ	O
vulnerable	vulnerable	ADJ	JJ	O
individuals	individual	NOUN	NNS	O
during	during	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
atypical	atypical	ADJ	JJ	O
antipsychotics	antipsychotic	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
clozapine	clozapine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
amisulpride	amisulpride	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Chloroquine	Chloroquine	PROPN	NNP	B-Chemical
related	relate	VERB	VBD	O
complete	complete	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
block	block	NOUN	NN	I-Disease
with	with	ADP	IN	O
blindness	blindness	NOUN	NN	B-Disease
:	:	PUNCT	:	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
27	27	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
old	old	ADJ	JJ	O
African	african	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
regular	regular	ADJ	JJ	O
chloroquine	chloroquine	NOUN	NN	B-Chemical
ingestion	ingestion	NOUN	NN	O
presented	present	VERB	VBN	O
with	with	ADP	IN	O
progressive	progressive	ADJ	JJ	O
deterioration	deterioration	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
vision	vision	NOUN	NN	I-Disease
,	,	PUNCT	,	O
easy	easy	ADJ	JJ	O
fatiguability	fatiguability	NOUN	NN	B-Disease
,	,	PUNCT	,	O
dyspnoea	dyspnoea	NOUN	NN	B-Disease
,	,	PUNCT	,	O
dizziness	dizziness	NOUN	NN	B-Disease
progressing	progressing	NOUN	NN	O
to	to	ADP	IN	O
syncopal	syncopal	ADJ	JJ	B-Disease
attacks	attack	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Ophthalmological	ophthalmological	ADJ	JJ	O
assessment	assessment	NOUN	NN	O
revealed	reveal	VERB	VBD	O
features	feature	NOUN	NNS	O
of	of	ADP	IN	O
chloroquine	chloroquine	NOUN	NN	B-Chemical
retinopathy	retinopathy	ADJ	JJ	B-Disease
,	,	PUNCT	,	O
cardiac	cardiac	ADJ	JJ	O
assessment	assessment	NOUN	NN	O
revealed	reveal	VERB	VBD	O
features	feature	NOUN	NNS	O
of	of	ADP	IN	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
a	a	DET	DT	O
complete	complete	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
block	block	NOUN	NN	I-Disease
with	with	ADP	IN	O
right	right	ADJ	JJ	B-Disease
bundle	bundle	NOUN	NN	I-Disease
branch	branch	NOUN	NN	I-Disease
block	block	NOUN	NN	I-Disease
pattern	pattern	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
heart	heart	NOUN	NN	B-Disease
block	block	NOUN	NN	I-Disease
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
by	by	ADP	IN	O
pacemaker	pacemaker	NOUN	NN	O
insertion	insertion	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
resolved	resolve	VERB	VBD	O
spontaneously	spontaneously	ADV	RB	O
following	follow	VERB	VBG	O
chloroquine	chloroquine	NOUN	NN	B-Chemical
discontinuation	discontinuation	NOUN	NN	O
.	.	PUNCT	.	O

She	-PRON-	PRON	PRP	O
however	however	ADV	RB	O
remains	remain	VERB	VBZ	O
blind	blind	ADJ	JJ	B-Disease
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
suprofen	suprofen	NOUN	NN	B-Chemical
on	on	ADP	IN	O
the	the	DET	DT	O
isolated	isolate	VERB	VBN	O
perfused	perfused	ADJ	JJ	O
rat	rat	NOUN	NN	O
kidney	kidney	NOUN	NN	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
suprofen	suprofen	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
in	in	ADP	IN	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
100	100	NUM	CD	O
subjects	subject	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
damage	damage	NOUN	NN	O
remains	remain	VERB	VBZ	O
unclear	unclear	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
direct	direct	ADJ	JJ	O
nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
15	15	NUM	CD	O
mg	mg	NOUN	NN	O
of	of	ADP	IN	O
suprofen	suprofen	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
recirculating	recirculating	NOUN	NN	O
isolated	isolate	VERB	VBN	O
rat	rat	NOUN	NN	O
kidney	kidney	NOUN	NN	O
perfused	perfuse	VERB	VBN	O
with	with	ADP	IN	O
cell	cell	NOUN	NN	O
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
buffer	buffer	NOUN	NN	O
with	with	ADP	IN	O
or	or	CCONJ	CC	O
without	without	ADP	IN	O
the	the	DET	DT	O
addition	addition	NOUN	NN	O
of	of	ADP	IN	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
dL	dL	NOUN	NNS	O
of	of	ADP	IN	O
uric	uric	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
sodium	sodium	NOUN	NN	B-Chemical
excretion	excretion	NOUN	NN	O
,	,	PUNCT	,	O
oxygen	oxygen	NOUN	NN	B-Chemical
consumption	consumption	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
urinary	urinary	ADJ	JJ	O
flow	flow	NOUN	NN	O
rates	rate	NOUN	NNS	O
in	in	ADP	IN	O
kidneys	kidney	NOUN	NNS	O
perfused	perfuse	VERB	VBN	O
with	with	ADP	IN	O
suprofen	suprofen	NOUN	NN	B-Chemical
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
control	control	NOUN	NN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
decline	decline	NOUN	NN	O
in	in	ADP	IN	O
glomerular	glomerular	ADJ	JJ	O
filtration	filtration	NOUN	NN	O
rate	rate	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
after	after	ADP	IN	O
the	the	DET	DT	O
introduction	introduction	NOUN	NN	O
of	of	ADP	IN	O
suprofen	suprofen	NOUN	NN	B-Chemical
to	to	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
perfused	perfuse	VERB	VBN	O
with	with	ADP	IN	O
uric	uric	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
;	;	PUNCT	:	O
no	no	DET	DT	O
changes	change	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
with	with	ADP	IN	O
suprofen	suprofen	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
uric	uric	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
baseline	baseline	ADJ	JJ	O
excretion	excretion	NOUN	NN	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
uric	uric	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
was	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
given	give	VERB	VBN	O
suprofen	suprofen	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
fractional	fractional	ADJ	JJ	O
excretion	excretion	NOUN	NN	O
of	of	ADP	IN	O
uric	uric	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
was	be	VERB	VBD	O
unchanged	unchanged	ADJ	JJ	O
between	between	ADP	IN	O
the	the	DET	DT	O
groups	group	NOUN	NNS	O
over	over	ADP	IN	O
the	the	DET	DT	O
experimental	experimental	ADJ	JJ	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
summary	summary	NOUN	NN	O
,	,	PUNCT	,	O
suprofen	suprofen	ADJ	JJ	B-Chemical
causes	cause	VERB	VBZ	O
acute	acute	ADJ	JJ	B-Disease
declines	decline	NOUN	NNS	I-Disease
in	in	ADP	IN	I-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
,	,	PUNCT	,	O
most	most	ADV	RBS	O
likely	likely	ADJ	JJ	O
by	by	ADP	IN	O
directly	directly	ADV	RB	O
altering	alter	VERB	VBG	O
the	the	DET	DT	O
intrarenal	intrarenal	ADJ	JJ	O
distribution	distribution	NOUN	NN	O
of	of	ADP	IN	O
uric	uric	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Microinjection	microinjection	NOUN	NN	O
of	of	ADP	IN	O
ritanserin	ritanserin	NOUN	NN	B-Chemical
into	into	ADP	IN	O
the	the	DET	DT	O
CA1	CA1	PROPN	NNPS	O
region	region	NOUN	NN	O
of	of	ADP	IN	O
hippocampus	hippocampus	NOUN	NN	O
improves	improve	VERB	VBZ	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
ritanserin	ritanserin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
HT2	ht2	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
muscarinic	muscarinic	ADJ	JJ	O
cholinergic	cholinergic	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
in	in	ADP	IN	O
Morris	Morris	PROPN	NNP	O
water	water	NOUN	NN	O
maze	maze	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MWM	MWM	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
.	.	PUNCT	.	O

Rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
divided	divide	VERB	VBN	O
into	into	ADP	IN	O
eight	eight	NUM	CD	O
groups	group	NOUN	NNS	O
and	and	CCONJ	CC	O
bilaterally	bilaterally	ADV	RB	O
cannulated	cannulate	VERB	VBN	O
into	into	ADP	IN	O
CA1	CA1	PROPN	NNPS	O
region	region	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hippocampus	hippocampus	NOUN	NN	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
week	week	NOUN	NN	O
later	later	ADV	RB	O
,	,	PUNCT	,	O
they	-PRON-	PRON	PRP	O
received	receive	VERB	VBD	O
repeatedly	repeatedly	ADV	RB	O
vehicles	vehicle	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
saline	saline	NOUN	NN	O
,	,	PUNCT	,	O
DMSO	DMSO	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
saline	saline	NOUN	NN	O
+	+	CCONJ	CC	O
DMSO	DMSO	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
saline	saline	NOUN	NN	O
/	/	SYM	SYM	O
side	side	NOUN	NN	O
;	;	PUNCT	:	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
training	training	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
ritanserin	ritanserin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
and	and	CCONJ	CC	O
8	8	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
DMSO	DMSO	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
side	side	NOUN	NN	O
;	;	PUNCT	:	O
20	20	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
training	training	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
;	;	PUNCT	:	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
ritanserin	ritanserin	NOUN	NN	B-Chemical
injection	injection	NOUN	NN	O
)	)	PUNCT	-RRB-	O
+	+	CCONJ	CC	O
ritanserin	ritanserin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
DMSO	DMSO	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
through	through	ADP	IN	O
cannulae	cannulae	NOUN	NN	O
each	each	DET	DT	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

Animals	animal	NOUN	NNS	O
were	be	VERB	VBD	O
tested	test	VERB	VBN	O
for	for	ADP	IN	O
four	four	NUM	CD	O
consecutive	consecutive	ADJ	JJ	O
days	day	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
trial	trial	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
MWM	MWM	PROPN	NNP	O
during	during	ADP	IN	O
which	which	DET	WDT	O
the	the	DET	DT	O
position	position	NOUN	NN	O
of	of	ADP	IN	O
hidden	hidden	ADJ	JJ	O
platform	platform	NOUN	NN	O
was	be	VERB	VBD	O
unchanged	unchanged	ADJ	JJ	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
fifth	fifth	ADJ	JJ	O
day	day	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
platform	platform	NOUN	NN	O
was	be	VERB	VBD	O
elevated	elevate	VERB	VBN	O
above	above	ADP	IN	O
the	the	DET	DT	O
water	water	NOUN	NN	O
surface	surface	NOUN	NN	O
in	in	ADP	IN	O
another	another	DET	DT	O
position	position	NOUN	NN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
function	function	NOUN	NN	O
of	of	ADP	IN	O
motor	motor	NOUN	NN	O
,	,	PUNCT	,	O
motivational	motivational	ADJ	JJ	O
and	and	CCONJ	CC	O
visual	visual	ADJ	JJ	O
systems	system	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
escape	escape	NOUN	NN	O
latencies	latency	NOUN	NNS	O
and	and	CCONJ	CC	O
traveled	travel	VERB	VBD	O
distances	distance	NOUN	NNS	O
to	to	PART	TO	O
find	find	VERB	VB	O
platform	platform	NOUN	NN	O
in	in	ADP	IN	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
group	group	NOUN	NN	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
to	to	PART	TO	O
saline	saline	VERB	VB	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Ritanserin	ritanserin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
/	/	SYM	SYM	O
side	side	NOUN	NN	O
)	)	PUNCT	-RRB-	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
mentioned	mention	VERB	VBN	O
parameters	parameter	NOUN	NNS	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
DMSO	DMSO	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
scopolamine	scopolamine	VERB	VB	B-Chemical
and	and	CCONJ	CC	O
ritanserin	ritanserin	NOUN	NN	B-Chemical
co	co	NOUN	NN	O
-	-	NOUN	NN	O
administration	administration	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
escape	escape	NOUN	NN	O
latencies	latency	NOUN	NNS	O
and	and	CCONJ	CC	O
traveled	travel	VERB	VBD	O
distances	distance	NOUN	NNS	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
findings	finding	NOUN	NNS	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
microinjection	microinjection	NOUN	NN	O
of	of	ADP	IN	O
ritanserin	ritanserin	NOUN	NN	B-Chemical
into	into	ADP	IN	O
the	the	DET	DT	O
CA1	CA1	PROPN	NNPS	O
region	region	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hippocampus	hippocampus	NOUN	NN	O
improves	improve	VERB	VBZ	O
the	the	DET	DT	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

PTU	ptu	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
vasculitis	vasculitis	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
girl	girl	NOUN	NN	O
with	with	ADP	IN	O
Turner	Turner	PROPN	NNP	B-Disease
Syndrome	Syndrome	PROPN	NNP	I-Disease
and	and	CCONJ	CC	O
Graves	Graves	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Palpable	palpable	ADJ	JJ	O
purpura	purpura	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
concerning	concern	VERB	VBG	O
clinical	clinical	ADJ	JJ	O
finding	finding	NOUN	NN	O
in	in	ADP	IN	O
pediatric	pediatric	ADJ	JJ	O
patients	patient	NOUN	NNS	O
and	and	CCONJ	CC	O
can	can	VERB	MD	O
have	have	VERB	VB	O
many	many	ADJ	JJ	O
causes	cause	NOUN	NNS	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
infectious	infectious	ADJ	JJ	O
and	and	CCONJ	CC	O
autoimmune	autoimmune	ADJ	JJ	O
processes	process	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
rare	rare	ADJ	JJ	O
cause	cause	NOUN	NN	O
,	,	PUNCT	,	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
vasculitis	vasculitis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
may	may	VERB	MD	O
result	result	VERB	VB	O
from	from	ADP	IN	O
the	the	DET	DT	O
production	production	NOUN	NN	O
of	of	ADP	IN	O
antineutrophil	antineutrophil	NOUN	NN	O
cytoplasmic	cytoplasmic	ADJ	JJ	O
antibodies	antibody	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
ANCAs	ANCAs	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
a	a	DET	DT	O
medication	medication	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
girl	girl	NOUN	NN	O
with	with	ADP	IN	O
Turner	Turner	PROPN	NNP	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
Graves	Graves	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
who	who	PRON	WP	O
presented	present	VERB	VBD	O
with	with	ADP	IN	O
palpable	palpable	ADJ	JJ	O
purpuric	purpuric	NOUN	NN	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
propylthiouracil	propylthiouracil	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
PTU	PTU	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
vasculitis	vasculitis	NOUN	NN	B-Disease
was	be	VERB	VBD	O
made	make	VERB	VBN	O
by	by	ADP	IN	O
observation	observation	NOUN	NN	O
of	of	ADP	IN	O
consistent	consistent	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
features	feature	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
detection	detection	NOUN	NN	O
of	of	ADP	IN	O
elevated	elevated	ADJ	JJ	O
ANA	ANA	PROPN	NNP	O
and	and	CCONJ	CC	O
ANCA	ANCA	PROPN	NNP	O
in	in	ADP	IN	O
the	the	DET	DT	O
blood	blood	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
observed	observed	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
resolution	resolution	NOUN	NN	O
of	of	ADP	IN	O
symptoms	symptom	NOUN	NNS	O
following	follow	VERB	VBG	O
withdrawal	withdrawal	NOUN	NN	O
of	of	ADP	IN	O
PTU	PTU	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Subsequent	subsequent	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
persistent	persistent	ADJ	JJ	O
hyperthyroidism	hyperthyroidism	NOUN	NN	B-Disease
with	with	ADP	IN	O
radioablation	radioablation	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
result	result	VERB	VB	O
in	in	ADP	IN	O
an	an	DET	DT	O
exacerbation	exacerbation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
vasculitis	vasculitis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
a	a	DET	DT	O
complication	complication	NOUN	NN	O
described	describe	VERB	VBN	O
in	in	ADP	IN	O
prior	prior	ADJ	JJ	O
case	case	NOUN	NN	O
reports	report	NOUN	NNS	O
.	.	PUNCT	.	O

Daidzein	daidzein	NOUN	NN	B-Chemical
activates	activate	VERB	VBZ	O
choline	choline	NOUN	NN	B-Chemical
acetyltransferase	acetyltransferase	NOUN	NN	O
from	from	ADP	IN	O
MC	MC	PROPN	NNP	O
-	-	PUNCT	HYPH	O
IXC	IXC	PROPN	NNP	O
cells	cell	NOUN	NNS	O
and	and	CCONJ	CC	O
improves	improve	VERB	VBZ	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
choline	choline	NOUN	NN	B-Chemical
acetyltransferase	acetyltransferase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ChAT	ChAT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
activator	activator	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
enhances	enhance	VERB	VBZ	O
cholinergic	cholinergic	NOUN	NN	O
transmission	transmission	NOUN	NN	O
via	via	ADP	IN	O
an	an	DET	DT	O
augmentation	augmentation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
enzymatic	enzymatic	ADJ	JJ	O
production	production	NOUN	NN	O
of	of	ADP	IN	O
acetylcholine	acetylcholine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
ACh	ACh	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
factor	factor	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
Alzheimer	Alzheimer	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
AD	ad	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Methanolic	methanolic	NOUN	NN	O
extracts	extract	NOUN	NNS	O
from	from	ADP	IN	O
Pueraria	Pueraria	PROPN	NNP	O
thunbergiana	thunbergiana	NOUN	NNS	O
exhibited	exhibit	VERB	VBD	O
an	an	DET	DT	O
activation	activation	NOUN	NN	O
effect	effect	NOUN	NN	O
(	(	PUNCT	-LRB-	O
46	46	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
ChAT	ChAT	PROPN	NNP	O
in	in	ADP	IN	O
vitro	vitro	NOUN	NN	O
.	.	PUNCT	.	O

Via	via	ADP	IN	O
the	the	DET	DT	O
sequential	sequential	ADJ	JJ	O
isolation	isolation	NOUN	NN	O
of	of	ADP	IN	O
Pueraria	Pueraria	PROPN	NNP	O
thunbergiana	thunbergiana	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
active	active	ADJ	JJ	O
component	component	NOUN	NN	O
was	be	VERB	VBD	O
ultimately	ultimately	ADV	RB	O
identified	identify	VERB	VBN	O
as	as	ADP	IN	O
daidzein	daidzein	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	B-Chemical
'	'	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
7	7	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dihydroxy	dihydroxy	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
isoflavone	isoflavone	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
daidzein	daidzein	NOUN	NN	B-Chemical
from	from	ADP	IN	O
Pueraria	Pueraria	PROPN	NNP	O
thunbergiana	thunbergiana	NOUN	NNS	O
on	on	ADP	IN	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
impairments	impairment	NOUN	NNS	B-Disease
of	of	ADP	IN	I-Disease
learning	learning	NOUN	NN	I-Disease
and	and	CCONJ	CC	I-Disease
memory	memory	NOUN	NN	I-Disease
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
conducted	conduct	VERB	VBD	O
a	a	DET	DT	O
series	series	NOUN	NN	O
of	of	ADP	IN	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
tests	test	NOUN	NNS	O
.	.	PUNCT	.	O

Administration	administration	NOUN	NN	O
of	of	ADP	IN	O
daidzein	daidzein	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
mice	mouse	NOUN	NNS	O
was	be	VERB	VBD	O
shown	show	VERB	VBN	O
significantly	significantly	ADV	RB	O
to	to	PART	TO	O
reverse	reverse	VERB	VB	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
according	accord	VERB	VBG	O
to	to	ADP	IN	O
the	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
a	a	DET	DT	O
Y	Y	PROPN	NNP	O
-	-	PUNCT	HYPH	O
maze	maze	NOUN	NN	O
test	test	NOUN	NN	O
.	.	PUNCT	.	O

Injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
into	into	ADP	IN	O
mice	mouse	NOUN	NNS	O
resulted	result	VERB	VBN	O
in	in	ADP	IN	O
impaired	impaired	ADJ	JJ	O
performance	performance	NOUN	NN	O
on	on	ADP	IN	O
Y	Y	PROPN	NNP	O
-	-	PUNCT	HYPH	O
maze	maze	PROPN	NNP	O
tests	test	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
a	a	DET	DT	O
37	37	NUM	CD	O
%	%	NOUN	NN	O
decreases	decrease	NOUN	NNS	O
in	in	ADP	IN	O
alternation	alternation	NOUN	NN	O
behavior	behavior	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

By	by	ADP	IN	O
way	way	NOUN	NN	O
of	of	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
mice	mouse	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
daidzein	daidzein	NOUN	NN	B-Chemical
prior	prior	ADV	RB	O
to	to	ADP	IN	O
the	the	DET	DT	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
injections	injection	NOUN	NNS	O
were	be	VERB	VBD	O
noticeably	noticeably	ADV	RB	O
protected	protect	VERB	VBN	O
from	from	ADP	IN	O
this	this	DET	DT	O
performance	performance	NOUN	NN	O
impairment	impairment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
an	an	DET	DT	O
approximately	approximately	ADV	RB	O
12	12	NUM	CD	O
%	%	NOUN	NN	O
-	-	PUNCT	HYPH	O
21	21	NUM	CD	O
%	%	NOUN	NN	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
alternation	alternation	NOUN	NN	O
behavior	behavior	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
daidzein	daidzein	NOUN	NN	B-Chemical
might	may	VERB	MD	O
play	play	VERB	VB	O
a	a	DET	DT	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
acetylcholine	acetylcholine	NOUN	NN	B-Chemical
biosynthesis	biosynthesis	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
ChAT	ChAT	PROPN	NNP	O
activator	activator	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
also	also	ADV	RB	O
ameliorates	ameliorate	VERB	VBZ	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Urinary	urinary	NOUN	NN	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
quality	quality	NOUN	NN	O
of	of	ADP	IN	O
life	life	NOUN	NN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
Thai	thai	ADJ	JJ	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
overactive	overactive	ADJ	JJ	B-Disease
bladder	bladder	NOUN	NN	I-Disease
after	after	ADP	IN	O
tolterodine	tolterodine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

OBJECTIVES	objectives	NOUN	NN	O
:	:	PUNCT	:	O
To	to	PART	TO	O
study	study	VERB	VB	O
the	the	DET	DT	O
urinary	urinary	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
quality	quality	NOUN	NN	O
of	of	ADP	IN	O
life	life	NOUN	NN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
Thai	thai	ADJ	JJ	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
overactive	overactive	ADJ	JJ	B-Disease
bladder	bladder	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
OAB	OAB	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
after	after	ADP	IN	O
tolterodine	tolterodine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

MATERIAL	MATERIAL	PROPN	NNP	O
AND	and	CCONJ	CC	O
METHOD	method	NOUN	NN	O
:	:	PUNCT	:	O
Thirty	thirty	NUM	CD	O
women	woman	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
aged	age	VERB	VBN	O
30	30	NUM	CD	O
-	-	SYM	SYM	O
77	77	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
diagnosed	diagnose	VERB	VBN	O
as	as	ADP	IN	O
having	have	VERB	VBG	O
OAB	OAB	PROPN	NNP	B-Disease
at	at	ADP	IN	O
the	the	DET	DT	O
Gynecology	Gynecology	PROPN	NNP	O
Clinic	Clinic	PROPN	NNP	O
,	,	PUNCT	,	O
King	King	PROPN	NNP	O
Chulalongkorn	Chulalongkorn	PROPN	NNP	O
Memorial	Memorial	PROPN	NNP	O
Hospital	Hospital	PROPN	NNP	O
from	from	ADP	IN	O
January	January	PROPN	NNP	O
to	to	ADP	IN	O
April	April	PROPN	NNP	O
2004	2004	NUM	CD	O
were	be	VERB	VBD	O
included	include	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Tolterodine	Tolterodine	PROPN	NNP	B-Chemical
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
,	,	PUNCT	,	O
twice	twice	ADV	RB	O
daily	daily	ADV	RB	O
was	be	VERB	VBD	O
given	give	VERB	VBN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
8	8	NUM	CD	O
weeks	week	NOUN	NNS	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
micturition	micturition	NOUN	NN	O
diary	diary	NOUN	NN	O
variables	variable	NOUN	NNS	O
and	and	CCONJ	CC	O
tolerability	tolerability	NOUN	NN	O
were	be	VERB	VBD	O
determined	determine	VERB	VBN	O
.	.	PUNCT	.	O

Short	short	ADJ	JJ	O
form	form	NOUN	NN	O
36	36	NUM	CD	O
(	(	PUNCT	-LRB-	O
SF36	SF36	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
questionaires	questionaire	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
Thai	thai	ADJ	JJ	O
version	version	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
before	before	ADV	RB	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
8	8	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
At	at	ADP	IN	O
8	8	NUM	CD	O
weeks	week	NOUN	NNS	O
,	,	PUNCT	,	O
all	all	DET	DT	O
micturition	micturition	NOUN	NN	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
decreased	decrease	VERB	VBD	O
from	from	ADP	IN	O
16	16	NUM	CD	O
.	.	PUNCT	.	O

7	7	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
.	.	PUNCT	.	O

3	3	NUM	CD	O
to	to	ADP	IN	O
6	6	NUM	CD	O
.	.	PUNCT	.	O

7	7	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
times	time	NOUN	NNS	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
nocturia	nocturia	NOUN	NN	B-Disease
episodes	episode	NOUN	NNS	O
decreased	decrease	VERB	VBD	O
from	from	ADP	IN	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
to	to	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
times	time	NOUN	NNS	O
per	per	ADP	IN	O
night	night	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
was	be	VERB	VBD	O
dry	dry	ADJ	JJ	B-Disease
month	month	NOUN	NN	I-Disease
in	in	ADP	IN	O
5	5	NUM	CD	O
cases	case	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
16	16	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
2	2	NUM	CD	O
cases	case	NOUN	NNS	O
reporting	report	VERB	VBG	O
a	a	DET	DT	O
moderate	moderate	ADJ	JJ	O
degree	degree	NOUN	NN	O
and	and	CCONJ	CC	O
1	1	NUM	CD	O
case	case	NOUN	NN	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
degree	degree	NOUN	NN	O
.	.	PUNCT	.	O

Only	only	ADV	RB	O
one	one	NUM	CD	O
case	case	NOUN	NN	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
withdrew	withdraw	VERB	VBD	O
from	from	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
a	a	DET	DT	O
severe	severe	ADJ	JJ	O
dry	dry	ADJ	JJ	B-Disease
mouth	mouth	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
SF	SF	PROPN	NNP	O
-	-	PUNCT	HYPH	O
36	36	NUM	CD	O
scores	score	NOUN	NNS	O
changed	change	VERB	VBD	O
significantly	significantly	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
domains	domain	NOUN	NNS	O
of	of	ADP	IN	O
physical	physical	ADJ	JJ	O
functioning	functioning	NOUN	NN	O
,	,	PUNCT	,	O
role	role	NOUN	NN	O
function	function	NOUN	NN	O
emotional	emotional	ADJ	JJ	O
,	,	PUNCT	,	O
social	social	ADJ	JJ	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
mental	mental	ADJ	JJ	O
heath	heath	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Tolterodine	Tolterodine	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
effects	effect	NOUN	NNS	O
improved	improve	VERB	VBD	O
the	the	DET	DT	O
quality	quality	NOUN	NN	O
of	of	ADP	IN	O
life	life	NOUN	NN	O
in	in	ADP	IN	O
Thai	Thai	PROPN	NNP	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
OAB	OAB	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Remifentanil	remifentanil	NOUN	NN	B-Chemical
pretreatment	pretreatment	NOUN	NN	O
reduces	reduce	VERB	VBZ	O
myoclonus	myoclonus	ADV	RB	B-Disease
after	after	ADP	IN	O
etomidate	etomidate	VERB	VBP	B-Chemical
.	.	PUNCT	.	O

STUDY	study	NOUN	NN	O
OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
compare	compare	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
1	1	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
gender	gender	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
myoclonus	myoclonus	NOUN	NN	B-Disease
after	after	ADP	IN	O
anesthesia	anesthesia	ADJ	JJ	O
induction	induction	NOUN	NN	O
with	with	ADP	IN	O
etomidate	etomidate	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
This	this	DET	DT	O
was	be	VERB	VBD	O
a	a	DET	DT	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

SETTING	setting	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
at	at	ADP	IN	O
a	a	DET	DT	O
university	university	NOUN	NN	O
hospital	hospital	NOUN	NN	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
:	:	PUNCT	:	O
Sixty	sixty	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
pretreated	pretreate	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
randomized	randomize	VERB	VBN	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blinded	blinded	ADJ	JJ	O
fashion	fashion	NOUN	NN	O
with	with	ADP	IN	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
1	1	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
minutes	minute	NOUN	NNS	O
after	after	ADP	IN	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
injection	injection	NOUN	NN	O
,	,	PUNCT	,	O
etomidate	etomidate	VERB	VB	B-Chemical
0	0	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	PROPN	NNP	O
was	be	VERB	VBD	O
given	give	VERB	VBN	O
.	.	PUNCT	.	O

MEASUREMENTS	measurement	NOUN	NNS	O
:	:	PUNCT	:	O
Myoclonus	myoclonus	NOUN	NN	B-Disease
was	be	VERB	VBD	O
recorded	record	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
scale	scale	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
to	to	ADP	IN	O
3	3	NUM	CD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
grade	grade	NOUN	NN	O
of	of	ADP	IN	O
sedation	sedation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
none	none	NOUN	NN	O
,	,	PUNCT	,	O
mild	mild	ADJ	JJ	O
,	,	PUNCT	,	O
moderate	moderate	ADJ	JJ	O
,	,	PUNCT	,	O
severe	severe	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
nausea	nausea	NOUN	NN	B-Disease
,	,	PUNCT	,	O
pruritus	pruritus	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
apnea	apnea	NOUN	NN	B-Disease
were	be	VERB	VBD	O
recorded	record	VERB	VBN	O
after	after	ADP	IN	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
both	both	DET	DT	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

MAIN	main	ADJ	JJ	O
RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
myoclonus	myoclonus	NOUN	NN	B-Disease
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
70	70	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

None	none	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
experienced	experience	VERB	VBD	O
sedation	sedation	NOUN	NN	O
,	,	PUNCT	,	O
apnea	apnea	NOUN	NN	B-Disease
,	,	PUNCT	,	O
nausea	nausea	NOUN	NN	B-Disease
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
pruritus	pruritus	NOUN	NN	B-Disease
after	after	ADP	IN	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
both	both	DET	DT	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
male	male	ADJ	JJ	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBN	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
myoclonus	myoclonus	NOUN	NN	B-Disease
after	after	ADP	IN	O
etomidate	etomidate	VERB	VBP	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
1	1	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	PUNCT	,	O
kg	kg	ADP	IN	O
reduced	reduce	VERB	VBN	O
myoclonus	myoclonus	NOUN	NN	B-Disease
after	after	ADP	IN	O
etomidate	etomidate	VERB	VBP	B-Chemical
induction	induction	NOUN	NN	O
without	without	ADP	IN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
sedation	sedation	NOUN	NN	O
,	,	PUNCT	,	O
apnea	apnea	NOUN	NN	B-Disease
,	,	PUNCT	,	O
nausea	nausea	NOUN	NN	B-Disease
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
pruritus	pruritus	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Men	men	NOUN	NN	O
experience	experience	NOUN	NN	O
increased	increase	VERB	VBN	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
myoclonus	myoclonus	NOUN	NN	B-Disease
than	than	ADP	IN	O
women	woman	NOUN	NNS	O
after	after	ADP	IN	O
etomidate	etomidate	VERB	VBP	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Memory	memory	NOUN	NN	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
serotonin	serotonin	NOUN	NN	B-Chemical
transporter	transporter	NOUN	NN	O
promoter	promoter	NOUN	NN	O
gene	gene	NOUN	NN	O
polymorphism	polymorphism	NOUN	NN	O
in	in	ADP	IN	O
ecstasy	ecstasy	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
MDMA	MDMA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
users	user	NOUN	NNS	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
3	3	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
methylenedioxymethamphetamine	methylenedioxymethamphetamine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
MDMA	MDMA	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
ecstasy	ecstasy	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
shown	show	VERB	VBN	O
to	to	PART	TO	O
damage	damage	NOUN	NN	O
brain	brain	NOUN	NN	O
serotonin	serotonin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
animals	animal	NOUN	NNS	O
and	and	CCONJ	CC	O
possibly	possibly	ADV	RB	O
humans	human	NOUN	NNS	O
,	,	PUNCT	,	O
little	little	ADJ	JJ	O
is	be	VERB	VBZ	O
known	know	VERB	VBN	O
about	about	ADP	IN	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
consequences	consequence	NOUN	NNS	O
of	of	ADP	IN	O
MDMA	MDMA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	ht	NOUN	NN	I-Chemical
neurotoxic	neurotoxic	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
on	on	ADP	IN	O
functions	function	NOUN	NNS	O
in	in	ADP	IN	O
which	which	DET	WDT	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
is	be	VERB	VBZ	O
involved	involve	VERB	VBN	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
cognitive	cognitive	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

Because	because	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
transporters	transporter	NOUN	NNS	O
play	play	VERB	VBP	O
a	a	DET	DT	O
key	key	ADJ	JJ	O
element	element	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
synaptic	synaptic	ADJ	JJ	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
transmission	transmission	NOUN	NN	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
be	be	VERB	VB	O
important	important	ADJ	JJ	O
to	to	PART	TO	O
control	control	VERB	VB	O
for	for	ADP	IN	O
the	the	DET	DT	O
potential	potential	ADJ	JJ	O
covariance	covariance	NOUN	NN	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
polymorphism	polymorphism	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
transporter	transporter	NOUN	NN	O
promoter	promoter	NOUN	NN	O
gene	gene	NOUN	NN	O
region	region	NOUN	NN	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
HTTLPR	HTTLPR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
when	when	ADV	WRB	O
studying	study	VERB	VBG	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
MDMA	MDMA	PROPN	NNP	B-Chemical
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
cognitive	cognitive	ADJ	JJ	O
functioning	functioning	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
moderate	moderate	ADJ	JJ	O
and	and	CCONJ	CC	O
heavy	heavy	ADJ	JJ	O
MDMA	MDMA	PROPN	NNP	B-Chemical
use	use	NOUN	NN	O
on	on	ADP	IN	O
cognitive	cognitive	ADJ	JJ	O
function	function	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
abstention	abstention	NOUN	NN	O
from	from	ADP	IN	O
MDMA	MDMA	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
in	in	ADP	IN	O
subjects	subject	NOUN	NNS	O
genotyped	genotype	VERB	VBN	O
for	for	ADP	IN	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
HTTLPR	httlpr	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
second	second	ADJ	JJ	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
whether	whether	ADP	IN	O
these	these	DET	DT	O
effects	effect	NOUN	NNS	O
differ	differ	VERB	VBP	O
for	for	ADP	IN	O
females	female	NOUN	NNS	O
and	and	CCONJ	CC	O
males	male	NOUN	NNS	O
.	.	PUNCT	.	O

Fifteen	fifteen	NUM	CD	O
moderate	moderate	ADJ	JJ	O
MDMA	MDMA	PROPN	NNP	B-Chemical
users	user	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
<	<	X	XX	O
55	55	NUM	CD	O
lifetime	lifetime	NOUN	NN	O
tablets	tablet	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
22	22	NUM	CD	O
heavy	heavy	ADJ	JJ	O
MDMA	MDMA	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
users	user	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
>	>	X	XX	O
55	55	NUM	CD	O
lifetime	lifetime	NOUN	NN	O
tablets	tablet	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
16	16	NUM	CD	O
ex	ex	NOUN	NN	O
-	-	ADJ	JJ	O
MDMA	MDMA	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
users	user	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
last	last	ADJ	JJ	O
tablet	tablet	NOUN	NN	O
>	>	X	XX	O
1	1	NUM	CD	O
year	year	NOUN	NN	O
ago	ago	ADV	RB	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
13	13	NUM	CD	O
controls	control	NOUN	NNS	O
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
on	on	ADP	IN	O
a	a	DET	DT	O
battery	battery	NOUN	NN	O
of	of	ADP	IN	O
neuropsychological	neuropsychological	ADJ	JJ	O
tests	test	NOUN	NNS	O
.	.	PUNCT	.	O

DNA	dna	NOUN	NN	O
from	from	ADP	IN	O
peripheral	peripheral	ADJ	JJ	O
nuclear	nuclear	ADJ	JJ	O
blood	blood	NOUN	NN	O
cells	cell	NOUN	NNS	O
was	be	VERB	VBD	O
genotyped	genotype	VERB	VBN	O
for	for	ADP	IN	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
HTTLPR	httlpr	NOUN	NN	O
using	use	VERB	VBG	O
standard	standard	ADJ	JJ	O
polymerase	polymerase	NOUN	NN	O
chain	chain	NOUN	NN	O
reaction	reaction	NOUN	NN	O
methods	method	NOUN	NNS	O
.	.	PUNCT	.	O
A	a	DET	DT	O
significant	significant	ADJ	JJ	O
group	group	NOUN	NN	O
effect	effect	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
only	only	ADV	RB	O
on	on	ADP	IN	O
memory	memory	NOUN	NN	O
function	function	NOUN	NN	O
tasks	task	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
04	04	NUM	CD	O
)	)	PUNCT	-RRB-	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
on	on	ADP	IN	O
reaction	reaction	NOUN	NN	O
times	time	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
61	61	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
attention	attention	NOUN	NN	O
/	/	SYM	SYM	O
executive	executive	NOUN	NN	O
functioning	functioning	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
59	59	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Heavy	heavy	ADJ	JJ	O
and	and	CCONJ	CC	O
ex	ex	PROPN	NNP	O
-	-	ADJ	JJ	O
MDMA	MDMA	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
users	user	NOUN	NNS	O
performed	perform	VERB	VBD	O
significantly	significantly	ADV	RB	O
poorer	poorer	ADV	RBR	O
on	on	ADP	IN	O
memory	memory	NOUN	NN	O
tasks	task	NOUN	NNS	O
than	than	ADP	IN	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
no	no	DET	DT	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
memory	memory	NOUN	NN	B-Disease
impairment	impairment	NOUN	NN	I-Disease
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
moderate	moderate	ADJ	JJ	O
MDMA	MDMA	PROPN	NNP	B-Chemical
users	user	NOUN	NNS	O
.	.	PUNCT	.	O

No	no	DET	DT	O
significant	significant	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
HTTLPR	HTTLPR	PROPN	NNP	O
or	or	CCONJ	CC	O
gender	gender	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

While	while	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
MDMA	MDMA	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
quantities	quantity	NOUN	NNS	O
that	that	DET	WDT	O
may	may	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
"	"	PUNCT	``	O
moderate	moderate	ADJ	JJ	O
"	"	PUNCT	''	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
impaired	impaired	ADJ	JJ	B-Disease
memory	memory	NOUN	NN	I-Disease
functioning	functioning	NOUN	NN	I-Disease
,	,	PUNCT	,	O
heavy	heavy	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
MDMA	MDMA	PROPN	NNP	B-Chemical
use	use	NOUN	NN	O
may	may	VERB	MD	O
lead	lead	VERB	VB	O
to	to	ADP	IN	O
long	long	ADJ	JJ	O
lasting	last	VERB	VBG	O
memory	memory	NOUN	NN	B-Disease
impairments	impairment	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

No	no	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
HTTLPR	HTTLPR	PROPN	NNP	O
or	or	CCONJ	CC	O
gender	gender	NOUN	NN	O
on	on	ADP	IN	O
memory	memory	NOUN	NN	O
function	function	NOUN	NN	O
or	or	CCONJ	CC	O
MDMA	MDMA	PROPN	NNP	B-Chemical
use	use	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

Role	role	NOUN	NN	O
of	of	ADP	IN	O
mangiferin	mangiferin	NOUN	NN	B-Chemical
on	on	ADP	IN	O
biochemical	biochemical	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
and	and	CCONJ	CC	O
antioxidant	antioxidant	ADJ	JJ	O
status	status	NOUN	NN	O
in	in	ADP	IN	O
isoproterenol	isoproterenol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
current	current	ADJ	JJ	O
study	study	NOUN	NN	O
dealt	deal	VERB	VBD	O
with	with	ADP	IN	O
the	the	DET	DT	O
protective	protective	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
mangiferin	mangiferin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
polyphenol	polyphenol	NOUN	NN	B-Chemical
from	from	ADP	IN	O
Mangifera	Mangifera	PROPN	NNP	O
indica	indica	NOUN	NN	O
Linn	Linn	PROPN	NNP	O
.	.	PUNCT	.	O

(	(	PUNCT	-LRB-	O
Anacardiaceae	Anacardiaceae	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
isoproterenol	isoproterenol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
ISPH	ISPH	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
MI	MI	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
through	through	ADP	IN	O
its	-PRON-	DET	PRP$	O
antioxidative	antioxidative	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
.	.	PUNCT	.	O

Subcutaneous	subcutaneous	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
ISPH	ISPH	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
in	in	ADP	IN	O
1	1	NUM	CD	O
ml	ml	NOUN	NN	O
saline	saline	NOUN	NN	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
rats	rat	NOUN	NNS	O
for	for	ADP	IN	O
2	2	NUM	CD	O
consecutive	consecutive	ADJ	JJ	O
days	day	NOUN	NNS	O
caused	cause	VERB	VBD	O
myocardial	myocardial	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
in	in	ADP	IN	O
rat	rat	NOUN	NN	O
heart	heart	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
determined	determine	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
increased	increase	VERB	VBN	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
serum	serum	ADJ	JJ	O
lactate	lactate	NOUN	NN	B-Chemical
dehydrogenase	dehydrogenase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
LDH	LDH	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
creatine	creatine	NOUN	NN	B-Chemical
phosphokinase	phosphokinase	NOUN	NN	O
isoenzymes	isoenzyme	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
CK	CK	PROPN	NNP	O
-	-	PUNCT	HYPH	O
MB	MB	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
increased	increase	VERB	VBN	O
uric	uric	ADJ	JJ	B-Chemical
acid	acid	ADJ	JJ	I-Chemical
level	level	NOUN	NN	O
and	and	CCONJ	CC	O
reduced	reduced	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
iron	iron	NOUN	NN	B-Chemical
binding	bind	VERB	VBG	O
capacity	capacity	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
protective	protective	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
mangiferin	mangiferin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
by	by	ADP	IN	O
triphenyl	triphenyl	NOUN	NN	B-Chemical
tetrazolium	tetrazolium	NOUN	NN	I-Chemical
chloride	chloride	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
TTC	TTC	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
test	test	NOUN	NN	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
macroscopic	macroscopic	ADJ	JJ	O
enzyme	enzyme	ADJ	JJ	O
mapping	mapping	NOUN	NN	O
assay	assay	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ischemic	ischemic	ADJ	JJ	B-Disease
myocardium	myocardium	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
heart	heart	NOUN	NN	O
tissue	tissue	NOUN	NN	O
antioxidant	antioxidant	NOUN	NN	O
enzymes	enzyme	VERB	VBZ	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
superoxide	superoxide	NOUN	NN	B-Chemical
dismutase	dismutase	NOUN	NN	O
,	,	PUNCT	,	O
catalase	catalase	NOUN	NN	O
,	,	PUNCT	,	O
glutathione	glutathione	ADJ	JJ	B-Chemical
peroxidase	peroxidase	NOUN	NN	O
,	,	PUNCT	,	O
glutathione	glutathione	ADJ	JJ	B-Chemical
transferase	transferase	NOUN	NN	O
and	and	CCONJ	CC	O
glutathione	glutathione	NOUN	NN	B-Chemical
reductase	reductase	NOUN	NN	O
activities	activity	NOUN	NNS	O
,	,	PUNCT	,	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
enzymic	enzymic	ADJ	JJ	O
antioxidants	antioxidant	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
cerruloplasmin	cerruloplasmin	NOUN	NN	O
,	,	PUNCT	,	O
Vitamin	Vitamin	PROPN	NNP	B-Chemical
C	C	PROPN	NNP	I-Chemical
,	,	PUNCT	,	O
Vitamin	vitamin	NOUN	NN	B-Chemical
E	e	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
glutathione	glutathione	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
altered	alter	VERB	VBN	O
in	in	ADP	IN	O
MI	MI	PROPN	NNP	B-Disease
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Upon	upon	ADP	IN	O
pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
mangiferin	mangiferin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
suspended	suspend	VERB	VBD	O
in	in	ADP	IN	O
2	2	NUM	CD	O
ml	ml	NOUN	NNS	O
of	of	ADP	IN	O
dimethyl	dimethyl	ADJ	JJ	B-Chemical
sulphoxide	sulphoxide	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
given	give	VERB	VBN	O
intraperitoneally	intraperitoneally	ADV	RB	O
for	for	ADP	IN	O
28	28	NUM	CD	O
days	day	NOUN	NNS	O
to	to	ADP	IN	O
MI	MI	PROPN	NNP	B-Disease
rats	rat	NOUN	NNS	O
protected	protect	VERB	VBD	O
the	the	DET	DT	O
above	above	ADV	RB	O
-	-	PUNCT	HYPH	O
mentioned	mention	VERB	VBN	O
parameters	parameter	NOUN	NNS	O
to	to	PART	TO	O
fall	fall	VERB	VB	O
from	from	ADP	IN	O
the	the	DET	DT	O
normal	normal	ADJ	JJ	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

Activities	activity	NOUN	NNS	O
of	of	ADP	IN	O
heart	heart	NOUN	NN	O
tissue	tissue	NOUN	NN	O
enzymic	enzymic	ADJ	JJ	O
antioxidants	antioxidant	NOUN	NNS	O
and	and	CCONJ	CC	O
serum	serum	ADJ	JJ	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
enzymic	enzymic	ADJ	JJ	O
antioxidants	antioxidant	NOUN	NNS	O
levels	level	NOUN	NNS	O
rose	rise	VERB	VBD	O
significantly	significantly	ADV	RB	O
upon	upon	ADP	IN	O
mangiferin	mangiferin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
ISPH	ISPH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
MI	MI	PROPN	NNP	B-Disease
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

From	from	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
concluded	conclude	VERB	VBN	O
that	that	ADP	IN	O
mangiferin	mangiferin	NOUN	NN	B-Chemical
exerts	exert	VERB	VBZ	O
a	a	DET	DT	O
beneficial	beneficial	ADJ	JJ	O
effect	effect	NOUN	NN	O
against	against	ADP	IN	O
ISPH	ISPH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
MI	MI	PROPN	NNP	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
its	-PRON-	DET	PRP$	O
antioxidant	antioxidant	ADJ	JJ	O
potential	potential	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
regulated	regulate	VERB	VBD	O
the	the	DET	DT	O
tissues	tissue	NOUN	NNS	O
defense	defense	NOUN	NN	O
system	system	NOUN	NN	O
against	against	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Cardiovascular	cardiovascular	ADJ	JJ	O
risk	risk	NOUN	NN	O
with	with	ADP	IN	O
cyclooxygenase	cyclooxygenase	NOUN	NN	B-Chemical
inhibitors	inhibitor	NOUN	NNS	I-Chemical
:	:	PUNCT	:	O
general	general	ADJ	JJ	O
problem	problem	NOUN	NN	O
with	with	ADP	IN	O
substance	substance	NOUN	NN	O
specific	specific	ADJ	JJ	O
differences	difference	NOUN	NNS	O
?	?	PUNCT	.	O

Randomised	randomise	VERB	VBN	O
clinical	clinical	ADJ	JJ	O
trials	trial	NOUN	NNS	O
and	and	CCONJ	CC	O
observational	observational	ADJ	JJ	O
studies	study	NOUN	NNS	O
have	have	VERB	VBP	O
shown	show	VERB	VBN	O
an	an	DET	DT	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
,	,	PUNCT	,	O
stroke	stroke	NOUN	NN	B-Disease
,	,	PUNCT	,	O
hypertension	hypertension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
during	during	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
cyclooxygenase	cyclooxygenase	NOUN	NN	B-Chemical
inhibitors	inhibitor	NOUN	NNS	I-Chemical
.	.	PUNCT	.	O

Adverse	adverse	ADJ	JJ	O
cardiovascular	cardiovascular	ADJ	JJ	O
effects	effect	NOUN	NNS	O
occurred	occur	VERB	VBD	O
mainly	mainly	ADV	RB	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
exclusively	exclusively	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
concomitant	concomitant	ADJ	JJ	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
.	.	PUNCT	.	O

Cyclooxygenase	cyclooxygenase	NOUN	NN	B-Chemical
inhibitors	inhibitor	NOUN	NNS	I-Chemical
cause	cause	VERB	VBP	O
complex	complex	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
,	,	PUNCT	,	O
vascular	vascular	NOUN	NN	O
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	O
prostanoid	prostanoid	NOUN	NN	O
profiles	profile	NOUN	NNS	O
thereby	thereby	ADV	RB	O
increasing	increase	VERB	VBG	O
vascular	vascular	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
and	and	CCONJ	CC	O
fluid	fluid	ADJ	JJ	O
retention	retention	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
tends	tend	VERB	VBZ	O
to	to	PART	TO	O
increase	increase	VERB	VB	O
with	with	ADP	IN	O
the	the	DET	DT	O
daily	daily	ADJ	JJ	O
dose	dose	NOUN	NN	O
and	and	CCONJ	CC	O
total	total	ADJ	JJ	O
exposure	exposure	NOUN	NN	O
time	time	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
comparison	comparison	NOUN	NN	O
of	of	ADP	IN	O
individual	individual	ADJ	JJ	O
selective	selective	ADJ	JJ	O
and	and	CCONJ	CC	O
unselective	unselective	ADJ	JJ	O
cyclooxygenase	cyclooxygenase	NOUN	NN	B-Chemical
inhibitors	inhibitor	NOUN	NNS	I-Chemical
suggests	suggest	VERB	VBZ	O
substance	substance	NOUN	NN	O
-	-	PUNCT	HYPH	O
specific	specific	ADJ	JJ	O
differences	difference	NOUN	NNS	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
may	may	VERB	MD	O
depend	depend	VERB	VB	O
on	on	ADP	IN	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
pharmacokinetic	pharmacokinetic	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
or	or	CCONJ	CC	O
inhibitory	inhibitory	ADJ	JJ	O
potency	potency	NOUN	NN	O
and	and	CCONJ	CC	O
may	may	VERB	MD	O
be	be	VERB	VB	O
contributed	contribute	VERB	VBN	O
by	by	ADP	IN	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
independent	independent	ADJ	JJ	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

Diagnostic	diagnostic	ADJ	JJ	O
markers	marker	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
terminal	terminal	NOUN	NN	I-Chemical
pro	pro	ADJ	JJ	I-Chemical
brain	brain	NOUN	NN	I-Chemical
natriuretic	natriuretic	ADJ	JJ	I-Chemical
peptide	peptide	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NT	NT	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
proBNP	proBNP	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
sensitive	sensitive	ADJ	JJ	O
C	c	NOUN	NN	O
-	-	PUNCT	HYPH	O
reactive	reactive	ADJ	JJ	O
protein	protein	NOUN	NN	O
might	may	VERB	MD	O
help	help	VERB	VB	O
in	in	ADP	IN	O
the	the	DET	DT	O
early	early	ADJ	JJ	O
identification	identification	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
,	,	PUNCT	,	O
thus	thus	ADV	RB	O
avoiding	avoid	VERB	VBG	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
serious	serious	ADJ	JJ	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Pilocarpine	pilocarpine	NOUN	NN	B-Chemical
seizures	seizure	NOUN	NNS	B-Disease
cause	cause	VERB	VBP	O
age	age	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
impairment	impairment	NOUN	NN	B-Disease
in	in	ADP	IN	I-Disease
auditory	auditory	NOUN	NN	I-Disease
location	location	NOUN	NN	I-Disease
discrimination	discrimination	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Children	child	NOUN	NNS	O
who	who	PRON	WP	O
have	have	VERB	VBP	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
have	have	VERB	VBP	O
continuous	continuous	ADJ	JJ	O
or	or	CCONJ	CC	O
rapidly	rapidly	ADV	RB	O
repeating	repeat	VERB	VBG	O
seizures	seizure	NOUN	NNS	B-Disease
that	that	DET	WDT	O
may	may	VERB	MD	O
be	be	VERB	VB	O
life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
threatening	threaten	VERB	VBG	O
and	and	CCONJ	CC	O
may	may	VERB	MD	O
cause	cause	VERB	VB	O
life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
long	long	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
brain	brain	NOUN	NN	O
and	and	CCONJ	CC	O
behavior	behavior	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
extent	extent	NOUN	NN	O
to	to	PART	TO	O
which	which	DET	WDT	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
causes	cause	VERB	VBZ	O
deficits	deficit	NOUN	NNS	B-Disease
in	in	ADP	IN	I-Disease
auditory	auditory	NOUN	NN	I-Disease
discrimination	discrimination	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
unknown	unknown	ADJ	JJ	O
.	.	PUNCT	.	O

A	a	DET	DT	O
naturalistic	naturalistic	ADJ	JJ	O
auditory	auditory	NOUN	NN	O
location	location	NOUN	NN	O
discrimination	discrimination	NOUN	NN	O
method	method	NOUN	NN	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
this	this	DET	DT	O
question	question	NOUN	NN	O
using	use	VERB	VBG	O
an	an	DET	DT	O
animal	animal	NOUN	NN	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Male	Male	PROPN	NNP	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
injected	inject	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
on	on	ADP	IN	O
postnatal	postnatal	ADJ	JJ	O
day	day	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
)	)	PUNCT	-RRB-	O
20	20	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
a	a	DET	DT	O
convulsant	convulsant	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
P20	P20	PROPN	NNP	O
or	or	CCONJ	CC	O
P45	P45	PROPN	NNP	O
.	.	PUNCT	.	O

Pilocarpine	pilocarpine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
either	either	DET	DT	O
day	day	NOUN	NN	O
induced	induce	VERB	VBD	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
;	;	PUNCT	:	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
at	at	ADP	IN	O
P45	P45	PROPN	NNP	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
CA3	CA3	PROPN	NNP	O
cell	cell	NOUN	NN	O
loss	loss	NOUN	NN	O
and	and	CCONJ	CC	O
spontaneous	spontaneous	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
P20	P20	PROPN	NNP	O
rats	rat	NOUN	NNS	O
had	have	VERB	VBD	O
no	no	DET	DT	O
cell	cell	NOUN	NN	O
loss	loss	NOUN	NN	O
or	or	CCONJ	CC	O
spontaneous	spontaneous	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Mature	mature	ADJ	JJ	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
trained	train	VERB	VBN	O
with	with	ADP	IN	O
sound	sound	NOUN	NN	O
-	-	PUNCT	HYPH	O
source	source	NOUN	NN	O
location	location	NOUN	NN	O
and	and	CCONJ	CC	O
sound	sound	ADJ	JJ	O
-	-	PUNCT	HYPH	O
silence	silence	NOUN	NN	O
discriminations	discrimination	NOUN	NNS	O
.	.	PUNCT	.	O

Control	Control	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
saline	saline	VERB	VB	O
P20	P20	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
rats	rat	NOUN	NNS	O
acquired	acquire	VERB	VBD	O
both	both	DET	DT	O
discriminations	discrimination	NOUN	NNS	O
immediately	immediately	ADV	RB	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
P20	P20	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
acquisition	acquisition	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
sound	sound	ADJ	JJ	O
-	-	PUNCT	HYPH	O
source	source	NOUN	NN	O
location	location	NOUN	NN	O
discrimination	discrimination	NOUN	NN	O
was	be	VERB	VBD	O
moderately	moderately	ADV	RB	O
impaired	impair	VERB	VBN	O
.	.	PUNCT	.	O

Status	Status	PROPN	NNP	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
P45	P45	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
rats	rat	NOUN	NNS	O
failed	fail	VERB	VBD	O
to	to	PART	TO	O
acquire	acquire	VERB	VB	O
either	either	DET	DT	O
sound	sound	ADJ	JJ	O
-	-	PUNCT	HYPH	O
source	source	NOUN	NN	O
location	location	NOUN	NN	O
or	or	CCONJ	CC	O
sound	sound	ADJ	JJ	O
-	-	PUNCT	HYPH	O
silence	silence	NOUN	NN	O
discriminations	discrimination	NOUN	NNS	O
.	.	PUNCT	.	O

Status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
in	in	ADP	IN	O
rat	rat	NOUN	NN	O
causes	cause	VERB	VBZ	O
an	an	DET	DT	O
age	age	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
,	,	PUNCT	,	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
impairment	impairment	NOUN	NN	B-Disease
in	in	ADP	IN	I-Disease
auditory	auditory	NOUN	NN	I-Disease
discrimination	discrimination	NOUN	NN	I-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
impairment	impairment	NOUN	NN	O
may	may	VERB	MD	O
explain	explain	VERB	VB	O
one	one	NUM	CD	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
impaired	impaired	ADJ	JJ	B-Disease
auditory	auditory	NOUN	NN	I-Disease
location	location	NOUN	NN	I-Disease
discrimination	discrimination	NOUN	NN	I-Disease
in	in	ADP	IN	O
humans	human	NOUN	NNS	O
.	.	PUNCT	.	O

Nerve	nerve	NOUN	NN	O
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
and	and	CCONJ	CC	O
prostaglandins	prostaglandin	NOUN	NNS	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
urine	urine	NOUN	NN	O
of	of	ADP	IN	O
female	female	ADJ	JJ	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
overactive	overactive	ADJ	JJ	B-Disease
bladder	bladder	NOUN	NN	I-Disease
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
NGF	NGF	PROPN	NNP	O
and	and	CCONJ	CC	O
PGs	pg	NOUN	NNS	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
bladder	bladder	NOUN	NN	O
can	can	VERB	MD	O
be	be	VERB	VB	O
affected	affect	VERB	VBN	O
by	by	ADP	IN	O
pathological	pathological	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
bladder	bladder	NOUN	NN	O
and	and	CCONJ	CC	O
these	these	DET	DT	O
changes	change	NOUN	NNS	O
can	can	VERB	MD	O
be	be	VERB	VB	O
detected	detect	VERB	VBN	O
in	in	ADP	IN	O
urine	urine	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
urinary	urinary	ADJ	JJ	O
NGF	NGF	PROPN	NNP	O
and	and	CCONJ	CC	O
PGs	pg	NOUN	NNS	B-Chemical
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
OAB	OAB	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

MATERIALS	material	NOUN	NNS	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
study	study	NOUN	NN	O
groups	group	NOUN	NNS	O
included	include	VERB	VBD	O
65	65	NUM	CD	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
OAB	OAB	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
20	20	NUM	CD	O
without	without	ADP	IN	O
bladder	bladder	NOUN	NN	O
symptoms	symptom	NOUN	NNS	O
who	who	PRON	WP	O
served	serve	VERB	VBD	O
as	as	ADP	IN	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

Evaluation	evaluation	NOUN	NN	O
included	include	VERB	VBD	O
patient	patient	ADJ	JJ	O
history	history	NOUN	NN	O
,	,	PUNCT	,	O
urinalysis	urinalysis	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
voiding	void	VERB	VBG	O
diary	diary	NOUN	NN	O
and	and	CCONJ	CC	O
urodynamic	urodynamic	ADJ	JJ	O
studies	study	NOUN	NNS	O
.	.	PUNCT	.	O

Urine	Urine	PROPN	NNP	O
samples	sample	NOUN	NNS	O
were	be	VERB	VBD	O
collected	collect	VERB	VBN	O
.	.	PUNCT	.	O

NGF	NGF	PROPN	NNP	O
,	,	PUNCT	,	O
PGE2	PGE2	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
PGF2alpha	PGF2alpha	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
PGI2	PGI2	PROPN	NNP	B-Chemical
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
using	use	VERB	VBG	O
enzyme	enzyme	NOUN	NN	O
-	-	PUNCT	HYPH	O
linked	link	VERB	VBN	O
immunosorbent	immunosorbent	NOUN	NN	O
assay	assay	NOUN	NN	O
and	and	CCONJ	CC	O
compared	compare	VERB	VBN	O
between	between	ADP	IN	O
the	the	DET	DT	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
correlations	correlation	NOUN	NNS	O
between	between	ADP	IN	O
urinary	urinary	ADJ	JJ	O
NGF	NGF	PROPN	NNP	O
and	and	CCONJ	CC	O
PG	PG	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
urodynamic	urodynamic	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
OAB	OAB	PROPN	NNP	B-Disease
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Urinary	Urinary	PROPN	NNP	O
NGF	NGF	PROPN	NNP	O
,	,	PUNCT	,	O
PGE2	PGE2	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
PGF2alpha	PGF2alpha	PROPN	NNP	B-Chemical
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
OAB	OAB	PROPN	NNP	B-Disease
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
controls	control	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
urinary	urinary	NOUN	NN	O
PGI2	PGI2	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
not	not	ADV	RB	O
different	different	ADJ	JJ	O
between	between	ADP	IN	O
controls	control	NOUN	NNS	O
and	and	CCONJ	CC	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
OAB	OAB	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
OAB	OAB	PROPN	NNP	B-Disease
urinary	urinary	NOUN	NN	O
PGE2	PGE2	PROPN	NNP	B-Chemical
positively	positively	ADV	RB	O
correlated	correlate	VERB	VBD	O
with	with	ADP	IN	O
volume	volume	NOUN	NN	O
at	at	ADP	IN	O
first	first	ADJ	JJ	O
desire	desire	NOUN	NN	O
to	to	PART	TO	O
void	void	VERB	VB	O
and	and	CCONJ	CC	O
maximum	maximum	ADJ	JJ	O
cystometric	cystometric	ADJ	JJ	O
capacity	capacity	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Urinary	Urinary	PROPN	NNP	O
NGF	NGF	PROPN	NNP	O
,	,	PUNCT	,	O
PGF2alpha	PGF2alpha	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
PGI2	PGI2	PROPN	NNP	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
correlate	correlate	VERB	VB	O
with	with	ADP	IN	O
urodynamic	urodynamic	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
OAB	OAB	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
NGF	NGF	PROPN	NNP	O
and	and	CCONJ	CC	O
PGs	pg	NOUN	NNS	B-Chemical
have	have	VERB	VBP	O
important	important	ADJ	JJ	O
roles	role	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
OAB	OAB	PROPN	NNP	B-Disease
symptoms	symptom	NOUN	NNS	O
in	in	ADP	IN	O
female	female	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Urinary	urinary	NOUN	NN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
these	these	DET	DT	O
factors	factor	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
as	as	ADP	IN	O
markers	marker	NOUN	NNS	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
OAB	OAB	PROPN	NNP	B-Disease
symptoms	symptom	NOUN	NNS	O
.	.	PUNCT	.	O

Definition	definition	NOUN	NN	O
and	and	CCONJ	CC	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
anemia	anemia	NOUN	NN	B-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
infected	infect	VERB	VBN	B-Disease
with	with	ADP	IN	I-Disease
hepatitis	hepatitis	PROPN	NNP	I-Disease
C	C	PROPN	NNP	I-Disease
virus	virus	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Chronic	chronic	ADJ	JJ	B-Disease
infection	infection	NOUN	NN	I-Disease
with	with	ADP	IN	I-Disease
hepatitis	hepatitis	PROPN	NNP	I-Disease
C	C	PROPN	NNP	I-Disease
virus	virus	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
HCV	HCV	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
can	can	VERB	MD	O
progress	progress	VERB	VB	O
to	to	ADP	IN	O
cirrhosis	cirrhosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
hepatocellular	hepatocellular	ADJ	JJ	B-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
end	end	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
stage	stage	NOUN	NN	I-Disease
liver	liver	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
current	current	ADJ	JJ	O
best	good	ADJ	JJS	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
HCV	HCV	PROPN	NNP	B-Disease
infection	infection	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
pegylated	pegylated	ADJ	JJ	O
interferon	interferon	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Although	although	ADP	IN	O
this	this	DET	DT	O
regimen	regimen	NOUN	NN	O
produces	produce	VERB	VBZ	O
sustained	sustain	VERB	VBD	O
virologic	virologic	ADJ	JJ	O
responses	response	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
SVRs	svr	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
approximately	approximately	ADV	RB	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
can	can	VERB	MD	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
potentially	potentially	ADV	RB	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
limiting	limit	VERB	VBG	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Hemoglobin	hemoglobin	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
decrease	decrease	NOUN	NN	O
mainly	mainly	ADV	RB	O
as	as	ADP	IN	O
a	a	DET	DT	O
result	result	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hemolysis	hemolysis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
this	this	DET	DT	O
anemia	anemia	NOUN	NN	B-Disease
can	can	VERB	MD	O
be	be	VERB	VB	O
problematic	problematic	ADJ	JJ	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
HCV	HCV	PROPN	NNP	B-Disease
infection	infection	NOUN	NN	I-Disease
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
those	those	DET	DT	O
who	who	PRON	WP	O
have	have	VERB	VBP	O
comorbid	comorbid	NOUN	NN	O
renal	renal	ADJ	JJ	B-Disease
or	or	CCONJ	CC	I-Disease
cardiovascular	cardiovascular	ADJ	JJ	I-Disease
disorders	disorder	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
general	general	ADJ	JJ	O
,	,	PUNCT	,	O
anemia	anemia	NOUN	NN	B-Disease
can	can	VERB	MD	O
increase	increase	VERB	VB	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
morbidity	morbidity	NOUN	NN	O
and	and	CCONJ	CC	O
mortality	mortality	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
may	may	VERB	MD	O
have	have	VERB	VB	O
negative	negative	ADJ	JJ	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
cerebral	cerebral	ADJ	JJ	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
quality	quality	NOUN	NN	O
of	of	ADP	IN	O
life	life	NOUN	NN	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
anemia	anemia	NOUN	NN	B-Disease
can	can	VERB	MD	O
be	be	VERB	VB	O
reversed	reverse	VERB	VBN	O
by	by	ADP	IN	O
dose	dose	NOUN	NN	O
reduction	reduction	NOUN	NN	O
or	or	CCONJ	CC	O
discontinuation	discontinuation	NOUN	NN	O
,	,	PUNCT	,	O
this	this	DET	DT	O
approach	approach	NOUN	NN	O
compromises	compromise	VERB	VBZ	O
outcomes	outcome	NOUN	NNS	O
by	by	ADP	IN	O
significantly	significantly	ADV	RB	O
decreasing	decrease	VERB	VBG	O
SVR	SVR	PROPN	NNP	O
rates	rate	NOUN	NNS	O
.	.	PUNCT	.	O

Recombinant	recombinant	ADJ	JJ	O
human	human	ADJ	JJ	O
erythropoietin	erythropoietin	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
used	use	VERB	VBN	O
to	to	PART	TO	O
manage	manage	VERB	VB	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
anemia	anemia	NOUN	NN	B-Disease
but	but	CCONJ	CC	O
has	have	VERB	VBZ	O
other	other	ADJ	JJ	O
potential	potential	ADJ	JJ	O
disadvantages	disadvantage	NOUN	NNS	O
.	.	PUNCT	.	O

Viramidine	Viramidine	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
liver	liver	NOUN	NN	O
-	-	PUNCT	HYPH	O
targeting	target	VERB	VBG	O
prodrug	prodrug	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
has	have	VERB	VBZ	O
the	the	DET	DT	O
potential	potential	NOUN	NN	O
to	to	PART	TO	O
maintain	maintain	VERB	VB	O
the	the	DET	DT	O
virologic	virologic	ADJ	JJ	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
while	while	ADP	IN	O
decreasing	decrease	VERB	VBG	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
C	C	PROPN	NNP	I-Disease
.	.	PUNCT	.	O

Impact	impact	NOUN	NN	O
of	of	ADP	IN	O
alcohol	alcohol	NOUN	NN	B-Chemical
exposure	exposure	NOUN	NN	O
after	after	ADP	IN	O
pregnancy	pregnancy	NOUN	NN	O
recognition	recognition	NOUN	NN	O
on	on	ADP	IN	O
ultrasonographic	ultrasonographic	ADJ	JJ	O
fetal	fetal	ADJ	JJ	O
growth	growth	NOUN	NN	O
measures	measure	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
More	More	ADJ	JJR	O
than	than	ADP	IN	O
3	3	NUM	CD	O
decades	decade	NOUN	NNS	O
after	after	ADP	IN	O
Jones	Jones	PROPN	NNP	O
and	and	CCONJ	CC	O
Smith	Smith	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
1973	1973	NUM	CD	O
)	)	PUNCT	-RRB-	O
reported	report	VERB	VBN	O
on	on	ADP	IN	O
the	the	DET	DT	O
devastation	devastation	NOUN	NN	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
alcohol	alcohol	NOUN	NN	B-Chemical
exposure	exposure	NOUN	NN	O
on	on	ADP	IN	O
fetal	fetal	ADJ	JJ	O
development	development	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
rates	rate	NOUN	NNS	O
of	of	ADP	IN	O
heavy	heavy	ADJ	JJ	O
drinking	drinking	NOUN	NN	O
during	during	ADP	IN	O
pregnancy	pregnancy	NOUN	NN	O
remain	remain	VERB	VBP	O
relatively	relatively	ADV	RB	O
unchanged	unchanged	ADJ	JJ	O
.	.	PUNCT	.	O

Early	early	ADJ	JJ	O
identification	identification	NOUN	NN	O
of	of	ADP	IN	O
fetal	fetal	ADJ	JJ	O
alcohol	alcohol	NOUN	NN	B-Chemical
exposure	exposure	NOUN	NN	O
and	and	CCONJ	CC	O
maternal	maternal	ADJ	JJ	O
abstinence	abstinence	NOUN	NN	O
led	lead	VERB	VBD	O
to	to	ADP	IN	O
better	well	ADJ	JJR	O
infant	infant	NOUN	NN	O
outcomes	outcome	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
examined	examine	VERB	VBD	O
the	the	DET	DT	O
utility	utility	NOUN	NN	O
of	of	ADP	IN	O
biometry	biometry	NOUN	NN	O
for	for	ADP	IN	O
detecting	detect	VERB	VBG	O
alcohol	alcohol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
fetal	fetal	ADJ	JJ	O
growth	growth	NOUN	NN	B-Disease
impairment	impairment	NOUN	NN	I-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
obtained	obtain	VERB	VBD	O
fetal	fetal	ADJ	JJ	O
ultrasound	ultrasound	ADJ	JJ	O
measures	measure	NOUN	NNS	O
from	from	ADP	IN	O
routine	routine	ADJ	JJ	O
ultrasound	ultrasound	ADJ	JJ	O
examinations	examination	NOUN	NNS	O
for	for	ADP	IN	O
167	167	NUM	CD	O
pregnant	pregnant	ADJ	JJ	O
hazardous	hazardous	ADJ	JJ	O
drinkers	drinker	NOUN	NNS	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
enrolled	enrol	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
brief	brief	ADJ	JJ	O
alcohol	alcohol	NOUN	NN	B-Chemical
intervention	intervention	NOUN	NN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
fetal	fetal	ADJ	JJ	O
measures	measure	NOUN	NNS	O
for	for	ADP	IN	O
women	woman	NOUN	NNS	O
who	who	PRON	WP	O
quit	quit	VERB	VBP	O
after	after	ADP	IN	O
learning	learn	VERB	VBG	O
of	of	ADP	IN	O
their	-PRON-	DET	PRP$	O
pregnancies	pregnancy	NOUN	NNS	O
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
measures	measure	NOUN	NNS	O
for	for	ADP	IN	O
women	woman	NOUN	NNS	O
who	who	PRON	WP	O
continued	continue	VERB	VBD	O
some	some	DET	DT	O
drinking	drinking	NOUN	NN	O
throughout	throughout	ADP	IN	O
the	the	DET	DT	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
their	-PRON-	DET	PRP$	O
pregnancies	pregnancy	NOUN	NNS	O
.	.	PUNCT	.	O

Because	because	ADP	IN	O
intensity	intensity	NOUN	NN	O
of	of	ADP	IN	O
alcohol	alcohol	NOUN	NN	B-Chemical
consumption	consumption	NOUN	NN	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
poorer	poor	ADJ	JJR	O
fetal	fetal	ADJ	JJ	O
outcomes	outcome	NOUN	NNS	O
,	,	PUNCT	,	O
separate	separate	ADJ	JJ	O
analyses	analysis	NOUN	NNS	O
were	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
heavy	heavy	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
average	average	ADJ	JJ	O
of	of	ADP	IN	O
>	>	X	XX	O
or	or	CCONJ	CC	O
=	=	VERB	VBZ	O
5	5	NUM	CD	O
drinks	drink	NOUN	NNS	O
per	per	ADP	IN	O
drinking	drinking	NOUN	NN	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
alcohol	alcohol	NOUN	NN	B-Chemical
consumers	consumer	NOUN	NNS	O
.	.	PUNCT	.	O

Fetal	fetal	ADJ	JJ	O
measures	measure	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
heavy	heavy	ADV	RB	O
-	-	PUNCT	HYPH	O
exposed	expose	VERB	VBN	O
fetuses	fetus	NOUN	NNS	O
were	be	VERB	VBD	O
also	also	ADV	RB	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
measures	measure	NOUN	NNS	O
from	from	ADP	IN	O
a	a	DET	DT	O
nondrinking	nondrinking	NOUN	NN	O
group	group	NOUN	NN	O
that	that	DET	WDT	O
was	be	VERB	VBD	O
representative	representative	NOUN	NN	O
of	of	ADP	IN	O
normal	normal	ADJ	JJ	O
,	,	PUNCT	,	O
uncomplicated	uncomplicated	ADJ	JJ	O
pregnancies	pregnancy	NOUN	NNS	O
from	from	ADP	IN	O
our	-PRON-	DET	PRP$	O
clinics	clinic	NOUN	NNS	O
.	.	PUNCT	.	O

Analyses	analysis	NOUN	NNS	O
of	of	ADP	IN	O
covariance	covariance	NOUN	NN	O
were	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
whether	whether	ADP	IN	O
there	there	ADV	EX	O
were	be	VERB	VBD	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
groups	group	NOUN	NNS	O
after	after	ADP	IN	O
controlling	control	VERB	VBG	O
for	for	ADP	IN	O
influences	influence	NOUN	NNS	O
of	of	ADP	IN	O
gestational	gestational	ADJ	JJ	O
age	age	NOUN	NN	O
and	and	CCONJ	CC	O
drug	drug	NOUN	NN	B-Disease
abuse	abuse	NOUN	NN	I-Disease
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Nearly	nearly	ADV	RB	O
half	half	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
pregnant	pregnant	ADJ	JJ	O
drinkers	drinker	NOUN	NNS	O
abstained	abstain	VERB	VBD	O
after	after	ADP	IN	O
learning	learn	VERB	VBG	O
of	of	ADP	IN	O
their	-PRON-	DET	PRP$	O
pregnancies	pregnancy	NOUN	NNS	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
women	woman	NOUN	NNS	O
reportedly	reportedly	ADV	RB	O
quit	quit	VERB	VBP	O
drinking	drink	VERB	VBG	O
early	early	ADV	RB	O
in	in	ADP	IN	O
their	-PRON-	DET	PRP$	O
pregnancies	pregnancy	NOUN	NNS	O
,	,	PUNCT	,	O
fetal	fetal	ADJ	JJ	O
growth	growth	NOUN	NN	O
measures	measure	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
different	different	ADJ	JJ	O
from	from	ADP	IN	O
a	a	DET	DT	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
alcohol	alcohol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
exposed	expose	VERB	VBN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
regardless	regardless	ADV	RB	O
of	of	ADP	IN	O
prior	prior	ADJ	JJ	O
drinking	drinking	NOUN	NN	O
patterns	pattern	NOUN	NNS	O
.	.	PUNCT	.	O

Any	any	DET	DT	O
alcohol	alcohol	NOUN	NN	B-Chemical
consumption	consumption	NOUN	NN	O
postpregnancy	postpregnancy	NOUN	NN	O
recognition	recognition	NOUN	NN	O
among	among	ADP	IN	O
the	the	DET	DT	O
heavy	heavy	ADJ	JJ	O
drinkers	drinker	NOUN	NNS	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
reduced	reduce	VERB	VBN	B-Disease
cerebellar	cerebellar	ADJ	JJ	I-Disease
growth	growth	NOUN	NN	I-Disease
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
decreased	decrease	VERB	VBN	B-Disease
cranial	cranial	NOUN	NN	I-Disease
to	to	ADP	IN	I-Disease
body	body	NOUN	NN	I-Disease
growth	growth	NOUN	NN	I-Disease
in	in	ADP	IN	O
comparison	comparison	NOUN	NN	O
with	with	ADP	IN	O
women	woman	NOUN	NNS	O
who	who	PRON	WP	O
either	either	CCONJ	CC	O
quit	quit	VERB	VBD	O
drinking	drinking	NOUN	NN	O
or	or	CCONJ	CC	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
nondrinkers	nondrinker	NOUN	NNS	O
.	.	PUNCT	.	O

Amphetamine	Amphetamine	PROPN	NNP	B-Chemical
abuse	abuse	NOUN	NN	O
was	be	VERB	VBD	O
predictive	predictive	ADJ	JJ	O
of	of	ADP	IN	O
larger	large	ADJ	JJR	O
cranial	cranial	NOUN	NN	O
to	to	ADP	IN	O
body	body	NOUN	NN	O
growth	growth	NOUN	NN	O
ratios	ratio	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
fetal	fetal	ADJ	JJ	O
biometric	biometric	ADJ	JJ	O
measurements	measurement	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
among	among	ADP	IN	O
the	the	DET	DT	O
heavy	heavy	ADJ	JJ	O
drinkers	drinker	NOUN	NNS	O
only	only	ADV	RB	O
when	when	ADV	WRB	O
they	-PRON-	PRON	PRP	O
continued	continue	VERB	VBD	O
drinking	drink	VERB	VBG	O
after	after	ADP	IN	O
becoming	become	VERB	VBG	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
their	-PRON-	DET	PRP$	O
pregnancies	pregnancy	NOUN	NNS	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
the	the	DET	DT	O
reliance	reliance	NOUN	NN	O
on	on	ADP	IN	O
self	self	NOUN	NN	O
-	-	PUNCT	HYPH	O
reported	report	VERB	VBN	O
drinking	drinking	NOUN	NN	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
limitation	limitation	NOUN	NN	O
in	in	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
these	these	DET	DT	O
findings	finding	NOUN	NNS	O
support	support	VERB	VBP	O
the	the	DET	DT	O
benefits	benefit	NOUN	NNS	O
of	of	ADP	IN	O
early	early	ADJ	JJ	O
abstinence	abstinence	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
potential	potential	NOUN	NN	O
for	for	ADP	IN	O
ultrasound	ultrasound	ADJ	JJ	O
examinations	examination	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
detection	detection	NOUN	NN	O
of	of	ADP	IN	O
fetal	fetal	ADJ	JJ	O
alcohol	alcohol	NOUN	NN	B-Chemical
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

Ethambutol	Ethambutol	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

INTRODUCTION	INTRODUCTION	PROPN	NNP	O
:	:	PUNCT	:	O
Ethambutol	Ethambutol	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
tuberculosis	tuberculosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
still	still	ADV	RB	O
prevalent	prevalent	ADJ	JJ	O
in	in	ADP	IN	O
Southeast	Southeast	PROPN	NNP	O
Asia	Asia	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
can	can	VERB	MD	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
permanent	permanent	ADJ	JJ	O
visual	visual	ADJ	JJ	B-Disease
loss	loss	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
3	3	NUM	CD	O
cases	case	NOUN	NNS	O
which	which	DET	WDT	O
presented	present	VERB	VBD	O
with	with	ADP	IN	O
bitemporal	bitemporal	ADJ	JJ	B-Disease
hemianopia	hemianopia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

CLINICAL	CLINICAL	PROPN	NNP	O
PICTURE	PICTURE	PROPN	NNP	O
:	:	PUNCT	:	O
Three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
toxic	toxic	ADJ	JJ	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
are	be	VERB	VBP	O
described	describe	VERB	VBN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
loss	loss	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
central	central	ADJ	JJ	I-Disease
visual	visual	ADJ	JJ	I-Disease
acuity	acuity	NOUN	NN	I-Disease
,	,	PUNCT	,	I-Disease
colour	colour	NOUN	NN	I-Disease
vision	vision	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	I-Disease
Ishihara	Ishihara	PROPN	NNP	I-Disease
)	)	PUNCT	-RRB-	I-Disease
and	and	CCONJ	CC	I-Disease
visual	visual	ADJ	JJ	I-Disease
field	field	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
visual	visual	ADJ	JJ	B-Disease
field	field	NOUN	NN	I-Disease
loss	loss	NOUN	NN	I-Disease
had	have	VERB	VBD	O
a	a	DET	DT	O
bitemporal	bitemporal	ADJ	JJ	O
flavour	flavour	NOUN	NN	O
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
involvement	involvement	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
optic	optic	ADJ	JJ	O
chiasm	chiasm	NOUN	NN	O
.	.	PUNCT	.	O

TREATMENT	treatment	NOUN	NN	O
:	:	PUNCT	:	O
Despite	despite	ADP	IN	O
stopping	stop	VERB	VBG	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
on	on	ADP	IN	O
diagnosis	diagnosis	NOUN	NN	O
,	,	PUNCT	,	O
visual	visual	ADJ	JJ	O
function	function	NOUN	NN	O
continued	continue	VERB	VBD	O
to	to	PART	TO	O
deteriorate	deteriorate	VERB	VB	O
for	for	ADP	IN	O
a	a	DET	DT	O
few	few	ADJ	JJ	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Subsequent	subsequent	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
was	be	VERB	VBD	O
mild	mild	ADJ	JJ	O
in	in	ADP	IN	O
2	2	NUM	CD	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
third	third	ADJ	JJ	O
case	case	NOUN	NN	O
,	,	PUNCT	,	O
visual	visual	ADJ	JJ	O
acuity	acuity	NOUN	NN	O
and	and	CCONJ	CC	O
colour	colour	NOUN	NN	O
vision	vision	NOUN	NN	O
normalised	normalise	VERB	VBN	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
optic	optic	ADJ	JJ	O
discs	discs	NOUN	NN	O
were	be	VERB	VBD	O
pale	pale	ADJ	JJ	O
.	.	PUNCT	.	O

OUTCOME	outcome	NOUN	NN	O
:	:	PUNCT	:	O
All	all	DET	DT	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
some	some	DET	DT	O
permanent	permanent	ADJ	JJ	O
loss	loss	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
visual	visual	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Ethambutol	Ethambutol	PROPN	NNP	B-Chemical
usage	usage	NOUN	NN	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
permanent	permanent	ADJ	JJ	O
visual	visual	ADJ	JJ	B-Disease
loss	loss	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
should	should	VERB	MD	O
be	be	VERB	VB	O
avoided	avoid	VERB	VBN	O
if	if	ADP	IN	O
possible	possible	ADJ	JJ	O
or	or	CCONJ	CC	O
used	use	VERB	VBN	O
with	with	ADP	IN	O
caution	caution	NOUN	NN	O
and	and	CCONJ	CC	O
proper	proper	ADJ	JJ	O
ophthalmological	ophthalmological	ADJ	JJ	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
author	author	NOUN	NN	O
postulates	postulate	VERB	VBZ	O
that	that	DET	WDT	O
in	in	ADP	IN	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
associated	associate	VERB	VBN	O
chiasmopathy	chiasmopathy	NOUN	NN	O
,	,	PUNCT	,	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
may	may	VERB	MD	O
initially	initially	ADV	RB	O
affect	affect	VERB	VB	O
the	the	DET	DT	O
optic	optic	ADJ	JJ	O
nerves	nerve	NOUN	NNS	O
and	and	CCONJ	CC	O
subsequently	subsequently	ADV	RB	O
progress	progress	VERB	VBP	O
to	to	PART	TO	O
involve	involve	VERB	VB	O
the	the	DET	DT	O
optic	optic	ADJ	JJ	O
chiasm	chiasm	NOUN	NN	O
.	.	PUNCT	.	O

Possible	possible	ADJ	JJ	O
neuroleptic	neuroleptic	ADJ	JJ	B-Disease
malignant	malignant	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
related	relate	VERB	VBN	O
to	to	ADP	IN	O
concomitant	concomitant	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
paroxetine	paroxetine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
alprazolam	alprazolam	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
74	74	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
with	with	ADP	IN	O
depressive	depressive	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
was	be	VERB	VBD	O
admitted	admit	VERB	VBN	O
to	to	ADP	IN	O
a	a	DET	DT	O
psychiatric	psychiatric	ADJ	JJ	B-Disease
hospital	hospital	NOUN	NN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
insomnia	insomnia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
loss	loss	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
appetite	appetite	NOUN	NN	I-Disease
,	,	PUNCT	,	O
exhaustion	exhaustion	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
agitation	agitation	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Medical	medical	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
was	be	VERB	VBD	O
initiated	initiate	VERB	VBN	O
at	at	ADP	IN	O
a	a	DET	DT	O
daily	daily	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
paroxetine	paroxetine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
alprazolam	alprazolam	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
10th	10th	ADJ	JJ	O
day	day	NOUN	NN	O
of	of	ADP	IN	O
paroxetine	paroxetine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
alprazolam	alprazolam	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
exhibited	exhibit	VERB	VBD	O
marked	mark	VERB	VBN	O
psychomotor	psychomotor	NOUN	NN	B-Disease
retardation	retardation	NOUN	NN	I-Disease
,	,	PUNCT	,	O
disorientation	disorientation	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
severe	severe	ADJ	JJ	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
with	with	ADP	IN	O
tremors	tremor	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
a	a	DET	DT	O
fever	fever	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
38	38	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
degrees	degree	NOUN	NNS	O
C	C	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
fluctuating	fluctuate	VERB	VBG	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
(	(	PUNCT	-LRB-	O
between	between	ADP	IN	O
165	165	NUM	CD	O
/	/	SYM	SYM	O
90	90	NUM	CD	O
and	and	CCONJ	CC	O
130	130	NUM	CD	O
/	/	SYM	SYM	O
70	70	NUM	CD	O
mg	mg	NOUN	NN	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
severe	severe	ADJ	JJ	O
extrapyramidal	extrapyramidal	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Laboratory	laboratory	NOUN	NN	O
tests	test	NOUN	NNS	O
showed	show	VERB	VBD	O
an	an	DET	DT	O
elevation	elevation	NOUN	NN	O
of	of	ADP	IN	O
creatine	creatine	NOUN	NN	B-Chemical
phosphokinase	phosphokinase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2218	2218	NUM	CD	O
IU	IU	PROPN	NNP	O
/	/	SYM	SYM	O
L	L	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
aspartate	aspartate	VERB	VB	B-Chemical
aminotransferase	aminotransferase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
134	134	NUM	CD	O
IU	IU	PROPN	NNP	O
/	/	SYM	SYM	O
L	L	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
alanine	alanine	NOUN	NN	B-Chemical
aminotransferase	aminotransferase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
78	78	NUM	CD	O
IU	IU	PROPN	NNP	O
/	/	SYM	SYM	O
L	L	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
BUN	BUN	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
27	27	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
)	)	PUNCT	-RRB-	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
received	receive	VERB	VBD	O
bromocriptine	bromocriptine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
diazepam	diazepam	NOUN	NN	B-Chemical
to	to	PART	TO	O
treat	treat	VERB	VB	O
his	-PRON-	DET	PRP$	O
symptoms	symptom	NOUN	NNS	O
.	.	PUNCT	.	O

7	7	NUM	CD	O
days	day	NOUN	NNS	O
later	later	ADV	RBR	O
,	,	PUNCT	,	O
the	the	DET	DT	O
fever	fever	NOUN	NN	B-Disease
disappeared	disappear	VERB	VBD	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	VERB	VBZ	O
serum	serum	ADJ	JJ	O
CPK	CPK	PROPN	NNP	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
normalized	normalize	VERB	VBN	O
(	(	PUNCT	-LRB-	O
175	175	NUM	CD	O
IU	IU	PROPN	NNP	O
/	/	SYM	SYM	O
L	L	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

This	this	DET	DT	O
patient	patient	NOUN	NN	O
presented	present	VERB	VBD	O
with	with	ADP	IN	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	B-Disease
malignant	malignant	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
NMS	NMS	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
thus	thus	ADV	RB	O
demonstrating	demonstrate	VERB	VBG	O
that	that	ADP	IN	O
NMS	nms	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
can	can	VERB	MD	O
occur	occur	VERB	VB	O
after	after	ADP	IN	O
combined	combined	ADJ	JJ	O
paroxetine	paroxetine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
alprazolam	alprazolam	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
adverse	adverse	ADJ	JJ	O
drug	drug	NOUN	NN	O
reaction	reaction	NOUN	NN	O
score	score	NOUN	NN	O
obtained	obtain	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
Naranjo	Naranjo	PROPN	NNP	O
algorithm	algorithm	NOUN	NN	O
was	be	VERB	VBD	O
6	6	NUM	CD	O
in	in	ADP	IN	O
our	-PRON-	DET	PRP$	O
case	case	NOUN	NN	O
,	,	PUNCT	,	O
indicating	indicate	VERB	VBG	O
a	a	DET	DT	O
probable	probable	ADJ	JJ	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	VERB	VBZ	O
NMS	nms	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
combined	combined	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
this	this	DET	DT	O
case	case	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
involvement	involvement	NOUN	NN	O
of	of	ADP	IN	O
physiologic	physiologic	NOUN	NN	O
and	and	CCONJ	CC	O
environmental	environmental	ADJ	JJ	O
aspects	aspect	NOUN	NNS	O
specific	specific	ADJ	JJ	O
to	to	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
suspected	suspect	VERB	VBN	O
.	.	PUNCT	.	O

Several	several	ADJ	JJ	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
for	for	ADP	IN	O
NMS	NMS	PROPN	NNP	B-Disease
should	should	VERB	MD	O
be	be	VERB	VB	O
noted	note	VERB	VBN	O
in	in	ADP	IN	O
elderly	elderly	ADJ	JJ	O
depressive	depressive	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
whose	whose	DET	WP$	O
symptoms	symptom	NOUN	NNS	O
often	often	ADV	RB	O
include	include	VERB	VBP	O
dehydration	dehydration	NOUN	NN	B-Disease
,	,	PUNCT	,	O
agitation	agitation	NOUN	NN	B-Disease
,	,	PUNCT	,	O
malnutrition	malnutrition	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
exhaustion	exhaustion	NOUN	NN	O
.	.	PUNCT	.	O

Careful	careful	ADJ	JJ	O
therapeutic	therapeutic	ADJ	JJ	O
intervention	intervention	NOUN	NN	O
is	be	VERB	VBZ	O
necessary	necessary	ADJ	JJ	O
in	in	ADP	IN	O
cases	case	NOUN	NNS	O
involving	involve	VERB	VBG	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
suffer	suffer	VERB	VBP	O
from	from	ADP	IN	O
depression	depression	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Down	down	ADP	IN	O
-	-	PUNCT	HYPH	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
transporter	transporter	NOUN	NN	O
function	function	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
chronic	chronic	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
desipramine	desipramine	NOUN	NN	B-Chemical
linking	linking	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
alteration	alteration	NOUN	NN	O
of	of	ADP	IN	O
sensitivity	sensitivity	NOUN	NN	O
of	of	ADP	IN	O
local	local	ADJ	JJ	O
-	-	PUNCT	HYPH	O
anesthetics	anesthetic	NOUN	NNS	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
the	the	DET	DT	O
counteraction	counteraction	NOUN	NN	O
by	by	ADP	IN	O
co	co	NOUN	NN	O
-	-	NOUN	NN	O
administration	administration	NOUN	NN	O
with	with	ADP	IN	O
local	local	ADJ	JJ	O
anesthetics	anesthetic	NOUN	NNS	O
.	.	PUNCT	.	O

Alterations	alteration	NOUN	NNS	O
of	of	ADP	IN	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
transporter	transporter	NOUN	NN	O
(	(	PUNCT	-LRB-	O
NET	net	NOUN	NN	O
)	)	PUNCT	-RRB-	O
function	function	NOUN	NN	O
by	by	ADP	IN	O
chronic	chronic	ADJ	JJ	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
NET	net	NOUN	NN	O
in	in	ADP	IN	O
relation	relation	NOUN	NN	O
to	to	PART	TO	O
sensitization	sensitization	NOUN	NN	O
to	to	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
induce	induce	VERB	VB	O
by	by	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
local	local	ADJ	JJ	O
anesthetics	anesthetic	NOUN	NNS	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Daily	daily	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
desipramine	desipramine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
an	an	DET	DT	O
inhibitor	inhibitor	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
NET	net	NOUN	NN	O
,	,	PUNCT	,	O
for	for	ADP	IN	O
5	5	NUM	CD	O
days	day	NOUN	NNS	O
decreased	decrease	VERB	VBD	O
[	[	PUNCT	-LRB-	O
(	(	PUNCT	-LRB-	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
H	h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
uptake	uptake	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
P2	P2	PROPN	NNP	O
fractions	fraction	NOUN	NNS	O
of	of	ADP	IN	O
hippocampus	hippocampus	NOUN	NN	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
cortex	cortex	NOUN	NN	O
,	,	PUNCT	,	O
striatum	striatum	NOUN	NN	O
or	or	CCONJ	CC	O
amygdalae	amygdalae	NOUN	NN	O
.	.	PUNCT	.	O

Co	co	NOUN	NN	O
-	-	NOUN	NN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
tricaine	tricaine	NOUN	NN	B-Chemical
with	with	ADP	IN	O
desipramine	desipramine	NOUN	NN	B-Chemical
reversed	reverse	VERB	VBD	O
this	this	DET	DT	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Daily	daily	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
increased	increase	VERB	VBD	O
[	[	PUNCT	-LRB-	O
(	(	PUNCT	-LRB-	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
H	h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
uptake	uptake	NOUN	NN	O
into	into	ADP	IN	O
the	the	DET	DT	O
hippocampus	hippocampus	NOUN	NN	O
.	.	PUNCT	.	O

Daily	daily	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
desipramine	desipramine	NOUN	NN	B-Chemical
increased	increase	VERB	VBD	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
appearance	appearance	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
decreased	decrease	VERB	VBD	O
that	that	DET	DT	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Co	co	NOUN	NN	O
-	-	NOUN	NN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
with	with	ADP	IN	O
desipramine	desipramine	NOUN	NN	B-Chemical
reversed	reverse	VERB	VBD	O
the	the	DET	DT	O
changes	change	NOUN	NNS	O
of	of	ADP	IN	O
convulsive	convulsive	ADJ	JJ	B-Disease
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
cocaine	cocaine	NOUN	NN	B-Chemical
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
repeated	repeat	VERB	VBN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
desipramine	desipramine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
down	down	ADP	IN	O
-	-	PUNCT	HYPH	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
hippocampal	hippocampal	ADJ	JJ	O
NET	net	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
chronic	chronic	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
desipramine	desipramine	NOUN	NN	B-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
relevant	relevant	ADJ	JJ	O
to	to	PART	TO	O
desipramine	desipramine	VERB	VB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
sensitization	sensitization	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
convulsions	convulsion	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
Na	Na	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
channels	channel	NOUN	NNS	O
by	by	ADP	IN	O
local	local	ADJ	JJ	O
anesthetics	anesthetic	NOUN	NNS	O
may	may	VERB	MD	O
regulate	regulate	VERB	VB	O
desipramine	desipramine	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
down	down	ADP	IN	O
-	-	PUNCT	HYPH	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
NET	net	NOUN	NN	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

Repeated	repeat	VERB	VBN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
induces	induce	VERB	VBZ	O
up	up	ADP	IN	O
-	-	PUNCT	HYPH	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
hippocampal	hippocampal	ADJ	JJ	O
NET	net	NOUN	NN	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

Desipramine	desipramine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
sensitization	sensitization	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
seizures	seizure	NOUN	NNS	B-Disease
may	may	VERB	MD	O
have	have	VERB	VB	O
a	a	DET	DT	O
mechanism	mechanism	NOUN	NN	O
distinct	distinct	NOUN	NN	O
from	from	ADP	IN	O
kindling	kindle	VERB	VBG	O
resulting	result	VERB	VBG	O
from	from	ADP	IN	O
repeated	repeat	VERB	VBN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Atorvastatin	Atorvastatin	PROPN	NNP	B-Chemical
prevented	prevent	VERB	VBD	O
and	and	CCONJ	CC	O
reversed	reverse	VERB	VBD	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

To	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
antioxidant	antioxidant	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
atorvastatin	atorvastatin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
atorva	atorva	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
dex	dex	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypertension	hypertension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
60	60	NUM	CD	O
male	male	NOUN	NN	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
atorva	atorva	NOUN	NN	B-Chemical
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
or	or	CCONJ	CC	O
tap	tap	NOUN	NN	O
water	water	NOUN	NN	O
for	for	ADP	IN	O
15	15	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Dex	dex	VERB	VB	B-Chemical
increased	increase	VERB	VBD	O
systolic	systolic	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SBP	SBP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
from	from	ADP	IN	O
109	109	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
to	to	ADP	IN	O
135	135	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
mmHg	mmHg	NOUN	NNS	O
and	and	CCONJ	CC	O
plasma	plasma	VERB	VB	O
superoxide	superoxide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5711	5711	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
284	284	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
saline	saline	NOUN	NN	O
,	,	PUNCT	,	O
7931	7931	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
392	392	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
U	u	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
dex	dex	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
prevention	prevention	NOUN	NN	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
SBP	SBP	PROPN	NNP	O
in	in	ADP	IN	O
the	the	DET	DT	O
atorva	atorva	NOUN	NN	B-Chemical
+	+	PUNCT	-LRB-	O
dex	dex	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
from	from	ADP	IN	O
115	115	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
to	to	ADP	IN	O
124	124	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mmHg	mmhg	SYM	SYM	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
this	this	DET	DT	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
dex	dex	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
only	only	ADJ	JJ	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
'	'	PUNCT	''	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Atorva	Atorva	PROPN	NNP	B-Chemical
reversed	reverse	VERB	VBN	O
dex	dex	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypertension	hypertension	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
129	129	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
mmHg	mmhg	SYM	SYM	O
,	,	PUNCT	,	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
135	135	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
mmHg	mmhg	SYM	SYM	O
P	p	NOUN	NN	O
'	'	PUNCT	''	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
decreased	decrease	VERB	VBD	O
plasma	plasma	NOUN	NN	O
superoxide	superoxide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
7931	7931	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
392	392	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
dex	dex	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
1187	1187	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
441	441	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
atorva	atorva	NOUN	NN	B-Chemical
+	+	CCONJ	CC	O
dex	dex	VERB	VB	B-Chemical
,	,	PUNCT	,	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0001	0001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Plasma	Plasma	PROPN	NNP	O
nitrate	nitrate	NOUN	NN	B-Chemical
/	/	SYM	SYM	O
nitrite	nitrite	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
NOx	NOx	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
in	in	ADP	IN	O
dex	dex	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
saline	saline	NOUN	NN	O
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
08	08	NUM	CD	O
microm	microm	NOUN	NN	O
,	,	PUNCT	,	O
15	15	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
17	17	NUM	CD	O
microm	microm	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Atorva	Atorva	PROPN	NNP	B-Chemical
affected	affect	VERB	VBD	O
neither	neither	CCONJ	CC	O
plasma	plasma	NOUN	NN	O
NOx	NOx	NOUN	NNS	O
nor	nor	CCONJ	CC	O
thymus	thymus	ADJ	JJ	O
weight	weight	NOUN	NN	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
atorvastatin	atorvastatin	ADV	RB	B-Chemical
prevented	prevent	VERB	VBN	O
and	and	CCONJ	CC	O
reversed	reverse	VERB	VBD	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

Peripheral	peripheral	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
cytosine	cytosine	NOUN	NN	B-Chemical
arabinoside	arabinoside	NOUN	NN	I-Chemical
treatment	treatment	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
myeloid	myeloid	ADJ	JJ	I-Disease
leukemia	leukemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
central	central	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
cytosine	cytosine	NOUN	NN	B-Chemical
arabinoside	arabinoside	NOUN	NN	I-Chemical
is	be	VERB	VBZ	O
well	well	ADV	RB	O
recognized	recognize	VERB	VBN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
cytosine	cytosine	ADJ	JJ	B-Chemical
arabinoside	arabinoside	NOUN	NN	I-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
infrequently	infrequently	ADV	RB	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
49	49	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
Japanese	japanese	ADJ	JJ	O
man	man	NOUN	NN	O
was	be	VERB	VBD	O
diagnosed	diagnose	VERB	VBN	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
myeloid	myeloid	ADJ	JJ	I-Disease
leukemia	leukemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

After	after	ADP	IN	O
he	-PRON-	PRON	PRP	O
achieved	achieve	VERB	VBD	O
complete	complete	ADJ	JJ	O
remission	remission	NOUN	NN	O
,	,	PUNCT	,	O
he	-PRON-	PRON	PRP	O
received	receive	VERB	VBD	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
cytosine	cytosine	NOUN	NN	B-Chemical
arabinoside	arabinoside	NOUN	NN	I-Chemical
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
twice	twice	ADV	RB	O
a	a	DET	DT	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
5	5	NUM	CD	O
days	day	NOUN	NNS	O
;	;	PUNCT	:	O
total	total	NOUN	NN	O
,	,	PUNCT	,	O
20	20	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
)	)	PUNCT	-RRB-	O
as	as	ADP	IN	O
consolidation	consolidation	NOUN	NN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
first	first	ADJ	JJ	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
cytosine	cytosine	NOUN	NN	B-Chemical
arabinoside	arabinoside	NOUN	NN	I-Chemical
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
no	no	DET	DT	O
unusual	unusual	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
on	on	ADP	IN	O
day	day	NOUN	NN	O
21	21	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
second	second	ADJ	JJ	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
complained	complain	VERB	VBD	O
of	of	ADP	IN	O
numbness	numbness	NOUN	NN	B-Disease
in	in	ADP	IN	O
his	-PRON-	DET	PRP$	O
right	right	ADJ	JJ	O
foot	foot	NOUN	NN	O
.	.	PUNCT	.	O

Electromyogram	Electromyogram	PROPN	NNP	O
and	and	CCONJ	CC	O
nerve	nerve	NOUN	NN	O
-	-	PUNCT	HYPH	O
conduction	conduction	NOUN	NN	O
studies	study	NOUN	NNS	O
showed	show	VERB	VBD	O
peripheral	peripheral	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
in	in	ADP	IN	O
both	both	DET	DT	O
peroneal	peroneal	NOUN	NN	O
nerves	nerve	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
neuropathy	neuropathy	NOUN	NN	B-Disease
was	be	VERB	VBD	O
gradually	gradually	ADV	RB	O
resolving	resolve	VERB	VBG	O
;	;	PUNCT	:	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
after	after	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
received	receive	VERB	VBD	O
allogeneic	allogeneic	ADJ	JJ	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
symptoms	symptom	NOUN	NNS	O
worsened	worsen	VERB	VBD	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
graft	graft	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
versus	versus	ADP	IN	I-Disease
-	-	PUNCT	HYPH	I-Disease
host	host	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
symptoms	symptom	NOUN	NNS	O
subsequently	subsequently	ADV	RB	O
responded	respond	VERB	VBD	O
to	to	ADP	IN	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Although	although	ADP	IN	O
the	the	DET	DT	O
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
peripheral	peripheral	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
are	be	VERB	VBP	O
still	still	ADV	RB	O
unclear	unclear	ADJ	JJ	O
,	,	PUNCT	,	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
cytosine	cytosine	NOUN	NN	B-Chemical
arabinoside	arabinoside	NOUN	NN	I-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
therapy	therapy	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
potentially	potentially	ADV	RB	O
toxic	toxic	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
auto	auto	NOUN	NN	O
/	/	SYM	SYM	O
alloimmunity	alloimmunity	NOUN	NN	O
may	may	VERB	MD	O
play	play	VERB	VB	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
mechanisms	mechanism	NOUN	NNS	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
tocopherol	tocopherol	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
deferoxamine	deferoxamine	VERB	VB	B-Chemical
on	on	ADP	IN	O
methamphetamine	methamphetamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Methamphetamine	Methamphetamine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
MA	MA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
dopaminergic	dopaminergic	ADJ	JJ	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
believed	believe	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
increased	increase	VERB	VBN	O
formation	formation	NOUN	NN	O
of	of	ADP	IN	O
free	free	ADJ	JJ	O
radicals	radical	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
examined	examine	VERB	VBD	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
tocopherol	tocopherol	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
TC	TC	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
scavenger	scavenger	NOUN	NN	O
of	of	ADP	IN	O
reactive	reactive	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
species	specie	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
deferoxamine	deferoxamine	VERB	VB	B-Chemical
(	(	PUNCT	-LRB-	O
DFO	DFO	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
an	an	DET	DT	O
iron	iron	NOUN	NN	B-Chemical
chelator	chelator	NOUN	NN	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
the	the	DET	DT	O
MA	MA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
MA	MA	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
every	every	DET	DT	O
2	2	NUM	CD	O
h	h	NOUN	NN	O
for	for	ADP	IN	O
four	four	NUM	CD	O
injections	injection	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
rat	rat	NOUN	NN	O
received	receive	VERB	VBD	O
either	either	CCONJ	CC	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
TC	tc	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
intraperitoneally	intraperitoneally	ADV	RB	O
for	for	ADP	IN	O
3	3	NUM	CD	O
days	day	NOUN	NNS	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
MA	MA	PROPN	NNP	B-Chemical
administration	administration	NOUN	NN	O
or	or	CCONJ	CC	O
DFO	DFO	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
subcutaneously	subcutaneously	ADV	RB	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
MA	MA	PROPN	NNP	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DA	DA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
serotonin	serotonin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
their	-PRON-	DET	PRP$	O
metabolites	metabolite	NOUN	NNS	O
decreased	decrease	VERB	VBD	O
significantly	significantly	ADV	RB	O
after	after	ADP	IN	O
MA	MA	PROPN	NNP	B-Chemical
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
inhibited	inhibit	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
TC	tc	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
DFO	DFO	PROPN	NNP	B-Chemical
pretreatment	pretreatment	NOUN	NN	O
.	.	PUNCT	.	O

alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	:	I-Chemical
TC	tc	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
DFO	DFO	PROPN	NNP	B-Chemical
attenuated	attenuate	VERB	VBD	O
the	the	DET	DT	O
MA	MA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperthermia	hyperthermia	NOUN	NN	B-Disease
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
the	the	DET	DT	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
locomotor	locomotor	NOUN	NN	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
lipid	lipid	NOUN	NN	O
peroxidation	peroxidation	NOUN	NN	O
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
reduced	reduced	ADJ	JJ	O
glutathione	glutathione	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
was	be	VERB	VBD	O
lower	low	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
MA	ma	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
changes	change	NOUN	NNS	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
attenuated	attenuate	VERB	VBN	O
by	by	ADP	IN	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
TC	tc	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
DFO	DFO	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
TC	tc	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
DFO	DFO	PROPN	NNP	B-Chemical
ameliorate	ameliorate	VERB	VBP	O
the	the	DET	DT	O
MA	ma	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
neuronal	neuronal	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
by	by	ADP	IN	O
decreasing	decrease	VERB	VBG	O
the	the	DET	DT	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
.	.	PUNCT	.	O

Blockade	Blockade	PROPN	NNP	O
of	of	ADP	IN	O
both	both	CCONJ	CC	O
D	D	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
D	D	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
dopamine	dopamine	NOUN	NN	B-Chemical
receptors	receptor	NOUN	NNS	O
may	may	VERB	MD	O
induce	induce	VERB	VB	O
catalepsy	catalepsy	NOUN	NN	B-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

1	1	PUNCT	LS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
antagonists	antagonist	NOUN	NNS	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
tested	test	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
possible	possible	ADJ	JJ	O
dopamine	dopamine	NOUN	NN	B-Chemical
subtypes	subtype	NOUN	NNS	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
was	be	VERB	VBD	O
determined	determine	VERB	VBN	O
.	.	PUNCT	.	O

2	2	PUNCT	LS	O
.	.	PUNCT	.	O

Dopamine	dopamine	NOUN	NN	B-Chemical
antagonist	antagonist	NOUN	NN	O
fluphenazine	fluphenazine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
D	D	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
antagonist	antagonist	NOUN	NN	O
SCH	SCH	PROPN	NNP	B-Chemical
23390	23390	NUM	CD	I-Chemical
or	or	CCONJ	CC	O
D	D	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
antagonist	antagonist	NOUN	NN	O
sulpiride	sulpiride	NOUN	NN	B-Chemical
induced	induce	VERB	VBN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
fluphenazine	fluphenazine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
sulpiride	sulpiride	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
.	.	PUNCT	.	O

Combination	combination	NOUN	NN	O
of	of	ADP	IN	O
SCH	SCH	PROPN	NNP	B-Chemical
23390	23390	NUM	CD	I-Chemical
with	with	ADP	IN	O
sulpiride	sulpiride	NOUN	NN	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
induce	induce	VERB	VB	O
catalepsy	catalepsy	NOUN	NN	B-Disease
potentiation	potentiation	NOUN	NN	O
.	.	PUNCT	.	O

3	3	PUNCT	LS	O
.	.	PUNCT	.	O

D	D	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
agonist	agonist	NOUN	NN	O
SKF	SKF	PROPN	NNP	B-Chemical
38393	38393	NUM	CD	I-Chemical
or	or	CCONJ	CC	O
D	D	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
agonist	agonist	NOUN	NN	O
quinpirole	quinpirole	NOUN	NN	B-Chemical
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
fluphenazine	fluphenazine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
SCH	SCH	PROPN	NNP	B-Chemical
23390	23390	NUM	CD	I-Chemical
or	or	CCONJ	CC	O
sulpiride	sulpiride	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

4	4	PUNCT	LS	O
.	.	PUNCT	.	O

Combination	combination	NOUN	NN	O
of	of	ADP	IN	O
SKF	SKF	PROPN	NNP	B-Chemical
38393	38393	NUM	CD	I-Chemical
with	with	ADP	IN	O
quinpirole	quinpirole	NOUN	NN	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
cause	cause	VERB	VB	O
potentiated	potentiate	VERB	VBN	O
inhibitory	inhibitory	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
antagonists	antagonist	NOUN	NNS	O
.	.	PUNCT	.	O

5	5	PUNCT	LS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
data	datum	NOUN	NNS	O
may	may	VERB	MD	O
indicate	indicate	VERB	VB	O
that	that	ADP	IN	O
although	although	ADP	IN	O
D	D	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
receptor	receptor	NOUN	NN	O
blockade	blockade	NOUN	NN	O
is	be	VERB	VBZ	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
D	D	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
receptor	receptor	NOUN	NN	O
may	may	VERB	MD	O
plan	plan	VERB	VB	O
a	a	DET	DT	O
role	role	NOUN	NN	O
.	.	PUNCT	.	O

Sustained	sustained	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
decompensated	decompensated	ADJ	JJ	O
hepatitis	hepatitis	NOUN	NN	B-Disease
B	B	PROPN	NNP	I-Disease
virus	virus	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
cirrhosis	cirrhosis	NOUN	NN	B-Disease
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
lamivudine	lamivudine	ADJ	JJ	B-Chemical
monotherapy	monotherapy	NOUN	NN	O
.	.	PUNCT	.	O

Hepatitis	Hepatitis	PROPN	NNP	B-Disease
B	B	PROPN	NNP	I-Disease
virus	virus	PROPN	NNP	I-Disease
(	(	PUNCT	-LRB-	I-Disease
HBV	HBV	PROPN	NNP	I-Disease
)	)	PUNCT	-RRB-	I-Disease
infection	infection	NOUN	NN	I-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
causes	cause	VERB	VBZ	O
liver	liver	NOUN	NN	B-Disease
cirrhosis	cirrhosis	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
hepatocellular	hepatocellular	ADJ	JJ	B-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
,	,	PUNCT	,	O
remains	remain	VERB	VBZ	O
a	a	DET	DT	O
major	major	ADJ	JJ	O
health	health	NOUN	NN	O
problem	problem	NOUN	NN	O
in	in	ADP	IN	O
Asian	asian	ADJ	JJ	O
countries	country	NOUN	NNS	O
.	.	PUNCT	.	O

Recent	recent	ADJ	JJ	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
vaccine	vaccine	NOUN	NN	O
for	for	ADP	IN	O
prevention	prevention	NOUN	NN	O
is	be	VERB	VBZ	O
reported	report	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
successful	successful	ADJ	JJ	O
in	in	ADP	IN	O
reducing	reduce	VERB	VBG	O
the	the	DET	DT	O
size	size	NOUN	NN	O
of	of	ADP	IN	O
chronically	chronically	ADV	RB	O
infected	infect	VERB	VBN	O
carriers	carrier	NOUN	NNS	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
the	the	DET	DT	O
standard	standard	ADJ	JJ	O
medical	medical	ADJ	JJ	O
therapies	therapy	NOUN	NNS	O
have	have	VERB	VBP	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
established	establish	VERB	VBN	O
up	up	PART	RP	O
to	to	ADP	IN	O
now	now	ADV	RB	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
report	report	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
encountered	encounter	VERB	VBD	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
decompensated	decompensated	ADJ	JJ	O
HBV	HBV	PROPN	NNP	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
cirrhosis	cirrhosis	NOUN	NN	B-Disease
who	who	PRON	WP	O
exhibited	exhibit	VERB	VBD	O
the	the	DET	DT	O
dramatic	dramatic	ADJ	JJ	O
improvements	improvement	NOUN	NNS	O
after	after	ADP	IN	O
antiviral	antiviral	NOUN	NN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
a	a	DET	DT	O
50	50	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
.	.	PUNCT	.	O

Previous	previous	ADJ	JJ	O
conventional	conventional	ADJ	JJ	O
medical	medical	ADJ	JJ	O
treatments	treatment	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
effective	effective	ADJ	JJ	O
for	for	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
,	,	PUNCT	,	O
thus	thus	ADV	RB	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
referred	refer	VERB	VBN	O
to	to	ADP	IN	O
our	-PRON-	DET	PRP$	O
hospital	hospital	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
lamivudine	lamivudine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
reverse	reverse	ADJ	JJ	O
transcriptase	transcriptase	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
,	,	PUNCT	,	O
for	for	ADP	IN	O
23	23	NUM	CD	O
months	month	NOUN	NNS	O
dramatically	dramatically	ADV	RB	O
improved	improve	VERB	VBD	O
her	-PRON-	DET	PRP$	O
liver	liver	NOUN	NN	O
severity	severity	NOUN	NN	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
this	this	DET	DT	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
no	no	DET	DT	O
drug	drug	NOUN	NN	O
resistant	resistant	ADJ	JJ	O
mutant	mutant	ADJ	JJ	O
HBV	HBV	PROPN	NNP	O
emerged	emerge	VERB	VBD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
serum	serum	ADJ	JJ	O
HBV	HBV	PROPN	NNP	O
-	-	PUNCT	HYPH	O
DNA	DNA	PROPN	NNP	O
level	level	NOUN	NN	O
was	be	VERB	VBD	O
continuously	continuously	ADV	RB	O
suppressed	suppress	VERB	VBN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
virological	virological	ADJ	JJ	O
responses	response	NOUN	NNS	O
were	be	VERB	VBD	O
also	also	ADV	RB	O
maintained	maintain	VERB	VBN	O
even	even	ADV	RB	O
after	after	ADP	IN	O
the	the	DET	DT	O
antiviral	antiviral	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
was	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
both	both	DET	DT	O
hepatitis	hepatitis	PROPN	NNP	B-Chemical
B	B	PROPN	NNP	I-Chemical
surface	surface	NOUN	NN	I-Chemical
antigen	antigen	NOUN	NN	I-Chemical
and	and	CCONJ	CC	I-Chemical
e	e	NOUN	NN	I-Chemical
antigen	antigen	NOUN	NN	I-Chemical
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
disappeared	disappear	VERB	VBN	O
in	in	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
lamivudine	lamivudine	NOUN	NN	B-Chemical
to	to	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
HBV	HBV	PROPN	NNP	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
cirrhosis	cirrhosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
like	like	ADP	IN	O
our	-PRON-	DET	PRP$	O
present	present	ADJ	JJ	O
case	case	NOUN	NN	O
,	,	PUNCT	,	O
should	should	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
as	as	ADP	IN	O
an	an	DET	DT	O
initial	initial	ADJ	JJ	O
medical	medical	ADJ	JJ	O
therapeutic	therapeutic	ADJ	JJ	O
option	option	NOUN	NN	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
in	in	ADP	IN	O
countries	country	NOUN	NNS	O
where	where	ADV	WRB	O
liver	liver	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
reliably	reliably	ADV	RB	O
available	available	ADJ	JJ	O
.	.	PUNCT	.	O

Antiarrhythmic	antiarrhythmic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
optical	optical	ADJ	JJ	O
isomers	isomer	NOUN	NNS	O
of	of	ADP	IN	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
on	on	ADP	IN	O
canine	canine	NOUN	NN	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Antiarrhythmic	antiarrhythmic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
using	use	VERB	VBG	O
two	two	NUM	CD	O
canine	canine	NOUN	NN	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmia	arrhythmia	NOUN	NN	I-Disease
models	model	NOUN	NNS	O
.	.	PUNCT	.	O

Digitalis	digitalis	NOUN	NN	B-Chemical
arrhythmia	arrhythmia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
suppressed	suppress	VERB	VBN	O
by	by	ADP	IN	O
Na	Na	PROPN	NNP	B-Chemical
channel	channel	NOUN	NN	O
blockers	blocker	NOUN	NNS	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
intermittent	intermittent	ADJ	JJ	O
intravenous	intravenous	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
ouabain	ouabain	NOUN	NN	B-Chemical
in	in	ADP	IN	O
pentobarbital	pentobarbital	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
anesthetized	anesthetized	ADJ	JJ	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

Adrenaline	adrenaline	NOUN	NN	B-Disease
arrhythmia	arrhythmia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
suppressed	suppress	VERB	VBN	O
by	by	ADP	IN	O
Ca	Ca	VERB	VBG	B-Chemical
channel	channel	NOUN	NN	O
blockers	blocker	NOUN	NNS	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
infusion	infusion	NOUN	NN	O
in	in	ADP	IN	O
halothane	halothane	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
anesthetized	anesthetized	ADJ	JJ	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

Ten	ten	NUM	CD	O
and	and	CCONJ	CC	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
suppressed	suppress	VERB	VBD	O
digitalis	digitalis	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
arrhythmias	arrhythmia	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
minimum	minimum	ADJ	JJ	O
effective	effective	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
for	for	ADP	IN	O
digitalis	digitalis	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
arrhythmias	arrhythmia	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
SD	SD	PROPN	NNP	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
lower	low	ADJ	JJR	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
of	of	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
suppressed	suppress	VERB	VBD	O
the	the	DET	DT	O
digitalis	digitalis	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
was	be	VERB	VBD	O
needed	need	VERB	VBN	O
to	to	PART	TO	O
suppress	suppress	VERB	VB	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
arrhythmias	arrhythmia	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
minimum	minimum	ADJ	JJ	O
effective	effective	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
for	for	ADP	IN	O
digitalis	digitalis	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
were	be	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
06	06	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
04	04	NUM	CD	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
SD	SD	PROPN	NNP	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
stronger	strong	ADJ	JJR	O
antiarrhythmic	antiarrhythmic	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
indicates	indicate	VERB	VBZ	O
that	that	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
isomer	isomer	NOUN	NN	O
may	may	VERB	MD	O
have	have	VERB	VB	O
an	an	DET	DT	O
effect	effect	NOUN	NN	O
nearly	nearly	ADV	RB	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
20	20	NUM	CD	O
times	time	NOUN	NNS	O
stronger	strong	ADJ	JJR	O
in	in	ADP	IN	O
suppressing	suppress	VERB	VBG	O
Na	Na	PROPN	NNP	B-Chemical
channels	channel	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
both	both	DET	DT	O
drugs	drug	NOUN	NNS	O
on	on	ADP	IN	O
Ca	ca	NOUN	NN	B-Chemical
channels	channel	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
almost	almost	ADV	RB	O
equipotent	equipotent	ADJ	JJ	O
.	.	PUNCT	.	O

Passage	passage	NOUN	NN	O
of	of	ADP	IN	O
mannitol	mannitol	NOUN	NN	B-Chemical
into	into	ADP	IN	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
around	around	ADP	IN	O
gliomas	glioma	NOUN	NNS	B-Disease
:	:	PUNCT	:	O
a	a	DET	DT	O
potential	potential	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
rebound	rebound	NOUN	NN	O
phenomenon	phenomenon	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
study	study	NOUN	NN	O
on	on	ADP	IN	O
21	21	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

AIM	AIM	PROPN	NNP	O
:	:	PUNCT	:	O
Widespread	widespread	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
mannitol	mannitol	NOUN	NN	B-Chemical
to	to	PART	TO	O
reduce	reduce	VERB	VB	O
brain	brain	NOUN	NN	B-Disease
edema	edema	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
lower	low	ADJ	JJR	O
elevated	elevated	ADJ	JJ	B-Disease
ICP	icp	NOUN	NN	I-Disease
in	in	ADP	IN	O
brain	brain	NOUN	NN	B-Disease
tumor	tumor	NOUN	NN	I-Disease
patients	patient	NOUN	NNS	O
continues	continue	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
afflicted	afflict	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
so	so	ADV	RB	O
-	-	PUNCT	HYPH	O
called	call	VERB	VBN	O
rebound	rebound	NOUN	NN	O
phenomenon	phenomenon	NOUN	NN	O
.	.	PUNCT	.	O

Leakage	leakage	NOUN	NN	O
of	of	ADP	IN	O
mannitol	mannitol	NOUN	NN	B-Chemical
into	into	ADP	IN	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
parenchyma	parenchyma	NOUN	NN	O
through	through	ADP	IN	O
an	an	DET	DT	O
altered	alter	VERB	VBN	O
BBB	BBB	PROPN	NNP	O
and	and	CCONJ	CC	O
secondary	secondary	ADJ	JJ	O
reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
osmotic	osmotic	ADJ	JJ	O
gradient	gradient	NOUN	NN	O
is	be	VERB	VBZ	O
considered	consider	VERB	VBN	O
the	the	DET	DT	O
major	major	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
rebound	rebound	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
has	have	VERB	VBZ	O
only	only	ADV	RB	O
been	be	VERB	VBN	O
demonstrated	demonstrate	VERB	VBN	O
experimentally	experimentally	ADV	RB	O
in	in	ADP	IN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

As	as	ADP	IN	O
a	a	DET	DT	O
contribution	contribution	NOUN	NN	O
to	to	ADP	IN	O
this	this	DET	DT	O
issue	issue	NOUN	NN	O
we	-PRON-	PRON	PRP	O
decided	decide	VERB	VBD	O
to	to	PART	TO	O
research	research	VERB	VB	O
the	the	DET	DT	O
possible	possible	ADJ	JJ	O
passage	passage	NOUN	NN	O
of	of	ADP	IN	O
mannitol	mannitol	NOUN	NN	B-Chemical
into	into	ADP	IN	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
to	to	ADP	IN	O
21	21	NUM	CD	O
brain	brain	NOUN	NN	B-Disease
tumor	tumor	NOUN	NN	I-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Mannitol	Mannitol	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
18	18	NUM	CD	O
%	%	NOUN	NN	O
solution	solution	NOUN	NN	O
;	;	PUNCT	:	O
1	1	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
bolus	bolus	NOUN	NN	O
to	to	ADP	IN	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
ten	ten	NUM	CD	O
had	have	VERB	VBD	O
malignant	malignant	ADJ	JJ	B-Disease
glioma	glioma	NOUN	NN	I-Disease
,	,	PUNCT	,	O
seven	seven	NUM	CD	O
brain	brain	NOUN	NN	O
metastases	metastasis	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
four	four	NUM	CD	O
meningioma	meningioma	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
about	about	ADP	IN	O
30	30	NUM	CD	O
minutes	minute	NOUN	NNS	O
before	before	ADP	IN	O
craniotomy	craniotomy	NOUN	NN	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
resection	resection	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
sample	sample	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
surrounding	surround	VERB	VBG	O
edematous	edematous	ADJ	JJ	B-Disease
white	white	ADJ	JJ	O
matter	matter	NOUN	NN	O
was	be	VERB	VBD	O
taken	take	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
time	time	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
10	10	NUM	CD	O
ml	ml	NOUN	NN	O
venous	venous	ADJ	JJ	O
blood	blood	NOUN	NN	O
sample	sample	NOUN	NN	O
.	.	PUNCT	.	O

Mannitol	Mannitol	PROPN	NNP	B-Chemical
concentrations	concentration	NOUN	NNS	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
in	in	ADP	IN	O
plasma	plasma	NOUN	NN	O
and	and	CCONJ	CC	O
white	white	ADJ	JJ	O
matter	matter	NOUN	NN	O
by	by	ADP	IN	O
a	a	DET	DT	O
modified	modify	VERB	VBN	O
version	version	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
enzyme	enzyme	ADJ	JJ	O
assay	assay	NOUN	NN	O
of	of	ADP	IN	O
Blonquist	Blonquist	PROPN	NNP	O
et	et	X	FW	O
al	al	PROPN	NNP	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
most	most	ADJ	JJS	O
glioma	glioma	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
mannitol	mannitol	NOUN	NN	B-Chemical
concentrations	concentration	NOUN	NNS	O
in	in	ADP	IN	O
white	white	ADJ	JJ	O
matter	matter	NOUN	NN	O
were	be	VERB	VBD	O
2	2	NUM	CD	O
to	to	ADP	IN	O
6	6	NUM	CD	O
times	time	NOUN	NNS	O
higher	high	ADJ	JJR	O
than	than	ADP	IN	O
in	in	ADP	IN	O
plasma	plasma	NOUN	NN	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
times	time	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
meningioma	meningioma	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
metastases	metastase	VERB	VBZ	B-Disease
patients	patient	NOUN	NNS	O
plasma	plasma	VERB	VBP	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
mannitol	mannitol	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
higher	high	ADJ	JJR	O
than	than	ADP	IN	O
white	white	ADJ	JJ	O
matter	matter	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
except	except	ADP	IN	O
in	in	ADP	IN	O
three	three	NUM	CD	O
cases	case	NOUN	NNS	O
with	with	ADP	IN	O
infiltration	infiltration	NOUN	NN	O
by	by	ADP	IN	O
neoplastic	neoplastic	ADJ	JJ	O
cells	cell	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
our	-PRON-	DET	PRP$	O
study	study	NOUN	NN	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
even	even	ADV	RB	O
after	after	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
bolus	bolus	NOUN	NN	O
,	,	PUNCT	,	O
mannitol	mannitol	NOUN	NN	B-Chemical
may	may	VERB	MD	O
leak	leak	VERB	VB	O
through	through	ADP	IN	O
the	the	DET	DT	O
altered	altered	ADJ	JJ	O
BBB	BBB	PROPN	NNP	O
near	near	ADP	IN	O
gliomas	glioma	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
reversing	reverse	VERB	VBG	O
the	the	DET	DT	O
initial	initial	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
blood	blood	NOUN	NN	O
osmotic	osmotic	ADJ	JJ	O
gradient	gradient	NOUN	NN	O
,	,	PUNCT	,	O
aggravating	aggravate	VERB	VBG	O
peritumoral	peritumoral	ADJ	JJ	O
edema	edema	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
promoting	promote	VERB	VBG	O
rebound	rebound	NOUN	NN	O
of	of	ADP	IN	O
ICP	ICP	PROPN	NNP	O
.	.	PUNCT	.	O

Placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
level	level	NOUN	NN	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
extrapyramidal	extrapyramidal	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
EPS	EPS	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
controlled	control	VERB	VBN	O
studies	study	NOUN	NNS	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
bipolar	bipolar	ADJ	JJ	B-Disease
mania	mania	NOUN	NN	I-Disease
.	.	PUNCT	.	O

OBJECTIVES	objectives	NOUN	NN	O
:	:	PUNCT	:	O
To	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
extrapyramidal	extrapyramidal	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
EPS	EPS	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
akathisia	akathisia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
with	with	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
bipolar	bipolar	ADJ	JJ	B-Disease
mania	mania	NOUN	NN	I-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Data	datum	NOUN	NNS	O
were	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
from	from	ADP	IN	O
four	four	NUM	CD	O
similarly	similarly	ADV	RB	O
designed	design	VERB	VBN	O
,	,	PUNCT	,	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
12	12	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
studies	study	NOUN	NNS	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
studies	study	NOUN	NNS	O
evaluated	evaluate	VERB	VBD	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
monotherapy	monotherapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
up	up	ADP	IN	O
to	to	ADP	IN	O
800	800	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
209	209	NUM	CD	O
)	)	PUNCT	-RRB-	O
versus	versus	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
198	198	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
monotherapy	monotherapy	NOUN	NN	O
as	as	ADP	IN	O
respective	respective	ADJ	JJ	O
active	active	ADJ	JJ	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
studies	study	NOUN	NNS	O
evaluated	evaluate	VERB	VBD	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
up	up	ADP	IN	O
to	to	ADP	IN	O
800	800	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
mood	mood	NOUN	NN	O
stabilizer	stabilizer	NOUN	NN	O
(	(	PUNCT	-LRB-	O
lithium	lithium	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
divalproex	divalproex	VERB	VBN	B-Chemical
,	,	PUNCT	,	O
QTP	QTP	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
Li	Li	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
DVP	DVP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
196	196	NUM	CD	O
)	)	PUNCT	-RRB-	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
placebo	placebo	NOUN	NN	O
and	and	CCONJ	CC	O
mood	mood	NOUN	NN	O
stabilizer	stabilizer	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PBO	PBO	PROPN	NNP	O
+	+	CCONJ	CC	O
Li	Li	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
DVP	DVP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
203	203	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Extrapyramidal	extrapyramidal	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
using	use	VERB	VBG	O
the	the	DET	DT	O
Simpson	Simpson	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Angus	Angus	PROPN	NNP	O
Scale	Scale	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
SAS	SAS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
Barnes	Barnes	PROPN	NNP	O
Akathisia	Akathisia	PROPN	NNP	O
Rating	Rating	PROPN	NNP	O
Scale	Scale	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
BARS	BARS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
adverse	adverse	ADJ	JJ	O
event	event	NOUN	NN	O
reports	report	NOUN	NNS	O
and	and	CCONJ	CC	O
anticholinergic	anticholinergic	ADJ	JJ	O
drug	drug	NOUN	NN	O
usage	usage	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
EPS	EPS	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
akathisia	akathisia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
was	be	VERB	VBD	O
no	no	ADV	RB	O
different	different	ADJ	JJ	O
with	with	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
monotherapy	monotherapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
13	13	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Similarly	similarly	ADV	RB	O
,	,	PUNCT	,	O
EPS	EPS	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
with	with	ADP	IN	O
QTP	QTP	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
Li	Li	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
DVP	DVP	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
21	21	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
no	no	ADV	RB	O
different	different	ADJ	JJ	O
than	than	ADP	IN	O
with	with	ADP	IN	O
PBO	PBO	PROPN	NNP	O
+	+	CCONJ	CC	O
Li	Li	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
DVP	DVP	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
19	19	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
EPS	EPS	PROPN	NNP	B-Disease
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
59	59	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
99	99	NUM	CD	O
)	)	PUNCT	-RRB-	O
monotherapy	monotherapy	NOUN	NN	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
26	26	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
98	98	NUM	CD	O
)	)	PUNCT	-RRB-	O
monotherapy	monotherapy	NOUN	NN	O
experienced	experience	VERB	VBD	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
EPS	EPS	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
akathisia	akathisia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
low	low	ADJ	JJ	O
and	and	CCONJ	CC	O
similar	similar	ADJ	JJ	O
with	with	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
monotherapy	monotherapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
with	with	ADP	IN	O
QTP	QTP	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
Li	Li	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
DVP	DVP	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
PBO	PBO	PROPN	NNP	O
+	+	CCONJ	CC	O
Li	Li	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
DVP	DVP	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Lithium	Lithium	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
significantly	significantly	ADV	RB	O
higher	high	ADJ	JJR	O
incidence	incidence	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
tremor	tremor	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
18	18	NUM	CD	O
.	.	NOUN	NN	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	,	O
cerebellar	cerebellar	ADJ	JJ	O
tremor	tremor	NOUN	NN	B-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
known	know	VERB	VBN	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
may	may	VERB	MD	O
have	have	VERB	VB	O
contributed	contribute	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
elevated	elevated	ADJ	JJ	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
tremor	tremor	NOUN	NN	B-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
lithium	lithium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Haloperidol	Haloperidol	PROPN	NNP	B-Chemical
induced	induce	VERB	VBD	O
a	a	DET	DT	O
significantly	significantly	ADV	RB	O
higher	high	ADJ	JJR	O
incidence	incidence	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
akathisia	akathisia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
33	33	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
versus	versus	ADP	IN	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
tremor	tremor	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
.	.	NOUN	NN	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
versus	versus	ADP	IN	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
extrapyramidal	extrapyramidal	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
35	35	NUM	CD	O
.	.	NOUN	NN	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
versus	versus	ADP	IN	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

No	no	DET	DT	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
between	between	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
on	on	ADP	IN	O
SAS	SAS	PROPN	NNP	O
and	and	CCONJ	CC	O
BARS	BARS	PROPN	NNP	O
scores	score	NOUN	NNS	O
.	.	PUNCT	.	O

Anticholinergic	Anticholinergic	PROPN	NNP	O
use	use	NOUN	NN	O
was	be	VERB	VBD	O
low	low	ADJ	JJ	O
and	and	CCONJ	CC	O
similar	similar	ADJ	JJ	O
with	with	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
bipolar	bipolar	ADJ	JJ	B-Disease
mania	mania	NOUN	NN	I-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
EPS	EPS	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
including	include	VERB	VBG	O
akathisia	akathisia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
with	with	ADP	IN	O
quetiapine	quetiapine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
is	be	VERB	VBZ	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
that	that	DET	DT	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

Is	be	VERB	VBZ	O
phenytoin	phenytoin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
safe	safe	ADJ	JJ	O
in	in	ADP	IN	O
a	a	DET	DT	O
hypothermic	hypothermic	ADJ	JJ	B-Disease
child	child	NOUN	NN	O
?	?	PUNCT	.	O

A	a	DET	DT	O
male	male	ADJ	JJ	O
neonate	neonate	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
Chiari	Chiari	PROPN	NNP	B-Disease
malformation	malformation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
a	a	DET	DT	O
leaking	leak	VERB	VBG	O
myelomeningocoele	myelomeningocoele	NOUN	NN	O
underwent	underwent	NOUN	NN	O
ventriculoperitoneal	ventriculoperitoneal	NOUN	NN	O
shunt	shunt	NOUN	NN	O
insertion	insertion	NOUN	NN	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
repair	repair	NOUN	NN	O
of	of	ADP	IN	O
myelomeningocoele	myelomeningocoele	NOUN	NN	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
anaesthesia	anaesthesia	NOUN	NN	O
and	and	CCONJ	CC	O
surgery	surgery	NOUN	NN	O
,	,	PUNCT	,	O
he	-PRON-	PRON	PRP	O
inadvertently	inadvertently	ADV	RB	O
became	become	VERB	VBD	O
moderately	moderately	ADV	RB	O
hypothermic	hypothermic	ADJ	JJ	B-Disease
.	.	PUNCT	.	O

Intravenous	intravenous	ADJ	JJ	O
phenytoin	phenytoin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
during	during	ADP	IN	O
the	the	DET	DT	O
later	later	ADJ	JJ	O
part	part	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
surgery	surgery	NOUN	NN	O
for	for	ADP	IN	O
seizure	seizure	NOUN	NN	B-Disease
prophylaxis	prophylaxis	NOUN	NN	O
.	.	PUNCT	.	O

Following	follow	VERB	VBG	O
phenytoin	phenytoin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
developed	develop	VERB	VBN	O
acute	acute	ADJ	JJ	O
severe	severe	ADJ	JJ	O
bradycardia	bradycardia	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
refractory	refractory	NOUN	NN	O
to	to	ADP	IN	O
atropine	atropine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
cardiac	cardiac	ADJ	JJ	O
depressant	depressant	NOUN	NN	O
actions	action	NOUN	NNS	O
of	of	ADP	IN	O
phenytoin	phenytoin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
hypothermia	hypothermia	NOUN	NN	B-Disease
can	can	VERB	MD	O
be	be	VERB	VB	O
additive	additive	ADJ	JJ	O
.	.	PUNCT	.	O

Administration	administration	NOUN	NN	O
of	of	ADP	IN	O
phenytoin	phenytoin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
hypothermia	hypothermia	NOUN	NN	B-Disease
may	may	VERB	MD	O
lead	lead	VERB	VB	O
to	to	ADP	IN	O
an	an	DET	DT	O
adverse	adverse	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
event	event	NOUN	NN	O
in	in	ADP	IN	O
children	child	NOUN	NNS	O
.	.	PUNCT	.	O

As	as	ADP	IN	O
phenytoin	phenytoin	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
commonly	commonly	ADV	RB	O
used	use	VERB	VBN	O
drug	drug	NOUN	NN	O
,	,	PUNCT	,	O
clinicians	clinician	NOUN	NNS	O
need	need	VERB	VBP	O
to	to	PART	TO	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
this	this	DET	DT	O
interaction	interaction	NOUN	NN	O
.	.	PUNCT	.	O

Valproate	valproate	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
chorea	chorea	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
encephalopathy	encephalopathy	ADJ	JJ	B-Disease
in	in	ADP	IN	O
atypical	atypical	ADJ	JJ	O
nonketotic	nonketotic	ADJ	JJ	B-Disease
hyperglycinemia	hyperglycinemia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Nonketotic	nonketotic	ADJ	JJ	B-Disease
hyperglycinemia	hyperglycinemia	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
disorder	disorder	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
amino	amino	ADJ	JJ	I-Disease
acid	acid	NOUN	NN	I-Disease
metabolism	metabolism	NOUN	NN	I-Disease
in	in	ADP	IN	O
which	which	DET	WDT	O
a	a	DET	DT	O
defect	defect	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
glycine	glycine	NOUN	NN	B-Chemical
cleavage	cleavage	NOUN	NN	O
system	system	NOUN	NN	O
leads	lead	VERB	VBZ	O
to	to	ADP	IN	O
an	an	DET	DT	O
accumulation	accumulation	NOUN	NN	O
of	of	ADP	IN	O
glycine	glycine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
and	and	CCONJ	CC	O
other	other	ADJ	JJ	O
body	body	NOUN	NN	O
compartments	compartment	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
classical	classical	ADJ	JJ	O
form	form	NOUN	NN	O
it	-PRON-	PRON	PRP	O
presents	present	VERB	VBZ	O
as	as	ADP	IN	O
neonatal	neonatal	ADJ	JJ	O
apnea	apnea	NOUN	NN	B-Disease
,	,	PUNCT	,	O
intractable	intractable	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
hypotonia	hypotonia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
significant	significant	ADJ	JJ	O
psychomotor	psychomotor	NOUN	NN	B-Disease
retardation	retardation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

An	an	DET	DT	O
important	important	ADJ	JJ	O
subset	subset	NOUN	NN	O
of	of	ADP	IN	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
nonketotic	nonketotic	ADJ	JJ	B-Disease
hyperglycinemia	hyperglycinemia	NOUN	NN	I-Disease
are	be	VERB	VBP	O
atypical	atypical	ADJ	JJ	O
variants	variant	NOUN	NNS	O
who	who	PRON	WP	O
present	present	VERB	VBP	O
in	in	ADP	IN	O
a	a	DET	DT	O
heterogeneous	heterogeneous	ADJ	JJ	O
manner	manner	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
report	report	NOUN	NN	O
describes	describe	VERB	VBZ	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
mild	mild	ADJ	JJ	O
language	language	NOUN	NN	B-Disease
delay	delay	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
mental	mental	ADJ	JJ	B-Disease
retardation	retardation	NOUN	NN	I-Disease
,	,	PUNCT	,	O
who	who	PRON	WP	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
nonketotic	nonketotic	ADJ	JJ	B-Disease
hyperglycinemia	hyperglycinemia	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
her	-PRON-	DET	PRP$	O
presentation	presentation	NOUN	NN	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	O
encephalopathy	encephalopathy	ADJ	JJ	B-Disease
and	and	CCONJ	CC	O
chorea	chorea	NOUN	NN	B-Disease
shortly	shortly	ADV	RB	O
after	after	ADP	IN	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
valproate	valproate	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Delayed	delay	VERB	VBN	O
institution	institution	NOUN	NN	O
of	of	ADP	IN	O
hypertension	hypertension	NOUN	NN	B-Disease
during	during	ADP	IN	O
focal	focal	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
:	:	PUNCT	:	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
brain	brain	NOUN	NN	B-Disease
edema	edema	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
induced	induced	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
instituted	institute	VERB	VBN	O
after	after	ADP	IN	O
a	a	DET	DT	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
h	h	NOUN	NN	O
delay	delay	NOUN	NN	O
following	follow	VERB	VBG	O
middle	middle	ADJ	JJ	B-Disease
cerebral	cerebral	ADJ	JJ	I-Disease
artery	artery	NOUN	NN	I-Disease
occlusion	occlusion	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
MCAO	MCAO	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
brain	brain	NOUN	NN	B-Disease
edema	edema	NOUN	NN	I-Disease
formation	formation	NOUN	NN	O
and	and	CCONJ	CC	O
histochemical	histochemical	NOUN	NN	O
injury	injury	NOUN	NN	O
was	be	VERB	VBD	O
studied	study	VERB	VBN	O
.	.	PUNCT	.	O

Under	under	ADP	IN	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
anesthesia	anesthesia	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
MCA	MCA	PROPN	NNP	O
of	of	ADP	IN	O
14	14	NUM	CD	O
spontaneously	spontaneously	ADV	RB	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
was	be	VERB	VBD	O
occluded	occlude	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
7	7	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MAP	MAP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
manipulated	manipulate	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
7	7	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
MAP	MAP	PROPN	NNP	O
was	be	VERB	VBD	O
elevated	elevate	VERB	VBN	O
by	by	ADP	IN	O
25	25	NUM	CD	O
-	-	SYM	SYM	O
30	30	NUM	CD	O
mm	mm	NOUN	NN	O
Hg	Hg	PROPN	NNP	O
beginning	begin	VERB	VBG	O
2	2	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
MCAO	MCAO	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Four	four	NUM	CD	O
hours	hour	NOUN	NNS	O
after	after	ADP	IN	O
MCAO	MCAO	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
killed	kill	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
brains	brain	NOUN	NNS	O
harvested	harvest	VERB	VBD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
brains	brain	NOUN	NNS	O
were	be	VERB	VBD	O
sectioned	section	VERB	VBN	O
along	along	ADP	IN	O
coronal	coronal	ADJ	JJ	O
planes	plane	NOUN	NNS	O
spanning	span	VERB	VBG	O
the	the	DET	DT	O
distribution	distribution	NOUN	NN	O
of	of	ADP	IN	O
ischemia	ischemia	NOUN	NN	B-Disease
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
MCAO	MCAO	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Specific	specific	ADJ	JJ	O
gravity	gravity	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SG	SG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
determined	determine	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
subcortex	subcortex	NOUN	NN	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
two	two	NUM	CD	O
sites	site	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
cortex	cortex	NOUN	NN	O
(	(	PUNCT	-LRB-	O
core	core	NOUN	NN	O
and	and	CCONJ	CC	O
periphery	periphery	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ischemic	ischemic	ADJ	JJ	B-Disease
territory	territory	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
extent	extent	NOUN	NN	O
of	of	ADP	IN	O
neuronal	neuronal	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
was	be	VERB	VBD	O
determined	determine	VERB	VBN	O
by	by	ADP	IN	O
2	2	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
3	3	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
5	5	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
triphenyltetrazolium	triphenyltetrazolium	NOUN	NN	I-Chemical
staining	staining	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
ischemic	ischemic	ADJ	JJ	B-Disease
core	core	NOUN	NN	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
difference	difference	NOUN	NN	O
in	in	ADP	IN	O
SG	SG	PROPN	NNP	O
in	in	ADP	IN	O
the	the	DET	DT	O
subcortex	subcortex	NOUN	NN	O
and	and	CCONJ	CC	O
cortex	cortex	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
periphery	periphery	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ischemic	ischemic	ADJ	JJ	B-Disease
territory	territory	NOUN	NN	O
,	,	PUNCT	,	O
SG	SG	PROPN	NNP	O
in	in	ADP	IN	O
the	the	DET	DT	O
cortex	cortex	NOUN	NN	O
was	be	VERB	VBD	O
greater	great	ADJ	JJR	O
(	(	PUNCT	-LRB-	O
less	less	ADJ	JJR	O
edema	edema	NOUN	NN	B-Disease
accumulation	accumulation	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
041	041	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
vs	vs	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
039	039	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
area	area	NOUN	NN	O
of	of	ADP	IN	O
histochemical	histochemical	ADJ	JJ	O
injury	injury	NOUN	NN	O
(	(	PUNCT	-LRB-	O
as	as	ADP	IN	O
a	a	DET	DT	O
percent	percent	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cross	cross	ADJ	JJ	O
-	-	ADJ	JJ	O
sectional	sectional	ADJ	JJ	O
area	area	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hemisphere	hemisphere	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
less	less	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
33	33	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
vs	vs	ADP	IN	O
21	21	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
data	datum	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
phenylephrine	phenylephrine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypertension	hypertension	NOUN	NN	B-Disease
instituted	institute	VERB	VBD	O
2	2	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
MCAO	MCAO	PROPN	NNP	B-Disease
does	do	VERB	VBZ	O
not	not	ADV	RB	O
aggravate	aggravate	VERB	VB	O
edema	edema	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
ischemic	ischemic	ADJ	JJ	B-Disease
core	core	NOUN	NN	O
,	,	PUNCT	,	O
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
improves	improve	VERB	VBZ	O
edema	edema	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
periphery	periphery	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ischemic	ischemic	ADJ	JJ	B-Disease
territory	territory	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
reduces	reduce	VERB	VBZ	O
the	the	DET	DT	O
area	area	NOUN	NN	O
of	of	ADP	IN	O
histochemical	histochemical	ADJ	JJ	O
neuronal	neuronal	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Behavioral	behavioral	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
pubertal	pubertal	ADJ	JJ	O
anabolic	anabolic	ADJ	JJ	O
androgenic	androgenic	NOUN	NN	O
steroid	steroid	NOUN	NN	B-Chemical
exposure	exposure	NOUN	NN	O
in	in	ADP	IN	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
low	low	ADJ	JJ	O
serotonin	serotonin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
goal	goal	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
interactive	interactive	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	O
anabolic	anabolic	ADJ	JJ	O
androgenic	androgenic	NOUN	NN	O
steroid	steroid	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
AAS	AAS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
exposure	exposure	NOUN	NN	O
and	and	CCONJ	CC	O
brain	brain	NOUN	NN	O
serotonin	serotonin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxytryptamine	hydroxytryptamine	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
5	5	NUM	CD	B-Chemical
-	-	SYM	SYM	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
depletion	depletion	NOUN	NN	O
on	on	ADP	IN	O
behavior	behavior	NOUN	NN	O
of	of	ADP	IN	O
pubertal	pubertal	ADJ	JJ	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Serotonin	Serotonin	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
depleted	deplete	VERB	VBN	O
beginning	beginning	NOUN	NN	O
on	on	ADP	IN	O
postnatal	postnatal	ADJ	JJ	O
day	day	NOUN	NN	O
26	26	NUM	CD	O
with	with	ADP	IN	O
parachlorophenylalanine	parachlorophenylalanine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
PCPA	PCPA	PROPN	NNP	B-Chemical
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
every	every	DET	DT	O
other	other	ADJ	JJ	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
controls	control	NOUN	NNS	O
received	receive	VERB	VBN	O
saline	saline	NOUN	NN	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
puberty	puberty	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P40	P40	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
half	half	DET	PDT	O
the	the	DET	DT	O
PCPA	pcpa	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
half	half	DET	PDT	O
the	the	DET	DT	O
saline	saline	NOUN	NN	O
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
began	begin	VERB	VBD	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
testosterone	testosterone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
T	t	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
days	day	NOUN	NNS	O
/	/	SYM	SYM	O
week	week	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Behavioral	behavioral	ADJ	JJ	O
measures	measure	NOUN	NNS	O
included	include	VERB	VBD	O
locomotion	locomotion	NOUN	NN	O
,	,	PUNCT	,	O
irritability	irritability	NOUN	NN	B-Disease
,	,	PUNCT	,	O
copulation	copulation	NOUN	NN	O
,	,	PUNCT	,	O
partner	partner	NOUN	NN	O
preference	preference	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
aggression	aggression	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Animals	animal	NOUN	NNS	O
were	be	VERB	VBD	O
tested	test	VERB	VBN	O
for	for	ADP	IN	O
aggression	aggression	NOUN	NN	B-Disease
in	in	ADP	IN	O
their	-PRON-	DET	PRP$	O
home	home	NOUN	NN	O
cage	cage	NOUN	NN	O
,	,	PUNCT	,	O
both	both	CCONJ	CC	O
with	with	ADP	IN	O
and	and	CCONJ	CC	O
without	without	ADP	IN	O
physical	physical	ADJ	JJ	O
provocation	provocation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
mild	mild	ADJ	JJ	O
tail	tail	NOUN	NN	O
pinch	pinch	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Brain	brain	NOUN	NN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
metabolite	metabolite	NOUN	NN	O
,	,	PUNCT	,	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxyindoleacetic	hydroxyindoleacetic	ADJ	JJ	I-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HIAA	HIAA	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
determined	determine	VERB	VBN	O
using	use	VERB	VBG	O
HPLC	HPLC	PROPN	NNP	O
.	.	PUNCT	.	O

PCPA	PCPA	NOUN	NNS	B-Chemical
significantly	significantly	ADV	RB	O
and	and	CCONJ	CC	O
substantially	substantially	ADV	RB	O
depleted	deplete	VERB	VBD	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
and	and	CCONJ	CC	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HIAA	HIAA	PROPN	NNP	I-Chemical
in	in	ADP	IN	O
all	all	DET	DT	O
brain	brain	NOUN	NN	O
regions	region	NOUN	NNS	O
examined	examine	VERB	VBD	O
.	.	PUNCT	.	O

Chronic	Chronic	PROPN	NNP	O
T	T	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
significantly	significantly	ADV	RB	O
decreased	decrease	VERB	VBD	O
5	5	NUM	CD	B-Chemical
-	-	SYM	SYM	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
and	and	CCONJ	CC	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HIAA	HIAA	PROPN	NNP	I-Chemical
in	in	ADP	IN	O
certain	certain	ADJ	JJ	O
brain	brain	NOUN	NN	O
areas	area	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
to	to	ADP	IN	O
a	a	DET	DT	O
much	much	ADV	RB	O
lesser	less	ADJ	JJR	O
extent	extent	NOUN	NN	O
than	than	ADP	IN	O
PCPA	PCPA	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Chronic	chronic	ADJ	JJ	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
PCPA	PCPA	PROPN	NNP	B-Chemical
alone	alone	ADV	RB	O
significantly	significantly	ADV	RB	O
decreased	decrease	VERB	VBD	O
locomotor	locomotor	NOUN	NN	O
activity	activity	NOUN	NN	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBN	O
irritability	irritability	NOUN	NN	B-Disease
but	but	CCONJ	CC	O
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
sexual	sexual	ADJ	JJ	O
behavior	behavior	NOUN	NN	O
,	,	PUNCT	,	O
partner	partner	NOUN	NN	O
preference	preference	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
aggression	aggression	NOUN	NN	B-Disease
.	.	PUNCT	.	O

T	t	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
locomotion	locomotion	NOUN	NN	O
,	,	PUNCT	,	O
irritability	irritability	NOUN	NN	B-Disease
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
sexual	sexual	ADJ	JJ	O
behavior	behavior	NOUN	NN	O
but	but	CCONJ	CC	O
increased	increase	VERB	VBD	O
partner	partner	NOUN	NN	O
preference	preference	NOUN	NN	O
and	and	CCONJ	CC	O
aggression	aggression	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
most	most	ADV	RBS	O
striking	striking	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
combining	combine	VERB	VBG	O
T	t	NOUN	NN	B-Chemical
+	+	CCONJ	CC	O
PCPA	PCPA	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
attack	attack	NOUN	NN	O
frequency	frequency	NOUN	NN	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
latency	latency	NOUN	NN	O
to	to	PART	TO	O
attack	attack	VERB	VB	O
,	,	PUNCT	,	O
particularly	particularly	ADV	RB	O
following	follow	VERB	VBG	O
physical	physical	ADJ	JJ	O
provocation	provocation	NOUN	NN	O
.	.	PUNCT	.	O

Based	base	VERB	VBN	O
on	on	ADP	IN	O
these	these	DET	DT	O
data	datum	NOUN	NNS	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
can	can	VERB	MD	O
be	be	VERB	VB	O
speculated	speculate	VERB	VBN	O
that	that	ADP	IN	O
pubertal	pubertal	ADJ	JJ	O
AAS	AAS	PROPN	NNP	O
users	user	NOUN	NNS	O
with	with	ADP	IN	O
low	low	ADJ	JJ	O
central	central	ADJ	JJ	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
especially	especially	ADV	RB	O
prone	prone	ADJ	JJ	O
to	to	PART	TO	O
exhibit	exhibit	VERB	VB	O
aggressive	aggressive	ADJ	JJ	B-Disease
behavior	behavior	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
UMB24	UMB24	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
SM	sm	NOUN	NN	B-Chemical
21	21	NUM	CD	I-Chemical
,	,	PUNCT	,	O
putative	putative	ADJ	JJ	O
sigma2	sigma2	NOUN	NN	O
-	-	PUNCT	HYPH	O
preferring	prefer	VERB	VBG	O
antagonists	antagonist	NOUN	NNS	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
behavioral	behavioral	ADJ	JJ	O
toxic	toxic	ADJ	JJ	O
and	and	CCONJ	CC	O
stimulant	stimulant	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Earlier	early	ADJ	JJR	O
studies	study	NOUN	NNS	O
have	have	VERB	VBP	O
demonstrated	demonstrate	VERB	VBN	O
that	that	ADP	IN	O
antagonism	antagonism	NOUN	NN	O
of	of	ADP	IN	O
sigma1	sigma1	NOUN	NN	O
receptors	receptor	NOUN	NNS	O
attenuates	attenuate	VERB	VBZ	O
the	the	DET	DT	O
convulsive	convulsive	ADJ	JJ	B-Disease
,	,	PUNCT	,	O
lethal	lethal	ADJ	JJ	O
,	,	PUNCT	,	O
locomotor	locomotor	NOUN	NN	O
stimulatory	stimulatory	NOUN	NN	O
and	and	CCONJ	CC	O
rewarding	rewarding	ADJ	JJ	O
actions	action	NOUN	NNS	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
contribution	contribution	NOUN	NN	O
of	of	ADP	IN	O
sigma2	sigma2	ADJ	JJ	O
receptors	receptor	NOUN	NNS	O
is	be	VERB	VBZ	O
unclear	unclear	ADJ	JJ	O
because	because	ADP	IN	O
experimental	experimental	ADJ	JJ	O
tools	tool	NOUN	NNS	O
to	to	PART	TO	O
selectively	selectively	ADV	RB	O
target	target	VERB	VB	O
this	this	DET	DT	O
subtype	subtype	NOUN	NN	O
are	be	VERB	VBP	O
unavailable	unavailable	ADJ	JJ	O
.	.	PUNCT	.	O

To	to	PART	TO	O
begin	begin	VERB	VB	O
addressing	address	VERB	VBG	O
this	this	DET	DT	O
need	need	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
characterized	characterize	VERB	VBD	O
UMB24	UMB24	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
phenethyl	phenethyl	ADV	RB	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
pyridyl	pyridyl	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
piperazine	piperazine	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
SM	sm	NOUN	NN	B-Chemical
21	21	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
3alpha	3alpha	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
tropanyl	tropanyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
chorophenoxy	chorophenoxy	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
butyrate	butyrate	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
receptor	receptor	NOUN	NN	O
binding	binding	NOUN	NN	O
and	and	CCONJ	CC	O
behavioral	behavioral	ADJ	JJ	O
studies	study	NOUN	NNS	O
.	.	PUNCT	.	O

Receptor	receptor	NOUN	NN	O
binding	bind	VERB	VBG	O
studies	study	NOUN	NNS	O
confirmed	confirm	VERB	VBD	O
that	that	ADP	IN	O
UMB24	UMB24	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
SM	sm	NOUN	NN	B-Chemical
21	21	NUM	CD	I-Chemical
display	display	NOUN	NN	O
preferential	preferential	ADJ	JJ	O
affinity	affinity	NOUN	NN	O
for	for	ADP	IN	O
sigma2	sigma2	NOUN	NN	O
over	over	ADP	IN	O
sigma1	sigma1	NOUN	NN	O
receptors	receptor	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
behavioral	behavioral	ADJ	JJ	O
studies	study	NOUN	NNS	O
,	,	PUNCT	,	O
pretreatment	pretreatment	NOUN	NN	O
of	of	ADP	IN	O
Swiss	Swiss	PROPN	NNP	O
Webster	Webster	PROPN	NNP	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
UMB24	UMB24	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
SM	sm	NOUN	NN	B-Chemical
21	21	NUM	CD	I-Chemical
significantly	significantly	ADV	RB	O
attenuated	attenuate	VERB	VBN	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
locomotor	locomotor	NOUN	NN	O
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
lethality	lethality	NOUN	NN	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
administered	administer	VERB	VBN	O
alone	alone	ADV	RB	O
,	,	PUNCT	,	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
SM	sm	NOUN	NN	B-Chemical
21	21	NUM	CD	I-Chemical
produced	produce	VERB	VBD	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
effects	effect	NOUN	NNS	O
compared	compare	VERB	VBN	O
to	to	PART	TO	O
control	control	VERB	VB	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
saline	saline	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
UMB24	UMB24	PROPN	NNP	B-Chemical
had	have	VERB	VBD	O
locomotor	locomotor	NOUN	NN	O
depressant	depressant	NOUN	NN	O
actions	action	NOUN	NNS	O
.	.	PUNCT	.	O

Together	together	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	DET	DT	O
sigma2	sigma2	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
antagonists	antagonist	NOUN	NNS	O
have	have	VERB	VBP	O
the	the	DET	DT	O
potential	potential	NOUN	NN	O
to	to	PART	TO	O
attenuate	attenuate	VERB	VB	O
some	some	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
behavioral	behavioral	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
further	further	ADJ	JJ	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
more	more	ADV	RBR	O
selective	selective	ADJ	JJ	O
,	,	PUNCT	,	O
high	high	ADJ	JJ	O
affinity	affinity	NOUN	NN	O
ligands	ligand	NOUN	NNS	O
are	be	VERB	VBP	O
warranted	warrant	VERB	VBN	O
.	.	PUNCT	.	O

Cardiac	cardiac	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
child	child	NOUN	NN	O
with	with	ADP	IN	O
cerebral	cerebral	ADJ	JJ	B-Disease
palsy	palsy	ADJ	JJ	I-Disease
undergoing	undergo	VERB	VBG	O
sevoflurane	sevoflurane	NOUN	NN	B-Chemical
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
anesthesia	anesthesia	NOUN	NN	O
after	after	ADP	IN	O
preoperative	preoperative	ADJ	JJ	O
clonidine	clonidine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Clonidine	Clonidine	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
frequently	frequently	ADV	RB	O
administered	administer	VERB	VBN	O
alpha2	alpha2	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenergic	adrenergic	NOUN	NN	O
agonist	agonist	NOUN	NN	O
which	which	DET	WDT	O
can	can	VERB	MD	O
decrease	decrease	VERB	VB	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
and	and	CCONJ	CC	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
present	present	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
child	child	NOUN	NN	O
with	with	ADP	IN	O
cerebral	cerebral	ADJ	JJ	B-Disease
palsy	palsy	ADJ	JJ	I-Disease
and	and	CCONJ	CC	O
seizure	seizure	VERB	VB	B-Disease
disorder	disorder	NOUN	NN	I-Disease
,	,	PUNCT	,	O
receiving	receive	VERB	VBG	O
clonidine	clonidine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
restlessness	restlessness	NOUN	NN	B-Disease
,	,	PUNCT	,	O
who	who	PRON	WP	O
presented	present	VERB	VBD	O
for	for	ADP	IN	O
placement	placement	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
baclofen	baclofen	NOUN	NN	B-Chemical
pump	pump	NOUN	NN	O
.	.	PUNCT	.	O

Without	without	ADP	IN	O
the	the	DET	DT	O
knowledge	knowledge	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
medical	medical	ADJ	JJ	O
personnel	personnel	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	PART	POS	O
mother	mother	NOUN	NN	O
administered	administer	VERB	VBD	O
three	three	NUM	CD	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
clonidine	clonidine	NOUN	NN	B-Chemical
during	during	ADP	IN	O
the	the	DET	DT	O
evening	evening	NOUN	NN	O
before	before	ADV	RB	O
and	and	CCONJ	CC	O
morning	morning	NOUN	NN	O
of	of	ADP	IN	O
surgery	surgery	NOUN	NN	O
to	to	PART	TO	O
reduce	reduce	VERB	VB	O
anxiety	anxiety	NOUN	NN	B-Disease
.	.	PUNCT	.	O

During	during	ADP	IN	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
anesthesia	anesthesia	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
developed	develop	VERB	VBD	O
bradycardia	bradycardia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
hypotension	hypotension	NOUN	NN	B-Disease
requiring	require	VERB	VBG	O
cardiac	cardiac	ADJ	JJ	O
resuscitation	resuscitation	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
are	be	VERB	VBP	O
no	no	DET	DT	O
previous	previous	ADJ	JJ	O
reports	report	NOUN	NNS	O
of	of	ADP	IN	O
clonidine	clonidine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
child	child	NOUN	NN	O
undergoing	undergo	VERB	VBG	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
anesthesia	anesthesia	NOUN	NN	O
.	.	PUNCT	.	O

Angiotensin	angiotensin	NOUN	NN	O
-	-	PUNCT	HYPH	O
converting	convert	VERB	VBG	O
enzyme	enzyme	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ACE	ACE	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
inhibitor	inhibitor	NOUN	NN	O
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
angioedema	angioedema	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
stomach	stomach	NOUN	NN	O
and	and	CCONJ	CC	O
small	small	ADJ	JJ	O
intestine	intestine	NOUN	NN	O
:	:	PUNCT	:	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
on	on	ADP	IN	O
a	a	DET	DT	O
45	45	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
old	old	ADJ	JJ	O
African	african	ADJ	JJ	O
-	-	PUNCT	HYPH	O
American	american	ADJ	JJ	O
female	female	NOUN	NN	O
with	with	ADP	IN	O
newly	newly	ADV	RB	O
diagnosed	diagnose	VERB	VBN	O
hypertension	hypertension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
who	who	PRON	WP	O
was	be	VERB	VBD	O
started	start	VERB	VBN	O
on	on	ADP	IN	O
a	a	DET	DT	O
combination	combination	NOUN	NN	O
pill	pill	NOUN	NN	O
of	of	ADP	IN	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
/	/	SYM	SYM	O
benazapril	benazapril	ADJ	JJ	B-Chemical
10	10	NUM	CD	O
/	/	SYM	SYM	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
very	very	ADV	RB	O
next	next	ADJ	JJ	O
day	day	NOUN	NN	O
,	,	PUNCT	,	O
she	-PRON-	PRON	PRP	O
presented	present	VERB	VBD	O
at	at	ADP	IN	O
the	the	DET	DT	O
emergency	emergency	NOUN	NN	O
room	room	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ER	ER	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
abdominal	abdominal	ADJ	JJ	B-Disease
pain	pain	NOUN	NN	I-Disease
,	,	PUNCT	,	O
nausea	nausea	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
vomiting	vomiting	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Physical	physical	ADJ	JJ	O
exam	exam	NOUN	NN	O
,	,	PUNCT	,	O
complete	complete	ADJ	JJ	O
metabolic	metabolic	ADJ	JJ	O
panel	panel	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
hemogram	hemogram	NOUN	NN	O
were	be	VERB	VBD	O
in	in	ADP	IN	O
the	the	DET	DT	O
normal	normal	ADJ	JJ	O
range	range	NOUN	NN	O
.	.	PUNCT	.	O

She	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
discharged	discharge	VERB	VBN	O
from	from	ADP	IN	O
the	the	DET	DT	O
ER	ER	PROPN	NNP	O
after	after	ADP	IN	O
a	a	DET	DT	O
few	few	ADJ	JJ	O
hours	hour	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
fluid	fluid	NOUN	NN	O
and	and	CCONJ	CC	O
analgesics	analgesic	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
she	-PRON-	PRON	PRP	O
returned	return	VERB	VBD	O
to	to	ADP	IN	O
the	the	DET	DT	O
ER	ER	PROPN	NNP	O
the	the	DET	DT	O
next	next	ADJ	JJ	O
day	day	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
complaints	complaint	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
time	time	NOUN	NN	O
the	the	DET	DT	O
physical	physical	ADJ	JJ	O
exam	exam	NOUN	NN	O
was	be	VERB	VBD	O
significant	significant	ADJ	JJ	O
for	for	ADP	IN	O
a	a	DET	DT	O
distended	distended	ADJ	JJ	O
abdomen	abdoman	NOUN	NNS	O
with	with	ADP	IN	O
dullness	dullness	NOUN	NN	O
to	to	ADP	IN	O
percussion	percussion	NOUN	NN	O
.	.	PUNCT	.	O

CT	CT	PROPN	NNP	O
scan	scan	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
abdomen	abdoman	NOUN	NNS	O
revealed	reveal	VERB	VBN	O
markedly	markedly	ADV	RB	O
thickened	thicken	VERB	VBN	O
antrum	antrum	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
stomach	stomach	NOUN	NN	O
,	,	PUNCT	,	O
duodenum	duodenum	NOUN	NN	O
and	and	CCONJ	CC	O
jejunum	jejunum	NOUN	NN	O
,	,	PUNCT	,	O
along	along	ADP	IN	O
with	with	ADP	IN	O
fluid	fluid	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
abdominal	abdominal	ADJ	JJ	O
and	and	CCONJ	CC	O
pelvic	pelvic	ADJ	JJ	O
cavity	cavity	NOUN	NN	O
.	.	PUNCT	.	O

Angiotensin	angiotensin	NOUN	NN	O
-	-	PUNCT	HYPH	O
converting	convert	VERB	VBG	O
enzyme	enzyme	ADJ	JJ	O
inhibitor	inhibitor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ACEI	ACEI	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
angioedema	angioedema	NOUN	NN	B-Disease
was	be	VERB	VBD	O
suspected	suspect	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
medications	medication	NOUN	NNS	O
were	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
.	.	PUNCT	.	O

Her	-PRON-	DET	PRP$	O
symptoms	symptom	NOUN	NNS	O
improved	improve	VERB	VBD	O
within	within	ADP	IN	O
the	the	DET	DT	O
next	next	ADJ	JJ	O
24	24	NUM	CD	O
hours	hour	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
repeat	repeat	VERB	VB	O
CT	CT	PROPN	NNP	O
after	after	ADP	IN	O
72	72	NUM	CD	O
hours	hour	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
marked	marked	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
stomach	stomach	NOUN	NN	O
and	and	CCONJ	CC	O
small	small	ADJ	JJ	O
bowel	bowel	NOUN	NN	O
thickening	thickening	NOUN	NN	O
and	and	CCONJ	CC	O
resolution	resolution	NOUN	NN	O
of	of	ADP	IN	O
ascites	ascite	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
recognition	recognition	NOUN	NN	O
of	of	ADP	IN	O
angiotensin	angiotensin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
converting	convert	VERB	VBG	O
enzyme	enzyme	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ACE	ACE	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
angiotensin	angiotensin	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
blocker	blocker	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ARB	ARB	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
intestinal	intestinal	ADJ	JJ	B-Disease
angioedema	angioedema	NOUN	NN	I-Disease
constitutes	constitute	VERB	VBZ	O
a	a	DET	DT	O
challenge	challenge	NOUN	NN	O
to	to	ADP	IN	O
primary	primary	ADJ	JJ	O
care	care	NOUN	NN	O
physicians	physician	NOUN	NNS	O
,	,	PUNCT	,	O
internists	internist	NOUN	NNS	O
,	,	PUNCT	,	O
emergency	emergency	NOUN	NN	O
room	room	NOUN	NN	O
personal	personal	ADJ	JJ	O
and	and	CCONJ	CC	O
surgeons	surgeon	NOUN	NNS	O
.	.	PUNCT	.	O

Carbamazepine	carbamazepine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiac	cardiac	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Characterization	characterization	NOUN	NN	O
of	of	ADP	IN	O
two	two	NUM	CD	O
distinct	distinct	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
syndromes	syndrome	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
sinus	sinus	NOUN	NN	O
bradycardia	bradycardia	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
atrioventricular	atrioventricular	ADJ	JJ	B-Disease
block	block	NOUN	NN	I-Disease
,	,	PUNCT	,	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
prompted	prompt	VERB	VBD	O
an	an	DET	DT	O
extensive	extensive	ADJ	JJ	O
literature	literature	NOUN	NN	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
all	all	DET	DT	O
previously	previously	ADV	RB	O
reported	report	VERB	VBN	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

From	from	ADP	IN	O
the	the	DET	DT	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
two	two	NUM	CD	O
distinct	distinct	ADJ	JJ	O
forms	form	NOUN	NNS	O
of	of	ADP	IN	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
cardiac	cardiac	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
emerged	emerge	VERB	VBD	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
patient	patient	NOUN	NN	O
group	group	NOUN	NN	O
developed	develop	VERB	VBD	O
sinus	sinus	NOUN	NN	B-Disease
tachycardias	tachycardias	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
setting	setting	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
massive	massive	ADJ	JJ	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
second	second	ADJ	JJ	O
group	group	NOUN	NN	O
consisted	consist	VERB	VBD	O
almost	almost	ADV	RB	O
exclusively	exclusively	ADV	RB	O
of	of	ADP	IN	O
elderly	elderly	ADJ	JJ	O
women	woman	NOUN	NNS	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
potentially	potentially	ADV	RB	O
life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
threatening	threaten	VERB	VBG	O
bradyarrhythmias	bradyarrhythmia	NOUN	NNS	B-Disease
or	or	CCONJ	CC	O
atrioventricular	atrioventricular	ADJ	JJ	B-Disease
conduction	conduction	NOUN	NN	I-Disease
delay	delay	NOUN	NN	I-Disease
,	,	PUNCT	,	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
either	either	CCONJ	CC	O
therapeutic	therapeutic	ADJ	JJ	O
or	or	CCONJ	CC	O
modestly	modestly	ADV	RB	O
elevated	elevate	VERB	VBN	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
serum	serum	NOUN	NN	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

Because	because	ADP	IN	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
many	many	ADJ	JJ	O
neurologic	neurologic	ADJ	JJ	O
and	and	CCONJ	CC	O
psychiatric	psychiatric	ADJ	JJ	B-Disease
conditions	condition	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
recognition	recognition	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
latter	latter	ADJ	JJ	O
syndrome	syndrome	NOUN	NN	O
has	have	VERB	VBZ	O
important	important	ADJ	JJ	O
implications	implication	NOUN	NNS	O
for	for	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
drug	drug	NOUN	NN	O
in	in	ADP	IN	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Detection	detection	NOUN	NN	O
of	of	ADP	IN	O
abnormal	abnormal	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
adrenergic	adrenergic	ADP	IN	O
neuron	neuron	NOUN	NN	O
activity	activity	NOUN	NN	O
in	in	ADP	IN	O
adriamycin	adriamycin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
with	with	ADP	IN	O
iodine	iodine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
125	125	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
metaiodobenzylguanidine	metaiodobenzylguanidine	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Radiolabeled	radiolabeled	ADJ	JJ	B-Chemical
metaiodobenzylguanidine	metaiodobenzylguanidine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
MIBG	MIBG	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
an	an	DET	DT	O
analog	analog	NOUN	NN	O
of	of	ADP	IN	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
NE	NE	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
serves	serve	VERB	VBZ	O
as	as	ADP	IN	O
an	an	DET	DT	O
index	index	NOUN	NN	O
of	of	ADP	IN	O
adrenergic	adrenergic	NOUN	NN	O
neuron	neuron	NOUN	NN	O
integrity	integrity	NOUN	NN	O
and	and	CCONJ	CC	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

Using	use	VERB	VBG	O
a	a	DET	DT	O
rat	rat	NOUN	NN	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
adriamycin	adriamycin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
tested	test	VERB	VBD	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
that	that	DET	WDT	O
abnormal	abnormal	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
adrenergic	adrenergic	ADP	IN	O
neuron	neuron	NOUN	NN	O
activity	activity	NOUN	NN	O
may	may	VERB	MD	O
appear	appear	VERB	VB	O
and	and	CCONJ	CC	O
be	be	VERB	VB	O
exacerbated	exacerbate	VERB	VBN	O
dose	dose	NOUN	NN	O
-	-	PUNCT	:	O
dependently	dependently	ADV	RB	O
in	in	ADP	IN	O
adriamycin	adriamycin	ADJ	JJ	B-Chemical
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
vacuolar	vacuolar	ADJ	JJ	B-Disease
degeneration	degeneration	NOUN	NN	I-Disease
of	of	ADP	IN	I-Disease
myocardial	myocardial	ADJ	JJ	I-Disease
cells	cell	NOUN	NNS	I-Disease
was	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
in	in	ADP	IN	O
relation	relation	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
adriamycin	adriamycin	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
once	once	ADV	RB	O
a	a	DET	DT	O
week	week	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
abnormalities	abnormality	NOUN	NNS	O
or	or	CCONJ	CC	O
only	only	ADV	RB	O
isolated	isolate	VERB	VBN	O
degeneration	degeneration	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
wk	wk	NOUN	NN	O
treatment	treatment	NOUN	NN	O
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
isolated	isolate	VERB	VBN	O
or	or	CCONJ	CC	O
scattered	scatter	VERB	VBN	O
degeneration	degeneration	NOUN	NN	O
in	in	ADP	IN	O
half	half	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
wk	wk	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
frequent	frequent	ADJ	JJ	O
scattered	scatter	VERB	VBN	O
degeneration	degeneration	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
4	4	NUM	CD	O
-	-	PUNCT	HYPH	O
wk	wk	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
scattered	scatter	VERB	VBN	O
or	or	CCONJ	CC	O
focal	focal	ADJ	JJ	O
degeneration	degeneration	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
wk	wk	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
extensive	extensive	ADJ	JJ	O
degeneration	degeneration	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
8	8	NUM	CD	O
-	-	PUNCT	HYPH	O
wk	wk	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Myocardial	myocardial	ADJ	JJ	O
accumulation	accumulation	NOUN	NN	O
of	of	ADP	IN	O
[	[	PUNCT	-LRB-	O
125I	125i	NUM	CD	O
]	]	PUNCT	-RRB-	O
MIBG	MIBG	PROPN	NNP	B-Chemical
4	4	NUM	CD	O
hr	hr	INTJ	UH	O
after	after	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
injection	injection	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
differ	differ	VERB	VB	O
between	between	ADP	IN	O
the	the	DET	DT	O
controls	control	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
groups	group	NOUN	NNS	O
treated	treat	VERB	VBD	O
3	3	NUM	CD	O
wk	wk	ADP	IN	O
or	or	CCONJ	CC	O
less	less	ADJ	JJR	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
4	4	NUM	CD	O
-	-	PUNCT	HYPH	O
wk	wk	NOUN	NN	O
group	group	NOUN	NN	O
had	have	VERB	VBD	O
a	a	DET	DT	O
slightly	slightly	ADV	RB	O
lower	low	ADJ	JJR	O
accumulation	accumulation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
right	right	ADJ	JJ	O
ventricular	ventricular	ADJ	JJ	O
wall	wall	NOUN	NN	O
(	(	PUNCT	-LRB-	O
82	82	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
accumulation	accumulation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
left	left	ADJ	JJ	O
ventricular	ventricular	ADJ	JJ	O
wall	wall	NOUN	NN	O
(	(	PUNCT	-LRB-	O
about	about	ADV	RB	O
66	66	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
:	:	PUNCT	:	O
p	p	X	XX	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
wk	wk	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
MIBG	MIBG	PROPN	NNP	B-Chemical
accumulation	accumulation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
right	right	NOUN	NN	O
and	and	CCONJ	CC	O
left	leave	VERB	VBD	O
ventricular	ventricular	ADJ	JJ	O
wall	wall	NOUN	NN	O
was	be	VERB	VBD	O
35	35	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
27	27	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
that	that	DET	DT	O
in	in	ADP	IN	O
controls	control	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
(	(	PUNCT	-LRB-	O
p	p	X	XX	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
8	8	NUM	CD	O
-	-	PUNCT	HYPH	O
wk	wk	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
MIBG	MIBG	PROPN	NNP	B-Chemical
accumulation	accumulation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
right	right	NOUN	NN	O
and	and	CCONJ	CC	O
left	leave	VERB	VBD	O
ventricular	ventricular	ADJ	JJ	O
wall	wall	NOUN	NN	O
was	be	VERB	VBD	O
18	18	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
14	14	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
that	that	DET	DT	O
in	in	ADP	IN	O
controls	control	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
(	(	PUNCT	-LRB-	O
p	p	X	XX	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
MIBG	MIBG	PROPN	NNP	B-Chemical
accumulation	accumulation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
myocardium	myocardium	NOUN	NN	O
decreased	decrease	VERB	VBD	O
in	in	ADP	IN	O
an	an	DET	DT	O
adriamycin	adriamycin	ADJ	JJ	B-Chemical
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
manner	manner	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
appearance	appearance	NOUN	NN	O
of	of	ADP	IN	O
impaired	impaired	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
adrenergic	adrenergic	ADP	IN	O
neuron	neuron	NOUN	NN	O
activity	activity	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
slight	slight	ADJ	JJ	O
myocardial	myocardial	ADJ	JJ	B-Disease
impairment	impairment	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
scattered	scatter	VERB	VBN	O
or	or	CCONJ	CC	O
focal	focal	ADJ	JJ	O
vacuolar	vacuolar	ADJ	JJ	B-Disease
degeneration	degeneration	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	O
indicates	indicate	VERB	VBZ	O
that	that	ADP	IN	O
MIBG	MIBG	PROPN	NNP	B-Chemical
scintigraphy	scintigraphy	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
useful	useful	ADJ	JJ	O
method	method	NOUN	NN	O
for	for	ADP	IN	O
detection	detection	NOUN	NN	O
of	of	ADP	IN	O
adriamycin	adriamycin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Syncope	Syncope	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
QT	QT	PROPN	NNP	B-Disease
prolongation	prolongation	NOUN	NN	I-Disease
among	among	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
methadone	methadone	NOUN	NN	B-Chemical
for	for	ADP	IN	O
heroin	heroin	NOUN	NN	B-Chemical
dependence	dependence	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
city	city	NOUN	NN	O
of	of	ADP	IN	O
Copenhagen	Copenhagen	PROPN	NNP	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Methadone	Methadone	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
prescribed	prescribe	VERB	VBN	O
to	to	PART	TO	O
heroin	heroin	VERB	VB	B-Chemical
addicts	addict	NOUN	NNS	O
to	to	PART	TO	O
decrease	decrease	VERB	VB	O
illicit	illicit	ADJ	JJ	O
opioid	opioid	NOUN	NN	O
use	use	NOUN	NN	O
.	.	PUNCT	.	O

Prolongation	prolongation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
QT	QT	PROPN	NNP	O
interval	interval	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ECG	ECG	PROPN	NNP	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
torsade	torsade	NOUN	NN	B-Disease
de	de	X	FW	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
TdP	tdp	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
methadone	methadone	NOUN	NN	B-Chemical
users	user	NOUN	NNS	O
.	.	PUNCT	.	O

As	as	ADP	IN	O
heroin	heroin	NOUN	NN	B-Chemical
addicts	addict	NOUN	NNS	O
sometimes	sometimes	ADV	RB	O
faint	faint	ADJ	JJ	O
while	while	ADP	IN	O
using	use	VERB	VBG	O
illicit	illicit	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
,	,	PUNCT	,	O
doctors	doctor	NOUN	NNS	O
might	may	VERB	MD	O
attribute	attribute	VERB	VB	O
too	too	ADV	RB	O
many	many	ADJ	JJ	O
episodes	episode	NOUN	NNS	O
of	of	ADP	IN	O
syncope	syncope	NOUN	NN	B-Disease
to	to	PART	TO	O
illicit	illicit	VERB	VB	O
drug	drug	NOUN	NN	O
use	use	NOUN	NN	O
and	and	CCONJ	CC	O
thereby	thereby	ADV	RB	O
underestimate	underestimate	VERB	VB	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
TdP	tdp	NOUN	NN	B-Disease
in	in	ADP	IN	O
this	this	DET	DT	O
special	special	ADJ	JJ	O
population	population	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
high	high	ADJ	JJ	O
mortality	mortality	NOUN	NN	O
in	in	ADP	IN	O
this	this	DET	DT	O
population	population	NOUN	NN	O
may	may	VERB	MD	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
part	part	NOUN	NN	O
,	,	PUNCT	,	O
be	be	VERB	VB	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
proarrhythmic	proarrhythmic	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
methadone	methadone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
this	this	DET	DT	O
cross	cross	ADJ	JJ	O
-	-	ADJ	JJ	O
sectional	sectional	ADJ	JJ	O
study	study	NOUN	NN	O
interview	interview	NOUN	NN	O
,	,	PUNCT	,	O
ECGs	ecg	NOUN	NNS	O
and	and	CCONJ	CC	O
blood	blood	NOUN	NN	O
samples	sample	NOUN	NNS	O
were	be	VERB	VBD	O
collected	collect	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
population	population	NOUN	NN	O
of	of	ADP	IN	O
adult	adult	NOUN	NN	O
heroin	heroin	NOUN	NN	B-Chemical
addicts	addict	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
methadone	methadone	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
buprenorphine	buprenorphine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
a	a	DET	DT	O
daily	daily	ADJ	JJ	O
basis	basis	NOUN	NN	O
.	.	PUNCT	.	O

Of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
at	at	ADP	IN	O
the	the	DET	DT	O
Drug	Drug	PROPN	NNP	O
Addiction	Addiction	PROPN	NNP	O
Service	Service	PROPN	NNP	O
in	in	ADP	IN	O
the	the	DET	DT	O
municipal	municipal	NOUN	NN	O
of	of	ADP	IN	O
Copenhagen	Copenhagen	PROPN	NNP	O
,	,	PUNCT	,	O
450	450	NUM	CD	O
(	(	PUNCT	-LRB-	O
approximately	approximately	ADV	RB	O
52	52	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
included	include	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
QT	QT	PROPN	NNP	O
interval	interval	NOUN	NN	O
was	be	VERB	VBD	O
estimated	estimate	VERB	VBN	O
from	from	ADP	IN	O
12	12	NUM	CD	O
lead	lead	NOUN	NN	O
ECGs	ecg	NOUN	NNS	O
.	.	PUNCT	.	O

All	all	DET	DT	O
participants	participant	NOUN	NNS	O
were	be	VERB	VBD	O
interviewed	interview	VERB	VBN	O
about	about	ADP	IN	O
any	any	DET	DT	O
experience	experience	NOUN	NN	O
of	of	ADP	IN	O
syncope	syncope	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
opioid	opioid	NOUN	NN	O
dose	dose	NOUN	NN	O
and	and	CCONJ	CC	O
QT	QT	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
methadone	methadone	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
and	and	CCONJ	CC	O
reporting	reporting	NOUN	NN	O
of	of	ADP	IN	O
syncope	syncope	NOUN	NN	B-Disease
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
using	use	VERB	VBG	O
multivariate	multivariate	ADJ	JJ	O
linear	linear	ADJ	JJ	O
regression	regression	NOUN	NN	O
and	and	CCONJ	CC	O
logistic	logistic	ADJ	JJ	O
regression	regression	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Methadone	Methadone	PROPN	NNP	B-Chemical
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
longer	long	ADJ	JJR	O
QT	QT	PROPN	NNP	O
interval	interval	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
140	140	NUM	CD	O
ms	ms	NOUN	NN	O
/	/	SYM	SYM	O
mg	mg	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
002	002	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

No	no	DET	DT	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
buprenorphine	buprenorphine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
QTc	QTc	PROPN	NNP	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
.	.	PUNCT	.	O

Among	among	ADP	IN	O
the	the	DET	DT	O
subjects	subject	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
methadone	methadone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
28	28	NUM	CD	O
%	%	NOUN	NN	O
men	man	NOUN	NNS	O
and	and	CCONJ	CC	O
32	32	NUM	CD	O
%	%	NOUN	NN	O
women	woman	NOUN	NNS	O
had	have	VERB	VBD	O
prolonged	prolong	VERB	VBN	B-Disease
QTc	qtc	ADJ	JJ	I-Disease
interval	interval	NOUN	NN	I-Disease
.	.	PUNCT	.	O

None	none	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
subjects	subject	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
buprenorphine	buprenorphine	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
QTc	qtc	ADJ	JJ	O
interval	interval	NOUN	NN	O
>	>	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
440	440	NUM	CD	O
s	s	NOUN	NN	O
(	(	PUNCT	-LRB-	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
/	/	SYM	SYM	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
higher	high	ADJ	JJR	O
methadone	methadone	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
to	to	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
4	4	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
times	time	NOUN	NNS	O
higher	high	ADJ	JJR	O
odds	odd	NOUN	NNS	O
for	for	ADP	IN	O
syncope	syncope	NOUN	NN	B-Disease
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Methadone	Methadone	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
QT	QT	PROPN	NNP	B-Disease
prolongation	prolongation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
higher	high	ADJ	JJR	O
reporting	reporting	NOUN	NN	O
of	of	ADP	IN	O
syncope	syncope	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
population	population	NOUN	NN	O
of	of	ADP	IN	O
heroin	heroin	NOUN	NN	B-Chemical
addicts	addict	NOUN	NNS	O
.	.	PUNCT	.	O

Neuroleptic	neuroleptic	ADJ	JJ	B-Disease
malignant	malignant	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
ziprasidone	ziprasidone	NOUN	NN	B-Chemical
on	on	ADP	IN	O
the	the	DET	DT	O
second	second	ADJ	JJ	O
day	day	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Neuroleptic	neuroleptic	ADJ	JJ	B-Disease
malignant	malignant	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
NMS	nms	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
rarest	rare	ADJ	JJS	O
and	and	CCONJ	CC	O
most	most	ADV	RBS	O
serious	serious	ADJ	JJ	O
of	of	ADP	IN	O
the	the	DET	DT	O
neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
movement	movement	NOUN	NN	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	B-Disease
malignant	malignant	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
NMS	NMS	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
ziprasidone	ziprasidone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Although	although	ADP	IN	O
conventional	conventional	ADJ	JJ	O
neuroleptics	neuroleptic	NOUN	NNS	O
are	be	VERB	VBP	O
more	more	ADV	RBR	O
frequently	frequently	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
NMS	NMS	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
atypical	atypical	ADJ	JJ	O
antipsychotic	antipsychotic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
like	like	ADP	IN	O
ziprasidone	ziprasidone	NOUN	NN	B-Chemical
may	may	VERB	MD	O
also	also	ADV	RB	O
be	be	VERB	VB	O
a	a	DET	DT	O
cause	cause	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
male	male	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
schizophrenia	schizophrenia	NOUN	NN	B-Disease
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
signs	sign	NOUN	NNS	O
and	and	CCONJ	CC	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
NMS	NMS	PROPN	NNP	B-Disease
after	after	ADP	IN	O
2	2	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
an	an	DET	DT	O
80	80	NUM	CD	O
-	-	PUNCT	HYPH	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
orally	orally	ADV	RB	O
administrated	administrate	VERB	VBN	O
ziprasidone	ziprasidone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
case	case	NOUN	NN	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
earliest	early	ADJ	JJS	O
(	(	PUNCT	-LRB-	O
second	second	ADJ	JJ	O
day	day	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
)	)	PUNCT	-RRB-	O
NMS	nms	NOUN	NN	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
ziprasidone	ziprasidone	NOUN	NN	B-Chemical
reported	report	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

Peripheral	peripheral	ADJ	JJ	O
iron	iron	NOUN	NN	B-Chemical
dextran	dextran	NOUN	NN	I-Chemical
induced	induced	ADJ	JJ	O
degeneration	degeneration	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
dopaminergic	dopaminergic	ADJ	JJ	I-Disease
neurons	neuron	NOUN	NNS	I-Disease
in	in	ADP	IN	O
rat	rat	NOUN	NN	O
substantia	substantia	NOUN	NN	O
nigra	nigra	NOUN	NN	O
.	.	PUNCT	.	O

Iron	iron	NOUN	NN	B-Chemical
accumulation	accumulation	NOUN	NN	O
is	be	VERB	VBZ	O
considered	consider	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pathogenesis	pathogenesis	NOUN	NN	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

To	to	PART	TO	O
demonstrate	demonstrate	VERB	VB	O
the	the	DET	DT	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
peripheral	peripheral	ADJ	JJ	O
iron	iron	NOUN	NN	B-Chemical
overload	overload	NOUN	NN	O
and	and	CCONJ	CC	O
dopaminergic	dopaminergic	ADJ	JJ	O
neuron	neuron	NOUN	NN	O
loss	loss	NOUN	NN	O
in	in	ADP	IN	O
rat	rat	NOUN	NN	O
substantia	substantia	NOUN	NN	O
nigra	nigra	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SN	SN	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
we	-PRON-	PRON	PRP	O
used	use	VERB	VBD	O
fast	fast	ADJ	JJ	O
cyclic	cyclic	NOUN	NN	O
voltammetry	voltammetry	NOUN	NN	O
,	,	PUNCT	,	O
tyrosine	tyrosine	NOUN	NN	B-Chemical
hydroxylase	hydroxylase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
TH	th	NOUN	NN	O
)	)	PUNCT	-RRB-	O
immunohistochemistry	immunohistochemistry	NOUN	NN	O
,	,	PUNCT	,	O
Perls	Perls	PROPN	NNP	O
'	'	PART	POS	O
iron	iron	NOUN	NN	B-Chemical
staining	staining	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
high	high	ADJ	JJ	O
performance	performance	NOUN	NN	O
liquid	liquid	NOUN	NN	O
chromatography	chromatography	NOUN	NN	O
-	-	PUNCT	HYPH	O
electrochemical	electrochemical	ADJ	JJ	O
detection	detection	NOUN	NN	O
to	to	PART	TO	O
study	study	VERB	VB	O
the	the	DET	DT	O
degeneration	degeneration	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
dopaminergic	dopaminergic	ADJ	JJ	I-Disease
neurons	neuron	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
increased	increase	VERB	VBN	O
iron	iron	NOUN	NN	B-Chemical
content	content	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
SN	sn	NOUN	NN	O
of	of	ADP	IN	O
iron	iron	NOUN	NN	B-Chemical
dextran	dextran	NOUN	NN	I-Chemical
overloaded	overload	VERB	VBN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
findings	finding	NOUN	NNS	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
peripheral	peripheral	ADJ	JJ	O
iron	iron	NOUN	NN	B-Chemical
dextran	dextran	NOUN	NN	I-Chemical
overload	overload	NOUN	NN	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
iron	iron	NOUN	NN	B-Chemical
staining	stain	VERB	VBG	O
positive	positive	ADJ	JJ	O
cells	cell	NOUN	NNS	O
and	and	CCONJ	CC	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
TH	th	NOUN	NN	O
-	-	PUNCT	HYPH	O
immunoreactive	immunoreactive	ADJ	JJ	O
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
SN	sn	NOUN	NN	O
.	.	PUNCT	.	O

As	as	ADP	IN	O
a	a	DET	DT	O
result	result	NOUN	NN	O
,	,	PUNCT	,	O
dopamine	dopamine	NOUN	NN	B-Chemical
release	release	NOUN	NN	O
and	and	CCONJ	CC	O
content	content	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
its	-PRON-	DET	PRP$	O
metabolites	metabolite	NOUN	NNS	O
contents	content	NOUN	NNS	O
were	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
in	in	ADP	IN	O
caudate	caudate	ADJ	JJ	O
putamen	putaman	NOUN	NNS	O
.	.	PUNCT	.	O

Even	even	ADV	RB	O
more	more	ADV	RBR	O
dramatic	dramatic	ADJ	JJ	O
changes	change	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
chronic	chronic	ADJ	JJ	O
overload	overload	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
peripheral	peripheral	ADJ	JJ	O
iron	iron	NOUN	NN	B-Chemical
dextran	dextran	NOUN	NN	I-Chemical
can	can	VERB	MD	O
increase	increase	VERB	VB	O
the	the	DET	DT	O
iron	iron	NOUN	NN	B-Chemical
level	level	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
SN	sn	NOUN	NN	O
,	,	PUNCT	,	O
where	where	ADV	WRB	O
excessive	excessive	ADJ	JJ	O
iron	iron	NOUN	NN	B-Chemical
causes	cause	VERB	VBZ	O
the	the	DET	DT	O
degeneration	degeneration	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
dopaminergic	dopaminergic	ADJ	JJ	I-Disease
neurons	neuron	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
chronic	chronic	ADJ	JJ	O
iron	iron	NOUN	NN	B-Chemical
overload	overload	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
more	more	ADV	RBR	O
destructive	destructive	ADJ	JJ	O
to	to	ADP	IN	O
dopaminergic	dopaminergic	ADJ	JJ	O
neurons	neuron	NOUN	NNS	O
than	than	ADP	IN	O
the	the	DET	DT	O
acute	acute	ADJ	JJ	O
iron	iron	NOUN	NN	B-Chemical
overload	overload	NOUN	NN	O
.	.	PUNCT	.	O

Attenuated	attenuate	VERB	VBN	O
disruption	disruption	NOUN	NN	O
of	of	ADP	IN	O
prepulse	prepulse	NOUN	NN	O
inhibition	inhibition	NOUN	NN	O
by	by	ADP	IN	O
dopaminergic	dopaminergic	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
after	after	ADP	IN	O
maternal	maternal	ADJ	JJ	O
deprivation	deprivation	NOUN	NN	O
and	and	CCONJ	CC	O
adolescent	adolescent	NOUN	NN	O
corticosterone	corticosterone	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
schizophrenia	schizophrenia	NOUN	NN	B-Disease
may	may	VERB	MD	O
include	include	VERB	VB	O
an	an	DET	DT	O
early	early	ADJ	JJ	O
neurodevelopmental	neurodevelopmental	ADJ	JJ	O
stress	stress	NOUN	NN	O
component	component	NOUN	NN	O
which	which	DET	WDT	O
increases	increase	VERB	VBZ	O
vulnerability	vulnerability	NOUN	NN	O
to	to	PART	TO	O
later	later	ADV	RB	O
stressful	stressful	ADJ	JJ	O
life	life	NOUN	NN	O
events	event	NOUN	NNS	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
leading	lead	VERB	VBG	O
to	to	ADP	IN	O
overt	overt	ADJ	JJ	O
disease	disease	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
early	early	ADJ	JJ	O
stress	stress	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
form	form	NOUN	NN	O
of	of	ADP	IN	O
maternal	maternal	ADJ	JJ	O
deprivation	deprivation	NOUN	NN	O
,	,	PUNCT	,	O
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
later	later	ADJ	JJ	O
stress	stress	NOUN	NN	O
,	,	PUNCT	,	O
simulated	simulate	VERB	VBN	O
by	by	ADP	IN	O
chronic	chronic	ADJ	JJ	O
periadolescent	periadolescent	ADJ	JJ	O
corticosterone	corticosterone	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
behaviour	behaviour	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
caused	cause	VERB	VBN	O
disruption	disruption	NOUN	NN	O
of	of	ADP	IN	O
prepulse	prepulse	NOUN	NN	O
inhibition	inhibition	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PPI	PPI	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
controls	control	NOUN	NNS	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
that	that	DET	WDT	O
had	have	VERB	VBD	O
undergone	undergo	VERB	VBN	O
either	either	CCONJ	CC	O
maternal	maternal	ADJ	JJ	O
deprivation	deprivation	NOUN	NN	O
or	or	CCONJ	CC	O
corticosterone	corticosterone	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
was	be	VERB	VBD	O
surprisingly	surprisingly	ADV	RB	O
absent	absent	ADJ	JJ	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
that	that	DET	WDT	O
had	have	VERB	VBD	O
undergone	undergo	VERB	VBN	O
the	the	DET	DT	O
combined	combine	VERB	VBN	O
early	early	ADJ	JJ	O
and	and	CCONJ	CC	O
late	late	ADJ	JJ	O
stress	stress	NOUN	NN	O
.	.	PUNCT	.	O

Amphetamine	amphetamine	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
significantly	significantly	ADV	RB	O
disrupted	disrupt	VERB	VBD	O
PPI	PPI	PROPN	NNP	O
in	in	ADP	IN	O
both	both	DET	DT	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
deprived	deprived	ADJ	JJ	O
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
was	be	VERB	VBD	O
absent	absent	ADJ	JJ	O
in	in	ADP	IN	O
both	both	DET	DT	O
maternally	maternally	ADV	RB	O
deprived	deprive	VERB	VBN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
serotonin	serotonin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
1A	1a	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
,	,	PUNCT	,	O
8	8	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
OH	oh	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
DPAT	DPAT	PROPN	NNP	I-Chemical
,	,	PUNCT	,	O
induced	induce	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
disruption	disruption	NOUN	NN	O
of	of	ADP	IN	O
PPI	PPI	PROPN	NNP	O
in	in	ADP	IN	O
all	all	DET	DT	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Amphetamine	amphetamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
locomotor	locomotor	NOUN	NN	B-Disease
hyperactivity	hyperactivity	NOUN	NN	I-Disease
was	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
in	in	ADP	IN	O
all	all	DET	DT	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
show	show	VERB	VBP	O
an	an	DET	DT	O
inhibitory	inhibitory	ADJ	JJ	O
interaction	interaction	NOUN	NN	O
of	of	ADP	IN	O
early	early	ADJ	JJ	O
stress	stress	NOUN	NN	O
,	,	PUNCT	,	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
maternal	maternal	ADJ	JJ	O
deprivation	deprivation	NOUN	NN	O
,	,	PUNCT	,	O
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
'	'	PUNCT	``	O
adolescent	adolescent	NOUN	NN	O
'	'	PUNCT	''	O
stress	stress	NOUN	NN	O
,	,	PUNCT	,	O
simulated	simulate	VERB	VBN	O
by	by	ADP	IN	O
corticosterone	corticosterone	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
dopaminergic	dopaminergic	ADJ	JJ	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
PPI	PPI	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
altered	altered	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
could	could	VERB	MD	O
indicate	indicate	VERB	VB	O
differential	differential	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
signalling	signal	VERB	VBG	O
leading	lead	VERB	VBG	O
to	to	ADP	IN	O
functional	functional	ADJ	JJ	O
desensitisation	desensitisation	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
altered	altered	ADJ	JJ	O
modulation	modulation	NOUN	NN	O
of	of	ADP	IN	O
sensory	sensory	ADJ	JJ	O
gating	gating	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
nucleus	nucleus	NOUN	NN	O
accumbens	accumben	NOUN	NNS	O
by	by	ADP	IN	O
limbic	limbic	ADJ	JJ	O
structures	structure	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
the	the	DET	DT	O
hippocampus	hippocampus	NOUN	NN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
extremely	extremely	ADV	RB	O
rare	rare	ADJ	JJ	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
delusional	delusional	ADJ	JJ	B-Disease
parasitosis	parasitosis	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
chronic	chronic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
C	C	PROPN	NNP	I-Disease
patient	patient	NOUN	NN	O
during	during	ADP	IN	O
pegylated	pegylate	VERB	VBN	B-Chemical
interferon	interferon	ADJ	JJ	I-Chemical
alpha	alpha	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2b	2b	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
C	C	PROPN	NNP	I-Disease
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
interferon	interferon	NOUN	NN	O
and	and	CCONJ	CC	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
lot	lot	NOUN	NN	O
of	of	ADP	IN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
are	be	VERB	VBP	O
described	describe	VERB	VBN	O
.	.	PUNCT	.	O

Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
three	three	NUM	CD	O
percent	percent	NOUN	NN	O
to	to	ADP	IN	O
44	44	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
develop	develop	VERB	VBP	O
depression	depression	NOUN	NN	B-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
minority	minority	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
evolve	evolve	VERB	VBP	O
to	to	ADP	IN	O
psychosis	psychosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

To	to	ADP	IN	O
the	the	DET	DT	O
best	good	ADJ	JJS	O
of	of	ADP	IN	O
our	-PRON-	DET	PRP$	O
knowledge	knowledge	NOUN	NN	O
,	,	PUNCT	,	O
no	no	DET	DT	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
psychogenic	psychogenic	ADJ	JJ	B-Disease
parasitosis	parasitosis	NOUN	NN	I-Disease
occurring	occur	VERB	VBG	O
during	during	ADP	IN	O
interferon	interferon	NOUN	NN	O
therapy	therapy	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
described	describe	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
present	present	VERB	VBP	O
a	a	DET	DT	O
49	49	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
a	a	DET	DT	O
delusional	delusional	ADJ	JJ	B-Disease
parasitosis	parasitosis	NOUN	NN	I-Disease
during	during	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
pegylated	pegylated	ADJ	JJ	B-Chemical
interferon	interferon	ADJ	JJ	I-Chemical
alpha	alpha	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2b	2b	NUM	CD	I-Chemical
weekly	weekly	NOUN	NN	O
and	and	CCONJ	CC	O
ribavirin	ribavirin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

She	-PRON-	PRON	PRP	O
complained	complain	VERB	VBD	O
of	of	ADP	IN	O
seeing	see	VERB	VBG	O
parasites	parasite	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
larvae	larvae	NOUN	NN	O
of	of	ADP	IN	O
fleas	flea	NOUN	NNS	O
in	in	ADP	IN	O
her	-PRON-	DET	PRP$	O
stools	stool	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
could	could	VERB	MD	O
not	not	ADV	RB	O
be	be	VERB	VB	O
confirmed	confirm	VERB	VBN	O
by	by	ADP	IN	O
any	any	DET	DT	O
technical	technical	ADJ	JJ	O
examination	examination	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	PDT	O
the	the	DET	DT	O
complaints	complaint	NOUN	NNS	O
disappeared	disappear	VERB	VBD	O
after	after	ADP	IN	O
stopping	stop	VERB	VBG	O
pegylated	pegylate	VERB	VBN	B-Chemical
interferon	interferon	ADJ	JJ	I-Chemical
alpha	alpha	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2b	2b	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
reappeared	reappear	VERB	VBN	O
after	after	ADP	IN	O
restarting	restart	VERB	VBG	O
it	-PRON-	PRON	PRP	O
.	.	PUNCT	.	O

She	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
a	a	DET	DT	O
complete	complete	ADJ	JJ	O
sustained	sustain	VERB	VBN	O
viral	viral	ADJ	JJ	O
response	response	NOUN	NN	O
.	.	PUNCT	.	O

Hepatonecrosis	Hepatonecrosis	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
cholangitis	cholangitis	NOUN	NN	B-Disease
related	relate	VERB	VBN	O
to	to	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
phenobarbital	phenobarbital	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
:	:	PUNCT	:	O
an	an	DET	DT	O
autopsy	autopsy	ADJ	JJ	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Phenobarbital	Phenobarbital	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
PB	PB	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
has	have	VERB	VBZ	O
a	a	DET	DT	O
reputation	reputation	NOUN	NN	O
for	for	ADP	IN	O
safety	safety	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
commonly	commonly	ADV	RB	O
believed	believe	VERB	VBN	O
that	that	ADP	IN	O
PB	pb	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
serum	serum	NOUN	NN	O
aminotransferase	aminotransferase	NOUN	NN	O
levels	level	NOUN	NNS	O
do	do	VERB	VBP	O
not	not	ADV	RB	O
indicate	indicate	VERB	VB	O
or	or	CCONJ	CC	O
predict	predict	VERB	VB	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
significant	significant	ADJ	JJ	O
chronic	chronic	ADJ	JJ	O
liver	liver	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Here	here	ADV	RB	O
we	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
of	of	ADP	IN	O
two	two	NUM	CD	O
adult	adult	NOUN	NN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
long	long	ADJ	JJ	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
epilepsy	epilepsy	NOUN	NN	B-Disease
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
PB	PB	PROPN	NNP	B-Chemical
who	who	PRON	WP	O
died	die	VERB	VBD	O
suddenly	suddenly	ADV	RB	O
:	:	PUNCT	:	O
one	one	NUM	CD	O
as	as	ADP	IN	O
consequence	consequence	NOUN	NN	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
bronchopneumonia	bronchopneumonia	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

At	at	ADP	IN	O
autopsy	autopsy	ADJ	JJ	O
,	,	PUNCT	,	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
liver	liver	NOUN	NN	O
parenchyma	parenchyma	NOUN	NN	O
revealed	reveal	VERB	VBD	O
rich	rich	ADJ	JJ	O
portal	portal	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
infiltrate	infiltrate	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
consisted	consist	VERB	VBD	O
of	of	ADP	IN	O
mixed	mixed	ADJ	JJ	O
eosinophil	eosinophil	NOUN	NN	O
and	and	CCONJ	CC	O
monocyte	monocyte	NOUN	NN	O
cells	cell	NOUN	NNS	O
,	,	PUNCT	,	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
several	several	ADJ	JJ	O
foci	foci	NOUN	NN	O
of	of	ADP	IN	O
necrosis	necrosis	NOUN	NN	B-Disease
surrounded	surround	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
hard	hard	ADJ	JJ	O
ring	ring	NOUN	NN	O
of	of	ADP	IN	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
specific	specific	ADJ	JJ	O
granulomatous	granulomatous	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
.	.	PUNCT	.	O

Inflammatory	inflammatory	ADJ	JJ	O
reactions	reaction	NOUN	NNS	O
of	of	ADP	IN	O
internal	internal	ADJ	JJ	O
and	and	CCONJ	CC	O
external	external	ADJ	JJ	O
hepatic	hepatic	ADJ	JJ	O
biliary	biliary	ADJ	JJ	O
ducts	duct	NOUN	NNS	O
were	be	VERB	VBD	O
also	also	ADV	RB	O
seen	see	VERB	VBN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
findings	finding	NOUN	NNS	O
illustrate	illustrate	VERB	VBP	O
that	that	ADP	IN	O
PB	PB	PROPN	NNP	B-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	O
liver	liver	NOUN	NN	B-Disease
damage	damage	NOUN	NN	I-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
may	may	VERB	MD	O
lead	lead	VERB	VB	O
to	to	ADP	IN	O
more	more	ADV	RBR	O
serious	serious	ADJ	JJ	O
and	and	CCONJ	CC	O
deleterious	deleterious	ADJ	JJ	O
consequences	consequence	NOUN	NNS	O
.	.	PUNCT	.	O

For	for	ADP	IN	O
this	this	DET	DT	O
reason	reason	NOUN	NN	O
,	,	PUNCT	,	O
each	each	DET	DT	O
clinician	clinician	NOUN	NN	O
should	should	VERB	MD	O
recognize	recognize	VERB	VB	O
this	this	DET	DT	O
entity	entity	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
differential	differential	ADJ	JJ	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
PB	PB	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
asymptomatic	asymptomatic	ADJ	JJ	O
chronic	chronic	ADJ	JJ	B-Disease
hepatic	hepatic	ADJ	JJ	I-Disease
enzyme	enzyme	ADJ	JJ	I-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Delayed	delay	VERB	VBN	O
leukoencephalopathy	leukoencephalopathy	ADJ	JJ	B-Disease
with	with	ADP	IN	O
stroke	stroke	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
presentation	presentation	NOUN	NN	O
in	in	ADP	IN	O
chemotherapy	chemotherapy	NOUN	NN	O
recipients	recipient	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
A	a	DET	DT	O
transient	transient	ADJ	JJ	O
leukoencephalopathy	leukoencephalopathy	ADJ	JJ	B-Disease
mimicking	mimicking	NOUN	NN	O
cerebrovascular	cerebrovascular	ADJ	JJ	B-Disease
accident	accident	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
described	describe	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
complication	complication	NOUN	NN	O
of	of	ADP	IN	O
chemotherapy	chemotherapy	NOUN	NN	O
,	,	PUNCT	,	O
most	most	ADV	RBS	O
commonly	commonly	ADV	RB	O
in	in	ADP	IN	O
recipients	recipient	NOUN	NNS	O
of	of	ADP	IN	O
intrathecal	intrathecal	ADJ	JJ	O
methotrexate	methotrexate	NOUN	NN	B-Chemical
for	for	ADP	IN	O
childhood	childhood	NOUN	NN	O
leukaemia	leukaemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Recently	recently	ADV	RB	O
published	publish	VERB	VBN	O
neuroimaging	neuroimage	VERB	VBG	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
a	a	DET	DT	O
common	common	ADJ	JJ	O
pathophysiology	pathophysiology	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
variety	variety	NOUN	NN	O
of	of	ADP	IN	O
chemotherapy	chemotherapy	NOUN	NN	O
agents	agent	NOUN	NNS	O
and	and	CCONJ	CC	O
modes	mode	NOUN	NNS	O
of	of	ADP	IN	O
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
reviewed	review	VERB	VBD	O
the	the	DET	DT	O
medical	medical	ADJ	JJ	O
literature	literature	NOUN	NN	O
for	for	ADP	IN	O
single	single	ADJ	JJ	O
reports	report	NOUN	NNS	O
and	and	CCONJ	CC	O
case	case	NOUN	NN	O
series	series	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
presenting	present	VERB	VBG	O
with	with	ADP	IN	O
stroke	stroke	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
episodes	episode	NOUN	NNS	O
while	while	ADP	IN	O
receiving	receive	VERB	VBG	O
systemic	systemic	ADJ	JJ	O
or	or	CCONJ	CC	O
intrathecal	intrathecal	ADJ	JJ	O
chemotherapy	chemotherapy	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
only	only	ADV	RB	O
included	include	VERB	VBD	O
studies	study	NOUN	NNS	O
providing	provide	VERB	VBG	O
detailed	detailed	ADJ	JJ	O
neuroimaging	neuroimaging	NOUN	NN	O
data	datum	NOUN	NNS	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
cerebrovascular	cerebrovascular	ADJ	JJ	B-Disease
accidents	accident	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
excluded	exclude	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
identified	identify	VERB	VBD	O
27	27	NUM	CD	O
reports	report	NOUN	NNS	O
of	of	ADP	IN	O
toxic	toxic	ADJ	JJ	O
leukoencephalopathy	leukoencephalopathy	NOUN	NN	B-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
methotrexate	methotrexate	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
intrathecal	intrathecal	ADJ	JJ	O
,	,	PUNCT	,	O
systemic	systemic	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
fluorouracil	fluorouracil	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
derivative	derivative	ADJ	JJ	O
carmofur	carmofur	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
capecitabine	capecitabine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Diffusion	diffusion	NOUN	NN	O
weighted	weight	VERB	VBD	O
imaging	image	VERB	VBG	O
(	(	PUNCT	-LRB-	O
DWI	DWI	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
well	well	ADV	RB	O
demarcated	demarcated	ADJ	JJ	O
hyperintense	hyperintense	NOUN	NN	O
lesions	lesion	NOUN	NNS	B-Disease
within	within	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
subcortical	subcortical	ADJ	JJ	I-Disease
white	white	ADJ	JJ	I-Disease
matter	matter	NOUN	NN	I-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
cerebral	cerebral	ADJ	JJ	O
hemispheres	hemisphere	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
corpus	corpus	NOUN	NN	O
callosum	callosum	NOUN	NN	O
,	,	PUNCT	,	O
corresponding	correspond	VERB	VBG	O
to	to	ADP	IN	O
areas	area	NOUN	NNS	O
of	of	ADP	IN	O
decreased	decrease	VERB	VBN	O
proton	proton	NOUN	NN	O
diffusion	diffusion	NOUN	NN	O
on	on	ADP	IN	O
apparent	apparent	ADJ	JJ	O
diffusion	diffusion	NOUN	NN	O
coefficient	coefficient	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ADC	adc	NOUN	NN	O
)	)	PUNCT	-RRB-	O
maps	map	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
available	available	ADJ	JJ	O
in	in	ADP	IN	O
21	21	NUM	CD	O
/	/	SYM	SYM	O
27	27	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Lesions	lesion	NOUN	NNS	O
exceeded	exceed	VERB	VBD	O
the	the	DET	DT	O
confines	confine	NOUN	NNS	O
of	of	ADP	IN	O
adjacent	adjacent	ADJ	JJ	O
vascular	vascular	ADJ	JJ	O
territories	territory	NOUN	NNS	O
.	.	PUNCT	.	O

Complete	complete	ADJ	JJ	O
resolution	resolution	NOUN	NN	O
of	of	ADP	IN	O
symptoms	symptom	NOUN	NNS	O
within	within	ADP	IN	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
4	4	NUM	CD	O
days	day	NOUN	NNS	O
was	be	VERB	VBD	O
accompanied	accompany	VERB	VBN	O
by	by	ADP	IN	O
normalisation	normalisation	NOUN	NN	O
of	of	ADP	IN	O
ADC	adc	NOUN	NN	O
abnormalities	abnormality	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
fluid	fluid	ADJ	JJ	O
attenuated	attenuate	VERB	VBN	O
inversion	inversion	NOUN	NN	O
recovery	recovery	NOUN	NN	O
(	(	PUNCT	-LRB-	O
FLAIR	FLAIR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
sequences	sequence	VERB	VBZ	O
frequently	frequently	ADV	RB	O
revealed	reveal	VERB	VBD	O
persistent	persistent	ADJ	JJ	O
white	white	ADJ	JJ	B-Disease
matter	matter	NOUN	NN	I-Disease
abnormalities	abnormality	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Several	several	ADJ	JJ	O
pathophysiological	pathophysiological	ADJ	JJ	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
delayed	delay	VERB	VBN	O
leukoencephalopathy	leukoencephalopathy	ADJ	JJ	B-Disease
after	after	ADP	IN	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
intrathecal	intrathecal	ADJ	JJ	O
or	or	CCONJ	CC	O
systemic	systemic	ADJ	JJ	O
chemotherapy	chemotherapy	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
proposed	propose	VERB	VBN	O
.	.	PUNCT	.	O

DWI	DWI	PROPN	NNP	O
findings	finding	NOUN	NNS	O
in	in	ADP	IN	O
this	this	DET	DT	O
cohort	cohort	NOUN	NN	O
are	be	VERB	VBP	O
indicative	indicative	ADJ	JJ	O
of	of	ADP	IN	O
cytotoxic	cytotoxic	ADJ	JJ	B-Disease
oedema	oedema	NOUN	NN	I-Disease
within	within	ADP	IN	I-Disease
cerebral	cerebral	ADJ	JJ	I-Disease
white	white	ADJ	JJ	I-Disease
matter	matter	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
lend	lend	VERB	VB	O
support	support	NOUN	NN	O
to	to	ADP	IN	O
an	an	DET	DT	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
partially	partially	ADV	RB	O
reversible	reversible	ADJ	JJ	O
metabolic	metabolic	NOUN	NN	O
derangement	derangement	NOUN	NN	O
as	as	ADP	IN	O
the	the	DET	DT	O
basis	basis	NOUN	NN	O
for	for	ADP	IN	O
this	this	DET	DT	O
syndrome	syndrome	NOUN	NN	O
.	.	PUNCT	.	O

Prenatal	prenatal	ADJ	JJ	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
induces	induce	NOUN	NNS	O
fetal	fetal	ADJ	JJ	B-Disease
pulmonary	pulmonary	ADJ	JJ	I-Disease
hypertension	hypertension	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

RATIONALE	RATIONALE	PROPN	NNP	O
:	:	PUNCT	:	O
Fluoxetine	Fluoxetine	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
selective	selective	ADJ	JJ	O
serotonin	serotonin	NOUN	NN	B-Chemical
reuptake	reuptake	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
antidepressant	antidepressant	NOUN	NN	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
by	by	ADP	IN	O
pregnant	pregnant	ADJ	JJ	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

Epidemiological	epidemiological	ADJ	JJ	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
exposure	exposure	NOUN	NN	O
prenatally	prenatally	ADV	RB	O
increases	increase	VERB	VBZ	O
the	the	DET	DT	O
prevalence	prevalence	NOUN	NN	O
of	of	ADP	IN	O
persistent	persistent	ADJ	JJ	O
pulmonary	pulmonary	ADJ	JJ	B-Disease
hypertension	hypertension	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
newborn	newborn	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
this	this	DET	DT	O
effect	effect	NOUN	NN	O
is	be	VERB	VBZ	O
unclear	unclear	ADJ	JJ	O
and	and	CCONJ	CC	O
paradoxical	paradoxical	ADJ	JJ	O
,	,	PUNCT	,	O
considering	consider	VERB	VBG	O
the	the	DET	DT	O
current	current	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
pulmonary	pulmonary	ADJ	JJ	B-Disease
hypertension	hypertension	NOUN	NN	I-Disease
protective	protective	ADJ	JJ	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
effect	effect	NOUN	NN	O
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
rodents	rodent	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVES	objectives	NOUN	NN	O
:	:	PUNCT	:	O
To	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
fetal	fetal	ADJ	JJ	O
rat	rat	NOUN	NN	O
pulmonary	pulmonary	ADJ	JJ	O
vascular	vascular	NOUN	NN	O
smooth	smooth	ADJ	JJ	O
muscle	muscle	NOUN	NN	O
mechanical	mechanical	ADJ	JJ	O
properties	property	NOUN	NNS	O
and	and	CCONJ	CC	O
cell	cell	NOUN	NN	O
proliferation	proliferation	NOUN	NN	O
rate	rate	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Pregnant	pregnant	ADJ	JJ	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
from	from	ADP	IN	O
Day	day	NOUN	NN	O
11	11	NUM	CD	O
through	through	ADP	IN	O
Day	day	NOUN	NN	O
21	21	NUM	CD	O
of	of	ADP	IN	O
gestation	gestation	NOUN	NN	O
.	.	PUNCT	.	O

MEASUREMENTS	measurement	NOUN	NNS	O
AND	and	CCONJ	CC	O
MAIN	main	ADJ	JJ	O
RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Fetuses	fetus	NOUN	NNS	O
were	be	VERB	VBD	O
delivered	deliver	VERB	VBN	O
by	by	ADP	IN	O
cesarean	cesarean	ADJ	JJ	O
section	section	NOUN	NN	O
.	.	PUNCT	.	O

As	as	ADP	IN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
controls	control	NOUN	NNS	O
,	,	PUNCT	,	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
exposure	exposure	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
fetal	fetal	ADJ	JJ	B-Disease
pulmonary	pulmonary	ADJ	JJ	I-Disease
hypertension	hypertension	NOUN	NN	I-Disease
as	as	ADP	IN	O
evidenced	evidence	VERB	VBN	O
by	by	ADP	IN	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
weight	weight	NOUN	NN	O
ratio	ratio	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
right	right	ADJ	JJ	O
ventricle	ventricle	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
left	left	ADJ	JJ	O
ventricle	ventricle	NOUN	NN	O
plus	plus	CCONJ	CC	O
septum	septum	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
02	02	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
by	by	ADP	IN	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
pulmonary	pulmonary	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
medial	medial	ADJ	JJ	O
thickness	thickness	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Postnatal	postnatal	NOUN	NN	O
mortality	mortality	NOUN	NN	O
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
among	among	ADP	IN	O
experimental	experimental	ADJ	JJ	O
animals	animal	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
arterial	arterial	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
saturation	saturation	NOUN	NN	O
was	be	VERB	VBD	O
96	96	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
in	in	ADP	IN	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
day	day	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
control	control	NOUN	NN	O
animals	animal	NOUN	NNS	O
and	and	CCONJ	CC	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
exposed	expose	VERB	VBN	O
pups	pup	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
79	79	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
vitro	vitro	NOUN	NN	O
,	,	PUNCT	,	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
induced	induce	VERB	VBN	O
pulmonary	pulmonary	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
muscle	muscle	NOUN	NN	O
contraction	contraction	NOUN	NN	O
in	in	ADP	IN	O
fetal	fetal	ADJ	JJ	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
adult	adult	NOUN	NN	O
,	,	PUNCT	,	O
animals	animal	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
reduced	reduce	VERB	VBN	O
serotonin	serotonin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
contraction	contraction	NOUN	NN	O
at	at	ADP	IN	O
both	both	DET	DT	O
ages	age	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
in	in	ADP	IN	O
utero	utero	ADJ	JJ	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
a	a	DET	DT	O
low	low	ADJ	JJ	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
the	the	DET	DT	O
pulmonary	pulmonary	ADJ	JJ	O
arterial	arterial	NOUN	NN	O
smooth	smooth	ADJ	JJ	O
muscle	muscle	NOUN	NN	O
cell	cell	NOUN	NN	O
proliferation	proliferation	NOUN	NN	O
rate	rate	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBN	O
in	in	ADP	IN	O
fetal	fetal	ADJ	JJ	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
adult	adult	NOUN	NN	O
,	,	PUNCT	,	O
cells	cell	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
adult	adult	NOUN	NN	O
,	,	PUNCT	,	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
exposure	exposure	NOUN	NN	O
in	in	ADP	IN	O
utero	utero	ADJ	JJ	O
induces	induce	NOUN	NNS	O
pulmonary	pulmonary	ADJ	JJ	B-Disease
hypertension	hypertension	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
fetal	fetal	ADJ	JJ	O
rat	rat	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
result	result	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
developmentally	developmentally	ADV	RB	O
regulated	regulated	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
pulmonary	pulmonary	ADJ	JJ	O
vascular	vascular	NOUN	NN	O
smooth	smooth	ADJ	JJ	O
muscle	muscle	NOUN	NN	O
proliferation	proliferation	NOUN	NN	O
.	.	PUNCT	.	O

Disulfiram	Disulfiram	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
transient	transient	ADJ	JJ	O
optic	optic	NOUN	NN	B-Disease
and	and	CCONJ	CC	I-Disease
peripheral	peripheral	ADJ	JJ	I-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
:	:	PUNCT	:	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

AIM	AIM	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
report	report	VERB	VB	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
optic	optic	ADJ	JJ	B-Disease
and	and	CCONJ	CC	I-Disease
peripheral	peripheral	ADJ	JJ	I-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
after	after	ADP	IN	O
chronic	chronic	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
disulfiram	disulfiram	NOUN	NN	B-Chemical
for	for	ADP	IN	O
alcohol	alcohol	NOUN	NN	B-Disease
dependence	dependence	NOUN	NN	I-Disease
management	management	NOUN	NN	O
.	.	PUNCT	.	O

MATERIALS	material	NOUN	NNS	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
A	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
A	a	DET	DT	O
57	57	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
male	male	NOUN	NN	O
presented	present	VERB	VBN	O
with	with	ADP	IN	O
gradual	gradual	ADJ	JJ	O
loss	loss	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
vision	vision	NOUN	NN	I-Disease
in	in	ADP	IN	O
both	both	DET	DT	O
eyes	eye	NOUN	NNS	O
with	with	ADP	IN	O
intermittent	intermittent	ADJ	JJ	O
headaches	headache	NOUN	NNS	B-Disease
for	for	ADP	IN	O
2	2	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
also	also	ADV	RB	O
complained	complain	VERB	VBD	O
of	of	ADP	IN	O
paraesthesia	paraesthesia	NOUN	NN	B-Disease
with	with	ADP	IN	O
numbness	numbness	NOUN	NN	B-Disease
in	in	ADP	IN	O
both	both	DET	DT	O
feet	foot	NOUN	NNS	O
.	.	PUNCT	.	O

His	-PRON-	DET	PRP$	O
vision	vision	NOUN	NN	O
was	be	VERB	VBD	O
6	6	NUM	CD	O
/	/	SYM	SYM	O
15	15	NUM	CD	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
/	/	SYM	SYM	O
60	60	NUM	CD	O
in	in	ADP	IN	O
the	the	DET	DT	O
right	right	NOUN	NN	O
and	and	CCONJ	CC	O
left	left	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Fundoscopy	Fundoscopy	PROPN	NNP	O
revealed	reveal	VERB	VBD	O
bilaterally	bilaterally	ADV	RB	O
swollen	swollen	ADJ	JJ	O
optic	optic	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
heads	head	NOUN	NNS	O
.	.	PUNCT	.	O

Visual	visual	ADJ	JJ	O
field	field	NOUN	NN	O
testing	testing	NOUN	NN	O
confirmed	confirm	VERB	VBD	O
bilateral	bilateral	ADJ	JJ	O
central	central	ADJ	JJ	O
-	-	PUNCT	HYPH	O
caecal	caecal	ADJ	JJ	O
scotomata	scotomata	NOUN	NN	B-Disease
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
taking	take	VERB	VBG	O
disulfiram	disulfiram	NOUN	NN	B-Chemical
for	for	ADP	IN	O
alcohol	alcohol	NOUN	NN	B-Disease
dependence	dependence	NOUN	NN	I-Disease
for	for	ADP	IN	O
the	the	DET	DT	O
preceding	precede	VERB	VBG	O
3	3	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

Disulfiram	Disulfiram	PROPN	NNP	B-Chemical
discontinuation	discontinuation	NOUN	NN	O
lead	lead	VERB	VBP	O
to	to	ADP	IN	O
an	an	DET	DT	O
immediate	immediate	ADJ	JJ	O
symptomatic	symptomatic	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Physicians	physician	NOUN	NNS	O
initiating	initiate	VERB	VBG	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
disulfiram	disulfiram	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
these	these	DET	DT	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

They	-PRON-	PRON	PRP	O
should	should	VERB	MD	O
recommend	recommend	VERB	VB	O
annual	annual	ADJ	JJ	O
ophthalmic	ophthalmic	ADJ	JJ	O
reviews	review	NOUN	NNS	O
with	with	ADP	IN	O
visual	visual	ADJ	JJ	O
field	field	NOUN	NN	O
testing	testing	NOUN	NN	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
reassured	reassure	VERB	VBN	O
with	with	ADP	IN	O
respect	respect	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
reversibility	reversibility	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

Intraocular	intraocular	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
uveitis	uveitis	ADJ	JJ	B-Disease
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
fluocinolone	fluocinolone	NOUN	NN	B-Chemical
acetonide	acetonide	NOUN	NN	I-Chemical
implants	implant	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
report	report	VERB	VB	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
and	and	CCONJ	CC	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
elevated	elevated	ADJ	JJ	B-Disease
intraocular	intraocular	ADJ	JJ	I-Disease
pressure	pressure	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
IOP	IOP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
uveitis	uveitis	ADJ	JJ	B-Disease
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
fluocinolone	fluocinolone	NOUN	NN	B-Chemical
acetonide	acetonide	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
FA	FA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
intravitreal	intravitreal	ADJ	JJ	O
implant	implant	ADJ	JJ	O
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
Pooled	pool	VERB	VBN	O
data	datum	NOUN	NNS	O
from	from	ADP	IN	O
3	3	NUM	CD	O
multicenter	multicenter	NOUN	NN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
masked	masked	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
controlled	control	VERB	VBN	O
,	,	PUNCT	,	O
phase	phase	NOUN	NN	O
2b	2b	NUM	CD	O
/	/	SYM	SYM	O
3	3	NUM	CD	O
clinical	clinical	ADJ	JJ	O
trials	trial	NOUN	NNS	O
evaluating	evaluate	VERB	VBG	O
the	the	DET	DT	O
safety	safety	NOUN	NN	O
and	and	CCONJ	CC	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
59	59	NUM	CD	O
-	-	PUNCT	HYPH	O
mg	mg	NOUN	NN	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
mg	mg	NOUN	NN	O
FA	FA	PROPN	NNP	B-Chemical
intravitreal	intravitreal	ADJ	JJ	O
implant	implant	ADJ	JJ	O
or	or	CCONJ	CC	O
standard	standard	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
were	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
During	during	ADP	IN	O
the	the	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
,	,	PUNCT	,	O
71	71	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
implanted	implanted	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
had	have	VERB	VBD	O
an	an	DET	DT	O
IOP	IOP	PROPN	NNP	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
10	10	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
baseline	baseline	NOUN	NN	O
and	and	CCONJ	CC	O
55	55	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
24	24	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
eyes	eye	NOUN	NNS	O
reached	reach	VERB	VBD	O
an	an	DET	DT	O
IOP	IOP	PROPN	NNP	O
of	of	ADP	IN	O
30	30	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
,	,	PUNCT	,	O
40	40	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
50	50	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Topical	topical	ADJ	JJ	O
IOP	IOP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
lowering	lower	VERB	VBG	O
medication	medication	NOUN	NN	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
in	in	ADP	IN	O
74	74	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
implanted	implanted	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
IOP	IOP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
lowering	lower	VERB	VBG	O
surgeries	surgery	NOUN	NNS	O
,	,	PUNCT	,	O
most	most	ADJ	JJS	O
of	of	ADP	IN	O
which	which	DET	WDT	O
were	be	VERB	VBD	O
trabeculectomies	trabeculectomie	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
76	76	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
on	on	ADP	IN	O
36	36	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
implanted	implanted	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
.	.	PUNCT	.	O

Intraocular	intraocular	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
-	-	PUNCT	HYPH	O
lowering	lower	VERB	VBG	O
surgeries	surgery	NOUN	NNS	O
were	be	VERB	VBD	O
considered	consider	VERB	VBN	O
a	a	DET	DT	O
success	success	NOUN	NN	O
(	(	PUNCT	-LRB-	O
postoperative	postoperative	ADJ	JJ	O
IOP	IOP	PROPN	NNP	O
of	of	ADP	IN	O
6	6	NUM	CD	O
-	-	SYM	SYM	O
21	21	NUM	CD	O
mm	mm	NOUN	NNS	O
Hg	Hg	PROPN	NNP	O
with	with	ADP	IN	O
or	or	CCONJ	CC	O
without	without	ADP	IN	O
additional	additional	ADJ	JJ	O
IOP	IOP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
lowering	lower	VERB	VBG	O
medication	medication	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
85	85	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
eyes	eye	NOUN	NNS	O
at	at	ADP	IN	O
1	1	NUM	CD	O
year	year	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
hypotony	hypotony	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
IOP	IOP	PROPN	NNP	O
<	<	X	XX	O
/	/	SYM	SYM	O
=	=	SYM	SYM	O
5	5	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
following	follow	VERB	VBG	O
IOP	IOP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
lowering	lower	VERB	VBG	O
surgery	surgery	NOUN	NN	O
(	(	PUNCT	-LRB-	O
42	42	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
different	different	ADJ	JJ	O
from	from	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
implanted	implant	VERB	VBN	O
eyes	eye	NOUN	NNS	O
not	not	ADV	RB	O
subjected	subject	VERB	VBN	O
to	to	ADP	IN	O
surgery	surgery	NOUN	NN	O
(	(	PUNCT	-LRB-	O
35	35	NUM	CD	O
.	.	NOUN	NN	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	X	XX	O
.	.	PUNCT	.	O
09	09	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Elevated	elevated	ADJ	JJ	O
IOP	IOP	PROPN	NNP	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
complication	complication	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
FA	FA	PROPN	NNP	O
intravitreal	intravitreal	ADJ	JJ	O
implant	implant	ADJ	JJ	O
but	but	CCONJ	CC	O
may	may	VERB	MD	O
be	be	VERB	VB	O
controlled	control	VERB	VBN	O
with	with	ADP	IN	O
medication	medication	NOUN	NN	O
and	and	CCONJ	CC	O
surgery	surgery	NOUN	NN	O
.	.	PUNCT	.	O

Myocardial	Myocardial	PROPN	NNP	O
Fas	Fas	PROPN	NNP	O
ligand	ligand	NOUN	NN	O
expression	expression	NOUN	NN	O
increases	increase	VERB	VBZ	O
susceptibility	susceptibility	NOUN	NN	O
to	to	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Dilated	dilate	VERB	VBN	B-Disease
cardiomyopathy	cardiomyopathy	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
DCM	DCM	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
myocarditis	myocarditis	NOUN	NN	B-Disease
occur	occur	VERB	VBP	O
in	in	ADP	IN	O
many	many	ADJ	JJ	O
HIV	HIV	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	I-Disease
infected	infect	VERB	VBN	I-Disease
individuals	individual	NOUN	NNS	O
,	,	PUNCT	,	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
symptomatic	symptomatic	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
in	in	ADP	IN	O
up	up	ADP	IN	O
to	to	PART	TO	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Highly	highly	ADV	RB	O
active	active	ADJ	JJ	O
antiretroviral	antiretroviral	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HAART	HAART	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
has	have	VERB	VBZ	O
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBN	O
morbidity	morbidity	NOUN	NN	O
and	and	CCONJ	CC	O
mortality	mortality	NOUN	NN	O
of	of	ADP	IN	O
acquired	acquire	VERB	VBN	B-Disease
immunodeficiency	immunodeficiency	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
AIDS	AIDS	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
has	have	VERB	VBZ	O
resulted	result	VERB	VBN	O
in	in	ADP	IN	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
and	and	CCONJ	CC	I-Disease
skeletal	skeletal	ADJ	JJ	I-Disease
myopathies	myopathy	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
AND	and	CCONJ	CC	O
RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
whether	whether	ADP	IN	O
the	the	DET	DT	O
HAART	HAART	PROPN	NNP	O
component	component	NOUN	NN	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	B-Chemical
'	'	PART	POS	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
azido	azido	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2	2	NUM	CD	I-Chemical
'	'	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
3	3	NUM	CD	I-Chemical
'	'	PART	POS	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
deoxythymidine	deoxythymidine	NOUN	NN	I-Chemical
;	;	PUNCT	:	O
AZT	AZT	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
triggers	trigger	VERB	VBZ	O
the	the	DET	DT	O
Fas	Fas	PROPN	NNP	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
cell	cell	NOUN	NN	O
-	-	PUNCT	HYPH	O
death	death	NOUN	NN	O
pathway	pathway	NOUN	NN	O
and	and	CCONJ	CC	O
cause	cause	VERB	VB	O
cytoskeletal	cytoskeletal	ADJ	JJ	O
disruption	disruption	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
murine	murine	ADJ	JJ	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
DCM	DCM	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
8	8	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
transgenic	transgenic	NOUN	NN	O
(	(	PUNCT	-LRB-	O
expressing	express	VERB	VBG	O
Fas	Fas	PROPN	NNP	O
ligand	ligand	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
myocardium	myocardium	NOUN	NN	O
:	:	PUNCT	:	O
FasL	FasL	PROPN	NNP	O
Tg	Tg	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
transgenic	transgenic	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
NTg	NTg	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
received	receive	VERB	VBD	O
water	water	NOUN	NN	O
ad	ad	NOUN	NN	O
libitum	libitum	NOUN	NN	O
containing	contain	VERB	VBG	O
different	different	ADJ	JJ	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
07	07	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
,	,	PUNCT	,	O
cardiac	cardiac	ADJ	JJ	O
function	function	NOUN	NN	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
echocardiography	echocardiography	NOUN	NN	O
and	and	CCONJ	CC	O
morphology	morphology	NOUN	NN	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
histopathologic	histopathologic	ADJ	JJ	O
and	and	CCONJ	CC	O
immunohistochemical	immunohistochemical	ADJ	JJ	O
methods	method	NOUN	NNS	O
.	.	PUNCT	.	O

NTg	NTg	NOUN	NNS	O
and	and	CCONJ	CC	O
untreated	untreated	ADJ	JJ	O
FasL	FasL	PROPN	NNP	O
Tg	Tg	PROPN	NNP	O
mice	mouse	NOUN	NNS	O
showed	show	VERB	VBD	O
little	little	ADJ	JJ	O
or	or	CCONJ	CC	O
no	no	DET	DT	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
structure	structure	NOUN	NN	O
or	or	CCONJ	CC	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
AZT	AZT	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
FasL	FasL	PROPN	NNP	O
Tg	Tg	PROPN	NNP	O
mice	mouse	NOUN	NNS	O
developed	develop	VERB	VBD	O
cardiac	cardiac	ADJ	JJ	B-Disease
dilation	dilation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
depressed	depressed	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
manner	manner	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
concomitant	concomitant	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
infiltration	infiltration	NOUN	NN	O
of	of	ADP	IN	O
both	both	DET	DT	O
ventricles	ventricle	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
changes	change	NOUN	NNS	O
were	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
increased	increase	VERB	VBN	O
sarcolemmal	sarcolemmal	ADJ	JJ	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
Fas	Fas	PROPN	NNP	O
and	and	CCONJ	CC	O
FasL	FasL	PROPN	NNP	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
increased	increase	VERB	VBN	O
activation	activation	NOUN	NN	O
of	of	ADP	IN	O
caspase	caspase	NOUN	NN	O
3	3	NUM	CD	O
,	,	PUNCT	,	O
translocation	translocation	NOUN	NN	O
of	of	ADP	IN	O
calpain	calpain	NOUN	NN	O
1	1	NUM	CD	O
to	to	ADP	IN	O
the	the	DET	DT	O
sarcolemma	sarcolemma	NOUN	NN	O
and	and	CCONJ	CC	O
sarcomere	sarcomere	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBN	O
numbers	number	NOUN	NNS	O
of	of	ADP	IN	O
cells	cell	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
apoptosis	apoptosis	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
were	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
dystrophin	dystrophin	NOUN	NN	O
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	O
troponin	troponin	NOUN	NN	O
I	-PRON-	PRON	PRP	O
localization	localization	VERB	VBP	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
sarcolemmal	sarcolemmal	ADJ	JJ	O
integrity	integrity	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
Fas	Fas	PROPN	NNP	O
ligand	ligand	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
myocardium	myocardium	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
identified	identify	VERB	VBN	O
in	in	ADP	IN	O
HIV	HIV	PROPN	NNP	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
might	may	VERB	MD	O
increase	increase	VERB	VB	O
the	the	DET	DT	O
susceptibility	susceptibility	NOUN	NN	O
to	to	ADP	IN	O
HAART	HAART	PROPN	NNP	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
activation	activation	NOUN	NN	O
of	of	ADP	IN	O
apoptotic	apoptotic	ADJ	JJ	O
pathways	pathway	NOUN	NNS	O
,	,	PUNCT	,	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
dilation	dilation	NOUN	NN	I-Disease
and	and	CCONJ	CC	I-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Gastrointestinal	gastrointestinal	ADJ	JJ	O
tolerability	tolerability	NOUN	NN	O
of	of	ADP	IN	O
etoricoxib	etoricoxib	NOUN	NN	B-Chemical
in	in	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
patients	patient	NOUN	NNS	O
:	:	PUNCT	:	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
etoricoxib	etoricoxib	NOUN	NN	B-Chemical
vs	vs	ADP	IN	O
diclofenac	diclofenac	NOUN	NN	B-Chemical
sodium	sodium	NOUN	NN	I-Chemical
gastrointestinal	gastrointestinal	ADJ	JJ	O
tolerability	tolerability	NOUN	NN	O
and	and	CCONJ	CC	O
effectiveness	effectiveness	NOUN	NN	O
trial	trial	NOUN	NN	O
(	(	PUNCT	-LRB-	O
EDGE	EDGE	PROPN	NNP	O
-	-	PUNCT	HYPH	O
II	II	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
A	a	DET	DT	O
randomised	randomise	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
study	study	NOUN	NN	O
to	to	PART	TO	O
compare	compare	VERB	VB	O
the	the	DET	DT	O
gastrointestinal	gastrointestinal	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
GI	GI	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
tolerability	tolerability	NOUN	NN	O
,	,	PUNCT	,	O
safety	safety	NOUN	NN	O
and	and	CCONJ	CC	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
etoricoxib	etoricoxib	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
diclofenac	diclofenac	NOUN	NN	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
RA	RA	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
A	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
4086	4086	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
age	age	NOUN	NN	O
60	60	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
diagnosed	diagnose	VERB	VBN	O
with	with	ADP	IN	O
RA	RA	PROPN	NNP	B-Disease
were	be	VERB	VBD	O
enrolled	enrol	VERB	VBN	O
and	and	CCONJ	CC	O
received	receive	VERB	VBN	O
etoricoxib	etoricoxib	NOUN	NN	B-Chemical
90	90	NUM	CD	O
mg	mg	NOUN	NN	O
daily	daily	ADV	RB	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
2032	2032	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
diclofenac	diclofenac	NOUN	NN	B-Chemical
75	75	NUM	CD	O
mg	mg	NOUN	NN	O
twice	twice	ADV	RB	O
daily	daily	ADV	RB	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
2054	2054	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Use	use	NOUN	NN	O
of	of	ADP	IN	O
gastroprotective	gastroprotective	ADJ	JJ	O
agents	agent	NOUN	NNS	O
and	and	CCONJ	CC	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
aspirin	aspirin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
allowed	allow	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
prespecified	prespecifie	VERB	VBN	O
primary	primary	ADJ	JJ	O
end	end	NOUN	NN	O
point	point	NOUN	NN	O
consisted	consist	VERB	VBN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cumulative	cumulative	ADJ	JJ	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
patient	patient	ADJ	JJ	O
discontinuations	discontinuation	NOUN	NNS	O
due	due	ADP	IN	O
to	to	ADP	IN	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
laboratory	laboratory	NOUN	NN	O
GI	GI	PROPN	NNP	O
adverse	adverse	ADJ	JJ	O
experiences	experience	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
AEs	ae	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

General	general	ADJ	JJ	O
safety	safety	NOUN	NN	O
was	be	VERB	VBD	O
also	also	ADV	RB	O
assessed	assess	VERB	VBN	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
adjudicated	adjudicate	VERB	VBN	O
thrombotic	thrombotic	ADJ	JJ	B-Disease
cardiovascular	cardiovascular	ADJ	JJ	I-Disease
event	event	NOUN	NN	O
data	datum	NOUN	NNS	O
.	.	PUNCT	.	O

Efficacy	Efficacy	PROPN	NNP	O
was	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
using	use	VERB	VBG	O
the	the	DET	DT	O
Patient	Patient	PROPN	NNP	O
Global	Global	PROPN	NNP	O
Assessment	Assessment	PROPN	NNP	O
of	of	ADP	IN	O
Disease	Disease	PROPN	NNP	O
Status	Status	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
PGADS	PGADS	PROPN	NNP	O
;	;	PUNCT	:	O
0	0	NUM	CD	O
-	-	SYM	SYM	O
4	4	NUM	CD	O
point	point	NOUN	NN	O
scale	scale	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Mean	Mean	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
SD	sd	NOUN	NN	O
;	;	PUNCT	:	O
maximum	maximum	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
was	be	VERB	VBD	O
19	19	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
;	;	PUNCT	:	O
32	32	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
19	19	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
;	;	SYM	SYM	O
33	33	NUM	CD	O
.	.	PUNCT	.	O
1	1	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
months	month	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
etoricoxib	etoricoxib	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
diclofenac	diclofenac	NOUN	NN	B-Chemical
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
cumulative	cumulative	ADJ	JJ	O
discontinuation	discontinuation	NOUN	NN	O
rate	rate	NOUN	NN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
GI	GI	PROPN	NNP	B-Disease
AEs	ae	NOUN	NNS	I-Disease
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
with	with	ADP	IN	O
etoricoxib	etoricoxib	NOUN	NN	B-Chemical
than	than	ADP	IN	O
diclofenac	diclofenac	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
.	.	NOUN	NN	O
2	2	NUM	CD	O
vs	vs	ADP	IN	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
events	event	NOUN	NNS	O
per	per	ADP	IN	O
100	100	NUM	CD	O
patient	patient	NOUN	NN	O
-	-	PUNCT	HYPH	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
;	;	PUNCT	:	O
hazard	hazard	NOUN	NN	O
ratio	ratio	NOUN	NN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
62	62	NUM	CD	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
:	:	PUNCT	:	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
47	47	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
81	81	NUM	CD	O
;	;	PUNCT	:	O
p	p	PUNCT	LS	O
<	<	X	XX	O
or	or	CCONJ	CC	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
discontinuations	discontinuation	NOUN	NNS	O
for	for	ADP	IN	O
hypertension	hypertension	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
and	and	CCONJ	CC	O
oedema	oedema	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
AEs	ae	NOUN	NNS	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
higher	high	ADJ	JJR	O
with	with	ADP	IN	O
etoricoxib	etoricoxib	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
diclofenac	diclofenac	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
respectively	respectively	ADV	RB	O
;	;	PUNCT	:	O
p	p	PUNCT	LS	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
for	for	ADP	IN	O
hypertension	hypertension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
for	for	ADP	IN	O
oedema	oedema	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Etoricoxib	etoricoxib	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
diclofenac	diclofenac	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
similar	similar	ADJ	JJ	O
efficacy	efficacy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PGADS	PGADS	PROPN	NNP	O
mean	mean	VERB	VB	O
changes	change	NOUN	NNS	O
from	from	ADP	IN	O
baseline	baseline	NOUN	NN	O
-	-	PUNCT	HYPH	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
62	62	NUM	CD	O
vs	vs	NOUN	NN	O
-	-	PUNCT	HYPH	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
58	58	NUM	CD	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Etoricoxib	Etoricoxib	PROPN	NNP	B-Chemical
90	90	NUM	CD	O
mg	mg	NOUN	NNS	O
demonstrated	demonstrate	VERB	VBD	O
a	a	DET	DT	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
discontinuing	discontinue	VERB	VBG	O
treatment	treatment	NOUN	NN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
GI	GI	PROPN	NNP	B-Disease
AEs	ae	NOUN	NNS	I-Disease
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
diclofenac	diclofenac	NOUN	NN	B-Chemical
150	150	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O

Discontinuations	discontinuation	NOUN	NNS	O
from	from	ADP	IN	O
renovascular	renovascular	ADJ	JJ	O
AEs	ae	NOUN	NNS	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
less	less	ADV	RBR	O
common	common	ADJ	JJ	O
than	than	ADP	IN	O
discontinuations	discontinuation	NOUN	NNS	O
from	from	ADP	IN	O
GI	GI	PROPN	NNP	B-Disease
AEs	ae	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
higher	high	ADJ	JJR	O
with	with	ADP	IN	O
etoricoxib	etoricoxib	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Anxiogenic	anxiogenic	ADJ	JJ	O
potential	potential	NOUN	NN	O
of	of	ADP	IN	O
ciprofloxacin	ciprofloxacin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
norfloxacin	norfloxacin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

INTRODUCTION	introduction	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
possible	possible	ADJ	JJ	O
anxiogenic	anxiogenic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
fluoroquinolones	fluoroquinolone	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
namely	namely	ADV	RB	O
ciprofloxacin	ciprofloxacin	VERB	VBD	B-Chemical
and	and	CCONJ	CC	O
norfloxacin	norfloxacin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
were	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
Charles	Charles	PROPN	NNP	O
Foster	Foster	PROPN	NNP	O
albino	albino	ADJ	JJ	O
rats	rat	NOUN	NNS	O
of	of	ADP	IN	O
either	either	DET	DT	O
sex	sex	NOUN	NN	O
,	,	PUNCT	,	O
weighing	weigh	VERB	VBG	O
150	150	NUM	CD	O
-	-	SYM	SYM	O
200	200	NUM	CD	O
g	g	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
drugs	drug	NOUN	NNS	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
orally	orally	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	VERB	VB	O
for	for	ADP	IN	O
five	five	NUM	CD	O
consecutive	consecutive	ADJ	JJ	O
days	day	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
experiments	experiment	NOUN	NNS	O
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
on	on	ADP	IN	O
the	the	DET	DT	O
fifth	fifth	ADJ	JJ	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
tests	test	NOUN	NNS	O
included	include	VERB	VBD	O
open	open	ADJ	JJ	O
-	-	PUNCT	HYPH	O
field	field	NOUN	NN	O
exploratory	exploratory	ADJ	JJ	O
behaviour	behaviour	NOUN	NN	O
,	,	PUNCT	,	O
elevated	elevated	ADJ	JJ	O
plus	plus	CCONJ	CC	O
maze	maze	NOUN	NN	O
and	and	CCONJ	CC	O
elevated	elevate	VERB	VBD	O
zero	zero	NUM	CD	O
maze	maze	NOUN	NN	O
,	,	PUNCT	,	O
social	social	ADJ	JJ	O
interaction	interaction	NOUN	NN	O
and	and	CCONJ	CC	O
novelty	novelty	NOUN	NN	O
-	-	PUNCT	HYPH	O
suppressed	suppress	VERB	VBN	O
feeding	feed	VERB	VBG	O
latency	latency	NOUN	NN	O
behaviour	behaviour	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
ciprofloxacin	ciprofloxacin	NOUN	NN	B-Chemical
-	-	PUNCT	:	O
and	and	CCONJ	CC	O
norfloxacin	norfloxacin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
showed	show	VERB	VBD	O
anxious	anxious	ADJ	JJ	B-Disease
behaviour	behaviour	NOUN	NN	I-Disease
in	in	ADP	IN	O
comparison	comparison	NOUN	NN	O
to	to	PART	TO	O
control	control	VERB	VB	O
rats	rat	NOUN	NNS	O
in	in	ADP	IN	O
all	all	DET	PDT	O
the	the	DET	DT	O
parameters	parameter	NOUN	NNS	O
studied	study	VERB	VBD	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
ciprofloxacin	ciprofloxacin	NOUN	NN	B-Chemical
-	-	PUNCT	:	O
and	and	CCONJ	CC	O
norfloxacin	norfloxacin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
differ	differ	VERB	VB	O
significantly	significantly	ADV	RB	O
from	from	ADP	IN	O
each	each	DET	DT	O
other	other	ADJ	JJ	O
in	in	ADP	IN	O
various	various	ADJ	JJ	O
behavioural	behavioural	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
present	present	ADJ	JJ	O
experimental	experimental	ADJ	JJ	O
findings	finding	NOUN	NNS	O
substantiate	substantiate	VERB	VBP	O
the	the	DET	DT	O
clinically	clinically	ADV	RB	O
observed	observe	VERB	VBN	O
anxiogenic	anxiogenic	ADJ	JJ	O
potential	potential	NOUN	NN	O
of	of	ADP	IN	O
ciprofloxacin	ciprofloxacin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
norfloxacin	norfloxacin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
during	during	ADP	IN	O
induction	induction	NOUN	NN	O
with	with	ADP	IN	O
target	target	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
propofol	propofol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Pain	pain	NOUN	NN	B-Disease
on	on	ADP	IN	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
propofol	propofol	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
unpleasant	unpleasant	ADJ	JJ	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
hypothesized	hypothesize	VERB	VBD	O
that	that	ADP	IN	O
propofol	propofol	ADJ	JJ	B-Chemical
infusion	infusion	NOUN	NN	O
pain	pain	NOUN	NN	B-Disease
might	may	VERB	MD	O
be	be	VERB	VB	O
prevented	prevent	VERB	VBN	O
by	by	ADP	IN	O
infusing	infuse	VERB	VBG	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
before	before	ADP	IN	O
starting	start	VERB	VBG	O
the	the	DET	DT	O
propofol	propofol	ADJ	JJ	B-Chemical
infusion	infusion	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
setting	setting	NOUN	NN	O
where	where	ADV	WRB	O
target	target	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
infusions	infusion	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
TCI	TCI	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
both	both	DET	DT	O
drugs	drug	NOUN	NNS	O
were	be	VERB	VBD	O
used	use	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
trial	trial	NOUN	NN	O
was	be	VERB	VBD	O
performed	perform	VERB	VBN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
-	-	PUNCT	HYPH	O
site	site	NOUN	NN	O
concentration	concentration	NOUN	NN	O
(	(	PUNCT	-LRB-	O
Ce	Ce	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
to	to	PART	TO	O
prevent	prevent	VERB	VB	O
the	the	DET	DT	O
pain	pain	NOUN	NN	B-Disease
without	without	ADP	IN	O
producing	produce	VERB	VBG	O
complications	complication	NOUN	NNS	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
A	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
128	128	NUM	CD	O
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
general	general	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
allocated	allocate	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
normal	normal	ADJ	JJ	O
saline	saline	NOUN	NN	O
(	(	PUNCT	-LRB-	O
control	control	NOUN	NN	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
to	to	ADP	IN	O
a	a	DET	DT	O
target	target	NOUN	NN	O
Ce	Ce	PROPN	NNP	O
of	of	ADP	IN	O
2	2	NUM	CD	O
ng	ng	ADP	IN	O
ml	ml	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
R2	R2	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
ng	ng	ADP	IN	O
ml	ml	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
R4	R4	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
6	6	NUM	CD	O
ng	ng	NOUN	NNS	O
ml	ml	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
R6	R6	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
administered	administer	VERB	VBD	O
via	via	ADP	IN	O
TCI	TCI	PROPN	NNP	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
the	the	DET	DT	O
target	target	NOUN	NN	O
Ce	Ce	PROPN	NNP	O
was	be	VERB	VBD	O
achieved	achieve	VERB	VBN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
propofol	propofol	ADJ	JJ	B-Chemical
was	be	VERB	VBD	O
started	start	VERB	VBN	O
.	.	PUNCT	.	O

Remifentanil	remifentanil	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
complications	complication	NOUN	NNS	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
during	during	ADP	IN	O
the	the	DET	DT	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
infusion	infusion	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
pain	pain	NOUN	NN	B-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
propofol	propofol	ADJ	JJ	B-Chemical
was	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
using	use	VERB	VBG	O
a	a	DET	DT	O
four	four	NUM	CD	O
-	-	PUNCT	HYPH	O
point	point	NOUN	NN	O
scale	scale	NOUN	NN	O
during	during	ADP	IN	O
the	the	DET	DT	O
propofol	propofol	ADJ	JJ	B-Chemical
infusion	infusion	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
in	in	ADP	IN	O
Groups	Groups	PROPN	NNP	O
R4	R4	PROPN	NNP	O
and	and	CCONJ	CC	O
R6	r6	NOUN	NN	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
and	and	CCONJ	CC	O
R2	R2	PROPN	NNP	O
groups	group	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
/	/	SYM	SYM	O
32	32	NUM	CD	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
/	/	SYM	SYM	O
31	31	NUM	CD	O
vs	vs	ADP	IN	O
26	26	NUM	CD	O
/	/	SYM	SYM	O
31	31	NUM	CD	O
and	and	CCONJ	CC	O
25	25	NUM	CD	O
/	/	SYM	SYM	O
32	32	NUM	CD	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Pain	Pain	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
less	less	ADV	RBR	O
severe	severe	ADJ	JJ	O
in	in	ADP	IN	O
Groups	Groups	PROPN	NNP	O
R4	R4	PROPN	NNP	O
and	and	CCONJ	CC	O
R6	r6	NOUN	NN	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
and	and	CCONJ	CC	O
R2	R2	PROPN	NNP	O
groups	group	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
both	both	CCONJ	CC	O
incidence	incidence	NOUN	NN	O
and	and	CCONJ	CC	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
were	be	VERB	VBD	O
not	not	ADV	RB	O
different	different	ADJ	JJ	O
between	between	ADP	IN	O
Groups	Groups	PROPN	NNPS	O
R4	R4	PROPN	NNP	O
and	and	CCONJ	CC	O
R6	r6	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
significant	significant	ADJ	JJ	O
complications	complication	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
during	during	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
During	during	ADP	IN	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
anaesthesia	anaesthesia	NOUN	NN	O
with	with	ADP	IN	O
TCI	TCI	PROPN	NNP	O
of	of	ADP	IN	O
propofol	propofol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
propofol	propofol	ADJ	JJ	B-Chemical
infusion	infusion	NOUN	NN	O
pain	pain	NOUN	NN	B-Disease
was	be	VERB	VBD	O
achieved	achieve	VERB	VBN	O
without	without	ADP	IN	O
significant	significant	ADJ	JJ	O
complications	complication	NOUN	NNS	O
by	by	ADP	IN	O
prior	prior	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
remifentanil	remifentanil	NOUN	NN	B-Chemical
at	at	ADP	IN	O
a	a	DET	DT	O
target	target	NOUN	NN	O
Ce	Ce	PROPN	NNP	O
of	of	ADP	IN	O
4	4	NUM	CD	O
ng	ng	ADP	IN	O
ml	ml	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	O
protection	protection	NOUN	NN	O
for	for	ADP	IN	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
:	:	PUNCT	:	O
a	a	DET	DT	O
meta	meta	ADJ	JJ	O
-	-	PUNCT	HYPH	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
randomised	randomise	VERB	VBN	O
controlled	control	VERB	VBN	O
trials	trial	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conducted	conduct	VERB	VBD	O
a	a	DET	DT	O
systematic	systematic	ADJ	JJ	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
outcomes	outcome	NOUN	NNS	O
following	follow	VERB	VBG	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
included	include	VERB	VBD	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
randomised	randomise	VERB	VBN	O
peri	peri	NOUN	NN	O
-	-	PUNCT	HYPH	O
operative	operative	ADJ	JJ	O
studies	study	NOUN	NNS	O
of	of	ADP	IN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
that	that	DET	WDT	O
reported	report	VERB	VBD	O
mortality	mortality	NOUN	NN	O
,	,	PUNCT	,	O
cardiac	cardiac	ADJ	JJ	O
morbidity	morbidity	NOUN	NN	O
or	or	CCONJ	CC	O
adverse	adverse	ADJ	JJ	O
drug	drug	NOUN	NN	O
events	event	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
PubMed	PubMed	PROPN	NNP	O
Central	Central	PROPN	NNP	O
and	and	CCONJ	CC	O
EMBASE	EMBASE	PROPN	NNP	O
search	search	NOUN	NN	O
was	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
up	up	PART	RP	O
to	to	ADP	IN	O
July	July	PROPN	NNP	O
2007	2007	NUM	CD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
reference	reference	NOUN	NN	O
lists	list	NOUN	NNS	O
of	of	ADP	IN	O
identified	identify	VERB	VBN	O
papers	paper	NOUN	NNS	O
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
for	for	ADP	IN	O
further	further	ADJ	JJ	O
trials	trial	NOUN	NNS	O
.	.	PUNCT	.	O

Of	of	ADP	IN	O
425	425	NUM	CD	O
studies	study	NOUN	NNS	O
identified	identify	VERB	VBN	O
,	,	PUNCT	,	O
20	20	NUM	CD	O
were	be	VERB	VBD	O
included	include	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
meta	meta	ADJ	JJ	O
-	-	PUNCT	HYPH	O
analysis	analysis	NOUN	NN	O
(	(	PUNCT	-LRB-	O
840	840	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Dexmedetomidine	Dexmedetomidine	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
trend	trend	NOUN	NN	O
towards	towards	ADP	IN	O
improved	improve	VERB	VBD	O
cardiac	cardiac	ADJ	JJ	O
outcomes	outcome	NOUN	NNS	O
;	;	PUNCT	:	O
all	all	DET	DT	O
-	-	PUNCT	HYPH	O
cause	cause	NOUN	NN	O
mortality	mortality	NOUN	NN	O
(	(	PUNCT	-LRB-	O
OR	or	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
27	27	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
13	13	NUM	CD	O
,	,	PUNCT	,	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
44	44	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
fatal	fatal	ADJ	JJ	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
OR	or	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
26	26	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
04	04	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
60	60	NUM	CD	O
,	,	PUNCT	,	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
14	14	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
myocardial	myocardial	ADJ	JJ	B-Disease
ischaemia	ischaemia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
OR	or	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
65	65	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
26	26	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
63	63	NUM	CD	O
,	,	PUNCT	,	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
36	36	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Peri	peri	NOUN	NN	O
-	-	PUNCT	HYPH	O
operative	operative	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
26	26	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
OR	or	CCONJ	CC	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
80	80	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
91	91	NUM	CD	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
54	54	NUM	CD	O
,	,	PUNCT	,	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0001	0001	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
bradycardia	bradycardia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
17	17	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
OR	or	CCONJ	CC	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
45	45	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
98	98	NUM	CD	O
-	-	SYM	SYM	O
9	9	NUM	CD	O
.	.	PUNCT	.	O
95	95	NUM	CD	O
,	,	PUNCT	,	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
00001	00001	NUM	CD	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
anticholinergic	anticholinergic	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
reduce	reduce	VERB	VB	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
bradycardia	bradycardia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
43	43	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
randomised	randomise	VERB	VBN	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
warranted	warrant	VERB	VBN	O
.	.	PUNCT	.	O

Myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
in	in	ADP	IN	O
pregnancy	pregnancy	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
clomiphene	clomiphene	NOUN	NN	B-Chemical
citrate	citrate	NOUN	NN	I-Chemical
for	for	ADP	IN	O
ovulation	ovulation	NOUN	NN	O
induction	induction	NOUN	NN	O
:	:	PUNCT	:	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Clomiphene	Clomiphene	PROPN	NNP	B-Chemical
citrate	citrate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
CC	CC	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
commonly	commonly	ADV	RB	O
prescribed	prescribe	VERB	VBN	O
for	for	ADP	IN	O
ovulation	ovulation	NOUN	NN	O
induction	induction	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
considered	consider	VERB	VBN	O
safe	safe	ADJ	JJ	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
minimal	minimal	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

Thromboembolism	thromboembolism	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
rare	rare	ADJ	JJ	O
but	but	CCONJ	CC	O
life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
threatening	threaten	VERB	VBG	O
complication	complication	NOUN	NN	O
that	that	DET	WDT	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
after	after	ADP	IN	O
ovulation	ovulation	NOUN	NN	O
induction	induction	NOUN	NN	O
with	with	ADP	IN	O
CC	CC	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Spontaneous	spontaneous	ADJ	JJ	O
coronary	coronary	ADJ	JJ	B-Disease
thrombosis	thrombosis	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
thromboembolism	thromboembolism	NOUN	NN	B-Disease
with	with	ADP	IN	O
subsequent	subsequent	ADJ	JJ	O
clot	clot	NOUN	NN	O
lysis	lysis	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
suggested	suggest	VERB	VBN	O
as	as	ADP	IN	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
causes	cause	NOUN	NNS	O
of	of	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
MI	MI	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
during	during	ADP	IN	O
pregnancy	pregnancy	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
a	a	DET	DT	O
subsequently	subsequently	ADV	RB	O
normal	normal	ADJ	JJ	O
coronary	coronary	ADJ	JJ	O
angiogram	angiogram	NOUN	NN	O
.	.	PUNCT	.	O

CASE	case	NOUN	NN	O
:	:	PUNCT	:	O
A	a	DET	DT	O
33	33	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
gestation	gestation	NOUN	NN	O
had	have	VERB	VBD	O
recently	recently	ADV	RB	O
received	receive	VERB	VBN	O
CC	cc	NOUN	NN	B-Chemical
for	for	ADP	IN	O
ovulation	ovulation	NOUN	NN	O
induction	induction	NOUN	NN	O
and	and	CCONJ	CC	O
presented	present	VERB	VBN	O
with	with	ADP	IN	O
chest	chest	NOUN	NN	B-Disease
pain	pain	NOUN	NN	I-Disease
.	.	PUNCT	.	O

An	an	DET	DT	O
electrocardiogram	electrocardiogram	NOUN	NN	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
lateral	lateral	ADJ	JJ	O
and	and	CCONJ	CC	O
anterior	anterior	ADJ	JJ	O
wall	wall	NOUN	NN	O
myocardial	myocardial	NOUN	NN	B-Disease
infarction	infarction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Cardiac	cardiac	ADJ	JJ	O
enzymes	enzyme	NOUN	NNS	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
peak	peak	NOUN	NN	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
troponin	troponin	NOUN	NN	O
I	-PRON-	PRON	PRP	O
to	to	ADP	IN	O
9	9	NUM	CD	O
.	.	PUNCT	.	O
10	10	NUM	CD	O
ng	ng	ADP	IN	O
/	/	SYM	SYM	O
mL	ml	NOUN	NN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
initial	initial	ADJ	JJ	O
exercise	exercise	NOUN	NN	O
stress	stress	NOUN	NN	O
test	test	NOUN	NN	O
was	be	VERB	VBD	O
normal	normal	ADJ	JJ	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
the	the	DET	DT	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
admission	admission	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
at	at	ADP	IN	O
high	high	ADJ	JJ	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
radiation	radiation	NOUN	NN	B-Disease
injury	injury	NOUN	NN	I-Disease
to	to	ADP	IN	O
the	the	DET	DT	O
fetus	fetus	NOUN	NN	O
,	,	PUNCT	,	O
so	so	ADV	RB	O
a	a	DET	DT	O
coronary	coronary	ADJ	JJ	O
angiogram	angiogram	NOUN	NN	O
was	be	VERB	VBD	O
postponed	postpone	VERB	VBN	O
until	until	ADP	IN	O
the	the	DET	DT	O
second	second	ADJ	JJ	O
trimester	trimester	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
showed	show	VERB	VBD	O
normal	normal	ADJ	JJ	O
coronary	coronary	ADJ	JJ	O
vessels	vessel	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
This	this	DET	DT	O
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
reported	report	VERB	VBN	O
case	case	NOUN	NN	O
documenting	document	VERB	VBG	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
CC	cc	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Thrombosis	thrombosis	NOUN	NN	B-Disease
might	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
rare	rare	ADJ	JJ	O
but	but	CCONJ	CC	O
hazardous	hazardous	ADJ	JJ	O
complication	complication	NOUN	NN	O
of	of	ADP	IN	O
CC	CC	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Given	give	VERB	VBN	O
this	this	DET	DT	O
life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
threatening	threaten	VERB	VBG	O
complication	complication	NOUN	NN	O
,	,	PUNCT	,	O
appropriate	appropriate	ADJ	JJ	O
prophylactic	prophylactic	ADJ	JJ	O
measures	measure	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
risk	risk	NOUN	NN	O
woman	woman	NOUN	NN	O
undergoing	undergo	VERB	VBG	O
ovarian	ovarian	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
.	.	PUNCT	.	O

Reverse	Reverse	PROPN	NNP	O
or	or	CCONJ	CC	O
inverted	invert	VERB	VBD	O
left	leave	VERB	VBN	B-Disease
ventricular	ventricular	ADJ	JJ	I-Disease
apical	apical	ADJ	JJ	I-Disease
ballooning	ballooning	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
reverse	reverse	ADJ	JJ	O
Takotsubo	Takotsubo	PROPN	NNP	B-Disease
cardiomyopathy	cardiomyopathy	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
a	a	DET	DT	O
young	young	ADJ	JJ	O
woman	woman	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
setting	setting	NOUN	NN	O
of	of	ADP	IN	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
.	.	PUNCT	.	O

Transient	Transient	PROPN	NNP	O
left	leave	VERB	VBD	B-Disease
ventricular	ventricular	ADJ	JJ	I-Disease
apical	apical	ADJ	JJ	I-Disease
ballooning	ballooning	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
was	be	VERB	VBD	O
first	first	ADV	RB	O
described	describe	VERB	VBN	O
in	in	ADP	IN	O
Japan	Japan	PROPN	NNP	O
as	as	ADP	IN	O
"	"	PUNCT	``	O
Takotsubo	takotsubo	NOUN	NN	B-Disease
cardiomyopathy	cardiomyopathy	NOUN	NN	I-Disease
.	.	PUNCT	.	O
"	"	PUNCT	''	O
This	this	DET	DT	O
syndrome	syndrome	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
identified	identify	VERB	VBN	O
in	in	ADP	IN	O
many	many	ADJ	JJ	O
other	other	ADJ	JJ	O
countries	country	NOUN	NNS	O
.	.	PUNCT	.	O

Many	many	ADJ	JJ	O
variations	variation	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
syndrome	syndrome	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
recently	recently	ADV	RB	O
described	describe	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
rarest	rare	ADJ	JJS	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
reverse	reverse	ADJ	JJ	O
type	type	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
syndrome	syndrome	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
hyperdynamic	hyperdynamic	ADJ	JJ	O
apex	apex	ADJ	JJ	O
and	and	CCONJ	CC	O
complete	complete	ADJ	JJ	O
akinesia	akinesia	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
base	base	NOUN	NN	O
(	(	PUNCT	-LRB-	O
as	as	ADP	IN	O
opposed	oppose	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
classic	classic	ADJ	JJ	O
apical	apical	ADJ	JJ	B-Disease
ballooning	ballooning	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
article	article	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
an	an	DET	DT	O
interesting	interesting	ADJ	JJ	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
young	young	ADJ	JJ	O
woman	woman	NOUN	NN	O
who	who	PRON	WP	O
presented	present	VERB	VBD	O
with	with	ADP	IN	O
this	this	DET	DT	O
rare	rare	ADJ	JJ	O
type	type	NOUN	NN	O
of	of	ADP	IN	O
reverse	reverse	ADJ	JJ	O
apical	apical	ADJ	JJ	B-Disease
ballooning	ballooning	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
occurring	occur	VERB	VBG	O
after	after	ADP	IN	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
report	report	NOUN	NN	O
is	be	VERB	VBZ	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

Results	result	NOUN	NNS	O
of	of	ADP	IN	O
a	a	DET	DT	O
comparative	comparative	ADJ	JJ	O
,	,	PUNCT	,	O
phase	phase	NOUN	NN	O
III	iii	NUM	CD	O
,	,	PUNCT	,	O
12	12	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
,	,	PUNCT	,	O
multicenter	multicenter	NOUN	NN	O
,	,	PUNCT	,	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
assessment	assessment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
tolerability	tolerability	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
fixed	fix	VERB	VBN	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
combination	combination	NOUN	NN	O
of	of	ADP	IN	O
telmisartan	telmisartan	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
amlodipine	amlodipine	VERB	VBP	B-Chemical
versus	versus	ADP	IN	O
amlodipine	amlodipine	ADJ	JJ	B-Chemical
monotherapy	monotherapy	NOUN	NN	O
in	in	ADP	IN	O
Indian	indian	ADJ	JJ	O
adults	adult	NOUN	NNS	O
with	with	ADP	IN	O
stage	stage	NOUN	NN	O
II	II	PROPN	NNP	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
tolerability	tolerability	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
fixed	fix	VERB	VBN	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
combination	combination	NOUN	NN	O
(	(	PUNCT	-LRB-	O
FDC	FDC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
telmisartan	telmisartan	ADV	RB	B-Chemical
40	40	NUM	CD	O
mg	mg	NOUN	NN	O
+	+	CCONJ	CC	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
(	(	PUNCT	-LRB-	O
T	t	NOUN	NN	O
+	+	CCONJ	CC	O
A	a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
amlodipine	amlodipine	ADJ	JJ	B-Chemical
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
mg	mg	NOUN	NN	O
monotherapy	monotherapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
A	a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
Indian	indian	ADJ	JJ	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
stage	stage	NOUN	NN	O
II	II	PROPN	NNP	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
This	this	DET	DT	O
comparative	comparative	ADJ	JJ	O
,	,	PUNCT	,	O
Phase	Phase	PROPN	NNP	O
III	III	PROPN	NNP	O
,	,	PUNCT	,	O
12	12	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
,	,	PUNCT	,	O
multicenter	multicenter	NOUN	NN	O
,	,	PUNCT	,	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
in	in	ADP	IN	O
Indian	indian	ADJ	JJ	O
patients	patient	NOUN	NNS	O
aged	age	VERB	VBN	O
18	18	NUM	CD	O
to	to	PART	TO	O
65	65	NUM	CD	O
years	year	NOUN	NNS	O
with	with	ADP	IN	O
established	establish	VERB	VBN	O
stage	stage	NOUN	NN	O
II	II	PROPN	NNP	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
oral	oral	ADJ	JJ	O
FDC	FDC	PROPN	NNP	O
of	of	ADP	IN	O
T	T	PROPN	NNP	O
+	+	CCONJ	CC	O
A	a	NOUN	NN	O
or	or	CCONJ	CC	O
A	a	DET	DT	O
QD	QD	PROPN	NNP	O
before	before	ADP	IN	O
breakfast	breakfast	NOUN	NN	O
for	for	ADP	IN	O
12	12	NUM	CD	O
weeks	week	NOUN	NNS	O
;	;	PUNCT	:	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BP	BP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
sitting	sit	VERB	VBG	O
position	position	NOUN	NN	O
.	.	PUNCT	.	O

Primary	primary	ADJ	JJ	O
efficacy	efficacy	NOUN	NN	O
end	end	NOUN	NN	O
points	point	NOUN	NNS	O
were	be	VERB	VBD	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
clinical	clinical	ADJ	JJ	O
systolic	systolic	NOUN	NN	O
BP	BP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
SBP	SBP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
/	/	SYM	SYM	O
diastolic	diastolic	ADJ	JJ	O
BP	BP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
DBP	DBP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
from	from	ADP	IN	O
baseline	baseline	NOUN	NN	O
to	to	PART	TO	O
study	study	VERB	VB	O
end	end	NOUN	NN	O
and	and	CCONJ	CC	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
responders	responder	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
ie	ie	X	FW	O
,	,	PUNCT	,	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
achieved	achieve	VERB	VBD	O
target	target	NOUN	NN	O
SBP	SBP	PROPN	NNP	O
/	/	SYM	SYM	O
DBP	DBP	PROPN	NNP	O
<	<	X	XX	O
130	130	NUM	CD	O
/	/	SYM	SYM	O
<	<	X	XX	O
80	80	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Tolerability	tolerability	NOUN	NN	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
treatment	treatment	NOUN	NN	O
-	-	PUNCT	HYPH	O
emergent	emergent	NOUN	NN	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
,	,	PUNCT	,	O
identified	identify	VERB	VBD	O
using	use	VERB	VBG	O
physical	physical	ADJ	JJ	O
examination	examination	NOUN	NN	O
,	,	PUNCT	,	O
laboratory	laboratory	NOUN	NN	O
analysis	analysis	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
electrocardiography	electrocardiography	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
A	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
210	210	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
enrolled	enrol	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
;	;	PUNCT	:	O
203	203	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
143	143	NUM	CD	O
men	man	NOUN	NNS	O
,	,	PUNCT	,	O
60	60	NUM	CD	O
women	woman	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
completed	complete	VERB	VBD	O
the	the	DET	DT	O
study	study	NOUN	NN	O
while	while	ADP	IN	O
7	7	NUM	CD	O
were	be	VERB	VBD	O
lost	lose	VERB	VBN	O
to	to	PART	TO	O
follow	follow	VERB	VB	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
T	t	NOUN	NN	O
+	+	CCONJ	CC	O
A	a	DET	DT	O
group	group	NOUN	NN	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
in	in	ADP	IN	O
the	the	DET	DT	O
A	a	DET	DT	O
group	group	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
considered	consider	VERB	VBN	O
with	with	ADP	IN	O
-	-	PUNCT	HYPH	O
drawn	draw	VERB	VBN	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
study	study	NOUN	NN	O
end	end	NOUN	NN	O
,	,	PUNCT	,	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
percentage	percentage	NOUN	NN	O
reductions	reduction	NOUN	NNS	O
from	from	ADP	IN	O
baseline	baseline	NOUN	NN	O
within	within	ADP	IN	O
groups	group	NOUN	NNS	O
and	and	CCONJ	CC	O
between	between	ADP	IN	O
groups	group	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
SBP	SBP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
T	t	NOUN	NN	O
+	+	CCONJ	CC	O
A	a	DET	DT	O
[	[	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
27	27	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
]	]	PUNCT	-RRB-	O
;	;	PUNCT	:	O
A	a	DET	DT	O
[	[	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
16	16	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
]	]	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
DBP	DBP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
T	t	NOUN	NN	O
+	+	CCONJ	CC	O
A	a	NOUN	NN	O
[	[	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
20	20	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
]	]	PUNCT	-RRB-	O
;	;	PUNCT	:	O
A	a	DET	DT	O
[	[	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
13	13	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
]	]	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
all	all	DET	DT	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Response	response	NOUN	NN	O
rates	rate	NOUN	NNS	O
were	be	VERB	VBD	O
87	87	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
89	89	NUM	CD	O
/	/	SYM	SYM	O
102	102	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
T	t	NOUN	NN	O
+	+	CCONJ	CC	O
A	a	DET	DT	O
group	group	NOUN	NN	O
and	and	CCONJ	CC	O
69	69	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
70	70	NUM	CD	O
/	/	SYM	SYM	O
101	101	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
A	a	DET	DT	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
prevalences	prevalence	NOUN	NNS	O
of	of	ADP	IN	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
different	different	ADJ	JJ	O
between	between	ADP	IN	O
the	the	DET	DT	O
2	2	NUM	CD	O
treatment	treatment	NOUN	NN	O
groups	group	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
T	t	NOUN	NN	O
+	+	CCONJ	CC	O
A	a	NOUN	NN	O
,	,	PUNCT	,	O
16	16	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
[	[	PUNCT	-LRB-	O
17	17	NUM	CD	O
/	/	SYM	SYM	O
106	106	NUM	CD	O
]	]	PUNCT	-RRB-	O
;	;	PUNCT	:	O
A	a	DET	DT	O
,	,	PUNCT	,	O
15	15	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
[	[	PUNCT	-LRB-	O
16	16	NUM	CD	O
/	/	SYM	SYM	O
104	104	NUM	CD	O
]	]	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Peripheral	peripheral	ADJ	JJ	O
edema	edema	NOUN	NN	B-Disease
was	be	VERB	VBD	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
/	/	SYM	SYM	O
106	106	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
T	t	NOUN	NN	O
+	+	CCONJ	CC	O
A	a	DET	DT	O
group	group	NOUN	NN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
13	13	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
14	14	NUM	CD	O
/	/	SYM	SYM	O
104	104	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
A	a	DET	DT	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
cough	cough	NOUN	NN	B-Disease
was	be	VERB	VBD	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
/	/	SYM	SYM	O
106	106	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
T	t	NOUN	NN	O
+	+	CCONJ	CC	O
A	a	DET	DT	O
group	group	NOUN	NN	O
and	and	CCONJ	CC	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
/	/	SYM	SYM	O
104	104	NUM	CD	O
)	)	PUNCT	-RRB-	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
A	a	DET	DT	O
group	group	NOUN	NN	O
;	;	PUNCT	:	O
these	these	DET	DT	O
differences	difference	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
reach	reach	VERB	VB	O
statistical	statistical	ADJ	JJ	O
significance	significance	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidences	incidence	NOUN	NNS	O
of	of	ADP	IN	O
headache	headache	NOUN	NN	B-Disease
,	,	PUNCT	,	O
dizziness	dizziness	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
diarrhea	diarrhea	NOUN	NN	B-Disease
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
between	between	ADP	IN	O
the	the	DET	DT	O
2	2	NUM	CD	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Among	among	ADP	IN	O
these	these	DET	DT	O
Indian	indian	ADJ	JJ	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
stage	stage	NOUN	NN	O
II	II	PROPN	NNP	O
hypertension	hypertension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
FDC	FDC	PROPN	NNP	O
of	of	ADP	IN	O
T	T	PROPN	NNP	O
+	+	CCONJ	CC	O
A	a	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
significantly	significantly	ADV	RB	O
more	more	ADV	RBR	O
effective	effective	ADJ	JJ	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
regard	regard	NOUN	NN	O
to	to	ADP	IN	O
BP	BP	PROPN	NNP	O
reductions	reduction	NOUN	NNS	O
,	,	PUNCT	,	O
than	than	ADP	IN	O
A	A	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
both	both	DET	DT	O
treatments	treatment	NOUN	NNS	O
were	be	VERB	VBD	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
.	.	PUNCT	.	O

Increased	increase	VERB	VBN	O
mental	mental	ADJ	JJ	B-Disease
slowing	slowing	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
APOE	apoe	NOUN	NN	O
epsilon4	epsilon4	NOUN	NN	O
allele	allele	NOUN	NN	O
after	after	ADP	IN	O
trihexyphenidyl	trihexyphenidyl	NOUN	NN	B-Chemical
oral	oral	ADJ	JJ	O
anticholinergic	anticholinergic	ADJ	JJ	O
challenge	challenge	NOUN	NN	O
in	in	ADP	IN	O
healthy	healthy	ADJ	JJ	O
elderly	elderly	ADJ	JJ	O
.	.	PUNCT	.	O

OBJECTIVES	objectives	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
objectives	objective	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
were	be	VERB	VBD	O
to	to	PART	TO	O
examine	examine	VERB	VB	O
the	the	DET	DT	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
APOE	apoe	NOUN	NN	O
epsilon4	epsilon4	NOUN	NN	O
and	and	CCONJ	CC	O
subjective	subjective	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
trihexyphenidyl	trihexyphenidyl	NOUN	NN	B-Chemical
on	on	ADP	IN	O
measures	measure	NOUN	NNS	O
reflecting	reflect	VERB	VBG	O
sedation	sedation	NOUN	NN	O
and	and	CCONJ	CC	O
confusion	confusion	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
trihexyphenidyl	trihexyphenidyl	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
subjective	subjective	ADJ	JJ	O
effects	effect	NOUN	NNS	O
and	and	CCONJ	CC	O
objective	objective	ADJ	JJ	O
memory	memory	NOUN	NN	O
performance	performance	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
This	this	DET	DT	O
study	study	NOUN	NN	O
comprised	comprise	VERB	VBD	O
24	24	NUM	CD	O
cognitively	cognitively	ADV	RB	O
intact	intact	ADJ	JJ	O
,	,	PUNCT	,	O
health	health	NOUN	NN	O
elderly	elderly	ADJ	JJ	O
adults	adult	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
APOE	apoe	NOUN	NN	O
epsilon4	epsilon4	NOUN	NN	O
carriers	carrier	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
an	an	DET	DT	O
outpatient	outpatient	NOUN	NN	O
geriatric	geriatric	ADJ	JJ	O
psychiatry	psychiatry	NOUN	NN	O
research	research	NOUN	NN	O
clinic	clinic	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
was	be	VERB	VBD	O
a	a	DET	DT	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
,	,	PUNCT	,	O
three	three	NUM	CD	O
-	-	PUNCT	HYPH	O
way	way	NOUN	NN	O
,	,	PUNCT	,	O
crossover	crossover	NOUN	NN	O
experimental	experimental	ADJ	JJ	O
design	design	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
participants	participant	NOUN	NNS	O
received	receive	VERB	VBD	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
trihexyphenidyl	trihexyphenidyl	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
administered	administer	VERB	VBN	O
in	in	ADP	IN	O
counterbalanced	counterbalanced	ADJ	JJ	O
sequences	sequence	NOUN	NNS	O
over	over	ADP	IN	O
a	a	DET	DT	O
period	period	NOUN	NN	O
of	of	ADP	IN	O
three	three	NUM	CD	O
consecutive	consecutive	ADJ	JJ	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

Bond	bond	NOUN	NN	O
and	and	CCONJ	CC	O
Lader	Lader	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	PART	POS	O
visual	visual	ADJ	JJ	O
analog	analog	NOUN	NN	O
scales	scale	NOUN	NNS	O
and	and	CCONJ	CC	O
alternate	alternate	ADJ	JJ	O
versions	version	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
Buschke	Buschke	PROPN	NNP	O
Selective	Selective	PROPN	NNP	O
Reminding	Reminding	PROPN	NNP	O
Test	Test	PROPN	NNP	O
were	be	VERB	VBD	O
administered	administer	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
repeated	repeat	VERB	VBN	O
measures	measure	NOUN	NNS	O
design	design	NOUN	NN	O
at	at	ADP	IN	O
baseline	baseline	NOUN	NN	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
5	5	NUM	CD	O
hours	hour	NOUN	NNS	O
postdrug	postdrug	NOUN	NN	O
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
A	a	DET	DT	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
-	-	PUNCT	HYPH	O
mg	mg	NOUN	NN	O
oral	oral	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
trihexyphenidyl	trihexyphenidyl	NOUN	NN	B-Chemical
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
increased	increase	VERB	VBN	O
subjective	subjective	ADJ	JJ	O
ratings	rating	NOUN	NNS	O
of	of	ADP	IN	O
mental	mental	ADJ	JJ	B-Disease
slowness	slowness	NOUN	NN	I-Disease
in	in	ADP	IN	O
carriers	carrier	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
APOE	apoe	NOUN	NN	O
epsilon4	epsilon4	NOUN	NN	O
allele	allele	NOUN	NN	O
only	only	ADV	RB	O
.	.	PUNCT	.	O

Drug	drug	NOUN	NN	O
effects	effect	NOUN	NNS	O
as	as	ADP	IN	O
determined	determine	VERB	VBN	O
by	by	ADP	IN	O
difference	difference	NOUN	NN	O
scores	score	NOUN	NNS	O
between	between	ADP	IN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
trihexyphenidyl	trihexyphenidyl	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
on	on	ADP	IN	O
ratings	rating	NOUN	NNS	O
of	of	ADP	IN	O
mental	mental	ADJ	JJ	B-Disease
slowness	slowness	NOUN	NN	I-Disease
significantly	significantly	ADV	RB	O
correlated	correlate	VERB	VBD	O
with	with	ADP	IN	O
total	total	ADJ	JJ	O
and	and	CCONJ	CC	O
delayed	delay	VERB	VBN	O
recall	recall	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
Buschke	Buschke	PROPN	NNP	O
Selective	Selective	PROPN	NNP	O
Reminding	Reminding	PROPN	NNP	O
Test	test	NOUN	NN	O
in	in	ADP	IN	O
carriers	carrier	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
APOE	apoe	NOUN	NN	O
epsilon4	epsilon4	NOUN	NN	O
allele	allele	NOUN	NN	O
only	only	ADV	RB	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
effects	effect	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
visual	visual	ADJ	JJ	O
analog	analog	NOUN	NN	O
scales	scale	NOUN	NNS	O
reflecting	reflect	VERB	VBG	O
subjective	subjective	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
and	and	CCONJ	CC	O
clear	clear	ADJ	JJ	O
-	-	PUNCT	HYPH	O
headedness	headedness	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
epsilon4	epsilon4	NOUN	NN	O
allele	allele	NOUN	NN	O
in	in	ADP	IN	O
healthy	healthy	ADJ	JJ	O
elderly	elderly	ADJ	JJ	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
increased	increase	VERB	VBN	O
subjective	subjective	ADJ	JJ	O
mental	mental	ADJ	JJ	B-Disease
slowing	slowing	NOUN	NN	I-Disease
after	after	ADP	IN	O
trihexyphenidyl	trihexyphenidyl	NOUN	NN	B-Chemical
anticholinergic	anticholinergic	NOUN	NN	O
challenge	challenge	NOUN	NN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
amikacin	amikacin	ADJ	JJ	B-Chemical
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
hematology	hematology	NOUN	NN	O
/	/	SYM	SYM	O
oncology	oncology	NOUN	NN	O
population	population	NOUN	NN	O
.	.	PUNCT	.	O

Amikacin	Amikacin	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
an	an	DET	DT	O
aminoglycoside	aminoglycoside	NOUN	NN	B-Chemical
commonly	commonly	ADV	RB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
provide	provide	VERB	VB	O
empirical	empirical	ADJ	JJ	O
double	double	ADJ	JJ	O
gram	gram	NOUN	NN	O
-	-	PUNCT	HYPH	O
negative	negative	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
febrile	febrile	ADJ	JJ	B-Disease
neutropenia	neutropenia	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
other	other	ADJ	JJ	O
suspected	suspect	VERB	VBN	O
infections	infection	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Strategies	strategy	NOUN	NNS	O
of	of	ADP	IN	O
extended	extended	ADJ	JJ	O
-	-	PUNCT	HYPH	O
interval	interval	ADJ	JJ	O
and	and	CCONJ	CC	O
conventional	conventional	ADJ	JJ	O
dosing	dosing	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
utilized	utilize	VERB	VBN	O
extensively	extensively	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
general	general	ADJ	JJ	O
medical	medical	ADJ	JJ	O
population	population	NOUN	NN	O
;	;	PUNCT	:	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
data	datum	NOUN	NNS	O
are	be	VERB	VBP	O
lacking	lack	VERB	VBG	O
to	to	PART	TO	O
support	support	VERB	VB	O
a	a	DET	DT	O
dosing	dosing	ADJ	JJ	O
strategy	strategy	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
hematology	hematology	NOUN	NN	O
/	/	SYM	SYM	O
oncology	oncology	NOUN	NN	O
population	population	NOUN	NN	O
.	.	PUNCT	.	O

To	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
amikacin	amikacin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
an	an	DET	DT	O
adult	adult	NOUN	NN	O
hematology	hematology	NOUN	NN	O
/	/	SYM	SYM	O
oncology	oncology	NOUN	NN	O
population	population	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
open	open	ADJ	JJ	O
-	-	PUNCT	HYPH	O
label	label	NOUN	NN	O
trial	trial	NOUN	NN	O
was	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
at	at	ADP	IN	O
a	a	DET	DT	O
university	university	NOUN	NN	O
-	-	PUNCT	HYPH	O
affiliated	affiliate	VERB	VBN	O
medical	medical	ADJ	JJ	O
center	center	NOUN	NN	O
.	.	PUNCT	.	O

Forty	forty	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
a	a	DET	DT	O
hematologic	hematologic	NOUN	NN	B-Disease
/	/	SYM	SYM	I-Disease
oncologic	oncologic	ADJ	JJ	I-Disease
disorder	disorder	NOUN	NN	I-Disease
that	that	DET	WDT	O
required	require	VERB	VBD	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
an	an	DET	DT	O
aminoglycoside	aminoglycoside	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
randomized	randomize	VERB	VBN	O
to	to	ADP	IN	O
either	either	CCONJ	CC	O
conventional	conventional	ADJ	JJ	O
or	or	CCONJ	CC	O
extended	extended	ADJ	JJ	O
-	-	PUNCT	HYPH	O
interval	interval	ADJ	JJ	O
amikacin	amikacin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
by	by	ADP	IN	O
means	mean	NOUN	NNS	O
of	of	ADP	IN	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
efficacy	efficacy	NOUN	NN	O
via	via	ADP	IN	O
amikacin	amikacin	VERB	VBG	B-Chemical
serum	serum	ADJ	JJ	O
concentrations	concentration	NOUN	NNS	O
with	with	ADP	IN	O
respective	respective	ADJ	JJ	O
pathogens	pathogen	NOUN	NNS	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
was	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
between	between	ADP	IN	O
the	the	DET	DT	O
conventional	conventional	ADJ	JJ	O
and	and	CCONJ	CC	O
extended	extended	ADJ	JJ	O
-	-	PUNCT	HYPH	O
interval	interval	ADJ	JJ	O
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
at	at	ADP	IN	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
00	00	PUNCT	NFP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Six	six	NUM	CD	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
conventional	conventional	ADJ	JJ	O
group	group	NOUN	NN	O
had	have	VERB	VBD	O
a	a	DET	DT	O
positive	positive	ADJ	JJ	O
culture	culture	NOUN	NN	O
,	,	PUNCT	,	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
none	none	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
extended	extended	ADJ	JJ	O
-	-	PUNCT	HYPH	O
interval	interval	NOUN	NN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
002	002	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
was	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
between	between	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
dosing	dose	VERB	VBG	O
regimens	regimen	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
distribution	distribution	NOUN	NN	O
of	of	ADP	IN	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
was	be	VERB	VBD	O
variable	variable	ADJ	JJ	O
between	between	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Efficacy	efficacy	NOUN	NN	O
could	could	VERB	MD	O
not	not	ADV	RB	O
be	be	VERB	VB	O
assessed	assess	VERB	VBN	O
.	.	PUNCT	.	O

High	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
as	as	ADP	IN	O
the	the	DET	DT	O
sole	sole	ADJ	JJ	O
sedative	sedative	NOUN	NN	O
for	for	ADP	IN	O
pediatric	pediatric	ADJ	JJ	O
MRI	mri	NOUN	NN	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
This	this	DET	DT	O
large	large	ADJ	JJ	O
-	-	PUNCT	HYPH	O
scale	scale	NOUN	NN	O
retrospective	retrospective	ADJ	JJ	O
review	review	NOUN	NN	O
evaluates	evaluate	VERB	VBZ	O
the	the	DET	DT	O
sedation	sedation	NOUN	NN	O
profile	profile	NOUN	NN	O
of	of	ADP	IN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

AIM	AIM	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
hemodynamic	hemodynamic	ADJ	JJ	O
responses	response	NOUN	NNS	O
,	,	PUNCT	,	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
as	as	ADP	IN	O
the	the	DET	DT	O
sole	sole	ADJ	JJ	O
sedative	sedative	NOUN	NN	O
for	for	ADP	IN	O
magnetic	magnetic	ADJ	JJ	O
resonance	resonance	NOUN	NN	O
imaging	imaging	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MRI	MRI	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
studies	study	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Dexmedetomidine	Dexmedetomidine	PROPN	NNP	B-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
used	use	VERB	VBN	O
at	at	ADP	IN	O
our	-PRON-	DET	PRP$	O
institution	institution	NOUN	NN	O
since	since	ADP	IN	O
2005	2005	NUM	CD	O
to	to	PART	TO	O
provide	provide	VERB	VB	O
sedation	sedation	NOUN	NN	O
for	for	ADP	IN	O
pediatric	pediatric	ADJ	JJ	O
radiological	radiological	ADJ	JJ	O
imaging	imaging	NOUN	NN	O
studies	study	NOUN	NNS	O
.	.	PUNCT	.	O

Over	over	ADP	IN	O
time	time	NOUN	NN	O
,	,	PUNCT	,	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
protocol	protocol	NOUN	NN	O
utilizing	utilize	VERB	VBG	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
as	as	ADP	IN	O
the	the	DET	DT	O
sole	sole	ADJ	JJ	O
sedative	sedative	ADJ	JJ	O
agent	agent	NOUN	NN	O
has	have	VERB	VBZ	O
evolved	evolve	VERB	VBN	O
.	.	PUNCT	.	O

METHODS	METHODS	PROPN	NNP	O
/	/	SYM	SYM	O
MATERIALS	material	NOUN	NNS	O
:	:	PUNCT	:	O
As	as	ADP	IN	O
part	part	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ongoing	ongoing	ADJ	JJ	O
Quality	Quality	PROPN	NNP	O
Assurance	Assurance	PROPN	NNP	O
process	process	NOUN	NN	O
,	,	PUNCT	,	O
data	datum	NOUN	NNS	O
on	on	ADP	IN	O
all	all	DET	DT	O
sedations	sedation	NOUN	NNS	O
are	be	VERB	VBP	O
reviewed	review	VERB	VBN	O
monthly	monthly	ADJ	JJ	O
and	and	CCONJ	CC	O
protocols	protocol	NOUN	NNS	O
modified	modify	VERB	VBN	O
as	as	ADP	IN	O
needed	need	VERB	VBN	O
.	.	PUNCT	.	O

Data	datum	NOUN	NNS	O
were	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
from	from	ADP	IN	O
all	all	DET	DT	O
747	747	NUM	CD	O
consecutive	consecutive	ADJ	JJ	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
received	receive	VERB	VBD	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
MRI	MRI	PROPN	NNP	O
sedation	sedation	NOUN	NN	O
from	from	ADP	IN	O
April	April	PROPN	NNP	O
2005	2005	NUM	CD	O
to	to	ADP	IN	O
April	April	PROPN	NNP	O
2007	2007	NUM	CD	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Since	since	ADP	IN	O
2005	2005	NUM	CD	O
,	,	PUNCT	,	O
the	the	DET	DT	O
10	10	NUM	CD	O
-	-	PUNCT	HYPH	O
min	min	NOUN	NN	O
loading	loading	NOUN	NN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
our	-PRON-	DET	PRP$	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
protocol	protocol	NOUN	NN	O
increased	increase	VERB	VBD	O
from	from	ADP	IN	O
2	2	NUM	CD	O
to	to	ADP	IN	O
3	3	NUM	CD	O
microg	microg	NOUN	NN	O
.	.	PUNCT	.	O
kg	kg	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
infusion	infusion	NOUN	NN	O
rate	rate	NOUN	NN	O
increased	increase	VERB	VBD	O
from	from	ADP	IN	O
1	1	NUM	CD	O
to	to	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
to	to	PART	TO	O
2	2	NUM	CD	O
microg	microg	NOUN	NN	O
.	.	PUNCT	.	O
kg	kg	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O
h	h	DET	DT	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
current	current	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
protocol	protocol	NOUN	NN	O
progressively	progressively	ADV	RB	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
successful	successful	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
able	able	ADJ	JJ	O
to	to	PART	TO	O
complete	complete	VERB	VB	O
the	the	DET	DT	O
imaging	image	VERB	VBG	O
study	study	NOUN	NN	O
)	)	PUNCT	-RRB-	O
when	when	ADV	WRB	O
using	use	VERB	VBG	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
from	from	ADP	IN	O
91	91	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
to	to	ADP	IN	O
97	97	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
009	009	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
reducing	reduce	VERB	VBG	O
the	the	DET	DT	O
requirement	requirement	NOUN	NN	O
for	for	ADP	IN	O
adjuvant	adjuvant	ADJ	JJ	O
pentobarbital	pentobarbital	ADJ	JJ	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
event	event	NOUN	NN	O
of	of	ADP	IN	O
sedation	sedation	NOUN	NN	O
failure	failure	NOUN	NN	O
with	with	ADP	IN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
and	and	CCONJ	CC	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
recovery	recovery	NOUN	NN	O
time	time	NOUN	NN	O
by	by	ADP	IN	O
10	10	NUM	CD	O
min	min	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
sedation	sedation	NOUN	NN	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
16	16	NUM	CD	O
%	%	NOUN	NN	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
bradycardia	bradycardia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
all	all	DET	DT	O
concomitant	concomitant	ADJ	JJ	O
mean	mean	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressures	pressure	NOUN	NNS	O
were	be	VERB	VBD	O
within	within	ADP	IN	O
20	20	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
-	-	PUNCT	HYPH	O
adjusted	adjust	VERB	VBN	O
normal	normal	ADJ	JJ	O
range	range	NOUN	NN	O
and	and	CCONJ	CC	O
oxygen	oxygen	NOUN	NN	B-Chemical
saturations	saturation	NOUN	NNS	O
were	be	VERB	VBD	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
or	or	CCONJ	CC	O
higher	high	ADJ	JJR	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
provides	provide	VERB	VBZ	O
adequate	adequate	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
for	for	ADP	IN	O
pediatric	pediatric	ADJ	JJ	O
MRI	MRI	PROPN	NNP	O
studies	study	NOUN	NNS	O
.	.	PUNCT	.	O

While	while	ADP	IN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
decreases	decrease	NOUN	NNS	O
in	in	ADP	IN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
and	and	CCONJ	CC	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
outside	outside	ADP	IN	O
the	the	DET	DT	O
established	establish	VERB	VBN	O
'	'	PUNCT	``	O
awake	awake	ADJ	JJ	O
'	'	PUNCT	''	O
norms	norm	NOUN	NNS	O
,	,	PUNCT	,	O
this	this	DET	DT	O
deviation	deviation	NOUN	NN	O
is	be	VERB	VBZ	O
generally	generally	ADV	RB	O
within	within	ADP	IN	O
20	20	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
norms	norm	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
adverse	adverse	ADJ	JJ	O
sequelae	sequelae	NOUN	NN	O
.	.	PUNCT	.	O

Dexmedetomidine	Dexmedetomidine	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
useful	useful	ADJ	JJ	O
as	as	ADP	IN	O
the	the	DET	DT	O
sole	sole	ADJ	JJ	O
sedative	sedative	NOUN	NN	O
for	for	ADP	IN	O
pediatric	pediatric	ADJ	JJ	O
MRI	mri	NOUN	NN	O
.	.	PUNCT	.	O

Hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
sulfasalazine	sulfasalazine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
inflammatory	inflammatory	ADJ	JJ	O
arthritis	arthritis	NOUN	NN	B-Disease
:	:	PUNCT	:	O
A	a	DET	DT	O
case	case	NOUN	NN	O
series	series	NOUN	NN	O
from	from	ADP	IN	O
a	a	DET	DT	O
local	local	ADJ	JJ	O
surveillance	surveillance	NOUN	NN	O
of	of	ADP	IN	O
serious	serious	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Spontaneous	spontaneous	ADJ	JJ	O
reporting	reporting	NOUN	NN	O
systems	system	NOUN	NNS	O
for	for	ADP	IN	O
adverse	adverse	ADJ	JJ	O
drug	drug	NOUN	NN	O
reactions	reaction	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
ADRs	adr	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
are	be	VERB	VBP	O
handicapped	handicap	VERB	VBN	O
by	by	ADP	IN	O
under	under	ADP	IN	O
-	-	PUNCT	HYPH	O
reporting	report	VERB	VBG	O
and	and	CCONJ	CC	O
limited	limited	ADJ	JJ	O
detail	detail	NOUN	NN	O
on	on	ADP	IN	O
individual	individual	ADJ	JJ	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
an	an	DET	DT	O
investigation	investigation	NOUN	NN	O
from	from	ADP	IN	O
a	a	DET	DT	O
local	local	ADJ	JJ	O
surveillance	surveillance	NOUN	NN	O
for	for	ADP	IN	O
serious	serious	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
drug	drug	NOUN	NN	O
reactions	reaction	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
disease	disease	NOUN	NN	O
modifying	modify	VERB	VBG	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
rheumatic	rheumatic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
that	that	DET	WDT	O
was	be	VERB	VBD	O
triggered	trigger	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
liver	liver	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
in	in	ADP	IN	O
two	two	NUM	CD	O
of	of	ADP	IN	O
our	-PRON-	DET	PRP$	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Serious	serious	ADJ	JJ	O
ADR	ADR	PROPN	NNP	O
reports	report	NOUN	NNS	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
solicited	solicit	VERB	VBN	O
from	from	ADP	IN	O
local	local	ADJ	JJ	O
clinicians	clinician	NOUN	NNS	O
by	by	ADP	IN	O
regular	regular	ADJ	JJ	O
postcards	postcard	NOUN	NNS	O
over	over	ADP	IN	O
the	the	DET	DT	O
past	past	ADJ	JJ	O
seven	seven	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
'	'	PART	POS	O
,	,	PUNCT	,	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
on	on	ADP	IN	O
sulfasalazine	sulfasalazine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
met	meet	VERB	VBD	O
a	a	DET	DT	O
definition	definition	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
serious	serious	ADJ	JJ	O
ADR	ADR	PROPN	NNP	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
identified	identify	VERB	VBN	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
clinicians	clinician	NOUN	NNS	O
reviewed	review	VERB	VBD	O
structured	structured	ADJ	JJ	O
case	case	NOUN	NN	O
reports	report	NOUN	NNS	O
and	and	CCONJ	CC	O
assessed	assessed	ADJ	JJ	O
causality	causality	NOUN	NN	O
by	by	ADP	IN	O
consensus	consensus	NOUN	NN	O
and	and	CCONJ	CC	O
by	by	ADP	IN	O
using	use	VERB	VBG	O
a	a	DET	DT	O
causality	causality	NOUN	NN	O
assessment	assessment	NOUN	NN	O
instrument	instrument	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
likely	likely	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
of	of	ADP	IN	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
with	with	ADP	IN	O
sulfasalazine	sulfasalazine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
estimated	estimate	VERB	VBN	O
by	by	ADP	IN	O
making	make	VERB	VBG	O
a	a	DET	DT	O
series	series	NOUN	NN	O
of	of	ADP	IN	O
conservative	conservative	ADJ	JJ	O
assumptions	assumption	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Ten	ten	NUM	CD	O
cases	case	NOUN	NNS	O
were	be	VERB	VBD	O
identified	identify	VERB	VBN	O
:	:	PUNCT	:	O
eight	eight	NUM	CD	O
occurred	occur	VERB	VBD	O
during	during	ADP	IN	O
surveillance	surveillance	NOUN	NN	O
.	.	PUNCT	.	O

Eight	eight	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
hospitalised	hospitalise	VERB	VBN	O
,	,	PUNCT	,	O
two	two	NUM	CD	O
in	in	ADP	IN	O
hepatic	hepatic	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	O
one	one	NOUN	NN	O
died	die	VERB	VBD	O
after	after	ADP	IN	O
a	a	DET	DT	O
liver	liver	NOUN	NN	O
transplant	transplant	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
but	but	ADP	IN	O
one	one	NUM	CD	O
event	event	NOUN	NN	O
occurred	occur	VERB	VBD	O
within	within	ADP	IN	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Seven	seven	NUM	CD	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
a	a	DET	DT	O
skin	skin	NOUN	NN	B-Disease
rash	rash	NOUN	NN	I-Disease
,	,	PUNCT	,	O
three	three	NUM	CD	O
eosinophilia	eosinophilia	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
one	one	NUM	CD	O
interstitial	interstitial	ADJ	JJ	B-Disease
nephritis	nephritis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
of	of	ADP	IN	O
Black	Black	PROPN	NNP	O
British	British	PROPN	NNP	O
of	of	ADP	IN	O
African	african	ADJ	JJ	O
or	or	CCONJ	CC	O
Caribbean	caribbean	ADJ	JJ	O
descent	descent	NOUN	NN	O
.	.	PUNCT	.	O

Liver	liver	NOUN	NN	O
enzymes	enzyme	NOUN	NNS	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
hepatocellular	hepatocellular	ADJ	JJ	O
pattern	pattern	NOUN	NN	O
in	in	ADP	IN	O
four	four	NUM	CD	O
cases	case	NOUN	NNS	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
mixed	mixed	ADJ	JJ	O
pattern	pattern	NOUN	NN	O
in	in	ADP	IN	O
six	six	NUM	CD	O
.	.	PUNCT	.	O

Drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
was	be	VERB	VBD	O
judged	judge	VERB	VBN	O
probable	probable	ADJ	JJ	O
or	or	CCONJ	CC	O
highly	highly	ADV	RB	O
probable	probable	ADJ	JJ	O
in	in	ADP	IN	O
8	8	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
likely	likely	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
of	of	ADP	IN	O
serious	serious	ADJ	JJ	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
with	with	ADP	IN	O
sulfasalazine	sulfasalazine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
estimated	estimate	VERB	VBN	O
at	at	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Serious	serious	ADJ	JJ	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
sulfasalazine	sulfasalazine	NOUN	NN	B-Chemical
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
under	under	ADV	RB	O
-	-	PUNCT	HYPH	O
appreciated	appreciate	VERB	VBN	O
and	and	CCONJ	CC	O
intensive	intensive	ADJ	JJ	O
monitoring	monitoring	NOUN	NN	O
and	and	CCONJ	CC	O
vigilance	vigilance	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
is	be	VERB	VBZ	O
especially	especially	ADV	RB	O
important	important	ADJ	JJ	O
.	.	PUNCT	.	O

Complete	complete	VERB	VB	O
atrioventricular	atrioventricular	ADJ	JJ	B-Disease
block	block	NOUN	NN	I-Disease
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Sinus	sinus	NOUN	NN	B-Disease
node	node	NOUN	NN	I-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
most	most	ADV	RBS	O
frequently	frequently	ADV	RB	O
among	among	ADP	IN	O
the	the	DET	DT	O
adverse	adverse	ADJ	JJ	O
cardiovascular	cardiovascular	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
case	case	NOUN	NN	O
,	,	PUNCT	,	O
complete	complete	ADJ	JJ	O
atrioventricular	atrioventricular	ADJ	JJ	B-Disease
(	(	PUNCT	-LRB-	I-Disease
AV	av	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	I-Disease
block	block	NOUN	NN	I-Disease
with	with	ADP	IN	O
syncopal	syncopal	ADJ	JJ	B-Disease
attacks	attack	NOUN	NNS	I-Disease
developed	develop	VERB	VBD	O
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
necessitating	necessitate	VERB	VBG	O
permanent	permanent	ADJ	JJ	O
pacemaker	pacemaker	NOUN	NN	O
implantation	implantation	NOUN	NN	O
.	.	PUNCT	.	O

Serum	serum	ADJ	JJ	O
lithium	lithium	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
remained	remain	VERB	VBD	O
under	under	ADP	IN	O
or	or	CCONJ	CC	O
within	within	ADP	IN	O
the	the	DET	DT	O
therapeutic	therapeutic	ADJ	JJ	O
range	range	NOUN	NN	O
during	during	ADP	IN	O
the	the	DET	DT	O
syncopal	syncopal	ADJ	JJ	B-Disease
attacks	attack	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Lithium	Lithium	PROPN	NNP	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
with	with	ADP	IN	O
extreme	extreme	ADJ	JJ	O
caution	caution	NOUN	NN	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
mild	mild	ADJ	JJ	O
disturbance	disturbance	NOUN	NN	O
of	of	ADP	IN	O
AV	av	NOUN	NN	O
conduction	conduction	NOUN	NN	O
.	.	PUNCT	.	O

Exaggerated	exaggerated	ADJ	JJ	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
inflammatory	inflammatory	ADJ	JJ	O
mediators	mediator	NOUN	NNS	O
in	in	ADP	IN	O
vasoactive	vasoactive	ADJ	JJ	O
intestinal	intestinal	ADJ	JJ	O
polypeptide	polypeptide	NOUN	NN	O
knockout	knockout	NOUN	NN	O
(	(	PUNCT	-LRB-	O
VIP	VIP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
CYP	CYP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cystitis	cystitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Vasoactive	vasoactive	ADJ	JJ	O
intestinal	intestinal	ADJ	JJ	O
polypeptide	polypeptide	NOUN	NN	O
(	(	PUNCT	-LRB-	O
VIP	VIP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
immunomodulatory	immunomodulatory	ADJ	JJ	O
neuropeptide	neuropeptide	NOUN	NN	O
distributed	distribute	VERB	VBN	O
in	in	ADP	IN	O
micturition	micturition	NOUN	NN	O
pathways	pathway	NOUN	NNS	O
.	.	PUNCT	.	O

VIP	VIP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
exhibit	exhibit	NOUN	NN	O
altered	alter	VERB	VBN	O
bladder	bladder	NOUN	NN	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
neurochemical	neurochemical	ADJ	JJ	O
properties	property	NOUN	NNS	O
in	in	ADP	IN	O
micturition	micturition	NOUN	NN	O
pathways	pathway	NOUN	NNS	O
after	after	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
CYP	CYP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cystitis	cystitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Given	give	VERB	VBN	O
VIP	vip	NOUN	NN	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
role	role	NOUN	NN	O
as	as	ADP	IN	O
an	an	DET	DT	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
mediator	mediator	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
hypothesized	hypothesize	VERB	VBD	O
that	that	ADP	IN	O
VIP	VIP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
would	would	VERB	MD	O
exhibit	exhibit	VERB	VB	O
enhanced	enhance	VERB	VBN	O
inflammatory	inflammatory	ADJ	JJ	O
mediator	mediator	NOUN	NN	O
expression	expression	NOUN	NN	O
after	after	ADP	IN	O
cystitis	cystitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
mouse	mouse	NOUN	NN	O
inflammatory	inflammatory	ADJ	JJ	O
cytokine	cytokine	NOUN	NN	O
and	and	CCONJ	CC	O
receptor	receptor	NOUN	NN	O
RT2	rt2	NOUN	NN	O
profiler	profiler	NOUN	NN	O
array	array	NOUN	NN	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
regulated	regulated	ADJ	JJ	O
transcripts	transcript	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
urinary	urinary	ADJ	JJ	O
bladder	bladder	NOUN	NN	O
of	of	ADP	IN	O
wild	wild	ADJ	JJ	O
type	type	NOUN	NN	O
(	(	PUNCT	-LRB-	O
WT	WT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
VIP	VIP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
or	or	CCONJ	CC	O
without	without	ADP	IN	O
CYP	CYP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cystitis	cystitis	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
150	150	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
;	;	PUNCT	:	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
;	;	PUNCT	:	O
48	48	NUM	CD	O
h	h	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Four	four	NUM	CD	O
binary	binary	ADJ	JJ	O
comparisons	comparison	NOUN	NNS	O
were	be	VERB	VBD	O
made	make	VERB	VBN	O
:	:	PUNCT	:	O
WT	wt	NOUN	NN	O
control	control	NOUN	NN	O
versus	versus	ADP	IN	O
CYP	CYP	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
48	48	NUM	CD	O
h	h	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
VIP	VIP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
control	control	NOUN	NN	O
versus	versus	ADP	IN	O
CYP	CYP	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
48	48	NUM	CD	O
h	h	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
WT	wt	NOUN	NN	O
control	control	NOUN	NN	O
versus	versus	ADP	IN	O
VIP	VIP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
control	control	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
WT	WT	PROPN	NNP	O
with	with	ADP	IN	O
CYP	CYP	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
48	48	NUM	CD	O
h	h	NOUN	NN	O
)	)	PUNCT	-RRB-	O
versus	versus	ADP	IN	O
VIP	VIP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
CYP	CYP	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
48	48	NUM	CD	O
h	h	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
genes	gene	NOUN	NNS	O
presented	present	VERB	VBD	O
represent	represent	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
-	-	PUNCT	:	O
fold	fold	VERB	VB	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
either	either	DET	DT	O
direction	direction	NOUN	NN	O
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
the	the	DET	DT	O
p	p	NOUN	NN	O
value	value	NOUN	NN	O
is	be	VERB	VBZ	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
for	for	ADP	IN	O
the	the	DET	DT	O
comparison	comparison	NOUN	NN	O
being	be	VERB	VBG	O
made	make	VERB	VBN	O
.	.	PUNCT	.	O

Several	several	ADJ	JJ	O
regulated	regulate	VERB	VBN	O
genes	gene	NOUN	NNS	O
were	be	VERB	VBD	O
validated	validate	VERB	VBN	O
using	use	VERB	VBG	O
enzyme	enzyme	ADJ	JJ	O
-	-	PUNCT	HYPH	O
linked	link	VERB	VBN	O
immunoassays	immunoassay	NOUN	NNS	O
including	include	VERB	VBG	O
IL	IL	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1beta	1beta	PROPN	NNP	O
and	and	CCONJ	CC	O
CXCL1	CXCL1	PROPN	NNP	O
.	.	PUNCT	.	O

CYP	CYP	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
significantly	significantly	ADV	RB	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
or	or	CCONJ	CC	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
increased	increase	VERB	VBN	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
CXCL1	CXCL1	PROPN	NNP	O
and	and	CCONJ	CC	O
IL	IL	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1beta	1beta	PROPN	NNP	O
in	in	ADP	IN	O
the	the	DET	DT	O
urinary	urinary	ADJ	JJ	O
bladder	bladder	NOUN	NN	O
of	of	ADP	IN	O
WT	WT	PROPN	NNP	O
and	and	CCONJ	CC	O
VIP	VIP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
VIP	VIP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
CYP	CYP	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
or	or	CCONJ	CC	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
greater	great	ADJ	JJR	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
-	-	PUNCT	:	O
to	to	ADP	IN	O
13	13	NUM	CD	O
-	-	PUNCT	HYPH	O
fold	fold	ADJ	JJ	O
increase	increase	NOUN	NN	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
that	that	DET	DT	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
WT	WT	PROPN	NNP	O
urinary	urinary	NOUN	NN	O
bladder	bladder	NOUN	NN	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
fold	fold	ADJ	JJ	O
increase	increase	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
in	in	ADP	IN	O
VIP	VIP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
bladder	bladder	NOUN	NN	B-Disease
inflammation	inflammation	NOUN	NN	I-Disease
,	,	PUNCT	,	O
inflammatory	inflammatory	ADJ	JJ	O
mediators	mediator	NOUN	NNS	O
are	be	VERB	VBP	O
increased	increase	VERB	VBN	O
above	above	ADP	IN	O
that	that	DET	DT	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
WT	WT	PROPN	NNP	O
with	with	ADP	IN	O
CYP	CYP	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
shift	shift	NOUN	NN	O
in	in	ADP	IN	O
balance	balance	NOUN	NN	O
may	may	VERB	MD	O
contribute	contribute	VERB	VB	O
to	to	ADP	IN	O
increased	increase	VERB	VBN	O
bladder	bladder	NOUN	NN	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
in	in	ADP	IN	O
VIP	VIP	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
bladder	bladder	NOUN	NN	B-Disease
inflammation	inflammation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
altered	alter	VERB	VBN	O
neurochemical	neurochemical	ADJ	JJ	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
micturition	micturition	NOUN	NN	O
pathways	pathway	NOUN	NNS	O
.	.	PUNCT	.	O

Debrisoquine	debrisoquine	NOUN	NN	B-Chemical
phenotype	phenotype	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
pharmacokinetics	pharmacokinetic	NOUN	NNS	O
and	and	CCONJ	CC	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
receptor	receptor	NOUN	NN	O
pharmacodynamics	pharmacodynamic	NOUN	NNS	O
of	of	ADP	IN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
enantiomers	enantiomer	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
metabolism	metabolism	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cardioselective	cardioselective	ADJ	JJ	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
blocker	blocker	NOUN	NN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
under	under	ADP	IN	O
genetic	genetic	ADJ	JJ	O
control	control	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
debrisoquine	debrisoquine	NOUN	NN	B-Chemical
/	/	SYM	SYM	O
sparteine	sparteine	NOUN	NN	B-Chemical
type	type	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
two	two	NUM	CD	O
metabolic	metabolic	ADJ	JJ	O
phenotypes	phenotype	NOUN	NNS	O
,	,	PUNCT	,	O
extensive	extensive	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
EM	EM	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
poor	poor	ADJ	JJ	O
metabolizers	metabolizer	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
PM	PM	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
show	show	VERB	VBP	O
different	different	ADJ	JJ	O
stereoselective	stereoselective	ADJ	JJ	O
metabolism	metabolism	NOUN	NN	O
,	,	PUNCT	,	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
apparently	apparently	ADV	RB	O
higher	high	ADJ	JJR	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
adrenoceptor	adrenoceptor	NOUN	NN	O
antagonistic	antagonistic	ADJ	JJ	O
potency	potency	NOUN	NN	O
of	of	ADP	IN	O
racemic	racemic	ADJ	JJ	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
in	in	ADP	IN	O
EMs	em	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
if	if	ADP	IN	O
the	the	DET	DT	O
latter	latter	NOUN	NN	O
also	also	ADV	RB	O
applies	apply	VERB	VBZ	O
to	to	ADP	IN	O
the	the	DET	DT	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
adrenoceptor	adrenoceptor	NOUN	NN	O
antagonism	antagonism	NOUN	NN	O
by	by	ADP	IN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
drug	drug	NOUN	NN	O
effect	effect	NOUN	NN	O
studied	study	VERB	VBD	O
was	be	VERB	VBD	O
the	the	DET	DT	O
antagonism	antagonism	NOUN	NN	O
by	by	ADP	IN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
of	of	ADP	IN	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

By	by	ADP	IN	O
using	use	VERB	VBG	O
pharmacokinetic	pharmacokinetic	ADJ	JJ	O
pharmacodynamic	pharmacodynamic	NOUN	NN	O
modeling	model	VERB	VBG	O
the	the	DET	DT	O
pharmacodynamics	pharmacodynamic	NOUN	NNS	O
of	of	ADP	IN	O
racemic	racemic	NOUN	NN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
active	active	ADJ	JJ	O
S	S	PROPN	NNP	O
-	-	PUNCT	HYPH	O
isomer	isomer	PROPN	NNP	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
quantitated	quantitate	VERB	VBN	O
in	in	ADP	IN	O
EMs	em	NOUN	NNS	O
and	and	CCONJ	CC	O
PMs	pm	NOUN	NNS	O
in	in	ADP	IN	O
terms	term	NOUN	NNS	O
of	of	ADP	IN	O
IC50	ic50	ADJ	JJ	O
values	value	NOUN	NNS	O
,	,	PUNCT	,	O
representing	represent	VERB	VBG	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
plasma	plasma	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
half	half	ADJ	JJ	O
-	-	PUNCT	HYPH	O
maximum	maximum	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
occupancy	occupancy	NOUN	NN	O
.	.	PUNCT	.	O

Six	six	NUM	CD	O
EMs	em	NOUN	NNS	O
received	receive	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
of	of	ADP	IN	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
s	s	NOUN	NN	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
on	on	ADP	IN	O
two	two	NUM	CD	O
different	different	ADJ	JJ	O
occasions	occasion	NOUN	NNS	O
:	:	PUNCT	:	O
1	1	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
1	1	NUM	CD	O
hr	hr	NOUN	NN	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
placebo	placebo	NOUN	NN	O
and	and	CCONJ	CC	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
1	1	NUM	CD	O
hr	hr	NOUN	NN	O
after	after	ADP	IN	O
150	150	NUM	CD	O
mg	mg	NOUN	NN	O
of	of	ADP	IN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
p	p	NOUN	NN	O
.	.	PUNCT	.	O
o	o	X	XX	O
.	.	PUNCT	.	O

Five	five	NUM	CD	O
PMs	pm	NOUN	NNS	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
according	accord	VERB	VBG	O
to	to	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
protocol	protocol	NOUN	NN	O
,	,	PUNCT	,	O
except	except	ADP	IN	O
for	for	ADP	IN	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
75	75	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
day	day	NOUN	NN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O

Blood	blood	NOUN	NN	O
samples	sample	NOUN	NNS	O
for	for	ADP	IN	O
the	the	DET	DT	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
potassium	potassium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
racemic	racemic	NOUN	NN	O
,	,	PUNCT	,	O
R	r	NOUN	NN	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
S	S	PROPN	NNP	O
-	-	PUNCT	HYPH	O
isomer	isomer	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxymetoprolol	hydroxymetoprolol	NOUN	NN	I-Chemical
concentrations	concentration	NOUN	NNS	O
were	be	VERB	VBD	O
taken	take	VERB	VBN	O
at	at	ADP	IN	O
regular	regular	ADJ	JJ	O
time	time	NOUN	NN	O
intervals	interval	NOUN	NNS	O
,	,	PUNCT	,	O
during	during	ADP	IN	O
8	8	NUM	CD	O
hr	hr	NOUN	NNS	O
after	after	ADP	IN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
PMs	pm	NOUN	NNS	O
,	,	PUNCT	,	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
increased	increase	VERB	VBD	O
the	the	DET	DT	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
area	area	NOUN	NN	O
under	under	ADP	IN	O
the	the	DET	DT	O
plasma	plasma	NOUN	NN	O
concentration	concentration	NOUN	NN	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
time	time	NOUN	NN	O
curve	curve	NOUN	NN	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
67	67	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Higher	high	ADJ	JJR	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
/	/	SYM	SYM	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxymetoprolol	hydroxymetoprolol	NOUN	NN	I-Chemical
ratios	ratio	NOUN	NNS	O
in	in	ADP	IN	O
PMs	pm	NOUN	NNS	O
were	be	VERB	VBD	O
predictive	predictive	ADJ	JJ	O
for	for	ADP	IN	O
higher	high	ADJ	JJR	O
R	r	NOUN	NN	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
S	s	NOUN	NN	O
-	-	PUNCT	HYPH	O
isomer	isomer	NOUN	NN	O
ratios	ratio	NOUN	NNS	O
of	of	ADP	IN	O
unchanged	unchanged	ADJ	JJ	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
difference	difference	NOUN	NN	O
in	in	ADP	IN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
potency	potency	NOUN	NN	O
with	with	ADP	IN	O
higher	high	ADJ	JJR	O
racemic	racemic	NOUN	NN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
IC50	ic50	DET	PRP$	O
values	value	NOUN	NNS	O
in	in	ADP	IN	O
PMs	pm	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
72	72	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
ng	ng	NOUN	NN	O
.	.	PUNCT	.	O
ml	ml	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
EMs	em	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
42	42	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
8	8	NUM	CD	O
ng	ng	NOUN	NN	O
.	.	PUNCT	.	O
ml	ml	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
ABSTRACT	ABSTRACT	PROPN	NNP	O
TRUNCATED	truncated	NUM	CD	O
AT	at	ADP	IN	O
250	250	NUM	CD	O
WORDS	word	NOUN	NNS	O
)	)	PUNCT	-RRB-	O

The	the	DET	DT	O
hemodynamics	hemodynamic	NOUN	NNS	O
of	of	ADP	IN	O
oxytocin	oxytocin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
other	other	ADJ	JJ	O
vasoactive	vasoactive	ADJ	JJ	O
agents	agent	NOUN	NNS	O
during	during	ADP	IN	O
neuraxial	neuraxial	ADJ	JJ	O
anesthesia	anesthesia	NOUN	NN	O
for	for	ADP	IN	O
cesarean	cesarean	ADJ	JJ	O
delivery	delivery	NOUN	NN	O
:	:	PUNCT	:	O
findings	finding	NOUN	NNS	O
in	in	ADP	IN	O
six	six	NUM	CD	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

Oxytocin	Oxytocin	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
commonly	commonly	ADV	RB	O
used	use	VERB	VBN	O
uterotonic	uterotonic	ADJ	JJ	O
that	that	DET	WDT	O
can	can	VERB	MD	O
cause	cause	VERB	VB	O
significant	significant	ADJ	JJ	O
and	and	CCONJ	CC	O
even	even	ADV	RB	O
fatal	fatal	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
particularly	particularly	ADV	RB	O
when	when	ADV	WRB	O
given	give	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
bolus	bolus	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
resulting	result	VERB	VBG	O
hypotension	hypotension	NOUN	NN	B-Disease
can	can	VERB	MD	O
be	be	VERB	VB	O
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
systemic	systemic	ADJ	JJ	O
vascular	vascular	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
or	or	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	O
output	output	NOUN	NN	O
through	through	ADP	IN	O
a	a	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
venous	venous	ADJ	JJ	O
return	return	NOUN	NN	O
.	.	PUNCT	.	O

Parturients	parturient	NOUN	NNS	O
with	with	ADP	IN	O
normal	normal	ADJ	JJ	O
volume	volume	NOUN	NN	O
status	status	NOUN	NN	O
,	,	PUNCT	,	O
heart	heart	NOUN	NN	O
valves	valve	NOUN	NNS	O
and	and	CCONJ	CC	O
pulmonary	pulmonary	ADJ	JJ	O
vasculature	vasculature	NOUN	NN	O
most	most	ADV	RBS	O
often	often	ADV	RB	O
respond	respond	VERB	VBP	O
to	to	ADP	IN	O
this	this	DET	DT	O
hypotension	hypotension	NOUN	NN	B-Disease
with	with	ADP	IN	O
a	a	DET	DT	O
compensatory	compensatory	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
and	and	CCONJ	CC	O
stroke	stroke	NOUN	NN	B-Disease
volume	volume	NOUN	NN	O
.	.	PUNCT	.	O

Oxytocin	Oxytocin	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
at	at	ADP	IN	O
cesarean	cesarean	ADJ	JJ	O
delivery	delivery	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
incorrectly	incorrectly	ADV	RB	O
attributed	attribute	VERB	VBN	O
to	to	ADP	IN	O
blood	blood	NOUN	NN	B-Disease
loss	loss	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Pulse	pulse	VERB	VB	O
power	power	NOUN	NN	O
analysis	analysis	NOUN	NN	O
(	(	PUNCT	-LRB-	O
also	also	ADV	RB	O
called	call	VERB	VBN	O
"	"	PUNCT	``	O
pulse	pulse	NOUN	NN	O
contour	contour	NOUN	NN	O
analysis	analysis	NOUN	NN	O
"	"	PUNCT	''	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
an	an	DET	DT	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
wave	wave	NOUN	NN	O
form	form	NOUN	NN	O
allows	allow	VERB	VBZ	O
continuous	continuous	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
systemic	systemic	ADJ	JJ	O
vascular	vascular	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	O
output	output	NOUN	NN	O
in	in	ADP	IN	O
real	real	ADJ	JJ	O
time	time	NOUN	NN	O
,	,	PUNCT	,	O
thereby	thereby	ADV	RB	O
elucidating	elucidate	VERB	VBG	O
the	the	DET	DT	O
causative	causative	ADJ	JJ	O
factors	factor	NOUN	NNS	O
behind	behind	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
.	.	PUNCT	.	O

Pulse	pulse	NOUN	NN	O
power	power	NOUN	NN	O
analysis	analysis	NOUN	NN	O
was	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
in	in	ADP	IN	O
six	six	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
cesarean	cesarean	ADJ	JJ	O
delivery	delivery	NOUN	NN	O
performed	perform	VERB	VBN	O
under	under	ADP	IN	O
neuraxial	neuraxial	ADJ	JJ	O
anesthesia	anesthesia	NOUN	NN	O
.	.	PUNCT	.	O

Hypotension	hypotension	NOUN	NN	B-Disease
in	in	ADP	IN	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
oxytocin	oxytocin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
systemic	systemic	ADJ	JJ	O
vascular	vascular	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
compensatory	compensatory	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
stroke	stroke	NOUN	NN	B-Disease
volume	volume	NOUN	NN	O
,	,	PUNCT	,	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	O
output	output	NOUN	NN	O
.	.	PUNCT	.	O

Pulse	pulse	NOUN	NN	O
power	power	NOUN	NN	O
analysis	analysis	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
helpful	helpful	ADJ	JJ	O
in	in	ADP	IN	O
determining	determine	VERB	VBG	O
the	the	DET	DT	O
etiology	etiology	NOUN	NN	O
of	of	ADP	IN	O
and	and	CCONJ	CC	O
treating	treat	VERB	VBG	O
hypotension	hypotension	NOUN	NN	B-Disease
during	during	ADP	IN	O
cesarean	cesarean	ADJ	JJ	O
delivery	delivery	NOUN	NN	O
under	under	ADP	IN	O
neuraxial	neuraxial	ADJ	JJ	O
anesthesia	anesthesia	NOUN	NN	O
.	.	PUNCT	.	O

Protective	protective	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
antithrombin	antithrombin	NOUN	NN	O
on	on	ADP	IN	O
puromycin	puromycin	NOUN	NN	B-Chemical
aminonucleoside	aminonucleoside	ADP	IN	I-Chemical
nephrosis	nephrosis	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
antithrombin	antithrombin	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
plasma	plasma	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
of	of	ADP	IN	O
coagulation	coagulation	NOUN	NN	O
factors	factor	NOUN	NNS	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
puromycin	puromycin	ADJ	JJ	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrosis	nephrosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
experimental	experimental	ADJ	JJ	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
human	human	ADJ	JJ	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Antithrombin	Antithrombin	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
50	50	NUM	CD	O
or	or	CCONJ	CC	O
500	500	NUM	CD	O
IU	iu	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	PROPN	NNP	O
/	/	SYM	SYM	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
to	to	PART	TO	O
rats	rat	NOUN	NNS	O
once	once	ADV	RB	O
a	a	DET	DT	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
10	10	NUM	CD	O
days	day	NOUN	NNS	O
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
the	the	DET	DT	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
puromycin	puromycin	NOUN	NN	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
(	(	PUNCT	-LRB-	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
antithrombin	antithrombin	NOUN	NN	O
attenuated	attenuate	VERB	VBD	O
the	the	DET	DT	O
puromycin	puromycin	ADJ	JJ	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hematological	hematological	ADJ	JJ	B-Disease
abnormalities	abnormality	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Puromycin	Puromycin	PROPN	NNP	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
renal	renal	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
hyperlipidemia	hyperlipidemia	NOUN	NN	B-Disease
were	be	VERB	VBD	O
also	also	ADV	RB	O
suppressed	suppress	VERB	VBN	O
.	.	PUNCT	.	O

Histopathological	histopathological	ADJ	JJ	O
examination	examination	NOUN	NN	O
revealed	reveal	VERB	VBD	O
severe	severe	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
such	such	ADJ	JJ	O
as	as	ADP	IN	O
proteinaceous	proteinaceous	ADJ	JJ	O
casts	cast	NOUN	NNS	O
in	in	ADP	IN	O
tubuli	tubuli	NOUN	NN	O
and	and	CCONJ	CC	O
tubular	tubular	ADJ	JJ	O
expansion	expansion	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
of	of	ADP	IN	O
control	control	NOUN	NN	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
an	an	DET	DT	O
improvement	improvement	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
damage	damage	NOUN	NN	O
was	be	VERB	VBD	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
antithrombin	antithrombin	NOUN	NN	O
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
antithrombin	antithrombin	NOUN	NN	O
treatment	treatment	NOUN	NN	O
markedly	markedly	ADV	RB	O
suppressed	suppress	VERB	VBD	O
puromycin	puromycin	ADJ	JJ	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
apoptosis	apoptosis	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
tubular	tubular	ADJ	JJ	O
epithelial	epithelial	ADJ	JJ	O
cells	cell	NOUN	NNS	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
puromycin	puromycin	ADJ	JJ	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
cytokine	cytokine	NOUN	NN	O
content	content	NOUN	NN	O
were	be	VERB	VBD	O
also	also	ADV	RB	O
decreased	decrease	VERB	VBN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
thrombin	thrombin	NOUN	NN	O
plays	play	VERB	VBZ	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pathogenesis	pathogenesis	NOUN	NN	O
of	of	ADP	IN	O
puromycin	puromycin	ADJ	JJ	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
antithrombin	antithrombin	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
clinically	clinically	ADV	RB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Heparin	Heparin	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
after	after	ADP	IN	O
liver	liver	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Unfractionated	unfractionated	ADJ	JJ	B-Chemical
heparin	heparin	ADJ	JJ	I-Chemical
sodium	sodium	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
UFH	UFH	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
low	low	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
molecular	molecular	ADJ	JJ	I-Chemical
weight	weight	NOUN	NN	I-Chemical
heparin	heparin	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
LMWH	LMWH	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
anticoagulant	anticoagulant	ADJ	JJ	O
protocols	protocol	NOUN	NNS	O
at	at	ADP	IN	O
several	several	ADJ	JJ	O
institutions	institution	NOUN	NNS	O
to	to	PART	TO	O
prevent	prevent	VERB	VB	O
thrombosis	thrombosis	NOUN	NN	B-Disease
after	after	ADP	IN	O
liver	liver	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

Heparin	Heparin	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
HIT	HIT	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
adverse	adverse	ADJ	JJ	O
immune	immune	NOUN	NN	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
reaction	reaction	NOUN	NN	O
to	to	ADP	IN	O
heparin	heparin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
platelet	platelet	NOUN	NN	O
count	count	NOUN	NN	O
decreases	decrease	NOUN	NNS	O
of	of	ADP	IN	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
frequencies	frequency	NOUN	NNS	O
of	of	ADP	IN	O
HIT	HIT	PROPN	NNP	B-Disease
after	after	ADP	IN	O
liver	liver	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
and	and	CCONJ	CC	O
platelet	platelet	NOUN	NN	O
factor	factor	NOUN	NN	O
4	4	NUM	CD	O
/	/	SYM	SYM	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
reactive	reactive	ADJ	JJ	O
antibody	antibody	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HIT	HIT	PROPN	NNP	B-Disease
antibody	antibody	NOUN	NN	O
)	)	PUNCT	-RRB-	O
positivity	positivity	NOUN	NN	O
in	in	ADP	IN	O
liver	liver	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
are	be	VERB	VBP	O
unknown	unknown	ADJ	JJ	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
32	32	NUM	CD	O
men	man	NOUN	NNS	O
and	and	CCONJ	CC	O
20	20	NUM	CD	O
women	woman	NOUN	NNS	O
underwent	undergo	VERB	VBD	O
living	live	VERB	VBG	O
donor	donor	NOUN	NN	O
liver	liver	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
started	start	VERB	VBD	O
LMWH	LMWH	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
25	25	NUM	CD	O
IU	iu	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
h	h	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
postoperative	postoperative	ADJ	JJ	O
day	day	NOUN	NN	O
(	(	PUNCT	-LRB-	O
POD	POD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
switching	switch	VERB	VBG	O
to	to	ADP	IN	O
UFH	UFH	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
5000	5000	NUM	CD	O
U	U	PROPN	NNP	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
POD	POD	PROPN	NNP	O
2	2	NUM	CD	O
or	or	CCONJ	CC	O
3	3	NUM	CD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
UFH	UFH	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
changed	change	VERB	VBN	O
according	accord	VERB	VBG	O
to	to	ADP	IN	O
the	the	DET	DT	O
activated	activate	VERB	VBN	O
clotting	clot	VERB	VBG	O
time	time	NOUN	NN	O
level	level	NOUN	NN	O
.	.	PUNCT	.	O

HIT	HIT	PROPN	NNP	B-Disease
antibody	antibody	NOUN	NN	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
the	the	DET	DT	O
day	day	NOUN	NN	O
before	before	ADP	IN	O
surgery	surgery	NOUN	NN	O
and	and	CCONJ	CC	O
on	on	ADP	IN	O
POD	POD	PROPN	NNP	O
7	7	NUM	CD	O
and	and	CCONJ	CC	O
14	14	NUM	CD	O
.	.	PUNCT	.	O

Platelet	Platelet	PROPN	NNP	O
count	count	NOUN	NN	O
was	be	VERB	VBD	O
measured	measure	VERB	VBN	O
daily	daily	ADV	RB	O
for	for	ADP	IN	O
3	3	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
average	average	ADJ	JJ	O
platelet	platelet	NOUN	NN	O
counts	count	NOUN	NNS	O
preoperatively	preoperatively	ADV	RB	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
on	on	ADP	IN	O
POD	POD	PROPN	NNP	O
7	7	NUM	CD	O
,	,	PUNCT	,	O
14	14	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
21	21	NUM	CD	O
were	be	VERB	VBD	O
65	65	NUM	CD	O
,	,	PUNCT	,	O
88	88	NUM	CD	O
,	,	PUNCT	,	O
149	149	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
169	169	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
hepatic	hepatic	ADJ	JJ	O
artery	artery	NOUN	NN	O
thrombosis	thrombosis	NOUN	NN	B-Disease
on	on	ADP	IN	O
POD	POD	PROPN	NNP	O
11	11	NUM	CD	O
and	and	CCONJ	CC	O
19	19	NUM	CD	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
they	-PRON-	PRON	PRP	O
were	be	VERB	VBD	O
HIT	HIT	VERB	VBN	B-Disease
antibody	antibody	NOUN	NN	O
-	-	PUNCT	HYPH	O
negative	negative	ADJ	JJ	O
and	and	CCONJ	CC	O
their	-PRON-	DET	PRP$	O
platelet	platelet	NOUN	NN	O
counts	count	NOUN	NNS	O
were	be	VERB	VBD	O
stable	stable	ADJ	JJ	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
2	2	NUM	CD	O
other	other	ADJ	JJ	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
platelet	platelet	NOUN	NN	O
count	count	NOUN	NN	O
decreased	decrease	VERB	VBD	O
suddenly	suddenly	ADV	RB	O
from	from	ADP	IN	O
107	107	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
on	on	ADP	IN	O
POD	POD	PROPN	NNP	O
4	4	NUM	CD	O
to	to	ADP	IN	O
65	65	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
on	on	ADP	IN	O
POD	POD	PROPN	NNP	O
6	6	NUM	CD	O
and	and	CCONJ	CC	O
from	from	ADP	IN	O
76	76	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
on	on	ADP	IN	O
POD	POD	PROPN	NNP	O
7	7	NUM	CD	O
to	to	PART	TO	O
33	33	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
on	on	ADP	IN	O
POD	POD	PROPN	NNP	O
9	9	NUM	CD	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
platelet	platelet	NOUN	NN	B-Disease
aggregation	aggregation	NOUN	NN	I-Disease
test	test	NOUN	NN	O
was	be	VERB	VBD	O
negative	negative	ADJ	JJ	O
in	in	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
percentage	percentage	NOUN	NN	O
of	of	ADP	IN	O
HIT	HIT	PROPN	NNP	B-Disease
antibody	antibody	NOUN	NN	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
patients	patient	NOUN	NNS	O
was	be	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
preoperatively	preoperatively	ADV	RB	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
on	on	ADP	IN	O
POD	POD	PROPN	NNP	O
7	7	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
on	on	ADP	IN	O
POD	POD	PROPN	NNP	O
14	14	NUM	CD	O
.	.	PUNCT	.	O

None	none	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
subjects	subject	NOUN	NNS	O
/	/	SYM	SYM	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
UFH	UFH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
HIT	HIT	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
our	-PRON-	DET	PRP$	O
series	series	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
HIT	HIT	PROPN	NNP	B-Disease
after	after	ADP	IN	O
liver	liver	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
was	be	VERB	VBD	O
uncommon	uncommon	ADJ	JJ	O
.	.	PUNCT	.	O

Doxorubicin	Doxorubicin	PROPN	NNP	B-Chemical
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
inflammation	inflammation	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
apoptosis	apoptosis	NOUN	NN	O
are	be	VERB	VBP	O
attenuated	attenuate	VERB	VBN	O
by	by	ADP	IN	O
gene	gene	NOUN	NN	O
deletion	deletion	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
kinin	kinin	NOUN	NN	O
B1	b1	NOUN	NN	O
receptor	receptor	NOUN	NN	O
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
anthracycline	anthracycline	ADJ	JJ	B-Chemical
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DOX	DOX	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
limited	limit	VERB	VBN	O
by	by	ADP	IN	O
its	-PRON-	DET	PRP$	O
cardiotoxic	cardiotoxic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
are	be	VERB	VBP	O
attributed	attribute	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
apoptosis	apoptosis	NOUN	NN	O
.	.	PUNCT	.	O

To	to	PART	TO	O
elucidate	elucidate	VERB	VB	O
the	the	DET	DT	O
possible	possible	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
kinin	kinin	NOUN	NN	O
B1	b1	NOUN	NN	O
receptor	receptor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
B1R	B1R	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
during	during	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
DOX	DOX	PROPN	NNP	B-Chemical
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
studied	study	VERB	VBD	O
B1R	B1R	PROPN	NNP	O
knockout	knockout	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
B1R	B1R	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
by	by	ADP	IN	O
investigating	investigate	VERB	VBG	O
cardiac	cardiac	ADJ	JJ	O
inflammation	inflammation	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
apoptosis	apoptosis	NOUN	NN	O
after	after	ADP	IN	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
DOX	DOX	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

DOX	dox	NOUN	NN	B-Chemical
control	control	NOUN	NN	O
mice	mouse	NOUN	NNS	O
showed	show	VERB	VBD	O
cardiac	cardiac	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
measured	measure	VERB	VBN	O
by	by	ADP	IN	O
pressure	pressure	NOUN	NN	O
-	-	PUNCT	HYPH	O
volume	volume	NOUN	NN	O
loops	loop	NOUN	NNS	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
reduced	reduced	ADJ	JJ	O
activation	activation	NOUN	NN	O
state	state	NOUN	NN	O
of	of	ADP	IN	O
AKT	AKT	PROPN	NNP	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
an	an	DET	DT	O
increased	increase	VERB	VBN	O
bax	bax	NOUN	NN	O
/	/	SYM	SYM	O
bcl2	bcl2	NOUN	NN	O
ratio	ratio	NOUN	NN	O
in	in	ADP	IN	O
Western	western	ADJ	JJ	O
blots	blot	NOUN	NNS	O
,	,	PUNCT	,	O
indicating	indicate	VERB	VBG	O
cardiac	cardiac	ADJ	JJ	B-Disease
apoptosis	apoptosis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
mRNA	mRNA	PROPN	NNP	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
proinflammatory	proinflammatory	NOUN	NN	O
cytokine	cytokine	NOUN	NN	O
interleukin	interleukin	NOUN	NN	O
6	6	NUM	CD	O
were	be	VERB	VBD	O
increased	increase	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
cardiac	cardiac	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
DOX	DOX	PROPN	NNP	B-Chemical
B1R	B1R	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
cardiac	cardiac	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
was	be	VERB	VBD	O
improved	improve	VERB	VBN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
DOX	DOX	PROPN	NNP	B-Chemical
control	control	NOUN	NN	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
normalization	normalization	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
bax	bax	NOUN	NN	O
/	/	SYM	SYM	O
bcl	bcl	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
ratio	ratio	NOUN	NN	O
and	and	CCONJ	CC	O
interleukin	interleukin	NOUN	NN	O
6	6	NUM	CD	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
AKT	AKT	PROPN	NNP	O
activation	activation	NOUN	NN	O
state	state	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
B1R	B1R	PROPN	NNP	O
is	be	VERB	VBZ	O
detrimental	detrimental	ADJ	JJ	O
in	in	ADP	IN	O
DOX	DOX	PROPN	NNP	B-Chemical
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
in	in	ADP	IN	O
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
mediates	mediate	VERB	VBZ	O
the	the	DET	DT	O
inflammatory	inflammatory	ADJ	JJ	O
response	response	NOUN	NN	O
and	and	CCONJ	CC	O
apoptosis	apoptosis	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
insights	insight	NOUN	NNS	O
might	may	VERB	MD	O
have	have	VERB	VB	O
useful	useful	ADJ	JJ	O
implications	implication	NOUN	NNS	O
for	for	ADP	IN	O
future	future	ADJ	JJ	O
studies	study	NOUN	NNS	O
utilizing	utilize	VERB	VBG	O
B1R	B1R	PROPN	NNP	O
antagonists	antagonist	NOUN	NNS	O
for	for	ADP	IN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
human	human	ADJ	JJ	O
DOX	DOX	PROPN	NNP	B-Chemical
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Detailed	detailed	ADJ	JJ	O
spectral	spectral	ADJ	JJ	O
profile	profile	NOUN	NN	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
penicillin	penicillin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
epileptiform	epileptiform	NOUN	NN	B-Disease
activity	activity	NOUN	NN	I-Disease
in	in	ADP	IN	O
anesthetized	anesthetized	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Penicillin	Penicillin	PROPN	NNP	B-Chemical
model	model	NOUN	NN	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
experimental	experimental	ADJ	JJ	O
model	model	NOUN	NN	O
for	for	ADP	IN	O
epilepsy	epilepsy	NOUN	NN	B-Disease
research	research	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
we	-PRON-	PRON	PRP	O
aimed	aim	VERB	VBD	O
to	to	PART	TO	O
portray	portray	VERB	VB	O
a	a	DET	DT	O
detailed	detailed	ADJ	JJ	O
spectral	spectral	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
penicillin	penicillin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
epileptiform	epileptiform	NOUN	NN	B-Disease
activity	activity	NOUN	NN	I-Disease
in	in	ADP	IN	O
comparison	comparison	NOUN	NN	O
with	with	ADP	IN	O
basal	basal	NOUN	NN	O
brain	brain	NOUN	NN	O
activity	activity	NOUN	NN	O
in	in	ADP	IN	O
anesthetized	anesthetized	ADJ	JJ	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Male	Male	PROPN	NNP	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
anesthetized	anesthetize	VERB	VBN	O
with	with	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
urethane	urethane	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
connected	connect	VERB	VBD	O
to	to	ADP	IN	O
an	an	DET	DT	O
electrocorticogram	electrocorticogram	ADJ	JJ	O
setup	setup	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
a	a	DET	DT	O
short	short	ADJ	JJ	O
period	period	NOUN	NN	O
of	of	ADP	IN	O
basal	basal	NOUN	NN	O
activity	activity	NOUN	NN	O
recording	recording	NOUN	NN	O
,	,	PUNCT	,	O
epileptic	epileptic	ADJ	JJ	B-Disease
focus	focus	NOUN	NN	O
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
injecting	inject	VERB	VBG	O
400IU	400IU	PROPN	NNP	O
/	/	SYM	SYM	O
2	2	NUM	CD	O
microl	microl	NOUN	NN	O
penicillin	penicillin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
G	g	NOUN	NN	I-Chemical
potassium	potassium	NOUN	NN	I-Chemical
into	into	ADP	IN	O
the	the	DET	DT	O
left	left	ADJ	JJ	O
lateral	lateral	ADJ	JJ	O
ventricle	ventricle	NOUN	NN	O
while	while	ADP	IN	O
the	the	DET	DT	O
cortical	cortical	ADJ	JJ	O
activity	activity	NOUN	NN	O
was	be	VERB	VBD	O
continuously	continuously	ADV	RB	O
recorded	record	VERB	VBN	O
.	.	PUNCT	.	O

Basal	basal	NOUN	NN	O
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
latent	latent	NOUN	NN	O
period	period	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
penicillin	penicillin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
epileptiform	epileptiform	NOUN	NN	B-Disease
activity	activity	NOUN	NN	I-Disease
periods	period	NOUN	NNS	O
were	be	VERB	VBD	O
then	then	ADV	RB	O
analyzed	analyze	VERB	VBN	O
using	use	VERB	VBG	O
both	both	DET	DT	O
conventional	conventional	ADJ	JJ	O
methods	method	NOUN	NNS	O
and	and	CCONJ	CC	O
spectral	spectral	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
.	.	PUNCT	.	O

Spectral	spectral	ADJ	JJ	O
analyses	analysis	NOUN	NNS	O
were	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
by	by	ADP	IN	O
dividing	divide	VERB	VBG	O
the	the	DET	DT	O
whole	whole	ADJ	JJ	O
spectrum	spectrum	NOUN	NN	O
into	into	ADP	IN	O
different	different	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
bands	band	NOUN	NNS	O
including	include	VERB	VBG	O
delta	delta	NOUN	NN	O
,	,	PUNCT	,	O
theta	theta	NOUN	NN	O
(	(	PUNCT	-LRB-	O
slow	slow	ADJ	JJ	O
and	and	CCONJ	CC	O
fast	fast	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
sigma	sigma	NOUN	NN	O
,	,	PUNCT	,	O
beta	beta	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
gamma	gamma	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
bands	band	NOUN	NNS	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
most	most	ADV	RBS	O
affected	affected	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
bands	band	NOUN	NNS	O
were	be	VERB	VBD	O
delta	delta	NOUN	NN	O
,	,	PUNCT	,	O
theta	theta	NOUN	NN	O
,	,	PUNCT	,	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
and	and	CCONJ	CC	O
gamma	gamma	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
bands	band	NOUN	NNS	O
during	during	ADP	IN	O
the	the	DET	DT	O
epileptiform	epileptiform	NOUN	NN	B-Disease
activity	activity	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
there	there	ADV	EX	O
were	be	VERB	VBD	O
marked	mark	VERB	VBN	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
terms	term	NOUN	NNS	O
of	of	ADP	IN	O
spectral	spectral	ADJ	JJ	O
densities	density	NOUN	NNS	O
between	between	ADP	IN	O
three	three	NUM	CD	O
investigated	investigate	VERB	VBN	O
episodes	episode	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
basal	basal	NOUN	NN	O
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
latent	latent	NOUN	NN	O
period	period	NOUN	NN	O
and	and	CCONJ	CC	O
epileptiform	epileptiform	NOUN	NN	B-Disease
activity	activity	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
may	may	VERB	MD	O
help	help	VERB	VB	O
to	to	PART	TO	O
analyze	analyze	VERB	VB	O
novel	novel	ADJ	JJ	O
data	datum	NOUN	NNS	O
obtained	obtain	VERB	VBN	O
using	use	VERB	VBG	O
similar	similar	ADJ	JJ	O
experimental	experimental	ADJ	JJ	O
models	model	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
simple	simple	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
method	method	NOUN	NN	O
described	describe	VERB	VBN	O
here	here	ADV	RB	O
can	can	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
similar	similar	ADJ	JJ	O
studies	study	NOUN	NNS	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
basic	basic	ADJ	JJ	O
neuronal	neuronal	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
or	or	CCONJ	CC	O
other	other	ADJ	JJ	O
types	type	NOUN	NNS	O
of	of	ADP	IN	O
experimental	experimental	ADJ	JJ	O
epilepsies	epilepsy	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

High	high	ADJ	JJ	O
fat	fat	ADJ	JJ	B-Chemical
diet	diet	NOUN	NN	O
-	-	PUNCT	HYPH	O
fed	feed	VERB	VBN	O
obese	obese	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
are	be	VERB	VBP	O
highly	highly	ADV	RB	O
sensitive	sensitive	ADJ	JJ	O
to	to	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Often	often	ADV	RB	O
,	,	PUNCT	,	O
chemotherapy	chemotherapy	NOUN	NN	O
by	by	ADP	IN	O
doxorubicin	doxorubicin	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
Adriamycin	Adriamycin	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
limited	limit	VERB	VBN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
life	life	NOUN	NN	O
threatening	threaten	VERB	VBG	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
during	during	ADP	IN	O
and	and	CCONJ	CC	O
posttherapy	posttherapy	NOUN	NN	O
.	.	PUNCT	.	O

Recently	recently	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
have	have	VERB	VBP	O
shown	show	VERB	VBN	O
that	that	DET	DT	O
moderate	moderate	ADJ	JJ	O
diet	diet	NOUN	NN	O
restriction	restriction	NOUN	NN	O
remarkably	remarkably	ADV	RB	O
protects	protect	VERB	VBZ	O
against	against	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
cardioprotection	cardioprotection	NOUN	NN	O
is	be	VERB	VBZ	O
accompanied	accompany	VERB	VBN	O
by	by	ADP	IN	O
decreased	decrease	VERB	VBN	O
cardiac	cardiac	ADJ	JJ	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
and	and	CCONJ	CC	O
triglycerides	triglyceride	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
increased	increase	VERB	VBN	O
cardiac	cardiac	ADJ	JJ	O
fatty	fatty	NOUN	NN	O
-	-	PUNCT	HYPH	O
acid	acid	NOUN	NN	O
oxidation	oxidation	NOUN	NN	O
,	,	PUNCT	,	O
ATP	ATP	PROPN	NNP	B-Chemical
synthesis	synthesis	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
upregulated	upregulate	VERB	VBD	O
JAK	JAK	PROPN	NNP	O
/	/	SYM	SYM	O
STAT3	STAT3	PROPN	NNP	O
pathway	pathway	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
current	current	ADJ	JJ	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
whether	whether	ADP	IN	O
a	a	DET	DT	O
physiological	physiological	ADJ	JJ	O
intervention	intervention	NOUN	NN	O
by	by	ADP	IN	O
feeding	feed	VERB	VBG	O
40	40	NUM	CD	O
%	%	NOUN	NN	O
high	high	ADJ	JJ	O
fat	fat	ADJ	JJ	B-Chemical
diet	diet	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HFD	HFD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
induces	induce	VERB	VBZ	O
obesity	obesity	NOUN	NN	B-Disease
in	in	ADP	IN	O
male	male	ADJ	JJ	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
250	250	NUM	CD	O
-	-	SYM	SYM	O
275	275	NUM	CD	O
g	g	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
sensitizes	sensitize	VERB	VBZ	O
to	to	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
LD	LD	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
)	)	PUNCT	-RRB-	O
dose	dose	NOUN	NN	O
(	(	PUNCT	-LRB-	O
8	8	NUM	CD	O
mg	mg	NOUN	NN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
/	/	PUNCT	,	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
ip	ip	NOUN	NN	O
)	)	PUNCT	-RRB-	O
administered	administer	VERB	VBD	O
on	on	ADP	IN	O
day	day	NOUN	NN	O
43	43	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
HFD	HFD	PROPN	NNP	O
feeding	feeding	NOUN	NN	O
regimen	regimen	NOUN	NN	O
led	lead	VERB	VBD	O
to	to	ADP	IN	O
higher	high	ADJ	JJR	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
cardiac	cardiac	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
,	,	PUNCT	,	O
lipid	lipid	NOUN	NN	O
peroxidation	peroxidation	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
80	80	NUM	CD	O
%	%	NOUN	NN	O
mortality	mortality	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
obese	obese	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
OB	OB	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
rats	rat	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
any	any	DET	DT	O
significant	significant	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
or	or	CCONJ	CC	I-Disease
hepatic	hepatic	ADJ	JJ	I-Disease
toxicity	toxicity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Doxorubicin	doxorubicin	ADJ	JJ	B-Chemical
toxicokinetics	toxicokinetic	NOUN	NNS	O
studies	study	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
no	no	DET	DT	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
accumulation	accumulation	NOUN	NN	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
doxorubicinol	doxorubicinol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
toxic	toxic	ADJ	JJ	O
metabolite	metabolite	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
normal	normal	ADJ	JJ	O
diet	diet	NOUN	NN	O
-	-	PUNCT	HYPH	O
fed	fed	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
ND	ND	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
OB	OB	PROPN	NNP	B-Disease
hearts	heart	NOUN	NNS	O
.	.	PUNCT	.	O

Mechanistic	mechanistic	ADJ	JJ	O
studies	study	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
that	that	ADP	IN	O
OB	OB	PROPN	NNP	B-Disease
rats	rat	NOUN	NNS	O
are	be	VERB	VBP	O
sensitized	sensitize	VERB	VBN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
:	:	PUNCT	:	O
(	(	PUNCT	-LRB-	O
1	1	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
higher	high	ADJ	JJR	O
oxyradical	oxyradical	ADJ	JJ	O
stress	stress	NOUN	NN	O
leading	lead	VERB	VBG	O
to	to	ADP	IN	O
upregulation	upregulation	NOUN	NN	O
of	of	ADP	IN	O
uncoupling	uncoupling	ADJ	JJ	O
proteins	protein	NOUN	NNS	O
2	2	NUM	CD	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
,	,	PUNCT	,	O
(	(	PUNCT	-LRB-	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
downregulation	downregulation	NOUN	NN	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
peroxisome	peroxisome	NOUN	NN	O
proliferators	proliferator	NOUN	NNS	O
activated	activate	VERB	VBD	O
receptor	receptor	NOUN	NN	O
-	-	PUNCT	HYPH	O
alpha	alpha	NOUN	NN	O
,	,	PUNCT	,	O
(	(	PUNCT	-LRB-	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
decreased	decrease	VERB	VBN	O
plasma	plasma	NOUN	NN	O
adiponectin	adiponectin	NOUN	NN	O
levels	level	NOUN	NNS	O
,	,	PUNCT	,	O
(	(	PUNCT	-LRB-	O
4	4	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
decreased	decrease	VERB	VBD	O
cardiac	cardiac	ADJ	JJ	O
fatty	fatty	NOUN	NN	O
-	-	PUNCT	HYPH	O
acid	acid	NOUN	NN	O
oxidation	oxidation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
666	666	NUM	CD	O
.	.	NOUN	NN	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
14	14	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
nmol	nmol	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
/	/	SYM	SYM	O
g	g	NOUN	NN	O
heart	heart	NOUN	NN	O
in	in	ADP	IN	O
ND	ND	PROPN	NNP	O
versus	versus	ADP	IN	O
400	400	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
nmol	nmol	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
/	/	SYM	SYM	O
g	g	NOUN	NN	O
heart	heart	NOUN	NN	O
in	in	ADP	IN	O
OB	OB	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
(	(	PUNCT	-LRB-	O
5	5	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
decreased	decrease	VERB	VBD	O
mitochondrial	mitochondrial	ADJ	JJ	O
AMP	AMP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
alpha2	alpha2	NOUN	NN	O
protein	protein	NOUN	NN	O
kinase	kinase	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
86	86	NUM	CD	O
%	%	NOUN	NN	O
drop	drop	NOUN	NN	O
in	in	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
ATP	ATP	PROPN	NNP	B-Chemical
levels	level	NOUN	NNS	O
accompanied	accompany	VERB	VBN	O
by	by	ADP	IN	O
decreased	decrease	VERB	VBN	O
ATP	ATP	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
ADP	ADP	PROPN	NNP	B-Chemical
ratio	ratio	NOUN	NN	O
after	after	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Decreased	decrease	VERB	VBN	O
cardiac	cardiac	ADJ	JJ	O
erythropoietin	erythropoietin	NOUN	NN	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBD	O
SOCS3	SOCS3	PROPN	NNP	O
further	further	ADV	RB	O
downregulated	downregulate	VERB	VBD	O
the	the	DET	DT	O
cardioprotective	cardioprotective	ADJ	JJ	O
JAK	JAK	PROPN	NNP	O
/	/	SYM	SYM	O
STAT3	STAT3	PROPN	NNP	O
pathway	pathway	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
HFD	HFD	PROPN	NNP	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
obese	obese	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
are	be	VERB	VBP	O
highly	highly	ADV	RB	O
sensitized	sensitize	VERB	VBN	O
to	to	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
by	by	ADP	IN	O
substantially	substantially	ADV	RB	O
downregulating	downregulate	VERB	VBG	O
cardiac	cardiac	ADJ	JJ	O
mitochondrial	mitochondrial	ADJ	JJ	O
ATP	ATP	PROPN	NNP	B-Chemical
generation	generation	NOUN	NN	O
,	,	PUNCT	,	O
increasing	increase	VERB	VBG	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
and	and	CCONJ	CC	O
downregulating	downregulate	VERB	VBG	O
the	the	DET	DT	O
JAK	JAK	PROPN	NNP	O
/	/	SYM	SYM	O
STAT3	STAT3	PROPN	NNP	O
pathway	pathway	NOUN	NN	O
.	.	PUNCT	.	O

Isoproterenol	isoproterenol	NOUN	NN	B-Chemical
induces	induce	VERB	VBZ	O
primary	primary	ADJ	JJ	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
dystrophin	dystrophin	NOUN	NN	O
in	in	ADP	IN	O
rat	rat	NOUN	NN	O
hearts	heart	NOUN	NNS	O
:	:	PUNCT	:	O
correlation	correlation	NOUN	NN	O
with	with	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
isoproterenol	isoproterenol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
myocardial	myocardial	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
unknown	unknown	ADJ	JJ	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
a	a	DET	DT	O
mismatch	mismatch	NOUN	NN	O
of	of	ADP	IN	O
oxygen	oxygen	NOUN	NN	B-Chemical
supply	supply	NOUN	NN	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
demand	demand	NOUN	NN	O
following	follow	VERB	VBG	O
coronary	coronary	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
myocardial	myocardial	ADJ	JJ	B-Disease
hyperactivity	hyperactivity	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
the	the	DET	DT	O
best	good	ADJ	JJS	O
explanation	explanation	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
complex	complex	ADJ	JJ	O
morphological	morphological	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
observed	observe	VERB	VBD	O
.	.	PUNCT	.	O

Severe	severe	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
structural	structural	ADJ	JJ	O
integrity	integrity	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
sarcolemma	sarcolemma	NOUN	NN	O
of	of	ADP	IN	O
cardiomyocytes	cardiomyocyte	NOUN	NNS	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
demonstrated	demonstrate	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
isoproterenol	isoproterenol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Taking	take	VERB	VBG	O
into	into	ADP	IN	O
account	account	NOUN	NN	O
that	that	ADP	IN	O
the	the	DET	DT	O
sarcolemmal	sarcolemmal	ADJ	JJ	O
integrity	integrity	NOUN	NN	O
is	be	VERB	VBZ	O
stabilized	stabilize	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
dystrophin	dystrophin	ADV	RB	O
-	-	PUNCT	HYPH	O
glycoprotein	glycoprotein	NOUN	NN	O
complex	complex	NOUN	NN	O
(	(	PUNCT	-LRB-	O
DGC	DGC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
that	that	DET	WDT	O
connects	connect	VERB	VBZ	O
actin	actin	ADJ	JJ	O
and	and	CCONJ	CC	O
laminin	laminin	ADJ	JJ	O
in	in	ADP	IN	O
contractile	contractile	NOUN	NN	O
machinery	machinery	NOUN	NN	O
and	and	CCONJ	CC	O
extracellular	extracellular	ADJ	JJ	O
matrix	matrix	NOUN	NN	O
and	and	CCONJ	CC	O
by	by	ADP	IN	O
integrins	integrin	NOUN	NNS	O
,	,	PUNCT	,	O
this	this	DET	DT	O
study	study	NOUN	NN	O
tests	test	VERB	VBZ	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
that	that	DET	WDT	O
isoproterenol	isoproterenol	NOUN	NN	B-Chemical
affects	affect	VERB	VBZ	O
sarcolemmal	sarcolemmal	ADJ	JJ	O
stability	stability	NOUN	NN	O
through	through	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
DGC	DGC	PROPN	NNP	O
and	and	CCONJ	CC	O
integrins	integrin	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
found	find	VERB	VBD	O
different	different	ADJ	JJ	O
sensitivity	sensitivity	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
DGC	DGC	PROPN	NNP	O
and	and	CCONJ	CC	O
integrin	integrin	NOUN	NN	O
to	to	PART	TO	O
isoproterenol	isoproterenol	VERB	VB	B-Chemical
subcutaneous	subcutaneous	ADJ	JJ	O
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Immunofluorescent	immunofluorescent	ADJ	JJ	O
staining	staining	NOUN	NN	O
revealed	reveal	VERB	VBD	O
that	that	ADP	IN	O
dystrophin	dystrophin	ADV	RB	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
most	most	ADV	RBS	O
sensitive	sensitive	ADJ	JJ	O
among	among	ADP	IN	O
the	the	DET	DT	O
structures	structure	NOUN	NNS	O
connecting	connect	VERB	VBG	O
the	the	DET	DT	O
actin	actin	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
cardiomyocyte	cardiomyocyte	NOUN	NN	O
cytoskeleton	cytoskeleton	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
extracellular	extracellular	ADJ	JJ	O
matrix	matrix	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
sarcomeric	sarcomeric	ADJ	JJ	O
actin	actin	NOUN	NN	O
dissolution	dissolution	NOUN	NN	O
occurred	occur	VERB	VBD	O
after	after	ADP	IN	O
the	the	DET	DT	O
reduction	reduction	NOUN	NN	O
or	or	CCONJ	CC	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
dystrophin	dystrophin	NOUN	NN	O
.	.	PUNCT	.	O

Subsequently	subsequently	ADV	RB	O
,	,	PUNCT	,	O
after	after	ADP	IN	O
lysis	lysis	NOUN	NN	O
of	of	ADP	IN	O
myofilaments	myofilament	NOUN	NNS	O
,	,	PUNCT	,	O
gamma	gamma	NOUN	NN	O
-	-	PUNCT	HYPH	O
sarcoglycan	sarcoglycan	ADJ	JJ	O
,	,	PUNCT	,	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
dystroglycan	dystroglycan	ADJ	JJ	O
,	,	PUNCT	,	O
beta1	beta1	NOUN	NN	O
-	-	PUNCT	HYPH	O
integrin	integrin	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
laminin	laminin	ADJ	JJ	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
expressions	expression	NOUN	NNS	O
were	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
their	-PRON-	DET	PRP$	O
breakdown	breakdown	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
epiphenomena	epiphenomenon	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
myocytolytic	myocytolytic	ADJ	JJ	O
process	process	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
isoproterenol	isoproterenol	NOUN	NN	B-Chemical
to	to	PART	TO	O
rats	rats	VERB	VB	O
results	result	NOUN	NNS	O
in	in	ADP	IN	O
primary	primary	ADJ	JJ	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
dystrophin	dystrophin	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
most	most	ADV	RBS	O
sensitive	sensitive	ADJ	JJ	O
among	among	ADP	IN	O
the	the	DET	DT	O
structural	structural	ADJ	JJ	O
proteins	protein	NOUN	NNS	O
that	that	DET	WDT	O
form	form	VERB	VBP	O
the	the	DET	DT	O
DGC	DGC	PROPN	NNP	O
that	that	DET	WDT	O
connects	connect	VERB	VBZ	O
the	the	DET	DT	O
extracellular	extracellular	ADJ	JJ	O
matrix	matrix	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
cytoskeleton	cytoskeleton	NOUN	NN	O
in	in	ADP	IN	O
cardiomyocyte	cardiomyocyte	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
changes	change	NOUN	NNS	O
,	,	PUNCT	,	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
ischaemic	ischaemic	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
,	,	PUNCT	,	O
explain	explain	VERB	VB	O
the	the	DET	DT	O
severe	severe	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
structural	structural	ADJ	JJ	O
integrity	integrity	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
sarcolemma	sarcolemma	NOUN	NN	O
of	of	ADP	IN	O
cardiomyocytes	cardiomyocyte	NOUN	NNS	O
and	and	CCONJ	CC	O
hence	hence	ADV	RB	O
severe	severe	ADJ	JJ	O
and	and	CCONJ	CC	O
irreversible	irreversible	ADJ	JJ	O
injury	injury	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
isoproterenol	isoproterenol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Etiologic	etiologic	ADJ	JJ	O
factors	factor	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
pathogenesis	pathogenesis	NOUN	NN	O
of	of	ADP	IN	O
liver	liver	NOUN	NN	B-Disease
tumors	tumor	NOUN	NNS	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
oral	oral	ADJ	JJ	B-Chemical
contraceptives	contraceptive	NOUN	NNS	I-Chemical
.	.	PUNCT	.	O

Within	within	ADP	IN	O
the	the	DET	DT	O
last	last	ADJ	JJ	O
several	several	ADJ	JJ	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
previously	previously	ADV	RB	O
rare	rare	ADJ	JJ	O
liver	liver	NOUN	NN	B-Disease
tumors	tumor	NOUN	NNS	I-Disease
have	have	VERB	VBP	O
been	be	VERB	VBN	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
young	young	ADJ	JJ	O
women	woman	NOUN	NNS	O
using	use	VERB	VBG	O
oral	oral	ADJ	JJ	B-Chemical
contraceptive	contraceptive	ADJ	JJ	I-Chemical
steroids	steroid	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
Registry	Registry	PROPN	NNP	O
for	for	ADP	IN	O
Liver	Liver	PROPN	NNP	B-Disease
Tumors	Tumors	PROPN	NNP	I-Disease
Associated	associate	VERB	VBN	O
with	with	ADP	IN	O
Oral	Oral	PROPN	NNP	B-Chemical
Contraceptives	Contraceptives	PROPN	NNP	I-Chemical
at	at	ADP	IN	O
the	the	DET	DT	O
University	University	PROPN	NNP	O
of	of	ADP	IN	O
California	California	PROPN	NNP	O
,	,	PUNCT	,	O
Irvine	Irvine	PROPN	NNP	O
,	,	PUNCT	,	O
has	have	VERB	VBZ	O
clearly	clearly	ADV	RB	O
identified	identify	VERB	VBN	O
27	27	NUM	CD	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
recent	recent	ADJ	JJ	O
literature	literature	NOUN	NN	O
contains	contain	VERB	VBZ	O
44	44	NUM	CD	O
case	case	NOUN	NN	O
reports	report	NOUN	NNS	O
.	.	PUNCT	.	O

Common	common	ADJ	JJ	O
to	to	ADP	IN	O
these	these	DET	DT	O
71	71	NUM	CD	O
cases	case	NOUN	NNS	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
a	a	DET	DT	O
histopathologic	histopathologic	ADJ	JJ	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
focal	focal	ADJ	JJ	B-Disease
nodular	nodular	ADJ	JJ	I-Disease
hyperplasia	hyperplasia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
adenoma	adenoma	NOUN	NN	B-Disease
,	,	PUNCT	,	O
hamartoma	hamartoma	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
hepatoma	hepatoma	ADJ	JJ	B-Disease
.	.	PUNCT	.	O

Significant	significant	ADJ	JJ	O
statistical	statistical	ADJ	JJ	O
etiologic	etiologic	ADJ	JJ	O
factors	factor	NOUN	NNS	O
include	include	VERB	VBP	O
prolonged	prolong	VERB	VBN	O
uninterrupted	uninterrupted	ADJ	JJ	O
usage	usage	NOUN	NN	O
of	of	ADP	IN	O
oral	oral	ADJ	JJ	B-Chemical
contraceptive	contraceptive	ADJ	JJ	I-Chemical
steroids	steroid	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

Eight	eight	NUM	CD	O
deaths	death	NOUN	NNS	O
and	and	CCONJ	CC	O
liver	liver	NOUN	NN	O
rupture	rupture	NOUN	NN	B-Disease
in	in	ADP	IN	O
18	18	NUM	CD	O
patients	patient	NOUN	NNS	O
attest	attest	VERB	VBP	O
to	to	ADP	IN	O
the	the	DET	DT	O
seriousness	seriousness	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
new	new	ADJ	JJ	O
potentially	potentially	ADV	RB	O
lethal	lethal	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
phenomenon	phenomenon	NOUN	NN	O
.	.	PUNCT	.	O

Ifosfamide	ifosfamide	ADJ	JJ	B-Chemical
continuous	continuous	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
without	without	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
phase	phase	NOUN	NN	O
I	-PRON-	PRON	PRP	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
14	14	NUM	CD	O
-	-	PUNCT	HYPH	O
day	day	NOUN	NN	O
cycle	cycle	NOUN	NN	O
.	.	PUNCT	.	O

Twenty	twenty	NUM	CD	O
patients	patient	NOUN	NNS	O
received	receive	VERB	VBD	O
27	27	NUM	CD	O
courses	course	NOUN	NNS	O
of	of	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
administered	administer	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
continuous	continuous	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
for	for	ADP	IN	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
without	without	ADP	IN	O
Mesna	Mesna	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
goal	goal	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
deliver	deliver	VERB	VB	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
rate	rate	NOUN	NN	O
and	and	CCONJ	CC	O
total	total	ADJ	JJ	O
cumulative	cumulative	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
that	that	DET	WDT	O
would	would	VERB	MD	O
be	be	VERB	VB	O
comparable	comparable	ADJ	JJ	O
to	to	ADP	IN	O
standard	standard	ADJ	JJ	O
bolus	bolus	NOUN	NN	O
or	or	CCONJ	CC	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
infusions	infusion	NOUN	NNS	O
administered	administer	VERB	VBN	O
with	with	ADP	IN	O
Mesna	Mesna	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Dose	dose	NOUN	NN	O
escalations	escalation	NOUN	NNS	O
proceeded	proceed	VERB	VBD	O
from	from	ADP	IN	O
200	200	NUM	CD	O
to	to	ADP	IN	O
300	300	NUM	CD	O
,	,	PUNCT	,	O
400	400	NUM	CD	O
,	,	PUNCT	,	O
450	450	NUM	CD	O
,	,	PUNCT	,	O
500	500	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
550	550	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
.	.	PUNCT	.	O

Four	four	NUM	CD	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
transient	transient	ADJ	JJ	O
microscopic	microscopic	ADJ	JJ	O
hematuria	hematuria	NOUN	NN	B-Disease
at	at	ADP	IN	O
400	400	NUM	CD	O
,	,	PUNCT	,	O
450	450	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
500	500	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
instances	instance	NOUN	NNS	O
of	of	ADP	IN	O
macroscopic	macroscopic	ADJ	JJ	O
hematuria	hematuria	NOUN	NN	B-Disease
.	.	PUNCT	.	O

At	at	ADP	IN	O
550	550	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
,	,	PUNCT	,	O
three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
experienced	experience	VERB	VBD	O
nonurologic	nonurologic	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
;	;	PUNCT	:	O
confusion	confusion	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
nausea	nausea	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
Grade	Grade	PROPN	NNP	O
2	2	NUM	CD	O
leukopenia	leukopenia	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
recommended	recommend	VERB	VBN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
500	500	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
/	/	SYM	SYM	O
d	d	PROPN	NNP	O
delivers	deliver	VERB	VBZ	O
a	a	DET	DT	O
total	total	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
7	7	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
per	per	ADP	IN	O
cycle	cycle	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
comparable	comparable	ADJ	JJ	O
to	to	ADP	IN	O
that	that	DET	DT	O
delivered	deliver	VERB	VBN	O
in	in	ADP	IN	O
clinical	clinical	ADJ	JJ	O
practice	practice	NOUN	NN	O
for	for	ADP	IN	O
bolus	bolus	NOUN	NN	O
or	or	CCONJ	CC	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
infusion	infusion	NOUN	NN	O
.	.	PUNCT	.	O

Because	because	ADP	IN	O
few	few	ADJ	JJ	O
patients	patient	NOUN	NNS	O
received	receive	VERB	VBD	O
multiple	multiple	ADJ	JJ	O
courses	course	NOUN	NNS	O
over	over	ADP	IN	O
time	time	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
cumulative	cumulative	ADJ	JJ	O
effects	effect	NOUN	NNS	O
are	be	VERB	VBP	O
indeterminate	indeterminate	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
trial	trial	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
frequency	frequency	NOUN	NN	O
and	and	CCONJ	CC	O
predictability	predictability	NOUN	NN	O
of	of	ADP	IN	O
hematuria	hematuria	NOUN	NN	B-Disease
are	be	VERB	VBP	O
not	not	ADV	RB	O
precise	precise	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
daily	daily	ADJ	JJ	O
monitoring	monitoring	NOUN	NN	O
by	by	ADP	IN	O
urine	urine	NOUN	NN	O
Hematest	Hematest	PROPN	NNP	O
is	be	VERB	VBZ	O
essential	essential	ADJ	JJ	O
,	,	PUNCT	,	O
adding	add	VERB	VBG	O
Mesna	Mesna	PROPN	NNP	B-Chemical
to	to	ADP	IN	O
the	the	DET	DT	O
infusate	infusate	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
persistent	persistent	ADJ	JJ	O
hematuria	hematuria	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
protracted	protracted	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
schedule	schedule	NOUN	NN	O
for	for	ADP	IN	O
ifosfamide	ifosfamide	ADJ	JJ	B-Chemical
permits	permit	NOUN	NNS	O
convenient	convenient	ADJ	JJ	O
outpatient	outpatient	NOUN	NN	O
administration	administration	NOUN	NN	O
without	without	ADP	IN	O
Mesna	Mesna	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
reduces	reduce	VERB	VBZ	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
cost	cost	NOUN	NN	O
of	of	ADP	IN	O
clinical	clinical	ADJ	JJ	O
usage	usage	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
agent	agent	NOUN	NN	O
by	by	ADP	IN	O
up	up	ADP	IN	O
to	to	PART	TO	O
890	890	NUM	CD	O
per	per	ADP	IN	O
cycle	cycle	NOUN	NN	O
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
activity	activity	NOUN	NN	O
was	be	VERB	VBD	O
demonstrated	demonstrate	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
patient	patient	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
a	a	DET	DT	O
comparative	comparative	ADJ	JJ	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
standard	standard	ADJ	JJ	O
bolus	bolus	NOUN	NN	O
schedules	schedule	NOUN	NNS	O
with	with	ADP	IN	O
the	the	DET	DT	O
protracted	protract	VERB	VBN	O
infusion	infusion	NOUN	NN	O
schedule	schedule	NOUN	NN	O
will	will	VERB	MD	O
be	be	VERB	VB	O
necessary	necessary	ADJ	JJ	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
if	if	ADP	IN	O
the	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
effectiveness	effectiveness	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
is	be	VERB	VBZ	O
maintained	maintain	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
related	relate	VERB	VBN	O
to	to	ADP	IN	O
caffeine	caffeine	NOUN	NN	B-Chemical
pretreatment	pretreatment	NOUN	NN	O
.	.	PUNCT	.	O

Suboptimal	suboptimal	ADJ	JJ	O
seizure	seizure	NOUN	NN	B-Disease
duration	duration	NOUN	NN	O
is	be	VERB	VBZ	O
commonly	commonly	ADV	RB	O
encountered	encounter	VERB	VBN	O
in	in	ADP	IN	O
electroconvulsive	electroconvulsive	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
practice	practice	NOUN	NN	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
in	in	ADP	IN	O
older	old	ADJ	JJR	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
higher	high	ADJ	JJR	O
seizure	seizure	NOUN	NN	B-Disease
thresholds	threshold	NOUN	NNS	O
.	.	PUNCT	.	O

Intravenous	intravenous	ADJ	JJ	O
caffeine	caffeine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
commonly	commonly	ADV	RB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
improve	improve	VERB	VB	O
seizure	seizure	NOUN	NN	B-Disease
duration	duration	NOUN	NN	O
and	and	CCONJ	CC	O
quality	quality	NOUN	NN	O
in	in	ADP	IN	O
such	such	ADJ	JJ	O
patients	patient	NOUN	NNS	O
and	and	CCONJ	CC	O
is	be	VERB	VBZ	O
generally	generally	ADV	RB	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
aside	aside	ADV	RB	O
from	from	ADP	IN	O
occasional	occasional	ADJ	JJ	O
reports	report	NOUN	NNS	O
of	of	ADP	IN	O
relatively	relatively	ADV	RB	O
benign	benign	ADJ	JJ	O
ventricular	ventricular	ADJ	JJ	B-Disease
ectopy	ectopy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
no	no	DET	DT	O
previous	previous	ADJ	JJ	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
sustained	sustain	VERB	VBN	O
bigeminy	bigeminy	NOUN	NN	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
brief	brief	ADJ	JJ	O
runs	run	NOUN	NNS	O
of	of	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
after	after	ADP	IN	O
caffeine	caffeine	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
caffeine	caffeine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
generally	generally	ADV	RB	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
clinician	clinician	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
the	the	DET	DT	O
potential	potential	NOUN	NN	O
for	for	ADP	IN	O
unpredictable	unpredictable	ADJ	JJ	O
and	and	CCONJ	CC	O
serious	serious	ADJ	JJ	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Fatal	fatal	ADJ	JJ	O
haemopericardium	haemopericardium	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
gastrointestinal	gastrointestinal	ADJ	JJ	B-Disease
haemorrhage	haemorrhage	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
possible	possible	ADJ	JJ	O
interaction	interaction	NOUN	NN	O
of	of	ADP	IN	O
cranberry	cranberry	ADJ	JJ	O
juice	juice	NOUN	NN	O
with	with	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
fatal	fatal	ADJ	JJ	O
internal	internal	ADJ	JJ	O
haemorrhage	haemorrhage	NOUN	NN	B-Disease
in	in	ADP	IN	O
an	an	DET	DT	O
elderly	elderly	ADJ	JJ	O
man	man	NOUN	NN	O
who	who	PRON	WP	O
consumed	consume	VERB	VBD	O
only	only	ADV	RB	O
cranberry	cranberry	ADJ	JJ	O
juice	juice	NOUN	NN	O
for	for	ADP	IN	O
two	two	NUM	CD	O
weeks	week	NOUN	NNS	O
while	while	ADP	IN	O
maintaining	maintain	VERB	VBG	O
his	-PRON-	DET	PRP$	O
usual	usual	ADJ	JJ	O
dosage	dosage	NOUN	NN	O
of	of	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
propose	propose	VERB	VBP	O
that	that	ADP	IN	O
naturally	naturally	ADV	RB	O
occurring	occur	VERB	VBG	O
compounds	compound	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
flavonoids	flavonoid	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
are	be	VERB	VBP	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
fruit	fruit	NOUN	NN	O
juices	juice	NOUN	NNS	O
,	,	PUNCT	,	O
may	may	VERB	MD	O
increase	increase	VERB	VB	O
the	the	DET	DT	O
potency	potency	NOUN	NN	O
of	of	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
by	by	ADP	IN	O
competing	compete	VERB	VBG	O
for	for	ADP	IN	O
the	the	DET	DT	O
enzymes	enzyme	NOUN	NNS	O
that	that	DET	WDT	O
normally	normally	ADV	RB	O
inactivate	inactivate	VERB	VBP	O
warfarin	warfarin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

While	while	ADP	IN	O
traditionally	traditionally	ADV	RB	O
regarded	regard	VERB	VBN	O
as	as	ADP	IN	O
foodstuffs	foodstuff	NOUN	NNS	O
,	,	PUNCT	,	O
consumption	consumption	NOUN	NN	O
of	of	ADP	IN	O
fruit	fruit	NOUN	NN	O
juices	juice	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
when	when	ADV	WRB	O
patients	patient	NOUN	NNS	O
develop	develop	VERB	VB	O
adverse	adverse	ADJ	JJ	O
drug	drug	NOUN	NN	O
reactions	reaction	NOUN	NNS	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
increasing	increase	VERB	VBG	O
intraperitoneal	intraperitoneal	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
rates	rate	NOUN	NNS	O
on	on	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
known	know	VERB	VBN	O
if	if	ADP	IN	O
there	there	ADV	EX	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
input	input	NOUN	NN	O
rate	rate	NOUN	NN	O
and	and	CCONJ	CC	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
important	important	ADJ	JJ	O
,	,	PUNCT	,	O
since	since	ADP	IN	O
different	different	ADJ	JJ	O
controlled	control	VERB	VBN	O
release	release	NOUN	NN	O
formulations	formulation	NOUN	NNS	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
release	release	VERB	VBP	O
the	the	DET	DT	O
active	active	ADJ	JJ	O
drug	drug	NOUN	NN	O
at	at	ADP	IN	O
different	different	ADJ	JJ	O
rates	rate	NOUN	NNS	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
varying	vary	VERB	VBG	O
the	the	DET	DT	O
intraperitoneal	intraperitoneal	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
rates	rate	NOUN	NNS	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
HCl	HCl	PROPN	NNPS	I-Chemical
120	120	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
known	know	VERB	VBN	O
convulsive	convulsive	ADJ	JJ	B-Disease
dose	dose	NOUN	NN	O
50	50	NUM	CD	O
(	(	PUNCT	-LRB-	O
CD50	CD50	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
and	and	CCONJ	CC	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
Swiss	swiss	ADJ	JJ	O
albino	albino	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
69	69	NUM	CD	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
approximately	approximately	ADV	RB	O
7	7	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
weighing	weigh	VERB	VBG	O
21	21	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
to	to	ADP	IN	O
29	29	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
g	g	NOUN	NN	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
assigned	assign	VERB	VBN	O
to	to	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
HCl	HCl	NOUN	NNS	I-Chemical
120	120	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
treatment	treatment	NOUN	NN	O
by	by	ADP	IN	O
intraperitoneal	intraperitoneal	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
IP	IP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
administration	administration	NOUN	NN	O
in	in	ADP	IN	O
7	7	NUM	CD	O
groups	group	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
to	to	PART	TO	O
10	10	NUM	CD	O
animals	animal	NOUN	NNS	O
per	per	ADP	IN	O
group	group	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Bupropion	bupropion	NOUN	NN	B-Chemical
HCl	HCl	NOUN	NNS	I-Chemical
was	be	VERB	VBD	O
infused	infuse	VERB	VBN	O
through	through	ADP	IN	O
a	a	DET	DT	O
surgically	surgically	ADV	RB	O
implanted	implant	VERB	VBN	O
IP	IP	PROPN	NNP	O
dosing	dose	VERB	VBG	O
catheter	catheter	NOUN	NN	O
with	with	ADP	IN	O
infusions	infusion	NOUN	NNS	O
in	in	ADP	IN	O
each	each	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
min	min	NOUN	NN	O
,	,	PUNCT	,	O
15	15	NUM	CD	O
min	min	NOUN	NN	O
,	,	PUNCT	,	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
,	,	PUNCT	,	O
60	60	NUM	CD	O
min	min	NOUN	NN	O
,	,	PUNCT	,	O
90	90	NUM	CD	O
min	min	NOUN	NN	O
,	,	PUNCT	,	O
120	120	NUM	CD	O
min	min	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
240	240	NUM	CD	O
min	min	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
number	number	NOUN	NN	O
,	,	PUNCT	,	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
onset	onset	NOUN	NN	O
,	,	PUNCT	,	O
duration	duration	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
intensity	intensity	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
convulsions	convulsion	NOUN	NNS	B-Disease
or	or	CCONJ	CC	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
convulsions	convulsion	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
recorded	record	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
results	result	NOUN	NNS	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
IP	IP	PROPN	NNP	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
HCl	HCl	PROPN	NNPS	I-Chemical
120	120	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	VERB	VB	O
by	by	ADP	IN	O
bolus	bolus	NOUN	NN	O
injection	injection	NOUN	NN	O
induced	induce	VERB	VBD	O
convulsions	convulsion	NOUN	NNS	B-Disease
in	in	ADP	IN	O
6	6	NUM	CD	O
out	out	ADP	IN	O
of	of	ADP	IN	O
10	10	NUM	CD	O
mice	mouse	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
60	60	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
convulsing	convulsing	NOUN	NN	O
mice	mouse	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
group	group	NOUN	NN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O

Logistic	logistic	ADJ	JJ	O
regression	regression	NOUN	NN	O
analysis	analysis	NOUN	NN	O
revealed	reveal	VERB	VBD	O
that	that	ADP	IN	O
infusion	infusion	NOUN	NN	O
time	time	NOUN	NN	O
was	be	VERB	VBD	O
significant	significant	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0004	0004	NUM	CD	O
;	;	PUNCT	:	O
odds	odd	NOUN	NNS	O
ratio	ratio	NOUN	NN	O
=	=	PUNCT	NFP	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
974	974	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
increasing	increase	VERB	VBG	O
the	the	DET	DT	O
IP	IP	PROPN	NNP	O
infusion	infusion	NOUN	NN	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
HCl	HCl	PROPN	NNPS	I-Chemical
120	120	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	PROPN	NNP	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
91	91	NUM	CD	O
%	%	NOUN	NN	O
reduced	reduce	VERB	VBN	O
odds	odd	NOUN	NNS	O
of	of	ADP	IN	O
convulsions	convulsion	NOUN	NNS	B-Disease
at	at	ADP	IN	O
infusion	infusion	NOUN	NN	O
times	time	NOUN	NNS	O
of	of	ADP	IN	O
15	15	NUM	CD	O
to	to	PART	TO	O
90	90	NUM	CD	O
min	min	NOUN	NN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
bolus	bolus	NOUN	NN	O
injection	injection	NOUN	NN	O
.	.	PUNCT	.	O

Further	further	ADV	RB	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
infusion	infusion	NOUN	NN	O
time	time	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
further	further	ADJ	JJ	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
odds	odd	NOUN	NNS	O
of	of	ADP	IN	O
convulsions	convulsion	NOUN	NNS	B-Disease
to	to	ADP	IN	O
99	99	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
reduction	reduction	NOUN	NN	O
at	at	ADP	IN	O
240	240	NUM	CD	O
min	min	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
demonstration	demonstration	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
inverse	inverse	NOUN	NN	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
infusion	infusion	NOUN	NN	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
fixed	fix	VERB	VBN	O
and	and	CCONJ	CC	O
convulsive	convulsive	ADJ	JJ	B-Disease
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
bupropion	bupropion	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
convulsions	convulsion	NOUN	NNS	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
study	study	NOUN	NN	O
is	be	VERB	VBZ	O
novel	novel	ADJ	JJ	O
.	.	PUNCT	.	O

Graft	graft	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
versus	versus	ADP	IN	I-Disease
-	-	PUNCT	HYPH	I-Disease
host	host	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
prophylaxis	prophylaxis	NOUN	NN	O
with	with	ADP	IN	O
everolimus	everolimus	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
high	high	ADJ	JJ	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
sinusoidal	sinusoidal	ADJ	JJ	B-Disease
obstruction	obstruction	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
microangiopathy	microangiopathy	NOUN	NN	B-Disease
:	:	PUNCT	:	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
EVTAC	EVTAC	PROPN	NNP	O
trial	trial	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
calcineurin	calcineurin	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
methotrexate	methotrexate	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
the	the	DET	DT	O
standard	standard	ADJ	JJ	O
prophylaxis	prophylaxis	NOUN	NN	O
for	for	ADP	IN	O
graft	graft	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
versus	versus	ADP	IN	I-Disease
-	-	PUNCT	HYPH	I-Disease
host	host	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
GVHD	GVHD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
after	after	ADP	IN	O
allogeneic	allogeneic	ADJ	JJ	O
hematopoietic	hematopoietic	ADJ	JJ	O
stem	stem	NOUN	NN	O
cell	cell	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HSCT	HSCT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Everolimus	Everolimus	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
derivative	derivative	NOUN	NN	O
of	of	ADP	IN	O
sirolimus	sirolimus	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
mediate	mediate	VERB	VB	O
antileukemia	antileukemia	ADJ	JJ	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
on	on	ADP	IN	O
a	a	DET	DT	O
combination	combination	NOUN	NN	O
of	of	ADP	IN	O
everolimus	everolimus	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
tacrolimus	tacrolimus	VERB	VB	B-Chemical
in	in	ADP	IN	O
24	24	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
median	median	ADJ	JJ	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
62	62	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
either	either	CCONJ	CC	O
myelodysplastic	myelodysplastic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
MDS	MDS	PROPN	NNP	B-Disease
;	;	PUNCT	:	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
17	17	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
acute	acute	ADJ	JJ	B-Disease
myeloid	myeloid	ADJ	JJ	I-Disease
leukemia	leukemia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
AML	aml	NOUN	NN	B-Disease
;	;	PUNCT	:	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
7	7	NUM	CD	O
)	)	PUNCT	-RRB-	O
undergoing	undergo	VERB	VBG	O
intensive	intensive	ADJ	JJ	O
conditioning	conditioning	NOUN	NN	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
HSCT	HSCT	PROPN	NNP	O
from	from	ADP	IN	O
related	related	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
4	4	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
unrelated	unrelated	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
20	20	NUM	CD	O
)	)	PUNCT	-RRB-	O
donors	donor	NOUN	NNS	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
engrafted	engraft	VERB	VBD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
only	only	ADV	RB	O
1	1	NUM	CD	O
patient	patient	NOUN	NN	O
experienced	experienced	ADJ	JJ	O
grade	grade	NOUN	NN	O
IV	IV	PROPN	NNP	O
mucositis	mucositis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Nine	nine	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
37	37	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
developed	develop	VERB	VBN	O
acute	acute	ADJ	JJ	O
grade	grade	NOUN	NN	O
II	II	PROPN	NNP	O
-	-	PUNCT	HYPH	O
IV	IV	PROPN	NNP	O
GVHD	GVHD	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
11	11	NUM	CD	O
of	of	ADP	IN	O
17	17	NUM	CD	O
evaluable	evaluable	ADJ	JJ	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
64	64	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
developed	develop	VERB	VBD	O
chronic	chronic	ADJ	JJ	O
extensive	extensive	ADJ	JJ	O
GVHD	GVHD	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Transplantation	transplantation	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
associated	associate	VERB	VBN	I-Disease
microangiopathy	microangiopathy	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
TMA	tma	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
7	7	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
29	29	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
2	2	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
terminated	terminate	VERB	VBN	O
prematurely	prematurely	ADV	RB	O
because	because	ADP	IN	O
an	an	DET	DT	O
additional	additional	ADJ	JJ	O
6	6	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
25	25	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
developed	develop	VERB	VBD	O
sinusoidal	sinusoidal	ADJ	JJ	B-Disease
obstruction	obstruction	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
SOS	SOS	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
fatal	fatal	ADJ	JJ	O
in	in	ADP	IN	O
2	2	NUM	CD	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

With	with	ADP	IN	O
a	a	DET	DT	O
median	median	ADJ	JJ	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
of	of	ADP	IN	O
26	26	NUM	CD	O
months	month	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
overall	overall	ADJ	JJ	O
survival	survival	NOUN	NN	O
rate	rate	NOUN	NN	O
was	be	VERB	VBD	O
47	47	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
this	this	DET	DT	O
new	new	ADJ	JJ	O
combination	combination	NOUN	NN	O
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
effective	effective	ADJ	JJ	O
as	as	ADP	IN	O
a	a	DET	DT	O
prophylactic	prophylactic	ADJ	JJ	O
regimen	regimen	NOUN	NN	O
for	for	ADP	IN	O
acute	acute	ADJ	JJ	O
GVHD	GVHD	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
TMA	tma	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
SOS	sos	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
considerably	considerably	ADV	RB	O
higher	high	ADJ	JJR	O
than	than	ADP	IN	O
seen	see	VERB	VBN	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
regimens	regimen	NOUN	NNS	O
.	.	PUNCT	.	O

Longitudinal	longitudinal	ADJ	JJ	O
assessment	assessment	NOUN	NN	O
of	of	ADP	IN	O
air	air	NOUN	NN	O
conduction	conduction	NOUN	NN	O
audiograms	audiogram	NOUN	NNS	O
in	in	ADP	IN	O
a	a	DET	DT	O
phase	phase	NOUN	NN	O
III	iii	NUM	CD	O
clinical	clinical	ADJ	JJ	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
difluoromethylornithine	difluoromethylornithine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
sulindac	sulindac	NOUN	NN	B-Chemical
for	for	ADP	IN	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
sporadic	sporadic	ADJ	JJ	O
colorectal	colorectal	ADJ	JJ	B-Disease
adenomas	adenoma	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
phase	phase	NOUN	NN	O
III	iii	NUM	CD	O
clinical	clinical	ADJ	JJ	O
trial	trial	NOUN	NN	O
assessed	assess	VERB	VBD	O
the	the	DET	DT	O
recurrence	recurrence	NOUN	NN	O
of	of	ADP	IN	O
adenomatous	adenomatous	ADJ	JJ	B-Disease
polyps	polyp	NOUN	NNS	I-Disease
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
36	36	NUM	CD	O
months	month	NOUN	NNS	O
with	with	ADP	IN	O
difluoromethylornithine	difluoromethylornithine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DFMO	DFMO	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
plus	plus	CCONJ	CC	O
sulindac	sulindac	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
matched	match	VERB	VBN	O
placebos	placebo	NOUN	NNS	O
.	.	PUNCT	.	O

Temporary	temporary	ADJ	JJ	O
hearing	hearing	NOUN	NN	B-Disease
loss	loss	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
known	known	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
DFMO	DFMO	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
thus	thus	ADV	RB	O
a	a	DET	DT	O
comprehensive	comprehensive	ADJ	JJ	O
approach	approach	NOUN	NN	O
was	be	VERB	VBD	O
developed	develop	VERB	VBN	O
to	to	PART	TO	O
analyze	analyze	VERB	VB	O
serial	serial	ADJ	JJ	O
air	air	NOUN	NN	O
conduction	conduction	NOUN	NN	O
audiograms	audiogram	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
generalized	generalized	ADJ	JJ	O
estimating	estimate	VERB	VBG	O
equation	equation	NOUN	NN	O
method	method	NOUN	NN	O
estimated	estimate	VERB	VBD	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
difference	difference	NOUN	NN	O
between	between	ADP	IN	O
treatment	treatment	NOUN	NN	O
arms	arm	NOUN	NNS	O
with	with	ADP	IN	O
regard	regard	NOUN	NN	O
to	to	PART	TO	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
air	air	NOUN	NN	O
conduction	conduction	NOUN	NN	O
pure	pure	ADJ	JJ	O
tone	tone	NOUN	NN	O
thresholds	threshold	VERB	VBZ	O
while	while	ADP	IN	O
accounting	account	VERB	VBG	O
for	for	ADP	IN	O
within	within	ADP	IN	O
-	-	PUNCT	HYPH	O
subject	subject	NOUN	NN	O
correlation	correlation	NOUN	NN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
repeated	repeat	VERB	VBN	O
measurements	measurement	NOUN	NNS	O
at	at	ADP	IN	O
frequencies	frequency	NOUN	NNS	O
.	.	PUNCT	.	O

Based	base	VERB	VBN	O
on	on	ADP	IN	O
290	290	NUM	CD	O
subjects	subject	NOUN	NNS	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
an	an	DET	DT	O
average	average	ADJ	JJ	O
difference	difference	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
50	50	NUM	CD	O
dB	db	NOUN	NN	O
between	between	ADP	IN	O
subjects	subject	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
DFMO	DFMO	PROPN	NNP	B-Chemical
plus	plus	CCONJ	CC	O
sulindac	sulindac	NOUN	NN	B-Chemical
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
those	those	DET	DT	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
-	-	PUNCT	HYPH	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
64	64	NUM	CD	O
to	to	PART	TO	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
63	63	NUM	CD	O
dB	db	NOUN	NN	O
;	;	PUNCT	:	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
39	39	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
adjusted	adjust	VERB	VBN	O
for	for	ADP	IN	O
baseline	baseline	NOUN	NN	O
values	value	NOUN	NNS	O
,	,	PUNCT	,	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
frequencies	frequency	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
normal	normal	ADJ	JJ	O
speech	speech	NOUN	NN	O
range	range	NOUN	NN	O
of	of	ADP	IN	O
500	500	NUM	CD	O
to	to	ADP	IN	O
3	3	NUM	CD	O
,	,	PUNCT	,	O
000	000	NUM	CD	O
Hz	Hz	PROPN	NNP	O
,	,	PUNCT	,	O
an	an	DET	DT	O
estimated	estimate	VERB	VBN	O
difference	difference	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
99	99	NUM	CD	O
dB	dB	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
17	17	NUM	CD	O
to	to	ADP	IN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
14	14	NUM	CD	O
dB	db	NOUN	NN	O
;	;	PUNCT	:	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
09	09	NUM	CD	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
detected	detect	VERB	VBN	O
.	.	PUNCT	.	O

Dose	dose	NOUN	NN	O
intensity	intensity	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
add	add	VERB	VB	O
information	information	NOUN	NN	O
to	to	ADP	IN	O
models	model	NOUN	NNS	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
14	14	NUM	CD	O
of	of	ADP	IN	O
151	151	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
.	.	NOUN	NN	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
DFMO	DFMO	PROPN	NNP	B-Chemical
plus	plus	CCONJ	CC	O
sulindac	sulindac	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
and	and	CCONJ	CC	O
4	4	NUM	CD	O
of	of	ADP	IN	O
139	139	NUM	CD	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
who	who	PRON	WP	O
experienced	experience	VERB	VBD	O
at	at	ADV	RB	O
least	least	ADJ	JJS	O
15	15	NUM	CD	O
dB	db	NOUN	NN	O
hearing	hearing	NOUN	NN	O
reduction	reduction	NOUN	NN	O
from	from	ADP	IN	O
baseline	baseline	NOUN	NN	O
in	in	ADP	IN	O
2	2	NUM	CD	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
consecutive	consecutive	ADJ	JJ	O
frequencies	frequency	NOUN	NNS	O
across	across	ADP	IN	O
the	the	DET	DT	O
entire	entire	ADJ	JJ	O
range	range	NOUN	NN	O
tested	test	VERB	VBN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
02	02	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Follow	follow	VERB	VB	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
air	air	NOUN	NN	O
conduction	conduction	NOUN	NN	O
done	do	VERB	VBN	O
at	at	ADV	RB	O
least	least	ADV	RBS	O
6	6	NUM	CD	O
months	month	NOUN	NNS	O
after	after	ADP	IN	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
showed	show	VERB	VBD	O
an	an	DET	DT	O
adjusted	adjust	VERB	VBN	O
mean	mean	ADJ	JJ	O
difference	difference	NOUN	NN	O
in	in	ADP	IN	O
hearing	hear	VERB	VBG	O
thresholds	threshold	NOUN	NNS	O
of	of	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
08	08	NUM	CD	O
dB	dB	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
81	81	NUM	CD	O
to	to	PART	TO	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
96	96	NUM	CD	O
dB	db	NUM	CD	O
;	;	PUNCT	:	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
26	26	NUM	CD	O
)	)	PUNCT	-RRB-	O
between	between	ADP	IN	O
treatment	treatment	NOUN	NN	O
arms	arm	NOUN	NNS	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
difference	difference	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
proportion	proportion	NOUN	NN	O
of	of	ADP	IN	O
subjects	subject	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
DFMO	DFMO	PROPN	NNP	B-Chemical
plus	plus	CCONJ	CC	O
sulindac	sulindac	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
who	who	PRON	WP	O
experienced	experience	VERB	VBD	O
clinically	clinically	ADV	RB	O
significant	significant	ADJ	JJ	O
hearing	hearing	NOUN	NN	B-Disease
loss	loss	NOUN	NN	I-Disease
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
estimated	estimate	VERB	VBN	O
attributable	attributable	ADJ	JJ	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
ototoxicity	ototoxicity	NOUN	NN	B-Disease
from	from	ADP	IN	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
is	be	VERB	VBZ	O
8	8	NUM	CD	O
.	.	NOUN	NN	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
to	to	ADP	IN	O
18	18	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
;	;	PUNCT	:	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
12	12	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
<	<	X	XX	O
2	2	NUM	CD	O
dB	db	NUM	CD	O
difference	difference	NOUN	NN	O
in	in	ADP	IN	O
mean	mean	ADJ	JJ	O
threshold	threshold	NOUN	NN	O
for	for	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
DFMO	DFMO	PROPN	NNP	B-Chemical
plus	plus	CCONJ	CC	O
sulindac	sulindac	NOUN	NN	B-Chemical
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
those	those	DET	DT	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

Proteinase	proteinase	NOUN	NN	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
antineutrophil	antineutrophil	NOUN	NN	O
cytoplasmic	cytoplasmic	ADJ	JJ	O
antibody	antibody	NOUN	NN	O
-	-	PUNCT	HYPH	O
(	(	PUNCT	-LRB-	O
PR3	PR3	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ANCA	ANCA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
positive	positive	ADJ	JJ	O
necrotizing	necrotize	VERB	VBG	O
glomerulonephritis	glomerulonephritis	ADJ	JJ	B-Disease
after	after	ADP	IN	O
restarting	restart	VERB	VBG	O
sulphasalazine	sulphasalazine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
59	59	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
ulcerative	ulcerative	ADJ	JJ	B-Disease
colitis	colitis	NOUN	NN	I-Disease
developed	develop	VERB	VBD	O
red	red	ADJ	JJ	B-Disease
eyes	eye	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
pleural	pleural	ADJ	JJ	B-Disease
effusion	effusion	NOUN	NN	I-Disease
,	,	PUNCT	,	O
eosinophilia	eosinophilia	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
urinary	urinary	NOUN	NN	B-Disease
abnormalities	abnormality	NOUN	NNS	I-Disease
after	after	ADP	IN	O
restarting	restart	VERB	VBG	O
of	of	ADP	IN	O
sulphasalazine	sulphasalazine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Light	light	ADJ	JJ	O
microscopy	microscopy	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
kidney	kidney	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
revealed	reveal	VERB	VBD	O
segmental	segmental	ADJ	JJ	B-Disease
necrotizing	necrotize	VERB	VBG	I-Disease
glomerulonephritis	glomerulonephritis	ADJ	JJ	I-Disease
without	without	ADP	IN	O
deposition	deposition	NOUN	NN	O
of	of	ADP	IN	O
immunoglobulin	immunoglobulin	NOUN	NN	O
or	or	CCONJ	CC	O
complement	complement	NOUN	NN	O
.	.	PUNCT	.	O

Proteinase	proteinase	NOUN	NN	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
antineutrophil	antineutrophil	NOUN	NN	O
cytoplasmic	cytoplasmic	ADJ	JJ	O
antibody	antibody	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PR3	PR3	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ANCA	ANCA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
titer	titer	NOUN	NN	O
was	be	VERB	VBD	O
elevated	elevate	VERB	VBN	O
at	at	ADP	IN	O
183	183	NUM	CD	O
ELISA	ELISA	PROPN	NNP	O
units	unit	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
EU	EU	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
sera	sera	NOUN	NN	O
(	(	PUNCT	-LRB-	O
normal	normal	ADJ	JJ	O
range	range	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
10	10	NUM	CD	O
EU	EU	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
myeloperoxidase	myeloperoxidase	NOUN	NN	O
-	-	PUNCT	HYPH	O
ANCA	ANCA	PROPN	NNP	O
was	be	VERB	VBD	O
negative	negative	ADJ	JJ	O
.	.	PUNCT	.	O

PR3	PR3	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ANCA	ANCA	PROPN	NNP	O
titer	titer	NOUN	NN	O
was	be	VERB	VBD	O
250	250	NUM	CD	O
and	and	CCONJ	CC	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
070	070	NUM	CD	O
EU	EU	PROPN	NNP	O
in	in	ADP	IN	O
pleural	pleural	ADJ	JJ	B-Disease
effusions	effusion	NOUN	NNS	I-Disease
on	on	ADP	IN	O
right	right	ADV	RB	O
and	and	CCONJ	CC	O
left	leave	VERB	VBD	O
side	side	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
cessation	cessation	NOUN	NN	O
of	of	ADP	IN	O
sulphasalazine	sulphasalazine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
improvements	improvement	NOUN	NNS	O
in	in	ADP	IN	O
fever	fever	NOUN	NN	B-Disease
,	,	PUNCT	,	O
red	red	ADJ	JJ	B-Disease
eyes	eye	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
chest	chest	NOUN	NN	B-Disease
pain	pain	NOUN	NN	I-Disease
,	,	PUNCT	,	O
titer	titer	NOUN	NN	O
of	of	ADP	IN	O
C	c	NOUN	NN	O
-	-	PUNCT	HYPH	O
reactive	reactive	ADJ	JJ	O
protein	protein	NOUN	NN	O
and	and	CCONJ	CC	O
volume	volume	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
pleural	pleural	ADJ	JJ	B-Disease
effusions	effusion	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
initiated	initiate	VERB	VBD	O
steroid	steroid	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
because	because	ADP	IN	O
PR3	PR3	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ANCA	ANCA	PROPN	NNP	O
titer	titer	NOUN	NN	O
rose	rise	VERB	VBD	O
to	to	ADP	IN	O
320	320	NUM	CD	O
EU	EU	PROPN	NNP	O
,	,	PUNCT	,	O
eosinophil	eosinophil	NOUN	NN	O
count	count	NOUN	NN	O
increased	increase	VERB	VBD	O
to	to	ADP	IN	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
100	100	NUM	CD	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
microl	microl	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
pleural	pleural	ADJ	JJ	B-Disease
effusion	effusion	NOUN	NN	I-Disease
remained	remain	VERB	VBD	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
month	month	NOUN	NN	O
after	after	ADP	IN	O
steroid	steroid	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
pleural	pleural	ADJ	JJ	B-Disease
effusion	effusion	NOUN	NN	I-Disease
disappeared	disappear	VERB	VBD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
PR3	PR3	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ANCA	ANCA	PROPN	NNP	O
titer	titer	NOUN	NN	O
normalized	normalize	VERB	VBN	O
3	3	NUM	CD	O
months	month	NOUN	NNS	O
later	later	ADV	RB	O
.	.	PUNCT	.	O

This	this	DET	DT	O
case	case	NOUN	NN	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
sulphasalazine	sulphasalazine	NOUN	NN	B-Chemical
can	can	VERB	MD	O
induce	induce	VERB	VB	O
PR3	PR3	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ANCA	ANCA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
necrotizing	necrotizing	NOUN	NN	O
glomerulonephritis	glomerulonephritis	ADJ	JJ	B-Disease
.	.	PUNCT	.	O

Comparison	comparison	NOUN	NN	O
of	of	ADP	IN	O
unilateral	unilateral	ADJ	JJ	O
pallidotomy	pallidotomy	NOUN	NN	O
and	and	CCONJ	CC	O
subthalamotomy	subthalamotomy	NOUN	NN	O
findings	finding	NOUN	NNS	O
in	in	ADP	IN	O
advanced	advanced	ADJ	JJ	O
idiopathic	idiopathic	ADJ	JJ	B-Disease
Parkinson	Parkinson	PROPN	NNP	I-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
pilot	pilot	NOUN	NN	O
study	study	NOUN	NN	O
to	to	PART	TO	O
compare	compare	VERB	VB	O
the	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
stereotactic	stereotactic	ADJ	JJ	O
unilateral	unilateral	ADJ	JJ	O
pallidotomy	pallidotomy	NOUN	NN	O
and	and	CCONJ	CC	O
subthalamotomy	subthalamotomy	NOUN	NN	O
in	in	ADP	IN	O
advanced	advanced	ADJ	JJ	O
idiopathic	idiopathic	ADJ	JJ	B-Disease
Parkinson	Parkinson	PROPN	NNP	I-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
PD	PD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
refractory	refractory	NOUN	NN	O
to	to	ADP	IN	O
medical	medical	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
was	be	VERB	VBD	O
designed	design	VERB	VBN	O
.	.	PUNCT	.	O

Ten	ten	NUM	CD	O
consecutive	consecutive	ADJ	JJ	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
58	58	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
years	year	NOUN	NNS	O
;	;	PUNCT	:	O
7	7	NUM	CD	O
men	man	NOUN	NNS	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
women	woman	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
similar	similar	ADJ	JJ	O
characteristics	characteristic	NOUN	NNS	O
at	at	ADP	IN	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
disease	disease	NOUN	NN	O
(	(	PUNCT	-LRB-	O
mean	mean	ADJ	JJ	O
disease	disease	NOUN	NN	O
time	time	NOUN	NN	O
,	,	PUNCT	,	O
8	8	NUM	CD	O
.	.	NOUN	NN	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
disabling	disable	VERB	VBG	O
motor	motor	NOUN	NN	O
fluctuations	fluctuation	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
Hoehn	Hoehn	PROPN	NNP	O
_	_	PROPN	NNP	O
Yahr	Yahr	PROPN	NNP	O
stage	stage	NOUN	NN	O
3	3	NUM	CD	O
-	-	SYM	SYM	O
5	5	NUM	CD	O
in	in	ADP	IN	O
off	off	ADP	IN	O
-	-	PUNCT	HYPH	O
drug	drug	NOUN	NN	O
phases	phase	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
selected	select	VERB	VBN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
bilateral	bilateral	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
their	-PRON-	DET	PRP$	O
levodopa	levodopa	ADJ	JJ	B-Chemical
equivalent	equivalent	NOUN	NN	O
dosing	dosing	NOUN	NN	O
were	be	VERB	VBD	O
analysed	analyse	VERB	VBN	O
.	.	PUNCT	.	O

Six	six	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
operated	operate	VERB	VBN	O
on	on	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
globus	globus	NOUN	NN	O
pallidus	pallidus	NOUN	NN	O
interna	interna	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GPi	GPi	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
four	four	NUM	CD	O
in	in	ADP	IN	O
the	the	DET	DT	O
subthalamic	subthalamic	ADJ	JJ	O
nucleus	nucleus	NOUN	NN	O
(	(	PUNCT	-LRB-	O
STN	STN	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
included	include	VERB	VBD	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
Unified	Unified	PROPN	NNP	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
Disease	Disease	PROPN	NNP	I-Disease
Rating	Rating	PROPN	NNP	O
Scale	Scale	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
UPDRS	UPDRS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
Hoehn	Hoehn	PROPN	NNP	O
_	_	PROPN	NNP	O
Yahr	Yahr	PROPN	NNP	O
score	score	NOUN	NN	O
and	and	CCONJ	CC	O
Schwab	Schwab	PROPN	NNP	O
England	England	PROPN	NNP	O
activities	activity	NOUN	NNS	O
of	of	ADP	IN	O
daily	daily	ADJ	JJ	O
living	living	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ADL	ADL	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
score	score	VERB	VB	O
in	in	ADP	IN	O
'	'	PUNCT	``	O
on	on	ADP	IN	O
'	'	PUNCT	''	O
-	-	PUNCT	:	O
and	and	CCONJ	CC	O
'	'	PUNCT	``	O
off	off	PART	RP	O
'	'	PUNCT	``	O
-	-	PUNCT	HYPH	O
drug	drug	NOUN	NN	O
conditions	condition	NOUN	NNS	O
before	before	ADP	IN	O
surgery	surgery	NOUN	NN	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
months	month	NOUN	NNS	O
after	after	ADP	IN	O
surgery	surgery	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
all	all	DET	DT	O
contralateral	contralateral	ADJ	JJ	O
major	major	ADJ	JJ	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
motor	motor	NOUN	NN	O
signs	sign	NOUN	NNS	O
in	in	ADP	IN	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
followed	follow	VERB	VBD	O
for	for	ADP	IN	O
6	6	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Levodopa	levodopa	ADJ	JJ	B-Chemical
equivalent	equivalent	ADJ	JJ	O
daily	daily	ADV	RB	O
intake	intake	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
STN	STN	PROPN	NNP	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Changes	change	NOUN	NNS	O
in	in	ADP	IN	O
UPDRS	UPDRS	PROPN	NNP	O
,	,	PUNCT	,	O
Hoehn	Hoehn	PROPN	NNP	O
_	_	PROPN	NNP	O
Yahr	Yahr	PROPN	NNP	O
and	and	CCONJ	CC	O
Schwab	Schwab	PROPN	NNP	O
England	England	PROPN	NNP	O
ADL	ADL	PROPN	NNP	O
scores	score	NOUN	NNS	O
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Cognitive	cognitive	ADJ	JJ	O
functions	function	NOUN	NNS	O
were	be	VERB	VBD	O
unchanged	unchanged	ADJ	JJ	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Complications	complication	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
:	:	PUNCT	:	O
one	one	PRON	PRP	O
had	have	VERB	VBD	O
a	a	DET	DT	O
left	left	ADJ	JJ	O
homonymous	homonymous	ADJ	JJ	B-Disease
hemianopsia	hemianopsia	NOUN	NN	I-Disease
after	after	ADP	IN	O
pallidotomy	pallidotomy	NOUN	NN	O
and	and	CCONJ	CC	O
another	another	DET	DT	O
one	one	NOUN	NN	O
developed	develop	VERB	VBD	O
left	leave	VERB	VBN	O
hemiballistic	hemiballistic	ADJ	JJ	O
movements	movement	NOUN	NNS	O
3	3	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
subthalamotomy	subthalamotomy	NOUN	NN	O
which	which	DET	WDT	O
partly	partly	ADV	RB	O
improved	improve	VERB	VBD	O
within	within	ADP	IN	O
1	1	NUM	CD	O
month	month	NOUN	NN	O
with	with	ADP	IN	O
Valproate	Valproate	PROPN	NNP	B-Chemical
1000	1000	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
findings	finding	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
lesions	lesion	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
unilateral	unilateral	ADJ	JJ	O
STN	STN	PROPN	NNP	O
and	and	CCONJ	CC	O
GPi	GPi	NOUN	NNS	O
are	be	VERB	VBP	O
equally	equally	ADV	RB	O
effective	effective	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
advanced	advanced	ADJ	JJ	O
PD	pd	NOUN	NN	B-Disease
refractory	refractory	NOUN	NN	O
to	to	ADP	IN	O
medical	medical	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

DSMM	DSMM	PROPN	NNP	O
XI	XI	PROPN	NNP	O
study	study	NOUN	NN	O
:	:	PUNCT	:	O
dose	dose	NOUN	NN	O
definition	definition	NOUN	NN	O
for	for	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
bortezomib	bortezomib	NOUN	NN	B-Chemical
/	/	SYM	SYM	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
for	for	ADP	IN	O
remission	remission	NOUN	NN	O
induction	induction	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
newly	newly	ADV	RB	O
diagnosed	diagnose	VERB	VBN	O
myeloma	myeloma	NOUN	NN	B-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
trial	trial	NOUN	NN	O
was	be	VERB	VBD	O
initiated	initiate	VERB	VBN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
recommended	recommend	VERB	VBN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
bortezomib	bortezomib	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
as	as	ADP	IN	O
induction	induction	NOUN	NN	O
treatment	treatment	NOUN	NN	O
before	before	ADP	IN	O
stem	stem	NOUN	NN	O
cell	cell	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
for	for	ADP	IN	O
younger	young	ADJ	JJR	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
newly	newly	ADV	RB	O
diagnosed	diagnose	VERB	VBN	O
multiple	multiple	ADJ	JJ	B-Disease
myeloma	myeloma	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
MM	MM	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Thirty	thirty	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
three	three	NUM	CD	O
21	21	NUM	CD	O
-	-	PUNCT	HYPH	O
day	day	NOUN	NN	O
cycles	cycle	NOUN	NNS	O
of	of	ADP	IN	O
bortezomib	bortezomib	NOUN	NN	B-Chemical
1	1	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m	m	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
days	day	NOUN	NNS	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
8	8	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
11	11	NUM	CD	O
plus	plus	CCONJ	CC	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
40	40	NUM	CD	O
mg	mg	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
day	day	NOUN	NN	O
of	of	ADP	IN	O
bortezomib	bortezomib	NOUN	NN	B-Chemical
injection	injection	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
day	day	NOUN	NN	O
after	after	ADP	IN	O
plus	plus	CCONJ	CC	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
at	at	ADP	IN	O
900	900	NUM	CD	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
200	200	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
500	500	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m	m	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
day	day	NOUN	NN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
maximum	maximum	ADJ	JJ	O
tolerated	tolerate	VERB	VBN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
defined	define	VERB	VBN	O
as	as	ADP	IN	O
900	900	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m	m	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
this	this	DET	DT	O
dose	dose	NOUN	NN	O
level	level	NOUN	NN	O
,	,	PUNCT	,	O
92	92	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
achieved	achieve	VERB	VBN	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
a	a	DET	DT	O
partial	partial	ADJ	JJ	O
response	response	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
overall	overall	ADJ	JJ	O
response	response	NOUN	NN	O
rate	rate	NOUN	NN	O
[	[	PUNCT	-LRB-	O
complete	complete	ADJ	JJ	O
response	response	NOUN	NN	O
(	(	PUNCT	-LRB-	O
CR	CR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
plus	plus	CCONJ	CC	O
partial	partial	ADJ	JJ	O
response	response	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PR	PR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
]	]	PUNCT	-RRB-	O
across	across	ADP	IN	O
all	all	DET	DT	O
dose	dose	NOUN	NN	O
levels	level	NOUN	NNS	O
was	be	VERB	VBD	O
77	77	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
a	a	DET	DT	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
CR	cr	NOUN	NN	O
rate	rate	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
patient	patient	NOUN	NN	O
experienced	experience	VERB	VBD	O
progressive	progressive	ADJ	JJ	O
disease	disease	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
most	most	ADV	RBS	O
frequent	frequent	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
were	be	VERB	VBD	O
hematological	hematological	ADJ	JJ	B-Disease
and	and	CCONJ	CC	I-Disease
gastrointestinal	gastrointestinal	ADJ	JJ	I-Disease
toxicities	toxicity	NOUN	NNS	I-Disease
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
neuropathy	neuropathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
bortezomib	bortezomib	NOUN	NN	B-Chemical
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
at	at	ADP	IN	O
900	900	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m	m	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
induction	induction	NOUN	NN	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
newly	newly	ADV	RB	O
diagnosed	diagnose	VERB	VBN	O
MM	mm	NOUN	NN	B-Disease
that	that	DET	WDT	O
warrants	warrant	VERB	VBZ	O
further	further	ADJ	JJ	O
investigation	investigation	NOUN	NN	O
.	.	PUNCT	.	O

Naloxone	naloxone	NOUN	NN	B-Chemical
reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
captopril	captopril	ADJ	JJ	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
hemodynamic	hemodynamic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
captopril	captopril	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
other	other	ADJ	JJ	O
angiotensin	angiotensin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
converting	convert	VERB	VBG	I-Chemical
enzyme	enzyme	ADJ	JJ	I-Chemical
inhibitors	inhibitor	NOUN	NNS	I-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
endogenous	endogenous	ADJ	JJ	O
opioid	opioid	NOUN	NN	O
system	system	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
opioid	opioid	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
naloxone	naloxone	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
shown	show	VERB	VBN	O
to	to	PART	TO	O
block	block	VERB	VB	O
or	or	CCONJ	CC	O
reverse	reverse	VERB	VB	O
the	the	DET	DT	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
actions	action	NOUN	NNS	O
of	of	ADP	IN	O
captopril	captopril	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
intentional	intentional	ADJ	JJ	O
captopril	captopril	NOUN	NN	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
,	,	PUNCT	,	O
manifested	manifest	VERB	VBN	O
by	by	ADP	IN	O
marked	mark	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
that	that	DET	WDT	O
resolved	resolve	VERB	VBD	O
promptly	promptly	ADV	RB	O
with	with	ADP	IN	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
naloxone	naloxone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

To	to	ADP	IN	O
our	-PRON-	DET	PRP$	O
knowledge	knowledge	NOUN	NN	O
,	,	PUNCT	,	O
this	this	DET	DT	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
reported	report	VERB	VBN	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
captopril	captopril	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
naloxone	naloxone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
experience	experience	NOUN	NN	O
demonstrates	demonstrate	VERB	VBZ	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
naloxone	naloxone	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
resulting	result	VERB	VBG	O
from	from	ADP	IN	O
captopril	captopril	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Identification	identification	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
simple	simple	ADJ	JJ	O
and	and	CCONJ	CC	O
sensitive	sensitive	ADJ	JJ	O
microplate	microplate	ADJ	JJ	O
method	method	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
detection	detection	NOUN	NN	O
of	of	ADP	IN	O
oversulfated	oversulfate	VERB	VBN	O
chondroitin	chondroitin	NOUN	NN	B-Chemical
sulfate	sulfate	NOUN	NN	I-Chemical
in	in	ADP	IN	O
heparin	heparin	ADJ	JJ	B-Chemical
products	product	NOUN	NNS	O
.	.	PUNCT	.	O

Heparin	Heparin	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
commonly	commonly	ADV	RB	O
implemented	implement	VERB	VBN	O
anticoagulant	anticoagulant	NOUN	NN	O
used	use	VERB	VBN	O
to	to	PART	TO	O
treat	treat	VERB	VB	O
critically	critically	ADV	RB	O
ill	ill	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Recently	recently	ADV	RB	O
,	,	PUNCT	,	O
a	a	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
commercial	commercial	ADJ	JJ	O
lots	lot	NOUN	NNS	O
of	of	ADP	IN	O
heparin	heparin	ADJ	JJ	B-Chemical
products	product	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
contaminated	contaminate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
oversulfated	oversulfate	VERB	VBN	O
chondroitin	chondroitin	NOUN	NN	B-Chemical
sulfate	sulfate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
OSCS	OSCS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
derivative	derivative	ADJ	JJ	O
that	that	DET	WDT	O
could	could	VERB	MD	O
elicit	elicit	VERB	VB	O
a	a	DET	DT	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
response	response	NOUN	NN	O
in	in	ADP	IN	O
pigs	pig	NOUN	NNS	O
following	follow	VERB	VBG	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
infusion	infusion	NOUN	NN	O
.	.	PUNCT	.	O

Using	use	VERB	VBG	O
both	both	DET	DT	O
contaminated	contaminate	VERB	VBN	O
heparin	heparin	ADJ	JJ	B-Chemical
products	product	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
synthetically	synthetically	ADV	RB	O
produced	produce	VERB	VBN	O
derivative	derivative	ADJ	JJ	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
the	the	DET	DT	O
OSCS	OSCS	PROPN	NNP	O
produces	produce	VERB	VBZ	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
in	in	ADP	IN	O
pigs	pig	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
no	no	DET	DT	O
observed	observed	ADJ	JJ	O
effect	effect	NOUN	NN	O
level	level	NOUN	NN	O
(	(	PUNCT	-LRB-	O
NOEL	noel	NOUN	NN	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
this	this	DET	DT	O
contaminant	contaminant	NOUN	NN	O
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
approximately	approximately	ADV	RB	O
1mg	1mg	ADJ	JJ	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
corresponding	correspond	VERB	VBG	O
to	to	ADP	IN	O
a	a	DET	DT	O
contamination	contamination	NOUN	NN	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
approximately	approximately	ADV	RB	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
also	also	ADV	RB	O
demonstrated	demonstrate	VERB	VBD	O
that	that	ADP	IN	O
OSCS	OSCS	PROPN	NNP	O
can	can	VERB	MD	O
be	be	VERB	VB	O
identified	identify	VERB	VBN	O
in	in	ADP	IN	O
heparin	heparin	ADJ	JJ	B-Chemical
products	product	NOUN	NNS	O
using	use	VERB	VBG	O
a	a	DET	DT	O
simple	simple	ADJ	JJ	O
,	,	PUNCT	,	O
inexpensive	inexpensive	ADJ	JJ	O
,	,	PUNCT	,	O
commercially	commercially	ADV	RB	O
available	available	ADJ	JJ	O
heparin	heparin	ADJ	JJ	B-Chemical
enzyme	enzyme	ADJ	JJ	O
immunoassay	immunoassay	NOUN	NN	O
(	(	PUNCT	-LRB-	O
EIA	EIA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
kit	kit	NOUN	NN	O
that	that	DET	WDT	O
has	have	VERB	VBZ	O
a	a	DET	DT	O
limit	limit	NOUN	NN	O
of	of	ADP	IN	O
detection	detection	NOUN	NN	O
of	of	ADP	IN	O
approximately	approximately	ADV	RB	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
well	well	ADV	RB	O
below	below	ADP	IN	O
the	the	DET	DT	O
NOEL	NOEL	PROPN	NNP	O
.	.	PUNCT	.	O

This	this	DET	DT	O
kit	kit	NOUN	NN	O
may	may	VERB	MD	O
provide	provide	VERB	VB	O
a	a	DET	DT	O
useful	useful	ADJ	JJ	O
method	method	NOUN	NN	O
to	to	PART	TO	O
test	test	VERB	VB	O
heparin	heparin	ADJ	JJ	B-Chemical
products	product	NOUN	NNS	O
for	for	ADP	IN	O
contamination	contamination	NOUN	NN	O
with	with	ADP	IN	O
oversulfated	oversulfate	VERB	VBN	O
GAG	GAG	PROPN	NNP	O
derivatives	derivative	NOUN	NNS	O
.	.	PUNCT	.	O

5	5	NUM	CD	B-Chemical
flourouracil	flourouracil	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
apical	apical	ADJ	JJ	B-Disease
ballooning	ballooning	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
:	:	PUNCT	:	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
apical	apical	ADJ	JJ	B-Disease
ballooning	ballooning	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
ABS	abs	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
recently	recently	ADV	RB	O
described	describe	VERB	VBN	O
stress	stress	NOUN	NN	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
acute	acute	ADJ	JJ	B-Disease
cardiac	cardiac	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
characterized	characterize	VERB	VBN	O
by	by	ADP	IN	O
transient	transient	ADJ	JJ	O
wall	wall	NOUN	NN	O
-	-	PUNCT	HYPH	O
motion	motion	NOUN	NN	O
abnormalities	abnormality	NOUN	NNS	O
involving	involve	VERB	VBG	O
the	the	DET	DT	O
apex	apex	ADJ	JJ	O
and	and	CCONJ	CC	O
midventricle	midventricle	NOUN	NN	O
with	with	ADP	IN	O
hyperkinesis	hyperkinesis	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
basal	basal	NOUN	NN	O
left	leave	VERB	VBN	O
ventricular	ventricular	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
LV	LV	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
segments	segment	NOUN	NNS	O
without	without	ADP	IN	O
obstructive	obstructive	ADJ	JJ	O
epicardial	epicardial	ADJ	JJ	B-Disease
coronary	coronary	ADJ	JJ	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
not	not	ADV	RB	O
an	an	DET	DT	O
uncommon	uncommon	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
chemotherapeutic	chemotherapeutic	ADJ	JJ	O
agents	agent	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
are	be	VERB	VBP	O
no	no	DET	DT	O
reports	report	NOUN	NNS	O
of	of	ADP	IN	O
ABS	abs	NOUN	NN	B-Disease
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
chemotherapeutic	chemotherapeutic	ADJ	JJ	O
agents	agent	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
the	the	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
woman	woman	NOUN	NN	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
the	the	DET	DT	O
syndrome	syndrome	NOUN	NN	O
after	after	ADP	IN	O
chemotherapy	chemotherapy	NOUN	NN	O
for	for	ADP	IN	O
metastatic	metastatic	ADJ	JJ	O
cancer	cancer	NOUN	NN	B-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
79	79	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
presented	present	VERB	VBN	O
with	with	ADP	IN	O
typical	typical	ADJ	JJ	O
ischemic	ischemic	ADJ	JJ	B-Disease
chest	chest	NOUN	NN	B-Disease
pain	pain	NOUN	NN	I-Disease
,	,	PUNCT	,	O
elevated	elevate	VERB	VBD	O
cardiac	cardiac	ADJ	JJ	O
enzymes	enzyme	NOUN	NNS	O
with	with	ADP	IN	O
significant	significant	ADJ	JJ	O
ST	ST	PROPN	NNP	O
-	-	PUNCT	HYPH	O
segment	segment	NOUN	NN	O
abnormalities	abnormality	NOUN	NNS	O
on	on	ADP	IN	O
her	-PRON-	DET	PRP$	O
electrocardiogram	electrocardiogram	NOUN	NN	O
.	.	PUNCT	.	O

She	-PRON-	PRON	PRP	O
underwent	undergo	VERB	VBD	O
recent	recent	ADJ	JJ	O
chemotherapy	chemotherapy	NOUN	NN	O
with	with	ADP	IN	O
fluorouracil	fluorouracil	NOUN	NN	B-Chemical
for	for	ADP	IN	O
metastatic	metastatic	ADJ	JJ	O
colorectal	colorectal	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Echocardiography	Echocardiography	PROPN	NNP	O
revealed	reveal	VERB	VBD	O
a	a	DET	DT	O
wall	wall	NOUN	NN	O
-	-	PUNCT	HYPH	O
motion	motion	NOUN	NN	O
abnormality	abnormality	NOUN	NN	O
involving	involve	VERB	VBG	O
the	the	DET	DT	O
apical	apical	ADJ	JJ	O
and	and	CCONJ	CC	O
periapical	periapical	ADJ	JJ	O
segments	segment	NOUN	NNS	O
which	which	DET	WDT	O
appeared	appear	VERB	VBD	O
akinetic	akinetic	ADJ	JJ	B-Disease
.	.	PUNCT	.	O

Coronary	coronary	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
revealed	reveal	VERB	VBD	O
no	no	DET	DT	O
obstructive	obstructive	ADJ	JJ	O
coronary	coronary	ADJ	JJ	O
lesions	lesion	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
stabilized	stabilize	VERB	VBN	O
with	with	ADP	IN	O
medical	medical	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Four	four	NUM	CD	O
weeks	week	NOUN	NNS	O
later	later	ADV	RB	O
she	-PRON-	PRON	PRP	O
remained	remain	VERB	VBD	O
completely	completely	ADV	RB	O
asymptomatic	asymptomatic	ADJ	JJ	O
.	.	PUNCT	.	O

Echocardiogram	Echocardiogram	PROPN	NNP	O
revealed	reveal	VERB	VBD	O
a	a	DET	DT	O
normal	normal	ADJ	JJ	O
ejection	ejection	NOUN	NN	O
fraction	fraction	NOUN	NN	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
resolution	resolution	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
apical	apical	ADJ	JJ	O
akinesis	akinesis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Pathogenetic	pathogenetic	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	I-Disease
in	in	ADP	IN	O
cancer	cancer	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
chemotherapy	chemotherapy	NOUN	NN	O
include	include	VERB	VBP	O
coronary	coronary	ADJ	JJ	B-Disease
vasospasm	vasospasm	NOUN	NN	I-Disease
,	,	PUNCT	,	O
endothelial	endothelial	ADJ	JJ	O
damage	damage	NOUN	NN	O
and	and	CCONJ	CC	O
consequent	consequent	ADJ	JJ	O
thrombus	thrombus	NOUN	NN	B-Disease
formation	formation	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
our	-PRON-	DET	PRP$	O
patient	patient	NOUN	NN	O
,	,	PUNCT	,	O
both	both	DET	DT	O
supraphysiologic	supraphysiologic	ADJ	JJ	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
catecholamines	catecholamine	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
stress	stress	NOUN	NN	O
related	related	ADJ	JJ	O
neuropeptides	neuropeptide	NOUN	NNS	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
cancer	cancer	NOUN	NN	B-Disease
diagnosis	diagnosis	NOUN	NN	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
chemotherapy	chemotherapy	NOUN	NN	O
may	may	VERB	MD	O
have	have	VERB	VB	O
contributed	contribute	VERB	VBN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
ABS	abs	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Rapid	rapid	ADJ	JJ	O
reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
anticoagulation	anticoagulation	NOUN	NN	O
reduces	reduce	VERB	VBZ	O
hemorrhage	hemorrhage	NOUN	NN	B-Disease
volume	volume	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
mouse	mouse	NOUN	NN	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
intracerebral	intracerebral	ADJ	JJ	B-Disease
hemorrhage	hemorrhage	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Warfarin	warfarin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
intracerebral	intracerebral	ADJ	JJ	B-Disease
hemorrhage	hemorrhage	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
W	W	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ICH	ICH	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
severe	severe	ADJ	JJ	O
type	type	NOUN	NN	O
of	of	ADP	IN	O
stroke	stroke	NOUN	NN	B-Disease
.	.	PUNCT	.	O

There	there	ADV	EX	O
is	be	VERB	VBZ	O
no	no	DET	DT	O
consensus	consensus	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
optimal	optimal	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
W	W	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ICH	ICH	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Using	use	VERB	VBG	O
a	a	DET	DT	O
mouse	mouse	NOUN	NN	O
model	model	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
tested	test	VERB	VBD	O
whether	whether	ADP	IN	O
the	the	DET	DT	O
rapid	rapid	ADJ	JJ	O
reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
anticoagulation	anticoagulation	NOUN	NN	O
using	use	VERB	VBG	O
human	human	ADJ	JJ	O
prothrombin	prothrombin	NOUN	NN	B-Chemical
complex	complex	ADJ	JJ	I-Chemical
concentrate	concentrate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
PCC	PCC	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
can	can	VERB	MD	O
reduce	reduce	VERB	VB	O
hemorrhagic	hemorrhagic	ADJ	JJ	O
blood	blood	NOUN	NN	O
volume	volume	NOUN	NN	O
.	.	PUNCT	.	O

Male	male	ADJ	JJ	O
CD	CD	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
mice	mouse	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
warfarin	warfarin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
over	over	ADP	IN	O
24	24	NUM	CD	O
h	h	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
a	a	DET	DT	O
mean	mean	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
s	s	NOUN	NN	O
.	.	PUNCT	.	O
d	d	X	XX	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
International	International	PROPN	NNP	O
Normalized	Normalized	PROPN	NNP	O
Ratio	Ratio	PROPN	NNP	O
of	of	ADP	IN	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
.	.	PUNCT	.	O

First	first	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
an	an	DET	DT	O
intravenous	intravenous	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
human	human	ADJ	JJ	O
PCC	PCC	PROPN	NNP	B-Chemical
rapidly	rapidly	ADV	RB	O
reversed	reverse	VERB	VBD	O
anticoagulation	anticoagulation	NOUN	NN	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Second	second	ADV	RB	O
,	,	PUNCT	,	O
a	a	DET	DT	O
stereotactic	stereotactic	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
collagenase	collagenase	NOUN	NN	O
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
to	to	PART	TO	O
induce	induce	VERB	VB	O
hemorrhage	hemorrhage	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
right	right	ADJ	JJ	O
striatum	striatum	NOUN	NN	O
.	.	PUNCT	.	O

Forty	forty	NUM	CD	O
-	-	PUNCT	HYPH	O
five	five	NUM	CD	O
minutes	minute	NOUN	NNS	O
later	later	ADV	RBR	O
,	,	PUNCT	,	O
the	the	DET	DT	O
animals	animal	NOUN	NNS	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
PCC	PCC	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
100	100	NUM	CD	O
U	u	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
saline	saline	VERB	VB	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
12	12	NUM	CD	O
per	per	ADP	IN	O
group	group	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
four	four	NUM	CD	O
hours	hour	NOUN	NNS	O
after	after	ADP	IN	O
hemorrhage	hemorrhage	NOUN	NN	B-Disease
induction	induction	NOUN	NN	O
,	,	PUNCT	,	O
hemorrhagic	hemorrhagic	ADJ	JJ	O
blood	blood	NOUN	NN	O
volume	volume	NOUN	NN	O
was	be	VERB	VBD	O
quantified	quantify	VERB	VBN	O
using	use	VERB	VBG	O
a	a	DET	DT	O
photometric	photometric	ADJ	JJ	O
hemoglobin	hemoglobin	NOUN	NN	O
assay	assay	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
hemorrhagic	hemorrhagic	ADJ	JJ	O
blood	blood	NOUN	NN	O
volume	volume	NOUN	NN	O
was	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
in	in	ADP	IN	O
PCC	PCC	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
microL	microL	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
controls	control	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
15	15	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
microL	microL	PROPN	NNP	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
015	015	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
saline	saline	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
45	45	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
mice	mouse	NOUN	NNS	O
developed	develop	VERB	VBD	O
large	large	ADJ	JJ	O
hematomas	hematomas	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
e	e	PUNCT	LS	O
.	.	PUNCT	.	O
,	,	PUNCT	,	O
>	>	X	XX	O
15	15	NUM	CD	O
microL	microL	PROPN	NNPS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
extensive	extensive	ADJ	JJ	O
lesions	lesion	NOUN	NNS	O
were	be	VERB	VBD	O
never	never	ADV	RB	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
PCC	PCC	PROPN	NNP	B-Chemical
group	group	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
provide	provide	VERB	VBP	O
experimental	experimental	ADJ	JJ	O
data	datum	NOUN	NNS	O
suggesting	suggest	VERB	VBG	O
PCC	PCC	PROPN	NNP	B-Chemical
to	to	PART	TO	O
be	be	VERB	VB	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
acute	acute	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
W	W	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ICH	ICH	PROPN	NNP	B-Disease
in	in	ADP	IN	O
terms	term	NOUN	NNS	O
of	of	ADP	IN	O
reducing	reduce	VERB	VBG	O
hemorrhagic	hemorrhagic	ADJ	JJ	O
blood	blood	NOUN	NN	O
volume	volume	NOUN	NN	O
.	.	PUNCT	.	O

Future	future	ADJ	JJ	O
studies	study	NOUN	NNS	O
are	be	VERB	VBP	O
needed	need	VERB	VBN	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
therapeutic	therapeutic	ADJ	JJ	O
potential	potential	NOUN	NN	O
emerging	emerge	VERB	VBG	O
from	from	ADP	IN	O
our	-PRON-	DET	PRP$	O
finding	finding	NOUN	NN	O
for	for	ADP	IN	O
human	human	ADJ	JJ	O
W	W	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ICH	ICH	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Long	long	ADJ	JJ	O
term	term	NOUN	NN	O
hormone	hormone	NOUN	NN	O
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
perimenopausal	perimenopausal	NOUN	NN	O
and	and	CCONJ	CC	O
postmenopausal	postmenopausal	NOUN	NN	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Hormone	hormone	NOUN	NN	O
therapy	therapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HT	HT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
controlling	control	VERB	VBG	O
menopausal	menopausal	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
has	have	VERB	VBZ	O
also	also	ADV	RB	O
been	be	VERB	VBN	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
management	management	NOUN	NN	O
and	and	CCONJ	CC	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
osteoporosis	osteoporosis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
dementia	dementia	NOUN	NN	B-Disease
in	in	ADP	IN	O
older	old	ADJ	JJR	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
updated	update	VERB	VBN	O
version	version	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
original	original	ADJ	JJ	O
Cochrane	Cochrane	PROPN	NNP	O
review	review	NOUN	NN	O
first	first	ADV	RB	O
published	publish	VERB	VBN	O
in	in	ADP	IN	O
2005	2005	NUM	CD	O
.	.	PUNCT	.	O

OBJECTIVES	objectives	NOUN	NN	O
:	:	PUNCT	:	O
To	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
HT	HT	PROPN	NNP	O
on	on	ADP	IN	O
mortality	mortality	NOUN	NN	O
,	,	PUNCT	,	O
cardiovascular	cardiovascular	ADJ	JJ	O
outcomes	outcome	NOUN	NNS	O
,	,	PUNCT	,	O
cancer	cancer	NOUN	NN	B-Disease
,	,	PUNCT	,	O
gallbladder	gallbladder	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
cognition	cognition	NOUN	NN	O
,	,	PUNCT	,	O
fractures	fracture	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
quality	quality	NOUN	NN	O
of	of	ADP	IN	O
life	life	NOUN	NN	O
.	.	PUNCT	.	O

SEARCH	SEARCH	PROPN	NNP	O
STRATEGY	strategy	NOUN	NN	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
searched	search	VERB	VBD	O
the	the	DET	DT	O
following	follow	VERB	VBG	O
databases	database	NOUN	NNS	O
to	to	ADP	IN	O
November	November	PROPN	NNP	O
2007	2007	NUM	CD	O
:	:	PUNCT	:	O
Trials	Trials	PROPN	NNPS	O
Register	Register	PROPN	NNP	O
of	of	ADP	IN	O
the	the	DET	DT	O
Cochrane	Cochrane	PROPN	NNP	O
Menstrual	Menstrual	PROPN	NNP	B-Disease
Disorders	Disorders	PROPN	NNPS	I-Disease
and	and	CCONJ	CC	O
Subfertility	Subfertility	PROPN	NNP	O
Group	Group	PROPN	NNP	O
,	,	PUNCT	,	O
Cochrane	Cochrane	PROPN	NNP	O
Central	Central	PROPN	NNP	O
Register	Register	PROPN	NNP	O
of	of	ADP	IN	O
Controlled	Controlled	PROPN	NNP	O
Trials	Trials	PROPN	NNPS	O
,	,	PUNCT	,	O
MEDLINE	MEDLINE	PROPN	NNP	O
,	,	PUNCT	,	O
EMBASE	EMBASE	PROPN	NNP	O
,	,	PUNCT	,	O
Biological	Biological	PROPN	NNP	O
Abstracts	Abstracts	PROPN	NNPS	O
.	.	PUNCT	.	O

Also	also	ADV	RB	O
relevant	relevant	ADJ	JJ	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
indexed	indexed	ADJ	JJ	O
journals	journal	NOUN	NNS	O
and	and	CCONJ	CC	O
conference	conference	NOUN	NN	O
abstracts	abstract	NOUN	NNS	O
.	.	PUNCT	.	O

SELECTION	selection	NOUN	NN	O
CRITERIA	criterion	NOUN	NNS	O
:	:	PUNCT	:	O
Randomised	randomise	VERB	VBN	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
trials	trial	NOUN	NNS	O
of	of	ADP	IN	O
HT	HT	PROPN	NNP	O
versus	versus	ADP	IN	O
placebo	placebo	NOUN	NN	O
,	,	PUNCT	,	O
taken	take	VERB	VBN	O
for	for	ADP	IN	O
at	at	ADV	RB	O
least	least	ADV	RBS	O
one	one	NUM	CD	O
year	year	NOUN	NN	O
by	by	ADP	IN	O
perimenopausal	perimenopausal	NOUN	NN	O
or	or	CCONJ	CC	O
postmenopausal	postmenopausal	NOUN	NN	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

HT	HT	PROPN	NNP	O
included	include	VERB	VBD	O
oestrogens	oestrogen	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
with	with	ADP	IN	O
or	or	CCONJ	CC	O
without	without	ADP	IN	O
progestogens	progestogen	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
via	via	ADP	IN	O
oral	oral	ADJ	JJ	O
,	,	PUNCT	,	O
transdermal	transdermal	ADJ	JJ	O
,	,	PUNCT	,	O
subcutaneous	subcutaneous	ADJ	JJ	O
or	or	CCONJ	CC	O
transnasal	transnasal	ADJ	JJ	O
routes	route	NOUN	NNS	O
.	.	PUNCT	.	O

DATA	data	ADJ	JJ	O
COLLECTION	collection	NOUN	NN	O
AND	and	CCONJ	CC	O
ANALYSIS	analysis	NOUN	NN	O
:	:	PUNCT	:	O
Two	two	NUM	CD	O
authors	author	NOUN	NNS	O
independently	independently	ADV	RB	O
assessed	assess	VERB	VBD	O
trial	trial	NOUN	NN	O
quality	quality	NOUN	NN	O
and	and	CCONJ	CC	O
extracted	extract	VERB	VBN	O
data	datum	NOUN	NNS	O
.	.	PUNCT	.	O

MAIN	main	ADJ	JJ	O
RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Nineteen	nineteen	NUM	CD	O
trials	trial	NOUN	NNS	O
involving	involve	VERB	VBG	O
41	41	NUM	CD	O
,	,	PUNCT	,	O
904	904	NUM	CD	O
women	woman	NOUN	NNS	O
were	be	VERB	VBD	O
included	include	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
relatively	relatively	ADV	RB	O
healthy	healthy	ADJ	JJ	O
women	woman	NOUN	NNS	O
,	,	PUNCT	,	O
combined	combine	VERB	VBN	O
continuous	continuous	ADJ	JJ	O
HT	HT	PROPN	NNP	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
venous	venous	ADJ	JJ	B-Disease
thrombo	thrombo	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	I-Disease
embolism	embolism	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
coronary	coronary	ADJ	JJ	O
event	event	NOUN	NN	O
(	(	PUNCT	-LRB-	O
after	after	ADP	IN	O
one	one	NUM	CD	O
year	year	NOUN	NN	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
use	use	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
stroke	stroke	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
after	after	ADP	IN	O
three	three	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
gallbladder	gallbladder	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
oestrogen	oestrogen	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
only	only	ADV	RB	O
HT	HT	PROPN	NNP	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
venous	venous	ADJ	JJ	B-Disease
thrombo	thrombo	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	I-Disease
embolism	embolism	NOUN	NN	I-Disease
,	,	PUNCT	,	O
stroke	stroke	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
gallbladder	gallbladder	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
after	after	ADP	IN	O
one	one	NUM	CD	O
to	to	PART	TO	O
two	two	NUM	CD	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
three	three	NUM	CD	O
years	year	NOUN	NNS	O
and	and	CCONJ	CC	O
seven	seven	NUM	CD	O
years	year	NOUN	NNS	O
'	'	PART	POS	O
use	use	NOUN	NN	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
increase	increase	VERB	VB	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
only	only	ADJ	JJ	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
benefits	benefit	NOUN	NNS	O
of	of	ADP	IN	O
HT	HT	PROPN	NNP	O
were	be	VERB	VBD	O
a	a	DET	DT	O
decreased	decrease	VERB	VBN	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
fractures	fracture	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
for	for	ADP	IN	O
combined	combine	VERB	VBN	O
HT	HT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
colon	colon	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
,	,	PUNCT	,	O
with	with	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
use	use	NOUN	NN	O
.	.	PUNCT	.	O

Among	among	ADP	IN	O
women	woman	NOUN	NNS	O
aged	age	VERB	VBN	O
over	over	ADP	IN	O
65	65	NUM	CD	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
relatively	relatively	ADV	RB	O
healthy	healthy	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
e	e	PUNCT	LS	O
.	.	PUNCT	.	O
generally	generally	ADV	RB	O
fit	fit	ADJ	JJ	O
,	,	PUNCT	,	O
without	without	ADP	IN	O
overt	overt	ADJ	JJ	O
disease	disease	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
taking	take	VERB	VBG	O
continuous	continuous	ADJ	JJ	O
combined	combine	VERB	VBN	O
HT	HT	PROPN	NNP	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
dementia	dementia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Among	among	ADP	IN	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
combined	combined	ADJ	JJ	O
continuous	continuous	ADJ	JJ	O
HT	HT	PROPN	NNP	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
venous	venous	ADJ	JJ	B-Disease
thrombo	thrombo	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	I-Disease
embolism	embolism	NOUN	NN	I-Disease
.	.	PUNCT	.	O
One	one	NUM	CD	O
trial	trial	NOUN	NN	O
analysed	analyse	VERB	VBD	O
subgroups	subgroup	NOUN	NNS	O
of	of	ADP	IN	O
2839	2839	NUM	CD	O
relatively	relatively	ADV	RB	O
healthy	healthy	ADJ	JJ	O
50	50	NUM	CD	O
to	to	PART	TO	O
59	59	NUM	CD	O
year	year	NOUN	NN	O
old	old	ADJ	JJ	O
women	woman	NOUN	NNS	O
taking	take	VERB	VBG	O
combined	combine	VERB	VBN	O
continuous	continuous	ADJ	JJ	O
HT	HT	PROPN	NNP	O
and	and	CCONJ	CC	O
1637	1637	NUM	CD	O
taking	take	VERB	VBG	O
oestrogen	oestrogen	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
only	only	ADV	RB	O
HT	HT	PROPN	NNP	O
,	,	PUNCT	,	O
versus	versus	ADP	IN	O
similar	similar	ADJ	JJ	O
-	-	PUNCT	HYPH	O
sized	sized	ADJ	JJ	O
placebo	placebo	NOUN	NN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
only	only	ADJ	JJ	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
reported	report	VERB	VBN	O
was	be	VERB	VBD	O
for	for	ADP	IN	O
venous	venous	ADJ	JJ	B-Disease
thrombo	thrombo	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	I-Disease
embolism	embolism	NOUN	NN	I-Disease
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
taking	take	VERB	VBG	O
combined	combine	VERB	VBN	O
continuous	continuous	ADJ	JJ	O
HT	HT	PROPN	NNP	O
:	:	PUNCT	:	O
their	-PRON-	DET	PRP$	O
absolute	absolute	ADJ	JJ	O
risk	risk	NOUN	NN	O
remained	remain	VERB	VBD	O
low	low	ADJ	JJ	O
,	,	PUNCT	,	O
at	at	ADP	IN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
1	1	NUM	CD	O
/	/	SYM	SYM	O
500	500	NUM	CD	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
powered	power	VERB	VBN	O
to	to	PART	TO	O
detect	detect	VERB	VB	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
younger	young	ADJ	JJR	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

AUTHORS	authors	NOUN	NN	O
'	'	PUNCT	''	O
CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
HT	HT	PROPN	NNP	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
indicated	indicate	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
routine	routine	ADJ	JJ	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	O
disease	disease	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
need	need	VERB	VBP	O
more	more	ADJ	JJR	O
evidence	evidence	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
safety	safety	NOUN	NN	O
of	of	ADP	IN	O
HT	HT	PROPN	NNP	O
for	for	ADP	IN	O
menopausal	menopausal	ADJ	JJ	O
symptom	symptom	NOUN	NN	O
control	control	NOUN	NN	O
,	,	PUNCT	,	O
though	though	ADP	IN	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
use	use	NOUN	NN	O
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
relatively	relatively	ADV	RB	O
safe	safe	ADJ	JJ	O
for	for	ADP	IN	O
healthy	healthy	ADJ	JJ	O
younger	young	ADJ	JJR	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
AIDS	AIDS	PROPN	NNP	B-Disease
on	on	ADP	IN	O
tenofovir	tenofovir	ADJ	JJ	B-Chemical
while	while	ADP	IN	O
receiving	receive	VERB	VBG	O
prolonged	prolong	VERB	VBN	O
vancomycin	vancomycin	NOUN	NN	B-Chemical
course	course	NOUN	NN	O
for	for	ADP	IN	O
osteomyelitis	osteomyelitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
developed	develop	VERB	VBD	O
after	after	ADP	IN	O
a	a	DET	DT	O
prolonged	prolong	VERB	VBN	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
vancomycin	vancomycin	PROPN	NNP	B-Chemical
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
2	2	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
receiving	receive	VERB	VBG	O
tenofovir	tenofovir	ADJ	JJ	B-Chemical
disoproxil	disoproxil	NOUN	NN	I-Chemical
fumarate	fumarate	NOUN	NN	I-Chemical
as	as	ADP	IN	O
part	part	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
antiretroviral	antiretroviral	ADJ	JJ	O
regimen	regimen	NOUN	NN	O
.	.	PUNCT	.	O

Tenofovir	tenofovir	DET	DT	B-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
Fanconi	Fanconi	PROPN	NNP	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
renal	renal	ADJ	JJ	B-Disease
insufficiency	insufficiency	NOUN	NN	I-Disease
because	because	ADP	IN	O
of	of	ADP	IN	O
its	-PRON-	DET	PRP$	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
the	the	DET	DT	O
proximal	proximal	ADJ	JJ	O
renal	renal	ADJ	JJ	O
tubule	tubule	NOUN	NN	O
.	.	PUNCT	.	O

Vancomycin	Vancomycin	PROPN	NNP	B-Chemical
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
infrequent	infrequent	ADJ	JJ	O
but	but	CCONJ	CC	O
may	may	VERB	MD	O
result	result	VERB	VB	O
from	from	ADP	IN	O
coadministration	coadministration	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
agent	agent	NOUN	NN	O
.	.	PUNCT	.	O

Clinicians	clinician	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
that	that	ADP	IN	O
tenofovir	tenofovir	DET	DT	B-Chemical
may	may	VERB	MD	O
raise	raise	VERB	VB	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
during	during	ADP	IN	O
prolonged	prolong	VERB	VBN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
vancomycin	vancomycin	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Recurrent	Recurrent	PROPN	NNP	O
dysosmia	dysosmia	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
pyrazinamide	pyrazinamide	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Pyrazinamide	pyrazinamide	NOUN	NN	B-Chemical
can	can	VERB	MD	O
have	have	VERB	VB	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
hepatic	hepatic	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
,	,	PUNCT	,	O
hyperuricemia	hyperuricemia	NOUN	NN	B-Disease
or	or	CCONJ	CC	O
digestive	digestive	ADJ	JJ	O
disorders	disorder	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
rare	rare	ADJ	JJ	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
taste	taste	NOUN	NN	O
and	and	CCONJ	CC	O
smell	smell	NOUN	NN	O
function	function	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
for	for	ADP	IN	O
pyrazinamide	pyrazinamide	NOUN	NN	B-Chemical
when	when	ADV	WRB	O
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
reversible	reversible	ADJ	JJ	O
olfactory	olfactory	ADJ	JJ	B-Disease
disorder	disorder	NOUN	NN	I-Disease
related	relate	VERB	VBN	O
to	to	PART	TO	O
pyrazinamide	pyrazinamide	VERB	VB	B-Chemical
in	in	ADP	IN	O
a	a	DET	DT	O
woman	woman	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
a	a	DET	DT	O
positive	positive	ADJ	JJ	O
rechallenge	rechallenge	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
presented	present	VERB	VBD	O
every	every	DET	DT	O
day	day	NOUN	NN	O
a	a	DET	DT	O
sensation	sensation	NOUN	NN	O
of	of	ADP	IN	O
smelling	smell	VERB	VBG	O
something	something	NOUN	NN	O
burning	burn	VERB	VBG	O
15	15	NUM	CD	O
min	min	NOUN	NN	O
after	after	ADP	IN	O
drug	drug	NOUN	NN	O
intake	intake	NOUN	NN	O
.	.	PUNCT	.	O

Dysosmia	Dysosmia	PROPN	NNP	B-Disease
disappeared	disappear	VERB	VBD	O
completely	completely	ADV	RB	O
after	after	ADP	IN	O
pyrazinamide	pyrazinamide	NOUN	NN	B-Chemical
withdrawal	withdrawal	NOUN	NN	O
and	and	CCONJ	CC	O
recurred	recur	VERB	VBD	O
after	after	ADP	IN	O
its	-PRON-	DET	PRP$	O
rechallenge	rechallenge	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
case	case	NOUN	NN	O
was	be	VERB	VBD	O
reported	report	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
Tunisian	Tunisian	PROPN	NNP	O
Centre	Centre	PROPN	NNP	O
of	of	ADP	IN	O
Pharmacovigilance	Pharmacovigilance	PROPN	NNP	O
.	.	PUNCT	.	O

Mice	mouse	NOUN	NNS	O
lacking	lack	VERB	VBG	O
mPGES	mPGES	PROPN	NNP	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
are	be	VERB	VBP	O
resistant	resistant	ADJ	JJ	O
to	to	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
polyuria	polyuria	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Cyclooxygenase	Cyclooxygenase	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
activity	activity	NOUN	NN	O
is	be	VERB	VBZ	O
required	require	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
polyuria	polyuria	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
involvement	involvement	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
specific	specific	ADJ	JJ	O
,	,	PUNCT	,	O
terminal	terminal	ADJ	JJ	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
PG	PG	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
isomerase	isomerase	NOUN	NN	O
has	have	VERB	VBZ	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
evaluated	evaluate	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
undertaken	undertake	VERB	VBN	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
lithium	lithium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
polyuria	polyuria	NOUN	NN	B-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
deficient	deficient	ADJ	JJ	O
in	in	ADP	IN	O
microsomal	microsomal	ADJ	JJ	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
E	e	NOUN	NN	I-Chemical
synthase	synthase	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
(	(	PUNCT	-LRB-	O
mPGES	mpges	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
wk	wk	NOUN	NN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
LiCl	LiCl	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
mmol	mmol	NOUN	NN	O
.	.	PUNCT	.	O
kg	kg	X	FW	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O
day	day	NOUN	NN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
ip	ip	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
mPGES	mPGES	PROPN	NNP	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
+	+	NOUN	NN	O
/	/	SYM	SYM	O
+	+	SYM	SYM	O
mice	mouse	NOUN	NNS	O
led	lead	VERB	VBD	O
to	to	ADP	IN	O
a	a	DET	DT	O
marked	mark	VERB	VBN	O
polyuria	polyuria	NOUN	NN	B-Disease
with	with	ADP	IN	O
hyposmotic	hyposmotic	ADJ	JJ	O
urine	urine	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
elevated	elevated	ADJ	JJ	O
renal	renal	ADJ	JJ	O
mPGES	mPGES	PROPN	NNP	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
protein	protein	NOUN	NN	O
expression	expression	NOUN	NN	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBD	O
urine	urine	NOUN	NN	O
PGE	PGE	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2	2	PUNCT	LS	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
excretion	excretion	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
mPGES	mpges	NUM	CD	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
mice	mouse	NOUN	NNS	O
were	be	VERB	VBD	O
largely	largely	ADV	RB	O
resistant	resistant	ADJ	JJ	O
to	to	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
polyuria	polyuria	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
a	a	DET	DT	O
urine	urine	NOUN	NN	O
concentrating	concentrating	NOUN	NN	O
defect	defect	NOUN	NN	O
,	,	PUNCT	,	O
accompanied	accompany	VERB	VBN	O
by	by	ADP	IN	O
nearly	nearly	ADV	RB	O
complete	complete	ADJ	JJ	O
blockade	blockade	NOUN	NN	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
urine	urine	NOUN	NN	O
PGE	PGE	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2	2	NUM	CD	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
and	and	CCONJ	CC	O
cAMP	cAMP	PROPN	NNP	O
output	output	NOUN	NN	O
.	.	PUNCT	.	O

Immunoblotting	immunoblotting	NOUN	NN	O
,	,	PUNCT	,	O
immunohistochemistry	immunohistochemistry	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
quantitative	quantitative	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
q	q	NOUN	NN	O
)	)	PUNCT	-RRB-	O
RT	RT	PROPN	NNP	O
-	-	PUNCT	HYPH	O
PCR	PCR	PROPN	NNP	O
consistently	consistently	ADV	RB	O
detected	detect	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
aquaporin	aquaporin	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
(	(	PUNCT	-LRB-	O
AQP2	AQP2	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
protein	protein	NOUN	NN	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
renal	renal	ADJ	JJ	O
cortex	cortex	NOUN	NN	O
and	and	CCONJ	CC	O
medulla	medulla	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
+	+	SYM	SYM	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
decrease	decrease	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
attenuated	attenuate	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

qRT	qRT	PUNCT	LS	O
-	-	PUNCT	HYPH	O
PCR	PCR	PROPN	NNP	O
detected	detect	VERB	VBD	O
similar	similar	ADJ	JJ	O
patterns	pattern	NOUN	NNS	O
of	of	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
AQP2	AQP2	PROPN	NNP	O
mRNA	mRNA	PROPN	NNPS	O
in	in	ADP	IN	O
the	the	DET	DT	O
medulla	medulla	NOUN	NN	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
cortex	cortex	NOUN	NN	O
.	.	PUNCT	.	O

Similarly	similarly	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
total	total	ADJ	JJ	O
protein	protein	NOUN	NN	O
abundance	abundance	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
Na	Na	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
K	K	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
2Cl	2cl	NUM	CD	B-Chemical
cotransporter	cotransporter	NOUN	NN	O
(	(	PUNCT	-LRB-	O
NKCC2	NKCC2	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
medulla	medulla	NOUN	NN	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
cortex	cortex	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
+	+	NOUN	NN	O
/	/	SYM	SYM	O
+	+	CCONJ	CC	O
mice	mouse	NOUN	NNS	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBN	O
by	by	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
dowregulation	dowregulation	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
medullary	medullary	NOUN	NN	O
NKCC2	nkcc2	DET	DT	O
expression	expression	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
attenuated	attenuate	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
mPGES	mpges	NUM	CD	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
derived	derive	VERB	VBN	O
PGE	PGE	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2	2	PUNCT	LS	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
mediates	mediate	VERB	VBZ	O
lithium	lithium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
polyuria	polyuria	NOUN	NN	B-Disease
likely	likely	ADJ	JJ	O
via	via	ADP	IN	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
AQP2	AQP2	PROPN	NNP	O
and	and	CCONJ	CC	O
NKCC2	NKCC2	PROPN	NNP	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

Preservation	preservation	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
during	during	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
with	with	ADP	IN	O
fenoldopam	fenoldopam	NOUN	NN	B-Chemical
in	in	ADP	IN	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
introduction	introduction	NOUN	NN	O
of	of	ADP	IN	O
drugs	drug	NOUN	NNS	O
that	that	DET	WDT	O
could	could	VERB	MD	O
induce	induce	VERB	VB	O
hypotension	hypotension	NOUN	NN	B-Disease
with	with	ADP	IN	O
different	different	ADJ	JJ	O
pharmacological	pharmacological	ADJ	JJ	O
actions	action	NOUN	NNS	O
would	would	VERB	MD	O
be	be	VERB	VB	O
advantageous	advantageous	ADJ	JJ	O
because	because	ADP	IN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
unique	unique	ADJ	JJ	O
to	to	ADP	IN	O
a	a	DET	DT	O
specific	specific	ADJ	JJ	O
drug	drug	NOUN	NN	O
could	could	VERB	MD	O
be	be	VERB	VB	O
minimized	minimize	VERB	VBN	O
by	by	ADP	IN	O
selecting	select	VERB	VBG	O
appropriate	appropriate	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Specific	specific	ADJ	JJ	O
dopamine	dopamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
(	(	PUNCT	-LRB-	O
DA1	da1	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
dopamine	dopamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
(	(	PUNCT	-LRB-	O
DA2	DA2	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
receptor	receptor	NOUN	NN	O
agonists	agonist	NOUN	NNS	O
are	be	VERB	VBP	O
now	now	ADV	RB	O
under	under	ADP	IN	O
clinical	clinical	ADJ	JJ	O
investigation	investigation	NOUN	NN	O
.	.	PUNCT	.	O

Fenoldopam	fenoldopam	NOUN	NN	B-Chemical
mesylate	mesylate	NOUN	NN	I-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
specific	specific	ADJ	JJ	O
DA1	da1	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
that	that	DET	WDT	O
lowers	lower	VERB	VBZ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
by	by	ADP	IN	O
vasodilatation	vasodilatation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
that	that	DET	DT	O
fenoldopam	fenoldopam	NOUN	NN	B-Chemical
could	could	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
induce	induce	VERB	VB	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
preserve	preserve	VERB	VB	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
was	be	VERB	VBD	O
tested	test	VERB	VBN	O
.	.	PUNCT	.	O

Systemic	systemic	ADJ	JJ	O
aortic	aortic	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
renal	renal	ADJ	JJ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
continuously	continuously	ADV	RB	O
with	with	ADP	IN	O
a	a	DET	DT	O
carotid	carotid	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
catheter	catheter	NOUN	NN	O
and	and	CCONJ	CC	O
an	an	DET	DT	O
electromagnetic	electromagnetic	ADJ	JJ	O
flow	flow	NOUN	NN	O
probe	probe	NOUN	NN	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
compare	compare	VERB	VB	O
the	the	DET	DT	O
cardiovascular	cardiovascular	ADJ	JJ	O
and	and	CCONJ	CC	O
renal	renal	ADJ	JJ	O
vascular	vascular	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
fenoldopam	fenoldopam	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
sodium	sodium	NOUN	NN	B-Chemical
nitroprusside	nitroprusside	ADV	RB	B-Chemical
in	in	ADP	IN	O
ten	ten	NUM	CD	O
dogs	dog	NOUN	NNS	O
under	under	ADP	IN	O
halothane	halothane	NOUN	NN	B-Chemical
general	general	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
.	.	PUNCT	.	O

Mean	mean	VERB	VB	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
was	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
30	30	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
8	8	NUM	CD	O
per	per	NOUN	NN	O
cent	cent	NOUN	NN	O
from	from	ADP	IN	O
control	control	NOUN	NN	O
with	with	ADP	IN	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
fenoldopam	fenoldopam	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
.	.	PUNCT	.	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
min	min	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
34	34	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
4	4	NUM	CD	O
per	per	ADP	IN	O
cent	cent	NOUN	NN	O
with	with	ADP	IN	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
nitroprusside	nitroprusside	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
.	.	PUNCT	.	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
min	min	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
NS	NS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
(	(	PUNCT	-LRB-	O
RBF	RBF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
increased	increase	VERB	VBD	O
during	during	ADP	IN	O
fenoldopam	fenoldopam	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
11	11	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
per	per	NOUN	NN	O
cent	cent	NOUN	NN	O
and	and	CCONJ	CC	O
decreased	decrease	VERB	VBD	O
21	21	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
8	8	NUM	CD	O
per	per	NOUN	NN	O
cent	cent	NOUN	NN	O
during	during	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
nitroprusside	nitroprusside	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Sodium	sodium	NOUN	NN	O
nitroprusside	nitroprusside	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
selective	selective	ADJ	JJ	O
arteriolar	arteriolar	NOUN	NN	O
and	and	CCONJ	CC	O
venous	venous	ADJ	JJ	O
vasodilator	vasodilator	NOUN	NN	O
that	that	DET	WDT	O
can	can	VERB	MD	O
produce	produce	VERB	VB	O
redistribution	redistribution	NOUN	NN	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
flow	flow	VERB	VB	O
away	away	ADV	RB	O
from	from	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
during	during	ADP	IN	O
induced	induced	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Fenoldopam	Fenoldopam	PROPN	NNP	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
selective	selective	ADJ	JJ	O
dopamine	dopamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
(	(	PUNCT	-LRB-	O
DA1	da1	NOUN	NN	O
)	)	PUNCT	-RRB-	O
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
that	that	DET	WDT	O
causes	cause	VERB	VBZ	O
vasodilatation	vasodilatation	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
and	and	CCONJ	CC	O
other	other	ADJ	JJ	O
organs	organ	NOUN	NNS	O
with	with	ADP	IN	O
DA1	da1	ADJ	JJ	O
receptors	receptor	NOUN	NNS	O
and	and	CCONJ	CC	O
preserves	preserve	VERB	VBZ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
during	during	ADP	IN	O
induced	induced	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Seizures	seizure	NOUN	NNS	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
levofloxacin	levofloxacin	ADJ	JJ	B-Chemical
:	:	PUNCT	:	O
case	case	NOUN	NN	O
presentation	presentation	NOUN	NN	O
and	and	CCONJ	CC	O
literature	literature	NOUN	NN	O
review	review	NOUN	NN	O
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
present	present	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
seizures	seizure	NOUN	NNS	B-Disease
shortly	shortly	ADV	RB	O
after	after	ADP	IN	O
initiating	initiate	VERB	VBG	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
levofloxacin	levofloxacin	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
to	to	PART	TO	O
discuss	discuss	VERB	VB	O
the	the	DET	DT	O
potential	potential	ADJ	JJ	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
drug	drug	NOUN	NN	O
interactions	interaction	NOUN	NNS	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
cytochrome	cytochrome	ADJ	JJ	O
P450	P450	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
CYP	CYP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
1A2	1a2	NUM	CD	O
in	in	ADP	IN	O
this	this	DET	DT	O
case	case	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
in	in	ADP	IN	O
other	other	ADJ	JJ	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
of	of	ADP	IN	O
levofloxacin	levofloxacin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Several	several	ADJ	JJ	O
biomedical	biomedical	ADJ	JJ	O
databases	database	NOUN	NNS	O
were	be	VERB	VBD	O
searched	search	VERB	VBN	O
including	include	VERB	VBG	O
MEDLINE	MEDLINE	PROPN	NNP	O
,	,	PUNCT	,	O
Cochrane	Cochrane	PROPN	NNP	O
and	and	CCONJ	CC	O
Ovid	Ovid	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
main	main	ADJ	JJ	O
search	search	NOUN	NN	O
terms	term	NOUN	NNS	O
utilized	utilize	VERB	VBN	O
were	be	VERB	VBD	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
and	and	CCONJ	CC	O
levofloxacin	levofloxacin	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
search	search	NOUN	NN	O
was	be	VERB	VBD	O
limited	limit	VERB	VBN	O
to	to	ADP	IN	O
studies	study	NOUN	NNS	O
published	publish	VERB	VBN	O
in	in	ADP	IN	O
English	English	PROPN	NNP	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Six	six	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
levofloxacin	levofloxacin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

Drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
drug	drug	NOUN	NN	O
interactions	interaction	NOUN	NNS	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
CYP1A2	cyp1a2	NOUN	NN	O
by	by	ADP	IN	O
levofloxacin	levofloxacin	ADJ	JJ	B-Chemical
are	be	VERB	VBP	O
likely	likely	ADV	RB	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
outcome	outcome	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Clinicians	clinician	NOUN	NNS	O
are	be	VERB	VBP	O
exhorted	exhort	VERB	VBN	O
to	to	PART	TO	O
pay	pay	VERB	VB	O
close	close	ADJ	JJ	O
attention	attention	NOUN	NN	O
when	when	ADV	WRB	O
initiating	initiate	VERB	VBG	O
levofloxacin	levofloxacin	ADJ	JJ	B-Chemical
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
taking	take	VERB	VBG	O
medications	medication	NOUN	NNS	O
with	with	ADP	IN	O
epileptogenic	epileptogenic	ADJ	JJ	O
properties	property	NOUN	NNS	O
that	that	DET	WDT	O
are	be	VERB	VBP	O
CYP1A2	cyp1a2	NOUN	NN	O
substrates	substrate	NOUN	NNS	O
.	.	PUNCT	.	O

Dextran	dextran	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
etodolac	etodolac	NOUN	NN	B-Chemical
conjugates	conjugate	NOUN	NNS	O
:	:	PUNCT	:	O
synthesis	synthesis	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
vitro	vitro	X	FW	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
evaluation	evaluation	NOUN	NN	O
.	.	PUNCT	.	O

Etodolac	Etodolac	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
E	E	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
narcotic	narcotic	ADJ	JJ	O
analgesic	analgesic	NOUN	NN	O
and	and	CCONJ	CC	O
antiinflammatory	antiinflammatory	ADJ	JJ	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
biodegradable	biodegradable	ADJ	JJ	O
polymer	polymer	NOUN	NN	O
dextran	dextran	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
utilized	utilize	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
carrier	carrier	NOUN	NN	O
for	for	ADP	IN	O
synthesis	synthesis	NOUN	NN	O
of	of	ADP	IN	O
etodolac	etodolac	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
dextran	dextran	NOUN	NN	B-Chemical
conjugates	conjugate	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
ED	ED	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
to	to	PART	TO	O
improve	improve	VERB	VB	O
its	-PRON-	DET	PRP$	O
aqueous	aqueous	ADJ	JJ	O
solubility	solubility	NOUN	NN	O
and	and	CCONJ	CC	O
reduce	reduce	VERB	VB	O
gastrointestinal	gastrointestinal	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

An	an	DET	DT	O
activated	activate	VERB	VBN	O
moiety	moiety	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
e	e	PUNCT	LS	O
.	.	PUNCT	.	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
acylimidazole	acylimidazole	NOUN	NN	I-Chemical
derivative	derivative	NOUN	NN	O
of	of	ADP	IN	O
etodolac	etodolac	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
EAI	EAI	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
condensed	condense	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
polysaccharide	polysaccharide	NOUN	NN	O
polymer	polymer	NOUN	NN	O
dextran	dextran	NOUN	NN	B-Chemical
of	of	ADP	IN	O
different	different	ADJ	JJ	O
molecular	molecular	ADJ	JJ	O
weights	weight	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
40000	40000	NUM	CD	O
,	,	PUNCT	,	O
60000	60000	NUM	CD	O
,	,	PUNCT	,	O
110000	110000	NUM	CD	O
and	and	CCONJ	CC	O
200000	200000	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

IR	IR	PROPN	NNP	O
spectral	spectral	ADJ	JJ	O
data	datum	NOUN	NNS	O
confirmed	confirm	VERB	VBD	O
formation	formation	NOUN	NN	O
of	of	ADP	IN	O
ester	ester	NOUN	NN	O
bonding	bonding	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
conjugates	conjugate	NOUN	NNS	O
.	.	PUNCT	.	O

Etodolac	Etodolac	PROPN	NNP	B-Chemical
contents	content	NOUN	NNS	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
by	by	ADP	IN	O
UV	uv	NOUN	NN	O
-	-	PUNCT	HYPH	O
spectrophotometric	spectrophotometric	NOUN	NN	O
analysis	analysis	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
molecular	molecular	ADJ	JJ	O
weights	weight	NOUN	NNS	O
were	be	VERB	VBD	O
determined	determine	VERB	VBN	O
by	by	ADP	IN	O
measuring	measure	VERB	VBG	O
viscosity	viscosity	NOUN	NN	O
using	use	VERB	VBG	O
the	the	DET	DT	O
Mark	Mark	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Howink	Howink	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Sakurada	Sakurada	PROPN	NNP	O
equation	equation	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
vitro	vitro	X	FW	O
hydrolysis	hydrolysis	NOUN	NN	O
of	of	ADP	IN	O
ED	ED	PROPN	NNP	O
was	be	VERB	VBD	O
done	do	VERB	VBN	O
in	in	ADP	IN	O
aqueous	aqueous	ADJ	JJ	O
buffers	buffer	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
pH	pH	NOUN	NNS	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
7	7	NUM	CD	O
.	.	NOUN	NN	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
80	80	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
v	v	NOUN	NN	O
/	/	SYM	SYM	O
v	v	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
human	human	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
(	(	PUNCT	-LRB-	O
pH	ph	X	XX	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
pH	pH	PROPN	NNP	O
9	9	NUM	CD	O
,	,	PUNCT	,	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
etodolac	etodolac	NOUN	NN	B-Chemical
release	release	NOUN	NN	O
from	from	ADP	IN	O
ED	ED	PROPN	NNP	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
aqueous	aqueous	ADJ	JJ	O
buffer	buffer	NOUN	NN	O
of	of	ADP	IN	O
pH	pH	NOUN	NNS	O
7	7	NUM	CD	O
.	.	NOUN	NN	O
4	4	NUM	CD	O
and	and	CCONJ	CC	O
80	80	NUM	CD	O
%	%	NOUN	NN	O
human	human	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
(	(	PUNCT	-LRB-	O
pH	ph	X	XX	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
following	follow	VERB	VBG	O
first	first	ADJ	JJ	O
-	-	PUNCT	HYPH	O
order	order	NOUN	NN	O
kinetics	kinetic	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
investigations	investigation	NOUN	NNS	O
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
in	in	ADP	IN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	O
analgesic	analgesic	NOUN	NN	O
and	and	CCONJ	CC	O
antiinflammatory	antiinflammatory	NOUN	NN	O
activities	activity	NOUN	NNS	O
were	be	VERB	VBD	O
ascertained	ascertain	VERB	VBN	O
using	use	VERB	VBG	O
acetic	acetic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
induced	induce	VERB	VBN	O
writhing	writhing	NOUN	NN	B-Disease
model	model	NOUN	NN	O
(	(	PUNCT	-LRB-	O
mice	mouse	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
carrageenan	carrageenan	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
rat	rat	NOUN	NN	O
paw	paw	DET	PRP$	O
edema	edema	NOUN	NN	B-Disease
model	model	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
comparison	comparison	NOUN	NN	O
to	to	PART	TO	O
control	control	VERB	VB	O
,	,	PUNCT	,	O
E	e	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
ED1	ED1	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ED4	ED4	PROPN	NNP	O
showed	show	VERB	VBD	O
highly	highly	ADV	RB	O
significant	significant	ADJ	JJ	O
analgesic	analgesic	NOUN	NN	O
and	and	CCONJ	CC	O
antiinflammatory	antiinflammatory	NOUN	NN	O
activities	activity	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Biological	biological	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
suggested	suggest	VERB	VBD	O
that	that	ADP	IN	O
conjugates	conjugate	VERB	VBZ	O
(	(	PUNCT	-LRB-	O
ED1	ED1	PROPN	NNP	O
-	-	PUNCT	HYPH	O
ED4	ED4	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
retained	retain	VERB	VBD	O
comparable	comparable	ADJ	JJ	O
analgesic	analgesic	NOUN	NN	O
and	and	CCONJ	CC	O
antiinflammatory	antiinflammatory	NOUN	NN	O
activities	activity	NOUN	NNS	O
with	with	ADP	IN	O
remarkably	remarkably	ADV	RB	O
reduced	reduce	VERB	VBN	O
ulcerogenicity	ulcerogenicity	NOUN	NN	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
their	-PRON-	DET	PRP$	O
parent	parent	NOUN	NN	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
-	-	PUNCT	HYPH	O
etodolac	etodolac	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
antiarrhythmic	antiarrhythmic	ADJ	JJ	O
effect	effect	NOUN	NN	O
and	and	CCONJ	CC	O
possible	possible	ADJ	JJ	O
ionic	ionic	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
animal	animal	NOUN	NN	O
models	model	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
designed	design	VERB	VBN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
explore	explore	VERB	VB	O
the	the	DET	DT	O
underlying	underlying	ADJ	JJ	O
ionic	ionic	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
,	,	PUNCT	,	O
using	use	VERB	VBG	O
both	both	CCONJ	CC	O
aconitine	aconitine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
rat	rat	NOUN	NN	O
and	and	CCONJ	CC	O
ouabain	ouabain	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
guinea	guinea	NOUN	NN	O
pig	pig	NOUN	NN	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
models	model	NOUN	NNS	O
.	.	PUNCT	.	O

Confocal	confocal	ADJ	JJ	O
microscopy	microscopy	NOUN	NN	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
measure	measure	VERB	VB	O
intracellular	intracellular	ADJ	JJ	O
free	free	ADJ	JJ	O
-	-	PUNCT	HYPH	O
calcium	calcium	NOUN	NN	B-Chemical
concentrations	concentration	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
[	[	PUNCT	-LRB-	O
Ca	Ca	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
+	+	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
]	]	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
)	)	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
isolated	isolated	ADJ	JJ	O
myocytes	myocyte	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
current	current	ADJ	JJ	O
data	datum	NOUN	NNS	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
significantly	significantly	ADV	RB	O
delayed	delay	VERB	VBD	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
arrhythmias	arrhythmia	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
time	time	NOUN	NN	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
and	and	CCONJ	CC	I-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
,	,	PUNCT	,	O
reduced	reduce	VERB	VBN	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
score	score	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
survival	survival	NOUN	NN	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
arrhythmic	arrhythmic	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
guinea	guinea	NOUN	NN	O
pigs	pig	NOUN	NNS	O
.	.	PUNCT	.	O

[	[	PUNCT	-LRB-	O
Ca	Ca	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
+	+	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
]	]	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
)	)	PUNCT	-RRB-	O
overload	overload	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
aconitine	aconitine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
ouabain	ouabain	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
in	in	ADP	IN	O
isolated	isolated	ADJ	JJ	O
myocytes	myocyte	NOUN	NNS	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
M	M	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
muscarinic	muscarinic	ADJ	JJ	O
acetylcholine	acetylcholine	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
mAChR	machr	NOUN	NN	O
)	)	PUNCT	-RRB-	O
antagonist	antagonist	VERB	VBP	O
4	4	NUM	CD	B-Chemical
-	-	PUNCT	:	I-Chemical
DAMP	damp	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
diphenylacetoxy	diphenylacetoxy	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
N	n	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
methylpiperidine	methylpiperidine	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
methiodide	methiodide	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
partially	partially	ADV	RB	O
abolished	abolish	VERB	VBD	O
the	the	DET	DT	O
beneficial	beneficial	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
produced	produce	VERB	VBD	O
antiarrhythmic	antiarrhythmic	ADJ	JJ	O
actions	action	NOUN	NNS	O
on	on	ADP	IN	O
arrhythmic	arrhythmic	ADJ	JJ	B-Disease
rat	rat	NOUN	NN	O
and	and	CCONJ	CC	O
guinea	guinea	NOUN	NN	O
pig	pig	NOUN	NN	O
models	model	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
aconitine	aconitine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
ouabain	ouabain	NOUN	NN	B-Chemical
via	via	ADP	IN	O
stimulating	stimulate	VERB	VBG	O
the	the	DET	DT	O
cardiac	cardiac	ADJ	JJ	O
M	m	NOUN	NN	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	:	O
mAChR	machr	NUM	CD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
improvement	improvement	NOUN	NN	O
of	of	ADP	IN	O
Ca	Ca	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
+	+	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
handling	handling	NOUN	NN	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
Hibiscus	Hibiscus	PROPN	NNP	B-Chemical
rosa	rosa	NOUN	NN	I-Chemical
sinensis	sinensis	NOUN	NN	I-Chemical
on	on	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
neurobehavioral	neurobehavioral	ADJ	JJ	O
and	and	CCONJ	CC	O
biochemical	biochemical	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
methanolic	methanolic	ADJ	JJ	O
extract	extract	NOUN	NN	O
of	of	ADP	IN	O
Hibiscus	Hibiscus	PROPN	NNP	B-Chemical
rosa	rosa	NOUN	NN	I-Chemical
sinensis	sinensis	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
100	100	NUM	CD	O
-	-	SYM	SYM	O
300	300	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
studied	study	VERB	VBN	O
on	on	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
orofacial	orofacial	ADJ	JJ	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
neurochemical	neurochemical	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
intraperitoneal	intraperitoneal	ADJ	JJ	O
reserpine	reserpine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
ip	ip	NOUN	NN	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
3	3	NUM	CD	O
days	day	NOUN	NNS	O
every	every	DET	DT	O
other	other	ADJ	JJ	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
day	day	NOUN	NN	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
vacuous	vacuous	ADJ	JJ	O
chewing	chewing	NOUN	NN	O
movements	movement	NOUN	NNS	O
and	and	CCONJ	CC	O
tongue	tongue	NOUN	NN	O
protrusions	protrusion	NOUN	NNS	O
were	be	VERB	VBD	O
counted	count	VERB	VBN	O
for	for	ADP	IN	O
5	5	NUM	CD	O
min	min	NOUN	NN	O
.	.	PUNCT	.	O

Reserpine	reserpine	NOUN	NN	B-Chemical
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
significantly	significantly	ADV	RB	O
developed	develop	VERB	VBD	O
vacuous	vacuous	ADJ	JJ	O
chewing	chewing	NOUN	NN	O
movements	movement	NOUN	NNS	O
and	and	CCONJ	CC	O
tongue	tongue	NOUN	NN	O
protrusions	protrusion	NOUN	NNS	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
coadministration	coadministration	NOUN	NN	O
of	of	ADP	IN	O
Hibiscus	Hibiscus	PROPN	NNP	B-Chemical
rosa	rosa	NOUN	NN	I-Chemical
sinensis	sinensis	NOUN	NN	I-Chemical
roots	root	NOUN	NNS	O
extract	extract	VERB	VBP	O
(	(	PUNCT	-LRB-	O
100	100	NUM	CD	O
,	,	PUNCT	,	O
200	200	NUM	CD	O
and	and	CCONJ	CC	O
300	300	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
per	per	ADP	IN	O
orally	orally	ADV	RB	O
)	)	PUNCT	-RRB-	O
attenuated	attenuate	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

Biochemical	biochemical	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
brain	brain	NOUN	NN	O
revealed	reveal	VERB	VBD	O
that	that	ADP	IN	O
the	the	DET	DT	O
reserpine	reserpine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBD	O
lipid	lipid	NOUN	NN	O
peroxidation	peroxidation	NOUN	NN	O
and	and	CCONJ	CC	O
decreased	decrease	VERB	VBD	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
superoxide	superoxide	NOUN	NN	B-Chemical
dismutase	dismutase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SOD	SOD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
catalase	catalase	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
CAT	CAT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
glutathione	glutathione	NOUN	NN	B-Chemical
reductase	reductase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GSH	GSH	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
an	an	DET	DT	O
index	index	NOUN	NN	O
of	of	ADP	IN	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
process	process	NOUN	NN	O
.	.	PUNCT	.	O

Coadministration	coadministration	NOUN	NN	O
of	of	ADP	IN	O
extract	extract	NOUN	NN	O
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
lipid	lipid	NOUN	NN	O
peroxidation	peroxidation	NOUN	NN	O
and	and	CCONJ	CC	O
reversed	reverse	VERB	VBD	O
the	the	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
brain	brain	NOUN	NN	O
SOD	SOD	PROPN	NNP	O
,	,	PUNCT	,	O
CAT	CAT	PROPN	NNP	O
and	and	CCONJ	CC	O
GSH	GSH	PROPN	NNP	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
suggested	suggest	VERB	VBD	O
that	that	ADP	IN	O
Hibiscus	Hibiscus	PROPN	NNP	B-Chemical
rosa	rosa	NOUN	NN	I-Chemical
sinensis	sinensis	NOUN	NN	I-Chemical
had	have	VERB	VBD	O
a	a	DET	DT	O
protective	protective	ADJ	JJ	O
role	role	NOUN	NN	O
against	against	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
orofacial	orofacial	ADJ	JJ	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
.	.	PUNCT	.	O

Dynamic	dynamic	ADJ	JJ	O
response	response	NOUN	NN	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
vessel	vessel	NOUN	NN	O
in	in	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
we	-PRON-	PRON	PRP	O
postulated	postulate	VERB	VBD	O
that	that	ADP	IN	O
during	during	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
the	the	DET	DT	O
transient	transient	ADJ	JJ	O
or	or	CCONJ	CC	O
dynamic	dynamic	ADJ	JJ	O
response	response	NOUN	NN	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
vessels	vessel	NOUN	NNS	O
could	could	VERB	MD	O
be	be	VERB	VB	O
affected	affect	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
that	that	ADP	IN	O
antioxidants	antioxidant	NOUN	NNS	O
can	can	VERB	MD	O
prevent	prevent	VERB	VB	O
the	the	DET	DT	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
dynamic	dynamic	ADJ	JJ	O
responses	response	NOUN	NNS	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
vessels	vessel	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
new	new	ADJ	JJ	O
approach	approach	NOUN	NN	O
to	to	ADP	IN	O
ex	ex	NOUN	NN	O
vivo	vivo	NOUN	NNS	O
blood	blood	NOUN	NN	O
vessel	vessel	NOUN	NN	O
experiments	experiment	NOUN	NNS	O
in	in	ADP	IN	O
which	which	DET	WDT	O
not	not	ADV	RB	O
only	only	ADV	RB	O
the	the	DET	DT	O
end	end	NOUN	NN	O
points	point	NOUN	NNS	O
of	of	ADP	IN	O
vessels	vessel	NOUN	NNS	O
response	response	NOUN	NN	O
within	within	ADP	IN	O
the	the	DET	DT	O
time	time	NOUN	NN	O
interval	interval	NOUN	NN	O
is	be	VERB	VBZ	O
considered	consider	VERB	VBN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
also	also	ADV	RB	O
dynamics	dynamic	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
response	response	NOUN	NN	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
this	this	DET	DT	O
paper	paper	NOUN	NN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
confirm	confirm	VERB	VBP	O
the	the	DET	DT	O
alteration	alteration	NOUN	NN	O
in	in	ADP	IN	O
dynamic	dynamic	ADJ	JJ	O
response	response	NOUN	NN	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
vessels	vessel	NOUN	NNS	O
during	during	ADP	IN	O
the	the	DET	DT	O
change	change	NOUN	NN	O
of	of	ADP	IN	O
pressure	pressure	NOUN	NN	O
in	in	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
beneficial	beneficial	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
vitamin	vitamin	NOUN	NN	B-Chemical
C	c	NOUN	NN	I-Chemical
administration	administration	NOUN	NN	O
to	to	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
are	be	VERB	VBP	O
also	also	ADV	RB	O
confirmed	confirm	VERB	VBN	O
through	through	ADP	IN	O
:	:	PUNCT	:	O
lower	low	ADJ	JJR	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
urea	urea	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
creatinine	creatinine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
higher	high	ADJ	JJR	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
potassium	potassium	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
pressure	pressure	NOUN	NN	O
dynamic	dynamic	ADJ	JJ	O
responses	response	NOUN	NNS	O
of	of	ADP	IN	O
isolated	isolated	ADJ	JJ	O
blood	blood	NOUN	NN	O
vessels	vessel	NOUN	NNS	O
show	show	VERB	VBP	O
a	a	DET	DT	O
faster	fast	ADJ	JJR	O
pressure	pressure	NOUN	NN	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
07	07	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
s	s	NOUN	NN	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
64	64	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
18	18	NUM	CD	O
s	s	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Vitamin	vitamin	NOUN	NN	B-Chemical
C	C	PROPN	NNP	I-Chemical
administration	administration	NOUN	NN	O
induced	induce	VERB	VBD	O
slowdown	slowdown	NOUN	NN	O
of	of	ADP	IN	O
pressure	pressure	NOUN	NN	O
change	change	VERB	VBP	O
back	back	ADV	RB	O
to	to	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
values	value	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
pressure	pressure	NOUN	NN	O
dynamic	dynamic	ADJ	JJ	O
properties	property	NOUN	NNS	O
,	,	PUNCT	,	O
quantitatively	quantitatively	ADV	RB	O
defined	define	VERB	VBN	O
by	by	ADP	IN	O
comparative	comparative	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
dynamic	dynamic	ADJ	JJ	O
and	and	CCONJ	CC	O
total	total	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
dynamic	dynamic	ADJ	JJ	O
,	,	PUNCT	,	O
confirm	confirm	VERB	VB	O
the	the	DET	DT	O
alteration	alteration	NOUN	NN	O
in	in	ADP	IN	O
dynamic	dynamic	ADJ	JJ	O
response	response	NOUN	NN	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
vessels	vessel	NOUN	NNS	O
during	during	ADP	IN	O
the	the	DET	DT	O
change	change	NOUN	NN	O
of	of	ADP	IN	O
pressure	pressure	NOUN	NN	O
in	in	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
and	and	CCONJ	CC	O
beneficial	beneficial	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
vitamin	vitamin	NOUN	NN	B-Chemical
C	c	NOUN	NN	I-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Reversible	reversible	ADJ	JJ	O
myocardial	myocardial	ADJ	JJ	B-Disease
hypertrophy	hypertrophy	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
in	in	ADP	IN	O
a	a	DET	DT	O
pediatric	pediatric	ADJ	JJ	O
heart	heart	NOUN	NN	O
transplant	transplant	NOUN	NN	O
recipient	recipient	NOUN	NN	O
:	:	PUNCT	:	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

Tacrolimus	Tacrolimus	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
potent	potent	ADJ	JJ	O
immunosuppressant	immunosuppressant	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
frequently	frequently	ADV	RB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
organ	organ	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
include	include	VERB	VBP	O
cardiac	cardiac	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Herein	Herein	PROPN	NNP	O
we	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
transient	transient	ADJ	JJ	O
myocardial	myocardial	ADJ	JJ	B-Disease
hypertrophy	hypertrophy	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
after	after	ADP	IN	O
heart	heart	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
hypertrophy	hypertrophy	NOUN	NN	B-Disease
caused	cause	VERB	VBD	O
no	no	DET	DT	O
clinical	clinical	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
but	but	CCONJ	CC	O
was	be	VERB	VBD	O
noted	note	VERB	VBN	O
because	because	ADP	IN	O
of	of	ADP	IN	O
elevation	elevation	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
brain	brain	NOUN	NN	O
natriuretic	natriuretic	ADJ	JJ	O
peptide	peptide	NOUN	NN	O
concentration	concentration	NOUN	NN	O
and	and	CCONJ	CC	O
confirmed	confirm	VERB	VBD	O
at	at	ADP	IN	O
echocardiography	echocardiography	NOUN	NN	O
.	.	PUNCT	.	O

Initially	initially	ADV	RB	O
,	,	PUNCT	,	O
allograft	allograft	NOUN	NN	O
rejection	rejection	NOUN	NN	O
was	be	VERB	VBD	O
feared	fear	VERB	VBN	O
;	;	PUNCT	:	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
myocardial	myocardial	ADJ	JJ	O
biopsy	biopsy	NOUN	NN	O
samples	sample	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
only	only	ADV	RB	O
interstitial	interstitial	ADJ	JJ	O
edema	edema	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
mild	mild	ADJ	JJ	O
myocardial	myocardial	ADJ	JJ	B-Disease
hypertrophy	hypertrophy	NOUN	NN	I-Disease
;	;	PUNCT	:	O
neither	neither	CCONJ	CC	O
cellular	cellular	ADJ	JJ	O
nor	nor	CCONJ	CC	O
humoral	humoral	ADJ	JJ	O
rejection	rejection	NOUN	NN	O
was	be	VERB	VBD	O
detected	detect	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
blood	blood	NOUN	NN	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
than	than	ADP	IN	O
usual	usual	ADJ	JJ	O
at	at	ADP	IN	O
that	that	DET	DT	O
time	time	NOUN	NN	O
;	;	PUNCT	:	O
thus	thus	ADV	RB	O
,	,	PUNCT	,	O
tacrolimus	tacrolimus	ADJ	JJ	B-Chemical
dosage	dosage	NOUN	NN	O
was	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
.	.	PUNCT	.	O

Myocardial	myocardial	ADJ	JJ	B-Disease
hypertrophy	hypertrophy	NOUN	NN	I-Disease
completely	completely	ADV	RB	O
resolved	resolve	VERB	VBD	O
upon	upon	ADP	IN	O
reducing	reduce	VERB	VBG	O
the	the	DET	DT	O
target	target	NOUN	NN	O
concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
recur	recur	VERB	VB	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
confirmed	confirm	VERB	VBN	O
at	at	ADP	IN	O
echocardiography	echocardiography	NOUN	NN	O
and	and	CCONJ	CC	O
myocardial	myocardial	ADJ	JJ	O
biopsy	biopsy	NOUN	NN	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
induces	induce	NOUN	NNS	O
reversible	reversible	ADJ	JJ	O
myocardial	myocardial	ADJ	JJ	B-Disease
hypertrophy	hypertrophy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
blood	blood	NOUN	NN	O
concentration	concentration	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
carefully	carefully	ADV	RB	O
controlled	control	VERB	VBN	O
and	and	CCONJ	CC	O
extreme	extreme	ADJ	JJ	O
attention	attention	NOUN	NN	O
paid	pay	VERB	VBN	O
to	to	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
involvement	involvement	NOUN	NN	O
.	.	PUNCT	.	O

Nimodipine	nimodipine	NOUN	NN	B-Chemical
prevents	prevent	VERB	VBZ	O
memory	memory	NOUN	NN	B-Disease
impairment	impairment	NOUN	NN	I-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
nitroglycerin	nitroglycerin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
a	a	DET	DT	O
resultant	resultant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
cerebral	cerebral	ADJ	JJ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
cognitive	cognitive	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
tested	test	VERB	VBD	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
that	that	ADP	IN	O
nimodipine	nimodipine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
NIMO	NIMO	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
administered	administer	VERB	VBD	O
at	at	ADP	IN	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
nitroglycerin	nitroglycerin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
NTG	NTG	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
would	would	VERB	MD	O
preserve	preserve	VERB	VB	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
associative	associative	ADJ	JJ	O
memory	memory	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
passive	passive	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PA	PA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
paradigm	paradigm	NOUN	NN	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
memory	memory	NOUN	NN	O
retention	retention	NOUN	NN	O
.	.	PUNCT	.	O

For	for	ADP	IN	O
PA	PA	PROPN	NNP	O
training	training	NOUN	NN	O
,	,	PUNCT	,	O
latencies	latency	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
seconds	second	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
recorded	record	VERB	VBN	O
for	for	ADP	IN	O
entry	entry	NOUN	NN	O
from	from	ADP	IN	O
a	a	DET	DT	O
suspended	suspend	VERB	VBN	O
platform	platform	NOUN	NN	O
into	into	ADP	IN	O
a	a	DET	DT	O
Plexiglas	Plexiglas	PROPN	NNP	O
tube	tube	NOUN	NN	O
where	where	ADV	WRB	O
a	a	DET	DT	O
shock	shock	NOUN	NN	O
was	be	VERB	VBD	O
automatically	automatically	ADV	RB	O
delivered	deliver	VERB	VBN	O
.	.	PUNCT	.	O

Latencies	latency	NOUN	NNS	O
were	be	VERB	VBD	O
recorded	record	VERB	VBN	O
48	48	NUM	CD	O
h	h	NOUN	NN	O
later	later	ADV	RB	O
for	for	ADP	IN	O
a	a	DET	DT	O
testing	testing	NOUN	NN	O
trial	trial	NOUN	NN	O
.	.	PUNCT	.	O

Ninety	ninety	NUM	CD	O
-	-	PUNCT	HYPH	O
six	six	NUM	CD	O
Swiss	Swiss	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Webster	Webster	PROPN	NNP	O
mice	mouse	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
-	-	SYM	SYM	O
35	35	NUM	CD	O
g	g	NOUN	NN	O
,	,	PUNCT	,	O
6	6	NUM	CD	O
-	-	SYM	SYM	O
8	8	NUM	CD	O
wk	wk	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
randomized	randomize	VERB	VBN	O
into	into	ADP	IN	O
6	6	NUM	CD	O
groups	group	NOUN	NNS	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
saline	saline	NOUN	NN	O
(	(	PUNCT	-LRB-	O
control	control	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
NTG	NTG	PROPN	NNP	B-Chemical
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
learning	learn	VERB	VBG	O
,	,	PUNCT	,	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
NTG	NTG	PROPN	NNP	B-Chemical
3	3	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
learning	learn	VERB	VBG	O
,	,	PUNCT	,	O
4	4	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
NTG	NTG	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
NIMO	NIMO	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
5	5	NUM	CD	O
)	)	PUNCT	-RRB-	O
vehicle	vehicle	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
6	6	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
NIMO	nimo	ADV	RB	B-Chemical
alone	alone	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
extent	extent	NOUN	NN	O
of	of	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
brain	brain	NOUN	NN	O
tissue	tissue	NOUN	NN	O
oxygenation	oxygenation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PbtO	PbtO	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
cerebral	cerebral	ADJ	JJ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
separate	separate	ADJ	JJ	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
All	all	DET	DT	O
groups	group	NOUN	NNS	O
exhibited	exhibit	VERB	VBD	O
similar	similar	ADJ	JJ	O
training	training	NOUN	NN	O
latencies	latency	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
17	17	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
s	s	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Mice	mouse	NOUN	NNS	O
subjected	subject	VERB	VBN	O
to	to	ADP	IN	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
episodes	episode	NOUN	NNS	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
latency	latency	NOUN	NN	O
time	time	NOUN	NN	O
(	(	PUNCT	-LRB-	O
178	178	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
156	156	NUM	CD	O
s	s	NOUN	NN	O
)	)	PUNCT	-RRB-	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
those	those	DET	DT	O
injected	inject	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
,	,	PUNCT	,	O
NTG	NTG	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
NIMO	nimo	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
delayed	delay	VERB	VBN	O
NTG	NTG	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
580	580	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
81	81	NUM	CD	O
s	s	NOUN	NN	O
,	,	PUNCT	,	O
557	557	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
67	67	NUM	CD	O
s	s	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
493	493	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
146	146	NUM	CD	O
s	s	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
Kruskal	Kruskal	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Wallis	Wallis	PROPN	NNP	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
way	way	NOUN	NN	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
variance	variance	NOUN	NN	O
indicated	indicate	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
difference	difference	NOUN	NN	O
among	among	ADP	IN	O
the	the	DET	DT	O
4	4	NUM	CD	O
treatment	treatment	NOUN	NN	O
groups	group	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
H	h	NOUN	NN	O
=	=	SYM	SYM	O
15	15	NUM	CD	O
.	.	PUNCT	.	O
34	34	NUM	CD	O
;	;	PUNCT	:	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
a	a	DET	DT	O
separate	separate	ADJ	JJ	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
mice	mouse	NOUN	NNS	O
not	not	ADV	RB	O
subjected	subject	VERB	VBN	O
to	to	ADP	IN	O
behavioral	behavioral	ADJ	JJ	O
studies	study	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
NTG	NTG	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
3	3	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
NTG	NTG	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
NIMO	NIMO	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
caused	cause	VERB	VBD	O
mean	mean	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
to	to	PART	TO	O
decrease	decrease	VERB	VB	O
from	from	ADP	IN	O
85	85	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
mm	mm	NOUN	NN	O
Hg	Hg	PROPN	NNP	O
sem	sem	ADJ	JJ	O
to	to	ADP	IN	O
31	31	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
mm	mm	NOUN	NN	O
Hg	Hg	PROPN	NNP	O
sem	sem	NOUN	NN	O
and	and	CCONJ	CC	O
from	from	ADP	IN	O
86	86	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
sem	sem	NOUN	NN	O
to	to	ADP	IN	O
32	32	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
sem	sem	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Mean	mean	VERB	VB	O
arterial	arterial	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
NIMO	NIMO	PROPN	NNP	B-Chemical
alone	alone	ADV	RB	O
decreased	decrease	VERB	VBD	O
from	from	ADP	IN	O
88	88	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
mm	mm	NOUN	NN	O
Hg	Hg	PROPN	NNP	O
to	to	ADP	IN	O
80	80	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
intergroup	intergroup	NOUN	NN	O
difference	difference	NOUN	NN	O
was	be	VERB	VBD	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

PbtO	PbtO	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
decreased	decrease	VERB	VBD	O
from	from	ADP	IN	O
51	51	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
sem	sem	ADJ	JJ	O
to	to	ADP	IN	O
33	33	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
sem	sem	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
NTG	NTG	PROPN	NNP	B-Chemical
group	group	NOUN	NN	O
and	and	CCONJ	CC	O
from	from	ADP	IN	O
38	38	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
sem	sem	ADJ	JJ	O
to	to	ADP	IN	O
25	25	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
sem	sem	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
NTG	NTG	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
NIMO	nimo	ADJ	JJ	B-Chemical
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
among	among	ADP	IN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
a	a	DET	DT	O
PA	PA	PROPN	NNP	O
retention	retention	NOUN	NN	O
paradigm	paradigm	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
NTG	NTG	PROPN	NNP	B-Chemical
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
learning	learn	VERB	VBG	O
produced	produce	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
impairment	impairment	NOUN	NN	O
of	of	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
associative	associative	ADJ	JJ	O
memory	memory	NOUN	NN	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
delayed	delay	VERB	VBN	O
induced	induced	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

NIMO	NIMO	PROPN	NNP	B-Chemical
attenuated	attenuate	VERB	VBD	O
the	the	DET	DT	O
disruption	disruption	NOUN	NN	O
in	in	ADP	IN	O
consolidation	consolidation	NOUN	NN	O
of	of	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
memory	memory	NOUN	NN	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
NTG	NTG	PROPN	NNP	B-Chemical
but	but	CCONJ	CC	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
improve	improve	VERB	VB	O
latency	latency	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
observed	observed	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
NIMO	NIMO	PROPN	NNP	B-Chemical
may	may	VERB	MD	O
have	have	VERB	VB	O
been	be	VERB	VBN	O
attributable	attributable	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
preservation	preservation	NOUN	NN	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
homeostasis	homeostasis	NOUN	NN	O
during	during	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
because	because	ADP	IN	O
there	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
PbtO	PbtO	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
indices	index	NOUN	NNS	O
among	among	ADP	IN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Metabotropic	Metabotropic	PROPN	NNP	O
glutamate	glutamate	VERB	VBP	B-Chemical
7	7	NUM	CD	O
receptor	receptor	NOUN	NN	O
subtype	subtype	NOUN	NN	O
modulates	modulate	NOUN	NNS	O
motor	motor	NOUN	NN	O
symptoms	symptom	NOUN	NNS	O
in	in	ADP	IN	O
rodent	rodent	ADJ	JJ	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Metabotropic	Metabotropic	PROPN	NNP	O
glutamate	glutamate	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
mGlu	mGlu	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
receptors	receptor	NOUN	NNS	O
modulate	modulate	VERB	VBP	O
synaptic	synaptic	ADJ	JJ	O
transmission	transmission	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
central	central	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
and	and	CCONJ	CC	O
represent	represent	VERB	VB	O
promising	promising	ADJ	JJ	O
therapeutic	therapeutic	ADJ	JJ	O
targets	target	NOUN	NNS	O
for	for	ADP	IN	O
symptomatic	symptomatic	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
PD	PD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Among	among	ADP	IN	O
the	the	DET	DT	O
eight	eight	NUM	CD	O
mGlu	mGlu	PROPN	NNP	O
receptor	receptor	NOUN	NN	O
subtypes	subtype	NOUN	NNS	O
,	,	PUNCT	,	O
mGlu7	mglu7	DET	DT	O
receptor	receptor	NOUN	NN	O
is	be	VERB	VBZ	O
prominently	prominently	ADV	RB	O
expressed	express	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
basal	basal	NOUN	NN	O
ganglia	ganglion	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
restoring	restore	VERB	VBG	O
motor	motor	NOUN	NN	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
animal	animal	NOUN	NN	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
PD	PD	PROPN	NNP	B-Disease
is	be	VERB	VBZ	O
not	not	ADV	RB	O
known	know	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
N	n	NOUN	NN	B-Chemical
,	,	PUNCT	,	I-Chemical
N	N	PROPN	NNP	I-Chemical
'	'	PART	POS	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dibenzhydrylethane	dibenzhydrylethane	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
1	1	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
diamine	diamine	NOUN	NN	I-Chemical
dihydrochloride	dihydrochloride	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
AMN082	AMN082	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
selective	selective	ADJ	JJ	O
allosteric	allosteric	ADJ	JJ	O
activator	activator	NOUN	NN	O
of	of	ADP	IN	O
mGlu7	mglu7	NUM	CD	O
receptors	receptor	NOUN	NNS	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
thus	thus	ADV	RB	O
tested	test	VERB	VBN	O
in	in	ADP	IN	O
different	different	ADJ	JJ	O
rodent	rodent	ADJ	JJ	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
PD	PD	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Here	here	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
oral	oral	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
intrastriatal	intrastriatal	ADJ	JJ	O
administration	administration	NOUN	NN	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
nmol	nmol	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
AMN082	AMN082	PROPN	NNP	B-Chemical
reverses	reverse	VERB	VBZ	O
haloperidol	haloperidol	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

AMN082	AMN082	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
and	and	CCONJ	CC	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
reduces	reduce	VERB	VBZ	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
rotations	rotation	NOUN	NNS	O
in	in	ADP	IN	O
unilateral	unilateral	ADJ	JJ	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxydopamine	hydroxydopamine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
OHDA	ohda	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
lesioned	lesione	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
a	a	DET	DT	O
more	more	ADV	RBR	O
complex	complex	ADJ	JJ	O
task	task	NOUN	NN	O
commonly	commonly	ADV	RB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
major	major	ADJ	JJ	O
akinetic	akinetic	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
PD	pd	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
AMN082	AMN082	PROPN	NNP	B-Chemical
reverses	reverse	VERB	VBZ	O
the	the	DET	DT	O
increased	increase	VERB	VBN	O
reaction	reaction	NOUN	NN	O
time	time	NOUN	NN	O
to	to	PART	TO	O
respond	respond	VERB	VB	O
to	to	ADP	IN	O
a	a	DET	DT	O
cue	cue	NOUN	NN	O
of	of	ADP	IN	O
bilateral	bilateral	ADJ	JJ	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
OHDA	ohda	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
lesioned	lesione	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
AMN082	AMN082	PROPN	NNP	B-Chemical
reduces	reduce	VERB	VBZ	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
mGlu7	mglu7	NUM	CD	O
receptor	receptor	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
manner	manner	NOUN	NN	O
in	in	ADP	IN	O
wild	wild	ADJ	JJ	O
-	-	PUNCT	HYPH	O
type	type	NOUN	NN	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
mGlu7	mglu7	DET	DT	O
receptor	receptor	NOUN	NN	O
knockout	knockout	NOUN	NN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Higher	high	ADJ	JJR	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
AMN082	AMN082	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
and	and	CCONJ	CC	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
p	p	NOUN	NN	O
.	.	PUNCT	.	O
o	o	X	XX	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
have	have	VERB	VBP	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
PD	PD	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Overall	overall	ADV	RB	O
these	these	DET	DT	O
findings	finding	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
mGlu7	mglu7	NUM	CD	O
receptor	receptor	NOUN	NN	O
activation	activation	NOUN	NN	O
can	can	VERB	MD	O
reverse	reverse	VERB	VB	O
motor	motor	NOUN	NN	O
dysfunction	dysfunction	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
reduced	reduced	ADJ	JJ	O
dopamine	dopamine	NOUN	NN	B-Chemical
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Selective	selective	ADJ	JJ	O
ligands	ligand	NOUN	NNS	O
of	of	ADP	IN	O
mGlu7	mglu7	NUM	CD	O
receptor	receptor	NOUN	NN	O
subtypes	subtype	NOUN	NNS	O
may	may	VERB	MD	O
thus	thus	ADV	RB	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
as	as	ADP	IN	O
promising	promising	ADJ	JJ	O
compounds	compound	NOUN	NNS	O
for	for	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
antiparkinsonian	antiparkinsonian	ADJ	JJ	O
therapeutic	therapeutic	ADJ	JJ	O
strategies	strategy	NOUN	NNS	O
.	.	PUNCT	.	O

Sorafenib	Sorafenib	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
acute	acute	ADJ	JJ	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
spasm	spasm	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
65	65	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
with	with	ADP	IN	O
advanced	advanced	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
cell	cell	NOUN	NN	I-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
was	be	VERB	VBD	O
admitted	admit	VERB	VBN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
continuing	continue	VERB	VBG	O
chest	chest	NOUN	NN	B-Disease
pain	pain	NOUN	NN	I-Disease
at	at	ADP	IN	O
rest	rest	NOUN	NN	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
weeks	week	NOUN	NNS	O
before	before	ADP	IN	O
his	-PRON-	DET	PRP$	O
admission	admission	NOUN	NN	O
,	,	PUNCT	,	O
sorafenib	sorafenib	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
been	be	VERB	VBN	O
started	start	VERB	VBN	O
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
diagnosed	diagnose	VERB	VBN	O
with	with	ADP	IN	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
ST	st	ADJ	JJ	O
-	-	PUNCT	HYPH	O
elevation	elevation	NOUN	NN	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
by	by	ADP	IN	O
laboratory	laboratory	NOUN	NN	O
data	datum	NOUN	NNS	O
and	and	CCONJ	CC	O
electrocardiogram	electrocardiogram	NOUN	NN	O
.	.	PUNCT	.	O

Enhanced	enhanced	ADJ	JJ	O
heart	heart	NOUN	NN	O
magnetic	magnetic	ADJ	JJ	O
resonance	resonance	NOUN	NN	O
imaging	imaging	NOUN	NN	O
also	also	ADV	RB	O
showed	show	VERB	VBD	O
subendocardial	subendocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
stenosis	stenosis	NOUN	NN	O
in	in	ADP	IN	O
coronary	coronary	ADJ	JJ	O
arteries	artery	NOUN	NNS	O
on	on	ADP	IN	O
angiography	angiography	NOUN	NN	O
.	.	PUNCT	.	O

Coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
spasm	spasm	NOUN	NN	I-Disease
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
provocative	provocative	ADJ	JJ	O
test	test	NOUN	NN	O
.	.	PUNCT	.	O

Cessation	cessation	NOUN	NN	O
of	of	ADP	IN	O
sorafenib	sorafenib	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
Ca	ca	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
channel	channel	NOUN	NN	O
blocker	blocker	NOUN	NN	O
and	and	CCONJ	CC	O
nitrates	nitrate	NOUN	NNS	B-Chemical
ameliorated	ameliorate	VERB	VBD	O
his	-PRON-	DET	PRP$	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
relapse	relapse	NOUN	NN	O
occurred	occur	VERB	VBD	O
after	after	ADP	IN	O
resumption	resumption	NOUN	NN	O
of	of	ADP	IN	O
sorafenib	sorafenib	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Addition	addition	NOUN	NN	O
of	of	ADP	IN	O
oral	oral	ADJ	JJ	O
nicorandil	nicorandil	NOUN	NNS	B-Chemical
reduced	reduce	VERB	VBD	O
his	-PRON-	DET	PRP$	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
maintained	maintain	VERB	VBD	O
stable	stable	ADJ	JJ	B-Disease
angina	angina	NOUN	NN	I-Disease
status	status	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
sorafenib	sorafenib	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
spasm	spasm	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Sorafenib	Sorafenib	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
multikinase	multikinase	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
that	that	DET	WDT	O
targets	target	VERB	VBZ	O
signaling	signal	VERB	VBG	O
pathways	pathway	NOUN	NNS	O
necessary	necessary	ADJ	JJ	O
for	for	ADP	IN	O
cellular	cellular	ADJ	JJ	O
proliferation	proliferation	NOUN	NN	O
and	and	CCONJ	CC	O
survival	survival	NOUN	NN	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
hand	hand	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
Rho	Rho	PROPN	NNP	O
/	/	SYM	SYM	O
ROCK	ROCK	PROPN	NNP	O
pathway	pathway	NOUN	NN	O
has	have	VERB	VBZ	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pathogenesis	pathogenesis	NOUN	NN	O
of	of	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
spasm	spasm	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
report	report	NOUN	NN	O
may	may	VERB	MD	O
show	show	VERB	VB	O
an	an	DET	DT	O
adverse	adverse	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
Rho	Rho	PROPN	NNP	O
/	/	SYM	SYM	O
ROCK	ROCK	PROPN	NNP	O
pathway	pathway	NOUN	NN	O
by	by	ADP	IN	O
sorafenib	sorafenib	ADJ	JJ	B-Chemical
use	use	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
novel	novel	ADJ	JJ	O
animal	animal	NOUN	NN	O
model	model	NOUN	NN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
ability	ability	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
drug	drug	NOUN	NN	O
delivery	delivery	NOUN	NN	O
system	system	NOUN	NN	O
to	to	PART	TO	O
promote	promote	VERB	VB	O
the	the	DET	DT	O
passage	passage	NOUN	NN	O
through	through	ADP	IN	O
the	the	DET	DT	O
BBB	BBB	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
purpose	purpose	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
investigation	investigation	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
explore	explore	VERB	VB	O
the	the	DET	DT	O
potentiality	potentiality	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
novel	novel	ADJ	JJ	O
animal	animal	NOUN	NN	O
model	model	NOUN	NN	O
to	to	PART	TO	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ability	ability	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
drug	drug	NOUN	NN	O
delivery	delivery	NOUN	NN	O
system	system	NOUN	NN	O
to	to	PART	TO	O
promote	promote	VERB	VB	O
the	the	DET	DT	O
passage	passage	NOUN	NN	O
through	through	ADP	IN	O
the	the	DET	DT	O
blood	blood	NOUN	NN	O
-	-	PUNCT	HYPH	O
brain	brain	NOUN	NN	O
barrier	barrier	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BBB	BBB	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
to	to	PART	TO	O
improve	improve	VERB	VB	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
localization	localization	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
bioactive	bioactive	ADJ	JJ	O
compound	compound	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
Tween	Tween	PROPN	NNP	O
80	80	NUM	CD	O
-	-	PUNCT	HYPH	O
coated	coat	VERB	VBN	O
poly	poly	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
L	l	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
lactid	lactid	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
nanoparticles	nanoparticle	NOUN	NNS	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
colloidal	colloidal	ADJ	JJ	O
drug	drug	NOUN	NN	O
delivery	delivery	NOUN	NN	O
system	system	NOUN	NN	O
,	,	PUNCT	,	O
able	able	ADJ	JJ	O
to	to	PART	TO	O
trespass	trespass	VERB	VB	O
the	the	DET	DT	O
BBB	BBB	PROPN	NNP	O
.	.	PUNCT	.	O

Tacrine	Tacrine	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
administered	administer	VERB	VBN	O
in	in	ADP	IN	O
LiCl	LiCl	PROPN	NNP	B-Chemical
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
treated	treated	ADJ	JJ	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
induces	induce	VERB	VBZ	O
electrocorticographic	electrocorticographic	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
delayed	delay	VERB	VBD	O
hippocampal	hippocampal	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
toxic	toxic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
tacrine	tacrine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
loaded	load	VERB	VBN	O
poly	poly	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
L	l	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
lactid	lactid	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
nanoparticles	nanoparticle	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
5mg	5mg	PROPN	NNP	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
saline	saline	NOUN	NN	O
solution	solution	NOUN	NN	O
of	of	ADP	IN	O
tacrine	tacrine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5mg	5mg	PROPN	NNP	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
an	an	DET	DT	O
empty	empty	ADJ	JJ	O
colloidal	colloidal	ADJ	JJ	O
nanoparticle	nanoparticle	NOUN	NN	O
suspension	suspension	NOUN	NN	O
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
following	follow	VERB	VBG	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
administration	administration	NOUN	NN	O
in	in	ADP	IN	O
LiCl	LiCl	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
pre	pre	PROPN	NNP	O
-	-	ADJ	JJ	O
treated	treated	ADJ	JJ	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

All	all	DET	PDT	O
the	the	DET	DT	O
animals	animal	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
tacrine	tacrine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
loaded	load	VERB	VBN	O
nanoparticles	nanoparticle	NOUN	NNS	O
showed	show	VERB	VBD	O
an	an	DET	DT	O
earlier	early	ADJ	JJR	O
outcome	outcome	NOUN	NN	O
of	of	ADP	IN	O
CNS	CNS	PROPN	NNP	O
adverse	adverse	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
e	e	PUNCT	LS	O
.	.	PUNCT	.	O
epileptic	epileptic	ADJ	JJ	B-Disease
onset	onset	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
respect	respect	NOUN	NN	O
to	to	ADP	IN	O
those	those	DET	DT	O
animals	animal	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
free	free	ADJ	JJ	O
compound	compound	NOUN	NN	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
min	min	NOUN	NN	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
22	22	NUM	CD	O
min	min	NOUN	NN	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
tacrine	tacrine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
loaded	load	VERB	VBN	O
nanoparticles	nanoparticle	NOUN	NNS	O
administration	administration	NOUN	NN	O
induced	induce	VERB	VBD	O
damage	damage	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
neuronal	neuronal	ADJ	JJ	I-Disease
cells	cell	NOUN	NNS	I-Disease
in	in	ADP	IN	O
CA1	CA1	NOUN	NNS	O
field	field	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hippocampus	hippocampus	NOUN	NN	O
in	in	ADP	IN	O
all	all	DET	DT	O
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
the	the	DET	DT	O
saline	saline	NOUN	NN	O
solution	solution	NOUN	NN	O
of	of	ADP	IN	O
tacrine	tacrine	NOUN	NN	B-Chemical
only	only	ADV	RB	O
in	in	ADP	IN	O
60	60	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

Empty	empty	ADJ	JJ	O
nanoparticles	nanoparticle	NOUN	NNS	O
provided	provide	VERB	VBD	O
similar	similar	ADJ	JJ	O
results	result	NOUN	NNS	O
to	to	PART	TO	O
control	control	VERB	VB	O
(	(	PUNCT	-LRB-	O
saline	saline	NOUN	NN	O
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
)	)	PUNCT	-RRB-	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
time	time	NOUN	NN	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
neurodegenerative	neurodegenerative	ADJ	JJ	O
processes	process	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
tacrine	tacrine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
lithium	lithium	NOUN	NN	B-Chemical
model	model	NOUN	NN	O
of	of	ADP	IN	O
epilepsy	epilepsy	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
,	,	PUNCT	,	O
could	could	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
preliminarily	preliminarily	ADV	RB	O
the	the	DET	DT	O
capability	capability	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
drug	drug	NOUN	NN	O
delivery	delivery	NOUN	NN	O
system	system	NOUN	NN	O
to	to	ADP	IN	O
trespass	trespass	NOUN	NN	O
(	(	PUNCT	-LRB-	O
or	or	CCONJ	CC	O
not	not	ADV	RB	O
)	)	PUNCT	-RRB-	O
the	the	DET	DT	O
BBB	BBB	PROPN	NNP	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
.	.	PUNCT	.	O

High	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
tranexamic	tranexamic	NOUN	NN	B-Chemical
Acid	Acid	PROPN	NNP	I-Chemical
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
nonischemic	nonischemic	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
in	in	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
surgical	surgical	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
2	2	NUM	CD	O
separate	separate	ADJ	JJ	O
centers	center	NOUN	NNS	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
observed	observe	VERB	VBD	O
a	a	DET	DT	O
notable	notable	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
postoperative	postoperative	ADJ	JJ	O
convulsive	convulsive	ADJ	JJ	B-Disease
seizures	seizure	NOUN	NNS	B-Disease
from	from	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
to	to	ADP	IN	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
having	have	VERB	VBG	O
undergone	undergo	VERB	VBN	O
major	major	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
surgical	surgical	ADJ	JJ	O
procedures	procedure	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
events	event	NOUN	NNS	O
were	be	VERB	VBD	O
temporally	temporally	ADV	RB	O
coincident	coincident	ADJ	JJ	O
with	with	ADP	IN	O
the	the	DET	DT	O
initial	initial	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
tranexamic	tranexamic	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
TXA	TXA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
therapy	therapy	NOUN	NN	O
after	after	ADP	IN	O
withdrawal	withdrawal	NOUN	NN	O
of	of	ADP	IN	O
aprotinin	aprotinin	NOUN	NN	O
from	from	ADP	IN	O
general	general	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
usage	usage	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
purpose	purpose	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
review	review	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
perform	perform	VERB	VB	O
a	a	DET	DT	O
retrospective	retrospective	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
to	to	PART	TO	O
examine	examine	VERB	VB	O
whether	whether	ADP	IN	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
relation	relation	NOUN	NN	O
between	between	ADP	IN	O
TXA	txa	NOUN	NN	B-Chemical
usage	usage	NOUN	NN	O
and	and	CCONJ	CC	O
seizures	seizure	NOUN	NNS	B-Disease
after	after	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
An	an	DET	DT	O
in	in	ADP	IN	O
-	-	PUNCT	HYPH	O
depth	depth	NOUN	NN	O
chart	chart	NOUN	NN	O
review	review	NOUN	NN	O
was	be	VERB	VBD	O
undertaken	undertake	VERB	VBN	O
in	in	ADP	IN	O
all	all	DET	DT	O
24	24	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
perioperative	perioperative	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Electroencephalographic	electroencephalographic	ADJ	JJ	O
activity	activity	NOUN	NN	O
was	be	VERB	VBD	O
recorded	record	VERB	VBN	O
in	in	ADP	IN	O
11	11	NUM	CD	O
of	of	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
a	a	DET	DT	O
formal	formal	ADJ	JJ	O
neurological	neurological	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
and	and	CCONJ	CC	O
brain	brain	NOUN	NN	O
imaging	imaging	NOUN	NN	O
studies	study	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
24	24	NUM	CD	O
patients	patient	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
have	have	VERB	VB	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
new	new	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	B-Disease
ischemic	ischemic	ADJ	JJ	I-Disease
injury	injury	NOUN	NN	I-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
seizures	seizure	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
likely	likely	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
ischemic	ischemic	ADJ	JJ	B-Disease
brain	brain	NOUN	NN	I-Disease
injury	injury	NOUN	NN	I-Disease
in	in	ADP	IN	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
did	do	VERB	VBD	O
not	not	ADV	RB	O
have	have	VERB	VB	O
permanent	permanent	ADJ	JJ	O
neurological	neurological	ADJ	JJ	B-Disease
abnormalities	abnormality	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

All	all	DET	DT	O
24	24	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
received	receive	VERB	VBD	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
TXA	TXA	PROPN	NNP	B-Chemical
intraoperatively	intraoperatively	ADV	RB	O
ranging	range	VERB	VBG	O
from	from	ADP	IN	O
61	61	NUM	CD	O
to	to	ADP	IN	O
259	259	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
had	have	VERB	VBD	O
a	a	DET	DT	O
mean	mean	ADJ	JJ	O
age	age	NOUN	NN	O
of	of	ADP	IN	O
69	69	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
21	21	NUM	CD	O
of	of	ADP	IN	O
24	24	NUM	CD	O
had	have	VERB	VBD	O
undergone	undergo	VERB	VBN	O
open	open	ADJ	JJ	O
chamber	chamber	NOUN	NN	O
rather	rather	ADV	RB	O
than	than	ADP	IN	O
coronary	coronary	ADJ	JJ	O
bypass	bypass	NOUN	NN	O
procedures	procedure	NOUN	NNS	O
.	.	PUNCT	.	O

All	all	DET	DT	O
but	but	ADP	IN	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
were	be	VERB	VBD	O
managed	manage	VERB	VBN	O
using	use	VERB	VBG	O
cardiopulmonary	cardiopulmonary	ADJ	JJ	O
bypass	bypass	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
brain	brain	NOUN	NN	B-Disease
ischemic	ischemic	ADJ	JJ	I-Disease
,	,	PUNCT	,	O
metabolic	metabolic	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
hyperthermia	hyperthermia	ADV	RB	B-Disease
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
causes	cause	NOUN	NNS	O
for	for	ADP	IN	O
their	-PRON-	DET	PRP$	O
seizures	seizure	NOUN	NNS	B-Disease
was	be	VERB	VBD	O
apparent	apparent	ADJ	JJ	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
TXA	txa	NOUN	NN	B-Chemical
in	in	ADP	IN	O
older	old	ADJ	JJR	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
conjunction	conjunction	NOUN	NN	O
with	with	ADP	IN	O
cardiopulmonary	cardiopulmonary	ADJ	JJ	O
bypass	bypass	NOUN	NN	O
and	and	CCONJ	CC	O
open	open	ADJ	JJ	O
-	-	PUNCT	HYPH	O
chamber	chamber	NOUN	NN	O
cardiac	cardiac	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
clinical	clinical	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
in	in	ADP	IN	O
susceptible	susceptible	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Electrocardiographic	electrocardiographic	ADJ	JJ	O
changes	change	NOUN	NNS	O
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
psychotropic	psychotropic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

Eight	eight	NUM	CD	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
cardiac	cardiac	ADJ	JJ	O
manifestations	manifestation	NOUN	NNS	O
that	that	DET	WDT	O
were	be	VERB	VBD	O
life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
threatening	threaten	VERB	VBG	O
in	in	ADP	IN	O
five	five	NUM	CD	O
while	while	ADP	IN	O
taking	take	VERB	VBG	O
psychotropic	psychotropic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
,	,	PUNCT	,	O
either	either	CCONJ	CC	O
phenothiazines	phenothiazine	NOUN	NNS	B-Chemical
or	or	CCONJ	CC	O
tricyclic	tricyclic	ADJ	JJ	O
antidepressants	antidepressant	NOUN	NNS	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
most	most	ADJ	JJS	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
receiving	receive	VERB	VBG	O
several	several	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
,	,	PUNCT	,	O
Mellaril	Mellaril	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
thioridazine	thioridazine	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
appeared	appear	VERB	VBD	O
to	to	PART	TO	O
be	be	VERB	VB	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
five	five	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
one	one	NUM	CD	O
of	of	ADP	IN	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
fatal	fatal	ADJ	JJ	O
in	in	ADP	IN	O
a	a	DET	DT	O
35	35	NUM	CD	O
year	year	NOUN	NN	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
.	.	PUNCT	.	O

Supraventricular	supraventricular	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
developed	develop	VERB	VBD	O
in	in	ADP	IN	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
receiving	receive	VERB	VBG	O
Thorazine	Thorazine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
chlorpromazine	chlorpromazine	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Aventyl	Aventyl	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
nortriptyline	nortriptyline	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
Elavil	Elavil	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
amitriptyline	amitriptyline	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
each	each	DET	DT	O
produced	produce	VERB	VBD	O
left	leave	VERB	VBD	B-Disease
bundle	bundle	NOUN	NN	I-Disease
branch	branch	NOUN	NN	I-Disease
block	block	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
73	73	NUM	CD	O
year	year	NOUN	NN	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
.	.	PUNCT	.	O

Electrocardiographic	Electrocardiographic	PROPN	NNP	O
T	T	PROPN	NNP	O
and	and	CCONJ	CC	O
U	u	NOUN	NN	O
wave	wave	NOUN	NN	O
abnormalities	abnormality	NOUN	NNS	O
were	be	VERB	VBD	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
most	most	ADJ	JJS	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
responded	respond	VERB	VBD	O
to	to	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
to	to	PART	TO	O
direct	direct	VERB	VB	O
current	current	ADJ	JJ	O
electric	electric	ADJ	JJ	O
shock	shock	NOUN	NN	O
;	;	PUNCT	:	O
ventricular	ventricular	ADJ	JJ	O
pacing	pacing	NOUN	NN	O
was	be	VERB	VBD	O
required	require	VERB	VBN	O
in	in	ADP	IN	O
some	some	DET	DT	O
instances	instance	NOUN	NNS	O
and	and	CCONJ	CC	O
intravenous	intravenous	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
propranolol	propranolol	NOUN	NN	B-Chemical
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
ventricular	ventricular	ADJ	JJ	O
pacing	pacing	NOUN	NN	O
in	in	ADP	IN	O
one	one	NUM	CD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
tachyarrhythmias	tachyarrhythmia	NOUN	NNS	B-Disease
generally	generally	ADV	RB	O
subsided	subside	VERB	VBD	O
within	within	ADP	IN	O
48	48	NUM	CD	O
hours	hour	NOUN	NNS	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
drugs	drug	NOUN	NNS	O
was	be	VERB	VBD	O
stopped	stop	VERB	VBN	O
.	.	PUNCT	.	O

Five	five	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
eight	eight	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
50	50	NUM	CD	O
years	year	NOUN	NNS	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
or	or	CCONJ	CC	O
younger	young	ADJ	JJR	O
;	;	PUNCT	:	O
only	only	ADV	RB	O
one	one	NUM	CD	O
clearly	clearly	ADV	RB	O
had	have	VERB	VBD	O
antecedent	antecedent	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Major	major	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
are	be	VERB	VBP	O
a	a	DET	DT	O
potential	potential	ADJ	JJ	O
hazard	hazard	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
without	without	ADP	IN	O
heart	heart	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
who	who	PRON	WP	O
are	be	VERB	VBP	O
receiving	receive	VERB	VBG	O
customary	customary	ADJ	JJ	O
therapeutic	therapeutic	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
psychotropic	psychotropic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
trial	trial	NOUN	NN	O
is	be	VERB	VBZ	O
suggested	suggest	VERB	VBN	O
to	to	PART	TO	O
quantify	quantify	VERB	VB	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	I-Disease
to	to	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
phenothiazines	phenothiazine	NOUN	NNS	B-Chemical
or	or	CCONJ	CC	O
tricyclic	tricyclic	ADJ	JJ	O
antidepressant	antidepressant	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

Sensitivity	sensitivity	NOUN	NN	O
of	of	ADP	IN	O
erythroid	erythroid	ADJ	JJ	O
progenitor	progenitor	NOUN	NN	O
colonies	colony	NOUN	NNS	O
to	to	ADP	IN	O
erythropoietin	erythropoietin	NOUN	NN	O
in	in	ADP	IN	O
azidothymidine	azidothymidine	ADJ	JJ	B-Chemical
treated	treated	ADJ	JJ	O
immunodeficient	immunodeficient	NOUN	NN	B-Disease
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
anaemia	anaemia	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
3	3	NUM	CD	B-Chemical
'	'	PART	POS	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
azido	azido	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
3	3	NUM	CD	I-Chemical
'	'	PART	POS	I-Chemical
dideoxythymidine	dideoxythymidine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
AZT	AZT	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
poorly	poorly	ADV	RB	O
understood	understand	VERB	VBN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
have	have	VERB	VBP	O
used	use	VERB	VBN	O
a	a	DET	DT	O
murine	murine	ADJ	JJ	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
AIDS	AIDS	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
infection	infection	NOUN	NN	B-Disease
of	of	ADP	IN	O
female	female	ADJ	JJ	O
C57BL	C57BL	PROPN	NNP	O
/	/	SYM	SYM	O
6	6	NUM	CD	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
LP	LP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
BM5	bm5	NOUN	NN	O
murine	murine	NOUN	NN	O
leukaemia	leukaemia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
MuLV	MuLV	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
virus	virus	NOUN	NN	O
,	,	PUNCT	,	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
if	if	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
anaemia	anaemia	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
due	due	ADJ	JJ	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
part	part	NOUN	NN	O
,	,	PUNCT	,	O
to	to	PART	TO	O
decreased	decrease	VERB	VBN	O
responsiveness	responsiveness	NOUN	NN	O
of	of	ADP	IN	O
erythropoietic	erythropoietic	ADJ	JJ	O
precursors	precursor	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
BFU	BFU	PROPN	NNP	O
-	-	PUNCT	HYPH	O
e	e	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
erythropoietin	erythropoietin	NOUN	NN	O
(	(	PUNCT	-LRB-	O
EPO	EPO	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Mice	mouse	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
early	early	ADJ	JJ	O
stage	stage	NOUN	NN	O
of	of	ADP	IN	O
LP	LP	PROPN	NNP	O
-	-	PUNCT	HYPH	O
BM5	BM5	PROPN	NNP	O
MuLV	MuLV	PROPN	NNP	O
disease	disease	NOUN	NN	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
AZT	AZT	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
their	-PRON-	DET	PRP$	O
drinking	drinking	NOUN	NN	O
water	water	NOUN	NN	O
at	at	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
.	.	PUNCT	.	O

AZT	AZT	PROPN	NNP	B-Chemical
produced	produce	VERB	VBD	O
anaemia	anaemia	NOUN	NN	B-Disease
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
fashion	fashion	NOUN	NN	O
.	.	PUNCT	.	O

Despite	despite	ADP	IN	O
the	the	DET	DT	O
anaemia	anaemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
splenic	splenic	ADJ	JJ	O
and	and	CCONJ	CC	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
BFU	BFU	PROPN	NNP	O
-	-	PUNCT	HYPH	O
e	e	PROPN	NNP	O
in	in	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
treated	treat	VERB	VBD	O
mice	mouse	NOUN	NNS	O
increased	increase	VERB	VBD	O
up	up	ADP	IN	O
to	to	PART	TO	O
five	five	NUM	CD	O
-	-	PUNCT	HYPH	O
fold	fold	VERB	VB	O
over	over	ADP	IN	O
levels	level	NOUN	NNS	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
infected	infected	ADJ	JJ	O
untreated	untreated	ADJ	JJ	O
animals	animal	NOUN	NNS	O
after	after	ADP	IN	O
15	15	NUM	CD	O
d	d	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Colony	colony	NOUN	NN	O
formation	formation	NOUN	NN	O
by	by	ADP	IN	O
splenic	splenic	ADJ	JJ	O
and	and	CCONJ	CC	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
BFUe	BFUe	NOUN	NNS	O
was	be	VERB	VBD	O
stimulated	stimulate	VERB	VBN	O
at	at	ADP	IN	O
lower	low	ADJ	JJR	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
EPO	EPO	PROPN	NNP	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
receiving	receive	VERB	VBG	O
AZT	AZT	PROPN	NNP	B-Chemical
for	for	ADP	IN	O
15	15	NUM	CD	O
d	d	NOUN	NN	O
than	than	ADP	IN	O
for	for	ADP	IN	O
infected	infect	VERB	VBN	O
,	,	PUNCT	,	O
untreated	untreated	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

By	by	ADP	IN	O
day	day	NOUN	NN	O
30	30	NUM	CD	O
,	,	PUNCT	,	O
sensitivity	sensitivity	NOUN	NN	O
of	of	ADP	IN	O
both	both	CCONJ	CC	O
splenic	splenic	ADJ	JJ	O
and	and	CCONJ	CC	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
BFU	BFU	PROPN	NNP	O
-	-	PUNCT	HYPH	O
e	e	PROPN	NNP	O
of	of	ADP	IN	O
treated	treated	ADJ	JJ	O
animals	animal	NOUN	NNS	O
returned	return	VERB	VBD	O
to	to	ADP	IN	O
that	that	DET	DT	O
observed	observe	VERB	VBD	O
from	from	ADP	IN	O
cells	cell	NOUN	NNS	O
of	of	ADP	IN	O
infected	infected	ADJ	JJ	O
untreated	untreated	ADJ	JJ	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
EPO	EPO	PROPN	NNP	O
observed	observe	VERB	VBD	O
in	in	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
treated	treat	VERB	VBD	O
mice	mouse	NOUN	NNS	O
were	be	VERB	VBD	O
appropriate	appropriate	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
anaemia	anaemia	NOUN	NN	B-Disease
observed	observe	VERB	VBN	O
when	when	ADV	WRB	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
phenylhydrazine	phenylhydrazine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
PHZ	PHZ	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
treated	treat	VERB	VBN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
numbers	number	NOUN	NNS	O
of	of	ADP	IN	O
BFU	BFU	PROPN	NNP	O
-	-	PUNCT	HYPH	O
e	e	PROPN	NNP	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
percentage	percentage	NOUN	NN	O
of	of	ADP	IN	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
erythroblasts	erythroblast	NOUN	NNS	O
observed	observe	VERB	VBN	O
were	be	VERB	VBD	O
comparable	comparable	ADJ	JJ	O
in	in	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
PHZ	PHZ	PROPN	NNP	B-Chemical
treated	treat	VERB	VBD	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
similar	similar	ADJ	JJ	O
degrees	degree	NOUN	NNS	O
of	of	ADP	IN	O
anaemia	anaemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
reticulocytosis	reticulocytosis	NOUN	NN	B-Disease
was	be	VERB	VBD	O
inappropriate	inappropriate	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
anaemia	anaemia	NOUN	NN	B-Disease
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
treated	treat	VERB	VBD	O
infected	infected	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

AZT	AZT	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
peripheral	peripheral	ADJ	JJ	O
anaemia	anaemia	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
face	face	NOUN	NN	O
of	of	ADP	IN	O
increased	increase	VERB	VBN	O
numbers	number	NOUN	NNS	O
of	of	ADP	IN	O
BFU	BFU	PROPN	NNP	O
-	-	PUNCT	HYPH	O
e	e	PROPN	NNP	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
EPO	EPO	PROPN	NNP	O
suggest	suggest	VERB	VBP	O
a	a	DET	DT	O
lesion	lesion	NOUN	NN	O
in	in	ADP	IN	O
terminal	terminal	ADJ	JJ	O
differentiation	differentiation	NOUN	NN	O
.	.	PUNCT	.	O

Sedation	sedation	NOUN	NN	O
depth	depth	NOUN	NN	O
during	during	ADP	IN	O
spinal	spinal	ADJ	JJ	O
anesthesia	anesthesia	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
postoperative	postoperative	ADJ	JJ	B-Disease
delirium	delirium	NOUN	NN	I-Disease
in	in	ADP	IN	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
hip	hip	NOUN	NN	B-Disease
fracture	fracture	NOUN	NN	I-Disease
repair	repair	NOUN	NN	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
determine	determine	VERB	VB	O
whether	whether	ADP	IN	O
limiting	limit	VERB	VBG	O
intraoperative	intraoperative	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
depth	depth	NOUN	NN	O
during	during	ADP	IN	O
spinal	spinal	ADJ	JJ	O
anesthesia	anesthesia	NOUN	NN	O
for	for	ADP	IN	O
hip	hip	NOUN	NN	B-Disease
fracture	fracture	NOUN	NN	I-Disease
repair	repair	NOUN	NN	O
in	in	ADP	IN	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
can	can	VERB	MD	O
decrease	decrease	VERB	VB	O
the	the	DET	DT	O
prevalence	prevalence	NOUN	NN	O
of	of	ADP	IN	O
postoperative	postoperative	ADJ	JJ	B-Disease
delirium	delirium	NOUN	NN	I-Disease
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
performed	perform	VERB	VBD	O
a	a	DET	DT	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomize	VERB	VBD	O
controlled	control	VERB	VBN	O
trial	trial	NOUN	NN	O
at	at	ADP	IN	O
an	an	DET	DT	O
academic	academic	ADJ	JJ	O
medical	medical	ADJ	JJ	O
center	center	NOUN	NN	O
of	of	ADP	IN	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
>	>	X	XX	O
or	or	CCONJ	CC	O
=	=	NOUN	NNS	O
65	65	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
without	without	ADP	IN	O
preoperative	preoperative	ADJ	JJ	O
delirium	delirium	NOUN	NN	B-Disease
or	or	CCONJ	CC	O
severe	severe	ADJ	JJ	O
dementia	dementia	NOUN	NN	B-Disease
who	who	PRON	WP	O
underwent	undergo	VERB	VBD	O
hip	hip	NOUN	NN	B-Disease
fracture	fracture	NOUN	NN	I-Disease
repair	repair	NOUN	NN	O
under	under	ADP	IN	O
spinal	spinal	ADJ	JJ	O
anesthesia	anesthesia	NOUN	NN	O
with	with	ADP	IN	O
propofol	propofol	ADJ	JJ	B-Chemical
sedation	sedation	NOUN	NN	O
.	.	PUNCT	.	O

Sedation	sedation	NOUN	NN	O
depth	depth	NOUN	NN	O
was	be	VERB	VBD	O
titrated	titrate	VERB	VBN	O
using	use	VERB	VBG	O
processed	process	VERB	VBN	O
electroencephalography	electroencephalography	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
bispectral	bispectral	ADJ	JJ	O
index	index	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BIS	BIS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
randomized	randomize	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
either	either	CCONJ	CC	O
deep	deep	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
BIS	BIS	PROPN	NNP	O
,	,	PUNCT	,	O
approximately	approximately	ADV	RB	O
50	50	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
light	light	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BIS	BIS	PROPN	NNP	O
,	,	PUNCT	,	O
>	>	X	XX	O
or	or	CCONJ	CC	O
=	=	SYM	SYM	O
80	80	NUM	CD	O
)	)	PUNCT	-RRB-	O
sedation	sedation	NOUN	NN	O
.	.	PUNCT	.	O

Postoperative	postoperative	ADJ	JJ	B-Disease
delirium	delirium	NOUN	NN	I-Disease
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
as	as	ADP	IN	O
defined	define	VERB	VBN	O
by	by	ADP	IN	O
Diagnostic	Diagnostic	PROPN	NNP	O
and	and	CCONJ	CC	O
Statistical	Statistical	PROPN	NNP	O
Manual	Manual	PROPN	NNP	O
of	of	ADP	IN	O
Mental	Mental	PROPN	NNP	B-Disease
Disorders	Disorders	PROPN	NNP	I-Disease
(	(	PUNCT	-LRB-	O
Third	Third	PROPN	NNP	O
Edition	Edition	PROPN	NNP	O
Revised	Revised	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
criteria	criterion	NOUN	NNS	O
using	use	VERB	VBG	O
the	the	DET	DT	O
Confusion	Confusion	PROPN	NNP	O
Assessment	Assessment	PROPN	NNP	O
Method	Method	PROPN	NNP	O
beginning	begin	VERB	VBG	O
at	at	ADP	IN	O
any	any	DET	DT	O
time	time	NOUN	NN	O
from	from	ADP	IN	O
the	the	DET	DT	O
second	second	ADJ	JJ	O
day	day	NOUN	NN	O
after	after	ADP	IN	O
surgery	surgery	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
From	from	ADP	IN	O
April	April	PROPN	NNP	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
2005	2005	NUM	CD	O
,	,	PUNCT	,	O
through	through	ADP	IN	O
October	October	PROPN	NNP	O
30	30	NUM	CD	O
,	,	PUNCT	,	O
2008	2008	NUM	CD	O
,	,	PUNCT	,	O
a	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
114	114	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
randomized	randomize	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
prevalence	prevalence	NOUN	NN	O
of	of	ADP	IN	O
postoperative	postoperative	ADJ	JJ	B-Disease
delirium	delirium	NOUN	NN	I-Disease
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
light	light	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
11	11	NUM	CD	O
/	/	SYM	SYM	O
57	57	NUM	CD	O
[	[	PUNCT	-LRB-	O
19	19	NUM	CD	O
%	%	NOUN	NN	O
]	]	PUNCT	-RRB-	O
vs	vs	ADP	IN	O
23	23	NUM	CD	O
/	/	SYM	SYM	O
57	57	NUM	CD	O
[	[	PUNCT	-LRB-	O
40	40	NUM	CD	O
%	%	NOUN	NN	O
]	]	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
deep	deep	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
group	group	NOUN	NN	O
;	;	PUNCT	:	O
P	p	NOUN	NN	O
=	=	X	XX	O
.	.	PUNCT	.	O
02	02	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
indicating	indicate	VERB	VBG	O
that	that	ADP	IN	O
1	1	NUM	CD	O
incident	incident	NOUN	NN	O
of	of	ADP	IN	O
delirium	delirium	NOUN	NN	B-Disease
will	will	VERB	MD	O
be	be	VERB	VB	O
prevented	prevent	VERB	VBN	O
for	for	ADP	IN	O
every	every	DET	DT	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
light	light	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
SD	sd	NOUN	NN	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
delirium	delirium	NOUN	NN	B-Disease
during	during	ADP	IN	O
hospitalization	hospitalization	NOUN	NN	O
was	be	VERB	VBD	O
lower	low	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
light	light	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
group	group	NOUN	NN	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
deep	deep	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
days	day	NOUN	NNS	O
vs	vs	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
days	day	NOUN	NNS	O
;	;	PUNCT	:	O
P	p	NOUN	NN	O
=	=	NOUN	NNS	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
light	light	ADJ	JJ	O
propofol	propofol	ADJ	JJ	B-Chemical
sedation	sedation	NOUN	NN	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
prevalence	prevalence	NOUN	NN	O
of	of	ADP	IN	O
postoperative	postoperative	ADJ	JJ	B-Disease
delirium	delirium	NOUN	NN	I-Disease
by	by	ADP	IN	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
deep	deep	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
.	.	PUNCT	.	O

Limiting	limit	VERB	VBG	O
depth	depth	NOUN	NN	O
of	of	ADP	IN	O
sedation	sedation	NOUN	NN	O
during	during	ADP	IN	O
spinal	spinal	ADJ	JJ	O
anesthesia	anesthesia	NOUN	NN	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
simple	simple	ADJ	JJ	O
,	,	PUNCT	,	O
safe	safe	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
cost	cost	NOUN	NN	O
-	-	PUNCT	HYPH	O
effective	effective	ADJ	JJ	O
intervention	intervention	NOUN	NN	O
for	for	ADP	IN	O
preventing	prevent	VERB	VBG	O
postoperative	postoperative	ADJ	JJ	B-Disease
delirium	delirium	NOUN	NN	I-Disease
in	in	ADP	IN	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
that	that	DET	WDT	O
could	could	VERB	MD	O
be	be	VERB	VB	O
widely	widely	ADV	RB	O
and	and	CCONJ	CC	O
readily	readily	ADV	RB	O
adopted	adopt	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
protective	protective	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
in	in	ADP	IN	O
streptozotocin	streptozotocin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
diabetic	diabetic	ADJ	JJ	B-Disease
nephropathy	nephropathy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
Diabetic	diabetic	ADJ	JJ	B-Disease
nephropathy	nephropathy	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
major	major	ADJ	JJ	O
causes	cause	NOUN	NNS	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
accompanied	accompany	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
production	production	NOUN	NN	O
of	of	ADP	IN	O
reactive	reactive	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
species	specie	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
ROS	ROS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Nrf2	Nrf2	PROPN	NNP	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
primary	primary	ADJ	JJ	O
transcription	transcription	NOUN	NN	O
factor	factor	NOUN	NN	O
that	that	DET	WDT	O
controls	control	VERB	VBZ	O
the	the	DET	DT	O
antioxidant	antioxidant	ADJ	JJ	O
response	response	NOUN	NN	O
essential	essential	ADJ	JJ	O
for	for	ADP	IN	O
maintaining	maintain	VERB	VBG	O
cellular	cellular	ADJ	JJ	O
redox	redox	NOUN	NN	O
homeostasis	homeostasis	NOUN	NN	O
.	.	PUNCT	.	O

Here	here	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
our	-PRON-	DET	PRP$	O
findings	finding	NOUN	NNS	O
demonstrating	demonstrate	VERB	VBG	O
a	a	DET	DT	O
protective	protective	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
against	against	ADP	IN	O
diabetic	diabetic	ADJ	JJ	B-Disease
nephropathy	nephropathy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

RESEARCH	research	NOUN	NN	O
DESIGN	DESIGN	PROPN	NNP	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
explore	explore	VERB	VBP	O
the	the	DET	DT	O
protective	protective	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
against	against	ADP	IN	O
diabetic	diabetic	ADJ	JJ	B-Disease
nephropathy	nephropathy	NOUN	NN	I-Disease
using	use	VERB	VBG	O
human	human	ADJ	JJ	O
kidney	kidney	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
tissues	tissue	NOUN	NNS	O
from	from	ADP	IN	O
diabetic	diabetic	ADJ	JJ	B-Disease
nephropathy	nephropathy	NOUN	NN	I-Disease
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
a	a	DET	DT	O
streptozotocin	streptozotocin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
diabetic	diabetic	ADJ	JJ	B-Disease
nephropathy	nephropathy	ADJ	JJ	I-Disease
model	model	NOUN	NN	O
in	in	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
cultured	culture	VERB	VBN	O
human	human	ADJ	JJ	O
mesangial	mesangial	NOUN	NN	O
cells	cell	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
glomeruli	glomeruli	NOUN	NN	O
of	of	ADP	IN	O
human	human	ADJ	JJ	O
diabetic	diabetic	ADJ	JJ	B-Disease
nephropathy	nephropathy	NOUN	NN	I-Disease
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
under	under	ADP	IN	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
and	and	CCONJ	CC	O
had	have	VERB	VBD	O
elevated	elevate	VERB	VBN	O
Nrf2	Nrf2	PROPN	NNP	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
animal	animal	NOUN	NN	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
Nrf2	Nrf2	PROPN	NNP	O
was	be	VERB	VBD	O
demonstrated	demonstrate	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
crucial	crucial	ADJ	JJ	O
in	in	ADP	IN	O
ameliorating	ameliorate	VERB	VBG	O
streptozotocin	streptozotocin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
renal	renal	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
evident	evident	ADJ	JJ	O
by	by	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
having	have	VERB	VBG	O
higher	high	ADJ	JJR	O
ROS	ROS	PROPN	NNP	O
production	production	NOUN	NN	O
and	and	CCONJ	CC	O
suffering	suffer	VERB	VBG	O
from	from	ADP	IN	O
greater	great	ADJ	JJR	O
oxidative	oxidative	ADJ	JJ	O
DNA	dna	NOUN	NN	O
damage	damage	NOUN	NN	O
and	and	CCONJ	CC	O
renal	renal	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
+	+	X	XX	O
/	/	SYM	SYM	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Mechanistic	mechanistic	ADJ	JJ	O
studies	study	NOUN	NNS	O
in	in	ADP	IN	O
both	both	DET	DT	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
vitro	vitro	X	FW	O
systems	system	NOUN	NNS	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
the	the	DET	DT	O
Nrf2	nrf2	ADV	RB	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
protection	protection	NOUN	NN	O
against	against	ADP	IN	O
diabetic	diabetic	ADJ	JJ	B-Disease
nephropathy	nephropathy	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
,	,	PUNCT	,	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
,	,	PUNCT	,	O
partially	partially	ADV	RB	O
through	through	ADP	IN	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
transforming	transform	VERB	VBG	O
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
-	-	PUNCT	HYPH	O
beta1	beta1	NOUN	NN	O
(	(	PUNCT	-LRB-	O
TGF	TGF	PROPN	NNP	O
-	-	PUNCT	HYPH	O
beta1	beta1	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
extracellular	extracellular	ADJ	JJ	O
matrix	matrix	NOUN	NN	O
production	production	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
human	human	ADJ	JJ	O
renal	renal	ADJ	JJ	O
mesangial	mesangial	ADJ	JJ	O
cells	cell	NOUN	NNS	O
,	,	PUNCT	,	O
high	high	ADJ	JJ	O
glucose	glucose	NOUN	NN	B-Chemical
induced	induce	VERB	VBD	O
ROS	ROS	PROPN	NNP	O
production	production	NOUN	NN	O
and	and	CCONJ	CC	O
activated	activate	VERB	VBN	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
downstream	downstream	ADJ	JJ	O
genes	gene	NOUN	NNS	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
activation	activation	NOUN	NN	O
or	or	CCONJ	CC	O
overexpression	overexpression	NOUN	NN	O
of	of	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
inhibited	inhibit	VERB	VBD	O
the	the	DET	DT	O
promoter	promoter	NOUN	NN	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
TGF	TGF	PROPN	NNP	O
-	-	PUNCT	HYPH	O
beta1	beta1	PROPN	NNP	O
in	in	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
manner	manner	NOUN	NN	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
knockdown	knockdown	NOUN	NN	O
of	of	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
by	by	ADP	IN	O
siRNA	siRNA	PROPN	NNP	O
enhanced	enhance	VERB	VBD	O
TGF	TGF	PROPN	NNP	O
-	-	PUNCT	HYPH	O
beta1	beta1	NOUN	NN	O
transcription	transcription	NOUN	NN	O
and	and	CCONJ	CC	O
fibronectin	fibronectin	NOUN	NN	O
production	production	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
This	this	DET	DT	O
work	work	NOUN	NN	O
clearly	clearly	ADV	RB	O
indicates	indicate	VERB	VBZ	O
a	a	DET	DT	O
protective	protective	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
in	in	ADP	IN	O
diabetic	diabetic	ADJ	JJ	B-Disease
nephropathy	nephropathy	NOUN	NN	I-Disease
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
that	that	ADP	IN	O
dietary	dietary	ADJ	JJ	O
or	or	CCONJ	CC	O
therapeutic	therapeutic	ADJ	JJ	O
activation	activation	NOUN	NN	O
of	of	ADP	IN	O
Nrf2	Nrf2	PROPN	NNP	O
could	could	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
strategy	strategy	NOUN	NN	O
to	to	PART	TO	O
prevent	prevent	VERB	VB	O
or	or	CCONJ	CC	O
slow	slow	VERB	VB	O
down	down	PART	RP	O
the	the	DET	DT	O
progression	progression	NOUN	NN	O
of	of	ADP	IN	O
diabetic	diabetic	ADJ	JJ	B-Disease
nephropathy	nephropathy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Metformin	metformin	NOUN	NN	B-Chemical
prevents	prevent	VERB	VBZ	O
experimental	experimental	ADJ	JJ	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephropathy	nephropathy	NOUN	NN	B-Disease
by	by	ADP	IN	O
a	a	DET	DT	O
mitochondria	mitochondria	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
pathway	pathway	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
antidiabetic	antidiabetic	ADJ	JJ	O
drug	drug	NOUN	NN	O
metformin	metformin	NOUN	NN	B-Chemical
can	can	VERB	MD	O
diminish	diminish	VERB	VB	O
apoptosis	apoptosis	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
oxidative	oxidative	ADJ	JJ	O
stress	stress	NOUN	NN	O
in	in	ADP	IN	O
endothelial	endothelial	ADJ	JJ	O
cells	cell	NOUN	NNS	O
and	and	CCONJ	CC	O
prevent	prevent	VERB	VB	O
vascular	vascular	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
even	even	ADV	RB	O
in	in	ADP	IN	O
nondiabetic	nondiabetic	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Here	here	ADV	RB	O
we	-PRON-	PRON	PRP	O
tested	test	VERB	VBD	O
whether	whether	ADP	IN	O
it	-PRON-	PRON	PRP	O
has	have	VERB	VBZ	O
a	a	DET	DT	O
beneficial	beneficial	ADJ	JJ	O
effect	effect	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
rat	rat	NOUN	NN	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Mitochondrial	mitochondrial	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
,	,	PUNCT	,	O
respiration	respiration	NOUN	NN	O
intensity	intensity	NOUN	NN	O
,	,	PUNCT	,	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
reactive	reactive	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
species	specie	NOUN	NNS	O
,	,	PUNCT	,	O
permeability	permeability	NOUN	NN	O
transition	transition	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
cytochrome	cytochrome	ADJ	JJ	O
c	c	DET	DT	O
release	release	NOUN	NN	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
3	3	NUM	CD	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Metformin	metformin	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
fully	fully	ADV	RB	O
blocked	block	VERB	VBD	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
was	be	VERB	VBD	O
accompanied	accompany	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
lower	low	ADJ	JJR	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
N	n	NOUN	NN	O
-	-	PUNCT	HYPH	O
acetyl	acetyl	NOUN	NN	O
-	-	PUNCT	HYPH	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
D	d	NOUN	NN	O
-	-	PUNCT	HYPH	O
glucosaminidase	glucosaminidase	NOUN	NN	O
,	,	PUNCT	,	O
together	together	ADV	RB	O
with	with	ADP	IN	O
a	a	DET	DT	O
decrease	decrease	NOUN	NN	O
of	of	ADP	IN	O
lipid	lipid	NOUN	NN	O
peroxidation	peroxidation	NOUN	NN	O
and	and	CCONJ	CC	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
antioxidant	antioxidant	ADJ	JJ	O
systems	system	NOUN	NNS	O
.	.	PUNCT	.	O

Metformin	Metformin	PROPN	NNP	B-Chemical
also	also	ADV	RB	O
protected	protect	VERB	VBD	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
from	from	ADP	IN	O
histological	histological	ADJ	JJ	O
damage	damage	NOUN	NN	O
6	6	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
markers	marker	NOUN	NNS	O
of	of	ADP	IN	O
kidney	kidney	NOUN	NN	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
their	-PRON-	DET	PRP$	O
correction	correction	NOUN	NN	O
by	by	ADP	IN	O
metformin	metformin	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
complemented	complement	VERB	VBN	O
by	by	ADP	IN	O
in	in	ADP	IN	O
vitro	vitro	X	FW	O
studies	study	NOUN	NNS	O
of	of	ADP	IN	O
mitochondrial	mitochondrial	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
found	find	VERB	VBD	O
that	that	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
depleted	deplete	VERB	VBD	O
respiratory	respiratory	ADJ	JJ	O
components	component	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
cytochrome	cytochrome	ADJ	JJ	O
c	c	NOUN	NN	O
,	,	PUNCT	,	O
NADH	NADH	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
probably	probably	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
opening	opening	NOUN	NN	O
of	of	ADP	IN	O
mitochondrial	mitochondrial	ADJ	JJ	O
transition	transition	NOUN	NN	O
pores	pore	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
injuries	injury	NOUN	NNS	O
,	,	PUNCT	,	O
partly	partly	ADV	RB	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
reactive	reactive	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
species	specie	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
electron	electron	NOUN	NN	O
transfer	transfer	NOUN	NN	O
chain	chain	NOUN	NN	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
decreased	decrease	VERB	VBN	O
by	by	ADP	IN	O
metformin	metformin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
our	-PRON-	DET	PRP$	O
study	study	NOUN	NN	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
pleiotropic	pleiotropic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
metformin	metformin	NOUN	NN	B-Chemical
can	can	VERB	MD	O
lessen	lessen	VERB	VB	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
improve	improve	VERB	VB	O
mitochondrial	mitochondrial	ADJ	JJ	O
homeostasis	homeostasis	NOUN	NN	O
.	.	PUNCT	.	O

Risk	risk	NOUN	NN	O
of	of	ADP	IN	O
nephropathy	nephropathy	NOUN	NN	B-Disease
after	after	ADP	IN	O
consumption	consumption	NOUN	NN	O
of	of	ADP	IN	O
nonionic	nonionic	ADJ	JJ	O
contrast	contrast	NOUN	NN	B-Chemical
media	medium	NOUN	NNS	I-Chemical
by	by	ADP	IN	O
children	child	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
cardiac	cardiac	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
:	:	PUNCT	:	O
a	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Despite	despite	ADP	IN	O
increasing	increase	VERB	VBG	O
reports	report	NOUN	NNS	O
on	on	ADP	IN	O
nonionic	nonionic	ADJ	JJ	O
contrast	contrast	NOUN	NN	B-Chemical
media	medium	NOUN	NNS	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephropathy	nephropathy	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
CIN	CIN	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
hospitalized	hospitalize	VERB	VBN	O
adult	adult	NOUN	NN	O
patients	patient	NOUN	NNS	O
during	during	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
procedures	procedure	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
studies	study	NOUN	NNS	O
in	in	ADP	IN	O
pediatrics	pediatric	NOUN	NNS	O
are	be	VERB	VBP	O
limited	limit	VERB	VBN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
even	even	ADV	RB	O
less	less	ADJ	JJR	O
focus	focus	NOUN	NN	O
on	on	ADP	IN	O
possible	possible	ADJ	JJ	O
predisposing	predispose	VERB	VBG	O
factors	factor	NOUN	NNS	O
and	and	CCONJ	CC	O
preventive	preventive	ADJ	JJ	O
measures	measure	NOUN	NNS	O
for	for	ADP	IN	O
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
cardiac	cardiac	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
prospective	prospective	ADJ	JJ	O
study	study	NOUN	NN	O
determined	determine	VERB	VBD	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
CIN	CIN	PROPN	NNP	B-Disease
for	for	ADP	IN	O
two	two	NUM	CD	O
nonionic	nonionic	ADJ	JJ	O
contrast	contrast	NOUN	NN	B-Chemical
media	medium	NOUN	NNS	I-Chemical
(	(	PUNCT	-LRB-	O
CM	CM	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
iopromide	iopromide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
iohexol	iohexol	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
among	among	ADP	IN	O
80	80	NUM	CD	O
patients	patient	NOUN	NNS	O
younger	young	ADJ	JJR	O
than	than	ADP	IN	O
18	18	NUM	CD	O
years	year	NOUN	NNS	O
and	and	CCONJ	CC	O
compared	compare	VERB	VBD	O
the	the	DET	DT	O
rates	rate	NOUN	NNS	O
for	for	ADP	IN	O
this	this	DET	DT	O
complication	complication	NOUN	NN	O
in	in	ADP	IN	O
relation	relation	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
type	type	NOUN	NN	O
and	and	CCONJ	CC	O
dosage	dosage	NOUN	NN	O
of	of	ADP	IN	O
CM	CM	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
cyanosis	cyanosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
80	80	NUM	CD	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
consecutively	consecutively	ADV	RB	O
received	receive	VERB	VBD	O
either	either	CCONJ	CC	O
iopromide	iopromide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
A	A	PROPN	NNP	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
40	40	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
iohexol	iohexol	ADJ	JJ	B-Chemical
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
B	B	PROPN	NNP	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
40	40	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Serum	serum	ADJ	JJ	O
sodium	sodium	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Na	Na	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
potassium	potassium	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
K	K	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
creatinine	creatinine	VERB	VB	B-Chemical
(	(	PUNCT	-LRB-	O
Cr	Cr	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
24	24	NUM	CD	O
h	h	NOUN	NNS	O
before	before	ADV	RB	O
angiography	angiography	NOUN	NN	O
as	as	ADP	IN	O
baseline	baseline	NOUN	NN	O
values	value	NOUN	NNS	O
,	,	PUNCT	,	O
then	then	ADV	RB	O
measured	measure	VERB	VBN	O
again	again	ADV	RB	O
at	at	ADP	IN	O
12	12	NUM	CD	O
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
48	48	NUM	CD	O
-	-	PUNCT	HYPH	O
h	h	NOUN	NN	O
intervals	interval	NOUN	NNS	O
after	after	ADP	IN	O
CM	CM	PROPN	NNP	B-Chemical
use	use	NOUN	NN	O
.	.	PUNCT	.	O

Urine	urine	NOUN	NN	O
samples	sample	NOUN	NNS	O
for	for	ADP	IN	O
Na	Na	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
Cr	Cr	PROPN	NNP	B-Chemical
also	also	ADV	RB	O
were	be	VERB	VBD	O
checked	check	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
intervals	interval	NOUN	NNS	O
.	.	PUNCT	.	O

Risk	risk	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
,	,	PUNCT	,	O
Injury	Injury	PROPN	NNP	B-Disease
to	to	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
kidney	kidney	NOUN	NN	I-Disease
,	,	PUNCT	,	O
Failure	failure	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
kidney	kidney	NOUN	NN	I-Disease
function	function	NOUN	NN	I-Disease
,	,	PUNCT	,	O
Loss	Loss	PROPN	NNP	B-Disease
of	of	ADP	IN	I-Disease
kidney	kidney	NOUN	NN	I-Disease
function	function	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
End	end	NOUN	NN	O
-	-	PUNCT	HYPH	O
stage	stage	NOUN	NN	O
renal	renal	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
RIFLE	rifle	NOUN	NN	O
criteria	criterion	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
define	define	VERB	VB	O
CIN	CIN	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
incidence	incidence	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
population	population	NOUN	NN	O
.	.	PUNCT	.	O

Accordingly	accordingly	ADV	RB	O
,	,	PUNCT	,	O
among	among	ADP	IN	O
the	the	DET	DT	O
15	15	NUM	CD	O
CIN	CIN	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
18	18	NUM	CD	O
.	.	PUNCT	.	O
75	75	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
group	group	NOUN	NN	O
A	A	PROPN	NNP	O
had	have	VERB	VBD	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
75	75	NUM	CD	O
%	%	NOUN	NN	O
had	have	VERB	VBD	O
renal	renal	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
group	group	NOUN	NN	O
B	B	PROPN	NNP	O
had	have	VERB	VBD	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
had	have	VERB	VBD	O
renal	renal	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Whereas	whereas	ADP	IN	O
33	33	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
CIN	CIN	PROPN	NNP	B-Disease
were	be	VERB	VBD	O
among	among	ADP	IN	O
those	those	DET	DT	O
who	who	PRON	WP	O
received	receive	VERB	VBD	O
the	the	DET	DT	O
proper	proper	ADJ	JJ	O
dosage	dosage	NOUN	NN	O
of	of	ADP	IN	O
CM	CM	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
percentage	percentage	NOUN	NN	O
increased	increase	VERB	VBD	O
to	to	ADP	IN	O
66	66	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
among	among	ADP	IN	O
those	those	DET	DT	O
who	who	PRON	WP	O
received	receive	VERB	VBD	O
larger	large	ADJ	JJR	O
doses	dose	NOUN	NNS	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
difference	difference	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
CIN	CIN	PROPN	NNP	B-Disease
related	relate	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
different	different	ADJ	JJ	O
dosages	dosage	NOUN	NNS	O
of	of	ADP	IN	O
CM	CM	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
014	014	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Among	among	ADP	IN	O
the	the	DET	DT	O
15	15	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
CIN	CIN	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
6	6	NUM	CD	O
had	have	VERB	VBD	O
cyanotic	cyanotic	ADJ	JJ	O
congenital	congenital	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
diseases	disease	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
differ	differ	VERB	VB	O
significantly	significantly	ADV	RB	O
from	from	ADP	IN	O
that	that	DET	DT	O
for	for	ADP	IN	O
the	the	DET	DT	O
noncyanotic	noncyanotic	ADJ	JJ	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
243	243	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
clinically	clinically	ADV	RB	O
silent	silent	ADJ	JJ	O
,	,	PUNCT	,	O
CIN	CIN	PROPN	NNP	B-Disease
is	be	VERB	VBZ	O
not	not	ADV	RB	O
rare	rare	ADJ	JJ	O
in	in	ADP	IN	O
pediatrics	pediatric	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
depends	depend	VERB	VBZ	O
on	on	ADP	IN	O
dosage	dosage	NOUN	NN	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
on	on	ADP	IN	O
the	the	DET	DT	O
type	type	NOUN	NN	O
of	of	ADP	IN	O
consumed	consume	VERB	VBN	O
nonionic	nonionic	ADJ	JJ	O
CM	CM	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
nor	nor	CCONJ	CC	O
on	on	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
cyanosis	cyanosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
although	although	ADP	IN	O
CIN	CIN	PROPN	NNP	B-Disease
usually	usually	ADV	RB	O
is	be	VERB	VBZ	O
reversible	reversible	ADJ	JJ	O
,	,	PUNCT	,	O
more	more	ADJ	JJR	O
concern	concern	NOUN	NN	O
is	be	VERB	VBZ	O
needed	need	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
such	such	DET	PDT	O
a	a	DET	DT	O
complication	complication	NOUN	NN	O
in	in	ADP	IN	O
children	child	NOUN	NNS	O
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
hemodynamics	hemodynamic	NOUN	NNS	O
during	during	ADP	IN	O
prolonged	prolong	VERB	VBN	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
in	in	ADP	IN	O
humans	human	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
on	on	ADP	IN	O
glomerular	glomerular	ADJ	JJ	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
renal	renal	ADJ	JJ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
was	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
in	in	ADP	IN	O
20	20	NUM	CD	O
human	human	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
.	.	PUNCT	.	O

Glomerular	glomerular	ADJ	JJ	O
filtration	filtration	NOUN	NN	O
rate	rate	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GFR	GFR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
effective	effective	ADJ	JJ	O
renal	renal	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
flow	flow	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ERPF	ERPF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
by	by	ADP	IN	O
inulin	inulin	NOUN	NN	O
and	and	CCONJ	CC	O
para	para	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminohippurate	aminohippurate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
PAH	PAH	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
clearance	clearance	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Anesthesia	Anesthesia	PROPN	NNP	O
was	be	VERB	VBD	O
maintained	maintain	VERB	VBN	O
with	with	ADP	IN	O
fentanyl	fentanyl	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
nitrous	nitrous	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
oxygen	oxygen	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Hypotension	hypotension	NOUN	NN	B-Disease
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
for	for	ADP	IN	O
236	236	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
15	15	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
min	min	NOUN	NN	O
by	by	ADP	IN	O
increasing	increase	VERB	VBG	O
the	the	DET	DT	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
inspired	inspire	VERB	VBN	O
concentration	concentration	NOUN	NN	O
to	to	PART	TO	O
maintain	maintain	VERB	VB	O
a	a	DET	DT	O
mean	mean	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
of	of	ADP	IN	O
59	59	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
mmHg	mmhg	SYM	SYM	O
.	.	PUNCT	.	O

GFR	GFR	PROPN	NNP	O
and	and	CCONJ	CC	O
ERPF	ERPF	PROPN	NNP	O
decreased	decrease	VERB	VBD	O
with	with	ADP	IN	O
the	the	DET	DT	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
anesthesia	anesthesia	NOUN	NN	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
more	more	ADV	RBR	O
during	during	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Postoperatively	postoperatively	ADV	RB	O
,	,	PUNCT	,	O
ERPF	ERPF	PROPN	NNP	O
returned	return	VERB	VBD	O
to	to	ADP	IN	O
preoperative	preoperative	ADJ	JJ	O
values	value	NOUN	NNS	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
GFR	GFR	PROPN	NNP	O
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
than	than	ADP	IN	O
preoperative	preoperative	ADJ	JJ	O
values	value	NOUN	NNS	O
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	O
vascular	vascular	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
increased	increase	VERB	VBD	O
during	during	ADP	IN	O
anesthesia	anesthesia	NOUN	NN	O
but	but	CCONJ	CC	O
decreased	decrease	VERB	VBD	O
when	when	ADV	WRB	O
hypotension	hypotension	NOUN	NN	B-Disease
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
,	,	PUNCT	,	O
allowing	allow	VERB	VBG	O
the	the	DET	DT	O
maintenance	maintenance	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
renal	renal	ADJ	JJ	O
compensatory	compensatory	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
are	be	VERB	VBP	O
preserved	preserve	VERB	VBN	O
during	during	ADP	IN	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
that	that	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
hemodynamics	hemodynamic	NOUN	NNS	O
quickly	quickly	ADV	RB	O
return	return	VERB	VB	O
to	to	ADP	IN	O
normal	normal	ADJ	JJ	O
when	when	ADV	WRB	O
normotension	normotension	NOUN	NN	O
is	be	VERB	VBZ	O
resumed	resume	VERB	VBN	O
.	.	PUNCT	.	O

Brainstem	Brainstem	PROPN	NNP	B-Disease
dysgenesis	dysgenesis	NOUN	NN	I-Disease
in	in	ADP	IN	O
an	an	DET	DT	O
infant	infant	NOUN	NN	O
prenatally	prenatally	ADV	RB	O
exposed	expose	VERB	VBN	O
to	to	PART	TO	O
cocaine	cocaine	VERB	VB	B-Chemical
.	.	PUNCT	.	O

Many	many	ADJ	JJ	O
authors	author	NOUN	NNS	O
described	describe	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
the	the	DET	DT	O
fetus	fetus	NOUN	NN	O
of	of	ADP	IN	O
maternal	maternal	ADJ	JJ	O
cocaine	cocaine	NOUN	NN	B-Disease
abuse	abuse	NOUN	NN	I-Disease
during	during	ADP	IN	O
pregnancy	pregnancy	NOUN	NN	O
.	.	PUNCT	.	O

Vasoconstriction	vasoconstriction	NOUN	NN	O
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
the	the	DET	DT	O
common	common	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
action	action	NOUN	NN	O
leading	lead	VERB	VBG	O
to	to	ADP	IN	O
a	a	DET	DT	O
wide	wide	ADJ	JJ	O
range	range	NOUN	NN	O
of	of	ADP	IN	O
fetal	fetal	ADJ	JJ	B-Disease
anomalies	anomaly	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
on	on	ADP	IN	O
an	an	DET	DT	O
infant	infant	NOUN	NN	O
with	with	ADP	IN	O
multiple	multiple	ADJ	JJ	B-Disease
cranial	cranial	ADJ	JJ	I-Disease
-	-	PUNCT	HYPH	I-Disease
nerve	nerve	NOUN	NN	I-Disease
involvement	involvement	NOUN	NN	I-Disease
attributable	attributable	ADJ	JJ	O
to	to	PART	TO	O
brainstem	brainstem	VERB	VB	B-Disease
dysgenesis	dysgenesis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
born	bear	VERB	VBN	O
to	to	ADP	IN	O
a	a	DET	DT	O
cocaine	cocaine	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
addicted	addict	VERB	VBN	I-Disease
mother	mother	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
cross	cross	ADJ	JJ	O
-	-	ADJ	JJ	O
sectional	sectional	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
selective	selective	ADJ	JJ	O
serotonin	serotonin	NOUN	NN	B-Chemical
reuptake	reuptake	NOUN	NN	O
inhibitors	inhibitor	NOUN	NNS	O
on	on	ADP	IN	O
bone	bone	NOUN	NN	O
mineral	mineral	NOUN	NN	O
density	density	NOUN	NN	O
in	in	ADP	IN	O
boys	boy	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
on	on	ADP	IN	O
trabecular	trabecular	ADJ	JJ	O
bone	bone	NOUN	NN	O
mineral	mineral	NOUN	NN	O
density	density	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BMD	BMD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
children	child	NOUN	NNS	O
and	and	CCONJ	CC	O
adolescents	adolescent	NOUN	NNS	O
.	.	PUNCT	.	O

METHOD	method	NOUN	NN	O
:	:	PUNCT	:	O
Medically	medically	ADV	RB	O
healthy	healthy	ADJ	JJ	O
7	7	NUM	CD	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
17	17	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
males	male	NOUN	NNS	O
chronically	chronically	ADV	RB	O
treated	treat	VERB	VBN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
a	a	DET	DT	O
naturalistic	naturalistic	ADJ	JJ	O
setting	setting	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
recruited	recruit	VERB	VBN	O
for	for	ADP	IN	O
this	this	DET	DT	O
cross	cross	ADJ	JJ	O
-	-	ADJ	JJ	O
sectional	sectional	ADJ	JJ	O
study	study	NOUN	NN	O
through	through	ADP	IN	O
child	child	NOUN	NN	O
psychiatry	psychiatry	NOUN	NN	O
outpatient	outpatient	NOUN	NN	O
clinics	clinic	NOUN	NNS	O
between	between	ADP	IN	O
November	November	PROPN	NNP	O
2005	2005	NUM	CD	O
and	and	CCONJ	CC	O
June	June	PROPN	NNP	O
2007	2007	NUM	CD	O
.	.	PUNCT	.	O

Anthropometric	anthropometric	ADJ	JJ	O
measurements	measurement	NOUN	NNS	O
and	and	CCONJ	CC	O
laboratory	laboratory	NOUN	NN	O
testing	testing	NOUN	NN	O
were	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
diagnoses	diagnosis	NOUN	NNS	O
were	be	VERB	VBD	O
based	base	VERB	VBN	O
on	on	ADP	IN	O
chart	chart	NOUN	NN	O
review	review	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
developmental	developmental	ADJ	JJ	O
and	and	CCONJ	CC	O
treatment	treatment	NOUN	NN	O
history	history	NOUN	NN	O
was	be	VERB	VBD	O
obtained	obtain	VERB	VBN	O
from	from	ADP	IN	O
the	the	DET	DT	O
medical	medical	ADJ	JJ	O
record	record	NOUN	NN	O
.	.	PUNCT	.	O

Volumetric	Volumetric	PROPN	NNP	O
BMD	BMD	PROPN	NNP	O
of	of	ADP	IN	O
the	the	DET	DT	O
ultradistal	ultradistal	ADJ	JJ	O
radius	radius	NOUN	NN	O
was	be	VERB	VBD	O
measured	measure	VERB	VBN	O
using	use	VERB	VBG	O
peripheral	peripheral	ADJ	JJ	O
quantitative	quantitative	ADJ	JJ	O
computed	computed	ADJ	JJ	O
tomography	tomography	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
areal	areal	ADJ	JJ	O
BMD	BMD	PROPN	NNP	O
of	of	ADP	IN	O
the	the	DET	DT	O
lumbar	lumbar	ADJ	JJ	O
spine	spine	NOUN	NN	O
was	be	VERB	VBD	O
estimated	estimate	VERB	VBN	O
using	use	VERB	VBG	O
dual	dual	ADJ	JJ	O
-	-	PUNCT	HYPH	O
energy	energy	NOUN	NN	O
x	x	NOUN	NNS	O
-	-	PUNCT	HYPH	O
ray	ray	NOUN	NN	O
absorptiometry	absorptiometry	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Hyperprolactinemia	Hyperprolactinemia	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
49	49	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
83	83	NUM	CD	O
boys	boy	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
41	41	NUM	CD	O
)	)	PUNCT	-RRB-	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
for	for	ADP	IN	O
a	a	DET	DT	O
mean	mean	NOUN	NN	O
of	of	ADP	IN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

Serum	serum	ADJ	JJ	O
testosterone	testosterone	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
increased	increase	VERB	VBD	O
with	with	ADP	IN	O
pubertal	pubertal	ADJ	JJ	O
status	status	NOUN	NN	O
but	but	CCONJ	CC	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
affected	affect	VERB	VBN	O
by	by	ADP	IN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

As	as	ADP	IN	O
expected	expect	VERB	VBN	O
,	,	PUNCT	,	O
bone	bone	NOUN	NN	O
mineral	mineral	NOUN	NN	O
content	content	NOUN	NN	O
and	and	CCONJ	CC	O
BMD	BMD	PROPN	NNP	O
increased	increase	VERB	VBD	O
with	with	ADP	IN	O
sexual	sexual	ADJ	JJ	O
maturity	maturity	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
adjusting	adjust	VERB	VBG	O
for	for	ADP	IN	O
the	the	DET	DT	O
stage	stage	NOUN	NN	O
of	of	ADP	IN	O
sexual	sexual	ADJ	JJ	O
development	development	NOUN	NN	O
and	and	CCONJ	CC	O
height	height	NOUN	NN	O
and	and	CCONJ	CC	O
BMI	BMI	PROPN	NNP	O
z	z	PROPN	NNP	O
scores	score	NOUN	NNS	O
,	,	PUNCT	,	O
serum	serum	NOUN	NN	O
prolactin	prolactin	NOUN	NN	O
was	be	VERB	VBD	O
negatively	negatively	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
trabecular	trabecular	ADJ	JJ	O
volumetric	volumetric	ADJ	JJ	O
BMD	BMD	PROPN	NNP	O
at	at	ADP	IN	O
the	the	DET	DT	O
ultradistal	ultradistal	ADJ	JJ	O
radius	radius	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Controlling	control	VERB	VBG	O
for	for	ADP	IN	O
relevant	relevant	ADJ	JJ	O
covariates	covariate	NOUN	NNS	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
also	also	ADV	RB	O
found	find	VERB	VBD	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
selective	selective	ADJ	JJ	O
serotonin	serotonin	NOUN	NN	B-Chemical
reuptake	reuptake	NOUN	NN	O
inhibitors	inhibitor	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
SSRIs	ssri	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
to	to	PART	TO	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
lower	low	ADJ	JJR	O
trabecular	trabecular	ADJ	JJ	O
BMD	BMD	PROPN	NNP	O
at	at	ADP	IN	O
the	the	DET	DT	O
radius	radius	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	X	XX	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
BMD	BMD	PROPN	NNP	O
z	z	X	XX	O
score	score	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
lumbar	lumbar	ADJ	JJ	O
spine	spine	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
became	become	VERB	VBD	O
more	more	ADV	RBR	O
marked	marked	ADJ	JJ	O
when	when	ADV	WRB	O
the	the	DET	DT	O
analysis	analysis	NOUN	NN	O
was	be	VERB	VBD	O
restricted	restrict	VERB	VBN	O
to	to	ADP	IN	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
Hispanic	hispanic	ADJ	JJ	O
white	white	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Of	of	ADP	IN	O
13	13	NUM	CD	O
documented	document	VERB	VBN	O
fractures	fracture	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
3	3	NUM	CD	O
occurred	occur	VERB	VBD	O
after	after	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
SSRIs	SSRIs	PROPN	NNPS	O
were	be	VERB	VBD	O
started	start	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
none	none	NOUN	NN	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
This	this	DET	DT	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
study	study	NOUN	NN	O
to	to	PART	TO	O
link	link	VERB	VB	O
risperidone	risperidone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
SSRI	SSRI	PROPN	NNP	O
treatment	treatment	NOUN	NN	O
to	to	PART	TO	O
lower	lower	VERB	VB	O
BMD	BMD	PROPN	NNP	O
in	in	ADP	IN	O
children	child	NOUN	NNS	O
and	and	CCONJ	CC	O
adolescents	adolescent	NOUN	NNS	O
.	.	PUNCT	.	O

Future	future	ADJ	JJ	O
research	research	NOUN	NN	O
should	should	VERB	MD	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
longitudinal	longitudinal	ADJ	JJ	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
adverse	adverse	ADJ	JJ	O
event	event	NOUN	NN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
its	-PRON-	DET	PRP$	O
temporal	temporal	ADJ	JJ	O
stability	stability	NOUN	NN	O
and	and	CCONJ	CC	O
whether	whether	ADP	IN	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
fracture	fracture	NOUN	NN	O
rate	rate	NOUN	NN	O
ensues	ensue	NOUN	NNS	O
.	.	PUNCT	.	O

Fear	fear	NOUN	NN	O
-	-	PUNCT	HYPH	O
potentiated	potentiate	VERB	VBN	O
startle	startle	NOUN	NN	B-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
light	light	ADV	RB	O
-	-	PUNCT	HYPH	O
enhanced	enhance	VERB	VBN	O
startle	startle	NOUN	NN	B-Disease
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
enhanced	enhance	VERB	VBN	O
by	by	ADP	IN	O
anxiogenic	anxiogenic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

RATIONALE	RATIONALE	PROPN	NNP	O
AND	and	CCONJ	CC	O
OBJECTIVES	objectives	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
light	light	ADV	RB	O
-	-	PUNCT	HYPH	O
enhanced	enhance	VERB	VBN	O
startle	startle	ADJ	JJ	B-Disease
paradigm	paradigm	NOUN	NN	O
(	(	PUNCT	-LRB-	O
LES	LES	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
suggested	suggest	VERB	VBN	O
to	to	PART	TO	O
model	model	VERB	VB	O
anxiety	anxiety	NOUN	NN	B-Disease
,	,	PUNCT	,	O
because	because	ADP	IN	O
of	of	ADP	IN	O
the	the	DET	DT	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
specific	specific	ADJ	JJ	O
cue	cue	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
fear	fear	NOUN	NN	O
-	-	PUNCT	HYPH	O
potentiated	potentiate	VERB	VBN	O
startle	startle	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
FPS	FPS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
suggested	suggest	VERB	VBN	O
to	to	PART	TO	O
model	model	VERB	VB	O
conditioned	condition	VERB	VBN	O
fear	fear	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
pharmacological	pharmacological	ADJ	JJ	O
profiles	profile	NOUN	NNS	O
of	of	ADP	IN	O
these	these	DET	DT	O
two	two	NUM	CD	O
paradigms	paradigms	NOUN	NN	O
are	be	VERB	VBP	O
very	very	ADV	RB	O
similar	similar	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
putative	putative	ADJ	JJ	O
anxiogenic	anxiogenic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
on	on	ADP	IN	O
LES	LES	PROPN	NNP	O
and	and	CCONJ	CC	O
FPS	FPS	PROPN	NNP	O
and	and	CCONJ	CC	O
aimed	aim	VERB	VBN	O
at	at	ADP	IN	O
determining	determine	VERB	VBG	O
the	the	DET	DT	O
sensitivity	sensitivity	NOUN	NN	O
of	of	ADP	IN	O
LES	LES	PROPN	NNP	O
for	for	ADP	IN	O
anxiogenic	anxiogenic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
potentially	potentially	ADV	RB	O
showing	show	VERB	VBG	O
a	a	DET	DT	O
pharmacological	pharmacological	ADJ	JJ	O
differentiation	differentiation	NOUN	NN	O
between	between	ADP	IN	O
these	these	DET	DT	O
two	two	NUM	CD	O
paradigms	paradigms	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Male	Male	PROPN	NNP	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
received	receive	VERB	VBD	O
each	each	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
alpha	alpha	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0mg	0mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
2C	2C	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
m	m	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
chlorophenylpiperazine	chlorophenylpiperazine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
mCPP	mCPP	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0mg	0mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
the	the	DET	DT	O
GABA	GABA	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
A	A	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
inverse	inverse	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
pentylenetetrazole	pentylenetetrazole	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
PTZ	PTZ	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
30mg	30mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
were	be	VERB	VBD	O
subsequently	subsequently	ADV	RB	O
tested	test	VERB	VBN	O
in	in	ADP	IN	O
either	either	DET	DT	O
LES	LES	PROPN	NNP	O
or	or	CCONJ	CC	O
FPS	FPS	PROPN	NNP	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
None	none	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
drugs	drug	NOUN	NNS	O
enhanced	enhance	VERB	VBN	O
LES	LES	PROPN	NNP	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
mCPP	mCPP	PROPN	NNP	B-Chemical
increased	increase	VERB	VBD	O
percentage	percentage	NOUN	NN	O
FPS	FPS	PROPN	NNP	O
and	and	CCONJ	CC	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
increased	increase	VERB	VBD	O
absolute	absolute	ADJ	JJ	O
FPS	FPS	PROPN	NNP	O
values	value	NOUN	NNS	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
increased	increase	VERB	VBD	O
baseline	baseline	ADJ	JJ	O
startle	startle	NOUN	NN	B-Disease
amplitude	amplitude	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
LES	LES	PROPN	NNP	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
mCPP	mCPP	PROPN	NNP	B-Chemical
suppressed	suppress	VERB	VBD	O
baseline	baseline	NOUN	NN	O
startle	startle	NOUN	NN	B-Disease
in	in	ADP	IN	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
LES	LES	PROPN	NNP	O
and	and	CCONJ	CC	O
FPS	FPS	PROPN	NNP	O
and	and	CCONJ	CC	O
PTZ	PTZ	PROPN	NNP	B-Chemical
suppressed	suppress	VERB	VBD	O
baseline	baseline	NOUN	NN	O
startle	startle	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
FPS	FPS	PROPN	NNP	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
to	to	ADP	IN	O
findings	finding	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
FPS	FPS	PROPN	NNP	O
paradigm	paradigm	NOUN	NN	O
,	,	PUNCT	,	O
none	none	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
drugs	drug	NOUN	NNS	O
were	be	VERB	VBD	O
able	able	ADJ	JJ	O
to	to	PART	TO	O
exacerbate	exacerbate	VERB	VB	O
the	the	DET	DT	O
LES	LES	PROPN	NNP	O
response	response	NOUN	NN	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
a	a	DET	DT	O
clear	clear	ADJ	JJ	O
pharmacological	pharmacological	ADJ	JJ	O
differentiation	differentiation	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
between	between	ADP	IN	O
LES	LES	PROPN	NNP	O
and	and	CCONJ	CC	O
FPS	FPS	PROPN	NNP	O
.	.	PUNCT	.	O

Rosaceiform	rosaceiform	NOUN	NN	O
dermatitis	dermatitis	NOUN	NN	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
topical	topical	ADJ	JJ	O
tacrolimus	tacrolimus	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
herein	herein	NOUN	NN	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
rosacea	rosacea	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
dermatitis	dermatitis	ADJ	JJ	B-Disease
eruptions	eruption	NOUN	NNS	B-Disease
while	while	ADP	IN	O
using	use	VERB	VBG	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
%	%	NOUN	NN	O
or	or	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
ointment	ointment	NOUN	NN	O
for	for	ADP	IN	O
facial	facial	ADJ	JJ	B-Disease
dermatitis	dermatitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Skin	skin	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
specimens	specimen	NOUN	NNS	O
showed	show	VERB	VBD	O
telangiectasia	telangiectasia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
noncaseating	noncaseate	VERB	VBG	O
epithelioid	epithelioid	VERB	VB	O
granulomatous	granulomatous	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
formation	formation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
papillary	papillary	NOUN	NN	O
to	to	ADP	IN	O
mid	mid	ADJ	JJ	O
dermis	dermis	NOUN	NN	O
.	.	PUNCT	.	O

Continuous	continuous	ADJ	JJ	O
topical	topical	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
immunomodulators	immunomodulator	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
tacrolimus	tacrolimus	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
pimecrolimus	pimecrolimus	NOUN	NN	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
regarded	regard	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
potential	potential	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
rosaceiform	rosaceiform	NOUN	NN	O
dermatitis	dermatitis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
although	although	ADP	IN	O
many	many	ADJ	JJ	O
cases	case	NOUN	NNS	O
have	have	VERB	VBP	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

Coenzyme	Coenzyme	PROPN	NNP	B-Chemical
Q10	Q10	PROPN	NNP	I-Chemical
treatment	treatment	NOUN	NN	O
ameliorates	ameliorate	NOUN	NNS	O
acute	acute	ADJ	JJ	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
nephroprotective	nephroprotective	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
coenzyme	coenzyme	NOUN	NN	B-Chemical
Q10	Q10	PROPN	NNP	I-Chemical
was	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
injury	injury	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Coenzyme	Coenzyme	PROPN	NNP	B-Chemical
Q10	Q10	PROPN	NNP	I-Chemical
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
applied	apply	VERB	VBN	O
for	for	ADP	IN	O
6	6	NUM	CD	O
consecutive	consecutive	ADJ	JJ	O
days	day	NOUN	NNS	O
,	,	PUNCT	,	O
starting	start	VERB	VBG	O
1	1	NUM	CD	O
day	day	NOUN	NN	O
before	before	ADP	IN	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Coenzyme	Coenzyme	PROPN	NNP	B-Chemical
Q10	Q10	PROPN	NNP	I-Chemical
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBD	O
blood	blood	NOUN	NN	B-Chemical
urea	urea	ADJ	JJ	I-Chemical
nitrogen	nitrogen	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
which	which	DET	WDT	O
were	be	VERB	VBD	O
increased	increase	VERB	VBN	O
by	by	ADP	IN	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Coenzyme	Coenzyme	PROPN	NNP	B-Chemical
Q10	Q10	PROPN	NNP	I-Chemical
significantly	significantly	ADV	RB	O
compensated	compensate	VERB	VBD	O
deficits	deficit	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
antioxidant	antioxidant	ADJ	JJ	O
defense	defense	NOUN	NN	O
mechanisms	mechanism	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
reduced	reduce	VERB	VBN	B-Chemical
glutathione	glutathione	ADJ	JJ	I-Chemical
level	level	NOUN	NN	O
and	and	CCONJ	CC	O
superoxide	superoxide	NOUN	NN	B-Chemical
dismutase	dismutase	NOUN	NN	O
activity	activity	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
suppressed	suppress	VERB	VBN	O
lipid	lipid	NOUN	NN	O
peroxidation	peroxidation	NOUN	NN	O
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
elevations	elevation	NOUN	NNS	O
of	of	ADP	IN	O
tumor	tumor	NOUN	NN	B-Disease
necrosis	necrosis	NOUN	NN	B-Disease
factor	factor	NOUN	NN	O
-	-	PUNCT	HYPH	O
alpha	alpha	NOUN	NN	O
,	,	PUNCT	,	O
nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
platinum	platinum	NOUN	NN	B-Chemical
ion	ion	NOUN	NN	O
concentration	concentration	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
attenuated	attenuate	VERB	VBD	O
the	the	DET	DT	O
reductions	reduction	NOUN	NNS	O
of	of	ADP	IN	O
selenium	selenium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
zinc	zinc	NOUN	NN	B-Chemical
ions	ion	NOUN	NNS	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
resulted	result	VERB	VBD	O
from	from	ADP	IN	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Also	also	ADV	RB	O
,	,	PUNCT	,	O
histopathological	histopathological	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
tissue	tissue	NOUN	NN	I-Disease
damage	damage	NOUN	NN	I-Disease
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
ameliorated	ameliorate	VERB	VBN	O
by	by	ADP	IN	O
coenzyme	coenzyme	NOUN	NN	B-Chemical
Q10	Q10	PROPN	NNP	I-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Immunohistochemical	immunohistochemical	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
revealed	reveal	VERB	VBD	O
that	that	ADP	IN	O
coenzyme	coenzyme	NOUN	NN	B-Chemical
Q10	Q10	PROPN	NNP	I-Chemical
significantly	significantly	ADV	RB	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
overexpression	overexpression	NOUN	NN	O
of	of	ADP	IN	O
inducible	inducible	ADJ	JJ	O
nitric	nitric	ADJ	JJ	B-Chemical
oxide	oxide	NOUN	NN	I-Chemical
synthase	synthase	NOUN	NN	O
,	,	PUNCT	,	O
nuclear	nuclear	ADJ	JJ	O
factor	factor	NOUN	NN	O
-	-	PUNCT	HYPH	O
kappaB	kappaB	PROPN	NNP	O
,	,	PUNCT	,	O
caspase	caspase	NOUN	NN	O
-	-	PUNCT	HYPH	O
3	3	NUM	CD	O
and	and	CCONJ	CC	O
p53	p53	NOUN	NN	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
concluded	conclude	VERB	VBN	O
that	that	ADP	IN	O
coenzyme	coenzyme	NOUN	NN	B-Chemical
Q10	Q10	PROPN	NNP	I-Chemical
represents	represent	VERB	VBZ	O
a	a	DET	DT	O
potential	potential	ADJ	JJ	O
therapeutic	therapeutic	ADJ	JJ	O
option	option	NOUN	NN	O
to	to	PART	TO	O
protect	protect	VERB	VB	O
against	against	ADP	IN	O
acute	acute	ADJ	JJ	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
commonly	commonly	ADV	RB	O
encountered	encounter	VERB	VBN	O
in	in	ADP	IN	O
clinical	clinical	ADJ	JJ	O
practice	practice	NOUN	NN	O
.	.	PUNCT	.	O

Reversible	reversible	ADJ	JJ	O
cholestasis	cholestasis	NOUN	NN	B-Disease
with	with	ADP	IN	O
bile	bile	ADJ	JJ	B-Disease
duct	duct	NOUN	NN	I-Disease
injury	injury	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
azathioprine	azathioprine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
67	67	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
patient	patient	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
primary	primary	ADJ	JJ	O
polymyositis	polymyositis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
without	without	ADP	IN	O
previous	previous	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
liver	liver	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
developed	develop	VERB	VBD	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
biochemical	biochemical	ADJ	JJ	O
features	feature	NOUN	NNS	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
cholestasis	cholestasis	NOUN	NN	B-Disease
3	3	NUM	CD	O
months	month	NOUN	NNS	O
after	after	ADP	IN	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
azathioprine	azathioprine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Liver	liver	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
showed	show	VERB	VBD	O
cholestasis	cholestasis	NOUN	NN	B-Disease
with	with	ADP	IN	O
both	both	CCONJ	CC	O
cytological	cytological	ADJ	JJ	O
and	and	CCONJ	CC	O
architectural	architectural	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
of	of	ADP	IN	O
interlobular	interlobular	ADJ	JJ	O
bile	bile	NOUN	NN	O
ducts	duct	NOUN	NNS	O
.	.	PUNCT	.	O

Azathioprine	Azathioprine	PROPN	NNP	B-Chemical
withdrawal	withdrawal	NOUN	NN	O
resulted	result	VERB	VBD	O
after	after	ADP	IN	O
7	7	NUM	CD	O
weeks	week	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
resolution	resolution	NOUN	NN	O
of	of	ADP	IN	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
biochemical	biochemical	ADJ	JJ	O
abnormalities	abnormality	NOUN	NNS	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
believed	believe	VERB	VBN	O
that	that	ADP	IN	O
this	this	DET	DT	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
reported	report	VERB	VBN	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
reversible	reversible	ADJ	JJ	O
azathioprine	azathioprine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cholestasis	cholestasis	NOUN	NN	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
histological	histological	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
bile	bile	ADJ	JJ	B-Disease
duct	duct	NOUN	NN	I-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Dopamine	dopamine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
not	not	ADV	RB	O
essential	essential	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
methamphetamine	methamphetamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
widely	widely	ADV	RB	O
believed	believe	VERB	VBN	O
that	that	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DA	DA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
mediates	mediate	VERB	VBZ	O
methamphetamine	methamphetamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
METH	METH	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
toxicity	toxicity	NOUN	NN	B-Disease
to	to	ADP	IN	O
brain	brain	NOUN	NN	O
dopaminergic	dopaminergic	ADJ	JJ	O
neurons	neuron	NOUN	NNS	O
,	,	PUNCT	,	O
because	because	ADP	IN	O
drugs	drug	NOUN	NNS	O
that	that	DET	WDT	O
interfere	interfere	VERB	VBP	O
with	with	ADP	IN	O
DA	DA	PROPN	NNP	B-Chemical
neurotransmission	neurotransmission	NOUN	NN	O
decrease	decrease	NOUN	NN	O
toxicity	toxicity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
drugs	drug	NOUN	NNS	O
that	that	DET	WDT	O
increase	increase	VERB	VBP	O
DA	DA	PROPN	NNP	B-Chemical
neurotransmission	neurotransmission	NOUN	NN	O
enhance	enhance	VERB	VB	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
temperature	temperature	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
drugs	drug	NOUN	NNS	O
that	that	DET	WDT	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
used	use	VERB	VBN	O
to	to	PART	TO	O
manipulate	manipulate	VERB	VB	O
brain	brain	NOUN	NN	O
DA	DA	PROPN	NNP	B-Chemical
neurotransmission	neurotransmission	NOUN	NN	O
confound	confound	NOUN	NN	O
interpretation	interpretation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
data	datum	NOUN	NNS	O
.	.	PUNCT	.	O

Here	here	ADV	RB	O
we	-PRON-	PRON	PRP	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
recently	recently	ADV	RB	O
reported	report	VERB	VBN	O
ability	ability	NOUN	NN	O
of	of	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dihydroxyphenylalanine	dihydroxyphenylalanine	NOUN	NN	I-Chemical
to	to	PART	TO	O
reverse	reverse	VERB	VB	O
the	the	DET	DT	O
protective	protective	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
para	para	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
tyrosine	tyrosine	NOUN	NN	I-Chemical
on	on	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
DA	DA	PROPN	NNP	B-Chemical
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
also	also	ADV	RB	O
confounded	confound	VERB	VBN	O
by	by	ADP	IN	O
drug	drug	NOUN	NN	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
body	body	NOUN	NN	O
temperature	temperature	NOUN	NN	O
.	.	PUNCT	.	O

Further	further	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
mice	mouse	NOUN	NNS	O
genetically	genetically	ADV	RB	O
engineered	engineer	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
deficient	deficient	ADJ	JJ	O
in	in	ADP	IN	O
brain	brain	NOUN	NN	O
DA	DA	PROPN	NNP	B-Chemical
develop	develop	VERB	VB	O
METH	METH	PROPN	NNP	B-Chemical
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
as	as	ADV	RB	O
long	long	ADV	RB	O
as	as	ADP	IN	O
the	the	DET	DT	O
thermic	thermic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
are	be	VERB	VBP	O
preserved	preserve	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
demonstrate	demonstrate	VERB	VBP	O
that	that	ADP	IN	O
mice	mouse	NOUN	NNS	O
genetically	genetically	ADV	RB	O
engineered	engineer	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
unilateral	unilateral	ADJ	JJ	O
brain	brain	NOUN	NN	O
DA	DA	PROPN	NNP	B-Chemical
deficits	deficit	NOUN	NNS	O
develop	develop	VERB	VBP	O
METH	METH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
dopaminergic	dopaminergic	ADJ	JJ	B-Disease
deficits	deficit	NOUN	NNS	I-Disease
that	that	DET	WDT	O
are	be	VERB	VBP	O
of	of	ADP	IN	O
comparable	comparable	ADJ	JJ	O
magnitude	magnitude	NOUN	NN	O
on	on	ADP	IN	O
both	both	DET	DT	O
sides	side	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
.	.	PUNCT	.	O

Taken	take	VERB	VBN	O
together	together	ADV	RB	O
,	,	PUNCT	,	O
these	these	DET	DT	O
findings	finding	NOUN	NNS	O
demonstrate	demonstrate	VERB	VBP	O
that	that	ADP	IN	O
DA	DA	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
not	not	ADV	RB	O
essential	essential	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
dopaminergic	dopaminergic	ADJ	JJ	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
mechanisms	mechanism	NOUN	NNS	O
independent	independent	ADJ	JJ	O
of	of	ADP	IN	O
DA	DA	PROPN	NNP	B-Chemical
warrant	warrant	VERB	VBP	O
more	more	ADV	RBR	O
intense	intense	ADJ	JJ	O
investigation	investigation	NOUN	NN	O
.	.	PUNCT	.	O

Swallowing	swallow	VERB	VBG	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
atrial	atrial	ADJ	JJ	B-Disease
tachyarrhythmia	tachyarrhythmia	NOUN	NN	I-Disease
triggered	trigger	VERB	VBN	O
by	by	ADP	IN	O
salbutamol	salbutamol	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
and	and	CCONJ	CC	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

CASE	case	NOUN	NN	O
:	:	PUNCT	:	O
A	a	DET	DT	O
49	49	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
patient	patient	NOUN	NN	O
experienced	experience	VERB	VBD	O
chest	chest	NOUN	NN	O
discomfort	discomfort	NOUN	NN	O
while	while	ADP	IN	O
swallowing	swallow	VERB	VBG	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
electrocardiogram	electrocardiogram	NOUN	NN	O
,	,	PUNCT	,	O
episodes	episode	NOUN	NNS	O
of	of	ADP	IN	O
atrial	atrial	ADJ	JJ	B-Disease
tachyarrhythmia	tachyarrhythmia	NOUN	NN	I-Disease
were	be	VERB	VBD	O
recorded	record	VERB	VBN	O
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
swallowing	swallow	VERB	VBG	O
;	;	PUNCT	:	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
Holter	holter	NOUN	NN	O
monitoring	monitoring	NOUN	NN	O
recorded	record	VERB	VBD	O
several	several	ADJ	JJ	O
events	event	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
resolved	resolve	VERB	VBD	O
after	after	ADP	IN	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
atenolol	atenolol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
recurred	recur	VERB	VBD	O
a	a	DET	DT	O
year	year	NOUN	NN	O
later	later	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
noticed	notice	VERB	VBD	O
that	that	ADP	IN	O
before	before	ADP	IN	O
these	these	DET	DT	O
episodes	episode	NOUN	NNS	O
he	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
using	use	VERB	VBG	O
an	an	DET	DT	O
inhalator	inhalator	NOUN	NN	O
of	of	ADP	IN	O
salbutamol	salbutamol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

After	after	ADP	IN	O
stopping	stop	VERB	VBG	O
the	the	DET	DT	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
agonist	agonist	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
a	a	DET	DT	O
week	week	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
atenolol	atenolol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
disappeared	disappear	VERB	VBD	O
.	.	PUNCT	.	O

DISCUSSION	discussion	NOUN	NN	O
:	:	PUNCT	:	O
Swallowing	swallow	VERB	VBG	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
atrial	atrial	ADJ	JJ	B-Disease
tachyarrhythmia	tachyarrhythmia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
SIAT	SIAT	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
rare	rare	ADJ	JJ	O
phenomenon	phenomenon	NOUN	NN	O
.	.	PUNCT	.	O

Fewer	few	ADJ	JJR	O
than	than	ADP	IN	O
50	50	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
SIAT	SIAT	PROPN	NNP	B-Disease
have	have	VERB	VBP	O
been	be	VERB	VBN	O
described	describe	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
article	article	NOUN	NN	O
summarizes	summarize	VERB	VBZ	O
all	all	DET	PDT	O
the	the	DET	DT	O
cases	case	NOUN	NNS	O
published	publish	VERB	VBN	O
,	,	PUNCT	,	O
creating	create	VERB	VBG	O
a	a	DET	DT	O
comprehensive	comprehensive	ADJ	JJ	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
current	current	ADJ	JJ	O
knowledge	knowledge	NOUN	NN	O
and	and	CCONJ	CC	O
approach	approach	VERB	VB	O
to	to	ADP	IN	O
SIAT	SIAT	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
discusses	discuss	VERB	VBZ	O
demographics	demographic	NOUN	NNS	O
,	,	PUNCT	,	O
clinical	clinical	ADJ	JJ	O
characteristics	characteristic	NOUN	NNS	O
and	and	CCONJ	CC	O
types	type	NOUN	NNS	O
of	of	ADP	IN	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
postulated	postulated	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
SIAT	SIAT	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
different	different	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
possibilities	possibility	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
medications	medication	NOUN	NNS	O
,	,	PUNCT	,	O
surgery	surgery	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
radiofrequency	radiofrequency	NOUN	NN	O
catheter	catheter	NOUN	NN	O
ablation	ablation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
RFCA	RFCA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Salbutamol	Salbutamol	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
presented	present	VERB	VBN	O
here	here	ADV	RB	O
as	as	ADP	IN	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
trigger	trigger	NOUN	NN	O
for	for	ADP	IN	O
SIAT	SIAT	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Although	although	ADP	IN	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
difficult	difficult	ADJ	JJ	O
to	to	PART	TO	O
define	define	VERB	VB	O
causality	causality	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
logical	logical	ADJ	JJ	O
to	to	PART	TO	O
think	think	VERB	VB	O
that	that	ADP	IN	O
a	a	DET	DT	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
agonist	agonist	NOUN	NN	O
like	like	ADP	IN	O
salbutamol	salbutamol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
known	know	VERB	VBN	O
to	to	PART	TO	O
induce	induce	VERB	VB	O
tachycardia	tachycardia	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
may	may	VERB	MD	O
be	be	VERB	VB	O
the	the	DET	DT	O
trigger	trigger	NOUN	NN	O
of	of	ADP	IN	O
adrenergic	adrenergic	NOUN	NN	O
reflexes	reflex	NOUN	NNS	O
originating	originate	VERB	VBG	O
in	in	ADP	IN	O
the	the	DET	DT	O
esophagus	esophagus	NOUN	NN	O
while	while	ADP	IN	O
swallowing	swallow	VERB	VBG	O
and	and	CCONJ	CC	O
that	that	ADP	IN	O
a	a	DET	DT	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
blocker	blocker	NOUN	NN	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
atenolol	atenolol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
that	that	DET	WDT	O
blocks	block	VERB	VBZ	O
the	the	DET	DT	O
adrenergic	adrenergic	NOUN	NN	O
activity	activity	NOUN	NN	O
)	)	PUNCT	-RRB-	O
may	may	VERB	MD	O
relieve	relieve	VERB	VB	O
it	-PRON-	PRON	PRP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
ability	ability	NOUN	NN	O
of	of	ADP	IN	O
insulin	insulin	NOUN	NN	O
treatment	treatment	NOUN	NN	O
to	to	PART	TO	O
reverse	reverse	VERB	VB	O
or	or	CCONJ	CC	O
prevent	prevent	VERB	VB	O
the	the	DET	DT	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
urinary	urinary	ADJ	JJ	O
bladder	bladder	NOUN	NN	O
function	function	NOUN	NN	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
streptozotocin	streptozotocin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
diabetes	diabetes	NOUN	NN	B-Disease
mellitus	mellitus	NOUN	NN	I-Disease
.	.	PUNCT	.	O

1	1	PUNCT	LS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
insulin	insulin	NOUN	NN	O
treatment	treatment	NOUN	NN	O
on	on	ADP	IN	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
vitro	vitro	NOUN	NN	O
urinary	urinary	ADJ	JJ	O
bladder	bladder	NOUN	NN	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
streptozotocin	streptozotocin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
diabetic	diabetic	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
.	.	PUNCT	.	O

2	2	PUNCT	LS	O
.	.	PUNCT	.	O

Diabetes	diabete	NOUN	NNS	B-Disease
of	of	ADP	IN	O
2	2	NUM	CD	O
months	month	NOUN	NNS	O
duration	duration	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
decreases	decrease	NOUN	NNS	O
in	in	ADP	IN	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
and	and	CCONJ	CC	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
fluid	fluid	ADJ	JJ	O
consumption	consumption	NOUN	NN	O
,	,	PUNCT	,	O
urine	urine	NOUN	NN	O
volume	volume	NOUN	NN	O
,	,	PUNCT	,	O
frequency	frequency	NOUN	NN	O
of	of	ADP	IN	O
micturition	micturition	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
average	average	ADJ	JJ	O
volume	volume	NOUN	NN	O
per	per	ADP	IN	O
micturition	micturition	NOUN	NN	O
;	;	PUNCT	:	O
effects	effect	NOUN	NNS	O
which	which	DET	WDT	O
were	be	VERB	VBD	O
prevented	prevent	VERB	VBN	O
by	by	ADP	IN	O
insulin	insulin	NOUN	NN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

3	3	PUNCT	LS	O
.	.	PUNCT	.	O

Insulin	Insulin	PROPN	NNP	O
treatment	treatment	NOUN	NN	O
also	also	ADV	RB	O
prevented	prevent	VERB	VBD	O
the	the	DET	DT	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
contractile	contractile	ADJ	JJ	O
responses	response	NOUN	NNS	O
of	of	ADP	IN	O
bladder	bladder	NOUN	NN	O
body	body	NOUN	NN	O
strips	strip	NOUN	NNS	O
from	from	ADP	IN	O
diabetic	diabetic	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
to	to	PART	TO	O
nerve	nerve	VERB	VB	O
stimulation	stimulation	NOUN	NN	O
,	,	PUNCT	,	O
ATP	ATP	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
bethanechol	bethanechol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

4	4	PUNCT	LS	O
.	.	PUNCT	.	O

Diabetes	diabete	NOUN	NNS	B-Disease
of	of	ADP	IN	O
4	4	NUM	CD	O
months	month	NOUN	NNS	O
duration	duration	NOUN	NN	O
also	also	ADV	RB	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
decreases	decrease	NOUN	NNS	O
in	in	ADP	IN	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
fluid	fluid	ADJ	JJ	O
consumption	consumption	NOUN	NN	O
,	,	PUNCT	,	O
urine	urine	NOUN	NN	O
volume	volume	NOUN	NN	O
,	,	PUNCT	,	O
frequency	frequency	NOUN	NN	O
of	of	ADP	IN	O
micturition	micturition	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
average	average	ADJ	JJ	O
volume	volume	NOUN	NN	O
per	per	ADP	IN	O
micturition	micturition	NOUN	NN	O
,	,	PUNCT	,	O
effects	effect	NOUN	NNS	O
which	which	DET	WDT	O
were	be	VERB	VBD	O
reversed	reverse	VERB	VBN	O
by	by	ADP	IN	O
insulin	insulin	NOUN	NN	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
final	final	ADJ	JJ	O
2	2	NUM	CD	O
months	month	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

5	5	PUNCT	LS	O
.	.	PUNCT	.	O

Insulin	Insulin	PROPN	NNP	O
treatment	treatment	NOUN	NN	O
reversed	reverse	VERB	VBD	O
the	the	DET	DT	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
contractile	contractile	ADJ	JJ	O
responses	response	NOUN	NNS	O
of	of	ADP	IN	O
bladder	bladder	NOUN	NN	O
body	body	NOUN	NN	O
strips	strip	NOUN	NNS	O
from	from	ADP	IN	O
diabetic	diabetic	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
to	to	PART	TO	O
nerve	nerve	VERB	VB	O
stimulation	stimulation	NOUN	NN	O
,	,	PUNCT	,	O
ATP	ATP	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
bethanechol	bethanechol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

6	6	PUNCT	LS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
data	datum	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
streptozotocin	streptozotocin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
diabetes	diabete	NOUN	NNS	B-Disease
on	on	ADP	IN	O
urinary	urinary	ADJ	JJ	O
bladder	bladder	NOUN	NN	O
function	function	NOUN	NN	O
are	be	VERB	VBP	O
both	both	DET	DT	O
prevented	prevent	VERB	VBN	O
and	and	CCONJ	CC	O
reversed	reverse	VERB	VBN	O
by	by	ADP	IN	O
insulin	insulin	NOUN	NN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Glutamatergic	glutamatergic	ADJ	JJ	O
neurotransmission	neurotransmission	NOUN	NN	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
receptors	receptor	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
inferior	inferior	ADJ	JJ	O
colliculus	colliculus	NOUN	NN	O
can	can	VERB	MD	O
modulate	modulate	VERB	VB	O
haloperidol	haloperidol	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
inferior	inferior	ADJ	JJ	O
colliculus	colliculus	NOUN	NN	O
(	(	PUNCT	-LRB-	O
IC	IC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
primarily	primarily	ADV	RB	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
processing	processing	NOUN	NN	O
of	of	ADP	IN	O
auditory	auditory	NOUN	NN	O
information	information	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
distinguished	distinguish	VERB	VBN	O
from	from	ADP	IN	O
other	other	ADJ	JJ	O
auditory	auditory	NOUN	NN	O
nuclei	nucleus	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
brainstem	brainstem	NOUN	NN	O
by	by	ADP	IN	O
its	-PRON-	DET	PRP$	O
connections	connection	NOUN	NNS	O
with	with	ADP	IN	O
structures	structure	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
motor	motor	NOUN	NN	O
system	system	NOUN	NN	O
.	.	PUNCT	.	O

Functional	functional	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
relating	relate	VERB	VBG	O
the	the	DET	DT	O
IC	IC	PROPN	NNP	O
to	to	PART	TO	O
motor	motor	NOUN	NN	O
behavior	behavior	NOUN	NN	O
derives	derive	NOUN	NNS	O
from	from	ADP	IN	O
experiments	experiment	NOUN	NNS	O
showing	show	VERB	VBG	O
that	that	DET	DT	O
activation	activation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
IC	IC	PROPN	NNP	O
by	by	ADP	IN	O
electrical	electrical	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
or	or	CCONJ	CC	O
excitatory	excitatory	ADJ	JJ	O
amino	amino	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
microinjection	microinjection	NOUN	NN	O
causes	cause	VERB	VBZ	O
freezing	freezing	NOUN	NN	O
,	,	PUNCT	,	O
escape	escape	NOUN	NN	O
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
behavior	behavior	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
immobility	immobility	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
nature	nature	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
immobility	immobility	NOUN	NN	O
is	be	VERB	VBZ	O
still	still	ADV	RB	O
unclear	unclear	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
examined	examine	VERB	VBD	O
the	the	DET	DT	O
influence	influence	NOUN	NN	O
of	of	ADP	IN	O
excitatory	excitatory	ADJ	JJ	O
amino	amino	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
mechanisms	mechanism	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
IC	IC	PROPN	NNP	O
on	on	ADP	IN	O
the	the	DET	DT	O
catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
dopamine	dopamine	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
blocker	blocker	NOUN	NN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
administered	administer	VERB	VBN	O
systemically	systemically	ADV	RB	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
or	or	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Haloperidol	haloperidol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
was	be	VERB	VBD	O
challenged	challenge	VERB	VBN	O
with	with	ADP	IN	O
prior	prior	ADJ	JJ	O
intracollicular	intracollicular	ADJ	JJ	O
microinjections	microinjection	NOUN	NNS	O
of	of	ADP	IN	O
glutamate	glutamate	ADJ	JJ	B-Chemical
NMDA	nmda	ADJ	JJ	B-Chemical
receptor	receptor	NOUN	NN	O
antagonists	antagonist	NOUN	NNS	O
,	,	PUNCT	,	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
15	15	NUM	CD	O
or	or	CCONJ	CC	O
30	30	NUM	CD	O
mmol	mmol	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
AP7	AP7	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
or	or	CCONJ	CC	O
20	20	NUM	CD	O
nmol	nmol	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
of	of	ADP	IN	O
the	the	DET	DT	O
NMDA	NMDA	PROPN	NNP	B-Chemical
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
d	d	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aspartate	aspartate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NMDA	NMDA	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
20	20	NUM	CD	O
or	or	CCONJ	CC	O
30	30	NUM	CD	O
nmol	nmol	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
intracollicular	intracollicular	ADJ	JJ	O
microinjection	microinjection	NOUN	NN	O
of	of	ADP	IN	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	PROPN	NNP	I-Chemical
and	and	CCONJ	CC	O
AP7	ap7	VERB	VB	B-Chemical
previous	previous	ADJ	JJ	O
to	to	ADP	IN	O
systemic	systemic	ADJ	JJ	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
significantly	significantly	ADV	RB	O
attenuated	attenuate	VERB	VBD	O
the	the	DET	DT	O
catalepsy	catalepsy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
as	as	ADP	IN	O
indicated	indicate	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
reduced	reduce	VERB	VBN	O
latency	latency	NOUN	NN	O
to	to	PART	TO	O
step	step	VERB	VB	O
down	down	PART	RP	O
from	from	ADP	IN	O
a	a	DET	DT	O
horizontal	horizontal	ADJ	JJ	O
bar	bar	NOUN	NN	O
.	.	PUNCT	.	O

Accordingly	accordingly	ADV	RB	O
,	,	PUNCT	,	O
intracollicular	intracollicular	ADJ	JJ	O
microinjection	microinjection	NOUN	NN	O
of	of	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
increased	increase	VERB	VBD	O
the	the	DET	DT	O
latency	latency	NOUN	NN	O
to	to	PART	TO	O
step	step	VERB	VB	O
down	down	PART	RP	O
the	the	DET	DT	O
bar	bar	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
glutamate	glutamate	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
mechanisms	mechanism	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
neural	neural	ADJ	JJ	O
circuits	circuit	NOUN	NNS	O
at	at	ADP	IN	O
the	the	DET	DT	O
IC	IC	PROPN	NNP	O
level	level	NOUN	NN	O
influence	influence	NOUN	NN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
participate	participate	VERB	VB	O
in	in	ADP	IN	O
the	the	DET	DT	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
motor	motor	NOUN	NN	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Severe	severe	ADJ	JJ	O
congestive	congestive	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
patient	patient	NOUN	NN	O
on	on	ADP	IN	O
amiodarone	amiodarone	ADV	RB	B-Chemical
presenting	present	VERB	VBG	O
with	with	ADP	IN	O
myxedemic	myxedemic	ADJ	JJ	B-Disease
coma	coma	NOUN	NN	I-Disease
:	:	PUNCT	:	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
myxedema	myxedema	NOUN	NN	B-Disease
coma	coma	NOUN	NN	I-Disease
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
amiodarone	amiodarone	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypothyroidism	hypothyroidism	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
congestive	congestive	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
CHF	CHF	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

To	to	ADP	IN	O
our	-PRON-	DET	PRP$	O
knowledge	knowledge	NOUN	NN	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
reviewing	review	VERB	VBG	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
there	there	ADV	EX	O
is	be	VERB	VBZ	O
one	one	NUM	CD	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
myxedema	myxedema	NOUN	NN	B-Disease
coma	coma	NOUN	NN	I-Disease
during	during	ADP	IN	O
long	long	ADJ	JJ	O
term	term	NOUN	NN	O
amiodarone	amiodarone	ADV	RB	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Myxedema	Myxedema	PROPN	NNP	B-Disease
coma	coma	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
life	life	NOUN	NN	O
threatening	threaten	VERB	VBG	O
condition	condition	NOUN	NN	O
that	that	DET	WDT	O
carries	carry	VERB	VBZ	O
a	a	DET	DT	O
mortality	mortality	NOUN	NN	O
reaching	reach	VERB	VBG	O
as	as	ADV	RB	O
high	high	ADJ	JJ	O
as	as	ADP	IN	O
20	20	NUM	CD	O
%	%	NOUN	NN	O
with	with	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
condition	condition	NOUN	NN	O
is	be	VERB	VBZ	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
thyroxine	thyroxine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
T4	T4	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
intravenous	intravenous	ADJ	JJ	O
tri	tri	NOUN	NNS	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
iodo	iodo	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
thyronine	thyronine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
T3	T3	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
CHF	CHF	PROPN	NNP	B-Disease
on	on	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
may	may	VERB	MD	O
suffer	suffer	VERB	VB	O
serious	serious	ADJ	JJ	O
morbidity	morbidity	NOUN	NN	O
and	and	CCONJ	CC	O
mortality	mortality	NOUN	NN	O
from	from	ADP	IN	O
hypothyroidism	hypothyroidism	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
thus	thus	ADV	RB	O
may	may	VERB	MD	O
deserve	deserve	VERB	VB	O
closer	close	ADJ	JJR	O
follow	follow	VERB	VB	O
up	up	PART	RP	O
for	for	ADP	IN	O
thyroid	thyroid	NOUN	NN	O
stimulating	stimulate	VERB	VBG	O
hormone	hormone	NOUN	NN	O
(	(	PUNCT	-LRB-	O
TSH	TSH	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
carries	carry	VERB	VBZ	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
application	application	NOUN	NN	O
given	give	VERB	VBN	O
the	the	DET	DT	O
frequent	frequent	ADJ	JJ	O
usage	usage	NOUN	NN	O
of	of	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
among	among	ADP	IN	O
CHF	CHF	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
myriad	myriad	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
presentation	presentation	NOUN	NN	O
of	of	ADP	IN	O
myxedema	myxedema	NOUN	NN	B-Disease
coma	coma	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
serious	serious	ADJ	JJ	O
morbidity	morbidity	NOUN	NN	O
and	and	CCONJ	CC	O
mortality	mortality	NOUN	NN	O
stresses	stress	VERB	VBZ	O
the	the	DET	DT	O
need	need	NOUN	NN	O
to	to	PART	TO	O
suspect	suspect	VERB	VB	O
this	this	DET	DT	O
clinical	clinical	ADJ	JJ	O
syndrome	syndrome	NOUN	NN	O
among	among	ADP	IN	O
CHF	CHF	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
presenting	present	VERB	VBG	O
with	with	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
weakness	weakness	NOUN	NN	B-Disease
or	or	CCONJ	CC	O
other	other	ADJ	JJ	O
unexplained	unexplained	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
active	active	ADJ	JJ	O
constituents	constituent	NOUN	NNS	O
of	of	ADP	IN	O
Crocus	Crocus	PROPN	NNP	O
sativus	sativus	NOUN	NN	O
L	L	PROPN	NNP	O
.	.	PROPN	NNP	O
,	,	PUNCT	,	O
crocin	crocin	NOUN	NN	B-Chemical
on	on	ADP	IN	O
streptozocin	streptozocin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
sporadic	sporadic	ADJ	JJ	O
Alzheimer	Alzheimer	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
in	in	ADP	IN	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
involvement	involvement	NOUN	NN	O
of	of	ADP	IN	O
water	water	NOUN	NN	O
-	-	PUNCT	HYPH	O
soluble	soluble	ADJ	JJ	O
carotenoids	carotenoid	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
crocins	crocin	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
as	as	ADP	IN	O
the	the	DET	DT	O
main	main	ADJ	JJ	O
and	and	CCONJ	CC	O
active	active	ADJ	JJ	O
components	component	NOUN	NNS	O
of	of	ADP	IN	O
Crocus	Crocus	PROPN	NNP	O
sativus	sativus	NOUN	NN	O
L	L	PROPN	NNP	O
.	.	PUNCT	.	O
extract	extract	NOUN	NN	O
in	in	ADP	IN	O
learning	learning	NOUN	NN	O
and	and	CCONJ	CC	O
memory	memory	NOUN	NN	O
processes	process	NOUN	NNS	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
proposed	propose	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
crocins	crocin	NOUN	NNS	B-Chemical
on	on	ADP	IN	O
sporadic	sporadic	ADJ	JJ	O
Alzheimer	Alzheimer	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
intracerebroventricular	intracerebroventricular	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
icv	icv	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
streptozocin	streptozocin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
STZ	STZ	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
was	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Male	male	ADJ	JJ	O
adult	adult	NOUN	NN	O
Wistar	wistar	NOUN	NN	O
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
90	90	NUM	CD	O
and	and	CCONJ	CC	O
260	260	NUM	CD	O
-	-	SYM	SYM	O
290	290	NUM	CD	O
g	g	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
divided	divide	VERB	VBN	O
into	into	ADP	IN	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
control	control	NOUN	NN	O
;	;	PUNCT	:	O
2	2	NUM	CD	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
,	,	PUNCT	,	O
crocins	crocin	NOUN	NNS	B-Chemical
(	(	PUNCT	-LRB-	O
15	15	NUM	CD	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
STZ	STZ	PROPN	NNP	B-Chemical
;	;	PUNCT	:	O
5	5	NUM	CD	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
,	,	PUNCT	,	O
STZ	STZ	PROPN	NNP	B-Chemical
+	+	SYM	SYM	O
crocins	crocin	NOUN	NNS	B-Chemical
(	(	PUNCT	-LRB-	O
15	15	NUM	CD	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
Alzheimer	Alzheimer	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
injected	inject	VERB	VBN	O
with	with	ADP	IN	O
STZ	STZ	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
icv	icv	VERB	VBN	O
bilaterally	bilaterally	ADV	RB	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
first	first	ADJ	JJ	O
day	day	NOUN	NN	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
days	day	NOUN	NNS	O
later	later	ADV	RB	O
,	,	PUNCT	,	O
a	a	DET	DT	O
similar	similar	ADJ	JJ	O
STZ	STZ	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
icv	icv	VERB	VBN	O
application	application	NOUN	NN	O
was	be	VERB	VBD	O
repeated	repeat	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
STZ	STZ	PROPN	NNP	B-Chemical
+	+	SYM	SYM	O
crocin	crocin	ADJ	JJ	B-Chemical
animal	animal	NOUN	NN	O
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
crocin	crocin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
applied	apply	VERB	VBN	O
in	in	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
15	15	NUM	CD	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
,	,	PUNCT	,	O
one	one	NUM	CD	O
day	day	NOUN	NN	O
pre	pre	ADJ	JJ	O
-	-	NOUN	NN	O
surgery	surgery	NOUN	NN	O
and	and	CCONJ	CC	O
continued	continue	VERB	VBD	O
for	for	ADP	IN	O
three	three	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

Prescription	prescription	NOUN	NN	O
of	of	ADP	IN	O
crocin	crocin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
each	each	DET	DT	O
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
repeated	repeat	VERB	VBN	O
once	once	ADV	RB	O
for	for	ADP	IN	O
two	two	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
learning	learning	NOUN	NN	O
and	and	CCONJ	CC	O
memory	memory	NOUN	NN	O
performance	performance	NOUN	NN	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
using	use	VERB	VBG	O
passive	passive	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
paradigm	paradigm	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
for	for	ADP	IN	O
spatial	spatial	ADJ	JJ	O
cognition	cognition	NOUN	NN	O
evaluation	evaluation	NOUN	NN	O
,	,	PUNCT	,	O
Y	Y	PROPN	NNP	O
-	-	PUNCT	HYPH	O
maze	maze	NOUN	NN	O
task	task	NOUN	NN	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
It	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
out	out	PART	RP	O
that	that	ADP	IN	O
crocin	crocin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
STZ	STZ	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
injected	inject	VERB	VBN	O
rats	rat	NOUN	NNS	O
show	show	VERB	VBP	O
higher	high	ADJ	JJR	O
correct	correct	ADJ	JJ	O
choices	choice	NOUN	NNS	O
and	and	CCONJ	CC	O
lower	low	ADJ	JJR	O
errors	error	NOUN	NNS	O
in	in	ADP	IN	O
Y	Y	PROPN	NNP	O
-	-	PUNCT	HYPH	O
maze	maze	PROPN	NNP	O
than	than	ADP	IN	O
vehicle	vehicle	NOUN	NN	O
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
STZ	STZ	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
injected	inject	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
crocin	crocin	ADJ	JJ	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
mentioned	mention	VERB	VBN	O
dose	dose	NOUN	NN	O
could	could	VERB	MD	O
significantly	significantly	ADV	RB	O
attenuated	attenuate	VERB	VBN	O
learning	learning	NOUN	NN	B-Disease
and	and	CCONJ	CC	I-Disease
memory	memory	NOUN	NN	I-Disease
impairment	impairment	NOUN	NN	I-Disease
in	in	ADP	IN	O
treated	treated	ADJ	JJ	O
STZ	STZ	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
injected	inject	VERB	VBN	O
group	group	NOUN	NN	O
in	in	ADP	IN	O
passive	passive	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
test	test	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Therefore	therefore	ADV	RB	O
,	,	PUNCT	,	O
these	these	DET	DT	O
results	result	NOUN	NNS	O
demonstrate	demonstrate	VERB	VBP	O
the	the	DET	DT	O
effectiveness	effectiveness	NOUN	NN	O
of	of	ADP	IN	O
crocin	crocin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
antagonizing	antagonize	VERB	VBG	O
the	the	DET	DT	O
cognitive	cognitive	ADJ	JJ	B-Disease
deficits	deficit	NOUN	NNS	I-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
STZ	STZ	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
icv	icv	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
potential	potential	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
neurodegenerative	neurodegenerative	ADJ	JJ	B-Disease
diseases	disease	NOUN	NNS	I-Disease
such	such	ADJ	JJ	O
as	as	ADP	IN	O
Alzheimer	Alzheimer	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Serotonin	serotonin	ADP	IN	B-Chemical
6	6	NUM	CD	O
receptor	receptor	NOUN	NN	O
gene	gene	NOUN	NN	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
methamphetamine	methamphetamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
psychosis	psychosis	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
Japanese	japanese	ADJ	JJ	O
population	population	NOUN	NN	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Altered	alter	VERB	VBN	O
serotonergic	serotonergic	ADJ	JJ	O
neural	neural	ADJ	JJ	O
transmission	transmission	NOUN	NN	O
is	be	VERB	VBZ	O
hypothesized	hypothesize	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
a	a	DET	DT	O
susceptibility	susceptibility	NOUN	NN	O
factor	factor	NOUN	NN	O
for	for	ADP	IN	O
psychotic	psychotic	ADJ	JJ	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
such	such	ADJ	JJ	O
as	as	ADP	IN	O
schizophrenia	schizophrenia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
serotonin	serotonin	NOUN	NN	B-Chemical
6	6	NUM	CD	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT6	ht6	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
receptor	receptor	NOUN	NN	O
is	be	VERB	VBZ	O
therapeutically	therapeutically	ADV	RB	O
targeted	target	VERB	VBN	O
by	by	ADP	IN	O
several	several	ADJ	JJ	O
second	second	ADJ	JJ	O
generation	generation	NOUN	NN	O
antipsychotics	antipsychotic	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
clozapine	clozapine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
olanzapine	olanzapine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
d	d	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
amphetamine	amphetamine	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperactivity	hyperactivity	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
is	be	VERB	VBZ	O
corrected	correct	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
selective	selective	ADJ	JJ	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT6	HT6	PROPN	NNP	I-Chemical
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
disrupted	disrupt	VERB	VBN	O
prepulse	prepulse	NOUN	NN	O
inhibition	inhibition	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
d	d	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
amphetamine	amphetamine	NOUN	NN	I-Chemical
or	or	CCONJ	CC	O
phencyclidine	phencyclidine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
restored	restore	VERB	VBN	O
by	by	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT6	ht6	PART	RP	I-Chemical
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
in	in	ADP	IN	O
an	an	DET	DT	O
animal	animal	NOUN	NN	O
study	study	NOUN	NN	O
using	use	VERB	VBG	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
animal	animal	NOUN	NN	O
models	model	NOUN	NNS	O
were	be	VERB	VBD	O
considered	consider	VERB	VBN	O
to	to	PART	TO	O
reflect	reflect	VERB	VB	O
the	the	DET	DT	O
positive	positive	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
schizophrenia	schizophrenia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
above	above	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
altered	alter	VERB	VBN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT6	HT6	PROPN	NNP	I-Chemical
receptors	receptor	NOUN	NNS	O
are	be	VERB	VBP	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pathophysiology	pathophysiology	NOUN	NN	O
of	of	ADP	IN	O
psychotic	psychotic	ADJ	JJ	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
methamphetamine	methamphetamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
METH	METH	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
psychosis	psychosis	NOUN	NN	B-Disease
are	be	VERB	VBP	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
paranoid	paranoid	ADJ	JJ	B-Disease
type	type	NOUN	NN	I-Disease
schizophrenia	schizophrenia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Therefore	therefore	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
conducted	conduct	VERB	VBD	O
an	an	DET	DT	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
association	association	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT6	HT6	PROPN	NNP	I-Chemical
gene	gene	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HTR6	HTR6	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
psychosis	psychosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

METHOD	method	NOUN	NN	O
:	:	PUNCT	:	O
Using	use	VERB	VBG	O
five	five	NUM	CD	O
tagging	tagging	NOUN	NN	O
SNPs	snp	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
rs6693503	rs6693503	PROPN	NNP	O
,	,	PUNCT	,	O
rs1805054	rs1805054	PROPN	NNP	O
,	,	PUNCT	,	O
rs4912138	rs4912138	INTJ	UH	O
,	,	PUNCT	,	O
rs3790757	rs3790757	PROPN	NNPS	O
and	and	CCONJ	CC	O
rs9659997	rs9659997	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
conducted	conduct	VERB	VBD	O
a	a	DET	DT	O
genetic	genetic	ADJ	JJ	O
association	association	NOUN	NN	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
case	case	NOUN	NN	O
-	-	PUNCT	HYPH	O
control	control	NOUN	NN	O
samples	sample	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
197	197	NUM	CD	O
METH	METH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
psychosis	psychosis	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
and	and	CCONJ	CC	O
337	337	NUM	CD	O
controls	control	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
Japanese	japanese	ADJ	JJ	O
population	population	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
age	age	NOUN	NN	O
and	and	CCONJ	CC	O
sex	sex	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
subjects	subject	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
differ	differ	VERB	VB	O
from	from	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
methamphetamine	methamphetamine	NOUN	NN	B-Chemical
dependence	dependence	NOUN	NN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
rs6693503	rs6693503	PROPN	NNP	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
psychosis	psychosis	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
allele	allele	NOUN	NN	O
/	/	SYM	SYM	O
genotype	genotype	NOUN	NN	O
-	-	PUNCT	HYPH	O
wise	wise	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
this	this	DET	DT	O
association	association	NOUN	NN	O
remained	remain	VERB	VBD	O
significant	significant	ADJ	JJ	O
after	after	ADP	IN	O
Bonferroni	Bonferroni	PROPN	NNP	O
correction	correction	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
haplotype	haplotype	NOUN	NN	O
-	-	PUNCT	HYPH	O
wise	wise	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
detected	detect	VERB	VBD	O
an	an	DET	DT	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
two	two	NUM	CD	O
markers	marker	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
rs6693503	rs6693503	PROPN	NNP	O
and	and	CCONJ	CC	O
rs1805054	rs1805054	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
three	three	NUM	CD	O
markers	marker	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
rs6693503	rs6693503	PROPN	NNP	O
,	,	PUNCT	,	O
rs1805054	rs1805054	PROPN	NNP	O
and	and	CCONJ	CC	O
rs4912138	rs4912138	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
HTR6	HTR6	PROPN	NNP	O
and	and	CCONJ	CC	O
METH	METH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
psychosis	psychosis	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
HTR6	HTR6	PROPN	NNP	O
may	may	VERB	MD	O
play	play	VERB	VB	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pathophysiology	pathophysiology	NOUN	NN	O
of	of	ADP	IN	O
METH	METH	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
psychosis	psychosis	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
Japanese	japanese	ADJ	JJ	O
population	population	NOUN	NN	O
.	.	PUNCT	.	O

Neural	neural	ADJ	JJ	O
correlates	correlate	NOUN	NNS	O
of	of	ADP	IN	O
S	S	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
ketamine	ketamine	PROPN	NNP	I-Chemical
induced	induced	ADJ	JJ	O
psychosis	psychosis	NOUN	NN	B-Disease
during	during	ADP	IN	O
overt	overt	ADJ	JJ	O
continuous	continuous	ADJ	JJ	O
verbal	verbal	ADJ	JJ	O
fluency	fluency	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
glutamatergic	glutamatergic	ADJ	JJ	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
D	d	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aspartate	aspartate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NMDA	NMDA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
receptor	receptor	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pathophysiology	pathophysiology	NOUN	NN	O
of	of	ADP	IN	O
schizophrenia	schizophrenia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Administered	administer	VERB	VBN	O
to	to	ADP	IN	O
healthy	healthy	ADJ	JJ	O
volunteers	volunteer	NOUN	NNS	O
,	,	PUNCT	,	O
a	a	DET	DT	O
subanesthetic	subanesthetic	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
competitive	competitive	ADJ	JJ	O
NMDA	nmda	ADJ	JJ	B-Chemical
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
ketamine	ketamine	NOUN	NN	B-Chemical
leads	lead	VERB	VBZ	O
to	to	ADP	IN	O
psychopathological	psychopathological	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
schizophrenia	schizophrenia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
schizophrenia	schizophrenia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
ketamine	ketamine	NOUN	NN	B-Chemical
exacerbates	exacerbate	VERB	VBZ	O
the	the	DET	DT	O
core	core	NOUN	NN	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
illness	illness	NOUN	NN	O
,	,	PUNCT	,	O
supporting	support	VERB	VBG	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
glutamatergic	glutamatergic	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
a	a	DET	DT	O
counterbalanced	counterbalanced	ADJ	JJ	O
,	,	PUNCT	,	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
study	study	NOUN	NN	O
design	design	NOUN	NN	O
,	,	PUNCT	,	O
healthy	healthy	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
were	be	VERB	VBD	O
administered	administer	VERB	VBN	O
a	a	DET	DT	O
continuous	continuous	ADJ	JJ	O
subanesthetic	subanesthetic	ADJ	JJ	O
S	S	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
ketamine	ketamine	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
while	while	ADP	IN	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
BOLD	BOLD	PROPN	NNP	O
responses	response	NOUN	NNS	O
measured	measure	VERB	VBN	O
with	with	ADP	IN	O
fMRI	fMRI	PROPN	NNP	O
were	be	VERB	VBD	O
detected	detect	VERB	VBN	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
the	the	DET	DT	O
scanning	scanning	NOUN	NN	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
subjects	subject	NOUN	NNS	O
performed	perform	VERB	VBD	O
continuous	continuous	ADJ	JJ	O
overt	overt	ADJ	JJ	O
verbal	verbal	ADJ	JJ	O
fluency	fluency	NOUN	NN	O
tasks	task	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
phonological	phonological	ADJ	JJ	O
,	,	PUNCT	,	O
lexical	lexical	ADJ	JJ	O
and	and	CCONJ	CC	O
semantic	semantic	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Ketamine	ketamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
psychopathological	psychopathological	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
Positive	Positive	PROPN	NNP	O
and	and	CCONJ	CC	O
Negative	Negative	PROPN	NNP	O
Syndrome	Syndrome	PROPN	NNP	O
Scale	Scale	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
PANSS	PANSS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Ketamine	Ketamine	PROPN	NNP	B-Chemical
elicited	elicit	VERB	VBD	O
psychosis	psychosis	NOUN	NN	B-Disease
like	like	ADP	IN	O
psychopathology	psychopathology	NOUN	NN	O
.	.	PUNCT	.	O

Post	Post	PROPN	NNP	O
-	-	PUNCT	HYPH	O
hoc	hoc	X	FW	O
t	t	NOUN	NN	O
-	-	PUNCT	HYPH	O
tests	test	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
placebo	placebo	NOUN	NN	O
and	and	CCONJ	CC	O
ketamine	ketamine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
the	the	DET	DT	O
amounts	amount	NOUN	NNS	O
of	of	ADP	IN	O
words	word	NOUN	NNS	O
generated	generate	VERB	VBN	O
during	during	ADP	IN	O
lexical	lexical	ADJ	JJ	O
and	and	CCONJ	CC	O
semantic	semantic	ADJ	JJ	O
verbal	verbal	ADJ	JJ	O
fluency	fluency	NOUN	NN	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
the	the	DET	DT	O
phonological	phonological	ADJ	JJ	O
domain	domain	NOUN	NN	O
remained	remain	VERB	VBD	O
unaffected	unaffected	ADJ	JJ	O
.	.	PUNCT	.	O

Ketamine	Ketamine	PROPN	NNP	B-Chemical
led	lead	VERB	VBD	O
to	to	ADP	IN	O
enhanced	enhance	VERB	VBN	O
cortical	cortical	ADJ	JJ	O
activations	activation	NOUN	NNS	O
in	in	ADP	IN	O
supramarginal	supramarginal	ADJ	JJ	O
and	and	CCONJ	CC	O
frontal	frontal	ADJ	JJ	O
brain	brain	NOUN	NN	O
regions	region	NOUN	NNS	O
for	for	ADP	IN	O
phonological	phonological	ADJ	JJ	O
and	and	CCONJ	CC	O
lexical	lexical	ADJ	JJ	O
verbal	verbal	ADJ	JJ	O
fluency	fluency	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
for	for	ADP	IN	O
semantic	semantic	ADJ	JJ	O
verbal	verbal	ADJ	JJ	O
fluency	fluency	NOUN	NN	O
.	.	PUNCT	.	O

Ketamine	ketamine	NOUN	NN	B-Chemical
induces	induce	VERB	VBZ	O
activation	activation	NOUN	NN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
healthy	healthy	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
schizophrenia	schizophrenia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
particularly	particularly	ADV	RB	O
in	in	ADP	IN	O
frontal	frontal	ADJ	JJ	O
and	and	CCONJ	CC	O
temporal	temporal	ADJ	JJ	O
brain	brain	NOUN	NN	O
regions	region	NOUN	NNS	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
provide	provide	VERB	VBP	O
further	further	ADJ	JJ	O
support	support	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
NMDA	nmda	ADJ	JJ	B-Chemical
receptor	receptor	NOUN	NN	O
dysfunction	dysfunction	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pathophysiology	pathophysiology	NOUN	NN	O
of	of	ADP	IN	O
schizophrenia	schizophrenia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
prognosis	prognosis	NOUN	NN	O
for	for	ADP	IN	O
transplant	transplant	NOUN	NN	O
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
survivors	survivor	NOUN	NNS	O
of	of	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
prognosis	prognosis	NOUN	NN	O
for	for	ADP	IN	O
transplant	transplant	NOUN	NN	O
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
survivors	survivor	NOUN	NNS	O
of	of	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
remains	remain	VERB	VBZ	O
unknown	unknown	ADJ	JJ	O
.	.	PUNCT	.	O

AIM	AIM	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
examine	examine	VERB	VB	O
whether	whether	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
increases	increase	VERB	VBZ	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
mortality	mortality	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
followed	follow	VERB	VBD	O
up	up	PART	RP	O
all	all	DET	DT	O
transplant	transplant	NOUN	NN	O
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
survivors	survivor	NOUN	NNS	O
of	of	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
injury	injury	NOUN	NN	I-Disease
,	,	PUNCT	,	O
hospitalized	hospitalize	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
Danish	danish	ADJ	JJ	O
national	national	ADJ	JJ	O
referral	referral	ADJ	JJ	O
centre	centre	NOUN	NN	O
during	during	ADP	IN	O
1984	1984	NUM	CD	O
-	-	SYM	SYM	O
2004	2004	NUM	CD	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
compared	compare	VERB	VBD	O
age	age	NOUN	NN	O
-	-	PUNCT	HYPH	O
specific	specific	ADJ	JJ	O
mortality	mortality	NOUN	NN	O
rates	rate	NOUN	NNS	O
from	from	ADP	IN	O
1	1	NUM	CD	O
year	year	NOUN	NN	O
post	post	ADJ	JJ	O
-	-	ADJ	JJ	O
discharge	discharge	NOUN	NN	O
through	through	ADP	IN	O
2008	2008	NUM	CD	O
between	between	ADP	IN	O
those	those	DET	DT	O
in	in	ADP	IN	O
whom	whom	PRON	WP	O
the	the	DET	DT	O
liver	liver	NOUN	NN	B-Disease
injury	injury	NOUN	NN	I-Disease
led	lead	VERB	VBD	O
to	to	ADP	IN	O
an	an	DET	DT	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
those	those	DET	DT	O
in	in	ADP	IN	O
whom	whom	PRON	WP	O
it	-PRON-	PRON	PRP	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
included	include	VERB	VBD	O
641	641	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
average	average	ADJ	JJ	O
,	,	PUNCT	,	O
age	age	NOUN	NN	O
-	-	PUNCT	HYPH	O
specific	specific	ADJ	JJ	O
mortality	mortality	NOUN	NN	O
rates	rate	NOUN	NNS	O
were	be	VERB	VBD	O
slightly	slightly	ADV	RB	O
higher	high	ADJ	JJR	O
for	for	ADP	IN	O
the	the	DET	DT	O
101	101	NUM	CD	O
patients	patient	NOUN	NNS	O
whose	whose	DET	WP$	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
liver	liver	NOUN	NN	B-Disease
injury	injury	NOUN	NN	I-Disease
had	have	VERB	VBD	O
caused	cause	VERB	VBN	O
an	an	DET	DT	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
adjusted	adjust	VERB	VBN	O
mortality	mortality	NOUN	NN	O
rate	rate	NOUN	NN	O
ratio	ratio	NOUN	NN	O
=	=	VERB	VBZ	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
70	70	NUM	CD	O
,	,	PUNCT	,	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
02	02	NUM	CD	O
-	-	SYM	SYM	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
85	85	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
association	association	NOUN	NN	O
was	be	VERB	VBD	O
age	age	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
no	no	DET	DT	O
survivors	survivor	NOUN	NNS	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
died	die	VERB	VBD	O
of	of	ADP	IN	O
liver	liver	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
suicides	suicide	NOUN	NNS	O
were	be	VERB	VBD	O
frequent	frequent	ADJ	JJ	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
observations	observation	NOUN	NNS	O
speak	speak	VERB	VBP	O
against	against	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

More	more	ADV	RBR	O
likely	likely	ADJ	JJ	O
,	,	PUNCT	,	O
the	the	DET	DT	O
elevated	elevated	ADJ	JJ	O
mortality	mortality	NOUN	NN	O
rate	rate	NOUN	NN	O
ratio	ratio	NOUN	NN	O
resulted	result	VERB	VBD	O
from	from	ADP	IN	O
incomplete	incomplete	ADJ	JJ	O
adjustment	adjustment	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
greater	great	ADJ	JJR	O
prevalence	prevalence	NOUN	NN	O
of	of	ADP	IN	O
substance	substance	NOUN	NN	B-Disease
abuse	abuse	NOUN	NN	I-Disease
among	among	ADP	IN	O
survivors	survivor	NOUN	NNS	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Paracetamol	paracetamol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
did	do	VERB	VBD	O
not	not	ADV	RB	O
affect	affect	VERB	VB	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
mortality	mortality	NOUN	NN	O
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
justified	justify	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
liver	liver	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
by	by	ADP	IN	O
the	the	DET	DT	O
liver	liver	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
itself	-PRON-	PRON	PRP	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
characterization	characterization	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
dual	dual	ADJ	JJ	O
adenosine	adenosine	NOUN	NN	B-Chemical
A2A	A2A	PROPN	NNP	I-Chemical
/	/	SYM	SYM	I-Chemical
A1	A1	PROPN	NNP	I-Chemical
receptor	receptor	NOUN	NN	I-Chemical
antagonist	antagonist	NOUN	NN	I-Chemical
in	in	ADP	IN	O
animal	animal	NOUN	NN	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
characterization	characterization	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
dual	dual	ADJ	JJ	O
adenosine	adenosine	NOUN	NN	B-Chemical
A	a	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2A	2a	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
/	/	SYM	SYM	I-Chemical
A	a	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
1	1	NUM	CD	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
receptor	receptor	NOUN	NN	I-Chemical
antagonist	antagonist	NOUN	NN	I-Chemical
in	in	ADP	IN	O
several	several	ADJ	JJ	O
animal	animal	NOUN	NN	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
described	describe	VERB	VBN	O
.	.	PUNCT	.	O

Discovery	discovery	NOUN	NN	O
and	and	CCONJ	CC	O
scale	scale	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
syntheses	synthesis	NOUN	NNS	O
of	of	ADP	IN	O
compound	compound	NOUN	NN	O
1	1	NUM	CD	O
are	be	VERB	VBP	O
described	describe	VERB	VBN	O
in	in	ADP	IN	O
detail	detail	NOUN	NN	O
,	,	PUNCT	,	O
highlighting	highlight	VERB	VBG	O
optimization	optimization	NOUN	NN	O
steps	step	NOUN	NNS	O
that	that	DET	WDT	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
overall	overall	ADJ	JJ	O
yield	yield	NOUN	NN	O
of	of	ADP	IN	O
1	1	NUM	CD	O
from	from	ADP	IN	O
10	10	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
to	to	ADP	IN	O
30	30	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

Compound	Compound	PROPN	NNP	O
1	1	NUM	CD	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
potent	potent	ADJ	JJ	O
A	a	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2A	2a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
/	/	SYM	SYM	O
A	a	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
in	in	ADP	IN	O
vitro	vitro	X	FW	O
(	(	PUNCT	-LRB-	O
A	a	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2A	2a	NOUN	NN	O
)	)	PUNCT	-RRB-	O
K	K	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
)	)	PUNCT	-RRB-	O
=	=	VERB	VBZ	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
nM	nm	NOUN	NN	O
;	;	PUNCT	:	O
A	a	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
K	K	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
)	)	PUNCT	-RRB-	O
=	=	SYM	SYM	O
17	17	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
nM	nm	X	XX	O
)	)	PUNCT	-RRB-	O
that	that	DET	WDT	O
has	have	VERB	VBZ	O
excellent	excellent	ADJ	JJ	O
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
after	after	ADP	IN	O
oral	oral	ADJ	JJ	O
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
across	across	ADP	IN	O
a	a	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
animal	animal	NOUN	NN	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
including	include	VERB	VBG	O
mouse	mouse	NOUN	NN	O
and	and	CCONJ	CC	O
rat	rat	NOUN	NN	O
models	model	NOUN	NNS	O
of	of	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
mouse	mouse	NOUN	NN	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
akinesia	akinesia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
rat	rat	NOUN	NN	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxydopamine	hydroxydopamine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
OHDA	ohda	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
lesion	lesion	NOUN	NN	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
rotation	rotation	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
MPTP	MPTP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
human	human	ADJ	JJ	O
primate	primate	ADJ	JJ	O
model	model	NOUN	NN	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
hippocampal	hippocampal	ADJ	JJ	O
deep	deep	ADJ	JJ	O
brain	brain	NOUN	NN	O
stimulation	stimulation	NOUN	NN	O
on	on	ADP	IN	O
cortical	cortical	ADJ	JJ	O
epileptic	epileptic	ADJ	JJ	B-Disease
discharges	discharge	NOUN	NNS	O
in	in	ADP	IN	O
penicillin	penicillin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
epilepsy	epilepsy	NOUN	NN	B-Disease
model	model	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

AIM	AIM	PROPN	NNP	O
:	:	PUNCT	:	O
Experimental	experimental	ADJ	JJ	O
and	and	CCONJ	CC	O
clinical	clinical	ADJ	JJ	O
studies	study	NOUN	NNS	O
have	have	VERB	VBP	O
revealed	reveal	VERB	VBN	O
that	that	ADP	IN	O
hippocampal	hippocampal	ADJ	JJ	O
DBS	DBS	PROPN	NNP	O
can	can	VERB	MD	O
control	control	VERB	VB	O
epileptic	epileptic	ADJ	JJ	B-Disease
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
action	action	NOUN	NN	O
is	be	VERB	VBZ	O
obscure	obscure	ADJ	JJ	O
and	and	CCONJ	CC	O
optimal	optimal	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
parameters	parameter	NOUN	NNS	O
are	be	VERB	VBP	O
not	not	ADV	RB	O
clearly	clearly	ADV	RB	O
defined	define	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
aim	aim	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
hippocampal	hippocampal	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
on	on	ADP	IN	O
cortical	cortical	ADJ	JJ	O
epileptic	epileptic	ADJ	JJ	B-Disease
activity	activity	NOUN	NN	O
in	in	ADP	IN	O
penicillin	penicillin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
epilepsy	epilepsy	NOUN	NN	B-Disease
model	model	NOUN	NN	O
.	.	PUNCT	.	O

MATERIAL	MATERIAL	PROPN	NNP	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
five	five	NUM	CD	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
implanted	implant	VERB	VBN	O
DBS	DBS	PROPN	NNP	O
electrodes	electrode	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
group	group	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
10	10	NUM	CD	O
)	)	PUNCT	-RRB-	O
hippocampal	hippocampal	ADJ	JJ	O
DBS	DBS	PROPN	NNP	O
was	be	VERB	VBD	O
off	off	ADV	RB	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
the	the	DET	DT	O
group	group	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
10	10	NUM	CD	O
)	)	PUNCT	-RRB-	O
hippocampal	hippocampal	ADJ	JJ	O
DBS	DBS	PROPN	NNP	O
was	be	VERB	VBD	O
on	on	ADP	IN	O
(	(	PUNCT	-LRB-	O
185	185	NUM	CD	O
Hz	Hz	PROPN	NNP	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5V	5v	NOUN	NN	O
,	,	PUNCT	,	O
1V	1V	PROPN	NNP	O
,	,	PUNCT	,	O
2V	2V	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
5V	5V	PROPN	NNP	O
for	for	ADP	IN	O
60	60	NUM	CD	O
sec	sec	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
following	follow	VERB	VBG	O
penicillin	penicillin	NOUN	NN	B-Chemical
G	g	NOUN	NN	I-Chemical
injection	injection	NOUN	NN	O
intracortically	intracortically	ADV	RB	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
hippocampal	hippocampal	ADJ	JJ	O
DBS	DBS	PROPN	NNP	O
was	be	VERB	VBD	O
on	on	ADP	IN	O
following	follow	VERB	VBG	O
8	8	NUM	CD	O
l	l	NOUN	NN	O
saline	saline	NOUN	NN	O
injection	injection	NOUN	NN	O
intracortically	intracortically	ADV	RB	O
.	.	PUNCT	.	O

EEG	EEG	PROPN	NNP	O
recordings	recording	NOUN	NNS	O
were	be	VERB	VBD	O
obtained	obtain	VERB	VBN	O
before	before	ADV	RB	O
and	and	CCONJ	CC	O
15	15	NUM	CD	O
minutes	minute	NOUN	NNS	O
following	follow	VERB	VBG	O
penicillin	penicillin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
G	g	NOUN	NN	I-Chemical
injection	injection	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
at	at	ADP	IN	O
10th	10th	ADJ	JJ	O
minutes	minute	NOUN	NNS	O
following	follow	VERB	VBG	O
each	each	DET	DT	O
stimulus	stimulus	NOUN	NN	O
for	for	ADP	IN	O
analysis	analysis	NOUN	NN	O
in	in	ADP	IN	O
terms	term	NOUN	NNS	O
of	of	ADP	IN	O
frequency	frequency	NOUN	NN	O
,	,	PUNCT	,	O
amplitude	amplitude	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
power	power	NOUN	NN	O
spectrum	spectrum	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
High	high	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
hippocampal	hippocampal	ADJ	JJ	O
DBS	DBS	PROPN	NNP	O
suppressed	suppress	VERB	VBD	O
the	the	DET	DT	O
acute	acute	ADJ	JJ	O
penicillin	penicillin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cortical	cortical	ADJ	JJ	O
epileptic	epileptic	ADJ	JJ	B-Disease
activity	activity	NOUN	NN	O
independent	independent	ADJ	JJ	O
from	from	ADP	IN	O
stimulus	stimulus	NOUN	NN	O
intensity	intensity	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
hippocampal	hippocampal	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
alone	alone	ADV	RB	O
lead	lead	VERB	VB	O
only	only	ADV	RB	O
to	to	PART	TO	O
diffuse	diffuse	VERB	VB	O
slowing	slowing	NOUN	NN	O
of	of	ADP	IN	O
cerebral	cerebral	ADJ	JJ	O
bioelectrical	bioelectrical	ADJ	JJ	O
activity	activity	NOUN	NN	O
at	at	ADP	IN	O
5V	5V	PROPN	NNP	O
stimulation	stimulation	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
that	that	ADP	IN	O
continuous	continuous	ADJ	JJ	O
high	high	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
stimulation	stimulation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hippocampus	hippocampus	NOUN	NN	O
suppressed	suppress	VERB	VBD	O
acute	acute	ADJ	JJ	O
cortical	cortical	ADJ	JJ	O
epileptic	epileptic	ADJ	JJ	B-Disease
activity	activity	NOUN	NN	O
effectively	effectively	ADV	RB	O
without	without	ADP	IN	O
causing	cause	VERB	VBG	O
secondary	secondary	ADJ	JJ	O
epileptic	epileptic	ADJ	JJ	B-Disease
discharges	discharge	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
are	be	VERB	VBP	O
important	important	ADJ	JJ	O
in	in	ADP	IN	O
terms	term	NOUN	NNS	O
of	of	ADP	IN	O
defining	define	VERB	VBG	O
the	the	DET	DT	O
optimal	optimal	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
of	of	ADP	IN	O
hippocampal	hippocampal	ADJ	JJ	O
DBS	DBS	PROPN	NNP	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
epilepsy	epilepsy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

CCNU	CCNU	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
lomustine	lomustine	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
toxicity	toxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
dogs	dog	NOUN	NNS	O
:	:	PUNCT	:	O
a	a	DET	DT	O
retrospective	retrospective	ADJ	JJ	O
study	study	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2002	2002	NUM	CD	O
-	-	SYM	SYM	O
07	07	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
describe	describe	VERB	VB	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
haematological	haematological	ADJ	JJ	B-Disease
,	,	PUNCT	,	I-Disease
renal	renal	ADJ	JJ	I-Disease
,	,	PUNCT	,	I-Disease
hepatic	hepatic	ADJ	JJ	I-Disease
and	and	CCONJ	CC	I-Disease
gastrointestinal	gastrointestinal	ADJ	JJ	I-Disease
toxicities	toxicity	NOUN	NNS	I-Disease
in	in	ADP	IN	O
tumour	tumour	NOUN	NN	O
-	-	PUNCT	HYPH	O
bearing	bear	VERB	VBG	O
dogs	dog	NOUN	NNS	O
receiving	receive	VERB	VBG	O
1	1	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
chloroethyl	chloroethyl	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
3	3	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
cyclohexyl	cyclohexyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
1	1	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
nitrosourea	nitrosourea	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
CCNU	CCNU	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
medical	medical	ADJ	JJ	O
records	record	NOUN	NNS	O
of	of	ADP	IN	O
206	206	NUM	CD	O
dogs	dog	NOUN	NNS	O
that	that	DET	WDT	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
CCNU	CCNU	PROPN	NNP	B-Chemical
at	at	ADP	IN	O
the	the	DET	DT	O
Melbourne	Melbourne	PROPN	NNP	O
Veterinary	Veterinary	PROPN	NNP	O
Specialist	Specialist	PROPN	NNP	O
Centre	Centre	PROPN	NNP	O
between	between	ADP	IN	O
February	February	PROPN	NNP	O
2002	2002	NUM	CD	O
and	and	CCONJ	CC	O
December	December	PROPN	NNP	O
2007	2007	NUM	CD	O
were	be	VERB	VBD	O
retrospectively	retrospectively	ADV	RB	O
evaluated	evaluate	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Of	of	ADP	IN	O
the	the	DET	DT	O
206	206	NUM	CD	O
dogs	dog	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
CCNU	CCNU	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
185	185	NUM	CD	O
met	meet	VERB	VBD	O
the	the	DET	DT	O
inclusion	inclusion	NOUN	NN	O
criteria	criterion	NOUN	NNS	O
for	for	ADP	IN	O
at	at	ADV	RB	O
least	least	ADV	RBS	O
one	one	NUM	CD	O
class	class	NOUN	NN	O
of	of	ADP	IN	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

CCNU	CCNU	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
used	use	VERB	VBN	O
most	most	ADV	RBS	O
commonly	commonly	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
lymphoma	lymphoma	NOUN	NN	B-Disease
,	,	PUNCT	,	O
mast	mast	ADJ	JJ	B-Disease
cell	cell	NOUN	NN	I-Disease
tumour	tumour	NOUN	NN	I-Disease
,	,	PUNCT	,	O
brain	brain	NOUN	NN	B-Disease
tumour	tumour	NOUN	NN	I-Disease
,	,	PUNCT	,	O
histiocytic	histiocytic	ADJ	JJ	B-Disease
tumours	tumour	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
epitheliotropic	epitheliotropic	VERB	VB	B-Disease
lymphoma	lymphoma	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Throughout	throughout	ADP	IN	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
56	56	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
dogs	dog	NOUN	NNS	O
experienced	experience	VERB	VBD	O
neutropenia	neutropenia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
34	34	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
experienced	experienced	ADJ	JJ	O
anaemia	anaemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
14	14	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
experienced	experienced	ADJ	JJ	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Gastrointestinal	gastrointestinal	ADJ	JJ	B-Disease
toxicosis	toxicosis	NOUN	NN	I-Disease
was	be	VERB	VBD	O
detected	detect	VERB	VBN	O
in	in	ADP	IN	O
37	37	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
dogs	dog	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
sign	sign	NOUN	NN	O
of	of	ADP	IN	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
vomiting	vomit	VERB	VBG	B-Disease
(	(	PUNCT	-LRB-	O
24	24	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Potential	potential	ADJ	JJ	O
renal	renal	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
elevated	elevated	ADJ	JJ	O
alanine	alanine	NOUN	NN	B-Chemical
transaminase	transaminase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ALT	ALT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
concentration	concentration	NOUN	NN	O
were	be	VERB	VBD	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
12	12	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
48	48	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
dogs	dog	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
hepatic	hepatic	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
was	be	VERB	VBD	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
CCNU	ccnu	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
toxicity	toxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
dogs	dog	NOUN	NNS	O
is	be	VERB	VBZ	O
common	common	ADJ	JJ	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
is	be	VERB	VBZ	O
usually	usually	ADV	RB	O
not	not	ADV	RB	O
life	life	NOUN	NN	O
threatening	threaten	VERB	VBG	O
.	.	PUNCT	.	O

Central	central	ADJ	JJ	O
vein	vein	NOUN	NN	B-Disease
thrombosis	thrombosis	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
topical	topical	ADJ	JJ	O
dipivalyl	dipivalyl	NOUN	NN	B-Chemical
epinephrine	epinephrine	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
report	report	NOUN	NN	O
is	be	VERB	VBZ	O
given	give	VERB	VBN	O
on	on	ADP	IN	O
an	an	DET	DT	O
83	83	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
female	female	NOUN	NN	O
who	who	PRON	WP	O
acquired	acquire	VERB	VBD	O
central	central	ADJ	JJ	O
vein	vein	NOUN	NN	B-Disease
thrombosis	thrombosis	NOUN	NN	I-Disease
in	in	ADP	IN	O
her	-PRON-	DET	PRP$	O
seeing	see	VERB	VBG	O
eye	eye	NOUN	NN	O
one	one	NUM	CD	O
day	day	NOUN	NN	O
after	after	ADP	IN	O
having	have	VERB	VBG	O
started	start	VERB	VBN	O
topical	topical	ADJ	JJ	O
medication	medication	NOUN	NN	O
with	with	ADP	IN	O
dipivalyl	dipivalyl	NOUN	NN	B-Chemical
epinephrine	epinephrine	NOUN	NN	I-Chemical
for	for	ADP	IN	O
advanced	advanced	ADJ	JJ	O
glaucoma	glaucoma	NOUN	NN	B-Disease
discovered	discover	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
eye	eye	NOUN	NN	O
.	.	PUNCT	.	O

From	from	ADP	IN	O
present	present	ADJ	JJ	O
knowledge	knowledge	NOUN	NN	O
about	about	ADP	IN	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
adrenergic	adrenergic	NOUN	NN	O
eye	eye	NOUN	NN	O
drops	drop	VERB	VBZ	O
on	on	ADP	IN	O
ocular	ocular	ADJ	JJ	O
blood	blood	NOUN	NN	O
circulation	circulation	NOUN	NN	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
difficult	difficult	ADJ	JJ	O
to	to	PART	TO	O
suggest	suggest	VERB	VB	O
an	an	DET	DT	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
events	event	NOUN	NNS	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
may	may	VERB	MD	O
be	be	VERB	VB	O
coincidental	coincidental	ADJ	JJ	O
only	only	ADV	RB	O
.	.	PUNCT	.	O

Benzylacyclouridine	benzylacyclouridine	NOUN	NN	B-Chemical
reverses	reverse	VERB	VBZ	O
azidothymidine	azidothymidine	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
marrow	marrow	NOUN	NN	B-Disease
suppression	suppression	NOUN	NN	I-Disease
without	without	ADP	IN	O
impairment	impairment	NOUN	NN	O
of	of	ADP	IN	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
human	human	ADJ	JJ	O
immunodeficiency	immunodeficiency	NOUN	NN	B-Disease
virus	virus	NOUN	NN	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Increased	increase	VERB	VBN	O
extracellular	extracellular	ADJ	JJ	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
uridine	uridine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Urd	Urd	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
to	to	PART	TO	O
reduce	reduce	VERB	VB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
vitro	vitro	NOUN	NN	O
,	,	PUNCT	,	O
azidothymidine	azidothymidine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
AZT	AZT	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
human	human	ADJ	JJ	O
granulocyte	granulocyte	NOUN	NN	O
-	-	PUNCT	HYPH	O
macrophage	macrophage	NOUN	NN	O
progenitor	progenitor	NOUN	NN	O
cells	cell	NOUN	NNS	O
without	without	ADP	IN	O
impairment	impairment	NOUN	NN	O
of	of	ADP	IN	O
its	-PRON-	DET	PRP$	O
antihuman	antihuman	ADJ	JJ	O
immunodeficiency	immunodeficiency	NOUN	NN	B-Disease
virus	virus	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HIV	HIV	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Because	because	ADP	IN	O
of	of	ADP	IN	O
the	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
toxicities	toxicity	NOUN	NNS	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	O
Urd	Urd	PROPN	NNP	B-Chemical
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
ability	ability	NOUN	NN	O
of	of	ADP	IN	O
benzylacyclouridine	benzylacyclouridine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
BAU	BAU	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
effect	effect	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
,	,	PUNCT	,	O
AZT	AZT	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
anemia	anemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
leukopenia	leukopenia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
agent	agent	NOUN	NN	O
inhibits	inhibit	VERB	VBZ	O
Urd	Urd	PROPN	NNP	B-Chemical
catabolism	catabolism	NOUN	NN	O
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
,	,	PUNCT	,	O
increases	increase	VERB	VBZ	O
the	the	DET	DT	O
plasma	plasma	NOUN	NN	O
concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
Urd	Urd	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
manner	manner	NOUN	NN	O
,	,	PUNCT	,	O
without	without	ADP	IN	O
Urd	Urd	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
rendered	render	VERB	VBD	O
anemic	anemic	ADJ	JJ	B-Disease
and	and	CCONJ	CC	O
leukopenic	leukopenic	ADJ	JJ	B-Disease
by	by	ADP	IN	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
for	for	ADP	IN	O
28	28	NUM	CD	O
days	day	NOUN	NNS	O
in	in	ADP	IN	O
drinking	drinking	NOUN	NN	O
water	water	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
mL	mL	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
continued	continued	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
plus	plus	CCONJ	CC	O
daily	daily	ADJ	JJ	O
BAU	BAU	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
300	300	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
orally	orally	ADV	RB	O
)	)	PUNCT	-RRB-	O
partially	partially	ADV	RB	O
reversed	reverse	VERB	VBD	O
AZT	AZT	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
anemia	anemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
leukopenia	leukopenia	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
increased	increase	VERB	VBN	O
peripheral	peripheral	ADJ	JJ	O
reticulocytes	reticulocyte	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
to	to	ADP	IN	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
increased	increase	VERB	VBN	O
cellularity	cellularity	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
marrow	marrow	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
improved	improved	ADJ	JJ	O
megaloblastosis	megaloblastosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

When	when	ADV	WRB	O
coadministered	coadministere	VERB	VBN	O
with	with	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
from	from	ADP	IN	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
BAU	BAU	PROPN	NNP	B-Chemical
reduced	reduce	VERB	VBD	O
AZT	AZT	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
marrow	marrow	NOUN	NN	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
vitro	vitro	NOUN	NN	O
,	,	PUNCT	,	O
at	at	ADP	IN	O
a	a	DET	DT	O
concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
100	100	NUM	CD	O
mumol	mumol	NOUN	NN	O
/	/	SYM	SYM	O
L	L	PROPN	NNP	O
,	,	PUNCT	,	O
BAU	BAU	PROPN	NNP	B-Chemical
possesses	possess	VERB	VBZ	O
minimal	minimal	ADJ	JJ	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
HIV	hiv	ADJ	JJ	O
activity	activity	NOUN	NN	O
and	and	CCONJ	CC	O
has	have	VERB	VBZ	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
ability	ability	NOUN	NN	O
of	of	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
to	to	PART	TO	O
reverse	reverse	VERB	VB	O
the	the	DET	DT	O
HIV	HIV	PROPN	NNP	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cytopathic	cytopathic	ADJ	JJ	O
effect	effect	NOUN	NN	O
in	in	ADP	IN	O
MT4	MT4	PROPN	NNP	O
cells	cell	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
biochemical	biochemical	ADJ	JJ	O
implications	implication	NOUN	NNS	O
of	of	ADP	IN	O
these	these	DET	DT	O
findings	finding	NOUN	NNS	O
are	be	VERB	VBP	O
discussed	discuss	VERB	VBN	O
.	.	PUNCT	.	O

Lethal	lethal	ADJ	JJ	O
anuria	anuria	NOUN	NN	B-Disease
complicating	complicate	VERB	VBG	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
ifosfamide	ifosfamide	ADJ	JJ	B-Chemical
chemotherapy	chemotherapy	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
an	an	DET	DT	O
impaired	impaired	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
sixty	sixty	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
advanced	advanced	ADJ	JJ	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
,	,	PUNCT	,	O
previously	previously	ADV	RB	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
developed	develop	VERB	VBD	O
an	an	DET	DT	O
irreversible	irreversible	ADJ	JJ	O
lethal	lethal	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
with	with	ADP	IN	O
anuria	anuria	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
day	day	NOUN	NN	O
after	after	ADP	IN	O
5	5	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
bolus	bolus	NOUN	NN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Postrenal	postrenal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
was	be	VERB	VBD	O
excluded	exclude	VERB	VBN	O
by	by	ADP	IN	O
echography	echography	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
prerenal	prerenal	ADJ	JJ	O
component	component	NOUN	NN	O
could	could	VERB	MD	O
have	have	VERB	VB	O
contributed	contribute	VERB	VBN	O
to	to	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
because	because	ADP	IN	O
of	of	ADP	IN	O
a	a	DET	DT	O
transient	transient	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
due	due	ADP	IN	O
to	to	ADP	IN	O
an	an	DET	DT	O
increasing	increase	VERB	VBG	O
ascitis	ascitis	NOUN	NN	O
,	,	PUNCT	,	O
occurring	occur	VERB	VBG	O
just	just	ADV	RB	O
before	before	ADP	IN	O
anuria	anuria	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
correction	correction	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hemodynamic	hemodynamic	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
improve	improve	VERB	VB	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

Ifosfamide	Ifosfamide	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
known	know	VERB	VBN	O
nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
drug	drug	NOUN	NN	O
with	with	ADP	IN	O
demonstrated	demonstrate	VERB	VBN	O
tubulopathies	tubulopathie	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
strongly	strongly	ADV	RB	O
suspect	suspect	VERB	VBP	O
that	that	ADP	IN	O
this	this	DET	DT	O
lethal	lethal	ADJ	JJ	O
anuria	anuria	NOUN	NN	B-Disease
was	be	VERB	VBD	O
mainly	mainly	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
occurring	occur	VERB	VBG	O
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
having	have	VERB	VBG	O
received	receive	VERB	VBN	O
previous	previous	ADJ	JJ	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
chemotherapy	chemotherapy	NOUN	NN	O
and	and	CCONJ	CC	O
with	with	ADP	IN	O
poor	poor	ADJ	JJ	O
kidney	kidney	NOUN	NN	O
perfusion	perfusion	NOUN	NN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
transient	transient	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
recommend	recommend	VERB	VBP	O
careful	careful	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
chemotherapy	chemotherapy	NOUN	NN	O
and	and	CCONJ	CC	O
inadequate	inadequate	ADJ	JJ	O
renal	renal	ADJ	JJ	O
perfusion	perfusion	NOUN	NN	O
.	.	PUNCT	.	O

Nociceptive	nociceptive	ADJ	JJ	O
effects	effect	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
intrathecal	intrathecal	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
D2	d2	NOUN	NN	I-Chemical
,	,	PUNCT	,	I-Chemical
E2	E2	PROPN	NNP	I-Chemical
,	,	PUNCT	,	I-Chemical
or	or	CCONJ	CC	I-Chemical
F2	F2	PROPN	NNP	I-Chemical
alpha	alpha	VERB	VBP	I-Chemical
to	to	ADP	IN	O
conscious	conscious	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
intrathecal	intrathecal	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
prostaglandins	prostaglandin	NOUN	NNS	B-Chemical
on	on	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
responses	response	NOUN	NNS	O
in	in	ADP	IN	O
conscious	conscious	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
by	by	ADP	IN	O
using	use	VERB	VBG	O
hot	hot	ADJ	JJ	O
plate	plate	NOUN	NN	O
and	and	CCONJ	CC	O
acetic	acetic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
writhing	writhing	NOUN	NN	O
tests	test	NOUN	NNS	O
.	.	PUNCT	.	O

Prostaglandin	Prostaglandin	PROPN	NNP	B-Chemical
D2	D2	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
ng	ng	NOUN	NN	O
/	/	SYM	SYM	O
mouse	mouse	NOUN	NN	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
a	a	DET	DT	O
hyperalgesic	hyperalgesic	ADJ	JJ	B-Disease
action	action	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
a	a	DET	DT	O
hot	hot	ADJ	JJ	O
plate	plate	NOUN	NN	O
during	during	ADP	IN	O
a	a	DET	DT	O
3	3	NUM	CD	O
-	-	SYM	SYM	O
60	60	NUM	CD	O
min	min	NOUN	NN	O
period	period	NOUN	NN	O
after	after	ADP	IN	O
injection	injection	NOUN	NN	O
.	.	PUNCT	.	O

Prostaglandin	Prostaglandin	PROPN	NNP	B-Chemical
E2	E2	PROPN	NNP	I-Chemical
showed	show	VERB	VBD	O
a	a	DET	DT	O
hyperalgesic	hyperalgesic	ADJ	JJ	B-Disease
effect	effect	NOUN	NN	O
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
1	1	NUM	CD	O
pg	pg	NOUN	NN	B-Chemical
to	to	ADP	IN	O
10	10	NUM	CD	O
ng	ng	NOUN	NNS	O
/	/	SYM	SYM	O
mouse	mouse	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
lasted	last	VERB	VBD	O
shorter	shorter	NOUN	NN	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
-	-	SYM	SYM	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
D2	d2	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Similar	similar	ADJ	JJ	O
results	result	NOUN	NNS	O
were	be	VERB	VBD	O
obtained	obtain	VERB	VBN	O
by	by	ADP	IN	O
acetic	acetic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
writhing	writhing	NOUN	NN	O
tests	test	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
hyperalgesic	hyperalgesic	ADJ	JJ	B-Disease
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
D2	d2	NOUN	NN	I-Chemical
was	be	VERB	VBD	O
blocked	block	VERB	VBN	O
by	by	ADP	IN	O
simultaneous	simultaneous	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
substance	substance	NOUN	NN	O
P	p	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
(	(	PUNCT	-LRB-	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
or	or	CCONJ	CC	O
equal	equal	ADJ	JJ	O
to	to	ADP	IN	O
100	100	NUM	CD	O
ng	ng	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
by	by	ADP	IN	O
AH6809	AH6809	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
prostanoid	prostanoid	NOUN	NN	O
EP1	EP1	PROPN	NNP	O
-	-	PUNCT	HYPH	O
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
.	.	PUNCT	.	O

Conversely	conversely	ADV	RB	O
,	,	PUNCT	,	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
E2	e2	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperalgesia	hyperalgesia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
blocked	block	VERB	VBN	O
by	by	ADP	IN	O
AH6809	AH6809	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
or	or	CCONJ	CC	O
equal	equal	ADJ	JJ	O
to	to	ADP	IN	O
500	500	NUM	CD	O
ng	ng	ADP	IN	O
)	)	PUNCT	-RRB-	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
by	by	ADP	IN	O
the	the	DET	DT	O
substance	substance	NOUN	NN	O
P	p	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
.	.	PUNCT	.	O

Prostaglandin	prostaglandin	NOUN	NN	B-Chemical
F2	F2	PROPN	NNP	I-Chemical
alpha	alpha	NOUN	NN	I-Chemical
had	have	VERB	VBD	O
little	little	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
responses	response	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
demonstrate	demonstrate	VERB	VBP	O
that	that	ADP	IN	O
both	both	DET	DT	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
D2	d2	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
E2	e2	NOUN	NN	I-Chemical
exert	exert	VERB	VBP	O
hyperalgesia	hyperalgesia	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
spinal	spinal	ADJ	JJ	O
cord	cord	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
in	in	ADP	IN	O
different	different	ADJ	JJ	O
ways	way	NOUN	NNS	O
.	.	PUNCT	.	O

D	d	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
localized	localize	VERB	VBN	B-Disease
scleroderma	scleroderma	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Localized	localize	VERB	VBN	B-Disease
scleroderma	scleroderma	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
no	no	DET	DT	O
recognized	recognize	VERB	VBN	O
internal	internal	ADJ	JJ	O
organ	organ	NOUN	NN	O
involvement	involvement	NOUN	NN	O
but	but	CCONJ	CC	O
may	may	VERB	MD	O
be	be	VERB	VB	O
disfiguring	disfigure	VERB	VBG	O
and	and	CCONJ	CC	O
disabling	disable	VERB	VBG	O
when	when	ADV	WRB	O
the	the	DET	DT	O
cutaneous	cutaneous	ADJ	JJ	O
lesions	lesion	NOUN	NNS	O
are	be	VERB	VBP	O
extensive	extensive	ADJ	JJ	O
or	or	CCONJ	CC	O
affect	affect	VERB	VB	O
children	child	NOUN	NNS	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
is	be	VERB	VBZ	O
no	no	DET	DT	O
accepted	accepted	ADJ	JJ	O
or	or	CCONJ	CC	O
proven	prove	VERB	VBN	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
localized	localize	VERB	VBN	B-Disease
scleroderma	scleroderma	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Case	case	NOUN	NN	O
reports	report	VERB	VBZ	O
of	of	ADP	IN	O
11	11	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
,	,	PUNCT	,	O
extensive	extensive	ADJ	JJ	O
localized	localize	VERB	VBN	B-Disease
scleroderma	scleroderma	NOUN	NNS	I-Disease
who	who	PRON	WP	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
D	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
are	be	VERB	VBP	O
summarized	summarize	VERB	VBN	O
in	in	ADP	IN	O
this	this	DET	DT	O
article	article	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
drug	drug	NOUN	NN	O
was	be	VERB	VBD	O
judged	judge	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
a	a	DET	DT	O
favorable	favorable	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
disease	disease	NOUN	NN	O
course	course	NOUN	NN	O
in	in	ADP	IN	O
7	7	NUM	CD	O
(	(	PUNCT	-LRB-	O
64	64	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
11	11	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Improvement	improvement	NOUN	NN	O
began	begin	VERB	VBD	O
within	within	ADP	IN	O
3	3	NUM	CD	O
to	to	ADP	IN	O
6	6	NUM	CD	O
months	month	NOUN	NNS	O
and	and	CCONJ	CC	O
consisted	consist	VERB	VBN	O
of	of	ADP	IN	O
cessation	cessation	NOUN	NN	O
of	of	ADP	IN	O
active	active	ADJ	JJ	O
cutaneous	cutaneous	ADJ	JJ	O
lesions	lesion	NOUN	NNS	O
in	in	ADP	IN	O
all	all	DET	DT	O
7	7	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
skin	skin	NOUN	NN	O
softening	softening	NOUN	NN	O
in	in	ADP	IN	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
more	more	ADV	RBR	O
normal	normal	ADJ	JJ	O
growth	growth	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
affected	affect	VERB	VBN	O
limb	limb	NOUN	NN	O
in	in	ADP	IN	O
2	2	NUM	CD	O
of	of	ADP	IN	O
3	3	NUM	CD	O
children	child	NOUN	NNS	O
.	.	PUNCT	.	O

Joint	joint	ADJ	JJ	O
stiffness	stiffness	NOUN	NN	O
and	and	CCONJ	CC	O
contractures	contracture	NOUN	NNS	B-Disease
also	also	ADV	RB	O
improved	improve	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
D	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
favorable	favorable	ADJ	JJ	O
response	response	NOUN	NN	O
was	be	VERB	VBD	O
as	as	ADV	RB	O
low	low	ADJ	JJ	O
as	as	ADP	IN	O
2	2	NUM	CD	O
to	to	PART	TO	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
given	give	VERB	VBN	O
over	over	ADP	IN	O
a	a	DET	DT	O
period	period	NOUN	NN	O
ranging	range	VERB	VBG	O
from	from	ADP	IN	O
15	15	NUM	CD	O
to	to	PART	TO	O
53	53	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
Penicillamine	Penicillamine	PROPN	NNP	I-Chemical
caused	cause	VERB	VBD	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
in	in	ADP	IN	O
1	1	NUM	CD	O
patient	patient	NOUN	NN	O
and	and	CCONJ	CC	O
milder	milder	VERB	VB	O
reversible	reversible	ADJ	JJ	O
proteinuria	proteinuria	NOUN	NN	B-Disease
in	in	ADP	IN	O
3	3	NUM	CD	O
other	other	ADJ	JJ	O
patients	patient	NOUN	NNS	O
;	;	PUNCT	:	O
none	none	NOUN	NN	O
developed	develop	VERB	VBD	O
renal	renal	ADJ	JJ	B-Disease
insufficiency	insufficiency	NOUN	NN	I-Disease
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
D	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
severe	severe	ADJ	JJ	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
localized	localize	VERB	VBN	B-Disease
scleroderma	scleroderma	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Cerebral	cerebral	ADJ	JJ	B-Disease
sinus	sinus	NOUN	NN	I-Disease
thrombosis	thrombosis	NOUN	NN	I-Disease
as	as	ADP	IN	O
a	a	DET	DT	O
potential	potential	ADJ	JJ	O
hazard	hazard	NOUN	NN	O
of	of	ADP	IN	O
antifibrinolytic	antifibrinolytic	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
in	in	ADP	IN	O
menorrhagia	menorrhagia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
a	a	DET	DT	O
42	42	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
superior	superior	ADJ	JJ	O
sagittal	sagittal	ADJ	JJ	B-Disease
and	and	CCONJ	CC	I-Disease
left	leave	VERB	VBD	I-Disease
transverse	transverse	NOUN	NN	I-Disease
sinus	sinus	NOUN	NN	I-Disease
thrombosis	thrombosis	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
prolonged	prolong	VERB	VBN	O
epsilon	epsilon	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminocaproic	aminocaproic	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
menorrhagia	menorrhagia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
antifibrinolytic	antifibrinolytic	ADJ	JJ	O
agent	agent	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
menorrhagia	menorrhagia	NOUN	NN	B-Disease
to	to	PART	TO	O
promote	promote	VERB	VB	O
clotting	clotting	NOUN	NN	O
and	and	CCONJ	CC	O
reduce	reduce	VERB	VB	O
blood	blood	NOUN	NN	B-Disease
loss	loss	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Although	although	ADP	IN	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
thromboembolic	thromboembolic	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
during	during	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
epsilon	epsilon	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminocaproic	aminocaproic	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
cerebral	cerebral	ADJ	JJ	B-Disease
sinus	sinus	NOUN	NN	I-Disease
thrombosis	thrombosis	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
previously	previously	ADV	RB	O
described	describe	VERB	VBN	O
.	.	PUNCT	.	O

Careful	careful	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
epsilon	epsilon	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminocaproic	aminocaproic	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
therapy	therapy	NOUN	NN	O
is	be	VERB	VBZ	O
recommended	recommend	VERB	VBN	O
.	.	PUNCT	.	O

Seizure	seizure	VERB	VB	B-Disease
activity	activity	NOUN	NN	O
with	with	ADP	IN	O
imipenem	imipenem	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
:	:	PUNCT	:	O
incidence	incidence	NOUN	NN	O
and	and	CCONJ	CC	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
either	either	DET	DT	O
cerebral	cerebral	ADJ	JJ	B-Disease
vascular	vascular	ADJ	JJ	I-Disease
accident	accident	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
CVA	CVA	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
head	head	VERB	VB	B-Disease
trauma	trauma	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
no	no	DET	DT	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
developed	develop	VERB	VBD	O
seizures	seizure	NOUN	NNS	B-Disease
while	while	ADP	IN	O
receiving	receive	VERB	VBG	O
maximum	maximum	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
imipenem	imipenem	NOUN	NN	B-Chemical
/	/	SYM	SYM	I-Chemical
cilastatin	cilastatin	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Neither	neither	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
reported	report	VERB	VBN	O
previous	previous	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
or	or	CCONJ	CC	O
seizure	seizure	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
activity	activity	NOUN	NN	O
nor	nor	CCONJ	CC	O
was	be	VERB	VBD	O
receiving	receive	VERB	VBG	O
anticonvulsant	anticonvulsant	ADJ	JJ	O
agents	agent	NOUN	NNS	O
.	.	PUNCT	.	O

All	all	DET	DT	O
seizures	seizure	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
controlled	control	VERB	VBN	O
with	with	ADP	IN	O
therapeutic	therapeutic	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
phenytoin	phenytoin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Both	both	DET	DT	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
received	receive	VERB	VBN	O
maximum	maximum	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
other	other	ADJ	JJ	O
beta	beta	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
lactam	lactam	NOUN	NN	I-Chemical
antibiotics	antibiotic	NOUN	NNS	O
without	without	ADP	IN	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
seizure	seizure	NOUN	NN	B-Disease
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Midline	Midline	PROPN	NNP	O
B3	B3	PROPN	NNP	O
serotonin	serotonin	NOUN	NN	B-Chemical
nerves	nerve	NOUN	NNS	O
in	in	ADP	IN	O
rat	rat	NOUN	NN	O
medulla	medulla	NOUN	NN	O
are	be	VERB	VBP	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
methyldopa	methyldopa	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Previous	previous	ADJ	JJ	O
experiments	experiment	NOUN	NNS	O
in	in	ADP	IN	O
this	this	DET	DT	O
laboratory	laboratory	NOUN	NN	O
have	have	VERB	VBP	O
shown	show	VERB	VBN	O
that	that	DET	DT	O
microinjection	microinjection	NOUN	NN	O
of	of	ADP	IN	O
methyldopa	methyldopa	NOUN	NN	B-Chemical
onto	onto	ADP	IN	O
the	the	DET	DT	O
ventrolateral	ventrolateral	ADJ	JJ	O
cells	cell	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
B3	B3	PROPN	NNP	O
serotonin	serotonin	NOUN	NN	B-Chemical
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
medulla	medulla	NOUN	NN	O
elicits	elicit	VERB	VBZ	O
a	a	DET	DT	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
response	response	NOUN	NN	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
projection	projection	NOUN	NN	O
descending	descend	VERB	VBG	O
into	into	ADP	IN	O
the	the	DET	DT	O
spinal	spinal	ADJ	JJ	O
cord	cord	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
experiments	experiment	NOUN	NNS	O
were	be	VERB	VBD	O
designed	design	VERB	VBN	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
midline	midline	NOUN	NN	O
cells	cell	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
B3	B3	PROPN	NNP	O
serotonin	serotonin	NOUN	NN	B-Chemical
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
medulla	medulla	NOUN	NN	O
,	,	PUNCT	,	O
coinciding	coincide	VERB	VBG	O
with	with	ADP	IN	O
the	the	DET	DT	O
raphe	raphe	NOUN	NN	O
magnus	magnus	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
spontaneously	spontaneously	ADV	RB	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
,	,	PUNCT	,	O
stroke	stroke	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
prone	prone	ADJ	JJ	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
microinjection	microinjection	NOUN	NN	O
of	of	ADP	IN	O
methyldopa	methyldopa	NOUN	NN	B-Chemical
into	into	ADP	IN	O
the	the	DET	DT	O
area	area	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
midline	midline	NOUN	NN	O
B3	B3	PROPN	NNP	O
serotonin	serotonin	NOUN	NN	B-Chemical
cell	cell	NOUN	NN	O
group	group	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ventral	ventral	ADJ	JJ	O
medulla	medulla	NOUN	NN	O
caused	cause	VERB	VBD	O
a	a	DET	DT	O
potent	potent	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
of	of	ADP	IN	O
30	30	NUM	CD	O
-	-	SYM	SYM	O
40	40	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
maximal	maximal	ADJ	JJ	O
2	2	NUM	CD	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
and	and	CCONJ	CC	O
was	be	VERB	VBD	O
abolished	abolish	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
serotonin	serotonin	NOUN	NN	B-Chemical
neurotoxin	neurotoxin	NOUN	NN	O
5	5	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
7	7	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dihydroxytryptamine	dihydroxytryptamine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
7	7	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
DHT	DHT	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
injected	inject	VERB	VBD	O
intracerebroventricularly	intracerebroventricularly	ADV	RB	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
intraspinal	intraspinal	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
5	5	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
7	7	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
DHT	DHT	PROPN	NNP	I-Chemical
to	to	PART	TO	O
produce	produce	VERB	VB	O
a	a	DET	DT	O
more	more	ADV	RBR	O
selective	selective	ADJ	JJ	O
lesion	lesion	NOUN	NN	O
of	of	ADP	IN	O
only	only	ADV	RB	O
descending	descend	VERB	VBG	O
serotonin	serotonin	NOUN	NN	B-Chemical
projections	projection	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
spinal	spinal	ADJ	JJ	O
cord	cord	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
affect	affect	VERB	VB	O
this	this	DET	DT	O
hypotension	hypotension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Further	further	ADV	RB	O
,	,	PUNCT	,	O
5	5	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
7	7	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
DHT	DHT	PROPN	NNP	I-Chemical
lesion	lesion	NOUN	NN	O
of	of	ADP	IN	O
serotonin	serotonin	NOUN	NN	B-Chemical
nerves	nerve	NOUN	NNS	O
travelling	travel	VERB	VBG	O
in	in	ADP	IN	O
the	the	DET	DT	O
median	median	ADJ	JJ	O
forebrain	forebrain	NOUN	NN	O
bundle	bundle	NOUN	NN	O
,	,	PUNCT	,	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
main	main	ADJ	JJ	O
ascending	ascending	NOUN	NN	O
pathways	pathway	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
B3	B3	PROPN	NNP	O
serotonin	serotonin	NOUN	NN	B-Chemical
cells	cell	NOUN	NNS	O
,	,	PUNCT	,	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
affect	affect	VERB	VB	O
the	the	DET	DT	O
fall	fall	NOUN	NN	O
in	in	ADP	IN	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
midline	midline	NOUN	NN	O
B3	B3	PROPN	NNP	O
serotonin	serotonin	NOUN	NN	B-Chemical
methyldopa	methyldopa	ADJ	JJ	B-Chemical
injection	injection	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
concluded	conclude	VERB	VBN	O
therefore	therefore	ADV	RB	O
that	that	ADP	IN	O
,	,	PUNCT	,	O
unlike	unlike	ADP	IN	O
the	the	DET	DT	O
ventrolateral	ventrolateral	ADJ	JJ	O
B3	B3	PROPN	NNP	O
cells	cell	NOUN	NNS	O
which	which	DET	WDT	O
mediate	mediate	VERB	VBP	O
a	a	DET	DT	O
methyldopa	methyldopa	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
via	via	ADP	IN	O
descending	descend	VERB	VBG	O
projections	projection	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
midline	midline	NOUN	NN	O
serotonin	serotonin	NOUN	NN	B-Chemical
B3	B3	PROPN	NNP	O
cells	cell	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
medulla	medulla	NOUN	NN	O
contribute	contribute	VERB	VB	O
to	to	ADP	IN	O
the	the	DET	DT	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
action	action	NOUN	NN	O
of	of	ADP	IN	O
methyldopa	methyldopa	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
either	either	CCONJ	CC	O
by	by	ADP	IN	O
way	way	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
ascending	ascend	VERB	VBG	O
projection	projection	NOUN	NN	O
which	which	DET	WDT	O
does	do	VERB	VBZ	O
not	not	ADV	RB	O
pass	pass	VERB	VB	O
through	through	ADP	IN	O
the	the	DET	DT	O
median	median	ADJ	JJ	O
forebrain	forebrain	NOUN	NN	O
bundle	bundle	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
through	through	ADP	IN	O
a	a	DET	DT	O
projection	projection	NOUN	NN	O
restricted	restrict	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
caudal	caudal	ADJ	JJ	O
brainstem	brainstem	NOUN	NN	O
.	.	PUNCT	.	O

Antiarrhythmic	antiarrhythmic	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
on	on	ADP	IN	O
canine	canine	NOUN	NN	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Using	use	VERB	VBG	O
two	two	NUM	CD	O
-	-	PUNCT	HYPH	O
stage	stage	NOUN	NN	O
coronary	coronary	ADJ	JJ	O
ligation	ligation	NOUN	NN	O
-	-	PUNCT	:	O
,	,	PUNCT	,	O
digitalis	digitalis	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
canine	canine	NOUN	NN	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
antiarrhythmic	antiarrhythmic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
minimum	minimum	ADJ	JJ	O
effective	effective	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
concentration	concentration	NOUN	NN	O
for	for	ADP	IN	O
each	each	DET	DT	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
model	model	NOUN	NN	O
was	be	VERB	VBD	O
determined	determine	VERB	VBN	O
.	.	PUNCT	.	O

Cibenzoline	cibenzoline	NOUN	NN	B-Chemical
suppressed	suppress	VERB	VBD	O
all	all	DET	PDT	O
the	the	DET	DT	O
arrhythmias	arrhythmia	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
minimum	minimum	ADJ	JJ	O
effective	effective	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
for	for	ADP	IN	O
arrhythmias	arrhythmia	NOUN	NNS	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
h	h	DET	DT	O
coronary	coronary	ADJ	JJ	O
ligation	ligation	NOUN	NN	O
,	,	PUNCT	,	O
48	48	NUM	CD	O
-	-	PUNCT	HYPH	O
h	h	NOUN	NN	O
coronary	coronary	ADJ	JJ	O
ligation	ligation	NOUN	NN	O
,	,	PUNCT	,	O
digitalis	digitalis	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
(	(	PUNCT	-LRB-	O
by	by	ADP	IN	O
8	8	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
(	(	PUNCT	-LRB-	O
by	by	ADP	IN	O
8	8	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	PUNCT	LS	O
(	(	PUNCT	-LRB-	O
by	by	ADP	IN	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
(	(	PUNCT	-LRB-	O
by	by	ADP	IN	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
micrograms	micrograms	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
SDM	SDM	PROPN	NNP	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
6	6	NUM	CD	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
concentration	concentration	NOUN	NN	O
for	for	ADP	IN	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
higher	high	ADJ	JJR	O
than	than	ADP	IN	O
those	those	DET	DT	O
for	for	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
types	type	NOUN	NNS	O
of	of	ADP	IN	O
arrhythmias	arrhythmia	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
pharmacological	pharmacological	ADJ	JJ	O
profile	profile	NOUN	NN	O
is	be	VERB	VBZ	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
mexiletine	mexiletine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
tocainide	tocainide	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
all	all	DET	DT	O
three	three	NUM	CD	O
drugs	drug	NOUN	NNS	O
have	have	VERB	VBP	O
central	central	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
(	(	PUNCT	-LRB-	O
CNS	CNS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
stimulant	stimulant	ADJ	JJ	O
action	action	NOUN	NN	O
.	.	PUNCT	.	O

Because	because	ADP	IN	O
cibenzoline	cibenzoline	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
only	only	ADV	RB	O
weak	weak	ADJ	JJ	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
and	and	CCONJ	CC	O
sinus	sinus	NOUN	NN	O
node	node	NOUN	NN	O
depressive	depressive	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
and	and	CCONJ	CC	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
orally	orally	ADV	RB	O
active	active	ADJ	JJ	O
when	when	ADV	WRB	O
given	give	VERB	VBN	O
to	to	ADP	IN	O
coronary	coronary	ADJ	JJ	O
ligation	ligation	NOUN	NN	O
arrhythmia	arrhythmia	NOUN	NN	B-Disease
dogs	dog	NOUN	NNS	O
,	,	PUNCT	,	O
its	-PRON-	DET	PRP$	O
clinical	clinical	ADJ	JJ	O
usefulness	usefulness	NOUN	NN	O
is	be	VERB	VBZ	O
expected	expect	VERB	VBN	O
.	.	PUNCT	.	O

Continuous	continuous	ADJ	JJ	O
ambulatory	ambulatory	NOUN	NN	O
ECG	ECG	PROPN	NNP	O
monitoring	monitoring	NOUN	NN	O
during	during	ADP	IN	O
fluorouracil	fluorouracil	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
:	:	PUNCT	:	O
a	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
there	there	ADV	EX	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
anecdotal	anecdotal	ADJ	JJ	O
reports	report	NOUN	NNS	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
fluorouracil	fluorouracil	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
this	this	DET	DT	O
phenomenon	phenomenon	NOUN	NN	O
has	have	VERB	VBZ	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
studied	study	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
systematic	systematic	ADJ	JJ	O
fashion	fashion	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
prospectively	prospectively	ADV	RB	O
performed	perform	VERB	VBD	O
continuous	continuous	ADJ	JJ	O
ambulatory	ambulatory	NOUN	NN	O
ECG	ECG	PROPN	NNP	O
monitoring	monitor	VERB	VBG	O
on	on	ADP	IN	O
25	25	NUM	CD	O
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
for	for	ADP	IN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
solid	solid	ADJ	JJ	O
tumors	tumor	NOUN	NNS	B-Disease
in	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
ischemic	ischemic	ADJ	JJ	B-Disease
ST	ST	PROPN	NNP	O
changes	change	NOUN	NNS	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
monitored	monitor	VERB	VBN	O
for	for	ADP	IN	O
23	23	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
4	4	NUM	CD	O
hours	hour	NOUN	NNS	O
before	before	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
98	98	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
9	9	NUM	CD	O
hours	hour	NOUN	NNS	O
during	during	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
.	.	PUNCT	.	O

Anginal	anginal	ADJ	JJ	B-Disease
episodes	episode	NOUN	NNS	O
were	be	VERB	VBD	O
rare	rare	ADJ	JJ	O
:	:	PUNCT	:	O
only	only	ADV	RB	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
angina	angina	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
during	during	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
asymptomatic	asymptomatic	ADJ	JJ	O
ST	ST	PROPN	NNP	O
changes	change	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
or	or	CCONJ	CC	O
equal	equal	ADJ	JJ	O
to	to	ADP	IN	O
1	1	NUM	CD	O
mm	mm	NOUN	NN	O
ST	ST	PROPN	NNP	O
deviation	deviation	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
common	common	ADJ	JJ	O
:	:	PUNCT	:	O
six	six	NUM	CD	O
of	of	ADP	IN	O
25	25	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
24	24	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
ST	ST	PROPN	NNP	O
changes	change	NOUN	NNS	O
before	before	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
v	v	ADP	IN	O
17	17	NUM	CD	O
(	(	PUNCT	-LRB-	O
68	68	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
during	during	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
.	.	PUNCT	.	O
002	002	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
ischemic	ischemic	ADJ	JJ	B-Disease
episodes	episode	NOUN	NNS	O
per	per	ADP	IN	O
patient	patient	NOUN	NN	O
per	per	ADP	IN	O
hour	hour	NOUN	NN	O
was	be	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
02	02	NUM	CD	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
v	v	NOUN	NN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
13	13	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
during	during	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
ECG	ECG	PROPN	NNP	O
changes	change	NOUN	NNS	O
was	be	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
minutes	minute	NOUN	NNS	O
per	per	ADP	IN	O
patient	patient	NOUN	NN	O
per	per	ADP	IN	O
hour	hour	NOUN	NN	O
before	before	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
v	v	NOUN	NN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
minutes	minute	NOUN	NNS	O
per	per	ADP	IN	O
patient	patient	NOUN	NN	O
per	per	ADP	IN	O
hour	hour	NOUN	NN	O
during	during	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

ECG	ECG	PROPN	NNP	O
changes	change	NOUN	NNS	O
were	be	VERB	VBD	O
more	more	ADV	RBR	O
common	common	ADJ	JJ	O
among	among	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
known	know	VERB	VBN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
sudden	sudden	ADJ	JJ	B-Disease
death	death	NOUN	NN	I-Disease
,	,	PUNCT	,	O
both	both	DET	DT	O
of	of	ADP	IN	O
which	which	DET	WDT	O
occurred	occur	VERB	VBD	O
at	at	ADP	IN	O
the	the	DET	DT	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
chemotherapy	chemotherapy	NOUN	NN	O
course	course	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
silent	silent	ADJ	JJ	O
ST	ST	PROPN	NNP	O
segment	segment	NOUN	NN	O
deviation	deviation	NOUN	NN	O
suggestive	suggestive	NOUN	NN	O
of	of	ADP	IN	O
ischemia	ischemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
particularly	particularly	ADV	RB	O
among	among	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
and	and	CCONJ	CC	O
clinical	clinical	ADJ	JJ	O
significance	significance	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
ECG	ECG	PROPN	NNP	O
changes	change	NOUN	NNS	O
remain	remain	VERB	VBP	O
to	to	PART	TO	O
be	be	VERB	VB	O
determined	determine	VERB	VBN	O
.	.	PUNCT	.	O

Nature	nature	NOUN	NN	O
,	,	PUNCT	,	O
time	time	NOUN	NN	O
course	course	NOUN	NN	O
and	and	CCONJ	CC	O
dose	dose	NOUN	NN	O
dependence	dependence	NOUN	NN	O
of	of	ADP	IN	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
:	:	PUNCT	:	O
results	result	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
Multicenter	Multicenter	PROPN	NNP	O
Canadian	Canadian	PROPN	NNP	O
Azidothymidine	Azidothymidine	PROPN	NNP	B-Chemical
Trial	Trial	PROPN	NNP	O
.	.	PUNCT	.	O

To	to	PART	TO	O
characterize	characterize	VERB	VB	O
the	the	DET	DT	O
nature	nature	NOUN	NN	O
,	,	PUNCT	,	O
time	time	NOUN	NN	O
course	course	NOUN	NN	O
and	and	CCONJ	CC	O
dose	dose	NOUN	NN	O
dependency	dependency	NOUN	NN	O
of	of	ADP	IN	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
undertook	undertake	VERB	VBD	O
a	a	DET	DT	O
multicenter	multicenter	NOUN	NN	O
,	,	PUNCT	,	O
prospective	prospective	ADJ	JJ	O
,	,	PUNCT	,	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
range	range	NOUN	NN	O
finding	find	VERB	VBG	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
study	study	NOUN	NN	O
group	group	NOUN	NN	O
consisted	consist	VERB	VBD	O
of	of	ADP	IN	O
74	74	NUM	CD	O
HIV	HIV	PROPN	NNP	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
homosexual	homosexual	ADJ	JJ	O
men	man	NOUN	NNS	O
belonging	belong	VERB	VBG	O
to	to	ADP	IN	O
groups	group	NOUN	NNS	O
II	II	PROPN	NNP	O
B	b	NOUN	NN	O
,	,	PUNCT	,	O
III	III	PROPN	NNP	O
and	and	CCONJ	CC	O
IV	IV	PROPN	NNP	O
C2	C2	PROPN	NNP	O
from	from	ADP	IN	O
the	the	DET	DT	O
Centers	Centers	PROPN	NNPS	O
for	for	ADP	IN	O
Disease	Disease	PROPN	NNP	O
Control	Control	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
CDC	CDC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
classification	classification	NOUN	NN	O
of	of	ADP	IN	O
HIV	HIV	PROPN	NNP	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Following	follow	VERB	VBG	O
a	a	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
observation	observation	NOUN	NN	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
volunteers	volunteer	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
zidovudine	zidovudine	PROPN	NNP	B-Chemical
600	600	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
18	18	NUM	CD	O
weeks	week	NOUN	NNS	O
,	,	PUNCT	,	O
900	900	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
9	9	NUM	CD	O
weeks	week	NOUN	NNS	O
and	and	CCONJ	CC	O
1200	1200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
9	9	NUM	CD	O
weeks	week	NOUN	NNS	O
,	,	PUNCT	,	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
washout	washout	NOUN	NN	O
period	period	NOUN	NN	O
of	of	ADP	IN	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
after	after	ADP	IN	O
which	which	DET	WDT	O
they	-PRON-	PRON	PRP	O
were	be	VERB	VBD	O
re	re	VERB	VBN	O
-	-	VERB	VBN	O
started	start	VERB	VBN	O
on	on	ADP	IN	O
1200	1200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
or	or	CCONJ	CC	O
the	the	DET	DT	O
highest	highest	ADV	RBS	O
tolerated	tolerated	ADJ	JJ	O
dose	dose	NOUN	NN	O
at	at	ADP	IN	O
8	8	NUM	CD	O
-	-	PUNCT	HYPH	O
hourly	hourly	ADJ	JJ	O
intervals	interval	NOUN	NNS	O
.	.	PUNCT	.	O

Subjects	subject	NOUN	NNS	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
assigned	assign	VERB	VBN	O
to	to	ADP	IN	O
4	4	NUM	CD	O
-	-	PUNCT	HYPH	O
hourly	hourly	ADJ	JJ	O
or	or	CCONJ	CC	O
8	8	NUM	CD	O
-	-	PUNCT	HYPH	O
hourly	hourly	ADJ	JJ	O
regimens	regimen	NOUN	NNS	O
within	within	ADP	IN	O
CDC	CDC	PROPN	NNP	O
groups	group	NOUN	NNS	O
while	while	ADP	IN	O
taking	take	VERB	VBG	O
600	600	NUM	CD	O
and	and	CCONJ	CC	O
1200	1200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
laboratory	laboratory	NOUN	NN	O
evaluations	evaluation	NOUN	NNS	O
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
at	at	ADP	IN	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
intervals	interval	NOUN	NNS	O
.	.	PUNCT	.	O

Symptomatic	symptomatic	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
were	be	VERB	VBD	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
96	96	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
subjects	subject	NOUN	NNS	O
,	,	PUNCT	,	O
most	most	ADV	RBS	O
commonly	commonly	ADV	RB	O
nausea	nausea	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
64	64	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
fatigue	fatigue	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
55	55	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
headache	headache	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
49	49	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
were	be	VERB	VBD	O
generally	generally	ADV	RB	O
self	self	NOUN	NN	O
-	-	PUNCT	HYPH	O
limited	limit	VERB	VBN	O
,	,	PUNCT	,	O
reappearing	reappear	VERB	VBG	O
briefly	briefly	NOUN	NN	O
at	at	ADP	IN	O
each	each	DET	DT	O
dose	dose	NOUN	NN	O
increment	increment	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
hemoglobin	hemoglobin	NOUN	NN	O
occurred	occur	VERB	VBD	O
shortly	shortly	ADV	RB	O
after	after	ADP	IN	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
dose	dose	NOUN	NN	O
dependent	dependent	ADJ	JJ	O
and	and	CCONJ	CC	O
reversed	reverse	VERB	VBD	O
rapidly	rapidly	ADV	RB	O
upon	upon	ADP	IN	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
red	red	ADJ	JJ	O
blood	blood	NOUN	NN	O
cell	cell	NOUN	NN	O
count	count	NOUN	NN	O
decrease	decrease	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
mean	mean	ADJ	JJ	O
cell	cell	NOUN	NN	O
volume	volume	NOUN	NN	O
increase	increase	NOUN	NN	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
granulocyte	granulocyte	NOUN	NN	O
count	count	NOUN	NN	O
decrease	decrease	NOUN	NN	O
developed	develop	VERB	VBD	O
early	early	ADV	RB	O
in	in	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
independent	independent	ADJ	JJ	O
fashion	fashion	NOUN	NN	O
,	,	PUNCT	,	O
reverting	revert	VERB	VBG	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
partially	partially	ADV	RB	O
during	during	ADP	IN	O
the	the	DET	DT	O
washout	washout	NOUN	NN	O
phase	phase	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
reticulocyte	reticulocyte	NOUN	NN	O
count	count	NOUN	NN	O
was	be	VERB	VBD	O
dose	dose	NOUN	NN	O
related	relate	VERB	VBN	O
between	between	ADP	IN	O
600	600	NUM	CD	O
and	and	CCONJ	CC	O
900	900	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
with	with	ADP	IN	O
no	no	DET	DT	O
further	further	ADJ	JJ	O
change	change	NOUN	NN	O
when	when	ADV	WRB	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
escalated	escalate	VERB	VBN	O
to	to	ADP	IN	O
1200	1200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

Bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
changes	change	NOUN	NNS	O
occurred	occur	VERB	VBD	O
rapidly	rapidly	ADV	RB	O
as	as	ADP	IN	O
demonstrated	demonstrate	VERB	VBN	O
by	by	ADP	IN	O
megaloblastosis	megaloblastosis	NOUN	NN	B-Disease
in	in	ADP	IN	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
65	65	NUM	CD	O
specimens	specimen	NOUN	NNS	O
at	at	ADP	IN	O
week	week	NOUN	NN	O
18	18	NUM	CD	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
ABSTRACT	ABSTRACT	PROPN	NNP	O
TRUNCATED	truncated	NUM	CD	O
AT	at	ADP	IN	O
250	250	NUM	CD	O
WORDS	word	NOUN	NNS	O
)	)	PUNCT	-RRB-	O

National	national	ADJ	JJ	O
project	project	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
mother	mother	NOUN	NN	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
infant	infant	NOUN	NN	O
infection	infection	NOUN	NN	B-Disease
by	by	ADP	IN	I-Disease
hepatitis	hepatitis	PROPN	NNP	I-Disease
B	B	PROPN	NNP	I-Disease
virus	virus	NOUN	NN	I-Disease
in	in	ADP	IN	O
Japan	Japan	PROPN	NNP	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
Japan	Japan	PROPN	NNP	O
,	,	PUNCT	,	O
a	a	DET	DT	O
nationwide	nationwide	ADJ	JJ	O
prevention	prevention	NOUN	NN	O
program	program	NOUN	NN	O
against	against	ADP	IN	O
mother	mother	NOUN	NN	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
infant	infant	NOUN	NN	O
infection	infection	NOUN	NN	B-Disease
by	by	ADP	IN	I-Disease
hepatitis	hepatitis	PROPN	NNP	I-Disease
B	B	PROPN	NNP	I-Disease
virus	virus	PROPN	NNP	I-Disease
(	(	PUNCT	-LRB-	O
HBV	HBV	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
started	start	VERB	VBD	O
in	in	ADP	IN	O
1985	1985	NUM	CD	O
.	.	PUNCT	.	O

This	this	DET	DT	O
program	program	NOUN	NN	O
consists	consist	VERB	VBZ	O
of	of	ADP	IN	O
double	double	ADJ	JJ	O
screenings	screening	NOUN	NNS	O
of	of	ADP	IN	O
pregnant	pregnant	ADJ	JJ	O
women	woman	NOUN	NNS	O
and	and	CCONJ	CC	O
prophylactic	prophylactic	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
infants	infant	NOUN	NNS	O
born	bear	VERB	VBN	O
to	to	ADP	IN	O
both	both	DET	DT	O
hepatitis	hepatitis	PROPN	NNP	B-Chemical
B	B	PROPN	NNP	I-Chemical
surface	surface	NOUN	NN	I-Chemical
antigen	antigen	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
HBsAg	HBsAg	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
hepatitis	hepatitis	PROPN	NNP	B-Chemical
B	B	PROPN	NNP	I-Chemical
e	e	PROPN	NNP	I-Chemical
antigen	antigen	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
HBeAg	HBeAg	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
positive	positive	ADJ	JJ	O
mothers	mother	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
infants	infant	NOUN	NNS	O
are	be	VERB	VBP	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
two	two	NUM	CD	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
hepatitis	hepatitis	PROPN	NNP	B-Disease
B	B	PROPN	NNP	I-Disease
immune	immune	ADJ	JJ	O
globulin	globulin	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HBIG	HBIG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
at	at	ADV	RB	O
least	least	ADV	RBS	O
three	three	NUM	CD	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
derived	derive	VERB	VBD	O
hepatitis	hepatitis	NOUN	NN	B-Chemical
B	B	PROPN	NNP	I-Chemical
vaccine	vaccine	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
sent	send	VERB	VBD	O
questionnaires	questionnaire	NOUN	NNS	O
about	about	ADP	IN	O
the	the	DET	DT	O
numbers	number	NOUN	NNS	O
of	of	ADP	IN	O
each	each	DET	DT	O
procedure	procedure	NOUN	NN	O
or	or	CCONJ	CC	O
examination	examination	NOUN	NN	O
during	during	ADP	IN	O
nine	nine	NUM	CD	O
months	month	NOUN	NNS	O
of	of	ADP	IN	O
investigation	investigation	NOUN	NN	O
period	period	NOUN	NN	O
to	to	ADP	IN	O
each	each	DET	DT	O
local	local	ADJ	JJ	O
government	government	NOUN	NN	O
in	in	ADP	IN	O
1986	1986	NUM	CD	O
and	and	CCONJ	CC	O
1987	1987	NUM	CD	O
.	.	PUNCT	.	O

93	93	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
pregnant	pregnant	ADJ	JJ	O
women	woman	NOUN	NNS	O
had	have	VERB	VBD	O
the	the	DET	DT	O
chance	chance	NOUN	NN	O
to	to	PART	TO	O
be	be	VERB	VB	O
examined	examine	VERB	VBN	O
for	for	ADP	IN	O
HBsAg	HBsAg	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
positive	positive	ADJ	JJ	O
rate	rate	NOUN	NN	O
was	be	VERB	VBD	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
to	to	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
HBeAg	HBeAg	PROPN	NNP	B-Chemical
positive	positive	ADJ	JJ	O
rate	rate	NOUN	NN	O
in	in	ADP	IN	O
HBsAg	HBsAg	PROPN	NNP	B-Chemical
positive	positive	ADJ	JJ	O
was	be	VERB	VBD	O
23	23	NUM	CD	O
to	to	PART	TO	O
26	26	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
HBsAg	HBsAg	PROPN	NNP	B-Chemical
positive	positive	ADJ	JJ	O
rate	rate	NOUN	NN	O
in	in	ADP	IN	O
neonates	neonate	NOUN	NNS	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
infants	infant	NOUN	NNS	O
before	before	ADP	IN	O
two	two	NUM	CD	O
months	month	NOUN	NNS	O
were	be	VERB	VBD	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Some	some	DET	DT	O
problems	problem	NOUN	NNS	O
may	may	VERB	MD	O
arise	arise	VERB	VB	O
,	,	PUNCT	,	O
because	because	ADP	IN	O
27	27	NUM	CD	O
to	to	PART	TO	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
infants	infant	NOUN	NNS	O
need	need	VERB	VBP	O
the	the	DET	DT	O
fourth	fourth	ADJ	JJ	O
vaccination	vaccination	NOUN	NN	O
in	in	ADP	IN	O
some	some	DET	DT	O
restricted	restrict	VERB	VBN	O
areas	area	NOUN	NNS	O
.	.	PUNCT	.	O

Involvement	involvement	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
mu	mu	ADJ	JJ	O
-	-	PUNCT	HYPH	O
opiate	opiate	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
in	in	ADP	IN	O
peripheral	peripheral	ADJ	JJ	O
analgesia	analgesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
intradermal	intradermal	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
mu	mu	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
morphine	morphine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
Tyr	Tyr	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
D	D	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
Ala	Ala	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
Gly	Gly	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
NMe	NMe	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
Phe	Phe	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
Gly	Gly	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
ol	ol	PROPN	NNP	I-Chemical
and	and	CCONJ	CC	O
morphiceptin	morphiceptin	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
kappa	kappa	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
trans	trans	PROPN	NNP	B-Chemical
-	-	PROPN	NNP	I-Chemical
3	3	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dichloro	dichloro	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
N	n	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
N	N	PROPN	NNP	I-Chemical
[	[	PUNCT	-LRB-	I-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
(	(	PUNCT	-LRB-	I-Chemical
1	1	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
pyrrolidinyl	pyrrolidinyl	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
cyclohexyl	cyclohexyl	NOUN	NN	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
benzeneactemide	benzeneactemide	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
delta	delta	NOUN	NN	O
(	(	PUNCT	-LRB-	O
[	[	PUNCT	-LRB-	B-Chemical
D	D	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
Pen2	Pen2	PROPN	NNP	I-Chemical
.	.	PUNCT	.	I-Chemical
5	5	NUM	CD	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
enkephalin	enkephalin	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
[	[	PUNCT	-LRB-	B-Chemical
D	D	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
Ser2	ser2	NOUN	NN	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
[	[	PUNCT	-LRB-	I-Chemical
Leu	Leu	PROPN	NNP	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
enkephalin	enkephalin	PROPN	NNP	I-Chemical
-	-	PUNCT	:	I-Chemical
Thr	Thr	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
selective	selective	ADJ	JJ	O
opioid	opioid	NOUN	NN	O
-	-	PUNCT	HYPH	O
agonists	agonist	NOUN	NNS	O
,	,	PUNCT	,	O
by	by	ADP	IN	O
themselves	-PRON-	PRON	PRP	O
,	,	PUNCT	,	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
affect	affect	VERB	VB	O
the	the	DET	DT	O
mechanical	mechanical	ADJ	JJ	O
nociceptive	nociceptive	ADJ	JJ	O
threshold	threshold	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
hindpaw	hindpaw	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

Intradermal	intradermal	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
mu	mu	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
delta	delta	NOUN	NN	O
or	or	CCONJ	CC	O
kappa	kappa	NOUN	NNS	O
opioid	opioid	NOUN	NN	O
-	-	PUNCT	HYPH	O
agonists	agonist	NOUN	NNS	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
produced	produce	VERB	VBD	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
E2	e2	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperalgesia	hyperalgesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
analgesic	analgesic	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
mu	mu	ADJ	JJ	O
-	-	PUNCT	HYPH	O
agonist	agonist	ADJ	JJ	O
morphine	morphine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
dose	dose	NOUN	NN	O
-	-	PUNCT	:	O
dependently	dependently	ADV	RB	O
antagonized	antagonize	VERB	VBN	O
by	by	ADP	IN	O
naloxone	naloxone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
prevented	prevent	VERB	VBN	O
by	by	ADP	IN	O
co	co	NOUN	NN	O
-	-	NOUN	NN	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
pertussis	pertussis	NOUN	NN	O
toxin	toxin	NOUN	NN	O
.	.	PUNCT	.	O

Morphine	Morphine	PROPN	NNP	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
alter	alter	VERB	VB	O
the	the	DET	DT	O
hyperalgesia	hyperalgesia	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
8	8	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
bromo	bromo	NOUN	NNS	I-Chemical
cyclic	cyclic	ADJ	JJ	I-Chemical
adenosine	adenosine	NOUN	NN	I-Chemical
monophosphate	monophosphate	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
analgesic	analgesic	ADJ	JJ	O
action	action	NOUN	NN	O
of	of	ADP	IN	O
opioids	opioid	NOUN	NNS	O
on	on	ADP	IN	O
the	the	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
terminals	terminal	NOUN	NNS	O
of	of	ADP	IN	O
primary	primary	ADJ	JJ	O
afferents	afferent	NOUN	NNS	O
is	be	VERB	VBZ	O
via	via	ADP	IN	O
a	a	DET	DT	O
binding	bind	VERB	VBG	O
site	site	NOUN	NN	O
with	with	ADP	IN	O
characteristics	characteristic	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
mu	mu	ADJ	JJ	O
-	-	PUNCT	HYPH	O
opioid	opioid	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
and	and	CCONJ	CC	O
that	that	ADP	IN	O
this	this	DET	DT	O
action	action	NOUN	NN	O
is	be	VERB	VBZ	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cyclic	cyclic	ADJ	JJ	B-Chemical
adenosine	adenosine	NOUN	NN	I-Chemical
monophosphate	monophosphate	VERB	VBP	I-Chemical
second	second	ADJ	JJ	O
messenger	messenger	NOUN	NN	O
system	system	NOUN	NN	O
.	.	PUNCT	.	O

Involvement	involvement	NOUN	NN	O
of	of	ADP	IN	O
locus	locus	NOUN	NN	O
coeruleus	coeruleus	NOUN	NN	O
and	and	CCONJ	CC	O
noradrenergic	noradrenergic	ADJ	JJ	O
neurotransmission	neurotransmission	NOUN	NN	O
in	in	ADP	IN	O
fentanyl	fentanyl	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
muscular	muscular	ADJ	JJ	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

Whereas	whereas	ADP	IN	O
muscular	muscular	ADJ	JJ	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
well	well	ADV	RB	O
-	-	PUNCT	HYPH	O
known	know	VERB	VBN	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
fentanyl	fentanyl	NOUN	NN	B-Chemical
anesthesia	anesthesia	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
paucity	paucity	NOUN	NN	O
of	of	ADP	IN	O
information	information	NOUN	NN	O
exists	exist	VERB	VBZ	O
with	with	ADP	IN	O
regard	regard	NOUN	NN	O
to	to	ADP	IN	O
its	-PRON-	DET	PRP$	O
underlying	underlying	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
(	(	PUNCT	-LRB-	O
s	s	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
in	in	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
the	the	DET	DT	O
possible	possible	ADJ	JJ	O
engagement	engagement	NOUN	NN	O
of	of	ADP	IN	O
locus	locus	NOUN	NN	O
coeruleus	coeruleus	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
pons	pon	NOUN	NNS	O
in	in	ADP	IN	O
this	this	DET	DT	O
phenomenon	phenomenon	NOUN	NN	O
,	,	PUNCT	,	O
using	use	VERB	VBG	O
male	male	NOUN	NN	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
anesthetized	anesthetize	VERB	VBD	O
with	with	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Under	under	ADP	IN	O
proper	proper	ADJ	JJ	O
control	control	NOUN	NN	O
of	of	ADP	IN	O
respiration	respiration	NOUN	NN	O
,	,	PUNCT	,	O
body	body	NOUN	NN	O
temperature	temperature	NOUN	NN	O
and	and	CCONJ	CC	O
end	end	NOUN	NN	O
-	-	PUNCT	HYPH	O
tidal	tidal	ADJ	JJ	O
CO2	CO2	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
intravenous	intravenous	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
fentanyl	fentanyl	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
50	50	NUM	CD	O
or	or	CCONJ	CC	O
100	100	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
consistently	consistently	ADV	RB	O
promoted	promote	VERB	VBD	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
electromyographic	electromyographic	ADJ	JJ	O
activity	activity	NOUN	NN	O
recorded	record	VERB	VBN	O
from	from	ADP	IN	O
the	the	DET	DT	O
gastrocnemius	gastrocnemius	NOUN	NN	O
and	and	CCONJ	CC	O
abdominal	abdominal	ADJ	JJ	O
rectus	rectus	NOUN	NN	O
muscles	muscle	NOUN	NNS	O
.	.	PUNCT	.	O

Such	such	DET	PDT	O
an	an	DET	DT	O
induced	induced	ADJ	JJ	O
muscular	muscular	ADJ	JJ	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
by	by	ADP	IN	O
the	the	DET	DT	O
narcotic	narcotic	ADJ	JJ	O
agent	agent	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
antagonized	antagonize	VERB	VBN	O
or	or	CCONJ	CC	O
even	even	ADV	RB	O
reduced	reduce	VERB	VBN	O
by	by	ADP	IN	O
prior	prior	ADJ	JJ	O
electrolytic	electrolytic	ADJ	JJ	O
lesions	lesion	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
locus	locus	NOUN	NN	O
coeruleus	coeruleus	NOUN	NN	O
or	or	CCONJ	CC	O
pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
blocker	blocker	NOUN	NN	O
,	,	PUNCT	,	O
prazosin	prazosin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Microinjection	microinjection	NOUN	NN	O
of	of	ADP	IN	O
fentanyl	fentanyl	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
/	/	SYM	SYM	O
50	50	NUM	CD	O
nl	nl	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
directly	directly	ADV	RB	O
into	into	ADP	IN	O
this	this	DET	DT	O
pontine	pontine	NOUN	NN	O
nucleus	nucleus	NOUN	NN	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
hand	hand	NOUN	NN	O
,	,	PUNCT	,	O
elicited	elicit	VERB	VBD	O
discernible	discernible	ADJ	JJ	O
electromyographic	electromyographic	ADJ	JJ	O
excitation	excitation	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
speculated	speculate	VERB	VBN	O
that	that	ADP	IN	O
the	the	DET	DT	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
muscular	muscular	ADJ	JJ	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
by	by	ADP	IN	O
fentanyl	fentanyl	NOUN	NN	B-Chemical
may	may	VERB	MD	O
involve	involve	VERB	VB	O
the	the	DET	DT	O
coerulospinal	coerulospinal	ADJ	JJ	O
noradrenergic	noradrenergic	ADJ	JJ	O
fibers	fiber	NOUN	NNS	O
to	to	ADP	IN	O
the	the	DET	DT	O
spinal	spinal	ADJ	JJ	O
motoneurons	motoneuron	NOUN	NNS	O
.	.	PUNCT	.	O

Dexmedetomidine	Dexmedetomidine	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
acting	act	VERB	VBG	O
through	through	ADP	IN	O
central	central	ADJ	JJ	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
adrenoceptors	adrenoceptor	NOUN	NNS	O
,	,	PUNCT	,	O
prevents	prevent	NOUN	NNS	O
opiate	opiate	VERB	VB	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
highly	highly	ADV	RB	O
-	-	PUNCT	HYPH	O
selective	selective	ADJ	JJ	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
adrenergic	adrenergic	NOUN	NN	O
agonist	agonist	NOUN	NN	O
dexmedetomidine	dexmedetomidine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
MED	MED	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
capable	capable	ADJ	JJ	O
of	of	ADP	IN	O
inducing	induce	VERB	VBG	O
muscle	muscle	NOUN	NN	B-Disease
flaccidity	flaccidity	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
anesthesia	anesthesia	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

Intense	intense	ADJ	JJ	O
generalized	generalized	ADJ	JJ	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
an	an	DET	DT	O
undesirable	undesirable	ADJ	JJ	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
potent	potent	ADJ	JJ	O
opiate	opiate	NOUN	NN	O
agonists	agonist	NOUN	NNS	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
the	the	DET	DT	O
neurochemistry	neurochemistry	NOUN	NN	O
of	of	ADP	IN	O
opiate	opiate	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
rigidity	rigidity	NOUN	NN	B-Disease
has	have	VERB	VBZ	O
yet	yet	ADV	RB	O
to	to	PART	TO	O
be	be	VERB	VB	O
fully	fully	ADV	RB	O
elucidated	elucidate	VERB	VBN	O
,	,	PUNCT	,	O
recent	recent	ADJ	JJ	O
work	work	NOUN	NN	O
suggests	suggest	VERB	VBZ	O
a	a	DET	DT	O
role	role	NOUN	NN	O
for	for	ADP	IN	O
a	a	DET	DT	O
central	central	ADJ	JJ	O
adrenergic	adrenergic	NOUN	NN	O
mechanism	mechanism	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
authors	author	NOUN	NNS	O
determined	determine	VERB	VBD	O
if	if	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
MED	MED	PROPN	NNP	I-Chemical
prevents	prevent	VERB	VBZ	O
the	the	DET	DT	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
alfentanil	alfentanil	NOUN	NN	B-Chemical
anesthesia	anesthesia	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

Animals	animal	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
42	42	NUM	CD	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
intraperitoneally	intraperitoneally	ADV	RB	O
with	with	ADP	IN	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
following	follow	VERB	VBG	O
six	six	NUM	CD	O
regimens	regimen	NOUN	NNS	O
:	:	PUNCT	:	O
1	1	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
L	L	PROPN	NNP	O
-	-	PUNCT	HYPH	O
MED	MED	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
the	the	DET	DT	O
inactive	inactive	ADJ	JJ	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
isomer	isomer	NOUN	NN	O
of	of	ADP	IN	O
medetomidine	medetomidine	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
30	30	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
;	;	PUNCT	:	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
MED	MED	PROPN	NNP	I-Chemical
,	,	PUNCT	,	O
10	10	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
;	;	PUNCT	:	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
MED	MED	PROPN	NNP	I-Chemical
,	,	PUNCT	,	O
30	30	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
;	;	PUNCT	:	O
4	4	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
MED	MED	PROPN	NNP	I-Chemical
[	[	PUNCT	-LRB-	O
30	30	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
]	]	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
central	central	ADJ	JJ	O
-	-	PUNCT	HYPH	O
acting	act	VERB	VBG	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
idazoxan	idazoxan	ADJ	JJ	B-Chemical
[	[	PUNCT	-LRB-	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
]	]	PUNCT	-RRB-	O
;	;	PUNCT	:	O
5	5	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
MED	MED	PROPN	NNP	I-Chemical
[	[	PUNCT	-LRB-	O
30	30	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
]	]	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
peripheral	peripheral	NOUN	NN	O
-	-	PUNCT	HYPH	O
acting	act	VERB	VBG	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
antagonist	antagonist	NOUN	NN	O
DG	DG	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
5128	5128	NUM	CD	I-Chemical
[	[	PUNCT	-LRB-	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
]	]	PUNCT	-RRB-	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
;	;	PUNCT	:	O
6	6	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
saline	saline	NOUN	NN	O
.	.	PUNCT	.	O

Baseline	baseline	ADJ	JJ	O
electromyographic	electromyographic	ADJ	JJ	O
activity	activity	NOUN	NN	O
was	be	VERB	VBD	O
recorded	record	VERB	VBN	O
from	from	ADP	IN	O
the	the	DET	DT	O
gastrocnemius	gastrocnemius	NOUN	NN	O
muscle	muscle	NOUN	NN	O
before	before	ADP	IN	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
drug	drug	NOUN	NN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Each	each	DET	DT	O
rat	rat	NOUN	NN	O
was	be	VERB	VBD	O
then	then	ADV	RB	O
injected	inject	VERB	VBN	O
with	with	ADP	IN	O
alfentanil	alfentanil	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
ALF	ALF	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
sc	sc	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

ALF	alf	NOUN	NN	B-Chemical
injection	injection	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
a	a	DET	DT	O
marked	marked	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
hindlimb	hindlimb	ADJ	JJ	O
EMG	EMG	PROPN	NNP	O
activity	activity	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
L	L	PROPN	NNP	O
-	-	PUNCT	HYPH	O
MED	MED	PROPN	NNP	O
treatment	treatment	NOUN	NN	O
group	group	NOUN	NN	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
indistinguishable	indistinguishable	ADJ	JJ	O
from	from	ADP	IN	O
that	that	DET	DT	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
animals	animal	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
MED	MED	PROPN	NNP	I-Chemical
prevented	prevent	VERB	VBD	O
alfentanil	alfentanil	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
fashion	fashion	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
small	small	ADJ	JJ	O
EMG	EMG	PROPN	NNP	O
values	value	NOUN	NNS	O
obtained	obtain	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
MED	MED	PROPN	NNP	I-Chemical
group	group	NOUN	NN	O
were	be	VERB	VBD	O
comparable	comparable	ADJ	JJ	O
with	with	ADP	IN	O
those	those	DET	DT	O
recorded	record	VERB	VBN	O
in	in	ADP	IN	O
earlier	early	ADJ	JJR	O
studies	study	NOUN	NNS	O
from	from	ADP	IN	O
control	control	NOUN	NN	O
animals	animal	NOUN	NNS	O
not	not	ADV	RB	O
given	give	VERB	VBN	O
any	any	DET	DT	O
opiate	opiate	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
MED	MED	PROPN	NNP	I-Chemical
animals	animal	NOUN	NNS	O
were	be	VERB	VBD	O
flaccid	flaccid	NOUN	NN	O
,	,	PUNCT	,	O
akinetic	akinetic	ADJ	JJ	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
lacked	lack	VERB	VBD	O
a	a	DET	DT	O
startle	startle	ADJ	JJ	B-Disease
response	response	NOUN	NN	O
during	during	ADP	IN	O
the	the	DET	DT	O
entire	entire	ADJ	JJ	O
experimental	experimental	ADJ	JJ	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
ABSTRACT	ABSTRACT	PROPN	NNP	O
TRUNCATED	truncated	NUM	CD	O
AT	at	ADP	IN	O
250	250	NUM	CD	O
WORDS	word	NOUN	NNS	O
)	)	PUNCT	-RRB-	O

Some	some	DET	DT	O
central	central	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
repeated	repeat	VERB	VBN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
repeated	repeat	VERB	VBN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
selective	selective	ADJ	JJ	O
serotonin	serotonin	NOUN	NN	B-Chemical
uptake	uptake	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
behavioral	behavioral	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
dopaminomimetics	dopaminomimetic	NOUN	NNS	O
and	and	CCONJ	CC	O
methoxamine	methoxamine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
on	on	ADP	IN	O
the	the	DET	DT	O
animal	animal	NOUN	NN	O
behavior	behavior	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
"	"	PUNCT	``	O
behavioral	behavioral	ADJ	JJ	O
despair	despair	NOUN	NN	O
"	"	PUNCT	''	O
test	test	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
repeated	repeat	VERB	VBN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
twice	twice	ADV	RB	O
daily	daily	ADJ	JJ	O
for	for	ADP	IN	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
potentiated	potentiate	VERB	VBN	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
weaker	weak	ADJ	JJR	O
)	)	PUNCT	-RRB-	O
the	the	DET	DT	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hyperactivity	hyperactivity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
hyperactivity	hyperactivity	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
nomifensine	nomifensine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
remained	remain	VERB	VBD	O
unaffected	unaffected	ADJ	JJ	O
by	by	ADP	IN	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
stimulation	stimulation	NOUN	NN	O
of	of	ADP	IN	O
locomotor	locomotor	NOUN	NN	O
activity	activity	NOUN	NN	O
by	by	ADP	IN	O
intracerebroventricularly	intracerebroventricularly	ADV	RB	O
administered	administer	VERB	VBN	O
methoxamine	methoxamine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
not	not	ADV	RB	O
affected	affect	VERB	VBN	O
by	by	ADP	IN	O
repeated	repeat	VERB	VBN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Given	give	VERB	VBN	O
three	three	NUM	CD	O
times	time	NOUN	NNS	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
immobilization	immobilization	NOUN	NN	O
time	time	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
"	"	PUNCT	``	O
behavioral	behavioral	ADJ	JJ	O
despair	despair	NOUN	NN	O
"	"	PUNCT	''	O
test	test	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
given	give	VERB	VBN	O
repeatedly	repeatedly	ADV	RB	O
acts	act	VERB	VBZ	O
differently	differently	ADV	RB	O
than	than	ADP	IN	O
citalopram	citalopram	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
another	another	DET	DT	O
selective	selective	ADJ	JJ	O
serotonin	serotonin	NOUN	NN	B-Chemical
uptake	uptake	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
differs	differ	NOUN	NNS	O
also	also	ADV	RB	O
from	from	ADP	IN	O
other	other	ADJ	JJ	O
antidepressant	antidepressant	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

Protective	protective	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
specific	specific	ADJ	JJ	O
platelet	platelet	NOUN	NN	O
-	-	PUNCT	HYPH	O
activating	activate	VERB	VBG	O
factor	factor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
BN	BN	PROPN	NNP	B-Chemical
52021	52021	NUM	CD	I-Chemical
,	,	PUNCT	,	O
on	on	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
impairments	impairment	NOUN	NNS	I-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Administration	administration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
local	local	ADJ	JJ	O
anaesthetic	anaesthetic	ADJ	JJ	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
rats	rat	NOUN	NNS	O
elicited	elicit	VERB	VBD	O
a	a	DET	DT	O
marked	marked	ADJ	JJ	O
decrease	decrease	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
mean	mean	ADJ	JJ	I-Disease
arterial	arterial	ADJ	JJ	I-Disease
blood	blood	NOUN	NN	I-Disease
pressure	pressure	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	I-Disease
MBP	MBP	PROPN	NNP	I-Disease
)	)	PUNCT	-RRB-	I-Disease
and	and	CCONJ	CC	I-Disease
heart	heart	NOUN	NN	I-Disease
rate	rate	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	I-Disease
HR	hr	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	I-Disease
leading	lead	VERB	VBG	O
to	to	ADP	IN	O
death	death	NOUN	NN	O
(	(	PUNCT	-LRB-	O
in	in	ADP	IN	O
67	67	NUM	CD	O
%	%	NOUN	NN	O
or	or	CCONJ	CC	O
90	90	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
animals	animal	NOUN	NNS	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Intravenous	intravenous	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
specific	specific	ADJ	JJ	O
platelet	platelet	NOUN	NN	O
-	-	PUNCT	HYPH	O
activating	activate	VERB	VBG	O
factor	factor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PAF	PAF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
antagonist	antagonist	NOUN	NN	O
BN	BN	PROPN	NNP	B-Chemical
52021	52021	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
bupivacaine	bupivacaine	ADJ	JJ	B-Chemical
administration	administration	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
suppressed	suppress	VERB	VBD	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
decrease	decrease	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
MBP	MBP	PROPN	NNP	I-Disease
and	and	CCONJ	CC	I-Disease
HR	hr	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
BN	BN	PROPN	NNP	B-Chemical
52021	52021	NUM	CD	I-Chemical
given	give	VERB	VBN	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADV	RB	O
or	or	CCONJ	CC	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	PUNCT	,	O
kg	kg	NOUN	NN	O
administered	administer	VERB	VBN	O
5	5	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
ineffective	ineffective	ADJ	JJ	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
BN	BN	PROPN	NNP	B-Chemical
52021	52021	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
injected	inject	VERB	VBN	O
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
partial	partial	ADJ	JJ	O
reversion	reversion	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
decrease	decrease	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
MBP	MBP	PROPN	NNP	I-Disease
and	and	CCONJ	CC	I-Disease
HR	hr	NOUN	NN	I-Disease
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
was	be	VERB	VBD	O
ineffective	ineffective	ADJ	JJ	O
.	.	PUNCT	.	O

A	a	DET	DT	O
partial	partial	ADJ	JJ	O
recovery	recovery	NOUN	NN	O
of	of	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
ECG	ECG	PROPN	NNP	O
alterations	alteration	NOUN	NNS	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
after	after	ADP	IN	O
pretreatment	pretreatment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
BN	BN	PROPN	NNP	B-Chemical
52021	52021	NUM	CD	I-Chemical
.	.	PUNCT	.	O

Since	since	ADP	IN	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
BN	BN	PROPN	NNP	B-Chemical
52021	52021	NUM	CD	I-Chemical
,	,	PUNCT	,	O
at	at	ADP	IN	O
all	all	DET	DT	O
doses	dose	NOUN	NNS	O
studied	study	VERB	VBN	O
,	,	PUNCT	,	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
alter	alter	VERB	VB	O
MBP	MBP	PROPN	NNP	O
and	and	CCONJ	CC	O
HR	hr	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
doses	dose	NOUN	NNS	O
used	use	VERB	VBN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
bulk	bulk	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
results	result	NOUN	NNS	O
clearly	clearly	ADV	RB	O
demonstrate	demonstrate	VERB	VBP	O
a	a	DET	DT	O
protective	protective	ADJ	JJ	O
action	action	NOUN	NN	O
of	of	ADP	IN	O
BN	BN	PROPN	NNP	B-Chemical
52021	52021	NUM	CD	I-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
specific	specific	ADJ	JJ	O
antagonist	antagonist	NOUN	NN	O
of	of	ADP	IN	O
PAF	PAF	PROPN	NNP	O
,	,	PUNCT	,	O
against	against	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
its	-PRON-	DET	PRP$	O
direct	direct	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
heart	heart	NOUN	NN	O
,	,	PUNCT	,	O
PAF	PAF	PROPN	NNP	O
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
alterations	alteration	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
epidemiology	epidemiology	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
acute	acute	ADJ	JJ	O
flank	flank	NOUN	NN	B-Disease
pain	pain	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	O
from	from	ADP	IN	O
suprofen	suprofen	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Suprofen	Suprofen	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
nonsteroidal	nonsteroidal	ADJ	JJ	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
drug	drug	NOUN	NN	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
marketed	market	VERB	VBN	O
in	in	ADP	IN	O
early	early	ADJ	JJ	O
1986	1986	NUM	CD	O
as	as	ADP	IN	O
an	an	DET	DT	O
analgesic	analgesic	ADJ	JJ	O
agent	agent	NOUN	NN	O
.	.	PUNCT	.	O

Until	until	ADP	IN	O
physicians	physician	NOUN	NNS	O
began	begin	VERB	VBD	O
reporting	report	VERB	VBG	O
an	an	DET	DT	O
unusual	unusual	ADJ	JJ	O
acute	acute	ADJ	JJ	O
flank	flank	NOUN	NN	B-Disease
pain	pain	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
spontaneous	spontaneous	ADJ	JJ	O
reporting	reporting	NOUN	NN	O
system	system	NOUN	NN	O
,	,	PUNCT	,	O
700	700	NUM	CD	O
,	,	PUNCT	,	O
000	000	NUM	CD	O
persons	person	NOUN	NNS	O
used	use	VERB	VBD	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
United	United	PROPN	NNP	O
States	States	PROPN	NNP	O
.	.	PUNCT	.	O

Through	through	ADP	IN	O
August	August	PROPN	NNP	O
1986	1986	NUM	CD	O
,	,	PUNCT	,	O
a	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
163	163	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
syndrome	syndrome	NOUN	NN	O
were	be	VERB	VBD	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

To	to	PART	TO	O
elucidate	elucidate	VERB	VB	O
the	the	DET	DT	O
epidemiology	epidemiology	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
syndrome	syndrome	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
case	case	NOUN	NN	O
-	-	PUNCT	HYPH	O
control	control	NOUN	NN	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
performed	perform	VERB	VBN	O
,	,	PUNCT	,	O
comparing	compare	VERB	VBG	O
62	62	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
case	case	NOUN	NN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
spontaneous	spontaneous	ADJ	JJ	O
reporting	reporting	NOUN	NN	O
system	system	NOUN	NN	O
to	to	ADP	IN	O
185	185	NUM	CD	O
suprofen	suprofen	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
exposed	expose	VERB	VBN	O
control	control	NOUN	NN	O
subjects	subject	NOUN	NNS	O
who	who	PRON	WP	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
have	have	VERB	VB	O
the	the	DET	DT	O
syndrome	syndrome	NOUN	NN	O
.	.	PUNCT	.	O

Case	case	NOUN	NN	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
more	more	ADV	RBR	O
likely	likely	ADJ	JJ	O
to	to	PART	TO	O
be	be	VERB	VB	O
men	man	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
odds	odd	NOUN	NNS	O
ratio	ratio	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
;	;	PUNCT	:	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
-	-	SYM	SYM	O
12	12	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
suffer	suffer	VERB	VBP	O
from	from	ADP	IN	O
hay	hay	ADJ	JJ	B-Disease
fever	fever	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
asthma	asthma	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
odds	odd	NOUN	NNS	O
ratio	ratio	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
;	;	PUNCT	:	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
-	-	SYM	SYM	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
to	to	PART	TO	O
participate	participate	VERB	VB	O
in	in	ADP	IN	O
regular	regular	ADJ	JJ	O
exercise	exercise	NOUN	NN	O
(	(	PUNCT	-LRB-	O
odds	odd	NOUN	NNS	O
ratio	ratio	NOUN	NN	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
;	;	PUNCT	:	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
30	30	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
Nautilus	nautilus	ADJ	JJ	O
equipment	equipment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
02	02	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
use	use	VERB	VB	O
alcohol	alcohol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
odds	odd	NOUN	NNS	O
ratio	ratio	NOUN	NN	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
;	;	PUNCT	:	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
17	17	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Possible	possible	ADJ	JJ	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
included	include	VERB	VBD	O
young	young	ADJ	JJ	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
concurrent	concurrent	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
other	other	ADJ	JJ	O
analgesic	analgesic	ADJ	JJ	O
agents	agent	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
especially	especially	ADV	RB	O
ibuprofen	ibuprofen	ADJ	JJ	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
preexisting	preexist	VERB	VBG	O
renal	renal	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
kidney	kidney	NOUN	NN	B-Disease
stones	stone	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
a	a	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
gout	gout	NOUN	NN	B-Disease
,	,	PUNCT	,	O
a	a	DET	DT	O
recent	recent	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
recent	recent	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
sun	sun	NOUN	NN	O
exposure	exposure	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
residence	residence	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
Sunbelt	Sunbelt	PROPN	NNP	O
.	.	PUNCT	.	O

These	these	DET	DT	O
were	be	VERB	VBD	O
findings	finding	NOUN	NNS	O
that	that	DET	WDT	O
were	be	VERB	VBD	O
suggestive	suggestive	ADJ	JJ	O
but	but	CCONJ	CC	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
reach	reach	VERB	VB	O
conventional	conventional	ADJ	JJ	O
statistical	statistical	ADJ	JJ	O
significance	significance	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
are	be	VERB	VBP	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
the	the	DET	DT	O
postulated	postulated	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
for	for	ADP	IN	O
this	this	DET	DT	O
unusual	unusual	ADJ	JJ	O
syndrome	syndrome	NOUN	NN	O
:	:	PUNCT	:	O
acute	acute	ADJ	JJ	O
diffuse	diffuse	NOUN	NN	O
crystallization	crystallization	NOUN	NN	O
of	of	ADP	IN	O
uric	uric	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
tubules	tubule	NOUN	NNS	O
.	.	PUNCT	.	O

Phlorizin	Phlorizin	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
glycosuria	glycosuria	NOUN	NN	B-Disease
does	do	VERB	VBZ	O
not	not	ADV	RB	O
prevent	prevent	VERB	VB	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Because	because	ADP	IN	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
streptozotocin	streptozotocin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
diabetes	diabetes	NOUN	NN	B-Disease
mellitus	mellitus	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
DM	DM	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
have	have	VERB	VBP	O
a	a	DET	DT	O
high	high	ADJ	JJ	O
solute	solute	NOUN	NN	O
diuresis	diuresis	NOUN	NN	O
(	(	PUNCT	-LRB-	O
glycosuria	glycosuria	NOUN	NN	B-Disease
of	of	ADP	IN	O
10	10	NUM	CD	O
to	to	PART	TO	O
12	12	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
have	have	VERB	VBP	O
suggested	suggest	VERB	VBN	O
that	that	ADP	IN	O
this	this	DET	DT	O
may	may	VERB	MD	O
in	in	ADP	IN	O
part	part	NOUN	NN	O
be	be	VERB	VB	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
their	-PRON-	DET	PRP$	O
resistance	resistance	NOUN	NN	O
to	to	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
ARF	ARF	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
protection	protection	NOUN	NN	O
from	from	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
was	be	VERB	VBD	O
studied	study	VERB	VBN	O
in	in	ADP	IN	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
diabetic	diabetic	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	O
solute	solute	NOUN	NN	O
diuresis	diuresis	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
blockage	blockage	NOUN	NN	O
of	of	ADP	IN	O
tubular	tubular	ADJ	JJ	O
glucose	glucose	NOUN	NN	B-Chemical
reabsorption	reabsorption	NOUN	NN	O
with	with	ADP	IN	O
phlorizin	phlorizin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

DM	dm	VERB	VB	B-Disease
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
mild	mild	ADJ	JJ	O
glycosuria	glycosuria	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
similar	similar	ADJ	JJ	O
in	in	ADP	IN	O
degree	degree	NOUN	NN	O
to	to	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
P	p	NOUN	NN	B-Chemical
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
also	also	ADV	RB	O
studied	study	VERB	VBN	O
.	.	PUNCT	.	O

Unanesthetized	unanesthetize	VERB	VBN	O
adult	adult	NOUN	NN	O
female	female	NOUN	NN	O
,	,	PUNCT	,	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
divided	divide	VERB	VBN	O
in	in	ADP	IN	O
four	four	NUM	CD	O
groups	group	NOUN	NNS	O
and	and	CCONJ	CC	O
studied	study	VERB	VBD	O
for	for	ADP	IN	O
15	15	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Group	group	NOUN	NN	O
1	1	NUM	CD	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
)	)	PUNCT	-RRB-	O
received	receive	VERB	VBD	O
P	p	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
360	360	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
,	,	PUNCT	,	O
for	for	ADP	IN	O
15	15	NUM	CD	O
days	day	NOUN	NNS	O
;	;	PUNCT	:	O
Group	Group	PROPN	NNP	O
II	II	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	B-Chemical
+	+	SYM	SYM	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
Group	Group	PROPN	NNP	O
III	III	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
Group	Group	PROPN	NNP	O
IV	IV	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
mild	mild	ADJ	JJ	O
DM	DM	PROPN	NNP	B-Disease
+	+	SYM	SYM	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Nephrotoxic	Nephrotoxic	PROPN	NNP	B-Disease
doses	dose	VERB	VBZ	O
(	(	PUNCT	-LRB-	O
40	40	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
body	body	NOUN	NN	O
wt	wt	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
injected	inject	VERB	VBN	O
during	during	ADP	IN	O
the	the	DET	DT	O
last	last	ADJ	JJ	O
nine	nine	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
study	study	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
animals	animal	NOUN	NNS	O
of	of	ADP	IN	O
groups	group	NOUN	NNS	O
II	II	PROPN	NNP	O
to	to	ADP	IN	O
IV	IV	PROPN	NNP	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
Group	Group	PROPN	NNP	O
I	I	PROPN	NNP	O
,	,	PUNCT	,	O
P	p	NOUN	NN	B-Chemical
induced	induce	VERB	VBD	O
a	a	DET	DT	O
moderate	moderate	ADJ	JJ	O
and	and	CCONJ	CC	O
stable	stable	ADJ	JJ	O
glycosuria	glycosuria	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
,	,	PUNCT	,	O
SE	SE	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
no	no	DET	DT	O
functional	functional	ADJ	JJ	O
or	or	CCONJ	CC	O
morphologic	morphologic	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
baseline	baseline	NOUN	NN	O
CCr	CCr	NOUN	NNS	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
ml	ml	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
,	,	PUNCT	,	O
undetectable	undetectable	ADJ	JJ	O
lysozymuria	lysozymuria	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
damage	damage	NOUN	NN	O
(	(	PUNCT	-LRB-	O
tubular	tubular	ADJ	JJ	B-Disease
necrosis	necrosis	NOUN	NN	I-Disease
score	score	NOUN	NN	O
[	[	PUNCT	-LRB-	O
maximum	maximum	NOUN	NN	O
4	4	NUM	CD	O
]	]	PUNCT	-RRB-	O
,	,	PUNCT	,	O
zero	zero	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
Group	Group	PROPN	NNP	O
II	II	PROPN	NNP	O
,	,	PUNCT	,	O
P	p	NOUN	NN	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
prevent	prevent	VERB	VB	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
ARF	ARF	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
maximal	maximal	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
CCr	CCr	NOUN	NNS	O
at	at	ADP	IN	O
day	day	NOUN	NN	O
9	9	NUM	CD	O
.	.	PUNCT	.	O
89	89	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
P	p	NOUN	NN	B-Chemical
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
;	;	PUNCT	:	O
peak	peak	NOUN	NN	O
lysozymuria	lysozymuria	NOUN	NN	O
,	,	PUNCT	,	O
1863	1863	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
321	321	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
tubular	tubular	ADJ	JJ	B-Disease
necrosis	necrosis	NOUN	NN	I-Disease
score	score	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
values	value	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
different	different	ADJ	JJ	O
from	from	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
Group	Group	PROPN	NNP	O
III	III	PROPN	NNP	O
:	:	PUNCT	:	O
maximal	maximal	NOUN	NN	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
CCr	CCr	PROPN	NNP	O
73	73	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	B-Chemical
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
lysozymuria	lysozymuria	NOUN	NNS	O
,	,	PUNCT	,	O
2147	2147	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
701	701	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
;	;	PUNCT	:	O
tubular	tubular	ADJ	JJ	B-Disease
necrosis	necrosis	NOUN	NN	I-Disease
score	score	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
ABSTRACT	ABSTRACT	PROPN	NNP	O
TRUNCATED	truncated	NUM	CD	O
AT	at	ADP	IN	O
250	250	NUM	CD	O
WORDS	word	NOUN	NNS	O
)	)	PUNCT	-RRB-	O

Catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
combinations	combination	NOUN	NNS	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
morphine	morphine	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
potentiation	potentiation	NOUN	NN	O
,	,	PUNCT	,	O
antagonism	antagonism	NOUN	NN	O
,	,	PUNCT	,	O
tolerance	tolerance	NOUN	NN	O
and	and	CCONJ	CC	O
cross	cross	NOUN	NN	O
-	-	NOUN	NN	O
tolerance	tolerance	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

Previous	previous	ADJ	JJ	O
studies	study	NOUN	NNS	O
demonstrated	demonstrate	VERB	VBD	O
that	that	ADP	IN	O
both	both	DET	DT	O
ketamine	ketamine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
morphine	morphine	NOUN	NN	B-Chemical
induced	induced	ADJ	JJ	O
analgesia	analgesia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
catalepsy	catalepsy	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

Pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
produced	produce	VERB	VBD	O
cross	cross	ADJ	JJ	O
-	-	NOUN	NN	O
tolerance	tolerance	NOUN	NN	O
to	to	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
induce	induce	VERB	VB	O
cross	cross	ADJ	JJ	O
-	-	NOUN	NN	O
tolerance	tolerance	NOUN	NN	O
to	to	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
but	but	CCONJ	CC	O
rather	rather	ADV	RB	O
augmented	augment	VERB	VBD	O
the	the	DET	DT	O
cataleptic	cataleptic	ADJ	JJ	B-Disease
response	response	NOUN	NN	O
;	;	PUNCT	:	O
this	this	DET	DT	O
augmentation	augmentation	NOUN	NN	O
was	be	VERB	VBD	O
attributed	attribute	VERB	VBN	O
to	to	ADP	IN	O
residual	residual	ADJ	JJ	O
morphine	morphine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
studies	study	NOUN	NNS	O
explored	explore	VERB	VBD	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
righting	right	VERB	VBG	O
reflex	reflex	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
sub	sub	NOUN	NN	O
-	-	PUNCT	HYPH	O
effective	effective	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
morphine	morphine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
administered	administer	VERB	VBD	O
simultaneously	simultaneously	ADV	RB	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
mutual	mutual	ADJ	JJ	O
potentiation	potentiation	NOUN	NN	O
between	between	ADP	IN	O
sub	sub	NOUN	NN	O
-	-	PUNCT	HYPH	O
effective	effective	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
morphine	morphine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
sub	sub	NOUN	NN	O
-	-	PUNCT	HYPH	O
effective	effective	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
partly	partly	ADV	RB	O
antagonized	antagonize	VERB	VBN	O
fully	fully	ADV	RB	O
-	-	PUNCT	HYPH	O
effective	effective	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Latency	latency	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
righting	right	VERB	VBG	O
reflex	reflex	NOUN	NN	O
,	,	PUNCT	,	O
rigidity	rigidity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
behavior	behavior	NOUN	NN	O
on	on	ADP	IN	O
recovery	recovery	NOUN	NN	O
,	,	PUNCT	,	O
reflected	reflect	VERB	VBD	O
the	the	DET	DT	O
relative	relative	ADJ	JJ	O
predominance	predominance	NOUN	NN	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
morphine	morphine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
each	each	DET	DT	O
combination	combination	NOUN	NN	O
.	.	PUNCT	.	O

Naloxone	naloxone	NOUN	NN	B-Chemical
inhibited	inhibit	VERB	VBD	O
the	the	DET	DT	O
induced	induced	ADJ	JJ	O
cataleptic	cataleptic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
degree	degree	NOUN	NN	O
and	and	CCONJ	CC	O
time	time	NOUN	NN	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
tolerance	tolerance	NOUN	NN	O
to	to	ADP	IN	O
daily	daily	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
sub	sub	NOUN	NN	O
-	-	PUNCT	HYPH	O
effective	effective	ADJ	JJ	O
dose	dose	NOUN	NN	O
combinations	combination	NOUN	NNS	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
morphine	morphine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
.	.	PUNCT	.	O

Rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
tolerant	tolerant	ADJ	JJ	O
to	to	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
dominant	dominant	ADJ	JJ	O
combinations	combination	NOUN	NNS	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
cross	cross	ADJ	JJ	O
-	-	ADJ	JJ	O
tolerant	tolerant	ADJ	JJ	O
to	to	ADP	IN	O
both	both	DET	DT	O
drugs	drug	NOUN	NNS	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
those	those	DET	DT	O
tolerant	tolerant	ADJ	JJ	O
to	to	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
dominant	dominant	ADJ	JJ	O
combinations	combination	NOUN	NNS	O
were	be	VERB	VBD	O
cross	cross	ADJ	JJ	O
-	-	ADJ	JJ	O
tolerant	tolerant	ADJ	JJ	O
to	to	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
but	but	CCONJ	CC	O
showed	show	VERB	VBD	O
either	either	CCONJ	CC	O
no	no	DET	DT	O
cross	cross	ADJ	JJ	O
-	-	NOUN	NN	O
tolerance	tolerance	NOUN	NN	O
or	or	CCONJ	CC	O
an	an	DET	DT	O
augmented	augmented	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

While	while	ADP	IN	O
the	the	DET	DT	O
mutual	mutual	ADJ	JJ	O
potentiation	potentiation	NOUN	NN	O
,	,	PUNCT	,	O
antagonism	antagonism	NOUN	NN	O
and	and	CCONJ	CC	O
tolerance	tolerance	NOUN	NN	O
suggest	suggest	VERB	VBP	O
common	common	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
for	for	ADP	IN	O
the	the	DET	DT	O
induced	induced	ADJ	JJ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
latency	latency	NOUN	NN	O
,	,	PUNCT	,	O
rigidity	rigidity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
behavior	behavior	NOUN	NN	O
,	,	PUNCT	,	O
asymmetry	asymmetry	NOUN	NN	O
of	of	ADP	IN	O
cross	cross	ADJ	JJ	O
-	-	NOUN	NN	O
tolerance	tolerance	NOUN	NN	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
widely	widely	ADV	RB	O
-	-	PUNCT	HYPH	O
different	different	ADJ	JJ	O
ID50	ID50	PROPN	NNP	O
for	for	ADP	IN	O
naloxone	naloxone	NOUN	NN	B-Chemical
would	would	VERB	MD	O
argue	argue	VERB	VB	O
against	against	ADP	IN	O
an	an	DET	DT	O
action	action	NOUN	NN	O
at	at	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
opioid	opioid	NOUN	NN	O
site	site	NOUN	NN	O
.	.	PUNCT	.	O

Hydrocortisone	hydrocortisone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypertension	hypertension	NOUN	NN	B-Disease
in	in	ADP	IN	O
humans	human	NOUN	NNS	O
:	:	PUNCT	:	O
pressor	pressor	NOUN	NN	O
responsiveness	responsiveness	NOUN	NN	O
and	and	CCONJ	CC	O
sympathetic	sympathetic	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

Oral	oral	ADJ	JJ	O
hydrocortisone	hydrocortisone	NOUN	NN	B-Chemical
increases	increase	VERB	VBZ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
enhances	enhance	VERB	VBZ	O
pressor	pressor	NOUN	NN	O
responsiveness	responsiveness	NOUN	NN	O
in	in	ADP	IN	O
normal	normal	ADJ	JJ	O
human	human	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
studied	study	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
1	1	NUM	CD	O
week	week	NOUN	NN	O
of	of	ADP	IN	O
oral	oral	ADJ	JJ	O
hydrocortisone	hydrocortisone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
,	,	PUNCT	,	O
cardiac	cardiac	ADJ	JJ	O
output	output	NOUN	NN	O
,	,	PUNCT	,	O
total	total	ADJ	JJ	O
peripheral	peripheral	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
,	,	PUNCT	,	O
forearm	forearm	NOUN	NN	O
vascular	vascular	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
norepinephrine	norepinephrine	ADJ	JJ	B-Chemical
spillover	spillover	NOUN	NN	O
to	to	PART	TO	O
plasma	plasma	VERB	VB	O
in	in	ADP	IN	O
eight	eight	NUM	CD	O
healthy	healthy	ADJ	JJ	O
male	male	ADJ	JJ	O
volunteers	volunteer	NOUN	NNS	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
diastolic	diastolic	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
remained	remain	VERB	VBD	O
unchanged	unchanged	ADJ	JJ	O
,	,	PUNCT	,	O
systolic	systolic	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
increased	increase	VERB	VBD	O
from	from	ADP	IN	O
119	119	NUM	CD	O
to	to	PART	TO	O
135	135	NUM	CD	O
mm	mm	NOUN	NN	O
Hg	Hg	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
SED	SED	PROPN	NNP	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
increased	increase	VERB	VBN	B-Disease
cardiac	cardiac	ADJ	JJ	I-Disease
output	output	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
85	85	NUM	CD	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
73	73	NUM	CD	O
l	l	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
,	,	PUNCT	,	O
SED	SED	PROPN	NNP	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
46	46	NUM	CD	O
,	,	PUNCT	,	O
p	p	NOUN	NNS	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Total	total	ADJ	JJ	O
peripheral	peripheral	ADJ	JJ	O
vascular	vascular	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
fell	fall	VERB	VBD	O
from	from	ADP	IN	O
15	15	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
to	to	ADP	IN	O
12	12	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
/	/	SYM	SYM	O
l	l	PROPN	NNP	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SED	sed	NOUN	NN	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Resting	rest	VERB	VBG	O
forearm	forearm	NOUN	NN	O
vascular	vascular	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
remained	remain	VERB	VBD	O
unchanged	unchanged	ADJ	JJ	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
reflex	reflex	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
cold	cold	ADJ	JJ	O
pressor	pressor	NOUN	NN	O
test	test	NOUN	NN	O
was	be	VERB	VBD	O
accentuated	accentuate	VERB	VBN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
resistance	resistance	NOUN	NN	O
increasing	increase	VERB	VBG	O
from	from	ADP	IN	O
10	10	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
/	/	SYM	SYM	O
100	100	NUM	CD	O
ml	ml	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
(	(	PUNCT	-LRB-	O
R	r	NOUN	NN	O
units	unit	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
before	before	ADP	IN	O
treatment	treatment	NOUN	NN	O
to	to	ADP	IN	O
32	32	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
R	r	NOUN	NN	O
units	unit	NOUN	NNS	O
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SED	SED	PROPN	NNP	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
025	025	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
forearm	forearm	NOUN	NN	O
vascular	vascular	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
accompanying	accompany	VERB	VBG	O
intra	intra	ADJ	JJ	O
-	-	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
25	25	NUM	CD	O
,	,	PUNCT	,	O
50	50	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
100	100	NUM	CD	O
ng	ng	NOUN	NNS	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
also	also	ADV	RB	O
significantly	significantly	ADV	RB	O
greater	great	ADJ	JJR	O
after	after	ADP	IN	O
hydrocortisone	hydrocortisone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
increasing	increase	VERB	VBG	O
from	from	ADP	IN	O
an	an	DET	DT	O
average	average	NOUN	NN	O
of	of	ADP	IN	O
14	14	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
R	r	NOUN	NN	O
units	unit	NOUN	NNS	O
before	before	ADP	IN	O
treatment	treatment	NOUN	NN	O
to	to	ADP	IN	O
35	35	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
R	r	NOUN	NN	O
units	unit	NOUN	NNS	O
after	after	ADP	IN	O
hydrocortisone	hydrocortisone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
SED	SED	PROPN	NNP	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
,	,	PUNCT	,	O
p	p	X	XX	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
shift	shift	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
left	left	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
response	response	NOUN	NN	O
relation	relation	NOUN	NN	O
and	and	CCONJ	CC	O
fall	fall	VERB	VB	O
in	in	ADP	IN	O
threshold	threshold	NOUN	NN	O
suggested	suggest	VERB	VBD	O
increased	increase	VERB	VBN	O
sensitivity	sensitivity	NOUN	NN	O
to	to	ADP	IN	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Measurement	measurement	NOUN	NN	O
of	of	ADP	IN	O
resting	rest	VERB	VBG	O
norepinephrine	norepinephrine	ADJ	JJ	B-Chemical
spillover	spillover	NOUN	NN	O
rate	rate	NOUN	NN	O
to	to	PART	TO	O
plasma	plasma	VERB	VB	O
and	and	CCONJ	CC	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
uptake	uptake	NOUN	NN	O
indicated	indicate	VERB	VBD	O
that	that	ADP	IN	O
overall	overall	ADV	RB	O
resting	rest	VERB	VBG	O
sympathetic	sympathetic	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
activity	activity	NOUN	NN	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
increased	increase	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
rise	rise	NOUN	NN	B-Disease
in	in	ADP	IN	I-Disease
resting	rest	VERB	VBG	I-Disease
blood	blood	NOUN	NN	I-Disease
pressure	pressure	NOUN	NN	I-Disease
with	with	ADP	IN	O
hydrocortisone	hydrocortisone	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
increased	increase	VERB	VBN	B-Disease
cardiac	cardiac	ADJ	JJ	I-Disease
output	output	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
presumably	presumably	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
increased	increase	VERB	VBN	O
blood	blood	NOUN	NN	O
volume	volume	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
ABSTRACT	ABSTRACT	PROPN	NNP	O
TRUNCATED	truncated	NUM	CD	O
AT	at	ADP	IN	O
250	250	NUM	CD	O
WORDS	word	NOUN	NNS	O
)	)	PUNCT	-RRB-	O

Neuromuscular	neuromuscular	ADJ	JJ	B-Disease
blockade	blockade	NOUN	NN	I-Disease
with	with	ADP	IN	O
magnesium	magnesium	NOUN	NN	B-Chemical
sulfate	sulfate	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
nifedipine	nifedipine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
received	receive	VERB	VBD	O
tocolysis	tocolysis	NOUN	NN	O
with	with	ADP	IN	O
nifedipine	nifedipine	NOUN	NN	B-Chemical
developed	develop	VERB	VBN	O
neuromuscular	neuromuscular	ADJ	JJ	B-Disease
blockade	blockade	NOUN	NN	I-Disease
after	after	ADP	IN	O
500	500	NUM	CD	O
mg	mg	NOUN	NN	O
of	of	ADP	IN	O
magnesium	magnesium	NOUN	NN	B-Chemical
sulfate	sulfate	NOUN	NN	I-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
reaction	reaction	NOUN	NN	O
demonstrates	demonstrate	VERB	VBZ	O
that	that	ADP	IN	O
nifedipine	nifedipine	NOUN	NN	B-Chemical
can	can	VERB	MD	O
seriously	seriously	ADV	RB	O
potentiate	potentiate	VERB	VB	O
the	the	DET	DT	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
magnesium	magnesium	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Caution	caution	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
exercised	exercise	VERB	VBN	O
when	when	ADV	WRB	O
these	these	DET	DT	O
two	two	NUM	CD	O
tocolytics	tocolytic	NOUN	NNS	O
are	be	VERB	VBP	O
combined	combine	VERB	VBN	O
.	.	PUNCT	.	O

Chronic	chronic	ADJ	JJ	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
inhibits	inhibit	VERB	VBZ	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
local	local	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
kindled	kindle	VERB	VBN	O
by	by	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
CBZ	CBZ	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
treatment	treatment	NOUN	NN	O
on	on	ADP	IN	O
local	local	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
kindled	kindle	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
lethality	lethality	NOUN	NN	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
in	in	ADP	IN	O
different	different	ADJ	JJ	O
stages	stage	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
kindling	kindle	VERB	VBG	O
process	process	NOUN	NN	O
and	and	CCONJ	CC	O
under	under	ADP	IN	O
different	different	ADJ	JJ	O
methods	method	NOUN	NNS	O
of	of	ADP	IN	O
CBZ	CBZ	PROPN	NNP	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Chronic	chronic	ADJ	JJ	O
oral	oral	ADJ	JJ	O
CBZ	CBZ	PROPN	NNP	B-Chemical
inhibited	inhibit	VERB	VBD	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
both	both	CCONJ	CC	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
had	have	VERB	VBD	O
little	little	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
fully	fully	ADV	RB	O
developed	develop	VERB	VBN	O
local	local	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Chronic	chronic	ADJ	JJ	O
CBZ	CBZ	PROPN	NNP	B-Chemical
also	also	ADV	RB	O
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
seizure	seizure	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
mortality	mortality	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
injected	inject	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	O
CBZ	CBZ	PROPN	NNP	B-Chemical
over	over	ADP	IN	O
a	a	DET	DT	O
range	range	NOUN	NN	O
of	of	ADP	IN	O
doses	dose	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
15	15	NUM	CD	O
-	-	SYM	SYM	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
completed	complete	VERB	VBN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
kindled	kindle	VERB	VBN	O
or	or	CCONJ	CC	O
acute	acute	ADJ	JJ	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Repeated	repeat	VERB	VBN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
CBZ	CBZ	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
15	15	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
also	also	ADV	RB	O
was	be	VERB	VBD	O
without	without	ADP	IN	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
or	or	CCONJ	CC	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
kindled	kindle	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
differential	differential	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
CBZ	CBZ	PROPN	NNP	B-Chemical
depending	depend	VERB	VBG	O
upon	upon	ADP	IN	O
stage	stage	NOUN	NN	O
of	of	ADP	IN	O
seizure	seizure	NOUN	NN	B-Disease
development	development	NOUN	NN	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
distinct	distinct	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
underlie	underlie	VERB	VBP	O
the	the	DET	DT	O
development	development	NOUN	NN	O
versus	versus	ADP	IN	O
maintenance	maintenance	NOUN	NN	O
of	of	ADP	IN	O
local	local	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
kindled	kindle	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
effectiveness	effectiveness	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	NOUN	NN	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
repeated	repeat	VERB	VBN	O
,	,	PUNCT	,	O
intermittent	intermittent	ADJ	JJ	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
CBZ	CBZ	PROPN	NNP	B-Chemical
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
different	different	ADJ	JJ	O
biochemical	biochemical	ADJ	JJ	O
consequences	consequence	NOUN	NNS	O
result	result	VERB	VBP	O
from	from	ADP	IN	O
the	the	DET	DT	O
different	different	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
regimens	regimen	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
possible	possible	ADJ	JJ	O
utility	utility	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	O
CBZ	cbz	NOUN	NN	B-Chemical
in	in	ADP	IN	O
preventing	prevent	VERB	VBG	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
toxic	toxic	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
in	in	ADP	IN	O
human	human	ADJ	JJ	O
cocaine	cocaine	NOUN	NN	B-Chemical
users	user	NOUN	NNS	O
is	be	VERB	VBZ	O
suggested	suggest	VERB	VBN	O
by	by	ADP	IN	O
these	these	DET	DT	O
data	datum	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
remains	remain	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
directly	directly	ADV	RB	O
evaluated	evaluate	VERB	VBN	O
.	.	PUNCT	.	O

Magnetic	magnetic	ADJ	JJ	O
resonance	resonance	NOUN	NN	O
imaging	imaging	NOUN	NN	O
of	of	ADP	IN	O
cerebral	cerebral	ADJ	JJ	O
venous	venous	ADJ	JJ	B-Disease
thrombosis	thrombosis	NOUN	NN	I-Disease
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
"	"	PUNCT	``	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
"	"	PUNCT	''	O
birth	birth	NOUN	NN	O
control	control	NOUN	NN	O
pills	pill	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
radiographic	radiographic	ADJ	JJ	O
features	feature	NOUN	NNS	O
of	of	ADP	IN	O
cerebral	cerebral	ADJ	JJ	O
deep	deep	ADJ	JJ	B-Disease
venous	venous	ADJ	JJ	I-Disease
thrombosis	thrombosis	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
21	21	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
white	white	ADJ	JJ	O
woman	woman	NOUN	NN	O
are	be	VERB	VBP	O
presented	present	VERB	VBN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
nulliparous	nulliparous	ADJ	JJ	O
patient	patient	NOUN	NN	O
presented	present	VERB	VBN	O
with	with	ADP	IN	O
relatively	relatively	ADV	RB	O
mild	mild	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
progressing	progress	VERB	VBG	O
mental	mental	ADJ	JJ	O
status	status	NOUN	NN	O
changes	change	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
only	only	ADV	RB	O
known	know	VERB	VBN	O
risk	risk	NOUN	NN	O
factor	factor	NOUN	NN	O
was	be	VERB	VBD	O
"	"	PUNCT	``	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
"	"	PUNCT	``	O
oral	oral	ADJ	JJ	B-Chemical
contraceptive	contraceptive	ADJ	JJ	I-Chemical
pills	pill	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
magnetic	magnetic	ADJ	JJ	O
resonance	resonance	NOUN	NN	O
image	image	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MRI	MRI	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
showed	show	VERB	VBD	O
increased	increase	VERB	VBN	O
signal	signal	NOUN	NN	O
intensity	intensity	NOUN	NN	O
from	from	ADP	IN	O
the	the	DET	DT	O
internal	internal	ADJ	JJ	O
cerebral	cerebral	NOUN	NN	O
veins	vein	NOUN	NNS	O
,	,	PUNCT	,	O
vein	vein	NOUN	NN	O
of	of	ADP	IN	O
Galen	Galen	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
straight	straight	ADJ	JJ	O
sinus	sinus	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
was	be	VERB	VBD	O
confirmed	confirm	VERB	VBN	O
by	by	ADP	IN	O
arterial	arterial	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
.	.	PUNCT	.	O

Beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
abolishment	abolishment	NOUN	NN	O
by	by	ADP	IN	O
oxprenolol	oxprenolol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
time	time	NOUN	NN	O
course	course	NOUN	NN	O
and	and	CCONJ	CC	O
concentration	concentration	NOUN	NN	O
-	-	PUNCT	HYPH	O
effect	effect	NOUN	NN	O
relationship	relationship	NOUN	NN	O
of	of	ADP	IN	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
studied	study	VERB	VBN	O
,	,	PUNCT	,	O
using	use	VERB	VBG	O
computer	computer	NOUN	NN	O
-	-	PUNCT	HYPH	O
aided	aid	VERB	VBN	O
pharmacokinetic	pharmacokinetic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dynamic	dynamic	ADJ	JJ	O
modeling	modeling	NOUN	NN	O
.	.	PUNCT	.	O

Subsequently	subsequently	ADV	RB	O
we	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
oxprenolol	oxprenolol	NOUN	NN	B-Chemical
in	in	ADP	IN	O
antagonizing	antagonize	VERB	VBG	O
such	such	ADJ	JJ	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
together	together	ADV	RB	O
with	with	ADP	IN	O
the	the	DET	DT	O
pharmacokinetic	pharmacokinetic	ADJ	JJ	O
interaction	interaction	NOUN	NN	O
between	between	ADP	IN	O
both	both	DET	DT	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

Six	six	NUM	CD	O
healthy	healthy	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
a	a	DET	DT	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
subcutaneous	subcutaneous	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
on	on	ADP	IN	O
two	two	NUM	CD	O
occasions	occasion	NOUN	NNS	O
:	:	PUNCT	:	O
1	1	NUM	CD	O
hour	hour	NOUN	NN	O
after	after	ADP	IN	O
oral	oral	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
placebo	placebo	NOUN	NN	O
and	and	CCONJ	CC	O
1	1	NUM	CD	O
hour	hour	NOUN	NN	O
after	after	ADP	IN	O
80	80	NUM	CD	O
mg	mg	NOUN	NN	O
oxprenolol	oxprenolol	NOUN	NN	B-Chemical
orally	orally	ADV	RB	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
7	7	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
period	period	NOUN	NN	O
after	after	ADP	IN	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
plasma	plasma	NOUN	NN	O
samples	sample	NOUN	NNS	O
were	be	VERB	VBD	O
taken	take	VERB	VBN	O
for	for	ADP	IN	O
determination	determination	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
potassium	potassium	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
and	and	CCONJ	CC	O
drug	drug	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
sigmoid	sigmoid	NOUN	NN	O
Emax	Emax	PROPN	NNP	O
model	model	NOUN	NN	O
offered	offer	VERB	VBD	O
a	a	DET	DT	O
good	good	ADJ	JJ	O
description	description	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
relation	relation	NOUN	NN	O
between	between	ADP	IN	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
concentrations	concentration	NOUN	NNS	O
and	and	CCONJ	CC	O
potassium	potassium	NOUN	NN	B-Chemical
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

Oxprenolol	Oxprenolol	PROPN	NNP	B-Chemical
caused	cause	VERB	VBD	O
decreases	decrease	NOUN	NNS	O
of	of	ADP	IN	O
65	65	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
56	56	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
volume	volume	NOUN	NN	O
of	of	ADP	IN	O
distribution	distribution	NOUN	NN	O
and	and	CCONJ	CC	O
clearance	clearance	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
130	130	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
its	-PRON-	DET	PRP$	O
AUC	AUC	PROPN	NNP	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
spite	spite	NOUN	NN	O
of	of	ADP	IN	O
higher	high	ADJ	JJR	O
terbutaline	terbutaline	NOUN	NN	B-Chemical
concentrations	concentration	NOUN	NNS	O
after	after	ADP	IN	O
oxprenolol	oxprenolol	ADJ	JJ	B-Chemical
pretreatment	pretreatment	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
almost	almost	ADV	RB	O
completely	completely	ADV	RB	O
antagonized	antagonize	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
beta	beta	ADJ	JJ	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
blocking	block	VERB	VBG	O
action	action	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
dystonia	dystonia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
syndrome	syndrome	NOUN	NN	O
after	after	ADP	IN	O
neuropeptide	neuropeptide	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MSH	MSH	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
ACTH	ACTH	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
stimulation	stimulation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
locus	locus	NOUN	NN	O
ceruleus	ceruleus	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
movement	movement	NOUN	NN	B-Disease
disorder	disorder	NOUN	NN	I-Disease
investigated	investigate	VERB	VBN	O
in	in	ADP	IN	O
these	these	DET	DT	O
studies	study	NOUN	NNS	O
has	have	VERB	VBZ	O
some	some	DET	DT	O
features	feature	NOUN	NNS	O
in	in	ADP	IN	O
common	common	ADJ	JJ	O
with	with	ADP	IN	O
human	human	ADJ	JJ	O
idiopathic	idiopathic	ADJ	JJ	O
dystonia	dystonia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
information	information	NOUN	NN	O
obtained	obtain	VERB	VBN	O
in	in	ADP	IN	O
these	these	DET	DT	O
studies	study	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
of	of	ADP	IN	O
potential	potential	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
benefit	benefit	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
experimental	experimental	ADJ	JJ	O
results	result	NOUN	NNS	O
indicated	indicate	VERB	VBD	O
that	that	ADP	IN	O
peptidergic	peptidergic	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
LC	LC	PROPN	NNP	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
a	a	DET	DT	O
NE	NE	PROPN	NNP	O
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
cerebellar	cerebellar	ADJ	JJ	O
Purkinje	Purkinje	PROPN	NNP	O
cells	cell	NOUN	NNS	O
located	locate	VERB	VBN	O
at	at	ADP	IN	O
terminals	terminal	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
ceruleo	ceruleo	ADJ	JJ	O
-	-	PUNCT	HYPH	O
cerebellar	cerebellar	ADJ	JJ	O
pathway	pathway	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
certain	certain	ADJ	JJ	O
as	as	ADP	IN	O
to	to	ADP	IN	O
the	the	DET	DT	O
following	follow	VERB	VBG	O
:	:	PUNCT	:	O
(	(	PUNCT	-LRB-	O
a	a	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
what	what	PRON	WP	O
receptors	receptor	NOUN	NNS	O
were	be	VERB	VBD	O
stimulated	stimulate	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
ACTH	ACTH	PROPN	NNP	B-Chemical
N	n	NOUN	NN	O
-	-	PUNCT	HYPH	O
terminal	terminal	NOUN	NN	O
fragments	fragment	NOUN	NNS	O
at	at	ADP	IN	O
the	the	DET	DT	O
LC	LC	PROPN	NNP	O
that	that	DET	WDT	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
this	this	DET	DT	O
disorder	disorder	NOUN	NN	O
;	;	PUNCT	,	O
(	(	PUNCT	-LRB-	O
b	b	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
whether	whether	ADP	IN	O
NE	NE	PROPN	NNP	O
,	,	PUNCT	,	O
released	release	VERB	VBN	O
onto	onto	ADP	IN	O
Purkinje	Purkinje	PROPN	NNP	O
cell	cell	NOUN	NN	O
synapses	synapsis	NOUN	NNS	O
located	locate	VERB	VBN	O
at	at	ADP	IN	O
terminals	terminal	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
ceruleo	ceruleo	ADJ	JJ	O
-	-	PUNCT	HYPH	O
cerebellar	cerebellar	ADJ	JJ	O
pathway	pathway	NOUN	NN	O
,	,	PUNCT	,	O
did	do	VERB	VBD	O
indeed	indeed	ADV	RB	O
cause	cause	VERB	VB	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
depression	depression	NOUN	NN	B-Disease
at	at	ADP	IN	O
Purkinje	Purkinje	PROPN	NNP	O
cell	cell	NOUN	NN	O
synapses	synapsis	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
previously	previously	ADV	RB	O
described	describe	VERB	VBN	O
by	by	ADP	IN	O
others	other	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
that	that	DET	WDT	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
movement	movement	NOUN	NN	B-Disease
disorder	disorder	NOUN	NN	I-Disease
;	;	PUNCT	,	O
(	(	PUNCT	-LRB-	O
c	c	NOUN	NN	O
)	)	PUNCT	-RRB-	O
whether	whether	ADP	IN	O
the	the	DET	DT	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
inhibitory	inhibitory	ADJ	JJ	O
Purkinje	Purkinje	PROPN	NNP	O
cells	cell	NOUN	NNS	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
disinhibition	disinhibition	NOUN	NN	O
or	or	CCONJ	CC	O
increased	increase	VERB	VBN	O
excitability	excitability	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
unilateral	unilateral	ADJ	JJ	O
cerebellar	cerebellar	ADJ	JJ	O
fastigial	fastigial	ADJ	JJ	O
or	or	CCONJ	CC	O
interpositus	interpositus	NOUN	NN	O
nuclei	nucleus	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
output	output	NOUN	NN	O
targets	target	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
Purkinje	Purkinje	PROPN	NNP	O
cell	cell	NOUN	NN	O
axons	axon	NOUN	NNS	O
,	,	PUNCT	,	O
that	that	DET	WDT	O
may	may	VERB	MD	O
have	have	VERB	VB	O
been	be	VERB	VBN	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
contributing	contributing	NOUN	NN	O
factor	factor	NOUN	NN	O
to	to	ADP	IN	O
this	this	DET	DT	O
disorder	disorder	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
questions	question	NOUN	NNS	O
are	be	VERB	VBP	O
currently	currently	ADV	RB	O
being	be	VERB	VBG	O
investigated	investigate	VERB	VBN	O
.	.	PUNCT	.	O

Enhanced	enhance	VERB	VBN	O
stimulus	stimulus	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
neurotransmitter	neurotransmitter	NOUN	NN	O
overflow	overflow	NOUN	NN	O
in	in	ADP	IN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
prejunctional	prejunctional	ADJ	JJ	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
activation	activation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
examines	examine	VERB	VBZ	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
6	6	NUM	CD	O
-	-	PUNCT	HYPH	O
day	day	NOUN	NN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
100	100	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
/	/	SYM	SYM	O
kg	kg	VERB	VB	O
per	per	ADP	IN	O
h	h	DET	DT	O
,	,	PUNCT	,	O
s	s	X	XX	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
stimulus	stimulus	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
Hz	Hz	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
endogenous	endogenous	ADJ	JJ	O
neurotransmitter	neurotransmitter	NOUN	NN	O
overflow	overflow	ADV	RB	O
from	from	ADP	IN	O
the	the	DET	DT	O
isolated	isolate	VERB	VBN	O
perfused	perfuse	VERB	VBN	O
kidney	kidney	NOUN	NN	O
of	of	ADP	IN	O
vehicle	vehicle	NOUN	NN	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	O
catecholamine	catecholamine	NOUN	NN	B-Chemical
stores	store	NOUN	NNS	O
and	and	CCONJ	CC	O
stimulus	stimulus	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
overflow	overflow	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
vehicle	vehicle	NOUN	NN	O
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
group	group	NOUN	NN	O
consisted	consist	VERB	VBD	O
of	of	ADP	IN	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
only	only	ADV	RB	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
the	the	DET	DT	O
incorporation	incorporation	NOUN	NN	O
of	of	ADP	IN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
into	into	ADP	IN	O
renal	renal	ADJ	JJ	O
catecholamine	catecholamine	NOUN	NN	B-Chemical
stores	store	NOUN	NNS	O
such	such	ADJ	JJ	O
that	that	ADP	IN	O
approximately	approximately	ADV	RB	O
40	40	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
catecholamine	catecholamine	NOUN	NN	B-Chemical
present	present	NOUN	NN	O
was	be	VERB	VBD	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
while	while	ADP	IN	O
the	the	DET	DT	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
content	content	NOUN	NN	O
was	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
similar	similar	ADJ	JJ	O
degree	degree	NOUN	NN	O
.	.	PUNCT	.	O

Total	total	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
catecholamine	catecholamine	NOUN	NN	B-Chemical
content	content	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
on	on	ADP	IN	O
a	a	DET	DT	O
molar	molar	ADJ	JJ	O
basis	basis	NOUN	NN	O
was	be	VERB	VBD	O
unchanged	unchanged	ADJ	JJ	O
.	.	PUNCT	.	O

Stimulus	stimulus	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
fractional	fractional	ADJ	JJ	O
overflow	overflow	NOUN	NN	O
of	of	ADP	IN	O
neurotransmitter	neurotransmitter	NOUN	NN	O
from	from	ADP	IN	O
the	the	DET	DT	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
kidneys	kidney	NOUN	NNS	O
was	be	VERB	VBD	O
approximately	approximately	ADV	RB	O
twice	twice	ADV	RB	O
normal	normal	ADJ	JJ	O
and	and	CCONJ	CC	O
consisted	consisted	ADJ	JJ	O
of	of	ADP	IN	O
both	both	CCONJ	CC	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
proportions	proportion	NOUN	NNS	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
difference	difference	NOUN	NN	O
in	in	ADP	IN	O
fractional	fractional	ADJ	JJ	O
overflow	overflow	NOUN	NN	O
between	between	ADP	IN	O
groups	group	NOUN	NNS	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
affected	affect	VERB	VBN	O
by	by	ADP	IN	O
neuronal	neuronal	ADJ	JJ	O
and	and	CCONJ	CC	O
extraneuronal	extraneuronal	ADJ	JJ	O
uptake	uptake	ADJ	JJ	O
blockade	blockade	NOUN	NN	O
.	.	PUNCT	.	O

Propranolol	Propranolol	PROPN	NNP	B-Chemical
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
stimulus	stimulus	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
overflow	overflow	NOUN	NN	O
in	in	ADP	IN	O
either	either	DET	DT	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Phentolamine	Phentolamine	PROPN	NNP	B-Chemical
increased	increase	VERB	VBD	O
stimulus	stimulus	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
overflow	overflow	NOUN	NN	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
although	although	ADP	IN	O
the	the	DET	DT	O
increment	increment	NOUN	NN	O
in	in	ADP	IN	O
overflow	overflow	NOUN	NN	O
was	be	VERB	VBD	O
greater	great	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
chronic	chronic	ADJ	JJ	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
results	result	NOUN	NNS	O
in	in	ADP	IN	O
enhanced	enhance	VERB	VBN	O
fractional	fractional	ADJ	JJ	O
neurotransmitter	neurotransmitter	NOUN	NN	O
overflow	overflow	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
neither	neither	DET	DT	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
prejunctional	prejunctional	ADJ	JJ	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
influences	influence	NOUN	NNS	O
nor	nor	CCONJ	CC	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
neuronal	neuronal	ADJ	JJ	O
and	and	CCONJ	CC	O
extraneuronal	extraneuronal	ADJ	JJ	O
uptake	uptake	NOUN	NN	O
mechanisms	mechanism	NOUN	NNS	O
appear	appear	VERB	VBP	O
to	to	PART	TO	O
be	be	VERB	VB	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
this	this	DET	DT	O
alteration	alteration	NOUN	NN	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
data	datum	NOUN	NNS	O
obtained	obtain	VERB	VBN	O
with	with	ADP	IN	O
phentolamine	phentolamine	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
do	do	VERB	VBP	O
not	not	ADV	RB	O
suggest	suggest	VERB	VB	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
desensitization	desensitization	NOUN	NN	O
as	as	ADP	IN	O
the	the	DET	DT	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
enhanced	enhance	VERB	VBN	O
neurotransmitter	neurotransmitter	NOUN	NN	O
overflow	overflow	ADV	RB	O
after	after	ADP	IN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

GABA	GABA	PROPN	NNP	B-Chemical
involvement	involvement	NOUN	NN	O
in	in	ADP	IN	O
naloxone	naloxone	ADV	RB	B-Chemical
induced	induced	ADJ	JJ	O
reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
respiratory	respiratory	ADJ	JJ	B-Disease
paralysis	paralysis	NOUN	NN	I-Disease
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
thiopental	thiopental	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

No	no	DET	DT	O
agent	agent	NOUN	NN	O
is	be	VERB	VBZ	O
yet	yet	ADV	RB	O
available	available	ADJ	JJ	O
to	to	PART	TO	O
reverse	reverse	VERB	VB	O
respiratory	respiratory	ADJ	JJ	B-Disease
paralysis	paralysis	NOUN	NN	I-Disease
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
CNS	CNS	PROPN	NNP	O
depressants	depressant	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
general	general	ADJ	JJ	O
anesthetics	anesthetic	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
naloxone	naloxone	ADV	RB	B-Chemical
reversed	reverse	VERB	VBD	O
respiratory	respiratory	ADJ	JJ	B-Disease
paralysis	paralysis	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
thiopental	thiopental	ADJ	JJ	B-Chemical
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

25	25	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
thiopental	thiopental	ADJ	JJ	B-Chemical
produced	produce	VERB	VBN	O
anesthesia	anesthesia	NOUN	NN	O
without	without	ADP	IN	O
altering	alter	VERB	VBG	O
respiratory	respiratory	ADJ	JJ	O
rate	rate	NOUN	NN	O
,	,	PUNCT	,	O
increased	increase	VERB	VBD	O
GABA	GABA	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
glutamate	glutamate	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
aspartate	aspartate	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
glycine	glycine	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
controls	control	NOUN	NNS	O
in	in	ADP	IN	O
rat	rat	NOUN	NN	O
cortex	cortex	NOUN	NN	O
and	and	CCONJ	CC	O
brain	brain	NOUN	NN	O
stem	stem	NOUN	NN	O
.	.	PUNCT	.	O

Pretreatment	pretreatment	NOUN	NN	O
of	of	ADP	IN	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
thiosemicarbazide	thiosemicarbazide	NOUN	NN	B-Chemical
for	for	ADP	IN	O
30	30	NUM	CD	O
minutes	minute	NOUN	NNS	O
abolished	abolish	VERB	VBD	O
the	the	DET	DT	O
anesthetic	anesthetic	ADJ	JJ	O
action	action	NOUN	NN	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
the	the	DET	DT	O
respiratory	respiratory	ADJ	JJ	O
depressant	depressant	ADJ	JJ	O
action	action	NOUN	NN	O
of	of	ADP	IN	O
thiopental	thiopental	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
thiopental	thiopental	ADJ	JJ	B-Chemical
produced	produce	VERB	VBD	O
respiratory	respiratory	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
with	with	ADP	IN	O
further	further	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
GABA	GABA	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
decrease	decrease	VERB	VB	O
in	in	ADP	IN	O
glutamate	glutamate	NOUN	NN	B-Chemical
again	again	ADV	RB	O
in	in	ADP	IN	O
cortex	cortex	NOUN	NN	O
and	and	CCONJ	CC	O
brain	brain	NOUN	NN	O
stem	stem	NOUN	NN	O
without	without	ADP	IN	O
affecting	affect	VERB	VBG	O
any	any	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
amino	amino	ADJ	JJ	B-Chemical
acids	acid	NOUN	NNS	I-Chemical
studied	study	VERB	VBN	O
in	in	ADP	IN	O
four	four	NUM	CD	O
regions	region	NOUN	NNS	O
of	of	ADP	IN	O
rat	rat	NOUN	NN	O
brain	brain	NOUN	NN	O
.	.	PUNCT	.	O

Naloxone	naloxone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
reversed	reverse	VERB	VBD	O
respiratory	respiratory	ADJ	JJ	B-Disease
paralysis	paralysis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
glutamate	glutamate	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
GABA	GABA	PROPN	NNP	B-Chemical
levels	level	NOUN	NNS	O
to	to	PART	TO	O
control	control	VERB	VB	O
values	value	NOUN	NNS	O
in	in	ADP	IN	O
brain	brain	NOUN	NN	O
stem	stem	NOUN	NN	O
and	and	CCONJ	CC	O
cortex	cortex	NOUN	NN	O
with	with	ADP	IN	O
no	no	DET	DT	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
caudate	caudate	NOUN	NN	O
or	or	CCONJ	CC	O
cerebellum	cerebellum	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
naloxone	naloxone	ADV	RB	B-Chemical
reverses	reverse	NOUN	NNS	O
respiratory	respiratory	ADJ	JJ	B-Disease
paralysis	paralysis	NOUN	NN	I-Disease
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
thiopental	thiopental	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
involves	involve	VERB	VBZ	O
GABA	GABA	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
its	-PRON-	DET	PRP$	O
action	action	NOUN	NN	O
.	.	PUNCT	.	O

Diazepam	diazepam	NOUN	NN	B-Chemical
facilitates	facilitate	NOUN	NNS	O
reflex	reflex	VERB	VBP	O
bradycardia	bradycardia	NOUN	NNS	B-Disease
in	in	ADP	IN	O
conscious	conscious	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
on	on	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	O
function	function	NOUN	NN	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
in	in	ADP	IN	O
conscious	conscious	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Intravenous	intravenous	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
produced	produce	VERB	VBD	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
.	.	PUNCT	.	O

Also	also	ADV	RB	O
,	,	PUNCT	,	O
reflex	reflex	ADJ	JJ	O
bradycardia	bradycardia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
produced	produce	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
by	by	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
-	-	SYM	SYM	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Intravenous	intravenous	ADJ	JJ	O
pretreatment	pretreatment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
although	although	ADP	IN	O
causing	cause	VERB	VBG	O
no	no	DET	DT	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
pressor	pressor	NOUN	NN	O
effect	effect	NOUN	NN	O
,	,	PUNCT	,	O
did	do	VERB	VBD	O
enhance	enhance	VERB	VB	O
the	the	DET	DT	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
reflex	reflex	ADJ	JJ	O
bradycardia	bradycardia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
diazepam	diazepam	NOUN	NN	B-Chemical
enhancement	enhancement	NOUN	NN	O
of	of	ADP	IN	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
reflex	reflex	ADJ	JJ	O
bradycardia	bradycardia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
antagonized	antagonize	VERB	VBN	O
by	by	ADP	IN	O
pretreatment	pretreatment	NOUN	NN	O
of	of	ADP	IN	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
an	an	DET	DT	O
intravenous	intravenous	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
picrotoxin	picrotoxin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
an	an	DET	DT	O
agent	agent	NOUN	NN	O
blocks	block	VERB	VBZ	O
chloride	chloride	NOUN	NN	B-Chemical
channels	channel	NOUN	NNS	O
by	by	ADP	IN	O
binding	bind	VERB	VBG	O
to	to	ADP	IN	O
sites	site	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
benzodiazepine	benzodiazepine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
GABA	gaba	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
chloride	chloride	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
macromolecular	macromolecular	NOUN	NN	O
complex	complex	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
data	datum	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
acts	act	VERB	VBZ	O
through	through	ADP	IN	O
the	the	DET	DT	O
benzodiazepine	benzodiazepine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
GABA	gaba	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
chloride	chloride	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
macromolecular	macromolecular	NOUN	NN	O
complex	complex	NOUN	NN	O
within	within	ADP	IN	O
the	the	DET	DT	O
central	central	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
to	to	PART	TO	O
facilitate	facilitate	VERB	VB	O
reflex	reflex	ADJ	JJ	O
bradycardia	bradycardia	NOUN	NNS	B-Disease
mediated	mediate	VERB	VBN	O
through	through	ADP	IN	O
baroreceptor	baroreceptor	NOUN	NN	O
reflexes	reflex	NOUN	NNS	O
in	in	ADP	IN	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
an	an	DET	DT	O
acute	acute	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
.	.	PUNCT	.	O

Initial	initial	ADJ	JJ	O
potassium	potassium	NOUN	NN	B-Chemical
loss	loss	NOUN	NN	O
and	and	CCONJ	CC	O
hypokalaemia	hypokalaemia	NOUN	NN	B-Disease
during	during	ADP	IN	O
chlorthalidone	chlorthalidone	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
essential	essential	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
:	:	PUNCT	:	O
the	the	DET	DT	O
influence	influence	NOUN	NN	O
of	of	ADP	IN	O
dietary	dietary	ADJ	JJ	O
sodium	sodium	NOUN	NN	B-Chemical
restriction	restriction	NOUN	NN	O
.	.	PUNCT	.	O

To	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
initial	initial	ADJ	JJ	O
potassium	potassium	NOUN	NN	B-Chemical
loss	loss	NOUN	NN	O
and	and	CCONJ	CC	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
hypokalaemia	hypokalaemia	NOUN	NN	B-Disease
during	during	ADP	IN	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
oral	oral	ADJ	JJ	O
diuretic	diuretic	ADJ	JJ	O
,	,	PUNCT	,	O
metabolic	metabolic	ADJ	JJ	O
balance	balance	NOUN	NN	O
studies	study	NOUN	NNS	O
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
in	in	ADP	IN	O
ten	ten	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
essential	essential	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
who	who	PRON	WP	O
had	have	VERB	VBD	O
shown	show	VERB	VBN	O
hypokalaemia	hypokalaemia	NOUN	NN	B-Disease
under	under	ADP	IN	O
prior	prior	ADJ	JJ	O
oral	oral	ADJ	JJ	O
diuretic	diuretic	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Chlorthalidone	Chlorthalidone	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
daily	daily	ADV	RB	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
given	give	VERB	VBN	O
for	for	ADP	IN	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Six	six	NUM	CD	O
patients	patient	NOUN	NNS	O
received	receive	VERB	VBD	O
a	a	DET	DT	O
normal	normal	ADJ	JJ	O
-	-	PUNCT	HYPH	O
sodium	sodium	NOUN	NN	B-Chemical
diet	diet	NOUN	NN	O
and	and	CCONJ	CC	O
four	four	NUM	CD	O
a	a	DET	DT	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
sodium	sodium	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
17	17	NUM	CD	O
mmol	mmol	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
diet	diet	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
a	a	DET	DT	O
normal	normal	ADJ	JJ	O
initial	initial	ADJ	JJ	O
total	total	ADJ	JJ	O
body	body	NOUN	NN	O
potassium	potassium	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
40K	40k	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
electrolyte	electrolyte	NOUN	NN	O
balances	balance	NOUN	NNS	O
,	,	PUNCT	,	O
weight	weight	NOUN	NN	O
,	,	PUNCT	,	O
bromide	bromide	ADP	IN	O
space	space	NOUN	NN	O
,	,	PUNCT	,	O
plasma	plasma	NOUN	NN	O
renin	renin	NOUN	NN	O
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
aldosterone	aldosterone	NOUN	NN	B-Chemical
secretion	secretion	NOUN	NN	O
rate	rate	NOUN	NN	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
a	a	DET	DT	O
potassium	potassium	NOUN	NN	B-Chemical
deficit	deficit	NOUN	NN	O
developed	develop	VERB	VBD	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
proportionally	proportionally	ADV	RB	O
larger	large	ADJ	JJR	O
losses	loss	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
extracellular	extracellular	NOUN	NN	O
than	than	ADP	IN	O
from	from	ADP	IN	O
the	the	DET	DT	O
intracellular	intracellular	ADJ	JJ	O
compartment	compartment	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
normal	normal	ADJ	JJ	O
-	-	PUNCT	HYPH	O
sodium	sodium	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
the	the	DET	DT	O
highest	high	ADJ	JJS	O
mean	mean	ADJ	JJ	O
potassium	potassium	NOUN	NN	B-Chemical
deficit	deficit	NOUN	NN	O
was	be	VERB	VBD	O
176	176	NUM	CD	O
mmol	mmol	NOUN	NN	O
on	on	ADP	IN	O
day	day	NOUN	NN	O
9	9	NUM	CD	O
,	,	PUNCT	,	O
after	after	ADP	IN	O
which	which	DET	WDT	O
some	some	DET	DT	O
potassium	potassium	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
regained	regain	VERB	VBN	O
;	;	PUNCT	:	O
in	in	ADP	IN	O
the	the	DET	DT	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
sodium	sodium	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
the	the	DET	DT	O
highest	high	ADJ	JJS	O
deficit	deficit	NOUN	NN	O
was	be	VERB	VBD	O
276	276	NUM	CD	O
mmol	mmol	NOUN	NN	O
on	on	ADP	IN	O
day	day	NOUN	NN	O
13	13	NUM	CD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
normal	normal	ADJ	JJ	O
-	-	PUNCT	HYPH	O
sodium	sodium	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
showed	show	VERB	VBD	O
an	an	DET	DT	O
immediate	immediate	ADJ	JJ	O
but	but	CCONJ	CC	O
temporary	temporary	ADJ	JJ	O
rise	rise	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
renin	renin	NOUN	NN	O
and	and	CCONJ	CC	O
aldosterone	aldosterone	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
;	;	PUNCT	:	O
in	in	ADP	IN	O
the	the	DET	DT	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
sodium	sodium	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
renin	renin	NOUN	NN	O
and	and	CCONJ	CC	O
aldosterone	aldosterone	NOUN	NN	B-Chemical
increased	increase	VERB	VBD	O
more	more	ADV	RBR	O
slowly	slowly	ADV	RB	O
but	but	CCONJ	CC	O
remained	remain	VERB	VBD	O
elevated	elevated	ADJ	JJ	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
concluded	conclude	VERB	VBN	O
that	that	ADP	IN	O
dietary	dietary	ADJ	JJ	O
sodium	sodium	NOUN	NN	B-Chemical
restriction	restriction	NOUN	NN	O
increases	increase	VERB	VBZ	O
diuretic	diuretic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
potassium	potassium	NOUN	NN	B-Chemical
loss	loss	NOUN	NN	O
,	,	PUNCT	,	O
presumably	presumably	ADV	RB	O
by	by	ADP	IN	O
an	an	DET	DT	O
increased	increased	ADJ	JJ	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
renin	renin	NOUN	NN	O
-	-	PUNCT	HYPH	O
angiotensin	angiotensin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
aldosterone	aldosterone	NOUN	NN	B-Chemical
system	system	NOUN	NN	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
delivery	delivery	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
distal	distal	ADJ	JJ	O
renal	renal	ADJ	JJ	O
tubules	tubule	NOUN	NNS	O
remains	remain	VERB	VBZ	O
sufficiently	sufficiently	ADV	RB	O
high	high	ADJ	JJ	O
to	to	PART	TO	O
allow	allow	VERB	VB	O
increased	increase	VERB	VBN	O
potassium	potassium	NOUN	NN	B-Chemical
secretion	secretion	NOUN	NN	O
.	.	PUNCT	.	O

Reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
by	by	ADP	IN	O
novel	novel	ADJ	JJ	O
aryl	aryl	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
piperazine	piperazine	NOUN	NN	I-Chemical
anxiolytic	anxiolytic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
novel	novel	ADJ	JJ	O
anxiolytic	anxiolytic	ADJ	JJ	O
drug	drug	NOUN	NN	O
,	,	PUNCT	,	O
buspirone	buspirone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
reverses	reverse	VERB	VBZ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
series	series	NOUN	NN	O
of	of	ADP	IN	O
aryl	aryl	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
piperazine	piperazine	NOUN	NN	I-Chemical
analogues	analogue	NOUN	NNS	O
of	of	ADP	IN	O
buspirone	buspirone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
other	other	ADJ	JJ	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxytryptaminergic	hydroxytryptaminergic	NOUN	NN	I-Chemical
agonists	agonist	NOUN	NNS	I-Chemical
were	be	VERB	VBD	O
tested	test	VERB	VBN	O
for	for	ADP	IN	O
their	-PRON-	DET	PRP$	O
ability	ability	NOUN	NN	O
to	to	PART	TO	O
reverse	reverse	VERB	VB	O
haloperidol	haloperidol	ADV	RB	B-Chemical
induced	induced	ADJ	JJ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Those	those	DET	DT	O
drugs	drug	NOUN	NNS	O
with	with	ADP	IN	O
strong	strong	ADJ	JJ	O
affinity	affinity	NOUN	NN	O
for	for	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxytryptamine1a	hydroxytryptamine1a	ADJ	JJ	I-Chemical
receptors	receptor	NOUN	NNS	O
were	be	VERB	VBD	O
able	able	ADJ	JJ	O
to	to	PART	TO	O
reverse	reverse	VERB	VB	O
catalepsy	catalepsy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Drugs	drug	NOUN	NNS	O
with	with	ADP	IN	O
affinity	affinity	NOUN	NN	O
for	for	ADP	IN	O
other	other	ADJ	JJ	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
receptors	receptor	NOUN	NNS	O
or	or	CCONJ	CC	O
weak	weak	ADJ	JJ	O
affinity	affinity	NOUN	NN	O
were	be	VERB	VBD	O
ineffective	ineffective	ADJ	JJ	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
postsynaptic	postsynaptic	ADJ	JJ	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
HT	HT	PROPN	NNP	I-Chemical
receptors	receptor	NOUN	NNS	O
neither	neither	CCONJ	CC	O
inhibited	inhibit	VERB	VBD	O
nor	nor	CCONJ	CC	O
potentiated	potentiate	VERB	VBN	O
reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
leaves	leave	NOUN	NNS	O
open	open	VERB	VBP	O
the	the	DET	DT	O
question	question	NOUN	NN	O
as	as	ADP	IN	O
to	to	ADP	IN	O
the	the	DET	DT	O
site	site	NOUN	NN	O
or	or	CCONJ	CC	O
mechanism	mechanism	NOUN	NN	O
for	for	ADP	IN	O
this	this	DET	DT	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Glycopyrronium	glycopyrronium	NOUN	NN	B-Chemical
requirements	requirement	NOUN	NNS	O
for	for	ADP	IN	O
antagonism	antagonism	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
muscarinic	muscarinic	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
edrophonium	edrophonium	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
have	have	VERB	VBP	O
compared	compare	VERB	VBN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
60	60	NUM	CD	O
adult	adult	NOUN	NN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
cardiovascular	cardiovascular	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
glycopyrronium	glycopyrronium	NOUN	NN	B-Chemical
5	5	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
10	10	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
given	give	VERB	VBN	O
either	either	CCONJ	CC	O
simultaneously	simultaneously	ADV	RB	O
or	or	CCONJ	CC	O
1	1	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
edrophonium	edrophonium	NOUN	NN	B-Chemical
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O

Significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
the	the	DET	DT	O
four	four	NUM	CD	O
groups	group	NOUN	NNS	O
were	be	VERB	VBD	O
detected	detect	VERB	VBN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
groups	group	NOUN	NNS	O
receiving	receive	VERB	VBG	O
10	10	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
showed	show	VERB	VBD	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
up	up	ADP	IN	O
to	to	PART	TO	O
30	30	NUM	CD	O
beat	beat	VERB	VBN	O
min	min	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
limits	limit	VERB	VBZ	O
28	28	NUM	CD	O
-	-	SYM	SYM	O
32	32	NUM	CD	O
beat	beat	VERB	VBN	O
min	min	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Use	Use	PROPN	NNP	O
of	of	ADP	IN	O
glycopyrronium	glycopyrronium	NOUN	NN	B-Chemical
5	5	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
kg	kg	NOUN	NN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
provided	provide	VERB	VBD	O
greater	great	ADJ	JJR	O
cardiovascular	cardiovascular	ADJ	JJ	O
stability	stability	NOUN	NN	O
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
given	give	VERB	VBN	O
1	1	NUM	CD	O
min	min	NOUN	NN	O
before	before	ADP	IN	O
the	the	DET	DT	O
edrophonium	edrophonium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
was	be	VERB	VBD	O
sufficient	sufficient	ADJ	JJ	O
to	to	PART	TO	O
minimize	minimize	VERB	VB	O
early	early	ADV	RB	O
,	,	PUNCT	,	O
edrophonium	edrophonium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
bradycardias	bradycardias	NOUN	NN	B-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
low	low	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
glycopyrronium	glycopyrronium	NOUN	NN	B-Chemical
provided	provide	VERB	VBN	O
good	good	ADJ	JJ	O
control	control	NOUN	NN	O
of	of	ADP	IN	O
oropharyngeal	oropharyngeal	ADJ	JJ	O
secretions	secretion	NOUN	NNS	O
.	.	PUNCT	.	O

Selective	selective	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
iopentol	iopentol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
iohexol	iohexol	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
metrizoate	metrizoate	VERB	VB	B-Chemical
into	into	ADP	IN	O
the	the	DET	DT	O
left	left	ADJ	JJ	O
coronary	coronary	ADJ	JJ	O
artery	artery	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
dog	dog	NOUN	NN	O
.	.	PUNCT	.	O

Induction	induction	NOUN	NN	O
of	of	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
decrease	decrease	NOUN	NN	O
of	of	ADP	IN	O
aortic	aortic	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
twenty	twenty	NUM	CD	O
beagle	beagle	NOUN	NN	O
dogs	dog	NOUN	NNS	O
selective	selective	ADJ	JJ	O
injections	injection	NOUN	NNS	O
were	be	VERB	VBD	O
made	make	VERB	VBN	O
into	into	ADP	IN	O
the	the	DET	DT	O
left	left	ADJ	JJ	O
coronary	coronary	ADJ	JJ	O
artery	artery	NOUN	NN	O
with	with	ADP	IN	O
iopentol	iopentol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
iohexol	iohexol	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
metrizoate	metrizoate	ADJ	JJ	B-Chemical
in	in	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
4	4	NUM	CD	O
ml	ml	NOUN	NN	O
,	,	PUNCT	,	O
8	8	NUM	CD	O
ml	ml	NOUN	NNS	O
and	and	CCONJ	CC	O
16	16	NUM	CD	O
ml	ml	NOUN	NN	O
.	.	PUNCT	.	O

Thirty	thirty	NUM	CD	O
-	-	PUNCT	HYPH	O
six	six	NUM	CD	O
iopentol	iopentol	NOUN	NN	B-Chemical
injections	injection	NOUN	NNS	O
,	,	PUNCT	,	O
35	35	NUM	CD	O
iohexol	iohexol	ADJ	JJ	B-Chemical
injections	injection	NOUN	NNS	O
and	and	CCONJ	CC	O
37	37	NUM	CD	O
metrizoate	metrizoate	ADJ	JJ	B-Chemical
injections	injection	NOUN	NNS	O
were	be	VERB	VBD	O
made	make	VERB	VBN	O
.	.	PUNCT	.	O

Frequencies	frequency	NOUN	NNS	O
of	of	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
(	(	PUNCT	-LRB-	O
p	p	X	XX	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
after	after	ADP	IN	O
iopentol	iopentol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
iohexol	iohexol	ADJ	JJ	B-Chemical
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
after	after	ADP	IN	O
metrizoate	metrizoate	ADJ	JJ	B-Chemical
(	(	PUNCT	-LRB-	O
22	22	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Iopentol	Iopentol	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
iohexol	iohexol	ADJ	JJ	B-Chemical
also	also	ADV	RB	O
produced	produce	VERB	VBD	O
significantly	significantly	ADV	RB	O
less	less	ADJ	JJR	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
aortic	aortic	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
than	than	ADP	IN	O
metrizoate	metrizoate	ADJ	JJ	B-Chemical
at	at	ADP	IN	O
the	the	DET	DT	O
different	different	ADJ	JJ	O
doses	dose	NOUN	NNS	O
.	.	PUNCT	.	O

Thyroid	Thyroid	PROPN	NNP	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
urine	urine	NOUN	NN	O
-	-	PUNCT	HYPH	O
concentrating	concentrate	VERB	VBG	O
ability	ability	NOUN	NN	O
during	during	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
suggested	suggest	VERB	VBN	O
that	that	ADP	IN	O
adenylate	adenylate	ADJ	JJ	O
cyclase	cyclase	NOUN	NN	O
inhibition	inhibition	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
important	important	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
both	both	DET	DT	O
nephrogenic	nephrogenic	ADJ	JJ	B-Disease
diabetes	diabetes	NOUN	NN	I-Disease
insipidus	insipidus	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
hypothyroidism	hypothyroidism	NOUN	NN	B-Disease
during	during	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
measured	measure	VERB	VBD	O
serum	serum	ADJ	JJ	O
thyroxine	thyroxine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
urine	urine	NOUN	NN	O
-	-	PUNCT	HYPH	O
concentrating	concentrate	VERB	VBG	O
ability	ability	NOUN	NN	O
(	(	PUNCT	-LRB-	O
Umax	Umax	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
desmopressin	desmopressin	NOUN	NN	O
(	(	PUNCT	-LRB-	O
DDAVP	DDAVP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
85	85	NUM	CD	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
lithium	lithium	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Hypothyroidism	hypothyroidism	NOUN	NN	B-Disease
developed	develop	VERB	VBD	O
in	in	ADP	IN	O
eight	eight	NUM	CD	O
patients	patient	NOUN	NNS	O
while	while	ADP	IN	O
they	-PRON-	PRON	PRP	O
were	be	VERB	VBD	O
taking	take	VERB	VBG	O
lithium	lithium	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Impaired	Impaired	PROPN	NNP	O
Umax	Umax	PROPN	NNP	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
both	both	CCONJ	CC	O
euthyroid	euthyroid	NOUN	NN	O
and	and	CCONJ	CC	O
hypothyroid	hypothyroid	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
while	while	ADP	IN	O
some	some	DET	DT	O
hypothyroid	hypothyroid	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
concentrated	concentrate	VERB	VBD	O
their	-PRON-	DET	PRP$	O
urine	urine	NOUN	NN	O
well	well	ADV	RB	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
concluded	conclude	VERB	VBN	O
that	that	ADP	IN	O
the	the	DET	DT	O
dominant	dominant	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
by	by	ADP	IN	O
which	which	DET	WDT	O
lithium	lithium	NOUN	NN	B-Chemical
exerts	exert	VERB	VBZ	O
these	these	DET	DT	O
two	two	NUM	CD	O
effects	effect	NOUN	NNS	O
are	be	VERB	VBP	O
different	different	ADJ	JJ	O
.	.	PUNCT	.	O

Remodelling	remodelling	NOUN	NN	O
of	of	ADP	IN	O
nerve	nerve	NOUN	NN	O
structure	structure	NOUN	NN	O
in	in	ADP	IN	O
experimental	experimental	ADJ	JJ	O
isoniazid	isoniazid	NOUN	NN	B-Chemical
neuropathy	neuropathy	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
neuropathy	neuropathy	NOUN	NN	B-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
isoniazid	isoniazid	NOUN	NN	B-Chemical
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
was	be	VERB	VBD	O
studied	study	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
computer	computer	NOUN	NN	O
-	-	PUNCT	HYPH	O
assisted	assist	VERB	VBN	O
morphometric	morphometric	ADJ	JJ	O
method	method	NOUN	NN	O
.	.	PUNCT	.	O

Scatter	Scatter	PROPN	NNP	O
diagrams	diagram	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
g	g	NOUN	NN	O
ratio	ratio	NOUN	NN	O
(	(	PUNCT	-LRB-	O
quotient	quotient	ADJ	JJ	O
fibre	fibre	NOUN	NN	O
diameter	diameter	NOUN	NN	O
/	/	SYM	SYM	O
axon	axon	VERB	VB	O
diameter	diameter	NOUN	NN	O
)	)	PUNCT	-RRB-	O
define	define	VERB	VB	O
regenerating	regenerate	VERB	VBG	O
fibres	fibre	NOUN	NNS	O
as	as	ADP	IN	O
a	a	DET	DT	O
distinct	distinct	ADJ	JJ	O
population	population	NOUN	NN	O
,	,	PUNCT	,	O
distinguishable	distinguishable	ADJ	JJ	O
from	from	ADP	IN	O
the	the	DET	DT	O
surviving	survive	VERB	VBG	O
fibres	fibre	NOUN	NNS	O
by	by	ADP	IN	O
reduced	reduced	ADJ	JJ	O
sheath	sheath	NOUN	NN	O
thickness	thickness	NOUN	NN	O
and	and	CCONJ	CC	O
reduced	reduced	ADJ	JJ	O
axon	axon	NOUN	NN	O
calibre	calibre	ADV	RB	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
also	also	ADV	RB	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
subtle	subtle	ADJ	JJ	O
direct	direct	ADJ	JJ	O
toxic	toxic	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
entire	entire	ADJ	JJ	O
fibre	fibre	NOUN	NN	O
population	population	NOUN	NN	O
,	,	PUNCT	,	O
causing	cause	VERB	VBG	O
axon	axon	VERB	VBD	O
shrinkage	shrinkage	NOUN	NN	O
masked	mask	VERB	VBN	O
by	by	ADP	IN	O
readjustment	readjustment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
myelin	myelin	ADJ	JJ	O
sheath	sheath	NOUN	NN	O
.	.	PUNCT	.	O

Multicenter	Multicenter	PROPN	NNP	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
multiple	multiple	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
parallel	parallel	NOUN	NN	O
-	-	PUNCT	HYPH	O
groups	group	NOUN	NNS	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
azelastine	azelastine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
chlorpheniramine	chlorpheniramine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
spring	spring	NOUN	NN	B-Disease
allergic	allergic	ADJ	JJ	I-Disease
rhinitis	rhinitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Azelastine	Azelastine	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
novel	novel	ADJ	JJ	O
antiallergic	antiallergic	NOUN	NN	O
medication	medication	NOUN	NN	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
chlorpheniramine	chlorpheniramine	NOUN	NN	B-Chemical
maleate	maleate	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
for	for	ADP	IN	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
spring	spring	NOUN	NN	B-Disease
allergic	allergic	ADJ	JJ	I-Disease
rhinitis	rhinitis	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
multicenter	multicenter	NOUN	NN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
multiple	multiple	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
parallel	parallel	NOUN	NN	O
-	-	PUNCT	HYPH	O
groups	group	NOUN	NNS	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
hundred	hundred	NUM	CD	O
fifty	fifty	NUM	CD	O
-	-	PUNCT	HYPH	O
five	five	NUM	CD	O
subjects	subject	NOUN	NNS	O
participated	participate	VERB	VBD	O
.	.	PUNCT	.	O

Subjects	subject	NOUN	NNS	O
ranged	range	VERB	VBD	O
in	in	ADP	IN	O
age	age	NOUN	NN	O
from	from	ADP	IN	O
18	18	NUM	CD	O
to	to	PART	TO	O
60	60	NUM	CD	O
years	year	NOUN	NNS	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
and	and	CCONJ	CC	O
had	have	VERB	VBD	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
a	a	DET	DT	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
spring	spring	NOUN	NN	B-Disease
allergic	allergic	ADJ	JJ	I-Disease
rhinitis	rhinitis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
confirmed	confirm	VERB	VBN	O
by	by	ADP	IN	O
positive	positive	ADJ	JJ	O
skin	skin	NOUN	NN	O
test	test	NOUN	NN	O
to	to	PART	TO	O
spring	spring	NOUN	NN	O
aeroallergens	aeroallergen	NOUN	NNS	O
.	.	PUNCT	.	O

Medications	medication	NOUN	NNS	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
four	four	NUM	CD	O
times	time	NOUN	NNS	O
daily	daily	ADV	RB	O
;	;	PUNCT	:	O
the	the	DET	DT	O
azelastine	azelastine	NOUN	NN	B-Chemical
groups	group	NOUN	NNS	O
received	receive	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
morning	morning	NOUN	NN	O
and	and	CCONJ	CC	O
evening	evening	NOUN	NN	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
early	early	ADJ	JJ	O
and	and	CCONJ	CC	O
late	late	ADJ	JJ	O
afternoon	afternoon	NOUN	NN	O
;	;	PUNCT	:	O
the	the	DET	DT	O
chlorpheniramine	chlorpheniramine	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
received	receive	VERB	VBD	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
four	four	NUM	CD	O
times	time	NOUN	NNS	O
daily	daily	ADV	RB	O
.	.	PUNCT	.	O

Daily	daily	ADJ	JJ	O
subject	subject	ADJ	JJ	O
symptom	symptom	NOUN	NN	O
cards	card	NOUN	NNS	O
were	be	VERB	VBD	O
completed	complete	VERB	VBN	O
during	during	ADP	IN	O
a	a	DET	DT	O
screening	screening	NOUN	NN	O
period	period	NOUN	NN	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
pretreatment	pretreatment	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
during	during	ADP	IN	O
a	a	DET	DT	O
4	4	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
treatment	treatment	NOUN	NN	O
period	period	NOUN	NN	O
while	while	ADP	IN	O
subjects	subject	NOUN	NNS	O
received	receive	VERB	VBD	O
study	study	NOUN	NN	O
medications	medication	NOUN	NNS	O
.	.	PUNCT	.	O

Individual	individual	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
total	total	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
major	major	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
medication	medication	NOUN	NN	O
.	.	PUNCT	.	O

Elicited	elicit	VERB	VBN	O
,	,	PUNCT	,	O
volunteered	volunteer	VERB	VBD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
observed	observe	VERB	VBD	O
adverse	adverse	ADJ	JJ	O
experiences	experience	NOUN	NNS	O
were	be	VERB	VBD	O
recorded	record	VERB	VBN	O
for	for	ADP	IN	O
each	each	DET	DT	O
subject	subject	NOUN	NN	O
and	and	CCONJ	CC	O
compared	compare	VERB	VBN	O
among	among	ADP	IN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Vital	vital	ADJ	JJ	O
signs	sign	NOUN	NNS	O
,	,	PUNCT	,	O
body	body	NOUN	NN	O
weights	weight	NOUN	NNS	O
,	,	PUNCT	,	O
serum	serum	ADJ	JJ	O
chemistry	chemistry	NOUN	NN	O
values	value	NOUN	NNS	O
,	,	PUNCT	,	O
complete	complete	ADJ	JJ	O
blood	blood	NOUN	NN	O
cell	cell	NOUN	NN	O
counts	count	NOUN	NNS	O
,	,	PUNCT	,	O
urine	urine	NOUN	NN	O
studies	study	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
electrocardiograms	electrocardiogram	NOUN	NNS	O
were	be	VERB	VBD	O
obtained	obtain	VERB	VBN	O
for	for	ADP	IN	O
each	each	DET	DT	O
subject	subject	NOUN	NN	O
and	and	CCONJ	CC	O
compared	compare	VERB	VBN	O
among	among	ADP	IN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Symptoms	symptom	NOUN	NNS	O
relief	relief	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
group	group	NOUN	NN	O
receiving	receive	VERB	VBG	O
the	the	DET	DT	O
highest	high	ADJ	JJS	O
concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
azelastine	azelastine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
twice	twice	ADV	RB	O
daily	daily	ADV	RB	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
statistically	statistically	ADV	RB	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
during	during	ADP	IN	O
all	all	DET	DT	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Lower	low	ADJ	JJR	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
azelastine	azelastine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
statistically	statistically	ADV	RB	O
more	more	ADV	RBR	O
effective	effective	ADJ	JJ	O
than	than	ADP	IN	O
placebo	placebo	NOUN	NN	O
only	only	ADV	RB	O
during	during	ADP	IN	O
portions	portion	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
3	3	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
the	the	DET	DT	O
chlorpheniramine	chlorpheniramine	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
did	do	VERB	VBD	O
have	have	VERB	VB	O
fewer	few	ADJ	JJR	O
symptoms	symptom	NOUN	NNS	O
than	than	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
during	during	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
difference	difference	NOUN	NN	O
never	never	ADV	RB	O
reached	reach	VERB	VBD	O
statistical	statistical	ADJ	JJ	O
significance	significance	NOUN	NN	O
during	during	ADP	IN	O
any	any	DET	DT	O
week	week	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
serious	serious	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
in	in	ADP	IN	O
any	any	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Drowsiness	drowsiness	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
altered	altered	ADJ	JJ	B-Disease
taste	taste	NOUN	NN	I-Disease
perception	perception	NOUN	NN	I-Disease
were	be	VERB	VBD	O
increased	increase	VERB	VBN	O
significantly	significantly	ADV	RB	O
over	over	ADP	IN	O
placebo	placebo	NOUN	NN	O
only	only	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
azelastine	azelastine	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Azelastine	Azelastine	PROPN	NNP	B-Chemical
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
a	a	DET	DT	O
safe	safe	ADJ	JJ	O
,	,	PUNCT	,	O
efficacious	efficacious	ADJ	JJ	O
medication	medication	NOUN	NN	O
for	for	ADP	IN	O
seasonal	seasonal	ADJ	JJ	B-Disease
allergic	allergic	ADJ	JJ	I-Disease
rhinitis	rhinitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Toxicity	toxicity	NOUN	NN	B-Disease
due	due	ADJ	JJ	O
to	to	ADP	IN	O
remission	remission	NOUN	NN	O
inducing	induce	VERB	VBG	O
drugs	drug	NOUN	NNS	O
in	in	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Association	association	NOUN	NN	O
with	with	ADP	IN	O
HLA	HLA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
B35	B35	PROPN	NNP	O
and	and	CCONJ	CC	O
Cw4	Cw4	PROPN	NNP	O
antigens	antigen	VERB	VBZ	O
.	.	PUNCT	.	O

Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
RA	RA	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
toxicity	toxicity	NOUN	NN	B-Disease
while	while	ADP	IN	O
taking	take	VERB	VBG	O
remission	remission	NOUN	NN	O
inducing	induce	VERB	VBG	O
drugs	drug	NOUN	NNS	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
without	without	ADP	IN	O
toxicity	toxicity	NOUN	NN	B-Disease
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
for	for	ADP	IN	O
possible	possible	ADJ	JJ	O
associations	association	NOUN	NNS	O
with	with	ADP	IN	O
class	class	NOUN	NN	O
I	I	PROPN	NNP	O
and	and	CCONJ	CC	O
II	II	PROPN	NNP	O
HLA	HLA	PROPN	NNP	O
antigens	antigen	VERB	VBZ	O
.	.	PUNCT	.	O

A	a	DET	DT	O
strong	strong	ADJ	JJ	O
association	association	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
found	find	VERB	VBN	O
between	between	ADP	IN	O
nephritis	nephritis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
dermatitis	dermatitis	NOUN	NN	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
Tiopronin	Tiopronin	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
a	a	DET	DT	O
D	D	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
Penicillamine	penicillamine	NOUN	NN	I-Chemical
like	like	ADP	IN	O
compound	compound	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
class	class	NOUN	NN	O
I	-PRON-	PRON	PRP	O
antigens	antigen	VERB	VBZ	O
B35	B35	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Cw4	Cw4	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
between	between	ADP	IN	O
dermatitis	dermatitis	NOUN	NN	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
gold	gold	NOUN	NN	B-Chemical
thiosulphate	thiosulphate	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
B35	B35	PROPN	NNP	O
.	.	PUNCT	.	O

Compared	compare	VERB	VBN	O
to	to	ADP	IN	O
healthy	healthy	ADJ	JJ	O
controls	control	NOUN	NNS	O
a	a	DET	DT	O
lower	low	ADJ	JJR	O
DR5	dr5	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
RA	RA	PROPN	NNP	B-Disease
except	except	ADP	IN	O
for	for	ADP	IN	O
the	the	DET	DT	O
Tiopronin	Tiopronin	PROPN	NNP	B-Chemical
related	relate	VERB	VBN	O
nephritis	nephritis	NOUN	NN	B-Disease
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Transient	transient	ADJ	JJ	O
contralateral	contralateral	ADJ	JJ	B-Disease
rotation	rotation	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
unilateral	unilateral	ADJ	JJ	O
substantia	substantia	NOUN	NN	B-Disease
nigra	nigra	NOUN	NN	I-Disease
lesion	lesion	NOUN	NN	I-Disease
reflects	reflect	VERB	VBZ	O
susceptibility	susceptibility	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
nigrostriatal	nigrostriatal	ADJ	JJ	O
system	system	NOUN	NN	O
to	to	PART	TO	O
exhaustion	exhaustion	NOUN	NN	O
by	by	ADP	IN	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Following	follow	VERB	VBG	O
unilateral	unilateral	ADJ	JJ	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
OHDA	ohda	NOUN	NN	I-Chemical
induced	induce	VERB	VBN	O
SN	sn	NOUN	NN	B-Disease
lesion	lesion	NOUN	NN	I-Disease
,	,	PUNCT	,	O
a	a	DET	DT	O
transient	transient	ADJ	JJ	O
period	period	NOUN	NN	O
of	of	ADP	IN	O
contralateral	contralateral	ADJ	JJ	B-Disease
rotation	rotation	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
to	to	PART	TO	O
precede	precede	VERB	VB	O
the	the	DET	DT	O
predominant	predominant	ADJ	JJ	O
ipsilateral	ipsilateral	ADJ	JJ	B-Disease
circling	circling	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
clarify	clarify	VERB	VB	O
the	the	DET	DT	O
nature	nature	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
initial	initial	ADJ	JJ	O
contralateral	contralateral	ADJ	JJ	B-Disease
rotation	rotation	NOUN	NN	I-Disease
we	-PRON-	PRON	PRP	O
examined	examine	VERB	VBD	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
recovery	recovery	NOUN	NN	O
period	period	NOUN	NN	O
after	after	ADP	IN	O
the	the	DET	DT	O
lesion	lesion	NOUN	NN	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
rotational	rotational	ADJ	JJ	B-Disease
behavior	behavior	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Three	three	NUM	CD	O
days	day	NOUN	NNS	O
post	post	NOUN	NN	O
lesion	lesion	NOUN	NN	O
,	,	PUNCT	,	O
most	most	ADJ	JJS	O
rats	rat	NOUN	NNS	O
circled	circle	VERB	VBD	O
predominantly	predominantly	ADV	RB	O
contralaterally	contralaterally	ADV	RB	O
to	to	ADP	IN	O
the	the	DET	DT	O
lesion	lesion	NOUN	NN	O
.	.	PUNCT	.	O

Such	such	ADJ	JJ	O
contralateral	contralateral	ADJ	JJ	B-Disease
rotation	rotation	NOUN	NN	I-Disease
may	may	VERB	MD	O
result	result	VERB	VB	O
from	from	ADP	IN	O
either	either	DET	DT	O
degeneration	degeneration	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
breakdown	breakdown	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
DA	DA	PROPN	NNP	O
pool	pool	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
lesion	lesion	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
DA	DA	PROPN	NNP	O
turnover	turnover	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
spared	spare	VERB	VBN	O
neurons	neuron	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
substantial	substantial	ADJ	JJ	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
contralateral	contralateral	ADJ	JJ	O
preference	preference	NOUN	NN	O
was	be	VERB	VBD	O
still	still	ADV	RB	O
evident	evident	ADJ	JJ	O
when	when	ADV	WRB	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
time	time	NOUN	NN	O
24	24	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
lesioning	lesione	VERB	VBG	O
,	,	PUNCT	,	O
indicating	indicate	VERB	VBG	O
involvement	involvement	NOUN	NN	O
of	of	ADP	IN	O
spared	spare	VERB	VBN	O
cells	cell	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
contralateral	contralateral	ADJ	JJ	B-Disease
rotation	rotation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
regardless	regardless	ADV	RB	O
of	of	ADP	IN	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
recovery	recovery	NOUN	NN	O
(	(	PUNCT	-LRB-	O
and	and	CCONJ	CC	O
irrespective	irrespective	ADV	RB	O
of	of	ADP	IN	O
either	either	DET	DT	O
lesion	lesion	NOUN	NN	O
volume	volume	NOUN	NN	O
,	,	PUNCT	,	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
post	post	ADJ	JJ	O
-	-	ADJ	JJ	O
lesion	lesion	ADJ	JJ	O
motor	motor	NOUN	NN	O
exercise	exercise	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
rotation	rotation	NOUN	NN	B-Disease
tended	tend	VERB	VBD	O
to	to	PART	TO	O
become	become	VERB	VB	O
gradually	gradually	ADV	RB	O
more	more	ADV	RBR	O
ipsilateral	ipsilateral	ADJ	JJ	O
as	as	ADP	IN	O
the	the	DET	DT	O
observation	observation	NOUN	NN	O
session	session	NOUN	NN	O
progressed	progress	VERB	VBD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
all	all	DET	DT	O
rats	rat	NOUN	NNS	O
circled	circle	VERB	VBD	O
ipsilaterally	ipsilaterally	ADV	RB	O
to	to	ADP	IN	O
the	the	DET	DT	O
lesion	lesion	NOUN	NN	O
in	in	ADP	IN	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
further	further	ADJ	JJ	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
injections	injection	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	DET	DT	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
an	an	DET	DT	O
irreversible	irreversible	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
post	post	ADJ	JJ	O
-	-	ADJ	JJ	O
lesion	lesion	NOUN	NN	O
DA	da	NOUN	NN	O
pool	pool	NOUN	NN	O
contributing	contribute	VERB	VBG	O
to	to	ADP	IN	O
contralateral	contralateral	ADJ	JJ	B-Disease
rotation	rotation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Mitomycin	Mitomycin	PROPN	NNP	B-Chemical
C	C	PROPN	NNP	I-Chemical
associated	associate	VERB	VBD	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
uremic	uremic	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Mitomycin	Mitomycin	PROPN	NNP	B-Chemical
C	C	PROPN	NNP	I-Chemical
associated	associate	VERB	VBD	O
Hemolytic	Hemolytic	PROPN	NNP	B-Disease
Uremic	Uremic	PROPN	NNP	I-Disease
Syndrome	Syndrome	PROPN	NNP	I-Disease
(	(	PUNCT	-LRB-	O
HUS	HUS	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
potentially	potentially	ADV	RB	O
fatal	fatal	ADJ	JJ	O
but	but	CCONJ	CC	O
uncommon	uncommon	ADJ	JJ	O
condition	condition	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
yet	yet	ADV	RB	O
widely	widely	ADV	RB	O
recognised	recognise	VERB	VBN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
consists	consist	VERB	VBZ	O
of	of	ADP	IN	O
microangiopathic	microangiopathic	ADJ	JJ	O
hemolytic	hemolytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
,	,	PUNCT	,	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
progressive	progressive	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
mitomycin	mitomycin	NOUN	NN	B-Chemical
C	C	PROPN	NNP	I-Chemical
treatment	treatment	NOUN	NN	O
and	and	CCONJ	CC	O
affects	affect	VERB	VBZ	O
about	about	ADP	IN	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
this	this	DET	DT	O
agent	agent	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
usually	usually	ADV	RB	O
develops	develop	VERB	VBZ	O
about	about	ADV	RB	O
8	8	NUM	CD	O
-	-	SYM	SYM	O
10	10	NUM	CD	O
mth	mth	NOUN	NN	O
after	after	ADP	IN	O
start	start	NOUN	NN	O
of	of	ADP	IN	O
mitomycin	mitomycin	NOUN	NN	B-Chemical
C	C	PROPN	NNP	I-Chemical
treatment	treatment	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
mortality	mortality	NOUN	NN	O
is	be	VERB	VBZ	O
approximately	approximately	ADV	RB	O
60	60	NUM	CD	O
%	%	NOUN	NN	O
from	from	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
pulmonary	pulmonary	ADJ	JJ	B-Disease
edema	edema	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
are	be	VERB	VBP	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
idiopathic	idiopathic	ADJ	JJ	O
HUS	HUS	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
include	include	VERB	VBP	O
arteriolar	arteriolar	ADJ	JJ	O
fibrin	fibrin	NOUN	NN	O
thrombi	thrombi	NOUN	NN	B-Disease
,	,	PUNCT	,	O
expanded	expand	VERB	VBD	O
subendothelial	subendothelial	ADJ	JJ	O
zones	zone	NOUN	NNS	O
in	in	ADP	IN	O
glomerular	glomerular	ADJ	JJ	O
capillary	capillary	ADJ	JJ	O
walls	wall	NOUN	NNS	O
,	,	PUNCT	,	O
ischemic	ischemic	ADJ	JJ	B-Disease
wrinkling	wrinkling	NOUN	NN	O
of	of	ADP	IN	O
glomerular	glomerular	ADJ	JJ	O
basement	basement	NOUN	NN	O
membranes	membrane	NOUN	NNS	O
and	and	CCONJ	CC	O
mesangiolysis	mesangiolysis	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
action	action	NOUN	NN	O
is	be	VERB	VBZ	O
postulated	postulate	VERB	VBN	O
as	as	ADP	IN	O
mitomycin	mitomycin	NOUN	NN	B-Chemical
C	C	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
endothelial	endothelial	ADJ	JJ	O
cell	cell	NOUN	NN	O
damage	damage	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
the	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
course	course	NOUN	NN	O
and	and	CCONJ	CC	O
pathological	pathological	ADJ	JJ	O
findings	finding	NOUN	NNS	O
in	in	ADP	IN	O
a	a	DET	DT	O
65	65	NUM	CD	O
yr	yr	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
with	with	ADP	IN	O
gastric	gastric	ADJ	JJ	B-Disease
adenocarcinoma	adenocarcinoma	NOUN	NN	I-Disease
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
while	while	ADP	IN	O
on	on	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
mitomycin	mitomycin	NOUN	NN	B-Chemical
C	C	PROPN	NNP	I-Chemical
and	and	CCONJ	CC	O
died	die	VERB	VBD	O
in	in	ADP	IN	O
pulmonary	pulmonary	ADJ	JJ	B-Disease
edema	edema	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Ketanserin	Ketanserin	PROPN	NNP	B-Chemical
pretreatment	pretreatment	NOUN	NN	O
reverses	reverse	VERB	VBZ	O
alfentanil	alfentanil	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Systemic	systemic	ADJ	JJ	O
pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
ketanserin	ketanserin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
relatively	relatively	ADV	RB	O
specific	specific	ADJ	JJ	O
type	type	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
serotonin	serotonin	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
significantly	significantly	ADV	RB	O
attenuated	attenuate	VERB	VBD	O
the	the	DET	DT	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
produced	produce	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
by	by	ADP	IN	O
the	the	DET	DT	O
potent	potent	ADJ	JJ	O
short	short	ADV	RB	O
-	-	PUNCT	HYPH	O
acting	act	VERB	VBG	O
opiate	opiate	ADJ	JJ	O
agonist	agonist	NOUN	NN	O
alfentanil	alfentanil	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Following	follow	VERB	VBG	O
placement	placement	NOUN	NN	O
of	of	ADP	IN	O
subcutaneous	subcutaneous	ADJ	JJ	O
electrodes	electrode	NOUN	NNS	O
in	in	ADP	IN	O
each	each	DET	DT	O
animal	animal	NOUN	NN	O
'	'	PUNCT	''	O
s	s	VERB	VBZ	O
left	leave	VERB	VBN	O
gastrocnemius	gastrocnemius	NOUN	NN	O
muscle	muscle	NOUN	NN	O
,	,	PUNCT	,	O
rigidity	rigidity	NOUN	NN	B-Disease
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
analyzing	analyze	VERB	VBG	O
root	root	NOUN	NN	O
-	-	PUNCT	HYPH	O
mean	mean	NOUN	NN	O
-	-	PUNCT	HYPH	O
square	square	ADJ	JJ	O
electromyographic	electromyographic	ADJ	JJ	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Intraperitoneal	intraperitoneal	NOUN	NN	O
ketanserin	ketanserin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
63	63	NUM	CD	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
prevented	prevent	VERB	VBN	O
the	the	DET	DT	O
alfentanil	alfentanil	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
electromyographic	electromyographic	ADJ	JJ	O
activity	activity	NOUN	NN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
animals	animal	NOUN	NNS	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
.	.	PUNCT	.	O

Chlordiazepoxide	chlordiazepoxide	NOUN	NN	B-Chemical
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
up	up	ADP	IN	O
to	to	PART	TO	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	PUNCT	,	O
kg	kg	ADP	IN	O
failed	fail	VERB	VBN	O
to	to	PART	TO	O
significantly	significantly	ADV	RB	O
influence	influence	VERB	VB	O
the	the	DET	DT	O
rigidity	rigidity	NOUN	NN	B-Disease
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
alfentanil	alfentanil	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Despite	despite	ADP	IN	O
the	the	DET	DT	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
rigidity	rigidity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
animals	animal	NOUN	NNS	O
that	that	DET	WDT	O
received	receive	VERB	VBD	O
ketanserin	ketanserin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
31	31	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
alfentanil	alfentanil	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
motionless	motionless	ADJ	JJ	O
,	,	PUNCT	,	O
flaccid	flaccid	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
less	less	ADV	RBR	O
responsive	responsive	ADJ	JJ	O
to	to	ADP	IN	O
external	external	ADJ	JJ	O
stimuli	stimulus	NOUN	NNS	O
than	than	ADP	IN	O
were	be	VERB	VBD	O
animals	animal	NOUN	NNS	O
receiving	receive	VERB	VBG	O
alfentanil	alfentanil	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
.	.	PUNCT	.	O

Rats	rat	NOUN	NNS	O
that	that	DET	WDT	O
received	receive	VERB	VBD	O
ketanserin	ketanserin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
alfentanil	alfentanil	NOUN	NN	B-Chemical
exhibited	exhibit	VERB	VBD	O
less	less	ADJ	JJR	O
rearing	rearing	NOUN	NN	O
and	and	CCONJ	CC	O
exploratory	exploratory	ADJ	JJ	O
behavior	behavior	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
60	60	NUM	CD	O
-	-	PUNCT	HYPH	O
min	min	NOUN	NN	O
recording	recording	NOUN	NN	O
period	period	NOUN	NN	O
than	than	ADP	IN	O
did	do	VERB	VBD	O
animals	animal	NOUN	NNS	O
that	that	DET	WDT	O
received	receive	VERB	VBD	O
ketanserin	ketanserin	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
previous	previous	ADJ	JJ	O
work	work	NOUN	NN	O
,	,	PUNCT	,	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
,	,	PUNCT	,	O
a	a	DET	DT	O
clinically	clinically	ADV	RB	O
relevant	relevant	ADJ	JJ	O
side	side	NOUN	NN	O
-	-	PUNCT	HYPH	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
parenteral	parenteral	ADJ	JJ	O
narcotic	narcotic	ADJ	JJ	O
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
may	may	VERB	MD	O
be	be	VERB	VB	O
partly	partly	ADV	RB	O
mediated	mediate	VERB	VBN	O
via	via	ADP	IN	O
serotonergic	serotonergic	NOUN	NN	O
pathways	pathway	NOUN	NNS	O
.	.	PUNCT	.	O

Pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
type	type	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
serotonin	serotonin	NOUN	NN	B-Chemical
antagonists	antagonist	NOUN	NNS	O
may	may	VERB	MD	O
be	be	VERB	VB	O
clinically	clinically	ADV	RB	O
useful	useful	ADJ	JJ	O
in	in	ADP	IN	O
attenuating	attenuate	VERB	VBG	O
opiate	opiate	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
rigidity	rigidity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
although	although	ADP	IN	O
further	further	ADJ	JJ	O
studies	study	NOUN	NNS	O
will	will	VERB	MD	O
be	be	VERB	VB	O
necessary	necessary	ADJ	JJ	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
interaction	interaction	NOUN	NN	O
of	of	ADP	IN	O
possibly	possibly	ADV	RB	O
enhanced	enhance	VERB	VBN	O
CNS	CNS	PROPN	NNP	O
,	,	PUNCT	,	O
cardiovascular	cardiovascular	NOUN	NN	B-Disease
,	,	PUNCT	,	I-Disease
and	and	CCONJ	CC	I-Disease
respiratory	respiratory	ADJ	JJ	I-Disease
depression	depression	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Antagonism	antagonism	NOUN	NN	O
of	of	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
sedative	sedative	ADJ	JJ	O
effects	effect	NOUN	NNS	O
by	by	ADP	IN	O
Ro15	Ro15	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
1788	1788	NUM	CD	I-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
after	after	ADP	IN	O
surgery	surgery	NOUN	NN	O
under	under	ADP	IN	O
lumbar	lumbar	ADJ	JJ	O
epidural	epidural	ADJ	JJ	O
block	block	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
investigation	investigation	NOUN	NN	O
of	of	ADP	IN	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
Ro15	Ro15	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
1788	1788	NUM	CD	I-Chemical
and	and	CCONJ	CC	O
a	a	DET	DT	O
placebo	placebo	NOUN	NN	O
in	in	ADP	IN	O
reversing	reverse	VERB	VBG	O
diazepam	diazepam	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
effects	effect	NOUN	NNS	O
after	after	ADP	IN	O
surgery	surgery	NOUN	NN	O
under	under	ADP	IN	O
epidural	epidural	ADJ	JJ	O
block	block	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
local	local	ADJ	JJ	O
tolerance	tolerance	NOUN	NN	O
and	and	CCONJ	CC	O
general	general	ADJ	JJ	O
safety	safety	NOUN	NN	O
of	of	ADP	IN	O
Ro15	Ro15	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
1788	1788	NUM	CD	I-Chemical
.	.	PUNCT	.	O

Fifty	fifty	NUM	CD	O
-	-	PUNCT	HYPH	O
seven	seven	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
sedated	sedate	VERB	VBN	O
with	with	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
for	for	ADP	IN	O
surgery	surgery	NOUN	NN	O
under	under	ADP	IN	O
epidural	epidural	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
.	.	PUNCT	.	O

Antagonism	antagonism	NOUN	NN	O
of	of	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
effects	effect	NOUN	NNS	O
by	by	ADP	IN	O
Ro15	Ro15	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
1788	1788	PROPN	NNP	I-Chemical
was	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
postoperatively	postoperatively	ADV	RB	O
in	in	ADP	IN	O
a	a	DET	DT	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
trial	trial	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	VERB	VBZ	O
subjective	subjective	ADJ	JJ	O
assessment	assessment	NOUN	NN	O
of	of	ADP	IN	O
mood	mood	NOUN	NN	O
rating	rating	NOUN	NN	O
,	,	PUNCT	,	O
an	an	DET	DT	O
objective	objective	ADJ	JJ	O
test	test	NOUN	NN	O
of	of	ADP	IN	O
performance	performance	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
test	test	NOUN	NN	O
for	for	ADP	IN	O
amnesia	amnesia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
vital	vital	ADJ	JJ	O
signs	sign	NOUN	NNS	O
were	be	VERB	VBD	O
recorded	record	VERB	VBN	O
for	for	ADP	IN	O
up	up	ADP	IN	O
to	to	PART	TO	O
300	300	NUM	CD	O
min	min	NOUN	NN	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
trial	trial	NOUN	NN	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
for	for	ADP	IN	O
mood	mood	NOUN	NN	O
rating	rating	NOUN	NN	O
,	,	PUNCT	,	O
amnesia	amnesia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
vital	vital	ADJ	JJ	O
signs	sign	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
Ro15	Ro15	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
1788	1788	NUM	CD	I-Chemical
group	group	NOUN	NN	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
performance	performance	NOUN	NN	O
test	test	NOUN	NN	O
up	up	ADP	IN	O
to	to	ADP	IN	O
120	120	NUM	CD	O
min	min	NOUN	NN	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
reaction	reaction	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
injection	injection	NOUN	NN	O
site	site	NOUN	NN	O
.	.	PUNCT	.	O

Chorea	chorea	NOUN	NN	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
oral	oral	ADJ	JJ	B-Chemical
contraception	contraception	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
chorea	chorea	NOUN	NN	B-Disease
while	while	ADP	IN	O
receiving	receive	VERB	VBG	O
oral	oral	ADJ	JJ	B-Chemical
contraceptives	contraceptive	NOUN	NNS	I-Chemical
.	.	PUNCT	.	O

Two	two	NUM	CD	O
were	be	VERB	VBD	O
young	young	ADJ	JJ	O
patients	patient	NOUN	NNS	O
whose	whose	DET	WP$	O
chorea	chorea	NOUN	NN	B-Disease
developed	develop	VERB	VBD	O
long	long	ADV	RB	O
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
started	start	VERB	VBN	O
and	and	CCONJ	CC	O
disappeared	disappear	VERB	VBD	O
soon	soon	ADV	RB	O
after	after	ADP	IN	O
it	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
discontinued	discontinue	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
third	third	ADJ	JJ	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
acute	acute	ADJ	JJ	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
chorea	chorea	NOUN	NN	B-Disease
after	after	ADP	IN	O
prolonged	prolong	VERB	VBN	O
oral	oral	ADJ	JJ	B-Chemical
contraception	contraception	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Prolonged	prolonged	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
female	female	ADJ	JJ	O
sex	sex	NOUN	NN	O
hormones	hormone	NOUN	NNS	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
chorea	chorea	NOUN	NN	B-Disease
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
who	who	PRON	WP	O
have	have	VERB	VBP	O
not	not	ADV	RB	O
previously	previously	ADV	RB	O
had	have	VERB	VBN	O
chorea	chorea	NOUN	NN	B-Disease
or	or	CCONJ	CC	O
rheumatic	rheumatic	ADJ	JJ	B-Disease
fever	fever	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Co	co	ADJ	JJ	O
-	-	ADJ	JJ	O
carcinogenic	carcinogenic	ADJ	JJ	B-Disease
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
retinyl	retinyl	NOUN	NN	B-Chemical
acetate	acetate	ADJ	JJ	I-Chemical
on	on	ADP	IN	O
forestomach	forestomach	NOUN	NN	B-Disease
carcinogenesis	carcinogenesis	NOUN	NN	I-Disease
of	of	ADP	IN	O
male	male	ADJ	JJ	O
F344	f344	NOUN	NN	O
rats	rat	NOUN	NNS	O
induced	induce	VERB	VBN	O
with	with	ADP	IN	O
butylated	butylate	VERB	VBN	B-Chemical
hydroxyanisole	hydroxyanisole	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
potential	potential	ADJ	JJ	O
modifying	modify	VERB	VBG	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
retinyl	retinyl	ADJ	JJ	B-Chemical
acetate	acetate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
RA	RA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
butylated	butylate	VERB	VBN	B-Chemical
hydroxyanisole	hydroxyanisole	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
BHA	BHA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
rat	rat	NOUN	NN	O
forestomach	forestomach	NOUN	NN	B-Disease
tumorigenesis	tumorigenesis	NOUN	NN	I-Disease
was	be	VERB	VBD	O
examined	examine	VERB	VBN	O
.	.	PUNCT	.	O

Male	Male	PROPN	NNP	O
F344	F344	PROPN	NNP	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
maintained	maintain	VERB	VBN	O
on	on	ADP	IN	O
diet	diet	NOUN	NN	O
containing	contain	VERB	VBG	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
BHA	BHA	PROPN	NNP	B-Chemical
by	by	ADP	IN	O
weight	weight	NOUN	NN	O
and	and	CCONJ	CC	O
simultaneously	simultaneously	ADV	RB	O
on	on	ADP	IN	O
drinking	drinking	NOUN	NN	O
water	water	NOUN	NN	O
supplemented	supplement	VERB	VBN	O
with	with	ADP	IN	O
RA	RA	PROPN	NNP	B-Chemical
at	at	ADP	IN	O
various	various	ADJ	JJ	O
concentrations	concentration	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
w	w	X	FW	O
/	/	SYM	SYM	O
v	v	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
52	52	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
groups	group	NOUN	NNS	O
given	give	VERB	VBN	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
BHA	BHA	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
although	although	ADP	IN	O
marked	marked	ADJ	JJ	O
hyperplastic	hyperplastic	ADJ	JJ	O
changes	change	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
forestomach	forestomach	ADJ	JJ	O
epithelium	epithelium	NOUN	NN	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
all	all	DET	DT	O
animals	animal	NOUN	NNS	O
,	,	PUNCT	,	O
co	co	NOUN	NN	O
-	-	NOUN	NN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
%	%	NOUN	NN	O
RA	RA	PROPN	NNP	B-Chemical
significantly	significantly	ADV	RB	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
forestomach	forestomach	ADJ	JJ	B-Disease
tumors	tumor	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
squamous	squamous	ADJ	JJ	B-Disease
cell	cell	NOUN	NN	I-Disease
papilloma	papilloma	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
carcinoma	carcinoma	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
60	60	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
/	/	SYM	SYM	O
15	15	NUM	CD	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
carcinoma	carcinoma	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
from	from	ADP	IN	O
15	15	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
/	/	SYM	SYM	O
20	20	NUM	CD	O
,	,	PUNCT	,	O
one	one	NUM	CD	O
rat	rat	NOUN	NN	O
with	with	ADP	IN	O
carcinoma	carcinoma	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
group	group	NOUN	NN	O
given	give	VERB	VBN	O
RA	RA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
water	water	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
rats	rat	NOUN	NNS	O
given	give	VERB	VBN	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
BHA	BHA	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
RA	RA	PROPN	NNP	B-Chemical
co	co	NOUN	NN	O
-	-	VERB	VBD	O
administered	administer	VERB	VBD	O
at	at	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
or	or	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
%	%	NOUN	NN	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
enhancing	enhance	VERB	VBG	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
BHA	BHA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
epithelial	epithelial	ADJ	JJ	B-Disease
hyperplasia	hyperplasia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Tumors	tumor	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
all	all	DET	DT	O
papillomas	papilloma	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
were	be	VERB	VBD	O
induced	induce	VERB	VBN	O
in	in	ADP	IN	O
3	3	NUM	CD	O
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
17	17	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
%	%	NOUN	NN	O
RA	RA	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
in	in	ADP	IN	O
one	one	NUM	CD	O
rat	rat	NOUN	NN	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
%	%	NOUN	NN	O
RA	RA	PROPN	NNP	B-Chemical
co	co	NOUN	NN	O
-	-	NOUN	NN	O
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

RA	RA	PROPN	NNP	B-Chemical
alone	alone	ADV	RB	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
induce	induce	VERB	VB	O
hyperplastic	hyperplastic	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
forestomach	forestomach	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
RA	RA	PROPN	NNP	B-Chemical
acted	act	VERB	VBD	O
as	as	ADP	IN	O
a	a	DET	DT	O
co	co	NOUN	NN	O
-	-	NOUN	NN	O
carcinogen	carcinogen	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
BHA	bha	ADJ	JJ	B-Chemical
forestomach	forestomach	NOUN	NN	B-Disease
carcinogenesis	carcinogenesis	NOUN	NN	I-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
study	study	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
dependency	dependency	NOUN	NN	O
of	of	ADP	IN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
mitomycin	mitomycin	NOUN	NN	B-Chemical
C	C	PROPN	NNP	I-Chemical
.	.	PUNCT	.	O

Since	since	ADP	IN	O
1975	1975	NUM	CD	O
mitomycin	mitomycin	NOUN	NN	B-Chemical
C	C	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
MMC	MMC	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
suggested	suggest	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
cardiotoxic	cardiotoxic	ADJ	JJ	B-Disease
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
when	when	ADV	WRB	O
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
or	or	CCONJ	CC	O
given	give	VERB	VBN	O
following	follow	VERB	VBG	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Data	datum	NOUN	NNS	O
on	on	ADP	IN	O
dose	dose	NOUN	NN	O
dependency	dependency	NOUN	NN	O
or	or	CCONJ	CC	O
incidence	incidence	NOUN	NN	O
concerning	concern	VERB	VBG	O
this	this	DET	DT	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
known	know	VERB	VBN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
have	have	VERB	VBP	O
initiated	initiate	VERB	VBN	O
a	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
study	study	NOUN	NN	O
to	to	PART	TO	O
obtain	obtain	VERB	VB	O
some	some	DET	DT	O
more	more	ADJ	JJR	O
data	datum	NOUN	NNS	O
on	on	ADP	IN	O
these	these	DET	DT	O
subjects	subject	NOUN	NNS	O
.	.	PUNCT	.	O

Forty	forty	NUM	CD	O
-	-	PUNCT	HYPH	O
four	four	NUM	CD	O
MMC	MMC	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
,	,	PUNCT	,	O
37	37	NUM	CD	O
of	of	ADP	IN	O
them	-PRON-	PRON	PRP	O
could	could	VERB	MD	O
be	be	VERB	VB	O
evaluated	evaluate	VERB	VBN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
by	by	ADP	IN	O
repeated	repeat	VERB	VBN	O
physical	physical	ADJ	JJ	O
examinations	examination	NOUN	NNS	O
,	,	PUNCT	,	O
chest	chest	NOUN	NN	O
X	X	NOUN	NNS	O
-	-	NOUN	NNS	O
rays	ray	NOUN	NNS	O
,	,	PUNCT	,	O
electro	electro	NOUN	NN	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
echocardiography	echocardiography	NOUN	NN	O
and	and	CCONJ	CC	O
radionuclide	radionuclide	VERB	VB	O
left	leave	VERB	VBD	O
ventricular	ventricular	ADJ	JJ	O
ejection	ejection	NOUN	NN	O
fraction	fraction	NOUN	NN	O
(	(	PUNCT	-LRB-	O
EF	EF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
determinations	determination	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
per	per	ADP	IN	O
cumulative	cumulative	ADJ	JJ	O
dose	dose	NOUN	NN	O
level	level	NOUN	NN	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
cardiac	cardiac	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
after	after	ADP	IN	O
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
m	m	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
MMC	mmc	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
only	only	ADV	RB	O
150	150	NUM	CD	O
mg	mg	NOUN	NN	O
m	m	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
cardiac	cardiac	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
was	be	VERB	VBD	O
predicted	predict	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
drop	drop	NOUN	NN	O
in	in	ADP	IN	O
EF	EF	PROPN	NNP	O
determined	determine	VERB	VBD	O
during	during	ADP	IN	O
a	a	DET	DT	O
cold	cold	ADJ	JJ	O
pressor	pressor	NOUN	NN	O
test	test	NOUN	NN	O
.	.	PUNCT	.	O

None	none	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
clinical	clinical	ADJ	JJ	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
nor	nor	CCONJ	CC	O
did	do	VERB	VBD	O
the	the	DET	DT	O
studied	study	VERB	VBN	O
parameters	parameter	NOUN	NNS	O
change	change	VERB	VBP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
literature	literature	NOUN	NN	O
on	on	ADP	IN	O
this	this	DET	DT	O
subject	subject	NOUN	NN	O
was	be	VERB	VBD	O
also	also	ADV	RB	O
reviewed	review	VERB	VBN	O
.	.	PUNCT	.	O

Based	base	VERB	VBN	O
on	on	ADP	IN	O
the	the	DET	DT	O
combined	combined	ADJ	JJ	O
data	datum	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
MMC	mmc	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
dose	dose	NOUN	NN	O
dependent	dependent	ADJ	JJ	O
,	,	PUNCT	,	O
occurring	occur	VERB	VBG	O
at	at	ADP	IN	O
cumulative	cumulative	ADJ	JJ	O
dose	dose	NOUN	NN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
m	m	NOUN	NN	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
,	,	PUNCT	,	O
mainly	mainly	ADV	RB	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
also	also	ADV	RB	O
(	(	PUNCT	-LRB-	O
previously	previously	ADV	RB	O
or	or	CCONJ	CC	O
simultaneously	simultaneously	ADV	RB	O
)	)	PUNCT	-RRB-	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
is	be	VERB	VBZ	O
likely	likely	ADJ	JJ	O
to	to	PART	TO	O
be	be	VERB	VB	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
even	even	ADV	RB	O
for	for	ADP	IN	O
this	this	DET	DT	O
risk	risk	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Reversible	reversible	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
tiazofurin	tiazofurin	NOUN	NN	B-Chemical
usage	usage	NOUN	NN	O
:	:	PUNCT	:	O
MR	MR	PROPN	NNP	O
demonstration	demonstration	NOUN	NN	O
.	.	PUNCT	.	O

Tiazofurin	tiazofurin	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
an	an	DET	DT	O
experimental	experimental	ADJ	JJ	O
chemotherapeutic	chemotherapeutic	ADJ	JJ	O
agent	agent	NOUN	NN	O
currently	currently	ADV	RB	O
undergoing	undergo	VERB	VBG	O
clinical	clinical	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
with	with	ADP	IN	O
magnetic	magnetic	ADJ	JJ	O
resonance	resonance	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MR	MR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
demonstrating	demonstrate	VERB	VBG	O
reversible	reversible	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	B-Disease
abnormalities	abnormality	NOUN	NNS	I-Disease
concurrent	concurrent	ADJ	JJ	O
with	with	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
abnormalities	abnormality	NOUN	NNS	O
on	on	ADP	IN	O
MR	MR	PROPN	NNP	O
were	be	VERB	VBD	O
correlated	correlate	VERB	VBN	O
with	with	ADP	IN	O
findings	finding	NOUN	NNS	O
on	on	ADP	IN	O
CT	CT	PROPN	NNP	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
with	with	ADP	IN	O
cerebral	cerebral	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
utility	utility	NOUN	NN	O
of	of	ADP	IN	O
MR	MR	PROPN	NNP	O
in	in	ADP	IN	O
the	the	DET	DT	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
this	this	DET	DT	O
new	new	ADJ	JJ	O
agent	agent	NOUN	NN	O
is	be	VERB	VBZ	O
illustrated	illustrate	VERB	VBN	O
.	.	PUNCT	.	O

Receptor	receptor	NOUN	NN	O
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
nicotine	nicotine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
locomotor	locomotor	NOUN	NN	B-Disease
hyperactivity	hyperactivity	NOUN	NN	I-Disease
in	in	ADP	IN	O
chronic	chronic	ADJ	JJ	O
nicotine	nicotine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
or	or	CCONJ	CC	O
nicotine	nicotine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
by	by	ADP	IN	O
subcutaneously	subcutaneously	ADV	RB	O
implanting	implant	VERB	VBG	O
each	each	DET	DT	O
animal	animal	NOUN	NN	O
with	with	ADP	IN	O
an	an	DET	DT	O
Alzet	Alzet	PROPN	NNP	O
osmotic	osmotic	ADJ	JJ	O
mini	mini	ADJ	JJ	O
-	-	PUNCT	:	O
pump	pump	NOUN	NN	O
which	which	DET	WDT	O
continuously	continuously	ADV	RB	O
released	release	VERB	VBD	O
saline	saline	NOUN	NN	O
or	or	CCONJ	CC	O
nicotine	nicotine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
and	and	CCONJ	CC	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
the	the	DET	DT	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
each	each	DET	DT	O
pretreatment	pretreatment	ADJ	JJ	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
animals	animal	NOUN	NNS	O
were	be	VERB	VBD	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
(	(	PUNCT	-LRB-	O
i	i	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
determining	determine	VERB	VBG	O
their	-PRON-	DET	PRP$	O
locomotor	locomotor	NOUN	NN	O
response	response	NOUN	NN	O
to	to	PART	TO	O
acutely	acutely	ADV	RB	O
injected	inject	VERB	VBN	O
nicotine	nicotine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
s	s	X	XX	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
ii	ii	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
measuring	measure	VERB	VBG	O
the	the	DET	DT	O
density	density	NOUN	NN	O
of	of	ADP	IN	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
[	[	PUNCT	-LRB-	O
3H	3h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
nicotine	nicotine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
[	[	PUNCT	-LRB-	O
3H	3h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
spiperone	spiperone	VERB	VBD	B-Chemical
binding	bind	VERB	VBG	O
sites	site	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
observed	observe	VERB	VBD	O
no	no	DET	DT	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
nicotine	nicotine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
locomotor	locomotor	NOUN	NN	O
response	response	NOUN	NN	O
,	,	PUNCT	,	O
striatal	striatal	ADJ	JJ	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
[	[	PUNCT	-LRB-	O
3H	3h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
nicotine	nicotine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
[	[	PUNCT	-LRB-	O
3H	3h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
spiperone	spiperone	VERB	VBN	B-Chemical
binding	bind	VERB	VBG	O
in	in	ADP	IN	O
the	the	DET	DT	O
animals	animal	NOUN	NNS	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
nicotine	nicotine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
1	1	NUM	CD	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
rats	rat	NOUN	NNS	O
which	which	DET	WDT	O
were	be	VERB	VBD	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
nicotine	nicotine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
5	5	NUM	CD	O
days	day	NOUN	NNS	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
nicotine	nicotine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
stimulated	stimulate	VERB	VBN	O
locomotor	locomotor	NOUN	NN	O
response	response	NOUN	NN	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
[	[	PUNCT	-LRB-	O
3H	3h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
nicotine	nicotine	NOUN	NN	B-Chemical
binding	bind	VERB	VBG	O
sites	site	NOUN	NNS	O
and	and	CCONJ	CC	O
also	also	ADV	RB	O
with	with	ADP	IN	O
an	an	DET	DT	O
elevated	elevated	ADJ	JJ	O
dopamine	dopamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DA	DA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
level	level	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
striatal	striatal	ADJ	JJ	O
[	[	PUNCT	-LRB-	O
3H	3h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
spiperone	spiperone	VERB	VBD	B-Chemical
binding	bind	VERB	VBG	O
sites	site	NOUN	NNS	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
affected	affect	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
animals	animal	NOUN	NNS	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
nicotine	nicotine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
nicotine	nicotine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
locomotor	locomotor	NOUN	NN	O
response	response	NOUN	NN	O
remained	remain	VERB	VBD	O
to	to	PART	TO	O
be	be	VERB	VB	O
potentiated	potentiate	VERB	VBN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
this	this	DET	DT	O
response	response	NOUN	NN	O
was	be	VERB	VBD	O
correlated	correlate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
elevated	elevated	ADJ	JJ	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
striatal	striatal	ADJ	JJ	O
[	[	PUNCT	-LRB-	O
3H	3h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
spiperone	spiperone	VERB	VBD	B-Chemical
binding	bind	VERB	VBG	O
sites	site	NOUN	NNS	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
the	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
striatal	striatal	ADJ	JJ	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
[	[	PUNCT	-LRB-	O
3H	3h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
nicotine	nicotine	NOUN	NN	B-Chemical
binding	bind	VERB	VBG	O
sites	site	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
striatal	striatal	ADJ	JJ	O
DA	DA	PROPN	NNP	B-Chemical
level	level	NOUN	NN	O
were	be	VERB	VBD	O
normal	normal	ADJ	JJ	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
chronic	chronic	ADJ	JJ	O
nicotine	nicotine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
develop	develop	VERB	VBP	O
locomotor	locomotor	NOUN	NN	B-Disease
hyperactivity	hyperactivity	NOUN	NN	I-Disease
in	in	ADP	IN	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
nicotine	nicotine	NOUN	NN	B-Chemical
initially	initially	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
increases	increase	NOUN	NNS	O
of	of	ADP	IN	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
density	density	NOUN	NN	O
of	of	ADP	IN	O
nicotinic	nicotinic	ADJ	JJ	O
receptors	receptor	NOUN	NNS	O
and	and	CCONJ	CC	O
DA	DA	PROPN	NNP	B-Chemical
concentration	concentration	NOUN	NN	O
,	,	PUNCT	,	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
inducing	induce	VERB	VBG	O
DA	DA	PROPN	NNP	B-Chemical
receptor	receptor	NOUN	NN	O
supersensitivity	supersensitivity	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
.	.	PUNCT	.	O

Amelioration	amelioration	NOUN	NN	O
of	of	ADP	IN	O
bendrofluazide	bendrofluazide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
by	by	ADP	IN	O
timolol	timolol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
beta	beta	NOUN	NN	O
adrenergic	adrenergic	NOUN	NN	O
blocking	block	VERB	VBG	O
drug	drug	NOUN	NN	O
,	,	PUNCT	,	O
timolol	timolol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
tended	tend	VERB	VBD	O
to	to	PART	TO	O
correct	correct	VERB	VB	O
the	the	DET	DT	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
of	of	ADP	IN	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
bendrofluazide	bendrofluazide	ADP	IN	B-Chemical
treatment	treatment	NOUN	NN	O
in	in	ADP	IN	O
6	6	NUM	CD	O
healthy	healthy	ADJ	JJ	O
male	male	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
and	and	CCONJ	CC	O
although	although	ADP	IN	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
was	be	VERB	VBD	O
small	small	ADJ	JJ	O
it	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
significant	significant	ADJ	JJ	O
.	.	PUNCT	.	O

Timolol	Timolol	PROPN	NNP	B-Chemical
also	also	ADV	RB	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
plasma	plasma	NOUN	NN	O
aldosterone	aldosterone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
urine	urine	NOUN	NN	O
potassium	potassium	NOUN	NN	B-Chemical
excretion	excretion	NOUN	NN	O
following	follow	VERB	VBG	O
bendrofluazide	bendrofluazide	ADV	RB	B-Chemical
and	and	CCONJ	CC	O
increased	increase	VERB	VBD	O
the	the	DET	DT	O
urine	urine	NOUN	NN	O
sodium	sodium	NOUN	NN	B-Chemical
/	/	SYM	SYM	O
potassium	potassium	NOUN	NN	B-Chemical
ratio	ratio	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
shift	shift	NOUN	NN	O
of	of	ADP	IN	O
potassium	potassium	NOUN	NN	B-Chemical
from	from	ADP	IN	O
the	the	DET	DT	O
intracellular	intracellular	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
extracellular	extracellular	ADJ	JJ	O
space	space	NOUN	NN	O
.	.	PUNCT	.	O

St	st	INTJ	UH	B-Disease
.	.	PUNCT	.	I-Disease

Anthony	Anthony	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	PART	POS	I-Disease
fire	fire	NOUN	NN	I-Disease
,	,	PUNCT	,	O
then	then	ADV	RB	O
and	and	CCONJ	CC	O
now	now	ADV	RB	O
:	:	PUNCT	:	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
and	and	CCONJ	CC	O
historical	historical	ADJ	JJ	O
review	review	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
rare	rare	ADJ	JJ	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
morbid	morbid	NOUN	NN	O
vasospasm	vasospasm	NOUN	NN	B-Disease
,	,	PUNCT	,	O
together	together	ADV	RB	O
with	with	ADP	IN	O
striking	strike	VERB	VBG	O
angiographic	angiographic	ADJ	JJ	O
findings	finding	NOUN	NNS	O
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
described	describe	VERB	VBN	O
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
ingestion	ingestion	NOUN	NN	O
of	of	ADP	IN	O
methysergide	methysergide	NOUN	NN	B-Chemical
by	by	ADP	IN	O
a	a	DET	DT	O
48	48	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
brief	brief	ADJ	JJ	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
on	on	ADP	IN	O
similar	similar	ADJ	JJ	O
cases	case	NOUN	NNS	O
is	be	VERB	VBZ	O
presented	present	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
discussion	discussion	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
ergot	ergot	NOUN	NN	B-Chemical
includes	include	VERB	VBZ	O
its	-PRON-	DET	PRP$	O
original	original	ADJ	JJ	O
discovery	discovery	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
epidemics	epidemic	NOUN	NNS	O
of	of	ADP	IN	O
gangrene	gangrene	NOUN	NN	B-Disease
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
has	have	VERB	VBZ	O
caused	cause	VERB	VBN	O
through	through	ADP	IN	O
the	the	DET	DT	O
ages	age	NOUN	NNS	O
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
past	past	ADJ	JJ	O
and	and	CCONJ	CC	O
present	present	ADJ	JJ	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
migraine	migraine	ADJ	JJ	B-Disease
headache	headache	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Despite	despite	ADP	IN	O
the	the	DET	DT	O
advent	advent	NOUN	NN	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
blockers	blocker	NOUN	NNS	O
and	and	CCONJ	CC	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenergic	adrenergic	NOUN	NN	O
antagonists	antagonist	NOUN	NNS	O
,	,	PUNCT	,	O
ergot	ergot	VERB	VBP	B-Chemical
preparations	preparation	NOUN	NNS	O
continue	continue	VERB	VBP	O
to	to	PART	TO	O
play	play	VERB	VB	O
a	a	DET	DT	O
major	major	ADJ	JJ	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
migraine	migraine	ADJ	JJ	B-Disease
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
so	so	ADP	IN	O
that	that	ADP	IN	O
the	the	DET	DT	O
danger	danger	NOUN	NN	O
of	of	ADP	IN	O
St	St	PROPN	NNP	B-Disease
.	.	PUNCT	.	I-Disease

Anthony	Anthony	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	PART	POS	I-Disease
fire	fire	NOUN	NN	I-Disease
persists	persist	VERB	VBZ	O
.	.	PUNCT	.	O

Cardiac	cardiac	ADJ	JJ	O
transplantation	transplantation	NOUN	NN	O
:	:	PUNCT	:	O
improved	improve	VERB	VBN	O
quality	quality	NOUN	NN	O
of	of	ADP	IN	O
survival	survival	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
modified	modify	VERB	VBN	O
immunosuppressive	immunosuppressive	ADJ	JJ	O
protocol	protocol	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
on	on	ADP	IN	O
two	two	NUM	CD	O
different	different	ADJ	JJ	O
immunosuppressive	immunosuppressive	ADJ	JJ	O
protocols	protocol	NOUN	NNS	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
retrospectively	retrospectively	ADV	RB	O
in	in	ADP	IN	O
two	two	NUM	CD	O
subsequent	subsequent	ADJ	JJ	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
heart	heart	NOUN	NN	O
transplant	transplant	NOUN	NN	O
recipients	recipient	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
group	group	NOUN	NN	O
I	-PRON-	PRON	PRP	O
,	,	PUNCT	,	O
cyclosporine	cyclosporine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
given	give	VERB	VBN	O
before	before	ADP	IN	O
the	the	DET	DT	O
procedure	procedure	NOUN	NN	O
at	at	ADP	IN	O
a	a	DET	DT	O
loading	loading	NOUN	NN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
17	17	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
and	and	CCONJ	CC	O
then	then	ADV	RB	O
continued	continue	VERB	VBD	O
after	after	ADP	IN	O
the	the	DET	DT	O
procedure	procedure	NOUN	NN	O
to	to	PART	TO	O
keep	keep	VERB	VB	O
a	a	DET	DT	O
whole	whole	ADJ	JJ	O
blood	blood	NOUN	NN	O
level	level	NOUN	NN	O
about	about	ADP	IN	O
1000	1000	NUM	CD	O
ng	ng	ADP	IN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
group	group	NOUN	NN	O
II	II	PROPN	NNP	O
,	,	PUNCT	,	O
cyclosporine	cyclosporine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
started	start	VERB	VBN	O
only	only	ADV	RB	O
after	after	ADP	IN	O
the	the	DET	DT	O
procedure	procedure	NOUN	NN	O
at	at	ADP	IN	O
a	a	DET	DT	O
lower	low	ADJ	JJR	O
dosage	dosage	NOUN	NN	O
and	and	CCONJ	CC	O
was	be	VERB	VBD	O
complemented	complement	VERB	VBN	O
by	by	ADP	IN	O
azathioprine	azathioprine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
postoperative	postoperative	ADJ	JJ	O
week	week	NOUN	NN	O
.	.	PUNCT	.	O

Group	Group	PROPN	NNP	O
II	II	PROPN	NNP	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
better	well	ADJ	JJR	O
perioperative	perioperative	ADJ	JJ	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
as	as	ADP	IN	O
determined	determine	VERB	VBN	O
by	by	ADP	IN	O
serum	serum	ADJ	JJ	O
blood	blood	NOUN	NN	O
urea	urea	ADJ	JJ	B-Chemical
nitrogen	nitrogen	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

Group	Group	PROPN	NNP	O
II	II	PROPN	NNP	O
also	also	ADV	RB	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
cyclosporine	cyclosporine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Despite	despite	ADP	IN	O
this	this	DET	DT	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
late	late	ADJ	JJ	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
,	,	PUNCT	,	O
group	group	NOUN	NN	O
II	II	PROPN	NNP	O
still	still	ADV	RB	O
shows	show	VERB	VBZ	O
a	a	DET	DT	O
slow	slow	ADJ	JJ	O
rise	rise	NOUN	NN	O
in	in	ADP	IN	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
think	think	VERB	VBP	O
that	that	ADP	IN	O
even	even	ADV	RB	O
these	these	DET	DT	O
lower	low	ADJ	JJR	O
dosages	dosage	NOUN	NNS	O
of	of	ADP	IN	O
cyclosporine	cyclosporine	NOUN	NN	B-Chemical
can	can	VERB	MD	O
cause	cause	VERB	VB	O
chronic	chronic	ADJ	JJ	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
that	that	ADP	IN	O
further	further	ADJ	JJ	O
modification	modification	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
immunosuppressive	immunosuppressive	ADJ	JJ	O
regimen	regimen	NOUN	NN	O
is	be	VERB	VBZ	O
required	require	VERB	VBN	O
to	to	PART	TO	O
completely	completely	ADV	RB	O
abolish	abolish	VERB	VB	O
this	this	DET	DT	O
toxic	toxic	ADJ	JJ	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Ethopropazine	Ethopropazine	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
benztropine	benztropine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
parkinsonism	parkinsonism	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
a	a	DET	DT	O
12	12	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
controlled	control	VERB	VBN	O
study	study	NOUN	NN	O
ethopropazine	ethopropazine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
compared	compare	VERB	VBN	O
to	to	PART	TO	O
benztropine	benztropine	VERB	VB	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
parkinsonism	parkinsonism	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
fluphenazine	fluphenazine	ADJ	JJ	B-Chemical
enanthate	enanthate	NOUN	NN	I-Chemical
in	in	ADP	IN	O
60	60	NUM	CD	O
schizophrenic	schizophrenic	ADJ	JJ	B-Disease
outpatients	outpatient	NOUN	NNS	O
.	.	PUNCT	.	O

Ethopropazine	Ethopropazine	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
benztropine	benztropine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
equally	equally	ADV	RB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
controlling	control	VERB	VBG	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
were	be	VERB	VBD	O
as	as	ADV	RB	O
efficacious	efficacious	ADJ	JJ	O
as	as	ADP	IN	O
procyclidine	procyclidine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
their	-PRON-	DET	PRP$	O
previous	previous	ADJ	JJ	O
antiparkinsonian	antiparkinsonian	ADJ	JJ	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
benztropine	benztropine	NOUN	NN	B-Chemical
treated	treat	VERB	VBD	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
tardive	tardive	ADJ	JJ	B-Disease
dyskinesia	dyskinesia	NOUN	NN	I-Disease
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
their	-PRON-	DET	PRP$	O
condition	condition	NOUN	NN	O
during	during	ADP	IN	O
procyclindine	procyclindine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
significantly	significantly	ADV	RB	O
more	more	ADJ	JJR	O
anxiety	anxiety	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
depression	depression	NOUN	NN	B-Disease
than	than	ADP	IN	O
ethopropazine	ethopropazine	NOUN	NN	B-Chemical
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
benztropine	benztropine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
not	not	ADV	RB	O
the	the	DET	DT	O
anticholinergic	anticholinergic	ADJ	JJ	O
drug	drug	NOUN	NN	O
of	of	ADP	IN	O
choice	choice	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
because	because	ADP	IN	O
of	of	ADP	IN	O
its	-PRON-	DET	PRP$	O
more	more	ADV	RBR	O
toxic	toxic	ADJ	JJ	O
central	central	ADJ	JJ	O
and	and	CCONJ	CC	O
peripheral	peripheral	ADJ	JJ	O
atropinic	atropinic	ADJ	JJ	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Quinidine	quinidine	NOUN	NN	B-Chemical
phenylethylbarbiturate	phenylethylbarbiturate	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
fulminant	fulminant	ADJ	JJ	O
hepatitis	hepatitis	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
pregnant	pregnant	ADJ	JJ	O
woman	woman	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
the	the	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
19	19	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
Laotian	laotian	ADJ	JJ	O
patient	patient	NOUN	NN	O
affected	affect	VERB	VBN	O
by	by	ADP	IN	O
fulminant	fulminant	ADJ	JJ	O
hepatitis	hepatitis	NOUN	NN	B-Disease
during	during	ADP	IN	O
the	the	DET	DT	O
third	third	ADJ	JJ	O
trimester	trimester	NOUN	NN	O
of	of	ADP	IN	O
her	-PRON-	DET	PRP$	O
pregnancy	pregnancy	NOUN	NN	O
after	after	ADP	IN	O
a	a	DET	DT	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
month	month	NOUN	NN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
quinidine	quinidine	NOUN	NN	B-Chemical
phenylethylbarbiturate	phenylethylbarbiturate	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

After	after	ADP	IN	O
delivery	delivery	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
underwent	underwent	NOUN	NN	O
orthotopic	orthotopic	ADJ	JJ	O
liver	liver	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
in	in	ADP	IN	O
good	good	ADJ	JJ	O
condition	condition	NOUN	NN	O
16	16	NUM	CD	O
months	month	NOUN	NNS	O
after	after	ADP	IN	O
liver	liver	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

Quinidine	quinidine	VERB	VB	B-Chemical
itself	-PRON-	PRON	PRP	O
or	or	CCONJ	CC	O
phenylethylbarbiturate	phenylethylbarbiturate	NOUN	NN	B-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
fulminant	fulminant	ADJ	JJ	O
hepatitis	hepatitis	NOUN	NN	B-Disease
in	in	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

Mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
comparison	comparison	NOUN	NN	O
with	with	ADP	IN	O
exercise	exercise	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
ischemia	ischemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
eliciting	elicit	VERB	VBG	O
myocardial	myocardial	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
was	be	VERB	VBD	O
examined	examine	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Objective	objective	ADJ	JJ	O
signs	sign	NOUN	NNS	O
of	of	ADP	IN	O
ischemia	ischemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
factors	factor	NOUN	NNS	O
increasing	increase	VERB	VBG	O
myocardial	myocardial	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
consumption	consumption	NOUN	NN	O
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
during	during	ADP	IN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
infusion	infusion	NOUN	NN	O
and	and	CCONJ	CC	O
supine	supine	NOUN	NN	O
bicycle	bicycle	NOUN	NN	O
exercise	exercise	NOUN	NN	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
exercise	exercise	NOUN	NN	O
produced	produce	VERB	VBD	O
myocardial	myocardial	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
as	as	ADP	IN	O
evidenced	evidence	VERB	VBN	O
by	by	ADP	IN	O
ST	ST	PROPN	NNP	O
segment	segment	NOUN	NN	O
depression	depression	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
angina	angina	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
different	different	ADJ	JJ	O
from	from	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
exercise	exercise	NOUN	NN	O
.	.	PUNCT	.	O

Exercise	exercise	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
myocardial	myocardial	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
was	be	VERB	VBD	O
marked	mark	VERB	VBN	O
predominantly	predominantly	ADV	RB	O
by	by	ADP	IN	O
increased	increase	VERB	VBN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
and	and	CCONJ	CC	O
rate	rate	NOUN	NN	O
-	-	PUNCT	HYPH	O
pressure	pressure	NOUN	NN	O
product	product	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
minor	minor	ADJ	JJ	O
contribution	contribution	NOUN	NN	O
of	of	ADP	IN	O
end	end	NOUN	NN	O
-	-	PUNCT	HYPH	O
diastolic	diastolic	ADJ	JJ	O
volume	volume	NOUN	NN	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
ischemia	ischemia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
characterized	characterize	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
marked	marked	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
contractility	contractility	NOUN	NN	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
less	less	ADV	RBR	O
pronounced	pronounced	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
and	and	CCONJ	CC	O
rate	rate	NOUN	NN	O
-	-	PUNCT	HYPH	O
pressure	pressure	NOUN	NN	O
product	product	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
ischemia	ischemia	NOUN	NN	B-Disease
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
as	as	ADP	IN	O
may	may	VERB	MD	O
occur	occur	VERB	VB	O
during	during	ADP	IN	O
states	state	NOUN	NNS	O
of	of	ADP	IN	O
emotional	emotional	ADJ	JJ	O
distress	distress	NOUN	NN	O
,	,	PUNCT	,	O
has	have	VERB	VBZ	O
a	a	DET	DT	O
mechanism	mechanism	NOUN	NN	O
distinct	distinct	ADJ	JJ	O
from	from	ADP	IN	O
that	that	DET	DT	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
physical	physical	ADJ	JJ	O
exertion	exertion	NOUN	NN	O
.	.	PUNCT	.	O

Recent	recent	ADJ	JJ	O
preclinical	preclinical	ADJ	JJ	O
and	and	CCONJ	CC	O
clinical	clinical	ADJ	JJ	O
studies	study	NOUN	NNS	O
with	with	ADP	IN	O
the	the	DET	DT	O
thymidylate	thymidylate	ADJ	JJ	O
synthase	synthase	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
N10	n10	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
propargyl	propargyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
5	5	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
8	8	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dideazafolic	dideazafolic	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
,	,	PUNCT	,	O
N10	n10	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
propargyl	propargyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
5	5	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
8	8	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dideazafolic	dideazafolic	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
tight	tight	ADV	RB	O
-	-	PUNCT	HYPH	O
binding	bind	VERB	VBG	O
inhibitor	inhibitor	NOUN	NN	O
of	of	ADP	IN	O
thymidylate	thymidylate	NOUN	NN	O
synthase	synthase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
TS	TS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
whose	whose	DET	WP$	O
cytotoxicity	cytotoxicity	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
mediated	mediate	VERB	VBN	O
solely	solely	ADV	RB	O
through	through	ADP	IN	O
the	the	DET	DT	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
enzyme	enzyme	NOUN	NN	O
.	.	PUNCT	.	O

Recent	recent	ADJ	JJ	O
preclinical	preclinical	ADJ	JJ	O
studies	study	NOUN	NNS	O
have	have	VERB	VBP	O
focused	focus	VERB	VBN	O
on	on	ADP	IN	O
the	the	DET	DT	O
intracellular	intracellular	ADJ	JJ	O
formation	formation	NOUN	NN	O
of	of	ADP	IN	O
CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
polyglutamates	polyglutamate	NOUN	NNS	O
.	.	PUNCT	.	O

Following	follow	VERB	VBG	O
a	a	DET	DT	O
12	12	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
exposure	exposure	NOUN	NN	O
of	of	ADP	IN	O
L1210	L1210	PROPN	NNP	O
cells	cell	NOUN	NNS	O
to	to	ADP	IN	O
50	50	NUM	CD	O
microM	microM	PROPN	NNP	O
[	[	PUNCT	-LRB-	O
3H	3h	NOUN	NN	O
]	]	PUNCT	-RRB-	O
CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
,	,	PUNCT	,	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
extractable	extractable	ADJ	JJ	O
radioactivity	radioactivity	NOUN	NN	O
could	could	VERB	MD	O
be	be	VERB	VB	O
accounted	account	VERB	VBN	O
for	for	ADP	IN	O
as	as	ADP	IN	O
CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
tetra	tetra	NOUN	NN	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
pentaglutamate	pentaglutamate	VERB	VB	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
determined	determine	VERB	VBN	O
by	by	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
pressure	pressure	NOUN	NN	O
liquid	liquid	NOUN	NN	O
chromatography	chromatography	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HPLC	HPLC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
analyses	analyse	VERB	VBZ	O
.	.	PUNCT	.	O

As	as	ADP	IN	O
inhibitors	inhibitor	NOUN	NNS	O
of	of	ADP	IN	O
isolated	isolate	VERB	VBN	O
L1210	L1210	PROPN	NNP	O
TS	TS	PROPN	NNP	O
,	,	PUNCT	,	O
CB	CB	PROPN	NNP	O
3717	3717	NUM	CD	O
di	di	NOUN	NN	O
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
tri	tri	NOUN	NN	O
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
tetra	tetra	NOUN	NN	O
-	-	PUNCT	:	O
and	and	CCONJ	CC	O
pentaglutamate	pentaglutamate	NOUN	NN	O
are	be	VERB	VBP	O
26	26	NUM	CD	O
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
87	87	NUM	CD	O
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
119	119	NUM	CD	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
114	114	NUM	CD	O
-	-	PUNCT	HYPH	O
fold	fold	VERB	VB	O
more	more	ADV	RBR	O
potent	potent	ADJ	JJ	O
than	than	ADP	IN	O
CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
their	-PRON-	DET	PRP$	O
formation	formation	NOUN	NN	O
may	may	VERB	MD	O
,	,	PUNCT	,	O
therefore	therefore	ADV	RB	O
,	,	PUNCT	,	O
be	be	VERB	VB	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
determinant	determinant	NOUN	NN	O
of	of	ADP	IN	O
CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
cytotoxicity	cytotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
early	early	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
studies	study	NOUN	NNS	O
with	with	ADP	IN	O
CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
,	,	PUNCT	,	O
activity	activity	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
,	,	PUNCT	,	O
ovarian	ovarian	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
,	,	PUNCT	,	O
hepatoma	hepatoma	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
mesothelioma	mesothelioma	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Toxicities	toxicity	NOUN	NNS	B-Disease
included	include	VERB	VBD	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
malaise	malaise	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
limiting	limit	VERB	VBG	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
latter	latter	ADJ	JJ	O
effect	effect	NOUN	NN	O
is	be	VERB	VBZ	O
thought	think	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
drug	drug	NOUN	NN	O
precipitation	precipitation	NOUN	NN	O
within	within	ADP	IN	O
the	the	DET	DT	O
renal	renal	ADJ	JJ	O
tubule	tubule	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
result	result	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
poor	poor	ADJ	JJ	O
solubility	solubility	NOUN	NN	O
of	of	ADP	IN	O
CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
under	under	ADP	IN	O
acidic	acidic	ADJ	JJ	O
conditions	condition	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
an	an	DET	DT	O
attempt	attempt	NOUN	NN	O
to	to	PART	TO	O
overcome	overcome	VERB	VB	O
this	this	DET	DT	O
problem	problem	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
administered	administer	VERB	VBD	O
with	with	ADP	IN	O
alkaline	alkaline	ADJ	JJ	O
diuresis	diuresis	NOUN	NN	O
is	be	VERB	VBZ	O
under	under	ADP	IN	O
way	way	NOUN	NN	O
.	.	PUNCT	.	O

Preliminary	preliminary	ADJ	JJ	O
results	result	NOUN	NNS	O
at	at	ADP	IN	O
400	400	NUM	CD	O
and	and	CCONJ	CC	O
500	500	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
a	a	DET	DT	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
may	may	VERB	MD	O
have	have	VERB	VB	O
been	be	VERB	VBN	O
achieved	achieve	VERB	VBN	O
with	with	ADP	IN	O
only	only	ADV	RB	O
1	1	NUM	CD	O
instance	instance	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
in	in	ADP	IN	O
10	10	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
malaise	malaise	NOUN	NN	B-Disease
are	be	VERB	VBP	O
again	again	ADV	RB	O
the	the	DET	DT	O
most	most	ADV	RBS	O
frequent	frequent	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

Evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
antitumor	antitumor	ADJ	JJ	O
activity	activity	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Pharmacokinetic	pharmacokinetic	ADJ	JJ	O
investigations	investigation	NOUN	NNS	O
have	have	VERB	VBP	O
shown	show	VERB	VBN	O
that	that	DET	DT	O
alkaline	alkaline	ADJ	JJ	O
diuresis	diuresis	NOUN	NN	O
does	do	VERB	VBZ	O
not	not	ADV	RB	O
alter	alter	VERB	VB	O
CB	CB	PROPN	NNP	B-Chemical
3717	3717	NUM	CD	I-Chemical
plasma	plasma	NOUN	NN	O
levels	level	NOUN	NNS	O
or	or	CCONJ	CC	O
urinary	urinary	ADJ	JJ	O
excretion	excretion	NOUN	NN	O
and	and	CCONJ	CC	O
that	that	ADP	IN	O
satisfactory	satisfactory	ADJ	JJ	O
urinary	urinary	ADJ	JJ	O
alkalinization	alkalinization	NOUN	NN	O
can	can	VERB	MD	O
be	be	VERB	VB	O
readily	readily	ADV	RB	O
achieved	achieve	VERB	VBN	O
.	.	PUNCT	.	O

Type	type	NOUN	NN	B-Disease
B	b	NOUN	NN	I-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
after	after	ADP	IN	O
needle	needle	NOUN	NN	O
-	-	PUNCT	HYPH	O
stick	stick	NOUN	NN	O
exposure	exposure	NOUN	NN	O
:	:	PUNCT	:	O
prevention	prevention	NOUN	NN	O
with	with	ADP	IN	O
hepatitis	hepatitis	PROPN	NNP	B-Disease
B	B	PROPN	NNP	I-Disease
immune	immune	ADJ	JJ	O
globulin	globulin	NOUN	NN	O
.	.	PUNCT	.	O

Final	final	ADJ	JJ	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
Veterans	Veterans	PROPN	NNPS	O
Administration	Administration	PROPN	NNP	O
Cooperative	Cooperative	PROPN	NNP	O
Study	Study	PROPN	NNP	O
.	.	PUNCT	.	O

Hepatitis	Hepatitis	PROPN	NNP	B-Disease
B	B	PROPN	NNP	I-Disease
immune	immune	ADJ	JJ	O
globulin	globulin	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HBIG	HBIG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
immune	immune	ADJ	JJ	O
serum	serum	NOUN	NN	O
globulin	globulin	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ISG	ISG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
trial	trial	NOUN	NN	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
their	-PRON-	DET	PRP$	O
relative	relative	ADJ	JJ	O
efficacies	efficacy	NOUN	NNS	O
in	in	ADP	IN	O
preventing	prevent	VERB	VBG	O
type	type	NOUN	NN	B-Disease
B	b	NOUN	NN	I-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
after	after	ADP	IN	O
needle	needle	NOUN	NN	O
-	-	PUNCT	HYPH	O
stick	stick	NOUN	NN	O
exposure	exposure	NOUN	NN	O
to	to	PART	TO	O
hepatitis	hepatitis	VERB	VB	B-Chemical
B	B	PROPN	NNP	I-Chemical
surface	surface	NOUN	NN	I-Chemical
antigen	antigen	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
HBsAG	hbsag	X	ADD	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
donors	donor	NOUN	NNS	O
.	.	PUNCT	.	O

Clinical	Clinical	PROPN	NNP	O
hepatitis	hepatitis	NOUN	NN	B-Disease
developed	develop	VERB	VBD	O
in	in	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
HBIG	HBIG	PROPN	NNP	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
ISG	ISG	PROPN	NNP	O
recipients	recipient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
016	016	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
seroconversion	seroconversion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
HBs	HBs	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
20	20	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
them	-PRON-	PRON	PRP	O
respectively	respectively	ADV	RB	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Mild	mild	ADJ	JJ	O
and	and	CCONJ	CC	O
transient	transient	ADJ	JJ	O
side	side	NOUN	NN	O
-	-	PUNCT	HYPH	O
effects	effect	NOUN	NNS	O
were	be	VERB	VBD	O
noted	note	VERB	VBN	O
in	in	ADP	IN	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
ISG	ISG	PROPN	NNP	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
HBIG	HBIG	PROPN	NNP	O
recipients	recipient	NOUN	NNS	O
.	.	PUNCT	.	O

Available	available	ADJ	JJ	O
donor	donor	NOUN	NN	O
sera	sera	NOUN	NN	O
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
for	for	ADP	IN	O
DNA	dna	NOUN	NN	O
polymerase	polymerase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
DNAP	DNAP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
e	e	NOUN	NN	O
antigen	antigen	NOUN	NN	O
and	and	CCONJ	CC	O
antibody	antibody	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HBeAg	HBeAg	PROPN	NNP	B-Chemical
;	;	PUNCT	:	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
HBE	HBE	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
DNAP	DNAP	NOUN	NNS	O
and	and	CCONJ	CC	O
HBeAg	HBeAg	PROPN	NNP	B-Chemical
showed	show	VERB	VBD	O
a	a	DET	DT	O
highly	highly	ADV	RB	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
correlation	correlation	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
infectivity	infectivity	NOUN	NN	O
of	of	ADP	IN	O
HBsAg	HBsAg	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
donors	donor	NOUN	NNS	O
.	.	PUNCT	.	O

Hepatitis	Hepatitis	PROPN	NNP	B-Disease
B	B	PROPN	NNP	I-Disease
immune	immune	ADJ	JJ	O
globulin	globulin	NOUN	NN	O
remained	remain	VERB	VBD	O
significantly	significantly	ADV	RB	O
superior	superior	ADJ	JJ	O
to	to	ADP	IN	O
ISG	ISG	PROPN	NNP	O
in	in	ADP	IN	O
preventing	prevent	VERB	VBG	O
type	type	NOUN	NN	B-Disease
B	b	NOUN	NN	I-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
even	even	ADV	RB	O
when	when	ADV	WRB	O
the	the	DET	DT	O
analysis	analysis	NOUN	NN	O
was	be	VERB	VBD	O
confined	confine	VERB	VBN	O
to	to	ADP	IN	O
these	these	DET	DT	O
two	two	NUM	CD	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
risk	risk	NOUN	NN	O
subgroups	subgroup	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
ISG	ISG	PROPN	NNP	O
in	in	ADP	IN	O
preventing	prevent	VERB	VBG	O
type	type	NOUN	NN	B-Disease
B	b	NOUN	NN	I-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
cannot	cannot	NOUN	NN	O
be	be	VERB	VB	O
ascertained	ascertain	VERB	VBN	O
because	because	ADP	IN	O
a	a	DET	DT	O
true	true	ADJ	JJ	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
included	include	VERB	VBN	O
.	.	PUNCT	.	O

Production	production	NOUN	NN	O
of	of	ADP	IN	O
autochthonous	autochthonous	ADJ	JJ	O
prostate	prostate	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
in	in	ADP	IN	O
Lobund	Lobund	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
by	by	ADP	IN	O
treatments	treatment	NOUN	NNS	O
with	with	ADP	IN	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
nitroso	nitroso	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
N	n	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
methylurea	methylurea	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
testosterone	testosterone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

More	More	ADJ	JJR	O
than	than	ADP	IN	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
Lobund	Lobund	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Wistar	Wistar	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
L	L	PROPN	NNP	O
-	-	PUNCT	HYPH	O
W	W	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
strain	strain	NOUN	NN	O
rats	rat	NOUN	NNS	O
developed	develop	VERB	VBD	O
large	large	ADJ	JJ	O
,	,	PUNCT	,	O
palpable	palpable	ADJ	JJ	O
prostate	prostate	NOUN	NN	B-Disease
adenocarcinomas	adenocarcinoma	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
PAs	pa	NOUN	NNS	B-Disease
)	)	PUNCT	-RRB-	O
following	follow	VERB	VBG	O
treatments	treatment	NOUN	NNS	O
with	with	ADP	IN	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
nitroso	nitroso	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
N	n	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
methylurea	methylurea	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
CAS	CAS	PROPN	NNP	O
:	:	PUNCT	:	O
684	684	NUM	CD	O
-	-	SYM	SYM	O
93	93	NUM	CD	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
testosterone	testosterone	NOUN	NN	B-Chemical
propionate	propionate	NOUN	NN	I-Chemical
[	[	PUNCT	-LRB-	O
(	(	PUNCT	-LRB-	O
TP	TP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
CAS	CAS	PROPN	NNP	O
:	:	PUNCT	:	O
57	57	NUM	CD	O
-	-	PUNCT	HYPH	O
85	85	NUM	CD	O
-	-	SYM	SYM	O
2	2	NUM	CD	O
]	]	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
most	most	ADJ	JJS	O
of	of	ADP	IN	O
the	the	DET	DT	O
tumor	tumor	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
bearing	bear	VERB	VBG	O
rats	rat	NOUN	NNS	O
manifested	manifest	VERB	VBD	O
metastatic	metastatic	ADJ	JJ	O
lesions	lesion	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incubation	incubation	NOUN	NN	O
periods	period	NOUN	NNS	O
averaged	average	VERB	VBD	O
10	10	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Within	within	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
timeframe	timeframe	NOUN	NN	O
,	,	PUNCT	,	O
no	no	DET	DT	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
W	W	PROPN	NNP	O
rat	rat	NOUN	NN	O
developed	develop	VERB	VBD	O
a	a	DET	DT	O
similar	similar	ADJ	JJ	O
palpable	palpable	ADJ	JJ	O
PA	pa	NOUN	NN	B-Disease
when	when	ADV	WRB	O
treated	treat	VERB	VBN	O
only	only	ADV	RB	O
with	with	ADP	IN	O
TP	TP	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
L	l	NOUN	NN	O
-	-	PUNCT	HYPH	O
W	W	PROPN	NNP	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
TP	TP	PROPN	NNP	B-Chemical
acted	act	VERB	VBD	O
as	as	ADP	IN	O
a	a	DET	DT	O
tumor	tumor	NOUN	NN	B-Disease
enhancement	enhancement	NOUN	NN	O
agent	agent	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
primary	primary	ADJ	JJ	O
emphasis	emphasis	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
prostate	prostate	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Relative	relative	ADJ	JJ	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
netilmicin	netilmicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
tobramycin	tobramycin	ADJ	JJR	B-Chemical
in	in	ADP	IN	O
oncology	oncology	NOUN	NN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
prospectively	prospectively	ADV	RB	O
compared	compare	VERB	VBD	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
of	of	ADP	IN	O
netilmicin	netilmicin	NOUN	NN	B-Chemical
sulfate	sulfate	NOUN	NN	I-Chemical
or	or	CCONJ	CC	O
tobramycin	tobramycin	ADJ	JJ	B-Chemical
sulfate	sulfate	NOUN	NN	I-Chemical
in	in	ADP	IN	O
conjunction	conjunction	NOUN	NN	O
with	with	ADP	IN	O
piperacillin	piperacillin	ADJ	JJ	B-Chemical
sodium	sodium	NOUN	NN	I-Chemical
in	in	ADP	IN	O
118	118	NUM	CD	O
immunocompromised	immunocompromise	VERB	VBN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
presumed	presume	VERB	VBN	O
severe	severe	ADJ	JJ	O
infections	infection	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
two	two	NUM	CD	O
treatment	treatment	NOUN	NN	O
regimens	regimen	NOUN	NNS	O
were	be	VERB	VBD	O
equally	equally	ADV	RB	O
efficacious	efficacious	ADJ	JJ	O
.	.	PUNCT	.	O

Nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
a	a	DET	DT	O
similar	similar	ADJ	JJ	O
proportion	proportion	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
netilmicin	netilmicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
tobramycin	tobramycin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
17	17	NUM	CD	O
%	%	NOUN	NN	O
vs	vs	ADP	IN	O
11	11	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Ototoxicity	ototoxicity	NOUN	NN	B-Disease
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
four	four	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
42	42	NUM	CD	O
netilmicin	netilmicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
piperacillin	piperacillin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
in	in	ADP	IN	O
12	12	NUM	CD	O
(	(	PUNCT	-LRB-	O
22	22	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
54	54	NUM	CD	O
tobramycin	tobramycin	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
piperacillin	piperacillin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Of	of	ADP	IN	O
those	those	DET	DT	O
evaluated	evaluate	VERB	VBN	O
with	with	ADP	IN	O
posttherapy	posttherapy	NOUN	NN	O
audiograms	audiogram	NOUN	NNS	O
,	,	PUNCT	,	O
three	three	NUM	CD	O
of	of	ADP	IN	O
four	four	NUM	CD	O
netilmicin	netilmicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
piperacillin	piperacillin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
auditory	auditory	NOUN	NN	O
thresholds	threshold	NOUN	NNS	O
return	return	VERB	VB	O
to	to	ADP	IN	O
baseline	baseline	NOUN	NN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
one	one	NUM	CD	O
of	of	ADP	IN	O
nine	nine	NUM	CD	O
tobramycin	tobramycin	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
piperacillin	piperacillin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
or	or	CCONJ	CC	O
equal	equal	ADJ	JJ	O
to	to	ADP	IN	O
15	15	NUM	CD	O
-	-	PUNCT	HYPH	O
dB	db	NOUN	NN	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
auditory	auditory	NOUN	NN	O
threshold	threshold	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
proportion	proportion	NOUN	NN	O
of	of	ADP	IN	O
total	total	NOUN	NN	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
or	or	CCONJ	CC	O
equal	equal	ADJ	JJ	O
to	to	ADP	IN	O
15	15	NUM	CD	O
-	-	PUNCT	HYPH	O
dB	db	NOUN	NN	O
changes	change	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
increases	increase	NOUN	NNS	O
and	and	CCONJ	CC	O
decreases	decrease	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
in	in	ADP	IN	O
netilmicin	netilmicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
piperacillin	piperacillin	NOUN	NN	B-Chemical
-	-	PUNCT	:	O
vs	vs	ADP	IN	O
tobramycin	tobramycin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
piperacillin	piperacillin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
18	18	NUM	CD	O
of	of	ADP	IN	O
78	78	NUM	CD	O
vs	vs	ADP	IN	O
67	67	NUM	CD	O
of	of	ADP	IN	O
115	115	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
aminoglycoside	aminoglycoside	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
ototoxicity	ototoxicity	NOUN	NN	B-Disease
was	be	VERB	VBD	O
less	less	ADV	RBR	O
severe	severe	ADJ	JJ	O
and	and	CCONJ	CC	O
more	more	ADV	RBR	O
often	often	ADV	RB	O
reversible	reversible	ADJ	JJ	O
with	with	ADP	IN	O
netilmicin	netilmicin	NOUN	NN	B-Chemical
than	than	ADP	IN	O
with	with	ADP	IN	O
tobramycin	tobramycin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Urinary	urinary	NOUN	NN	O
enzymes	enzyme	NOUN	NNS	O
and	and	CCONJ	CC	O
protein	protein	NOUN	NN	O
patterns	pattern	NOUN	NNS	O
as	as	ADP	IN	O
indicators	indicator	NOUN	NNS	O
of	of	ADP	IN	O
injury	injury	NOUN	NN	B-Disease
to	to	ADP	IN	I-Disease
different	different	ADJ	JJ	I-Disease
regions	region	NOUN	NNS	I-Disease
of	of	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
kidney	kidney	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	B-Disease
experimental	experimental	ADJ	JJ	I-Disease
models	model	NOUN	NNS	I-Disease
of	of	ADP	IN	I-Disease
renal	renal	ADJ	JJ	I-Disease
damage	damage	NOUN	NN	I-Disease
to	to	ADP	IN	O
the	the	DET	DT	O
proximal	proximal	ADJ	JJ	O
tubular	tubular	ADJ	JJ	O
,	,	PUNCT	,	O
glomerular	glomerular	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
papillary	papillary	ADJ	JJ	O
regions	region	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
were	be	VERB	VBD	O
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
hexachloro	hexachloro	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
1	1	NUM	CD	I-Chemical
:	:	SYM	SYM	I-Chemical
3	3	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
butadiene	butadiene	NOUN	NNS	I-Chemical
(	(	PUNCT	-LRB-	O
HCBD	HCBD	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
puromycin	puromycin	VERB	VBN	B-Chemical
aminonucleoside	aminonucleoside	PART	RP	I-Chemical
(	(	PUNCT	-LRB-	O
PAN	PAN	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
2	2	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
bromoethylamine	bromoethylamine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
BEA	BEA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Several	several	ADJ	JJ	O
routine	routine	ADJ	JJ	O
indicators	indicator	NOUN	NNS	O
of	of	ADP	IN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
enzymes	enzyme	NOUN	NNS	O
alkaline	alkaline	NOUN	NN	O
phosphatase	phosphatase	NOUN	NN	O
and	and	CCONJ	CC	O
N	n	NOUN	NN	O
-	-	PUNCT	HYPH	O
acetyl	acetyl	NOUN	NN	O
-	-	PUNCT	HYPH	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
glucosaminidase	glucosaminidase	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
molecular	molecular	ADJ	JJ	O
weight	weight	NOUN	NN	O
of	of	ADP	IN	O
protein	protein	NOUN	NN	B-Disease
excretion	excretion	NOUN	NN	I-Disease
were	be	VERB	VBD	O
determined	determine	VERB	VBN	O
on	on	ADP	IN	O
urine	urine	NOUN	NN	O
samples	sample	NOUN	NNS	O
.	.	PUNCT	.	O

Tubular	tubular	ADJ	JJ	O
damage	damage	NOUN	NN	O
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
HCBD	HCBD	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
BEA	BEA	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
discriminated	discriminate	VERB	VBN	O
both	both	CCONJ	CC	O
quantitatively	quantitatively	ADV	RB	O
and	and	CCONJ	CC	O
qualitatively	qualitatively	ADV	RB	O
from	from	ADP	IN	O
glomerular	glomerular	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
PAN	PAN	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
latter	latter	ADJ	JJ	O
was	be	VERB	VBD	O
characterized	characterize	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
pronounced	pronounced	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
protein	protein	NOUN	NN	B-Disease
excretion	excretion	NOUN	NN	I-Disease
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
proteins	protein	NOUN	NNS	O
with	with	ADP	IN	O
molecular	molecular	ADJ	JJ	O
weight	weight	NOUN	NN	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
40	40	NUM	CD	O
,	,	PUNCT	,	O
000	000	NUM	CD	O
Da	da	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
protein	protein	NOUN	NN	B-Disease
excretion	excretion	NOUN	NN	I-Disease
in	in	ADP	IN	O
tubular	tubular	ADJ	JJ	O
damage	damage	NOUN	NN	O
was	be	VERB	VBD	O
raised	raise	VERB	VBN	O
only	only	ADV	RB	O
slightly	slightly	ADV	RB	O
and	and	CCONJ	CC	O
characterized	characterize	VERB	VBN	O
by	by	ADP	IN	O
excretion	excretion	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
proteins	protein	NOUN	NNS	I-Disease
of	of	ADP	IN	O
a	a	DET	DT	O
wide	wide	ADJ	JJ	O
range	range	NOUN	NN	O
of	of	ADP	IN	O
molecular	molecular	ADJ	JJ	O
weights	weight	NOUN	NNS	O
.	.	PUNCT	.	O

Proximal	proximal	ADJ	JJ	O
tubular	tubular	ADJ	JJ	O
damage	damage	NOUN	NN	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
HCBD	HCBD	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
papillary	papillary	ADJ	JJ	O
damage	damage	NOUN	NN	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
BEA	BEA	PROPN	NNP	B-Chemical
were	be	VERB	VBD	O
distinguished	distinguish	VERB	VBN	O
both	both	CCONJ	CC	O
by	by	ADP	IN	O
conventional	conventional	ADJ	JJ	O
urinalysis	urinalysis	NOUN	NN	O
(	(	PUNCT	-LRB-	O
volume	volume	NOUN	NN	O
and	and	CCONJ	CC	O
specific	specific	ADJ	JJ	O
gravity	gravity	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
by	by	ADP	IN	O
measurement	measurement	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
urinary	urinary	ADJ	JJ	O
enzymes	enzyme	NOUN	NNS	O
.	.	PUNCT	.	O

Alkaline	alkaline	ADJ	JJ	O
phosphatase	phosphatase	NOUN	NN	O
and	and	CCONJ	CC	O
glucose	glucose	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
markedly	markedly	ADV	RB	O
and	and	CCONJ	CC	O
transiently	transiently	ADV	RB	O
elevated	elevate	VERB	VBN	O
in	in	ADP	IN	O
proximal	proximal	ADJ	JJ	O
tubular	tubular	ADJ	JJ	O
damage	damage	NOUN	NN	O
and	and	CCONJ	CC	O
N	n	NOUN	NN	O
-	-	PUNCT	HYPH	O
acetyl	acetyl	NOUN	NN	O
-	-	PUNCT	HYPH	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
glucosaminidase	glucosaminidase	NOUN	NN	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
sustained	sustained	ADJ	JJ	O
elevation	elevation	NOUN	NN	O
in	in	ADP	IN	O
papillary	papillary	ADJ	JJ	O
damage	damage	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
concluded	conclude	VERB	VBN	O
that	that	ADP	IN	O
both	both	DET	DT	O
selective	selective	ADJ	JJ	O
urinary	urinary	NOUN	NN	O
enzymes	enzyme	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
molecular	molecular	ADJ	JJ	O
weight	weight	NOUN	NN	O
pattern	pattern	NOUN	NN	O
of	of	ADP	IN	O
urinary	urinary	ADJ	JJ	O
proteins	protein	NOUN	NNS	O
can	can	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
provide	provide	VERB	VB	O
diagnostic	diagnostic	ADJ	JJ	O
information	information	NOUN	NN	O
about	about	ADP	IN	O
the	the	DET	DT	O
possible	possible	ADJ	JJ	O
site	site	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
catch	catch	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
Reye	Reye	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
six	six	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
Reye	Reye	PROPN	NNP	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
from	from	ADP	IN	O
The	the	DET	DT	O
Children	Children	PROPN	NNPS	O
'	'	PART	POS	O
s	s	PROPN	NNP	O
Hospital	Hospital	PROPN	NNP	O
,	,	PUNCT	,	O
Camperdown	Camperdown	PROPN	NNP	O
,	,	PUNCT	,	O
Australia	Australia	PROPN	NNP	O
,	,	PUNCT	,	O
occurring	occur	VERB	VBG	O
between	between	ADP	IN	O
1973	1973	NUM	CD	O
and	and	CCONJ	CC	O
1982	1982	NUM	CD	O
were	be	VERB	VBD	O
reviewed	review	VERB	VBN	O
.	.	PUNCT	.	O

Of	of	ADP	IN	O
these	these	DET	DT	O
,	,	PUNCT	,	O
20	20	NUM	CD	O
cases	case	NOUN	NNS	O
met	meet	VERB	VBD	O
the	the	DET	DT	O
US	US	PROPN	NNP	O
Public	Public	PROPN	NNP	O
Health	Health	PROPN	NNP	O
Service	Service	PROPN	NNP	O
Centers	Centers	PROPN	NNPS	O
for	for	ADP	IN	O
Disease	Disease	PROPN	NNP	O
Control	Control	PROPN	NNP	O
criteria	criterion	NOUN	NNS	O
for	for	ADP	IN	O
the	the	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
Reye	Reye	PROPN	NNP	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Aspirin	Aspirin	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
salicylate	salicylate	ADJ	JJ	B-Chemical
ingestion	ingestion	NOUN	NN	O
had	have	VERB	VBD	O
occurred	occur	VERB	VBN	O
in	in	ADP	IN	O
only	only	ADV	RB	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
20	20	NUM	CD	O
cases	case	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
administered	administer	VERB	VBN	O
in	in	ADP	IN	O
only	only	ADV	RB	O
six	six	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
cases	case	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Pathologic	pathologic	NOUN	NN	O
confirmation	confirmation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
Reye	Reye	PROPN	NNP	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
was	be	VERB	VBD	O
accomplished	accomplish	VERB	VBN	O
in	in	ADP	IN	O
90	90	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
Reye	Reye	PROPN	NNP	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
in	in	ADP	IN	O
New	New	PROPN	NNP	O
South	South	PROPN	NNP	O
Wales	Wales	PROPN	NNP	O
,	,	PUNCT	,	O
Australia	Australia	PROPN	NNP	O
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
estimated	estimate	VERB	VBN	O
from	from	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
to	to	PART	TO	O
be	be	VERB	VB	O
approximately	approximately	ADV	RB	O
nine	nine	NUM	CD	O
cases	case	NOUN	NNS	O
per	per	ADP	IN	O
1	1	NUM	CD	O
million	million	NUM	CD	O
children	child	NOUN	NNS	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
recent	recent	ADJ	JJ	O
US	US	PROPN	NNP	O
data	datum	NOUN	NNS	O
of	of	ADP	IN	O
ten	ten	NUM	CD	O
to	to	PART	TO	O
20	20	NUM	CD	O
cases	case	NOUN	NNS	O
per	per	ADP	IN	O
1	1	NUM	CD	O
million	million	NUM	CD	O
children	child	NOUN	NNS	O
and	and	CCONJ	CC	O
three	three	NUM	CD	O
to	to	PART	TO	O
seven	seven	NUM	CD	O
cases	case	NOUN	NNS	O
per	per	ADP	IN	O
1	1	NUM	CD	O
million	million	NUM	CD	O
children	child	NOUN	NNS	O
in	in	ADP	IN	O
Great	Great	PROPN	NNP	O
Britain	Britain	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mortality	mortality	NOUN	NN	O
for	for	ADP	IN	O
these	these	DET	DT	O
Reye	Reye	PROPN	NNP	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
cases	case	NOUN	NNS	O
in	in	ADP	IN	O
Australia	Australia	PROPN	NNP	O
was	be	VERB	VBD	O
45	45	NUM	CD	O
%	%	NOUN	NN	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
32	32	NUM	CD	O
%	%	NOUN	NN	O
case	case	NOUN	NN	O
-	-	PUNCT	HYPH	O
fatality	fatality	NOUN	NN	O
rate	rate	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
United	United	PROPN	NNP	O
States	States	PROPN	NNP	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
Australia	Australia	PROPN	NNP	O
,	,	PUNCT	,	O
the	the	DET	DT	O
pediatric	pediatric	ADJ	JJ	O
usage	usage	NOUN	NN	O
of	of	ADP	IN	O
aspirin	aspirin	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
extremely	extremely	ADV	RB	O
low	low	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
past	past	ADJ	JJ	O
25	25	NUM	CD	O
years	year	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
total	total	ADJ	JJ	O
dosage	dosage	NOUN	NN	O
units	unit	NOUN	NNS	O
sold	sell	VERB	VBN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
acetaminophen	acetaminophen	ADV	RB	B-Chemical
)	)	PUNCT	-RRB-	O
dominating	dominate	VERB	VBG	O
the	the	DET	DT	O
pediatric	pediatric	ADJ	JJ	O
analgesic	analgesic	ADJ	JJ	O
and	and	CCONJ	CC	O
antipyretic	antipyretic	ADJ	JJ	O
market	market	NOUN	NN	O
.	.	PUNCT	.	O

Reye	reye	NOUN	NN	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
disappearing	disappear	VERB	VBG	O
from	from	ADP	IN	O
Australia	Australia	PROPN	NNP	O
despite	despite	ADP	IN	O
a	a	DET	DT	O
total	total	ADJ	JJ	O
lack	lack	NOUN	NN	O
of	of	ADP	IN	O
association	association	NOUN	NN	O
with	with	ADP	IN	O
salicylates	salicylate	NOUN	NNS	B-Chemical
or	or	CCONJ	CC	O
aspirin	aspirin	ADJ	JJ	B-Chemical
ingestion	ingestion	NOUN	NN	O
,	,	PUNCT	,	O
since	since	ADP	IN	O
there	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
cases	case	NOUN	NNS	O
found	find	VERB	VBN	O
at	at	ADP	IN	O
The	the	DET	DT	O
Children	Children	PROPN	NNP	O
'	'	PART	POS	O
s	s	CCONJ	CC	O
Hospital	Hospital	PROPN	NNP	O
in	in	ADP	IN	O
1983	1983	NUM	CD	O
,	,	PUNCT	,	O
1984	1984	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
1985	1985	NUM	CD	O
.	.	PUNCT	.	O

Postpartum	Postpartum	PROPN	NNP	O
psychosis	psychosis	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
bromocriptine	bromocriptine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Two	two	NUM	CD	O
multigravida	multigravida	NOUN	NN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
no	no	DET	DT	O
prior	prior	ADJ	JJ	O
psychiatric	psychiatric	ADJ	JJ	B-Disease
history	history	NOUN	NN	O
were	be	VERB	VBD	O
seen	see	VERB	VBN	O
with	with	ADP	IN	O
postpartum	postpartum	ADJ	JJ	O
psychosis	psychosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
having	have	VERB	VBG	O
received	receive	VERB	VBN	O
bromocriptine	bromocriptine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
inhibition	inhibition	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
lactation	lactation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Bromocriptine	Bromocriptine	PROPN	NNP	B-Chemical
given	give	VERB	VBN	O
in	in	ADP	IN	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
psychosis	psychosis	NOUN	NN	B-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
for	for	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

These	these	DET	DT	O
cases	case	NOUN	NNS	O
demonstrate	demonstrate	VERB	VBP	O
that	that	ADP	IN	O
bromocriptine	bromocriptine	NOUN	NN	B-Chemical
may	may	VERB	MD	O
cause	cause	VERB	VB	O
psychosis	psychosis	NOUN	NN	B-Disease
even	even	ADV	RB	O
when	when	ADV	WRB	O
given	give	VERB	VBN	O
in	in	ADP	IN	O
low	low	ADJ	JJ	O
doses	dose	NOUN	NNS	O
.	.	PUNCT	.	O

Hyperglycemic	Hyperglycemic	PROPN	NNP	B-Disease
acidotic	acidotic	ADJ	JJ	I-Disease
coma	coma	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
death	death	NOUN	NN	O
in	in	ADP	IN	O
Kearns	Kearns	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	I-Disease
Sayre	Sayre	PROPN	NNP	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
paper	paper	NOUN	NN	O
presents	present	VERB	VBZ	O
the	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
metabolic	metabolic	ADJ	JJ	O
findings	finding	NOUN	NNS	O
in	in	ADP	IN	O
two	two	NUM	CD	O
young	young	ADJ	JJ	O
boys	boy	NOUN	NNS	O
with	with	ADP	IN	O
long	long	ADV	RB	O
-	-	PUNCT	HYPH	O
standing	stand	VERB	VBG	O
Kearns	Kearns	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	I-Disease
Sayre	Sayre	PROPN	NNP	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Following	follow	VERB	VBG	O
short	short	ADJ	JJ	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
oral	oral	ADJ	JJ	O
prednisone	prednisone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
both	both	DET	DT	O
boys	boy	NOUN	NNS	O
developed	develop	VERB	VBD	O
lethargy	lethargy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
increasing	increase	VERB	VBG	O
somnolence	somnolence	NOUN	NN	B-Disease
,	,	PUNCT	,	O
polydipsia	polydipsia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
polyphagia	polyphagia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
polyuria	polyuria	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Both	both	DET	DT	O
presented	present	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
emergency	emergency	NOUN	NN	O
room	room	NOUN	NN	O
with	with	ADP	IN	O
profound	profound	ADJ	JJ	O
coma	coma	NOUN	NN	B-Disease
,	,	PUNCT	,	O
hypotension	hypotension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
severe	severe	ADJ	JJ	O
hyperglycemia	hyperglycemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
acidosis	acidosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Nonketotic	nonketotic	ADJ	JJ	O
lactic	lactic	ADJ	JJ	B-Disease
acidosis	acidosis	NOUN	NN	I-Disease
was	be	VERB	VBD	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
one	one	NUM	CD	O
and	and	CCONJ	CC	O
ketosis	ketosis	NOUN	NN	B-Disease
without	without	ADP	IN	O
a	a	DET	DT	O
known	know	VERB	VBN	O
serum	serum	ADJ	JJ	O
lactate	lactate	NOUN	NN	B-Chemical
level	level	NOUN	NN	O
was	be	VERB	VBD	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
.	.	PUNCT	.	O

Respiratory	respiratory	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
rapidly	rapidly	ADV	RB	O
ensued	ensue	VERB	VBD	O
and	and	CCONJ	CC	O
both	both	DET	DT	O
patients	patient	NOUN	NNS	O
expired	expire	VERB	VBD	O
in	in	ADP	IN	O
spite	spite	NOUN	NN	O
of	of	ADP	IN	O
efforts	effort	NOUN	NNS	O
at	at	ADP	IN	O
resuscitation	resuscitation	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
believe	believe	VERB	VBP	O
these	these	DET	DT	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
represent	represent	VERB	VBP	O
a	a	DET	DT	O
newly	newly	ADV	RB	O
described	describe	VERB	VBN	O
and	and	CCONJ	CC	O
catastrophic	catastrophic	ADJ	JJ	O
metabolic	metabolic	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
endocrine	endocrine	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
Kearns	Kearns	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	I-Disease
Sayre	Sayre	PROPN	NNP	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Experimental	experimental	ADJ	JJ	O
cyclosporine	cyclosporine	NOUN	NN	B-Chemical
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
:	:	PUNCT	:	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
concomitant	concomitant	ADJ	JJ	O
chemotherapy	chemotherapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
cyclosporine	cyclosporine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
CSA	CSA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
alone	alone	ADV	RB	O
or	or	CCONJ	CC	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
various	various	ADJ	JJ	O
chemotherapeutics	chemotherapeutic	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
was	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Administration	administration	NOUN	NN	O
of	of	ADP	IN	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
CSA	CSA	PROPN	NNP	B-Chemical
for	for	ADP	IN	O
4	4	NUM	CD	O
weeks	week	NOUN	NNS	O
caused	cause	VERB	VBD	O
renal	renal	ADJ	JJ	O
functional	functional	ADJ	JJ	O
and	and	CCONJ	CC	O
structural	structural	ADJ	JJ	O
changes	change	NOUN	NNS	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
man	man	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
combined	combined	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
CSA	CSA	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
various	various	ADJ	JJ	O
chemotherapeutic	chemotherapeutic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
potential	potential	NOUN	NN	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
at	at	ADP	IN	O
therapeutic	therapeutic	ADJ	JJ	O
doses	dose	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
amphothericin	amphothericin	ADJ	JJ	B-Chemical
B	b	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
ketoconazole	ketoconazole	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
are	be	VERB	VBP	O
frequently	frequently	ADV	RB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
immunosuppressed	immunosuppresse	VERB	VBN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
aggravate	aggravate	VERB	VB	O
the	the	DET	DT	O
CSA	CSA	PROPN	NNP	B-Chemical
induced	induce	VERB	VBD	O
toxicity	toxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
model	model	NOUN	NN	O
.	.	PUNCT	.	O

Gentamicin	gentamicin	NOUN	NN	B-Chemical
at	at	ADP	IN	O
toxic	toxic	ADJ	JJ	O
doses	dose	NOUN	NNS	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
increased	increase	VERB	VBD	O
CSA	CSA	PROPN	NNP	B-Chemical
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
CSA	CSA	PROPN	NNP	B-Chemical
has	have	VERB	VBZ	O
a	a	DET	DT	O
different	different	ADJ	JJ	O
pathogenetic	pathogenetic	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
.	.	PUNCT	.	O

Diuretics	diuretic	NOUN	NNS	O
,	,	PUNCT	,	O
potassium	potassium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
arrhythmias	arrhythmia	NOUN	NNS	B-Disease
in	in	ADP	IN	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
coronary	coronary	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
proposed	propose	VERB	VBN	O
that	that	ADP	IN	O
modest	modest	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
plasma	plasma	NOUN	NN	O
potassium	potassium	NOUN	NN	B-Chemical
can	can	VERB	MD	O
alter	alter	VERB	VB	O
the	the	DET	DT	O
tendency	tendency	NOUN	NN	O
towards	towards	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

If	if	ADP	IN	O
this	this	DET	DT	O
were	be	VERB	VBD	O
so	so	ADV	RB	O
,	,	PUNCT	,	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
might	may	VERB	MD	O
be	be	VERB	VB	O
especially	especially	ADV	RB	O
susceptible	susceptible	ADJ	JJ	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
myocardial	myocardial	ADJ	JJ	O
electrical	electrical	ADJ	JJ	O
excitability	excitability	NOUN	NN	O
was	be	VERB	VBD	O
measured	measure	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
mild	mild	ADJ	JJ	O
essential	essential	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
known	know	VERB	VBN	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
after	after	ADP	IN	O
8	8	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
potassium	potassium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
conserving	conserve	VERB	VBG	O
diuretic	diuretic	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
amiloride	amiloride	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
similar	similar	ADJ	JJ	O
period	period	NOUN	NN	O
on	on	ADP	IN	O
a	a	DET	DT	O
potassium	potassium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
losing	lose	VERB	VBG	O
diuretic	diuretic	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
chlorthalidone	chlorthalidone	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
a	a	DET	DT	O
randomised	randomise	VERB	VBN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Plasma	plasma	ADJ	JJ	O
potassium	potassium	NOUN	NN	B-Chemical
concentrations	concentration	NOUN	NNS	O
were	be	VERB	VBD	O
on	on	ADP	IN	O
average	average	ADJ	JJ	O
1	1	NUM	CD	O
mmol	mmol	NOUN	NN	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
lower	low	ADJ	JJR	O
during	during	ADP	IN	O
the	the	DET	DT	O
chlorthalidone	chlorthalidone	NOUN	NN	B-Chemical
phase	phase	NOUN	NN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
amiloride	amiloride	ADP	IN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
volume	volume	NOUN	NN	O
states	state	NOUN	NNS	O
as	as	ADP	IN	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
bodyweight	bodyweight	NOUN	NN	O
,	,	PUNCT	,	O
plasma	plasma	NOUN	NN	O
renin	renin	NOUN	NN	O
and	and	CCONJ	CC	O
noradrenaline	noradrenaline	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
concentrations	concentration	NOUN	NNS	O
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
on	on	ADP	IN	O
the	the	DET	DT	O
2	2	NUM	CD	O
regimens	regimen	NOUN	NNS	O
.	.	PUNCT	.	O

Compared	compare	VERB	VBN	O
to	to	PART	TO	O
amiloride	amiloride	VERB	VB	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
chlorthalidone	chlorthalidone	NOUN	NN	B-Chemical
phase	phase	NOUN	NN	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
increased	increase	VERB	VBN	O
frequency	frequency	NOUN	NN	O
of	of	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
ectopic	ectopic	NOUN	NN	I-Disease
beats	beat	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
Holter	holter	NOUN	NN	O
monitoring	monitoring	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
Lown	Lown	PROPN	NNP	O
grading	grading	NOUN	NN	O
,	,	PUNCT	,	O
increased	increase	VERB	VBN	O
upslope	upslope	ADJ	JJ	O
and	and	CCONJ	CC	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
monophasic	monophasic	ADJ	JJ	O
action	action	NOUN	NN	O
potential	potential	NOUN	NN	O
,	,	PUNCT	,	O
prolonged	prolong	VERB	VBN	O
ventricular	ventricular	ADJ	JJ	O
effective	effective	ADJ	JJ	O
refractory	refractory	ADJ	JJ	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBD	O
electrical	electrical	ADJ	JJ	O
instability	instability	NOUN	NN	O
during	during	ADP	IN	O
programmed	program	VERB	VBN	O
ventricular	ventricular	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
above	above	ADJ	JJ	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
because	because	ADP	IN	O
potassium	potassium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
losing	lose	VERB	VBG	O
diuretic	diuretic	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
can	can	VERB	MD	O
increase	increase	VERB	VB	O
myocardial	myocardial	ADJ	JJ	O
electrical	electrical	ADJ	JJ	O
excitability	excitability	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
ischaemic	ischaemic	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
even	even	ADV	RB	O
minor	minor	ADJ	JJ	O
falls	fall	NOUN	NNS	O
in	in	ADP	IN	O
plasma	plasma	NOUN	NN	O
potassium	potassium	NOUN	NN	B-Chemical
concentrations	concentration	NOUN	NNS	O
are	be	VERB	VBP	O
probably	probably	ADV	RB	O
best	best	ADV	RB	O
avoided	avoid	VERB	VBN	O
in	in	ADP	IN	O
such	such	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Transketolase	transketolase	VERB	VB	O
abnormality	abnormality	NOUN	NN	O
in	in	ADP	IN	O
tolazamide	tolazamide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
Wernicke	Wernicke	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PUNCT	LS	I-Disease
encephalopathy	encephalopathy	ADJ	JJ	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
studied	study	VERB	VBD	O
a	a	DET	DT	O
thiamine	thiamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
enzyme	enzyme	NOUN	NN	O
,	,	PUNCT	,	O
transketolase	transketolase	NOUN	NN	O
,	,	PUNCT	,	O
from	from	ADP	IN	O
fibroblasts	fibroblast	NOUN	NNS	O
of	of	ADP	IN	O
a	a	DET	DT	O
diabetic	diabetic	ADJ	JJ	B-Disease
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
Wernicke	Wernicke	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	VERB	VBZ	I-Disease
encephalopathy	encephalopathy	ADJ	JJ	I-Disease
when	when	ADV	WRB	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
tolazamide	tolazamide	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
in	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
delineate	delineate	VERB	VB	O
if	if	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
also	also	ADV	RB	O
had	have	VERB	VBD	O
transketolase	transketolase	ADJ	JJ	O
abnormality	abnormality	NOUN	NN	O
[	[	PUNCT	-LRB-	O
high	high	ADJ	JJ	O
Km	Km	PROPN	NNP	O
for	for	ADP	IN	O
thiamine	thiamine	NOUN	NN	B-Chemical
pyrophosphate	pyrophosphate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
TPP	TPP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
]	]	PUNCT	-RRB-	O
,	,	PUNCT	,	O
as	as	ADP	IN	O
previously	previously	ADV	RB	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
postalcoholic	postalcoholic	ADJ	JJ	O
Wernicke	Wernicke	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	I-Disease
Korsakoff	Korsakoff	PROPN	NNP	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
to	to	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
also	also	ADV	RB	O
studied	study	VERB	VBD	O
this	this	DET	DT	O
enzyme	enzyme	NOUN	NN	O
from	from	ADP	IN	O
three	three	NUM	CD	O
diabetic	diabetic	ADJ	JJ	B-Disease
kindreds	kindred	NOUN	NNS	O
without	without	ADP	IN	O
any	any	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
Wernicke	Wernicke	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	VERB	VBZ	I-Disease
encephalopathy	encephalopathy	ADJ	JJ	I-Disease
and	and	CCONJ	CC	O
from	from	ADP	IN	O
four	four	NUM	CD	O
normal	normal	ADJ	JJ	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
found	find	VERB	VBD	O
that	that	ADP	IN	O
the	the	DET	DT	O
above	above	ADV	RB	O
-	-	PUNCT	HYPH	O
mentioned	mention	VERB	VBN	O
patient	patient	NOUN	NN	O
and	and	CCONJ	CC	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
diabetic	diabetic	ADJ	JJ	B-Disease
kindreds	kindred	NOUN	NNS	O
with	with	ADP	IN	O
no	no	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
Wernicke	Wernicke	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
encephalopathy	encephalopathy	ADJ	JJ	I-Disease
had	have	VERB	VBD	O
abnormal	abnormal	ADJ	JJ	O
transketolase	transketolase	NOUN	NN	O
as	as	ADP	IN	O
determined	determine	VERB	VBN	O
by	by	ADP	IN	O
its	-PRON-	DET	PRP$	O
Km	Km	PROPN	NNP	O
for	for	ADP	IN	O
TPP	TPP	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
a	a	DET	DT	O
similarity	similarity	NOUN	NN	O
between	between	ADP	IN	O
postalcoholic	postalcoholic	ADJ	JJ	O
Wernicke	Wernicke	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	I-Disease
Korsakoff	Korsakoff	PROPN	NNP	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
tolazamide	tolazamide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
Wernicke	Wernicke	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	VERB	VBZ	I-Disease
encephalopathy	encephalopathy	ADJ	JJ	I-Disease
from	from	ADP	IN	O
the	the	DET	DT	O
standpoint	standpoint	NOUN	NN	O
of	of	ADP	IN	O
transketolase	transketolase	ADJ	JJ	O
abnormality	abnormality	NOUN	NN	O
.	.	PUNCT	.	O

Bradycardia	Bradycardia	NOUN	NNS	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
trihexyphenidyl	trihexyphenidyl	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
chronic	chronic	ADJ	JJ	O
schizophrenic	schizophrenic	ADJ	JJ	B-Disease
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
anticholinergic	anticholinergic	ADJ	JJ	O
drug	drug	NOUN	NN	O
,	,	PUNCT	,	O
trihexyphenidyl	trihexyphenidyl	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
developed	develop	VERB	VBD	O
,	,	PUNCT	,	O
paradoxically	paradoxically	ADV	RB	O
,	,	PUNCT	,	O
sinus	sinus	NOUN	NN	O
bradycardia	bradycardia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
reaction	reaction	NOUN	NN	O
was	be	VERB	VBD	O
specific	specific	ADJ	JJ	O
to	to	ADP	IN	O
trihexyphenidyl	trihexyphenidyl	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
not	not	ADV	RB	O
to	to	ADP	IN	O
other	other	ADJ	JJ	O
anticholinergic	anticholinergic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
antidyskinetic	antidyskinetic	ADJ	JJ	O
drug	drug	NOUN	NN	O
is	be	VERB	VBZ	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
clinical	clinical	ADJ	JJ	O
psychiatric	psychiatric	ADJ	JJ	B-Disease
practice	practice	NOUN	NN	O
and	and	CCONJ	CC	O
physicians	physician	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
this	this	DET	DT	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Post	post	ADJ	JJ	O
-	-	ADJ	JJ	O
operative	operative	ADJ	JJ	O
rigidity	rigidity	NOUN	NN	B-Disease
after	after	ADP	IN	O
fentanyl	fentanyl	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
thoraco	thoraco	ADJ	JJ	O
-	-	PUNCT	HYPH	O
abdominal	abdominal	ADJ	JJ	O
rigidity	rigidity	NOUN	NN	B-Disease
leading	lead	VERB	VBG	O
to	to	ADP	IN	O
respiratory	respiratory	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
described	describe	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
post	post	ADJ	JJ	O
-	-	ADJ	JJ	O
operative	operative	ADJ	JJ	O
period	period	NOUN	NN	O
in	in	ADP	IN	O
an	an	DET	DT	O
elderly	elderly	ADJ	JJ	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
received	receive	VERB	VBD	O
a	a	DET	DT	O
moderate	moderate	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
fentanyl	fentanyl	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
was	be	VERB	VBD	O
successfully	successfully	ADV	RB	O
reversed	reverse	VERB	VBN	O
by	by	ADP	IN	O
naloxone	naloxone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanisms	mechanism	NOUN	NNS	O
possibly	possibly	ADV	RB	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
this	this	DET	DT	O
accident	accident	NOUN	NN	O
are	be	VERB	VBP	O
discussed	discuss	VERB	VBN	O
.	.	PUNCT	.	O

Anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
carcinogenic	carcinogenic	ADJ	JJ	B-Disease
action	action	NOUN	NN	O
of	of	ADP	IN	O
phenobarbital	phenobarbital	NOUN	NN	B-Chemical
given	give	VERB	VBN	O
simultaneously	simultaneously	ADV	RB	O
with	with	ADP	IN	O
diethylnitrosamine	diethylnitrosamine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
work	work	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
planned	plan	VERB	VBN	O
in	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
elucidate	elucidate	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
phenobarbital	phenobarbital	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
PB	PB	PROPN	NNP	B-Chemical
:	:	PUNCT	:	O
15	15	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
rat	rat	NOUN	NN	O
of	of	ADP	IN	O
ingested	ingested	ADJ	JJ	O
dose	dose	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
carcinogenesis	carcinogenesis	NOUN	NN	B-Disease
when	when	ADV	WRB	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
administered	administer	VERB	VBN	O
simultaneously	simultaneously	ADV	RB	O
with	with	ADP	IN	O
diethylnitrosamine	diethylnitrosamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DEN	DEN	PROPN	NNP	B-Chemical
:	:	PUNCT	:	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Wistar	wistar	NOUN	NN	O
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
180	180	NUM	CD	O
g	g	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
by	by	ADP	IN	O
DEN	DEN	PROPN	NNP	B-Chemical
alone	alone	ADJ	JJ	O
or	or	CCONJ	CC	O
by	by	ADP	IN	O
DEN	DEN	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
PB	pb	NOUN	NN	B-Chemical
during	during	ADP	IN	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
according	accord	VERB	VBG	O
to	to	ADP	IN	O
our	-PRON-	DET	PRP$	O
schedule	schedule	NOUN	NN	O
for	for	ADP	IN	O
hepatocarcinogenesis	hepatocarcinogenesis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

After	after	ADP	IN	O
the	the	DET	DT	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
number	number	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
size	size	NOUN	NN	O
of	of	ADP	IN	O
induced	induced	ADJ	JJ	O
PAS	PAS	PROPN	NNP	O
positive	positive	ADJ	JJ	O
preneoplastic	preneoplastic	ADJ	JJ	B-Disease
foci	foci	NOUN	NN	I-Disease
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBN	O
when	when	ADV	WRB	O
PB	PB	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
given	give	VERB	VBN	O
simultaneously	simultaneously	ADV	RB	O
with	with	ADP	IN	O
DEN	DEN	PROPN	NNP	B-Chemical
for	for	ADP	IN	O
4	4	NUM	CD	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mitotic	mitotic	ADJ	JJ	O
inhibition	inhibition	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
production	production	NOUN	NN	O
of	of	ADP	IN	O
micronuclei	micronuclei	VERB	VBN	O
normally	normally	ADV	RB	O
observed	observe	VERB	VBN	O
after	after	ADP	IN	O
partial	partial	ADJ	JJ	O
hepatectomy	hepatectomy	NOUN	NN	O
in	in	ADP	IN	O
DEN	DEN	PROPN	NNP	B-Chemical
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
also	also	ADV	RB	O
significantly	significantly	ADV	RB	O
decreased	decrease	VERB	VBN	O
in	in	ADP	IN	O
DEN	DEN	PROPN	NNP	B-Chemical
+	+	SYM	SYM	O
PB	PB	PROPN	NNP	B-Chemical
treated	treat	VERB	VBD	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
last	last	ADJ	JJ	O
only	only	ADV	RB	O
2	2	NUM	CD	O
weeks	week	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
PB	PB	PROPN	NNP	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
change	change	VERB	VB	O
significantly	significantly	ADV	RB	O
the	the	DET	DT	O
last	last	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
DEN	DEN	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
PB	PB	PROPN	NNP	B-Chemical
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
survival	survival	NOUN	NN	O
was	be	VERB	VBD	O
prolonged	prolong	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
tumor	tumor	NOUN	NN	B-Disease
incidence	incidence	NOUN	NN	O
decreased	decrease	VERB	VBD	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
results	result	NOUN	NNS	O
obtained	obtain	VERB	VBN	O
by	by	ADP	IN	O
DEN	DEN	PROPN	NNP	B-Chemical
alone	alone	ADJ	JJ	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
concluded	conclude	VERB	VBN	O
that	that	ADP	IN	O
PB	PB	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
promotes	promote	VERB	VBZ	O
carcinogenesis	carcinogenesis	NOUN	NN	B-Disease
when	when	ADV	WRB	O
administered	administer	VERB	VBN	O
after	after	ADP	IN	O
the	the	DET	DT	O
DEN	DEN	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
reduces	reduce	VERB	VBZ	O
the	the	DET	DT	O
carcinogen	carcinogen	NOUN	NN	O
effect	effect	NOUN	NN	O
when	when	ADV	WRB	O
given	give	VERB	VBN	O
simultaneously	simultaneously	ADV	RB	O
with	with	ADP	IN	O
DEN	DEN	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
'	'	PUNCT	``	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
carcinogen	carcinogen	ADJ	JJ	O
'	'	PUNCT	''	O
effect	effect	NOUN	NN	O
acts	act	NOUN	NNS	O
on	on	ADP	IN	O
the	the	DET	DT	O
initiation	initiation	NOUN	NN	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
on	on	ADP	IN	O
the	the	DET	DT	O
promotion	promotion	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
precancerous	precancerous	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Biochemical	biochemical	ADJ	JJ	O
investigations	investigation	NOUN	NNS	O
are	be	VERB	VBP	O
in	in	ADP	IN	O
progress	progress	NOUN	NN	O
to	to	PART	TO	O
obtain	obtain	VERB	VB	O
more	more	ADJ	JJR	O
information	information	NOUN	NN	O
about	about	ADP	IN	O
this	this	DET	DT	O
'	'	PUNCT	``	O
paradoxical	paradoxical	ADJ	JJ	O
'	'	PUNCT	``	O
PB	PB	PROPN	NNP	B-Chemical
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Bilateral	bilateral	ADJ	JJ	B-Disease
optic	optic	ADJ	JJ	I-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
combined	combined	ADJ	JJ	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
isoniazid	isoniazid	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
40	40	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
underwent	undergo	VERB	VBD	O
an	an	DET	DT	O
unsuccessful	unsuccessful	ADJ	JJ	O
cadaver	cadaver	NOUN	NN	O
kidney	kidney	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
and	and	CCONJ	CC	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
isoniazid	isoniazid	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
bilateral	bilateral	ADJ	JJ	B-Disease
retrobulbar	retrobulbar	NOUN	NN	I-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
with	with	ADP	IN	O
an	an	DET	DT	O
unusual	unusual	ADJ	JJ	O
central	central	ADJ	JJ	O
bitemporal	bitemporal	ADJ	JJ	O
hemianopic	hemianopic	ADJ	JJ	O
scotoma	scotoma	NOUN	NN	B-Disease
was	be	VERB	VBD	O
found	find	VERB	VBN	O
.	.	PUNCT	.	O

Ethambutol	Ethambutol	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
stopped	stop	VERB	VBN	O
and	and	CCONJ	CC	O
only	only	ADV	RB	O
small	small	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
visual	visual	ADJ	JJ	O
acuity	acuity	NOUN	NN	O
followed	follow	VERB	VBD	O
.	.	PUNCT	.	O

Isoniazid	Isoniazid	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
later	later	ADV	RB	O
,	,	PUNCT	,	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
dramatic	dramatic	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
visual	visual	ADJ	JJ	O
acuity	acuity	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
hazards	hazard	NOUN	NNS	O
of	of	ADP	IN	O
optic	optic	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
toxicity	toxicity	NOUN	NN	B-Disease
due	due	ADJ	JJ	O
to	to	ADP	IN	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
are	be	VERB	VBP	O
known	know	VERB	VBN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
emphasize	emphasize	VERB	VBP	O
the	the	DET	DT	O
potential	potential	ADJ	JJ	O
danger	danger	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
ethambutol	ethambutol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
isoniazid	isoniazid	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
adverse	adverse	ADJ	JJ	O
reactions	reaction	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
vancomycin	vancomycin	PROPN	NNP	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
prospective	prospective	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
of	of	ADP	IN	O
vancomycin	vancomycin	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
in	in	ADP	IN	O
54	54	NUM	CD	O
consecutive	consecutive	ADJ	JJ	O
patients	patient	NOUN	NNS	O
over	over	ADP	IN	O
a	a	DET	DT	O
16	16	NUM	CD	O
-	-	PUNCT	HYPH	O
month	month	NOUN	NN	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

Vancomycin	Vancomycin	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
curative	curative	ADJ	JJ	O
in	in	ADP	IN	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
43	43	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
proven	prove	VERB	VBN	O
infection	infection	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Drugs	drug	NOUN	NNS	O
were	be	VERB	VBD	O
ceased	cease	VERB	VBN	O
in	in	ADP	IN	O
six	six	NUM	CD	O
patients	patient	NOUN	NNS	O
because	because	ADP	IN	O
of	of	ADP	IN	O
adverse	adverse	ADJ	JJ	O
reactions	reaction	NOUN	NNS	O
;	;	PUNCT	:	O
in	in	ADP	IN	O
three	three	NUM	CD	O
of	of	ADP	IN	O
these	these	DET	DT	O
vancomycin	vancomycin	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
considered	consider	VERB	VBN	O
the	the	DET	DT	O
likely	likely	ADJ	JJ	O
cause	cause	NOUN	NN	O
.	.	PUNCT	.	O

Reactions	reaction	NOUN	NNS	O
included	include	VERB	VBD	O
thrombophlebitis	thrombophlebitis	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
of	of	ADP	IN	O
54	54	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
rash	rash	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
of	of	ADP	IN	O
54	54	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
of	of	ADP	IN	O
50	50	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
proteinuria	proteinuria	X	FW	B-Disease
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
of	of	ADP	IN	O
50	50	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
ototoxicity	ototoxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
of	of	ADP	IN	O
11	11	NUM	CD	O
patients	patient	NOUN	NNS	O
tested	test	VERB	VBN	O
by	by	ADP	IN	O
audiometry	audiometry	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Thrombophlebitis	Thrombophlebitis	PROPN	NNP	B-Disease
occurred	occur	VERB	VBD	O
only	only	ADV	RB	O
with	with	ADP	IN	O
infusion	infusion	NOUN	NN	O
through	through	ADP	IN	O
peripheral	peripheral	ADJ	JJ	O
cannulae	cannulae	NOUN	NN	O
;	;	PUNCT	:	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
ototoxicity	ototoxicity	NOUN	NN	B-Disease
were	be	VERB	VBD	O
confined	confine	VERB	VBN	O
to	to	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
an	an	DET	DT	O
aminoglycoside	aminoglycoside	NOUN	NN	B-Chemical
plus	plus	CCONJ	CC	O
vancomycin	vancomycin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	DET	DT	O
vancomycin	vancomycin	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
administered	administer	VERB	VBD	O
appropriately	appropriately	ADV	RB	O
,	,	PUNCT	,	O
constitutes	constitute	VERB	VBZ	O
safe	safe	ADJ	JJ	O
,	,	PUNCT	,	O
effective	effective	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
infections	infection	NOUN	NNS	B-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
susceptible	susceptible	ADJ	JJ	O
bacteria	bacteria	NOUN	NNS	O
.	.	PUNCT	.	O

Factors	factor	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
clinical	clinical	ADJ	JJ	O
outcome	outcome	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
amikacin	amikacin	ADV	RB	B-Chemical
.	.	PUNCT	.	O

Data	datum	NOUN	NNS	O
from	from	ADP	IN	O
60	60	NUM	CD	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
amikacin	amikacin	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
for	for	ADP	IN	O
factors	factor	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
42	42	NUM	CD	O
of	of	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
data	datum	NOUN	NNS	O
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
for	for	ADP	IN	O
factors	factor	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
clinical	clinical	ADJ	JJ	O
outcome	outcome	NOUN	NN	O
.	.	PUNCT	.	O

Variables	variable	NOUN	NNS	O
evaluated	evaluate	VERB	VBD	O
included	include	VERB	VBN	O
patient	patient	ADJ	JJ	O
weight	weight	NOUN	NN	O
,	,	PUNCT	,	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
sex	sex	NOUN	NN	O
,	,	PUNCT	,	O
serum	serum	ADV	RB	O
creatinine	creatinine	NOUN	NN	B-Chemical
level	level	NOUN	NN	O
,	,	PUNCT	,	O
creatinine	creatinine	NOUN	NN	B-Chemical
clearance	clearance	NOUN	NN	O
,	,	PUNCT	,	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
total	total	ADJ	JJ	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
mean	mean	VERB	VB	O
daily	daily	ADJ	JJ	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
organism	organism	NOUN	NN	O
minimum	minimum	ADJ	JJ	O
inhibitory	inhibitory	ADJ	JJ	O
concentration	concentration	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MIC	MIC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
mean	mean	ADJ	JJ	O
peak	peak	NOUN	NN	O
levels	level	NOUN	NNS	O
,	,	PUNCT	,	O
mean	mean	VERB	VB	O
trough	trough	NOUN	NN	O
levels	level	NOUN	NNS	O
,	,	PUNCT	,	O
mean	mean	VERB	VB	O
area	area	NOUN	NN	O
under	under	ADP	IN	O
the	the	DET	DT	O
serum	serum	ADJ	JJ	O
concentration	concentration	NOUN	NN	O
-	-	PUNCT	HYPH	O
time	time	NOUN	NN	O
curve	curve	NOUN	NN	O
(	(	PUNCT	-LRB-	O
AUC	AUC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
total	total	ADJ	JJ	O
AUC	AUC	PROPN	NNP	O
,	,	PUNCT	,	O
mean	mean	VERB	VB	O
AUC	AUC	PROPN	NNP	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
MIC	MIC	PROPN	NNP	O
,	,	PUNCT	,	O
total	total	ADJ	JJ	O
AUC	AUC	PROPN	NNP	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
MIC	MIC	PROPN	NNP	O
,	,	PUNCT	,	O
mean	mean	VERB	VB	O
Schumacher	Schumacher	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	VERB	VBZ	O
intensity	intensity	NOUN	NN	O
factor	factor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
IF	IF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
total	total	ADJ	JJ	O
IF	if	ADP	IN	O
,	,	PUNCT	,	O
In	in	ADP	IN	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
maximum	maximum	ADJ	JJ	O
concentration	concentration	NOUN	NN	O
[	[	PUNCT	-LRB-	O
Cmax	Cmax	PROPN	NNP	O
]	]	PUNCT	-RRB-	O
/	/	SYM	SYM	O
MIC	MIC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Model	model	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
pharmacokinetic	pharmacokinetic	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
were	be	VERB	VBD	O
calculated	calculate	VERB	VBN	O
by	by	ADP	IN	O
computer	computer	NOUN	NN	O
based	base	VERB	VBN	O
on	on	ADP	IN	O
a	a	DET	DT	O
one	one	NUM	CD	O
-	-	PUNCT	HYPH	O
compartment	compartment	NOUN	NN	O
model	model	NOUN	NN	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
the	the	DET	DT	O
parameters	parameter	NOUN	NNS	O
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
individually	individually	ADV	RB	O
,	,	PUNCT	,	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
and	and	CCONJ	CC	O
total	total	ADJ	JJ	O
AUC	AUC	PROPN	NNP	O
correlated	correlate	VERB	VBD	O
significantly	significantly	ADV	RB	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
stepwise	stepwise	ADJ	JJ	O
discriminant	discriminant	ADJ	JJ	O
function	function	NOUN	NN	O
analysis	analysis	NOUN	NN	O
identified	identify	VERB	VBD	O
only	only	ADV	RB	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
as	as	ADP	IN	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
factor	factor	NOUN	NN	O
.	.	PUNCT	.	O

Based	base	VERB	VBN	O
on	on	ADP	IN	O
this	this	DET	DT	O
model	model	NOUN	NN	O
and	and	CCONJ	CC	O
on	on	ADP	IN	O
Bayes	Bayes	PROPN	NNP	O
'	'	PART	POS	O
theorem	theorem	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
predictive	predictive	ADJ	JJ	O
accuracy	accuracy	NOUN	NN	O
of	of	ADP	IN	O
identifying	identify	VERB	VBG	O
"	"	PUNCT	``	O
nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
"	"	PUNCT	''	O
patients	patient	NOUN	NNS	O
increased	increase	VERB	VBD	O
from	from	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
17	17	NUM	CD	O
to	to	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
39	39	NUM	CD	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
examined	examine	VERB	VBN	O
individually	individually	ADV	RB	O
,	,	PUNCT	,	O
mean	mean	VERB	VB	O
IF	if	ADP	IN	O
,	,	PUNCT	,	O
MIC	MIC	PROPN	NNP	O
,	,	PUNCT	,	O
total	total	ADJ	JJ	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
mean	mean	VERB	VB	O
daily	daily	ADJ	JJ	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
ln	ln	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
Cmax	Cmax	PROPN	NNP	O
/	/	SYM	SYM	O
MIC	MIC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
correlated	correlate	VERB	VBD	O
significantly	significantly	ADV	RB	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
cure	cure	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
simultaneous	simultaneous	ADJ	JJ	O
multivariable	multivariable	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
identified	identify	VERB	VBN	O
IF	if	ADP	IN	O
,	,	PUNCT	,	O
MIC	MIC	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
total	total	ADJ	JJ	O
dose	dose	NOUN	NN	O
according	accord	VERB	VBG	O
to	to	ADP	IN	O
one	one	NUM	CD	O
model	model	NOUN	NN	O
and	and	CCONJ	CC	O
ln	ln	NOUN	NN	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
Cmax	Cmax	PROPN	NNP	O
/	/	SYM	SYM	O
MIC	MIC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
according	accord	VERB	VBG	O
to	to	ADP	IN	O
a	a	DET	DT	O
second	second	ADJ	JJ	O
statistical	statistical	ADJ	JJ	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
parameters	parameter	NOUN	NNS	O
selected	select	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
the	the	DET	DT	O
greatest	great	ADJ	JJS	O
prospective	prospective	ADJ	JJ	O
value	value	NOUN	NN	O
.	.	PUNCT	.	O

Based	base	VERB	VBN	O
on	on	ADP	IN	O
Bayes	Bayes	PROPN	NNP	O
'	'	PART	POS	O
theorem	theorem	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
model	model	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
predictive	predictive	ADJ	JJ	O
accuracy	accuracy	NOUN	NN	O
of	of	ADP	IN	O
identifying	identify	VERB	VBG	O
patients	patient	NOUN	NNS	O
not	not	ADV	RB	O
cured	cure	VERB	VBN	O
increased	increase	VERB	VBN	O
from	from	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
19	19	NUM	CD	O
to	to	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
83	83	NUM	CD	O
.	.	PUNCT	.	O

For	for	ADP	IN	O
the	the	DET	DT	O
second	second	ADJ	JJ	O
model	model	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
predictive	predictive	ADJ	JJ	O
accuracy	accuracy	NOUN	NN	O
increased	increase	VERB	VBD	O
from	from	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
19	19	NUM	CD	O
to	to	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
50	50	NUM	CD	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
ABSTRACT	ABSTRACT	PROPN	NNP	O
TRUNCATED	truncated	NUM	CD	O
AT	at	ADP	IN	O
250	250	NUM	CD	O
WORDS	word	NOUN	NNS	O
)	)	PUNCT	-RRB-	O

Cardiac	cardiac	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
of	of	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
fluorouracil	fluorouracil	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Report	Report	PROPN	NNP	O
of	of	ADP	IN	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
spontaneous	spontaneous	ADJ	JJ	O
angina	angina	NOUN	NN	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
colon	colon	NOUN	NN	B-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
liver	liver	NOUN	NN	O
metastasis	metastasis	NOUN	NN	B-Disease
who	who	PRON	WP	O
presented	present	VERB	VBD	O
chest	chest	NOUN	NN	B-Disease
pain	pain	NOUN	NN	I-Disease
after	after	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
fluorouracil	fluorouracil	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
electrocardiographic	electrocardiographic	ADJ	JJ	O
evolution	evolution	NOUN	NN	O
was	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
that	that	DET	DT	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
Prinzmetal	Prinzmetal	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	NOUN	NN	I-Disease
angina	angina	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
chest	chest	NOUN	NN	B-Disease
pain	pain	NOUN	NN	I-Disease
promptly	promptly	ADV	RB	O
resolved	resolve	VERB	VBD	O
with	with	ADP	IN	O
nifedipine	nifedipine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
spasm	spasm	NOUN	NNS	I-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
the	the	DET	DT	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
that	that	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
antagonists	antagonist	NOUN	NNS	O
may	may	VERB	MD	O
probably	probably	ADV	RB	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
prevention	prevention	NOUN	NN	O
or	or	CCONJ	CC	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
FU	fu	NOUN	NN	I-Chemical
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
beneficial	beneficial	ADJ	JJ	O
and	and	CCONJ	CC	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
dietary	dietary	ADJ	JJ	O
corticosterone	corticosterone	NOUN	NN	B-Chemical
on	on	ADP	IN	O
organophosphorus	organophosphorus	ADV	RB	B-Chemical
-	-	ADJ	JJ	O
induced	induced	ADJ	JJ	O
delayed	delay	VERB	VBN	O
neuropathy	neuropathy	NOUN	NN	B-Disease
in	in	ADP	IN	O
chickens	chicken	NOUN	NNS	O
.	.	PUNCT	.	O

Tri	Tri	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
ortho	ortho	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
tolyl	tolyl	NOUN	NN	I-Chemical
phosphate	phosphate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
TOTP	TOTP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
360	360	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
po	po	VERB	VB	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
0	0	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
0	0	NUM	CD	I-Chemical
'	'	PUNCT	''	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
diisopropyl	diisopropyl	NOUN	NN	I-Chemical
phosphorofluoridate	phosphorofluoridate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
DFP	DFP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
sc	sc	NOUN	NN	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
administered	administer	VERB	VBN	O
to	to	PART	TO	O
adult	adult	VERB	VB	O
White	White	PROPN	NNP	O
Leghorn	Leghorn	PROPN	NNP	O
chickens	chicken	NOUN	NNS	O
24	24	NUM	CD	O
hr	hr	INTJ	UH	O
after	after	ADP	IN	O
they	-PRON-	PRON	PRP	O
were	be	VERB	VBD	O
placed	place	VERB	VBN	O
on	on	ADP	IN	O
diets	diet	NOUN	NNS	O
containing	contain	VERB	VBG	O
0	0	NUM	CD	O
to	to	ADP	IN	O
300	300	NUM	CD	O
ppm	ppm	NOUN	NN	O
corticosterone	corticosterone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Supplemented	supplemented	ADJ	JJ	O
diets	diet	NOUN	NNS	O
were	be	VERB	VBD	O
continued	continue	VERB	VBN	O
until	until	ADP	IN	O
clinical	clinical	ADJ	JJ	O
signs	sign	NOUN	NNS	O
and	and	CCONJ	CC	O
lesions	lesion	NOUN	NNS	O
of	of	ADP	IN	O
delayed	delay	VERB	VBN	O
neuropathy	neuropathy	NOUN	NN	B-Disease
appeared	appear	VERB	VBD	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
low	low	ADJ	JJ	O
concentrations	concentration	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
or	or	CCONJ	CC	O
equal	equal	ADJ	JJ	O
to	to	ADP	IN	O
50	50	NUM	CD	O
ppm	ppm	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
corticosterone	corticosterone	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
beneficial	beneficial	ADJ	JJ	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
TOTP	TOTP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
neuropathy	neuropathy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
or	or	CCONJ	CC	O
equal	equal	ADJ	JJ	O
to	to	ADP	IN	O
200	200	NUM	CD	O
ppm	ppm	NOUN	NN	O
exacerbated	exacerbate	VERB	VBN	O
clinical	clinical	ADJ	JJ	O
signs	sign	NOUN	NNS	O
in	in	ADP	IN	O
chickens	chicken	NOUN	NNS	O
given	give	VERB	VBN	O
either	either	CCONJ	CC	O
TOTP	TOTP	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
DFP	dfp	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Neurotoxic	neurotoxic	ADJ	JJ	B-Disease
esterase	esterase	NOUN	NN	O
activities	activity	NOUN	NNS	O
24	24	NUM	CD	O
hr	hr	INTJ	UH	O
after	after	ADP	IN	O
TOTP	TOTP	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
DFP	DFP	PROPN	NNP	B-Chemical
were	be	VERB	VBD	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
20	20	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
values	value	NOUN	NNS	O
measured	measure	VERB	VBN	O
in	in	ADP	IN	O
chickens	chicken	NOUN	NNS	O
not	not	ADV	RB	O
given	give	VERB	VBN	O
organophosphorous	organophosphorous	ADJ	JJ	B-Chemical
compounds	compound	NOUN	NNS	O
.	.	PUNCT	.	O

Chickens	chicken	NOUN	NNS	O
given	give	VERB	VBD	O
200	200	NUM	CD	O
ppm	ppm	NOUN	NN	O
corticosterone	corticosterone	NOUN	NN	B-Chemical
without	without	ADP	IN	O
TOTP	TOTP	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
DFP	DFP	PROPN	NNP	B-Chemical
had	have	VERB	VBD	O
significantly	significantly	ADV	RB	O
elevated	elevate	VERB	VBN	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
cholinesterase	cholinesterase	NOUN	NN	O
and	and	CCONJ	CC	O
significantly	significantly	ADV	RB	O
inhibited	inhibit	VERB	VBD	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
liver	liver	NOUN	NN	O
carboxylesterase	carboxylesterase	NOUN	NN	O
.	.	PUNCT	.	O

Degenerating	degenerate	VERB	VBG	B-Disease
myelinated	myelinate	VERB	VBN	I-Disease
fibers	fiber	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
also	also	ADV	RB	O
evident	evident	ADJ	JJ	O
in	in	ADP	IN	O
distal	distal	ADJ	JJ	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
nerves	nerve	NOUN	NNS	O
of	of	ADP	IN	O
chickens	chicken	NOUN	NNS	O
given	give	VERB	VBN	O
TOTP	TOTP	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
DFP	dfp	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Amiodarone	Amiodarone	PROPN	NNP	B-Chemical
has	have	VERB	VBZ	O
proved	prove	VERB	VBN	O
very	very	ADV	RB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
otherwise	otherwise	ADV	RB	O
resistant	resistant	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
tachyarrhythmias	tachyarrhythmia	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
been	be	VERB	VBN	O
limited	limit	VERB	VBN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
its	-PRON-	DET	PRP$	O
serious	serious	ADJ	JJ	O
side	side	NOUN	NN	O
-	-	PUNCT	HYPH	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
cholestatic	cholestatic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
amiodarone	amiodarone	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
is	be	VERB	VBZ	O
presented	present	VERB	VBN	O
below	below	ADV	RB	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
given	give	VERB	VBN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
concluded	conclude	VERB	VBN	O
that	that	ADP	IN	O
solid	solid	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
exists	exist	VERB	VBZ	O
of	of	ADP	IN	O
hepatic	hepatic	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
amiodarone	amiodarone	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
steatosis	steatosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
alterations	alteration	NOUN	NNS	O
resembling	resemble	VERB	VBG	O
alcoholic	alcoholic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
cholestatic	cholestatic	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
micronodular	micronodular	ADJ	JJ	O
cirrhosis	cirrhosis	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
liver	liver	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
amiodarone	amiodarone	ADV	RB	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
regularly	regularly	ADV	RB	O
screened	screen	VERB	VBN	O
with	with	ADP	IN	O
respect	respect	NOUN	NN	O
to	to	ADP	IN	O
hepatic	hepatic	ADJ	JJ	O
enzyme	enzyme	ADJ	JJ	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

Therapy	therapy	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
discontinued	discontinue	VERB	VBN	O
on	on	ADP	IN	O
the	the	DET	DT	O
suspicion	suspicion	NOUN	NN	O
of	of	ADP	IN	O
cholestatic	cholestatic	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
hepatomegaly	hepatomegaly	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Promotional	promotional	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
testosterone	testosterone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
dietary	dietary	ADJ	JJ	O
fat	fat	NOUN	NN	O
on	on	ADP	IN	O
prostate	prostate	NOUN	NN	O
carcinogenesis	carcinogenesis	NOUN	NN	B-Disease
in	in	ADP	IN	O
genetically	genetically	ADV	RB	O
susceptible	susceptible	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Germfree	Germfree	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
GF	GF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
Lobund	Lobund	PROPN	NNP	O
strain	strain	NOUN	NN	O
Wistar	Wistar	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
LW	LW	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
fed	fed	ADJ	JJ	O
vegetable	vegetable	NOUN	NN	O
diet	diet	NOUN	NN	O
L	L	PROPN	NNP	O
-	-	PUNCT	HYPH	O
485	485	NUM	CD	O
,	,	PUNCT	,	O
have	have	VERB	VBP	O
developed	develop	VERB	VBN	O
prostate	prostate	NOUN	NN	B-Disease
adenocarcinomas	adenocarcinoma	NOUN	NNS	I-Disease
spontaneously	spontaneously	ADV	RB	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
incidence	incidence	NOUN	NN	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
average	average	ADJ	JJ	O
age	age	NOUN	NN	O
34	34	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Conventional	Conventional	PROPN	NNP	O
LW	LW	PROPN	NNP	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
implanted	implant	VERB	VBN	O
with	with	ADP	IN	O
testosterone	testosterone	NOUN	NN	B-Chemical
at	at	ADP	IN	O
age	age	NOUN	NN	O
4	4	NUM	CD	O
months	month	NOUN	NNS	O
,	,	PUNCT	,	O
developed	develop	VERB	VBD	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
prostate	prostate	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
after	after	ADP	IN	O
an	an	DET	DT	O
average	average	ADJ	JJ	O
interval	interval	NOUN	NN	O
of	of	ADP	IN	O
14	14	NUM	CD	O
months	month	NOUN	NNS	O
:	:	PUNCT	:	O
24	24	NUM	CD	O
%	%	NOUN	NN	O
had	have	VERB	VBD	O
developed	develop	VERB	VBN	O
gross	gross	ADJ	JJ	O
tumors	tumor	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
40	40	NUM	CD	O
%	%	NOUN	NN	O
when	when	ADV	WRB	O
it	-PRON-	PRON	PRP	O
included	include	VERB	VBD	O
microscopic	microscopic	ADJ	JJ	O
tumors	tumor	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Preliminary	preliminary	ADJ	JJ	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
testosterone	testosterone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
LW	LW	PROPN	NNP	O
rats	rat	NOUN	NNS	O
that	that	DET	WDT	O
were	be	VERB	VBD	O
fed	feed	VERB	VBN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
diet	diet	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
supplemented	supplement	VERB	VBN	O
with	with	ADP	IN	O
corn	corn	NOUN	NN	O
oil	oil	NOUN	NN	O
up	up	ADP	IN	O
to	to	PART	TO	O
20	20	NUM	CD	O
%	%	NOUN	NN	O
fat	fat	NOUN	NN	O
,	,	PUNCT	,	O
developed	develop	VERB	VBD	O
prostate	prostate	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
after	after	ADP	IN	O
intervals	interval	NOUN	NNS	O
of	of	ADP	IN	O
6	6	NUM	CD	O
-	-	SYM	SYM	O
12	12	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Aged	aged	ADJ	JJ	O
GF	GF	PROPN	NNP	O
Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
SD	SD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
rats	rat	NOUN	NNS	O
have	have	VERB	VBP	O
not	not	ADV	RB	O
developed	develop	VERB	VBN	O
prostate	prostate	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
spontaneously	spontaneously	ADV	RB	O
.	.	PUNCT	.	O

Conventional	Conventional	PROPN	NNP	O
SD	SD	PROPN	NNP	O
rats	rat	NOUN	NNS	O
fed	feed	VERB	VBD	O
diet	diet	NOUN	NN	O
L	L	PROPN	NNP	O
-	-	PUNCT	HYPH	O
485	485	NUM	CD	O
and	and	CCONJ	CC	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
testosterone	testosterone	NOUN	NN	B-Chemical
developed	develop	VERB	VBN	O
only	only	ADJ	JJ	O
prostatitis	prostatitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Experimental	experimental	ADJ	JJ	O
designs	design	NOUN	NNS	O
should	should	VERB	MD	O
consider	consider	VERB	VB	O
genetic	genetic	ADJ	JJ	O
susceptibility	susceptibility	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
basic	basic	ADJ	JJ	O
prerequisite	prerequisite	NOUN	NN	O
for	for	ADP	IN	O
studies	study	NOUN	NNS	O
on	on	ADP	IN	O
experimental	experimental	ADJ	JJ	O
prostate	prostate	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Time	time	NOUN	NN	O
course	course	NOUN	NN	O
alterations	alteration	NOUN	NNS	O
of	of	ADP	IN	O
QTC	QTC	PROPN	NNP	O
interval	interval	NOUN	NN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
hypaque	hypaque	NOUN	NN	B-Chemical
76	76	NUM	CD	I-Chemical
.	.	PUNCT	.	O

Sequential	sequential	ADJ	JJ	O
measurement	measurement	NOUN	NN	O
of	of	ADP	IN	O
QT	QT	PROPN	NNP	O
interval	interval	NOUN	NN	O
during	during	ADP	IN	O
left	leave	VERB	VBN	O
ventricular	ventricular	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
was	be	VERB	VBD	O
made	make	VERB	VBN	O
30	30	NUM	CD	O
seconds	second	NOUN	NNS	O
and	and	CCONJ	CC	O
one	one	NUM	CD	O
,	,	PUNCT	,	O
three	three	NUM	CD	O
,	,	PUNCT	,	O
five	five	NUM	CD	O
and	and	CCONJ	CC	O
ten	ten	NUM	CD	O
minutes	minute	NOUN	NNS	O
after	after	ADP	IN	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
hypaque	hypaque	NOUN	NN	B-Chemical
76	76	NUM	CD	I-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
subjects	subject	NOUN	NNS	O
were	be	VERB	VBD	O
ten	ten	NUM	CD	O
patients	patient	NOUN	NNS	O
found	find	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
normal	normal	ADJ	JJ	O
left	left	ADJ	JJ	O
ventricles	ventricle	NOUN	NNS	O
and	and	CCONJ	CC	O
coronary	coronary	ADJ	JJ	O
arteries	artery	NOUN	NNS	O
.	.	PUNCT	.	O

Significant	significant	ADJ	JJ	O
QTC	QTC	PROPN	NNP	B-Disease
prolongation	prolongation	NOUN	NN	I-Disease
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
30	30	NUM	CD	O
seconds	second	NOUN	NNS	O
to	to	ADP	IN	O
one	one	NUM	CD	O
minute	minute	NOUN	NN	O
in	in	ADP	IN	O
association	association	NOUN	NN	O
with	with	ADP	IN	O
marked	marked	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
elevation	elevation	NOUN	NN	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
output	output	NOUN	NN	O
.	.	PUNCT	.	O

Rat	Rat	PROPN	NNP	O
extraocular	extraocular	ADJ	JJ	O
muscle	muscle	NOUN	NN	O
regeneration	regeneration	NOUN	NN	O
.	.	PUNCT	.	O

Repair	repair	NOUN	NN	O
of	of	ADP	IN	O
local	local	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
damage	damage	NOUN	NN	O
.	.	PUNCT	.	O

Local	local	ADJ	JJ	O
anesthetics	anesthetic	NOUN	NNS	O
that	that	DET	WDT	O
are	be	VERB	VBP	O
commonly	commonly	ADV	RB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
ophthalmic	ophthalmic	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
75	75	NUM	CD	O
%	%	NOUN	NN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
mepivacaine	mepivacaine	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
plus	plus	CCONJ	CC	O
1	1	NUM	CD	O
:	:	SYM	SYM	O
100	100	NUM	CD	O
,	,	PUNCT	,	O
000	000	NUM	CD	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
injected	inject	VERB	VBN	O
into	into	ADP	IN	O
the	the	DET	DT	O
retrobulbar	retrobulbar	ADJ	JJ	O
area	area	NOUN	NN	O
of	of	ADP	IN	O
rat	rat	NOUN	NN	O
eyes	eye	NOUN	NNS	O
.	.	PUNCT	.	O

Controls	control	NOUN	NNS	O
were	be	VERB	VBD	O
injected	inject	VERB	VBN	O
with	with	ADP	IN	O
physiological	physiological	ADJ	JJ	O
saline	saline	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
three	three	NUM	CD	O
anesthetics	anesthetic	NOUN	NNS	O
produced	produce	VERB	VBD	O
massive	massive	ADJ	JJ	O
degeneration	degeneration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
extraocular	extraocular	ADJ	JJ	O
muscles	muscle	NOUN	NNS	O
.	.	PUNCT	.	O

Muscle	muscle	NOUN	NN	B-Disease
degeneration	degeneration	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
regeneration	regeneration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
damaged	damage	VERB	VBN	O
muscle	muscle	NOUN	NN	O
fibers	fiber	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
to	to	ADP	IN	O
muscle	muscle	NOUN	NN	B-Disease
damage	damage	NOUN	NN	I-Disease
,	,	PUNCT	,	O
severe	severe	ADJ	JJ	O
damage	damage	NOUN	NN	O
was	be	VERB	VBD	O
also	also	ADV	RB	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
harderian	harderian	ADJ	JJ	O
glands	gland	NOUN	NNS	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
after	after	ADP	IN	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
mepivacaine	mepivacaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
lidocaine	lidocaine	VERB	VB	B-Chemical
plus	plus	CCONJ	CC	O
epinephrine	epinephrine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

With	with	ADP	IN	O
these	these	DET	DT	O
findings	finding	NOUN	NNS	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
hypothesized	hypothesize	VERB	VBN	O
that	that	ADP	IN	O
the	the	DET	DT	O
temporary	temporary	ADJ	JJ	O
diplopia	diplopia	NOUN	NN	B-Disease
sometimes	sometimes	ADV	RB	O
seen	see	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
after	after	ADP	IN	O
ophthalmic	ophthalmic	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
might	may	VERB	MD	O
be	be	VERB	VB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
anesthetic	anesthetic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
damage	damage	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
extraocular	extraocular	ADJ	JJ	O
muscles	muscle	NOUN	NNS	O
.	.	PUNCT	.	O

Gentamicin	Gentamicin	PROPN	NNP	B-Chemical
nephropathy	nephropathy	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
neonate	neonate	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
and	and	CCONJ	CC	O
autopsy	autopsy	ADJ	JJ	O
findings	finding	NOUN	NNS	O
in	in	ADP	IN	O
a	a	DET	DT	O
premature	premature	ADJ	JJ	O
baby	baby	NOUN	NN	O
who	who	PRON	WP	O
died	die	VERB	VBD	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
after	after	ADP	IN	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
gentamicin	gentamicin	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
penicillin	penicillin	NOUN	NN	B-Chemical
are	be	VERB	VBP	O
presented	present	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
serum	serum	ADJ	JJ	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
concentration	concentration	NOUN	NN	O
had	have	VERB	VBD	O
reached	reach	VERB	VBN	O
toxic	toxic	ADJ	JJ	O
levels	level	NOUN	NNS	O
when	when	ADV	WRB	O
anuria	anuria	NOUN	NN	B-Disease
developed	develop	VERB	VBD	O
.	.	PUNCT	.	O

Numerous	numerous	ADJ	JJ	O
periodic	periodic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
Schiff	Schiff	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
PAS	PAS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
positive	positive	ADJ	JJ	O
,	,	PUNCT	,	O
diastase	diastase	NOUN	NN	O
resistant	resistant	ADJ	JJ	O
cytoplasmic	cytoplasmic	ADJ	JJ	O
inclusion	inclusion	NOUN	NN	O
bodies	body	NOUN	NNS	O
which	which	DET	WDT	O
appeared	appear	VERB	VBD	O
as	as	ADP	IN	O
myelin	myelin	ADJ	JJ	O
figures	figure	NOUN	NNS	O
in	in	ADP	IN	O
cytosegresomes	cytosegresome	NOUN	NNS	O
under	under	ADP	IN	O
the	the	DET	DT	O
electron	electron	NOUN	NN	O
microscope	microscope	NOUN	NN	O
were	be	VERB	VBD	O
identified	identify	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
proximal	proximal	ADJ	JJ	O
convoluted	convoluted	ADJ	JJ	O
tubules	tubule	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
pathological	pathological	ADJ	JJ	O
changes	change	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
human	human	ADJ	JJ	O
neonatal	neonatal	NOUN	NN	O
kidneys	kidney	NOUN	NNS	O
have	have	VERB	VBP	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
previously	previously	ADV	RB	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

Induction	induction	NOUN	NN	O
by	by	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
of	of	ADP	IN	O
bladder	bladder	NOUN	NN	B-Disease
and	and	CCONJ	CC	I-Disease
liver	liver	NOUN	NN	I-Disease
tumours	tumour	NOUN	NNS	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
hepatocyte	hepatocyte	ADJ	JJ	O
fine	fine	ADJ	JJ	O
structure	structure	NOUN	NN	O
.	.	PUNCT	.	O

Groups	group	NOUN	NNS	O
of	of	ADP	IN	O
male	male	ADJ	JJ	O
and	and	CCONJ	CC	O
female	female	ADJ	JJ	O
inbred	inbreed	VERB	VBN	O
Leeds	Leeds	PROPN	NNP	O
strain	strain	NOUN	NN	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
fed	feed	VERB	VBN	O
diets	diet	NOUN	NNS	O
containing	contain	VERB	VBG	O
either	either	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
or	or	CCONJ	CC	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
by	by	ADP	IN	O
weight	weight	NOUN	NN	O
for	for	ADP	IN	O
up	up	ADP	IN	O
to	to	PART	TO	O
18	18	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
the	the	DET	DT	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
dosage	dosage	NOUN	NN	O
level	level	NOUN	NN	O
,	,	PUNCT	,	O
20	20	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
rats	rat	NOUN	NNS	O
of	of	ADP	IN	O
both	both	DET	DT	O
sexes	sex	NOUN	NNS	O
developed	develop	VERB	VBD	O
neoplastic	neoplastic	ADJ	JJ	O
nodules	nodule	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
liver	liver	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
incidence	incidence	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
rats	rat	NOUN	NNS	O
also	also	ADV	RB	O
showed	show	VERB	VBD	O
gross	gross	ADJ	JJ	O
enlargement	enlargement	NOUN	NN	O
of	of	ADP	IN	O
their	-PRON-	DET	PRP$	O
livers	liver	NOUN	NNS	O
and	and	CCONJ	CC	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
foci	foci	NOUN	NN	O
of	of	ADP	IN	O
cellular	cellular	ADJ	JJ	O
alteration	alteration	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
latter	latter	ADJ	JJ	O
also	also	ADV	RB	O
being	be	VERB	VBG	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
low	low	ADJ	JJ	O
dosage	dosage	NOUN	NN	O
male	male	NOUN	NN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Papillomas	papilloma	NOUN	NNS	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
transitional	transitional	ADJ	JJ	O
epithelium	epithelium	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
bladder	bladder	NOUN	NN	O
developed	develop	VERB	VBD	O
in	in	ADP	IN	O
all	all	DET	DT	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
three	three	NUM	CD	O
rats	rat	NOUN	NNS	O
bore	bear	VERB	VBD	O
bladder	bladder	NOUN	NN	B-Disease
carcinomas	carcinoma	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
significant	significant	ADJ	JJ	O
yields	yield	NOUN	NNS	O
of	of	ADP	IN	O
bladder	bladder	NOUN	NN	B-Disease
tumours	tumour	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
only	only	ADV	RB	O
obtained	obtain	VERB	VBN	O
from	from	ADP	IN	O
low	low	ADJ	JJ	O
dosage	dosage	NOUN	NN	O
females	female	NOUN	NNS	O
and	and	CCONJ	CC	O
high	high	ADJ	JJ	O
dosage	dosage	NOUN	NN	O
males	male	NOUN	NNS	O
.	.	PUNCT	.	O

Additionally	additionally	ADV	RB	O
,	,	PUNCT	,	O
20	20	NUM	CD	O
to	to	PART	TO	O
25	25	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
developed	develop	VERB	VBD	O
hyperplasia	hyperplasia	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
bladder	bladder	NOUN	NN	O
epithelium	epithelium	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
coincident	coincident	ADJ	JJ	O
with	with	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
bladder	bladder	NOUN	NN	B-Disease
calculi	calculi	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
low	low	ADJ	JJ	O
yield	yield	NOUN	NN	O
of	of	ADP	IN	O
tumours	tumour	NOUN	NNS	B-Disease
at	at	ADP	IN	O
various	various	ADJ	JJ	O
other	other	ADJ	JJ	O
sites	site	NOUN	NNS	O
also	also	ADV	RB	O
arose	arise	VERB	VBD	O
following	follow	VERB	VBG	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
feeding	feeding	NOUN	NN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
electron	electron	NOUN	NN	O
microscope	microscope	NOUN	NN	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
livers	liver	NOUN	NNS	O
of	of	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
ultrastructural	ultrastructural	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
hepatocytes	hepatocyte	NOUN	NNS	O
that	that	DET	WDT	O
resemble	resemble	VERB	VBP	O
those	those	DET	DT	O
that	that	DET	WDT	O
result	result	VERB	VBP	O
from	from	ADP	IN	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
a	a	DET	DT	O
variety	variety	NOUN	NN	O
of	of	ADP	IN	O
known	known	ADJ	JJ	O
hepatocarcinogens	hepatocarcinogen	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Transient	transient	ADJ	JJ	O
hemiparesis	hemiparesis	NOUN	NN	B-Disease
:	:	PUNCT	:	O
a	a	DET	DT	O
rare	rare	ADJ	JJ	O
manifestation	manifestation	NOUN	NN	O
of	of	ADP	IN	O
diphenylhydantoin	diphenylhydantoin	NOUN	NN	B-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Report	report	NOUN	NN	O
of	of	ADP	IN	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

Among	among	ADP	IN	O
the	the	DET	DT	O
common	common	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
diphenylhydantoin	diphenylhydantoin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DPH	DPH	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
overdose	overdose	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
most	most	ADV	RBS	O
frequently	frequently	ADV	RB	O
encountered	encounter	VERB	VBN	O
neurological	neurological	ADJ	JJ	O
signs	sign	NOUN	NNS	O
are	be	VERB	VBP	O
those	those	DET	DT	O
of	of	ADP	IN	O
cerebellar	cerebellar	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Very	very	ADV	RB	O
rarely	rarely	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
toxic	toxic	ADJ	JJ	O
neurological	neurological	ADJ	JJ	O
manifestations	manifestation	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
drug	drug	NOUN	NN	O
are	be	VERB	VBP	O
of	of	ADP	IN	O
cerebral	cerebral	ADJ	JJ	O
origin	origin	NOUN	NN	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
are	be	VERB	VBP	O
presented	present	VERB	VBN	O
who	who	PRON	WP	O
suffered	suffer	VERB	VBD	O
progressive	progressive	ADJ	JJ	O
hemiparesis	hemiparesis	NOUN	NN	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
DPH	DPH	PROPN	NNP	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Both	both	DET	DT	O
had	have	VERB	VBD	O
brain	brain	NOUN	NN	O
surgery	surgery	NOUN	NN	O
before	before	ADP	IN	O
DPH	DPH	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
assumed	assume	VERB	VBN	O
that	that	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
some	some	DET	DT	O
cerebral	cerebral	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
are	be	VERB	VBP	O
liable	liable	ADJ	JJ	O
to	to	PART	TO	O
manifest	manifest	VERB	VB	O
DPH	DPH	PROPN	NNP	B-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
as	as	ADP	IN	O
focal	focal	ADJ	JJ	O
neurological	neurological	ADJ	JJ	O
signs	sign	NOUN	NNS	O
.	.	PUNCT	.	O

Tiapride	tiapride	VERB	VB	B-Chemical
in	in	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
involuntary	involuntary	ADJ	JJ	B-Disease
movements	movement	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Tiapride	Tiapride	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
substituted	substitute	VERB	VBN	O
benzamide	benzamide	ADJ	JJ	B-Chemical
derivative	derivative	NOUN	NN	O
closely	closely	ADV	RB	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
metoclopramide	metoclopramide	VERB	VB	B-Chemical
,	,	PUNCT	,	O
reduced	reduce	VERB	VBD	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
peak	peak	NOUN	NN	O
dose	dose	NOUN	NN	O
involuntary	involuntary	ADJ	JJ	B-Disease
movements	movement	NOUN	NNS	I-Disease
in	in	ADP	IN	O
16	16	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
idiopathic	idiopathic	ADJ	JJ	B-Disease
Parkinson	Parkinson	PROPN	NNP	I-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
an	an	DET	DT	O
unacceptable	unacceptable	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
disability	disability	NOUN	NN	O
from	from	ADP	IN	O
Parkinsonism	Parkinsonism	PROPN	NNP	B-Disease
with	with	ADP	IN	O
aggravation	aggravation	NOUN	NN	O
of	of	ADP	IN	O
end	end	NOUN	NN	O
-	-	PUNCT	HYPH	O
of	of	ADP	IN	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
akinesia	akinesia	NOUN	NN	B-Disease
led	lead	VERB	VBD	O
to	to	ADP	IN	O
its	-PRON-	DET	PRP$	O
cessation	cessation	NOUN	NN	O
in	in	ADP	IN	O
14	14	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Tiapride	tiapride	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
levodopa	levodopa	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
early	early	ADJ	JJ	O
morning	morning	NOUN	NN	O
of	of	ADP	IN	O
"	"	PUNCT	``	O
off	off	ADP	IN	O
-	-	PUNCT	HYPH	O
period	period	NOUN	NN	O
"	"	PUNCT	''	O
segmental	segmental	ADJ	JJ	O
dystonia	dystonia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
fail	fail	VERB	VBP	O
to	to	PART	TO	O
support	support	VERB	VB	O
the	the	DET	DT	O
notion	notion	NOUN	NN	O
that	that	ADP	IN	O
levodopa	levodopa	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
are	be	VERB	VBP	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
overstimulation	overstimulation	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
separate	separate	ADJ	JJ	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
receptors	receptor	NOUN	NNS	O
.	.	PUNCT	.	O

Quinidine	quinidine	NOUN	NN	B-Chemical
hepatitis	hepatitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
quinidine	quinidine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
persistent	persistent	ADJ	JJ	O
elevation	elevation	NOUN	NN	O
of	of	ADP	IN	O
serum	serum	ADJ	JJ	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
SGOT	SGOT	PROPN	NNP	O
,	,	PUNCT	,	O
lactic	lactic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
dehydrogenase	dehydrogenase	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
alkaline	alkaline	NOUN	NN	O
phosphatase	phosphatase	NOUN	NN	O
.	.	PUNCT	.	O

Liver	liver	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
showed	show	VERB	VBD	O
active	active	ADJ	JJ	O
hepatitis	hepatitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Discontinuance	discontinuance	NOUN	NN	O
of	of	ADP	IN	O
quinidine	quinidine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
led	lead	VERB	VBD	O
to	to	ADP	IN	O
normalization	normalization	NOUN	NN	O
of	of	ADP	IN	O
liver	liver	NOUN	NN	O
function	function	NOUN	NN	O
tests	test	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
challenge	challenge	NOUN	NN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
quinidine	quinidine	NOUN	NN	B-Chemical
caused	cause	VERB	VBD	O
clinical	clinical	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
abrupt	abrupt	ADJ	JJ	O
elevation	elevation	NOUN	NN	O
of	of	ADP	IN	O
SGOT	SGOT	PROPN	NNP	O
,	,	PUNCT	,	O
alkaline	alkaline	NOUN	NN	O
phosphatase	phosphatase	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
lactic	lactic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
dehydrogenase	dehydrogenase	NOUN	NN	O
values	value	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
concluded	conclude	VERB	VBD	O
that	that	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
quinidine	quinidine	NOUN	NN	B-Chemical
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
believe	believe	VERB	VBP	O
that	that	ADP	IN	O
this	this	DET	DT	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
case	case	NOUN	NN	O
reported	report	VERB	VBD	O
with	with	ADP	IN	O
liver	liver	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
documentation	documentation	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
report	report	NOUN	NN	O
also	also	ADV	RB	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
,	,	PUNCT	,	O
even	even	ADV	RB	O
after	after	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
hepatic	hepatic	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
reversible	reversible	ADJ	JJ	O
.	.	PUNCT	.	O

Arterial	arterial	ADJ	JJ	O
thromboembolism	thromboembolism	NOUN	NN	B-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
systemic	systemic	ADJ	JJ	O
heparin	heparin	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
:	:	PUNCT	:	O
a	a	DET	DT	O
complication	complication	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Arterial	arterial	ADJ	JJ	O
thromboembolism	thromboembolism	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
recognized	recognize	VERB	VBN	O
complication	complication	NOUN	NN	O
of	of	ADP	IN	O
systemic	systemic	ADJ	JJ	O
heparin	heparin	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Characteristic	characteristic	ADJ	JJ	O
of	of	ADP	IN	O
the	the	DET	DT	O
entity	entity	NOUN	NN	O
is	be	VERB	VBZ	O
arterial	arterial	ADJ	JJ	B-Disease
occlusion	occlusion	NOUN	NN	I-Disease
by	by	ADP	IN	O
platelet	platelet	NOUN	NN	O
-	-	PUNCT	HYPH	O
fibrin	fibrin	NOUN	NN	O
thrombi	thrombi	NOUN	NN	B-Disease
with	with	ADP	IN	O
distal	distal	ADJ	JJ	O
ischemia	ischemia	NOUN	NN	B-Disease
occurring	occur	VERB	VBG	O
four	four	NUM	CD	O
to	to	PART	TO	O
twenty	twenty	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
the	the	DET	DT	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
heparin	heparin	ADJ	JJ	B-Chemical
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
preceded	precede	VERB	VBN	O
by	by	ADP	IN	O
profound	profound	ADJ	JJ	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
with	with	ADP	IN	O
platelet	platelet	NOUN	NN	O
counts	count	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
range	range	NOUN	NN	O
of	of	ADP	IN	O
30	30	NUM	CD	O
,	,	PUNCT	,	O
000	000	NUM	CD	O
to	to	ADP	IN	O
40	40	NUM	CD	O
,	,	PUNCT	,	O
000	000	NUM	CD	O
per	per	ADP	IN	O
cubic	cubic	ADJ	JJ	O
millimeter	millimeter	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
clinically	clinically	ADV	RB	O
apparent	apparent	ADJ	JJ	O
occlusion	occlusion	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
preceded	precede	VERB	VBN	O
by	by	ADP	IN	O
gastrointestinal	gastrointestinal	ADJ	JJ	B-Disease
and	and	CCONJ	CC	I-Disease
musculoskeletal	musculoskeletal	ADJ	JJ	I-Disease
symptoms	symptom	NOUN	NNS	I-Disease
that	that	DET	WDT	O
appear	appear	VERB	VBP	O
to	to	PART	TO	O
be	be	VERB	VB	O
ischemic	ischemic	ADJ	JJ	B-Disease
in	in	ADP	IN	O
origin	origin	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
might	may	VERB	MD	O
serve	serve	VERB	VB	O
to	to	PART	TO	O
warn	warn	VERB	VB	O
the	the	DET	DT	O
clinician	clinician	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
complications	complication	NOUN	NNS	O
.	.	PUNCT	.	O

Previous	previous	ADJ	JJ	O
reports	report	NOUN	NNS	O
of	of	ADP	IN	O
these	these	DET	DT	O
phenomena	phenomenon	NOUN	NNS	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
recent	recent	ADJ	JJ	O
studies	study	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
heparin	heparin	NOUN	NN	B-Chemical
are	be	VERB	VBP	O
reviewed	review	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
common	common	ADJ	JJ	O
factor	factor	NOUN	NN	O
relating	relate	VERB	VBG	O
thromboembolism	thromboembolism	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
platelet	platelet	NOUN	NN	B-Disease
aggregation	aggregation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Appropriate	appropriate	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
consists	consist	VERB	VBZ	O
of	of	ADP	IN	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
heparin	heparin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
anticoagulation	anticoagulation	NOUN	NN	O
with	with	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
warfarin	warfarin	NOUN	NN	I-Chemical
if	if	ADP	IN	O
necessary	necessary	ADJ	JJ	O
.	.	PUNCT	.	O

Vascular	vascular	NOUN	NN	O
procedures	procedure	NOUN	NNS	O
are	be	VERB	VBP	O
performed	perform	VERB	VBN	O
as	as	ADP	IN	O
indicated	indicate	VERB	VBN	O
.	.	PUNCT	.	O

Pharmacology	pharmacology	NOUN	NN	O
of	of	ADP	IN	O
GYKI	GYKI	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
41	41	NUM	CD	I-Chemical
099	099	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
chlorpropanol	chlorpropanol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
Tobanum	Tobanum	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
potent	potent	ADJ	JJ	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenergic	adrenergic	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
compound	compound	NOUN	NN	O
GYKI	GYKI	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
41	41	NUM	CD	I-Chemical
099	099	NUM	CD	I-Chemical
,	,	PUNCT	,	O
as	as	ADP	IN	O
a	a	DET	DT	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenergic	adrenergic	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
3	3	NUM	CD	O
-	-	SYM	SYM	O
8	8	NUM	CD	O
times	time	NOUN	NNS	O
more	more	ADV	RBR	O
potent	potent	ADJ	JJ	O
than	than	ADP	IN	O
propranolol	propranolol	NOUN	NN	B-Chemical
in	in	ADP	IN	O
vitro	vitro	NOUN	NN	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
.	.	PUNCT	.	O

Its	-PRON-	DET	PRP$	O
antiarrhythmic	antiarrhythmic	ADJ	JJ	O
effectiveness	effectiveness	NOUN	NN	O
surpasses	surpass	VERB	VBZ	O
that	that	ADP	IN	O
of	of	ADP	IN	O
propranolol	propranolol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
pindolol	pindolol	NOUN	NN	B-Chemical
inhibiting	inhibit	VERB	VBG	O
the	the	DET	DT	O
ouabain	ouabain	NOUN	NN	B-Chemical
arrhythmia	arrhythmia	NOUN	NN	B-Disease
in	in	ADP	IN	O
dogs	dog	NOUN	NNS	O
and	and	CCONJ	CC	O
cats	cat	NOUN	NNS	O
.	.	PUNCT	.	O

GYKI	GYKI	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
41	41	NUM	CD	I-Chemical
900	900	NUM	CD	I-Chemical
has	have	VERB	VBZ	O
a	a	DET	DT	O
negligible	negligible	ADJ	JJ	O
cardiodepressant	cardiodepressant	ADJ	JJ	O
activity	activity	NOUN	NN	O
;	;	PUNCT	:	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
cardioselective	cardioselective	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
compound	compound	NOUN	NN	O
shows	show	VERB	VBZ	O
a	a	DET	DT	O
rapid	rapid	ADJ	JJ	O
and	and	CCONJ	CC	O
long	long	ADJ	JJ	O
lasting	last	VERB	VBG	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
prolonged	prolonged	ADJ	JJ	O
elimination	elimination	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
radioactivity	radioactivity	NOUN	NN	O
after	after	ADP	IN	O
the	the	DET	DT	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
14C	14c	NUM	CD	B-Chemical
-	-	SYM	SYM	I-Chemical
41	41	NUM	CD	I-Chemical
099	099	NUM	CD	I-Chemical
to	to	PART	TO	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
half	half	ADJ	JJ	O
life	life	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
unlabeled	unlabeled	ADJ	JJ	O
substance	substance	NOUN	NN	O
in	in	ADP	IN	O
humans	human	NOUN	NNS	O
was	be	VERB	VBD	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
10	10	NUM	CD	O
hours	hour	NOUN	NNS	O
.	.	PUNCT	.	O

Adverse	adverse	ADJ	JJ	O
reactions	reaction	NOUN	NNS	O
to	to	ADP	IN	O
bendrofluazide	bendrofluazide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
propranolol	propranolol	VERB	VB	B-Chemical
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
mild	mild	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Report	Report	PROPN	NNP	O
of	of	ADP	IN	O
Medical	Medical	PROPN	NNP	O
Research	Research	PROPN	NNP	O
Council	Council	PROPN	NNP	O
Working	Working	PROPN	NNP	O
Party	Party	PROPN	NNP	O
on	on	ADP	IN	O
Mild	Mild	PROPN	NNP	O
to	to	ADP	IN	O
Moderate	Moderate	PROPN	NNP	O
Hypertension	Hypertension	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Participants	participant	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
Medical	Medical	PROPN	NNP	O
Research	Research	PROPN	NNP	O
Council	Council	PROPN	NNP	O
treatment	treatment	NOUN	NN	O
trial	trial	NOUN	NN	O
for	for	ADP	IN	O
mild	mild	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
are	be	VERB	VBP	O
randomly	randomly	ADV	RB	O
allocated	allocate	VERB	VBN	O
to	to	ADP	IN	O
one	one	NUM	CD	O
of	of	ADP	IN	O
four	four	NUM	CD	O
treatment	treatment	NOUN	NN	O
groups	group	NOUN	NNS	O
:	:	PUNCT	:	O
bendrofluazide	bendrofluazide	ADV	RB	B-Chemical
,	,	PUNCT	,	O
propranolol	propranolol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
a	a	DET	DT	O
placebo	placebo	NOUN	NN	O
for	for	ADP	IN	O
either	either	DET	DT	O
of	of	ADP	IN	O
these	these	DET	DT	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
trial	trial	NOUN	NN	O
is	be	VERB	VBZ	O
single	single	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
.	.	PUNCT	.	O

23	23	NUM	CD	O
582	582	NUM	CD	O
patient	patient	NOUN	NN	O
-	-	PUNCT	HYPH	O
years	year	NOUN	NNS	O
of	of	ADP	IN	O
observation	observation	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
completed	complete	VERB	VBN	O
so	so	ADV	RB	O
far	far	ADV	RB	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
684	684	NUM	CD	O
on	on	ADP	IN	O
active	active	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
and	and	CCONJ	CC	O
12	12	NUM	CD	O
898	898	NUM	CD	O
on	on	ADP	IN	O
placebos	placebo	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
show	show	VERB	VBP	O
an	an	DET	DT	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
bendrofluazide	bendrofluazide	ADP	IN	B-Chemical
treatment	treatment	NOUN	NN	O
and	and	CCONJ	CC	O
impotence	impotence	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
impotence	impotence	NOUN	NN	B-Disease
also	also	ADV	RB	O
occurred	occur	VERB	VBD	O
more	more	ADV	RBR	O
frequently	frequently	ADV	RB	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
taking	take	VERB	VBG	O
propranolol	propranolol	NOUN	NN	B-Chemical
than	than	ADP	IN	O
in	in	ADP	IN	O
those	those	DET	DT	O
taking	take	VERB	VBG	O
placebos	placebos	NOUN	NN	O
.	.	PUNCT	.	O

Other	other	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
reactions	reaction	NOUN	NNS	O
significantly	significantly	ADV	RB	O
linked	link	VERB	VBD	O
with	with	ADP	IN	O
active	active	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
include	include	VERB	VBP	O
impaired	impaired	ADJ	JJ	B-Disease
glucose	glucose	NOUN	NN	I-Disease
tolerance	tolerance	NOUN	NN	I-Disease
in	in	ADP	IN	O
men	man	NOUN	NNS	O
and	and	CCONJ	CC	O
women	woman	NOUN	NNS	O
and	and	CCONJ	CC	O
gout	gout	NOUN	NN	B-Disease
in	in	ADP	IN	O
men	man	NOUN	NNS	O
,	,	PUNCT	,	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
bendrofluazide	bendrofluazide	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
Raynaud	Raynaud	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	NOUN	NN	I-Disease
phenomenon	phenomenon	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
dyspnoea	dyspnoea	VERB	VB	B-Disease
in	in	ADP	IN	O
men	man	NOUN	NNS	O
and	and	CCONJ	CC	O
women	woman	NOUN	NNS	O
taking	take	VERB	VBG	O
propranolol	propranolol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

No	no	DET	DT	O
corneal	corneal	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
known	know	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
occurred	occur	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
propranolol	propranolol	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Mean	mean	VERB	VB	O
serum	serum	ADJ	JJ	O
potassium	potassium	NOUN	NN	B-Chemical
level	level	NOUN	NN	O
fell	fall	VERB	VBD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
urea	urea	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
uric	uric	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
levels	level	NOUN	NNS	O
rose	rise	VERB	VBD	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
men	man	NOUN	NNS	O
and	and	CCONJ	CC	O
women	woman	NOUN	NNS	O
taking	take	VERB	VBG	O
bendrofluazide	bendrofluazide	ADV	RB	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
propranolol	propranolol	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
,	,	PUNCT	,	O
serum	serum	ADJ	JJ	O
potassium	potassium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
uric	uric	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
levels	level	NOUN	NNS	O
rose	rise	VERB	VBD	O
in	in	ADP	IN	O
both	both	DET	DT	O
sexes	sex	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
urea	urea	ADJ	JJ	B-Chemical
level	level	NOUN	NN	O
rose	rise	VERB	VBD	O
significantly	significantly	ADV	RB	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
only	only	ADV	RB	O
.	.	PUNCT	.	O

Serotonergic	serotonergic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
,	,	PUNCT	,	O
benzodiazepines	benzodiazepine	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
baclofen	baclofen	NOUN	NN	B-Chemical
block	block	NOUN	NN	O
muscimol	muscimol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
myoclonic	myoclonic	ADJ	JJ	B-Disease
jerks	jerk	NOUN	NNS	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
strain	strain	NOUN	NN	O
of	of	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
male	male	ADJ	JJ	O
Swiss	swiss	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
muscimol	muscimol	NOUN	NN	B-Chemical
produced	produce	VERB	VBD	O
myoclonic	myoclonic	ADJ	JJ	B-Disease
jerks	jerk	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
dose	dose	NOUN	NN	O
induced	induce	VERB	VBD	O
this	this	DET	DT	O
response	response	NOUN	NN	O
in	in	ADP	IN	O
all	all	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
mice	mouse	NOUN	NNS	O
tested	test	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
peak	peak	ADJ	JJ	O
response	response	NOUN	NN	O
of	of	ADP	IN	O
73	73	NUM	CD	O
jerks	jerk	NOUN	NNS	O
per	per	ADP	IN	O
min	min	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
between	between	ADP	IN	O
27	27	NUM	CD	O
and	and	CCONJ	CC	O
45	45	NUM	CD	O
min	min	NOUN	NN	O
.	.	PUNCT	.	O

Increasing	increase	VERB	VBG	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
serotonin	serotonin	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
by	by	ADP	IN	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxytryptophan	hydroxytryptophan	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
80	80	NUM	CD	O
-	-	SYM	SYM	O
160	160	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
decarboxylase	decarboxylase	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
an	an	DET	DT	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
muscimol	muscimol	NOUN	NN	B-Chemical
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
a	a	DET	DT	O
similar	similar	ADJ	JJ	O
experiment	experiment	NOUN	NN	O
l	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
80	80	NUM	CD	O
-	-	SYM	SYM	O
160	160	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
without	without	ADP	IN	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
3	3	NUM	CD	O
-	-	SYM	SYM	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
serotonin	serotonin	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
212	212	NUM	CD	I-Chemical
caused	cause	VERB	VBD	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
blockade	blockade	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
response	response	NOUN	NN	O
of	of	ADP	IN	O
muscimol	muscimol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Of	of	ADP	IN	O
the	the	DET	DT	O
benzodiazepines	benzodiazepine	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
clonazepam	clonazepam	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	NOUN	NN	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
several	several	ADJ	JJ	O
fold	fold	ADV	RB	O
more	more	ADV	RBR	O
potent	potent	ADJ	JJ	O
than	than	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
blocking	block	VERB	VBG	O
the	the	DET	DT	O
myoclonic	myoclonic	ADJ	JJ	B-Disease
jerks	jerk	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

While	while	ADP	IN	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
baclofen	baclofen	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
proved	prove	VERB	VBD	O
to	to	PART	TO	O
be	be	VERB	VB	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
antagonist	antagonist	NOUN	NN	O
of	of	ADP	IN	O
muscimol	muscimol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
its	-PRON-	DET	PRP$	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
isomer	isomer	NOUN	NN	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
lacked	lack	VERB	VBD	O
this	this	DET	DT	O
property	property	NOUN	NN	O
.	.	PUNCT	.	O

Considering	consider	VERB	VBG	O
the	the	DET	DT	O
fact	fact	NOUN	NN	O
that	that	ADP	IN	O
5	5	NUM	CD	B-Chemical
-	-	SYM	SYM	I-Chemical
HTP	HTP	PROPN	NNP	I-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
benzodiazepines	benzodiazepine	NOUN	NNS	B-Chemical
have	have	VERB	VBP	O
been	be	VERB	VBN	O
found	find	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
beneficial	beneficial	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
clinical	clinical	ADJ	JJ	O
myoclonus	myoclonus	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
muscimol	muscimol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
myoclonus	myoclonus	NOUN	NN	B-Disease
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
a	a	DET	DT	O
satisfactory	satisfactory	ADJ	JJ	O
animal	animal	NOUN	NN	O
model	model	NOUN	NN	O
that	that	DET	WDT	O
may	may	VERB	MD	O
prove	prove	VERB	VB	O
useful	useful	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
new	new	ADJ	JJ	O
drug	drug	NOUN	NN	O
treatments	treatment	NOUN	NNS	O
for	for	ADP	IN	O
this	this	DET	DT	O
condition	condition	NOUN	NN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
indicated	indicate	VERB	VBD	O
the	the	DET	DT	O
possible	possible	ADJ	JJ	O
value	value	NOUN	NN	O
of	of	ADP	IN	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
212	212	NUM	CD	I-Chemical
and	and	CCONJ	CC	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
baclofen	baclofen	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
clinical	clinical	ADJ	JJ	O
myoclonus	myoclonus	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Adverse	adverse	ADJ	JJ	O
interaction	interaction	NOUN	NN	O
between	between	ADP	IN	O
beta	beta	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
adrenergic	adrenergic	NOUN	NN	I-Chemical
blocking	block	VERB	VBG	I-Chemical
drugs	drug	NOUN	NNS	I-Chemical
and	and	CCONJ	CC	O
verapamil	verapamil	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
-	-	PUNCT	HYPH	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
three	three	NUM	CD	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

Three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
ischaemic	ischaemic	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
developed	develop	VERB	VBD	O
profound	profound	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
,	,	PUNCT	,	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
bradycardia	bradycardia	NOUN	NNS	B-Disease
during	during	ADP	IN	O
combined	combine	VERB	VBN	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
verapamil	verapamil	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
beta	beta	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
adrenergic	adrenergic	NOUN	NN	I-Chemical
blocking	block	VERB	VBG	I-Chemical
drugs	drug	NOUN	NNS	I-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
clinical	clinical	ADJ	JJ	O
picture	picture	NOUN	NN	O
resolved	resolve	VERB	VBD	O
completely	completely	ADV	RB	O
with	with	ADP	IN	O
cessation	cessation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
combined	combine	VERB	VBN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Baseline	Baseline	PROPN	NNP	O
left	leave	VERB	VBD	O
ventricular	ventricular	ADJ	JJ	O
function	function	NOUN	NN	O
,	,	PUNCT	,	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
catheterisation	catheterisation	NOUN	NN	O
or	or	CCONJ	CC	O
nuclear	nuclear	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
normal	normal	ADJ	JJ	O
in	in	ADP	IN	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
and	and	CCONJ	CC	O
only	only	ADV	RB	O
mildly	mildly	ADV	RB	O
reduced	reduce	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
.	.	PUNCT	.	O

Simultaneously	simultaneously	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
beta	beta	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
adrenergic	adrenergic	NOUN	NN	I-Chemical
blocking	block	VERB	VBG	I-Chemical
drugs	drug	NOUN	NNS	I-Chemical
and	and	CCONJ	CC	O
verapamil	verapamil	NOUN	NN	B-Chemical
may	may	VERB	MD	O
result	result	VERB	VB	O
in	in	ADP	IN	O
profound	profound	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
interactions	interaction	NOUN	NNS	O
and	and	CCONJ	CC	O
should	should	VERB	MD	O
only	only	ADV	RB	O
be	be	VERB	VB	O
administered	administer	VERB	VBN	O
with	with	ADP	IN	O
great	great	ADJ	JJ	O
caution	caution	NOUN	NN	O
.	.	PUNCT	.	O

Comparison	Comparison	PROPN	NNP	O
of	of	ADP	IN	O
the	the	DET	DT	O
effectiveness	effectiveness	NOUN	NN	O
of	of	ADP	IN	O
ranitidine	ranitidine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
cimetidine	cimetidine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
inhibiting	inhibit	VERB	VBG	O
acid	acid	NOUN	NN	O
secretion	secretion	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
gastric	gastric	ADJ	JJ	O
hypersecretory	hypersecretory	ADJ	JJ	O
states	state	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
H2	H2	PROPN	NNP	O
-	-	PUNCT	HYPH	O
histamine	histamine	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
antagonists	antagonist	NOUN	NNS	O
ranitidine	ranitidine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
cimetidine	cimetidine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
for	for	ADP	IN	O
their	-PRON-	DET	PRP$	O
abilities	ability	NOUN	NNS	O
to	to	PART	TO	O
control	control	VERB	VB	O
gastric	gastric	ADJ	JJ	O
acid	acid	NOUN	NN	O
hypersecretion	hypersecretion	NOUN	NN	O
on	on	ADP	IN	O
a	a	DET	DT	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
basis	basis	NOUN	NN	O
in	in	ADP	IN	O
22	22	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
gastric	gastric	ADJ	JJ	O
acid	acid	NOUN	NN	O
hypersecretory	hypersecretory	ADJ	JJ	O
states	state	NOUN	NNS	O
.	.	PUNCT	.	O

Nineteen	nineteen	NUM	CD	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
Zollinger	Zollinger	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	I-Disease
Ellison	Ellison	PROPN	NNP	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
,	,	PUNCT	,	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
systemic	systemic	ADJ	JJ	B-Disease
mastocytosis	mastocytosis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
idiopathic	idiopathic	ADJ	JJ	O
hypersecretion	hypersecretion	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
rates	rate	NOUN	NNS	O
of	of	ADP	IN	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
action	action	NOUN	NN	O
of	of	ADP	IN	O
cimetidine	cimetidine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
ranitidine	ranitidine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
actions	action	NOUN	NNS	O
of	of	ADP	IN	O
both	both	DET	DT	O
drugs	drug	NOUN	NNS	O
were	be	VERB	VBD	O
increased	increase	VERB	VBN	O
by	by	ADP	IN	O
anticholinergic	anticholinergic	ADJ	JJ	O
agents	agent	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
close	close	ADJ	JJ	O
correlation	correlation	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
daily	daily	ADJ	JJ	O
maintenance	maintenance	NOUN	NN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
each	each	DET	DT	O
drug	drug	NOUN	NN	O
needed	need	VERB	VBN	O
to	to	PART	TO	O
control	control	VERB	VB	O
acid	acid	NOUN	NN	O
secretion	secretion	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
ranitidine	ranitidine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
threefold	threefold	ADV	RB	O
more	more	ADV	RBR	O
potent	potent	ADJ	JJ	O
than	than	ADP	IN	O
cimetidine	cimetidine	NOUN	NN	B-Chemical
both	both	DET	DT	O
in	in	ADP	IN	O
acute	acute	ADJ	JJ	O
inhibition	inhibition	NOUN	NN	O
studies	study	NOUN	NNS	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
the	the	DET	DT	O
median	median	ADJ	JJ	O
maintenance	maintenance	NOUN	NN	O
dose	dose	NOUN	NN	O
needed	need	VERB	VBN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
g	g	NOUN	NN	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
ranitidine	ranitidine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
g	g	NOUN	NN	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
cimetidine	cimetidine	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Sixty	sixty	NUM	CD	O
percent	percent	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
males	male	NOUN	NNS	O
developed	develop	VERB	VBD	O
breast	breast	NOUN	NN	O
changes	change	NOUN	NNS	O
or	or	CCONJ	CC	O
impotence	impotence	NOUN	NN	B-Disease
while	while	ADP	IN	O
taking	take	VERB	VBG	O
cimetidine	cimetidine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
in	in	ADP	IN	O
all	all	DET	DT	O
cases	case	NOUN	NNS	O
these	these	DET	DT	O
changes	change	NOUN	NNS	O
disappeared	disappear	VERB	VBD	O
when	when	ADV	WRB	O
cimetidine	cimetidine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
replaced	replace	VERB	VBN	O
by	by	ADP	IN	O
ranitidine	ranitidine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
cimetidine	cimetidine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
one	one	NUM	CD	O
to	to	PART	TO	O
60	60	NUM	CD	O
months	month	NOUN	NNS	O
;	;	PUNCT	:	O
median	median	NOUN	NN	O
,	,	PUNCT	,	O
11	11	NUM	CD	O
months	month	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
ranitidine	ranitidine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
two	two	NUM	CD	O
to	to	PART	TO	O
31	31	NUM	CD	O
months	month	NOUN	NNS	O
;	;	PUNCT	:	O
median	median	NOUN	NN	O
,	,	PUNCT	,	O
14	14	NUM	CD	O
months	month	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
hepatic	hepatic	ADJ	JJ	B-Disease
or	or	CCONJ	CC	I-Disease
hematologic	hematologic	ADJ	JJ	I-Disease
toxicity	toxicity	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
alterations	alteration	NOUN	NNS	O
of	of	ADP	IN	O
serum	serum	NOUN	NN	O
gastrin	gastrin	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
ranitidine	ranitidine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
significantly	significantly	ADV	RB	O
lower	low	ADJ	JJR	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
level	level	NOUN	NN	O
than	than	ADP	IN	O
seen	see	VERB	VBN	O
with	with	ADP	IN	O
cimetidine	cimetidine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
both	both	DET	DT	O
drugs	drug	NOUN	NNS	O
can	can	VERB	MD	O
adequately	adequately	ADV	RB	O
inhibit	inhibit	VERB	VB	O
acid	acid	NOUN	NN	O
secretion	secretion	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
gastric	gastric	ADJ	JJ	O
hypersecretory	hypersecretory	ADJ	JJ	O
states	state	NOUN	NNS	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
are	be	VERB	VBP	O
safe	safe	ADJ	JJ	O
at	at	ADP	IN	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
ranitidine	ranitidine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
threefold	threefold	ADV	RB	O
more	more	ADV	RBR	O
potent	potent	ADJ	JJ	O
and	and	CCONJ	CC	O
does	do	VERB	VBZ	O
not	not	ADV	RB	O
cause	cause	VERB	VB	O
the	the	DET	DT	O
antiandrogen	antiandrogen	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
frequently	frequently	ADV	RB	O
seen	see	VERB	VBN	O
with	with	ADP	IN	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
cimetidine	cimetidine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Epileptogenic	epileptogenic	ADJ	JJ	O
properties	property	NOUN	NNS	O
of	of	ADP	IN	O
enflurane	enflurane	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
their	-PRON-	DET	PRP$	O
clinical	clinical	ADJ	JJ	O
interpretation	interpretation	NOUN	NN	O
.	.	PUNCT	.	O

Three	three	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
EEG	EEG	PROPN	NNP	O
changes	change	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
single	single	ADJ	JJ	O
exposure	exposure	NOUN	NN	O
to	to	PART	TO	O
enflurane	enflurane	VERB	VB	B-Chemical
anesthesia	anesthesia	NOUN	NN	O
are	be	VERB	VBP	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
,	,	PUNCT	,	O
enflurane	enflurane	NOUN	NN	B-Chemical
administered	administer	VERB	VBD	O
during	during	ADP	IN	O
a	a	DET	DT	O
donor	donor	NOUN	NN	O
nephrectomy	nephrectomy	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
unexpected	unexpected	ADJ	JJ	O
partial	partial	ADJ	JJ	O
motor	motor	NOUN	NN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Until	until	ADP	IN	O
the	the	DET	DT	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
seizures	seizure	NOUN	NNS	B-Disease
was	be	VERB	VBD	O
correctly	correctly	ADV	RB	O
identified	identify	VERB	VBN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
inappropriately	inappropriately	ADV	RB	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
anticonvulsants	anticonvulsant	NOUN	NNS	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
other	other	ADJ	JJ	O
patients	patient	NOUN	NNS	O
suffered	suffer	VERB	VBD	O
from	from	ADP	IN	O
partial	partial	ADJ	JJ	O
,	,	PUNCT	,	O
complex	complex	ADJ	JJ	O
and	and	CCONJ	CC	O
generalized	generalized	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
uncontrolled	uncontrolle	VERB	VBN	O
by	by	ADP	IN	O
medication	medication	NOUN	NN	O
.	.	PUNCT	.	O

Epileptic	epileptic	ADJ	JJ	B-Disease
foci	foci	NOUN	NN	O
delineated	delineate	VERB	VBD	O
and	and	CCONJ	CC	O
activated	activate	VERB	VBN	O
by	by	ADP	IN	O
enflurane	enflurane	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
surgically	surgically	ADV	RB	O
ablated	ablate	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
are	be	VERB	VBP	O
now	now	ADV	RB	O
seizure	seizure	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
.	.	PUNCT	.	O

Previous	previous	ADJ	JJ	O
exposures	exposure	NOUN	NNS	O
to	to	PART	TO	O
enflurane	enflurane	VERB	VB	B-Chemical
have	have	VERB	VB	O
to	to	PART	TO	O
be	be	VERB	VB	O
disclosed	disclose	VERB	VBN	O
to	to	PART	TO	O
avoid	avoid	VERB	VB	O
mistakes	mistake	NOUN	NNS	O
in	in	ADP	IN	O
clinical	clinical	ADJ	JJ	O
interpretation	interpretation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
EEG	EEG	PROPN	NNP	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
hand	hand	NOUN	NN	O
,	,	PUNCT	,	O
enflurane	enflurane	NOUN	NN	B-Chemical
may	may	VERB	MD	O
prove	prove	VERB	VB	O
to	to	PART	TO	O
be	be	VERB	VB	O
a	a	DET	DT	O
safe	safe	ADJ	JJ	O
fast	fast	ADJ	JJ	O
acting	act	VERB	VBG	O
activator	activator	NOUN	NN	O
of	of	ADP	IN	O
epileptic	epileptic	ADJ	JJ	B-Disease
foci	foci	NOUN	NN	O
during	during	ADP	IN	O
corticography	corticography	NOUN	NN	O
or	or	CCONJ	CC	O
depth	depth	NOUN	NN	O
electrode	electrode	NOUN	NN	O
intraoperative	intraoperative	ADJ	JJ	O
recordings	recording	NOUN	NNS	O
.	.	PUNCT	.	O

Development	development	NOUN	NN	O
of	of	ADP	IN	O
isoproterenol	isoproterenol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiac	cardiac	ADJ	JJ	B-Disease
hypertrophy	hypertrophy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
hypertrophy	hypertrophy	NOUN	NN	I-Disease
was	be	VERB	VBD	O
studied	study	VERB	VBN	O
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
female	female	ADJ	JJ	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
following	follow	VERB	VBG	O
daily	daily	ADJ	JJ	O
subcutaneous	subcutaneous	ADJ	JJ	O
injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
isoproterenol	isoproterenol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
ISO	ISO	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	NOUN	NN	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
time	time	NOUN	NN	O
course	course	NOUN	NN	O
was	be	VERB	VBD	O
established	establish	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
tissue	tissue	NOUN	NN	O
mass	mass	NOUN	NN	O
,	,	PUNCT	,	O
RNA	RNA	PROPN	NNP	O
and	and	CCONJ	CC	O
DNA	dna	NOUN	NN	O
content	content	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
hydroxyproline	hydroxyproline	NOUN	NN	B-Chemical
content	content	NOUN	NN	O
.	.	PUNCT	.	O

Heart	heart	NOUN	NN	O
weight	weight	NOUN	NN	O
increased	increase	VERB	VBD	O
44	44	NUM	CD	O
%	%	NOUN	NN	O
after	after	ADP	IN	O
8	8	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
half	half	ADJ	JJ	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Ventricular	ventricular	ADJ	JJ	O
RNA	RNA	PROPN	NNP	O
content	content	NOUN	NN	O
was	be	VERB	VBD	O
elevated	elevate	VERB	VBN	O
26	26	NUM	CD	O
%	%	NOUN	NN	O
after	after	ADP	IN	O
24	24	NUM	CD	O
h	h	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
injection	injection	NOUN	NN	O
and	and	CCONJ	CC	O
reached	reach	VERB	VBD	O
a	a	DET	DT	O
maximal	maximal	ADJ	JJ	O
level	level	NOUN	NN	O
following	follow	VERB	VBG	O
8	8	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
half	half	ADJ	JJ	O
time	time	NOUN	NN	O
for	for	ADP	IN	O
RNA	rna	NOUN	NN	O
accumulation	accumulation	NOUN	NN	O
was	be	VERB	VBD	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
total	total	ADJ	JJ	O
content	content	NOUN	NN	O
of	of	ADP	IN	O
hydroxyproline	hydroxyproline	NOUN	NN	B-Chemical
remained	remain	VERB	VBD	O
stable	stable	ADJ	JJ	O
during	during	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
2	2	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
but	but	CCONJ	CC	O
increased	increase	VERB	VBD	O
46	46	NUM	CD	O
%	%	NOUN	NN	O
after	after	ADP	IN	O
4	4	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Ventricular	ventricular	ADJ	JJ	O
DNA	DNA	PROPN	NNP	O
content	content	NOUN	NN	O
was	be	VERB	VBD	O
unchanged	unchanged	ADJ	JJ	O
during	during	ADP	IN	O
the	the	DET	DT	O
early	early	ADJ	JJ	O
stage	stage	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
4	4	NUM	CD	O
days	day	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
hypertrophic	hypertrophic	ADJ	JJ	B-Disease
growth	growth	NOUN	NN	O
but	but	CCONJ	CC	O
increased	increase	VERB	VBD	O
to	to	ADP	IN	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
steady	steady	ADJ	JJ	O
-	-	PUNCT	HYPH	O
state	state	NOUN	NN	O
level	level	NOUN	NN	O
19	19	NUM	CD	O
%	%	NOUN	NN	O
above	above	ADP	IN	O
the	the	DET	DT	O
controls	control	NOUN	NNS	O
after	after	ADP	IN	O
8	8	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Intraventricular	intraventricular	ADJ	JJ	O
pressures	pressure	NOUN	NNS	O
and	and	CCONJ	CC	O
coronary	coronary	ADJ	JJ	O
flow	flow	NOUN	NN	O
measures	measure	NOUN	NNS	O
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
for	for	ADP	IN	O
control	control	NOUN	NN	O
and	and	CCONJ	CC	O
experimental	experimental	ADJ	JJ	O
animals	animal	NOUN	NNS	O
following	follow	VERB	VBG	O
4	4	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
developed	developed	ADJ	JJ	O
hypertrophy	hypertrophy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
dP	dP	PROPN	NNP	O
/	/	PUNCT	NFP	O
dt	dt	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ISO	ISO	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
hearts	heart	NOUN	NNS	O
was	be	VERB	VBD	O
slightly	slightly	ADV	RB	O
but	but	CCONJ	CC	O
significantly	significantly	ADV	RB	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
elevated	elevate	VERB	VBN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
adaptive	adaptive	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
ISO	ISO	PROPN	NNP	B-Chemical
shows	show	VERB	VBZ	O
an	an	DET	DT	O
early	early	ADJ	JJ	O
hypertrophic	hypertrophic	ADJ	JJ	B-Disease
phase	phase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
4	4	NUM	CD	O
days	day	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
characterized	characterize	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
substantial	substantial	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
RNA	RNA	PROPN	NNP	O
content	content	NOUN	NN	O
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	O
mass	mass	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
DNA	dna	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
prolonged	prolong	VERB	VBN	O
stimulation	stimulation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
8	8	NUM	CD	O
-	-	SYM	SYM	O
12	12	NUM	CD	O
days	day	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
represent	represent	VERB	VB	O
a	a	DET	DT	O
complex	complex	ADJ	JJ	O
integration	integration	NOUN	NN	O
of	of	ADP	IN	O
both	both	CCONJ	CC	O
cellular	cellular	ADJ	JJ	O
hypertrophy	hypertrophy	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
hyperplasia	hyperplasia	NOUN	NN	B-Disease
within	within	ADP	IN	O
the	the	DET	DT	O
heart	heart	NOUN	NN	O
.	.	PUNCT	.	O

Multiple	multiple	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
penicillamine	penicillamine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Skin	skin	NOUN	NN	B-Disease
rashes	rash	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
proteinuria	proteinuria	NOUN	NN	B-Disease
,	,	PUNCT	,	O
systemic	systemic	ADJ	JJ	B-Disease
lupus	lupus	NOUN	NN	I-Disease
erythematosus	erythematosus	NOUN	NN	I-Disease
,	,	PUNCT	,	O
polymyositis	polymyositis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
myasthenia	myasthenia	ADJ	JJ	B-Disease
gravis	gravi	NOUN	NNS	I-Disease
have	have	VERB	VBP	O
all	all	ADV	RB	O
been	be	VERB	VBN	O
recorded	record	VERB	VBN	O
as	as	ADP	IN	O
complications	complication	NOUN	NNS	O
of	of	ADP	IN	O
penicillamine	penicillamine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
developed	develop	VERB	VBN	O
all	all	DET	DT	O
5	5	NUM	CD	O
is	be	VERB	VBZ	O
now	now	ADV	RB	O
described	describe	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
skin	skin	NOUN	NN	B-Disease
lesion	lesion	NOUN	NN	I-Disease
resembled	resemble	VERB	VBD	O
elastosis	elastosis	NOUN	NN	B-Disease
perforans	perforan	NOUN	NNS	I-Disease
serpiginosa	serpiginosa	NOUN	NN	I-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
rare	rare	ADJ	JJ	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
Wilson	Wilson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
but	but	CCONJ	CC	O
not	not	ADV	RB	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
penicillamine	penicillamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Obsolete	obsolete	ADJ	JJ	O
but	but	CCONJ	CC	O
dangerous	dangerous	ADJ	JJ	O
antacid	antacid	ADJ	JJ	O
preparations	preparation	NOUN	NNS	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
hypercalcaemia	hypercalcaemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
two	two	NUM	CD	O
of	of	ADP	IN	O
recurrent	recurrent	ADJ	JJ	O
nephrolithiasis	nephrolithiasis	NOUN	NN	B-Disease
are	be	VERB	VBP	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
regularly	regularly	ADV	RB	O
consumed	consume	VERB	VBN	O
large	large	ADJ	JJ	O
amounts	amount	NOUN	NNS	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
carbon	carbon	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
ate	ate	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
sodium	sodium	NOUN	NN	B-Chemical
bicarbonate	bicarbonate	NOUN	NN	I-Chemical
powders	powder	NOUN	NNS	O
for	for	ADP	IN	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
20	20	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
powders	powder	NOUN	NNS	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
obtained	obtain	VERB	VBN	O
from	from	ADP	IN	O
pharmacists	pharmacist	NOUN	NNS	O
unknown	unknown	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
'	'	PART	POS	O
medical	medical	ADJ	JJ	O
practitioners	practitioner	NOUN	NNS	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
suggested	suggest	VERB	VBN	O
that	that	ADP	IN	O
these	these	DET	DT	O
preparations	preparation	NOUN	NNS	O
were	be	VERB	VBD	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	PART	POS	O
problems	problem	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
that	that	ADP	IN	O
such	such	ADJ	JJ	O
powders	powder	NOUN	NNS	O
should	should	VERB	MD	O
no	no	ADV	RB	O
longer	longer	ADV	RB	O
be	be	VERB	VB	O
freely	freely	ADV	RB	O
obtainable	obtainable	ADJ	JJ	O
.	.	PUNCT	.	O

Doxorubicin	doxorubicin	ADJ	JJ	B-Chemical
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
in	in	ADP	IN	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
left	left	ADV	RB	O
-	-	PUNCT	HYPH	O
sided	sided	ADJ	JJ	O
Wilms	Wilms	PROPN	NNPS	B-Disease
tumor	tumor	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Two	two	NUM	CD	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
Wilms	Wilms	PROPN	NNPS	B-Disease
tumor	tumor	NOUN	NN	I-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
left	left	ADJ	JJ	O
kidney	kidney	NOUN	NN	O
experienced	experience	VERB	VBD	O
severe	severe	ADJ	JJ	O
anthracycline	anthracycline	ADJ	JJ	B-Chemical
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
after	after	ADP	IN	O
irradiation	irradiation	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
tumor	tumor	NOUN	NN	B-Disease
bed	bed	NOUN	NN	O
and	and	CCONJ	CC	O
conventional	conventional	ADJ	JJ	O
dosage	dosage	NOUN	NN	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
attributed	attribute	VERB	VBN	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
the	the	DET	DT	O
fact	fact	NOUN	NN	O
that	that	ADP	IN	O
radiation	radiation	NOUN	NN	O
fields	field	NOUN	NNS	O
for	for	ADP	IN	O
left	left	ADJ	JJ	O
Wilms	Wilms	PROPN	NNPS	B-Disease
tumor	tumor	NOUN	NN	I-Disease
include	include	VERB	VBP	O
the	the	DET	DT	O
lower	low	ADJ	JJR	O
portion	portion	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
heart	heart	NOUN	NN	O
and	and	CCONJ	CC	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
the	the	DET	DT	O
interaction	interaction	NOUN	NN	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
irradiation	irradiation	NOUN	NN	O
on	on	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
muscle	muscle	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
recommended	recommend	VERB	VBN	O
that	that	ADP	IN	O
doxorubicin	doxorubicin	ADJ	JJ	B-Chemical
dosage	dosage	NOUN	NN	O
be	be	VERB	VB	O
sharply	sharply	ADV	RB	O
restricted	restrict	VERB	VBN	O
in	in	ADP	IN	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
Wilms	Wilms	PROPN	NNPS	B-Disease
tumor	tumor	NOUN	NN	I-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
left	left	ADJ	JJ	O
kidney	kidney	NOUN	NN	O
who	who	PRON	WP	O
receive	receive	VERB	VBP	O
postoperative	postoperative	ADJ	JJ	O
irradiation	irradiation	NOUN	NN	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
calcitonin	calcitonin	NOUN	NN	O
on	on	ADP	IN	O
rat	rat	NOUN	NN	O
extrapyramidal	extrapyramidal	ADJ	JJ	O
motor	motor	NOUN	NN	O
system	system	NOUN	NN	O
:	:	PUNCT	:	O
behavioral	behavioral	ADJ	JJ	O
and	and	CCONJ	CC	O
biochemical	biochemical	ADJ	JJ	O
data	datum	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
human	human	NOUN	NN	O
and	and	CCONJ	CC	O
salmon	salmon	NOUN	NN	O
calcitonin	calcitonin	NOUN	NN	O
on	on	ADP	IN	O
biochemical	biochemical	ADJ	JJ	O
and	and	CCONJ	CC	O
behavioral	behavioral	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
extrapyramidal	extrapyramidal	ADJ	JJ	O
motor	motor	NOUN	NN	O
system	system	NOUN	NN	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
in	in	ADP	IN	O
male	male	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Calcitonin	calcitonin	ADJ	JJ	O
injection	injection	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
a	a	DET	DT	O
potentiation	potentiation	NOUN	NN	O
of	of	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
a	a	DET	DT	O
partial	partial	ADJ	JJ	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hyperactivity	hyperactivity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
calcitonin	calcitonin	NOUN	NN	O
induced	induce	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
nigral	nigral	ADJ	JJ	O
GAD	GAD	PROPN	NNP	O
activity	activity	NOUN	NN	O
but	but	CCONJ	CC	O
no	no	DET	DT	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
striatal	striatal	ADJ	JJ	O
DA	DA	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
DOPAC	DOPAC	PROPN	NNP	B-Chemical
concentration	concentration	NOUN	NN	O
or	or	CCONJ	CC	O
GAD	GAD	PROPN	NNP	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
are	be	VERB	VBP	O
discussed	discuss	VERB	VBN	O
in	in	ADP	IN	O
view	view	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
primary	primary	ADJ	JJ	O
action	action	NOUN	NN	O
of	of	ADP	IN	O
calcitonin	calcitonin	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
striatonigral	striatonigral	ADJ	JJ	O
GABAergic	GABAergic	PROPN	NNP	O
pathway	pathway	ADV	RB	O
mediating	mediate	VERB	VBG	O
the	the	DET	DT	O
DA	DA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
behavioral	behavioral	ADJ	JJ	O
messages	message	NOUN	NNS	O
of	of	ADP	IN	O
striatal	striatal	ADJ	JJ	O
origin	origin	NOUN	NN	O
.	.	PUNCT	.	O

Naloxazone	naloxazone	NOUN	NN	B-Chemical
pretreatment	pretreatment	ADJ	JJ	O
modifies	modifie	NOUN	NNS	O
cardiorespiratory	cardiorespiratory	NOUN	NN	O
,	,	PUNCT	,	O
temperature	temperature	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
behavioral	behavioral	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Behavioral	behavioral	ADJ	JJ	O
and	and	CCONJ	CC	O
cardiorespiratory	cardiorespiratory	NOUN	NN	O
responses	response	NOUN	NNS	O
to	to	ADP	IN	O
a	a	DET	DT	O
lethal	lethal	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
or	or	CCONJ	CC	O
naloxazone	naloxazone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
an	an	DET	DT	O
antagonist	antagonist	NOUN	NN	O
of	of	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
affinity	affinity	NOUN	NN	O
mu	mu	NOUN	NNS	O
1	1	NUM	CD	O
opioid	opioid	ADJ	JJ	O
receptors	receptor	NOUN	NNS	O
.	.	PUNCT	.	O

Pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
naloxazone	naloxazone	NOUN	NN	B-Chemical
significantly	significantly	ADV	RB	O
blocked	block	VERB	VBN	O
morphine	morphine	NOUN	NN	B-Chemical
analgesia	analgesia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
catalepsy	catalepsy	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
hypothermia	hypothermia	NOUN	NN	B-Disease
at	at	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
which	which	DET	WDT	O
completely	completely	ADV	RB	O
eliminated	eliminate	VERB	VBD	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
affinity	affinity	NOUN	NN	O
binding	bind	VERB	VBG	O
in	in	ADP	IN	O
brain	brain	NOUN	NN	O
membranes	membrane	NOUN	NNS	O
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
naloxazone	naloxazone	NOUN	NN	B-Chemical
significantly	significantly	ADV	RB	O
attenuated	attenuate	VERB	VBD	O
the	the	DET	DT	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
respiratory	respiratory	ADJ	JJ	B-Disease
depression	depression	NOUN	NN	I-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
bradycardia	bradycardia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
less	less	ADV	RBR	O
affected	affected	ADJ	JJ	O
.	.	PUNCT	.	O

Results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
subpopulations	subpopulation	NOUN	NNS	O
of	of	ADP	IN	O
mu	mu	NOUN	NNS	O
receptors	receptor	NOUN	NNS	O
may	may	VERB	MD	O
mediate	mediate	VERB	VB	O
selective	selective	ADJ	JJ	O
behavioral	behavioral	ADJ	JJ	O
and	and	CCONJ	CC	O
cardiorespiratory	cardiorespiratory	NOUN	NN	O
responses	response	NOUN	NNS	O
to	to	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Modification	modification	NOUN	NN	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
action	action	NOUN	NN	O
by	by	ADP	IN	O
hyperammonemia	hyperammonemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
ammonium	ammonium	NOUN	NN	B-Chemical
acetate	acetate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NH4Ac	NH4Ac	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
mmol	mmol	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	PROPN	NNP	O
s	s	PROPN	NNPS	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
approximately	approximately	ADV	RB	O
doubled	double	VERB	VBD	O
the	the	DET	DT	O
time	time	NOUN	NN	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
mice	mouse	NOUN	NNS	O
remained	remain	VERB	VBD	O
on	on	ADP	IN	O
a	a	DET	DT	O
hot	hot	ADJ	JJ	O
surface	surface	NOUN	NN	O
and	and	CCONJ	CC	O
similarly	similarly	ADV	RB	O
increased	increase	VERB	VBN	O
muscular	muscular	ADJ	JJ	O
incoordination	incoordination	NOUN	NN	B-Disease
by	by	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
NH4Ac	NH4Ac	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
alone	alone	ADV	RB	O
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
hyperammonemia	hyperammonemia	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
capable	capable	ADJ	JJ	O
of	of	ADP	IN	O
altering	alter	VERB	VBG	O
drug	drug	NOUN	NN	O
action	action	NOUN	NN	O
and	and	CCONJ	CC	O
must	must	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
along	along	PART	RP	O
with	with	ADP	IN	O
impaired	impaired	ADJ	JJ	O
drug	drug	NOUN	NN	O
metabolism	metabolism	NOUN	NN	O
in	in	ADP	IN	O
enhanced	enhance	VERB	VBN	O
drug	drug	NOUN	NN	O
responses	response	NOUN	NNS	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
liver	liver	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Experiments	experiment	NOUN	NNS	O
in	in	ADP	IN	O
vitro	vitro	NOUN	NN	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
acetylcholine	acetylcholine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
catecholamine	catecholamine	NOUN	NN	B-Chemical
release	release	NOUN	NN	O
from	from	ADP	IN	O
bovine	bovine	ADJ	JJ	O
adrenal	adrenal	ADJ	JJ	O
medulla	medulla	NOUN	NN	O
is	be	VERB	VBZ	O
depressed	depressed	ADJ	JJ	O
as	as	ADV	RB	O
much	much	ADJ	JJ	O
as	as	ADP	IN	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
by	by	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
mM	mM	PROPN	NNP	O
NH4Ac	NH4Ac	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
KCl	KCl	NOUN	NNS	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
contractions	contraction	NOUN	NNS	O
of	of	ADP	IN	O
guinea	guinea	NOUN	NN	O
-	-	PUNCT	HYPH	O
pig	pig	NOUN	NN	O
ileum	ileum	NOUN	NN	O
were	be	VERB	VBD	O
inhibited	inhibit	VERB	VBN	O
20	20	NUM	CD	O
%	%	NOUN	NN	O
by	by	ADP	IN	O
5	5	NUM	CD	O
mM	mM	PROPN	NNP	O
NH4Ac	NH4Ac	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Addition	addition	NOUN	NN	O
of	of	ADP	IN	O
excess	excess	ADJ	JJ	O
calcium	calcium	NOUN	NN	B-Chemical
reversed	reverse	VERB	VBD	O
the	the	DET	DT	O
depression	depression	NOUN	NN	B-Disease
in	in	ADP	IN	O
both	both	DET	DT	O
tissues	tissue	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
calcium	calcium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
independent	independent	ADJ	JJ	O
catecholamine	catecholamine	NOUN	NN	B-Chemical
release	release	NOUN	NN	O
by	by	ADP	IN	O
acetaldehyde	acetaldehyde	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
not	not	ADV	RB	O
blocked	block	VERB	VBN	O
by	by	ADP	IN	O
NH4Ac	NH4Ac	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggested	suggest	VERB	VBD	O
that	that	ADP	IN	O
ammonia	ammonia	NOUN	NN	B-Chemical
blocks	block	NOUN	NNS	O
calcium	calcium	NOUN	NN	B-Chemical
channels	channel	NOUN	NNS	O
.	.	PUNCT	.	O

Parallels	parallel	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
actions	action	NOUN	NNS	O
of	of	ADP	IN	O
NH4Ac	NH4Ac	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
calcium	calcium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
blocker	blocker	NOUN	NN	O
verapamil	verapamil	NOUN	NN	B-Chemical
support	support	NOUN	NN	O
this	this	DET	DT	O
concept	concept	NOUN	NN	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
verapamil	verapamil	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
NH4Ac	NH4Ac	PROPN	NNP	B-Chemical
pretreatment	pretreatment	NOUN	NN	O
enhanced	enhance	VERB	VBD	O
morphine	morphine	NOUN	NN	B-Chemical
analgesia	analgesia	NOUN	NN	B-Disease
-	-	PUNCT	,	O
and	and	CCONJ	CC	O
diazepam	diazepam	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
muscular	muscular	ADJ	JJ	O
incoordination	incoordination	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
antagonized	antagonize	VERB	VBN	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
motor	motor	NOUN	NN	O
activity	activity	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
neither	neither	CCONJ	CC	O
verapamil	verapamil	NOUN	NN	B-Chemical
nor	nor	CCONJ	CC	O
NH4Ac	NH4Ac	PROPN	NNP	B-Chemical
affected	affect	VERB	VBD	O
the	the	DET	DT	O
convulsant	convulsant	ADJ	JJ	O
action	action	NOUN	NN	O
of	of	ADP	IN	O
metrazol	metrazol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
hyperammonemia	hyperammonemia	NOUN	NN	B-Disease
exerts	exert	VERB	VBZ	O
a	a	DET	DT	O
calcium	calcium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
blocking	block	VERB	VBG	O
action	action	NOUN	NN	O
which	which	DET	WDT	O
enhances	enhance	VERB	VBZ	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
central	central	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
depressants	depressant	NOUN	NNS	O
and	and	CCONJ	CC	O
certain	certain	ADJ	JJ	O
opioid	opioid	NOUN	NN	O
analgesics	analgesic	NOUN	NNS	O
.	.	PUNCT	.	O

Levodopa	Levodopa	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
thalamotomy	thalamotomy	NOUN	NN	O
.	.	PUNCT	.	O

Levodopa	Levodopa	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
limbs	limb	NOUN	NNS	O
in	in	ADP	IN	O
thirteen	thirteen	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
Parkinsonism	Parkinsonism	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
choreic	choreic	NOUN	NN	O
,	,	PUNCT	,	O
ballistic	ballistic	ADJ	JJ	O
or	or	CCONJ	CC	O
dystonic	dystonic	ADJ	JJ	B-Disease
in	in	ADP	IN	O
type	type	NOUN	NN	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
alleviated	alleviate	VERB	VBN	O
almost	almost	ADV	RB	O
completely	completely	ADV	RB	O
by	by	ADP	IN	O
stereotaxic	stereotaxic	ADJ	JJ	O
surgery	surgery	NOUN	NN	O
using	use	VERB	VBG	O
a	a	DET	DT	O
microelectrode	microelectrode	NOUN	NN	O
technique	technique	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
ventralis	ventralis	NOUN	NN	O
oralis	oralis	ADP	IN	O
anterior	anterior	ADJ	JJ	O
and	and	CCONJ	CC	O
posterior	posterior	ADJ	JJ	O
nuclei	nucleus	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
thalamus	thalamus	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
much	much	ADV	RB	O
less	less	ADJ	JJR	O
by	by	ADP	IN	O
the	the	DET	DT	O
ventralis	ventralis	NOUN	NN	O
intermedius	intermedius	NOUN	NN	O
nucleus	nucleus	NOUN	NN	O
.	.	PUNCT	.	O

Control	control	NOUN	NN	O
of	of	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
by	by	ADP	IN	O
thalamic	thalamic	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
routine	routine	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
Parkinsonism	Parkinsonism	PROPN	NNP	B-Disease
is	be	VERB	VBZ	O
discussed	discuss	VERB	VBN	O
.	.	PUNCT	.	O

Treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
urothelial	urothelial	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
by	by	ADP	IN	O
oral	oral	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
mercaptoethane	mercaptoethane	NOUN	NN	I-Chemical
sulphonate	sulphonate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
MESNA	MESNA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
inoperable	inoperable	ADJ	JJ	O
lung	lung	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
protective	protective	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
oral	oral	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
thiol	thiol	NOUN	NN	B-Chemical
compound	compound	NOUN	NN	O
sodium	sodium	NOUN	NN	B-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
mercaptoethane	mercaptoethane	NOUN	NN	I-Chemical
sulphonate	sulphonate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
MESNA	MESNA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
against	against	ADP	IN	O
urothelial	urothelial	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
IF	IF	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
tested	test	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
45	45	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
inoperable	inoperable	ADJ	JJ	O
lung	lung	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
under	under	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
IF	IF	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
2250	2250	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
on	on	ADP	IN	O
days	day	NOUN	NNS	O
2	2	NUM	CD	O
-	-	SYM	SYM	O
5	5	NUM	CD	O
)	)	PUNCT	-RRB-	O
as	as	ADP	IN	O
part	part	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
polychemotherapy	polychemotherapy	NOUN	NN	O
regimen	regimen	NOUN	NN	O
repeated	repeat	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
4	4	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
cycle	cycle	NOUN	NN	O
.	.	PUNCT	.	O

MESNA	MESNA	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
given	give	VERB	VBN	O
orally	orally	ADV	RB	O
on	on	ADP	IN	O
the	the	DET	DT	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
IF	IF	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
3	3	NUM	CD	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
840	840	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
,	,	PUNCT	,	O
each	each	DET	DT	O
administered	administer	VERB	VBD	O
at	at	ADP	IN	O
0	0	NUM	CD	O
hr	hr	NOUN	NN	O
(	(	PUNCT	-LRB-	O
=	=	ADP	IN	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
IF	IF	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
hr	hr	NOUN	NN	O
and	and	CCONJ	CC	O
8	8	NUM	CD	O
hr	hr	NOUN	NN	O
p	p	X	XX	O
.	.	PUNCT	.	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O

Out	out	ADP	IN	O
of	of	ADP	IN	O
a	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
88	88	NUM	CD	O
courses	course	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
treatment	treatment	NOUN	NN	O
we	-PRON-	PRON	PRP	O
observed	observe	VERB	VBD	O
10	10	NUM	CD	O
episodes	episode	NOUN	NNS	O
of	of	ADP	IN	O
asymptomatic	asymptomatic	ADJ	JJ	O
microscopic	microscopic	ADJ	JJ	O
haematuria	haematuria	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
no	no	DET	DT	O
episodes	episode	NOUN	NNS	O
of	of	ADP	IN	O
gross	gross	ADJ	JJ	O
haematuria	haematuria	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
45	45	NUM	CD	O
patients	patient	NOUN	NNS	O
under	under	ADP	IN	O
protection	protection	NOUN	NN	O
with	with	ADP	IN	O
MESNA	MESNA	PROPN	NNP	B-Chemical
there	there	ADV	EX	O
were	be	VERB	VBD	O
5	5	NUM	CD	O
complete	complete	ADJ	JJ	O
remissions	remission	NOUN	NNS	O
and	and	CCONJ	CC	O
9	9	NUM	CD	O
partial	partial	ADJ	JJ	O
remissions	remission	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
total	total	ADJ	JJ	O
31	31	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
further	further	ADJ	JJ	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
25	25	NUM	CD	O
patients	patient	NOUN	NNS	O
under	under	ADP	IN	O
polychemotherapy	polychemotherapy	NOUN	NN	O
with	with	ADP	IN	O
IF	IF	PROPN	NNP	B-Chemical
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
by	by	ADP	IN	O
conventional	conventional	ADJ	JJ	O
prophylactic	prophylactic	ADJ	JJ	O
measures	measure	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
raised	raise	VERB	VBN	O
fluid	fluid	ADJ	JJ	O
intake	intake	NOUN	NN	O
and	and	CCONJ	CC	O
forced	force	VERB	VBN	O
diuresis	diuresis	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
group	group	NOUN	NN	O
there	there	ADV	EX	O
were	be	VERB	VBD	O
1	1	NUM	CD	O
complete	complete	ADJ	JJ	O
and	and	CCONJ	CC	O
5	5	NUM	CD	O
partial	partial	ADJ	JJ	O
remissions	remission	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
total	total	ADJ	JJ	O
24	24	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
nearly	nearly	ADV	RB	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
either	either	CCONJ	CC	O
gross	gross	ADJ	JJ	O
haematuria	haematuria	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
bladder	bladder	NOUN	NN	B-Disease
irritation	irritation	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
cystitis	cystitis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
pollakisuria	pollakisuria	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
appreciable	appreciable	ADJ	JJ	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
the	the	DET	DT	O
MESNA	MESNA	PROPN	NNP	B-Chemical
series	series	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
conventional	conventional	ADJ	JJ	O
prophylaxis	prophylaxis	NOUN	NN	O
series	series	NOUN	NN	O
with	with	ADP	IN	O
respect	respect	NOUN	NN	O
to	to	ADP	IN	O
either	either	CCONJ	CC	O
haematological	haematological	ADJ	JJ	O
or	or	CCONJ	CC	O
systemic	systemic	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
cytostatic	cytostatic	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
support	support	VERB	VBP	O
the	the	DET	DT	O
view	view	NOUN	NN	O
that	that	ADP	IN	O
MESNA	MESNA	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
given	give	VERB	VBN	O
orally	orally	ADV	RB	O
in	in	ADP	IN	O
conjunction	conjunction	NOUN	NN	O
with	with	ADP	IN	O
combined	combine	VERB	VBN	O
cytostatic	cytostatic	ADJ	JJ	O
regimens	regimen	NOUN	NNS	O
which	which	DET	WDT	O
include	include	VERB	VBP	O
IF	if	ADP	IN	B-Chemical
,	,	PUNCT	,	O
simplifies	simplify	VERB	VBZ	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
and	and	CCONJ	CC	O
provides	provide	VERB	VBZ	O
optimum	optimum	ADJ	JJ	O
protection	protection	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
urinary	urinary	ADJ	JJ	O
epithelium	epithelium	NOUN	NN	O
.	.	PUNCT	.	O

Protection	protection	NOUN	NN	O
with	with	ADP	IN	O
oral	oral	ADJ	JJ	O
MESNA	MESNA	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
particularly	particularly	ADV	RB	O
suitable	suitable	ADJ	JJ	O
for	for	ADP	IN	O
outpatients	outpatient	NOUN	NNS	O
.	.	PUNCT	.	O

Myoclonic	myoclonic	ADJ	JJ	B-Disease
,	,	PUNCT	,	I-Disease
atonic	atonic	ADJ	JJ	I-Disease
,	,	PUNCT	,	I-Disease
and	and	CCONJ	CC	I-Disease
absence	absence	NOUN	NN	I-Disease
seizures	seizure	NOUN	NNS	I-Disease
following	follow	VERB	VBG	O
institution	institution	NOUN	NN	O
of	of	ADP	IN	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
children	child	NOUN	NNS	O
.	.	PUNCT	.	O

Five	five	NUM	CD	O
children	child	NOUN	NNS	O
,	,	PUNCT	,	O
aged	age	VERB	VBN	O
3	3	NUM	CD	O
to	to	ADP	IN	O
11	11	NUM	CD	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
epilepsy	epilepsy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
had	have	VERB	VBD	O
an	an	DET	DT	O
acute	acute	ADJ	JJ	O
aberrant	aberrant	ADJ	JJ	O
reaction	reaction	NOUN	NN	O
characterized	characterize	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
myoclonic	myoclonic	ADJ	JJ	B-Disease
,	,	PUNCT	,	I-Disease
atypical	atypical	ADJ	JJ	I-Disease
absence	absence	NOUN	NN	I-Disease
and	and	CCONJ	CC	I-Disease
/	/	SYM	SYM	I-Disease
or	or	CCONJ	CC	I-Disease
atonic	atonic	ADJ	JJ	I-Disease
(	(	PUNCT	-LRB-	I-Disease
minor	minor	ADJ	JJ	I-Disease
motor	motor	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	I-Disease
seizures	seizure	NOUN	NNS	I-Disease
within	within	ADP	IN	O
a	a	DET	DT	O
few	few	ADJ	JJ	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
the	the	DET	DT	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
,	,	PUNCT	,	O
two	two	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
children	child	NOUN	NNS	O
returned	return	VERB	VBD	O
to	to	ADP	IN	O
their	-PRON-	DET	PRP$	O
former	former	ADJ	JJ	O
state	state	NOUN	NN	O
very	very	ADV	RB	O
quickly	quickly	ADV	RB	O
,	,	PUNCT	,	O
two	two	NUM	CD	O
had	have	VERB	VBD	O
the	the	DET	DT	O
minor	minor	ADJ	JJ	O
motor	motor	NOUN	NN	O
seizures	seizure	NOUN	NNS	B-Disease
resolve	resolve	VERB	VBP	O
in	in	ADP	IN	O
3	3	NUM	CD	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
months	month	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
one	one	PRON	PRP	O
had	have	VERB	VBD	O
the	the	DET	DT	O
seizures	seizure	NOUN	NNS	B-Disease
persist	persist	VERB	VB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
child	child	NOUN	NN	O
in	in	ADP	IN	O
whom	whom	PRON	WP	O
the	the	DET	DT	O
seizures	seizure	NOUN	NNS	B-Disease
persisted	persist	VERB	VBD	O
was	be	VERB	VBD	O
later	later	ADV	RB	O
found	find	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
ceroid	ceroid	ADJ	JJ	B-Disease
lipofuscinosis	lipofuscinosis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
other	other	ADJ	JJ	O
children	child	NOUN	NNS	O
are	be	VERB	VBP	O
doing	do	VERB	VBG	O
well	well	ADV	RB	O
on	on	ADP	IN	O
other	other	ADJ	JJ	O
anticonvulsants	anticonvulsant	NOUN	NNS	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
synthetase	synthetase	NOUN	NN	O
inhibitors	inhibitor	NOUN	NNS	O
on	on	ADP	IN	O
experimentally	experimentally	ADV	RB	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

To	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
relationship	relationship	NOUN	NN	O
of	of	ADP	IN	O
prostaglandins	prostaglandin	NOUN	NNS	B-Chemical
(	(	PUNCT	-LRB-	O
PGs	pg	NOUN	NNS	B-Chemical
)	)	PUNCT	-RRB-	O
to	to	PART	TO	O
seizure	seizure	VERB	VB	B-Disease
induction	induction	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
six	six	NUM	CD	O
PG	pg	NOUN	NN	O
synthetase	synthetase	NOUN	NN	O
inhibitors	inhibitor	NOUN	NNS	O
on	on	ADP	IN	O
convulsions	convulsion	NOUN	NNS	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
flurothyl	flurothyl	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
picrotoxin	picrotoxin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
pentetrazol	pentetrazol	ADP	IN	B-Chemical
(	(	PUNCT	-LRB-	O
PTZ	PTZ	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
electroshock	electroshock	NOUN	NN	O
or	or	CCONJ	CC	O
bicuculline	bicuculline	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
.	.	PUNCT	.	O

Ibuprofen	Ibuprofen	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
sulindac	sulindac	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
mefenamic	mefenamic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
low	low	ADJ	JJ	O
dose	dose	NOUN	NN	O
meclofenamic	meclofenamic	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
increased	increase	VERB	VBD	O
the	the	DET	DT	O
latency	latency	NOUN	NN	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
onset	onset	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
flurothyl	flurothyl	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
PTZ	ptz	NOUN	NN	B-Chemical
models	model	NOUN	NNS	O
;	;	PUNCT	:	O
the	the	DET	DT	O
electroshock	electroshock	NOUN	NN	O
,	,	PUNCT	,	O
picrotoxin	picrotoxin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
bicuculline	bicuculline	NOUN	NN	B-Chemical
models	model	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
affected	affect	VERB	VBN	O
by	by	ADP	IN	O
any	any	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
pretreatment	pretreatment	ADJ	JJ	O
agents	agent	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
PGs	pg	NOUN	NNS	B-Chemical
are	be	VERB	VBP	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
(	(	PUNCT	-LRB-	O
s	s	NOUN	NN	O
)	)	PUNCT	-RRB-	O
underlying	underlie	VERB	VBG	O
fluorthyl	fluorthyl	NOUN	NN	B-Chemical
-	-	PUNCT	:	O
and	and	CCONJ	CC	O
PTZ	ptz	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
picrotoxin	picrotoxin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
electroshock	electroshock	NOUN	NN	O
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
bicuculline	bicuculline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
convulsions	convulsion	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	O
changes	change	NOUN	NNS	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
ammonia	ammonia	NOUN	NN	B-Chemical
may	may	VERB	MD	O
predict	predict	VERB	VB	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
valproic	valproic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Valproic	Valproic	PROPN	NNP	B-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
VPA	VPA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
given	give	VERB	VBN	O
to	to	ADP	IN	O
24	24	NUM	CD	O
epileptic	epileptic	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
already	already	ADV	RB	O
being	be	VERB	VBG	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
antiepileptic	antiepileptic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
standardized	standardized	ADJ	JJ	O
loading	loading	NOUN	NN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
VPA	VPA	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
venous	venous	ADJ	JJ	O
blood	blood	NOUN	NN	O
was	be	VERB	VBD	O
sampled	sample	VERB	VBN	O
at	at	ADP	IN	O
0	0	NUM	CD	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
4	4	NUM	CD	O
hours	hour	NOUN	NNS	O
.	.	PUNCT	.	O

Ammonia	Ammonia	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
NH3	NH3	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
,	,	PUNCT	,	O
during	during	ADP	IN	O
continuous	continuous	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
complained	complain	VERB	VBD	O
of	of	ADP	IN	O
drowsiness	drowsiness	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
7	7	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
in	in	ADP	IN	O
those	those	DET	DT	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
symptom	symptom	NOUN	NN	O
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
17	17	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
VPA	VPA	PROPN	NNP	B-Chemical
plasma	plasma	NOUN	NN	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

By	by	ADP	IN	O
measuring	measure	VERB	VBG	O
VPA	VPA	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
changes	change	NOUN	NNS	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
NH3	NH3	PROPN	NNP	B-Chemical
content	content	NOUN	NN	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
be	be	VERB	VB	O
possible	possible	ADJ	JJ	O
to	to	PART	TO	O
identify	identify	VERB	VB	O
patients	patient	NOUN	NNS	O
at	at	ADP	IN	O
higher	high	ADJ	JJR	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
obtundation	obtundation	NOUN	NN	O
when	when	ADV	WRB	O
VPA	VPA	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
given	give	VERB	VBN	O
chronically	chronically	ADV	RB	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
captopril	captopril	NOUN	NN	B-Chemical
on	on	ADP	IN	O
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
existing	existing	ADJ	JJ	O
and	and	CCONJ	CC	O
aminonucleoside	aminonucleoside	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
proteinuria	proteinuria	NOUN	NN	B-Disease
in	in	ADP	IN	O
spontaneously	spontaneously	ADV	RB	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Proteinuria	Proteinuria	PROPN	NNP	B-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
captopril	captopril	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
in	in	ADP	IN	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
possibility	possibility	NOUN	NN	O
of	of	ADP	IN	O
reproducing	reproduce	VERB	VBG	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
abnormality	abnormality	NOUN	NN	I-Disease
with	with	ADP	IN	O
captopril	captopril	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
examined	examine	VERB	VBN	O
in	in	ADP	IN	O
SHR	SHR	PROPN	NNP	O
.	.	PUNCT	.	O

Oral	oral	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
captopril	captopril	NOUN	NN	B-Chemical
at	at	ADP	IN	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
for	for	ADP	IN	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
failed	fail	VERB	VBD	O
to	to	PART	TO	O
aggravate	aggravate	VERB	VB	O
proteinuria	proteinuria	X	FW	B-Disease
pre	pre	VERB	VBN	O
-	-	ADJ	JJ	O
existing	exist	VERB	VBG	O
in	in	ADP	IN	O
SHR	SHR	PROPN	NNP	O
.	.	PUNCT	.	O

Also	also	ADV	RB	O
,	,	PUNCT	,	O
captopril	captopril	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
failed	fail	VERB	VBD	O
to	to	PART	TO	O
potentiate	potentiate	VERB	VB	O
or	or	CCONJ	CC	O
facilitate	facilitate	VERB	VB	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
massive	massive	ADJ	JJ	O
proteinuria	proteinuria	NOUN	NN	B-Disease
invoked	invoke	VERB	VBN	O
by	by	ADP	IN	O
puromycin	puromycin	ADJ	JJ	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
in	in	ADP	IN	O
SHR	SHR	PROPN	NNP	O
.	.	PUNCT	.	O

Captopril	Captopril	PROPN	NNP	B-Chemical
had	have	VERB	VBD	O
little	little	ADJ	JJ	O
or	or	CCONJ	CC	O
no	no	DET	DT	O
demonstrable	demonstrable	ADJ	JJ	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
serum	serum	ADJ	JJ	O
electrolyte	electrolyte	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
,	,	PUNCT	,	O
excretion	excretion	NOUN	NN	O
of	of	ADP	IN	O
urine	urine	NOUN	NN	O
,	,	PUNCT	,	O
sodium	sodium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
potassium	potassium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
endogenous	endogenous	ADJ	JJ	O
creatinine	creatinine	NOUN	NN	B-Chemical
clearance	clearance	NOUN	NN	O
,	,	PUNCT	,	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
food	food	NOUN	NN	O
and	and	CCONJ	CC	O
water	water	NOUN	NN	O
consumption	consumption	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
ketone	ketone	VERB	VBD	B-Chemical
bodies	body	NOUN	NNS	O
were	be	VERB	VBD	O
consistently	consistently	ADV	RB	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
urine	urine	NOUN	NN	O
and	and	CCONJ	CC	O
several	several	ADJ	JJ	O
lethalities	lethality	NOUN	NNS	O
occurred	occur	VERB	VBD	O
during	during	ADP	IN	O
multiple	multiple	ADJ	JJ	O
dosing	dosing	NOUN	NN	O
of	of	ADP	IN	O
captopril	captopril	NOUN	NN	B-Chemical
in	in	ADP	IN	O
SHR	SHR	PROPN	NNP	O
.	.	PUNCT	.	O

Complete	complete	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
block	block	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
trazodone	trazodone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Forty	forty	NUM	CD	O
minutes	minute	NOUN	NNS	O
after	after	ADP	IN	O
receiving	receive	VERB	VBG	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
starting	starting	NOUN	NN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
trazodone	trazodone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
developed	develop	VERB	VBN	O
complete	complete	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
block	block	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
case	case	NOUN	NN	O
illustrates	illustrate	VERB	VBZ	O
that	that	ADP	IN	O
,	,	PUNCT	,	O
despite	despite	ADP	IN	O
the	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
earlier	early	ADJ	JJR	O
studies	study	NOUN	NNS	O
,	,	PUNCT	,	O
trazodone	trazodone	NOUN	NN	B-Chemical
'	'	PUNCT	''	O
s	s	VERB	VBZ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
conduction	conduction	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
severe	severe	ADJ	JJ	O
in	in	ADP	IN	O
individuals	individual	NOUN	NNS	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
conduction	conduction	NOUN	NN	O
delay	delay	NOUN	NN	O
.	.	PUNCT	.	O

Phenobarbital	phenobarbital	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
neurologically	neurologically	ADV	RB	B-Disease
-	-	PUNCT	HYPH	I-Disease
impaired	impair	VERB	VBN	I-Disease
child	child	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
child	child	NOUN	NN	O
with	with	ADP	IN	O
known	know	VERB	VBN	O
neurologic	neurologic	ADJ	JJ	B-Disease
impairment	impairment	NOUN	NN	I-Disease
developed	develop	VERB	VBD	O
a	a	DET	DT	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
soon	soon	ADV	RB	O
after	after	ADP	IN	O
starting	start	VERB	VBG	O
phenobarbital	phenobarbital	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Known	known	ADJ	JJ	O
causes	cause	NOUN	NNS	O
of	of	ADP	IN	O
movement	movement	NOUN	NN	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
eliminated	eliminate	VERB	VBN	O
after	after	ADP	IN	O
evaluation	evaluation	NOUN	NN	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
repeat	repeat	NOUN	NN	O
challenge	challenge	NOUN	NN	O
with	with	ADP	IN	O
phenobarbital	phenobarbital	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
recurred	recur	VERB	VBD	O
.	.	PUNCT	.	O

Phenobarbital	phenobarbital	NOUN	NN	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
added	add	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
list	list	NOUN	NN	O
of	of	ADP	IN	O
anticonvulsant	anticonvulsant	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
that	that	DET	WDT	O
can	can	VERB	MD	O
cause	cause	VERB	VB	O
movement	movement	NOUN	NN	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
amine	amine	NOUN	NN	B-Chemical
pretreatment	pretreatment	NOUN	NN	O
on	on	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
catatonia	catatonia	NOUN	NN	B-Disease
in	in	ADP	IN	O
pinealectomized	pinealectomized	ADJ	JJ	O
or	or	CCONJ	CC	O
hypophysectomized	hypophysectomize	VERB	VBN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
studies	study	NOUN	NNS	O
were	be	VERB	VBD	O
designed	design	VERB	VBN	O
to	to	PART	TO	O
clarify	clarify	VERB	VB	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
catecholamines	catecholamine	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
pineal	pineal	ADJ	JJ	O
idolamines	idolamine	NOUN	NNS	O
on	on	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
catatonia	catatonia	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
intact	intact	ADJ	JJ	O
,	,	PUNCT	,	O
pinealectomized	pinealectomized	ADJ	JJ	O
or	or	CCONJ	CC	O
hypophysectomized	hypophysectomize	VERB	VBN	O
chick	chick	NOUN	NN	O
and	and	CCONJ	CC	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
pinealectomized	pinealectomized	ADJ	JJ	O
chick	chick	NOUN	NN	O
,	,	PUNCT	,	O
pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
increased	increase	VERB	VBD	O
the	the	DET	DT	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
catatonia	catatonia	ADJ	JJ	B-Disease
(	(	PUNCT	-LRB-	O
DOC	DOC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
after	after	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
pretreatment	pretreatment	NOUN	NN	O
with	with	ADP	IN	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
pineal	pineal	ADJ	JJ	O
indolamines	indolamine	NOUN	NNS	O
exhibited	exhibit	VERB	VBD	O
mixed	mixed	ADJ	JJ	O
actions	action	NOUN	NNS	O
.	.	PUNCT	.	O

Serotonin	Serotonin	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
acetyl	acetyl	NOUN	NN	I-Chemical
serotonin	serotonin	NOUN	NN	I-Chemical
which	which	DET	WDT	O
augmented	augment	VERB	VBD	O
ketamine	ketamine	NOUN	NN	B-Chemical
DOC	DOC	PROPN	NNP	O
,	,	PUNCT	,	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
do	do	VERB	VB	O
so	so	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
pineal	pineal	ADJ	JJ	O
gland	gland	NOUN	NN	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
melatonin	melatonin	NOUN	NN	B-Chemical
potentiated	potentiate	VERB	VBD	O
the	the	DET	DT	O
ketamine	ketamine	NOUN	NN	B-Chemical
DOC	DOC	PROPN	NNP	O
in	in	ADP	IN	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
intact	intact	ADJ	JJ	O
and	and	CCONJ	CC	O
pinealectomized	pinealectomized	ADJ	JJ	O
chick	chick	NOUN	NN	O
.	.	PUNCT	.	O

Ketamine	Ketamine	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
more	more	ADV	RBR	O
potent	potent	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
hypophysectomized	hypophysectomized	ADJ	JJ	O
chick	chick	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
circadian	circadian	ADJ	JJ	O
rhythm	rhythm	NOUN	NN	O
noted	note	VERB	VBD	O
in	in	ADP	IN	O
the	the	DET	DT	O
intact	intact	ADJ	JJ	O
chick	chick	NOUN	NN	O
was	be	VERB	VBD	O
absent	absent	ADJ	JJ	O
;	;	PUNCT	:	O
furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
melatonin	melatonin	NOUN	NN	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
augment	augment	VERB	VB	O
the	the	DET	DT	O
ketamine	ketamine	NOUN	NN	B-Chemical
DOC	DOC	PROPN	NNP	O
whereas	whereas	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
continued	continue	VERB	VBD	O
to	to	PART	TO	O
do	do	VERB	VB	O
so	so	ADV	RB	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
demonstrate	demonstrate	VERB	VB	O
a	a	DET	DT	O
species	species	NOUN	NN	O
difference	difference	NOUN	NN	O
regarding	regard	VERB	VBG	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
amines	amine	NOUN	NNS	B-Chemical
on	on	ADP	IN	O
the	the	DET	DT	O
pineal	pineal	NOUN	NN	O
in	in	ADP	IN	O
spite	spite	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
immature	immature	ADJ	JJ	O
blood	blood	NOUN	NN	O
-	-	PUNCT	HYPH	O
brain	brain	NOUN	NN	O
barrier	barrier	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
young	young	ADJ	JJ	O
chick	chick	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
intact	intact	ADJ	JJ	O
barrier	barrier	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
these	these	DET	DT	O
data	datum	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
a	a	DET	DT	O
direct	direct	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
pituitary	pituitary	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
augmentation	augmentation	NOUN	NN	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
DOC	DOC	PROPN	NNP	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
melatonin	melatonin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
dopamine	dopamine	NOUN	NN	B-Chemical
appeared	appear	VERB	VBD	O
to	to	PART	TO	O
act	act	VERB	VB	O
on	on	ADP	IN	O
systems	system	NOUN	NNS	O
more	more	ADV	RBR	O
closely	closely	ADV	RB	O
involved	involved	ADJ	JJ	O
with	with	ADP	IN	O
the	the	DET	DT	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
catatonia	catatonia	NOUN	NN	B-Disease
rather	rather	ADV	RB	O
than	than	ADP	IN	O
directly	directly	ADV	RB	O
on	on	ADP	IN	O
the	the	DET	DT	O
pituitary	pituitary	NOUN	NN	O
.	.	PUNCT	.	O

Heparin	Heparin	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
thrombosis	thrombosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
hemorrhage	hemorrhage	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Sixty	sixty	NUM	CD	O
-	-	PUNCT	HYPH	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
are	be	VERB	VBP	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
manifestations	manifestation	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
disorder	disorder	NOUN	NN	O
include	include	VERB	VBP	O
hemorrhage	hemorrhage	NOUN	NN	B-Disease
or	or	CCONJ	CC	O
,	,	PUNCT	,	O
more	more	ADV	RBR	O
frequently	frequently	ADV	RB	O
,	,	PUNCT	,	O
thromboembolic	thromboembolic	ADJ	JJ	B-Disease
events	event	NOUN	NNS	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
heparin	heparin	ADV	RB	B-Chemical
.	.	PUNCT	.	O

Laboratory	laboratory	NOUN	NN	O
testing	testing	NOUN	NN	O
has	have	VERB	VBZ	O
revealed	reveal	VERB	VBN	O
a	a	DET	DT	B-Disease
falling	fall	VERB	VBG	I-Disease
platelet	platelet	NOUN	NN	I-Disease
count	count	NOUN	NN	I-Disease
,	,	PUNCT	,	O
increased	increase	VERB	VBN	O
resistance	resistance	NOUN	NN	O
to	to	ADP	IN	O
heparin	heparin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
aggregation	aggregation	NOUN	NN	O
of	of	ADP	IN	O
platelets	platelet	NOUN	NNS	O
by	by	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
plasma	plasma	NOUN	NN	O
when	when	ADV	WRB	O
heparin	heparin	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
added	add	VERB	VBN	O
.	.	PUNCT	.	O

Immunologic	immunologic	ADJ	JJ	O
testing	testing	NOUN	NN	O
has	have	VERB	VBZ	O
demonstrated	demonstrate	VERB	VBN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
platelet	platelet	NOUN	NN	O
membrane	membrane	NOUN	NN	O
antibody	antibody	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
20	20	NUM	CD	O
deaths	death	NOUN	NNS	O
,	,	PUNCT	,	O
52	52	NUM	CD	O
hemorrhagic	hemorrhagic	NOUN	NN	B-Disease
and	and	CCONJ	CC	I-Disease
thromboembolic	thromboembolic	ADJ	JJ	I-Disease
complications	complication	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
21	21	NUM	CD	O
surgical	surgical	ADJ	JJ	O
procedures	procedure	NOUN	NNS	O
to	to	PART	TO	O
manage	manage	VERB	VB	O
the	the	DET	DT	O
complications	complication	NOUN	NNS	O
confirm	confirm	VERB	VBP	O
the	the	DET	DT	O
seriousness	seriousness	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
disorder	disorder	NOUN	NN	O
.	.	PUNCT	.	O

Specific	specific	ADJ	JJ	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
have	have	VERB	VBP	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
identified	identify	VERB	VBN	O
;	;	PUNCT	:	O
therefore	therefore	ADV	RB	O
,	,	PUNCT	,	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
heparin	heparin	ADV	RB	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
monitored	monitor	VERB	VBN	O
.	.	PUNCT	.	O

If	if	ADP	IN	O
the	the	DET	DT	O
platelet	platelet	NOUN	NN	O
count	count	NOUN	NN	O
falls	fall	VERB	VBZ	O
to	to	ADP	IN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
100	100	NUM	CD	O
,	,	PUNCT	,	O
000	000	NUM	CD	O
/	/	SYM	SYM	O
mm3	mm3	NOUN	NNS	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
is	be	VERB	VBZ	O
receiving	receive	VERB	VBG	O
heparin	heparin	ADV	RB	B-Chemical
,	,	PUNCT	,	O
platelet	platelet	VERB	VB	B-Disease
aggregation	aggregation	NOUN	NN	I-Disease
testing	testing	NOUN	NN	O
,	,	PUNCT	,	O
using	use	VERB	VBG	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
plasma	plasma	NOUN	NN	O
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
indicated	indicate	VERB	VBN	O
.	.	PUNCT	.	O

Management	management	NOUN	NN	O
consists	consist	VERB	VBZ	O
of	of	ADP	IN	O
cessation	cessation	NOUN	NN	O
of	of	ADP	IN	O
heparin	heparin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
platelet	platelet	VERB	VB	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
aggregating	aggregating	ADJ	JJ	O
agents	agent	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
alternate	alternate	ADJ	JJ	O
forms	form	NOUN	NNS	O
of	of	ADP	IN	O
anticoagulation	anticoagulation	NOUN	NN	O
when	when	ADV	WRB	O
indicated	indicate	VERB	VBN	O
.	.	PUNCT	.	O

Ventricular	ventricular	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
from	from	ADP	IN	O
diatrizoate	diatrizoate	NOUN	NN	B-Chemical
with	with	ADP	IN	O
and	and	CCONJ	CC	O
without	without	ADP	IN	O
chelating	chelate	VERB	VBG	O
agents	agent	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
Renografin	Renografin	PROPN	NNP	B-Chemical
76	76	NUM	CD	I-Chemical
%	%	NOUN	NN	I-Chemical
was	be	VERB	VBD	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
Hypaque	Hypaque	PROPN	NNP	B-Chemical
76	76	NUM	CD	I-Chemical
%	%	NOUN	NN	I-Chemical
by	by	ADP	IN	O
selective	selective	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
each	each	DET	DT	O
into	into	ADP	IN	O
the	the	DET	DT	O
right	right	ADJ	JJ	O
coronary	coronary	ADJ	JJ	O
artery	artery	NOUN	NN	O
of	of	ADP	IN	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

Renografin	Renografin	PROPN	NNP	B-Chemical
contains	contain	VERB	VBZ	O
the	the	DET	DT	O
chelating	chelate	VERB	VBG	O
agents	agent	NOUN	NNS	O
sodium	sodium	NOUN	NN	B-Chemical
citrate	citrate	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
disodium	disodium	NOUN	NN	B-Chemical
edetate	edetate	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
while	while	ADP	IN	O
Hypaque	Hypaque	PROPN	NNP	B-Chemical
contains	contain	VERB	VBZ	O
calcium	calcium	NOUN	NN	B-Chemical
disodium	disodium	NOUN	NN	I-Chemical
edetate	edetate	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
no	no	DET	DT	O
sodium	sodium	NOUN	NN	B-Chemical
citrate	citrate	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Ventricular	ventricular	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
occurred	occur	VERB	VBD	O
significantly	significantly	ADV	RB	O
more	more	ADV	RBR	O
often	often	ADV	RB	O
with	with	ADP	IN	O
Renografin	Renografin	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
that	that	ADP	IN	O
chelating	chelate	VERB	VBG	O
agents	agent	NOUN	NNS	O
contribute	contribute	VERB	VBP	O
to	to	ADP	IN	O
toxicity	toxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
coronary	coronary	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
.	.	PUNCT	.	O

Long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
ventricular	ventricular	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Amiodarone	Amiodarone	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
to	to	ADP	IN	O
154	154	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
sustained	sustain	VERB	VBN	O
,	,	PUNCT	,	O
symptomatic	symptomatic	ADJ	JJ	O
ventricular	ventricular	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
VT	VT	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
118	118	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
a	a	DET	DT	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
36	36	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
refractory	refractory	ADJ	JJ	O
to	to	ADP	IN	O
conventional	conventional	ADJ	JJ	O
antiarrhythmic	antiarrhythmic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
loading	loading	NOUN	NN	O
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
800	800	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
maintenance	maintenance	NOUN	NN	O
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
600	600	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

Sixty	sixty	NUM	CD	O
-	-	PUNCT	HYPH	O
nine	nine	NUM	CD	O
percent	percent	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
continued	continue	VERB	VBD	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
had	have	VERB	VBD	O
no	no	DET	DT	O
recurrence	recurrence	NOUN	NN	O
of	of	ADP	IN	O
symptomatic	symptomatic	ADJ	JJ	O
VT	VT	PROPN	NNP	B-Disease
or	or	CCONJ	CC	O
ventricular	ventricular	ADJ	JJ	B-Disease
fibrillation	fibrillation	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
VF	VF	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
over	over	ADP	IN	O
a	a	DET	DT	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
of	of	ADP	IN	O
6	6	NUM	CD	O
to	to	PART	TO	O
52	52	NUM	CD	O
months	month	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
standard	standard	ADJ	JJ	O
deviation	deviation	NOUN	NN	O
14	14	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Six	six	NUM	CD	O
percent	percent	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
a	a	DET	DT	O
nonfatal	nonfatal	ADJ	JJ	O
recurrence	recurrence	NOUN	NN	O
of	of	ADP	IN	O
VT	VT	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
were	be	VERB	VBD	O
successfully	successfully	ADV	RB	O
managed	manage	VERB	VBN	O
by	by	ADP	IN	O
continuing	continue	VERB	VBG	O
amiodarone	amiodarone	ADV	RB	B-Chemical
at	at	ADP	IN	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
dose	dose	NOUN	NN	O
or	or	CCONJ	CC	O
by	by	ADP	IN	O
the	the	DET	DT	O
addition	addition	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
conventional	conventional	ADJ	JJ	O
antiarrhythmic	antiarrhythmic	ADJ	JJ	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
or	or	CCONJ	CC	O
more	more	ADV	RBR	O
adverse	adverse	ADJ	JJ	O
drug	drug	NOUN	NN	O
reactions	reaction	NOUN	NNS	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
51	51	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Adverse	Adverse	PROPN	NNP	O
effects	effect	NOUN	NNS	O
forced	force	VERB	VBD	O
a	a	DET	DT	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
in	in	ADP	IN	O
41	41	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
in	in	ADP	IN	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
symptomatic	symptomatic	ADJ	JJ	O
adverse	adverse	ADJ	JJ	O
reactions	reaction	NOUN	NNS	O
were	be	VERB	VBD	O
tremor	tremor	NOUN	NN	B-Disease
or	or	CCONJ	CC	O
ataxia	ataxia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
35	35	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
nausea	nausea	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
anorexia	anorexia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
visual	visual	ADJ	JJ	B-Disease
halos	halos	NOUN	NN	I-Disease
or	or	CCONJ	CC	I-Disease
blurring	blurring	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
thyroid	thyroid	NOUN	NN	B-Disease
function	function	NOUN	NN	I-Disease
abnormalities	abnormality	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
pulmonary	pulmonary	ADJ	JJ	B-Disease
interstitial	interstitial	ADJ	JJ	I-Disease
infiltrates	infiltrate	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
large	large	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
highly	highly	ADV	RB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
VT	VT	PROPN	NNP	B-Disease
or	or	CCONJ	CC	O
VF	VF	PROPN	NNP	B-Disease
refractory	refractory	NOUN	NN	O
to	to	ADP	IN	O
conventional	conventional	ADJ	JJ	O
antiarrhythmic	antiarrhythmic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
causes	cause	VERB	VBZ	O
significant	significant	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
approximately	approximately	ADV	RB	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
is	be	VERB	VBZ	O
adjusted	adjust	VERB	VBN	O
based	base	VERB	VBN	O
on	on	ADP	IN	O
clinical	clinical	ADJ	JJ	O
response	response	NOUN	NN	O
or	or	CCONJ	CC	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
,	,	PUNCT	,	O
75	75	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
VT	VT	PROPN	NNP	B-Disease
or	or	CCONJ	CC	O
VF	VF	PROPN	NNP	B-Disease
can	can	VERB	MD	O
be	be	VERB	VB	O
successfully	successfully	ADV	RB	O
managed	manage	VERB	VBN	O
with	with	ADP	IN	O
amiodarone	amiodarone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Why	why	ADV	WRB	O
may	may	VERB	MD	O
epsilon	epsilon	VERB	VB	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminocaproic	aminocaproic	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
EACA	EACA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
induce	induce	VERB	VB	O
myopathy	myopathy	NOUN	NN	B-Disease
in	in	ADP	IN	O
man	man	NOUN	NN	O
?	?	PUNCT	.	O

Report	Report	PROPN	NNP	O
of	of	ADP	IN	O
a	a	DET	DT	O
case	case	NOUN	NN	O
and	and	CCONJ	CC	O
literature	literature	NOUN	NN	O
review	review	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
necrotizing	necrotize	VERB	VBG	B-Disease
myopathy	myopathy	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
a	a	DET	DT	O
short	short	ADJ	JJ	O
epsilon	epsilon	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminocaproic	aminocaproic	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
EACA	EACA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
treatment	treatment	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
72	72	NUM	CD	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
subarachnoid	subarachnoid	ADJ	JJ	B-Disease
haemorrhage	haemorrhage	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
SAH	SAH	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
described	describe	VERB	VBN	O
.	.	PUNCT	.	O

Pathogenetic	pathogenetic	ADJ	JJ	O
hypotheses	hypothesis	NOUN	NNS	O
are	be	VERB	VBP	O
discussed	discuss	VERB	VBN	O
.	.	PUNCT	.	O

Cerebral	cerebral	ADJ	JJ	B-Disease
hemorrhage	hemorrhage	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
phenylpropanolamine	phenylpropanolamine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
caffeine	caffeine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Phenylpropanolamine	Phenylpropanolamine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
PPA	PPA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
drug	drug	NOUN	NN	O
that	that	DET	WDT	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
serious	serious	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
including	include	VERB	VBG	O
stroke	stroke	NOUN	NN	B-Disease
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
often	often	ADV	RB	O
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
caffeine	caffeine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
diet	diet	NOUN	NN	O
preparations	preparation	NOUN	NNS	O
and	and	CCONJ	CC	O
"	"	PUNCT	``	O
look	look	VERB	VB	O
-	-	PUNCT	HYPH	O
alike	alike	ADV	RB	O
"	"	PUNCT	''	O
pills	pill	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
if	if	ADP	IN	O
PPA	PPA	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
caffeine	caffeine	NOUN	NN	B-Chemical
can	can	VERB	MD	O
lead	lead	VERB	VB	O
to	to	PART	TO	O
stroke	stroke	VERB	VB	B-Disease
in	in	ADP	IN	O
normotensive	normotensive	ADJ	JJ	O
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
administered	administer	VERB	VBD	O
the	the	DET	DT	O
combination	combination	NOUN	NN	O
in	in	ADP	IN	O
six	six	NUM	CD	O
times	time	NOUN	NNS	O
the	the	DET	DT	O
allowed	allow	VERB	VBN	O
human	human	ADJ	JJ	O
dose	dose	NOUN	NN	O
calculated	calculate	VERB	VBN	O
on	on	ADP	IN	O
a	a	DET	DT	O
per	per	ADP	IN	O
weight	weight	NOUN	NN	O
basis	basis	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
rats	rat	NOUN	NNS	O
two	two	NUM	CD	O
times	time	NOUN	NNS	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
five	five	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Subarachnoid	Subarachnoid	PROPN	NNP	B-Disease
and	and	CCONJ	CC	I-Disease
cerebral	cerebral	ADJ	JJ	I-Disease
hemorrhage	hemorrhage	NOUN	NN	I-Disease
was	be	VERB	VBD	O
noted	note	VERB	VBN	O
in	in	ADP	IN	O
18	18	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
single	single	ADJ	JJ	O
PPA	PPA	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
caffeine	caffeine	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
(	(	PUNCT	-LRB-	O
same	same	ADJ	JJ	O
dose	dose	NOUN	NN	O
)	)	PUNCT	-RRB-	O
lead	lead	NOUN	NN	O
to	to	ADP	IN	O
acute	acute	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
in	in	ADP	IN	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
normotensive	normotensive	ADJ	JJ	O
and	and	CCONJ	CC	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
PPA	PPA	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
caffeine	caffeine	NOUN	NN	B-Chemical
can	can	VERB	MD	O
lead	lead	VERB	VB	O
to	to	ADP	IN	O
cerebral	cerebral	ADJ	JJ	B-Disease
hemorrhage	hemorrhage	NOUN	NN	I-Disease
in	in	ADP	IN	O
previously	previously	ADV	RB	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
animals	animal	NOUN	NNS	O
when	when	ADV	WRB	O
administered	administer	VERB	VBN	O
in	in	ADP	IN	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
the	the	DET	DT	O
allowed	allow	VERB	VBN	O
dosage	dosage	NOUN	NN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
acute	acute	ADJ	JJ	O
elevation	elevation	NOUN	NN	O
in	in	ADP	IN	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
contributing	contribute	VERB	VBG	O
factor	factor	NOUN	NN	O
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	B-Disease
papillary	papillary	ADJ	JJ	I-Disease
necrosis	necrosis	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
naproxen	naproxen	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
31	31	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
with	with	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
previously	previously	ADV	RB	O
been	be	VERB	VBN	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
sulindac	sulindac	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
fenoprofen	fenoprofen	ADJ	JJ	B-Chemical
calcium	calcium	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
salicylates	salicylate	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
gold	gold	NOUN	NN	B-Chemical
salts	salt	NOUN	NNS	O
,	,	PUNCT	,	O
developed	develop	VERB	VBD	O
renal	renal	ADJ	JJ	B-Disease
papillary	papillary	ADJ	JJ	I-Disease
necrosis	necrosis	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
RPN	RPN	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
4	4	NUM	CD	O
months	month	NOUN	NNS	O
after	after	ADP	IN	O
institution	institution	NOUN	NN	O
of	of	ADP	IN	O
naproxen	naproxen	ADJ	JJ	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
other	other	ADJ	JJ	O
factor	factor	NOUN	NN	O
predisposing	predispose	VERB	VBG	O
to	to	ADP	IN	O
RPN	RPN	PROPN	NNP	B-Disease
could	could	VERB	MD	O
be	be	VERB	VB	O
discovered	discover	VERB	VBN	O
.	.	PUNCT	.	O

Sulindac	Sulindac	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
substituted	substitute	VERB	VBN	O
for	for	ADP	IN	O
naproxen	naproxen	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
no	no	DET	DT	O
further	further	ADV	RB	O
adverse	adverse	ADJ	JJ	O
renal	renal	ADJ	JJ	O
effects	effect	NOUN	NNS	O
occurred	occur	VERB	VBD	O
over	over	ADP	IN	O
the	the	DET	DT	O
next	next	ADJ	JJ	O
12	12	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
review	review	VERB	VBP	O
previous	previous	ADJ	JJ	O
reports	report	NOUN	NNS	O
linking	link	VERB	VBG	O
RPN	RPN	PROPN	NNP	B-Disease
to	to	ADP	IN	O
antiinflammatory	antiinflammatory	ADJ	JJ	O
drug	drug	NOUN	NN	O
use	use	NOUN	NN	O
and	and	CCONJ	CC	O
discuss	discuss	VERB	VB	O
possible	possible	ADJ	JJ	O
advantages	advantage	NOUN	NNS	O
of	of	ADP	IN	O
sulindac	sulindac	NOUN	NN	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
have	have	VERB	VBP	O
experienced	experience	VERB	VBN	O
renal	renal	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
from	from	ADP	IN	O
other	other	ADJ	JJ	O
antiinflammatory	antiinflammatory	ADJ	JJ	O
agents	agent	NOUN	NNS	O
.	.	PUNCT	.	O

Nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
aminoglycoside	aminoglycoside	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
on	on	ADP	IN	O
renal	renal	ADJ	JJ	O
protein	protein	NOUN	NN	O
reabsorption	reabsorption	NOUN	NN	O
and	and	CCONJ	CC	O
accumulation	accumulation	NOUN	NN	O
.	.	PUNCT	.	O

To	to	PART	TO	O
quantify	quantify	VERB	VB	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
kanamycin	kanamycin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
netilmicin	netilmicin	NOUN	NN	B-Chemical
on	on	ADP	IN	O
renal	renal	ADJ	JJ	O
protein	protein	NOUN	NN	O
reabsorption	reabsorption	NOUN	NN	O
and	and	CCONJ	CC	O
accumulation	accumulation	NOUN	NN	O
,	,	PUNCT	,	O
these	these	DET	DT	O
drugs	drug	NOUN	NNS	O
were	be	VERB	VBD	O
administered	administer	VERB	VBN	O
to	to	PART	TO	O
rats	rat	NOUN	NNS	O
intraperitoneally	intraperitoneally	ADV	RB	O
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
for	for	ADP	IN	O
7	7	NUM	CD	O
,	,	PUNCT	,	O
14	14	NUM	CD	O
or	or	CCONJ	CC	O
21	21	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Scanning	scan	VERB	VBG	O
electron	electron	NOUN	NN	O
microscopy	microscopy	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
glomerular	glomerular	ADJ	JJ	O
endothelia	endothelia	NOUN	NN	O
,	,	PUNCT	,	O
urinary	urinary	ADJ	JJ	O
measurements	measurement	NOUN	NNS	O
of	of	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
potassium	potassium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
endogenous	endogenous	ADJ	JJ	O
lysozyme	lysozyme	NOUN	NN	O
,	,	PUNCT	,	O
N	n	NOUN	NN	O
-	-	PUNCT	HYPH	O
acetyl	acetyl	NOUN	NN	O
-	-	PUNCT	HYPH	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
D	d	NOUN	NN	O
-	-	PUNCT	HYPH	O
glucosaminidase	glucosaminidase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
NAG	NAG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
clearance	clearance	NOUN	NN	O
and	and	CCONJ	CC	O
accumulation	accumulation	NOUN	NN	O
experiments	experiment	NOUN	NNS	O
after	after	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
egg	egg	NOUN	NN	O
-	-	PUNCT	HYPH	O
white	white	ADJ	JJ	O
lysozyme	lysozyme	NOUN	NN	O
and	and	CCONJ	CC	O
measurements	measurement	NOUN	NNS	O
of	of	ADP	IN	O
inulin	inulin	ADJ	JJ	O
clearance	clearance	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GFR	GFR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
done	do	VERB	VBN	O
in	in	ADP	IN	O
each	each	DET	DT	O
treatment	treatment	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Gentamicin	Gentamicin	PROPN	NNP	B-Chemical
administration	administration	NOUN	NN	O
decreased	decrease	VERB	VBD	O
diameter	diameter	NOUN	NN	O
,	,	PUNCT	,	O
density	density	NOUN	NN	O
and	and	CCONJ	CC	O
shape	shape	NOUN	NN	O
of	of	ADP	IN	O
endothelial	endothelial	ADJ	JJ	O
fenestrae	fenestrae	NOUN	NN	O
.	.	PUNCT	.	O

Kanamycin	Kanamycin	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
netilmicin	netilmicin	NOUN	NN	B-Chemical
appeared	appear	VERB	VBD	O
to	to	PART	TO	O
have	have	VERB	VB	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
used	use	VERB	VBN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
three	three	NUM	CD	O
aminoglycosides	aminoglycoside	NOUN	NNS	B-Chemical
decreased	decrease	VERB	VBD	O
GFR	GFR	PROPN	NNP	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBD	O
urinary	urinary	ADJ	JJ	O
excretion	excretion	NOUN	NN	O
of	of	ADP	IN	O
sodium	sodium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
potassium	potassium	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

While	while	ADP	IN	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
kanamycin	kanamycin	NOUN	NN	B-Chemical
decreased	decrease	VERB	VBD	O
the	the	DET	DT	O
percentage	percentage	NOUN	NN	O
reabsorption	reabsorption	NOUN	NN	O
and	and	CCONJ	CC	O
accumulation	accumulation	NOUN	NN	O
of	of	ADP	IN	O
lysozyme	lysozyme	NOUN	NN	O
after	after	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
egg	egg	NOUN	NN	O
-	-	PUNCT	HYPH	O
white	white	ADJ	JJ	O
lysozyme	lysozyme	NOUN	NN	O
netilmicin	netilmicin	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Daily	daily	ADJ	JJ	O
excretion	excretion	NOUN	NN	O
of	of	ADP	IN	O
total	total	ADJ	JJ	O
protein	protein	NOUN	NN	O
,	,	PUNCT	,	O
endogenous	endogenous	ADJ	JJ	O
lysozyme	lysozyme	NOUN	NN	O
and	and	CCONJ	CC	O
NAG	NAG	PROPN	NNP	O
increased	increase	VERB	VBD	O
only	only	ADV	RB	O
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
kanamycin	kanamycin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
gentamicin	gentamicin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
aminoglycosides	aminoglycoside	NOUN	NNS	B-Chemical
may	may	VERB	MD	O
act	act	VERB	VB	O
as	as	ADP	IN	O
nephrotoxicants	nephrotoxicant	NOUN	NNS	O
at	at	ADP	IN	O
glomerular	glomerular	NOUN	NN	O
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
tubular	tubular	ADJ	JJ	O
level	level	NOUN	NN	O
inducing	induce	VERB	VBG	O
impairment	impairment	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
renal	renal	ADJ	JJ	I-Disease
reabsorption	reabsorption	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
accumulation	accumulation	NOUN	NN	O
of	of	ADP	IN	O
proteins	protein	NOUN	NNS	O
.	.	PUNCT	.	O

Induction	induction	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
obstructive	obstructive	ADJ	JJ	B-Disease
sleep	sleep	NOUN	NN	I-Disease
apnea	apnea	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
woman	woman	NOUN	NN	O
by	by	ADP	IN	O
exogenous	exogenous	ADJ	JJ	O
androgen	androgen	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
documented	document	VERB	VBD	O
airway	airway	NOUN	NN	O
occlusion	occlusion	NOUN	NN	O
during	during	ADP	IN	O
sleep	sleep	NOUN	NN	O
and	and	CCONJ	CC	O
an	an	DET	DT	O
abnormally	abnormally	ADV	RB	O
high	high	ADJ	JJ	O
supraglottic	supraglottic	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
while	while	ADP	IN	O
awake	awake	ADJ	JJ	O
in	in	ADP	IN	O
a	a	DET	DT	O
54	54	NUM	CD	O
-	-	PUNCT	HYPH	O
yr	yr	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
developed	develop	VERB	VBN	O
physical	physical	ADJ	JJ	O
changes	change	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
syndrome	syndrome	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
obstructive	obstructive	ADJ	JJ	I-Disease
sleep	sleep	NOUN	NN	I-Disease
apnea	apnea	NOUN	NN	I-Disease
while	while	ADP	IN	O
being	be	VERB	VBG	O
administered	administer	VERB	VBN	O
exogenous	exogenous	ADJ	JJ	O
androgens	androgen	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

When	when	ADV	WRB	O
the	the	DET	DT	O
androgens	androgen	NOUN	NNS	B-Chemical
were	be	VERB	VBD	O
withdrawn	withdraw	VERB	VBN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	PART	POS	O
physical	physical	ADJ	JJ	O
changes	change	NOUN	NNS	O
,	,	PUNCT	,	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
sleep	sleep	NOUN	NN	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
supraglottic	supraglottic	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
all	all	DET	DT	O
returned	return	VERB	VBD	O
to	to	ADP	IN	O
normal	normal	ADJ	JJ	O
.	.	PUNCT	.	O

A	a	DET	DT	O
rechallenge	rechallenge	NOUN	NN	O
with	with	ADP	IN	O
androgen	androgen	NOUN	NN	B-Chemical
produced	produce	VERB	VBD	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
obstructive	obstructive	ADJ	JJ	B-Disease
sleep	sleep	NOUN	NN	I-Disease
apnea	apnea	NOUN	NN	I-Disease
that	that	DET	WDT	O
abated	abate	VERB	VBD	O
upon	upon	ADP	IN	O
withdrawal	withdrawal	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hormone	hormone	NOUN	NN	O
.	.	PUNCT	.	O

Previous	previous	ADJ	JJ	O
reports	report	NOUN	NNS	O
have	have	VERB	VBP	O
favored	favor	VERB	VBN	O
a	a	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
androgens	androgen	NOUN	NNS	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
pathogenesis	pathogenesis	NOUN	NN	O
of	of	ADP	IN	O
sleep	sleep	NOUN	NN	B-Disease
apnea	apnea	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
report	report	NOUN	NN	O
provides	provide	VERB	VBZ	O
direct	direct	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
for	for	ADP	IN	O
this	this	DET	DT	O
role	role	NOUN	NN	O
.	.	PUNCT	.	O

Structural	structural	ADJ	JJ	O
and	and	CCONJ	CC	O
functional	functional	ADJ	JJ	O
measurements	measurement	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
androgens	androgen	VERB	VBZ	B-Chemical
exert	exert	VERB	VBP	O
a	a	DET	DT	O
permissive	permissive	ADJ	JJ	O
or	or	CCONJ	CC	O
necessary	necessary	ADJ	JJ	O
action	action	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
structural	structural	ADJ	JJ	O
configuration	configuration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
oropharynx	oropharynx	NOUN	NN	O
that	that	DET	WDT	O
predisposes	predispose	NOUN	NNS	O
to	to	ADP	IN	O
obstruction	obstruction	NOUN	NN	O
during	during	ADP	IN	O
sleep	sleep	NOUN	NN	O
.	.	PUNCT	.	O

Development	development	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
obstructive	obstructive	ADJ	JJ	B-Disease
sleep	sleep	NOUN	NN	I-Disease
apnea	apnea	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
must	must	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
androgen	androgen	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Cardiotoxic	Cardiotoxic	PROPN	NNP	B-Disease
and	and	CCONJ	CC	O
possible	possible	ADJ	JJ	O
leukemogenic	leukemogenic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
adriamycin	adriamycin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
nonhuman	nonhuman	NOUN	NN	O
primates	primate	NOUN	NNS	O
.	.	PUNCT	.	O

10	10	NUM	CD	O
monkeys	monkey	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
macaques	macaque	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
received	receive	VERB	VBD	O
adriamycin	adriamycin	NOUN	NN	B-Chemical
by	by	ADP	IN	O
monthly	monthly	ADJ	JJ	O
intravenous	intravenous	ADJ	JJ	O
injections	injection	NOUN	NNS	O
at	at	ADP	IN	O
12	12	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

8	8	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
10	10	NUM	CD	O
monkeys	monkey	NOUN	NNS	O
developed	develop	VERB	VBD	O
congestive	congestive	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
at	at	ADP	IN	O
an	an	DET	DT	O
average	average	ADJ	JJ	O
cumulative	cumulative	ADJ	JJ	O
adriamycin	adriamycin	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
(	(	PUNCT	-LRB-	O
310	310	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
)	)	PUNCT	-RRB-	O
well	well	ADV	RB	O
below	below	ADP	IN	O
that	that	DET	DT	O
considered	consider	VERB	VBD	O
the	the	DET	DT	O
safe	safe	ADJ	JJ	O
upper	upper	ADJ	JJ	O
limit	limit	NOUN	NN	O
(	(	PUNCT	-LRB-	O
550	550	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
man	man	NOUN	NN	O
.	.	PUNCT	.	O

Histologically	histologically	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
myocardial	myocardial	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
resembled	resemble	VERB	VBD	O
those	those	DET	DT	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
human	human	ADJ	JJ	O
anthracycline	anthracycline	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

1	1	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
10	10	NUM	CD	O
monkeys	monkey	NOUN	NNS	O
developed	develop	VERB	VBD	O
acute	acute	ADJ	JJ	B-Disease
myeloblastic	myeloblastic	ADJ	JJ	I-Disease
leukemia	leukemia	NOUN	NN	I-Disease
after	after	ADP	IN	O
receiving	receive	VERB	VBG	O
324	324	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
of	of	ADP	IN	O
adriamycin	adriamycin	NOUN	NN	B-Chemical
;	;	PUNCT	:	O
the	the	DET	DT	O
10th	10th	ADJ	JJ	O
monkey	monkey	NOUN	NN	O
is	be	VERB	VBZ	O
alive	alive	ADJ	JJ	O
and	and	CCONJ	CC	O
well	well	ADV	RB	O
26	26	NUM	CD	O
months	month	NOUN	NNS	O
after	after	ADP	IN	O
the	the	DET	DT	O
last	last	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
adriamycin	adriamycin	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
more	more	ADV	RBR	O
potent	potent	ADJ	JJ	O
cardiotoxin	cardiotoxin	NOUN	NN	O
in	in	ADP	IN	O
monkeys	monkey	NOUN	NNS	O
than	than	ADP	IN	O
in	in	ADP	IN	O
man	man	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
that	that	DET	DT	O
leukemia	leukemia	NOUN	NN	B-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
consequence	consequence	NOUN	NN	O
of	of	ADP	IN	O
prolonged	prolong	VERB	VBN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
this	this	DET	DT	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

Tricuspid	tricuspid	ADJ	JJ	B-Disease
valve	valve	NOUN	NN	I-Disease
regurgitation	regurgitation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
lithium	lithium	NOUN	NN	B-Chemical
carbonate	carbonate	NOUN	NN	I-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
newborn	newborn	ADJ	JJ	O
infant	infant	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
newborn	newborn	ADJ	JJ	O
with	with	ADP	IN	O
massive	massive	ADJ	JJ	O
tricuspid	tricuspid	ADJ	JJ	B-Disease
regurgitation	regurgitation	NOUN	NN	I-Disease
,	,	PUNCT	,	O
atrial	atrial	ADJ	JJ	B-Disease
flutter	flutter	ADV	RB	I-Disease
,	,	PUNCT	,	O
congestive	congestive	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
high	high	ADJ	JJ	O
serum	serum	NOUN	NN	O
lithium	lithium	NOUN	NN	B-Chemical
level	level	NOUN	NN	O
is	be	VERB	VBZ	O
described	describe	VERB	VBN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
patient	patient	NOUN	NN	O
to	to	PART	TO	O
initially	initially	ADV	RB	O
manifest	manifest	VERB	VB	O
tricuspid	tricuspid	ADJ	JJ	B-Disease
regurgitation	regurgitation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
atrial	atrial	ADJ	JJ	B-Disease
flutter	flutter	ADV	RB	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
11th	11th	ADJ	JJ	O
described	describe	VERB	VBN	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
among	among	ADP	IN	O
infants	infant	NOUN	NNS	O
exposed	expose	VERB	VBN	O
to	to	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
compounds	compound	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
trimester	trimester	NOUN	NN	O
of	of	ADP	IN	O
pregnancy	pregnancy	NOUN	NN	O
.	.	PUNCT	.	O

Sixty	sixty	NUM	CD	O
-	-	PUNCT	HYPH	O
three	three	NUM	CD	O
percent	percent	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
infants	infant	NOUN	NNS	O
had	have	VERB	VBD	O
tricuspid	tricuspid	ADJ	JJ	O
valve	valve	NOUN	NN	O
involvement	involvement	NOUN	NN	O
.	.	PUNCT	.	O

Lithium	Lithium	PROPN	NNP	B-Chemical
carbonate	carbonate	NOUN	NN	I-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
factor	factor	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
increasing	increase	VERB	VBG	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
congenital	congenital	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
when	when	ADV	WRB	O
taken	take	VERB	VBN	O
during	during	ADP	IN	O
early	early	ADJ	JJ	O
pregnancy	pregnancy	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
also	also	ADV	RB	O
causes	cause	VERB	VBZ	O
neurologic	neurologic	ADJ	JJ	B-Disease
depression	depression	NOUN	NN	I-Disease
,	,	PUNCT	,	O
cyanosis	cyanosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrhythmia	arrhythmia	NOUN	NN	I-Disease
when	when	ADV	WRB	O
consumed	consume	VERB	VBN	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
delivery	delivery	NOUN	NN	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
novel	novel	ADJ	JJ	O
compound	compound	NOUN	NN	O
aniracetam	aniracetam	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Ro	Ro	PROPN	NNP	B-Chemical
13	13	NUM	CD	I-Chemical
-	-	SYM	SYM	I-Chemical
5057	5057	NUM	CD	I-Chemical
)	)	PUNCT	-RRB-	O
upon	upon	ADP	IN	O
impaired	impaired	ADJ	JJ	B-Disease
learning	learning	NOUN	NN	I-Disease
and	and	CCONJ	CC	I-Disease
memory	memory	NOUN	NN	I-Disease
in	in	ADP	IN	O
rodents	rodent	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
aniracetam	aniracetam	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Ro	Ro	PROPN	NNP	B-Chemical
13	13	NUM	CD	I-Chemical
-	-	SYM	SYM	I-Chemical
5057	5057	NUM	CD	I-Chemical
,	,	PUNCT	,	O
1	1	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
anisoyl	anisoyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
pyrrolidinone	pyrrolidinone	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
studied	study	VERB	VBN	O
on	on	ADP	IN	O
various	various	ADJ	JJ	O
forms	form	NOUN	NNS	O
of	of	ADP	IN	O
experimentally	experimentally	ADV	RB	O
impaired	impair	VERB	VBN	B-Disease
cognitive	cognitive	ADJ	JJ	I-Disease
functions	function	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
learning	learning	NOUN	NN	O
and	and	CCONJ	CC	O
memory	memory	NOUN	NN	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
rodents	rodent	NOUN	NNS	O
and	and	CCONJ	CC	O
produced	produce	VERB	VBD	O
the	the	DET	DT	O
following	following	ADJ	JJ	O
effects	effect	NOUN	NNS	O
:	:	PUNCT	:	O
(	(	PUNCT	-LRB-	O
1	1	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
almost	almost	ADV	RB	O
complete	complete	ADJ	JJ	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
incapacity	incapacity	NOUN	NN	O
to	to	PART	TO	O
learn	learn	VERB	VB	O
a	a	DET	DT	O
discrete	discrete	ADJ	JJ	O
escape	escape	NOUN	NN	O
response	response	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
exposed	expose	VERB	VBN	O
to	to	PART	TO	O
sublethal	sublethal	ADJ	JJ	O
hypercapnia	hypercapnia	NOUN	NN	B-Disease
immediately	immediately	ADV	RB	O
before	before	ADP	IN	O
the	the	DET	DT	O
acquisition	acquisition	NOUN	NN	O
session	session	NOUN	NN	O
;	;	PUNCT	:	O
(	(	PUNCT	-LRB-	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
partial	partial	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
rats	rat	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
complete	complete	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
mice	mouse	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
amnesia	amnesia	NOUN	NN	B-Disease
for	for	ADP	IN	O
a	a	DET	DT	O
passive	passive	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
task	task	NOUN	NN	O
;	;	PUNCT	,	O
(	(	PUNCT	-LRB-	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
complete	complete	ADJ	JJ	O
protection	protection	NOUN	NN	O
against	against	ADP	IN	O
amnesia	amnesia	NOUN	NN	B-Disease
for	for	ADP	IN	O
a	a	DET	DT	O
passive	passive	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
task	task	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
submitted	submit	VERB	VBN	O
to	to	ADP	IN	O
electroconvulsive	electroconvulsive	ADJ	JJ	O
shock	shock	NOUN	NN	O
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
avoidance	avoidance	NOUN	NN	O
acquisition	acquisition	NOUN	NN	O
;	;	PUNCT	:	O
(	(	PUNCT	-LRB-	O
4	4	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
retention	retention	NOUN	NN	O
-	-	PUNCT	:	O
or	or	CCONJ	CC	O
retrieval	retrieval	NOUN	NN	O
-	-	PUNCT	HYPH	O
deficit	deficit	NOUN	NN	O
for	for	ADP	IN	O
a	a	DET	DT	O
passive	passive	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
task	task	NOUN	NN	O
induced	induce	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
mice	mouse	NOUN	NNS	O
by	by	ADP	IN	O
chloramphenicol	chloramphenicol	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
cycloheximide	cycloheximide	NOUN	NN	B-Chemical
administered	administer	VERB	VBN	O
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
acquisition	acquisition	NOUN	NN	O
;	;	PUNCT	:	O
(	(	PUNCT	-LRB-	O
5	5	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
reversal	reversal	NOUN	NN	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
administered	administer	VERB	VBN	O
as	as	ADV	RB	O
late	late	ADV	RB	O
as	as	ADP	IN	O
1	1	NUM	CD	O
h	h	NOUN	NN	O
before	before	ADP	IN	O
the	the	DET	DT	O
retention	retention	NOUN	NN	O
test	test	NOUN	NN	O
,	,	PUNCT	,	O
of	of	ADP	IN	O
the	the	DET	DT	O
deficit	deficit	NOUN	NN	O
in	in	ADP	IN	O
retention	retention	NOUN	NN	O
or	or	CCONJ	CC	O
retrieval	retrieval	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
passive	passive	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
task	task	NOUN	NN	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
cycloheximide	cycloheximide	NOUN	NN	B-Chemical
injected	inject	VERB	VBD	O
2	2	NUM	CD	O
days	day	NOUN	NNS	O
previously	previously	ADV	RB	O
;	;	PUNCT	:	O
(	(	PUNCT	-LRB-	O
6	6	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
deficit	deficit	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
retrieval	retrieval	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
active	active	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
task	task	NOUN	NN	O
induced	induce	VERB	VBN	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
by	by	ADP	IN	O
subconvulsant	subconvulsant	ADJ	JJ	O
electroshock	electroshock	NOUN	NN	O
or	or	CCONJ	CC	O
hypercapnia	hypercapnia	NOUN	NN	B-Disease
applied	apply	VERB	VBN	O
immediately	immediately	ADV	RB	O
before	before	ADP	IN	O
retrieval	retrieval	NOUN	NN	O
testing	testing	NOUN	NN	O
(	(	PUNCT	-LRB-	O
24	24	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
acquisition	acquisition	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
improvements	improvement	NOUN	NNS	O
or	or	CCONJ	CC	O
normalizations	normalization	NOUN	NNS	O
of	of	ADP	IN	O
impaired	impaired	ADJ	JJ	B-Disease
cognitive	cognitive	ADJ	JJ	I-Disease
functions	function	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
seen	see	VERB	VBN	O
at	at	ADP	IN	O
oral	oral	ADJ	JJ	O
aniracetam	aniracetam	NOUN	NN	B-Chemical
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
10	10	NUM	CD	O
-	-	SYM	SYM	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
.	.	PUNCT	.	O

Generally	generally	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
response	response	NOUN	NN	O
curves	curve	NOUN	NNS	O
were	be	VERB	VBD	O
bell	bell	NOUN	NN	O
-	-	PUNCT	HYPH	O
shaped	shape	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanisms	mechanism	NOUN	NNS	O
underlying	underlie	VERB	VBG	O
the	the	DET	DT	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
aniracetam	aniracetam	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
'	'	PUNCT	``	O
therapeutic	therapeutic	ADJ	JJ	O
window	window	NOUN	NN	O
'	'	PUNCT	''	O
are	be	VERB	VBP	O
unknown	unknown	ADJ	JJ	O
.	.	PUNCT	.	O

Piracetam	piracetam	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
another	another	DET	DT	O
pyrrolidinone	pyrrolidinone	NOUN	NN	B-Chemical
derivative	derivative	NOUN	NN	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
comparison	comparison	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
active	active	ADJ	JJ	O
only	only	ADV	RB	O
in	in	ADP	IN	O
six	six	NUM	CD	O
of	of	ADP	IN	O
nine	nine	NUM	CD	O
tests	test	NOUN	NNS	O
and	and	CCONJ	CC	O
had	have	VERB	VBD	O
about	about	ADV	RB	O
one	one	NUM	CD	O
-	-	PUNCT	HYPH	O
tenth	tenth	NOUN	NN	O
the	the	DET	DT	O
potency	potency	NOUN	NN	O
of	of	ADP	IN	O
aniracetam	aniracetam	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
aniracetam	aniracetam	NOUN	NN	B-Chemical
improves	improve	VERB	VBZ	O
cognitive	cognitive	ADJ	JJ	O
functions	function	NOUN	NNS	O
which	which	DET	WDT	O
are	be	VERB	VBP	O
impaired	impair	VERB	VBN	O
by	by	ADP	IN	O
different	different	ADJ	JJ	O
procedure	procedure	NOUN	NN	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
different	different	ADJ	JJ	O
phases	phase	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
learning	learning	NOUN	NN	O
and	and	CCONJ	CC	O
memory	memory	NOUN	NN	O
process	process	NOUN	NN	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
on	on	ADP	IN	O
gross	gross	ADJ	JJ	O
behavioural	behavioural	ADJ	JJ	O
changes	change	NOUN	NNS	O
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
carbachol	carbachol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
eserine	eserine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
cats	cat	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
injected	inject	VERB	VBN	O
into	into	ADP	IN	O
the	the	DET	DT	O
cerebral	cerebral	ADJ	JJ	O
ventricles	ventricle	NOUN	NNS	O
of	of	ADP	IN	O
group	group	NOUN	NN	O
-	-	PUNCT	HYPH	O
housed	house	VERB	VBN	O
unanaesthetized	unanaesthetized	ADJ	JJ	O
cats	cat	NOUN	NNS	O
upon	upon	ADP	IN	O
vocalization	vocalization	NOUN	NN	O
(	(	PUNCT	-LRB-	O
rage	rage	NOUN	NN	O
,	,	PUNCT	,	O
hissing	hiss	VERB	VBG	O
and	and	CCONJ	CC	O
snarling	snarling	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
fighting	fighting	NOUN	NN	O
(	(	PUNCT	-LRB-	O
attack	attack	NOUN	NN	O
with	with	ADP	IN	O
paws	paw	NOUN	NNS	O
and	and	CCONJ	CC	O
claws	claw	NOUN	NNS	O
,	,	PUNCT	,	O
defense	defense	NOUN	NN	O
with	with	ADP	IN	O
paws	paw	NOUN	NNS	O
and	and	CCONJ	CC	O
claws	claw	NOUN	NNS	O
and	and	CCONJ	CC	O
biting	biting	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
mydriasis	mydriasis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
tremor	tremor	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
clonic	clonic	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
tonic	tonic	NOUN	NN	I-Disease
convulsions	convulsion	NOUN	NNS	I-Disease
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
carbachol	carbachol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
eserine	eserine	NOUN	NN	B-Chemical
injected	inject	VERB	VBN	O
similarly	similarly	ADV	RB	O
was	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
.	.	PUNCT	.	O

Calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
depressed	depress	VERB	VBN	O
or	or	CCONJ	CC	O
almost	almost	ADV	RB	O
completely	completely	ADV	RB	O
abolished	abolish	VERB	VBD	O
the	the	DET	DT	O
vocalization	vocalization	NOUN	NN	O
and	and	CCONJ	CC	O
fighting	fighting	NOUN	NN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
carbachol	carbachol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
eserine	eserine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
hand	hand	NOUN	NN	O
,	,	PUNCT	,	O
mydriasis	mydriasis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
tremor	tremor	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
clonic	clonic	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
tonic	tonic	NOUN	NN	I-Disease
convulsions	convulsion	NOUN	NNS	I-Disease
evoked	evoke	VERB	VBN	O
by	by	ADP	IN	O
carbachol	carbachol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
eserine	eserine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
changed	change	VERB	VBN	O
by	by	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
apparent	apparent	ADJ	JJ	O
that	that	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
can	can	VERB	MD	O
"	"	PUNCT	``	O
dissociate	dissociate	VERB	VB	O
"	"	PUNCT	''	O
vocalization	vocalization	NOUN	NN	O
and	and	CCONJ	CC	O
fighting	fighting	NOUN	NN	O
from	from	ADP	IN	O
autonomic	autonomic	ADJ	JJ	O
and	and	CCONJ	CC	O
motor	motor	NOUN	NN	O
phenomena	phenomenon	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
mydriasis	mydriasis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
tremor	tremor	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
clonic	clonic	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
tonic	tonic	NOUN	NN	I-Disease
convulsions	convulsion	NOUN	NNS	I-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
carbachol	carbachol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
eserine	eserine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
inhibited	inhibit	VERB	VBD	O
the	the	DET	DT	O
vocalization	vocalization	NOUN	NN	O
and	and	CCONJ	CC	O
fighting	fighting	NOUN	NN	O
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
carbachol	carbachol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
eserine	eserine	NOUN	NN	B-Chemical
most	most	ADV	RBS	O
probably	probably	ADV	RB	O
by	by	ADP	IN	O
a	a	DET	DT	O
nonspecific	nonspecific	ADJ	JJ	O
stabilizing	stabilize	VERB	VBG	O
action	action	NOUN	NN	O
on	on	ADP	IN	O
central	central	ADJ	JJ	O
muscarinic	muscarinic	ADJ	JJ	O
cholinoceptive	cholinoceptive	ADJ	JJ	O
sites	site	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
further	further	ADV	RB	O
support	support	VERB	VBP	O
the	the	DET	DT	O
view	view	NOUN	NN	O
that	that	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
ions	ion	NOUN	NNS	O
in	in	ADP	IN	O
excess	excess	NOUN	NN	O
have	have	VERB	VBP	O
an	an	DET	DT	O
atropine	atropine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
action	action	NOUN	NN	O
also	also	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
central	central	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
.	.	PUNCT	.	O

Thiazide	thiazide	NOUN	NN	B-Chemical
diuretics	diuretic	NOUN	NNS	O
,	,	PUNCT	,	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Thiazide	thiazide	NOUN	NN	B-Chemical
diuretics	diuretic	NOUN	NNS	O
are	be	VERB	VBP	O
widely	widely	ADV	RB	O
accepted	accept	VERB	VBN	O
as	as	ADP	IN	O
the	the	DET	DT	O
cornerstone	cornerstone	NOUN	NN	O
of	of	ADP	IN	O
antihypertensive	antihypertensive	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
programs	program	NOUN	NNS	O
.	.	PUNCT	.	O

Hypokalemia	Hypokalemia	PROPN	NNP	B-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
commonly	commonly	ADV	RB	O
encountered	encounter	VERB	VBN	O
metabolic	metabolic	ADJ	JJ	O
consequence	consequence	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	NOUN	NN	O
thiazide	thiazide	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
treated	treat	VERB	VBD	O
38	38	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
22	22	NUM	CD	O
low	low	ADJ	JJ	O
renin	renin	NOUN	NN	O
,	,	PUNCT	,	O
16	16	NUM	CD	O
normal	normal	ADJ	JJ	O
renin	renin	NOUN	NN	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
moderate	moderate	ADJ	JJ	O
diastolic	diastolic	ADJ	JJ	B-Disease
hypertension	hypertension	NOUN	NN	I-Disease
with	with	ADP	IN	O
hydrochlorothiazide	hydrochlorothiazide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
HCTC	HCTC	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
administered	administer	VERB	VBD	O
on	on	ADP	IN	O
a	a	DET	DT	O
twice	twice	ADV	RB	O
daily	daily	ADJ	JJ	O
schedule	schedule	NOUN	NN	O
.	.	PUNCT	.	O

Initial	initial	ADJ	JJ	O
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
at	at	ADP	IN	O
monthly	monthly	ADJ	JJ	O
intervals	interval	NOUN	NNS	O
to	to	ADP	IN	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
,	,	PUNCT	,	O
150	150	NUM	CD	O
mg	mg	NOUN	NN	O
and	and	CCONJ	CC	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
daily	daily	ADV	RB	O
until	until	ADP	IN	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
normalized	normalize	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
serum	serum	ADJ	JJ	O
K	K	PROPN	NNP	B-Chemical
during	during	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
period	period	NOUN	NN	O
was	be	VERB	VBD	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
mEq	meq	NOUN	NN	O
/	/	SYM	SYM	O
l	l	NOUN	NN	O
an	an	DET	DT	O
on	on	ADP	IN	O
50	50	NUM	CD	O
,	,	PUNCT	,	O
100	100	NUM	CD	O
,	,	PUNCT	,	O
150	150	NUM	CD	O
and	and	CCONJ	CC	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
HCTZ	HCTZ	PROPN	NNP	B-Chemical
daily	daily	ADJ	JJ	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
mEq	meq	NOUN	NN	O
/	/	SYM	SYM	O
l	l	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Corresponding	correspond	VERB	VBG	O
figures	figure	NOUN	NNS	O
for	for	ADP	IN	O
whole	whole	ADJ	JJ	O
body	body	NOUN	NN	O
K	K	PROPN	NNP	B-Chemical
were	be	VERB	VBD	O
4107	4107	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
208	208	NUM	CD	O
,	,	PUNCT	,	O
3722	3722	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
319	319	NUM	CD	O
,	,	PUNCT	,	O
3628	3628	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
257	257	NUM	CD	O
,	,	PUNCT	,	O
3551	3551	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
336	336	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
3269	3269	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
380	380	NUM	CD	O
mEq	meq	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
13	13	NUM	CD	O
patients	patient	NOUN	NNS	O
we	-PRON-	PRON	PRP	O
observed	observe	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
HCTZ	HCTZ	PROPN	NNP	B-Chemical
therapy	therapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
daily	daily	ADV	RB	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
PVC	PVC	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
during	during	ADP	IN	O
rest	rest	NOUN	NN	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
during	during	ADP	IN	O
static	static	ADJ	JJ	O
and	and	CCONJ	CC	O
dynamic	dynamic	ADJ	JJ	O
exercise	exercise	NOUN	NN	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
rest	rest	NOUN	NN	O
we	-PRON-	PRON	PRP	O
observed	observe	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
08	08	NUM	CD	O
PVC	pvc	NOUN	NN	O
beats	beat	NOUN	NNS	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
+	+	X	XX	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
SEM	sem	NOUN	NN	O
and	and	CCONJ	CC	O
during	during	ADP	IN	O
static	static	ADJ	JJ	O
and	and	CCONJ	CC	O
dynamic	dynamic	ADJ	JJ	O
exercise	exercise	NOUN	NN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
06	06	NUM	CD	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
15	15	NUM	CD	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Corresponding	correspond	VERB	VBG	O
figures	figure	NOUN	NNS	O
during	during	ADP	IN	O
HCTZ	HCTZ	PROPN	NNP	B-Chemical
therapy	therapy	NOUN	NN	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
daily	daily	ADV	RB	O
were	be	VERB	VBD	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
and	and	CCONJ	CC	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
4	4	NUM	CD	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
PVC	PVC	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
correlated	correlate	VERB	VBD	O
significantly	significantly	ADV	RB	O
with	with	ADP	IN	O
the	the	DET	DT	O
fall	fall	NOUN	NN	O
in	in	ADP	IN	O
serum	serum	ADJ	JJ	O
K	K	PROPN	NNP	B-Chemical
+	+	CCONJ	CC	O
observed	observe	VERB	VBD	O
r	r	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
72	72	NUM	CD	O
,	,	PUNCT	,	O
p	p	X	XX	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
we	-PRON-	PRON	PRP	O
found	find	VERB	VBD	O
that	that	ADP	IN	O
thiazide	thiazide	NOUN	NN	B-Chemical
diuretics	diuretic	NOUN	NNS	O
cause	cause	VERB	VBP	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
depletion	depletion	NOUN	NN	O
of	of	ADP	IN	O
body	body	NOUN	NN	O
potassium	potassium	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
more	more	ADV	RBR	O
profound	profound	ADJ	JJ	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
greater	great	ADJ	JJR	O
the	the	DET	DT	O
propensity	propensity	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
PVC	PVC	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
.	.	PUNCT	.	O

Circulating	circulate	VERB	VBG	O
lysosomal	lysosomal	ADJ	JJ	O
enzymes	enzyme	NOUN	NNS	O
and	and	CCONJ	CC	O
acute	acute	ADJ	JJ	B-Disease
hepatic	hepatic	ADJ	JJ	I-Disease
necrosis	necrosis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
activities	activity	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
lysosomal	lysosomal	ADJ	JJ	O
enzymes	enzyme	NOUN	NNS	O
acid	acid	ADJ	JJ	O
and	and	CCONJ	CC	O
neutral	neutral	ADJ	JJ	O
protease	protease	NOUN	NN	O
,	,	PUNCT	,	O
N	n	NOUN	NN	O
-	-	PUNCT	HYPH	O
acetylglucosaminidase	acetylglucosaminidase	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
acid	acid	NOUN	NN	O
phosphatase	phosphatase	NOUN	NN	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
serum	serum	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
fulminant	fulminant	ADJ	JJ	B-Disease
hepatic	hepatic	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Acid	acid	ADJ	JJ	O
protease	protease	NOUN	NN	O
(	(	PUNCT	-LRB-	O
cathepsin	cathepsin	NOUN	NN	O
D	D	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
activity	activity	NOUN	NN	O
was	be	VERB	VBD	O
increased	increase	VERB	VBN	O
about	about	ADP	IN	O
tenfold	tenfold	ADV	RB	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
died	die	VERB	VBD	O
and	and	CCONJ	CC	O
nearly	nearly	ADV	RB	O
fourfold	fourfold	VERB	VBN	O
in	in	ADP	IN	O
those	those	DET	DT	O
who	who	PRON	WP	O
survived	survive	VERB	VBD	O
fulminant	fulminant	ADJ	JJ	B-Disease
hepatic	hepatic	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
after	after	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
activities	activity	NOUN	NNS	O
were	be	VERB	VBD	O
increased	increase	VERB	VBN	O
equally	equally	ADV	RB	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
fulminant	fulminant	ADJ	JJ	B-Disease
hepatic	hepatic	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
viral	viral	ADJ	JJ	B-Disease
hepatitis	hepatitis	NOUN	NN	I-Disease
whether	whether	ADP	IN	O
or	or	CCONJ	CC	O
not	not	ADV	RB	O
they	-PRON-	PRON	PRP	O
survived	survive	VERB	VBD	O
.	.	PUNCT	.	O

A	a	DET	DT	O
correlation	correlation	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
between	between	ADP	IN	O
serum	serum	ADJ	JJ	O
acid	acid	ADJ	JJ	O
protease	protease	NOUN	NN	O
activity	activity	NOUN	NN	O
and	and	CCONJ	CC	O
prothrombin	prothrombin	NOUN	NN	O
time	time	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
cathepsin	cathepsin	NOUN	NN	O
D	d	NOUN	NN	O
activity	activity	NOUN	NN	O
was	be	VERB	VBD	O
sustained	sustain	VERB	VBN	O
over	over	ADP	IN	O
several	several	ADJ	JJ	O
days	day	NOUN	NNS	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
aspartate	aspartate	NOUN	NN	B-Chemical
aminotransferase	aminotransferase	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
sharp	sharp	ADJ	JJ	O
early	early	ADJ	JJ	O
peak	peak	NOUN	NN	O
and	and	CCONJ	CC	O
then	then	ADV	RB	O
a	a	DET	DT	O
fall	fall	NOUN	NN	O
.	.	PUNCT	.	O

Circulating	circulate	VERB	VBG	O
lysosomal	lysosomal	ADJ	JJ	O
proteases	protease	NOUN	NNS	O
can	can	VERB	MD	O
damage	damage	VERB	VB	O
other	other	ADJ	JJ	O
organs	organ	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
measurement	measurement	NOUN	NN	O
of	of	ADP	IN	O
their	-PRON-	DET	PRP$	O
activity	activity	NOUN	NN	O
may	may	VERB	MD	O
therefore	therefore	ADV	RB	O
be	be	VERB	VB	O
of	of	ADP	IN	O
added	add	VERB	VBN	O
value	value	NOUN	NN	O
in	in	ADP	IN	O
assessing	assess	VERB	VBG	O
prognosis	prognosis	NOUN	NN	O
in	in	ADP	IN	O
this	this	DET	DT	O
condition	condition	NOUN	NN	O
.	.	PUNCT	.	O

Hepatic	hepatic	ADJ	JJ	B-Disease
veno	veno	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	I-Disease
occlusive	occlusive	ADJ	JJ	I-Disease
disease	disease	NOUN	NN	I-Disease
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
thioguanine	thioguanine	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Clinically	clinically	ADV	RB	O
reversible	reversible	ADJ	JJ	O
veno	veno	NOUN	NNS	B-Disease
-	-	PUNCT	HYPH	I-Disease
occlusive	occlusive	ADJ	JJ	I-Disease
disease	disease	NOUN	NN	I-Disease
of	of	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
liver	liver	NOUN	NN	I-Disease
developed	develop	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
23	23	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
lymphocytic	lymphocytic	ADJ	JJ	I-Disease
leukemia	leukemia	NOUN	NN	I-Disease
after	after	ADP	IN	O
10	10	NUM	CD	O
months	month	NOUN	NNS	O
of	of	ADP	IN	O
maintenance	maintenance	NOUN	NN	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
thioguanine	thioguanine	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Serial	serial	ADJ	JJ	O
liver	liver	NOUN	NN	O
biopsies	biopsy	NOUN	NNS	O
showed	show	VERB	VBD	O
the	the	DET	DT	O
development	development	NOUN	NN	O
and	and	CCONJ	CC	O
resolution	resolution	NOUN	NN	O
of	of	ADP	IN	O
intense	intense	ADJ	JJ	O
sinusoidal	sinusoidal	NOUN	NN	O
engorgement	engorgement	NOUN	NN	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
this	this	DET	DT	O
disease	disease	NOUN	NN	O
was	be	VERB	VBD	O
clinically	clinically	ADV	RB	O
reversible	reversible	ADJ	JJ	O
,	,	PUNCT	,	O
some	some	DET	DT	O
subintimal	subintimal	ADJ	JJ	O
fibrosis	fibrosis	NOUN	NN	B-Disease
about	about	ADP	IN	O
the	the	DET	DT	O
terminal	terminal	ADJ	JJ	O
hepatic	hepatic	ADJ	JJ	O
veins	vein	NOUN	NNS	O
persisted	persist	VERB	VBD	O
.	.	PUNCT	.	O

This	this	DET	DT	O
case	case	NOUN	NN	O
presented	present	VERB	VBD	O
a	a	DET	DT	O
unique	unique	ADJ	JJ	O
opportunity	opportunity	NOUN	NN	O
to	to	PART	TO	O
observe	observe	VERB	VB	O
the	the	DET	DT	O
histologic	histologic	ADJ	JJ	O
features	feature	NOUN	NNS	O
of	of	ADP	IN	O
clinically	clinically	ADV	RB	O
reversible	reversible	ADJ	JJ	O
hepatic	hepatic	ADJ	JJ	B-Disease
veno	veno	NOUN	NNS	I-Disease
-	-	PUNCT	HYPH	I-Disease
occlusive	occlusive	ADJ	JJ	I-Disease
disease	disease	NOUN	NN	I-Disease
over	over	ADP	IN	O
time	time	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
may	may	VERB	MD	O
be	be	VERB	VB	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
veno	veno	NOUN	NN	O
-	-	PUNCT	HYPH	O
occlusive	occlusive	ADJ	JJ	O
related	relate	VERB	VBN	O
solely	solely	ADV	RB	O
to	to	ADP	IN	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
thioguanine	thioguanine	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Chlorpropamide	chlorpropamide	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
65	65	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
adult	adult	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
onset	onset	NOUN	NN	I-Disease
diabetes	diabete	NOUN	NNS	I-Disease
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
chlorpropamide	chlorpropamide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Diabenese	Diabenese	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
a	a	DET	DT	O
toxic	toxic	ADJ	JJ	B-Disease
optic	optic	ADJ	JJ	I-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
that	that	DET	WDT	O
resolved	resolve	VERB	VBD	O
with	with	ADP	IN	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
chlorpropamide	chlorpropamide	ADJ	JJ	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Visual	visual	ADJ	JJ	B-Disease
loss	loss	NOUN	NN	I-Disease
occurs	occur	VERB	VBZ	O
in	in	ADP	IN	O
diabetics	diabetic	NOUN	NNS	B-Disease
for	for	ADP	IN	O
a	a	DET	DT	O
variety	variety	NOUN	NN	O
of	of	ADP	IN	O
reasons	reason	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
accurate	accurate	ADJ	JJ	O
diagnosis	diagnosis	NOUN	NN	O
is	be	VERB	VBZ	O
necessary	necessary	ADJ	JJ	O
to	to	PART	TO	O
institute	institute	VERB	VB	O
appropriate	appropriate	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
possibility	possibility	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
optic	optic	ADJ	JJ	B-Disease
neuropathy	neuropathy	NOUN	NN	I-Disease
should	should	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
differential	differential	ADJ	JJ	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
visual	visual	ADJ	JJ	B-Disease
loss	loss	NOUN	NN	I-Disease
in	in	ADP	IN	O
diabetics	diabetic	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Plasma	plasma	NOUN	NN	O
and	and	CCONJ	CC	O
urinary	urinary	ADJ	JJ	O
lipids	lipid	NOUN	NNS	O
and	and	CCONJ	CC	O
lipoproteins	lipoprotein	NOUN	NNS	O
during	during	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
by	by	ADP	IN	O
puromycin	puromycin	ADJ	JJ	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
undertaken	undertake	VERB	VBN	O
to	to	PART	TO	O
ascertain	ascertain	VERB	VB	O
whether	whether	ADP	IN	O
the	the	DET	DT	O
alterations	alteration	NOUN	NNS	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
lipoproteins	lipoprotein	NOUN	NNS	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
puromycin	puromycin	NOUN	NN	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
were	be	VERB	VBD	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
per	per	X	FW	O
se	se	X	FW	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
,	,	PUNCT	,	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
in	in	ADP	IN	O
part	part	NOUN	NN	O
,	,	PUNCT	,	O
to	to	ADP	IN	O
the	the	DET	DT	O
aminonucleoside	aminonucleoside	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
purpose	purpose	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
plasma	plasma	NOUN	NN	O
and	and	CCONJ	CC	O
urinary	urinary	ADJ	JJ	O
lipoproteins	lipoprotein	NOUN	NNS	O
during	during	ADP	IN	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
puromycin	puromycin	NOUN	NN	B-Chemical
aminonucleoside	aminonucleoside	ADV	RB	I-Chemical
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
for	for	ADP	IN	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
subsequent	subsequent	ADJ	JJ	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Since	since	ADP	IN	O
massive	massive	ADJ	JJ	O
albuminuria	albuminuria	NOUN	NN	B-Disease
occurred	occur	VERB	VBD	O
after	after	ADP	IN	O
6	6	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
time	time	NOUN	NN	O
-	-	PUNCT	HYPH	O
course	course	NOUN	NN	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
divided	divide	VERB	VBN	O
into	into	ADP	IN	O
two	two	NUM	CD	O
stages	stage	NOUN	NNS	O
:	:	PUNCT	:	O
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
stage	stage	NOUN	NN	O
(	(	PUNCT	-LRB-	O
day	day	NOUN	NN	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
5	5	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
stage	stage	NOUN	NN	O
(	(	PUNCT	-LRB-	O
day	day	NOUN	NN	O
6	6	NUM	CD	O
-	-	SYM	SYM	O
11	11	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
stage	stage	NOUN	NN	O
the	the	DET	DT	O
plasma	plasma	NOUN	NN	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
fatty	fatty	ADJ	JJ	B-Chemical
acids	acid	NOUN	NNS	I-Chemical
,	,	PUNCT	,	O
triacylglycerol	triacylglycerol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
VLDL	vldl	NOUN	NN	O
decreased	decrease	VERB	VBD	O
while	while	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
phospholipid	phospholipid	ADJ	JJ	O
,	,	PUNCT	,	O
cholesteryl	cholesteryl	NOUN	NN	B-Chemical
esters	ester	NOUN	NNS	I-Chemical
and	and	CCONJ	CC	O
HDL	HDL	PROPN	NNP	O
remained	remain	VERB	VBD	O
constant	constant	ADJ	JJ	O
.	.	PUNCT	.	O

Plasma	plasma	NOUN	NN	O
apolipoprotein	apolipoprotein	NOUN	NN	O
A	A	PROPN	NNP	O
-	-	PUNCT	:	O
I	-PRON-	PRON	PRP	O
tended	tend	VERB	VBD	O
to	to	PART	TO	O
increase	increase	VERB	VB	O
(	(	PUNCT	-LRB-	O
40	40	NUM	CD	O
%	%	NOUN	NN	O
increase	increase	NOUN	NN	O
at	at	ADP	IN	O
day	day	NOUN	NN	O
5	5	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
the	the	DET	DT	O
beginning	beginning	NOUN	NN	O
of	of	ADP	IN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
stage	stage	NOUN	NN	O
(	(	PUNCT	-LRB-	O
day	day	NOUN	NN	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
the	the	DET	DT	O
concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
albumin	albumin	NOUN	NN	O
dropped	drop	VERB	VBD	O
to	to	ADP	IN	O
a	a	DET	DT	O
very	very	ADV	RB	O
low	low	ADJ	JJ	O
level	level	NOUN	NN	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
apolipoprotein	apolipoprotein	NOUN	NN	O
A	A	PROPN	NNP	O
-	-	PUNCT	:	O
I	-PRON-	PRON	PRP	O
increased	increase	VERB	VBD	O
abruptly	abruptly	ADV	RB	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
-	-	ADV	RB	O
fold	fold	ADJ	JJ	O
increase	increase	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
continued	continue	VERB	VBD	O
to	to	PART	TO	O
rise	rise	VERB	VB	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
less	less	ADV	RBR	O
steeply	steeply	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
following	follow	VERB	VBG	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
plasma	plasma	NOUN	NN	O
concentration	concentration	NOUN	NN	O
of	of	ADP	IN	O
HDL	HDL	PROPN	NNP	O
followed	follow	VERB	VBD	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
pattern	pattern	NOUN	NN	O
.	.	PUNCT	.	O

Plasma	plasma	ADJ	JJ	O
VLDL	VLDL	NOUN	NNS	O
and	and	CCONJ	CC	O
LDL	LDL	PROPN	NNP	O
increased	increase	VERB	VBD	O
at	at	ADP	IN	O
a	a	DET	DT	O
later	later	ADJ	JJ	O
stage	stage	NOUN	NN	O
(	(	PUNCT	-LRB-	O
day	day	NOUN	NN	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Plasma	plasma	NOUN	NN	O
apolipoprotein	apolipoprotein	NOUN	NN	O
A	A	PROPN	NNP	O
-	-	PUNCT	:	O
I	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
not	not	ADV	RB	O
only	only	ADV	RB	O
in	in	ADP	IN	O
HDL	HDL	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
063	063	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
210	210	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
)	)	PUNCT	-RRB-	O
but	but	CCONJ	CC	O
also	also	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
LDL	LDL	PROPN	NNP	O
density	density	NOUN	NN	O
class	class	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
025	025	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
050	050	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
stage	stage	NOUN	NN	O
lipoproteinuria	lipoproteinuria	NOUN	NN	O
was	be	VERB	VBD	O
negligible	negligible	ADJ	JJ	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
early	early	ADJ	JJ	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
stage	stage	NOUN	NN	O
the	the	DET	DT	O
urinary	urinary	ADJ	JJ	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
lipoproteins	lipoprotein	NOUN	NNS	O
consisted	consist	VERB	VBN	O
mainly	mainly	ADV	RB	O
of	of	ADP	IN	O
HDL	HDL	PROPN	NNP	O
.	.	PUNCT	.	O

These	these	DET	DT	O
observations	observation	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
puromycin	puromycin	VERB	VBN	B-Chemical
aminonucleoside	aminonucleoside	ADP	IN	I-Chemical
alters	alter	NOUN	NNS	O
plasma	plasma	VERB	VBP	O
lipoproteins	lipoprotein	NOUN	NNS	O
by	by	ADP	IN	O
lowering	lower	VERB	VBG	O
VLDL	VLDL	NOUN	NNS	O
and	and	CCONJ	CC	O
increasing	increase	VERB	VBG	O
HDL	HDL	PROPN	NNP	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
likely	likely	ADJ	JJ	O
that	that	ADP	IN	O
the	the	DET	DT	O
early	early	ADJ	JJ	O
and	and	CCONJ	CC	O
striking	striking	ADJ	JJ	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
HDL	HDL	PROPN	NNP	O
found	find	VERB	VBD	O
in	in	ADP	IN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
is	be	VERB	VBZ	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
a	a	DET	DT	O
direct	direct	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
on	on	ADP	IN	O
HDL	HDL	PROPN	NNP	O
metabolism	metabolism	NOUN	NN	O
.	.	PUNCT	.	O

Fatal	fatal	ADJ	JJ	O
aplastic	aplastic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
topical	topical	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
ophthalmic	ophthalmic	ADJ	JJ	O
chloramphenicol	chloramphenicol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
73	73	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
died	die	VERB	VBD	O
of	of	ADP	IN	O
aplastic	aplastic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
less	less	ADJ	JJR	O
than	than	ADP	IN	O
two	two	NUM	CD	O
months	month	NOUN	NNS	O
after	after	ADP	IN	O
undergoing	undergo	VERB	VBG	O
cataract	cataract	ADJ	JJ	B-Disease
extraction	extraction	NOUN	NN	O
and	and	CCONJ	CC	O
beginning	begin	VERB	VBG	O
topical	topical	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
chloramphenicol	chloramphenicol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
first	first	ADJ	JJ	O
signs	sign	NOUN	NNS	O
of	of	ADP	IN	O
pancytopenia	pancytopenia	NOUN	NN	B-Disease
began	begin	VERB	VBD	O
within	within	ADP	IN	O
one	one	NUM	CD	O
month	month	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
surgery	surgery	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
pattern	pattern	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
aplastic	aplastic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
idiosyncratic	idiosyncratic	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	PART	TO	O
chloramphenicol	chloramphenicol	VERB	VB	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
was	be	VERB	VBD	O
the	the	DET	DT	O
second	second	ADJ	JJ	O
report	report	NOUN	NN	O
of	of	ADP	IN	O
fatal	fatal	ADJ	JJ	O
aplastic	aplastic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
after	after	ADP	IN	O
topical	topical	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
chloramphenicol	chloramphenicol	NOUN	NN	B-Chemical
for	for	ADP	IN	O
ocular	ocular	ADJ	JJ	O
conditions	condition	NOUN	NNS	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
reversible	reversible	ADJ	JJ	O
bone	bone	NOUN	NN	B-Disease
marrow	marrow	NOUN	NN	I-Disease
hypoplasia	hypoplasia	NOUN	NN	I-Disease
have	have	VERB	VBP	O
also	also	ADV	RB	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

Any	any	DET	DT	O
other	other	ADJ	JJ	O
suspected	suspect	VERB	VBN	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
ocular	ocular	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
topically	topically	ADV	RB	O
applied	apply	VERB	VBN	O
chloramphenicol	chloramphenicol	NOUN	NN	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
reported	report	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
National	National	PROPN	NNP	O
Registry	Registry	PROPN	NNP	O
of	of	ADP	IN	O
Drug	Drug	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Induced	Induced	PROPN	NNP	O
Ocular	Ocular	PROPN	NNP	O
Side	Side	PROPN	NNP	O
Effects	Effects	PROPN	NNPS	O
,	,	PUNCT	,	O
Oregon	Oregon	PROPN	NNP	O
Health	Health	PROPN	NNP	O
Sciences	Sciences	PROPN	NNPS	O
University	University	PROPN	NNP	O
,	,	PUNCT	,	O
Portland	Portland	PROPN	NNP	O
,	,	PUNCT	,	O
OR	or	CCONJ	CC	O
97201	97201	NUM	CD	O
.	.	PUNCT	.	O

Midazolam	Midazolam	PROPN	NNP	B-Chemical
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
thiopentone	thiopentone	NOUN	NN	B-Chemical
as	as	ADP	IN	O
an	an	DET	DT	O
induction	induction	NOUN	NN	O
agent	agent	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
patients	patient	NOUN	NNS	O
premedicated	premedicate	VERB	VBN	O
with	with	ADP	IN	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
+	+	CCONJ	CC	O
morphine	morphine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
nitrazepam	nitrazepam	NOUN	NN	B-Chemical
the	the	DET	DT	O
evening	evening	NOUN	NN	O
before	before	ADP	IN	O
surgery	surgery	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
sleep	sleep	NOUN	NN	O
-	-	PUNCT	HYPH	O
inducing	induce	VERB	VBG	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
midazolam	midazolam	NOUN	NN	B-Chemical
0	0	NUM	CD	O
.	.	PUNCT	.	O
15	15	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
was	be	VERB	VBD	O
clearly	clearly	ADV	RB	O
slower	slow	ADJ	JJR	O
in	in	ADP	IN	O
onset	onset	NOUN	NN	O
than	than	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
thiopentone	thiopentone	NOUN	NN	B-Chemical
4	4	NUM	CD	O
.	.	PUNCT	.	O
67	67	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
Somewhat	somewhat	ADV	RB	O
fewer	few	ADJ	JJR	O
cardiovascular	cardiovascular	ADJ	JJ	O
and	and	CCONJ	CC	O
local	local	ADJ	JJ	O
sequelae	sequelae	NOUN	NN	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
midazolam	midazolam	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
apnoea	apnoea	NOUN	NN	B-Disease
occurred	occur	VERB	VBD	O
less	less	ADV	RBR	O
often	often	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
midazolam	midazolam	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
it	-PRON-	PRON	PRP	O
lasted	last	VERB	VBD	O
longer	longer	ADV	RBR	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
whole	whole	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
midazolam	midazolam	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
thiopentone	thiopentone	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
no	no	DET	DT	O
apparent	apparent	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
consequences	consequence	NOUN	NNS	O
.	.	PUNCT	.	O

Midazolam	Midazolam	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
alternative	alternative	ADJ	JJ	O
agent	agent	NOUN	NN	O
for	for	ADP	IN	O
induction	induction	NOUN	NN	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
anaesthesia	anaesthesia	NOUN	NN	O
.	.	PUNCT	.	O

Extrapyramidal	extrapyramidal	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
and	and	CCONJ	CC	O
oral	oral	ADJ	JJ	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
an	an	DET	DT	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
explanatory	explanatory	ADJ	JJ	O
patient	patient	NOUN	NN	O
and	and	CCONJ	CC	O
treatment	treatment	NOUN	NN	O
characteristics	characteristic	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
extrapyramidal	extrapyramidal	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
EPS	EPS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
in	in	ADP	IN	O
98	98	NUM	CD	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
parkinsonism	parkinsonism	NOUN	NN	B-Disease
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
at	at	ADP	IN	O
higher	high	ADJ	JJR	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
in	in	ADP	IN	O
younger	young	ADJ	JJR	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Prophylactic	prophylactic	ADJ	JJ	O
antiparkinsonian	antiparkinsonian	ADJ	JJ	O
medication	medication	NOUN	NN	O
was	be	VERB	VBD	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
younger	young	ADJ	JJR	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
in	in	ADP	IN	O
older	old	ADJ	JJR	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
these	these	DET	DT	O
medications	medication	NOUN	NNS	O
were	be	VERB	VBD	O
more	more	ADV	RBR	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
both	both	CCONJ	CC	O
young	young	ADJ	JJ	O
and	and	CCONJ	CC	O
old	old	ADJ	JJ	O
patients	patient	NOUN	NNS	O
when	when	ADV	WRB	O
given	give	VERB	VBN	O
after	after	ADP	IN	O
parkinsonism	parkinsonism	NOUN	NN	B-Disease
developed	develop	VERB	VBD	O
.	.	PUNCT	.	O

Akathisia	Akathisia	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
controlled	control	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
benzodiazepine	benzodiazepine	NOUN	NN	B-Chemical
lorazepam	lorazepam	NOUN	NN	B-Chemical
in	in	ADP	IN	O
14	14	NUM	CD	O
out	out	ADP	IN	O
of	of	ADP	IN	O
16	16	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
while	while	ADP	IN	O
prophylactic	prophylactic	ADJ	JJ	O
antiparkinsonians	antiparkinsonian	NOUN	NNS	O
were	be	VERB	VBD	O
ineffective	ineffective	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
points	point	NOUN	NNS	O
to	to	ADP	IN	O
patient	patient	ADJ	JJ	O
characteristics	characteristic	NOUN	NNS	O
that	that	DET	WDT	O
may	may	VERB	MD	O
be	be	VERB	VB	O
of	of	ADP	IN	O
significance	significance	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
EPS	EPS	PROPN	NNP	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Deaths	death	NOUN	NNS	O
from	from	ADP	IN	O
local	local	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
convulsions	convulsion	NOUN	NNS	B-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Median	median	ADJ	JJ	O
convulsant	convulsant	NOUN	NN	O
(	(	PUNCT	-LRB-	O
CD50	CD50	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
median	median	NOUN	NN	O
lethal	lethal	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
LD50	LD50	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
three	three	NUM	CD	O
representative	representative	ADJ	JJ	O
local	local	ADJ	JJ	O
anesthetics	anesthetic	NOUN	NNS	O
were	be	VERB	VBD	O
determined	determine	VERB	VBN	O
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
mice	mouse	NOUN	NNS	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
threat	threat	NOUN	NN	O
to	to	ADP	IN	O
life	life	NOUN	NN	O
of	of	ADP	IN	O
local	local	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
convulsions	convulsion	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
CD50	CD50	PROPN	NNP	O
and	and	CCONJ	CC	O
LD50	LD50	PROPN	NNP	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
57	57	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
and	and	CCONJ	CC	O
58	58	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
for	for	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
111	111	NUM	CD	O
.	.	NOUN	NN	O
0	0	NUM	CD	O
and	and	CCONJ	CC	O
133	133	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
for	for	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
243	243	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
and	and	CCONJ	CC	O
266	266	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
for	for	ADP	IN	O
chloroprocaine	chloroprocaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

When	when	ADV	WRB	O
given	give	VERB	VBN	O
intraperitoneally	intraperitoneally	ADV	RB	O
,	,	PUNCT	,	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
thus	thus	ADV	RB	O
was	be	VERB	VBD	O
only	only	ADV	RB	O
about	about	ADV	RB	O
twice	twice	DET	PDT	O
as	as	ADV	RB	O
toxic	toxic	ADJ	JJ	O
as	as	ADP	IN	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
four	four	NUM	CD	O
times	time	NOUN	NNS	O
as	as	ADV	RB	O
toxic	toxic	ADJ	JJ	O
as	as	ADP	IN	O
chloroprocaine	chloroprocaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Convulsions	convulsion	NOUN	NNS	B-Disease
always	always	ADV	RB	O
preceded	precede	VERB	VBD	O
death	death	NOUN	NN	O
,	,	PUNCT	,	O
except	except	ADP	IN	O
after	after	ADP	IN	O
precipitous	precipitous	ADJ	JJ	O
cardiopulmonary	cardiopulmonary	ADJ	JJ	B-Disease
arrest	arrest	NOUN	NN	I-Disease
from	from	ADP	IN	O
extreme	extreme	ADJ	JJ	O
doses	dose	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
CD50	CD50	PROPN	NNP	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
local	local	ADJ	JJ	O
anesthetic	anesthetic	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
causing	cause	VERB	VBG	O
convulsions	convulsion	NOUN	NNS	B-Disease
in	in	ADP	IN	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
mice	mouse	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
fatal	fatal	ADJ	JJ	O
in	in	ADP	IN	O
90	90	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
in	in	ADP	IN	O
57	57	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
chloroprocaine	chloroprocaine	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
lidocaine	lidocaine	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
narrow	narrow	ADJ	JJ	O
gap	gap	NOUN	NN	O
between	between	ADP	IN	O
convulsant	convulsant	NOUN	NN	O
and	and	CCONJ	CC	O
lethal	lethal	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
local	local	ADJ	JJ	O
anesthetics	anesthetic	NOUN	NNS	O
indicates	indicate	VERB	VBZ	O
that	that	ADP	IN	O
untreated	untreated	ADJ	JJ	O
convulsions	convulsion	NOUN	NNS	B-Disease
present	present	VERB	VBP	O
much	much	ADV	RB	O
more	more	ADJ	JJR	O
of	of	ADP	IN	O
a	a	DET	DT	O
threat	threat	NOUN	NN	O
to	to	ADP	IN	O
life	life	NOUN	NN	O
than	than	ADP	IN	O
heretofore	heretofore	ADV	RB	O
appreciated	appreciate	VERB	VBN	O
.	.	PUNCT	.	O

REM	rem	NOUN	NN	B-Disease
sleep	sleep	NOUN	NN	I-Disease
deprivation	deprivation	NOUN	NN	I-Disease
changes	change	VERB	VBZ	O
behavioral	behavioral	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
catecholaminergic	catecholaminergic	NOUN	NN	O
and	and	CCONJ	CC	O
serotonergic	serotonergic	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
activation	activation	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
REM	rem	NOUN	NN	B-Disease
sleep	sleep	NOUN	NN	I-Disease
deprivation	deprivation	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
REMD	REMD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
aggressiveness	aggressiveness	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
quipazine	quipazine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
head	head	NOUN	NN	B-Disease
twitches	twitch	NOUN	NNS	I-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
determined	determine	VERB	VBN	O
.	.	PUNCT	.	O

Forty	forty	NUM	CD	O
-	-	PUNCT	HYPH	O
eight	eight	NUM	CD	O
hr	hr	NOUN	NN	O
of	of	ADP	IN	O
REMD	REMD	PROPN	NNP	B-Disease
increased	increase	VERB	VBD	O
apomorphine	apomorphine	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
aggressiveness	aggressiveness	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
reduced	reduce	VERB	VBN	O
(	(	PUNCT	-LRB-	O
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
completing	complete	VERB	VBG	O
of	of	ADP	IN	O
REMD	REMD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
increased	increase	VERB	VBN	O
(	(	PUNCT	-LRB-	O
96	96	NUM	CD	O
hr	hr	NOUN	NNS	O
after	after	ADP	IN	O
completing	complete	VERB	VBG	O
of	of	ADP	IN	O
REMD	REMD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
quipazine	quipazine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
head	head	NOUN	NN	B-Disease
twitches	twitch	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Results	result	NOUN	NNS	O
are	be	VERB	VBP	O
discussed	discuss	VERB	VBN	O
in	in	ADP	IN	O
terms	term	NOUN	NNS	O
of	of	ADP	IN	O
similarity	similarity	NOUN	NN	O
to	to	ADP	IN	O
pharmacological	pharmacological	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
other	other	ADJ	JJ	O
antidepressive	antidepressive	ADJ	JJ	O
treatments	treatment	NOUN	NNS	O
.	.	PUNCT	.	O

Fatal	fatal	ADJ	JJ	O
aplastic	aplastic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
indomethacin	indomethacin	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
-	-	PUNCT	HYPH	O
lymphocyte	lymphocyte	ADJ	JJ	O
transformation	transformation	NOUN	NN	O
tests	test	NOUN	NNS	O
in	in	ADP	IN	O
vitro	vitro	NOUN	NN	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
indomethacin	indomethacin	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
implicated	implicate	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
aplastic	aplastic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
on	on	ADP	IN	O
the	the	DET	DT	O
basis	basis	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
few	few	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
observations	observation	NOUN	NNS	O
,	,	PUNCT	,	O
its	-PRON-	DET	PRP$	O
role	role	NOUN	NN	O
has	have	VERB	VBZ	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
definitely	definitely	ADV	RB	O
established	establish	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
fatal	fatal	ADJ	JJ	O
aplastic	aplastic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
described	describe	VERB	VBN	O
in	in	ADP	IN	O
which	which	DET	WDT	O
no	no	DET	DT	O
drugs	drug	NOUN	NNS	O
other	other	ADJ	JJ	O
than	than	ADP	IN	O
allopurinol	allopurinol	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
indomethacin	indomethacin	ADV	RB	B-Chemical
were	be	VERB	VBD	O
given	give	VERB	VBN	O
.	.	PUNCT	.	O

Indomethacin	Indomethacin	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
first	first	ADV	RB	O
given	give	VERB	VBN	O
four	four	NUM	CD	O
weeks	week	NOUN	NNS	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
symptoms	symptom	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
positive	positive	ADJ	JJ	O
lymphocyte	lymphocyte	ADJ	JJ	O
transformation	transformation	NOUN	NN	O
test	test	NOUN	NN	O
with	with	ADP	IN	O
indomethacin	indomethacin	ADV	RB	B-Chemical
in	in	ADP	IN	O
vitro	vitro	X	FW	O
further	further	ADV	RB	O
substantiates	substantiate	VERB	VBZ	O
the	the	DET	DT	O
potential	potential	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
drug	drug	NOUN	NN	O
in	in	ADP	IN	O
causing	cause	VERB	VBG	O
aplastic	aplastic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
susceptible	susceptible	ADJ	JJ	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

Fortunately	fortunately	ADV	RB	O
,	,	PUNCT	,	O
this	this	DET	DT	O
seems	seem	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
a	a	DET	DT	O
very	very	ADV	RB	O
rare	rare	ADJ	JJ	O
complication	complication	NOUN	NN	O
.	.	PUNCT	.	O

Dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
effect	effect	NOUN	NN	O
and	and	CCONJ	CC	O
structure	structure	NOUN	NN	O
-	-	PUNCT	HYPH	O
function	function	NOUN	NN	O
relationships	relationship	NOUN	NNS	O
in	in	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
CM	CM	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
anticancer	anticancer	NOUN	NN	O
drug	drug	NOUN	NN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DXR	DXR	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
Adriamycin	Adriamycin	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
provides	provide	VERB	VBZ	O
a	a	DET	DT	O
unique	unique	ADJ	JJ	O
opportunity	opportunity	NOUN	NN	O
to	to	PART	TO	O
analyze	analyze	VERB	VB	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
effect	effect	NOUN	NN	O
and	and	CCONJ	CC	O
structure	structure	NOUN	NN	O
-	-	PUNCT	HYPH	O
function	function	NOUN	NN	O
relationships	relationship	NOUN	NNS	O
during	during	ADP	IN	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
myocardial	myocardial	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
measured	measure	VERB	VBD	O
the	the	DET	DT	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
morphologic	morphologic	ADJ	JJ	O
damage	damage	NOUN	NN	O
by	by	ADP	IN	O
ultrastructural	ultrastructural	ADJ	JJ	O
examination	examination	NOUN	NN	O
of	of	ADP	IN	O
endomyocardial	endomyocardial	ADJ	JJ	O
biopsy	biopsy	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
performance	performance	NOUN	NN	O
abnormally	abnormally	ADV	RB	O
by	by	ADP	IN	O
right	right	ADJ	JJ	O
heart	heart	NOUN	NN	O
catheterization	catheterization	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
DXR	DXR	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Morphologic	morphologic	ADJ	JJ	O
damage	damage	NOUN	NN	O
was	be	VERB	VBD	O
variable	variable	ADJ	JJ	O
but	but	CCONJ	CC	O
was	be	VERB	VBD	O
proportional	proportional	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
total	total	ADJ	JJ	O
cumulative	cumulative	ADJ	JJ	O
DXR	dxr	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
between	between	ADP	IN	O
100	100	NUM	CD	O
and	and	CCONJ	CC	O
600	600	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
.	.	PUNCT	.	O

Performance	performance	NOUN	NN	O
abnormalities	abnormality	NOUN	NNS	O
correlated	correlate	VERB	VBD	O
weakly	weakly	ADV	RB	O
with	with	ADP	IN	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
exhibited	exhibit	VERB	VBD	O
a	a	DET	DT	O
curvilinear	curvilinear	NOUN	NN	O
relationship	relationship	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
had	have	VERB	VBD	O
a	a	DET	DT	O
"	"	PUNCT	``	O
threshold	threshold	NOUN	NN	O
"	"	PUNCT	''	O
for	for	ADP	IN	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

Catheterization	catheterization	NOUN	NN	O
abnormalities	abnormality	NOUN	NNS	O
correlated	correlate	VERB	VBD	O
well	well	ADV	RB	O
with	with	ADP	IN	O
morphologic	morphologic	ADJ	JJ	O
damage	damage	NOUN	NN	O
(	(	PUNCT	-LRB-	O
r	r	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
57	57	NUM	CD	O
to	to	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
78	78	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
a	a	DET	DT	O
subgroup	subgroup	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
whom	whom	PRON	WP	O
exercise	exercise	NOUN	NN	O
hemodynamics	hemodynamic	NOUN	NNS	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
this	this	DET	DT	O
relationship	relationship	NOUN	NN	O
also	also	ADV	RB	O
exhibited	exhibit	VERB	VBD	O
a	a	DET	DT	O
curvilinear	curvilinear	NOUN	NN	O
,	,	PUNCT	,	O
threshold	threshold	NOUN	NN	O
configuration	configuration	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
DXR	DXR	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
CM	CM	PROPN	NNP	B-Disease
myocardial	myocardial	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
proportional	proportional	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
cytotoxic	cytotoxic	NOUN	NN	O
insult	insult	NOUN	NN	O
(	(	PUNCT	-LRB-	O
DXR	dxr	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
)	)	PUNCT	-RRB-	O
while	while	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
function	function	NOUN	NN	O
is	be	VERB	VBZ	O
preserved	preserve	VERB	VBN	O
until	until	ADP	IN	O
a	a	DET	DT	O
critical	critical	ADJ	JJ	O
dose	dose	NOUN	NN	O
or	or	CCONJ	CC	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
damage	damage	NOUN	NN	O
is	be	VERB	VBZ	O
reached	reach	VERB	VBN	O
,	,	PUNCT	,	O
after	after	ADP	IN	O
which	which	DET	WDT	O
myocardial	myocardial	ADJ	JJ	O
performance	performance	NOUN	NN	O
deteriorates	deteriorate	VERB	VBZ	O
rapidly	rapidly	ADV	RB	O
.	.	PUNCT	.	O

Massive	massive	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	B-Disease
edema	edema	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
fulminant	fulminant	ADJ	JJ	O
hepatic	hepatic	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
in	in	ADP	IN	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
overdose	overdose	ADJ	JJ	B-Disease
:	:	PUNCT	:	O
possible	possible	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
cranial	cranial	ADJ	JJ	O
decompression	decompression	NOUN	NN	O
.	.	PUNCT	.	O

Cerebral	cerebral	ADJ	JJ	B-Disease
edema	edema	NOUN	NN	I-Disease
may	may	VERB	MD	O
complicate	complicate	VERB	VB	O
the	the	DET	DT	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
fulminant	fulminant	ADJ	JJ	B-Disease
hepatic	hepatic	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Response	response	NOUN	NN	O
to	to	ADP	IN	O
conventional	conventional	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
disappointing	disappointing	ADJ	JJ	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
present	present	VERB	VBP	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
fatal	fatal	ADJ	JJ	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
fulminant	fulminant	ADJ	JJ	B-Disease
hepatic	hepatic	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
,	,	PUNCT	,	O
with	with	ADP	IN	O
signs	sign	NOUN	NNS	O
and	and	CCONJ	CC	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
cerebral	cerebral	ADJ	JJ	B-Disease
edema	edema	NOUN	NN	I-Disease
,	,	PUNCT	,	O
unresponsive	unresponsive	ADJ	JJ	O
to	to	ADP	IN	O
conventional	conventional	ADJ	JJ	O
medical	medical	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Cranial	cranial	ADJ	JJ	O
decompression	decompression	NOUN	NN	O
was	be	VERB	VBD	O
carried	carry	VERB	VBN	O
out	out	PART	RP	O
.	.	PUNCT	.	O

A	a	DET	DT	O
justification	justification	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
need	need	NOUN	NN	O
for	for	ADP	IN	O
further	further	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
cranial	cranial	ADJ	JJ	O
decompression	decompression	NOUN	NN	O
in	in	ADP	IN	O
such	such	ADJ	JJ	O
patients	patient	NOUN	NNS	O
is	be	VERB	VBZ	O
presented	present	VERB	VBN	O
.	.	PUNCT	.	O

Subjective	subjective	ADJ	JJ	O
assessment	assessment	NOUN	NN	O
of	of	ADP	IN	O
sexual	sexual	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
on	on	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
digoxin	digoxin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Various	various	ADJ	JJ	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
male	male	ADJ	JJ	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
have	have	VERB	VBP	O
received	receive	VERB	VBN	O
digoxin	digoxin	NOUN	NN	B-Chemical
on	on	ADP	IN	O
a	a	DET	DT	O
longterm	longterm	ADJ	JJ	O
basis	basis	NOUN	NN	O
have	have	VERB	VBP	O
increased	increase	VERB	VBN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
serum	serum	ADJ	JJ	O
estrogen	estrogen	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
decreased	decrease	VERB	VBD	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
testosterone	testosterone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
luteinizing	luteinize	VERB	VBG	O
hormone	hormone	NOUN	NN	O
(	(	PUNCT	-LRB-	O
LH	LH	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
undertaken	undertake	VERB	VBN	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
links	link	NOUN	NNS	O
between	between	ADP	IN	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
digoxin	digoxin	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
and	and	CCONJ	CC	O
sexual	sexual	ADJ	JJ	O
behavior	behavior	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
digoxin	digoxin	NOUN	NN	B-Chemical
on	on	ADP	IN	O
plasma	plasma	NOUN	NN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
estradiol	estradiol	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
testosterone	testosterone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
LH	LH	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patients	patient	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
and	and	CCONJ	CC	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
without	without	ADP	IN	O
digoxin	digoxin	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
of	of	ADP	IN	O
similar	similar	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
functional	functional	ADJ	JJ	O
capacity	capacity	NOUN	NN	O
and	and	CCONJ	CC	O
age	age	NOUN	NN	O
(	(	PUNCT	-LRB-	O
25	25	NUM	CD	O
-	-	SYM	SYM	O
40	40	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
selected	select	VERB	VBN	O
from	from	ADP	IN	O
the	the	DET	DT	O
rheumatic	rheumatic	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
subjective	subjective	ADJ	JJ	O
assessment	assessment	NOUN	NN	O
of	of	ADP	IN	O
sexual	sexual	ADJ	JJ	O
behavior	behavior	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
and	and	CCONJ	CC	O
control	control	NOUN	NN	O
groups	group	NOUN	NNS	O
was	be	VERB	VBD	O
carried	carry	VERB	VBN	O
out	out	PART	RP	O
,	,	PUNCT	,	O
using	use	VERB	VBG	O
parameters	parameter	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
sexual	sexual	ADJ	JJ	O
desire	desire	NOUN	NN	O
,	,	PUNCT	,	O
sexual	sexual	ADJ	JJ	O
excitement	excitement	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
frequency	frequency	NOUN	NN	O
of	of	ADP	IN	O
sexual	sexual	ADJ	JJ	O
relations	relation	NOUN	NNS	O
.	.	PUNCT	.	O

Personal	personal	ADJ	JJ	O
interviews	interview	NOUN	NNS	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
questionnaire	questionnaire	NOUN	NN	O
were	be	VERB	VBD	O
also	also	ADV	RB	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
sexual	sexual	ADJ	JJ	O
behavior	behavior	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
findings	finding	NOUN	NNS	O
support	support	VERB	VBP	O
the	the	DET	DT	O
reports	report	NOUN	NNS	O
concerning	concern	VERB	VBG	O
digoxin	digoxin	NOUN	NN	B-Chemical
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
plasma	plasma	NOUN	NN	O
estradiol	estradiol	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
testosterone	testosterone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
LH	LH	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
means	mean	NOUN	NNS	O
were	be	VERB	VBD	O
significant	significant	ADJ	JJ	O
.	.	PUNCT	.	O

Tests	test	NOUN	NNS	O
used	use	VERB	VBD	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
sexual	sexual	ADJ	JJ	O
behavior	behavior	NOUN	NN	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
decrease	decrease	NOUN	NN	B-Disease
in	in	ADP	IN	I-Disease
sexual	sexual	ADJ	JJ	I-Disease
desire	desire	NOUN	NN	I-Disease
,	,	PUNCT	,	O
sexual	sexual	ADJ	JJ	O
excitement	excitement	NOUN	NN	O
phase	phase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
erection	erection	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
frequency	frequency	NOUN	NN	O
of	of	ADP	IN	O
sexual	sexual	ADJ	JJ	O
relations	relation	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Endometrial	endometrial	ADJ	JJ	B-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
after	after	ADP	IN	O
Hodgkin	Hodgkin	PROPN	NNP	B-Disease
disease	disease	NOUN	NN	I-Disease
in	in	ADP	IN	O
childhood	childhood	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
34	34	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
patient	patient	NOUN	NN	O
developed	develop	VERB	VBD	O
metastic	metastic	ADJ	JJ	O
endometrial	endometrial	ADJ	JJ	B-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
after	after	ADP	IN	O
Hodgkin	Hodgkin	PROPN	NNP	B-Disease
disease	disease	NOUN	NN	I-Disease
in	in	ADP	IN	O
childhood	childhood	NOUN	NN	O
.	.	PUNCT	.	O

She	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
ovarian	ovarian	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
after	after	ADP	IN	O
abdominal	abdominal	ADJ	JJ	O
irradiation	irradiation	NOUN	NN	O
and	and	CCONJ	CC	O
chemotherapy	chemotherapy	NOUN	NN	O
for	for	ADP	IN	O
Hodgkin	Hodgkin	PROPN	NNP	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
received	receive	VERB	VBD	O
exogenous	exogenous	ADJ	JJ	O
estrogens	estrogen	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
treatment	treatment	NOUN	NN	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
endometrial	endometrial	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
in	in	ADP	IN	O
menopausal	menopausal	ADJ	JJ	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

Young	young	ADJ	JJ	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
replacement	replacement	NOUN	NN	O
estrogens	estrogen	VERB	VBZ	B-Chemical
for	for	ADP	IN	O
ovarian	ovarian	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
after	after	ADP	IN	O
cancer	cancer	NOUN	NN	B-Disease
therapy	therapy	NOUN	NN	O
may	may	VERB	MD	O
also	also	ADV	RB	O
have	have	VERB	VB	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
endometrial	endometrial	ADJ	JJ	B-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
should	should	VERB	MD	O
be	be	VERB	VB	O
examined	examine	VERB	VBN	O
periodically	periodically	ADV	RB	O
.	.	PUNCT	.	O

Long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
lithium	lithium	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
.	.	PUNCT	.	O

Interim	interim	ADJ	JJ	O
report	report	NOUN	NN	O
on	on	ADP	IN	O
fifty	fifty	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
report	report	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
part	part	NOUN	NN	O
of	of	ADP	IN	O
our	-PRON-	DET	PRP$	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
lithium	lithium	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
.	.	PUNCT	.	O

Creatinine	creatinine	ADJ	JJ	B-Chemical
clearance	clearance	NOUN	NN	O
,	,	PUNCT	,	O
maximum	maximum	ADJ	JJ	O
urinary	urinary	ADJ	JJ	O
osmolality	osmolality	NOUN	NN	O
and	and	CCONJ	CC	O
24	24	NUM	CD	O
hour	hour	NOUN	NN	O
urine	urine	NOUN	NN	O
volume	volume	NOUN	NN	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
tested	test	VERB	VBN	O
in	in	ADP	IN	O
50	50	NUM	CD	O
affectively	affectively	ADV	RB	O
ill	ill	ADJ	JJ	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
on	on	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
lithium	lithium	NOUN	NN	B-Chemical
for	for	ADP	IN	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
one	one	NUM	CD	O
year	year	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
norms	norm	NOUN	NNS	O
and	and	CCONJ	CC	O
with	with	ADP	IN	O
values	value	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
tests	test	NOUN	NNS	O
from	from	ADP	IN	O
screening	screen	VERB	VBG	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
available	available	ADJ	JJ	O
for	for	ADP	IN	O
most	most	ADJ	JJS	O
of	of	ADP	IN	O
our	-PRON-	DET	PRP$	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

No	no	DET	DT	O
evidence	evidence	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
for	for	ADP	IN	O
any	any	DET	DT	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
glomerular	glomerular	ADJ	JJ	O
filtration	filtration	NOUN	NN	O
during	during	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Low	low	ADJ	JJ	O
clearance	clearance	NOUN	NN	O
values	value	NOUN	NNS	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
several	several	ADJ	JJ	O
patients	patient	NOUN	NNS	O
could	could	VERB	MD	O
be	be	VERB	VB	O
accounted	account	VERB	VBN	O
for	for	ADP	IN	O
by	by	ADP	IN	O
their	-PRON-	DET	PRP$	O
age	age	NOUN	NN	O
and	and	CCONJ	CC	O
their	-PRON-	DET	PRP$	O
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
lithium	lithium	ADJ	JJ	B-Chemical
values	value	NOUN	NNS	O
.	.	PUNCT	.	O

Urinary	urinary	ADJ	JJ	O
concentration	concentration	NOUN	NN	O
defect	defect	NOUN	NN	O
appeared	appear	VERB	VBD	O
frequent	frequent	ADJ	JJ	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
extent	extent	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
impairment	impairment	NOUN	NN	O
is	be	VERB	VBZ	O
difficult	difficult	ADJ	JJ	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
because	because	ADP	IN	O
of	of	ADP	IN	O
the	the	DET	DT	O
uncertainty	uncertainty	NOUN	NN	O
about	about	ADP	IN	O
the	the	DET	DT	O
norms	norm	NOUN	NNS	O
applicable	applicable	ADJ	JJ	O
to	to	ADP	IN	O
this	this	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
concentration	concentration	NOUN	NN	O
defect	defect	NOUN	NN	O
appeared	appear	VERB	VBD	O
reversible	reversible	ADJ	JJ	O
,	,	PUNCT	,	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
in	in	ADP	IN	O
part	part	NOUN	NN	O
.	.	PUNCT	.	O

Polyuria	Polyuria	NOUN	NNS	B-Disease
above	above	ADP	IN	O
3	3	NUM	CD	O
litres	litre	NOUN	NNS	O
/	/	SYM	SYM	O
24	24	NUM	CD	O
hours	hour	NOUN	NNS	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

An	an	DET	DT	O
attempt	attempt	NOUN	NN	O
is	be	VERB	VBZ	O
made	make	VERB	VBN	O
to	to	PART	TO	O
draw	draw	VERB	VB	O
practical	practical	ADJ	JJ	O
conclusions	conclusion	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
preliminary	preliminary	ADJ	JJ	O
findings	finding	NOUN	NNS	O
.	.	PUNCT	.	O

Nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
cyclosporin	cyclosporin	NOUN	NN	B-Chemical
A	A	PROPN	NNP	I-Chemical
and	and	CCONJ	CC	O
FK506	fk506	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
calcineurin	calcineurin	NOUN	NN	O
phosphatase	phosphatase	NOUN	NN	O
.	.	PUNCT	.	O

Cyclosporin	Cyclosporin	PROPN	NNP	B-Chemical
A	A	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
CsA	csa	NOUN	NN	B-Chemical
;	;	PUNCT	:	O
50	50	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
Fujimycine	Fujimycine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
FK506	fk506	NOUN	NN	B-Chemical
;	;	PUNCT	:	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
the	the	DET	DT	O
related	related	ADJ	JJ	O
macrolide	macrolide	NOUN	NN	B-Chemical
immunosuppressant	immunosuppressant	NOUN	NN	O
rapamycin	rapamycin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
caused	cause	VERB	VBD	O
a	a	DET	DT	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
glomerular	glomerular	ADJ	JJ	O
filtration	filtration	NOUN	NN	O
rate	rate	NOUN	NN	O
,	,	PUNCT	,	O
degenerative	degenerative	ADJ	JJ	O
changes	change	NOUN	NNS	O
of	of	ADP	IN	O
proximal	proximal	ADJ	JJ	O
tubular	tubular	ADJ	JJ	O
epithelium	epithelium	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
hypertrophy	hypertrophy	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
juxtaglomerular	juxtaglomerular	ADJ	JJ	O
apparatus	apparatus	NOUN	NN	O
in	in	ADP	IN	O
male	male	ADJ	JJ	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
when	when	ADV	WRB	O
given	give	VERB	VBN	O
for	for	ADP	IN	O
10	10	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
molecular	molecular	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
CsA	CsA	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
FK506	fk506	NOUN	NN	B-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
were	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
.	.	PUNCT	.	O

Cyclophilin	Cyclophilin	PROPN	NNP	O
A	A	PROPN	NNP	O
and	and	CCONJ	CC	O
FK506	fk506	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
binding	bind	VERB	VBG	O
protein	protein	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
main	main	ADJ	JJ	O
intracytoplasmic	intracytoplasmic	ADJ	JJ	O
receptors	receptor	NOUN	NNS	O
for	for	ADP	IN	O
CsA	CsA	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
FK506	FK506	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
each	each	DET	DT	O
detected	detect	VERB	VBN	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
extract	extract	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
kidney	kidney	NOUN	NN	O
,	,	PUNCT	,	O
high	high	ADJ	JJ	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
immunoreactive	immunoreactive	NOUN	NN	O
and	and	CCONJ	CC	O
enzymatically	enzymatically	ADV	RB	O
active	active	ADJ	JJ	O
calcineurin	calcineurin	NOUN	NN	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
which	which	DET	WDT	O
were	be	VERB	VBD	O
inhibited	inhibit	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
immunosuppressants	immunosuppressant	NOUN	NNS	O
CsA	CsA	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
FK506	FK506	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
by	by	ADP	IN	O
rapamycin	rapamycin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Finally	finally	ADV	RB	O
,	,	PUNCT	,	O
specific	specific	ADJ	JJ	O
immunophilin	immunophilin	ADJ	JJ	O
-	-	PUNCT	HYPH	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
calcineurin	calcineurin	NOUN	NN	O
complexes	complex	NOUN	NNS	O
formed	form	VERB	VBN	O
only	only	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
CsA	CsA	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
FK506	FK506	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
rapamycin	rapamycin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
nephrotoxic	nephrotoxic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
CsA	CsA	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
FK506	FK506	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
likely	likely	ADV	RB	O
mediated	mediate	VERB	VBN	O
through	through	ADP	IN	O
binding	bind	VERB	VBG	O
to	to	ADP	IN	O
renal	renal	ADJ	JJ	O
immunophilin	immunophilin	NOUN	NN	O
and	and	CCONJ	CC	O
inhibiting	inhibit	VERB	VBG	O
calcineurin	calcineurin	NOUN	NN	O
phosphatase	phosphatase	NOUN	NN	O
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
in	in	ADP	IN	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
chemotherapy	chemotherapy	NOUN	NN	O
.	.	PUNCT	.	O

Carboplatin	Carboplatin	PROPN	NNP	B-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
to	to	PART	TO	O
cause	cause	VERB	VB	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
when	when	ADV	WRB	O
administered	administer	VERB	VBN	O
in	in	ADP	IN	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
to	to	PART	TO	O
adult	adult	VERB	VB	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
4	4	NUM	CD	O
1	1	NUM	CD	O
/	/	SYM	SYM	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
girl	girl	NOUN	NN	O
who	who	PRON	WP	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
for	for	ADP	IN	O
metastatic	metastatic	ADJ	JJ	O
parameningeal	parameningeal	ADJ	JJ	O
embryonal	embryonal	ADJ	JJ	B-Disease
rhabdomyosarcoma	rhabdomyosarcoma	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
developed	develop	VERB	VBD	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
slow	slow	ADJ	JJ	O
partial	partial	ADJ	JJ	O
recovery	recovery	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

Possible	possible	ADJ	JJ	O
contributing	contributing	NOUN	NN	O
factors	factor	NOUN	NNS	O
are	be	VERB	VBP	O
discussed	discuss	VERB	VBN	O
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
on	on	ADP	IN	O
combined	combined	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
oral	oral	ADJ	JJ	O
prostacyclin	prostacyclin	NOUN	NN	B-Chemical
analogue	analogue	NOUN	NN	O
beraprost	beraprost	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
phosphodiesterase	phosphodiesterase	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
cilostazol	cilostazol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Among	among	ADP	IN	O
various	various	ADJ	JJ	O
oral	oral	ADJ	JJ	O
antiplatelets	antiplatelet	NOUN	NNS	O
,	,	PUNCT	,	O
a	a	DET	DT	O
combination	combination	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
novel	novel	ADJ	JJ	O
prostacyclin	prostacyclin	NOUN	NN	B-Chemical
analogue	analogue	NOUN	NN	O
beraprost	beraprost	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
BPT	BPT	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
potent	potent	ADJ	JJ	O
phosphodiesterase	phosphodiesterase	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
cilostazol	cilostazol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
CLZ	CLZ	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
may	may	VERB	MD	O
result	result	VERB	VB	O
in	in	ADP	IN	O
untoward	untoward	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
effects	effect	NOUN	NNS	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
possible	possible	ADJ	JJ	O
synergistic	synergistic	ADJ	JJ	O
elevation	elevation	NOUN	NN	O
of	of	ADP	IN	O
intracellular	intracellular	ADJ	JJ	O
cAMP	cAMP	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
cyclic	cyclic	NOUN	NN	B-Chemical
adenosine	adenosine	NOUN	NN	I-Chemical
3	3	NUM	CD	I-Chemical
'	'	PUNCT	''	I-Chemical
,	,	PUNCT	,	I-Chemical
5	5	NUM	CD	I-Chemical
'	'	PUNCT	''	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
monophosphate	monophosphate	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Thereby	thereby	ADV	RB	O
,	,	PUNCT	,	O
a	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
combined	combined	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
agents	agent	NOUN	NNS	O
was	be	VERB	VBD	O
attempted	attempt	VERB	VBN	O
.	.	PUNCT	.	O

Twelve	twelve	NUM	CD	O
healthy	healthy	ADJ	JJ	O
volunteers	volunteer	NOUN	NNS	O
were	be	VERB	VBD	O
assigned	assign	VERB	VBN	O
to	to	PART	TO	O
take	take	VERB	VB	O
BPT	BPT	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
CLZ	CLZ	PROPN	NNP	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
following	following	ADJ	JJ	O
schedule	schedule	NOUN	NN	O
;	;	PUNCT	:	O
BPT	bpt	ADV	RB	B-Chemical
:	:	PUNCT	:	O
40	40	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
at	at	ADP	IN	O
day	day	NOUN	NN	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
120	120	NUM	CD	O
micrograms	micrograms	NOUN	NN	O
t	t	NOUN	NN	O
.	.	PUNCT	.	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
d	d	X	XX	O
.	.	PUNCT	.	O
from	from	ADP	IN	O
day	day	NOUN	NN	O
7	7	NUM	CD	O
to	to	ADP	IN	O
14	14	NUM	CD	O
,	,	PUNCT	,	O
CLZ	CLZ	PROPN	NNP	B-Chemical
:	:	PUNCT	:	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
t	t	NOUN	NN	O
.	.	PUNCT	.	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
d	d	X	XX	O
.	.	PUNCT	.	O
from	from	ADP	IN	O
day	day	NOUN	NN	O
3	3	NUM	CD	O
to	to	ADP	IN	O
14	14	NUM	CD	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
various	various	ADJ	JJ	O
time	time	NOUN	NN	O
intervals	interval	NOUN	NNS	O
,	,	PUNCT	,	O
physical	physical	ADJ	JJ	O
examination	examination	NOUN	NN	O
and	and	CCONJ	CC	O
blood	blood	NOUN	NN	O
collection	collection	NOUN	NN	O
for	for	ADP	IN	O
ex	ex	NOUN	NN	O
vivo	vivo	NOUN	NNS	O
platelet	platelet	NOUN	NN	B-Disease
aggregation	aggregation	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
determination	determination	NOUN	NN	O
of	of	ADP	IN	O
intraplatelet	intraplatelet	NOUN	NN	O
cAMP	cAMP	PROPN	NNP	B-Chemical
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
.	.	PUNCT	.	O

Throughout	throughout	ADP	IN	O
the	the	DET	DT	O
observation	observation	NOUN	NN	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
alteration	alteration	NOUN	NN	O
in	in	ADP	IN	O
vital	vital	ADJ	JJ	O
signs	sign	NOUN	NNS	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

Seven	seven	NUM	CD	O
out	out	ADP	IN	O
of	of	ADP	IN	O
12	12	NUM	CD	O
subjects	subject	NOUN	NNS	O
experienced	experience	VERB	VBD	O
headache	headache	NOUN	NN	B-Disease
of	of	ADP	IN	O
a	a	DET	DT	O
short	short	ADJ	JJ	O
duration	duration	NOUN	NN	O
accompanying	accompany	VERB	VBG	O
facial	facial	ADJ	JJ	B-Disease
flush	flush	NOUN	NN	I-Disease
in	in	ADP	IN	O
one	one	NUM	CD	O
and	and	CCONJ	CC	O
nausea	nausea	NOUN	NN	B-Disease
in	in	ADP	IN	O
one	one	NUM	CD	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
after	after	ADP	IN	O
ingestion	ingestion	NOUN	NN	O
of	of	ADP	IN	O
CLZ	CLZ	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

All	all	DET	DT	O
of	of	ADP	IN	O
these	these	DET	DT	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
probably	probably	ADV	RB	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
vasodilating	vasodilating	NOUN	NN	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
agents	agent	NOUN	NNS	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
of	of	ADP	IN	O
mild	mild	ADJ	JJ	O
degree	degree	NOUN	NN	O
and	and	CCONJ	CC	O
no	no	DET	DT	O
special	special	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
was	be	VERB	VBD	O
required	require	VERB	VBN	O
.	.	PUNCT	.	O

Intraplatelet	Intraplatelet	PROPN	NNP	O
cAMP	cAMP	PROPN	NNP	B-Chemical
content	content	NOUN	NN	O
was	be	VERB	VBD	O
gradually	gradually	ADV	RB	O
but	but	CCONJ	CC	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBD	O
to	to	ADP	IN	O
9	9	NUM	CD	O
.	.	PUNCT	.	O
84	84	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
59	59	NUM	CD	O
pmol	pmol	NOUN	NN	O
per	per	ADP	IN	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
platelets	platelet	NOUN	NNS	O
at	at	ADP	IN	O
day	day	NOUN	NN	O
14	14	NUM	CD	O
in	in	ADP	IN	O
comparison	comparison	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
initial	initial	ADJ	JJ	O
value	value	NOUN	NN	O
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
87	87	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
pmol	pmol	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
platelet	platelet	NOUN	NN	O
aggregability	aggregability	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
suppressed	suppress	VERB	VBN	O
at	at	ADP	IN	O
various	various	ADJ	JJ	O
time	time	NOUN	NN	O
intervals	interval	NOUN	NNS	O
but	but	CCONJ	CC	O
no	no	DET	DT	O
additive	additive	ADJ	JJ	O
or	or	CCONJ	CC	O
synergistic	synergistic	ADJ	JJ	O
inhibitory	inhibitory	ADJ	JJ	O
effect	effect	NOUN	NN	O
by	by	ADP	IN	O
the	the	DET	DT	O
combined	combined	ADJ	JJ	O
administration	administration	NOUN	NN	O
was	be	VERB	VBD	O
noted	note	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
combined	combined	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
BPT	BPT	PROPN	NNP	B-Chemical
/	/	SYM	SYM	O
CLZ	CLZ	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
safe	safe	ADJ	JJ	O
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
though	though	ADP	IN	O
the	the	DET	DT	O
beneficial	beneficial	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
combined	combined	ADJ	JJ	O
administration	administration	NOUN	NN	O
has	have	VERB	VBZ	O
yet	yet	ADV	RB	O
to	to	PART	TO	O
be	be	VERB	VB	O
elucidated	elucidate	VERB	VBN	O
.	.	PUNCT	.	O

Pravastatin	pravastatin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
myopathy	myopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Report	Report	PROPN	NNP	O
of	of	ADP	IN	O
a	a	DET	DT	O
case	case	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	B-Disease
myopathy	myopathy	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
pravastatin	pravastatin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
hydrophilic	hydrophilic	ADJ	JJ	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
hydroxy	hydroxy	NUM	CD	O
-	-	PUNCT	HYPH	O
3	3	NUM	CD	O
methylglutaril	methylglutaril	ADJ	JJ	O
coenzyme	coenzyme	NOUN	NN	O
A	a	DET	DT	O
reductase	reductase	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
69	69	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
was	be	VERB	VBD	O
affected	affect	VERB	VBN	O
by	by	ADP	IN	O
non	non	ADJ	JJ	B-Disease
-	-	ADJ	JJ	I-Disease
insulin	insulin	ADJ	JJ	I-Disease
-	-	PUNCT	HYPH	I-Disease
dependent	dependent	ADJ	JJ	I-Disease
diabetes	diabetes	NOUN	NN	I-Disease
mellitus	mellitus	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
assumed	assume	VERB	VBD	O
pravastatin	pravastatin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
because	because	ADP	IN	O
of	of	ADP	IN	O
hypercholesterolemia	hypercholesterolemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
admitted	admit	VERB	VBN	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	O
myopathy	myopathy	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
lower	low	ADJ	JJR	O
limbs	limb	NOUN	NNS	O
which	which	DET	WDT	O
resolved	resolve	VERB	VBD	O
in	in	ADP	IN	O
a	a	DET	DT	O
few	few	ADJ	JJ	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
pravastatin	pravastatin	ADJ	JJ	B-Chemical
discontinuation	discontinuation	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
previously	previously	ADV	RB	O
unknown	unknown	ADJ	JJ	O
hypothyroidism	hypothyroidism	NOUN	NN	B-Disease
,	,	PUNCT	,	O
probably	probably	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
chronic	chronic	ADJ	JJ	O
autoimmune	autoimmune	ADJ	JJ	B-Disease
thyroiditis	thyroiditis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
was	be	VERB	VBD	O
evidenced	evidence	VERB	VBN	O
.	.	PUNCT	.	O

Muscle	muscle	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
left	leave	VERB	VBN	O
gastrocnemius	gastrocnemius	NOUN	NN	O
)	)	PUNCT	-RRB-	O
revealed	reveal	VERB	VBD	O
a	a	DET	DT	O
perimysial	perimysial	ADJ	JJ	O
and	and	CCONJ	CC	O
endomysial	endomysial	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
infiltrate	infiltrate	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
prevalence	prevalence	NOUN	NN	O
of	of	ADP	IN	O
CD4	CD4	PROPN	NNP	O
+	+	SYM	SYM	O
lymphocytes	lymphocyte	NOUN	NNS	O
.	.	PUNCT	.	O

While	while	ADP	IN	O
lovastatin	lovastatin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
simvastatin	simvastatin	NOUN	NN	B-Chemical
have	have	VERB	VBP	O
been	be	VERB	VBN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
toxic	toxic	ADJ	JJ	O
myopathy	myopathy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
pravastatin	pravastatin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
myopathy	myopathy	NOUN	NN	B-Disease
could	could	VERB	MD	O
represent	represent	VERB	VB	O
a	a	DET	DT	O
distinct	distinct	ADJ	JJ	O
,	,	PUNCT	,	O
inflammatory	inflammatory	ADJ	JJ	O
entity	entity	NOUN	NN	O
.	.	PUNCT	.	O

Reversal	reversal	NOUN	NN	O
of	of	ADP	IN	O
ammonia	ammonia	ADJ	JJ	B-Chemical
coma	coma	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
by	by	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	PROPN	NNP	I-Chemical
:	:	PUNCT	:	O
a	a	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

Ammonia	ammonia	ADJ	JJ	B-Chemical
coma	coma	NOUN	NN	B-Disease
was	be	VERB	VBD	O
produced	produce	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
within	within	ADP	IN	O
10	10	NUM	CD	O
to	to	PART	TO	O
15	15	NUM	CD	O
minutes	minute	NOUN	NNS	O
of	of	ADP	IN	O
an	an	DET	DT	O
intraperitonealinjection	intraperitonealinjection	NOUN	NN	O
of	of	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
mmol	mmol	NOUN	NN	O
NH4CL	NH4CL	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
coma	coma	NOUN	NN	B-Disease
was	be	VERB	VBD	O
prevented	prevent	VERB	VBN	O
with	with	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
68	68	NUM	CD	O
mmol	mmol	NOUN	NN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	NOUN	NN	I-Chemical
given	give	VERB	VBN	O
by	by	ADP	IN	O
gastric	gastric	ADJ	JJ	O
intubation	intubation	NOUN	NN	O
15	15	NUM	CD	O
minutes	minute	NOUN	NNS	O
before	before	ADP	IN	O
the	the	DET	DT	O
ammonium	ammonium	NOUN	NN	B-Chemical
salt	salt	NOUN	NN	I-Chemical
injection	injection	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	PROPN	NNP	I-Chemical
was	be	VERB	VBD	O
correlated	correlate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
blood	blood	NOUN	NN	O
and	and	CCONJ	CC	O
brain	brain	NOUN	NN	O
ammonia	ammonia	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
brain	brain	NOUN	NN	O
dopamine	dopamine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
excretion	excretion	NOUN	NN	O
of	of	ADP	IN	O
ammonia	ammonia	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
urea	urea	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

Intraventricular	intraventricular	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
sufficient	sufficient	ADJ	JJ	O
to	to	PART	TO	O
raise	raise	VERB	VB	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
dopamine	dopamine	NOUN	NN	B-Chemical
to	to	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
extent	extent	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
prevent	prevent	VERB	VB	O
the	the	DET	DT	O
ammonia	ammonia	NOUN	NN	B-Chemical
coma	coma	NOUN	NN	B-Disease
nor	nor	CCONJ	CC	O
affect	affect	VERB	VBP	O
the	the	DET	DT	O
blood	blood	NOUN	NN	O
and	and	CCONJ	CC	O
brain	brain	NOUN	NN	O
ammonia	ammonia	NOUN	NN	B-Chemical
concentrations	concentration	NOUN	NNS	O
.	.	PUNCT	.	O

Bilateral	bilateral	ADJ	JJ	O
nephrectomy	nephrectomy	NOUN	NN	O
eliminated	eliminate	VERB	VBD	O
the	the	DET	DT	O
beneficial	beneficial	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	NOUN	NN	I-Chemical
on	on	ADP	IN	O
blood	blood	NOUN	NN	O
and	and	CCONJ	CC	O
brain	brain	NOUN	NN	O
ammonia	ammonia	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
ammonia	ammonia	ADJ	JJ	B-Chemical
coma	coma	NOUN	NN	B-Disease
was	be	VERB	VBD	O
not	not	ADV	RB	O
prevented	prevent	VERB	VBN	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
blood	blood	NOUN	NN	O
and	and	CCONJ	CC	O
brain	brain	NOUN	NN	O
ammonia	ammonia	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
ammonia	ammonia	ADJ	JJ	B-Chemical
coma	coma	NOUN	NN	B-Disease
after	after	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
can	can	VERB	MD	O
be	be	VERB	VB	O
accounted	account	VERB	VBN	O
for	for	ADP	IN	O
by	by	ADP	IN	O
the	the	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
rather	rather	ADV	RB	O
than	than	ADP	IN	O
its	-PRON-	DET	PRP$	O
central	central	ADJ	JJ	O
action	action	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
provide	provide	VERB	VBP	O
a	a	DET	DT	O
reasonable	reasonable	ADJ	JJ	O
explanation	explanation	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
beneficial	beneficial	ADJ	JJ	O
effects	effect	NOUN	NNS	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
some	some	DET	DT	O
encephalopathic	encephalopathic	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Etoposide	etoposide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
myocardial	myocardial	ADJ	JJ	B-Disease
infarction	infarction	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
reported	report	VERB	VBN	O
after	after	ADP	IN	O
chemotherapy	chemotherapy	NOUN	NN	O
containing	contain	VERB	VBG	O
etoposide	etoposide	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
in	in	ADP	IN	O
a	a	DET	DT	O
man	man	NOUN	NN	O
with	with	ADP	IN	O
no	no	DET	DT	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
for	for	ADP	IN	O
coronary	coronary	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Possible	possible	ADJ	JJ	O
causal	causal	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
are	be	VERB	VBP	O
discussed	discuss	VERB	VBN	O
.	.	PUNCT	.	O

Halogenated	halogenated	ADJ	JJ	O
anesthetics	anesthetic	NOUN	NNS	O
form	form	NOUN	NN	O
liver	liver	NOUN	NN	O
adducts	adduct	NOUN	NNS	O
and	and	CCONJ	CC	O
antigens	antigen	VERB	VBZ	O
that	that	ADP	IN	O
cross	cross	NOUN	NN	O
-	-	NOUN	NN	O
react	react	NOUN	NN	O
with	with	ADP	IN	O
halothane	halothane	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
antibodies	antibody	NOUN	NNS	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
halogenated	halogenated	ADJ	JJ	O
anesthetics	anesthetic	NOUN	NNS	O
,	,	PUNCT	,	O
enflurane	enflurane	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
allergic	allergic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
type	type	NOUN	NN	O
hepatic	hepatic	ADJ	JJ	B-Disease
injury	injury	NOUN	NN	I-Disease
both	both	CCONJ	CC	O
alone	alone	ADJ	JJ	O
and	and	CCONJ	CC	O
following	follow	VERB	VBG	O
previous	previous	ADJ	JJ	O
exposure	exposure	NOUN	NN	O
to	to	ADP	IN	O
halothane	halothane	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Halothane	halothane	NOUN	NN	B-Chemical
hepatitis	hepatitis	NOUN	NN	B-Disease
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
involve	involve	VERB	VB	O
an	an	DET	DT	O
aberrant	aberrant	ADJ	JJ	O
immune	immune	ADJ	JJ	O
response	response	NOUN	NN	O
.	.	PUNCT	.	O

An	an	DET	DT	O
antibody	antibody	NOUN	NN	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
a	a	DET	DT	O
protein	protein	NOUN	NN	O
-	-	PUNCT	HYPH	O
bound	bind	VERB	VBN	O
biotransformation	biotransformation	NOUN	NN	O
product	product	NOUN	NN	O
(	(	PUNCT	-LRB-	O
trifluoroacetyl	trifluoroacetyl	NOUN	NN	B-Chemical
adduct	adduct	NOUN	NN	O
)	)	PUNCT	-RRB-	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
detected	detect	VERB	VBN	O
on	on	ADP	IN	O
halothane	halothane	NOUN	NN	B-Chemical
hepatitis	hepatitis	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
performed	perform	VERB	VBN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
cross	cross	ADJ	JJ	O
-	-	ADJ	JJ	O
reactivity	reactivity	NOUN	NN	O
between	between	ADP	IN	O
enflurane	enflurane	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
isoflurane	isoflurane	VERB	VB	B-Chemical
with	with	ADP	IN	O
the	the	DET	DT	O
hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
halothane	halothane	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
subcellular	subcellular	ADJ	JJ	O
and	and	CCONJ	CC	O
lobular	lobular	ADJ	JJ	O
production	production	NOUN	NN	O
of	of	ADP	IN	O
hepatic	hepatic	ADJ	JJ	O
neoantigens	neoantigen	NOUN	NNS	O
recognized	recognize	VERB	VBN	O
by	by	ADP	IN	O
halothane	halothane	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
antibodies	antibody	NOUN	NNS	O
following	follow	VERB	VBG	O
enflurane	enflurane	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
biochemical	biochemical	ADJ	JJ	O
nature	nature	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
neoantigens	neoantigen	NOUN	NNS	O
was	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
in	in	ADP	IN	O
two	two	NUM	CD	O
animal	animal	NOUN	NN	O
models	model	NOUN	NNS	O
.	.	PUNCT	.	O

Enflurane	Enflurane	PROPN	NNP	B-Chemical
administration	administration	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
neoantigens	neoantigen	NOUN	NNS	O
detected	detect	VERB	VBN	O
in	in	ADP	IN	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
microsomal	microsomal	ADJ	JJ	O
and	and	CCONJ	CC	O
cytosolic	cytosolic	ADJ	JJ	O
fraction	fraction	NOUN	NN	O
of	of	ADP	IN	O
liver	liver	NOUN	NN	O
homogenates	homogenate	NOUN	NNS	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
the	the	DET	DT	O
centrilobular	centrilobular	ADJ	JJ	O
region	region	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
liver	liver	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
liver	liver	NOUN	NN	O
,	,	PUNCT	,	O
biochemical	biochemical	NOUN	NN	O
analysis	analysis	NOUN	NN	O
detected	detect	VERB	VBD	O
fluorinated	fluorinate	VERB	VBN	O
liver	liver	NOUN	NN	O
adducts	adduct	NOUN	NNS	O
that	that	DET	WDT	O
were	be	VERB	VBD	O
up	up	ADV	RB	O
to	to	PART	TO	O
20	20	NUM	CD	O
-	-	PUNCT	HYPH	O
fold	fold	VERB	VB	O
greater	great	ADJ	JJR	O
in	in	ADP	IN	O
guinea	guinea	NOUN	NN	O
pigs	pig	NOUN	NNS	O
than	than	ADP	IN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
supports	support	VERB	VBZ	O
and	and	CCONJ	CC	O
extends	extend	VERB	VBZ	O
previous	previous	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
for	for	ADP	IN	O
a	a	DET	DT	O
mechanism	mechanism	NOUN	NN	O
by	by	ADP	IN	O
which	which	DET	WDT	O
enflurane	enflurane	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
could	could	VERB	MD	O
produce	produce	VERB	VB	O
a	a	DET	DT	O
hypersensitivity	hypersensitivity	NOUN	NN	B-Disease
condition	condition	NOUN	NN	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
halothane	halothane	NOUN	NN	B-Chemical
hepatitis	hepatitis	NOUN	NN	B-Disease
either	either	CCONJ	CC	O
alone	alone	ADV	RB	O
or	or	CCONJ	CC	O
subsequent	subsequent	ADJ	JJ	O
to	to	PART	TO	O
halothane	halothane	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
guinea	guinea	NOUN	NN	O
pig	pig	NOUN	NN	O
would	would	VERB	MD	O
appear	appear	VERB	VB	O
to	to	PART	TO	O
be	be	VERB	VB	O
a	a	DET	DT	O
useful	useful	ADJ	JJ	O
model	model	NOUN	NN	O
for	for	ADP	IN	O
further	further	ADJ	JJ	O
investigations	investigation	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
immunological	immunological	ADJ	JJ	O
response	response	NOUN	NN	O
to	to	ADP	IN	O
these	these	DET	DT	O
antigens	antigen	NOUN	NNS	O
.	.	PUNCT	.	O

Cholinergic	Cholinergic	PROPN	NNP	O
toxicity	toxicity	NOUN	NN	B-Disease
resulting	result	VERB	VBG	O
from	from	ADP	IN	O
ocular	ocular	ADJ	JJ	O
instillation	instillation	NOUN	NN	O
of	of	ADP	IN	O
echothiophate	echothiophate	ADJ	JJ	B-Chemical
iodide	iodide	ADJ	JJ	I-Chemical
eye	eye	NOUN	NN	O
drops	drop	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
patient	patient	NOUN	NN	O
developed	develop	VERB	VBD	O
a	a	DET	DT	O
severe	severe	ADJ	JJ	O
cholinergic	cholinergic	NOUN	NN	O
syndrome	syndrome	NOUN	NN	O
from	from	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
echothiophate	echothiophate	ADJ	JJ	B-Chemical
iodide	iodide	ADJ	JJ	I-Chemical
ophthalmic	ophthalmic	ADJ	JJ	O
drops	drop	NOUN	NNS	O
,	,	PUNCT	,	O
presented	present	VERB	VBN	O
with	with	ADP	IN	O
profound	profound	ADJ	JJ	O
muscle	muscle	NOUN	NN	B-Disease
weakness	weakness	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
was	be	VERB	VBD	O
initially	initially	ADV	RB	O
given	give	VERB	VBN	O
the	the	DET	DT	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
myasthenia	myasthenia	ADJ	JJ	B-Disease
gravis	gravi	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Red	red	ADJ	JJ	O
blood	blood	NOUN	NN	O
cell	cell	NOUN	NN	O
and	and	CCONJ	CC	O
serum	serum	ADJ	JJ	O
cholinesterase	cholinesterase	NOUN	NN	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
severely	severely	ADV	RB	O
depressed	depressed	ADJ	JJ	O
and	and	CCONJ	CC	O
symptoms	symptom	NOUN	NNS	O
resolved	resolve	VERB	VBD	O
spontaneously	spontaneously	ADV	RB	O
following	follow	VERB	VBG	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
eye	eye	NOUN	NN	O
drops	drop	VERB	VBZ	O
.	.	PUNCT	.	O

Seizure	seizure	VERB	VB	B-Disease
after	after	ADP	IN	O
flumazenil	flumazenil	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
pediatric	pediatric	ADJ	JJ	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

Flumazenil	Flumazenil	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
benzodiazepine	benzodiazepine	ADJ	JJ	B-Chemical
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
used	use	VERB	VBN	O
to	to	PART	TO	O
reverse	reverse	VERB	VB	O
sedation	sedation	NOUN	NN	O
and	and	CCONJ	CC	O
respiratory	respiratory	ADJ	JJ	B-Disease
depression	depression	NOUN	NN	I-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
benzodiazepines	benzodiazepine	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

Seizures	seizure	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
have	have	VERB	VBP	O
complicated	complicate	VERB	VBN	O
its	-PRON-	DET	PRP$	O
use	use	NOUN	NN	O
in	in	ADP	IN	O
adult	adult	NOUN	NN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Overdose	Overdose	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
have	have	VERB	VBP	O
coingested	coingeste	VERB	VBN	O
tricyclic	tricyclic	ADJ	JJ	O
antidepressants	antidepressant	NOUN	NNS	O
have	have	VERB	VBP	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
these	these	DET	DT	O
complications	complication	NOUN	NNS	O
.	.	PUNCT	.	O

Little	little	ADJ	JJ	O
information	information	NOUN	NN	O
exists	exist	VERB	VBZ	O
concerning	concern	VERB	VBG	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
flumazenil	flumazenil	NOUN	NN	B-Chemical
in	in	ADP	IN	O
children	child	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
generalized	generalize	VERB	VBN	O
tonic	tonic	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
clonic	clonic	NOUN	NN	I-Disease
seizure	seizure	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
pediatric	pediatric	ADJ	JJ	O
patient	patient	NOUN	NN	O
following	follow	VERB	VBG	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
flumazenil	flumazenil	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Phase	Phase	PROPN	NNP	O
I	-PRON-	PRON	PRP	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
13	13	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
cis	cis	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
retinoic	retinoic	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
in	in	ADP	IN	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
neuroblastoma	neuroblastoma	NOUN	NN	B-Disease
following	follow	VERB	VBG	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
Treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
neuroblastoma	neuroblastoma	ADJ	JJ	B-Disease
cell	cell	NOUN	NN	O
lines	line	NOUN	NNS	O
with	with	ADP	IN	O
13	13	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
cis	cis	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
retinoic	retinoic	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
cis	cis	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
RA	ra	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
can	can	VERB	MD	O
cause	cause	VERB	VB	O
sustained	sustained	ADJ	JJ	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
proliferation	proliferation	NOUN	NN	O
.	.	PUNCT	.	O

Since	since	ADP	IN	O
cis	cis	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
RA	RA	PROPN	NNP	I-Chemical
has	have	VERB	VBZ	O
demonstrated	demonstrate	VERB	VBN	O
clinical	clinical	ADJ	JJ	O
responses	response	NOUN	NNS	O
in	in	ADP	IN	O
neuroblastoma	neuroblastoma	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
be	be	VERB	VB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
preventing	prevent	VERB	VBG	O
relapse	relapse	NOUN	NN	O
after	after	ADP	IN	O
cytotoxic	cytotoxic	NOUN	NN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
phase	phase	NOUN	NN	O
I	-PRON-	PRON	PRP	O
trial	trial	NOUN	NN	O
was	be	VERB	VBD	O
designed	design	VERB	VBN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
maximal	maximal	NOUN	NN	O
-	-	PUNCT	HYPH	O
tolerated	tolerate	VERB	VBN	O
dosage	dosage	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MTD	MTD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
toxicities	toxicity	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
pharmacokinetics	pharmacokinetic	NOUN	NNS	O
of	of	ADP	IN	O
cis	cis	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
RA	RA	PROPN	NNP	I-Chemical
administered	administer	VERB	VBD	O
on	on	ADP	IN	O
an	an	DET	DT	O
intermittent	intermittent	ADJ	JJ	O
schedule	schedule	NOUN	NN	O
in	in	ADP	IN	O
children	child	NOUN	NNS	O
with	with	ADP	IN	O
neuroblastoma	neuroblastoma	NOUN	NN	B-Disease
following	follow	VERB	VBG	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BMT	BMT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Fifty	fifty	NUM	CD	O
-	-	PUNCT	HYPH	O
one	one	NUM	CD	O
assessable	assessable	ADJ	JJ	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
to	to	PART	TO	O
12	12	NUM	CD	O
years	year	NOUN	NNS	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
oral	oral	ADJ	JJ	O
cis	cis	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
RA	RA	PROPN	NNP	I-Chemical
administered	administer	VERB	VBD	O
in	in	ADP	IN	O
two	two	NUM	CD	O
equally	equally	ADV	RB	O
divided	divide	VERB	VBN	O
doses	dose	NOUN	NNS	O
daily	daily	ADV	RB	O
for	for	ADP	IN	O
2	2	NUM	CD	O
weeks	week	NOUN	NNS	O
,	,	PUNCT	,	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
rest	rest	NOUN	NN	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
for	for	ADP	IN	O
up	up	ADP	IN	O
to	to	PART	TO	O
12	12	NUM	CD	O
courses	course	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
escalated	escalate	VERB	VBN	O
from	from	ADP	IN	O
100	100	NUM	CD	O
to	to	ADP	IN	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
until	until	ADP	IN	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
limiting	limit	VERB	VBG	O
toxicity	toxicity	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
DLT	DLT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
single	single	ADJ	JJ	O
intrapatient	intrapatient	ADJ	JJ	O
dose	dose	NOUN	NN	O
escalation	escalation	NOUN	NN	O
was	be	VERB	VBD	O
permitted	permit	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
MTD	MTD	PROPN	NNP	O
of	of	ADP	IN	O
cis	cis	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
RA	ra	NOUN	NN	I-Chemical
was	be	VERB	VBD	O
160	160	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
.	.	PUNCT	.	O

Dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
limiting	limit	VERB	VBG	O
toxicities	toxicity	NOUN	NNS	B-Disease
in	in	ADP	IN	O
six	six	NUM	CD	O
of	of	ADP	IN	O
nine	nine	NUM	CD	O
patients	patient	NOUN	NNS	O
at	at	ADP	IN	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
included	include	VERB	VBN	O
hypercalcemia	hypercalcemia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
3	3	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
rash	rash	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
anemia	anemia	NOUN	NN	B-Disease
/	/	SYM	SYM	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
/	/	SYM	SYM	O
emesis	emesis	NOUN	NN	B-Disease
/	/	SYM	SYM	O
rash	rash	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

All	all	DET	DT	O
toxicities	toxicity	NOUN	NNS	B-Disease
resolved	resolve	VERB	VBD	O
after	after	ADP	IN	O
cis	cis	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
RA	RA	PROPN	NNP	I-Chemical
was	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
.	.	PUNCT	.	O

Three	three	NUM	CD	O
complete	complete	ADJ	JJ	O
responses	response	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
marrow	marrow	NOUN	NN	O
metastases	metastasis	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Serum	serum	ADJ	JJ	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
mumol	mumol	NOUN	NN	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
(	(	PUNCT	-LRB-	O
peak	peak	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
mumol	mumol	NOUN	NN	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
(	(	PUNCT	-LRB-	O
trough	trough	NOUN	NN	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
the	the	DET	DT	O
MTD	MTD	PROPN	NNP	O
were	be	VERB	VBD	O
maintained	maintain	VERB	VBN	O
during	during	ADP	IN	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
DLT	DLT	PROPN	NNP	O
correlated	correlate	VERB	VBD	O
with	with	ADP	IN	O
serum	serum	ADJ	JJ	O
levels	level	NOUN	NNS	O
>	>	X	XX	O
or	or	CCONJ	CC	O
=	=	VERB	VBZ	O
10	10	NUM	CD	O
mumol	mumol	NOUN	NN	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
MTD	MTD	PROPN	NNP	O
of	of	ADP	IN	O
cis	cis	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
RA	ra	NOUN	NN	I-Chemical
given	give	VERB	VBN	O
on	on	ADP	IN	O
this	this	DET	DT	O
intermittent	intermittent	ADJ	JJ	O
schedule	schedule	NOUN	NN	O
was	be	VERB	VBD	O
160	160	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
.	.	PUNCT	.	O

Serum	serum	ADJ	JJ	O
levels	level	NOUN	NNS	O
known	know	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
effective	effective	ADJ	JJ	O
against	against	ADP	IN	O
neuroblastoma	neuroblastoma	NOUN	NN	B-Disease
in	in	ADP	IN	O
vitro	vitro	NOUN	NN	O
were	be	VERB	VBD	O
achieved	achieve	VERB	VBN	O
at	at	ADP	IN	O
this	this	DET	DT	O
dose	dose	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
DLT	DLT	PROPN	NNP	O
included	include	VERB	VBD	O
hypercalcemia	hypercalcemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
may	may	VERB	MD	O
be	be	VERB	VB	O
predicted	predict	VERB	VBN	O
by	by	ADP	IN	O
serum	serum	ADJ	JJ	O
cis	cis	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
RA	ra	NOUN	NN	I-Chemical
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

Monitoring	monitoring	NOUN	NN	O
of	of	ADP	IN	O
serum	serum	ADJ	JJ	O
calcium	calcium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
cis	cis	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
RA	ra	NOUN	NN	I-Chemical
levels	level	NOUN	NNS	O
is	be	VERB	VBZ	O
indicated	indicate	VERB	VBN	O
in	in	ADP	IN	O
future	future	ADJ	JJ	O
trials	trial	NOUN	NNS	O
.	.	PUNCT	.	O

Time	time	NOUN	NN	O
dependence	dependence	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
malondialdehyde	malondialdehyde	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
oxypurines	oxypurine	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
nucleosides	nucleoside	NOUN	NNS	B-Chemical
during	during	ADP	IN	O
incomplete	incomplete	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

Incomplete	incomplete	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	B-Disease
ischemia	ischemia	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
by	by	ADP	IN	O
bilaterally	bilaterally	ADV	RB	O
clamping	clamp	VERB	VBG	O
the	the	DET	DT	O
common	common	ADJ	JJ	O
carotid	carotid	ADJ	JJ	O
arteries	artery	NOUN	NNS	O
.	.	PUNCT	.	O

Peripheral	peripheral	ADJ	JJ	O
venous	venous	ADJ	JJ	O
blood	blood	NOUN	NN	O
samples	sample	NOUN	NNS	O
were	be	VERB	VBD	O
withdrawn	withdraw	VERB	VBN	O
from	from	ADP	IN	O
the	the	DET	DT	O
femoral	femoral	ADJ	JJ	O
vein	vein	NOUN	NN	O
four	four	NUM	CD	O
times	time	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
once	once	ADV	RB	O
every	every	DET	DT	O
5	5	NUM	CD	O
min	min	NOUN	NN	O
)	)	PUNCT	-RRB-	O
before	before	ADP	IN	O
ischemia	ischemia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
time	time	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
15	15	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
after	after	ADP	IN	O
ischemia	ischemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Plasma	plasma	NOUN	NN	O
extracts	extract	NOUN	NNS	O
were	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
highly	highly	ADV	RB	O
sensitive	sensitive	ADJ	JJ	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
performance	performance	NOUN	NN	O
liquid	liquid	NOUN	NN	O
chromatographic	chromatographic	ADJ	JJ	O
method	method	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
direct	direct	ADJ	JJ	O
determination	determination	NOUN	NN	O
of	of	ADP	IN	O
malondialdehyde	malondialdehyde	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
oxypurines	oxypurine	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
nucleosides	nucleoside	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

During	during	ADP	IN	O
ischemia	ischemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
a	a	DET	DT	O
time	time	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
oxypurines	oxypurine	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
nucleosides	nucleoside	NOUN	NNS	B-Chemical
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

Plasma	plasma	ADJ	JJ	O
malondialdehyde	malondialdehyde	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
minimal	minimal	ADJ	JJ	O
amount	amount	NOUN	NN	O
at	at	ADP	IN	O
zero	zero	NUM	CD	O
time	time	NOUN	NN	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
058	058	NUM	CD	O
mumol	mumol	NOUN	NN	O
/	/	SYM	SYM	O
liter	liter	NOUN	NN	O
plasma	plasma	NOUN	NN	O
;	;	PUNCT	:	O
SD	sd	NOUN	NN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
015	015	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
increased	increase	VERB	VBN	O
after	after	ADP	IN	O
5	5	NUM	CD	O
min	min	NOUN	NN	O
of	of	ADP	IN	O
ischemia	ischemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
a	a	DET	DT	O
fivefold	fivefold	ADJ	JJ	O
increase	increase	NOUN	NN	O
after	after	ADP	IN	O
30	30	NUM	CD	O
min	min	NOUN	NN	O
of	of	ADP	IN	O
carotid	carotid	ADJ	JJ	O
occlusion	occlusion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
298	298	NUM	CD	O
mumol	mumol	NOUN	NN	O
/	/	SYM	SYM	O
liter	liter	NOUN	NN	O
plasma	plasma	NOUN	NN	O
;	;	PUNCT	:	O
SD	sd	NOUN	NN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
078	078	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Increased	increase	VERB	VBN	O
plasma	plasma	NOUN	NN	O
malondialdehyde	malondialdehyde	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
also	also	ADV	RB	O
recorded	record	VERB	VBN	O
in	in	ADP	IN	O
two	two	NUM	CD	O
other	other	ADJ	JJ	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
animals	animal	NOUN	NNS	O
subjected	subject	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
experimental	experimental	ADJ	JJ	O
model	model	NOUN	NN	O
,	,	PUNCT	,	O
one	one	NUM	CD	O
receiving	receive	VERB	VBG	O
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
b	b	NOUN	NN	O
.	.	PUNCT	.	O
w	w	PUNCT	LS	O
.	.	PUNCT	.	O
of	of	ADP	IN	O
the	the	DET	DT	O
cyclooxygenase	cyclooxygenase	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
acetylsalicylate	acetylsalicylate	NOUN	NN	B-Chemical
intravenously	intravenously	ADV	RB	O
immediately	immediately	ADV	RB	O
before	before	ADP	IN	O
ischemia	ischemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
receiving	receive	VERB	VBG	O
650	650	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
b	b	NOUN	NN	O
.	.	PUNCT	.	O
w	w	PUNCT	LS	O
.	.	PUNCT	.	O
of	of	ADP	IN	O
the	the	DET	DT	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
drug	drug	NOUN	NN	O
nitroprusside	nitroprusside	ADV	RB	B-Chemical
at	at	ADP	IN	O
a	a	DET	DT	O
flow	flow	NOUN	NN	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
103	103	NUM	CD	O
microliters	microliter	NOUN	NNS	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
intravenously	intravenously	ADV	RB	O
during	during	ADP	IN	O
ischemia	ischemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
although	although	ADP	IN	O
in	in	ADP	IN	O
this	this	DET	DT	O
latter	latter	ADJ	JJ	O
group	group	NOUN	NN	O
malondialdehyde	malondialdehyde	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
higher	high	ADJ	JJR	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
data	datum	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
determination	determination	NOUN	NN	O
of	of	ADP	IN	O
malondialdehyde	malondialdehyde	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
oxypurines	oxypurine	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
nucleosides	nucleoside	NOUN	NNS	B-Chemical
in	in	ADP	IN	O
peripheral	peripheral	ADJ	JJ	O
blood	blood	NOUN	NN	O
,	,	PUNCT	,	O
may	may	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
to	to	PART	TO	O
monitor	monitor	VERB	VB	O
the	the	DET	DT	O
metabolic	metabolic	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
of	of	ADP	IN	O
tissues	tissue	NOUN	NNS	O
occurring	occur	VERB	VBG	O
during	during	ADP	IN	O
ischemic	ischemic	ADJ	JJ	B-Disease
phenomena	phenomenon	NOUN	NNS	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
ABSTRACT	ABSTRACT	PROPN	NNP	O
TRUNCATED	truncated	NUM	CD	O
AT	at	ADP	IN	O
250	250	NUM	CD	O
WORDS	word	NOUN	NNS	O
)	)	PUNCT	-RRB-	O

Acute	acute	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
adriamycin	adriamycin	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
loaded	load	VERB	VBN	O
cyanoacrylate	cyanoacrylate	NOUN	NN	B-Chemical
nanoparticles	nanoparticle	NOUN	NNS	O
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
loaded	load	VERB	VBN	O
nanoparticle	nanoparticle	NOUN	NN	O
(	(	PUNCT	-LRB-	O
DXNP	DXNP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
renal	renal	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
was	be	VERB	VBD	O
explored	explore	VERB	VBN	O
in	in	ADP	IN	O
both	both	DET	DT	O
normal	normal	ADJ	JJ	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
experimental	experimental	ADJ	JJ	O
glomerulonephritis	glomerulonephritis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
normal	normal	ADJ	JJ	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
/	/	SYM	SYM	O
6	6	NUM	CD	O
rats	rat	NOUN	NNS	O
given	give	VERB	VBN	O
free	free	ADJ	JJ	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DX	DX	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
died	die	VERB	VBD	O
within	within	ADP	IN	O
one	one	NUM	CD	O
week	week	NOUN	NN	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
all	all	DET	DT	O
control	control	NOUN	NN	O
animals	animal	NOUN	NNS	O
and	and	CCONJ	CC	O
all	all	DET	DT	O
rats	rat	NOUN	NNS	O
having	have	VERB	VBG	O
received	receive	VERB	VBN	O
free	free	ADJ	JJ	O
NP	NP	PROPN	NNP	O
or	or	CCONJ	CC	O
DXNP	DXNP	PROPN	NNP	O
survived	survive	VERB	VBD	O
.	.	PUNCT	.	O

A	a	DET	DT	O
3	3	NUM	CD	O
times	time	NOUN	NNS	O
higher	high	ADJ	JJR	O
proteinuria	proteinuria	NOUN	NNS	B-Disease
appeared	appear	VERB	VBD	O
in	in	ADP	IN	O
animals	animal	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
DXNP	DXNP	PROPN	NNP	O
than	than	ADP	IN	O
in	in	ADP	IN	O
those	those	DET	DT	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
DX	DX	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Free	Free	PROPN	NNP	O
NP	NP	PROPN	NNP	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
provoke	provoke	VERB	VB	O
any	any	DET	DT	O
proteinuria	proteinuria	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Two	two	NUM	CD	O
hr	hr	INTJ	UH	O
post	post	ADJ	JJ	O
-	-	ADJ	JJ	O
injection	injection	NOUN	NN	O
,	,	PUNCT	,	O
DXNP	DXNP	PROPN	NNP	O
was	be	VERB	VBD	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
times	time	NOUN	NNS	O
more	more	ADV	RBR	O
concentrated	concentrated	ADJ	JJ	O
in	in	ADP	IN	O
kidneys	kidney	NOUN	NNS	O
than	than	ADP	IN	O
free	free	ADJ	JJ	O
DX	DX	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
025	025	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
immune	immune	ADJ	JJ	O
experimental	experimental	ADJ	JJ	O
glomerulonephritis	glomerulonephritis	ADJ	JJ	B-Disease
,	,	PUNCT	,	O
5	5	NUM	CD	O
/	/	SYM	SYM	O
6	6	NUM	CD	O
rats	rat	NOUN	NNS	O
given	give	VERB	VBN	O
DX	DX	PROPN	NNP	B-Chemical
died	die	VERB	VBD	O
within	within	ADP	IN	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
to	to	ADP	IN	O
animals	animal	NOUN	NNS	O
treated	treat	VERB	VBN	O
by	by	ADP	IN	O
DXNP	DXNP	PROPN	NNP	O
,	,	PUNCT	,	O
NP	NP	PROPN	NNP	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
untreated	untreated	ADJ	JJ	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
all	all	DET	DT	O
survived	survive	VERB	VBD	O
.	.	PUNCT	.	O

Proteinuria	Proteinuria	PROPN	NNP	B-Disease
appeared	appear	VERB	VBD	O
in	in	ADP	IN	O
all	all	DET	DT	O
series	series	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
was	be	VERB	VBD	O
2	2	NUM	CD	O
-	-	SYM	SYM	O
5	5	NUM	CD	O
times	time	NOUN	NNS	O
more	more	ADV	RBR	O
intense	intense	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
>	>	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
prolonged	prolong	VERB	VBN	O
after	after	ADP	IN	O
doxorubicin	doxorubicin	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
400	400	NUM	CD	O
-	-	SYM	SYM	O
700	700	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
without	without	ADP	IN	O
significant	significant	ADJ	JJ	O
difference	difference	NOUN	NN	O
between	between	ADP	IN	O
DXNP	DXNP	PROPN	NNP	O
and	and	CCONJ	CC	O
DX	DX	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Rats	rat	NOUN	NNS	O
treated	treat	VERB	VBN	O
by	by	ADP	IN	O
unloaded	unloaded	ADJ	JJ	O
NP	NP	PROPN	NNP	O
behaved	behave	VERB	VBN	O
as	as	ADP	IN	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
demonstrate	demonstrate	VERB	VBP	O
that	that	ADP	IN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
these	these	DET	DT	O
experimental	experimental	ADJ	JJ	O
conditions	condition	NOUN	NNS	O
,	,	PUNCT	,	O
DXNP	DXNP	PROPN	NNP	O
killed	kill	VERB	VBD	O
less	less	ADJ	JJR	O
animals	animal	NOUN	NNS	O
than	than	ADP	IN	O
free	free	ADJ	JJ	O
DX	DX	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
despite	despite	ADP	IN	O
of	of	ADP	IN	O
an	an	DET	DT	O
enhanced	enhance	VERB	VBN	O
renal	renal	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
former	former	ADJ	JJ	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
effects	effect	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
better	well	ADJ	JJR	O
survival	survival	NOUN	NN	O
and	and	CCONJ	CC	O
nephrosis	nephrosis	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
are	be	VERB	VBP	O
most	most	ADV	RBS	O
probably	probably	ADV	RB	O
related	related	ADJ	JJ	O
to	to	ADP	IN	O
an	an	DET	DT	O
enhanced	enhanced	ADJ	JJ	O
capture	capture	NOUN	NN	O
of	of	ADP	IN	O
DXNP	DXNP	PROPN	NNP	O
by	by	ADP	IN	O
cells	cell	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
mononuclear	mononuclear	NOUN	NN	O
phagocyte	phagocyte	NOUN	NN	O
system	system	NOUN	NN	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
mesangial	mesangial	ADJ	JJ	O
cells	cell	NOUN	NNS	O
.	.	PUNCT	.	O

Prostaglandin	Prostaglandin	PROPN	NNP	B-Chemical
E2	E2	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
bladder	bladder	NOUN	NN	B-Disease
hyperactivity	hyperactivity	NOUN	NN	I-Disease
in	in	ADP	IN	O
normal	normal	ADJ	JJ	O
,	,	PUNCT	,	O
conscious	conscious	ADJ	JJ	O
rats	rat	NOUN	NNS	O
:	:	PUNCT	:	O
involvement	involvement	NOUN	NN	O
of	of	ADP	IN	O
tachykinins	tachykinin	NOUN	NNS	B-Chemical
?	?	PUNCT	.	O

In	in	ADP	IN	O
normal	normal	ADJ	JJ	O
conscious	conscious	ADJ	JJ	O
rats	rat	NOUN	NNS	O
investigated	investigate	VERB	VBN	O
by	by	ADP	IN	O
continuous	continuous	ADJ	JJ	O
cystometry	cystometry	NOUN	NN	O
,	,	PUNCT	,	O
intravesically	intravesically	ADV	RB	O
instilled	instill	VERB	VBN	O
prostaglandin	prostaglandin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	I-Chemical
PG	PG	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
E2	E2	PROPN	NNP	I-Chemical
facilitated	facilitate	VERB	VBD	O
micturition	micturition	NOUN	NN	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBN	O
basal	basal	ADJ	JJ	O
intravesical	intravesical	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effect	effect	NOUN	NN	O
was	be	VERB	VBD	O
attenuated	attenuate	VERB	VBN	O
by	by	ADP	IN	O
both	both	DET	DT	O
the	the	DET	DT	O
NK1	NK1	PROPN	NNP	O
receptor	receptor	NOUN	NN	O
selective	selective	ADJ	JJ	O
antagonist	antagonist	NOUN	NN	O
RP	RP	PROPN	NNP	B-Chemical
67	67	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
580	580	NUM	CD	I-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
NK2	NK2	PROPN	NNPS	O
receptor	receptor	VERB	VBP	O
selective	selective	ADJ	JJ	O
antagonist	antagonist	NOUN	NN	O
SR	SR	PROPN	NNP	B-Chemical
48	48	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
968	968	NUM	CD	I-Chemical
,	,	PUNCT	,	O
given	give	VERB	VBN	O
intra	intra	ADJ	JJ	O
-	-	NOUN	NN	O
arterially	arterially	ADV	RB	O
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
stimulation	stimulation	NOUN	NN	O
of	of	ADP	IN	O
both	both	CCONJ	CC	O
NK1	NK1	PROPN	NNP	O
and	and	CCONJ	CC	O
NK2	NK2	PROPN	NNP	O
receptors	receptor	NOUN	NNS	O
.	.	PUNCT	.	O

Intra	Intra	PROPN	NNP	O
-	-	PUNCT	:	O
arterially	arterially	ADV	RB	O
given	give	VERB	VBN	O
PGE2	PGE2	PROPN	NNP	B-Chemical
produced	produce	VERB	VBD	O
a	a	DET	DT	O
distinct	distinct	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
bladder	bladder	NOUN	NN	O
pressure	pressure	NOUN	NN	O
before	before	ADP	IN	O
initiating	initiate	VERB	VBG	O
a	a	DET	DT	O
micturition	micturition	NOUN	NN	O
reflex	reflex	NOUN	NN	O
,	,	PUNCT	,	O
indicating	indicate	VERB	VBG	O
that	that	ADP	IN	O
the	the	DET	DT	O
PG	PG	PROPN	NNP	B-Chemical
had	have	VERB	VBD	O
a	a	DET	DT	O
direct	direct	ADJ	JJ	O
contractant	contractant	NOUN	NN	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
detrusor	detrusor	NOUN	NN	O
smooth	smooth	ADJ	JJ	O
muscle	muscle	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
intra	intra	ADJ	JJ	O
-	-	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
PGE2	PGE2	PROPN	NNP	B-Chemical
could	could	VERB	MD	O
not	not	ADV	RB	O
be	be	VERB	VB	O
blocked	block	VERB	VBN	O
by	by	ADP	IN	O
intra	intra	ADJ	JJ	O
-	-	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
RP	RP	PROPN	NNP	B-Chemical
67	67	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
580	580	NUM	CD	I-Chemical
or	or	CCONJ	CC	O
SR	SR	PROPN	NNP	B-Chemical
48	48	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
968	968	NUM	CD	I-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
opens	open	VERB	VBZ	O
the	the	DET	DT	O
possibility	possibility	NOUN	NN	O
that	that	ADP	IN	O
the	the	DET	DT	O
micturition	micturition	NOUN	NN	O
reflex	reflex	NOUN	NN	O
elicited	elicit	VERB	VBN	O
by	by	ADP	IN	O
intra	intra	ADJ	JJ	O
-	-	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
PGE2	PGE2	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
mediated	mediate	VERB	VBN	O
by	by	ADP	IN	O
pathways	pathway	NOUN	NNS	O
other	other	ADJ	JJ	O
than	than	ADP	IN	O
the	the	DET	DT	O
reflex	reflex	NOUN	NN	O
initiated	initiate	VERB	VBD	O
when	when	ADV	WRB	O
the	the	DET	DT	O
PG	PG	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
given	give	VERB	VBN	O
intravesically	intravesically	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
results	result	NOUN	NNS	O
thus	thus	ADV	RB	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
intra	intra	ADJ	JJ	O
-	-	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
PGE2	PGE2	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
given	give	VERB	VBN	O
near	near	ADP	IN	O
the	the	DET	DT	O
bladder	bladder	NOUN	NN	O
,	,	PUNCT	,	O
may	may	VERB	MD	O
initiate	initiate	VERB	VB	O
micturition	micturition	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
normal	normal	ADJ	JJ	O
rat	rat	NOUN	NN	O
chiefly	chiefly	ADV	RB	O
by	by	ADP	IN	O
directly	directly	ADV	RB	O
contracting	contract	VERB	VBG	O
the	the	DET	DT	O
smooth	smooth	ADJ	JJ	O
muscle	muscle	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
detrusor	detrusor	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
given	give	VERB	VBN	O
intravesically	intravesically	ADV	RB	O
,	,	PUNCT	,	O
PGE2	PGE2	PROPN	NNP	B-Chemical
may	may	VERB	MD	O
stimulate	stimulate	VERB	VB	O
micturition	micturition	NOUN	NN	O
by	by	ADP	IN	O
releasing	release	VERB	VBG	O
tachykinins	tachykinin	NOUN	NNS	B-Chemical
from	from	ADP	IN	O
nerves	nerve	NOUN	NNS	O
in	in	ADP	IN	O
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
immediately	immediately	ADV	RB	O
below	below	ADP	IN	O
the	the	DET	DT	O
urothelium	urothelium	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
tachykinins	tachykinin	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
in	in	ADP	IN	O
turn	turn	NOUN	NN	O
,	,	PUNCT	,	O
initiate	initiate	VERB	VBP	O
a	a	DET	DT	O
micturition	micturition	NOUN	NN	O
reflex	reflex	NOUN	NN	O
by	by	ADP	IN	O
stimulating	stimulate	VERB	VBG	O
NK1	NK1	PROPN	NNP	O
and	and	CCONJ	CC	O
NK2	NK2	PROPN	NNP	O
receptors	receptor	NOUN	NNS	O
.	.	PUNCT	.	O

Prostanoids	prostanoid	NOUN	NNS	B-Chemical
may	may	VERB	MD	O
,	,	PUNCT	,	O
via	via	ADP	IN	O
release	release	NOUN	NN	O
of	of	ADP	IN	O
tachykinins	tachykinin	NOUN	NNS	B-Chemical
,	,	PUNCT	,	O
contribute	contribute	VERB	VBP	O
to	to	ADP	IN	O
both	both	DET	DT	O
urge	urge	NOUN	NN	O
and	and	CCONJ	CC	O
bladder	bladder	NOUN	NN	B-Disease
hyperactivity	hyperactivity	NOUN	NN	I-Disease
seen	see	VERB	VBN	O
in	in	ADP	IN	O
inflammatory	inflammatory	ADJ	JJ	O
conditions	condition	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
lower	low	ADJ	JJR	O
urinary	urinary	ADJ	JJ	O
tract	tract	NOUN	NN	O
.	.	PUNCT	.	O

Refractory	refractory	ADJ	JJ	O
cardiogenic	cardiogenic	ADJ	JJ	B-Disease
shock	shock	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
complete	complete	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
block	block	NOUN	NN	I-Disease
after	after	ADP	IN	O
verapamil	verapamil	NOUN	NN	B-Chemical
SR	sr	NOUN	NN	O
and	and	CCONJ	CC	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
seventy	seventy	NUM	CD	O
-	-	PUNCT	HYPH	O
eight	eight	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
presented	present	VERB	VBN	O
with	with	ADP	IN	O
complete	complete	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
block	block	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
refractory	refractory	NOUN	NN	O
hypotension	hypotension	NOUN	NN	B-Disease
two	two	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
a	a	DET	DT	O
therapeutic	therapeutic	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
sustained	sustained	ADJ	JJ	O
-	-	PUNCT	HYPH	O
release	release	NOUN	NN	O
verapamil	verapamil	NOUN	NN	B-Chemical
with	with	ADP	IN	O
concomitant	concomitant	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
metoprolol	metoprolol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
continued	continue	VERB	VBD	O
to	to	PART	TO	O
remain	remain	VERB	VB	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
with	with	ADP	IN	O
complete	complete	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
block	block	NOUN	NN	I-Disease
,	,	PUNCT	,	O
even	even	ADV	RB	O
with	with	ADP	IN	O
multiple	multiple	ADJ	JJ	O
uses	use	NOUN	NNS	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
atropine	atropine	NOUN	NN	B-Chemical
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
pressor	pressor	NOUN	NN	O
agents	agent	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
dobutamine	dobutamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
shortly	shortly	ADV	RB	O
after	after	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
refractory	refractory	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
complete	complete	ADJ	JJ	O
heart	heart	NOUN	NN	B-Disease
block	block	NOUN	NN	I-Disease
resolved	resolve	VERB	VBN	O
.	.	PUNCT	.	O

Protective	protective	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
misoprostol	misoprostol	NOUN	NN	B-Chemical
on	on	ADP	IN	O
indomethacin	indomethacin	ADV	RB	B-Chemical
induced	induce	VERB	VBN	O
renal	renal	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
in	in	ADP	IN	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
possible	possible	ADJ	JJ	O
protective	protective	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
misoprostol	misoprostol	NOUN	NN	B-Chemical
on	on	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
hospitalized	hospitalize	VERB	VBN	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
indomethacin	indomethacin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Forty	forty	NUM	CD	O
-	-	PUNCT	HYPH	O
five	five	NUM	CD	O
hospitalized	hospitalize	VERB	VBD	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
>	>	X	XX	O
65	65	NUM	CD	O
years	year	NOUN	NNS	O
old	old	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
who	who	PRON	WP	O
required	require	VERB	VBD	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
nonsteroidal	nonsteroidal	ADJ	JJ	O
antiinflammatory	antiinflammatory	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
NSAID	NSAID	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
assigned	assign	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
either	either	CCONJ	CC	O
indomethacin	indomethacin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
150	150	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
(	(	PUNCT	-LRB-	O
Group	Group	PROPN	NNP	O
A	A	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
indomethacin	indomethacin	VERB	VBD	B-Chemical
150	150	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
plus	plus	CCONJ	CC	O
misoprostol	misoprostol	NOUN	NN	B-Chemical
at	at	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
(	(	PUNCT	-LRB-	O
Group	Group	PROPN	NNP	O
B	B	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Laboratory	laboratory	NOUN	NN	O
variables	variable	NOUN	NNS	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
[	[	PUNCT	-LRB-	O
serum	serum	ADJ	JJ	O
creatinine	creatinine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
blood	blood	NOUN	NN	B-Chemical
urea	urea	ADJ	JJ	I-Chemical
nitrogen	nitrogen	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
BUN	BUN	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
electrolytes	electrolyte	NOUN	NNS	O
]	]	PUNCT	-RRB-	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
before	before	ADP	IN	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
and	and	CCONJ	CC	O
every	every	DET	DT	O
2	2	NUM	CD	O
days	day	NOUN	NNS	O
,	,	PUNCT	,	O
until	until	ADP	IN	O
termination	termination	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
(	(	PUNCT	-LRB-	O
a	a	DET	DT	O
period	period	NOUN	NN	O
of	of	ADP	IN	O
at	at	ADV	RB	O
least	least	ADV	RBS	O
6	6	NUM	CD	O
days	day	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Response	response	NOUN	NN	O
to	to	ADP	IN	O
treatment	treatment	NOUN	NN	O
was	be	VERB	VBD	O
estimated	estimate	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
visual	visual	ADJ	JJ	O
analog	analog	NOUN	NN	O
scale	scale	NOUN	NN	O
for	for	ADP	IN	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Forty	forty	NUM	CD	O
-	-	PUNCT	HYPH	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
completed	complete	VERB	VBD	O
the	the	DET	DT	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
22	22	NUM	CD	O
in	in	ADP	IN	O
Group	Group	PROPN	NNP	O
A	A	PROPN	NNP	O
and	and	CCONJ	CC	O
20	20	NUM	CD	O
in	in	ADP	IN	O
Group	Group	PROPN	NNP	O
B	B	PROPN	NNP	O
.	.	PUNCT	.	O

BUN	BUN	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
creatinine	creatinine	NOUN	NN	B-Chemical
increased	increase	VERB	VBN	O
by	by	ADP	IN	O
>	>	X	XX	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
baseline	baseline	NOUN	NN	O
levels	level	NOUN	NNS	O
in	in	ADP	IN	O
54	54	NUM	CD	O
and	and	CCONJ	CC	O
45	45	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
Group	Group	PROPN	NNP	O
A	A	PROPN	NNP	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
only	only	ADV	RB	O
20	20	NUM	CD	O
and	and	CCONJ	CC	O
10	10	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
Group	Group	PROPN	NNP	O
B	B	PROPN	NNP	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Potassium	potassium	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
K	K	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
increment	increment	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
mEq	meq	NOUN	NN	O
/	/	SYM	SYM	O
l	l	NOUN	NN	O
or	or	CCONJ	CC	O
more	more	ADV	RBR	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
Group	Group	PROPN	NNP	O
A	A	PROPN	NNP	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
in	in	ADP	IN	O
only	only	ADV	RB	O
15	15	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
Group	Group	PROPN	NNP	O
B	B	PROPN	NNP	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
increments	increment	NOUN	NNS	O
in	in	ADP	IN	O
BUN	BUN	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
creatinine	creatinine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
K	K	PROPN	NNP	B-Chemical
were	be	VERB	VBD	O
reduced	reduce	VERB	VBN	O
by	by	ADP	IN	O
63	63	NUM	CD	O
,	,	PUNCT	,	O
80	80	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
42	42	NUM	CD	O
%	%	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
Group	Group	PROPN	NNP	O
B	B	PROPN	NNP	O
patients	patient	NOUN	NNS	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
Group	Group	PROPN	NNP	O
A	A	PROPN	NNP	O
.	.	PUNCT	.	O
Response	response	NOUN	NN	O
to	to	ADP	IN	O
treatment	treatment	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
differ	differ	VERB	VB	O
significantly	significantly	ADV	RB	O
between	between	ADP	IN	O
the	the	DET	DT	O
2	2	NUM	CD	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Hospitalized	hospitalize	VERB	VBN	O
elderly	elderly	ADJ	JJ	O
patients	patient	NOUN	NNS	O
are	be	VERB	VBP	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
developing	develop	VERB	VBG	O
indomethacin	indomethacin	ADV	RB	B-Chemical
related	relate	VERB	VBN	O
renal	renal	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Addition	addition	NOUN	NN	O
of	of	ADP	IN	O
misoprostol	misoprostol	NOUN	NN	B-Chemical
can	can	VERB	MD	O
minimize	minimize	VERB	VB	O
this	this	DET	DT	O
renal	renal	ADJ	JJ	B-Disease
impairment	impairment	NOUN	NN	I-Disease
without	without	ADP	IN	O
affecting	affect	VERB	VBG	O
pain	pain	NOUN	NN	B-Disease
control	control	NOUN	NN	O
.	.	PUNCT	.	O

Cognitive	cognitive	ADJ	JJ	B-Disease
deterioration	deterioration	NOUN	NN	I-Disease
from	from	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
abuse	abuse	NOUN	NN	O
of	of	ADP	IN	O
dextromethorphan	dextromethorphan	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
a	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

Dextromethorphan	Dextromethorphan	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
DM	DM	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
dextrorotatory	dextrorotatory	ADJ	JJ	O
isomer	isomer	NOUN	NN	O
of	of	ADP	IN	O
3	3	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxy	hydroxy	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
N	n	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
methylmorphinan	methylmorphinan	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
the	the	DET	DT	O
main	main	ADJ	JJ	O
ingredient	ingredient	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
widely	widely	ADV	RB	O
available	available	ADJ	JJ	O
,	,	PUNCT	,	O
over	over	ADP	IN	O
-	-	PUNCT	HYPH	O
the	the	DET	DT	O
-	-	PUNCT	HYPH	O
counter	counter	NOUN	NN	O
antitussives	antitussive	NOUN	NNS	O
.	.	PUNCT	.	O

Initial	initial	ADJ	JJ	O
studies	study	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
Bornstein	Bornstein	PROPN	NNP	O
1968	1968	NUM	CD	O
)	)	PUNCT	-RRB-	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
possessed	possess	VERB	VBD	O
no	no	DET	DT	O
respiratory	respiratory	ADJ	JJ	O
suppressant	suppressant	ADJ	JJ	O
effects	effect	NOUN	NNS	O
and	and	CCONJ	CC	O
no	no	DET	DT	O
addiction	addiction	NOUN	NN	O
liability	liability	NOUN	NN	O
.	.	PUNCT	.	O

Subsequently	subsequently	ADV	RB	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
several	several	ADJ	JJ	O
articles	article	NOUN	NNS	O
reporting	report	VERB	VBG	O
abuse	abuse	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
drug	drug	NOUN	NN	O
have	have	VERB	VBP	O
appeared	appear	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
drug	drug	NOUN	NN	O
is	be	VERB	VBZ	O
known	know	VERB	VBN	O
to	to	PART	TO	O
cause	cause	VERB	VB	O
a	a	DET	DT	O
variety	variety	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
toxic	toxic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
,	,	PUNCT	,	O
ranging	range	VERB	VBG	O
from	from	ADP	IN	O
nausea	nausea	NOUN	NN	B-Disease
,	,	PUNCT	,	O
restlessness	restlessness	NOUN	NN	B-Disease
,	,	PUNCT	,	O
insomnia	insomnia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
ataxia	ataxia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
slurred	slur	VERB	VBN	O
speech	speech	NOUN	NN	O
and	and	CCONJ	CC	O
nystagmus	nystagmus	ADJ	JJ	B-Disease
to	to	ADP	IN	O
mood	mood	NOUN	NN	O
changes	change	NOUN	NNS	O
,	,	PUNCT	,	O
perceptual	perceptual	ADJ	JJ	O
alterations	alteration	NOUN	NNS	O
,	,	PUNCT	,	O
inattention	inattention	NOUN	NN	O
,	,	PUNCT	,	O
disorientation	disorientation	NOUN	NN	O
and	and	CCONJ	CC	O
aggressive	aggressive	ADJ	JJ	B-Disease
behavior	behavior	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
Rammer	rammer	NOUN	NN	O
et	et	PROPN	NNP	O
al	al	PROPN	NNP	O
1988	1988	NUM	CD	O
;	;	PUNCT	:	O
Katona	Katona	PROPN	NNP	O
and	and	CCONJ	CC	O
Watson	Watson	PROPN	NNP	O
1986	1986	NUM	CD	O
;	;	PUNCT	:	O
Isbell	Isbell	PROPN	NNP	O
and	and	CCONJ	CC	O
Fraser	Fraser	PROPN	NNP	O
1953	1953	NUM	CD	O
;	;	PUNCT	:	O
Devlin	Devlin	PROPN	NNP	O
et	et	X	FW	O
al	al	PROPN	NNP	O
1985	1985	NUM	CD	O
;	;	PUNCT	:	O
McCarthy	McCarthy	PROPN	NNP	O
1971	1971	NUM	CD	O
;	;	PUNCT	:	O
Dodds	Dodds	PROPN	NNP	O
and	and	CCONJ	CC	O
Revai	Revai	PROPN	NNP	O
1967	1967	NUM	CD	O
;	;	PUNCT	:	O
Degkwitz	Degkwitz	PROPN	NNP	O
1964	1964	NUM	CD	O
;	;	PUNCT	:	O
Hildebrand	Hildebrand	PROPN	NNP	O
et	et	PROPN	NNP	O
al	al	PROPN	NNP	O
1989	1989	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
have	have	VERB	VBP	O
also	also	ADV	RB	O
been	be	VERB	VBN	O
two	two	NUM	CD	O
reported	report	VERB	VBN	O
fatalities	fatality	NOUN	NNS	O
from	from	ADP	IN	O
DM	DM	PROPN	NNP	B-Chemical
overdoses	overdose	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
Fleming	fleme	VERB	VBG	O
1986	1986	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
are	be	VERB	VBP	O
no	no	DET	DT	O
reports	report	NOUN	NNS	O
describing	describe	VERB	VBG	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	O
abuse	abuse	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
report	report	NOUN	NN	O
describes	describe	VERB	VBZ	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
cognitive	cognitive	ADJ	JJ	B-Disease
deterioration	deterioration	NOUN	NN	I-Disease
resulting	result	VERB	VBG	O
from	from	ADP	IN	O
prolonged	prolong	VERB	VBN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
DM	DM	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
ouabain	ouabain	NOUN	NN	B-Chemical
on	on	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
supply	supply	NOUN	NN	O
and	and	CCONJ	CC	O
demand	demand	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
hemodynamic	hemodynamic	ADJ	JJ	O
,	,	PUNCT	,	O
volumetric	volumetric	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
metabolic	metabolic	ADJ	JJ	O
study	study	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
without	without	ADP	IN	O
heart	heart	NOUN	NN	B-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
digitalis	digitalis	NOUN	NN	B-Chemical
glycosides	glycoside	NOUN	NNS	I-Chemical
on	on	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
supply	supply	NOUN	NN	O
and	and	CCONJ	CC	O
demand	demand	NOUN	NN	O
are	be	VERB	VBP	O
of	of	ADP	IN	O
particular	particular	ADJ	JJ	O
interest	interest	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
obstructive	obstructive	ADJ	JJ	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
have	have	VERB	VBP	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
measured	measure	VERB	VBN	O
previously	previously	ADV	RB	O
in	in	ADP	IN	O
man	man	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
assessed	assess	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
ouabain	ouabain	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
015	015	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
hemodynamic	hemodynamic	ADJ	JJ	O
,	,	PUNCT	,	O
volumetric	volumetric	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
metabolic	metabolic	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
in	in	ADP	IN	O
11	11	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
severe	severe	ADJ	JJ	O
chronic	chronic	ADJ	JJ	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
without	without	ADP	IN	O
clinical	clinical	ADJ	JJ	O
congestive	congestive	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Because	because	ADP	IN	O
the	the	DET	DT	O
protocol	protocol	NOUN	NN	O
was	be	VERB	VBD	O
long	long	ADJ	JJ	O
and	and	CCONJ	CC	O
involved	involved	ADJ	JJ	O
interventions	intervention	NOUN	NNS	O
which	which	DET	WDT	O
might	may	VERB	MD	O
affect	affect	VERB	VB	O
the	the	DET	DT	O
determinations	determination	NOUN	NNS	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
also	also	ADV	RB	O
studied	study	VERB	VBD	O
in	in	ADP	IN	O
nine	nine	NUM	CD	O
patients	patient	NOUN	NNS	O
using	use	VERB	VBG	O
an	an	DET	DT	O
identical	identical	ADJ	JJ	O
protocol	protocol	NOUN	NN	O
except	except	ADP	IN	O
that	that	DET	DT	O
ouabain	ouabain	ADJ	JJ	B-Chemical
administration	administration	NOUN	NN	O
was	be	VERB	VBD	O
omitted	omit	VERB	VBN	O
.	.	PUNCT	.	O

Left	leave	VERB	VBN	O
ventricular	ventricular	ADJ	JJ	O
end	end	NOUN	NN	O
-	-	PUNCT	HYPH	O
diastolic	diastolic	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
left	leave	VERB	VBD	O
ventricular	ventricular	ADJ	JJ	O
end	end	NOUN	NN	O
-	-	PUNCT	HYPH	O
diastolic	diastolic	ADJ	JJ	O
volume	volume	NOUN	NN	O
fell	fall	VERB	VBD	O
in	in	ADP	IN	O
each	each	DET	DT	O
patient	patient	NOUN	NN	O
given	give	VERB	VBN	O
ouabain	ouabain	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
even	even	ADV	RB	O
though	though	ADP	IN	O
they	-PRON-	PRON	PRP	O
were	be	VERB	VBD	O
initially	initially	ADV	RB	O
elevated	elevate	VERB	VBN	O
in	in	ADP	IN	O
only	only	ADV	RB	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Left	leave	VERB	VBN	O
ventricular	ventricular	ADJ	JJ	O
end	end	NOUN	NN	O
-	-	PUNCT	HYPH	O
diastolic	diastolic	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
fell	fall	VERB	VBD	O
from	from	ADP	IN	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
SE	se	NOUN	NN	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
mm	mm	NOUN	NN	O
Hg	Hg	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
left	leave	VERB	VBD	O
ventricular	ventricular	ADJ	JJ	O
end	end	NOUN	NN	O
-	-	PUNCT	HYPH	O
diastolic	diastolic	ADJ	JJ	O
volume	volume	NOUN	NN	O
fell	fall	VERB	VBD	O
from	from	ADP	IN	O
100	100	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
17	17	NUM	CD	O
to	to	PART	TO	O
82	82	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
12	12	NUM	CD	O
ml	ml	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
1	1	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
ouabain	ouabain	NOUN	NN	B-Chemical
infusion	infusion	NOUN	NN	O
was	be	VERB	VBD	O
completed	complete	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
maximum	maximum	ADJ	JJ	O
velocity	velocity	NOUN	NN	O
of	of	ADP	IN	O
contractile	contractile	ADJ	JJ	O
element	element	NOUN	NN	O
shortening	shortening	NOUN	NN	O
increased	increase	VERB	VBD	O
from	from	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
68	68	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
11	11	NUM	CD	O
ml	ml	NOUN	NN	O
/	/	SYM	SYM	O
s	s	NOUN	NN	O
to	to	ADP	IN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
18	18	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
21	21	NUM	CD	O
muscle	muscle	NOUN	NN	O
-	-	PUNCT	HYPH	O
lengths	length	NOUN	NNS	O
/	/	SYM	SYM	O
s	s	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
is	be	VERB	VBZ	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
contractility	contractility	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
significant	significant	ADJ	JJ	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
parameters	parameter	NOUN	NNS	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

No	no	DET	DT	O
significant	significant	ADJ	JJ	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
consumption	consumption	NOUN	NN	O
occurred	occur	VERB	VBD	O
after	after	ADP	IN	O
ouabain	ouabain	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
but	but	CCONJ	CC	O
this	this	DET	DT	O
may	may	VERB	MD	O
be	be	VERB	VB	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
a	a	DET	DT	O
greater	great	ADJ	JJR	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
mean	mean	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ouabain	ouabain	ADJ	JJ	B-Chemical
patients	patient	NOUN	NNS	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	O
coronary	coronary	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
who	who	PRON	WP	O
are	be	VERB	VBP	O
not	not	ADV	RB	O
in	in	ADP	IN	O
clinical	clinical	ADJ	JJ	O
congestive	congestive	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
left	leave	VERB	VBD	B-Disease
ventricular	ventricular	ADJ	JJ	I-Disease
end	end	NOUN	NN	I-Disease
-	-	PUNCT	HYPH	I-Disease
diastolic	diastolic	ADJ	JJ	I-Disease
volume	volume	NOUN	NN	I-Disease
falls	fall	VERB	VBZ	I-Disease
after	after	ADP	IN	O
ouabain	ouabain	ADJ	JJ	B-Chemical
administration	administration	NOUN	NN	O
even	even	ADV	RB	O
when	when	ADV	WRB	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
initially	initially	ADV	RB	O
normal	normal	ADJ	JJ	O
.	.	PUNCT	.	O

Though	though	ADP	IN	O
this	this	DET	DT	O
fall	fall	NOUN	NN	O
would	would	VERB	MD	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
wall	wall	NOUN	NN	O
tension	tension	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
therefore	therefore	ADV	RB	O
,	,	PUNCT	,	O
of	of	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
consumption	consumption	NOUN	NN	O
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
may	may	VERB	MD	O
not	not	ADV	RB	O
be	be	VERB	VB	O
of	of	ADP	IN	O
sufficient	sufficient	ADJ	JJ	O
magnitude	magnitude	NOUN	NN	O
to	to	PART	TO	O
prevent	prevent	VERB	VB	O
a	a	DET	DT	O
net	net	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
myocardial	myocardial	ADJ	JJ	O
oxygen	oxygen	NOUN	NN	B-Chemical
consumption	consumption	NOUN	NN	O
.	.	PUNCT	.	O

Nevertheless	nevertheless	ADV	RB	O
,	,	PUNCT	,	O
compensatory	compensatory	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
prevent	prevent	VERB	VBP	O
a	a	DET	DT	O
deterioration	deterioration	NOUN	NN	O
of	of	ADP	IN	O
resting	rest	VERB	VBG	O
myocardial	myocardial	ADJ	JJ	O
metabolism	metabolism	NOUN	NN	O
.	.	PUNCT	.	O

Dexamethasone	dexamethasone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
ocular	ocular	ADJ	JJ	B-Disease
hypertension	hypertension	NOUN	NN	I-Disease
in	in	ADP	IN	O
perfusion	perfusion	NOUN	NN	O
-	-	PUNCT	HYPH	O
cultured	culture	VERB	VBN	O
human	human	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
Glucocorticoid	Glucocorticoid	PROPN	NNP	O
administration	administration	NOUN	NN	O
can	can	VERB	MD	O
lead	lead	VERB	VB	O
to	to	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
ocular	ocular	ADJ	JJ	B-Disease
hypertension	hypertension	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
corticosteroid	corticosteroid	ADJ	JJ	B-Disease
glaucoma	glaucoma	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
subset	subset	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
population	population	NOUN	NN	O
through	through	ADP	IN	O
a	a	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
aqueous	aqueous	ADJ	JJ	O
humor	humor	NOUN	NN	O
outflow	outflow	ADJ	JJ	O
facility	facility	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
purpose	purpose	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
whether	whether	ADP	IN	O
glucocorticoid	glucocorticoid	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
can	can	VERB	MD	O
directly	directly	ADV	RB	O
affect	affect	VERB	VB	O
the	the	DET	DT	O
outflow	outflow	ADJ	JJ	O
facility	facility	NOUN	NN	O
of	of	ADP	IN	O
isolated	isolated	ADJ	JJ	O
,	,	PUNCT	,	O
perfusion	perfusion	NOUN	NN	O
-	-	PUNCT	HYPH	O
cultured	culture	VERB	VBN	O
human	human	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
anterior	anterior	ADJ	JJ	O
segments	segment	NOUN	NNS	O
of	of	ADP	IN	O
human	human	ADJ	JJ	O
donor	donor	NOUN	NN	O
eyes	eye	NOUN	NNS	O
from	from	ADP	IN	O
regional	regional	ADJ	JJ	O
eye	eye	NOUN	NN	O
banks	bank	NOUN	NNS	O
were	be	VERB	VBD	O
placed	place	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
constant	constant	ADJ	JJ	O
flow	flow	NOUN	NN	O
,	,	PUNCT	,	O
variable	variable	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
perfusion	perfusion	NOUN	NN	O
culture	culture	NOUN	NN	O
system	system	NOUN	NN	O
.	.	PUNCT	.	O

Paired	pair	VERB	VBN	O
eyes	eye	NOUN	NNS	O
were	be	VERB	VBD	O
perfused	perfuse	VERB	VBN	O
in	in	ADP	IN	O
serum	serum	ADV	RB	O
-	-	PUNCT	HYPH	O
free	free	ADJ	JJ	O
media	medium	NOUN	NNS	O
with	with	ADP	IN	O
or	or	CCONJ	CC	O
without	without	ADP	IN	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
7	7	NUM	CD	O
)	)	PUNCT	-RRB-	O
M	m	NOUN	NN	O
dexamethasone	dexamethasone	ADJ	JJ	B-Chemical
for	for	ADP	IN	O
12	12	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

Intraocular	intraocular	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
was	be	VERB	VBD	O
monitored	monitor	VERB	VBN	O
daily	daily	ADV	RB	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
incubation	incubation	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
eyes	eye	NOUN	NNS	O
were	be	VERB	VBD	O
morphologically	morphologically	ADV	RB	O
characterized	characterize	VERB	VBN	O
by	by	ADP	IN	O
light	light	ADJ	JJ	O
microscopy	microscopy	NOUN	NN	O
,	,	PUNCT	,	O
transmission	transmission	NOUN	NN	O
and	and	CCONJ	CC	O
scanning	scan	VERB	VBG	O
electron	electron	NOUN	NN	O
microscopy	microscopy	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
scanning	scan	VERB	VBG	O
laser	laser	ADJ	JJ	O
confocal	confocal	ADJ	JJ	O
microscopy	microscopy	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
A	a	DET	DT	O
significant	significant	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
intraocular	intraocular	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
developed	develop	VERB	VBN	O
in	in	ADP	IN	O
13	13	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
44	44	NUM	CD	O
pairs	pair	NOUN	NNS	O
of	of	ADP	IN	O
eyes	eye	NOUN	NNS	O
perfused	perfuse	VERB	VBN	O
with	with	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
with	with	ADP	IN	O
an	an	DET	DT	O
average	average	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
rise	rise	NOUN	NN	O
of	of	ADP	IN	O
17	17	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
mm	mm	NOUN	NN	O
Hg	Hg	PROPN	NNP	O
after	after	ADP	IN	O
12	12	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
exposure	exposure	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
contralateral	contralateral	ADJ	JJ	O
control	control	NOUN	NN	O
eyes	eye	NOUN	NNS	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
receive	receive	VERB	VB	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
maintained	maintain	VERB	VBD	O
a	a	DET	DT	O
stable	stable	ADJ	JJ	O
intraocular	intraocular	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
during	during	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
outflow	outflow	NOUN	NN	O
pathway	pathway	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
untreated	untreated	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
appeared	appear	VERB	VBD	O
morphologically	morphologically	ADV	RB	O
normal	normal	ADJ	JJ	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
contrast	contrast	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treated	ADJ	JJ	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
eyes	eye	NOUN	NNS	I-Disease
had	have	VERB	VBD	O
thickened	thicken	VERB	VBN	O
trabecular	trabecular	ADJ	JJ	O
beams	beam	NOUN	NNS	O
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
intertrabecular	intertrabecular	ADJ	JJ	O
spaces	space	NOUN	NNS	O
,	,	PUNCT	,	O
thickened	thicken	VERB	VBD	O
juxtacanalicular	juxtacanalicular	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
,	,	PUNCT	,	O
activated	activate	VERB	VBD	O
trabecular	trabecular	ADJ	JJ	O
meshwork	meshwork	NOUN	NN	O
cells	cell	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBN	O
amounts	amount	NOUN	NNS	O
of	of	ADP	IN	O
amorphogranular	amorphogranular	ADJ	JJ	O
extracellular	extracellular	ADJ	JJ	O
material	material	NOUN	NN	O
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
juxtacanalicular	juxtacanalicular	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
and	and	CCONJ	CC	O
beneath	beneath	ADP	IN	O
the	the	DET	DT	O
endothelial	endothelial	ADJ	JJ	O
lining	lining	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
canal	canal	NOUN	NN	O
of	of	ADP	IN	O
Schlemm	Schlemm	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
nonresponder	nonresponder	NOUN	NN	O
eyes	eye	NOUN	NNS	O
appeared	appear	VERB	VBD	O
to	to	PART	TO	O
be	be	VERB	VB	O
morphologically	morphologically	ADV	RB	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
untreated	untreated	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
several	several	ADJ	JJ	O
subtle	subtle	ADJ	JJ	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
morphologic	morphologic	NOUN	NN	O
changes	change	NOUN	NNS	O
were	be	VERB	VBD	O
evident	evident	ADJ	JJ	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Dexamethasone	dexamethasone	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
isolated	isolated	ADJ	JJ	O
,	,	PUNCT	,	O
perfusion	perfusion	NOUN	NN	O
-	-	PUNCT	HYPH	O
cultured	culture	VERB	VBN	O
human	human	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
led	lead	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
generation	generation	NOUN	NN	O
of	of	ADP	IN	O
ocular	ocular	ADJ	JJ	B-Disease
hypertension	hypertension	NOUN	NN	I-Disease
in	in	ADP	IN	O
approximately	approximately	ADV	RB	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
dexamethasone	dexamethasone	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
eyes	eye	NOUN	NNS	O
.	.	PUNCT	.	O

Steroid	Steroid	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
morphologic	morphologic	NOUN	NN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
trabecular	trabecular	ADJ	JJ	O
meshwork	meshwork	NOUN	NN	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
reported	report	VERB	VBN	O
for	for	ADP	IN	O
corticosteroid	corticosteroid	ADJ	JJ	B-Disease
glaucoma	glaucoma	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
open	open	ADJ	JJ	B-Disease
angle	angle	NOUN	NN	I-Disease
glaucoma	glaucoma	NOUN	NN	I-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
system	system	NOUN	NN	O
may	may	VERB	MD	O
provide	provide	VERB	VB	O
an	an	DET	DT	O
acute	acute	ADJ	JJ	O
model	model	NOUN	NN	O
in	in	ADP	IN	O
which	which	DET	WDT	O
to	to	PART	TO	O
study	study	VERB	VB	O
the	the	DET	DT	O
pathogenic	pathogenic	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
steroid	steroid	NOUN	NN	B-Disease
glaucoma	glaucoma	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
primary	primary	ADJ	JJ	B-Disease
open	open	ADJ	JJ	I-Disease
angle	angle	NOUN	NN	I-Disease
glaucoma	glaucoma	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Auditory	auditory	NOUN	NN	O
disturbance	disturbance	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
interscalene	interscalene	ADJ	JJ	O
brachial	brachial	ADJ	JJ	O
plexus	plexus	NOUN	NN	O
block	block	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
performed	perform	VERB	VBD	O
an	an	DET	DT	O
audiometric	audiometric	ADJ	JJ	O
study	study	NOUN	NN	O
in	in	ADP	IN	O
20	20	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
underwent	undergo	VERB	VBD	O
surgery	surgery	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
shoulder	shoulder	NOUN	NN	O
region	region	NOUN	NN	O
under	under	ADP	IN	O
an	an	DET	DT	O
interscalene	interscalene	ADJ	JJ	O
brachial	brachial	ADJ	JJ	O
plexus	plexus	NOUN	NN	O
block	block	NOUN	NN	O
(	(	PUNCT	-LRB-	O
IBPB	IBPB	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Bupivacaine	Bupivacaine	PROPN	NNP	B-Chemical
0	0	NUM	CD	O
.	.	PUNCT	.	O
75	75	NUM	CD	O
%	%	NOUN	NN	O
with	with	ADP	IN	O
adrenaline	adrenaline	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
given	give	VERB	VBN	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hr	hr	NOUN	NN	O
continuous	continuous	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
%	%	NOUN	NN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Three	three	NUM	CD	O
audiometric	audiometric	ADJ	JJ	O
threshold	threshold	NOUN	NN	O
measurements	measurement	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
-	-	SYM	SYM	O
18	18	NUM	CD	O
kHz	khz	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
made	make	VERB	VBN	O
:	:	PUNCT	:	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
before	before	ADP	IN	O
IBPB	IBPB	PROPN	NNP	O
,	,	PUNCT	,	O
the	the	DET	DT	O
second	second	ADJ	JJ	O
2	2	NUM	CD	O
-	-	SYM	SYM	O
6	6	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
surgery	surgery	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
third	third	ADJ	JJ	O
on	on	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
day	day	NOUN	NN	O
after	after	ADP	IN	O
operation	operation	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
four	four	NUM	CD	O
patients	patient	NOUN	NNS	O
hearing	hear	VERB	VBG	B-Disease
impairment	impairment	NOUN	NN	I-Disease
on	on	ADP	IN	O
the	the	DET	DT	O
side	side	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
block	block	NOUN	NN	O
was	be	VERB	VBD	O
demonstrated	demonstrate	VERB	VBN	O
after	after	ADP	IN	O
operation	operation	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
three	three	NUM	CD	O
measurements	measurement	NOUN	NNS	O
on	on	ADP	IN	O
the	the	DET	DT	O
day	day	NOUN	NN	O
of	of	ADP	IN	O
surgery	surgery	NOUN	NN	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
one	one	NUM	CD	O
on	on	ADP	IN	O
the	the	DET	DT	O
following	follow	VERB	VBG	O
day	day	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
frequencies	frequency	NOUN	NNS	O
at	at	ADP	IN	O
which	which	DET	WDT	O
the	the	DET	DT	O
impairment	impairment	NOUN	NN	O
occurred	occur	VERB	VBD	O
varied	varied	ADJ	JJ	O
between	between	ADP	IN	O
patients	patient	NOUN	NNS	O
;	;	PUNCT	:	O
in	in	ADP	IN	O
one	one	NUM	CD	O
only	only	ADV	RB	O
low	low	ADJ	JJ	O
frequencies	frequency	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
kHz	khz	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
involved	involve	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
maximum	maximum	ADJ	JJ	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
threshold	threshold	NOUN	NN	O
was	be	VERB	VBD	O
35	35	NUM	CD	O
dB	db	NUM	CD	O
at	at	ADP	IN	O
6	6	NUM	CD	O
kHz	khz	NOUN	NN	O
measured	measure	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
continuous	continuous	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
bupivacaine	bupivacaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
hearing	hear	VERB	VBG	O
threshold	threshold	NOUN	NN	O
changes	change	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
15	15	NUM	CD	O
-	-	SYM	SYM	O
20	20	NUM	CD	O
dB	db	NUM	CD	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
6	6	NUM	CD	O
-	-	SYM	SYM	O
10	10	NUM	CD	O
kHz	khz	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
opposite	opposite	ADJ	JJ	O
side	side	NOUN	NN	O
also	also	ADV	RB	O
.	.	PUNCT	.	O

IBPB	IBPB	PROPN	NNP	O
may	may	VERB	MD	O
cause	cause	VERB	VB	O
transient	transient	ADJ	JJ	O
auditory	auditory	NOUN	NN	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
ipsilateral	ipsilateral	ADJ	JJ	O
ear	ear	NOUN	NN	O
,	,	PUNCT	,	O
possibly	possibly	ADV	RB	O
via	via	ADP	IN	O
an	an	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
sympathetic	sympathetic	ADJ	JJ	O
innervation	innervation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
safety	safety	NOUN	NN	O
and	and	CCONJ	CC	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
combination	combination	NOUN	NN	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
butyl	butyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
deoxynojirimycin	deoxynojirimycin	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
SC	SC	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
48334	48334	NUM	CD	I-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
HIV	HIV	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	I-Disease
1	1	NUM	CD	I-Disease
infection	infection	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
200	200	NUM	CD	O
-	-	SYM	SYM	O
500	500	NUM	CD	O
CD4	CD4	PROPN	NNPS	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
mm3	mm3	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conducted	conduct	VERB	VBD	O
a	a	DET	DT	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomized	ADJ	JJ	O
phase	phase	NOUN	NN	O
II	II	PROPN	NNP	O
study	study	NOUN	NN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
safety	safety	NOUN	NN	O
and	and	CCONJ	CC	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
with	with	ADP	IN	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
butyl	butyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
deoxynojirimycin	deoxynojirimycin	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
SC	SC	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
48334	48334	NUM	CD	I-Chemical
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
an	an	DET	DT	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
glucosidase	glucosidase	NOUN	NN	O
I	-PRON-	PRON	PRP	O
inhibitor	inhibitor	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
versus	versus	ADP	IN	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
200	200	NUM	CD	O
to	to	PART	TO	O
500	500	NUM	CD	O
CD4	cd4	NOUN	NN	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
mm3	mm3	NOUN	NNS	O
who	who	PRON	WP	O
tolerated	tolerate	VERB	VBD	O
<	<	X	XX	O
or	or	CCONJ	CC	O
=	=	VERB	VBZ	O
12	12	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
prior	prior	ADJ	JJ	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
received	receive	VERB	VBD	O
SC	SC	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
48334	48334	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
1000	1000	NUM	CD	O
mg	mg	NOUN	NN	O
every	every	DET	DT	O
8	8	NUM	CD	O
h	h	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
zidovudine	zidovudine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
100	100	NUM	CD	O
mg	mg	NOUN	NN	O
every	every	DET	DT	O
8	8	NUM	CD	O
h	h	NOUN	NN	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

Sixty	sixty	NUM	CD	O
patients	patient	NOUN	NNS	O
received	receive	VERB	VBD	O
combination	combination	NOUN	NN	O
therapy	therapy	NOUN	NN	O
and	and	CCONJ	CC	O
58	58	NUM	CD	O
,	,	PUNCT	,	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
38	38	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
15	15	NUM	CD	O
(	(	PUNCT	-LRB-	O
26	26	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
combination	combination	NOUN	NN	O
and	and	CCONJ	CC	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
discontinued	discontinue	VERB	VBN	O
therapy	therapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
15	15	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
SC	SC	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
48334	48334	NUM	CD	I-Chemical
steady	steady	ADJ	JJ	O
-	-	PUNCT	HYPH	O
state	state	NOUN	NN	O
trough	trough	NOUN	NN	O
level	level	NOUN	NN	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
04	04	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
99	99	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
below	below	ADP	IN	O
the	the	DET	DT	O
in	in	ADP	IN	O
vitro	vitro	X	FW	O
inhibitory	inhibitory	ADJ	JJ	O
concentration	concentration	NOUN	NN	O
for	for	ADP	IN	O
human	human	ADJ	JJ	O
immunodeficiency	immunodeficiency	NOUN	NN	B-Disease
virus	virus	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HIV	HIV	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
CD4	CD4	PROPN	NNP	O
cells	cell	NOUN	NNS	O
at	at	ADP	IN	O
week	week	NOUN	NN	O
4	4	NUM	CD	O
was	be	VERB	VBD	O
73	73	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
mm3	mm3	NOUN	NN	O
and	and	CCONJ	CC	O
52	52	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
mm3	mm3	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
combination	combination	NOUN	NN	O
and	and	CCONJ	CC	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
>	>	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
36	36	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

For	for	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
prior	prior	ADJ	JJ	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
CD4	CD4	PROPN	NNP	O
cells	cell	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
combination	combination	NOUN	NN	O
and	and	CCONJ	CC	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
groups	group	NOUN	NNS	O
was	be	VERB	VBD	O
63	63	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
mm3	mm3	NOUN	NN	O
and	and	CCONJ	CC	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
mm3	mm3	NOUN	NN	O
at	at	ADP	IN	O
week	week	NOUN	NN	O
8	8	NUM	CD	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
mm3	mm3	NOUN	NN	O
and	and	CCONJ	CC	O
-	-	PUNCT	HYPH	O
45	45	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
cells	cell	NOUN	NNS	O
/	/	SYM	SYM	O
mm3	mm3	NOUN	NN	O
at	at	ADP	IN	O
week	week	NOUN	NN	O
16	16	NUM	CD	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
suppression	suppression	NOUN	NN	O
of	of	ADP	IN	O
HIV	HIV	PROPN	NNP	O
p24	p24	NOUN	NN	O
antigenemia	antigenemia	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
combination	combination	NOUN	NN	O
and	and	CCONJ	CC	O
zidovudine	zidovudine	NOUN	NN	B-Chemical
groups	group	NOUN	NNS	O
was	be	VERB	VBD	O
six	six	NUM	CD	O
(	(	PUNCT	-LRB-	O
40	40	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
two	two	NUM	CD	O
(	(	PUNCT	-LRB-	O
11	11	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
week	week	NOUN	NN	O
4	4	NUM	CD	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
10	10	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
five	five	NUM	CD	O
(	(	PUNCT	-LRB-	O
45	45	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
two	two	NUM	CD	O
(	(	PUNCT	-LRB-	O
14	14	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
week	week	NOUN	NN	O
24	24	NUM	CD	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
08	08	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Diarrhea	diarrhea	NOUN	NN	B-Disease
,	,	PUNCT	,	O
flatulence	flatulence	NOUN	NN	B-Disease
,	,	PUNCT	,	O
abdominal	abdominal	ADJ	JJ	B-Disease
pain	pain	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
weight	weight	NOUN	NN	B-Disease
loss	loss	NOUN	NN	I-Disease
were	be	VERB	VBD	O
common	common	ADJ	JJ	O
for	for	ADP	IN	O
combination	combination	NOUN	NN	O
recipients	recipient	NOUN	NNS	O
.	.	PUNCT	.	O
(	(	PUNCT	-LRB-	O
ABSTRACT	ABSTRACT	PROPN	NNP	O
TRUNCATED	truncated	NUM	CD	O
AT	at	ADP	IN	O
250	250	NUM	CD	O
WORDS	word	NOUN	NNS	O
)	)	PUNCT	-RRB-	O

Prolonged	prolong	VERB	VBN	O
paralysis	paralysis	NOUN	NN	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
nondepolarizing	nondepolarize	VERB	VBG	B-Chemical
neuromuscular	neuromuscular	ADJ	JJ	I-Chemical
blocking	block	VERB	VBG	I-Chemical
agents	agent	NOUN	NNS	I-Chemical
and	and	CCONJ	CC	O
corticosteroids	corticosteroid	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
nondepolarizing	nondepolarize	VERB	VBG	B-Chemical
neuromuscular	neuromuscular	ADJ	JJ	I-Chemical
blocking	block	VERB	VBG	I-Chemical
agents	agent	NOUN	NNS	I-Chemical
(	(	PUNCT	-LRB-	O
ND	ND	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
NMBA	NMBA	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
has	have	VERB	VBZ	O
recently	recently	ADV	RB	O
been	be	VERB	VBN	O
implicated	implicate	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
prolonged	prolonged	ADJ	JJ	O
muscle	muscle	NOUN	NN	B-Disease
weakness	weakness	NOUN	NN	I-Disease
,	,	PUNCT	,	O
although	although	ADP	IN	O
the	the	DET	DT	O
site	site	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
lesion	lesion	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
predisposing	predispose	VERB	VBG	O
factors	factor	NOUN	NNS	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
unclear	unclear	ADJ	JJ	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
age	age	NOUN	NN	O
37	37	NUM	CD	O
-	-	SYM	SYM	O
52	52	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	O
respiratory	respiratory	ADJ	JJ	B-Disease
insufficiency	insufficiency	NOUN	NN	I-Disease
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
prolonged	prolong	VERB	VBN	O
weakness	weakness	NOUN	NN	B-Disease
following	follow	VERB	VBG	O
the	the	DET	DT	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
ND	ND	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
NMBAs	nmba	NOUN	NNS	I-Chemical
.	.	PUNCT	.	O

Two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
also	also	ADV	RB	O
received	receive	VERB	VBD	O
intravenous	intravenous	ADJ	JJ	O
corticosteroids	corticosteroid	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
was	be	VERB	VBD	O
normal	normal	ADJ	JJ	O
but	but	CCONJ	CC	O
hepatic	hepatic	ADJ	JJ	O
function	function	NOUN	NN	O
was	be	VERB	VBD	O
impaired	impair	VERB	VBN	O
in	in	ADP	IN	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
all	all	DET	DT	O
had	have	VERB	VBD	O
acidosis	acidosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Electrophysiologic	electrophysiologic	ADJ	JJ	O
studies	study	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
low	low	ADJ	JJ	O
amplitude	amplitude	NOUN	NN	O
compound	compound	NOUN	NN	O
motor	motor	NOUN	NN	O
action	action	NOUN	NN	O
potentials	potential	NOUN	NNS	O
,	,	PUNCT	,	O
normal	normal	ADJ	JJ	O
sensory	sensory	ADJ	JJ	O
studies	study	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
fibrillations	fibrillation	NOUN	NNS	O
.	.	PUNCT	.	O

Repetitive	repetitive	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
at	at	ADP	IN	O
2	2	NUM	CD	O
Hz	Hz	PROPN	NNP	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
decremental	decremental	ADJ	JJ	O
response	response	NOUN	NN	O
in	in	ADP	IN	O
2	2	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
serum	serum	ADJ	JJ	O
vecuronium	vecuronium	NOUN	NN	B-Chemical
level	level	NOUN	NN	O
measured	measure	VERB	VBN	O
in	in	ADP	IN	O
1	1	NUM	CD	O
patient	patient	ADJ	JJ	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
discontinued	discontinue	VERB	VBN	O
was	be	VERB	VBD	O
172	172	NUM	CD	O
ng	ng	ADP	IN	O
/	/	SYM	SYM	O
mL	ml	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
muscle	muscle	NOUN	NN	O
biopsy	biopsy	NOUN	NN	O
in	in	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
showed	show	VERB	VBD	O
loss	loss	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
thick	thick	ADJ	JJ	I-Disease
,	,	PUNCT	,	I-Disease
myosin	myosin	ADJ	JJ	I-Disease
filaments	filament	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
weakness	weakness	NOUN	NN	B-Disease
in	in	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
is	be	VERB	VBZ	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
pathology	pathology	NOUN	NN	B-Disease
at	at	ADP	IN	I-Disease
both	both	CCONJ	CC	I-Disease
the	the	DET	DT	I-Disease
neuromuscular	neuromuscular	ADJ	JJ	I-Disease
junction	junction	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
most	most	ADV	RBS	O
likely	likely	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
ND	ND	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
NMBA	NMBA	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
muscle	muscle	NOUN	NN	O
(	(	PUNCT	-LRB-	O
most	most	ADV	RBS	O
likely	likely	ADV	RB	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
corticosteroids	corticosteroid	NOUN	NNS	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Hepatic	hepatic	ADJ	JJ	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
acidosis	acidosis	NOUN	NN	B-Disease
are	be	VERB	VBP	O
contributing	contribute	VERB	VBG	O
risk	risk	NOUN	NN	O
factors	factor	NOUN	NNS	O
.	.	PUNCT	.	O

Failure	failure	NOUN	NN	O
of	of	ADP	IN	O
ancrod	ancrod	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
arterial	arterial	ADJ	JJ	O
thrombosis	thrombosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
morbidity	morbidity	NOUN	NN	O
and	and	CCONJ	CC	O
mortality	mortality	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombosis	thrombosis	NOUN	NN	B-Disease
remain	remain	VERB	VBP	O
high	high	ADJ	JJ	O
despite	despite	ADP	IN	O
numerous	numerous	ADJ	JJ	O
empirical	empirical	ADJ	JJ	O
therapies	therapy	NOUN	NNS	O
.	.	PUNCT	.	O

Ancrod	Ancrod	PROPN	NNP	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
used	use	VERB	VBN	O
successfully	successfully	ADV	RB	O
for	for	ADP	IN	O
prophylaxis	prophylaxis	NOUN	NN	O
against	against	ADP	IN	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
thrombosis	thrombosis	NOUN	NN	B-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
heparin	heparin	ADJ	JJ	B-Chemical
induced	induce	VERB	VBN	O
platelet	platelet	NOUN	NN	B-Disease
aggregation	aggregation	NOUN	NN	I-Disease
who	who	PRON	WP	O
require	require	VERB	VBP	O
brief	brief	ADJ	JJ	O
reexposure	reexposure	NOUN	NN	O
to	to	ADP	IN	O
heparin	heparin	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
success	success	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
have	have	VERB	VBP	O
developed	develop	VERB	VBN	O
the	the	DET	DT	O
thrombosis	thrombosis	NOUN	NN	B-Disease
syndrome	syndrome	NOUN	NN	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
well	well	ADV	RB	O
defined	define	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
authors	author	NOUN	NNS	O
present	present	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
failure	failure	NOUN	NN	O
of	of	ADP	IN	O
ancrod	ancrod	NOUN	NN	O
treatment	treatment	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
heparin	heparin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
thrombosis	thrombosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Water	water	NOUN	NN	B-Disease
intoxication	intoxication	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
oxytocin	oxytocin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
during	during	ADP	IN	O
saline	saline	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
abortion	abortion	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Four	four	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
water	water	NOUN	NN	B-Disease
intoxication	intoxication	NOUN	NN	I-Disease
in	in	ADP	IN	O
connection	connection	NOUN	NN	O
with	with	ADP	IN	O
oxytocin	oxytocin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
during	during	ADP	IN	O
saline	saline	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
abortions	abortion	NOUN	NNS	B-Disease
are	be	VERB	VBP	O
described	describe	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
water	water	NOUN	NN	B-Disease
intoxication	intoxication	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
discussed	discuss	VERB	VBN	O
in	in	ADP	IN	O
regard	regard	NOUN	NN	O
to	to	ADP	IN	O
these	these	DET	DT	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

Oxytocin	oxytocin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
during	during	ADP	IN	O
midtrimester	midtrimester	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
abortions	abortion	NOUN	NNS	B-Disease
is	be	VERB	VBZ	O
advocated	advocate	VERB	VBN	O
only	only	ADV	RB	O
if	if	ADP	IN	O
it	-PRON-	PRON	PRP	O
can	can	VERB	MD	O
be	be	VERB	VB	O
carried	carry	VERB	VBN	O
out	out	PART	RP	O
under	under	ADP	IN	O
careful	careful	ADJ	JJ	O
observations	observation	NOUN	NNS	O
of	of	ADP	IN	O
an	an	DET	DT	O
alert	alert	ADJ	JJ	O
nursing	nursing	NOUN	NN	O
staff	staff	NOUN	NN	O
,	,	PUNCT	,	O
aware	aware	ADJ	JJ	O
of	of	ADP	IN	O
the	the	DET	DT	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
water	water	NOUN	NN	B-Disease
intoxication	intoxication	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
instructed	instruct	VERB	VBN	O
to	to	PART	TO	O
watch	watch	VERB	VB	O
the	the	DET	DT	O
diuresis	diuresis	NOUN	NN	O
and	and	CCONJ	CC	O
report	report	VERB	VB	O
such	such	ADJ	JJ	O
early	early	ADJ	JJ	O
signs	sign	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
syndrome	syndrome	NOUN	NN	O
as	as	ADP	IN	O
asthenia	asthenia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
muscular	muscular	ADJ	JJ	O
irritability	irritability	NOUN	NN	B-Disease
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
headaches	headache	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
oxytocin	oxytocin	NOUN	NN	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
given	give	VERB	VBN	O
only	only	ADV	RB	O
in	in	ADP	IN	O
Ringers	ringer	NOUN	NNS	O
lactate	lactate	VERB	VBP	B-Chemical
or	or	CCONJ	CC	O
,	,	PUNCT	,	O
alternately	alternately	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
Ringers	ringer	NOUN	NNS	O
lactate	lactate	VERB	VBP	B-Chemical
and	and	CCONJ	CC	O
a	a	DET	DT	O
5	5	NUM	CD	O
per	per	ADP	IN	O
cent	cent	NOUN	NN	O
dextrose	dextrose	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
water	water	NOUN	NN	O
solutions	solution	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
urinary	urinary	ADJ	JJ	O
output	output	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
monitored	monitor	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
oxytocin	oxytocin	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
discontinued	discontinue	VERB	VBD	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
serum	serum	ADJ	JJ	O
electrolytes	electrolyte	NOUN	NNS	O
checked	check	VERB	VBD	O
if	if	ADP	IN	O
the	the	DET	DT	O
urinary	urinary	ADJ	JJ	O
output	output	NOUN	NN	O
decreases	decrease	VERB	VBZ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
oxytocin	oxytocin	NOUN	NN	B-Chemical
should	should	VERB	MD	O
not	not	ADV	RB	O
be	be	VERB	VB	O
administered	administer	VERB	VBN	O
in	in	ADP	IN	O
excess	excess	NOUN	NN	O
of	of	ADP	IN	O
36	36	NUM	CD	O
hours	hour	NOUN	NNS	O
.	.	PUNCT	.	O

If	if	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
has	have	VERB	VBZ	O
not	not	ADV	RB	O
aborted	abort	VERB	VBN	O
by	by	ADP	IN	O
then	then	ADV	RB	O
the	the	DET	DT	O
oxytocin	oxytocin	NOUN	NN	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
discontinued	discontinue	VERB	VBN	O
for	for	ADP	IN	O
10	10	NUM	CD	O
to	to	PART	TO	O
12	12	NUM	CD	O
hours	hour	NOUN	NNS	O
in	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
perform	perform	VERB	VB	O
electrolyte	electrolyte	NOUN	NN	O
determinations	determination	NOUN	NNS	O
and	and	CCONJ	CC	O
correct	correct	VERB	VB	O
any	any	DET	DT	O
electrolyte	electrolyte	NOUN	NN	O
imbalance	imbalance	NOUN	NN	O
.	.	PUNCT	.	O

Light	light	ADJ	JJ	O
chain	chain	NOUN	NN	O
proteinuria	proteinuria	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
cellular	cellular	ADJ	JJ	O
mediated	mediate	VERB	VBN	O
immunity	immunity	NOUN	NN	O
in	in	ADP	IN	O
rifampin	rifampin	NOUN	NN	B-Chemical
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
tuberculosis	tuberculosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Light	light	ADJ	JJ	O
chain	chain	NOUN	NN	O
proteinuria	proteinuria	NOUN	NN	B-Disease
was	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
9	9	NUM	CD	O
of	of	ADP	IN	O
17	17	NUM	CD	O
tuberculosis	tuberculosis	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
rifampin	rifampin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Concomitant	concomitant	ADJ	JJ	O
assay	assay	NOUN	NN	O
of	of	ADP	IN	O
cellular	cellular	ADJ	JJ	O
mediated	mediate	VERB	VBN	O
immunity	immunity	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
using	use	VERB	VBG	O
skin	skin	NOUN	NN	O
test	test	NOUN	NN	O
antigen	antigen	NOUN	NN	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
lymphokine	lymphokine	NOUN	NN	O
in	in	ADP	IN	O
vitro	vitro	X	FW	O
test	test	NOUN	NN	O
provided	provide	VERB	VBD	O
results	result	NOUN	NNS	O
that	that	DET	WDT	O
were	be	VERB	VBD	O
different	different	ADJ	JJ	O
.	.	PUNCT	.	O

Response	response	NOUN	NN	O
to	to	ADP	IN	O
Varidase	Varidase	PROPN	NNP	O
skin	skin	NOUN	NN	O
test	test	NOUN	NN	O
antigen	antigen	NOUN	NN	O
was	be	VERB	VBD	O
negative	negative	ADJ	JJ	O
for	for	ADP	IN	O
all	all	DET	DT	O
eight	eight	NUM	CD	O
tuberculosis	tuberculosis	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
tested	test	VERB	VBN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
there	there	ADV	EX	O
occurred	occur	VERB	VBD	O
a	a	DET	DT	O
hyper	hyper	NOUN	NN	O
-	-	PUNCT	HYPH	O
responsiveness	responsiveness	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
lymphocytes	lymphocyte	NOUN	NNS	O
of	of	ADP	IN	O
these	these	DET	DT	O
eight	eight	NUM	CD	O
patients	patient	NOUN	NNS	O
to	to	PART	TO	O
phytomitogen	phytomitogen	VERB	VB	O
(	(	PUNCT	-LRB-	O
PHA	PHA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
P	P	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
of	of	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
seven	seven	NUM	CD	O
other	other	ADJ	JJ	O
tuberculous	tuberculous	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
last	last	ADJ	JJ	O
finding	finding	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
testing	testing	NOUN	NN	O
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
endogenous	endogenous	ADJ	JJ	O
serum	serum	NOUN	NN	O
binding	bind	VERB	VBG	O
of	of	ADP	IN	O
rifampin	rifampin	NOUN	NN	B-Chemical
which	which	DET	WDT	O
could	could	VERB	MD	O
have	have	VERB	VB	O
inhibited	inhibit	VERB	VBN	O
mitogen	mitogen	NOUN	NN	O
activity	activity	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
lymphocyte	lymphocyte	NOUN	NN	O
.	.	PUNCT	.	O

KF17837	kf17837	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
a	a	DET	DT	O
novel	novel	ADJ	JJ	O
selective	selective	ADJ	JJ	O
adenosine	adenosine	NOUN	NN	B-Chemical
A2A	A2A	PROPN	NNP	O
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
with	with	ADP	IN	O
anticataleptic	anticataleptic	ADJ	JJ	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

KF17837	KF17837	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
novel	novel	ADJ	JJ	O
selective	selective	ADJ	JJ	O
adenosine	adenosine	NOUN	NN	B-Chemical
A2A	A2A	PROPN	NNP	O
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
.	.	PUNCT	.	O

Oral	oral	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
KF17837	KF17837	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
10	10	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
and	and	CCONJ	CC	O
30	30	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
significantly	significantly	ADV	RB	O
ameliorated	ameliorate	VERB	VBD	O
the	the	DET	DT	O
cataleptic	cataleptic	ADJ	JJ	B-Disease
responses	response	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
intracerebroventricular	intracerebroventricular	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
adenosine	adenosine	NOUN	NN	B-Chemical
A2A	A2A	PROPN	NNP	O
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
,	,	PUNCT	,	O
CGS	CGS	PROPN	NNP	B-Chemical
21680	21680	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
micrograms	microgram	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
manner	manner	NOUN	NN	O
.	.	PUNCT	.	O

KF17837	KF17837	PROPN	NNP	B-Chemical
also	also	ADV	RB	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
catalepsy	catalepsy	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
by	by	ADP	IN	O
reserpine	reserpine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
anticataleptic	anticataleptic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
were	be	VERB	VBD	O
exhibited	exhibit	VERB	VBN	O
dose	dose	NOUN	NN	O
dependently	dependently	ADV	RB	O
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
from	from	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
625	625	NUM	CD	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
p	p	NOUN	NN	O
.	.	PUNCT	.	O
o	o	X	XX	O
.	.	PUNCT	.	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
KF17837	KF17837	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
625	625	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
p	p	NOUN	NN	O
.	.	PUNCT	.	O
o	o	X	XX	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
potentiated	potentiate	VERB	VBD	O
the	the	DET	DT	O
anticataleptic	anticataleptic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
a	a	DET	DT	O
subthreshold	subthreshold	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
3	3	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dihydroxyphenylalanine	dihydroxyphenylalanine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
DOPA	DOPA	PROPN	NNP	I-Chemical
;	;	PUNCT	:	O
25	25	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
plus	plus	CCONJ	CC	O
benserazide	benserazide	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
25	25	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
suggested	suggest	VERB	VBD	O
that	that	ADP	IN	O
KF17837	KF17837	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
centrally	centrally	ADV	RB	O
active	active	ADJ	JJ	O
adenosine	adenosine	NOUN	NN	B-Chemical
A2A	A2A	PROPN	NNP	O
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
and	and	CCONJ	CC	O
that	that	ADP	IN	O
the	the	DET	DT	O
dopaminergic	dopaminergic	ADJ	JJ	O
function	function	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
nigrostriatal	nigrostriatal	ADJ	JJ	O
pathway	pathway	NOUN	NN	O
is	be	VERB	VBZ	O
potentiated	potentiate	VERB	VBN	O
by	by	ADP	IN	O
adenosine	adenosine	NOUN	NN	B-Chemical
A2A	A2A	PROPN	NNP	O
receptor	receptor	NOUN	NN	O
antagonists	antagonist	NOUN	NNS	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
KF17837	KF17837	PROPN	NNP	B-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
useful	useful	ADJ	JJ	O
drug	drug	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
parkinsonism	parkinsonism	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
nondopaminergic	nondopaminergic	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
on	on	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
in	in	ADP	IN	O
MPTP	MPTP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
monkeys	monkey	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
four	four	NUM	CD	O
monkeys	monkey	NOUN	NNS	O
was	be	VERB	VBD	O
rendered	render	VERB	VBN	O
parkinsonian	parkinsonian	ADV	RB	B-Disease
with	with	ADP	IN	O
the	the	DET	DT	O
toxin	toxin	NOUN	NN	O
MPTP	MPTP	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

They	-PRON-	PRON	PRP	O
were	be	VERB	VBD	O
then	then	ADV	RB	O
treated	treat	VERB	VBN	O
chronically	chronically	ADV	RB	O
with	with	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
DOPA	DOPA	PROPN	NNP	I-Chemical
/	/	SYM	SYM	I-Chemical
benserazide	benserazide	VERB	VB	I-Chemical
50	50	NUM	CD	O
/	/	SYM	SYM	O
12	12	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
given	give	VERB	VBN	O
orally	orally	ADV	RB	O
daily	daily	ADV	RB	O
for	for	ADP	IN	O
2	2	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
dose	dose	NOUN	NN	O
produced	produce	VERB	VBD	O
a	a	DET	DT	O
striking	striking	ADJ	JJ	O
antiparkinsonian	antiparkinsonian	ADJ	JJ	O
effect	effect	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
all	all	DET	DT	O
animals	animal	NOUN	NNS	O
manifested	manifest	VERB	VBD	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
series	series	NOUN	NN	O
of	of	ADP	IN	O
agents	agent	NOUN	NNS	O
acting	act	VERB	VBG	O
primarily	primarily	ADV	RB	O
on	on	ADP	IN	O
neurotransmitters	neurotransmitter	NOUN	NNS	O
other	other	ADJ	JJ	O
than	than	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
then	then	ADV	RB	O
tested	test	VERB	VBN	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
DOPA	DOPA	PROPN	NNP	I-Chemical
to	to	PART	TO	O
see	see	VERB	VB	O
if	if	ADP	IN	O
the	the	DET	DT	O
dyskinetic	dyskinetic	ADJ	JJ	B-Disease
movements	movement	NOUN	NNS	O
would	would	VERB	MD	O
be	be	VERB	VB	O
modified	modify	VERB	VBN	O
.	.	PUNCT	.	O

Several	several	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
clonidine	clonidine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
physostigmine	physostigmine	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
methysergide	methysergide	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
5	5	NUM	CD	B-Chemical
-	-	SYM	SYM	I-Chemical
MDOT	mdot	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
propranolol	propranolol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
MK	MK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
801	801	PROPN	NNP	I-Chemical
,	,	PUNCT	,	O
markedly	markedly	ADV	RB	O
reduced	reduce	VERB	VBD	O
the	the	DET	DT	O
dyskinetic	dyskinetic	ADJ	JJ	B-Disease
movements	movement	NOUN	NNS	O
but	but	CCONJ	CC	O
at	at	ADP	IN	O
the	the	DET	DT	O
cost	cost	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
return	return	NOUN	NN	O
of	of	ADP	IN	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
symptomatology	symptomatology	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
yohimbine	yohimbine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
meperidine	meperidine	NOUN	NN	B-Chemical
reduced	reduce	VERB	VBD	O
predominantly	predominantly	ADV	RB	O
the	the	DET	DT	O
dyskinetic	dyskinetic	ADJ	JJ	B-Disease
movements	movement	NOUN	NNS	O
.	.	PUNCT	.	O

Baclofen	Baclofen	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
also	also	ADV	RB	O
useful	useful	ADJ	JJ	O
in	in	ADP	IN	O
one	one	NUM	CD	O
monkey	monkey	NOUN	NN	O
against	against	ADP	IN	O
a	a	DET	DT	O
more	more	ADV	RBR	O
dystonic	dystonic	ADJ	JJ	B-Disease
form	form	NOUN	NN	O
of	of	ADP	IN	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Atropine	Atropine	PROPN	NNP	B-Chemical
converted	convert	VERB	VBD	O
the	the	DET	DT	O
dystonic	dystonic	ADJ	JJ	B-Disease
movements	movement	NOUN	NNS	O
into	into	ADP	IN	O
chorea	chorea	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Hallucinations	hallucination	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Hallucinations	hallucination	NOUN	NNS	B-Disease
as	as	ADP	IN	O
a	a	DET	DT	O
symptom	symptom	NOUN	NN	O
of	of	ADP	IN	O
central	central	ADJ	JJ	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
are	be	VERB	VBP	O
a	a	DET	DT	O
known	know	VERB	VBN	O
but	but	CCONJ	CC	O
poorly	poorly	ADV	RB	O
described	describe	VERB	VBN	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Most	Most	ADJ	JJS	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hallucinations	hallucination	NOUN	NNS	B-Disease
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
mental	mental	ADJ	JJ	O
status	status	NOUN	NN	O
changes	change	NOUN	NNS	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
authors	author	NOUN	NNS	O
interviewed	interview	VERB	VBD	O
six	six	NUM	CD	O
persons	person	NOUN	NNS	O
with	with	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hallucinations	hallucination	NOUN	NNS	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
clear	clear	ADJ	JJ	O
sensorium	sensorium	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
receiving	receive	VERB	VBG	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
as	as	ADP	IN	O
part	part	NOUN	NN	O
of	of	ADP	IN	O
their	-PRON-	DET	PRP$	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplant	transplant	NOUN	NN	O
procedure	procedure	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Hallucinations	hallucination	NOUN	NNS	B-Disease
occurred	occur	VERB	VBD	O
only	only	ADV	RB	O
when	when	ADV	WRB	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	PART	POS	O
eyes	eye	NOUN	NNS	O
were	be	VERB	VBD	O
closed	closed	ADJ	JJ	O
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
all	all	DET	DT	O
but	but	ADP	IN	O
one	one	NUM	CD	O
case	case	NOUN	NN	O
,	,	PUNCT	,	O
were	be	VERB	VBD	O
reported	report	VERB	VBN	O
as	as	ADP	IN	O
disturbing	disturbing	ADJ	JJ	O
or	or	CCONJ	CC	O
frightening	frightening	ADJ	JJ	O
.	.	PUNCT	.	O

Underreporting	underreporte	VERB	VBG	O
of	of	ADP	IN	O
these	these	DET	DT	O
hallucinations	hallucination	NOUN	NNS	B-Disease
by	by	ADP	IN	O
patients	patient	NOUN	NNS	O
is	be	VERB	VBZ	O
likely	likely	ADJ	JJ	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Hallucinations	hallucination	NOUN	NNS	B-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
the	the	DET	DT	O
sole	sole	ADJ	JJ	O
or	or	CCONJ	CC	O
first	first	ADJ	JJ	O
manifestation	manifestation	NOUN	NN	O
of	of	ADP	IN	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
dose	dose	NOUN	NN	O
and	and	CCONJ	CC	O
infusion	infusion	NOUN	NN	O
-	-	PUNCT	HYPH	O
time	time	NOUN	NN	O
related	relate	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
clinician	clinician	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
alerted	alert	VERB	VBN	O
for	for	ADP	IN	O
possible	possible	ADJ	JJ	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hallucinations	hallucination	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
may	may	VERB	MD	O
occur	occur	VERB	VB	O
without	without	ADP	IN	O
other	other	ADJ	JJ	O
signs	sign	NOUN	NNS	O
of	of	ADP	IN	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

"	"	PUNCT	``	O
Eyes	eye	NOUN	NNS	O
-	-	PUNCT	HYPH	O
closed	close	VERB	VBN	O
"	"	PUNCT	``	O
hallucinatory	hallucinatory	ADJ	JJ	B-Disease
experiences	experience	NOUN	NNS	O
appear	appear	VERB	VBP	O
to	to	PART	TO	O
be	be	VERB	VB	O
an	an	DET	DT	O
unusual	unusual	ADJ	JJ	O
feature	feature	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
presentation	presentation	NOUN	NN	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
anxious	anxious	ADJ	JJ	O
about	about	ADP	IN	O
this	this	DET	DT	O
experience	experience	NOUN	NN	O
respond	respond	NOUN	NN	O
well	well	ADV	RB	O
to	to	PART	TO	O
support	support	VERB	VB	O
and	and	CCONJ	CC	O
education	education	NOUN	NN	O
about	about	ADP	IN	O
this	this	DET	DT	O
occurrence	occurrence	NOUN	NN	O
.	.	PUNCT	.	O

Optimal	optimal	ADJ	JJ	O
pharmacologic	pharmacologic	NOUN	NN	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
disturbed	disturb	VERB	VBN	O
patients	patient	NOUN	NNS	O
is	be	VERB	VBZ	O
unclear	unclear	ADJ	JJ	O
.	.	PUNCT	.	O

If	if	ADP	IN	O
agitation	agitation	NOUN	NN	B-Disease
becomes	become	VERB	VBZ	O
marked	mark	VERB	VBN	O
,	,	PUNCT	,	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
potency	potency	NOUN	NN	O
neuroleptics	neuroleptic	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
e	e	PUNCT	LS	O
.	.	PUNCT	.	O
,	,	PUNCT	,	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
may	may	VERB	MD	O
be	be	VERB	VB	O
effective	effective	ADJ	JJ	O
.	.	PUNCT	.	O

Photodistributed	photodistribute	VERB	VBN	O
nifedipine	nifedipine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
facial	facial	ADJ	JJ	O
telangiectasia	telangiectasia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Five	five	NUM	CD	O
months	month	NOUN	NNS	O
after	after	ADP	IN	O
starting	start	VERB	VBG	O
nifedipine	nifedipine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Adalat	Adalat	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
photodistributed	photodistribute	VERB	VBN	O
facial	facial	ADJ	JJ	O
telangiectasia	telangiectasia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
which	which	DET	WDT	O
became	become	VERB	VBD	O
more	more	ADV	RBR	O
noticeable	noticeable	ADJ	JJ	O
with	with	ADP	IN	O
time	time	NOUN	NN	O
.	.	PUNCT	.	O

Neither	neither	DET	DT	O
patient	patient	NOUN	NN	O
complained	complain	VERB	VBD	O
of	of	ADP	IN	O
photosensitivity	photosensitivity	NOUN	NN	O
or	or	CCONJ	CC	O
flushing	flushing	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Both	both	DET	DT	O
patients	patient	NOUN	NNS	O
reported	report	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
cosmetic	cosmetic	ADJ	JJ	O
improvement	improvement	NOUN	NN	O
after	after	ADP	IN	O
discontinuing	discontinue	VERB	VBG	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
commenced	commence	VERB	VBD	O
the	the	DET	DT	O
closely	closely	ADV	RB	O
related	related	ADJ	JJ	O
drug	drug	NOUN	NN	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
3	3	NUM	CD	O
years	year	NOUN	NNS	O
later	later	ADV	RB	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
recurrence	recurrence	NOUN	NN	O
of	of	ADP	IN	O
telangiectasia	telangiectasia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
photodistribution	photodistribution	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
telangiectasia	telangiectasia	NOUN	NN	B-Disease
suggests	suggest	VERB	VBZ	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
drug	drug	NOUN	NN	O
/	/	SYM	SYM	O
light	light	ADJ	JJ	O
interaction	interaction	NOUN	NN	O
.	.	PUNCT	.	O

Penicillamine	penicillamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
rapidly	rapidly	ADV	RB	O
progressive	progressive	ADJ	JJ	O
glomerulonephritis	glomerulonephritis	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

A	a	DET	DT	O
67	67	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
with	with	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
presented	present	VERB	VBD	O
rapidly	rapidly	ADV	RB	O
progressive	progressive	ADJ	JJ	O
glomerulonephritis	glomerulonephritis	ADJ	JJ	B-Disease
(	(	PUNCT	-LRB-	O
RPGN	RPGN	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
after	after	ADP	IN	O
5	5	NUM	CD	O
months	month	NOUN	NNS	O
of	of	ADP	IN	O
D	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
250	250	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Light	light	ADJ	JJ	O
microscopy	microscopy	NOUN	NN	O
study	study	NOUN	NN	O
showed	show	VERB	VBD	O
severe	severe	ADJ	JJ	O
glomerulonephritis	glomerulonephritis	ADJ	JJ	B-Disease
with	with	ADP	IN	O
crescent	crescent	ADJ	JJ	O
formation	formation	NOUN	NN	O
in	in	ADP	IN	O
60	60	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
glomeruli	glomeruli	NOUN	NN	O
and	and	CCONJ	CC	O
infiltration	infiltration	NOUN	NN	O
of	of	ADP	IN	O
inflammatory	inflammatory	ADJ	JJ	O
cells	cell	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
wall	wall	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
arteriole	arteriole	NOUN	NN	O
.	.	PUNCT	.	O

Immunofluorescence	immunofluorescence	NOUN	NN	O
revealed	reveal	VERB	VBD	O
scanty	scanty	NUM	CD	O
granular	granular	NOUN	NN	O
IgG	igg	NOUN	NN	O
,	,	PUNCT	,	O
IgA	IgA	PROPN	NNP	O
and	and	CCONJ	CC	O
C3	C3	PROPN	NNP	O
deposits	deposit	NOUN	NNS	O
along	along	ADP	IN	O
the	the	DET	DT	O
capillary	capillary	ADJ	JJ	O
walls	wall	NOUN	NNS	O
and	and	CCONJ	CC	O
mesangium	mesangium	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
steroid	steroid	NOUN	NN	B-Chemical
pulse	pulse	NOUN	NN	O
,	,	PUNCT	,	O
plasmapheresis	plasmapheresis	NOUN	NN	O
,	,	PUNCT	,	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
antiplatelet	antiplatelet	NOUN	NN	B-Chemical
agents	agent	NOUN	NNS	I-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
complete	complete	ADJ	JJ	O
recovery	recovery	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
was	be	VERB	VBD	O
achieved	achieve	VERB	VBN	O
in	in	ADP	IN	O
a	a	DET	DT	O
few	few	ADJ	JJ	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
new	new	ADJ	JJ	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
RPGN	RPGN	PROPN	NNP	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
D	d	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
treatment	treatment	NOUN	NN	O
emphasizes	emphasize	VERB	VBZ	O
the	the	DET	DT	O
need	need	NOUN	NN	O
for	for	ADP	IN	O
frequent	frequent	ADJ	JJ	O
monitoring	monitoring	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
urinary	urinary	ADJ	JJ	O
sediment	sediment	NOUN	NN	O
and	and	CCONJ	CC	O
proteinuria	proteinuria	VERB	VB	B-Disease
in	in	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
prompt	prompt	ADJ	JJ	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
D	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
vigorous	vigorous	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
measures	measure	NOUN	NNS	O
could	could	VERB	MD	O
allow	allow	VERB	VB	O
for	for	ADP	IN	O
a	a	DET	DT	O
good	good	ADJ	JJ	O
prognosis	prognosis	NOUN	NN	O
as	as	ADP	IN	O
in	in	ADP	IN	O
this	this	DET	DT	O
case	case	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
polymyositis	polymyositis	NOUN	NN	B-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
primary	primary	ADJ	JJ	B-Disease
biliary	biliary	ADJ	JJ	I-Disease
cirrhosis	cirrhosis	NOUN	NN	I-Disease
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
D	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Although	although	ADP	IN	O
D	d	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
many	many	ADJ	JJ	O
rheumatologic	rheumatologic	NOUN	NN	B-Disease
diseases	disease	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
toxicity	toxicity	NOUN	NN	B-Disease
limits	limit	VERB	VBZ	O
its	-PRON-	DET	PRP$	O
usefulness	usefulness	NOUN	NN	O
in	in	ADP	IN	O
many	many	ADJ	JJ	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Polymyositis	Polymyositis	PROPN	NNP	B-Disease
/	/	SYM	SYM	O
dermatomyositis	dermatomyositis	NOUN	NN	B-Disease
can	can	VERB	MD	O
develop	develop	VERB	VB	O
as	as	ADP	IN	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
autoimmune	autoimmune	ADJ	JJ	O
complications	complication	NOUN	NNS	O
of	of	ADP	IN	O
D	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
exact	exact	ADJ	JJ	O
pathogenesis	pathogenesis	NOUN	NN	O
remains	remain	VERB	VBZ	O
unclear	unclear	ADJ	JJ	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
primary	primary	ADJ	JJ	B-Disease
biliary	biliary	ADJ	JJ	I-Disease
cirrhosis	cirrhosis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
polymyositis	polymyositis	NOUN	NN	B-Disease
while	while	ADP	IN	O
receiving	receive	VERB	VBG	O
D	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
described	describe	VERB	VBD	O
the	the	DET	DT	O
special	special	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
course	course	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
receiving	receive	VERB	VBG	O
D	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
therapy	therapy	NOUN	NN	O
should	should	VERB	MD	O
be	be	VERB	VB	O
followed	follow	VERB	VBN	O
carefully	carefully	ADV	RB	O
for	for	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
autoimmune	autoimmune	ADJ	JJ	O
complications	complication	NOUN	NNS	O
like	like	ADP	IN	O
polymyositis	polymyositis	NOUN	NN	B-Disease
/	/	SYM	SYM	O
dermatomyositis	dermatomyositis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Hyperalgesia	hyperalgesia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
myoclonus	myoclonus	NOUN	NN	B-Disease
in	in	ADP	IN	O
terminal	terminal	ADJ	JJ	O
cancer	cancer	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
continuous	continuous	ADJ	JJ	O
intravenous	intravenous	ADJ	JJ	O
morphine	morphine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Eight	eight	NUM	CD	O
cancer	cancer	NOUN	NN	B-Disease
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
terminal	terminal	ADJ	JJ	O
stages	stage	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
disease	disease	NOUN	NN	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
morphine	morphine	NOUN	NN	B-Chemical
developed	develop	VERB	VBD	O
hyperalgesia	hyperalgesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

All	all	DET	DT	O
cases	case	NOUN	NNS	O
were	be	VERB	VBD	O
retrospectively	retrospectively	ADV	RB	O
sampled	sample	VERB	VBN	O
from	from	ADP	IN	O
three	three	NUM	CD	O
different	different	ADJ	JJ	O
hospitals	hospital	NOUN	NNS	O
in	in	ADP	IN	O
Copenhagen	Copenhagen	PROPN	NNP	O
.	.	PUNCT	.	O

Five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
universal	universal	ADJ	JJ	O
hyperalgesia	hyperalgesia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
hyperesthesia	hyperesthesia	NOUN	NN	B-Disease
which	which	DET	WDT	O
in	in	ADP	IN	O
2	2	NUM	CD	O
cases	case	NOUN	NNS	O
were	be	VERB	VBD	O
accompanied	accompany	VERB	VBN	O
by	by	ADP	IN	O
myoclonus	myoclonus	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
a	a	DET	DT	O
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
existing	exist	VERB	VBG	O
neuralgia	neuralgia	NOUN	NN	B-Disease
increased	increase	VERB	VBD	O
to	to	ADP	IN	O
excruciating	excruciate	VERB	VBG	O
intensity	intensity	NOUN	NN	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
2	2	NUM	CD	O
of	of	ADP	IN	O
these	these	DET	DT	O
cases	case	NOUN	NNS	O
myoclonus	myoclonus	NOUN	NN	B-Disease
occurred	occur	VERB	VBD	O
simultaneously	simultaneously	ADV	RB	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
only	only	ADJ	JJ	O
few	few	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
descriptions	description	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
hyperalgesia	hyperalgesia	NOUN	NN	B-Disease
/	/	SYM	SYM	O
myoclonus	myoclonus	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
are	be	VERB	VBP	O
available	available	ADJ	JJ	O
,	,	PUNCT	,	O
experimental	experimental	ADJ	JJ	O
support	support	NOUN	NN	O
from	from	ADP	IN	O
animal	animal	NOUN	NN	O
studies	study	NOUN	NNS	O
indicates	indicate	VERB	VBZ	O
that	that	DET	DT	O
morphine	morphine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
metabolites	metabolite	NOUN	NNS	O
,	,	PUNCT	,	O
plays	play	VERB	VBZ	O
a	a	DET	DT	O
causative	causative	ADJ	JJ	O
role	role	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
observed	observed	ADJ	JJ	O
behavioural	behavioural	ADJ	JJ	O
syndrome	syndrome	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
possible	possible	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
are	be	VERB	VBP	O
discussed	discuss	VERB	VBN	O
and	and	CCONJ	CC	O
treatment	treatment	NOUN	NN	O
proposals	proposal	NOUN	NNS	O
given	give	VERB	VBN	O
suggesting	suggest	VERB	VBG	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
more	more	ADV	RBR	O
efficacious	efficacious	ADJ	JJ	O
opioids	opioid	NOUN	NNS	O
with	with	ADP	IN	O
less	less	ADJ	JJR	O
excitatory	excitatory	ADJ	JJ	O
potency	potency	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
situations	situation	NOUN	NNS	O
.	.	PUNCT	.	O

Liposomal	Liposomal	PROPN	NNP	O
daunorubicin	daunorubicin	VERB	VBP	B-Chemical
in	in	ADP	IN	O
advanced	advanced	ADJ	JJ	O
Kaposi	Kaposi	PROPN	NNPS	B-Disease
'	'	PART	POS	I-Disease
s	s	NOUN	NN	I-Disease
sarcoma	sarcoma	NOUN	NN	I-Disease
:	:	PUNCT	:	O
a	a	DET	DT	O
phase	phase	NOUN	NN	O
II	II	PROPN	NNP	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
randomized	randomized	ADJ	JJ	O
Phase	Phase	PROPN	NNP	O
II	II	PROPN	NNP	O
clinical	clinical	ADJ	JJ	O
trial	trial	NOUN	NN	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
of	of	ADP	IN	O
liposomal	liposomal	ADJ	JJ	O
daunorubicin	daunorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DaunoXome	DaunoXome	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
AIDS	AIDS	PROPN	NNP	B-Disease
related	relate	VERB	VBD	O
Kaposi	Kaposi	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	NOUN	NN	I-Disease
sarcoma	sarcoma	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Eleven	eleven	NUM	CD	O
homosexual	homosexual	ADJ	JJ	O
men	man	NOUN	NNS	O
with	with	ADP	IN	O
advanced	advanced	ADJ	JJ	O
Kaposi	Kaposi	PROPN	NNPS	B-Disease
'	'	PART	POS	I-Disease
s	s	NOUN	NN	I-Disease
sarcoma	sarcoma	NOUN	NN	I-Disease
were	be	VERB	VBD	O
entered	enter	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
trial	trial	NOUN	NN	O
.	.	PUNCT	.	O

Changes	change	NOUN	NNS	O
in	in	ADP	IN	O
size	size	NOUN	NN	O
,	,	PUNCT	,	O
colour	colour	NOUN	NN	O
and	and	CCONJ	CC	O
associated	associate	VERB	VBN	O
oedema	oedema	NOUN	NN	B-Disease
of	of	ADP	IN	O
selected	select	VERB	VBN	O
'	'	PART	POS	O
target	target	NOUN	NN	O
'	'	PUNCT	''	O
lesions	lesion	NOUN	NNS	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
,	,	PUNCT	,	O
biochemical	biochemical	NOUN	NN	O
and	and	CCONJ	CC	O
haematological	haematological	ADJ	JJ	O
toxicities	toxicity	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
.	.	PUNCT	.	O

Ten	ten	NUM	CD	O
subjects	subject	NOUN	NNS	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
partial	partial	ADJ	JJ	O
response	response	NOUN	NN	O
was	be	VERB	VBD	O
achieved	achieve	VERB	VBN	O
in	in	ADP	IN	O
four	four	NUM	CD	O
,	,	PUNCT	,	O
of	of	ADP	IN	O
whom	whom	PRON	WP	O
two	two	NUM	CD	O
subsequently	subsequently	ADV	RB	O
relapsed	relapse	VERB	VBN	O
.	.	PUNCT	.	O

Stabilization	stabilization	NOUN	NN	O
of	of	ADP	IN	O
Kaposi	Kaposi	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	NOUN	NN	I-Disease
sarcoma	sarcoma	NOUN	NN	I-Disease
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
the	the	DET	DT	O
remaining	remain	VERB	VBG	O
six	six	NUM	CD	O
,	,	PUNCT	,	O
maintained	maintain	VERB	VBN	O
until	until	ADP	IN	O
the	the	DET	DT	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
trial	trial	NOUN	NN	O
period	period	NOUN	NN	O
in	in	ADP	IN	O
four	four	NUM	CD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
drug	drug	NOUN	NN	O
was	be	VERB	VBD	O
generally	generally	ADV	RB	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
few	few	ADJ	JJ	O
mild	mild	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
main	main	ADJ	JJ	O
problem	problem	NOUN	NN	O
encountered	encounter	VERB	VBD	O
was	be	VERB	VBD	O
haematological	haematological	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
with	with	ADP	IN	O
three	three	NUM	CD	O
subjects	subject	NOUN	NNS	O
experiencing	experience	VERB	VBG	O
severe	severe	ADJ	JJ	O
neutropenia	neutropenia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
neutrophil	neutrophil	NOUN	NN	O
count	count	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
/	/	SYM	SYM	O
l	l	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
small	small	ADJ	JJ	O
patient	patient	ADJ	JJ	O
sample	sample	NOUN	NN	O
,	,	PUNCT	,	O
liposomal	liposomal	ADJ	JJ	O
daunorubicin	daunorubicin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
and	and	CCONJ	CC	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
agent	agent	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
Kaposi	Kaposi	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	NOUN	NN	I-Disease
sarcoma	sarcoma	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
vincristine	vincristine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
the	the	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
.	.	PUNCT	.	O

Forty	forty	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
Non	Non	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	I-Disease
Hodgkin	Hodgkin	PROPN	NNP	I-Disease
'	'	PUNCT	''	I-Disease
s	s	VERB	VBZ	I-Disease
Lymphoma	Lymphoma	PROPN	NNP	I-Disease
treated	treat	VERB	VBD	O
with	with	ADP	IN	O
vincristine	vincristine	NOUN	NN	B-Chemical
between	between	ADP	IN	O
1984	1984	NUM	CD	O
and	and	CCONJ	CC	O
1990	1990	NUM	CD	O
(	(	PUNCT	-LRB-	O
cumulative	cumulative	ADJ	JJ	O
dose	dose	NOUN	NN	O
12	12	NUM	CD	O
mg	mg	NOUN	NN	O
in	in	ADP	IN	O
18	18	NUM	CD	O
-	-	SYM	SYM	O
24	24	NUM	CD	O
weeks	week	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
investigated	investigate	VERB	VBN	O
in	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
term	term	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
vincristine	vincristine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
the	the	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
interviewed	interview	VERB	VBN	O
with	with	ADP	IN	O
emphasis	emphasis	NOUN	NN	O
on	on	ADP	IN	O
neuropathic	neuropathic	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Physical	physical	ADJ	JJ	O
and	and	CCONJ	CC	O
quantitative	quantitative	ADJ	JJ	O
sensory	sensory	ADJ	JJ	O
examination	examination	NOUN	NN	O
with	with	ADP	IN	O
determination	determination	NOUN	NN	O
of	of	ADP	IN	O
vibratory	vibratory	NOUN	NN	O
perception	perception	NOUN	NN	O
and	and	CCONJ	CC	O
thermal	thermal	ADJ	JJ	O
discrimination	discrimination	NOUN	NN	O
thresholds	threshold	NOUN	NNS	O
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
,	,	PUNCT	,	O
four	four	NUM	CD	O
to	to	PART	TO	O
77	77	NUM	CD	O
months	month	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
median	median	ADJ	JJ	O
34	34	NUM	CD	O
months	month	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
after	after	ADP	IN	O
vincristine	vincristine	ADJ	JJ	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
seven	seven	NUM	CD	O
patients	patient	NOUN	NNS	O
reported	report	VERB	VBD	O
neuropathic	neuropathic	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
13	13	NUM	CD	O
of	of	ADP	IN	O
these	these	DET	DT	O
27	27	NUM	CD	O
patients	patient	NOUN	NNS	O
symptoms	symptom	NOUN	NNS	O
were	be	VERB	VBD	O
still	still	ADV	RB	O
present	present	ADJ	JJ	O
at	at	ADP	IN	O
the	the	DET	DT	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
examination	examination	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
sensory	sensory	ADJ	JJ	O
signs	sign	NOUN	NNS	O
and	and	CCONJ	CC	O
symptoms	symptom	NOUN	NNS	O
predominated	predominate	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
14	14	NUM	CD	O
patients	patient	NOUN	NNS	O
symptoms	symptom	NOUN	NNS	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
past	past	NOUN	NN	O
.	.	PUNCT	.	O

Symptoms	symptom	NOUN	NNS	O
persisted	persist	VERB	VBD	O
maximally	maximally	ADV	RB	O
40	40	NUM	CD	O
months	month	NOUN	NNS	O
since	since	ADP	IN	O
cessation	cessation	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
age	age	NOUN	NN	O
difference	difference	NOUN	NN	O
between	between	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
and	and	CCONJ	CC	O
without	without	ADP	IN	O
complaints	complaint	NOUN	NNS	O
at	at	ADP	IN	O
the	the	DET	DT	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
examination	examination	NOUN	NN	O
.	.	PUNCT	.	O

Normal	normal	ADJ	JJ	O
reflexes	reflex	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
two	two	NUM	CD	O
third	third	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Neuropathic	neuropathic	ADJ	JJ	O
complaints	complaint	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
very	very	ADV	RB	O
troublesome	troublesome	ADJ	JJ	O
on	on	ADP	IN	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
term	term	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
concluded	conclude	VERB	VBN	O
that	that	ADP	IN	O
with	with	ADP	IN	O
the	the	DET	DT	O
above	above	ADV	RB	O
mentioned	mention	VERB	VBN	O
vincristine	vincristine	ADJ	JJ	B-Chemical
dose	dose	NOUN	NN	O
schedule	schedule	NOUN	NN	O
signs	sign	NOUN	NNS	O
and	and	CCONJ	CC	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
vincristine	vincristine	ADJ	JJ	B-Chemical
neuropathy	neuropathy	NOUN	NN	B-Disease
are	be	VERB	VBP	O
reversible	reversible	ADJ	JJ	O
for	for	ADP	IN	O
a	a	DET	DT	O
great	great	ADJ	JJ	O
deal	deal	NOUN	NN	O
and	and	CCONJ	CC	O
prognosis	prognosis	NOUN	NN	O
is	be	VERB	VBZ	O
fairly	fairly	ADV	RB	O
good	good	ADJ	JJ	O
.	.	PUNCT	.	O

Hepatic	hepatic	ADJ	JJ	O
adenomas	adenoma	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
focal	focal	ADJ	JJ	B-Disease
nodular	nodular	ADJ	JJ	I-Disease
hyperplasia	hyperplasia	NOUN	NN	I-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
liver	liver	NOUN	NN	O
in	in	ADP	IN	O
young	young	ADJ	JJ	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
oral	oral	ADJ	JJ	B-Chemical
contraceptives	contraceptive	NOUN	NNS	I-Chemical
:	:	PUNCT	:	O
case	case	NOUN	NN	O
reports	report	NOUN	NNS	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
hepatic	hepatic	ADJ	JJ	O
adenoma	adenoma	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
one	one	NUM	CD	O
of	of	ADP	IN	O
focal	focal	ADJ	JJ	B-Disease
nodular	nodular	ADJ	JJ	I-Disease
hyperplasia	hyperplasia	NOUN	NN	I-Disease
presumably	presumably	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
oral	oral	ADJ	JJ	B-Chemical
contraceptives	contraceptive	NOUN	NNS	I-Chemical
,	,	PUNCT	,	O
are	be	VERB	VBP	O
reported	report	VERB	VBN	O
.	.	PUNCT	.	O

Special	special	ADJ	JJ	O
reference	reference	NOUN	NN	O
is	be	VERB	VBZ	O
made	make	VERB	VBN	O
to	to	ADP	IN	O
their	-PRON-	DET	PRP$	O
clinical	clinical	ADJ	JJ	O
presentation	presentation	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
may	may	VERB	MD	O
be	be	VERB	VB	O
totally	totally	ADV	RB	O
asymptomatic	asymptomatic	ADJ	JJ	O
.	.	PUNCT	.	O

Liver	liver	NOUN	NN	O
-	-	PUNCT	HYPH	O
function	function	NOUN	NN	O
tests	test	NOUN	NNS	O
are	be	VERB	VBP	O
of	of	ADP	IN	O
little	little	ADJ	JJ	O
diagnostic	diagnostic	ADJ	JJ	O
value	value	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
valuable	valuable	ADJ	JJ	O
information	information	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
obtained	obtain	VERB	VBN	O
from	from	ADP	IN	O
both	both	DET	DT	O
liver	liver	NOUN	NN	O
scanning	scanning	NOUN	NN	O
and	and	CCONJ	CC	O
hepatic	hepatic	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
.	.	PUNCT	.	O

Histologic	histologic	ADJ	JJ	O
differences	difference	NOUN	NNS	O
and	and	CCONJ	CC	O
clinical	clinical	ADJ	JJ	O
similarities	similarity	NOUN	NNS	O
between	between	ADP	IN	O
hepatic	hepatic	ADJ	JJ	O
adenoma	adenoma	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
focal	focal	ADJ	JJ	B-Disease
nodular	nodular	ADJ	JJ	I-Disease
hyperplasia	hyperplasia	NOUN	NN	I-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
liver	liver	NOUN	NN	O
are	be	VERB	VBP	O
discussed	discuss	VERB	VBN	O
.	.	PUNCT	.	O

Loss	loss	NOUN	NN	O
of	of	ADP	IN	O
glutamate	glutamate	ADJ	JJ	B-Chemical
decarboxylase	decarboxylase	NOUN	NN	O
mRNA	mRNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
dentate	dentate	ADJ	JJ	O
gyrus	gyrus	NOUN	NN	O
following	follow	VERB	VBG	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
situ	situ	ADJ	JJ	O
hybridization	hybridization	NOUN	NN	O
methods	method	NOUN	NNS	O
were	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
if	if	ADP	IN	O
glutamic	glutamic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
decarboxylase	decarboxylase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GAD	GAD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
mRNA	mRNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
neurons	neuron	NOUN	NNS	O
within	within	ADP	IN	O
the	the	DET	DT	O
hilus	hilus	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
dentate	dentate	ADJ	JJ	O
gyrus	gyrus	NOUN	NN	O
are	be	VERB	VBP	O
vulnerable	vulnerable	ADJ	JJ	O
to	to	PART	TO	O
seizure	seizure	VERB	VB	B-Disease
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
damage	damage	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Sprague	Sprague	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Dawley	Dawley	PROPN	NNP	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
injected	inject	VERB	VBN	O
intraperitoneally	intraperitoneally	ADV	RB	O
with	with	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
hippocampal	hippocampal	ADJ	JJ	O
formation	formation	NOUN	NN	O
was	be	VERB	VBD	O
studied	study	VERB	VBN	O
histologically	histologically	ADV	RB	O
at	at	ADP	IN	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
8	8	NUM	CD	O
week	week	NOUN	NN	O
intervals	interval	NOUN	NNS	O
after	after	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
situ	situ	ADJ	JJ	O
hybridization	hybridization	NOUN	NN	O
histochemistry	histochemistry	NOUN	NN	O
,	,	PUNCT	,	O
using	use	VERB	VBG	O
a	a	DET	DT	O
digoxigenin	digoxigenin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
labeled	label	VERB	VBN	O
GAD	GAD	PROPN	NNP	O
cRNA	cRNA	PROPN	NNP	O
probe	probe	NOUN	NN	O
,	,	PUNCT	,	O
demonstrated	demonstrate	VERB	VBD	O
a	a	DET	DT	O
substantial	substantial	ADJ	JJ	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
GAD	GAD	PROPN	NNP	O
mRNA	mRNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
hilus	hilus	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
dentate	dentate	ADJ	JJ	O
gyrus	gyrus	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
as	as	ADP	IN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
controls	control	NOUN	NNS	O
at	at	ADP	IN	O
all	all	DET	DT	O
time	time	NOUN	NN	O
intervals	interval	NOUN	NNS	O
.	.	PUNCT	.	O

Additional	additional	ADJ	JJ	O
neuronanatomical	neuronanatomical	ADJ	JJ	O
studies	study	NOUN	NNS	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
cresyl	cresyl	NOUN	NN	B-Chemical
violet	violet	NOUN	NN	I-Chemical
staining	staining	NOUN	NN	O
,	,	PUNCT	,	O
neuronal	neuronal	ADJ	JJ	B-Disease
degeneration	degeneration	NOUN	NN	I-Disease
methods	method	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
histochemical	histochemical	ADJ	JJ	O
localization	localization	NOUN	NN	O
of	of	ADP	IN	O
glial	glial	ADJ	JJ	O
fibrillary	fibrillary	ADJ	JJ	O
acidic	acidic	ADJ	JJ	O
protein	protein	NOUN	NN	O
,	,	PUNCT	,	O
suggested	suggest	VERB	VBD	O
that	that	ADP	IN	O
the	the	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
GAD	GAD	PROPN	NNP	O
mRNA	mRNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
neurons	neuron	NOUN	NNS	O
was	be	VERB	VBD	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
neuronal	neuronal	ADJ	JJ	B-Disease
loss	loss	NOUN	NN	I-Disease
rather	rather	ADV	RB	O
than	than	ADP	IN	O
to	to	ADP	IN	O
a	a	DET	DT	O
decrease	decrease	NOUN	NN	O
in	in	ADP	IN	O
GAD	GAD	PROPN	NNP	O
mRNA	mRNA	PROPN	NNP	O
levels	level	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
GAD	GAD	PROPN	NNP	O
mRNA	mRNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
hilus	hilus	NOUN	NN	O
contrasted	contrast	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
relative	relative	ADJ	JJ	O
preservation	preservation	NOUN	NN	O
of	of	ADP	IN	O
labeled	label	VERB	VBN	O
putative	putative	ADJ	JJ	O
basket	basket	NOUN	NN	O
cells	cell	NOUN	NNS	O
along	along	ADP	IN	O
the	the	DET	DT	O
inner	inner	ADJ	JJ	O
margin	margin	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
granule	granule	ADJ	JJ	O
cell	cell	NOUN	NN	O
layer	layer	NOUN	NN	O
.	.	PUNCT	.	O

Quantitative	quantitative	ADJ	JJ	O
analyses	analyse	VERB	VBZ	O
of	of	ADP	IN	O
labeled	label	VERB	VBN	O
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
three	three	NUM	CD	O
regions	region	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
dentate	dentate	ADJ	JJ	O
gyrus	gyrus	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
week	week	NOUN	NN	O
groups	group	NOUN	NNS	O
showed	show	VERB	VBD	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
decreases	decrease	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
GAD	GAD	PROPN	NNP	O
mRNA	mRNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
neurons	neuron	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
hilus	hilus	NOUN	NN	O
of	of	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
experimental	experimental	ADJ	JJ	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

No	no	DET	DT	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
molecular	molecular	ADJ	JJ	O
layer	layer	NOUN	NN	O
or	or	CCONJ	CC	O
the	the	DET	DT	O
granule	granule	ADJ	JJ	O
cell	cell	NOUN	NN	O
layer	layer	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
included	include	VERB	VBD	O
labeled	label	VERB	VBN	O
neurons	neuron	NOUN	NNS	O
along	along	ADP	IN	O
the	the	DET	DT	O
lower	low	ADJ	JJR	O
margin	margin	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
granule	granule	ADJ	JJ	O
cell	cell	NOUN	NN	O
layer	layer	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
this	this	DET	DT	O
model	model	NOUN	NN	O
,	,	PUNCT	,	O
a	a	DET	DT	O
subpopulation	subpopulation	NOUN	NN	O
of	of	ADP	IN	O
GAD	GAD	PROPN	NNP	O
mRNA	mRNA	PROPN	NNP	O
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
neurons	neuron	NOUN	NNS	O
within	within	ADP	IN	O
the	the	DET	DT	O
dentate	dentate	ADJ	JJ	O
gyrus	gyrus	NOUN	NN	O
is	be	VERB	VBZ	O
selectively	selectively	ADV	RB	O
vulnerable	vulnerable	ADJ	JJ	O
to	to	ADP	IN	O
seizure	seizure	VERB	VB	B-Disease
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
damage	damage	NOUN	NN	O
.	.	PUNCT	.	O

Such	such	ADJ	JJ	O
differential	differential	ADJ	JJ	O
vulnerability	vulnerability	NOUN	NN	O
appears	appear	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
another	another	DET	DT	O
indication	indication	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
heterogeneity	heterogeneity	NOUN	NN	O
of	of	ADP	IN	O
GABA	GABA	PROPN	NNP	B-Chemical
neurons	neuron	NOUN	NNS	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
deliberate	deliberate	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
labetalol	labetalol	NOUN	NN	B-Chemical
with	with	ADP	IN	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
on	on	ADP	IN	O
neuropsychological	neuropsychological	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
deliberate	deliberate	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
on	on	ADP	IN	O
brain	brain	NOUN	NN	O
function	function	NOUN	NN	O
measured	measure	VERB	VBN	O
by	by	ADP	IN	O
neuropsychological	neuropsychological	ADJ	JJ	O
tests	test	NOUN	NNS	O
was	be	VERB	VBD	O
studied	study	VERB	VBN	O
in	in	ADP	IN	O
41	41	NUM	CD	O
adult	adult	NOUN	NN	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Twenty	twenty	NUM	CD	O
-	-	PUNCT	HYPH	O
four	four	NUM	CD	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
anaesthetized	anaesthetize	VERB	VBN	O
for	for	ADP	IN	O
middle	middle	ADJ	JJ	O
-	-	PUNCT	HYPH	O
ear	ear	NOUN	NN	O
surgery	surgery	NOUN	NN	O
with	with	ADP	IN	O
deliberate	deliberate	ADJ	JJ	O
hypotension	hypotension	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
labetalol	labetalol	NOUN	NN	B-Chemical
with	with	ADP	IN	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
group	group	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Seventeen	seventeen	NUM	CD	O
patients	patient	NOUN	NNS	O
without	without	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
served	serve	VERB	VBD	O
as	as	ADP	IN	O
a	a	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mean	mean	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
was	be	VERB	VBD	O
77	77	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
mmHg	mmhg	NOUN	NN	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
kPa	kpa	NOUN	NN	O
)	)	PUNCT	-RRB-	O
before	before	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
50	50	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
mmHg	mmhg	NOUN	NN	O
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
kPa	kpa	NOUN	NN	O
)	)	PUNCT	-RRB-	O
during	during	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
hypotensive	hypotensive	ADJ	JJ	B-Disease
group	group	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
86	86	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
mmHg	mmhg	NOUN	NN	O
(	(	PUNCT	-LRB-	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
kPa	kpa	NOUN	NN	O
)	)	PUNCT	-RRB-	O
during	during	ADP	IN	O
anaesthesia	anaesthesia	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
following	follow	VERB	VBG	O
psychological	psychological	ADJ	JJ	O
tests	test	NOUN	NNS	O
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
:	:	PUNCT	:	O
four	four	NUM	CD	O
subtests	subtest	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
Wechsler	Wechsler	PROPN	NNP	O
Adult	Adult	PROPN	NNP	O
Intelligence	Intelligence	PROPN	NNP	O
Scale	Scale	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
similarities	similarity	NOUN	NNS	O
,	,	PUNCT	,	O
digit	digit	NOUN	NN	O
span	span	NOUN	NN	O
,	,	PUNCT	,	O
vocabulary	vocabulary	NOUN	NN	O
and	and	CCONJ	CC	O
digit	digit	NOUN	NN	O
symbol	symbol	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
Trail	Trail	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Making	Making	PROPN	NNP	O
tests	test	NOUN	NNS	O
A	a	NOUN	NN	O
and	and	CCONJ	CC	O
B	B	PROPN	NNP	O
,	,	PUNCT	,	O
Zung	Zung	PROPN	NNP	O
tests	test	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
self	self	NOUN	NN	O
-	-	PUNCT	HYPH	O
rating	rate	VERB	VBG	O
anxiety	anxiety	NOUN	NN	B-Disease
scale	scale	NOUN	NN	O
and	and	CCONJ	CC	O
self	self	NOUN	NN	O
-	-	PUNCT	HYPH	O
rating	rate	VERB	VBG	O
depression	depression	NOUN	NN	B-Disease
scale	scale	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
two	two	NUM	CD	O
-	-	PUNCT	HYPH	O
part	part	NOUN	NN	O
memory	memory	NOUN	NN	O
test	test	NOUN	NN	O
battery	battery	NOUN	NN	O
with	with	ADP	IN	O
immediate	immediate	ADJ	JJ	O
and	and	CCONJ	CC	O
delayed	delay	VERB	VBN	O
recall	recall	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
tests	test	NOUN	NNS	O
were	be	VERB	VBD	O
performed	perform	VERB	VBN	O
preoperatively	preoperatively	ADV	RB	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
days	day	NOUN	NNS	O
postoperatively	postoperatively	ADV	RB	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
the	the	DET	DT	O
groups	group	NOUN	NNS	O
in	in	ADP	IN	O
any	any	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
tests	test	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
changes	change	NOUN	NNS	O
from	from	ADP	IN	O
preoperative	preoperative	ADJ	JJ	O
value	value	NOUN	NN	O
to	to	PART	TO	O
postoperative	postoperative	ADJ	JJ	O
value	value	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
hypotension	hypotension	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
labetalol	labetalol	NOUN	NN	B-Chemical
with	with	ADP	IN	O
isoflurane	isoflurane	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
harmful	harmful	ADJ	JJ	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
mental	mental	ADJ	JJ	O
functions	function	NOUN	NNS	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
normotensive	normotensive	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
.	.	PUNCT	.	O

Apparent	apparent	ADJ	JJ	O
cure	cure	NOUN	NN	O
of	of	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
by	by	ADP	IN	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
the	the	DET	DT	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
sustained	sustained	ADJ	JJ	O
remissions	remission	NOUN	NNS	O
and	and	CCONJ	CC	O
possible	possible	ADJ	JJ	O
cure	cure	NOUN	NN	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
erosive	erosive	ADJ	JJ	O
rheumatoid	rheumatoid	NOUN	NN	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
RA	RA	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
by	by	ADP	IN	O
bone	bone	NOUN	NN	O
marrow	marrow	NOUN	NN	O
transplantation	transplantation	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BMT	BMT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
2	2	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

BMT	BMT	PROPN	NNP	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
treat	treat	VERB	VB	O
severe	severe	ADJ	JJ	O
aplastic	aplastic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
which	which	DET	WDT	O
was	be	VERB	VBD	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
gold	gold	NOUN	NN	B-Chemical
in	in	ADP	IN	O
one	one	NUM	CD	O
case	case	NOUN	NN	O
and	and	CCONJ	CC	O
D	d	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
8	8	NUM	CD	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
years	year	NOUN	NNS	O
since	since	ADP	IN	O
the	the	DET	DT	O
transplants	transplant	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
representing	represent	VERB	VBG	O
8	8	NUM	CD	O
and	and	CCONJ	CC	O
4	4	NUM	CD	O
years	year	NOUN	NNS	O
since	since	ADP	IN	O
cessation	cessation	NOUN	NN	O
of	of	ADP	IN	O
all	all	DET	DT	O
immunosuppressive	immunosuppressive	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
RA	RA	PROPN	NNP	B-Disease
in	in	ADP	IN	O
each	each	DET	DT	O
case	case	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
completely	completely	ADV	RB	O
quiescent	quiescent	ADJ	JJ	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
short	short	ADJ	JJ	O
term	term	NOUN	NN	O
remission	remission	NOUN	NN	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
RA	RA	PROPN	NNP	B-Disease
following	follow	VERB	VBG	O
BMT	BMT	PROPN	NNP	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
,	,	PUNCT	,	O
these	these	DET	DT	O
are	be	VERB	VBP	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
cases	case	NOUN	NNS	O
for	for	ADP	IN	O
which	which	DET	WDT	O
prolonged	prolong	VERB	VBN	O
followup	followup	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
available	available	ADJ	JJ	O
.	.	PUNCT	.	O

This	this	DET	DT	O
experience	experience	NOUN	NN	O
raises	raise	VERB	VBZ	O
the	the	DET	DT	O
question	question	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
BMT	BMT	PROPN	NNP	O
itself	-PRON-	PRON	PRP	O
as	as	ADP	IN	O
a	a	DET	DT	O
therapeutic	therapeutic	ADJ	JJ	O
option	option	NOUN	NN	O
for	for	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
uncontrolled	uncontrolled	ADJ	JJ	O
destructive	destructive	ADJ	JJ	O
synovitis	synovitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Seizures	seizure	NOUN	NNS	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
combined	combined	ADJ	JJ	O
levomepromazine	levomepromazine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
combined	combine	VERB	VBN	O
levomepromazine	levomepromazine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
seems	seem	VERB	VBZ	O
that	that	ADP	IN	O
combined	combine	VERB	VBN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
fluvoxamine	fluvoxamine	NOUN	NN	B-Chemical
with	with	ADP	IN	O
phenothiazines	phenothiazine	NOUN	NNS	B-Chemical
may	may	VERB	MD	O
possess	possess	VERB	VB	O
proconvulsive	proconvulsive	ADJ	JJ	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Case	case	NOUN	NN	O
report	report	NOUN	NN	O
:	:	PUNCT	:	O
pentamidine	pentamidine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
polymorphic	polymorphic	ADJ	JJ	O
ventricular	ventricular	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
revisited	revisit	VERB	VBN	O
.	.	PUNCT	.	O

Pentamidine	pentamidine	ADJ	JJ	B-Chemical
isethionate	isethionate	NOUN	NN	I-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
tachyarrhythmias	tachyarrhythmia	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
including	include	VERB	VBG	O
torsade	torsade	NOUN	NN	B-Disease
de	de	X	FW	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
article	article	NOUN	NN	O
reports	report	VERB	VBZ	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
complication	complication	NOUN	NN	O
and	and	CCONJ	CC	O
reviews	review	VERB	VBZ	O
all	all	DET	DT	O
reported	report	VERB	VBN	O
cases	case	NOUN	NNS	O
to	to	ADP	IN	O
date	date	NOUN	NN	O
.	.	PUNCT	.	O

Pentamidine	pentamidine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
torsade	torsade	NOUN	NN	B-Disease
de	de	X	FW	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
serum	serum	VERB	VB	O
magnesium	magnesium	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
and	and	CCONJ	CC	O
hypomagnesemia	hypomagnesemia	NOUN	NN	B-Disease
may	may	VERB	MD	O
synergistically	synergistically	ADV	RB	O
induce	induce	VERB	VB	O
torsade	torsade	NOUN	NN	O
.	.	PUNCT	.	O

Torsade	Torsade	PROPN	NNP	B-Disease
de	de	ADP	IN	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
occurred	occur	VERB	VBD	O
after	after	ADP	IN	O
an	an	DET	DT	O
average	average	NOUN	NN	O
of	of	ADP	IN	O
10	10	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
pentamidine	pentamidine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
no	no	DET	DT	O
other	other	ADJ	JJ	O
acute	acute	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
pentamidine	pentamidine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

Torsade	Torsade	PROPN	NNP	B-Disease
de	de	ADP	IN	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
can	can	VERB	MD	O
be	be	VERB	VB	O
treated	treat	VERB	VBN	O
when	when	ADV	WRB	O
recognized	recognize	VERB	VBN	O
early	early	ADV	RB	O
,	,	PUNCT	,	O
possibly	possibly	ADV	RB	O
without	without	ADP	IN	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
pentamidine	pentamidine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

When	when	ADV	WRB	O
QTc	qtc	ADJ	JJ	B-Disease
interval	interval	ADJ	JJ	I-Disease
prolongation	prolongation	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
observed	observe	VERB	VBN	O
,	,	PUNCT	,	O
early	early	ADJ	JJ	O
magnesium	magnesium	NOUN	NN	B-Chemical
supplementation	supplementation	NOUN	NN	O
is	be	VERB	VBZ	O
advocated	advocate	VERB	VBN	O
.	.	PUNCT	.	O

Efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
tolerability	tolerability	NOUN	NN	O
of	of	ADP	IN	O
lovastatin	lovastatin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
3390	3390	NUM	CD	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
moderate	moderate	ADJ	JJ	O
hypercholesterolemia	hypercholesterolemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
of	of	ADP	IN	O
lovastatin	lovastatin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
moderate	moderate	ADJ	JJ	O
hypercholesterolemia	hypercholesterolemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
Expanded	Expanded	PROPN	NNP	O
Clinical	Clinical	PROPN	NNP	O
Evaluation	Evaluation	PROPN	NNP	O
of	of	ADP	IN	O
Lovastatin	Lovastatin	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
EXCEL	EXCEL	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
Study	Study	PROPN	NNP	O
,	,	PUNCT	,	O
a	a	DET	DT	O
multicenter	multicenter	NOUN	NN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
diet	diet	NOUN	NN	O
-	-	PUNCT	,	O
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
trial	trial	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
which	which	DET	WDT	O
participants	participant	NOUN	NNS	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
assigned	assign	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
placebo	placebo	NOUN	NN	O
or	or	CCONJ	CC	O
lovastatin	lovastatin	NOUN	NN	B-Chemical
at	at	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
20	20	NUM	CD	O
or	or	CCONJ	CC	O
40	40	NUM	CD	O
mg	mg	NOUN	NN	O
once	once	ADV	RB	O
daily	daily	ADV	RB	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
20	20	NUM	CD	O
or	or	CCONJ	CC	O
40	40	NUM	CD	O
mg	mg	NOUN	NN	O
twice	twice	ADV	RB	O
daily	daily	ADJ	JJ	O
for	for	ADP	IN	O
48	48	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

SETTING	set	VERB	VBG	O
:	:	PUNCT	:	O
Ambulatory	ambulatory	ADJ	JJ	O
patients	patient	NOUN	NNS	O
recruited	recruit	VERB	VBN	O
by	by	ADP	IN	O
362	362	NUM	CD	O
participating	participate	VERB	VBG	O
centers	center	NOUN	NNS	O
throughout	throughout	ADP	IN	O
the	the	DET	DT	O
United	United	PROPN	NNP	O
States	States	PROPN	NNP	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
:	:	PUNCT	:	O
Women	Women	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
3390	3390	NUM	CD	O
)	)	PUNCT	-RRB-	O
from	from	ADP	IN	O
the	the	DET	DT	O
total	total	ADJ	JJ	O
cohort	cohort	NOUN	NN	O
of	of	ADP	IN	O
8245	8245	NUM	CD	O
volunteers	volunteer	NOUN	NNS	O
.	.	PUNCT	.	O

MEASUREMENTS	measurement	NOUN	NNS	O
:	:	PUNCT	:	O
Plasma	plasma	VERB	VB	O
total	total	NOUN	NN	O
,	,	PUNCT	,	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
density	density	NOUN	NN	O
lipoprotein	lipoprotein	NOUN	NN	O
(	(	PUNCT	-LRB-	O
LDL	LDL	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
density	density	NOUN	NN	O
lipoprotein	lipoprotein	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HDL	HDL	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
cholesterol	cholesterol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
triglycerides	triglyceride	NOUN	NNS	B-Chemical
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
laboratory	laboratory	NOUN	NN	O
and	and	CCONJ	CC	O
clinical	clinical	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
monitored	monitor	VERB	VBD	O
periodically	periodically	ADV	RB	O
throughout	throughout	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Among	among	ADP	IN	O
women	woman	NOUN	NNS	O
,	,	PUNCT	,	O
lovastatin	lovastatin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
20	20	NUM	CD	O
to	to	PART	TO	O
80	80	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
)	)	PUNCT	-RRB-	O
produced	produce	VERB	VBN	O
sustained	sustained	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
48	48	NUM	CD	O
-	-	PUNCT	HYPH	O
week	week	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
changes	change	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
:	:	PUNCT	:	O
decreases	decrease	NOUN	NNS	O
in	in	ADP	IN	O
LDL	LDL	PROPN	NNP	O
cholesterol	cholesterol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
24	24	NUM	CD	O
%	%	NOUN	NN	O
to	to	ADP	IN	O
40	40	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
triglycerides	triglyceride	NOUN	NNS	B-Chemical
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
to	to	PART	TO	O
18	18	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
HDL	HDL	PROPN	NNP	O
cholesterol	cholesterol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
to	to	PART	TO	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Depending	depend	VERB	VBG	O
on	on	ADP	IN	O
the	the	DET	DT	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
from	from	ADP	IN	O
82	82	NUM	CD	O
%	%	NOUN	NN	O
to	to	PART	TO	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
lovastatin	lovastatin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
women	woman	NOUN	NNS	O
achieved	achieve	VERB	VBD	O
the	the	DET	DT	O
National	National	PROPN	NNP	O
Cholesterol	Cholesterol	PROPN	NNP	B-Chemical
Education	Education	PROPN	NNP	O
Program	Program	PROPN	NNP	O
goal	goal	NOUN	NN	O
of	of	ADP	IN	O
LDL	LDL	PROPN	NNP	O
cholesterol	cholesterol	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
14	14	NUM	CD	O
mmol	mmol	NOUN	NN	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
(	(	PUNCT	-LRB-	O
160	160	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
dL	dL	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
40	40	NUM	CD	O
%	%	NOUN	NN	O
to	to	PART	TO	O
87	87	NUM	CD	O
%	%	NOUN	NN	O
achieved	achieve	VERB	VBD	O
the	the	DET	DT	O
goal	goal	NOUN	NN	O
of	of	ADP	IN	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
36	36	NUM	CD	O
mmol	mmol	NOUN	NN	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
(	(	PUNCT	-LRB-	O
130	130	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
dL	dL	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Successive	successive	ADJ	JJ	O
transaminase	transaminase	NOUN	NN	O
elevations	elevation	VERB	VBZ	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
three	three	NUM	CD	O
times	time	NOUN	NNS	O
the	the	DET	DT	O
upper	upper	ADJ	JJ	O
limit	limit	NOUN	NN	O
of	of	ADP	IN	O
normal	normal	ADJ	JJ	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
women	woman	NOUN	NNS	O
and	and	CCONJ	CC	O
were	be	VERB	VBD	O
dose	dose	NOUN	NN	O
dependent	dependent	ADJ	JJ	O
above	above	ADP	IN	O
the	the	DET	DT	O
20	20	NUM	CD	O
-	-	PUNCT	HYPH	O
mg	mg	NOUN	NN	O
dose	dose	NOUN	NN	O
.	.	PUNCT	.	O

Myopathy	Myopathy	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
defined	define	VERB	VBN	O
as	as	ADP	IN	O
muscle	muscle	NOUN	NN	O
symptoms	symptom	NOUN	NNS	O
with	with	ADP	IN	O
creatine	creatine	NOUN	NN	B-Chemical
kinase	kinase	NOUN	NN	O
elevations	elevation	NOUN	NNS	O
greater	great	ADJ	JJR	O
than	than	ADP	IN	O
10	10	NUM	CD	O
times	time	NOUN	NNS	O
the	the	DET	DT	O
upper	upper	ADJ	JJ	O
limit	limit	NOUN	NN	O
of	of	ADP	IN	O
normal	normal	ADJ	JJ	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
rare	rare	ADJ	JJ	O
and	and	CCONJ	CC	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
highest	high	ADJ	JJS	O
recommended	recommend	VERB	VBN	O
daily	daily	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
lovastatin	lovastatin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
80	80	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Estrogen	estrogen	NOUN	NN	O
-	-	PUNCT	HYPH	O
replacement	replacement	NOUN	NN	O
therapy	therapy	NOUN	NN	O
appeared	appear	VERB	VBD	O
to	to	PART	TO	O
have	have	VERB	VB	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
either	either	CCONJ	CC	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
or	or	CCONJ	CC	O
safety	safety	NOUN	NN	O
profile	profile	NOUN	NN	O
of	of	ADP	IN	O
lovastatin	lovastatin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Lovastatin	Lovastatin	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
highly	highly	ADV	RB	O
effective	effective	ADJ	JJ	O
and	and	CCONJ	CC	O
generally	generally	ADV	RB	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
as	as	ADP	IN	O
therapy	therapy	NOUN	NN	O
for	for	ADP	IN	O
primary	primary	ADJ	JJ	O
hypercholesterolemia	hypercholesterolemia	NOUN	NN	B-Disease
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

Tetany	tetany	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
rhabdomyolysis	rhabdomyolysis	NOUN	NN	B-Disease
due	due	ADP	IN	O
to	to	ADP	IN	O
surreptitious	surreptitious	ADJ	JJ	O
furosemide	furosemide	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
-	-	PUNCT	HYPH	O
importance	importance	NOUN	NN	O
of	of	ADP	IN	O
magnesium	magnesium	NOUN	NN	B-Chemical
supplementation	supplementation	NOUN	NN	O
.	.	PUNCT	.	O

Diuretics	diuretic	NOUN	NNS	O
may	may	VERB	MD	O
induce	induce	VERB	VB	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
hypocalcemia	hypocalcemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
hypomagnesemia	hypomagnesemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

While	while	ADP	IN	O
severe	severe	ADJ	JJ	O
hypokalemia	hypokalemia	NOUN	NNS	B-Disease
may	may	VERB	MD	O
cause	cause	VERB	VB	O
muscle	muscle	NOUN	NN	B-Disease
weakness	weakness	NOUN	NN	I-Disease
,	,	PUNCT	,	O
severe	severe	ADJ	JJ	O
hypomagnesemia	hypomagnesemia	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
muscle	muscle	NOUN	NN	B-Disease
spasms	spasm	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
tetany	tetany	NOUN	NN	B-Disease
which	which	DET	WDT	O
cannot	cannot	NOUN	NN	O
be	be	VERB	VB	O
corrected	correct	VERB	VBN	O
by	by	ADP	IN	O
potassium	potassium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
calcium	calcium	NOUN	NN	B-Chemical
supplementation	supplementation	NOUN	NN	O
alone	alone	ADV	RB	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Surreptitious	surreptitious	ADJ	JJ	O
diuretic	diuretic	ADJ	JJ	O
ingestion	ingestion	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
described	describe	VERB	VBN	O
,	,	PUNCT	,	O
mainly	mainly	ADV	RB	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
who	who	PRON	WP	O
are	be	VERB	VBP	O
concerned	concerned	ADJ	JJ	O
that	that	ADP	IN	O
they	-PRON-	PRON	PRP	O
are	be	VERB	VBP	O
obese	obese	ADJ	JJ	B-Disease
or	or	CCONJ	CC	O
edematous	edematous	ADJ	JJ	B-Disease
.	.	PUNCT	.	O

Symptomatic	symptomatic	ADJ	JJ	O
hypokalemia	hypokalemia	NOUN	NN	B-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
such	such	ADJ	JJ	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
-	-	SYM	SYM	O
7	7	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
one	one	NUM	CD	O
case	case	NOUN	NN	O
hypocalcemia	hypocalcemia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
(	(	PUNCT	-LRB-	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
magnesium	magnesium	NOUN	NN	B-Chemical
depletion	depletion	NOUN	NN	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
noted	note	VERB	VBN	O
in	in	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

Ciprofloxacin	Ciprofloxacin	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
cancer	cancer	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
ciprofloxacin	ciprofloxacin	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
uncommon	uncommon	ADJ	JJ	O
.	.	PUNCT	.	O

Five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
cancer	cancer	NOUN	NN	B-Disease
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
that	that	DET	WDT	O
followed	follow	VERB	VBD	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
ciprofloxacin	ciprofloxacin	NOUN	NN	B-Chemical
are	be	VERB	VBP	O
described	describe	VERB	VBN	O
and	and	CCONJ	CC	O
an	an	DET	DT	O
additional	additional	ADJ	JJ	O
15	15	NUM	CD	O
cases	case	NOUN	NNS	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
are	be	VERB	VBP	O
reviewed	review	VERB	VBN	O
.	.	PUNCT	.	O

Other	other	ADJ	JJ	O
than	than	ADP	IN	O
elevation	elevation	NOUN	NN	O
of	of	ADP	IN	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
levels	level	NOUN	NNS	O
,	,	PUNCT	,	O
characteristic	characteristic	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
manifestations	manifestation	NOUN	NNS	O
and	and	CCONJ	CC	O
abnormal	abnormal	ADJ	JJ	O
laboratory	laboratory	NOUN	NN	O
findings	finding	NOUN	NNS	O
are	be	VERB	VBP	O
not	not	ADV	RB	O
frequently	frequently	ADV	RB	O
present	present	ADJ	JJ	O
.	.	PUNCT	.	O

Allergic	allergic	ADJ	JJ	O
interstitial	interstitial	ADJ	JJ	B-Disease
nephritis	nephritis	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
believed	believe	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
the	the	DET	DT	O
underlying	underlie	VERB	VBG	O
pathological	pathological	ADJ	JJ	O
-	-	PUNCT	HYPH	O
process	process	NOUN	NN	O
.	.	PUNCT	.	O

Definitive	definitive	ADJ	JJ	O
diagnosis	diagnosis	NOUN	NN	O
requires	require	VERB	VBZ	O
performance	performance	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
biopsy	biopsy	NOUN	NN	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
this	this	DET	DT	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
always	always	ADV	RB	O
feasible	feasible	ADJ	JJ	O
.	.	PUNCT	.	O

An	an	DET	DT	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
that	that	DET	WDT	O
followed	follow	VERB	VBD	O
the	the	DET	DT	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
offending	offend	VERB	VBG	O
antibiotic	antibiotic	NOUN	NN	O
supports	support	VERB	VBZ	O
the	the	DET	DT	O
presumptive	presumptive	ADJ	JJ	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
ciprofloxacin	ciprofloxacin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Venous	venous	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	I-Disease
of	of	ADP	IN	O
midazolam	midazolam	NOUN	NN	B-Chemical
versus	versus	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Although	although	ADP	IN	O
some	some	DET	DT	O
studies	study	NOUN	NNS	O
have	have	VERB	VBP	O
suggested	suggest	VERB	VBN	O
fewer	few	ADJ	JJR	O
venous	venous	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	I-Disease
are	be	VERB	VBP	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
midazolam	midazolam	NOUN	NN	B-Chemical
than	than	ADP	IN	O
with	with	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
for	for	ADP	IN	O
endoscopic	endoscopic	ADJ	JJ	O
procedures	procedure	NOUN	NNS	O
,	,	PUNCT	,	O
this	this	DET	DT	O
variable	variable	NOUN	NN	O
has	have	VERB	VBZ	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
well	well	ADV	RB	O
documented	document	VERB	VBN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
prospectively	prospectively	ADV	RB	O
evaluated	evaluate	VERB	VBD	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
venous	venous	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	I-Disease
after	after	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
midazolam	midazolam	NOUN	NN	B-Chemical
in	in	ADP	IN	O
122	122	NUM	CD	O
consecutive	consecutive	ADJ	JJ	O
patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
colonoscopy	colonoscopy	NOUN	NN	O
and	and	CCONJ	CC	O
esophagogastroduodenoscopy	esophagogastroduodenoscopy	NOUN	NN	O
.	.	PUNCT	.	O

Overall	overall	ADV	RB	O
,	,	PUNCT	,	O
venous	venous	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
more	more	ADV	RBR	O
frequent	frequent	ADJ	JJ	O
with	with	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
22	22	NUM	CD	O
of	of	ADP	IN	O
62	62	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
with	with	ADP	IN	O
midazolam	midazolam	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
of	of	ADP	IN	O
60	60	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
palpable	palpable	ADJ	JJ	O
venous	venous	ADJ	JJ	O
cord	cord	NOUN	NN	O
was	be	VERB	VBD	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
23	23	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
14	14	NUM	CD	O
of	of	ADP	IN	O
62	62	NUM	CD	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
diazepam	diazepam	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
,	,	PUNCT	,	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
of	of	ADP	IN	O
60	60	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
midazolam	midazolam	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
002	002	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Pain	pain	NOUN	NN	B-Disease
at	at	ADP	IN	O
the	the	DET	DT	O
injection	injection	NOUN	NN	O
site	site	NOUN	NN	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
35	35	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
22	22	NUM	CD	O
of	of	ADP	IN	O
62	62	NUM	CD	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
diazepam	diazepam	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
of	of	ADP	IN	O
60	60	NUM	CD	O
patients	patient	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
midazolam	midazolam	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Swelling	swell	VERB	VBG	B-Disease
and	and	CCONJ	CC	O
warmth	warmth	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
injection	injection	NOUN	NN	O
site	site	NOUN	NN	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
different	different	ADJ	JJ	O
between	between	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Smoking	smoking	NOUN	NN	O
,	,	PUNCT	,	O
nonsteroidal	nonsteroidal	ADJ	JJ	O
anti	anti	ADJ	JJ	O
-	-	ADJ	JJ	O
inflammatory	inflammatory	ADJ	JJ	O
drug	drug	NOUN	NN	O
use	use	NOUN	NN	O
,	,	PUNCT	,	O
intravenous	intravenous	ADJ	JJ	O
catheter	catheter	NOUN	NN	O
site	site	NOUN	NN	O
,	,	PUNCT	,	O
dwell	dwell	ADJ	JJ	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
needle	needle	NOUN	NN	O
,	,	PUNCT	,	O
alcohol	alcohol	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
pain	pain	NOUN	NN	B-Disease
during	during	ADP	IN	O
the	the	DET	DT	O
injection	injection	NOUN	NN	O
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
venous	venous	ADJ	JJ	B-Disease
complications	complication	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Clarithromycin	Clarithromycin	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
associated	associate	VERB	VBN	O
visual	visual	ADJ	JJ	B-Disease
hallucinations	hallucination	NOUN	NNS	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
on	on	ADP	IN	O
continuous	continuous	ADJ	JJ	O
ambulatory	ambulatory	ADJ	JJ	O
peritoneal	peritoneal	ADJ	JJ	O
dialysis	dialysis	NOUN	NN	O
.	.	PUNCT	.	O

Visual	visual	ADJ	JJ	B-Disease
hallucinations	hallucination	NOUN	NNS	I-Disease
are	be	VERB	VBP	O
a	a	DET	DT	O
rare	rare	ADJ	JJ	O
event	event	NOUN	NN	O
in	in	ADP	IN	O
chronic	chronic	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
not	not	ADV	RB	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
uremia	uremia	ADJ	JJ	B-Disease
per	per	ADP	IN	O
se	se	X	FW	O
.	.	PUNCT	.	O

Unreported	unreported	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
is	be	VERB	VBZ	O
visual	visual	ADJ	JJ	B-Disease
hallucinations	hallucination	NOUN	NNS	I-Disease
occurring	occur	VERB	VBG	O
in	in	ADP	IN	O
association	association	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
new	new	ADJ	JJ	O
macrolide	macrolide	NOUN	NN	B-Chemical
antibiotic	antibiotic	ADJ	JJ	O
,	,	PUNCT	,	O
clarithromycin	clarithromycin	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
such	such	DET	PDT	O
a	a	DET	DT	O
case	case	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
end	end	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
stage	stage	NOUN	NN	I-Disease
renal	renal	ADJ	JJ	I-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
ESRD	ESRD	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
maintained	maintain	VERB	VBN	O
on	on	ADP	IN	O
continuous	continuous	ADJ	JJ	O
ambulatory	ambulatory	ADJ	JJ	O
peritoneal	peritoneal	ADJ	JJ	O
dialysis	dialysis	NOUN	NN	O
(	(	PUNCT	-LRB-	O
CAPD	CAPD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
combination	combination	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
relatively	relatively	ADV	RB	O
high	high	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
clarithromycin	clarithromycin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
face	face	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
functionally	functionally	ADV	RB	O
anephric	anephric	ADJ	JJ	O
patient	patient	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
underlying	underlie	VERB	VBG	O
aluminum	aluminum	NOUN	NN	B-Chemical
intoxication	intoxication	NOUN	NN	O
,	,	PUNCT	,	O
may	may	VERB	MD	O
have	have	VERB	VB	O
facilitated	facilitate	VERB	VBN	O
the	the	DET	DT	O
appearance	appearance	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
neurotoxic	neurotoxic	ADJ	JJ	B-Disease
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
important	important	ADJ	JJ	O
to	to	PART	TO	O
understand	understand	VERB	VB	O
the	the	DET	DT	O
pharmacokinetics	pharmacokinetic	NOUN	NNS	O
of	of	ADP	IN	O
medications	medication	NOUN	NNS	O
in	in	ADP	IN	O
face	face	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
possibility	possibility	NOUN	NN	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
interactions	interaction	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
how	how	ADV	WRB	O
these	these	DET	DT	O
factors	factor	NOUN	NNS	O
should	should	VERB	MD	O
help	help	VERB	VB	O
guide	guide	VERB	VB	O
medication	medication	NOUN	NN	O
therapy	therapy	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ESRD	ESRD	PROPN	NNP	B-Disease
patient	patient	NOUN	NN	O
.	.	PUNCT	.	O

Changes	change	NOUN	NNS	O
in	in	ADP	IN	O
peroxisomes	peroxisome	NOUN	NNS	O
in	in	ADP	IN	O
preneoplastic	preneoplastic	ADJ	JJ	O
liver	liver	NOUN	NN	O
and	and	CCONJ	CC	O
hepatoma	hepatoma	NOUN	NN	B-Disease
of	of	ADP	IN	O
mice	mouse	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
benzene	benzene	NOUN	NN	I-Chemical
hexachloride	hexachloride	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Peroxisomes	peroxisome	NOUN	NNS	O
in	in	ADP	IN	O
hepatomas	hepatomas	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
hyperplastic	hyperplastic	ADJ	JJ	O
preneoplastic	preneoplastic	ADJ	JJ	O
liver	liver	NOUN	NN	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
induced	induce	VERB	VBN	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
by	by	ADP	IN	O
500	500	NUM	CD	O
ppm	ppm	NOUN	NNS	O
alpha	alpha	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
benzene	benzene	NOUN	NN	I-Chemical
hexachloride	hexachloride	NOUN	NNS	I-Chemical
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
histochemically	histochemically	ADV	RB	O
and	and	CCONJ	CC	O
electron	electron	VERB	VB	O
microscopically	microscopically	ADV	RB	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
most	most	ADJ	JJS	O
of	of	ADP	IN	O
the	the	DET	DT	O
hepatomas	hepatomas	NOUN	NN	B-Disease
were	be	VERB	VBD	O
well	well	ADV	RB	O
-	-	PUNCT	HYPH	O
differentiated	differentiate	VERB	VBN	O
tumors	tumor	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
contained	contain	VERB	VBD	O
a	a	DET	DT	O
considerable	considerable	ADJ	JJ	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
peroxisomes	peroxisome	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
tumor	tumor	NOUN	NN	B-Disease
cells	cell	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
respond	respond	VERB	VB	O
to	to	ADP	IN	O
ethyl	ethyl	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
alpha	alpha	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
p	p	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
chlorophenoxyisobutyrate	chlorophenoxyisobutyrate	NOUN	NN	I-Chemical
with	with	ADP	IN	O
proliferation	proliferation	NOUN	NN	O
of	of	ADP	IN	O
peroxisomes	peroxisome	NOUN	NNS	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
the	the	DET	DT	O
16th	16th	ADJ	JJ	O
week	week	NOUN	NN	O
of	of	ADP	IN	O
carcinogen	carcinogen	NOUN	NN	O
feeding	feeding	NOUN	NN	O
,	,	PUNCT	,	O
hyperplastic	hyperplastic	ADJ	JJ	O
nodules	nodule	NOUN	NNS	O
appeared	appear	VERB	VBD	O
and	and	CCONJ	CC	O
advanced	advance	VERB	VBD	O
to	to	ADP	IN	O
further	further	ADJ	JJ	O
stages	stage	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
majority	majority	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
nodules	nodule	NOUN	NNS	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
considerable	considerable	ADJ	JJ	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
peroxisomes	peroxisome	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
inductive	inductive	ADJ	JJ	O
proliferation	proliferation	NOUN	NN	O
of	of	ADP	IN	O
peroxisomes	peroxisome	NOUN	NNS	O
.	.	PUNCT	.	O

Within	within	ADP	IN	O
the	the	DET	DT	O
nodules	nodule	NOUN	NNS	O
,	,	PUNCT	,	O
foci	foci	NOUN	NN	O
of	of	ADP	IN	O
proliferation	proliferation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cells	cell	NOUN	NNS	O
that	that	DET	WDT	O
showed	show	VERB	VBD	O
no	no	DET	DT	O
inducibility	inducibility	NOUN	NN	O
of	of	ADP	IN	O
proliferation	proliferation	NOUN	NN	O
of	of	ADP	IN	O
peroxisomes	peroxisome	NOUN	NNS	O
appeared	appear	VERB	VBD	O
.	.	PUNCT	.	O

These	these	DET	DT	O
cells	cell	NOUN	NNS	O
proliferated	proliferate	VERB	VBD	O
further	further	ADV	RB	O
,	,	PUNCT	,	O
replacing	replace	VERB	VBG	O
the	the	DET	DT	O
most	most	ADJ	JJS	O
part	part	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
nodules	nodule	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
with	with	ADP	IN	O
this	this	DET	DT	O
process	process	NOUN	NN	O
hepatomas	hepatomas	NOUN	NN	B-Disease
appeared	appear	VERB	VBD	O
to	to	PART	TO	O
have	have	VERB	VB	O
been	be	VERB	VBN	O
formed	form	VERB	VBN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
abnormal	abnormal	ADJ	JJ	O
matrical	matrical	ADJ	JJ	O
inclusions	inclusion	NOUN	NNS	O
of	of	ADP	IN	O
peroxisomes	peroxisome	NOUN	NNS	O
were	be	VERB	VBD	O
formed	form	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
cells	cell	NOUN	NNS	O
of	of	ADP	IN	O
hyperplastic	hyperplastic	ADJ	JJ	O
nodules	nodule	NOUN	NNS	O
by	by	ADP	IN	O
ethyl	ethyl	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
alpha	alpha	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
p	p	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
chlorophenoxyisobutyrate	chlorophenoxyisobutyrate	NOUN	NN	I-Chemical
unlike	unlike	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Contribution	contribution	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
sympathetic	sympathetic	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
to	to	PART	TO	O
salt	salt	NOUN	NN	O
-	-	PUNCT	HYPH	O
sensitivity	sensitivity	NOUN	NN	O
in	in	ADP	IN	O
lifetime	lifetime	NOUN	NN	O
captopril	captopril	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
spontaneously	spontaneously	ADV	RB	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
test	test	VERB	VB	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
that	that	DET	WDT	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
lifetime	lifetime	NOUN	NN	O
captopril	captopril	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
spontaneously	spontaneously	ADV	RB	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
SHR	SHR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
sympathetic	sympathetic	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
contributes	contribute	VERB	VBZ	O
importantly	importantly	ADV	RB	O
to	to	ADP	IN	O
the	the	DET	DT	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
dietary	dietary	ADJ	JJ	B-Chemical
sodium	sodium	NOUN	NN	I-Chemical
chloride	chloride	NOUN	NN	I-Chemical
supplementation	supplementation	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Male	male	ADJ	JJ	O
SHR	SHR	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
aged	age	VERB	VBN	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
that	that	DET	WDT	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
treated	treat	VERB	VBN	O
from	from	ADP	IN	O
conception	conception	NOUN	NN	O
onward	onward	ADV	RB	O
with	with	ADP	IN	O
either	either	DET	DT	O
captopril	captopril	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
vehicle	vehicle	NOUN	NN	O
remained	remain	VERB	VBD	O
on	on	ADP	IN	O
a	a	DET	DT	O
basal	basal	NOUN	NN	O
sodium	sodium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
diet	diet	NOUN	NN	O
or	or	CCONJ	CC	O
were	be	VERB	VBD	O
fed	feed	VERB	VBN	O
a	a	DET	DT	O
high	high	ADJ	JJ	O
sodium	sodium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
diet	diet	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
2	2	NUM	CD	O
weeks	week	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
subjected	subject	VERB	VBN	O
to	to	ADP	IN	O
ganglionic	ganglionic	ADJ	JJ	O
blockade	blockade	NOUN	NN	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
days	day	NOUN	NNS	O
later	later	ADV	RB	O
,	,	PUNCT	,	O
an	an	DET	DT	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
clonidine	clonidine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Lifetime	lifetime	NOUN	NN	O
captopril	captopril	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
significantly	significantly	ADV	RB	O
lowered	lower	VERB	VBD	O
mean	mean	ADJ	JJ	O
arterial	arterial	ADJ	JJ	O
pressure	pressure	NOUN	NN	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Intravenous	intravenous	ADJ	JJ	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ganglionic	ganglionic	ADJ	JJ	O
blocker	blocker	NOUN	NN	O
hexamethonium	hexamethonium	NOUN	NN	B-Chemical
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
a	a	DET	DT	O
rapid	rapid	ADJ	JJ	O
decline	decline	NOUN	NN	O
in	in	ADP	IN	O
MAP	MAP	PROPN	NNP	O
that	that	DET	WDT	O
eliminated	eliminate	VERB	VBD	O
the	the	DET	DT	O
dietary	dietary	ADJ	JJ	B-Chemical
sodium	sodium	NOUN	NN	I-Chemical
chloride	chloride	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
increase	increase	NOUN	NN	B-Disease
in	in	ADP	IN	I-Disease
MAP	MAP	PROPN	NNP	I-Disease
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
central	central	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
alpha2	alpha2	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
adrenergic	adrenergic	NOUN	NN	I-Chemical
receptor	receptor	NOUN	NN	I-Chemical
agonist	agonist	NOUN	NN	I-Chemical
clonidine	clonidine	NOUN	NN	B-Chemical
also	also	ADV	RB	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
a	a	DET	DT	O
greater	great	ADJ	JJR	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
MAP	MAP	PROPN	NNP	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
SHR	SHR	PROPN	NNP	O
that	that	DET	WDT	O
were	be	VERB	VBD	O
fed	feed	VERB	VBN	O
the	the	DET	DT	O
high	high	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
basal	basal	NOUN	NN	O
)	)	PUNCT	-RRB-	O
sodium	sodium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
diet	diet	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
both	both	DET	DT	O
lifetime	lifetime	NOUN	NN	O
captopril	captopril	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
and	and	CCONJ	CC	O
control	control	VERB	VB	O
SHR	SHR	PROPN	NNP	O
,	,	PUNCT	,	O
the	the	DET	DT	O
sympathetic	sympathetic	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
contributes	contribute	NOUN	NNS	O
to	to	ADP	IN	O
the	the	DET	DT	O
pressor	pressor	NOUN	NN	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
a	a	DET	DT	O
high	high	ADJ	JJ	O
sodium	sodium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
diet	diet	NOUN	NN	O
.	.	PUNCT	.	O

Angioedema	Angioedema	PROPN	NNP	B-Disease
associated	associate	VERB	VBD	O
with	with	ADP	IN	O
droperidol	droperidol	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Angioedema	Angioedema	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
also	also	ADV	RB	O
known	know	VERB	VBN	O
as	as	ADP	IN	O
angioneurotic	angioneurotic	ADJ	JJ	B-Disease
edema	edema	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
Quincke	Quincke	PROPN	NNP	B-Disease
'	'	PUNCT	''	I-Disease
s	s	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
well	well	ADV	RB	O
-	-	PUNCT	HYPH	O
demarcated	demarcate	VERB	VBN	O
,	,	PUNCT	,	O
localized	localize	VERB	VBN	O
edema	edema	NOUN	NN	B-Disease
involving	involve	VERB	VBG	O
the	the	DET	DT	O
subcutaneous	subcutaneous	ADJ	JJ	O
tissues	tissue	NOUN	NNS	O
that	that	DET	WDT	O
may	may	VERB	MD	O
cause	cause	VERB	VB	O
upper	upper	ADJ	JJ	B-Disease
-	-	PUNCT	HYPH	I-Disease
airway	airway	NOUN	NN	I-Disease
obstruction	obstruction	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
the	the	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
previously	previously	ADV	RB	O
healthy	healthy	ADJ	JJ	O
19	19	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
man	man	NOUN	NN	O
with	with	ADP	IN	O
no	no	DET	DT	O
known	know	VERB	VBN	O
drug	drug	NOUN	NN	B-Disease
allergies	allergy	NOUN	NNS	I-Disease
in	in	ADP	IN	O
whom	whom	PRON	WP	O
angioedema	angioedema	VERB	VBP	B-Disease
with	with	ADP	IN	O
significant	significant	ADJ	JJ	O
tongue	tongue	NOUN	NN	B-Disease
swelling	swell	VERB	VBG	I-Disease
and	and	CCONJ	CC	O
protrusion	protrusion	NOUN	NN	O
developed	develop	VERB	VBD	O
within	within	ADP	IN	O
10	10	NUM	CD	O
minutes	minute	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
IV	iv	NOUN	NN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
droperidol	droperidol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Late	late	ADJ	JJ	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
a	a	DET	DT	O
malignant	malignant	ADJ	JJ	O
bone	bone	NOUN	NN	B-Disease
tumor	tumor	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Cardiac	cardiac	ADJ	JJ	O
function	function	NOUN	NN	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
in	in	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
survivors	survivor	NOUN	NNS	O
of	of	ADP	IN	O
malignant	malignant	ADJ	JJ	O
bone	bone	NOUN	NN	B-Disease
tumors	tumor	NOUN	NNS	I-Disease
who	who	PRON	WP	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
according	accord	VERB	VBG	O
to	to	ADP	IN	O
Rosen	Rosen	PROPN	NNP	B-Chemical
'	'	PART	POS	I-Chemical
s	s	NOUN	NN	I-Chemical
T5	t5	NOUN	NN	I-Chemical
or	or	CCONJ	CC	I-Chemical
T10	t10	NOUN	NN	I-Chemical
protocol	protocol	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
both	both	DET	DT	O
including	include	VERB	VBG	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Thirty	thirty	NUM	CD	O
-	-	PUNCT	HYPH	O
one	one	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
age	age	NOUN	NN	O
10	10	NUM	CD	O
-	-	SYM	SYM	O
45	45	NUM	CD	O
years	year	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
median	median	ADJ	JJ	O
age	age	NOUN	NN	O
17	17	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
-	-	SYM	SYM	O
14	14	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
years	year	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
median	median	NOUN	NN	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
following	follow	VERB	VBG	O
completion	completion	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Cumulative	cumulative	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
225	225	NUM	CD	O
-	-	SYM	SYM	O
550	550	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
median	median	NOUN	NN	O
dose	dose	NOUN	NN	O
360	360	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
evaluation	evaluation	NOUN	NN	O
consisted	consist	VERB	VBD	O
of	of	ADP	IN	O
a	a	DET	DT	O
history	history	NOUN	NN	O
,	,	PUNCT	,	O
physical	physical	ADJ	JJ	O
examination	examination	NOUN	NN	O
,	,	PUNCT	,	O
electrocardiogram	electrocardiogram	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ECG	ECG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
signal	signal	NOUN	NN	O
averaged	average	VERB	VBN	O
ECG	ECG	PROPN	NNP	O
,	,	PUNCT	,	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
ambulatory	ambulatory	NOUN	NN	O
ECG	ECG	PROPN	NNP	O
,	,	PUNCT	,	O
echocardiography	echocardiography	NOUN	NN	O
and	and	CCONJ	CC	O
radionuclide	radionuclide	VERB	VB	O
angiography	angiography	ADV	RB	O
.	.	PUNCT	.	O

Eighteen	eighteen	NUM	CD	O
of	of	ADP	IN	O
31	31	NUM	CD	O
(	(	PUNCT	-LRB-	O
58	58	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
patients	patient	NOUN	NNS	O
showed	show	VERB	VBD	O
cardiac	cardiac	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
,	,	PUNCT	,	O
defined	define	VERB	VBN	O
as	as	ADP	IN	O
having	have	VERB	VBG	O
one	one	NUM	CD	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
of	of	ADP	IN	O
the	the	DET	DT	O
following	follow	VERB	VBG	O
abnormalities	abnormality	NOUN	NNS	O
:	:	PUNCT	:	O
late	late	ADJ	JJ	O
potentials	potential	NOUN	NNS	O
,	,	PUNCT	,	O
complex	complex	ADJ	JJ	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
left	leave	VERB	VBD	O
ventricular	ventricular	ADJ	JJ	B-Disease
dilation	dilation	NOUN	NN	I-Disease
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
shortening	shorten	VERB	VBG	O
fraction	fraction	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
decreased	decrease	VERB	VBD	O
ejection	ejection	NOUN	NN	O
fraction	fraction	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	B-Disease
abnormalities	abnormality	NOUN	NNS	I-Disease
increased	increase	VERB	VBD	O
with	with	ADP	IN	O
length	length	NOUN	NN	O
of	of	ADP	IN	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
or	or	CCONJ	CC	O
=	=	NOUN	NNS	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

No	no	DET	DT	O
correlation	correlation	NOUN	NN	O
could	could	VERB	MD	O
be	be	VERB	VB	O
demonstrated	demonstrate	VERB	VBN	O
between	between	ADP	IN	O
cumulative	cumulative	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
cardiac	cardiac	ADJ	JJ	O
status	status	NOUN	NN	O
,	,	PUNCT	,	O
except	except	ADP	IN	O
for	for	ADP	IN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
variability	variability	NOUN	NN	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
adjusted	adjust	VERB	VBN	O
to	to	ADP	IN	O
body	body	NOUN	NN	O
surface	surface	NOUN	NN	O
area	area	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
left	left	ADJ	JJ	O
ventricular	ventricular	ADJ	JJ	O
posterior	posterior	ADJ	JJ	O
wall	wall	NOUN	NN	O
thickness	thickness	NOUN	NN	O
(	(	PUNCT	-LRB-	O
LVPW	LVPW	PROPN	NNP	O
index	index	NOUN	NN	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
in	in	ADP	IN	O
all	all	DET	DT	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
high	high	ADJ	JJ	O
and	and	CCONJ	CC	O
increases	increase	NOUN	NNS	O
with	with	ADP	IN	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
,	,	PUNCT	,	O
irrespective	irrespective	ADV	RB	O
of	of	ADP	IN	O
cumulative	cumulative	ADJ	JJ	O
dose	dose	NOUN	NN	O
.	.	PUNCT	.	O

Life	life	NOUN	NN	O
-	-	PUNCT	HYPH	O
long	long	ADJ	JJ	O
cardiac	cardiac	ADJ	JJ	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
is	be	VERB	VBZ	O
warranted	warrant	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
our	-PRON-	DET	PRP$	O
study	study	NOUN	NN	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
variability	variability	NOUN	NN	O
and	and	CCONJ	CC	O
LVPW	LVPW	PROPN	NNP	O
index	index	NOUN	NN	O
could	could	VERB	MD	O
be	be	VERB	VB	O
sensitive	sensitive	ADJ	JJ	O
indicators	indicator	NOUN	NNS	O
for	for	ADP	IN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
elevations	elevation	NOUN	NNS	O
with	with	ADP	IN	O
caffeine	caffeine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
men	man	NOUN	NNS	O
with	with	ADP	IN	O
borderline	borderline	NOUN	NN	O
systemic	systemic	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Whether	whether	ADP	IN	O
the	the	DET	DT	O
vasoconstrictive	vasoconstrictive	ADJ	JJ	O
actions	action	NOUN	NNS	O
of	of	ADP	IN	O
caffeine	caffeine	NOUN	NN	B-Chemical
are	be	VERB	VBP	O
enhanced	enhance	VERB	VBN	O
in	in	ADP	IN	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
persons	person	NOUN	NNS	O
has	have	VERB	VBZ	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
demonstrated	demonstrate	VERB	VBN	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
caffeine	caffeine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	NOUN	NN	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
versus	versus	ADP	IN	O
placebo	placebo	NOUN	NN	O
was	be	VERB	VBD	O
tested	test	VERB	VBN	O
in	in	ADP	IN	O
48	48	NUM	CD	O
healthy	healthy	ADJ	JJ	O
men	man	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
aged	age	VERB	VBN	O
20	20	NUM	CD	O
to	to	PART	TO	O
35	35	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
selected	select	VERB	VBN	O
after	after	ADP	IN	O
screening	screen	VERB	VBG	O
on	on	ADP	IN	O
2	2	NUM	CD	O
separate	separate	ADJ	JJ	O
occasions	occasion	NOUN	NNS	O
.	.	PUNCT	.	O

Borderline	Borderline	PROPN	NNP	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
men	man	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
24	24	NUM	CD	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
selected	select	VERB	VBN	O
with	with	ADP	IN	O
screening	screen	VERB	VBG	O
systolic	systolic	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BP	BP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
140	140	NUM	CD	O
to	to	PART	TO	O
160	160	NUM	CD	O
mm	mm	NOUN	NN	O
Hg	Hg	PROPN	NNP	O
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
diastolic	diastolic	ADJ	JJ	O
BP	BP	PROPN	NNP	O
90	90	NUM	CD	O
to	to	PART	TO	O
99	99	NUM	CD	O
mm	mm	NOUN	NNS	O
Hg	Hg	PROPN	NNP	O
.	.	PUNCT	.	O

Low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
risk	risk	NOUN	NN	O
controls	control	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
24	24	NUM	CD	O
)	)	PUNCT	-RRB-	O
reported	report	VERB	VBD	O
no	no	DET	DT	O
parental	parental	ADJ	JJ	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
hypertension	hypertension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
had	have	VERB	VBD	O
screening	screen	VERB	VBG	O
BP	BP	PROPN	NNP	O
<	<	X	XX	O
130	130	NUM	CD	O
/	/	SYM	SYM	O
85	85	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
.	.	PUNCT	.	O

Participants	participant	NOUN	NNS	O
were	be	VERB	VBD	O
then	then	ADV	RB	O
tested	test	VERB	VBN	O
on	on	ADP	IN	O
2	2	NUM	CD	O
occasions	occasion	NOUN	NNS	O
after	after	ADP	IN	O
12	12	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
abstinence	abstinence	NOUN	NN	O
from	from	ADP	IN	O
caffeine	caffeine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
each	each	DET	DT	O
of	of	ADP	IN	O
2	2	NUM	CD	O
protocols	protocol	NOUN	NNS	O
;	;	PUNCT	:	O
this	this	DET	DT	O
required	require	VERB	VBD	O
a	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
4	4	NUM	CD	O
laboratory	laboratory	NOUN	NN	O
visits	visit	NOUN	NNS	O
.	.	PUNCT	.	O

Caffeine	caffeine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
diastolic	diastolic	ADJ	JJ	O
BP	BP	PROPN	NNP	O
were	be	VERB	VBD	O
2	2	NUM	CD	O
to	to	ADP	IN	O
3	3	NUM	CD	O
times	time	NOUN	NNS	O
larger	large	ADJ	JJR	O
in	in	ADP	IN	O
borderline	borderline	NOUN	NN	O
subjects	subject	NOUN	NNS	O
than	than	ADP	IN	O
in	in	ADP	IN	O
controls	control	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
8	8	NUM	CD	O
.	.	NOUN	NN	O
4	4	NUM	CD	O
vs	vs	NOUN	NN	O
+	+	X	XX	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0001	0001	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
were	be	VERB	VBD	O
attributable	attributable	ADJ	JJ	O
to	to	PART	TO	O
larger	large	ADJ	JJR	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
impedance	impedance	NOUN	NN	O
-	-	PUNCT	HYPH	O
derived	derive	VERB	VBN	O
measures	measure	NOUN	NNS	O
of	of	ADP	IN	O
systemic	systemic	ADJ	JJ	O
vascular	vascular	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
(	(	PUNCT	-LRB-	O
+	+	CCONJ	CC	O
135	135	NUM	CD	O
vs	vs	NOUN	NN	O
+	+	CCONJ	CC	O
45	45	NUM	CD	O
dynes	dyne	NOUN	NNS	O
.	.	PUNCT	.	O
s	s	PUNCT	LS	O
.	.	PUNCT	.	O
cm	cm	NOUN	NNS	O
-	-	PUNCT	:	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
p	p	PUNCT	LS	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
004	004	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
were	be	VERB	VBD	O
consistent	consistent	ADJ	JJ	O
and	and	CCONJ	CC	O
reached	reach	VERB	VBN	O
significance	significance	NOUN	NN	O
in	in	ADP	IN	O
both	both	DET	DT	O
protocols	protocol	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
percentage	percentage	NOUN	NN	O
of	of	ADP	IN	O
borderline	borderline	NOUN	NN	O
subjects	subject	NOUN	NNS	O
in	in	ADP	IN	O
whom	whom	PRON	WP	O
diastolic	diastolic	ADJ	JJ	O
BP	BP	PROPN	NNP	O
changes	change	NOUN	NNS	O
exceeded	exceed	VERB	VBD	O
the	the	DET	DT	O
median	median	ADJ	JJ	O
control	control	NOUN	NN	O
response	response	NOUN	NN	O
was	be	VERB	VBD	O
96	96	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

Consequently	consequently	ADV	RB	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
all	all	DET	DT	O
participants	participant	NOUN	NNS	O
exhibited	exhibit	VERB	VBD	O
normotensive	normotensive	ADJ	JJ	O
levels	level	NOUN	NNS	O
during	during	ADP	IN	O
the	the	DET	DT	O
resting	rest	VERB	VBG	O
predrug	predrug	NOUN	NN	O
baseline	baseline	NOUN	NN	O
,	,	PUNCT	,	O
33	33	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
borderline	borderline	NOUN	NN	O
subjects	subject	NOUN	NNS	O
achieved	achieve	VERB	VBN	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
BP	BP	PROPN	NNP	O
levels	level	NOUN	NNS	O
after	after	ADP	IN	O
caffeine	caffeine	NOUN	NN	B-Chemical
ingestion	ingestion	NOUN	NN	O
.	.	PUNCT	.	O

Thus	thus	ADV	RB	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
borderline	borderline	NOUN	NN	O
hypertensive	hypertensive	ADJ	JJ	B-Disease
men	man	NOUN	NNS	O
,	,	PUNCT	,	O
exaggerated	exaggerated	ADJ	JJ	O
responses	response	NOUN	NNS	O
to	to	ADP	IN	O
caffeine	caffeine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
:	:	PUNCT	:	O
selective	selective	ADJ	JJ	O
for	for	ADP	IN	O
diastolic	diastolic	ADJ	JJ	O
BP	BP	PROPN	NNP	O
,	,	PUNCT	,	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
greater	great	ADJ	JJR	O
vasoconstriction	vasoconstriction	NOUN	NN	O
,	,	PUNCT	,	O
replicated	replicate	VERB	VBN	O
in	in	ADP	IN	O
2	2	NUM	CD	O
protocols	protocol	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
representative	representative	NOUN	NN	O
of	of	ADP	IN	O
nearly	nearly	ADV	RB	O
all	all	DET	DT	O
borderline	borderline	NOUN	NN	O
hypertensives	hypertensive	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
suspect	suspect	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
potential	potential	NOUN	NN	O
for	for	ADP	IN	O
caffeine	caffeine	NOUN	NN	B-Chemical
to	to	PART	TO	O
stabilize	stabilize	VERB	VB	O
high	high	ADJ	JJ	O
resistance	resistance	NOUN	NN	O
states	state	NOUN	NNS	O
in	in	ADP	IN	O
susceptible	susceptible	ADJ	JJ	O
persons	person	NOUN	NNS	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
its	-PRON-	DET	PRP$	O
use	use	NOUN	NN	O
may	may	VERB	MD	O
facilitate	facilitate	VERB	VB	O
their	-PRON-	DET	PRP$	O
disease	disease	NOUN	NN	O
progression	progression	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
hinder	hind	ADJ	JJR	O
accurate	accurate	ADJ	JJ	O
diagnosis	diagnosis	NOUN	NN	O
and	and	CCONJ	CC	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Absence	absence	NOUN	NN	O
of	of	ADP	IN	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
sertraline	sertraline	NOUN	NN	B-Chemical
on	on	ADP	IN	O
time	time	NOUN	NN	O
-	-	PUNCT	HYPH	O
based	base	VERB	VBN	O
sensitization	sensitization	NOUN	NN	O
of	of	ADP	IN	O
cognitive	cognitive	ADJ	JJ	B-Disease
impairment	impairment	NOUN	NN	I-Disease
with	with	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

This	this	DET	DT	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
study	study	NOUN	NN	O
evaluated	evaluate	VERB	VBD	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
alone	alone	ADV	RB	O
and	and	CCONJ	CC	O
haloperidol	haloperidol	ADV	RB	B-Chemical
plus	plus	CCONJ	CC	O
sertraline	sertraline	NOUN	NN	B-Chemical
on	on	ADP	IN	O
cognitive	cognitive	ADJ	JJ	O
and	and	CCONJ	CC	O
psychomotor	psychomotor	NOUN	NN	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
24	24	NUM	CD	O
healthy	healthy	ADJ	JJ	O
male	male	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
.	.	PUNCT	.	O

METHOD	method	NOUN	NN	O
:	:	PUNCT	:	O
All	all	DET	DT	O
subjects	subject	NOUN	NNS	O
received	receive	VERB	VBD	O
placebo	placebo	NOUN	NN	O
on	on	ADP	IN	O
Day	day	NOUN	NN	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
haloperidol	haloperidol	ADV	RB	B-Chemical
2	2	NUM	CD	O
mg	mg	NOUN	NN	O
on	on	ADP	IN	O
Days	day	NOUN	NNS	O
2	2	NUM	CD	O
and	and	CCONJ	CC	O
25	25	NUM	CD	O
.	.	PUNCT	.	O

From	from	ADP	IN	O
Days	day	NOUN	NNS	O
9	9	NUM	CD	O
to	to	ADP	IN	O
25	25	NUM	CD	O
,	,	PUNCT	,	O
subjects	subject	NOUN	NNS	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
assigned	assign	VERB	VBN	O
to	to	ADP	IN	O
either	either	DET	DT	O
sertraline	sertraline	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
subjects	subject	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
subjects	subject	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
the	the	DET	DT	O
sertraline	sertraline	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
titrated	titrate	VERB	VBN	O
from	from	ADP	IN	O
50	50	NUM	CD	O
to	to	ADP	IN	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
from	from	ADP	IN	O
Days	Days	PROPN	NNP	O
9	9	NUM	CD	O
to	to	ADP	IN	O
16	16	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
remained	remain	VERB	VBD	O
at	at	ADP	IN	O
200	200	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
final	final	ADJ	JJ	O
10	10	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
administration	administration	NOUN	NN	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

Cognitive	cognitive	ADJ	JJ	O
function	function	NOUN	NN	O
testing	testing	NOUN	NN	O
was	be	VERB	VBD	O
performed	perform	VERB	VBN	O
before	before	ADP	IN	O
dosing	dose	VERB	VBG	O
and	and	CCONJ	CC	O
over	over	ADP	IN	O
a	a	DET	DT	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
period	period	NOUN	NN	O
after	after	ADP	IN	O
dosing	dose	VERB	VBG	O
on	on	ADP	IN	O
Days	Days	PROPN	NNP	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
25	25	NUM	CD	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Impairment	impairment	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
cognitive	cognitive	ADJ	JJ	I-Disease
function	function	NOUN	NN	I-Disease
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
6	6	NUM	CD	O
to	to	PART	TO	O
8	8	NUM	CD	O
hours	hour	NOUN	NNS	O
after	after	ADP	IN	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
on	on	ADP	IN	O
Day	day	NOUN	NN	O
2	2	NUM	CD	O
but	but	CCONJ	CC	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
evident	evident	ADJ	JJ	O
23	23	NUM	CD	O
hours	hour	NOUN	NNS	O
after	after	ADP	IN	O
dosing	dose	VERB	VBG	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
single	single	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
given	give	VERB	VBN	O
again	again	ADV	RB	O
25	25	NUM	CD	O
days	day	NOUN	NNS	O
later	later	ADV	RB	O
,	,	PUNCT	,	O
greater	great	ADJ	JJR	O
impairment	impairment	NOUN	NN	O
with	with	ADP	IN	O
earlier	early	ADJ	JJR	O
onset	onset	NOUN	NN	O
was	be	VERB	VBD	O
noted	note	VERB	VBN	O
in	in	ADP	IN	O
several	several	ADJ	JJ	O
tests	test	NOUN	NNS	O
in	in	ADP	IN	O
both	both	DET	DT	O
treatment	treatment	NOUN	NN	O
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
enhancement	enhancement	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
effect	effect	NOUN	NN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
indication	indication	NOUN	NN	O
that	that	ADP	IN	O
sertraline	sertraline	NOUN	NN	B-Chemical
exacerbated	exacerbate	VERB	VBD	O
the	the	DET	DT	O
impairment	impairment	NOUN	NN	O
produced	produce	VERB	VBN	O
by	by	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
since	since	ADP	IN	O
an	an	DET	DT	O
equivalent	equivalent	ADJ	JJ	O
effect	effect	NOUN	NN	O
also	also	ADV	RB	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Three	three	NUM	CD	O
subjects	subject	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
on	on	ADP	IN	O
sertraline	sertraline	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
1	1	NUM	CD	O
on	on	ADP	IN	O
placebo	placebo	NOUN	NN	O
)	)	PUNCT	-RRB-	O
withdrew	withdraw	VERB	VBD	O
from	from	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
because	because	ADP	IN	O
of	of	ADP	IN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

Ten	ten	NUM	CD	O
subjects	subject	NOUN	NNS	O
in	in	ADP	IN	O
each	each	DET	DT	O
group	group	NOUN	NN	O
reported	report	VERB	VBD	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
side	side	NOUN	NN	O
effect	effect	NOUN	NN	O
profiles	profile	NOUN	NNS	O
of	of	ADP	IN	O
sertraline	sertraline	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
of	of	ADP	IN	O
placebo	placebo	NOUN	NN	O
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Haloperidol	Haloperidol	PROPN	NNP	B-Chemical
produced	produce	VERB	VBD	O
a	a	DET	DT	O
clear	clear	ADJ	JJ	O
profile	profile	NOUN	NN	O
of	of	ADP	IN	O
cognitive	cognitive	ADJ	JJ	B-Disease
impairment	impairment	NOUN	NN	I-Disease
that	that	DET	WDT	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
worsened	worsen	VERB	VBN	O
by	by	ADP	IN	O
concomitant	concomitant	ADJ	JJ	O
sertraline	sertraline	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Coexistence	coexistence	NOUN	NN	O
of	of	ADP	IN	O
cerebral	cerebral	ADJ	JJ	B-Disease
venous	venous	ADJ	JJ	I-Disease
sinus	sinus	NOUN	NN	I-Disease
and	and	CCONJ	CC	I-Disease
internal	internal	ADJ	JJ	I-Disease
carotid	carotid	ADJ	JJ	I-Disease
artery	artery	NOUN	NN	I-Disease
thrombosis	thrombosis	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
exogenous	exogenous	ADJ	JJ	O
sex	sex	NOUN	NN	O
hormones	hormone	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
forty	forty	NUM	CD	O
-	-	PUNCT	HYPH	O
six	six	NUM	CD	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
premenopausal	premenopausal	NOUN	NN	O
woman	woman	NOUN	NN	O
developed	develop	VERB	VBD	O
headache	headache	NOUN	NN	B-Disease
,	,	PUNCT	,	O
nausea	nausea	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
vomiting	vomiting	NOUN	NN	B-Disease
,	,	PUNCT	,	O
left	leave	VERB	VBD	O
hemiparesis	hemiparesis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
seizure	seizure	VERB	VB	B-Disease
two	two	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
parenteral	parenteral	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
progesterone	progesterone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
estradiol	estradiol	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

Diabetes	diabetes	NOUN	NN	B-Disease
mellitus	mellitus	PROPN	NNP	I-Disease
(	(	PUNCT	-LRB-	O
DM	DM	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
during	during	ADP	IN	O
admission	admission	NOUN	NN	O
.	.	PUNCT	.	O

Computed	compute	VERB	VBN	O
tomography	tomography	NOUN	NN	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
infarct	infarct	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
right	right	ADJ	JJ	O
frontal	frontal	ADJ	JJ	O
lobe	lobe	NOUN	NN	O
and	and	CCONJ	CC	O
increased	increase	VERB	VBN	O
density	density	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
superior	superior	ADJ	JJ	O
sagittal	sagittal	ADJ	JJ	O
sinus	sinus	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SSS	SSS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Left	leave	VERB	VBN	O
carotid	carotid	ADJ	JJ	O
angiography	angiography	NOUN	NN	O
found	find	VERB	VBD	O
occlusion	occlusion	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
left	left	ADJ	JJ	I-Disease
internal	internal	ADJ	JJ	I-Disease
carotid	carotid	ADJ	JJ	I-Disease
artery	artery	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
ICA	ICA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Right	right	ADJ	JJ	O
carotid	carotid	ADJ	JJ	O
angiograms	angiogram	NOUN	NNS	O
failed	fail	VERB	VBD	O
to	to	PART	TO	O
show	show	VERB	VB	O
the	the	DET	DT	O
SSS	SSS	PROPN	NNP	O
and	and	CCONJ	CC	O
inferior	inferior	ADJ	JJ	O
sagittal	sagittal	ADJ	JJ	O
sinus	sinus	NOUN	NN	O
,	,	PUNCT	,	O
suggestive	suggestive	NOUN	NN	O
of	of	ADP	IN	O
venous	venous	ADJ	JJ	B-Disease
sinus	sinus	NOUN	NN	I-Disease
thrombosis	thrombosis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Coexistence	coexistence	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cerebral	cerebral	ADJ	JJ	B-Disease
artery	artery	NOUN	NN	I-Disease
and	and	CCONJ	CC	I-Disease
the	the	DET	DT	I-Disease
venous	venous	ADJ	JJ	I-Disease
sinus	sinus	NOUN	NN	I-Disease
occlusion	occlusion	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
described	describe	VERB	VBN	O
infrequently	infrequently	ADV	RB	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
case	case	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
authors	author	NOUN	NNS	O
postulate	postulate	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
estradiol	estradiol	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
progesterone	progesterone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
underlying	underlie	VERB	VBG	O
DM	DM	PROPN	NNP	B-Disease
increased	increase	VERB	VBD	O
vascular	vascular	ADJ	JJ	O
thrombogenicity	thrombogenicity	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
provided	provide	VERB	VBD	O
a	a	DET	DT	O
common	common	ADJ	JJ	O
denominator	denominator	NOUN	NN	O
for	for	ADP	IN	O
thrombosis	thrombosis	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
both	both	CCONJ	CC	I-Disease
the	the	DET	DT	I-Disease
ICA	ICA	PROPN	NNP	I-Disease
and	and	CCONJ	CC	I-Disease
the	the	DET	DT	I-Disease
venous	venous	ADJ	JJ	I-Disease
sinus	sinus	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Chemotherapy	chemotherapy	NOUN	NN	O
of	of	ADP	IN	O
advanced	advanced	ADJ	JJ	O
inoperable	inoperable	ADJ	JJ	O
non	non	ADJ	JJ	B-Disease
-	-	ADJ	JJ	I-Disease
small	small	ADJ	JJ	I-Disease
cell	cell	NOUN	NN	I-Disease
lung	lung	NOUN	NN	I-Disease
cancer	cancer	NOUN	NN	I-Disease
with	with	ADP	IN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
a	a	DET	DT	O
phase	phase	NOUN	NN	O
II	II	PROPN	NNP	O
trial	trial	NOUN	NN	O
.	.	PUNCT	.	O

Paclitaxel	Paclitaxel	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
Taxol	Taxol	PROPN	NNP	B-Chemical
;	;	PUNCT	:	O
Bristol	Bristol	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Myers	Myers	PROPN	NNP	O
Squibb	Squibb	PROPN	NNP	O
Company	Company	PROPN	NNP	O
,	,	PUNCT	,	O
Princeton	Princeton	PROPN	NNP	O
,	,	PUNCT	,	O
NJ	NJ	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
has	have	VERB	VBZ	O
demonstrated	demonstrate	VERB	VBN	O
significant	significant	ADJ	JJ	O
antineoplastic	antineoplastic	ADJ	JJ	O
activity	activity	NOUN	NN	O
against	against	ADP	IN	O
different	different	ADJ	JJ	O
tumor	tumor	NOUN	NN	B-Disease
types	type	NOUN	NNS	O
,	,	PUNCT	,	O
notably	notably	ADV	RB	O
ovarian	ovarian	ADJ	JJ	B-Disease
and	and	CCONJ	CC	I-Disease
breast	breast	NOUN	NN	I-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Two	two	NUM	CD	O
phase	phase	NOUN	NN	O
II	II	PROPN	NNP	O
trials	trial	NOUN	NNS	O
of	of	ADP	IN	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
infusions	infusion	NOUN	NNS	O
in	in	ADP	IN	O
chemotherapy	chemotherapy	NOUN	NN	O
-	-	PUNCT	HYPH	O
naive	naive	ADJ	JJ	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
stage	stage	NOUN	NN	O
IIIB	IIIB	PROPN	NNP	O
or	or	CCONJ	CC	O
IV	IV	PROPN	NNP	O
non	non	ADJ	JJ	B-Disease
-	-	ADJ	JJ	I-Disease
small	small	ADJ	JJ	I-Disease
cell	cell	NOUN	NN	I-Disease
lung	lung	NOUN	NN	I-Disease
cancer	cancer	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
NSCLC	NSCLC	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
reported	report	VERB	VBD	O
response	response	NOUN	NN	O
rates	rate	NOUN	NNS	O
of	of	ADP	IN	O
21	21	NUM	CD	O
%	%	NOUN	NN	O
and	and	CCONJ	CC	O
24	24	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

Leukopenia	Leukopenia	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
dose	dose	NOUN	NN	O
limiting	limit	VERB	VBG	O
:	:	PUNCT	:	O
as	as	ADV	RB	O
many	many	ADJ	JJ	O
as	as	ADP	IN	O
62	62	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
experienced	experience	VERB	VBD	O
grade	grade	NOUN	NN	O
4	4	NUM	CD	O
leukopenia	leukopenia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
investigated	investigate	VERB	VBD	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
a	a	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
infusion	infusion	NOUN	NN	O
in	in	ADP	IN	O
a	a	DET	DT	O
phase	phase	NOUN	NN	O
II	II	PROPN	NNP	O
trial	trial	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
inoperable	inoperable	ADJ	JJ	O
stage	stage	NOUN	NN	O
IIIB	IIIB	PROPN	NNP	O
or	or	CCONJ	CC	O
IV	IV	PROPN	NNP	O
NSCLC	NSCLC	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
58	58	NUM	CD	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBD	O
(	(	PUNCT	-LRB-	O
41	41	NUM	CD	O
men	man	NOUN	NNS	O
and	and	CCONJ	CC	O
17	17	NUM	CD	O
women	woman	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
a	a	DET	DT	O
median	median	ADJ	JJ	O
age	age	NOUN	NN	O
of	of	ADP	IN	O
59	59	NUM	CD	O
years	year	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
age	age	NOUN	NN	O
range	range	NOUN	NN	O
,	,	PUNCT	,	O
25	25	NUM	CD	O
to	to	PART	TO	O
75	75	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
performance	performance	NOUN	NN	O
status	status	NOUN	NN	O
of	of	ADP	IN	O
0	0	NUM	CD	O
through	through	ADP	IN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O

Most	Most	ADJ	JJS	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
72	72	NUM	CD	O
.	.	NOUN	NN	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
stage	stage	NOUN	NN	O
IV	IV	PROPN	NNP	O
NSCLC	NSCLC	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Paclitaxel	Paclitaxel	PROPN	NNP	B-Chemical
225	225	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	PROPN	NNP	O
was	be	VERB	VBD	O
infused	infuse	VERB	VBN	O
over	over	ADP	IN	O
3	3	NUM	CD	O
hours	hour	NOUN	NNS	O
every	every	DET	DT	O
3	3	NUM	CD	O
weeks	week	NOUN	NNS	O
with	with	ADP	IN	O
standard	standard	ADJ	JJ	O
prophylactic	prophylactic	ADJ	JJ	O
premedication	premedication	NOUN	NN	O
.	.	PUNCT	.	O

Of	of	ADP	IN	O
50	50	NUM	CD	O
patients	patient	NOUN	NNS	O
evaluable	evaluable	ADJ	JJ	O
for	for	ADP	IN	O
response	response	NOUN	NN	O
,	,	PUNCT	,	O
12	12	NUM	CD	O
(	(	PUNCT	-LRB-	O
24	24	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
partial	partial	ADJ	JJ	O
remission	remission	NOUN	NN	O
,	,	PUNCT	,	O
26	26	NUM	CD	O
(	(	PUNCT	-LRB-	O
52	52	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
no	no	DET	DT	O
change	change	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
12	12	NUM	CD	O
had	have	VERB	VBD	O
disease	disease	NOUN	NN	O
progression	progression	NOUN	NN	O
(	(	PUNCT	-LRB-	O
24	24	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Hematologic	hematologic	ADJ	JJ	O
toxicities	toxicity	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
mild	mild	ADJ	JJ	O
:	:	PUNCT	:	O
only	only	ADV	RB	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
developed	develop	VERB	VBN	O
grade	grade	NOUN	NN	O
3	3	NUM	CD	O
or	or	CCONJ	CC	O
4	4	NUM	CD	O
neutropenia	neutropenia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
while	while	ADP	IN	O
29	29	NUM	CD	O
%	%	NOUN	NN	O
had	have	VERB	VBD	O
grade	grade	NOUN	NN	O
1	1	NUM	CD	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
.	.	PUNCT	.	O

Grade	Grade	PROPN	NNP	O
1	1	NUM	CD	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
polyneuropathy	polyneuropathy	NOUN	NN	B-Disease
affected	affect	VERB	VBN	O
56	56	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
while	while	ADP	IN	O
only	only	ADV	RB	O
one	one	NUM	CD	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
experienced	experience	VERB	VBD	O
severe	severe	ADJ	JJ	O
polyneuropathy	polyneuropathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Similarly	similarly	ADV	RB	O
,	,	PUNCT	,	O
grade	grade	NOUN	NN	O
1	1	NUM	CD	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
myalgia	myalgia	NOUN	NN	B-Disease
/	/	SYM	SYM	O
arthralgia	arthralgia	NOUN	NN	B-Disease
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
63	63	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
only	only	ADV	RB	O
14	14	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
experienced	experienced	ADJ	JJ	O
grade	grade	NOUN	NN	O
3	3	NUM	CD	O
or	or	CCONJ	CC	O
4	4	NUM	CD	O
.	.	PUNCT	.	O

Nausea	nausea	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
vomiting	vomiting	NOUN	NN	B-Disease
were	be	VERB	VBD	O
infrequent	infrequent	ADJ	JJ	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
14	14	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
experiencing	experience	VERB	VBG	O
grade	grade	NOUN	NN	O
1	1	NUM	CD	O
or	or	CCONJ	CC	O
2	2	NUM	CD	O
and	and	CCONJ	CC	O
only	only	ADV	RB	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
experiencing	experience	VERB	VBG	O
grade	grade	NOUN	NN	O
3	3	NUM	CD	O
or	or	CCONJ	CC	O
4	4	NUM	CD	O
.	.	PUNCT	.	O

Paclitaxel	Paclitaxel	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
thus	thus	ADV	RB	O
an	an	DET	DT	O
active	active	ADJ	JJ	O
single	single	ADJ	JJ	O
agent	agent	NOUN	NN	O
in	in	ADP	IN	O
this	this	DET	DT	O
patient	patient	ADJ	JJ	O
population	population	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
a	a	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
infusion	infusion	NOUN	NN	O
proving	prove	VERB	VBG	O
comparably	comparably	ADV	RB	O
effective	effective	ADJ	JJ	O
to	to	ADP	IN	O
a	a	DET	DT	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
infusion	infusion	NOUN	NN	O
and	and	CCONJ	CC	O
superior	superior	ADJ	JJ	O
in	in	ADP	IN	O
terms	term	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
hematologic	hematologic	NOUN	NN	O
and	and	CCONJ	CC	O
nonhematologic	nonhematologic	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Further	further	ADJ	JJ	O
phase	phase	VERB	VB	O
II	II	PROPN	NNP	O
studies	study	NOUN	NNS	O
with	with	ADP	IN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
active	active	ADJ	JJ	O
against	against	ADP	IN	O
NSCLC	NSCLC	PROPN	NNP	B-Disease
are	be	VERB	VBP	O
indicated	indicate	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
phase	phase	VERB	VB	O
III	III	PROPN	NNP	O
studies	study	NOUN	NNS	O
comparing	compare	VERB	VBG	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
with	with	ADP	IN	O
standard	standard	ADJ	JJ	O
chemotherapy	chemotherapy	NOUN	NN	O
remain	remain	VERB	VBP	O
to	to	PART	TO	O
be	be	VERB	VB	O
completed	complete	VERB	VBN	O
.	.	PUNCT	.	O

Paclitaxel	Paclitaxel	PROPN	NNP	B-Chemical
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
-	-	PUNCT	HYPH	O
line	line	NOUN	NN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
advanced	advanced	ADJ	JJ	O
ovarian	ovarian	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
a	a	DET	DT	O
phase	phase	NOUN	NN	O
I	-PRON-	PRON	PRP	O
study	study	VERB	VBP	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
maximum	maximum	ADJ	JJ	O
tolerated	tolerate	VERB	VBN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
Taxol	Taxol	PROPN	NNP	B-Chemical
;	;	PUNCT	:	O
Bristol	Bristol	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Myers	Myers	PROPN	NNP	O
Squibb	Squibb	PROPN	NNP	O
Company	Company	PROPN	NNP	O
,	,	PUNCT	,	O
Princeton	Princeton	PROPN	NNP	O
,	,	PUNCT	,	O
NJ	NJ	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
given	give	VERB	VBN	O
as	as	ADP	IN	O
a	a	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
infusion	infusion	NOUN	NN	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
administered	administer	VERB	VBN	O
every	every	DET	DT	O
21	21	NUM	CD	O
days	day	NOUN	NNS	O
to	to	ADP	IN	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
advanced	advanced	ADJ	JJ	O
ovarian	ovarian	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
,	,	PUNCT	,	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
doses	dose	NOUN	NNS	O
were	be	VERB	VBD	O
escalated	escalate	VERB	VBN	O
as	as	ADP	IN	O
follows	follow	VERB	VBZ	O
:	:	PUNCT	:	O
level	level	NOUN	NN	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
135	135	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
;	;	PUNCT	:	O
level	level	NOUN	NN	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
160	160	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
;	;	PUNCT	:	O
level	level	NOUN	NN	O
3	3	NUM	CD	O
,	,	PUNCT	,	O
185	185	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
level	level	NOUN	NN	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
210	210	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
fixed	fix	VERB	VBN	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
at	at	ADP	IN	O
levels	level	NOUN	NNS	O
1	1	NUM	CD	O
through	through	ADP	IN	O
4	4	NUM	CD	O
was	be	VERB	VBD	O
given	give	VERB	VBN	O
to	to	PART	TO	O
achieve	achieve	VERB	VB	O
an	an	DET	DT	O
area	area	NOUN	NN	O
under	under	ADP	IN	O
the	the	DET	DT	O
concentration	concentration	NOUN	NN	O
-	-	PUNCT	HYPH	O
time	time	NOUN	NN	O
curve	curve	NOUN	NN	O
(	(	PUNCT	-LRB-	O
AUC	AUC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
5	5	NUM	CD	O
using	use	VERB	VBG	O
the	the	DET	DT	O
Calvert	Calvert	PROPN	NNP	O
formula	formula	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
levels	level	NOUN	NNS	O
5	5	NUM	CD	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
the	the	DET	DT	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
was	be	VERB	VBD	O
targeted	target	VERB	VBN	O
at	at	ADP	IN	O
AUCs	auc	NOUN	NNS	O
of	of	ADP	IN	O
6	6	NUM	CD	O
and	and	CCONJ	CC	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
,	,	PUNCT	,	O
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
fixed	fix	VERB	VBN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
185	185	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
.	.	PUNCT	.	O

To	to	ADP	IN	O
date	date	NOUN	NN	O
,	,	PUNCT	,	O
30	30	NUM	CD	O
previously	previously	ADV	RB	O
untreated	untreated	ADJ	JJ	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
all	all	ADV	RB	O
with	with	ADP	IN	O
a	a	DET	DT	O
good	good	ADJ	JJ	O
performance	performance	NOUN	NN	O
status	status	NOUN	NN	O
(	(	PUNCT	-LRB-	O
Eastern	Eastern	PROPN	NNP	O
Cooperative	Cooperative	PROPN	NNP	O
Oncology	Oncology	PROPN	NNP	O
Group	Group	PROPN	NNP	O
0	0	NUM	CD	O
to	to	ADP	IN	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
entered	enter	VERB	VBN	O
into	into	ADP	IN	O
this	this	DET	DT	O
ongoing	ongoing	ADJ	JJ	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
limiting	limit	VERB	VBG	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
combination	combination	NOUN	NN	O
was	be	VERB	VBD	O
myelosuppression	myelosuppression	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
leukopenia	leukopenia	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
granulocytopenia	granulocytopenia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
was	be	VERB	VBD	O
largely	largely	ADV	RB	O
moderate	moderate	ADJ	JJ	O
.	.	PUNCT	.	O

So	so	ADV	RB	O
far	far	ADV	RB	O
,	,	PUNCT	,	O
14	14	NUM	CD	O
patients	patient	NOUN	NNS	O
are	be	VERB	VBP	O
evaluable	evaluable	ADJ	JJ	O
for	for	ADP	IN	O
response	response	NOUN	NN	O
;	;	PUNCT	:	O
of	of	ADP	IN	O
these	these	DET	DT	O
,	,	PUNCT	,	O
eight	eight	NUM	CD	O
(	(	PUNCT	-LRB-	O
57	57	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
showed	show	VERB	VBD	O
objective	objective	NOUN	NN	O
(	(	PUNCT	-LRB-	O
complete	complete	ADJ	JJ	O
or	or	CCONJ	CC	O
partial	partial	ADJ	JJ	O
)	)	PUNCT	-RRB-	O
response	response	NOUN	NN	O
and	and	CCONJ	CC	O
disease	disease	NOUN	NN	O
stabilized	stabilize	VERB	VBD	O
in	in	ADP	IN	O
six	six	NUM	CD	O
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

No	no	DET	DT	O
patient	patient	NOUN	NN	O
had	have	VERB	VBD	O
disease	disease	NOUN	NN	O
progression	progression	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
combination	combination	NOUN	NN	O
of	of	ADP	IN	O
paclitaxel	paclitaxel	NOUN	NN	B-Chemical
185	185	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
administered	administer	VERB	VBD	O
as	as	ADP	IN	O
a	a	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
infusion	infusion	NOUN	NN	O
followed	follow	VERB	VBD	O
immediately	immediately	ADV	RB	O
by	by	ADP	IN	O
a	a	DET	DT	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
hour	hour	NOUN	NN	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
at	at	ADP	IN	O
an	an	DET	DT	O
AUC	AUC	PROPN	NNP	O
of	of	ADP	IN	O
6	6	NUM	CD	O
can	can	VERB	MD	O
be	be	VERB	VB	O
administered	administer	VERB	VBN	O
safely	safely	ADV	RB	O
in	in	ADP	IN	O
a	a	DET	DT	O
21	21	NUM	CD	O
-	-	PUNCT	HYPH	O
day	day	NOUN	NN	O
schedule	schedule	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
outpatient	outpatient	NOUN	NN	O
setting	setting	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
recommended	recommend	VERB	VBN	O
dose	dose	NOUN	NN	O
for	for	ADP	IN	O
phase	phase	NOUN	NN	O
III	iii	NUM	CD	O
studies	study	NOUN	NNS	O
is	be	VERB	VBZ	O
paclitaxel	paclitaxel	VERB	VBN	B-Chemical
185	185	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
m2	m2	NOUN	NN	O
and	and	CCONJ	CC	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
AUC	AUC	PROPN	NNP	O
6	6	NUM	CD	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
steroid	steroid	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
on	on	ADP	IN	O
ventilatory	ventilatory	ADJ	JJ	O
and	and	CCONJ	CC	O
peripheral	peripheral	ADJ	JJ	O
muscles	muscle	NOUN	NNS	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Occasional	occasional	ADJ	JJ	O
case	case	NOUN	NN	O
reports	report	NOUN	NNS	O
have	have	VERB	VBP	O
shown	show	VERB	VBN	O
that	that	DET	DT	O
acute	acute	ADJ	JJ	O
myopathy	myopathy	NOUN	NN	B-Disease
may	may	VERB	MD	O
occur	occur	VERB	VB	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
massive	massive	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
corticosteroids	corticosteroid	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
myopathy	myopathy	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
poorly	poorly	ADV	RB	O
understood	understand	VERB	VBN	O
.	.	PUNCT	.	O

Therefore	therefore	ADV	RB	O
,	,	PUNCT	,	O
60	60	NUM	CD	O
male	male	NOUN	NN	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
assigned	assign	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
daily	daily	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
saline	saline	NOUN	NN	O
(	(	PUNCT	-LRB-	O
C	c	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
M	M	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
triamcinolone	triamcinolone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
T	t	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
80	80	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
d	d	NOUN	NN	O
for	for	ADP	IN	O
5	5	NUM	CD	O
d	d	NOUN	NN	O
.	.	PUNCT	.	O

Nutritional	nutritional	ADJ	JJ	O
intake	intake	NOUN	NN	O
,	,	PUNCT	,	O
measured	measure	VERB	VBN	O
daily	daily	ADV	RB	O
in	in	ADP	IN	O
15	15	NUM	CD	O
animals	animal	NOUN	NNS	O
,	,	PUNCT	,	O
showed	show	VERB	VBD	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
reduction	reduction	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
food	food	NOUN	NN	I-Disease
intake	intake	NOUN	NN	I-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
steroid	steroid	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
groups	group	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
50	50	NUM	CD	O
and	and	CCONJ	CC	O
-	-	PUNCT	HYPH	O
79	79	NUM	CD	O
%	%	NOUN	NN	O
in	in	ADP	IN	O
M	M	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
T	T	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

This	this	DET	DT	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
similar	similar	ADJ	JJ	O
loss	loss	NOUN	NN	B-Disease
in	in	ADP	IN	I-Disease
body	body	NOUN	NN	I-Disease
weight	weight	NOUN	NN	I-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
45	45	NUM	CD	O
remaining	remain	VERB	VBG	O
animals	animal	NOUN	NNS	O
,	,	PUNCT	,	O
diaphragm	diaphragm	NOUN	NN	O
contractility	contractility	NOUN	NN	O
and	and	CCONJ	CC	O
histopathologic	histopathologic	ADJ	JJ	O
features	feature	NOUN	NNS	O
of	of	ADP	IN	O
several	several	ADJ	JJ	O
muscles	muscle	NOUN	NNS	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
.	.	PUNCT	.	O

Weights	weight	NOUN	NNS	O
of	of	ADP	IN	O
respiratory	respiratory	ADJ	JJ	O
and	and	CCONJ	CC	O
peripheral	peripheral	ADJ	JJ	O
muscles	muscle	NOUN	NNS	O
were	be	VERB	VBD	O
similarly	similarly	ADV	RB	O
decreased	decrease	VERB	VBN	O
after	after	ADP	IN	O
steroid	steroid	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Maximal	maximal	ADJ	JJ	O
twitches	twitch	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
diaphragm	diaphragm	NOUN	NN	O
were	be	VERB	VBD	O
lower	low	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
C	c	NOUN	NN	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
653	653	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
174	174	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
cm	cm	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
M	M	PROPN	NNP	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
837	837	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
171	171	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
cm	cm	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
p	p	PUNCT	LS	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
T	t	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
765	765	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
145	145	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
cm	cm	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
NS	NS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Half	half	ADJ	JJ	O
-	-	PUNCT	HYPH	O
relaxation	relaxation	NOUN	NN	O
time	time	NOUN	NN	O
was	be	VERB	VBD	O
prolonged	prolong	VERB	VBN	O
in	in	ADP	IN	O
both	both	DET	DT	O
steroid	steroid	NOUN	NN	B-Chemical
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
time	time	NOUN	NN	O
to	to	PART	TO	O
peak	peak	VERB	VB	O
tension	tension	NOUN	NN	O
was	be	VERB	VBD	O
longer	long	ADJ	JJR	O
with	with	ADP	IN	O
M	M	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
tetanic	tetanic	ADJ	JJ	B-Disease
tensions	tension	NOUN	NNS	O
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
.	.	PUNCT	.	O

Steroid	Steroid	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
also	also	ADV	RB	O
induced	induce	VERB	VBD	O
a	a	DET	DT	O
leftward	leftward	NOUN	NN	O
shift	shift	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
force	force	NOUN	NN	O
-	-	PUNCT	HYPH	O
frequency	frequency	NOUN	NN	O
curve	curve	NOUN	NN	O
at	at	ADP	IN	O
25	25	NUM	CD	O
and	and	CCONJ	CC	O
50	50	NUM	CD	O
Hz	Hz	PROPN	NNPS	O
when	when	ADV	WRB	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
saline	saline	NOUN	NN	O
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

ATPase	ATPase	PROPN	NNP	O
staining	staining	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
diaphragm	diaphragm	NOUN	NN	O
,	,	PUNCT	,	O
scalenus	scalenus	ADJ	JJ	O
medius	medius	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
gastrocnemius	gastrocnemius	NOUN	NN	O
showed	show	VERB	VBD	O
type	type	NOUN	NN	O
IIb	IIb	NOUN	NNS	O
fiber	fiber	NOUN	NN	O
atrophy	atrophy	NOUN	NN	B-Disease
in	in	ADP	IN	O
the	the	DET	DT	O
steroid	steroid	NOUN	NN	B-Chemical
groups	group	NOUN	NNS	O
and	and	CCONJ	CC	O
also	also	ADV	RB	O
diaphragmatic	diaphragmatic	ADJ	JJ	O
type	type	NOUN	NN	O
IIa	IIa	NOUN	NNS	O
atrophy	atrophy	NOUN	NN	B-Disease
with	with	ADP	IN	O
T	T	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
histologic	histologic	ADJ	JJ	O
examinations	examination	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
a	a	DET	DT	O
normal	normal	ADJ	JJ	O
muscular	muscular	ADJ	JJ	O
pattern	pattern	NOUN	NN	O
with	with	ADP	IN	O
absence	absence	NOUN	NN	O
of	of	ADP	IN	O
necrosis	necrosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Finally	finally	ADV	RB	O
,	,	PUNCT	,	O
a	a	DET	DT	O
pair	pair	NOUN	NN	O
-	-	PUNCT	HYPH	O
fed	fed	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PF	PF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
performed	perform	VERB	VBN	O
in	in	ADP	IN	O
18	18	NUM	CD	O
rats	rat	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
C	c	NOUN	NN	O
,	,	PUNCT	,	O
T	T	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
PF	PF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
muscle	muscle	NOUN	NN	B-Disease
atrophy	atrophy	NOUN	NN	I-Disease
was	be	VERB	VBD	O
considerably	considerably	ADV	RB	O
less	less	ADV	RBR	O
pronounced	pronounce	VERB	VBN	O
in	in	ADP	IN	O
PF	PF	PROPN	NNP	O
animals	animal	NOUN	NNS	O
than	than	ADP	IN	O
in	in	ADP	IN	O
T	t	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
(	(	PUNCT	-LRB-	O
1	1	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
massive	massive	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
steroids	steroid	NOUN	NNS	B-Chemical
induced	induce	VERB	VBD	O
severe	severe	ADJ	JJ	O
respiratory	respiratory	NOUN	NN	O
and	and	CCONJ	CC	O
limb	limb	NOUN	NN	O
muscle	muscle	NOUN	NN	O
wasting	wasting	NOUN	NN	O
;	;	PUNCT	:	O
(	(	PUNCT	-LRB-	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
both	both	DET	DT	O
types	type	NOUN	NNS	O
of	of	ADP	IN	O
steroids	steroid	NOUN	NNS	B-Chemical
induced	induce	VERB	VBD	O
predominantly	predominantly	ADV	RB	O
type	type	NOUN	NN	O
IIb	IIb	NOUN	NNS	O
atrophy	atrophy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
the	the	DET	DT	O
expected	expect	VERB	VBN	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
diaphragm	diaphragm	NOUN	NN	O
contractile	contractile	NOUN	NN	O
properties	property	NOUN	NNS	O
;	;	PUNCT	,	O
(	(	PUNCT	-LRB-	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
neither	neither	CCONJ	CC	O
steroid	steroid	NOUN	NN	B-Chemical
caused	cause	VERB	VBD	O
muscle	muscle	NOUN	NN	O
necrosis	necrosis	NOUN	NN	B-Disease
;	;	PUNCT	,	O
(	(	PUNCT	-LRB-	O
4	4	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
type	type	NOUN	NN	O
IIb	IIb	NOUN	NNS	O
atrophy	atrophy	NOUN	NN	B-Disease
was	be	VERB	VBD	O
not	not	ADV	RB	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
acute	acute	ADJ	JJ	O
nutritional	nutritional	ADJ	JJ	O
deprivation	deprivation	NOUN	NN	O
alone	alone	ADV	RB	O
.	.	PUNCT	.	O

Continuous	continuous	ADJ	JJ	O
subcutaneous	subcutaneous	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
to	to	PART	TO	O
prevent	prevent	VERB	VB	O
ifosfamide	ifosfamide	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Hemorrhagic	hemorrhagic	ADJ	JJ	B-Disease
cystitis	cystitis	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
major	major	ADJ	JJ	O
potential	potential	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
ifosfamide	ifosfamide	NOUN	NN	B-Chemical
that	that	DET	WDT	O
can	can	VERB	MD	O
be	be	VERB	VB	O
prevented	prevent	VERB	VBN	O
by	by	ADP	IN	O
administering	administer	VERB	VBG	O
mesna	mesna	NOUN	NN	B-Chemical
along	along	ADP	IN	O
with	with	ADP	IN	O
the	the	DET	DT	O
cytotoxic	cytotoxic	NOUN	NN	O
agent	agent	NOUN	NN	O
.	.	PUNCT	.	O

Mesna	Mesna	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
generally	generally	ADV	RB	O
administered	administer	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
intravenous	intravenous	ADJ	JJ	O
route	route	NOUN	NN	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
experience	experience	NOUN	NN	O
with	with	ADP	IN	O
oral	oral	ADJ	JJ	O
delivery	delivery	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
has	have	VERB	VBZ	O
increased	increase	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
continuous	continuous	ADJ	JJ	O
subcutaneous	subcutaneous	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
mesna	mesna	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
the	the	DET	DT	O
advantage	advantage	NOUN	NN	O
of	of	ADP	IN	O
not	not	ADV	RB	O
requiring	require	VERB	VBG	O
intravenous	intravenous	ADJ	JJ	O
access	access	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
subcutaneous	subcutaneous	ADJ	JJ	O
delivery	delivery	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
neutralizing	neutralize	VERB	VBG	O
agent	agent	NOUN	NN	O
will	will	VERB	MD	O
not	not	ADV	RB	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
inadequate	inadequate	ADJ	JJ	O
urinary	urinary	ADJ	JJ	O
mesna	mesna	NOUN	NN	B-Chemical
concentrations	concentration	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
in	in	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
taking	take	VERB	VBG	O
oral	oral	ADJ	JJ	O
mesna	mesna	NOUN	NN	B-Chemical
who	who	PRON	WP	O
experiences	experience	VERB	VBZ	O
severe	severe	ADJ	JJ	O
ifosfamide	ifosfamide	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
emesis	emesis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
is	be	VERB	VBZ	O
unable	unable	ADJ	JJ	O
to	to	PART	TO	O
absorb	absorb	VERB	VB	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

Limited	limited	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
experience	experience	NOUN	NN	O
with	with	ADP	IN	O
continuous	continuous	ADJ	JJ	O
subcutaneous	subcutaneous	ADJ	JJ	O
mesna	mesna	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
suggests	suggest	VERB	VBZ	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
safe	safe	ADJ	JJ	O
,	,	PUNCT	,	O
practical	practical	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
economic	economic	ADJ	JJ	O
method	method	NOUN	NN	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
delivery	delivery	NOUN	NN	O
that	that	DET	WDT	O
permits	permit	VERB	VBZ	O
ifosfamide	ifosfamide	ADJ	JJ	B-Chemical
to	to	PART	TO	O
be	be	VERB	VB	O
administered	administer	VERB	VBN	O
successfully	successfully	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
outpatient	outpatient	NOUN	NN	O
setting	setting	NOUN	NN	O
.	.	PUNCT	.	O

Leg	Leg	PROPN	NNP	B-Disease
and	and	CCONJ	CC	I-Disease
back	back	ADJ	JJ	I-Disease
pain	pain	NOUN	NN	I-Disease
after	after	ADP	IN	O
spinal	spinal	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
involving	involve	VERB	VBG	O
hyperbaric	hyperbaric	ADJ	JJ	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
lignocaine	lignocaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Fifty	fifty	NUM	CD	O
-	-	PUNCT	HYPH	O
four	four	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
aged	age	VERB	VBN	O
27	27	NUM	CD	O
-	-	SYM	SYM	O
90	90	NUM	CD	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
lignocaine	lignocaine	NOUN	NN	B-Chemical
5	5	NUM	CD	O
%	%	NOUN	NN	O
in	in	ADP	IN	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
glucose	glucose	NOUN	NN	B-Chemical
solution	solution	NOUN	NN	O
for	for	ADP	IN	O
spinal	spinal	ADJ	JJ	O
anaesthesia	anaesthesia	NOUN	NN	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
.	.	PUNCT	.	O

Thirteen	thirteen	NUM	CD	O
of	of	ADP	IN	O
these	these	DET	DT	O
patients	patient	NOUN	NNS	O
experienced	experience	VERB	VBD	O
pain	pain	NOUN	NN	B-Disease
in	in	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
legs	leg	NOUN	NNS	I-Disease
and	and	CCONJ	CC	I-Disease
/	/	SYM	SYM	I-Disease
or	or	CCONJ	CC	I-Disease
back	back	ADV	RB	I-Disease
after	after	ADP	IN	O
recovery	recovery	NOUN	NN	O
from	from	ADP	IN	O
anaesthesia	anaesthesia	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patients	patient	NOUN	NNS	O
affected	affect	VERB	VBN	O
were	be	VERB	VBD	O
younger	young	ADJ	JJR	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
site	site	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
dural	dural	ADJ	JJ	O
puncture	puncture	NOUN	NN	O
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
those	those	DET	DT	O
individuals	individual	NOUN	NNS	O
without	without	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Five	five	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
13	13	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
38	38	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
seven	seven	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
41	41	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
17	17	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
without	without	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
admitted	admit	VERB	VBN	O
to	to	ADP	IN	O
a	a	DET	DT	O
high	high	ADJ	JJ	O
alcohol	alcohol	NOUN	NN	B-Chemical
intake	intake	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
might	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
contributing	contribute	VERB	VBG	O
factor	factor	NOUN	NN	O
.	.	PUNCT	.	O

Leg	Leg	PROPN	NNP	B-Disease
and	and	CCONJ	CC	I-Disease
/	/	SYM	SYM	I-Disease
or	or	CCONJ	CC	I-Disease
back	back	ADJ	JJ	I-Disease
pain	pain	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
intrathecal	intrathecal	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
hyperbaric	hyperbaric	ADJ	JJ	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
lignocaine	lignocaine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
serum	serum	ADJ	JJ	O
cholinesterase	cholinesterase	NOUN	NN	O
in	in	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
apnoea	apnoea	ADV	RB	B-Disease
.	.	PUNCT	.	O

Fifteen	fifteen	NUM	CD	O
patients	patient	NOUN	NNS	O
demonstrating	demonstrate	VERB	VBG	O
unexpected	unexpected	ADJ	JJ	O
prolonged	prolong	VERB	VBN	O
apnoea	apnoea	ADV	RB	B-Disease
lasting	last	VERB	VBG	O
several	several	ADJ	JJ	O
hours	hour	NOUN	NNS	O
after	after	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
have	have	VERB	VBP	O
been	be	VERB	VBN	O
treated	treat	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
preparation	preparation	NOUN	NN	O
of	of	ADP	IN	O
human	human	ADJ	JJ	O
serum	serum	NOUN	NN	O
cholinesterase	cholinesterase	NOUN	NN	O
.	.	PUNCT	.	O

Adequate	adequate	ADJ	JJ	O
spontaneous	spontaneous	ADJ	JJ	O
respiration	respiration	NOUN	NN	O
was	be	VERB	VBD	O
re	re	VERB	VBN	O
-	-	VERB	VBN	O
established	establish	VERB	VBN	O
in	in	ADP	IN	O
an	an	DET	DT	O
average	average	ADJ	JJ	O
period	period	NOUN	NN	O
of	of	ADP	IN	O
ten	ten	NUM	CD	O
minutes	minute	NOUN	NNS	O
after	after	ADP	IN	O
the	the	DET	DT	O
injection	injection	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
12	12	NUM	CD	O
patients	patient	NOUN	NNS	O
biochemical	biochemical	ADJ	JJ	O
genetic	genetic	ADJ	JJ	O
examinations	examination	NOUN	NNS	O
confirmed	confirm	VERB	VBD	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
an	an	DET	DT	O
atypical	atypical	ADJ	JJ	O
serum	serum	ADJ	JJ	O
cholinesterase	cholinesterase	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
none	none	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
usual	usual	ADJ	JJ	O
variants	variant	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
therefore	therefore	ADV	RB	O
supposed	suppose	VERB	VBN	O
that	that	ADP	IN	O
other	other	ADJ	JJ	O
unknown	unknown	ADJ	JJ	O
variants	variant	NOUN	NNS	O
of	of	ADP	IN	O
serum	serum	ADJ	JJ	O
cholinesterase	cholinesterase	NOUN	NN	O
exist	exist	VERB	VBP	O
which	which	DET	WDT	O
cannot	cannot	NOUN	NN	O
hydrolyze	hydrolyze	ADJ	JJ	O
succinylcholine	succinylcholine	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
serum	serum	ADJ	JJ	O
cholinesterase	cholinesterase	NOUN	NN	O
in	in	ADP	IN	O
succinylcholine	succinylcholine	NOUN	NN	B-Chemical
apnoea	apnoea	NOUN	NN	B-Disease
provided	provide	VERB	VBD	O
considerable	considerable	ADJ	JJ	O
relief	relief	NOUN	NN	O
to	to	ADP	IN	O
both	both	CCONJ	CC	O
patient	patient	ADJ	JJ	O
and	and	CCONJ	CC	O
anaesthetist	anaesthetist	NOUN	NN	O
.	.	PUNCT	.	O

Increased	increase	VERB	VBN	O
sulfation	sulfation	NOUN	NN	O
and	and	CCONJ	CC	O
decreased	decrease	VERB	VBD	O
7alpha	7alpha	NUM	CD	O
-	-	PUNCT	HYPH	O
hydroxylation	hydroxylation	NOUN	NN	O
of	of	ADP	IN	O
deoxycholic	deoxycholic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
in	in	ADP	IN	O
ethinyl	ethinyl	ADJ	JJ	B-Chemical
estradiol	estradiol	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cholestasis	cholestasis	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Deoxycholic	deoxycholic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
conjugation	conjugation	NOUN	NN	O
,	,	PUNCT	,	O
transport	transport	NOUN	NN	O
capacity	capacity	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
metabolism	metabolism	NOUN	NN	O
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
in	in	ADP	IN	O
control	control	NOUN	NN	O
and	and	CCONJ	CC	O
ethinyl	ethinyl	VERB	VB	B-Chemical
estradiol	estradiol	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Control	control	NOUN	NN	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
a	a	DET	DT	O
lower	low	ADJ	JJR	O
capacity	capacity	NOUN	NN	O
to	to	PART	TO	O
transport	transport	VERB	VB	O
deoxycholic	deoxycholic	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
than	than	ADP	IN	O
taurodeoxycholic	taurodeoxycholic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
both	both	DET	DT	O
were	be	VERB	VBD	O
decreased	decrease	VERB	VBN	O
by	by	ADP	IN	O
ethinyl	ethinyl	ADJ	JJ	B-Chemical
estradiol	estradiol	NOUN	NN	I-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
[	[	PUNCT	-LRB-	O
24	24	NUM	CD	O
-	-	SYM	SYM	O
14C	14c	NUM	CD	O
]	]	PUNCT	-RRB-	O
sodium	sodium	NOUN	NN	B-Chemical
deoxycholate	deoxycholate	ADJ	JJ	I-Chemical
infusion	infusion	NOUN	NN	O
,	,	PUNCT	,	O
[	[	PUNCT	-LRB-	O
14C	14c	NUM	CD	O
]	]	PUNCT	-RRB-	O
biliary	biliary	ADJ	JJ	O
bile	bile	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
secretion	secretion	NOUN	NN	O
increased	increase	VERB	VBD	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
bile	bile	NOUN	NN	O
flow	flow	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
change	change	VERB	VB	O
significantly	significantly	ADV	RB	O
in	in	ADP	IN	O
either	either	DET	DT	O
control	control	NOUN	NN	O
or	or	CCONJ	CC	O
ethinyl	ethinyl	VERB	VB	B-Chemical
estradiol	estradiol	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Ethinyl	ethinyl	VERB	VB	B-Chemical
estradiol	estradiol	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
animals	animal	NOUN	NNS	O
excreted	excrete	VERB	VBD	O
significantly	significantly	ADV	RB	O
less	less	ADJ	JJR	O
14C	14c	NUM	CD	O
as	as	ADP	IN	O
taurocholic	taurocholic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
than	than	ADP	IN	O
did	do	VERB	VBD	O
control	control	NOUN	NN	O
animals	animal	NOUN	NNS	O
,	,	PUNCT	,	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
an	an	DET	DT	O
impairment	impairment	NOUN	NN	O
of	of	ADP	IN	O
7alpha	7alpha	NUM	CD	O
-	-	PUNCT	HYPH	O
hydroxylation	hydroxylation	NOUN	NN	O
of	of	ADP	IN	O
taurodeoxycholic	taurodeoxycholic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Ethinyl	ethinyl	VERB	VB	B-Chemical
estradiol	estradiol	NOUN	NN	I-Chemical
treatment	treatment	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
impair	impair	VERB	VB	O
conjugation	conjugation	NOUN	NN	O
of	of	ADP	IN	O
deoxycholic	deoxycholic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
did	do	VERB	VBD	O
result	result	VERB	VB	O
in	in	ADP	IN	O
an	an	DET	DT	O
increase	increase	NOUN	NN	O
in	in	ADP	IN	O
sulfation	sulfation	NOUN	NN	O
of	of	ADP	IN	O
taurodeoxycholic	taurodeoxycholic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
from	from	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
%	%	NOUN	NN	O
in	in	ADP	IN	O
controls	control	NOUN	NNS	O
to	to	ADP	IN	O
nearly	nearly	ADV	RB	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
less	less	ADJ	JJR	O
than	than	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
are	be	VERB	VBP	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
that	that	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
has	have	VERB	VBZ	O
a	a	DET	DT	O
poorer	poor	ADJ	JJR	O
tolerance	tolerance	NOUN	NN	O
for	for	ADP	IN	O
deoxycholic	deoxycholic	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
than	than	ADP	IN	O
do	do	VERB	VB	O
certain	certain	ADJ	JJ	O
other	other	ADJ	JJ	O
species	specie	NOUN	NNS	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
converts	convert	NOUN	NNS	O
deoxycholic	deoxycholic	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
poor	poor	ADJ	JJ	O
choleretic	choleretic	NOUN	NN	O
,	,	PUNCT	,	O
to	to	PART	TO	O
taurocholic	taurocholic	VERB	VB	B-Chemical
acid	acid	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
good	good	ADJ	JJ	O
choleretic	choleretic	NOUN	NN	O
.	.	PUNCT	.	O

When	when	ADV	WRB	O
this	this	DET	DT	O
conversion	conversion	NOUN	NN	O
is	be	VERB	VBZ	O
impaired	impair	VERB	VBN	O
with	with	ADP	IN	O
ethinyl	ethinyl	ADJ	JJ	B-Chemical
estradiol	estradiol	NOUN	NNS	I-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
sulfation	sulfation	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
alternate	alternate	ADJ	JJ	O
pathway	pathway	NOUN	NN	O
for	for	ADP	IN	O
excretion	excretion	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
potentially	potentially	ADV	RB	O
harmful	harmful	ADJ	JJ	O
bile	bile	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Influence	influence	NOUN	NN	O
of	of	ADP	IN	O
diet	diet	NOUN	NN	O
free	free	ADJ	JJ	O
of	of	ADP	IN	O
NAD	NAD	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
precursors	precursor	NOUN	NNS	O
on	on	ADP	IN	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Recently	recently	ADV	RB	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
demonstrated	demonstrate	VERB	VBD	O
the	the	DET	DT	O
hepatoprotective	hepatoprotective	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
nicotinic	nicotinic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
amide	amide	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
selective	selective	ADJ	JJ	O
inhibitor	inhibitor	NOUN	NN	O
of	of	ADP	IN	O
poly	poly	ADJ	JJ	B-Chemical
(	(	PUNCT	-LRB-	I-Chemical
ADP	ADP	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
ribose	ribose	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	I-Chemical
polymerase	polymerase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PARP	PARP	PROPN	NNP	O
;	;	PUNCT	:	O
EC	EC	PROPN	NNP	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
30	30	NUM	CD	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
mice	mouse	NOUN	NNS	O
suffering	suffer	VERB	VBG	O
from	from	ADP	IN	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
AAP	AAP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
hepatitis	hepatitis	PROPN	NNP	B-Disease
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
that	that	ADP	IN	O
the	the	DET	DT	O
AAP	AAP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
liver	liver	NOUN	NN	B-Disease
injury	injury	NOUN	NN	I-Disease
involves	involve	VERB	VBZ	O
a	a	DET	DT	O
step	step	NOUN	NN	O
which	which	DET	WDT	O
depends	depend	VERB	VBZ	O
on	on	ADP	IN	O
adenoribosylation	adenoribosylation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
investigates	investigate	VERB	VBZ	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
a	a	DET	DT	O
diet	diet	NOUN	NN	O
free	free	ADJ	JJ	O
of	of	ADP	IN	O
precursors	precursor	NOUN	NNS	O
of	of	ADP	IN	O
NAD	NAD	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
substrate	substrate	NOUN	NN	O
on	on	ADP	IN	O
which	which	DET	WDT	O
PARP	PARP	PROPN	NNP	O
acts	act	VERB	VBZ	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
female	female	ADJ	JJ	O
NMRI	nmri	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
AAP	AAP	PROPN	NNP	B-Chemical
hepatitis	hepatitis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
evaluates	evaluate	VERB	VBZ	O
the	the	DET	DT	O
influence	influence	NOUN	NN	O
of	of	ADP	IN	O
simultaneous	simultaneous	ADJ	JJ	O
ethanol	ethanol	NOUN	NN	B-Chemical
consumption	consumption	NOUN	NN	O
in	in	ADP	IN	O
these	these	DET	DT	O
animals	animal	NOUN	NNS	O
.	.	PUNCT	.	O

Liver	liver	NOUN	NN	B-Disease
injuries	injury	NOUN	NNS	I-Disease
were	be	VERB	VBD	O
quantified	quantify	VERB	VBN	O
as	as	ADP	IN	O
serum	serum	ADJ	JJ	O
activities	activity	NOUN	NNS	O
of	of	ADP	IN	O
glutamate	glutamate	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
oxaloacetate	oxaloacetate	NOUN	NN	B-Chemical
transaminase	transaminase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GOT	GOT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
glutamate	glutamate	VERB	VB	B-Chemical
-	-	PUNCT	HYPH	O
pyruvate	pyruvate	NOUN	NN	B-Chemical
transaminase	transaminase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GPT	GPT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

While	while	ADP	IN	O
AAP	AAP	PROPN	NNP	B-Chemical
caused	cause	VERB	VBD	O
a	a	DET	DT	O
117	117	NUM	CD	O
-	-	PUNCT	HYPH	O
fold	fold	ADJ	JJ	O
elevation	elevation	NOUN	NN	O
of	of	ADP	IN	O
serum	serum	NOUN	NN	O
transaminase	transaminase	NOUN	NN	O
activities	activity	NOUN	NNS	O
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
kept	keep	VERB	VBN	O
on	on	ADP	IN	O
a	a	DET	DT	O
standard	standard	ADJ	JJ	O
laboratory	laboratory	NOUN	NN	O
diet	diet	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
exacerbated	exacerbate	VERB	VBN	O
by	by	ADP	IN	O
ethanol	ethanol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
inhibited	inhibit	VERB	VBN	O
by	by	ADP	IN	O
nicotinic	nicotinic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
amide	amide	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NAA	NAA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
adverse	adverse	ADJ	JJ	O
effects	effect	NOUN	NNS	O
were	be	VERB	VBD	O
noted	note	VERB	VBN	O
in	in	ADP	IN	O
animals	animal	NOUN	NNS	O
fed	feed	VERB	VBD	O
a	a	DET	DT	O
diet	diet	NOUN	NN	O
free	free	ADJ	JJ	O
of	of	ADP	IN	O
precursors	precursor	NOUN	NNS	O
of	of	ADP	IN	O
NAD	NAD	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
these	these	DET	DT	O
animals	animal	NOUN	NNS	O
,	,	PUNCT	,	O
only	only	ADV	RB	O
minor	minor	ADJ	JJ	O
increases	increase	NOUN	NNS	O
of	of	ADP	IN	O
serum	serum	NOUN	NN	O
transaminase	transaminase	NOUN	NN	O
activities	activity	NOUN	NNS	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
AAP	AAP	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
unlike	unlike	ADP	IN	O
the	the	DET	DT	O
exacerbation	exacerbation	NOUN	NN	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
ethanol	ethanol	NOUN	NN	B-Chemical
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
on	on	ADP	IN	O
a	a	DET	DT	O
standard	standard	ADJ	JJ	O
diet	diet	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
liver	liver	NOUN	NN	B-Disease
damage	damage	NOUN	NN	I-Disease
was	be	VERB	VBD	O
inhibited	inhibit	VERB	VBN	O
by	by	ADP	IN	O
50	50	NUM	CD	O
%	%	NOUN	NN	O
by	by	ADP	IN	O
ethanol	ethanol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
further	further	ADJ	JJ	O
64	64	NUM	CD	O
%	%	NOUN	NN	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
hepatitis	hepatitis	NOUN	NN	B-Disease
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
NAA	NAA	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
given	give	VERB	VBN	O
to	to	ADP	IN	O
ethanol	ethanol	NOUN	NN	B-Chemical
/	/	SYM	SYM	O
AAP	aap	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
provide	provide	VERB	VBP	O
evidence	evidence	NOUN	NN	O
that	that	ADP	IN	O
the	the	DET	DT	O
AAP	AAP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hepatitis	hepatitis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
exacerbation	exacerbation	NOUN	NN	O
by	by	ADP	IN	O
ethanol	ethanol	NOUN	NN	B-Chemical
can	can	VERB	MD	O
either	either	CCONJ	CC	O
be	be	VERB	VB	O
reduced	reduce	VERB	VBN	O
by	by	ADP	IN	O
end	end	NOUN	NN	O
-	-	PUNCT	HYPH	O
product	product	NOUN	NN	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
PARP	PARP	PROPN	NNP	O
by	by	ADP	IN	O
NAA	NAA	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
by	by	ADP	IN	O
dietary	dietary	ADJ	JJ	O
depletion	depletion	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
enzyme	enzyme	ADJ	JJ	O
'	'	PUNCT	``	O
s	s	PART	POS	O
substrate	substrate	NOUN	NN	O
NAD	NAD	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
see	see	VERB	VBP	O
the	the	DET	DT	O
main	main	ADJ	JJ	O
application	application	NOUN	NN	O
of	of	ADP	IN	O
NAA	NAA	PROPN	NNP	B-Chemical
as	as	ADP	IN	O
for	for	ADP	IN	O
the	the	DET	DT	O
combinational	combinational	ADJ	JJ	O
use	use	NOUN	NN	O
in	in	ADP	IN	O
pharmaceutical	pharmaceutical	ADJ	JJ	O
preparations	preparation	NOUN	NNS	O
of	of	ADP	IN	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
in	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
avoid	avoid	VERB	VB	O
hepatic	hepatic	ADJ	JJ	B-Disease
damage	damage	NOUN	NN	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
this	this	DET	DT	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
analgesic	analgesic	NOUN	NN	O
.	.	PUNCT	.	O

Nightmares	nightmare	NOUN	NNS	O
and	and	CCONJ	CC	O
hallucinations	hallucination	NOUN	NNS	B-Disease
after	after	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
intake	intake	NOUN	NN	O
of	of	ADP	IN	O
tramadol	tramadol	NOUN	NN	B-Chemical
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
antidepressants	antidepressant	NOUN	NNS	O
.	.	PUNCT	.	O

Tramadol	tramadol	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
weak	weak	ADJ	JJ	O
opioid	opioid	NOUN	NN	O
with	with	ADP	IN	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
adrenergic	adrenergic	NOUN	NN	O
and	and	CCONJ	CC	O
serotonergic	serotonergic	NOUN	NN	O
neurotransmission	neurotransmission	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
used	use	VERB	VBN	O
to	to	PART	TO	O
treat	treat	VERB	VB	O
cancer	cancer	NOUN	NN	B-Disease
pain	pain	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
chronic	chronic	VERB	VB	O
non	non	ADJ	JJ	O
malignant	malignant	ADJ	JJ	O
pain	pain	NOUN	NN	B-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
drug	drug	NOUN	NN	O
was	be	VERB	VBD	O
initiated	initiate	VERB	VBN	O
in	in	ADP	IN	O
association	association	NOUN	NN	O
with	with	ADP	IN	O
paroxetine	paroxetine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
dosulepine	dosulepine	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
in	in	ADP	IN	O
a	a	DET	DT	O
tetraparetic	tetraparetic	ADJ	JJ	B-Disease
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
chronic	chronic	ADJ	JJ	B-Disease
pain	pain	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Fifty	fifty	NUM	CD	O
-	-	PUNCT	HYPH	O
six	six	NUM	CD	O
days	day	NOUN	NNS	O
after	after	ADP	IN	O
initiation	initiation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
presented	present	VERB	VBN	O
hallucinations	hallucination	NOUN	NNS	B-Disease
that	that	DET	WDT	O
only	only	ADV	RB	O
stopped	stop	VERB	VBD	O
after	after	ADP	IN	O
the	the	DET	DT	O
withdrawal	withdrawal	NOUN	NN	O
of	of	ADP	IN	O
psycho	psycho	NOUN	NN	O
-	-	PUNCT	HYPH	O
active	active	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
and	and	CCONJ	CC	O
tramadol	tramadol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
questions	question	VERB	VBZ	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
term	term	NOUN	NN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
killers	killer	NOUN	NNS	O
combined	combine	VERB	VBN	O
with	with	ADP	IN	O
psycho	psycho	NOUN	NN	O
-	-	PUNCT	HYPH	O
active	active	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
in	in	ADP	IN	O
chronic	chronic	ADJ	JJ	O
non	non	ADJ	JJ	O
malignant	malignant	ADJ	JJ	O
pain	pain	NOUN	NN	B-Disease
,	,	PUNCT	,	O
especially	especially	ADV	RB	O
if	if	ADP	IN	O
pain	pain	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
under	under	ADP	IN	O
control	control	NOUN	NN	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
chloride	chloride	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
4	4	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminopyridine	aminopyridine	NOUN	NN	I-Chemical
therapy	therapy	NOUN	NN	O
on	on	ADP	IN	O
desipramine	desipramine	NOUN	NN	B-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Hypotension	hypotension	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
major	major	ADJ	JJ	O
contributor	contributor	NOUN	NN	O
to	to	ADP	IN	O
mortality	mortality	NOUN	NN	O
in	in	ADP	IN	O
tricyclic	tricyclic	ADJ	JJ	O
antidepressant	antidepressant	ADJ	JJ	O
overdose	overdose	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Recent	recent	ADJ	JJ	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
tricyclic	tricyclic	ADJ	JJ	O
antidepressants	antidepressant	NOUN	NNS	O
inhibit	inhibit	VERB	VBP	O
calcium	calcium	NOUN	NN	B-Chemical
influx	influx	NOUN	NN	O
in	in	ADP	IN	O
some	some	DET	DT	O
tissues	tissue	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
addressed	address	VERB	VBD	O
the	the	DET	DT	O
potential	potential	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
blockade	blockade	NOUN	NN	O
in	in	ADP	IN	O
tricyclic	tricyclic	ADJ	JJ	O
antidepressant	antidepressant	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Two	two	NUM	CD	O
interventions	intervention	NOUN	NNS	O
were	be	VERB	VBD	O
studied	study	VERB	VBN	O
that	that	DET	WDT	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
shown	show	VERB	VBN	O
previously	previously	ADV	RB	O
to	to	PART	TO	O
improve	improve	VERB	VB	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
with	with	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
blocker	blocker	NOUN	NN	O
overdose	overdose	NOUN	NN	B-Disease
.	.	PUNCT	.	O

CaCl2	CaCl2	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
4	4	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminopyridine	aminopyridine	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Anesthetized	anesthetized	ADJ	JJ	O
rats	rat	NOUN	NNS	O
received	receive	VERB	VBD	O
the	the	DET	DT	O
tricyclic	tricyclic	ADJ	JJ	O
antidepressant	antidepressant	NOUN	NN	O
desipramine	desipramine	NOUN	NN	B-Chemical
IP	IP	PROPN	NNP	O
to	to	PART	TO	O
produce	produce	VERB	VB	O
hypotension	hypotension	NOUN	NN	B-Disease
,	,	PUNCT	,	O
QRS	QRS	PROPN	NNP	O
prolongation	prolongation	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
bradycardia	bradycardia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Fifteen	fifteen	ADJ	JJ	O
min	min	NOUN	NN	O
later	later	ADV	RB	O
,	,	PUNCT	,	O
animals	animal	NOUN	NNS	O
received	receive	VERB	VBD	O
CaCl2	CaCl2	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
NaHCO3	nahco3	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
saline	saline	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
a	a	DET	DT	O
second	second	ADJ	JJ	O
experiment	experiment	NOUN	NN	O
,	,	PUNCT	,	O
rats	rat	NOUN	NNS	O
received	receive	VERB	VBD	O
tricyclic	tricyclic	ADJ	JJ	O
antidepressant	antidepressant	NOUN	NN	O
desipramine	desipramine	NOUN	NN	B-Chemical
IP	IP	PROPN	NNP	O
followed	follow	VERB	VBD	O
in	in	ADP	IN	O
15	15	NUM	CD	O
min	min	NOUN	NN	O
by	by	ADP	IN	O
4	4	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminopyridine	aminopyridine	NOUN	NN	I-Chemical
or	or	CCONJ	CC	O
saline	saline	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
NaHCO3	nahco3	NOUN	NN	B-Chemical
briefly	briefly	ADV	RB	O
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	O
min	min	NOUN	NN	O
)	)	PUNCT	-RRB-	O
reversed	reverse	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
QRS	QRS	PROPN	NNP	O
prolongation	prolongation	NOUN	NN	O
.	.	PUNCT	.	O

CaCl2	CaCl2	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
4	4	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminopyridine	aminopyridine	NOUN	NN	I-Chemical
failed	fail	VERB	VBD	O
to	to	PART	TO	O
improve	improve	VERB	VB	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
004	004	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
seizures	seizure	NOUN	NNS	B-Disease
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
the	the	DET	DT	O
CaCl2	CaCl2	PROPN	NNP	B-Chemical
group	group	NOUN	NN	O
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
than	than	ADP	IN	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
CaCl2	CaCl2	PROPN	NNP	B-Chemical
or	or	CCONJ	CC	O
4	4	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminopyridine	aminopyridine	NOUN	NN	I-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
reverse	reverse	VERB	VB	O
tricyclic	tricyclic	ADJ	JJ	O
antidepressant	antidepressant	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

CaCl2	cacl2	ADJ	JJ	B-Chemical
therapy	therapy	NOUN	NN	O
may	may	VERB	MD	O
possibly	possibly	ADV	RB	O
worsen	worsen	VERB	VB	O
both	both	CCONJ	CC	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
and	and	CCONJ	CC	I-Disease
central	central	ADJ	JJ	I-Disease
nervous	nervous	ADJ	JJ	I-Disease
system	system	NOUN	NN	I-Disease
toxicity	toxicity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
do	do	VERB	VBP	O
not	not	ADV	RB	O
support	support	VERB	VB	O
a	a	DET	DT	O
role	role	NOUN	NN	O
for	for	ADP	IN	O
calcium	calcium	NOUN	NN	B-Chemical
channel	channel	NOUN	NN	O
inhibition	inhibition	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pathogenesis	pathogenesis	NOUN	NN	O
of	of	ADP	IN	O
tricyclic	tricyclic	ADJ	JJ	O
antidepressant	antidepressant	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
hypotension	hypotension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Valsartan	Valsartan	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
angiotensin	angiotensin	NOUN	NN	B-Chemical
II	ii	NUM	CD	I-Chemical
antagonist	antagonist	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
essential	essential	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
:	:	PUNCT	:	O
a	a	DET	DT	O
comparative	comparative	ADJ	JJ	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
against	against	ADP	IN	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
compare	compare	VERB	VB	O
the	the	DET	DT	O
antihypertensive	antihypertensive	ADJ	JJ	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
angiotensin	angiotensin	NOUN	NN	B-Chemical
II	ii	NOUN	NN	I-Chemical
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
valsartan	valsartan	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
with	with	ADP	IN	O
a	a	DET	DT	O
reference	reference	NOUN	NN	O
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
One	one	NUM	CD	O
hundred	hundred	NUM	CD	O
sixty	sixty	NUM	CD	O
-	-	PUNCT	HYPH	O
eight	eight	NUM	CD	O
adult	adult	NOUN	NN	O
outpatients	outpatient	NOUN	NNS	O
with	with	ADP	IN	O
mild	mild	ADJ	JJ	O
to	to	PART	TO	O
moderate	moderate	ADJ	JJ	O
hypertension	hypertension	NOUN	NN	B-Disease
were	be	VERB	VBD	O
randomly	randomly	ADV	RB	O
allocated	allocate	VERB	VBN	O
in	in	ADP	IN	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
fashion	fashion	NOUN	NN	O
and	and	CCONJ	CC	O
equal	equal	ADJ	JJ	O
number	number	NOUN	NN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
80	80	NUM	CD	O
mg	mg	NOUN	NN	O
valsartan	valsartan	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
12	12	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
8	8	NUM	CD	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
whose	whose	DET	WP$	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
remained	remain	VERB	VBD	O
uncontrolled	uncontrolled	ADJ	JJ	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
added	add	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
initial	initial	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
at	at	ADP	IN	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
8	8	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
12	12	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
primary	primary	ADJ	JJ	O
efficacy	efficacy	NOUN	NN	O
variable	variable	NOUN	NN	O
was	be	VERB	VBD	O
change	change	NOUN	NN	O
from	from	ADP	IN	O
baseline	baseline	NOUN	NN	O
in	in	ADP	IN	O
mean	mean	ADJ	JJ	O
sitting	sit	VERB	VBG	O
diastolic	diastolic	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
at	at	ADP	IN	O
8	8	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

Secondary	secondary	ADJ	JJ	O
variables	variable	NOUN	NNS	O
included	include	VERB	VBD	O
change	change	NOUN	NN	O
in	in	ADP	IN	O
sitting	sit	VERB	VBG	O
systolic	systolic	ADJ	JJ	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
responder	responder	NOUN	NN	O
rates	rate	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Both	both	CCONJ	CC	O
valsartan	valsartan	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
effective	effective	ADJ	JJ	O
at	at	ADP	IN	O
lowering	lower	VERB	VBG	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
at	at	ADP	IN	O
4	4	NUM	CD	O
,	,	PUNCT	,	O
8	8	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
12	12	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

Similar	similar	ADJ	JJ	O
decreases	decrease	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
both	both	DET	DT	O
groups	group	NOUN	NNS	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
no	no	DET	DT	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
between	between	ADP	IN	O
the	the	DET	DT	O
groups	group	NOUN	NNS	O
for	for	ADP	IN	O
any	any	DET	DT	O
variable	variable	NOUN	NN	O
analyzed	analyze	VERB	VBN	O
.	.	PUNCT	.	O

For	for	ADP	IN	O
the	the	DET	DT	O
primary	primary	ADJ	JJ	O
variable	variable	NOUN	NN	O
the	the	DET	DT	O
difference	difference	NOUN	NN	O
was	be	VERB	VBD	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
in	in	ADP	IN	O
favor	favor	NOUN	NN	O
of	of	ADP	IN	O
valsartan	valsartan	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
68	68	NUM	CD	O
;	;	PUNCT	:	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
to	to	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Responder	responder	NOUN	NN	O
rates	rate	NOUN	NNS	O
at	at	ADP	IN	O
8	8	NUM	CD	O
weeks	week	NOUN	NNS	O
were	be	VERB	VBD	O
66	66	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
%	%	NOUN	NN	O
for	for	ADP	IN	O
valsartan	valsartan	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
60	60	NUM	CD	O
.	.	NOUN	NNS	O
2	2	NUM	CD	O
%	%	NOUN	NN	O
for	for	ADP	IN	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
39	39	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Both	both	DET	DT	O
treatments	treatment	NOUN	NNS	O
were	be	VERB	VBD	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
dependent	dependent	ADJ	JJ	O
edema	edema	NOUN	NN	B-Disease
was	be	VERB	VBD	O
somewhat	somewhat	ADV	RB	O
higher	high	ADJ	JJR	O
in	in	ADP	IN	O
the	the	DET	DT	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
group	group	NOUN	NN	O
,	,	PUNCT	,	O
particularly	particularly	ADV	RB	O
at	at	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
%	%	NOUN	NN	O
for	for	ADP	IN	O
80	80	NUM	CD	O
mg	mg	NOUN	NN	O
valsartan	valsartan	NOUN	NN	B-Chemical
;	;	PUNCT	:	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
for	for	ADP	IN	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
;	;	PUNCT	:	O
0	0	NUM	CD	O
%	%	NOUN	NN	O
for	for	ADP	IN	O
valsartan	valsartan	ADJ	JJ	B-Chemical
plus	plus	CCONJ	CC	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
;	;	PUNCT	:	O
14	14	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
for	for	ADP	IN	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
data	datum	NOUN	NNS	O
show	show	VERB	VBP	O
that	that	ADP	IN	O
valsartan	valsartan	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
as	as	ADV	RB	O
effective	effective	ADJ	JJ	O
as	as	ADP	IN	O
amlodipine	amlodipine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
mild	mild	ADJ	JJ	O
to	to	PART	TO	O
moderate	moderate	VERB	VB	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
also	also	ADV	RB	O
show	show	VERB	VBP	O
valsartan	valsartan	ADJ	JJ	B-Chemical
to	to	PART	TO	O
be	be	VERB	VB	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
and	and	CCONJ	CC	O
suggest	suggest	VERB	VB	O
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
characteristic	characteristic	ADJ	JJ	O
of	of	ADP	IN	O
this	this	DET	DT	O
comparator	comparator	NOUN	NN	O
class	class	NOUN	NN	O
,	,	PUNCT	,	O
dihydropyridine	dihydropyridine	NOUN	NN	B-Chemical
calcium	calcium	NOUN	NN	B-Chemical
antagonists	antagonist	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
measure	measure	NOUN	NN	O
of	of	ADP	IN	O
pupillary	pupillary	ADJ	JJ	B-Disease
oscillation	oscillation	NOUN	NN	I-Disease
as	as	ADP	IN	O
a	a	DET	DT	O
marker	marker	NOUN	NN	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
paranoia	paranoia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
paranoia	paranoia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
CIP	CIP	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
remains	remain	VERB	VBZ	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
idiopathic	idiopathic	ADJ	JJ	O
paranoia	paranoia	NOUN	NN	B-Disease
for	for	ADP	IN	O
which	which	DET	WDT	O
no	no	DET	DT	O
psychophysiologic	psychophysiologic	ADJ	JJ	O
marker	marker	NOUN	NN	O
has	have	VERB	VBZ	O
yet	yet	ADV	RB	O
emerged	emerge	VERB	VBN	O
.	.	PUNCT	.	O

Measures	measure	NOUN	NNS	O
of	of	ADP	IN	O
pupillary	pupillary	ADJ	JJ	B-Disease
oscillation	oscillation	NOUN	NN	I-Disease
were	be	VERB	VBD	O
able	able	ADJ	JJ	O
to	to	PART	TO	O
significantly	significantly	ADV	RB	O
distinguish	distinguish	VERB	VB	O
a	a	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
abstinent	abstinent	ADJ	JJ	O
crack	crack	NOUN	NN	B-Chemical
cocaine	cocaine	NOUN	NN	I-Chemical
abusers	abuser	NOUN	NNS	O
endorsing	endorse	VERB	VBG	O
past	past	ADP	IN	O
CIP	CIP	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
32	32	NUM	CD	O
)	)	PUNCT	-RRB-	O
from	from	ADP	IN	O
another	another	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
crack	crack	NOUN	NN	B-Chemical
addicts	addict	NOUN	NNS	O
who	who	PRON	WP	O
denied	deny	VERB	VBD	O
past	past	ADP	IN	O
CIP	CIP	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
29	29	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Serotonin	serotonin	ADP	IN	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
from	from	ADP	IN	O
venlafaxine	venlafaxine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
tranylcypromine	tranylcypromine	NOUN	NN	B-Chemical
interaction	interaction	NOUN	NN	O
.	.	PUNCT	.	O

Excessive	excessive	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
of	of	ADP	IN	O
serotonin	serotonin	NOUN	NN	B-Chemical
5HT1A	5ht1a	NUM	CD	O
receptors	receptor	NOUN	NNS	O
causes	cause	VERB	VBZ	O
a	a	DET	DT	O
syndrome	syndrome	NOUN	NN	O
of	of	ADP	IN	O
serotonin	serotonin	NOUN	NN	B-Chemical
excess	excess	NOUN	NN	O
that	that	DET	WDT	O
consists	consist	VERB	VBZ	O
of	of	ADP	IN	O
shivering	shivering	NOUN	NN	O
,	,	PUNCT	,	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
,	,	PUNCT	,	O
salivation	salivation	NOUN	NN	B-Disease
,	,	PUNCT	,	O
confusion	confusion	NOUN	NN	B-Disease
,	,	PUNCT	,	O
agitation	agitation	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
hyperthermia	hyperthermia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
syndrome	syndrome	NOUN	NN	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
interaction	interaction	NOUN	NN	O
between	between	ADP	IN	O
a	a	DET	DT	O
monoamine	monoamine	NOUN	NN	O
oxidase	oxidase	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MAOI	MAOI	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
a	a	DET	DT	O
specific	specific	ADJ	JJ	O
serotonin	serotonin	NOUN	NN	B-Chemical
reuptake	reuptake	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
.	.	PUNCT	.	O

Venlafaxine	Venlafaxine	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
new	new	ADJ	JJ	O
antidepressant	antidepressant	ADJ	JJ	O
agent	agent	NOUN	NN	O
that	that	DET	WDT	O
inhibits	inhibit	VERB	VBZ	O
the	the	DET	DT	O
reuptake	reuptake	NOUN	NN	O
of	of	ADP	IN	O
serotonin	serotonin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
norepinephrine	norepinephrine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
venlafaxine	venlafaxine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
MAOI	maoi	ADJ	JJ	O
interaction	interaction	NOUN	NN	O
that	that	DET	WDT	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
the	the	DET	DT	O
serotonin	serotonin	NOUN	NN	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
23	23	NUM	CD	O
-	-	PUNCT	HYPH	O
y	y	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
male	male	NOUN	NN	O
who	who	PRON	WP	O
was	be	VERB	VBD	O
taking	take	VERB	VBG	O
tranylcypromine	tranylcypromine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
depression	depression	NOUN	NN	B-Disease
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
well	well	ADV	RB	O
until	until	ADP	IN	O
the	the	DET	DT	O
morning	morning	NOUN	NN	O
of	of	ADP	IN	O
presentation	presentation	NOUN	NN	O
when	when	ADV	WRB	O
he	-PRON-	PRON	PRP	O
took	take	VERB	VBD	O
1	1	NUM	CD	O
/	/	SYM	SYM	O
2	2	NUM	CD	O
tab	tab	NOUN	NN	O
of	of	ADP	IN	O
venlafaxine	venlafaxine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Within	within	ADP	IN	O
2	2	NUM	CD	O
h	h	NOUN	NN	O
he	-PRON-	PRON	PRP	O
became	become	VERB	VBD	O
confused	confused	ADJ	JJ	O
with	with	ADP	IN	O
jerking	jerk	VERB	VBG	O
movements	movement	NOUN	NNS	O
of	of	ADP	IN	O
his	-PRON-	DET	PRP$	O
extremities	extremity	NOUN	NNS	O
,	,	PUNCT	,	O
tremors	tremor	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
rigidity	rigidity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
brought	bring	VERB	VBN	O
directly	directly	ADV	RB	O
to	to	ADP	IN	O
a	a	DET	DT	O
hospital	hospital	NOUN	NN	O
where	where	ADV	WRB	O
he	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
agitated	agitate	VERB	VBN	O
and	and	CCONJ	CC	O
confused	confuse	VERB	VBN	O
with	with	ADP	IN	O
shivering	shivering	NOUN	NN	O
,	,	PUNCT	,	O
myoclonic	myoclonic	ADJ	JJ	B-Disease
jerks	jerk	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
rigidity	rigidity	NOUN	NN	B-Disease
,	,	PUNCT	,	O
salivation	salivation	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
diaphoresis	diaphoresis	NOUN	NN	O
.	.	PUNCT	.	O

His	-PRON-	DET	PRP$	O
pupils	pupil	NOUN	NNS	O
were	be	VERB	VBD	O
7	7	NUM	CD	O
mm	mm	NOUN	NN	O
and	and	CCONJ	CC	O
sluggishly	sluggishly	ADV	RB	O
reactive	reactive	ADJ	JJ	O
to	to	ADP	IN	O
light	light	NOUN	NN	O
.	.	PUNCT	.	O

Vital	vital	ADJ	JJ	O
signs	sign	NOUN	NNS	O
were	be	VERB	VBD	O
:	:	PUNCT	:	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
120	120	NUM	CD	O
/	/	SYM	SYM	O
67	67	NUM	CD	O
mm	mm	NOUN	NNS	O
Hg	Hg	PROPN	NNP	O
,	,	PUNCT	,	O
heart	heart	NOUN	NN	O
rate	rate	NOUN	NN	O
127	127	NUM	CD	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
,	,	PUNCT	,	O
respiratory	respiratory	ADJ	JJ	O
rate	rate	NOUN	NN	O
28	28	NUM	CD	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
temperature	temperature	NOUN	NN	O
97	97	NUM	CD	O
F	f	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
180	180	NUM	CD	O
mg	mg	NOUN	NN	O
of	of	ADP	IN	O
diazepam	diazepam	NOUN	NN	B-Chemical
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
he	-PRON-	PRON	PRP	O
remained	remain	VERB	VBD	O
tremulous	tremulous	ADJ	JJ	O
with	with	ADP	IN	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
clenched	clench	VERB	VBN	O
jaws	jaw	NOUN	NNS	O
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
intubated	intubate	VERB	VBN	O
for	for	ADP	IN	O
airway	airway	NOUN	NN	O
protection	protection	NOUN	NN	O
and	and	CCONJ	CC	O
because	because	ADP	IN	O
of	of	ADP	IN	O
hypoventilation	hypoventilation	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
was	be	VERB	VBD	O
paralyzed	paralyzed	ADJ	JJ	B-Disease
to	to	PART	TO	O
control	control	VERB	VB	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

His	-PRON-	DET	PRP$	O
subsequent	subsequent	ADJ	JJ	O
course	course	NOUN	NN	O
was	be	VERB	VBD	O
remarkable	remarkable	ADJ	JJ	O
for	for	ADP	IN	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
immune	immune	ADJ	JJ	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
which	which	DET	WDT	O
resolved	resolve	VERB	VBD	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	PART	POS	O
maximal	maximal	ADJ	JJ	O
temperature	temperature	NOUN	NN	O
was	be	VERB	VBD	O
101	101	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
F	F	PROPN	NNP	O
and	and	CCONJ	CC	O
his	-PRON-	DET	PRP$	O
CPK	CPK	PROPN	NNP	O
remained	remain	VERB	VBD	O
<	<	X	XX	O
500	500	NUM	CD	O
units	unit	NOUN	NNS	O
/	/	SYM	SYM	O
L	l	NOUN	NN	O
with	with	ADP	IN	O
no	no	DET	DT	O
other	other	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
rhabdomyolysis	rhabdomyolysis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

His	-PRON-	DET	PRP$	O
mental	mental	ADJ	JJ	O
status	status	NOUN	NN	O
normalized	normalize	VERB	VBN	O
and	and	CCONJ	CC	O
he	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
transferred	transfer	VERB	VBN	O
to	to	ADP	IN	O
a	a	DET	DT	O
psychiatry	psychiatry	NOUN	NN	O
ward	ward	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
patient	patient	NOUN	NN	O
survived	survive	VERB	VBD	O
without	without	ADP	IN	O
sequelae	sequelae	NOUN	NN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
the	the	DET	DT	O
aggressive	aggressive	ADJ	JJ	O
sedation	sedation	NOUN	NN	O
and	and	CCONJ	CC	O
neuromuscular	neuromuscular	ADJ	JJ	O
paralysis	paralysis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Cyclophosphamide	Cyclophosphamide	PROPN	NNP	B-Chemical
associated	associate	VERB	VBD	O
bladder	bladder	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
-	-	PUNCT	,	O
-	-	PUNCT	:	O
a	a	DET	DT	O
highly	highly	ADV	RB	O
aggressive	aggressive	ADJ	JJ	O
disease	disease	NOUN	NN	O
:	:	PUNCT	:	O
analysis	analysis	NOUN	NN	O
of	of	ADP	IN	O
12	12	NUM	CD	O
cases	case	NOUN	NNS	O
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
We	-PRON-	PRON	PRP	O
gained	gain	VERB	VBD	O
knowledge	knowledge	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
etiology	etiology	NOUN	NN	O
,	,	PUNCT	,	O
treatment	treatment	NOUN	NN	O
and	and	CCONJ	CC	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
associated	associate	VERB	VBD	O
urothelial	urothelial	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

MATERIALS	material	NOUN	NNS	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
medical	medical	ADJ	JJ	O
records	record	NOUN	NNS	O
of	of	ADP	IN	O
6	6	NUM	CD	O
men	man	NOUN	NNS	O
and	and	CCONJ	CC	O
6	6	NUM	CD	O
women	woman	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
age	age	NOUN	NN	O
55	55	NUM	CD	O
years	year	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
with	with	ADP	IN	O
cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
associated	associate	VERB	VBN	O
bladder	bladder	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
were	be	VERB	VBD	O
reviewed	review	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
All	all	DET	DT	O
tumors	tumor	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
grade	grade	NOUN	NN	O
3	3	NUM	CD	O
or	or	CCONJ	CC	O
4	4	NUM	CD	O
transitional	transitional	ADJ	JJ	O
cell	cell	NOUN	NN	O
carcinoma	carcinoma	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Of	of	ADP	IN	O
the	the	DET	DT	O
5	5	NUM	CD	O
patients	patient	NOUN	NNS	O
initially	initially	ADV	RB	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
endoscopic	endoscopic	ADJ	JJ	O
resection	resection	NOUN	NN	O
alone	alone	ADV	RB	O
only	only	ADV	RB	O
1	1	NUM	CD	O
is	be	VERB	VBZ	O
alive	alive	ADJ	JJ	O
without	without	ADP	IN	O
disease	disease	NOUN	NN	O
.	.	PUNCT	.	O

Of	of	ADP	IN	O
the	the	DET	DT	O
6	6	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
underwent	undergo	VERB	VBD	O
early	early	ADJ	JJ	O
cystectomy	cystectomy	NOUN	NN	O
4	4	NUM	CD	O
were	be	VERB	VBD	O
alive	alive	ADJ	JJ	O
at	at	ADP	IN	O
24	24	NUM	CD	O
to	to	PART	TO	O
111	111	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
remaining	remain	VERB	VBG	O
patient	patient	NOUN	NN	O
with	with	ADP	IN	O
extensive	extensive	ADJ	JJ	O
cancer	cancer	NOUN	NN	B-Disease
underwent	undergo	VERB	VBD	O
partial	partial	ADJ	JJ	O
cystectomy	cystectomy	NOUN	NN	O
for	for	ADP	IN	O
palliation	palliation	NOUN	NN	O
and	and	CCONJ	CC	O
died	die	VERB	VBD	O
3	3	NUM	CD	O
months	month	NOUN	NNS	O
later	later	ADV	RB	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
Cyclophosphamide	cyclophosphamide	NOUN	NN	B-Chemical
associated	associate	VERB	VBN	O
bladder	bladder	NOUN	NN	B-Disease
tumor	tumor	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
an	an	DET	DT	O
aggressive	aggressive	ADJ	JJ	O
disease	disease	NOUN	NN	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
survival	survival	NOUN	NN	O
is	be	VERB	VBZ	O
possible	possible	ADJ	JJ	O
when	when	ADV	WRB	O
radical	radical	ADJ	JJ	O
cystectomy	cystectomy	NOUN	NN	O
is	be	VERB	VBZ	O
performed	perform	VERB	VBN	O
for	for	ADP	IN	O
bladder	bladder	NOUN	NN	B-Disease
tumors	tumor	NOUN	NNS	I-Disease
with	with	ADP	IN	O
any	any	DET	DT	O
sign	sign	NOUN	NN	O
of	of	ADP	IN	O
invasion	invasion	NOUN	NN	O
and	and	CCONJ	CC	O
for	for	ADP	IN	O
recurrent	recurrent	ADJ	JJ	O
high	high	ADJ	JJ	O
grade	grade	NOUN	NN	O
disease	disease	NOUN	NN	O
,	,	PUNCT	,	O
even	even	ADV	RB	O
when	when	ADV	WRB	O
noninvasive	noninvasive	ADJ	JJ	O
.	.	PUNCT	.	O

A	a	DET	DT	O
phase	phase	NOUN	NN	O
I	-PRON-	PRON	PRP	O
clinical	clinical	ADJ	JJ	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
antipurine	antipurine	NOUN	NN	B-Chemical
antifolate	antifolate	NOUN	NN	O
lometrexol	lometrexol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DDATHF	DDATHF	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
given	give	VERB	VBN	O
with	with	ADP	IN	O
oral	oral	ADJ	JJ	O
folic	folic	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Lometrexol	Lometrexol	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
an	an	DET	DT	O
antifolate	antifolate	NOUN	NN	O
which	which	DET	WDT	O
inhibits	inhibit	VERB	VBZ	O
glycinamide	glycinamide	ADJ	JJ	B-Chemical
ribonucleotide	ribonucleotide	NOUN	NN	I-Chemical
formyltransferase	formyltransferase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
GARFT	GARFT	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
an	an	DET	DT	O
enzyme	enzyme	ADJ	JJ	O
essential	essential	NOUN	NN	O
for	for	ADP	IN	O
de	de	X	FW	O
novo	novo	X	FW	O
purine	purine	ADJ	JJ	B-Chemical
synthesis	synthesis	NOUN	NN	O
.	.	PUNCT	.	O

Extensive	extensive	ADJ	JJ	O
experimental	experimental	ADJ	JJ	O
and	and	CCONJ	CC	O
limited	limited	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
data	datum	NOUN	NNS	O
have	have	VERB	VBP	O
shown	show	VERB	VBN	O
that	that	ADP	IN	O
lometrexol	lometrexol	NOUN	NN	B-Chemical
has	have	VERB	VBZ	O
activity	activity	NOUN	NN	O
against	against	ADP	IN	O
tumours	tumour	NOUN	NNS	B-Disease
which	which	DET	WDT	O
are	be	VERB	VBP	O
refractory	refractory	ADJ	JJ	O
to	to	ADP	IN	O
other	other	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
,	,	PUNCT	,	O
notably	notably	ADV	RB	O
methotrexate	methotrexate	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
initial	initial	ADJ	JJ	O
clinical	clinical	ADJ	JJ	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
lometrexol	lometrexol	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
curtailed	curtail	VERB	VBN	O
because	because	ADP	IN	O
of	of	ADP	IN	O
severe	severe	ADJ	JJ	O
and	and	CCONJ	CC	O
cumulative	cumulative	ADJ	JJ	O
antiproliferative	antiproliferative	ADJ	JJ	O
toxicities	toxicity	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Preclinical	preclinical	ADJ	JJ	O
murine	murine	NOUN	NN	O
studies	study	NOUN	NNS	O
demonstrated	demonstrate	VERB	VBD	O
that	that	ADP	IN	O
the	the	DET	DT	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
lometrexol	lometrexol	NOUN	NN	B-Chemical
can	can	VERB	MD	O
be	be	VERB	VB	O
prevented	prevent	VERB	VBN	O
by	by	ADP	IN	O
low	low	ADJ	JJ	O
dose	dose	NOUN	NN	O
folic	folic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
administration	administration	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
e	e	PUNCT	LS	O
.	.	PUNCT	.	O
for	for	ADP	IN	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
and	and	CCONJ	CC	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
following	follow	VERB	VBG	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
bolus	bolus	NOUN	NN	O
dose	dose	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
observation	observation	NOUN	NN	O
prompted	prompt	VERB	VBD	O
a	a	DET	DT	O
Phase	Phase	PROPN	NNP	O
I	-PRON-	PRON	PRP	O
clinical	clinical	ADJ	JJ	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
lometrexol	lometrexol	NOUN	NN	B-Chemical
given	give	VERB	VBN	O
with	with	ADP	IN	O
folic	folic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
supplementation	supplementation	NOUN	NN	O
which	which	DET	WDT	O
has	have	VERB	VBZ	O
confirmed	confirm	VERB	VBN	O
that	that	ADP	IN	O
the	the	DET	DT	O
toxicity	toxicity	NOUN	NN	B-Disease
of	of	ADP	IN	O
lometrexol	lometrexol	NOUN	NN	B-Chemical
can	can	VERB	MD	O
be	be	VERB	VB	O
markedly	markedly	ADV	RB	O
reduced	reduce	VERB	VBN	O
by	by	ADP	IN	O
folic	folic	ADJ	JJ	B-Chemical
acid	acid	ADJ	JJ	I-Chemical
supplementation	supplementation	NOUN	NN	O
.	.	PUNCT	.	O

Thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
mucositis	mucositis	NOUN	NN	B-Disease
were	be	VERB	VBD	O
the	the	DET	DT	O
major	major	ADJ	JJ	O
toxicities	toxicity	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

There	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
clear	clear	ADJ	JJ	O
relationship	relationship	NOUN	NN	O
between	between	ADP	IN	O
clinical	clinical	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
the	the	DET	DT	O
extent	extent	NOUN	NN	O
of	of	ADP	IN	O
plasma	plasma	NOUN	NN	O
folate	folate	ADJ	JJ	B-Chemical
elevation	elevation	NOUN	NN	O
.	.	PUNCT	.	O

Associated	associated	ADJ	JJ	O
studies	study	NOUN	NNS	O
demonstrated	demonstrate	VERB	VBD	O
that	that	ADP	IN	O
lometrexol	lometrexol	ADJ	JJ	B-Chemical
plasma	plasma	NOUN	NN	O
pharmacokinetics	pharmacokinetic	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
altered	alter	VERB	VBN	O
by	by	ADP	IN	O
folic	folic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
administration	administration	NOUN	NN	O
indicating	indicate	VERB	VBG	O
that	that	DET	DT	O
supplementation	supplementation	NOUN	NN	O
is	be	VERB	VBZ	O
unlikely	unlikely	ADJ	JJ	O
to	to	PART	TO	O
reduce	reduce	VERB	VB	O
toxicity	toxicity	NOUN	NN	B-Disease
by	by	ADP	IN	O
enhancing	enhance	VERB	VBG	O
lometrexol	lometrexol	ADJ	JJ	B-Chemical
plasma	plasma	NOUN	NN	O
clearance	clearance	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
work	work	NOUN	NN	O
described	describe	VERB	VBN	O
in	in	ADP	IN	O
this	this	DET	DT	O
report	report	NOUN	NN	O
has	have	VERB	VBZ	O
identified	identify	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
time	time	NOUN	NN	O
a	a	DET	DT	O
clinically	clinically	ADV	RB	O
acceptable	acceptable	ADJ	JJ	O
schedule	schedule	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
GARFT	GARFT	PROPN	NNP	O
inhibitor	inhibitor	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
information	information	NOUN	NN	O
will	will	VERB	MD	O
facilitate	facilitate	VERB	VB	O
the	the	DET	DT	O
future	future	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
class	class	NOUN	NN	O
of	of	ADP	IN	O
compounds	compound	NOUN	NNS	O
in	in	ADP	IN	O
cancer	cancer	NOUN	NN	B-Disease
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Fatal	fatal	ADJ	JJ	O
excited	excited	ADJ	JJ	O
delirium	delirium	NOUN	NN	B-Disease
following	follow	VERB	VBG	O
cocaine	cocaine	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
:	:	PUNCT	:	O
epidemiologic	epidemiologic	ADJ	JJ	O
findings	finding	NOUN	NNS	O
provide	provide	VERB	VBP	O
new	new	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
for	for	ADP	IN	O
mechanisms	mechanism	NOUN	NNS	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
describe	describe	VERB	VBP	O
an	an	DET	DT	O
outbreak	outbreak	NOUN	NN	O
of	of	ADP	IN	O
deaths	death	NOUN	NNS	O
from	from	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
excited	excited	ADJ	JJ	O
delirium	delirium	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
EDDs	EDDs	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
Dade	Dade	PROPN	NNP	O
County	County	PROPN	NNP	O
,	,	PUNCT	,	O
Florida	Florida	PROPN	NNP	O
between	between	ADP	IN	O
1979	1979	NUM	CD	O
and	and	CCONJ	CC	O
1990	1990	NUM	CD	O
.	.	PUNCT	.	O

From	from	ADP	IN	O
a	a	DET	DT	O
registry	registry	NOUN	NN	O
of	of	ADP	IN	O
all	all	DET	DT	O
cocaine	cocaine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
deaths	death	NOUN	NNS	O
in	in	ADP	IN	O
Dade	Dade	PROPN	NNP	O
County	County	PROPN	NNP	O
,	,	PUNCT	,	O
Florida	Florida	PROPN	NNP	O
,	,	PUNCT	,	O
from	from	ADP	IN	O
1969	1969	NUM	CD	O
-	-	SYM	SYM	O
1990	1990	NUM	CD	O
,	,	PUNCT	,	O
58	58	NUM	CD	O
EDDs	edd	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
125	125	NUM	CD	O
victims	victim	NOUN	NNS	O
of	of	ADP	IN	O
accidental	accidental	ADJ	JJ	O
cocaine	cocaine	NOUN	NN	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
without	without	ADP	IN	O
excited	excited	ADJ	JJ	O
delirium	delirium	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Compared	compare	VERB	VBN	O
with	with	ADP	IN	O
controls	control	NOUN	NNS	O
,	,	PUNCT	,	O
EDDs	edd	NOUN	NNS	B-Disease
were	be	VERB	VBD	O
more	more	ADV	RBR	O
frequently	frequently	ADV	RB	O
black	black	ADJ	JJ	O
,	,	PUNCT	,	O
male	male	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
younger	young	ADJ	JJR	O
.	.	PUNCT	.	O

They	-PRON-	PRON	PRP	O
were	be	VERB	VBD	O
less	less	ADV	RBR	O
likely	likely	ADJ	JJ	O
to	to	PART	TO	O
have	have	VERB	VB	O
a	a	DET	DT	O
low	low	ADJ	JJ	O
body	body	NOUN	NN	O
mass	mass	NOUN	NN	O
index	index	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
more	more	ADV	RBR	O
likely	likely	ADJ	JJ	O
to	to	PART	TO	O
have	have	VERB	VB	O
died	die	VERB	VBN	O
in	in	ADP	IN	O
police	police	NOUN	NN	O
custody	custody	NOUN	NN	O
,	,	PUNCT	,	O
to	to	PART	TO	O
have	have	VERB	VB	O
received	receive	VERB	VBN	O
medical	medical	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
immediately	immediately	ADV	RB	O
before	before	ADP	IN	O
death	death	NOUN	NN	O
,	,	PUNCT	,	O
to	to	PART	TO	O
have	have	VERB	VB	O
survived	survive	VERB	VBN	O
for	for	ADP	IN	O
a	a	DET	DT	O
longer	long	ADJ	JJR	O
period	period	NOUN	NN	O
,	,	PUNCT	,	O
to	to	PART	TO	O
have	have	VERB	VB	O
developed	develop	VERB	VBN	O
hyperthermia	hyperthermia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
to	to	PART	TO	O
have	have	VERB	VB	O
died	die	VERB	VBN	O
in	in	ADP	IN	O
summer	summer	NOUN	NN	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

EDDs	EDDs	PROPN	NNP	B-Disease
had	have	VERB	VBD	O
concentrations	concentration	NOUN	NNS	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
benzoylecgonine	benzoylecgonine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
autopsy	autopsy	ADJ	JJ	O
blood	blood	NOUN	NN	O
that	that	DET	WDT	O
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
for	for	ADP	IN	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
epidemiologic	epidemiologic	ADJ	JJ	O
findings	finding	NOUN	NNS	O
are	be	VERB	VBP	O
most	most	ADV	RBS	O
consistent	consistent	ADJ	JJ	O
with	with	ADP	IN	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
that	that	DET	WDT	O
chronic	chronic	ADJ	JJ	O
cocaine	cocaine	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
disrupts	disrupt	NOUN	NNS	O
dopaminergic	dopaminergic	ADJ	JJ	O
function	function	NOUN	NN	O
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
coupled	couple	VERB	VBN	O
with	with	ADP	IN	O
recent	recent	ADJ	JJ	O
cocaine	cocaine	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
,	,	PUNCT	,	O
may	may	VERB	MD	O
precipitate	precipitate	VERB	VB	O
agitation	agitation	NOUN	NN	B-Disease
,	,	PUNCT	,	O
delirium	delirium	NOUN	NN	B-Disease
,	,	PUNCT	,	O
aberrant	aberrant	ADJ	JJ	O
thermoregulation	thermoregulation	NOUN	NN	O
,	,	PUNCT	,	O
rhabdomyolysis	rhabdomyolysis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
sudden	sudden	ADJ	JJ	B-Disease
death	death	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Pemoline	Pemoline	PROPN	NNP	B-Chemical
induced	induce	VERB	VBD	O
acute	acute	ADJ	JJ	O
choreoathetosis	choreoathetosis	NOUN	NN	B-Disease
:	:	PUNCT	:	O
case	case	NOUN	NN	O
report	report	NOUN	NN	O
and	and	CCONJ	CC	O
review	review	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Pemoline	Pemoline	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
an	an	DET	DT	O
oxazolidine	oxazolidine	NOUN	NN	B-Chemical
derivative	derivative	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
structurally	structurally	ADV	RB	O
different	different	ADJ	JJ	O
from	from	ADP	IN	O
amphetamines	amphetamine	NOUN	NNS	B-Chemical
and	and	CCONJ	CC	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
attention	attention	NOUN	NN	B-Disease
deficit	deficit	NOUN	NN	I-Disease
disorder	disorder	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Pemoline	Pemoline	PROPN	NNP	B-Chemical
has	have	VERB	VBZ	O
not	not	ADV	RB	O
been	be	VERB	VBN	O
commonly	commonly	ADV	RB	O
associated	associate	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
movement	movement	NOUN	NN	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
following	follow	VERB	VBG	O
case	case	NOUN	NN	O
describes	describe	VERB	VBZ	O
two	two	NUM	CD	O
children	child	NOUN	NNS	O
acutely	acutely	ADV	RB	O
poisoned	poison	VERB	VBD	O
with	with	ADP	IN	O
pemoline	pemoline	NOUN	NN	B-Chemical
who	who	PRON	WP	O
experienced	experience	VERB	VBD	O
profound	profound	ADJ	JJ	O
choreoathetosis	choreoathetosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

CASE	case	NOUN	NN	O
REPORT	REPORT	PROPN	NNP	O
:	:	PUNCT	:	O
Two	two	NUM	CD	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
male	male	NOUN	NN	O
,	,	PUNCT	,	O
identical	identical	ADJ	JJ	O
twin	twin	ADJ	JJ	O
siblings	sibling	NOUN	NNS	O
presented	present	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
emergency	emergency	NOUN	NN	O
department	department	NOUN	NN	O
after	after	ADP	IN	O
found	find	VERB	VBD	O
playing	play	VERB	VBG	O
with	with	ADP	IN	O
a	a	DET	DT	O
an	an	DET	DT	O
empty	empty	ADJ	JJ	O
bottle	bottle	NOUN	NN	O
of	of	ADP	IN	O
pemoline	pemoline	NOUN	NN	B-Chemical
originally	originally	ADV	RB	O
containing	contain	VERB	VBG	O
59	59	NUM	CD	O
tablets	tablet	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
children	child	NOUN	NNS	O
had	have	VERB	VBD	O
a	a	DET	DT	O
medical	medical	ADJ	JJ	O
history	history	NOUN	NN	O
significant	significant	ADJ	JJ	O
for	for	ADP	IN	O
attention	attention	NOUN	NN	B-Disease
deficit	deficit	NOUN	NN	I-Disease
disorder	disorder	NOUN	NN	I-Disease
previously	previously	ADV	RB	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
methylphenidate	methylphenidate	NOUN	NN	B-Chemical
without	without	ADP	IN	O
success	success	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
was	be	VERB	VBD	O
their	-PRON-	DET	PRP$	O
first	first	ADJ	JJ	O
day	day	NOUN	NN	O
of	of	ADP	IN	O
pemoline	pemoline	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
choreoathetoid	choreoathetoid	ADJ	JJ	B-Disease
movements	movement	NOUN	NNS	O
began	begin	VERB	VBD	O
45	45	NUM	CD	O
min	min	NOUN	NN	O
to	to	ADP	IN	O
1	1	NUM	CD	O
h	h	NOUN	NN	O
after	after	ADP	IN	O
ingestion	ingestion	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
children	child	NOUN	NNS	O
gave	give	VERB	VBD	O
no	no	DET	DT	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
prior	prior	ADJ	JJ	O
movement	movement	NOUN	NN	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
no	no	DET	DT	O
family	family	NOUN	NN	O
history	history	NOUN	NN	O
of	of	ADP	IN	O
movement	movement	NOUN	NN	B-Disease
disorders	disorder	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
children	child	NOUN	NNS	O
received	receive	VERB	VBD	O
gastrointestinal	gastrointestinal	ADJ	JJ	O
decontamination	decontamination	NOUN	NN	O
and	and	CCONJ	CC	O
high	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
benzodiazepines	benzodiazepine	NOUN	NNS	B-Chemical
in	in	ADP	IN	O
an	an	DET	DT	O
attempt	attempt	NOUN	NN	O
to	to	PART	TO	O
control	control	VERB	VB	O
the	the	DET	DT	O
choreoathetoid	choreoathetoid	ADJ	JJ	B-Disease
movements	movement	NOUN	NNS	O
.	.	PUNCT	.	O

Despite	despite	ADP	IN	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
children	child	NOUN	NNS	O
continued	continue	VERB	VBD	O
to	to	PART	TO	O
have	have	VERB	VB	O
choreoathetosis	choreoathetosis	NOUN	NN	B-Disease
for	for	ADP	IN	O
approximately	approximately	ADV	RB	O
24	24	NUM	CD	O
hours	hour	NOUN	NNS	O
.	.	PUNCT	.	O

Forty	forty	NUM	CD	O
-	-	PUNCT	HYPH	O
eight	eight	NUM	CD	O
hours	hour	NOUN	NNS	O
after	after	ADP	IN	O
admission	admission	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
children	child	NOUN	NNS	O
appeared	appear	VERB	VBD	O
to	to	PART	TO	O
be	be	VERB	VB	O
at	at	ADP	IN	O
their	-PRON-	DET	PRP$	O
baseline	baseline	NOUN	NN	O
and	and	CCONJ	CC	O
were	be	VERB	VBD	O
discharged	discharge	VERB	VBN	O
home	home	ADV	RB	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Pemoline	Pemoline	PROPN	NNP	B-Chemical
associated	associate	VERB	VBN	O
movement	movement	NOUN	NN	B-Disease
disorder	disorder	NOUN	NN	I-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
rarely	rarely	ADV	RB	O
reported	report	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
acute	acute	ADJ	JJ	O
toxicology	toxicology	NOUN	NN	O
literature	literature	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
possibility	possibility	NOUN	NN	O
of	of	ADP	IN	O
choreoathetoid	choreoathetoid	ADJ	JJ	B-Disease
movements	movement	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
considered	consider	VERB	VBN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
presenting	present	VERB	VBG	O
after	after	ADP	IN	O
pemoline	pemoline	NOUN	NN	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
myopic	myopic	ADJ	JJ	O
excimer	excimer	ADJ	JJ	O
laser	laser	NOUN	NN	O
photorefractive	photorefractive	ADJ	JJ	O
keratectomy	keratectomy	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
electrophysiologic	electrophysiologic	ADJ	JJ	O
function	function	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
retina	retina	NOUN	NN	O
and	and	CCONJ	CC	O
optic	optic	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
assess	assess	VERB	VB	O
by	by	ADP	IN	O
electrophysiologic	electrophysiologic	ADJ	JJ	O
testing	test	VERB	VBG	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
photorefractive	photorefractive	ADJ	JJ	O
keratectomy	keratectomy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PRK	PRK	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
the	the	DET	DT	O
retina	retina	NOUN	NN	O
and	and	CCONJ	CC	O
optic	optic	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
.	.	PUNCT	.	O

SETTING	setting	NOUN	NN	O
:	:	PUNCT	:	O
Eye	Eye	PROPN	NNP	O
Clinic	Clinic	PROPN	NNP	O
,	,	PUNCT	,	O
S	S	PROPN	NNP	O
.	.	PUNCT	.	O

Salvatore	Salvatore	PROPN	NNP	O
Hospital	Hospital	PROPN	NNP	O
,	,	PUNCT	,	O
L	L	PROPN	NNP	O
'	'	PUNCT	``	O
Aquila	Aquila	PROPN	NNP	O
University	University	PROPN	NNP	O
,	,	PUNCT	,	O
Italy	Italy	PROPN	NNP	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Standard	standard	ADJ	JJ	O
pattern	pattern	NOUN	NN	O
electroretinograms	electroretinogram	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
-	-	PUNCT	HYPH	O
ERGs	ERGs	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
standard	standard	ADJ	JJ	O
pattern	pattern	NOUN	NN	O
visual	visual	ADJ	JJ	O
evoked	evoke	VERB	VBN	O
potentials	potential	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
-	-	PUNCT	HYPH	O
VEPs	VEPs	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
done	do	VERB	VBN	O
in	in	ADP	IN	O
25	25	NUM	CD	O
eyes	eye	NOUN	NNS	O
of	of	ADP	IN	O
25	25	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
myopic	myopic	ADJ	JJ	O
PRK	PRK	PROPN	NNP	O
for	for	ADP	IN	O
an	an	DET	DT	O
attempted	attempt	VERB	VBN	O
correction	correction	NOUN	NN	O
between	between	ADP	IN	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
00	00	PUNCT	NFP	O
and	and	CCONJ	CC	O
15	15	NUM	CD	O
.	.	PUNCT	.	O
00	00	PUNCT	NFP	O
diopters	diopter	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
D	D	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
(	(	PUNCT	-LRB-	O
mean	mean	VERB	VB	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
00	00	PUNCT	NFP	O
D	d	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Testing	Testing	PROPN	NNP	O
was	be	VERB	VBD	O
done	do	VERB	VBN	O
preoperatively	preoperatively	ADV	RB	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
,	,	PUNCT	,	O
6	6	NUM	CD	O
,	,	PUNCT	,	O
12	12	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
18	18	NUM	CD	O
months	month	NOUN	NNS	O
postoperatively	postoperatively	ADV	RB	O
.	.	PUNCT	.	O

The	the	DET	DT	O
contralateral	contralateral	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
served	serve	VERB	VBD	O
as	as	ADP	IN	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

During	during	ADP	IN	O
the	the	DET	DT	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
developed	develop	VERB	VBD	O
steroid	steroid	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
elevated	elevated	ADJ	JJ	B-Disease
intraocular	intraocular	ADJ	JJ	I-Disease
pressure	pressure	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
IOP	IOP	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
that	that	DET	WDT	O
resolved	resolve	VERB	VBD	O
after	after	ADP	IN	O
corticosteroid	corticosteroid	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
was	be	VERB	VBD	O
discontinued	discontinue	VERB	VBN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
No	no	DET	DT	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
were	be	VERB	VBD	O
seen	see	VERB	VBN	O
between	between	ADP	IN	O
treated	treat	VERB	VBN	O
and	and	CCONJ	CC	O
control	control	NOUN	NN	O
eyes	eye	NOUN	NNS	O
nor	nor	CCONJ	CC	O
between	between	ADP	IN	O
treated	treated	ADJ	JJ	O
eyes	eye	NOUN	NNS	O
preoperatively	preoperatively	ADV	RB	O
and	and	CCONJ	CC	O
postoperatively	postoperatively	ADV	RB	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Myopic	myopic	ADJ	JJ	O
excimer	excimer	NOUN	NN	O
laser	laser	NOUN	NN	O
PRK	PRK	PROPN	NNP	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
seem	seem	VERB	VB	O
to	to	PART	TO	O
affect	affect	VERB	VB	O
the	the	DET	DT	O
posterior	posterior	ADJ	JJ	O
segment	segment	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
transient	transient	ADJ	JJ	O
steroid	steroid	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
IOP	IOP	PROPN	NNP	B-Disease
rise	rise	NOUN	NN	I-Disease
did	do	VERB	VBD	O
not	not	ADV	RB	O
seem	seem	VERB	VB	O
to	to	PART	TO	O
cause	cause	VERB	VB	O
functional	functional	ADJ	JJ	O
impairment	impairment	NOUN	NN	O
.	.	PUNCT	.	O

Neutrophil	neutrophil	NOUN	NN	O
superoxide	superoxide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
hydrogen	hydrogen	NOUN	NN	B-Chemical
peroxide	peroxide	NOUN	NN	I-Chemical
production	production	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Defects	defect	NOUN	NNS	O
in	in	ADP	IN	O
superoxide	superoxide	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
hydrogen	hydrogen	NOUN	NN	B-Chemical
peroxide	peroxide	NOUN	NN	I-Chemical
production	production	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
implicated	implicate	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
high	high	ADJ	JJ	O
incidence	incidence	NOUN	NN	O
of	of	ADP	IN	O
bacterial	bacterial	ADJ	JJ	B-Disease
infections	infection	NOUN	NNS	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
liver	liver	NOUN	NN	I-Disease
failure	failure	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
ALF	ALF	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
oxygen	oxygen	NOUN	NN	B-Chemical
radical	radical	ADJ	JJ	O
production	production	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
ALF	ALF	PROPN	NNP	B-Disease
due	due	ADJ	JJ	O
to	to	ADP	IN	O
paracetamol	paracetamol	NOUN	NN	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
was	be	VERB	VBD	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
healthy	healthy	ADJ	JJ	O
volunteers	volunteer	NOUN	NNS	O
.	.	PUNCT	.	O

Neutrophils	neutrophil	NOUN	NNS	O
from	from	ADP	IN	O
14	14	NUM	CD	O
ALF	ALF	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
stimulated	stimulate	VERB	VBN	O
via	via	ADP	IN	O
the	the	DET	DT	O
complement	complement	NOUN	NN	O
receptors	receptor	NOUN	NNS	O
using	use	VERB	VBG	O
zymosan	zymosan	NOUN	NN	O
opsonized	opsonize	VERB	VBN	O
with	with	ADP	IN	O
ALF	ALF	PROPN	NNP	B-Disease
or	or	CCONJ	CC	O
control	control	NOUN	NN	O
serum	serum	ADV	RB	O
.	.	PUNCT	.	O

Superoxide	Superoxide	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
hydrogen	hydrogen	NOUN	NN	B-Chemical
peroxide	peroxide	NOUN	NN	I-Chemical
production	production	NOUN	NN	O
by	by	ADP	IN	O
ALF	ALF	PROPN	NNP	B-Disease
neutrophils	neutrophil	NOUN	NNS	O
stimulated	stimulate	VERB	VBN	O
with	with	ADP	IN	O
zymosan	zymosan	NOUN	NN	O
opsonized	opsonize	VERB	VBN	O
with	with	ADP	IN	O
ALF	ALF	PROPN	NNP	B-Disease
serum	serum	NOUN	NN	O
was	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBN	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
control	control	NOUN	NN	O
subjects	subject	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

This	this	DET	DT	O
defect	defect	NOUN	NN	O
persisted	persist	VERB	VBD	O
when	when	ADV	WRB	O
zymosan	zymosan	NOUN	NN	O
opsonized	opsonize	VERB	VBN	O
by	by	ADP	IN	O
control	control	NOUN	NN	O
serum	serum	NOUN	NN	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Superoxide	Superoxide	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
hydrogen	hydrogen	NOUN	NN	B-Chemical
peroxide	peroxide	NOUN	NN	I-Chemical
production	production	NOUN	NN	O
in	in	ADP	IN	O
neutrophils	neutrophil	NOUN	NNS	O
stimulated	stimulate	VERB	VBN	O
with	with	ADP	IN	O
formyl	formyl	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methionyl	methionyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
leucyl	leucyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
phenylalanine	phenylalanine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
fMLP	fMLP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
from	from	ADP	IN	O
a	a	DET	DT	O
further	further	ADJ	JJ	O
18	18	NUM	CD	O
ALF	ALF	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
was	be	VERB	VBD	O
unaffected	unaffected	ADJ	JJ	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
control	control	NOUN	NN	O
neutrophils	neutrophil	NOUN	NNS	O
.	.	PUNCT	.	O

Serum	Serum	PROPN	NNP	O
C3	C3	PROPN	NNP	O
complement	complement	NOUN	NN	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
reduced	reduce	VERB	VBN	O
in	in	ADP	IN	O
ALF	ALF	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
control	control	NOUN	NN	O
subjects	subject	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0005	0005	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
demonstrate	demonstrate	VERB	VBP	O
a	a	DET	DT	O
neutrophil	neutrophil	NOUN	NN	O
defect	defect	NOUN	NN	O
in	in	ADP	IN	O
ALF	ALF	PROPN	NNP	B-Disease
due	due	ADJ	JJ	O
to	to	ADP	IN	O
paracetamol	paracetamol	ADJ	JJ	B-Chemical
overdose	overdose	NOUN	NN	B-Disease
,	,	PUNCT	,	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
complement	complement	NOUN	NN	O
dependent	dependent	ADJ	JJ	O
but	but	CCONJ	CC	O
independent	independent	ADJ	JJ	O
of	of	ADP	IN	O
serum	serum	ADJ	JJ	O
complement	complement	NOUN	NN	O
,	,	PUNCT	,	O
possibly	possibly	ADV	RB	O
connected	connect	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
complement	complement	NOUN	NN	O
receptor	receptor	NOUN	NN	O
.	.	PUNCT	.	O

Cholesteryl	cholesteryl	NOUN	NN	B-Chemical
hemisuccinate	hemisuccinate	ADJ	JJ	I-Chemical
treatment	treatment	NOUN	NN	O
protects	protect	VERB	VBZ	O
rodents	rodent	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
toxic	toxic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
adriamycin	adriamycin	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
carbon	carbon	NOUN	NN	B-Chemical
tetrachloride	tetrachloride	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
chloroform	chloroform	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
galactosamine	galactosamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
to	to	ADP	IN	O
its	-PRON-	DET	PRP$	O
use	use	NOUN	NN	O
as	as	ADP	IN	O
a	a	DET	DT	O
stabilizer	stabilizer	NOUN	NN	O
/	/	SYM	SYM	O
rigidifier	rigidifier	NOUN	NN	O
of	of	ADP	IN	O
membranes	membrane	NOUN	NNS	O
,	,	PUNCT	,	O
cholesteryl	cholesteryl	NOUN	NN	B-Chemical
hemisuccinate	hemisuccinate	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
tris	tris	NOUN	NN	B-Chemical
salt	salt	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
CS	CS	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
administration	administration	NOUN	NN	O
has	have	VERB	VBZ	O
also	also	ADV	RB	O
been	be	VERB	VBN	O
shown	show	VERB	VBN	O
to	to	PART	TO	O
protect	protect	VERB	VB	O
rats	rat	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
hepatotoxic	hepatotoxic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
carbon	carbon	NOUN	NN	B-Chemical
tetrachloride	tetrachloride	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
CCl4	CCl4	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

To	to	PART	TO	O
further	further	VERB	VB	O
our	-PRON-	DET	PRP$	O
understanding	understanding	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
CS	CS	PROPN	NNP	B-Chemical
cytoprotection	cytoprotection	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
examined	examine	VERB	VBD	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
mice	mouse	NOUN	NNS	O
the	the	DET	DT	O
protective	protective	ADJ	JJ	O
abilities	ability	NOUN	NNS	O
of	of	ADP	IN	O
CS	CS	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
hydrolyzable	hydrolyzable	ADJ	JJ	O
ether	ether	ADJ	JJ	O
form	form	NOUN	NN	O
of	of	ADP	IN	O
CS	CS	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
gamma	gamma	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
cholesteryloxybutyric	cholesteryloxybutyric	NOUN	NN	I-Chemical
acid	acid	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
tris	tris	NOUN	NN	B-Chemical
salt	salt	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
CSE	CSE	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
against	against	ADP	IN	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
adriamycin	adriamycin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
carbon	carbon	NOUN	NN	B-Chemical
tetrachloride	tetrachloride	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
chloroform	chloroform	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
galactosamine	galactosamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
these	these	DET	DT	O
studies	study	NOUN	NNS	O
demonstrated	demonstrate	VERB	VBD	O
that	that	ADP	IN	O
CS	CS	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
protection	protection	NOUN	NN	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
selective	selective	ADJ	JJ	O
for	for	ADP	IN	O
a	a	DET	DT	O
particular	particular	ADJ	JJ	O
species	specie	NOUN	NNS	O
,	,	PUNCT	,	O
organ	organ	NOUN	NN	O
system	system	NOUN	NN	O
or	or	CCONJ	CC	O
toxic	toxic	ADJ	JJ	O
chemical	chemical	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
24	24	NUM	CD	O
-	-	SYM	SYM	O
h	h	NOUN	NN	O
pretreatment	pretreatment	NOUN	NN	O
of	of	ADP	IN	O
both	both	DET	DT	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
CS	CS	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
100mg	100mg	PROPN	NNP	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
resulted	result	VERB	VBD	O
in	in	ADP	IN	O
significant	significant	ADJ	JJ	O
protection	protection	NOUN	NN	O
against	against	ADP	IN	O
the	the	DET	DT	O
hepatotoxic	hepatotoxic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
CCl4	CCl4	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
CHCl3	CHCl3	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
acetaminophen	acetaminophen	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
galactosamine	galactosamine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
against	against	ADP	IN	O
the	the	DET	DT	O
lethal	lethal	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
and	and	CCONJ	CC	O
presumably	presumably	ADV	RB	O
cardiotoxic	cardiotoxic	ADJ	JJ	B-Disease
)	)	PUNCT	-RRB-	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
adriamycin	adriamycin	ADJ	JJ	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

Maximal	Maximal	PROPN	NNP	O
CS	CS	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
protection	protection	NOUN	NN	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
experimental	experimental	ADJ	JJ	O
animals	animal	NOUN	NNS	O
pretreated	pretreate	VERB	VBD	O
24	24	NUM	CD	O
h	h	NOUN	NN	O
prior	prior	ADV	RB	O
to	to	ADP	IN	O
the	the	DET	DT	O
toxic	toxic	ADJ	JJ	O
insult	insult	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
CS	CS	PROPN	NNP	B-Chemical
intervenes	intervene	NOUN	NNS	O
in	in	ADP	IN	O
a	a	DET	DT	O
critical	critical	ADJ	JJ	O
cellular	cellular	ADJ	JJ	O
event	event	NOUN	NN	O
that	that	DET	WDT	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
common	common	ADJ	JJ	O
pathway	pathway	NOUN	NN	O
to	to	ADP	IN	O
toxic	toxic	ADJ	JJ	O
cell	cell	NOUN	NN	O
death	death	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanism	mechanism	NOUN	NN	O
of	of	ADP	IN	O
CS	CS	PROPN	NNP	B-Chemical
protection	protection	NOUN	NN	O
does	do	VERB	VBZ	O
not	not	ADV	RB	O
appear	appear	VERB	VB	O
to	to	PART	TO	O
be	be	VERB	VB	O
dependent	dependent	ADJ	JJ	O
on	on	ADP	IN	O
the	the	DET	DT	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
chemical	chemical	ADJ	JJ	O
bioactivation	bioactivation	NOUN	NN	O
to	to	ADP	IN	O
a	a	DET	DT	O
toxic	toxic	ADJ	JJ	O
reactive	reactive	ADJ	JJ	O
intermediate	intermediate	NOUN	NN	O
(	(	PUNCT	-LRB-	O
in	in	ADP	IN	O
light	light	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
protection	protection	NOUN	NN	O
observed	observe	VERB	VBN	O
against	against	ADP	IN	O
galactosamine	galactosamine	ADJ	JJ	B-Chemical
hepatotoxicity	hepatotoxicity	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
based	base	VERB	VBN	O
on	on	ADP	IN	O
the	the	DET	DT	O
data	datum	NOUN	NNS	O
presented	present	VERB	VBN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
can	can	VERB	MD	O
not	not	ADV	RB	O
exclude	exclude	VERB	VB	O
the	the	DET	DT	O
possibility	possibility	NOUN	NN	O
that	that	ADP	IN	O
CS	CS	PROPN	NNP	B-Chemical
administration	administration	NOUN	NN	O
inhibits	inhibit	VERB	VBZ	O
chemical	chemical	NOUN	NN	O
bioactivation	bioactivation	NOUN	NN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
findings	finding	NOUN	NNS	O
do	do	VERB	VBP	O
suggest	suggest	VERB	VB	O
that	that	ADP	IN	O
CS	CS	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
mediated	mediate	VERB	VBN	O
protection	protection	NOUN	NN	O
is	be	VERB	VBZ	O
dependent	dependent	ADJ	JJ	O
on	on	ADP	IN	O
the	the	DET	DT	O
action	action	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
intact	intact	ADJ	JJ	O
anionic	anionic	ADJ	JJ	O
CS	CS	PROPN	NNP	B-Chemical
molecule	molecule	NOUN	NN	O
(	(	PUNCT	-LRB-	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
hydrolyzable	hydrolyzable	ADJ	JJ	O
CSE	CSE	PROPN	NNP	B-Chemical
was	be	VERB	VBD	O
as	as	ADV	RB	O
protective	protective	ADJ	JJ	O
as	as	ADP	IN	O
CS	CS	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
whose	whose	DET	WP$	O
mechanism	mechanism	NOUN	NN	O
has	have	VERB	VBZ	O
yet	yet	ADV	RB	O
to	to	PART	TO	O
be	be	VERB	VB	O
defined	define	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
murine	murine	ADJ	JJ	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
adenomyosis	adenomyosis	NOUN	NN	B-Disease
:	:	PUNCT	:	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
selective	selective	ADJ	JJ	O
serotonin	serotonin	NOUN	NN	B-Chemical
reuptake	reuptake	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
adenomyosis	adenomyosis	NOUN	NN	B-Disease
induction	induction	NOUN	NN	O
in	in	ADP	IN	O
Wistar	Wistar	PROPN	NNP	O
albino	albino	ADJ	JJ	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
whether	whether	ADP	IN	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
given	give	VERB	VBN	O
to	to	ADP	IN	O
castrated	castrate	VERB	VBN	O
and	and	CCONJ	CC	O
noncastrated	noncastrated	ADJ	JJ	O
rats	rat	NOUN	NNS	O
caused	cause	VERB	VBD	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
effects	effect	NOUN	NNS	O
with	with	ADP	IN	O
respect	respect	NOUN	NN	O
to	to	ADP	IN	O
adenomyosis	adenomyosis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
Fluoxetine	Fluoxetine	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
serotonin	serotonin	NOUN	NN	B-Chemical
reuptake	reuptake	NOUN	NN	O
inhibitor	inhibitor	NOUN	NN	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
given	give	VERB	VBN	O
to	to	ADP	IN	O
Wistar	Wistar	PROPN	NNP	O
Albino	Albino	PROPN	NNP	O
rats	rat	NOUN	NNS	O
for	for	ADP	IN	O
98	98	NUM	CD	O
days	day	NOUN	NNS	O
to	to	PART	TO	O
produce	produce	VERB	VB	O
hyperprolactinemia	hyperprolactinemia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
drug	drug	NOUN	NN	O
was	be	VERB	VBD	O
given	give	VERB	VBN	O
to	to	ADP	IN	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
consisting	consist	VERB	VBG	O
of	of	ADP	IN	O
castrated	castrate	VERB	VBN	O
and	and	CCONJ	CC	O
noncastrated	noncastrated	ADJ	JJ	O
rats	rat	NOUN	NNS	O
and	and	CCONJ	CC	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
castrated	castrate	VERB	VBN	O
and	and	CCONJ	CC	O
noncastrated	noncastrated	ADJ	JJ	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

Prolactin	prolactin	NOUN	NN	O
levels	level	NOUN	NNS	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
uteri	uteri	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
removed	remove	VERB	VBN	O
for	for	ADP	IN	O
histopathological	histopathological	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
at	at	ADP	IN	O
the	the	DET	DT	O
end	end	NOUN	NN	O
of	of	ADP	IN	O
98	98	NUM	CD	O
days	day	NOUN	NNS	O
.	.	PUNCT	.	O

SETTING	setting	NOUN	NN	O
:	:	PUNCT	:	O
Marmara	Marmara	PROPN	NNP	O
University	University	PROPN	NNP	O
School	School	PROPN	NNP	O
of	of	ADP	IN	O
Medicine	Medicine	PROPN	NNP	O
,	,	PUNCT	,	O
Department	Department	PROPN	NNP	O
of	of	ADP	IN	O
Histology	Histology	PROPN	NNP	O
and	and	CCONJ	CC	O
Embryology	Embryology	PROPN	NNP	O
,	,	PUNCT	,	O
Zeynep	Zeynep	PROPN	NNP	O
Kamil	Kamil	PROPN	NNP	O
Women	Women	PROPN	NNP	O
and	and	CCONJ	CC	O
Children	Children	PROPN	NNP	O
'	'	PART	POS	O
s	s	PROPN	NNP	O
Hospital	Hospital	PROPN	NNP	O
.	.	PUNCT	.	O

MAIN	MAIN	PROPN	NNP	O
OUTCOME	OUTCOME	PROPN	NNP	O
MEASURES	MEASURES	PROPN	NNP	O
:	:	PUNCT	:	O
Serum	serum	ADJ	JJ	O
prolactin	prolactin	NOUN	NN	O
levels	level	NOUN	NNS	O
,	,	PUNCT	,	O
uterine	uterine	ADJ	JJ	O
histopathology	histopathology	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
prolactin	prolactin	NOUN	NN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
castrated	castrate	VERB	VBN	O
and	and	CCONJ	CC	O
noncastrated	noncastrated	ADJ	JJ	O
groups	group	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
statistically	statistically	ADV	RB	O
significantly	significantly	ADV	RB	O
higher	high	ADJ	JJR	O
when	when	ADV	WRB	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
their	-PRON-	DET	PRP$	O
respective	respective	ADJ	JJ	O
control	control	NOUN	NN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Histological	histological	ADJ	JJ	O
studies	study	NOUN	NNS	O
revealed	reveal	VERB	VBD	O
11	11	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
adenomyosis	adenomyosis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
all	all	DET	DT	O
within	within	ADP	IN	O
the	the	DET	DT	O
noncastrated	noncastrated	ADJ	JJ	O
group	group	NOUN	NN	O
receiving	receive	VERB	VBG	O
fluoxetine	fluoxetine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
It	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
suggested	suggest	VERB	VBN	O
that	that	ADP	IN	O
high	high	ADJ	JJ	O
serum	serum	NOUN	NN	O
prolactin	prolactin	NOUN	NN	O
levels	level	NOUN	NNS	O
cause	cause	VERB	VBP	O
degeneration	degeneration	NOUN	NN	O
of	of	ADP	IN	O
myometrial	myometrial	ADJ	JJ	O
cells	cell	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
presence	presence	NOUN	NN	O
of	of	ADP	IN	O
ovarian	ovarian	ADJ	JJ	O
steroids	steroid	NOUN	NNS	B-Chemical
that	that	DET	WDT	O
results	result	VERB	VBZ	O
in	in	ADP	IN	O
a	a	DET	DT	O
myometrial	myometrial	ADJ	JJ	O
invasion	invasion	NOUN	NN	O
by	by	ADP	IN	O
endometrial	endometrial	ADJ	JJ	O
stroma	stroma	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
invasion	invasion	NOUN	NN	O
eventually	eventually	ADV	RB	O
progresses	progress	VERB	VBZ	O
to	to	PART	TO	O
adenomyosis	adenomyosis	VERB	VB	B-Disease
.	.	PUNCT	.	O

Postinfarction	postinfarction	NOUN	NN	O
ventricular	ventricular	ADJ	JJ	B-Disease
septal	septal	ADJ	JJ	I-Disease
defect	defect	NOUN	NN	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
steroid	steroid	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
postinfarction	postinfarction	NOUN	NN	O
ventricular	ventricular	ADJ	JJ	B-Disease
septal	septal	ADJ	JJ	I-Disease
rupture	rupture	NOUN	NN	I-Disease
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
on	on	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
steroid	steroid	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
are	be	VERB	VBP	O
presented	present	VERB	VBN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
favourable	favourable	ADJ	JJ	O
outcome	outcome	NOUN	NN	O
in	in	ADP	IN	O
both	both	DET	DT	O
cases	case	NOUN	NNS	O
described	describe	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
possible	possible	ADJ	JJ	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
steroid	steroid	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
and	and	CCONJ	CC	O
subsequent	subsequent	ADJ	JJ	O
postinfarction	postinfarction	NOUN	NN	O
septal	septal	ADJ	JJ	B-Disease
rupture	rupture	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
discussed	discuss	VERB	VBN	O
.	.	PUNCT	.	O

Neuroactive	neuroactive	ADJ	JJ	O
steroids	steroid	NOUN	NNS	B-Chemical
protect	protect	VERB	VBP	O
against	against	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
kainic	kainic	VERB	VB	B-Chemical
acid	acid	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
limbic	limbic	NOUN	NN	O
seizures	seizure	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Several	several	ADJ	JJ	O
structurally	structurally	ADV	RB	O
related	relate	VERB	VBN	O
metabolites	metabolite	NOUN	NNS	O
of	of	ADP	IN	O
progesterone	progesterone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	B-Chemical
alpha	alpha	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxy	hydroxy	NOUN	NN	I-Chemical
pregnane	pregnane	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
20	20	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
ones	one	NOUN	NNS	I-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
deoxycorticosterone	deoxycorticosterone	ADJ	JJ	B-Chemical
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	B-Chemical
alpha	alpha	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxy	hydroxy	NOUN	NN	I-Chemical
pregnane	pregnane	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
21	21	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
diol	diol	NOUN	NNS	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
20	20	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
ones	one	NOUN	NNS	I-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
their	-PRON-	DET	PRP$	O
3	3	NUM	CD	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
epimers	epimer	NOUN	NNS	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
for	for	ADP	IN	O
protective	protective	ADJ	JJ	O
activity	activity	NOUN	NN	O
against	against	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
,	,	PUNCT	,	O
kainic	kainic	VERB	VB	B-Chemical
acid	acid	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
N	n	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
D	d	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aspartate	aspartate	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
NMDA	NMDA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
.	.	PUNCT	.	O

Steroids	steroid	NOUN	NNS	B-Chemical
with	with	ADP	IN	O
the	the	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
hydroxy	hydroxy	NOUN	NN	O
group	group	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
position	position	NOUN	NN	O
and	and	CCONJ	CC	O
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
H	h	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
or	or	CCONJ	CC	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
configurations	configuration	NOUN	NNS	O
were	be	VERB	VBD	O
highly	highly	ADV	RB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
protecting	protect	VERB	VBG	O
against	against	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
416	416	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
s	s	X	XX	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	:	O
induced	induce	VERB	VBN	O
limbic	limbic	ADJ	JJ	O
motor	motor	NOUN	NN	O
seizures	seizure	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
ED50	ED50	PROPN	NNP	O
values	value	NOUN	NNS	O
,	,	PUNCT	,	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
0	0	NUM	CD	O
-	-	SYM	SYM	O
18	18	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
corresponding	correspond	VERB	VBG	O
epimers	epimer	NOUN	NNS	O
with	with	ADP	IN	O
the	the	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
hydroxy	hydroxy	NOUN	NN	O
group	group	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
position	position	NOUN	NN	O
were	be	VERB	VBD	O
also	also	ADV	RB	O
effective	effective	ADJ	JJ	O
but	but	CCONJ	CC	O
less	less	ADV	RBR	O
potent	potent	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
ED50	ED50	PROPN	NNP	O
values	value	NOUN	NNS	O
,	,	PUNCT	,	O
33	33	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
-	-	SYM	SYM	O
63	63	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
the	the	DET	DT	O
neuroactive	neuroactive	ADJ	JJ	O
steroids	steroid	NOUN	NNS	B-Chemical
were	be	VERB	VBD	O
considerably	considerably	ADV	RB	O
less	less	ADV	RBR	O
potent	potent	ADJ	JJ	O
than	than	ADP	IN	O
the	the	DET	DT	O
benzodiazepine	benzodiazepine	NOUN	NN	B-Chemical
clonazepam	clonazepam	NOUN	NN	B-Chemical
in	in	ADP	IN	O
protecting	protect	VERB	VBG	O
against	against	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
seizures	seizure	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
steroids	steroid	NOUN	NNS	B-Chemical
with	with	ADP	IN	O
the	the	DET	DT	O
5	5	NUM	CD	O
alpha	alpha	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
configuration	configuration	NOUN	NN	O
had	have	VERB	VBD	O
comparable	comparable	ADJ	JJ	O
or	or	CCONJ	CC	O
higher	high	ADJ	JJR	O
protective	protective	ADJ	JJ	O
index	index	NOUN	NN	O
values	value	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
TD50	TD50	PROPN	NNP	O
for	for	ADP	IN	O
motor	motor	NOUN	NN	O
impairment	impairment	NOUN	NN	O
divided	divide	VERB	VBN	O
by	by	ADP	IN	O
ED50	ED50	PROPN	NNP	O
for	for	ADP	IN	O
seizure	seizure	NOUN	NN	B-Disease
protection	protection	NOUN	NN	O
)	)	PUNCT	-RRB-	O
than	than	ADP	IN	O
clonazepam	clonazepam	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
indicating	indicate	VERB	VBG	O
that	that	ADP	IN	O
some	some	DET	DT	O
neuroactive	neuroactive	ADJ	JJ	O
steroids	steroid	NOUN	NNS	B-Chemical
may	may	VERB	MD	O
have	have	VERB	VB	O
lower	low	ADJ	JJR	O
relative	relative	ADJ	JJ	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Steroids	steroid	NOUN	NNS	B-Chemical
with	with	ADP	IN	O
the	the	DET	DT	O
5	5	NUM	CD	O
alpha	alpha	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
or	or	CCONJ	CC	O
5	5	NUM	CD	O
beta	beta	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
alpha	alpha	NOUN	NN	O
-	-	PUNCT	HYPH	O
configurations	configuration	NOUN	NNS	O
also	also	ADV	RB	O
produced	produce	VERB	VBD	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
delay	delay	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
onset	onset	NOUN	NN	O
of	of	ADP	IN	O
limbic	limbic	ADJ	JJ	O
seizures	seizure	NOUN	NNS	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
kainic	kainic	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
32	32	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
s	s	X	XX	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
completely	completely	ADV	RB	O
protect	protect	VERB	VB	O
against	against	ADP	IN	O
the	the	DET	DT	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
a	a	DET	DT	O
second	second	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
steroid	steroid	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
1	1	NUM	CD	O
hr	hr	NOUN	NN	O
after	after	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
complete	complete	ADJ	JJ	O
protection	protection	NOUN	NN	O
from	from	ADP	IN	O
the	the	DET	DT	O
kainic	kainic	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
limbic	limbic	NOUN	NN	O
seizures	seizure	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
was	be	VERB	VBD	O
obtained	obtain	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
steroids	steroid	NOUN	NNS	B-Chemical
also	also	ADV	RB	O
caused	cause	VERB	VBD	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
delay	delay	NOUN	NN	O
in	in	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
257	257	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
,	,	PUNCT	,	O
s	s	X	XX	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	:	O
induced	induce	VERB	VBN	O
lethality	lethality	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
completely	completely	ADV	RB	O
protect	protect	VERB	VB	O
against	against	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
seizures	seizure	NOUN	NNS	B-Disease
or	or	CCONJ	CC	O
lethality	lethality	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
neuroactive	neuroactive	ADJ	JJ	O
steroids	steroid	NOUN	NNS	B-Chemical
are	be	VERB	VBP	O
highly	highly	ADV	RB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
protecting	protect	VERB	VBG	O
against	against	ADP	IN	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
kainic	kainic	VERB	VB	B-Chemical
acid	acid	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
seizures	seizure	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
may	may	VERB	MD	O
be	be	VERB	VB	O
of	of	ADP	IN	O
utility	utility	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
some	some	DET	DT	O
forms	form	NOUN	NNS	O
of	of	ADP	IN	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
in	in	ADP	IN	O
humans	human	NOUN	NNS	O
.	.	PUNCT	.	O

Hepatic	hepatic	ADJ	JJ	O
and	and	CCONJ	CC	O
extrahepatic	extrahepatic	ADJ	JJ	O
angiotensinogen	angiotensinogen	NOUN	NN	O
gene	gene	NOUN	NN	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Plasma	plasma	ADJ	JJ	O
concentration	concentration	NOUN	NN	O
and	and	CCONJ	CC	O
urine	urine	NOUN	NN	O
excretion	excretion	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
renin	renin	NOUN	NN	O
-	-	PUNCT	HYPH	O
angiotensin	angiotensin	NOUN	NN	B-Chemical
system	system	NOUN	NN	O
proteins	protein	NOUN	NNS	O
are	be	VERB	VBP	O
altered	alter	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
with	with	ADP	IN	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
NS	NS	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
this	this	DET	DT	O
work	work	NOUN	NN	O
the	the	DET	DT	O
messenger	messenger	NOUN	NN	O
ribonucleic	ribonucleic	NOUN	NN	O
acid	acid	NOUN	NN	O
(	(	PUNCT	-LRB-	O
mRNA	mRNA	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
angiotensinogen	angiotensinogen	NOUN	NN	O
(	(	PUNCT	-LRB-	O
Ao	Ao	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
slot	slot	NOUN	NN	O
-	-	PUNCT	HYPH	O
blot	blot	NOUN	NN	O
hybridization	hybridization	NOUN	NN	O
technique	technique	NOUN	NN	O
in	in	ADP	IN	O
liver	liver	NOUN	NN	O
and	and	CCONJ	CC	O
other	other	ADJ	JJ	O
extrahepatic	extrahepatic	ADJ	JJ	O
tissues	tissue	NOUN	NNS	O
:	:	PUNCT	:	O
kidney	kidney	NOUN	NN	O
,	,	PUNCT	,	O
heart	heart	NOUN	NN	O
,	,	PUNCT	,	O
brain	brain	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
adrenal	adrenal	ADJ	JJ	O
gland	gland	NOUN	NN	O
from	from	ADP	IN	O
control	control	NOUN	NN	O
,	,	PUNCT	,	O
nephrotic	nephrotic	ADJ	JJ	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
pair	pair	NOUN	NN	O
-	-	PUNCT	HYPH	O
fed	fed	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PF	PF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

NS	NS	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
puromycin	puromycin	ADJ	JJ	B-Chemical
amino	amino	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
nucleoside	nucleoside	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
PAN	PAN	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
a	a	DET	DT	O
great	great	ADJ	JJ	O
urinary	urinary	ADJ	JJ	O
excretion	excretion	NOUN	NN	O
and	and	CCONJ	CC	O
half	half	ADJ	JJ	O
-	-	PUNCT	HYPH	O
normal	normal	ADJ	JJ	O
plasma	plasma	NOUN	NN	O
levels	level	NOUN	NNS	O
of	of	ADP	IN	O
Ao	Ao	PROPN	NNP	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
on	on	ADP	IN	O
day	day	NOUN	NN	O
6	6	NUM	CD	O
after	after	ADP	IN	O
PAN	PAN	PROPN	NNP	B-Chemical
injection	injection	NOUN	NN	O
,	,	PUNCT	,	O
when	when	ADV	WRB	O
NS	NS	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
clearly	clearly	ADV	RB	O
established	establish	VERB	VBN	O
,	,	PUNCT	,	O
hepatic	hepatic	ADJ	JJ	O
Ao	Ao	PROPN	NNP	O
mRNA	mRNA	PROPN	NNP	O
levels	level	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
change	change	VERB	VB	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
Ao	Ao	PROPN	NNP	O
mRNA	mRNA	PROPN	NNP	O
levels	level	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
change	change	VERB	VB	O
in	in	ADP	IN	O
any	any	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
extrahepatic	extrahepatic	ADJ	JJ	O
tissues	tissue	NOUN	NNS	O
studied	study	VERB	VBD	O
on	on	ADP	IN	O
day	day	NOUN	NN	O
6	6	NUM	CD	O
,	,	PUNCT	,	O
nor	nor	CCONJ	CC	O
did	do	VERB	VBD	O
its	-PRON-	DET	PRP$	O
hepatic	hepatic	ADJ	JJ	O
levels	level	NOUN	NNS	O
at	at	ADP	IN	O
days	day	NOUN	NNS	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
7	7	NUM	CD	O
after	after	ADP	IN	O
PAN	PAN	PROPN	NNP	B-Chemical
injection	injection	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
hepatic	hepatic	ADJ	JJ	O
and	and	CCONJ	CC	O
extrahepatic	extrahepatic	ADJ	JJ	O
Ao	Ao	PROPN	NNP	O
mRNA	mRNA	PROPN	NNP	O
levels	level	NOUN	NNS	O
are	be	VERB	VBP	O
unaltered	unaltered	ADJ	JJ	O
during	during	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
acute	acute	ADJ	JJ	O
NS	NS	PROPN	NNP	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
PAN	PAN	PROPN	NNP	B-Chemical
.	.	PUNCT	.	O

Neuroleptic	neuroleptic	ADJ	JJ	B-Disease
malignant	malignant	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Neuroleptic	neuroleptic	ADJ	JJ	B-Disease
malignant	malignant	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
thought	think	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
a	a	DET	DT	O
result	result	NOUN	NN	O
of	of	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
D2	d2	NOUN	NN	O
receptor	receptor	NOUN	NN	O
blockade	blockade	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
basal	basal	ADJ	JJ	O
ganglia	ganglion	NOUN	NNS	O
.	.	PUNCT	.	O

Risperidone	Risperidone	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
benzisoxazole	benzisoxazole	NOUN	NN	B-Chemical
derivative	derivative	ADJ	JJ	O
antipsychotic	antipsychotic	NOUN	NN	O
,	,	PUNCT	,	O
has	have	VERB	VBZ	O
high	high	ADJ	JJ	O
serotonin	serotonin	NOUN	NN	B-Chemical
5	5	NUM	CD	O
-	-	PUNCT	HYPH	O
HT2	ht2	NOUN	NN	O
receptor	receptor	NOUN	NN	O
blockade	blockade	NOUN	NN	O
and	and	CCONJ	CC	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
D2	d2	NOUN	NN	O
receptor	receptor	NOUN	NN	O
blockade	blockade	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
high	high	ADJ	JJ	O
ratio	ratio	NOUN	NN	O
is	be	VERB	VBZ	O
believed	believe	VERB	VBN	O
to	to	PART	TO	O
impart	impart	VERB	VB	O
the	the	DET	DT	O
low	low	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
of	of	ADP	IN	O
extrapyramidal	extrapyramidal	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
at	at	ADP	IN	O
low	low	ADJ	JJ	O
dosages	dosage	NOUN	NNS	O
.	.	PUNCT	.	O

With	with	ADP	IN	O
this	this	DET	DT	O
low	low	ADJ	JJ	O
frequency	frequency	NOUN	NN	O
of	of	ADP	IN	O
extrapyramidal	extrapyramidal	ADJ	JJ	B-Disease
symptoms	symptom	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
thought	think	VERB	VBN	O
the	the	DET	DT	O
frequency	frequency	NOUN	NN	O
of	of	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	B-Disease
malignant	malignant	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
might	may	VERB	MD	O
also	also	ADV	RB	O
be	be	VERB	VB	O
lowered	lower	VERB	VBN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
73	73	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
developed	develop	VERB	VBD	O
neuroleptic	neuroleptic	ADJ	JJ	B-Disease
malignant	malignant	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
after	after	ADP	IN	O
monotherapy	monotherapy	NOUN	NN	O
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
syndrome	syndrome	NOUN	NN	O
reversed	reverse	VERB	VBD	O
after	after	ADP	IN	O
discontinuing	discontinue	VERB	VBG	O
risperidone	risperidone	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
starting	start	VERB	VBG	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
dantrolene	dantrolene	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
bromocriptine	bromocriptine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
appears	appear	VERB	VBZ	O
that	that	ADP	IN	O
the	the	DET	DT	O
protection	protection	NOUN	NN	O
from	from	ADP	IN	O
extrapyramidal	extrapyramidal	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
observed	observe	VERB	VBN	O
with	with	ADP	IN	O
risperidone	risperidone	NOUN	NN	B-Chemical
does	do	VERB	VBZ	O
not	not	ADV	RB	O
ensure	ensure	VERB	VB	O
protection	protection	NOUN	NN	O
from	from	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	B-Disease
malignant	malignant	ADJ	JJ	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
attenuating	attenuate	VERB	VBG	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
carteolol	carteolol	NOUN	NN	B-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
known	know	VERB	VBN	O
that	that	ADP	IN	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
antagonists	antagonist	NOUN	NNS	O
are	be	VERB	VBP	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
akathisia	akathisia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
extrapyramidal	extrapyramidal	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
that	that	DET	WDT	O
occur	occur	VERB	VBP	O
during	during	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
a	a	DET	DT	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
extrapyramidal	extrapyramidal	ADJ	JJ	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
,	,	PUNCT	,	O
was	be	VERB	VBD	O
considered	consider	VERB	VBN	O
suitable	suitable	ADJ	JJ	O
as	as	ADP	IN	O
a	a	DET	DT	O
model	model	NOUN	NN	O
for	for	ADP	IN	O
predicting	predict	VERB	VBG	O
neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
akathisia	akathisia	NOUN	NN	B-Disease
in	in	ADP	IN	O
humans	human	NOUN	NNS	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
catalepsy	catalepsy	NOUN	NN	B-Disease
was	be	VERB	VBD	O
not	not	ADV	RB	O
considered	consider	VERB	VBN	O
a	a	DET	DT	O
specific	specific	ADJ	JJ	O
test	test	NOUN	NN	O
for	for	ADP	IN	O
neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
akathisia	akathisia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Therefore	therefore	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
carteolol	carteolol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
on	on	ADP	IN	O
haloperidol	haloperidol	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
were	be	VERB	VBD	O
behaviorally	behaviorally	ADV	RB	O
studied	study	VERB	VBN	O
and	and	CCONJ	CC	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
propranolol	propranolol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
biperiden	biperiden	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
muscarinic	muscarinic	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
.	.	PUNCT	.	O

Carteolol	Carteolol	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
propranolol	propranolol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
biperiden	biperiden	ADV	RB	B-Chemical
,	,	PUNCT	,	O
inhibited	inhibit	VERB	VBD	O
the	the	DET	DT	O
haloperidol	haloperidol	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
inhibitory	inhibitory	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
carteolol	carteolol	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
almost	almost	ADV	RB	O
comparable	comparable	ADJ	JJ	O
to	to	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
propranolol	propranolol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
was	be	VERB	VBD	O
weaker	weak	ADJ	JJR	O
than	than	ADP	IN	O
that	that	DET	DT	O
of	of	ADP	IN	O
biperiden	biperiden	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Carteolol	Carteolol	PROPN	NNP	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
evoke	evoke	VERB	VB	O
postsynaptic	postsynaptic	ADJ	JJ	O
dopamine	dopamine	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
-	-	PUNCT	HYPH	O
stimulating	stimulate	VERB	VBG	O
behavioral	behavioral	ADJ	JJ	O
signs	sign	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
stereotypy	stereotypy	NOUN	NN	O
and	and	CCONJ	CC	O
hyperlocomotion	hyperlocomotion	NOUN	NN	B-Disease
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Carteolol	Carteolol	PROPN	NNP	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
antagonize	antagonize	VERB	VB	O
the	the	DET	DT	O
inhibitory	inhibitory	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
on	on	ADP	IN	O
apomorphine	apomorphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
stereotypy	stereotypy	NOUN	NN	O
and	and	CCONJ	CC	O
locomotor	locomotor	NOUN	NN	O
activity	activity	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
carteolol	carteolol	NOUN	NN	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
evoke	evoke	VERB	VB	O
5	5	NUM	CD	O
-	-	SYM	SYM	O
HT1A	ht1a	NOUN	NN	O
receptor	receptor	NOUN	NN	O
-	-	PUNCT	HYPH	O
stimulating	stimulate	VERB	VBG	O
behavioral	behavioral	ADJ	JJ	O
signs	sign	NOUN	NNS	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
flat	flat	ADJ	JJ	O
body	body	NOUN	NN	O
posture	posture	NOUN	NN	O
and	and	CCONJ	CC	O
forepaw	forepaw	ADV	RB	O
treading	tread	VERB	VBG	O
and	and	CCONJ	CC	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
inhibit	inhibit	VERB	VB	O
5	5	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
hydroxytryptophan	hydroxytryptophan	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
head	head	NOUN	NN	O
twitch	twitch	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Finally	finally	ADV	RB	O
,	,	PUNCT	,	O
carteolol	carteolol	NOUN	NN	B-Chemical
did	do	VERB	VBD	O
not	not	ADV	RB	O
inhibit	inhibit	VERB	VB	O
physostigmine	physostigmine	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
lethality	lethality	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
strongly	strongly	ADV	RB	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
carteolol	carteolol	NOUN	NN	B-Chemical
improves	improve	VERB	VBZ	O
haloperidol	haloperidol	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
catalepsy	catalepsy	NOUN	NN	B-Disease
via	via	ADP	IN	O
its	-PRON-	DET	PRP$	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
antagonistic	antagonistic	ADJ	JJ	O
activity	activity	NOUN	NN	O
and	and	CCONJ	CC	O
is	be	VERB	VBZ	O
expected	expect	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
effective	effective	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
akathisia	akathisia	NOUN	NN	B-Disease
without	without	ADP	IN	O
attenuating	attenuate	VERB	VBG	O
neuroleptic	neuroleptic	ADJ	JJ	O
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
antipsychotic	antipsychotic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
its	-PRON-	DET	PRP$	O
postsynaptic	postsynaptic	ADJ	JJ	O
dopamine	dopamine	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
antagonistic	antagonistic	ADJ	JJ	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Granulosa	Granulosa	PROPN	NNP	B-Disease
cell	cell	NOUN	NN	I-Disease
tumor	tumor	NOUN	NN	I-Disease
of	of	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
ovary	ovary	ADJ	JJ	I-Disease
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
antecedent	antecedent	NOUN	NN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Increased	increase	VERB	VBN	O
attention	attention	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
focused	focus	VERB	VBN	O
recently	recently	ADV	RB	O
on	on	ADP	IN	O
the	the	DET	DT	O
estrogenic	estrogenic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Review	review	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
literature	literature	NOUN	NN	O
reveals	reveal	VERB	VBZ	O
an	an	DET	DT	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
and	and	CCONJ	CC	O
gynecologic	gynecologic	ADJ	JJ	O
tumors	tumor	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

CASE	case	NOUN	NN	O
:	:	PUNCT	:	O
A	a	DET	DT	O
52	52	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
postmenopausal	postmenopausal	NOUN	NN	O
woman	woman	NOUN	NN	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
for	for	ADP	IN	O
stage	stage	NOUN	NN	O
II	II	PROPN	NNP	O
estrogen	estrogen	NOUN	NN	B-Chemical
receptor	receptor	NOUN	NN	O
-	-	PUNCT	HYPH	O
positive	positive	ADJ	JJ	O
breast	breast	NOUN	NN	B-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Her	-PRON-	DET	PRP$	O
aspartate	aspartate	NOUN	NN	B-Chemical
transaminase	transaminase	NOUN	NN	O
and	and	CCONJ	CC	O
alanine	alanine	NOUN	NN	B-Chemical
transaminase	transaminase	NOUN	NN	O
levels	level	NOUN	NNS	O
increase	increase	VERB	VBP	O
markedly	markedly	ADV	RB	O
after	after	ADP	IN	O
6	6	NUM	CD	O
months	month	NOUN	NNS	O
of	of	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
an	an	DET	DT	O
additional	additional	ADJ	JJ	O
17	17	NUM	CD	O
months	month	NOUN	NNS	O
of	of	ADP	IN	O
elevated	elevated	ADJ	JJ	O
serum	serum	NOUN	NN	O
transaminases	transaminase	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
a	a	DET	DT	O
stage	stage	NOUN	NN	O
Ic	Ic	PROPN	NNP	O
granulosa	granulosa	NOUN	NN	B-Disease
cell	cell	NOUN	NN	I-Disease
tumor	tumor	NOUN	NN	I-Disease
of	of	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
ovary	ovary	NOUN	NN	I-Disease
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
liver	liver	NOUN	NN	B-Disease
dysfunction	dysfunction	NOUN	NN	I-Disease
may	may	VERB	MD	O
be	be	VERB	VB	O
at	at	ADP	IN	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
granulosa	granulosa	NOUN	NN	B-Disease
cell	cell	NOUN	NN	I-Disease
tumors	tumor	NOUN	NNS	I-Disease
because	because	ADP	IN	O
of	of	ADP	IN	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
metabolism	metabolism	NOUN	NN	O
.	.	PUNCT	.	O

Lifetime	lifetime	NOUN	NN	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
azidothymidine	azidothymidine	PROPN	NNP	B-Chemical
(	(	PUNCT	-LRB-	O
AZT	AZT	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
produces	produce	VERB	VBZ	O
myelodysplasia	myelodysplasia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

AZT	AZT	PROPN	NNP	B-Chemical
has	have	VERB	VBZ	O
induced	induce	VERB	VBN	O
a	a	DET	DT	O
macrocytic	macrocytic	ADJ	JJ	B-Disease
anemia	anemia	NOUN	NN	I-Disease
in	in	ADP	IN	O
AIDS	AIDS	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
on	on	ADP	IN	O
long	long	ADJ	JJ	O
term	term	NOUN	NN	O
AZT	AZT	PROPN	NNP	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
generally	generally	ADV	RB	O
assumed	assume	VERB	VBN	O
that	that	ADP	IN	O
DNA	dna	NOUN	NN	O
elongation	elongation	NOUN	NN	O
is	be	VERB	VBZ	O
stopped	stop	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
insertion	insertion	NOUN	NN	O
of	of	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
into	into	ADP	IN	O
the	the	DET	DT	O
chain	chain	NOUN	NN	O
in	in	ADP	IN	O
place	place	NOUN	NN	O
of	of	ADP	IN	O
thymidine	thymidine	NOUN	NN	B-Chemical
thus	thus	ADV	RB	O
preventing	prevent	VERB	VBG	O
the	the	DET	DT	O
phosphate	phosphate	ADJ	JJ	B-Chemical
hydroxyl	hydroxyl	NOUN	NN	O
linkages	linkage	NOUN	NNS	O
and	and	CCONJ	CC	O
therefore	therefore	ADV	RB	O
suppresses	suppress	VERB	VBZ	O
hemopoietic	hemopoietic	ADJ	JJ	O
progenitor	progenitor	NOUN	NN	O
cell	cell	NOUN	NN	O
proliferation	proliferation	NOUN	NN	O
in	in	ADP	IN	O
an	an	DET	DT	O
early	early	ADJ	JJ	O
stage	stage	NOUN	NN	O
of	of	ADP	IN	O
differentiation	differentiation	NOUN	NN	O
.	.	PUNCT	.	O

CBA	CBA	PROPN	NNP	O
/	/	SYM	SYM	O
Ca	ca	NOUN	NN	O
male	male	ADJ	JJ	O
mice	mouse	NOUN	NNS	O
started	start	VERB	VBD	O
on	on	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
0	0	NUM	CD	O
.	.	PUNCT	.	O
75	75	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
H2O	H2O	PROPN	NNP	O
at	at	ADP	IN	O
84	84	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
age	age	NOUN	NN	O
and	and	CCONJ	CC	O
kept	keep	VERB	VBD	O
on	on	ADP	IN	O
it	-PRON-	PRON	PRP	O
for	for	ADP	IN	O
687	687	NUM	CD	O
days	day	NOUN	NNS	O
when	when	ADV	WRB	O
dosage	dosage	NOUN	NN	O
reduced	reduce	VERB	VBN	O
to	to	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
H2O	H2O	PROPN	NNP	O
for	for	ADP	IN	O
a	a	DET	DT	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
another	another	DET	DT	O
group	group	NOUN	NN	O
removed	remove	VERB	VBD	O
from	from	ADP	IN	O
AZT	AZT	PROPN	NNP	B-Chemical
to	to	PART	TO	O
see	see	VERB	VB	O
recovery	recovery	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
third	third	ADJ	JJ	O
group	group	NOUN	NN	O
remained	remain	VERB	VBD	O
on	on	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
75	75	NUM	CD	O
mg	mg	NOUN	NN	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
687	687	NUM	CD	O
days	day	NOUN	NNS	O
mice	mouse	NOUN	NNS	O
that	that	DET	WDT	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
on	on	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
75	75	NUM	CD	O
mg	mg	NOUN	NN	O
had	have	VERB	VBD	O
average	average	ADJ	JJ	O
platelet	platelet	NOUN	NN	O
counts	count	NOUN	NNS	O
of	of	ADP	IN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Histological	histological	ADJ	JJ	O
examination	examination	NOUN	NN	O
on	on	ADP	IN	O
9	9	NUM	CD	O
of	of	ADP	IN	O
10	10	NUM	CD	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
such	such	ADJ	JJ	O
thrombocytopenia	thrombocytopenia	NOUN	NN	B-Disease
showed	show	VERB	VBD	O
changes	change	NOUN	NNS	O
compatible	compatible	ADJ	JJ	O
with	with	ADP	IN	O
myelodysplastic	myelodysplastic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
MDS	MDS	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

A	a	DET	DT	O
variety	variety	NOUN	NN	O
of	of	ADP	IN	O
histological	histological	ADJ	JJ	O
patterns	pattern	NOUN	NNS	O
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
hypocellular	hypocellular	ADJ	JJ	O
myelodysplasia	myelodysplasia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
hypersegmented	hypersegmented	ADJ	JJ	O
myelodysplastic	myelodysplastic	ADJ	JJ	B-Disease
granulocytosis	granulocytosis	NOUN	NN	O
,	,	PUNCT	,	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
hypercellular	hypercellular	ADJ	JJ	O
marrow	marrow	NOUN	NN	O
with	with	ADP	IN	O
abnormal	abnormal	ADJ	JJ	O
megakaryocytes	megakaryocyte	NOUN	NNS	O
with	with	ADP	IN	O
bizarre	bizarre	ADJ	JJ	O
nuclei	nucleus	NOUN	NNS	O
,	,	PUNCT	,	O
one	one	NUM	CD	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
megakaryocytic	megakaryocytic	ADJ	JJ	O
myelosis	myelosis	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
hyperplastic	hyperplastic	ADJ	JJ	B-Disease
marrow	marrow	NOUN	NN	I-Disease
,	,	PUNCT	,	O
dysmyelopoiesis	dysmyelopoiesis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
a	a	DET	DT	O
hypocellular	hypocellular	ADJ	JJ	B-Disease
marrow	marrow	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
two	two	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
myelodysplasia	myelodysplasia	NOUN	NN	B-Disease
with	with	ADP	IN	O
dyserythropoiesis	dyserythropoiesis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
hemosiderosis	hemosiderosis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
a	a	DET	DT	O
hypocellular	hypocellular	ADJ	JJ	B-Disease
marrow	marrow	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Above	above	ADP	IN	O
mentioned	mention	VERB	VBD	O
AZT	AZT	PROPN	NNP	B-Chemical
incorporation	incorporation	NOUN	NN	O
may	may	VERB	MD	O
have	have	VERB	VB	O
induced	induce	VERB	VBN	O
an	an	DET	DT	O
ineffective	ineffective	ADJ	JJ	O
hemopoiesis	hemopoiesis	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
primitive	primitive	ADJ	JJ	O
hemopoietic	hemopoietic	ADJ	JJ	O
progenitor	progenitor	NOUN	NN	O
cells	cell	NOUN	NNS	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
known	know	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
seen	see	VERB	VBN	O
commonly	commonly	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
myelodysplastic	myelodysplastic	ADJ	JJ	B-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Biphasic	biphasic	ADJ	JJ	O
response	response	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
SA	SA	PROPN	NNP	O
node	node	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
dog	dog	NOUN	NN	O
heart	heart	NOUN	NN	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
to	to	ADP	IN	O
selective	selective	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
on	on	ADP	IN	O
the	the	DET	DT	O
SA	SA	PROPN	NNP	O
node	node	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
dog	dog	NOUN	NN	O
heart	heart	NOUN	NN	O
was	be	VERB	VBD	O
studied	study	VERB	VBN	O
in	in	ADP	IN	O
vivo	vivo	NOUN	NNS	O
using	use	VERB	VBG	O
a	a	DET	DT	O
selective	selective	ADJ	JJ	O
perfusion	perfusion	NOUN	NN	O
technique	technique	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
SA	SA	PROPN	NNP	O
node	node	NOUN	NN	O
artery	artery	NOUN	NN	O
.	.	PUNCT	.	O

Injections	injection	NOUN	NNS	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
in	in	ADP	IN	O
doses	dose	NOUN	NNS	O
from	from	ADP	IN	O
100	100	NUM	CD	O
microgram	microgram	NOUN	NN	O
to	to	ADP	IN	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
into	into	ADP	IN	O
the	the	DET	DT	O
artery	artery	NOUN	NN	O
produced	produce	VERB	VBD	O
a	a	DET	DT	O
depression	depression	NOUN	NN	B-Disease
of	of	ADP	IN	O
the	the	DET	DT	O
SA	SA	PROPN	NNP	O
nodal	nodal	ADJ	JJ	O
activity	activity	NOUN	NN	O
by	by	ADP	IN	O
a	a	DET	DT	O
direct	direct	ADJ	JJ	O
action	action	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
depression	depression	NOUN	NN	B-Disease
was	be	VERB	VBD	O
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
sudden	sudden	ADJ	JJ	O
appearance	appearance	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
stimulatory	stimulatory	ADJ	JJ	O
phase	phase	NOUN	NN	O
.	.	PUNCT	.	O

Bilateral	bilateral	ADJ	JJ	O
vagotomy	vagotomy	NOUN	NN	O
and	and	CCONJ	CC	O
sympathectomy	sympathectomy	ADJ	JJ	O
or	or	CCONJ	CC	O
prior	prior	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
ganglion	ganglion	NOUN	NN	O
blocker	blocker	NOUN	NN	O
failed	fail	VERB	VBD	O
to	to	PART	TO	O
inhibit	inhibit	VERB	VB	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
ketamine	ketamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
tachycardia	tachycardia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
while	while	ADP	IN	O
it	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
completely	completely	ADV	RB	O
abolished	abolish	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
reserpinized	reserpinize	VERB	VBN	O
dogs	dog	NOUN	NNS	O
or	or	CCONJ	CC	O
by	by	ADP	IN	O
a	a	DET	DT	O
prior	prior	ADJ	JJ	O
injection	injection	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
blocking	block	VERB	VBG	O
agent	agent	NOUN	NN	O
into	into	ADP	IN	O
the	the	DET	DT	O
SA	SA	PROPN	NNP	O
node	node	NOUN	NN	O
artery	artery	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
may	may	VERB	MD	O
indicate	indicate	VERB	VB	O
that	that	ADP	IN	O
an	an	DET	DT	O
activation	activation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
adrenergic	adrenergic	NOUN	NN	O
mechanism	mechanism	NOUN	NN	O
plays	play	VERB	VBZ	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
induction	induction	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
excitatory	excitatory	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
ketamine	ketamine	NOUN	NN	B-Chemical
injected	inject	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
SA	SA	PROPN	NNP	O
node	node	NOUN	NN	O
artery	artery	NOUN	NN	O
.	.	PUNCT	.	O

Over	over	ADP	IN	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
vascular	vascular	ADJ	JJ	O
endothelial	endothelial	ADJ	JJ	O
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
receptor	receptor	NOUN	NN	O
during	during	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
estrogen	estrogen	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
rat	rat	NOUN	NN	O
pituitary	pituitary	ADJ	JJ	B-Disease
tumors	tumor	NOUN	NNS	I-Disease
may	may	VERB	MD	O
mediate	mediate	VERB	VB	O
estrogen	estrogen	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
initiated	initiate	VERB	VBN	O
tumor	tumor	NOUN	NN	B-Disease
angiogenesis	angiogenesis	NOUN	NN	O
.	.	PUNCT	.	O

Estrogens	Estrogens	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
which	which	DET	WDT	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
several	several	ADJ	JJ	O
types	type	NOUN	NNS	O
of	of	ADP	IN	O
human	human	ADJ	JJ	O
and	and	CCONJ	CC	O
animal	animal	NOUN	NN	O
cancers	cancer	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
can	can	VERB	MD	O
induce	induce	VERB	VB	O
tumor	tumor	NOUN	NN	B-Disease
angiogenesis	angiogenesis	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pituitary	pituitary	NOUN	NN	O
of	of	ADP	IN	O
Fischer	Fischer	PROPN	NNP	O
344	344	NUM	CD	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
mechanistic	mechanistic	ADJ	JJ	O
details	detail	NOUN	NNS	O
of	of	ADP	IN	O
tumor	tumor	NOUN	NN	B-Disease
angiogenesis	angiogenesis	NOUN	NN	O
induction	induction	NOUN	NN	O
,	,	PUNCT	,	O
during	during	ADP	IN	O
estrogen	estrogen	NOUN	NN	B-Chemical
carcinogenesis	carcinogenesis	NOUN	NN	B-Disease
,	,	PUNCT	,	O
are	be	VERB	VBP	O
still	still	ADV	RB	O
unknown	unknown	ADJ	JJ	O
.	.	PUNCT	.	O

To	to	PART	TO	O
elucidate	elucidate	VERB	VB	O
the	the	DET	DT	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
estrogen	estrogen	NOUN	NN	B-Chemical
in	in	ADP	IN	O
the	the	DET	DT	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
tumor	tumor	NOUN	NN	B-Disease
angiogenesis	angiogenesis	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pituitary	pituitary	NOUN	NN	O
of	of	ADP	IN	O
female	female	ADJ	JJ	O
rats	rat	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
density	density	NOUN	NN	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
vessels	vessel	NOUN	NNS	O
was	be	VERB	VBD	O
analysed	analyse	VERB	VBN	O
using	use	VERB	VBG	O
factor	factor	NOUN	NN	O
VIII	viii	NUM	CD	O
related	relate	VERB	VBN	O
antigen	antigen	NOUN	NN	O
(	(	PUNCT	-LRB-	O
FVIIIRAg	FVIIIRAg	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
immunohistochemistry	immunohistochemistry	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
vascular	vascular	ADJ	JJ	O
endothelial	endothelial	ADJ	JJ	O
growth	growth	NOUN	NN	O
factor	factor	NOUN	NN	O
/	/	SYM	SYM	O
vascular	vascular	NOUN	NN	O
permeability	permeability	NOUN	NN	O
factor	factor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
VEGF	VEGF	PROPN	NNP	O
/	/	SYM	SYM	O
VPF	VPF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
examined	examine	VERB	VBN	O
by	by	ADP	IN	O
Western	western	ADJ	JJ	O
blot	blot	NOUN	NN	O
and	and	CCONJ	CC	O
immunohistochemical	immunohistochemical	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
VEGF	VEGF	PROPN	NNP	O
receptor	receptor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
VEGFR	VEGFR	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	PROPN	NNP	O
/	/	SYM	SYM	O
Flk	Flk	PROPN	NNP	O
-	-	PUNCT	HYPH	O
1	1	PROPN	NNP	O
/	/	SYM	SYM	O
KDR	KDR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
also	also	ADV	RB	O
examined	examine	VERB	VBN	O
by	by	ADP	IN	O
immunohistochemistry	immunohistochemistry	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
demonstrated	demonstrate	VERB	VBD	O
that	that	ADP	IN	O
17beta	17beta	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
estradiol	estradiol	NOUN	NNS	I-Chemical
(	(	PUNCT	-LRB-	O
E2	E2	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
induces	induce	VERB	VBZ	O
neovascularization	neovascularization	NOUN	NN	O
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
the	the	DET	DT	O
growth	growth	NOUN	NN	O
and	and	CCONJ	CC	O
enlargement	enlargement	NOUN	NN	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
vessels	vessel	NOUN	NNS	O
after	after	ADP	IN	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
exposure	exposure	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
high	high	ADJ	JJ	O
tumor	tumor	NOUN	NN	B-Disease
angiogenic	angiogenic	ADJ	JJ	O
potential	potential	NOUN	NN	O
was	be	VERB	VBD	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
an	an	DET	DT	O
elevated	elevated	ADJ	JJ	O
VEGF	VEGF	PROPN	NNP	O
/	/	SYM	SYM	O
VPF	VPF	PROPN	NNP	O
protein	protein	NOUN	NN	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
E2	E2	PROPN	NNP	B-Chemical
exposed	expose	VERB	VBN	O
pituitary	pituitary	NOUN	NN	O
of	of	ADP	IN	O
ovariectomized	ovariectomized	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
OVEX	OVEX	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

VEGF	VEGF	PROPN	NNP	O
/	/	SYM	SYM	O
VPF	VPF	PROPN	NNP	O
and	and	CCONJ	CC	O
FVIIIRAg	FVIIIRAg	NOUN	NNS	O
immunohistochemistry	immunohistochemistry	NOUN	NN	O
and	and	CCONJ	CC	O
endothelial	endothelial	ADJ	JJ	O
specific	specific	ADJ	JJ	O
lectin	lectin	NOUN	NN	O
(	(	PUNCT	-LRB-	O
UEA1	UEA1	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
binding	bind	VERB	VBG	O
studies	study	NOUN	NNS	O
,	,	PUNCT	,	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
elevation	elevation	NOUN	NN	O
of	of	ADP	IN	O
VEGF	VEGF	PROPN	NNP	O
protein	protein	NOUN	NN	O
expression	expression	NOUN	NN	O
initially	initially	ADV	RB	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
both	both	DET	DT	O
blood	blood	NOUN	NN	O
vessels	vessel	NOUN	NNS	O
and	and	CCONJ	CC	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
endothelial	endothelial	ADJ	JJ	O
cells	cell	NOUN	NNS	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
15	15	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
E2	E2	PROPN	NNP	B-Chemical
exposure	exposure	NOUN	NN	O
,	,	PUNCT	,	O
VEGF	VEGF	PROPN	NNP	O
/	/	SYM	SYM	O
VPF	VPF	PROPN	NNP	O
protein	protein	NOUN	NN	O
expression	expression	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
endothelial	endothelial	ADJ	JJ	O
cell	cell	NOUN	NN	O
population	population	NOUN	NN	O
,	,	PUNCT	,	O
sharply	sharply	ADV	RB	O
declined	decline	VERB	VBD	O
and	and	CCONJ	CC	O
was	be	VERB	VBD	O
restricted	restrict	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
blood	blood	NOUN	NN	O
vessels	vessel	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
function	function	NOUN	NN	O
of	of	ADP	IN	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
endothelial	endothelial	ADJ	JJ	O
-	-	PUNCT	HYPH	O
derived	derive	VERB	VBN	O
VEGF	VEGF	PROPN	NNP	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
clear	clear	ADJ	JJ	O
.	.	PUNCT	.	O

Furthermore	furthermore	ADV	RB	O
,	,	PUNCT	,	O
immunohistochemical	immunohistochemical	ADJ	JJ	O
studies	study	NOUN	NNS	O
demonstrated	demonstrate	VERB	VBD	O
that	that	ADP	IN	O
VEGFR	VEGFR	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
flk	flk	VERB	VBN	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
/	/	SYM	SYM	O
KDR	KDR	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
expression	expression	NOUN	NN	O
was	be	VERB	VBD	O
elevated	elevate	VERB	VBN	O
significantly	significantly	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
endothelial	endothelial	ADJ	JJ	O
cells	cell	NOUN	NNS	O
of	of	ADP	IN	O
microblood	microblood	NOUN	NN	O
vessels	vessel	NOUN	NNS	O
after	after	ADP	IN	O
7	7	NUM	CD	O
days	day	NOUN	NNS	O
of	of	ADP	IN	O
E2	E2	PROPN	NNP	B-Chemical
exposure	exposure	NOUN	NN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
over	over	ADP	IN	O
expression	expression	NOUN	NN	O
of	of	ADP	IN	O
VEGF	VEGF	PROPN	NNP	O
and	and	CCONJ	CC	O
its	-PRON-	DET	PRP$	O
receptor	receptor	NOUN	NN	O
(	(	PUNCT	-LRB-	O
VEGFR	VEGFR	PROPN	NNP	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
may	may	VERB	MD	O
play	play	VERB	VB	O
an	an	DET	DT	O
important	important	ADJ	JJ	O
role	role	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
initial	initial	ADJ	JJ	O
step	step	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
estrogen	estrogen	NOUN	NN	B-Chemical
induced	induce	VERB	VBN	O
tumor	tumor	NOUN	NN	B-Disease
angiogenesis	angiogenesis	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
pituitary	pituitary	NOUN	NN	O
.	.	PUNCT	.	O

Persistent	persistent	ADJ	JJ	O
nephrogenic	nephrogenic	ADJ	JJ	B-Disease
diabetes	diabetes	NOUN	NN	I-Disease
insipidus	insipidus	NOUN	NN	I-Disease
following	follow	VERB	VBG	O
lithium	lithium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
the	the	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
patient	patient	NOUN	NN	O
who	who	PRON	WP	O
developed	develop	VERB	VBD	O
severe	severe	ADJ	JJ	O
hypernatraemic	hypernatraemic	ADJ	JJ	O
dehydration	dehydration	NOUN	NN	B-Disease
following	follow	VERB	VBG	O
a	a	DET	DT	O
head	head	NOUN	NN	B-Disease
injury	injury	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Ten	ten	NUM	CD	O
years	year	NOUN	NNS	O
previously	previously	ADV	RB	O
he	-PRON-	PRON	PRP	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
diagnosed	diagnose	VERB	VBN	O
to	to	PART	TO	O
have	have	VERB	VB	O
lithium	lithium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrogenic	nephrogenic	ADJ	JJ	B-Disease
diabetes	diabetes	NOUN	NN	I-Disease
insipidus	insipidus	NOUN	NN	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
lithium	lithium	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
discontinued	discontinue	VERB	VBN	O
.	.	PUNCT	.	O

He	-PRON-	PRON	PRP	O
remained	remain	VERB	VBD	O
thirsty	thirsty	ADJ	JJ	O
and	and	CCONJ	CC	O
polyuric	polyuric	ADJ	JJ	B-Disease
despite	despite	ADP	IN	O
cessation	cessation	NOUN	NN	O
of	of	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
investigations	investigation	NOUN	NNS	O
on	on	ADP	IN	O
admission	admission	NOUN	NN	O
showed	show	VERB	VBD	O
him	-PRON-	PRON	PRP	O
to	to	PART	TO	O
have	have	VERB	VB	O
normal	normal	ADJ	JJ	O
osmoregulated	osmoregulate	VERB	VBN	O
thirst	thirst	NOUN	NN	O
and	and	CCONJ	CC	O
vasopressin	vasopressin	NOUN	NN	B-Chemical
secretion	secretion	NOUN	NN	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
clear	clear	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
nephrogenic	nephrogenic	ADJ	JJ	B-Disease
diabetes	diabetes	NOUN	NN	I-Disease
insipidus	insipidus	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Lithium	Lithium	PROPN	NNP	B-Chemical
induced	induce	VERB	VBD	O
nephrogenic	nephrogenic	ADJ	JJ	B-Disease
diabetes	diabetes	NOUN	NN	I-Disease
insipidus	insipidus	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
considered	consider	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
reversible	reversible	ADJ	JJ	O
on	on	ADP	IN	O
cessation	cessation	NOUN	NN	O
of	of	ADP	IN	O
therapy	therapy	NOUN	NN	O
but	but	CCONJ	CC	O
polyuria	polyuria	NOUN	NN	B-Disease
persisted	persist	VERB	VBD	O
in	in	ADP	IN	O
this	this	DET	DT	O
patient	patient	NOUN	NN	O
for	for	ADP	IN	O
ten	ten	NUM	CD	O
years	year	NOUN	NNS	O
after	after	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
stopped	stop	VERB	VBN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
discuss	discuss	VERB	VBP	O
the	the	DET	DT	O
possible	possible	ADJ	JJ	O
renal	renal	ADJ	JJ	O
mechanisms	mechanism	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
implications	implication	NOUN	NNS	O
for	for	ADP	IN	O
management	management	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
lithium	lithium	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
nephrogenic	nephrogenic	ADJ	JJ	B-Disease
diabetes	diabetes	NOUN	NN	I-Disease
insipidus	insipidus	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
NIK	NIK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
247	247	NUM	CD	I-Chemical
on	on	ADP	IN	O
cholinesterase	cholinesterase	NOUN	NN	O
and	and	CCONJ	CC	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
NIK	NIK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
247	247	NUM	CD	I-Chemical
on	on	ADP	IN	O
cholinesterase	cholinesterase	NOUN	NN	O
,	,	PUNCT	,	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
spontaneous	spontaneous	ADJ	JJ	O
movement	movement	NOUN	NN	O
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
and	and	CCONJ	CC	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
well	well	ADV	RB	O
-	-	PUNCT	HYPH	O
known	know	VERB	VBN	O
cholinesterase	cholinesterase	NOUN	NN	O
inhibitors	inhibitor	NOUN	NNS	O
tacrine	tacrine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
E	e	NOUN	NN	B-Chemical
-	-	NOUN	NN	I-Chemical
2020	2020	NUM	CD	I-Chemical
.	.	PUNCT	.	O

NIK	NIK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
247	247	NUM	CD	I-Chemical
,	,	PUNCT	,	O
tacrine	tacrine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
E	e	NOUN	NN	B-Chemical
-	-	NOUN	NN	I-Chemical
2020	2020	NUM	CD	I-Chemical
all	all	DET	DT	O
strongly	strongly	ADV	RB	O
inhibited	inhibited	ADJ	JJ	O
acetylcholinesterase	acetylcholinesterase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
AChE	AChE	PROPN	NNPS	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
human	human	ADJ	JJ	O
red	red	ADJ	JJ	O
blood	blood	NOUN	NN	O
cells	cell	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
IC50s	ic50s	X	FW	O
=	=	SYM	SYM	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
6	6	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
7	7	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
x	x	SYM	SYM	O
10	10	NUM	CD	O
(	(	PUNCT	-LRB-	O
-	-	PUNCT	HYPH	O
8	8	NUM	CD	O
)	)	PUNCT	-RRB-	O
M	m	NOUN	NN	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
NIK	NIK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
247	247	NUM	CD	I-Chemical
and	and	CCONJ	CC	O
tacrine	tacrine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
E	e	NOUN	NN	B-Chemical
-	-	NOUN	NN	I-Chemical
2020	2020	NUM	CD	I-Chemical
,	,	PUNCT	,	O
strongly	strongly	ADV	RB	O
inhibited	inhibited	ADJ	JJ	O
butyrylcholinestrase	butyrylcholinestrase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
BuChE	BuChE	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
human	human	ADJ	JJ	O
serum	serum	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
three	three	NUM	CD	O
drugs	drug	NOUN	NNS	O
produced	produce	VERB	VBD	O
mixed	mixed	ADJ	JJ	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
AChE	AChE	PROPN	NNPS	O
activity	activity	NOUN	NN	O
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
inhibitory	inhibitory	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
NIK	NIK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
247	247	NUM	CD	I-Chemical
on	on	ADP	IN	O
AChE	AChE	PROPN	NNPS	O
was	be	VERB	VBD	O
reversible	reversible	ADJ	JJ	O
.	.	PUNCT	.	O

All	all	DET	DT	O
compounds	compound	NOUN	NNS	O
at	at	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
p	p	NOUN	NN	O
.	.	PUNCT	.	O
o	o	INTJ	UH	O
.	.	PUNCT	.	O
significantly	significantly	ADV	RB	O
improved	improve	VERB	VBD	O
the	the	DET	DT	O
amnesia	amnesia	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
s	s	PROPN	NNPS	O
.	.	PUNCT	.	O
c	c	NOUN	NN	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
performing	perform	VERB	VBG	O
a	a	DET	DT	O
passive	passive	ADJ	JJ	O
avoidance	avoidance	NOUN	NN	O
task	task	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
three	three	NUM	CD	O
compounds	compound	NOUN	NNS	O
at	at	ADP	IN	O
1	1	NUM	CD	O
and	and	CCONJ	CC	O
3	3	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
p	p	NOUN	NN	O
.	.	PUNCT	.	O
o	o	X	XX	O
.	.	PUNCT	.	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
significantly	significantly	ADV	RB	O
decrease	decrease	VERB	VB	O
spontaneous	spontaneous	ADJ	JJ	O
movement	movement	NOUN	NN	O
by	by	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
findings	finding	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
NIK	NIK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
247	247	NUM	CD	I-Chemical
at	at	ADP	IN	O
a	a	DET	DT	O
low	low	ADJ	JJ	O
dose	dose	NOUN	NN	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
p	p	NOUN	NN	O
.	.	PUNCT	.	O
o	o	X	XX	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
improves	improve	VERB	VBZ	O
scopolamine	scopolamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
amnesia	amnesia	NOUN	NN	B-Disease
but	but	CCONJ	CC	O
does	do	VERB	VBZ	O
not	not	ADV	RB	O
affect	affect	VERB	VB	O
spontaneous	spontaneous	ADJ	JJ	O
movement	movement	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
findings	finding	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	ADP	IN	O
NIK	NIK	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
247	247	NUM	CD	I-Chemical
may	may	VERB	MD	O
be	be	VERB	VB	O
a	a	DET	DT	O
useful	useful	ADJ	JJ	O
drug	drug	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
Alzheimer	Alzheimer	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Potential	potential	ADJ	JJ	O
therapeutic	therapeutic	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
selective	selective	ADJ	JJ	O
dopamine	dopamine	NOUN	NN	B-Chemical
D1	d1	NOUN	NN	O
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
,	,	PUNCT	,	O
A	a	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
86929	86929	NUM	CD	I-Chemical
:	:	PUNCT	:	O
an	an	DET	DT	O
acute	acute	ADJ	JJ	O
study	study	NOUN	NN	O
in	in	ADP	IN	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
primed	primed	ADJ	JJ	O
monkeys	monkey	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
clinical	clinical	ADJ	JJ	O
utility	utility	NOUN	NN	O
of	of	ADP	IN	O
dopamine	dopamine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
DA	DA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
D1	d1	NOUN	NN	O
receptor	receptor	NOUN	NN	O
agonists	agonist	VERB	VBZ	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
PD	pd	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
still	still	ADV	RB	O
unclear	unclear	ADJ	JJ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
therapeutic	therapeutic	ADJ	JJ	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
selective	selective	ADJ	JJ	O
DA	DA	PROPN	NNP	B-Chemical
D1	d1	NOUN	NN	O
receptor	receptor	NOUN	NN	O
agonists	agonist	VERB	VBZ	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
SKF	SKF	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
82958	82958	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
6	6	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
chloro	chloro	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
7	7	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
8	8	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dihydroxy	dihydroxy	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
3	3	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
allyl	allyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
1	1	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
phenyl	phenyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2	2	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
3	3	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
4	4	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
5	5	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
tetrahydro	tetrahydro	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
1H	1h	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
3	3	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
benzaze	benzaze	NOUN	NN	I-Chemical
pine	pine	NOUN	NN	I-Chemical
hydrobromide	hydrobromide	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
A	a	DET	DT	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
77636	77636	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
[	[	PUNCT	-LRB-	B-Chemical
1R	1r	NOUN	NN	I-Chemical
,	,	PUNCT	,	I-Chemical
3S	3s	NOUN	NN	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
3	3	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
[	[	PUNCT	-LRB-	I-Chemical
1	1	NUM	CD	I-Chemical
'	'	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
admantyl	admantyl	NOUN	NN	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
1	1	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminomethyl	aminomethyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
3	3	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dihydro	dihydro	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
5	5	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
6	6	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dihydroxy	dihydroxy	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
1H	1h	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
benzo	benzo	NOUN	NN	I-Chemical
pyran	pyran	NOUN	NN	I-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
seems	seem	VERB	VBZ	O
limited	limited	ADJ	JJ	O
because	because	ADP	IN	O
of	of	ADP	IN	O
their	-PRON-	DET	PRP$	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
action	action	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
is	be	VERB	VBZ	O
too	too	ADV	RB	O
short	short	ADJ	JJ	O
for	for	ADP	IN	O
SKF	SKF	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
82958	82958	PROPN	NNP	I-Chemical
(	(	PUNCT	-LRB-	O
<	<	X	XX	O
1	1	NUM	CD	O
hr	hr	INTJ	UH	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
too	too	ADV	RB	O
long	long	ADJ	JJ	O
for	for	ADP	IN	O
A	a	DET	DT	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
77636	77636	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
>	>	X	XX	O
20	20	NUM	CD	O
hr	hr	NOUN	NN	O
,	,	PUNCT	,	O
leading	lead	VERB	VBG	O
to	to	ADP	IN	O
behavioral	behavioral	ADJ	JJ	O
tolerance	tolerance	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
therefore	therefore	ADV	RB	O
conducted	conduct	VERB	VBD	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
acute	acute	ADJ	JJ	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
response	response	NOUN	NN	O
study	study	NOUN	NN	O
in	in	ADP	IN	O
four	four	NUM	CD	O
1	1	NUM	CD	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
methyl	methyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
phenyl	phenyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
1	1	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
2	2	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
3	3	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
6	6	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
tetrahydropyridine	tetrahydropyridine	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
MPTP	MPTP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
exposed	expose	VERB	VBN	O
cynomolgus	cynomolgus	ADJ	JJ	O
monkeys	monkey	NOUN	NNS	O
primed	prime	VERB	VBN	O
to	to	PART	TO	O
exhibit	exhibit	VERB	VB	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
to	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
locomotor	locomotor	NOUN	NN	O
and	and	CCONJ	CC	O
dyskinetic	dyskinetic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
challenge	challenge	NOUN	NN	O
with	with	ADP	IN	O
four	four	NUM	CD	O
doses	dose	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
from	from	ADP	IN	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
to	to	ADP	IN	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
A	A	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
86929	86929	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
[	[	PUNCT	-LRB-	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
[	[	PUNCT	-LRB-	I-Chemical
5aR	5ar	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
11bS	11bs	NUM	CD	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
4	4	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
5	5	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
5a	5a	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
6	6	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
7	7	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
11b	11b	NOUN	NNS	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
hexahydro	hexahydro	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2	2	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
propyl	propyl	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
3	3	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
thia	thia	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
5	5	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
+	+	CCONJ	CC	I-Chemical
+	+	X	XX	I-Chemical
+	+	CCONJ	CC	I-Chemical
azacyclopent	azacyclopent	ADJ	JJ	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
1	1	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
ena	ena	NOUN	NN	I-Chemical
[	[	PUNCT	-LRB-	I-Chemical
c	c	NOUN	NN	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
phenathrene	phenathrene	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
9	9	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
10	10	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
diol	diol	NOUN	NNS	I-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
selective	selective	ADJ	JJ	O
and	and	CCONJ	CC	O
full	full	ADJ	JJ	O
DA	DA	PROPN	NNP	B-Chemical
D1	D1	PROPN	NNP	O
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
with	with	ADP	IN	O
an	an	DET	DT	O
intermediate	intermediate	ADJ	JJ	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
action	action	NOUN	NN	O
.	.	PUNCT	.	O

Levodopa	Levodopa	PROPN	NNP	B-Chemical
and	and	CCONJ	CC	O
the	the	DET	DT	O
DA	DA	PROPN	NNP	B-Chemical
D2	D2	PROPN	NNP	O
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
,	,	PUNCT	,	O
LY	LY	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
171555	171555	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
[	[	PUNCT	-LRB-	B-Chemical
4aR	4ar	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
trans	trans	NOUN	NN	I-Chemical
]	]	PUNCT	-RRB-	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
4	4	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
4a	4a	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
5	5	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
6	6	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
7	7	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
8	8	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
8a	8a	NUM	CD	I-Chemical
,	,	PUNCT	,	I-Chemical
9	9	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
o	o	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dihydro	dihydro	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
5n	5n	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
propyl	propyl	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
2H	2h	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
pyrazo	pyrazo	NOUN	NN	I-Chemical
lo	lo	PROPN	NNP	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
3	3	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
4	4	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
quinoline	quinoline	NOUN	NN	I-Chemical
hydrochloride	hydrochloride	NOUN	NN	I-Chemical
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
also	also	ADV	RB	O
used	use	VERB	VBN	O
for	for	ADP	IN	O
comparison	comparison	NOUN	NN	O
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
A	A	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
86929	86929	NUM	CD	I-Chemical
was	be	VERB	VBD	O
as	as	ADV	RB	O
efficacious	efficacious	ADJ	JJ	O
in	in	ADP	IN	O
alleviating	alleviate	VERB	VBG	O
MPTP	MPTP	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
parkinsonism	parkinsonism	NOUN	NN	B-Disease
as	as	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
LY	LY	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
171555	171555	NUM	CD	I-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
was	be	VERB	VBD	O
less	less	ADV	RBR	O
likely	likely	ADJ	JJ	O
to	to	PART	TO	O
reproduce	reproduce	VERB	VB	O
the	the	DET	DT	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
in	in	ADP	IN	O
these	these	DET	DT	O
animals	animal	NOUN	NNS	O
than	than	ADP	IN	O
with	with	ADP	IN	O
either	either	DET	DT	O
LY	LY	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
171555	171555	NUM	CD	I-Chemical
or	or	CCONJ	CC	O
subsequent	subsequent	ADJ	JJ	O
challenge	challenge	NOUN	NN	O
of	of	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

Selective	selective	ADJ	JJ	O
stimulation	stimulation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
DA	DA	PROPN	NNP	B-Chemical
D1	d1	NOUN	NN	O
receptor	receptor	NOUN	NN	O
may	may	VERB	MD	O
provide	provide	VERB	VB	O
better	well	ADJ	JJR	O
integration	integration	NOUN	NN	O
of	of	ADP	IN	O
neural	neural	ADJ	JJ	O
inputs	input	NOUN	NNS	O
transmitted	transmit	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
internal	internal	ADJ	JJ	O
segment	segment	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
globus	globus	NOUN	NN	O
pallidus	pallidus	NOUN	NN	O
(	(	PUNCT	-LRB-	O
referred	refer	VERB	VBN	O
to	to	ADP	IN	O
as	as	ADP	IN	O
the	the	DET	DT	O
basal	basal	ADJ	JJ	O
ganglia	ganglia	NOUN	NN	O
output	output	NOUN	NN	O
)	)	PUNCT	-RRB-	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
levodopa	levodopa	ADJ	JJ	B-Chemical
and	and	CCONJ	CC	O
selective	selective	ADJ	JJ	O
DA	DA	PROPN	NNP	B-Chemical
D2	d2	NOUN	NN	O
receptor	receptor	NOUN	NN	O
agonist	agonist	NOUN	NN	O
.	.	PUNCT	.	O

Potent	potent	ADJ	JJ	O
DA	DA	PROPN	NNP	B-Chemical
D1	d1	NOUN	NN	O
receptor	receptor	NOUN	NN	O
agents	agent	NOUN	NNS	O
with	with	ADP	IN	O
an	an	DET	DT	O
intermediate	intermediate	ADJ	JJ	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
efficacy	efficacy	NOUN	NN	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
A	A	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
86929	86929	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
approximately	approximately	ADV	RB	O
4	4	NUM	CD	O
hr	hr	INTJ	UH	O
at	at	ADP	IN	O
higher	high	ADJ	JJR	O
doses	dose	NOUN	NNS	O
tested	test	VERB	VBN	O
)	)	PUNCT	-RRB-	O
are	be	VERB	VBP	O
potential	potential	ADJ	JJ	O
therapeutic	therapeutic	ADJ	JJ	O
tools	tool	NOUN	NNS	O
in	in	ADP	IN	O
PD	pd	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
merit	merit	NOUN	NN	O
further	further	ADJ	JJ	O
attention	attention	NOUN	NN	O
.	.	PUNCT	.	O

Neuropeptide	Neuropeptide	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Y	Y	PROPN	NNP	O
immunoreactivity	immunoreactivity	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
model	model	NOUN	NN	O
of	of	ADP	IN	O
temporal	temporal	ADJ	JJ	B-Disease
lobe	lobe	NOUN	NN	I-Disease
epilepsy	epilepsy	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Neuropeptide	Neuropeptide	PROPN	NNP	O
-	-	PUNCT	HYPH	O
Y	Y	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
NPY	NPY	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
expressed	express	VERB	VBN	O
by	by	ADP	IN	O
granule	granule	ADJ	JJ	O
cells	cell	NOUN	NNS	O
and	and	CCONJ	CC	O
mossy	mossy	NOUN	NN	O
fibres	fibre	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
hippocampal	hippocampal	ADJ	JJ	O
dentate	dentate	ADJ	JJ	O
gyrus	gyrus	NOUN	NN	O
during	during	ADP	IN	O
experimental	experimental	ADJ	JJ	O
temporal	temporal	ADJ	JJ	B-Disease
lobe	lobe	NOUN	NN	I-Disease
epilepsy	epilepsy	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
TLE	tle	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

This	this	DET	DT	O
expression	expression	NOUN	NN	O
may	may	VERB	MD	O
represent	represent	VERB	VB	O
an	an	DET	DT	O
endogenous	endogenous	ADJ	JJ	O
damping	damping	NOUN	NN	O
mechanism	mechanism	NOUN	NN	O
since	since	ADP	IN	O
NPY	NPY	PROPN	NNP	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
shown	show	VERB	VBN	O
to	to	PART	TO	O
block	block	VERB	VB	O
seizure	seizure	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
like	like	ADJ	JJ	O
events	event	NOUN	NNS	O
following	follow	VERB	VBG	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
frequency	frequency	NOUN	NN	O
stimulation	stimulation	NOUN	NN	O
in	in	ADP	IN	O
hippocampal	hippocampal	ADJ	JJ	O
slices	slice	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
pilocarpine	pilocarpine	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
PILO	PILO	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
model	model	NOUN	NN	O
of	of	ADP	IN	O
epilepsy	epilepsy	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
characterized	characterize	VERB	VBN	O
by	by	ADP	IN	O
an	an	DET	DT	O
acute	acute	ADJ	JJ	O
period	period	NOUN	NN	O
of	of	ADP	IN	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
followed	follow	VERB	VBN	O
by	by	ADP	IN	O
spontaneous	spontaneous	ADJ	JJ	O
recurrent	recurrent	NOUN	NN	O
seizures	seizure	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
related	related	ADJ	JJ	O
brain	brain	NOUN	NN	B-Disease
damage	damage	NOUN	NN	I-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
peroxidase	peroxidase	NOUN	NN	O
-	-	PUNCT	HYPH	O
antiperoxidase	antiperoxidase	NOUN	NN	O
immunostaining	immunostaining	NOUN	NN	O
for	for	ADP	IN	O
NPY	NPY	PROPN	NNP	O
in	in	ADP	IN	O
several	several	ADJ	JJ	O
brain	brain	NOUN	NN	O
regions	region	NOUN	NNS	O
in	in	ADP	IN	O
this	this	DET	DT	O
model	model	NOUN	NN	O
.	.	PUNCT	.	O

PILO	PILO	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
injected	inject	VERB	VBN	O
animals	animal	NOUN	NNS	O
exhibited	exhibit	VERB	VBD	O
NPY	NPY	PROPN	NNP	O
immunoreactivity	immunoreactivity	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
region	region	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
mossy	mossy	NOUN	NN	O
fibre	fibre	NOUN	NN	O
terminals	terminal	NOUN	NNS	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
dentate	dentate	ADJ	JJ	O
gyrus	gyrus	NOUN	NN	O
inner	inner	ADJ	JJ	O
molecular	molecular	ADJ	JJ	O
layer	layer	NOUN	NN	O
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
a	a	DET	DT	O
few	few	ADJ	JJ	O
cases	case	NOUN	NNS	O
,	,	PUNCT	,	O
within	within	ADP	IN	O
presumed	presume	VERB	VBN	O
granule	granule	ADJ	JJ	O
cells	cell	NOUN	NNS	O
.	.	PUNCT	.	O

NPY	npy	NOUN	NN	O
immunoreactivity	immunoreactivity	NOUN	NN	O
was	be	VERB	VBD	O
also	also	ADV	RB	O
dramatically	dramatically	ADV	RB	O
changed	change	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
entorhinal	entorhinal	ADJ	JJ	O
cortex	cortex	NOUN	NN	O
,	,	PUNCT	,	O
amygdala	amygdala	NOUN	NN	O
and	and	CCONJ	CC	O
sensorimotor	sensorimotor	NOUN	NN	O
areas	area	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
addition	addition	NOUN	NN	O
,	,	PUNCT	,	O
PILO	PILO	PROPN	NNP	B-Chemical
injected	inject	VERB	VBD	O
animals	animal	NOUN	NNS	O
exhibited	exhibit	VERB	VBD	O
a	a	DET	DT	O
reduction	reduction	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
NPY	npy	NOUN	NN	O
-	-	PUNCT	HYPH	O
immunoreactive	immunoreactive	ADJ	JJ	O
interneurons	interneuron	NOUN	NNS	O
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
results	result	NOUN	NNS	O
demonstrate	demonstrate	VERB	VBP	O
that	that	ADP	IN	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
NPY	NPY	PROPN	NNP	O
expression	expression	NOUN	NN	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
expression	expression	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
granule	granule	ADJ	JJ	O
cells	cell	NOUN	NNS	O
and	and	CCONJ	CC	O
mossy	mossy	NOUN	NN	O
fibres	fibre	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
loss	loss	NOUN	NN	O
of	of	ADP	IN	O
vulnerable	vulnerable	ADJ	JJ	O
NPY	NPY	PROPN	NNP	O
neurons	neuron	NOUN	NNS	O
,	,	PUNCT	,	O
are	be	VERB	VBP	O
present	present	ADJ	JJ	O
in	in	ADP	IN	O
the	the	DET	DT	O
PILO	PILO	PROPN	NNP	B-Chemical
model	model	NOUN	NN	O
of	of	ADP	IN	O
TLE	TLE	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
significance	significance	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
changed	change	VERB	VBN	O
synthesis	synthesis	NOUN	NN	O
of	of	ADP	IN	O
NPY	NPY	PROPN	NNP	O
remains	remain	VERB	VBZ	O
to	to	PART	TO	O
be	be	VERB	VB	O
determined	determine	VERB	VBN	O
.	.	PUNCT	.	O

Posteroventral	posteroventral	ADJ	JJ	O
medial	medial	ADJ	JJ	O
pallidotomy	pallidotomy	NOUN	NN	O
in	in	ADP	IN	O
advanced	advanced	ADJ	JJ	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Posteroventral	posteroventral	ADJ	JJ	O
medial	medial	ADJ	JJ	O
pallidotomy	pallidotomy	NOUN	NN	O
sometimes	sometimes	ADV	RB	O
produces	produce	VERB	VBZ	O
striking	strike	VERB	VBG	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
advanced	advanced	ADJ	JJ	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
the	the	DET	DT	O
studies	study	NOUN	NNS	O
to	to	ADP	IN	O
date	date	NOUN	NN	O
have	have	VERB	VBP	O
involved	involve	VERB	VBN	O
small	small	ADJ	JJ	O
numbers	number	NOUN	NNS	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
and	and	CCONJ	CC	O
short	short	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Forty	forty	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
underwent	undergo	VERB	VBD	O
serial	serial	NOUN	NN	O
,	,	PUNCT	,	O
detailed	detailed	ADJ	JJ	O
assessments	assessment	NOUN	NNS	O
both	both	DET	DT	O
after	after	ADP	IN	O
drug	drug	NOUN	NN	O
withdrawal	withdrawal	NOUN	NN	O
(	(	PUNCT	-LRB-	O
"	"	PUNCT	``	O
off	off	ADP	IN	O
"	"	PUNCT	''	O
period	period	NOUN	NN	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
while	while	ADP	IN	O
taking	take	VERB	VBG	O
their	-PRON-	DET	PRP$	O
optimal	optimal	ADJ	JJ	O
medical	medical	ADJ	JJ	O
regimens	regimen	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
"	"	PUNCT	``	O
on	on	ADP	IN	O
"	"	PUNCT	``	O
period	period	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
preoperatively	preoperatively	ADV	RB	O
and	and	CCONJ	CC	O
39	39	NUM	CD	O
were	be	VERB	VBD	O
examined	examine	VERB	VBN	O
at	at	ADP	IN	O
six	six	NUM	CD	O
months	month	NOUN	NNS	O
;	;	PUNCT	:	O
27	27	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
also	also	ADV	RB	O
examined	examine	VERB	VBN	O
at	at	ADP	IN	O
one	one	NUM	CD	O
year	year	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
11	11	NUM	CD	O
at	at	ADP	IN	O
two	two	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
percent	percent	NOUN	NN	O
improvements	improvement	NOUN	NNS	O
at	at	ADP	IN	O
six	six	NUM	CD	O
months	month	NOUN	NNS	O
were	be	VERB	VBD	O
as	as	ADP	IN	O
follows	follow	VERB	VBZ	O
:	:	PUNCT	:	O
off	off	ADP	IN	O
-	-	PUNCT	HYPH	O
period	period	NOUN	NN	O
score	score	NOUN	NN	O
for	for	ADP	IN	O
overall	overall	ADJ	JJ	O
motor	motor	NOUN	NN	O
function	function	NOUN	NN	O
,	,	PUNCT	,	O
28	28	NUM	CD	O
percent	percent	NOUN	NN	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
percent	percent	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
19	19	NUM	CD	O
to	to	PART	TO	O
38	38	NUM	CD	O
percent	percent	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
most	most	ADJ	JJS	O
of	of	ADP	IN	O
the	the	DET	DT	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
contralateral	contralateral	ADJ	JJ	O
limbs	limb	NOUN	NNS	O
;	;	PUNCT	:	O
off	off	ADP	IN	O
-	-	PUNCT	HYPH	O
period	period	NOUN	NN	O
score	score	NOUN	NN	O
for	for	ADP	IN	O
activities	activity	NOUN	NNS	O
of	of	ADP	IN	O
daily	daily	ADJ	JJ	O
living	living	NOUN	NN	O
,	,	PUNCT	,	O
29	29	NUM	CD	O
percent	percent	NOUN	NN	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
percent	percent	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
19	19	NUM	CD	O
to	to	PART	TO	O
39	39	NUM	CD	O
percent	percent	NOUN	NN	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	,	O
on	on	ADP	IN	O
-	-	PUNCT	HYPH	O
period	period	NOUN	NN	O
score	score	NOUN	NN	O
for	for	ADP	IN	O
contralateral	contralateral	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
82	82	NUM	CD	O
percent	percent	NOUN	NN	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
percent	percent	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
72	72	NUM	CD	O
to	to	PART	TO	O
91	91	NUM	CD	O
percent	percent	NOUN	NN	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
on	on	ADP	IN	O
-	-	PUNCT	HYPH	O
period	period	NOUN	NN	O
score	score	NOUN	NN	O
for	for	ADP	IN	O
ipsilateral	ipsilateral	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
,	,	PUNCT	,	O
44	44	NUM	CD	O
percent	percent	NOUN	NN	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
percent	percent	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
,	,	PUNCT	,	O
29	29	NUM	CD	O
to	to	PART	TO	O
59	59	NUM	CD	O
percent	percent	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
improvements	improvement	NOUN	NNS	O
in	in	ADP	IN	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
the	the	DET	DT	O
total	total	ADJ	JJ	O
scores	score	NOUN	NNS	O
for	for	ADP	IN	O
off	off	ADP	IN	O
-	-	PUNCT	HYPH	O
period	period	NOUN	NN	O
parkinsonism	parkinsonism	NOUN	NN	B-Disease
,	,	PUNCT	,	O
contralateral	contralateral	ADJ	JJ	O
bradykinesia	bradykinesia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
rigidity	rigidity	NOUN	NN	B-Disease
were	be	VERB	VBD	O
sustained	sustain	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
11	11	NUM	CD	O
patients	patient	NOUN	NNS	O
examined	examine	VERB	VBN	O
at	at	ADP	IN	O
two	two	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
improvement	improvement	NOUN	NN	O
in	in	ADP	IN	O
ipsilateral	ipsilateral	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
was	be	VERB	VBD	O
lost	lose	VERB	VBN	O
after	after	ADP	IN	O
one	one	NUM	CD	O
year	year	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
improvements	improvement	NOUN	NNS	O
in	in	ADP	IN	O
postural	postural	ADJ	JJ	O
stability	stability	NOUN	NN	O
and	and	CCONJ	CC	O
gait	gait	VERB	VB	O
lasted	last	VERB	VBD	O
only	only	ADV	RB	O
three	three	NUM	CD	O
to	to	PART	TO	O
six	six	NUM	CD	O
months	month	NOUN	NNS	O
.	.	PUNCT	.	O

Approximately	approximately	ADV	RB	O
half	half	DET	PDT	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
been	be	VERB	VBN	O
dependent	dependent	ADJ	JJ	O
on	on	ADP	IN	O
assistance	assistance	NOUN	NN	O
in	in	ADP	IN	O
activities	activity	NOUN	NNS	O
of	of	ADP	IN	O
daily	daily	ADJ	JJ	O
living	live	VERB	VBG	O
in	in	ADP	IN	O
the	the	DET	DT	O
off	off	ADJ	JJ	O
period	period	NOUN	NN	O
before	before	ADP	IN	O
surgery	surgery	NOUN	NN	O
became	become	VERB	VBD	O
independent	independent	ADJ	JJ	O
after	after	ADP	IN	O
surgery	surgery	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
complications	complication	NOUN	NNS	O
of	of	ADP	IN	O
surgery	surgery	NOUN	NN	O
were	be	VERB	VBD	O
generally	generally	ADV	RB	O
well	well	ADV	RB	O
tolerated	tolerate	VERB	VBN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
there	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
significant	significant	ADJ	JJ	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
medication	medication	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
late	late	ADJ	JJ	O
-	-	PUNCT	HYPH	O
stage	stage	NOUN	NN	O
Parkinson	Parkinson	PROPN	NNP	B-Disease
'	'	PART	POS	I-Disease
s	s	PART	POS	I-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
pallidotomy	pallidotomy	NOUN	NN	O
significantly	significantly	ADV	RB	O
reduces	reduce	VERB	VBZ	O
levodopa	levodopa	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
dyskinesias	dyskinesia	NOUN	NNS	B-Disease
and	and	CCONJ	CC	O
off	off	ADP	IN	O
-	-	PUNCT	HYPH	O
period	period	NOUN	NN	O
disability	disability	NOUN	NN	O
.	.	PUNCT	.	O

Much	much	ADJ	JJ	O
of	of	ADP	IN	O
the	the	DET	DT	O
benefit	benefit	NOUN	NN	O
is	be	VERB	VBZ	O
sustained	sustain	VERB	VBN	O
at	at	ADP	IN	O
two	two	NUM	CD	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
although	although	ADP	IN	O
some	some	DET	DT	O
improvements	improvement	NOUN	NNS	O
,	,	PUNCT	,	O
such	such	ADJ	JJ	O
as	as	ADP	IN	O
those	those	DET	DT	O
on	on	ADP	IN	O
the	the	DET	DT	O
ipsilateral	ipsilateral	ADJ	JJ	O
side	side	NOUN	NN	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
axial	axial	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
,	,	PUNCT	,	O
wane	wane	NOUN	NN	O
within	within	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
year	year	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
on	on	ADP	IN	O
-	-	PUNCT	HYPH	O
period	period	NOUN	NN	O
symptoms	symptom	NOUN	NNS	O
that	that	DET	WDT	O
are	be	VERB	VBP	O
resistant	resistant	ADJ	JJ	O
to	to	ADP	IN	O
dopaminergic	dopaminergic	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
do	do	VERB	VBP	O
not	not	ADV	RB	O
respond	respond	VERB	VB	O
to	to	ADP	IN	O
pallidotomy	pallidotomy	NOUN	NN	O
.	.	PUNCT	.	O

Clarithromycin	Clarithromycin	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
ventricular	ventricular	ADJ	JJ	B-Disease
tachycardia	tachycardia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Clarithromycin	Clarithromycin	PROPN	NNP	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
relatively	relatively	ADV	RB	O
new	new	ADJ	JJ	O
macrolide	macrolide	NOUN	NN	B-Chemical
antibiotic	antibiotic	NOUN	NN	O
that	that	DET	WDT	O
offers	offer	VERB	VBZ	O
twice	twice	ADV	RB	O
-	-	PUNCT	HYPH	O
daily	daily	ADV	RB	O
dosing	dosing	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
differs	differ	VERB	VBZ	O
from	from	ADP	IN	O
erythromycin	erythromycin	ADV	RB	B-Chemical
only	only	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
methylation	methylation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
hydroxyl	hydroxyl	NOUN	NN	O
group	group	NOUN	NN	O
at	at	ADP	IN	O
position	position	NOUN	NN	O
6	6	NUM	CD	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
the	the	DET	DT	O
side	side	NOUN	NN	O
-	-	PUNCT	HYPH	O
effect	effect	NOUN	NN	O
profile	profile	NOUN	NN	O
of	of	ADP	IN	O
erythromycin	erythromycin	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
established	establish	VERB	VBN	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
gastroenteritis	gastroenteritis	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
interactions	interaction	NOUN	NNS	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
subject	subject	ADJ	JJ	O
to	to	ADP	IN	O
hepatic	hepatic	ADJ	JJ	O
mixed	mixed	ADJ	JJ	O
-	-	PUNCT	HYPH	O
function	function	NOUN	NN	O
oxidase	oxidase	NOUN	NN	O
metabolism	metabolism	NOUN	NN	O
,	,	PUNCT	,	O
experience	experience	NOUN	NN	O
with	with	ADP	IN	O
the	the	DET	DT	O
newer	new	ADJ	JJR	O
macrolides	macrolide	NOUN	NNS	B-Chemical
is	be	VERB	VBZ	O
still	still	ADV	RB	O
being	be	VERB	VBG	O
recorded	record	VERB	VBN	O
.	.	PUNCT	.	O

Cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
demonstrated	demonstrate	VERB	VBN	O
after	after	ADP	IN	O
both	both	CCONJ	CC	O
intravenous	intravenous	ADJ	JJ	O
and	and	CCONJ	CC	O
oral	oral	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
erythromycin	erythromycin	NOUN	NN	B-Chemical
but	but	CCONJ	CC	O
has	have	VERB	VBZ	O
never	never	ADV	RB	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
newer	new	ADJ	JJR	O
macrolides	macrolide	NOUN	NNS	B-Chemical
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
report	report	VERB	VBP	O
a	a	DET	DT	O
case	case	NOUN	NN	O
of	of	ADP	IN	O
ventricular	ventricular	ADJ	JJ	B-Disease
dysrhythmias	dysrhythmia	NOUN	NNS	I-Disease
that	that	DET	WDT	O
occurred	occur	VERB	VBD	O
after	after	ADP	IN	O
six	six	NUM	CD	O
therapeutic	therapeutic	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
clarithromycin	clarithromycin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
dysrhythmias	dysrhythmia	NOUN	NNS	B-Disease
resolved	resolve	VERB	VBD	O
after	after	ADP	IN	O
discontinuation	discontinuation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

Effect	effect	NOUN	NN	O
of	of	ADP	IN	O
glyceryl	glyceryl	NOUN	NN	B-Chemical
trinitrate	trinitrate	NOUN	NN	I-Chemical
on	on	ADP	IN	O
the	the	DET	DT	O
sphincter	sphincter	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
Oddi	Oddi	PROPN	NNP	I-Disease
spasm	spasm	NOUN	NNS	I-Disease
evoked	evoke	VERB	VBN	O
by	by	ADP	IN	O
prostigmine	prostigmine	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
morphine	morphine	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
glyceryl	glyceryl	NOUN	NN	B-Chemical
trinitrate	trinitrate	NOUN	NN	I-Chemical
on	on	ADP	IN	O
the	the	DET	DT	O
prostigmine	prostigmine	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
sphincter	sphincter	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
Oddi	Oddi	PROPN	NNP	I-Disease
spasm	spasm	NOUN	NNS	I-Disease
was	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
in	in	ADP	IN	O
nine	nine	NUM	CD	O
female	female	ADJ	JJ	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
sphincter	sphincter	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
Oddi	Oddi	PROPN	NNP	I-Disease
dyskinesia	dyskinesia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

METHOD	method	NOUN	NN	O
:	:	PUNCT	:	O
Sphincter	sphincter	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
Oddi	Oddi	PROPN	NNP	I-Disease
spasm	spasm	NOUN	NNS	I-Disease
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
prostigmine	prostigmine	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
morphine	morphine	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
prostigmine	prostigmine	NOUN	NN	B-Chemical
intramuscularly	intramuscularly	ADV	RB	O
and	and	CCONJ	CC	O
10	10	NUM	CD	O
mg	mg	NUM	CD	O
morphine	morphine	NOUN	NN	B-Chemical
subcutaneously	subcutaneously	ADV	RB	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
visualized	visualize	VERB	VBN	O
by	by	ADP	IN	O
quantitative	quantitative	ADJ	JJ	O
hepatobiliary	hepatobiliary	ADJ	JJ	O
scintigraphy	scintigraphy	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
entire	entire	ADJ	JJ	O
procedure	procedure	NOUN	NN	O
was	be	VERB	VBD	O
repeated	repeat	VERB	VBN	O
during	during	ADP	IN	O
glyceryl	glyceryl	NOUN	NN	B-Chemical
trinitrate	trinitrate	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
Nitrolingual	Nitrolingual	PROPN	NNP	B-Chemical
1	1	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
for	for	ADP	IN	O
120	120	NUM	CD	O
min	min	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
Prostigmine	prostigmine	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
morphine	morphine	NOUN	NN	B-Chemical
provocation	provocation	NOUN	NN	O
caused	cause	VERB	VBD	O
significant	significant	ADJ	JJ	O
increases	increase	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
time	time	NOUN	NN	O
to	to	PART	TO	O
peak	peak	VERB	VB	O
activity	activity	NOUN	NN	O
(	(	PUNCT	-LRB-	O
Tmax	Tmax	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
over	over	ADP	IN	O
the	the	DET	DT	O
hepatic	hepatic	ADJ	JJ	O
hilum	hilum	NOUN	NN	O
(	(	PUNCT	-LRB-	O
HH	HH	PROPN	NNP	O
:	:	PUNCT	:	O
34	34	NUM	CD	O
.	.	PUNCT	.	O
33	33	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
vs	vs	NOUN	NN	O
.	.	PUNCT	.	O
22	22	NUM	CD	O
.	.	PUNCT	.	O
77	77	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
26	26	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
common	common	ADJ	JJ	O
bile	bile	NOUN	NN	O
duct	duct	NOUN	NN	O
(	(	PUNCT	-LRB-	O
CBD	CBD	PROPN	NNP	O
:	:	PUNCT	:	O
60	60	NUM	CD	O
.	.	PUNCT	.	O
44	44	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
.	.	PUNCT	.	O
99	99	NUM	CD	O
vs	vs	NOUN	NN	O
.	.	PUNCT	.	O
40	40	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
88	88	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
the	the	DET	DT	O
half	half	ADJ	JJ	O
-	-	PUNCT	HYPH	O
time	time	NOUN	NN	O
of	of	ADP	IN	O
excretion	excretion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
T1	T1	PROPN	NNP	O
/	/	SYM	SYM	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
over	over	ADP	IN	O
the	the	DET	DT	O
liver	liver	NOUN	NN	O
parenchyma	parenchyma	NOUN	NN	O
(	(	PUNCT	-LRB-	O
LP	LP	PROPN	NNP	O
:	:	PUNCT	:	O
120	120	NUM	CD	O
.	.	PUNCT	.	O
04	04	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
16	16	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
vs	vs	NOUN	NN	O
.	.	PUNCT	.	O
27	27	NUM	CD	O
.	.	PUNCT	.	O
37	37	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
19	19	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
HH	HH	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
117	117	NUM	CD	O
.	.	PUNCT	.	O
61	61	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
14	14	NUM	CD	O
.	.	PUNCT	.	O
71	71	NUM	CD	O
vs	vs	NOUN	NN	O
.	.	PUNCT	.	O
31	31	NUM	CD	O
.	.	PUNCT	.	O
85	85	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
99	99	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
CBD	CBD	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
158	158	NUM	CD	O
.	.	PUNCT	.	O
11	11	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
9	9	NUM	CD	O
.	.	PUNCT	.	O
18	18	NUM	CD	O
vs	vs	NOUN	NN	O
.	.	PUNCT	.	O
40	40	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
24	24	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
indicating	indicate	VERB	VBG	O
a	a	DET	DT	O
complete	complete	ADJ	JJ	O
spasm	spasm	NOUN	NN	B-Disease
at	at	ADP	IN	O
the	the	DET	DT	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
sphincter	sphincter	NOUN	NN	O
of	of	ADP	IN	O
Oddi	Oddi	PROPN	NNP	O
.	.	PUNCT	.	O

Glyceryl	glyceryl	NOUN	NN	B-Chemical
trinitrate	trinitrate	NOUN	NN	I-Chemical
infusion	infusion	NOUN	NN	O
completely	completely	ADV	RB	O
normalized	normalize	VERB	VBD	O
the	the	DET	DT	O
prostigmine	prostigmine	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
alterations	alteration	NOUN	NNS	O
in	in	ADP	IN	O
these	these	DET	DT	O
quantitative	quantitative	ADJ	JJ	O
parameters	parameter	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
TmaX	TmaX	NOUN	NNS	O
over	over	ADP	IN	O
the	the	DET	DT	O
LP	LP	PROPN	NNP	O
:	:	PUNCT	:	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
33	33	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
13	13	NUM	CD	O
;	;	PUNCT	:	O
over	over	ADP	IN	O
the	the	DET	DT	O
HH	HH	PROPN	NNP	O
:	:	PUNCT	:	O
18	18	NUM	CD	O
.	.	PUNCT	.	O
88	88	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
48	48	NUM	CD	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
over	over	ADP	IN	O
the	the	DET	DT	O
CBD	CBD	PROPN	NNP	O
:	:	PUNCT	:	O
36	36	NUM	CD	O
.	.	PUNCT	.	O
22	22	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
92	92	NUM	CD	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
T1	T1	PROPN	NNP	O
/	/	SYM	SYM	O
2	2	NUM	CD	O
over	over	ADP	IN	O
the	the	DET	DT	O
LP	LP	PROPN	NNP	O
:	:	PUNCT	:	O
28	28	NUM	CD	O
.	.	PUNCT	.	O
21	21	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
83	83	NUM	CD	O
;	;	PUNCT	:	O
over	over	ADP	IN	O
the	the	DET	DT	O
HH	HH	PROPN	NNP	O
:	:	PUNCT	:	O
33	33	NUM	CD	O
.	.	PUNCT	.	O
42	42	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
10	10	NUM	CD	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
over	over	ADP	IN	O
the	the	DET	DT	O
CBD	CBD	PROPN	NNP	O
:	:	PUNCT	:	O
41	41	NUM	CD	O
.	.	PUNCT	.	O
66	66	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
33	33	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
suggesting	suggest	VERB	VBG	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
sphincter	sphincter	NOUN	NN	O
-	-	PUNCT	HYPH	O
relaxing	relax	VERB	VBG	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
glyceryl	glyceryl	NOUN	NN	B-Chemical
trinitrate	trinitrate	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
These	these	DET	DT	O
results	result	NOUN	NNS	O
provide	provide	VERB	VBP	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
effectiveness	effectiveness	NOUN	NN	O
of	of	ADP	IN	O
glyceryl	glyceryl	NOUN	NN	B-Chemical
trinitrate	trinitrate	NOUN	NN	I-Chemical
on	on	ADP	IN	O
the	the	DET	DT	O
morphine	morphine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
sphincter	sphincter	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
Oddi	Oddi	PROPN	NNP	I-Disease
spasm	spasm	NOUN	NNS	I-Disease
in	in	ADP	IN	O
humans	human	NOUN	NNS	O
.	.	PUNCT	.	O

Since	since	ADP	IN	O
glyceryl	glyceryl	NOUN	NN	B-Chemical
trinitrate	trinitrate	NOUN	NN	I-Chemical
is	be	VERB	VBZ	O
able	able	ADJ	JJ	O
to	to	PART	TO	O
overcome	overcome	VERB	VB	O
even	even	ADV	RB	O
the	the	DET	DT	O
drastic	drastic	ADJ	JJ	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
morphine	morphine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
it	-PRON-	PRON	PRP	O
might	may	VERB	MD	O
be	be	VERB	VB	O
of	of	ADP	IN	O
relevance	relevance	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
sphincter	sphincter	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
Oddi	Oddi	PROPN	NNP	I-Disease
dyskinesia	dyskinesia	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Immunopathology	immunopathology	NOUN	NN	O
of	of	ADP	IN	O
penicillamine	penicillamine	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
glomerular	glomerular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Four	four	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
rheumatoid	rheumatoid	ADJ	JJ	B-Disease
arthritis	arthritis	NOUN	NN	I-Disease
developed	develop	VERB	VBD	O
heavy	heavy	ADJ	JJ	O
proteinuria	proteinuria	NOUN	NN	B-Disease
after	after	ADP	IN	O
five	five	NUM	CD	O
to	to	PART	TO	O
12	12	NUM	CD	O
months	month	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
D	d	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
penicillamine	penicillamine	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Light	light	ADJ	JJ	O
microscopy	microscopy	NOUN	NN	O
of	of	ADP	IN	O
renal	renal	ADJ	JJ	O
biopsy	biopsy	NOUN	NN	O
samples	sample	NOUN	NNS	O
showed	show	VERB	VBD	O
minimal	minimal	ADJ	JJ	O
glomerular	glomerular	ADJ	JJ	O
capillary	capillary	ADJ	JJ	O
wall	wall	NOUN	NN	O
thickening	thickening	NOUN	NN	O
and	and	CCONJ	CC	O
mesangial	mesangial	NOUN	NN	O
matrix	matrix	NOUN	NN	O
increase	increase	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
no	no	DET	DT	O
departure	departure	NOUN	NN	O
from	from	ADP	IN	O
normal	normal	ADJ	JJ	O
.	.	PUNCT	.	O

Electron	Electron	PROPN	NNP	O
microscopy	microscopy	NOUN	NN	O
,	,	PUNCT	,	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
revealed	reveal	VERB	VBD	O
subepithelial	subepithelial	ADJ	JJ	O
electron	electron	NOUN	NN	O
-	-	PUNCT	HYPH	O
dense	dense	ADJ	JJ	O
deposits	deposit	NOUN	NNS	O
,	,	PUNCT	,	O
fusion	fusion	NOUN	NN	O
of	of	ADP	IN	O
epithelial	epithelial	ADJ	JJ	O
cell	cell	NOUN	NN	O
foot	foot	NOUN	NN	O
processes	process	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
mesangial	mesangial	ADJ	JJ	O
cell	cell	NOUN	NN	O
hyperactivity	hyperactivity	NOUN	NN	O
.	.	PUNCT	.	O

Immunofluorescence	immunofluorescence	NOUN	NN	O
microscopy	microscopy	NOUN	NN	O
demonstrated	demonstrate	VERB	VBD	O
granular	granular	ADJ	JJ	O
capillary	capillary	ADJ	JJ	O
wall	wall	NOUN	NN	O
deposits	deposit	NOUN	NNS	O
of	of	ADP	IN	O
IgG	igg	NOUN	NN	O
and	and	CCONJ	CC	O
C3	c3	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
findings	finding	NOUN	NNS	O
were	be	VERB	VBD	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
in	in	ADP	IN	O
early	early	ADJ	JJ	O
membranous	membranous	ADJ	JJ	B-Disease
glomerulonephritis	glomerulonephritis	NOUN	NN	I-Disease
,	,	PUNCT	,	O
differences	difference	NOUN	NNS	O
being	be	VERB	VBG	O
observed	observe	VERB	VBN	O
however	however	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
staining	staining	NOUN	NN	O
for	for	ADP	IN	O
the	the	DET	DT	O
early	early	ADV	RB	O
-	-	PUNCT	HYPH	O
acting	act	VERB	VBG	O
complement	complement	NOUN	NN	O
components	component	NOUN	NNS	O
C1q	c1q	VERB	VB	O
and	and	CCONJ	CC	O
C4	C4	NOUN	NNS	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
tentatively	tentatively	ADV	RB	O
concluded	conclude	VERB	VBN	O
that	that	ADP	IN	O
complement	complement	NOUN	NN	O
was	be	VERB	VBD	O
activated	activate	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
classical	classical	ADJ	JJ	O
pathway	pathway	NOUN	NN	O
.	.	PUNCT	.	O

Experimental	experimental	ADJ	JJ	O
cranial	cranial	ADJ	JJ	O
pain	pain	NOUN	NN	B-Disease
elicited	elicit	VERB	VBN	O
by	by	ADP	IN	O
capsaicin	capsaicin	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
a	a	DET	DT	O
PET	PET	PROPN	NNP	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Using	use	VERB	VBG	O
a	a	DET	DT	O
positron	positron	NOUN	NN	O
emission	emission	NOUN	NN	O
tomography	tomography	NOUN	NN	O
(	(	PUNCT	-LRB-	O
PET	PET	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
study	study	VERB	VBP	O
it	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
shown	show	VERB	VBN	O
recently	recently	ADV	RB	O
that	that	ADP	IN	O
in	in	ADP	IN	O
migraine	migraine	NOUN	NN	B-Disease
without	without	ADP	IN	O
aura	aura	NOUN	NN	O
certain	certain	ADJ	JJ	O
areas	area	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
brain	brain	NOUN	NN	O
stem	stem	NOUN	NN	O
were	be	VERB	VBD	O
activated	activate	VERB	VBN	O
during	during	ADP	IN	O
the	the	DET	DT	O
headache	headache	NOUN	NN	B-Disease
state	state	NOUN	NN	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
headache	headache	NOUN	NN	B-Disease
free	free	ADJ	JJ	O
interval	interval	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
was	be	VERB	VBD	O
suggested	suggest	VERB	VBN	O
that	that	ADP	IN	O
this	this	DET	DT	O
brain	brain	NOUN	NN	O
stem	stem	NOUN	NN	O
activation	activation	NOUN	NN	O
is	be	VERB	VBZ	O
inherent	inherent	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
migraine	migraine	ADJ	JJ	B-Disease
attack	attack	NOUN	NN	O
itself	-PRON-	PRON	PRP	O
and	and	CCONJ	CC	O
represents	represent	VERB	VBZ	O
the	the	DET	DT	O
so	so	ADV	RB	O
called	call	VERB	VBN	O
'	'	PUNCT	``	O
migraine	migraine	ADJ	JJ	B-Disease
generator	generator	NOUN	NN	O
'	'	PUNCT	''	O
.	.	PUNCT	.	O

To	to	PART	TO	O
test	test	VERB	VB	O
this	this	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
we	-PRON-	PRON	PRP	O
performed	perform	VERB	VBD	O
an	an	DET	DT	O
experimental	experimental	ADJ	JJ	O
pain	pain	NOUN	NN	B-Disease
study	study	NOUN	NN	O
in	in	ADP	IN	O
seven	seven	NUM	CD	O
healthy	healthy	ADJ	JJ	O
volunteers	volunteer	NOUN	NNS	O
,	,	PUNCT	,	O
using	use	VERB	VBG	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
positioning	positioning	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
PET	PET	PROPN	NNP	O
scanner	scanner	NOUN	NN	O
as	as	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
migraine	migraine	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
small	small	ADJ	JJ	O
amount	amount	NOUN	NN	O
of	of	ADP	IN	O
capsaicin	capsaicin	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
administered	administer	VERB	VBN	O
subcutaneously	subcutaneously	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
right	right	ADJ	JJ	O
forehead	forehead	NOUN	NN	O
to	to	PART	TO	O
evoke	evoke	VERB	VB	O
a	a	DET	DT	O
burning	burn	VERB	VBG	O
painful	painful	ADJ	JJ	B-Disease
sensation	sensation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
division	division	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
trigeminal	trigeminal	ADJ	JJ	O
nerve	nerve	NOUN	NN	O
.	.	PUNCT	.	O

Increases	increase	NOUN	NNS	O
of	of	ADP	IN	O
regional	regional	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
(	(	PUNCT	-LRB-	O
rCBF	rCBF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
bilaterally	bilaterally	ADV	RB	O
in	in	ADP	IN	O
the	the	DET	DT	O
insula	insula	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
the	the	DET	DT	O
anterior	anterior	ADJ	JJ	O
cingulate	cingulate	NOUN	NN	O
cortex	cortex	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
cavernous	cavernous	ADJ	JJ	O
sinus	sinus	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
cerebellum	cerebellum	NOUN	NN	O
.	.	PUNCT	.	O

Using	use	VERB	VBG	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
stereotactic	stereotactic	ADJ	JJ	O
space	space	NOUN	NN	O
limits	limit	NOUN	NNS	O
as	as	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
above	above	ADV	RB	O
mentioned	mention	VERB	VBN	O
migraine	migraine	ADJ	JJ	B-Disease
study	study	NOUN	NN	O
no	no	DET	DT	O
brain	brain	NOUN	NN	O
stem	stem	NOUN	NN	O
activation	activation	NOUN	NN	O
was	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
acute	acute	ADJ	JJ	O
pain	pain	NOUN	NN	B-Disease
state	state	NOUN	NN	O
compared	compare	VERB	VBN	O
to	to	ADP	IN	O
the	the	DET	DT	O
pain	pain	NOUN	NN	B-Disease
free	free	ADJ	JJ	O
state	state	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
increase	increase	NOUN	NN	O
of	of	ADP	IN	O
activation	activation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
region	region	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
cavernous	cavernous	ADJ	JJ	O
sinus	sinus	NOUN	NN	O
however	however	ADV	RB	O
,	,	PUNCT	,	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
this	this	DET	DT	O
structure	structure	NOUN	NN	O
is	be	VERB	VBZ	O
more	more	ADV	RBR	O
likely	likely	ADJ	JJ	O
to	to	PART	TO	O
be	be	VERB	VB	O
involved	involve	VERB	VBN	O
in	in	ADP	IN	O
trigeminal	trigeminal	ADJ	JJ	O
transmitted	transmit	VERB	VBN	O
pain	pain	NOUN	NN	B-Disease
as	as	ADP	IN	O
such	such	ADJ	JJ	O
,	,	PUNCT	,	O
rather	rather	ADV	RB	O
than	than	ADP	IN	O
in	in	ADP	IN	O
a	a	DET	DT	O
specific	specific	ADJ	JJ	O
type	type	NOUN	NN	O
of	of	ADP	IN	O
headache	headache	NOUN	NN	B-Disease
as	as	ADP	IN	O
was	be	VERB	VBD	O
suggested	suggest	VERB	VBN	O
for	for	ADP	IN	O
cluster	cluster	NOUN	NN	B-Disease
headache	headache	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Value	value	NOUN	NN	O
of	of	ADP	IN	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
in	in	ADP	IN	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
arthralgia	arthralgia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
myalgia	myalgia	NOUN	NN	B-Disease
syndrome	syndrome	NOUN	NN	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
total	total	ADJ	JJ	O
dose	dose	NOUN	NN	O
infusion	infusion	NOUN	NN	O
of	of	ADP	IN	O
iron	iron	NOUN	NN	B-Chemical
dextran	dextran	NOUN	NN	I-Chemical
:	:	PUNCT	:	O
a	a	DET	DT	O
double	double	ADJ	JJ	O
blind	blind	ADJ	JJ	O
randomized	randomize	VERB	VBN	O
trial	trial	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
safety	safety	NOUN	NN	O
and	and	CCONJ	CC	O
efficacy	efficacy	NOUN	NN	O
of	of	ADP	IN	O
total	total	ADJ	JJ	O
dose	dose	NOUN	NN	O
infusion	infusion	NOUN	NN	O
(	(	PUNCT	-LRB-	O
TDI	TDI	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
iron	iron	NOUN	NN	B-Chemical
dextran	dextran	NOUN	NN	I-Chemical
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
well	well	ADV	RB	O
documented	document	VERB	VBN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
40	40	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
treated	treat	VERB	VBN	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
an	an	DET	DT	O
arthralgia	arthralgia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
myalgia	myalgia	NOUN	NN	B-Disease
syndrome	syndrome	NOUN	NN	O
develops	develop	VERB	VBZ	O
.	.	PUNCT	.	O

The	the	DET	DT	O
purpose	purpose	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
randomized	randomize	VERB	VBN	O
,	,	PUNCT	,	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
,	,	PUNCT	,	O
prospective	prospective	ADJ	JJ	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
whether	whether	ADP	IN	O
intravenous	intravenous	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
methylprednisolone	methylprednisolone	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
MP	MP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
prevents	prevent	VERB	VBZ	O
this	this	DET	DT	O
complication	complication	NOUN	NN	O
.	.	PUNCT	.	O

Sixty	sixty	NUM	CD	O
-	-	PUNCT	HYPH	O
five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
34	34	NUM	CD	O
women	woman	NOUN	NNS	O
and	and	CCONJ	CC	O
31	31	NUM	CD	O
men	man	NOUN	NNS	O
,	,	PUNCT	,	O
ages	age	NOUN	NNS	O
36	36	NUM	CD	O
to	to	PART	TO	O
80	80	NUM	CD	O
years	year	NOUN	NNS	O
,	,	PUNCT	,	O
received	receive	VERB	VBD	O
either	either	CCONJ	CC	O
normal	normal	ADJ	JJ	O
saline	saline	NOUN	NN	O
before	before	ADV	RB	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
TDI	TDI	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
1	1	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
125	125	NUM	CD	O
mg	mg	NOUN	NN	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
MP	mp	VERB	VB	B-Chemical
before	before	ADV	RB	O
and	and	CCONJ	CC	O
saline	saline	NOUN	NN	O
after	after	ADP	IN	O
TDI	TDI	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
2	2	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
125	125	NUM	CD	O
mg	mg	NOUN	NN	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
MP	mp	VERB	VB	B-Chemical
before	before	ADV	RB	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
TDI	TDI	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
group	group	NOUN	NN	O
3	3	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
for	for	ADP	IN	O
72	72	NUM	CD	O
hours	hour	NOUN	NNS	O
and	and	CCONJ	CC	O
reactions	reaction	NOUN	NNS	O
were	be	VERB	VBD	O
recorded	record	VERB	VBN	O
and	and	CCONJ	CC	O
graded	grade	VERB	VBN	O
according	accord	VERB	VBG	O
to	to	ADP	IN	O
severity	severity	NOUN	NN	O
.	.	PUNCT	.	O

Fifty	fifty	NUM	CD	O
-	-	PUNCT	HYPH	O
eight	eight	NUM	CD	O
percent	percent	NOUN	NN	O
of	of	ADP	IN	O
group	group	NOUN	NN	O
1	1	NUM	CD	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
33	33	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
group	group	NOUN	NN	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
26	26	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
group	group	NOUN	NN	O
3	3	NUM	CD	O
had	have	VERB	VBD	O
reactions	reaction	NOUN	NNS	O
to	to	ADP	IN	O
TDI	TDI	PROPN	NNP	O
.	.	PUNCT	.	O

The	the	DET	DT	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
reactions	reaction	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
minimal	minimal	ADJ	JJ	O
,	,	PUNCT	,	O
mild	mild	ADJ	JJ	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
moderate	moderate	ADJ	JJ	O
,	,	PUNCT	,	O
respectively	respectively	ADV	RB	O
)	)	PUNCT	-RRB-	O
was	be	VERB	VBD	O
as	as	ADP	IN	O
follows	follow	VERB	VBZ	O
:	:	PUNCT	:	O
group	group	NOUN	NN	O
1	1	NUM	CD	O
-	-	PUNCT	HYPH	O
-	-	SYM	SYM	O
6	6	NUM	CD	O
,	,	PUNCT	,	O
6	6	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
2	2	NUM	CD	O
;	;	PUNCT	:	O
group	group	NOUN	NN	O
2	2	NUM	CD	O
-	-	PUNCT	HYPH	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
;	;	PUNCT	:	O
group	group	NOUN	NN	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
,	,	PUNCT	,	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
0	0	NUM	CD	O
.	.	PUNCT	.	O

Data	datum	NOUN	NNS	O
were	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
-	-	PUNCT	HYPH	O
sided	sided	ADJ	JJ	O
Fisher	Fisher	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	PART	POS	O
exact	exact	ADJ	JJ	O
test	test	NOUN	NN	O
using	use	VERB	VBG	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
intervals	interval	NOUN	NNS	O
with	with	ADP	IN	O
the	the	DET	DT	O
approximation	approximation	NOUN	NN	O
of	of	ADP	IN	O
Woolf	Woolf	PROPN	NNP	O
.	.	PUNCT	.	O

These	these	DET	DT	O
data	datum	NOUN	NNS	O
demonstrate	demonstrate	VERB	VBP	O
that	that	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
MP	MP	PROPN	NNP	B-Chemical
before	before	ADV	RB	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
TDI	TDI	PROPN	NNP	O
reduces	reduce	VERB	VBZ	O
the	the	DET	DT	O
frequency	frequency	NOUN	NN	O
and	and	CCONJ	CC	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
arthralgia	arthralgia	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
myalgia	myalgia	NOUN	NN	B-Disease
syndrome	syndrome	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
125	125	NUM	CD	O
mg	mg	NOUN	NN	O
i	i	NOUN	NN	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
MP	MP	PROPN	NNP	B-Chemical
should	should	VERB	MD	O
be	be	VERB	VB	O
given	give	VERB	VBN	O
routinely	routinely	ADV	RB	O
before	before	ADP	IN	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
TDI	TDI	PROPN	NNP	O
of	of	ADP	IN	O
iron	iron	NOUN	NN	B-Chemical
dextran	dextran	NOUN	NN	I-Chemical
.	.	PUNCT	.	O

Prolongation	prolongation	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
the	the	DET	DT	I-Disease
QT	QT	PROPN	NNP	I-Disease
interval	interval	NOUN	NN	I-Disease
related	relate	VERB	VBN	O
to	to	ADP	IN	O
cisapride	cisapride	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
diltiazem	diltiazem	ADJ	JJ	B-Chemical
interaction	interaction	NOUN	NN	O
.	.	PUNCT	.	O

Cisapride	Cisapride	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
a	a	DET	DT	O
cytochrome	cytochrome	ADJ	JJ	O
P450	P450	PROPN	NNP	O
3A4	3a4	NUM	CD	O
(	(	PUNCT	-LRB-	O
CYP3A4	CYP3A4	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
substrate	substrate	NOUN	NN	O
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
widely	widely	ADV	RB	O
prescribed	prescribe	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
gastrointestinal	gastrointestinal	ADJ	JJ	B-Disease
motility	motility	NOUN	NN	I-Disease
disorders	disorder	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Prolongation	prolongation	NOUN	NN	B-Disease
of	of	ADP	IN	I-Disease
QT	QT	PROPN	NNP	I-Disease
interval	interval	NOUN	NN	I-Disease
,	,	PUNCT	,	O
torsades	torsade	NOUN	NNS	B-Disease
de	de	X	FW	I-Disease
pointes	pointe	NOUN	NNS	I-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
sudden	sudden	ADJ	JJ	B-Disease
cardiac	cardiac	ADJ	JJ	I-Disease
death	death	NOUN	NN	I-Disease
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
after	after	ADP	IN	O
concomitant	concomitant	ADJ	JJ	O
administration	administration	NOUN	NN	O
with	with	ADP	IN	O
erythromycin	erythromycin	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
azole	azole	NOUN	NN	B-Chemical
antifungal	antifungal	ADJ	JJ	O
agents	agent	NOUN	NNS	O
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
CYP3A4	cyp3a4	NOUN	NN	O
inhibitors	inhibitor	NOUN	NNS	O
.	.	PUNCT	.	O

A	a	DET	DT	O
possible	possible	ADJ	JJ	O
drug	drug	NOUN	NN	O
interaction	interaction	NOUN	NN	O
occurred	occur	VERB	VBD	O
in	in	ADP	IN	O
a	a	DET	DT	O
45	45	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
woman	woman	NOUN	NN	O
who	who	PRON	WP	O
was	be	VERB	VBD	O
taking	take	VERB	VBG	O
cisapride	cisapride	ADV	RB	B-Chemical
for	for	ADP	IN	O
gastroesophageal	gastroesophageal	NOUN	NN	B-Disease
reflux	reflux	NOUN	NN	I-Disease
disorder	disorder	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
diltiazem	diltiazem	ADJ	JJ	B-Chemical
,	,	PUNCT	,	O
an	an	DET	DT	O
agent	agent	NOUN	NN	O
that	that	DET	WDT	O
has	have	VERB	VBZ	O
inhibitory	inhibitory	ADJ	JJ	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
CYP3A4	CYP3A4	PROPN	NNP	O
,	,	PUNCT	,	O
for	for	ADP	IN	O
hypertension	hypertension	NOUN	NN	B-Disease
.	.	PUNCT	.	O

The	the	DET	DT	O
patient	patient	NOUN	NN	O
was	be	VERB	VBD	O
in	in	ADP	IN	O
near	near	ADP	IN	O
syncope	syncope	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
had	have	VERB	VBD	O
QT	QT	PROPN	NNP	B-Disease
-	-	PUNCT	HYPH	I-Disease
interval	interval	ADJ	JJ	I-Disease
prolongation	prolongation	NOUN	NN	I-Disease
.	.	PUNCT	.	O

After	after	ADP	IN	O
discontinuing	discontinue	VERB	VBG	O
cisapride	cisapride	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
the	the	DET	DT	O
QT	QT	PROPN	NNP	O
interval	interval	NOUN	NN	O
returned	return	VERB	VBD	O
to	to	ADP	IN	O
normal	normal	ADJ	JJ	O
and	and	CCONJ	CC	O
symptoms	symptom	NOUN	NNS	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
recur	recur	VERB	VB	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
suggest	suggest	VERB	VBP	O
that	that	DET	DT	O
caution	caution	NOUN	NN	O
be	be	VERB	VB	O
taken	take	VERB	VBN	O
when	when	ADV	WRB	O
cisapride	cisapride	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
prescribed	prescribe	VERB	VBN	O
with	with	ADP	IN	O
any	any	DET	DT	O
potent	potent	ADJ	JJ	O
inhibitor	inhibitor	NOUN	NN	O
of	of	ADP	IN	O
CYP3A4	cyp3a4	NOUN	NN	O
,	,	PUNCT	,	O
including	include	VERB	VBG	O
diltiazem	diltiazem	ADJ	JJ	B-Chemical
.	.	PUNCT	.	O

Cortical	cortical	ADJ	JJ	O
motor	motor	NOUN	NN	O
overactivation	overactivation	NOUN	NN	O
in	in	ADP	IN	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
peak	peak	NOUN	NN	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
have	have	VERB	VBP	O
studied	study	VERB	VBN	O
the	the	DET	DT	O
regional	regional	ADJ	JJ	O
cerebral	cerebral	ADJ	JJ	O
blood	blood	NOUN	NN	O
flow	flow	NOUN	NN	O
(	(	PUNCT	-LRB-	O
rCBF	rCBF	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
changes	change	NOUN	NNS	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
execution	execution	NOUN	NN	O
of	of	ADP	IN	O
a	a	DET	DT	O
finger	finger	NOUN	NN	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
thumb	thumb	NOUN	NN	O
opposition	opposition	NOUN	NN	O
motor	motor	NOUN	NN	O
task	task	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
supplementary	supplementary	ADJ	JJ	O
and	and	CCONJ	CC	O
primary	primary	ADJ	JJ	O
motor	motor	NOUN	NN	O
cortex	cortex	NOUN	NN	O
of	of	ADP	IN	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
of	of	ADP	IN	O
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
on	on	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	ADJ	JJ	I-Chemical
medication	medication	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
first	first	ADJ	JJ	O
one	one	NOUN	NN	O
without	without	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	NOUN	NN	I-Chemical
induced	induced	ADJ	JJ	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
23	23	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
other	other	ADJ	JJ	O
with	with	ADP	IN	O
moderate	moderate	ADJ	JJ	O
peak	peak	NOUN	NN	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
15	15	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
of	of	ADP	IN	O
a	a	DET	DT	O
group	group	NOUN	NN	O
of	of	ADP	IN	O
14	14	NUM	CD	O
normal	normal	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
.	.	PUNCT	.	O

Single	single	ADJ	JJ	O
photon	photon	NOUN	NN	O
emission	emission	NOUN	NN	O
tomography	tomography	NOUN	NN	O
with	with	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
133Xe	133xe	NUM	CD	O
was	be	VERB	VBD	O
used	use	VERB	VBN	O
to	to	PART	TO	O
measure	measure	VERB	VB	O
the	the	DET	DT	O
rCBF	rCBF	PROPN	NNP	O
changes	change	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
dyskinetic	dyskinetic	ADJ	JJ	B-Disease
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
exhibited	exhibit	VERB	VBD	O
a	a	DET	DT	O
pattern	pattern	NOUN	NN	O
of	of	ADP	IN	O
response	response	NOUN	NN	O
which	which	DET	WDT	O
was	be	VERB	VBD	O
markedly	markedly	ADV	RB	O
different	different	ADJ	JJ	O
from	from	ADP	IN	O
those	those	DET	DT	O
of	of	ADP	IN	O
the	the	DET	DT	O
normal	normal	ADJ	JJ	O
subjects	subject	NOUN	NNS	O
and	and	CCONJ	CC	O
non	non	ADJ	JJ	O
-	-	ADJ	JJ	O
dyskinetic	dyskinetic	ADJ	JJ	B-Disease
parkinsonian	parkinsonian	ADJ	JJ	B-Disease
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
with	with	ADP	IN	O
a	a	DET	DT	O
significant	significant	ADJ	JJ	O
overactivation	overactivation	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
supplementary	supplementary	ADJ	JJ	O
motor	motor	NOUN	NN	O
area	area	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
ipsi	ipsi	NOUN	NN	O
-	-	PUNCT	HYPH	O
and	and	CCONJ	CC	O
contralateral	contralateral	ADJ	JJ	O
primary	primary	ADJ	JJ	O
motor	motor	NOUN	NN	O
areas	area	NOUN	NNS	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
are	be	VERB	VBP	O
compatible	compatible	ADJ	JJ	O
with	with	ADP	IN	O
the	the	DET	DT	O
hypothesis	hypothesis	NOUN	NN	O
that	that	ADP	IN	O
an	an	DET	DT	O
hyperkinetic	hyperkinetic	ADJ	JJ	B-Disease
abnormal	abnormal	ADJ	JJ	B-Disease
involuntary	involuntary	ADJ	JJ	I-Disease
movement	movement	NOUN	NN	I-Disease
,	,	PUNCT	,	O
like	like	ADP	IN	O
L	l	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
dopa	dopa	ADV	RB	I-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
peak	peak	NOUN	NN	O
dose	dose	NOUN	NN	O
dyskinesia	dyskinesia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
is	be	VERB	VBZ	O
due	due	ADJ	JJ	O
to	to	ADP	IN	O
a	a	DET	DT	O
disinhibition	disinhibition	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
primary	primary	ADJ	JJ	O
and	and	CCONJ	CC	O
associated	associated	ADJ	JJ	O
motor	motor	NOUN	NN	O
cortex	cortex	NOUN	NN	O
secondary	secondary	ADJ	JJ	O
to	to	ADP	IN	O
an	an	DET	DT	O
excessive	excessive	ADJ	JJ	O
outflow	outflow	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
pallidothalamocortical	pallidothalamocortical	ADJ	JJ	O
motor	motor	NOUN	NN	O
loop	loop	NOUN	NN	O
.	.	PUNCT	.	O

Open	open	ADJ	JJ	O
-	-	PUNCT	HYPH	O
label	label	NOUN	NN	O
assessment	assessment	NOUN	NN	O
of	of	ADP	IN	O
levofloxacin	levofloxacin	NOUN	NN	B-Chemical
for	for	ADP	IN	O
the	the	DET	DT	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	O
bacterial	bacterial	ADJ	JJ	O
sinusitis	sinusitis	NOUN	NN	B-Disease
in	in	ADP	IN	O
adults	adult	NOUN	NNS	O
.	.	PUNCT	.	O

PURPOSE	PURPOSE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
efficacy	efficacy	NOUN	NN	O
and	and	CCONJ	CC	O
safety	safety	NOUN	NN	O
of	of	ADP	IN	O
levofloxacin	levofloxacin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
500	500	NUM	CD	O
mg	mg	NOUN	NN	O
orally	orally	ADV	RB	O
once	once	ADV	RB	O
daily	daily	ADV	RB	O
for	for	ADP	IN	O
10	10	NUM	CD	O
to	to	PART	TO	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
treating	treat	VERB	VBG	O
adult	adult	NOUN	NN	O
outpatients	outpatient	NOUN	NNS	O
with	with	ADP	IN	O
acute	acute	ADJ	JJ	O
bacterial	bacterial	ADJ	JJ	O
sinusitis	sinusitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
A	a	DET	DT	O
total	total	NOUN	NN	O
of	of	ADP	IN	O
329	329	NUM	CD	O
patients	patient	NOUN	NNS	O
enrolled	enrol	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
at	at	ADP	IN	O
24	24	NUM	CD	O
centers	center	NOUN	NNS	O
.	.	PUNCT	.	O

All	all	DET	DT	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
a	a	DET	DT	O
pre	pre	ADJ	JJ	O
-	-	NOUN	NN	O
therapy	therapy	ADJ	JJ	O
Gram	Gram	PROPN	NNP	O
'	'	PUNCT	''	O
s	s	NOUN	NN	O
stain	stain	NOUN	NN	O
and	and	CCONJ	CC	O
culture	culture	NOUN	NN	O
of	of	ADP	IN	O
sinus	sinus	NOUN	NN	O
exudate	exudate	NOUN	NN	O
obtained	obtain	VERB	VBN	O
by	by	ADP	IN	O
antral	antral	ADJ	JJ	O
puncture	puncture	NOUN	NN	O
or	or	CCONJ	CC	O
nasal	nasal	NOUN	NN	O
endoscopy	endoscopy	NOUN	NN	O
.	.	PUNCT	.	O

Clinical	clinical	ADJ	JJ	O
response	response	NOUN	NN	O
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
on	on	ADP	IN	O
the	the	DET	DT	O
basis	basis	NOUN	NN	O
of	of	ADP	IN	O
signs	sign	NOUN	NNS	O
and	and	CCONJ	CC	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
sinus	sinus	NOUN	NN	O
radiograph	radiograph	NOUN	NNS	O
or	or	CCONJ	CC	O
computed	compute	VERB	VBN	O
tomography	tomography	NOUN	NN	O
results	result	NOUN	NNS	O
.	.	PUNCT	.	O

Microbiologic	Microbiologic	PROPN	NNP	O
cure	cure	NOUN	NN	O
rates	rate	NOUN	NNS	O
were	be	VERB	VBD	O
determined	determine	VERB	VBN	O
on	on	ADP	IN	O
the	the	DET	DT	O
basis	basis	NOUN	NN	O
of	of	ADP	IN	O
presumed	presume	VERB	VBN	O
plus	plus	CCONJ	CC	O
documented	document	VERB	VBN	O
eradication	eradication	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
therapy	therapy	ADJ	JJ	O
pathogen	pathogen	NOUN	NN	O
(	(	PUNCT	-LRB-	O
s	s	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
pathogens	pathogen	NOUN	NNS	O
were	be	VERB	VBD	O
Haemophilus	Haemophilus	PROPN	NNP	O
influenzae	influenzae	NOUN	NNS	O
,	,	PUNCT	,	O
Streptococcus	Streptococcus	PROPN	NNP	O
pneumoniae	pneumoniae	NOUN	NN	O
,	,	PUNCT	,	O
Staphylococcus	Staphylococcus	PROPN	NNP	O
aureus	aureus	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
Moraxella	Moraxella	PROPN	NNP	O
catarrhalis	catarrhalis	VERB	VBP	O
.	.	PUNCT	.	O

Of	of	ADP	IN	O
300	300	NUM	CD	O
clinically	clinically	ADV	RB	O
evaluable	evaluable	ADJ	JJ	O
patients	patient	NOUN	NNS	O
,	,	PUNCT	,	O
175	175	NUM	CD	O
(	(	PUNCT	-LRB-	O
58	58	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
cured	cure	VERB	VBN	O
and	and	CCONJ	CC	O
90	90	NUM	CD	O
(	(	PUNCT	-LRB-	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
improved	improve	VERB	VBN	O
at	at	ADP	IN	O
the	the	DET	DT	O
post	post	ADJ	JJ	O
-	-	ADJ	JJ	O
therapy	therapy	ADJ	JJ	O
evaluation	evaluation	NOUN	NN	O
,	,	PUNCT	,	O
resulting	result	VERB	VBG	O
in	in	ADP	IN	O
a	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
success	success	NOUN	NN	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
88	88	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

Thirty	thirty	NUM	CD	O
-	-	PUNCT	HYPH	O
five	five	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
12	12	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
clinically	clinically	ADV	RB	O
failed	fail	VERB	VBD	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
microbiologic	microbiologic	ADJ	JJ	O
eradication	eradication	NOUN	NN	O
rate	rate	NOUN	NN	O
(	(	PUNCT	-LRB-	O
presumed	presume	VERB	VBN	O
plus	plus	CCONJ	CC	O
documented	document	VERB	VBN	O
)	)	PUNCT	-RRB-	O
among	among	ADP	IN	O
138	138	NUM	CD	O
microbiologically	microbiologically	ADV	RB	O
evaluable	evaluable	ADJ	JJ	O
patients	patient	NOUN	NNS	O
was	be	VERB	VBD	O
92	92	NUM	CD	O
%	%	NOUN	NN	O
.	.	PUNCT	.	O

Microbiologic	Microbiologic	PROPN	NNP	O
eradication	eradication	NOUN	NN	O
rates	rate	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
presumed	presume	VERB	VBN	O
plus	plus	CCONJ	CC	O
documented	document	VERB	VBN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
the	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
pathogens	pathogen	NOUN	NNS	O
ranged	range	VERB	VBD	O
from	from	ADP	IN	O
93	93	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
M	M	PROPN	NNP	O
.	.	PROPN	NNP	O
catarrhalis	catarrhalis	NOUN	NN	O
)	)	PUNCT	-RRB-	O
to	to	ADP	IN	O
100	100	NUM	CD	O
%	%	NOUN	NN	O
(	(	PUNCT	-LRB-	O
S	S	PROPN	NNP	O
.	.	PUNCT	.	O
pneumoniae	pneumoniae	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
at	at	ADP	IN	O
the	the	DET	DT	O
post	post	ADJ	JJ	O
-	-	ADJ	JJ	O
therapy	therapy	ADJ	JJ	O
visit	visit	NOUN	NN	O
.	.	PUNCT	.	O

All	all	DET	DT	O
but	but	ADP	IN	O
one	one	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
265	265	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
were	be	VERB	VBD	O
cured	cure	VERB	VBN	O
or	or	CCONJ	CC	O
improved	improve	VERB	VBN	O
at	at	ADP	IN	O
post	post	ADJ	JJ	O
-	-	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
returned	return	VERB	VBD	O
for	for	ADP	IN	O
a	a	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
visit	visit	NOUN	NN	O
;	;	PUNCT	:	O
243	243	NUM	CD	O
(	(	PUNCT	-LRB-	O
92	92	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
remained	remain	VERB	VBD	O
well	well	ADV	RB	O
4	4	NUM	CD	O
to	to	PART	TO	O
6	6	NUM	CD	O
weeks	week	NOUN	NNS	O
after	after	ADP	IN	O
therapy	therapy	NOUN	NN	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
21	21	NUM	CD	O
(	(	PUNCT	-LRB-	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
had	have	VERB	VBD	O
a	a	DET	DT	O
relapse	relapse	NOUN	NN	O
of	of	ADP	IN	O
symptoms	symptom	NOUN	NNS	O
.	.	PUNCT	.	O

Adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
considered	consider	VERB	VBN	O
to	to	PART	TO	O
be	be	VERB	VB	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
levofloxacin	levofloxacin	ADJ	JJ	B-Chemical
administration	administration	NOUN	NN	O
were	be	VERB	VBD	O
reported	report	VERB	VBN	O
by	by	ADP	IN	O
29	29	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
9	9	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
most	most	ADV	RBS	O
common	common	ADJ	JJ	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
were	be	VERB	VBD	O
diarrhea	diarrhea	NOUN	NN	B-Disease
,	,	PUNCT	,	O
flatulence	flatulence	NOUN	NN	B-Disease
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
nausea	nausea	NOUN	NN	B-Disease
;	;	PUNCT	:	O
most	most	ADJ	JJS	O
adverse	adverse	ADJ	JJ	O
events	event	NOUN	NNS	O
were	be	VERB	VBD	O
mild	mild	ADJ	JJ	O
to	to	PART	TO	O
moderate	moderate	VERB	VB	O
in	in	ADP	IN	O
severity	severity	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
The	the	DET	DT	O
results	result	NOUN	NNS	O
of	of	ADP	IN	O
this	this	DET	DT	O
study	study	NOUN	NN	O
indicate	indicate	VERB	VBP	O
that	that	ADP	IN	O
levofloxacin	levofloxacin	ADJ	JJ	B-Chemical
500	500	NUM	CD	O
mg	mg	NOUN	NN	O
once	once	ADV	RB	O
daily	daily	ADV	RB	O
is	be	VERB	VBZ	O
an	an	DET	DT	O
effective	effective	ADJ	JJ	O
and	and	CCONJ	CC	O
safe	safe	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
acute	acute	ADJ	JJ	O
bacterial	bacterial	ADJ	JJ	O
sinusitis	sinusitis	NOUN	NN	B-Disease
.	.	PUNCT	.	O

Iatrogenic	iatrogenic	ADJ	JJ	O
risks	risk	NOUN	NNS	O
of	of	ADP	IN	O
endometrial	endometrial	ADJ	JJ	B-Disease
carcinoma	carcinoma	NOUN	NN	I-Disease
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
large	large	ADJ	JJ	O
French	french	ADJ	JJ	O
case	case	NOUN	NN	O
-	-	PUNCT	HYPH	O
control	control	NOUN	NN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

F	F	PROPN	NNP	O
d	d	NOUN	NN	O
ration	ration	NOUN	NN	O
Nationale	Nationale	PROPN	NNP	O
des	des	PROPN	NNP	O
Centres	Centres	PROPN	NNP	O
de	de	PROPN	NNP	O
Lutte	Lutte	PROPN	NNP	O
Contre	Contre	PROPN	NNP	O
le	le	VERB	VBD	O
Cancer	Cancer	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
FNCLCC	FNCLCC	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Since	since	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
widely	widely	ADV	RB	O
used	use	VERB	VBN	O
in	in	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
treatment	treatment	NOUN	NN	O
and	and	CCONJ	CC	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
proposed	propose	VERB	VBN	O
for	for	ADP	IN	O
the	the	DET	DT	O
prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
,	,	PUNCT	,	O
its	-PRON-	DET	PRP$	O
endometrial	endometrial	ADJ	JJ	O
iatrogenic	iatrogenic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
must	must	VERB	MD	O
be	be	VERB	VB	O
carefully	carefully	ADV	RB	O
examined	examine	VERB	VBN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
have	have	VERB	VBP	O
investigated	investigate	VERB	VBN	O
the	the	DET	DT	O
association	association	NOUN	NN	O
between	between	ADP	IN	O
endometrial	endometrial	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
or	or	CCONJ	CC	O
other	other	ADJ	JJ	O
treatments	treatment	NOUN	NNS	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
treated	treat	VERB	VBN	O
for	for	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
in	in	ADP	IN	O
a	a	DET	DT	O
case	case	NOUN	NN	O
-	-	PUNCT	HYPH	O
control	control	NOUN	NN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Cases	case	NOUN	NNS	O
of	of	ADP	IN	O
endometrial	endometrial	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
diagnosed	diagnose	VERB	VBN	O
after	after	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
135	135	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
467	467	NUM	CD	O
controls	control	NOUN	NNS	O
matched	match	VERB	VBN	O
for	for	ADP	IN	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
year	year	NOUN	NN	O
of	of	ADP	IN	O
diagnosis	diagnosis	NOUN	NN	O
of	of	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
hospital	hospital	NOUN	NN	O
and	and	CCONJ	CC	O
survival	survival	NOUN	NN	O
time	time	NOUN	NN	O
with	with	ADP	IN	O
an	an	DET	DT	O
intact	intact	ADJ	JJ	O
uterus	uterus	NOUN	NN	O
were	be	VERB	VBD	O
included	include	VERB	VBN	O
.	.	PUNCT	.	O

Women	woman	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
received	receive	VERB	VBN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
more	more	ADV	RBR	O
likely	likely	ADJ	JJ	O
to	to	PART	TO	O
have	have	VERB	VB	O
endometrial	endometrial	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
diagnosed	diagnose	VERB	VBN	O
than	than	ADP	IN	O
those	those	DET	DT	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
not	not	ADV	RB	O
(	(	PUNCT	-LRB-	O
crude	crude	ADJ	JJ	O
relative	relative	ADJ	JJ	O
risk	risk	NOUN	NN	O
=	=	SYM	SYM	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
,	,	PUNCT	,	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0001	0001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Univariate	univariate	ADJ	JJ	O
and	and	CCONJ	CC	O
adjusted	adjust	VERB	VBN	O
analyses	analysis	NOUN	NNS	O
showed	show	VERB	VBD	O
that	that	ADP	IN	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
increased	increase	VERB	VBD	O
with	with	ADP	IN	O
the	the	DET	DT	O
length	length	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0001	0001	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
the	the	DET	DT	O
cumulative	cumulative	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
received	receive	VERB	VBN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0001	0001	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
irrespective	irrespective	ADV	RB	O
of	of	ADP	IN	O
the	the	DET	DT	O
daily	daily	ADJ	JJ	O
dose	dose	NOUN	NN	O
.	.	PUNCT	.	O

Women	woman	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
undergone	undergo	VERB	VBN	O
pelvic	pelvic	ADJ	JJ	O
radiotherapy	radiotherapy	NOUN	NN	O
also	also	ADV	RB	O
had	have	VERB	VBD	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
risk	risk	NOUN	NN	O
(	(	PUNCT	-LRB-	O
crude	crude	ADJ	JJ	O
relative	relative	ADJ	JJ	O
risk	risk	NOUN	NN	O
=	=	SYM	SYM	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
,	,	PUNCT	,	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0001	0001	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
adjusting	adjust	VERB	VBG	O
for	for	ADP	IN	O
confounding	confound	VERB	VBG	O
factors	factor	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
for	for	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
users	user	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
0012	0012	NUM	CD	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
more	more	ADJ	JJR	O
than	than	ADP	IN	O
3	3	NUM	CD	O
years	year	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
all	all	DET	DT	O
p	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
pelvic	pelvic	ADJ	JJ	O
radiotherapy	radiotherapy	NOUN	NN	O
(	(	PUNCT	-LRB-	O
p	p	NOUN	NN	O
=	=	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
012	012	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Women	woman	NOUN	NNS	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
endometrial	endometrial	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
had	have	VERB	VBD	O
received	receive	VERB	VBN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
more	more	ADV	RBR	O
advanced	advanced	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
poorer	poor	ADJ	JJR	O
prognosis	prognosis	NOUN	NN	O
than	than	ADP	IN	O
those	those	DET	DT	O
with	with	ADP	IN	O
endometrial	endometrial	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
who	who	PRON	WP	O
had	have	VERB	VBD	O
not	not	ADV	RB	O
received	receive	VERB	VBN	O
this	this	DET	DT	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
a	a	DET	DT	O
causal	causal	ADJ	JJ	O
role	role	NOUN	NN	O
of	of	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
in	in	ADP	IN	O
endometrial	endometrial	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
,	,	PUNCT	,	O
particularly	particularly	ADV	RB	O
when	when	ADV	WRB	O
used	use	VERB	VBN	O
as	as	ADV	RB	O
currently	currently	ADV	RB	O
proposed	propose	VERB	VBN	O
for	for	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
prevention	prevention	NOUN	NN	O
.	.	PUNCT	.	O

Pelvic	pelvic	ADJ	JJ	O
radiotherapy	radiotherapy	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
an	an	DET	DT	O
additional	additional	ADJ	JJ	O
iatrogenic	iatrogenic	ADJ	JJ	O
factor	factor	NOUN	NN	O
for	for	ADP	IN	O
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Endometrial	endometrial	ADJ	JJ	B-Disease
cancers	cancer	NOUN	NNS	I-Disease
diagnosed	diagnose	VERB	VBN	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
have	have	VERB	VBP	O
poorer	poor	ADJ	JJR	O
prognosis	prognosis	NOUN	NN	O
.	.	PUNCT	.	O

Women	woman	NOUN	NNS	O
who	who	PRON	WP	O
receive	receive	VERB	VBP	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
for	for	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
should	should	VERB	MD	O
be	be	VERB	VB	O
offered	offer	VERB	VBN	O
gynaecological	gynaecological	ADJ	JJ	O
surveillance	surveillance	NOUN	NN	O
during	during	ADP	IN	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

A	a	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
evaluation	evaluation	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
-	-	PUNCT	HYPH	O
benefit	benefit	NOUN	NN	O
ratio	ratio	NOUN	NN	O
of	of	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
as	as	ADP	IN	O
a	a	DET	DT	O
preventive	preventive	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
for	for	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
clearly	clearly	ADV	RB	O
warranted	warrant	VERB	VBN	O
.	.	PUNCT	.	O

Contribution	contribution	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
glycine	glycine	NOUN	NN	B-Chemical
site	site	NOUN	NN	O
of	of	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
receptors	receptor	NOUN	NNS	O
in	in	ADP	IN	O
rostral	rostral	ADJ	JJ	O
and	and	CCONJ	CC	O
intermediate	intermediate	ADJ	JJ	O
-	-	PUNCT	HYPH	O
caudal	caudal	ADJ	JJ	O
parts	part	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
muscle	muscle	NOUN	NN	O
tone	tone	NOUN	NN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
aim	aim	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
contribution	contribution	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
glycine	glycine	NOUN	NN	B-Chemical
site	site	NOUN	NN	O
of	of	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
receptors	receptor	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
to	to	ADP	IN	O
the	the	DET	DT	O
regulation	regulation	NOUN	NN	O
of	of	ADP	IN	O
muscle	muscle	NOUN	NN	O
tone	tone	NOUN	NN	O
.	.	PUNCT	.	O

Muscle	muscle	NOUN	NN	O
tone	tone	NOUN	NN	O
was	be	VERB	VBD	O
examined	examine	VERB	VBN	O
using	use	VERB	VBG	O
a	a	DET	DT	O
combined	combined	ADJ	JJ	O
mechanoand	mechanoand	NOUN	NN	O
electromyographic	electromyographic	ADJ	JJ	O
method	method	NOUN	NN	O
,	,	PUNCT	,	O
which	which	DET	WDT	O
measured	measure	VERB	VBD	O
simultaneously	simultaneously	ADV	RB	O
the	the	DET	DT	O
muscle	muscle	NOUN	NN	O
resistance	resistance	NOUN	NN	O
(	(	PUNCT	-LRB-	O
MMG	MMG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
'	'	PUNCT	``	O
s	s	PART	POS	O
hind	hind	NOUN	NN	O
foot	foot	NOUN	NN	O
to	to	ADP	IN	O
passive	passive	ADJ	JJ	O
extension	extension	NOUN	NN	O
and	and	CCONJ	CC	O
flexion	flexion	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
ankle	ankle	NOUN	NN	O
joint	joint	NOUN	NN	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
electromyographic	electromyographic	ADJ	JJ	O
activity	activity	NOUN	NN	O
(	(	PUNCT	-LRB-	O
EMG	EMG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
the	the	DET	DT	O
antagonistic	antagonistic	ADJ	JJ	O
muscles	muscle	NOUN	NNS	O
of	of	ADP	IN	O
that	that	DET	DT	O
joint	joint	NOUN	NN	O
:	:	PUNCT	:	O
gastrocnemius	gastrocnemius	NOUN	NN	O
and	and	CCONJ	CC	O
tibialis	tibialis	NOUN	NN	O
anterior	anterior	NOUN	NN	O
.	.	PUNCT	.	O

Muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

5	5	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
7	7	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
dichlorokynurenic	dichlorokynurenic	ADJ	JJ	I-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
5	5	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
7	7	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
DCKA	DCKA	PROPN	NNP	I-Chemical
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
a	a	DET	DT	O
selective	selective	ADJ	JJ	O
glycine	glycine	NOUN	NN	B-Chemical
site	site	NOUN	NN	O
antagonist	antagonist	NOUN	NN	O
,	,	PUNCT	,	O
injected	inject	VERB	VBN	O
in	in	ADP	IN	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
and	and	CCONJ	CC	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
bilaterally	bilaterally	ADV	RB	O
,	,	PUNCT	,	O
into	into	ADP	IN	O
the	the	DET	DT	O
rostral	rostral	ADJ	JJ	O
region	region	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
,	,	PUNCT	,	O
decreased	decrease	VERB	VBD	O
both	both	CCONJ	CC	O
the	the	DET	DT	O
haloperidol	haloperidol	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
muscle	muscle	NOUN	NN	B-Disease
rigidity	rigidity	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
MMG	MMG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
enhanced	enhance	VERB	VBN	O
electromyographic	electromyographic	ADJ	JJ	O
activity	activity	NOUN	NN	O
(	(	PUNCT	-LRB-	O
EMG	EMG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

5	5	NUM	CD	B-Chemical
,	,	PUNCT	,	I-Chemical
7	7	NUM	CD	I-Chemical
-	-	PUNCT	HYPH	I-Chemical
DCKA	DCKA	PROPN	NNP	I-Chemical
injected	inject	VERB	VBD	O
bilaterally	bilaterally	ADV	RB	O
in	in	ADP	IN	O
a	a	DET	DT	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
microl	microl	NOUN	NN	O
into	into	ADP	IN	O
the	the	DET	DT	O
intermediate	intermediate	ADJ	JJ	O
-	-	PUNCT	HYPH	O
caudal	caudal	ADJ	JJ	O
region	region	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
of	of	ADP	IN	O
rats	rat	NOUN	NNS	O
not	not	ADV	RB	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
haloperidol	haloperidol	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
no	no	DET	DT	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
muscle	muscle	NOUN	NN	O
tone	tone	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
present	present	ADJ	JJ	O
results	result	NOUN	NNS	O
suggest	suggest	VERB	VBP	O
that	that	DET	DT	O
blockade	blockade	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
glycine	glycine	NOUN	NN	B-Chemical
site	site	NOUN	NN	O
of	of	ADP	IN	O
NMDA	NMDA	PROPN	NNP	B-Chemical
receptors	receptor	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
rostral	rostral	ADJ	JJ	O
part	part	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
striatum	striatum	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
mainly	mainly	ADV	RB	O
responsible	responsible	ADJ	JJ	O
for	for	ADP	IN	O
the	the	DET	DT	O
antiparkinsonian	antiparkinsonian	ADJ	JJ	O
action	action	NOUN	NN	O
of	of	ADP	IN	O
this	this	DET	DT	O
drug	drug	NOUN	NN	O
.	.	PUNCT	.	O

Carboplatin	carboplatin	ADJ	JJ	B-Chemical
toxic	toxic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
on	on	ADP	IN	O
the	the	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
rat	rat	NOUN	NN	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
most	most	ADV	RBS	O
striking	striking	ADJ	JJ	O
of	of	ADP	IN	O
carboplatin	carboplatin	NOUN	NN	B-Chemical
'	'	PUNCT	''	O
s	s	PART	POS	O
advantages	advantage	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
CBDCA	CBDCA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
over	over	ADP	IN	O
cisplatin	cisplatin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
CDDP	CDDP	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
is	be	VERB	VBZ	O
its	-PRON-	DET	PRP$	O
markedly	markedly	ADV	RB	O
reduced	reduce	VERB	VBN	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
neurotoxic	neurotoxic	ADJ	JJ	B-Disease
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
CBDCA	cbdca	NOUN	NN	B-Chemical
higher	high	ADJ	JJR	O
-	-	PUNCT	HYPH	O
intensity	intensity	NOUN	NN	O
schedules	schedule	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
association	association	NOUN	NN	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
neurotoxic	neurotoxic	ADJ	JJ	B-Disease
drugs	drug	NOUN	NNS	O
in	in	ADP	IN	O
polychemotherapy	polychemotherapy	NOUN	NN	O
may	may	VERB	MD	O
cause	cause	VERB	VB	O
some	some	DET	DT	O
concern	concern	NOUN	NN	O
about	about	ADP	IN	O
its	-PRON-	DET	PRP$	O
safety	safety	NOUN	NN	O
with	with	ADP	IN	O
respect	respect	NOUN	NN	O
to	to	ADP	IN	O
peripheral	peripheral	ADJ	JJ	B-Disease
nervous	nervous	ADJ	JJ	I-Disease
system	system	NOUN	NN	I-Disease
damage	damage	NOUN	NN	I-Disease
.	.	PUNCT	.	O

MATERIALS	material	NOUN	NNS	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Two	two	NUM	CD	O
different	different	ADJ	JJ	O
schedules	schedule	NOUN	NNS	O
of	of	ADP	IN	O
CBDCA	CBDCA	PROPN	NNP	B-Chemical
administration	administration	NOUN	NN	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
and	and	CCONJ	CC	O
15	15	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
twice	twice	DET	PDT	O
a	a	DET	DT	O
week	week	NOUN	NN	O
for	for	ADP	IN	O
nine	nine	NUM	CD	O
times	time	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
evaluated	evaluate	VERB	VBN	O
in	in	ADP	IN	O
Wistar	Wistar	PROPN	NNP	O
rats	rat	NOUN	NNS	O
.	.	PUNCT	.	O

Neurotoxicity	Neurotoxicity	PROPN	NNP	B-Disease
was	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
for	for	ADP	IN	O
behavioral	behavioral	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
tail	tail	NOUN	NN	O
-	-	PUNCT	HYPH	O
flick	flick	NOUN	NN	O
test	test	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
neurophysiological	neurophysiological	ADJ	JJ	O
(	(	PUNCT	-LRB-	O
nerve	nerve	NOUN	NN	O
conduction	conduction	NOUN	NN	O
velocity	velocity	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
tail	tail	NOUN	NN	O
nerve	nerve	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
morphological	morphological	ADJ	JJ	O
,	,	PUNCT	,	O
morphometrical	morphometrical	ADJ	JJ	O
and	and	CCONJ	CC	O
analytical	analytical	ADJ	JJ	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
CBDCA	cbdca	NOUN	NN	B-Chemical
administration	administration	NOUN	NN	O
induced	induce	VERB	VBD	O
dose	dose	NOUN	NN	O
-	-	PUNCT	HYPH	O
dependent	dependent	ADJ	JJ	O
peripheral	peripheral	ADJ	JJ	B-Disease
neurotoxicity	neurotoxicity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Pain	pain	NOUN	NN	B-Disease
perception	perception	NOUN	NN	O
and	and	CCONJ	CC	O
nerve	nerve	NOUN	NN	O
conduction	conduction	NOUN	NN	O
velocity	velocity	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
tail	tail	NOUN	NN	O
were	be	VERB	VBD	O
significantly	significantly	ADV	RB	O
impaired	impair	VERB	VBN	O
,	,	PUNCT	,	O
particularly	particularly	ADV	RB	O
after	after	ADP	IN	O
the	the	DET	DT	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
dorsal	dorsal	ADJ	JJ	O
root	root	NOUN	NN	O
ganglia	ganglia	VERB	VBZ	O
sensory	sensory	ADJ	JJ	O
neurons	neuron	NOUN	NNS	O
and	and	CCONJ	CC	O
,	,	PUNCT	,	O
to	to	ADP	IN	O
a	a	DET	DT	O
lesser	less	ADJ	JJR	O
extent	extent	NOUN	NN	O
,	,	PUNCT	,	O
satellite	satellite	NOUN	NN	O
cells	cell	NOUN	NNS	O
showed	show	VERB	VBD	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
changes	change	NOUN	NNS	O
as	as	ADP	IN	O
those	those	DET	DT	O
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
CDDP	CDDP	PROPN	NNP	B-Chemical
,	,	PUNCT	,	O
mainly	mainly	ADV	RB	O
affecting	affect	VERB	VBG	O
the	the	DET	DT	O
nucleus	nucleus	NOUN	NN	O
and	and	CCONJ	CC	O
nucleolus	nucleolus	NOUN	NN	O
of	of	ADP	IN	O
ganglionic	ganglionic	ADJ	JJ	O
sensory	sensory	ADJ	JJ	O
neurons	neuron	NOUN	NNS	O
.	.	PUNCT	.	O

Moreover	moreover	ADV	RB	O
,	,	PUNCT	,	O
significant	significant	ADJ	JJ	O
amounts	amount	NOUN	NNS	O
of	of	ADP	IN	O
platinum	platinum	NOUN	NN	B-Chemical
were	be	VERB	VBD	O
detected	detect	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
dorsal	dorsal	ADJ	JJ	O
root	root	NOUN	NN	O
ganglia	ganglion	NOUN	NNS	O
and	and	CCONJ	CC	O
kidney	kidney	NOUN	NN	O
after	after	ADP	IN	O
CBDCA	CBDCA	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
CBDCA	cbdca	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
neurotoxic	neurotoxic	ADJ	JJ	B-Disease
in	in	ADP	IN	O
our	-PRON-	DET	PRP$	O
model	model	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
type	type	NOUN	NN	O
of	of	ADP	IN	O
pathological	pathological	ADJ	JJ	O
changes	change	NOUN	NNS	O
it	-PRON-	PRON	PRP	O
induces	induce	VERB	VBZ	O
are	be	VERB	VBP	O
so	so	ADV	RB	O
closely	closely	ADV	RB	O
similar	similar	ADJ	JJ	O
to	to	ADP	IN	O
those	those	DET	DT	O
caused	cause	VERB	VBN	O
by	by	ADP	IN	O
CDDP	CDDP	PROPN	NNP	B-Chemical
that	that	ADP	IN	O
it	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
probable	probable	ADJ	JJ	O
that	that	ADP	IN	O
neurotoxicity	neurotoxicity	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
induced	induce	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
drugs	drug	NOUN	NNS	O
by	by	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
model	model	NOUN	NN	O
can	can	VERB	MD	O
be	be	VERB	VB	O
used	use	VERB	VBN	O
alone	alone	ADJ	JJ	O
or	or	CCONJ	CC	O
in	in	ADP	IN	O
combination	combination	NOUN	NN	O
with	with	ADP	IN	O
other	other	ADJ	JJ	O
drugs	drug	NOUN	NNS	O
to	to	PART	TO	O
explore	explore	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
CBDCA	CBDCA	PROPN	NNP	B-Chemical
on	on	ADP	IN	O
the	the	DET	DT	O
peripheral	peripheral	ADJ	JJ	O
nervous	nervous	ADJ	JJ	O
system	system	NOUN	NN	O
.	.	PUNCT	.	O

Effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
cisapride	cisapride	NOUN	NN	B-Chemical
on	on	ADP	IN	O
symptoms	symptom	NOUN	NNS	O
and	and	CCONJ	CC	O
postcibal	postcibal	ADJ	JJ	O
small	small	ADJ	JJ	O
-	-	PUNCT	HYPH	O
bowel	bowel	NOUN	NN	O
motor	motor	NOUN	NN	O
function	function	NOUN	NN	O
in	in	ADP	IN	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
irritable	irritable	ADJ	JJ	B-Disease
bowel	bowel	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Irritable	irritable	ADJ	JJ	B-Disease
bowel	bowel	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
is	be	VERB	VBZ	O
a	a	DET	DT	O
common	common	ADJ	JJ	O
cause	cause	NOUN	NN	O
of	of	ADP	IN	O
abdominal	abdominal	ADJ	JJ	B-Disease
pain	pain	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
discomfort	discomfort	NOUN	NN	O
and	and	CCONJ	CC	O
may	may	VERB	MD	O
be	be	VERB	VB	O
related	relate	VERB	VBN	O
to	to	ADP	IN	O
disordered	disordered	ADJ	JJ	B-Disease
gastrointestinal	gastrointestinal	ADJ	JJ	I-Disease
motility	motility	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
aim	aim	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
assess	assess	VERB	VB	O
the	the	DET	DT	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
a	a	DET	DT	O
prokinetic	prokinetic	ADJ	JJ	O
agent	agent	NOUN	NN	O
,	,	PUNCT	,	O
cisapride	cisapride	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
on	on	ADP	IN	O
postprandial	postprandial	ADJ	JJ	O
jejunal	jejunal	ADJ	JJ	O
motility	motility	NOUN	NN	O
and	and	CCONJ	CC	O
symptoms	symptom	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
irritable	irritable	ADJ	JJ	B-Disease
bowel	bowel	NOUN	NN	I-Disease
syndrome	syndrome	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
IBS	IBS	PROPN	NNP	B-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

METHODS	METHODS	PROPN	NNP	O
:	:	PUNCT	:	O
Thirty	thirty	NUM	CD	O
-	-	PUNCT	HYPH	O
eight	eight	NUM	CD	O
patients	patient	NOUN	NNS	O
with	with	ADP	IN	O
IBS	IBS	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
constipation	constipation	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
predominant	predominant	NOUN	NN	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
17	17	NUM	CD	O
;	;	PUNCT	:	O
diarrhoea	diarrhoea	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
predominant	predominant	ADJ	JJ	O
,	,	PUNCT	,	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
21	21	NUM	CD	O
)	)	PUNCT	-RRB-	O
underwent	undergo	VERB	VBD	O
24	24	NUM	CD	O
-	-	PUNCT	HYPH	O
h	h	DET	DT	O
ambulatory	ambulatory	ADJ	JJ	O
jejunal	jejunal	ADJ	JJ	O
manometry	manometry	NOUN	NN	O
before	before	ADP	IN	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
12	12	NUM	CD	O
week	week	NOUN	NN	O
'	'	PUNCT	''	O
s	s	PUNCT	LS	O
treatment	treatment	NOUN	NN	O
[	[	PUNCT	-LRB-	O
cisapride	cisapride	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
three	three	NUM	CD	O
times	time	NOUN	NNS	O
daily	daily	ADV	RB	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
19	19	NUM	CD	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
19	19	NUM	CD	O
)	)	PUNCT	-RRB-	O
]	]	PUNCT	-RRB-	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
diarrhoea	diarrhoea	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
predominant	predominant	ADJ	JJ	O
patients	patient	NOUN	NNS	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
contraction	contraction	NOUN	NN	O
characteristics	characteristic	NOUN	NNS	O
were	be	VERB	VBD	O
observed	observe	VERB	VBN	O
between	between	ADP	IN	O
the	the	DET	DT	O
cisapride	cisapride	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
cisapride	cisapride	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
diarrhoea	diarrhoea	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
predominant	predominant	ADJ	JJ	O
patients	patient	NOUN	NNS	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
contraction	contraction	NOUN	NN	O
amplitude	amplitude	NOUN	NN	O
was	be	VERB	VBD	O
higher	high	ADJ	JJR	O
(	(	PUNCT	-LRB-	O
29	29	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
versus	versus	ADP	IN	O
24	24	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
,	,	PUNCT	,	O
cisapride	cisapride	NOUN	NN	B-Chemical
versus	versus	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	,	O
pretreatment	pretreatment	NOUN	NN	O
,	,	PUNCT	,	O
25	25	NUM	CD	O
.	.	PUNCT	.	O
7	7	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
mm	mm	PROPN	NNP	O
Hg	Hg	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
contraction	contraction	NOUN	NN	O
duration	duration	NOUN	NN	O
longer	longer	ADV	RBR	O
(	(	PUNCT	-LRB-	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
versus	versus	ADP	IN	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
sec	sec	NOUN	NN	O
,	,	PUNCT	,	O
cisapride	cisapride	NOUN	NN	B-Chemical
versus	versus	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	,	O
pretreatment	pretreatment	NOUN	NN	O
,	,	PUNCT	,	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
sec	sec	NOUN	NN	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
mean	mean	ADJ	JJ	O
contraction	contraction	NOUN	NN	O
frequency	frequency	NOUN	NN	O
lower	lower	ADV	RBR	O
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
2	2	NUM	CD	O
versus	versus	ADP	IN	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
4	4	NUM	CD	O
cont	cont	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
min	min	INTJ	UH	O
,	,	PUNCT	,	O
cisapride	cisapride	NOUN	NN	B-Chemical
versus	versus	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
001	001	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	,	O
pretreatment	pretreatment	NOUN	NN	O
,	,	PUNCT	,	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
cont	cont	NOUN	NN	O
.	.	PUNCT	.	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
]	]	PUNCT	-RRB-	O
than	than	ADP	IN	O
patients	patient	NOUN	NNS	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
placebo	placebo	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
in	in	ADP	IN	O
jejunal	jejunal	ADJ	JJ	O
motility	motility	NOUN	NN	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
constipation	constipation	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
predominant	predominant	ADJ	JJ	O
IBS	IBS	PROPN	NNP	B-Disease
group	group	NOUN	NN	O
.	.	PUNCT	.	O

Symptoms	symptom	NOUN	NNS	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
by	by	ADP	IN	O
using	use	VERB	VBG	O
a	a	DET	DT	O
visual	visual	ADJ	JJ	O
analogue	analogue	NOUN	NN	O
scale	scale	NOUN	NN	O
before	before	ADP	IN	O
and	and	CCONJ	CC	O
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Symptom	symptom	NOUN	NN	O
scores	score	NOUN	NNS	O
relating	relate	VERB	VBG	O
to	to	ADP	IN	O
the	the	DET	DT	O
severity	severity	NOUN	NN	O
of	of	ADP	IN	O
constipation	constipation	NOUN	NN	B-Disease
were	be	VERB	VBD	O
lower	low	ADJ	JJR	O
in	in	ADP	IN	O
cisapride	cisapride	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
treated	treat	VERB	VBN	O
constipation	constipation	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
predominant	predominant	ADJ	JJ	O
IBS	IBS	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
[	[	PUNCT	-LRB-	O
score	score	NOUN	NN	O
,	,	PUNCT	,	O
54	54	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
5	5	NUM	CD	O
versus	versus	ADP	IN	O
67	67	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
14	14	NUM	CD	O
mm	mm	NOUN	NN	O
,	,	PUNCT	,	O
cisapride	cisapride	NOUN	NN	B-Chemical
versus	versus	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	,	O
pretreatment	pretreatment	NOUN	NN	O
,	,	PUNCT	,	O
62	62	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
19	19	NUM	CD	O
mm	mm	NOUN	NN	O
]	]	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Diarrhoea	diarrhoea	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
predominant	predominant	ADJ	JJ	O
IBS	IBS	PROPN	NNP	B-Disease
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
a	a	DET	DT	O
higher	high	ADJ	JJR	O
pain	pain	NOUN	NN	B-Disease
score	score	NOUN	NN	O
after	after	ADP	IN	O
cisapride	cisapride	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
[	[	PUNCT	-LRB-	O
score	score	NOUN	NN	O
,	,	PUNCT	,	O
55	55	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
15	15	NUM	CD	O
versus	versus	ADP	IN	O
34	34	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
12	12	NUM	CD	O
mm	mm	NOUN	NN	O
,	,	PUNCT	,	O
cisapride	cisapride	NOUN	NN	B-Chemical
versus	versus	ADP	IN	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
05	05	NUM	CD	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	,	O
pretreatment	pretreatment	NOUN	NN	O
,	,	PUNCT	,	O
67	67	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
19	19	NUM	CD	O
mm	mm	NOUN	NN	O
]	]	PUNCT	-RRB-	O
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Cisapride	cisapride	NOUN	NN	B-Chemical
affects	affect	VERB	VBZ	O
jejunal	jejunal	ADJ	JJ	O
contraction	contraction	NOUN	NN	O
characteristics	characteristic	NOUN	NNS	O
and	and	CCONJ	CC	O
some	some	DET	DT	O
symptoms	symptom	NOUN	NNS	O
in	in	ADP	IN	O
IBS	IBS	PROPN	NNP	B-Disease
.	.	PUNCT	.	O

Prevention	prevention	NOUN	NN	O
of	of	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
with	with	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
preliminary	preliminary	ADJ	JJ	O
findings	finding	NOUN	NNS	O
from	from	ADP	IN	O
the	the	DET	DT	O
Italian	Italian	PROPN	NNP	O
randomised	randomise	VERB	VBN	O
trial	trial	NOUN	NN	O
among	among	ADP	IN	O
hysterectomised	hysterectomise	VERB	VBN	O
women	woman	NOUN	NNS	O
.	.	PUNCT	.	O

Italian	italian	ADJ	JJ	O
Tamoxifen	Tamoxifen	PROPN	NNP	B-Chemical
Prevention	Prevention	PROPN	NNP	O
Study	Study	PROPN	NNP	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Tamoxifen	tamoxifen	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
candidate	candidate	ADJ	JJ	O
chemopreventive	chemopreventive	ADJ	JJ	O
agent	agent	NOUN	NN	O
in	in	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
,	,	PUNCT	,	O
although	although	ADP	IN	O
the	the	DET	DT	O
drug	drug	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
associated	associate	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
development	development	NOUN	NN	O
of	of	ADP	IN	O
endometrial	endometrial	ADJ	JJ	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Therefore	therefore	ADV	RB	O
we	-PRON-	PRON	PRP	O
did	do	VERB	VBD	O
a	a	DET	DT	O
trial	trial	NOUN	NN	O
in	in	ADP	IN	O
hysterectomised	hysterectomise	VERB	VBN	O
women	woman	NOUN	NNS	O
of	of	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
as	as	ADP	IN	O
a	a	DET	DT	O
chemopreventive	chemopreventive	NOUN	NN	O
.	.	PUNCT	.	O

METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
In	in	ADP	IN	O
October	October	PROPN	NNP	O
,	,	PUNCT	,	O
1992	1992	NUM	CD	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
started	start	VERB	VBD	O
a	a	DET	DT	O
double	double	ADJ	JJ	O
-	-	PUNCT	HYPH	O
blind	blind	ADJ	JJ	O
placebo	placebo	NOUN	NN	O
-	-	PUNCT	HYPH	O
controlled	control	VERB	VBN	O
,	,	PUNCT	,	O
randomised	randomise	VERB	VBN	O
trial	trial	NOUN	NN	O
of	of	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
mainly	mainly	ADV	RB	O
in	in	ADP	IN	O
Italy	Italy	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
who	who	PRON	WP	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
have	have	VERB	VB	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
who	who	PRON	WP	O
had	have	VERB	VBD	O
had	have	VERB	VBN	O
a	a	DET	DT	O
hysterectomy	hysterectomy	NOUN	NN	O
.	.	PUNCT	.	O

Women	woman	NOUN	NNS	O
were	be	VERB	VBD	O
randomised	randomise	VERB	VBN	O
to	to	PART	TO	O
receive	receive	VERB	VB	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
20	20	NUM	CD	O
mg	mg	NOUN	NN	O
per	per	ADP	IN	O
day	day	NOUN	NN	O
or	or	CCONJ	CC	O
placebo	placebo	NOUN	NN	O
,	,	PUNCT	,	O
both	both	DET	DT	O
orally	orally	ADV	RB	O
for	for	ADP	IN	O
5	5	NUM	CD	O
years	year	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
original	original	ADJ	JJ	O
plan	plan	NOUN	NN	O
was	be	VERB	VBD	O
to	to	PART	TO	O
follow	follow	VERB	VB	O
the	the	DET	DT	O
intervention	intervention	NOUN	NN	O
phase	phase	NOUN	NN	O
by	by	ADP	IN	O
5	5	NUM	CD	O
years	year	NOUN	NNS	O
'	'	PART	POS	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
June	June	PROPN	NNP	O
,	,	PUNCT	,	O
1997	1997	NUM	CD	O
,	,	PUNCT	,	O
the	the	DET	DT	O
trialists	trialist	NOUN	NNS	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
data	data	NOUN	NN	O
-	-	PUNCT	HYPH	O
monitoring	monitor	VERB	VBG	O
committee	committee	NOUN	NN	O
decided	decide	VERB	VBD	O
to	to	PART	TO	O
end	end	VERB	VB	O
recruitment	recruitment	NOUN	NN	O
primarily	primarily	ADV	RB	O
because	because	ADP	IN	O
of	of	ADP	IN	O
the	the	DET	DT	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
women	woman	NOUN	NNS	O
dropping	drop	VERB	VBG	O
out	out	ADP	IN	O
of	of	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

Recruitment	recruitment	NOUN	NN	O
ended	end	VERB	VBD	O
on	on	ADP	IN	O
July	July	PROPN	NNP	O
11	11	NUM	CD	O
,	,	PUNCT	,	O
1997	1997	NUM	CD	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
the	the	DET	DT	O
study	study	NOUN	NN	O
will	will	VERB	MD	O
continue	continue	VERB	VB	O
as	as	ADP	IN	O
planned	plan	VERB	VBN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
primary	primary	ADJ	JJ	O
endpoints	endpoint	NOUN	NNS	O
are	be	VERB	VBP	O
the	the	DET	DT	O
occurrence	occurrence	NOUN	NN	O
of	of	ADP	IN	O
and	and	CCONJ	CC	O
deaths	death	NOUN	NNS	O
from	from	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

This	this	DET	DT	O
preliminary	preliminary	ADJ	JJ	O
interim	interim	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
is	be	VERB	VBZ	O
based	base	VERB	VBN	O
on	on	ADP	IN	O
intention	intention	NOUN	NN	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
treat	treat	NOUN	NN	O
.	.	PUNCT	.	O

FINDINGS	finding	NOUN	NNS	O
:	:	PUNCT	:	O
5408	5408	NUM	CD	O
women	woman	NOUN	NNS	O
were	be	VERB	VBD	O
randomised	randomise	VERB	VBN	O
;	;	PUNCT	:	O
participating	participate	VERB	VBG	O
women	woman	NOUN	NNS	O
have	have	VERB	VBP	O
a	a	DET	DT	O
median	median	ADJ	JJ	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
of	of	ADP	IN	O
46	46	NUM	CD	O
months	month	NOUN	NNS	O
for	for	ADP	IN	O
major	major	ADJ	JJ	O
endpoints	endpoint	NOUN	NNS	O
.	.	PUNCT	.	O

41	41	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
occurred	occur	VERB	VBD	O
so	so	ADV	RB	O
far	far	ADV	RB	O
;	;	PUNCT	:	O
there	there	ADV	EX	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
no	no	DET	DT	O
deaths	death	NOUN	NNS	O
from	from	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
.	.	PUNCT	.	O

There	there	ADV	EX	O
is	be	VERB	VBZ	O
no	no	DET	DT	O
difference	difference	NOUN	NN	O
in	in	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	I-Disease
cancer	cancer	NOUN	NN	I-Disease
frequency	frequency	NOUN	NN	O
between	between	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
(	(	PUNCT	-LRB-	O
22	22	NUM	CD	O
cases	case	NOUN	NNS	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
19	19	NUM	CD	O
)	)	PUNCT	-RRB-	O
arms	arm	NOUN	NNS	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
is	be	VERB	VBZ	O
a	a	DET	DT	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
reduction	reduction	NOUN	NN	O
of	of	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
among	among	ADP	IN	O
women	woman	NOUN	NNS	O
receiving	receive	VERB	VBG	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
who	who	PRON	WP	O
also	also	ADV	RB	O
used	use	VERB	VBD	O
hormone	hormone	NOUN	NN	O
-	-	PUNCT	HYPH	O
replacement	replacement	NOUN	NN	O
therapy	therapy	NOUN	NN	O
during	during	ADP	IN	O
the	the	DET	DT	O
trial	trial	NOUN	NN	O
:	:	PUNCT	:	O
among	among	ADP	IN	O
390	390	NUM	CD	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
such	such	ADJ	JJ	O
therapy	therapy	NOUN	NN	O
and	and	CCONJ	CC	O
allocated	allocate	VERB	VBN	O
to	to	ADP	IN	O
placebo	placebo	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
found	find	VERB	VBD	O
eight	eight	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
compared	compare	VERB	VBN	O
with	with	ADP	IN	O
one	one	NUM	CD	O
case	case	NOUN	NN	O
among	among	ADP	IN	O
362	362	NUM	CD	O
women	woman	NOUN	NNS	O
allocated	allocate	VERB	VBN	O
to	to	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Compared	compare	VERB	VBN	O
with	with	ADP	IN	O
the	the	DET	DT	O
placebo	placebo	NOUN	NN	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
there	there	ADV	EX	O
was	be	VERB	VBD	O
a	a	DET	DT	O
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBN	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
vascular	vascular	ADJ	JJ	B-Disease
events	event	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
hypertriglyceridaemia	hypertriglyceridaemia	NOUN	NN	B-Disease
among	among	ADP	IN	O
women	woman	NOUN	NNS	O
on	on	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

INTERPRETATION	interpretation	NOUN	NN	O
:	:	PUNCT	:	O
Although	although	ADP	IN	O
this	this	DET	DT	O
preliminary	preliminary	ADJ	JJ	O
analysis	analysis	NOUN	NN	O
has	have	VERB	VBZ	O
low	low	ADJ	JJ	O
power	power	NOUN	NN	O
,	,	PUNCT	,	O
in	in	ADP	IN	O
this	this	DET	DT	O
cohort	cohort	NOUN	NN	O
of	of	ADP	IN	O
women	woman	NOUN	NNS	O
at	at	ADP	IN	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
normal	normal	ADJ	JJ	O
risk	risk	NOUN	NN	O
of	of	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
,	,	PUNCT	,	O
the	the	DET	DT	O
postulated	postulated	ADJ	JJ	O
protective	protective	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
are	be	VERB	VBP	O
not	not	ADV	RB	O
yet	yet	ADV	RB	O
apparent	apparent	ADJ	JJ	O
.	.	PUNCT	.	O

Women	woman	NOUN	NNS	O
using	use	VERB	VBG	O
hormone	hormone	NOUN	NN	O
-	-	PUNCT	HYPH	O
replacement	replacement	NOUN	NN	O
therapy	therapy	NOUN	NN	O
appear	appear	VERB	VBP	O
to	to	PART	TO	O
have	have	VERB	VB	O
benefited	benefit	VERB	VBN	O
from	from	ADP	IN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
no	no	DET	DT	O
deaths	death	NOUN	NNS	O
from	from	ADP	IN	O
breast	breast	NOUN	NN	B-Disease
cancer	cancer	NOUN	NN	I-Disease
recorded	record	VERB	VBN	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
in	in	ADP	IN	O
the	the	DET	DT	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

It	-PRON-	PRON	PRP	O
is	be	VERB	VBZ	O
essential	essential	ADJ	JJ	O
to	to	PART	TO	O
continue	continue	VERB	VB	O
follow	follow	VERB	VB	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
to	to	PART	TO	O
quantify	quantify	VERB	VB	O
the	the	DET	DT	O
long	long	ADJ	JJ	O
-	-	PUNCT	HYPH	O
term	term	NOUN	NN	O
risks	risk	NOUN	NNS	O
and	and	CCONJ	CC	O
benefits	benefit	NOUN	NNS	O
of	of	ADP	IN	O
tamoxifen	tamoxifen	NOUN	NN	B-Chemical
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

Epileptogenic	epileptogenic	ADJ	JJ	O
activity	activity	NOUN	NN	O
of	of	ADP	IN	O
folic	folic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
after	after	ADP	IN	O
drug	drug	NOUN	NN	O
induces	induce	NOUN	NNS	O
SLE	SLE	PROPN	NNP	B-Disease
(	(	PUNCT	-LRB-	O
folic	folic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
and	and	CCONJ	CC	O
epilepsy	epilepsy	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
study	study	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
folic	folic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
multivitamin	multivitamin	NOUN	NN	O
supplementation	supplementation	NOUN	NN	O
in	in	ADP	IN	O
epileptic	epileptic	ADJ	JJ	B-Disease
women	woman	NOUN	NNS	O
before	before	ADV	RB	O
and	and	CCONJ	CC	O
during	during	ADP	IN	O
pregnancy	pregnancy	NOUN	NN	O
in	in	ADP	IN	O
order	order	NOUN	NN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
rate	rate	NOUN	NN	O
of	of	ADP	IN	O
structural	structural	ADJ	JJ	O
birth	birth	NOUN	NN	B-Disease
defects	defect	NOUN	NNS	I-Disease
and	and	CCONJ	CC	O
epilepsy	epilepsy	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
.	.	PUNCT	.	O

STUDY	STUDY	PROPN	NNP	O
DESIGN	DESIGN	PROPN	NNP	O
:	:	PUNCT	:	O
First	first	ADV	RB	O
a	a	DET	DT	O
randomised	randomise	VERB	VBN	O
trial	trial	NOUN	NN	O
,	,	PUNCT	,	O
later	later	ADV	RB	O
periconception	periconception	NOUN	NN	O
care	care	NOUN	NN	O
including	include	VERB	VBG	O
in	in	ADP	IN	O
total	total	ADJ	JJ	O
12225	12225	NUM	CD	O
females	female	NOUN	NNS	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Of	of	ADP	IN	O
60	60	NUM	CD	O
epileptic	epileptic	ADJ	JJ	B-Disease
women	woman	NOUN	NNS	O
with	with	ADP	IN	O
periconceptional	periconceptional	ADJ	JJ	O
folic	folic	NOUN	NN	B-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
multivitamin	multivitamin	NOUN	NN	O
supplementation	supplementation	NOUN	NN	O
,	,	PUNCT	,	O
no	no	DET	DT	O
one	one	NOUN	NN	O
developed	develop	VERB	VBD	O
epilepsy	epilepsy	NOUN	NN	B-Disease
-	-	PUNCT	HYPH	O
related	relate	VERB	VBN	O
side	side	NOUN	NN	O
effects	effect	NOUN	NNS	O
during	during	ADP	IN	O
the	the	DET	DT	O
periconception	periconception	NOUN	NN	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

One	one	NUM	CD	O
epileptic	epileptic	ADJ	JJ	B-Disease
woman	woman	NOUN	NN	O
delivered	deliver	VERB	VBD	O
a	a	DET	DT	O
newborn	newborn	NOUN	NN	O
with	with	ADP	IN	O
cleft	cleft	ADJ	JJ	B-Disease
lip	lip	NOUN	NN	I-Disease
and	and	CCONJ	CC	I-Disease
palate	palate	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Another	another	DET	DT	O
patient	patient	NOUN	NN	O
exhibited	exhibit	VERB	VBN	O
with	with	ADP	IN	O
a	a	DET	DT	O
cluster	cluster	NOUN	NN	O
of	of	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
after	after	ADP	IN	O
the	the	DET	DT	O
periconception	periconception	NOUN	NN	O
period	period	NOUN	NN	O
using	use	VERB	VBG	O
another	another	DET	DT	O
multivitamin	multivitamin	NOUN	NN	O
.	.	PUNCT	.	O

This	this	DET	DT	O
22	22	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
-	-	PUNCT	HYPH	O
old	old	ADJ	JJ	O
epileptic	epileptic	ADJ	JJ	B-Disease
woman	woman	NOUN	NN	O
was	be	VERB	VBD	O
treated	treat	VERB	VBN	O
continuously	continuously	ADV	RB	O
by	by	ADP	IN	O
carbamazepine	carbamazepine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
a	a	DET	DT	O
folic	folic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
-	-	PUNCT	HYPH	O
containing	contain	VERB	VBG	O
multivitamin	multivitamin	NOUN	NN	O
from	from	ADP	IN	O
the	the	DET	DT	O
20th	20th	ADJ	JJ	O
week	week	NOUN	NN	O
of	of	ADP	IN	O
gestation	gestation	NOUN	NN	O
.	.	PUNCT	.	O

She	-PRON-	PRON	PRP	O
developed	develop	VERB	VBD	O
status	status	NOUN	NN	B-Disease
epilepticus	epilepticus	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
later	later	ADJ	JJ	O
symptoms	symptom	NOUN	NNS	O
of	of	ADP	IN	O
systemic	systemic	ADJ	JJ	B-Disease
lupus	lupus	NOUN	NN	I-Disease
erythematodes	erythematode	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Her	-PRON-	DET	PRP$	O
pregnancy	pregnancy	NOUN	NN	O
ended	end	VERB	VBD	O
with	with	ADP	IN	O
stillbirth	stillbirth	NOUN	NN	B-Disease
.	.	PUNCT	.	O

CONCLUSIONS	conclusion	NOUN	NNS	O
:	:	PUNCT	:	O
The	the	DET	DT	O
epileptic	epileptic	ADJ	JJ	B-Disease
pregnant	pregnant	ADJ	JJ	O
patient	patient	NOUN	NN	O
'	'	PUNCT	''	O
s	s	PART	POS	O
autoimmune	autoimmune	NOUN	NN	B-Disease
disease	disease	NOUN	NN	I-Disease
(	(	PUNCT	-LRB-	O
probably	probably	ADV	RB	O
drug	drug	NOUN	NN	O
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
lupus	lupus	NOUN	NN	B-Disease
)	)	PUNCT	-RRB-	O
could	could	VERB	MD	O
damage	damage	VERB	VB	O
the	the	DET	DT	O
blood	blood	NOUN	NN	O
-	-	PUNCT	HYPH	O
brain	brain	NOUN	NN	O
barrier	barrier	NOUN	NN	O
,	,	PUNCT	,	O
therefore	therefore	ADV	RB	O
the	the	DET	DT	O
therapeutic	therapeutic	ADJ	JJ	O
dose	dose	NOUN	NN	O
(	(	PUNCT	-LRB-	O
>	>	X	XX	O
or	or	CCONJ	CC	O
=	=	NOUN	NNS	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
folic	folic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
triggered	trigger	VERB	VBD	O
a	a	DET	DT	O
cluster	cluster	NOUN	NN	O
of	of	ADP	IN	O
seizures	seizure	NOUN	NNS	B-Disease
.	.	PUNCT	.	O

Physiological	physiological	ADJ	JJ	O
dose	dose	NOUN	NN	O
(	(	PUNCT	-LRB-	O
<	<	X	XX	O
1	1	NUM	CD	O
mg	mg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
folic	folic	ADJ	JJ	B-Chemical
acid	acid	NOUN	NN	I-Chemical
both	both	DET	DT	O
in	in	ADP	IN	O
healthy	healthy	ADJ	JJ	O
and	and	CCONJ	CC	O
60	60	NUM	CD	O
epileptic	epileptic	ADJ	JJ	B-Disease
women	woman	NOUN	NNS	O
,	,	PUNCT	,	O
all	all	ADV	RB	O
without	without	ADP	IN	O
any	any	DET	DT	O
autoimmune	autoimmune	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
increase	increase	VERB	VB	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
epileptic	epileptic	ADJ	JJ	B-Disease
seizures	seizure	NOUN	NNS	I-Disease
.	.	PUNCT	.	O

Stroke	stroke	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
cocaine	cocaine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
association	association	NOUN	NN	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
use	use	NOUN	NN	O
with	with	ADP	IN	O
hemorrhagic	hemorrhagic	ADJ	JJ	O
and	and	CCONJ	CC	O
ischemic	ischemic	ADJ	JJ	B-Disease
stroke	stroke	NOUN	NN	B-Disease
is	be	VERB	VBZ	O
based	base	VERB	VBN	O
almost	almost	ADV	RB	O
solely	solely	ADV	RB	O
on	on	ADP	IN	O
data	datum	NOUN	NNS	O
from	from	ADP	IN	O
case	case	NOUN	NN	O
series	series	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
limited	limited	ADJ	JJ	O
number	number	NOUN	NN	O
of	of	ADP	IN	O
epidemiologic	epidemiologic	ADJ	JJ	O
studies	study	NOUN	NNS	O
of	of	ADP	IN	O
stroke	stroke	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
have	have	VERB	VBP	O
been	be	VERB	VBN	O
done	do	VERB	VBN	O
in	in	ADP	IN	O
settings	setting	NOUN	NNS	O
that	that	DET	WDT	O
serve	serve	VERB	VBP	O
mostly	mostly	ADV	RB	O
the	the	DET	DT	O
poor	poor	ADJ	JJ	O
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
minorities	minority	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
case	case	NOUN	NN	O
-	-	PUNCT	HYPH	O
control	control	NOUN	NN	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
conducted	conduct	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
defined	define	VERB	VBN	O
population	population	NOUN	NN	O
comprising	comprise	VERB	VBG	O
members	member	NOUN	NNS	O
of	of	ADP	IN	O
Kaiser	Kaiser	PROPN	NNP	O
Permanente	Permanente	PROPN	NNP	O
of	of	ADP	IN	O
Northern	Northern	PROPN	NNP	O
and	and	CCONJ	CC	O
Southern	Southern	PROPN	NNP	O
California	California	PROPN	NNP	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
attempted	attempt	VERB	VBD	O
to	to	PART	TO	O
identify	identify	VERB	VB	O
all	all	DET	DT	O
incident	incident	NOUN	NN	O
strokes	stroke	NOUN	NNS	B-Disease
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
ages	age	VERB	VBZ	O
15	15	NUM	CD	O
-	-	SYM	SYM	O
44	44	NUM	CD	O
years	year	NOUN	NNS	O
during	during	ADP	IN	O
a	a	DET	DT	O
3	3	NUM	CD	O
-	-	PUNCT	HYPH	O
year	year	NOUN	NN	O
period	period	NOUN	NN	O
using	use	VERB	VBG	O
hospital	hospital	NOUN	NN	O
admission	admission	NOUN	NN	O
and	and	CCONJ	CC	O
discharge	discharge	NOUN	NN	O
records	record	NOUN	NNS	O
,	,	PUNCT	,	O
emergency	emergency	NOUN	NN	O
department	department	NOUN	NN	O
logs	log	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
payment	payment	NOUN	NN	O
requests	request	NOUN	NNS	O
for	for	ADP	IN	O
out	out	ADV	RB	O
-	-	PUNCT	HYPH	O
of	of	ADP	IN	O
-	-	PUNCT	HYPH	O
plan	plan	NOUN	NN	O
hospitalizations	hospitalization	NOUN	NNS	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
selected	select	VERB	VBD	O
controls	control	NOUN	NNS	O
,	,	PUNCT	,	O
matched	match	VERB	VBN	O
on	on	ADP	IN	O
age	age	NOUN	NN	O
and	and	CCONJ	CC	O
facility	facility	NOUN	NN	O
of	of	ADP	IN	O
usual	usual	ADJ	JJ	O
care	care	NOUN	NN	O
,	,	PUNCT	,	O
at	at	ADP	IN	O
random	random	ADJ	JJ	O
from	from	ADP	IN	O
healthy	healthy	ADJ	JJ	O
members	member	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
health	health	NOUN	NN	O
plan	plan	NOUN	NN	O
.	.	PUNCT	.	O

We	-PRON-	PRON	PRP	O
obtained	obtain	VERB	VBD	O
information	information	NOUN	NN	O
in	in	ADP	IN	O
face	face	NOUN	NN	O
-	-	PUNCT	HYPH	O
to	to	ADP	IN	O
-	-	PUNCT	HYPH	O
face	face	NOUN	NN	O
interviews	interview	NOUN	NNS	O
.	.	PUNCT	.	O

There	there	ADV	EX	O
were	be	VERB	VBD	O
347	347	NUM	CD	O
confirmed	confirm	VERB	VBN	O
stroke	stroke	NOUN	NN	B-Disease
cases	case	NOUN	NNS	O
and	and	CCONJ	CC	O
1	1	NUM	CD	O
,	,	PUNCT	,	O
021	021	NUM	CD	O
controls	control	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
univariate	univariate	ADJ	JJ	O
matched	match	VERB	VBN	O
odds	odd	NOUN	NNS	O
ratio	ratio	NOUN	NN	O
for	for	ADP	IN	O
stroke	stroke	NOUN	NN	B-Disease
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
who	who	PRON	WP	O
admitted	admit	VERB	VBD	O
to	to	ADP	IN	O
using	use	VERB	VBG	O
cocaine	cocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
8	8	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
=	=	SYM	SYM	O
3	3	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
-	-	SYM	SYM	O
20	20	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

After	after	ADP	IN	O
further	further	ADJ	JJ	O
adjustment	adjustment	NOUN	NN	O
for	for	ADP	IN	O
potential	potential	ADJ	JJ	O
confounders	confounder	NOUN	NNS	O
,	,	PUNCT	,	O
the	the	DET	DT	O
odds	odd	NOUN	NNS	O
ratio	ratio	NOUN	NN	O
in	in	ADP	IN	O
women	woman	NOUN	NNS	O
who	who	PRON	WP	O
reported	report	VERB	VBD	O
using	use	VERB	VBG	O
cocaine	cocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
7	7	NUM	CD	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
(	(	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
confidence	confidence	NOUN	NN	O
interval	interval	NOUN	NN	O
=	=	SYM	SYM	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
-	-	SYM	SYM	O
17	17	NUM	CD	O
.	.	PUNCT	.	O
9	9	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
cocaine	cocaine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
amphetamine	amphetamine	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
a	a	DET	DT	O
strong	strong	ADJ	JJ	O
risk	risk	NOUN	NN	O
factor	factor	NOUN	NN	O
for	for	ADP	IN	O
stroke	stroke	NOUN	NN	B-Disease
in	in	ADP	IN	O
this	this	DET	DT	O
socioeconomically	socioeconomically	ADV	RB	O
heterogeneous	heterogeneous	ADJ	JJ	O
,	,	PUNCT	,	O
insured	insure	VERB	VBN	O
urban	urban	ADJ	JJ	O
population	population	NOUN	NN	O
.	.	PUNCT	.	O

Acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
subsequent	subsequent	ADJ	JJ	O
to	to	ADP	IN	O
the	the	DET	DT	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
rifampicin	rifampicin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

A	a	DET	DT	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
study	study	NOUN	NN	O
of	of	ADP	IN	O
cases	case	NOUN	NNS	O
reported	report	VERB	VBN	O
earlier	earlier	ADV	RBR	O
.	.	PUNCT	.	O

A	a	DET	DT	O
clinical	clinical	ADJ	JJ	O
presentation	presentation	NOUN	NN	O
is	be	VERB	VBZ	O
made	make	VERB	VBN	O
of	of	ADP	IN	O
a	a	DET	DT	O
2	2	NUM	CD	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
year	year	NOUN	NN	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	NOUN	NN	O
of	of	ADP	IN	O
six	six	NUM	CD	O
cases	case	NOUN	NNS	O
of	of	ADP	IN	O
acute	acute	ADJ	JJ	B-Disease
renal	renal	ADJ	JJ	I-Disease
failure	failure	NOUN	NN	I-Disease
that	that	DET	WDT	O
have	have	VERB	VBP	O
been	be	VERB	VBN	O
reported	report	VERB	VBN	O
earlier	earlier	ADV	RBR	O
.	.	PUNCT	.	O

The	the	DET	DT	O
patients	patient	NOUN	NNS	O
had	have	VERB	VBD	O
developed	develop	VERB	VBN	O
transient	transient	ADJ	JJ	O
renal	renal	ADJ	JJ	B-Disease
failure	failure	NOUN	NN	I-Disease
after	after	ADP	IN	O
the	the	DET	DT	O
intermittent	intermittent	ADJ	JJ	O
administration	administration	NOUN	NN	O
of	of	ADP	IN	O
rifampicin	rifampicin	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

The	the	DET	DT	O
stage	stage	NOUN	NN	O
of	of	ADP	IN	O
olig	olig	ADJ	JJ	O
-	-	PUNCT	HYPH	O
anuria	anuria	NOUN	NN	B-Disease
lasted	last	VERB	VBD	O
for	for	ADP	IN	O
1	1	NUM	CD	O
-	-	SYM	SYM	O
3	3	NUM	CD	O
weeks	week	NOUN	NNS	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
five	five	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
treated	treat	VERB	VBN	O
by	by	ADP	IN	O
hemodialysis	hemodialysis	NOUN	NN	O
.	.	PUNCT	.	O

Two	two	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
died	die	VERB	VBD	O
due	due	ADP	IN	O
to	to	ADP	IN	O
unrelated	unrelated	ADJ	JJ	O
causes	cause	NOUN	NNS	O
during	during	ADP	IN	O
the	the	DET	DT	O
follow	follow	NOUN	NN	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
period	period	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
four	four	NUM	CD	O
patients	patient	NOUN	NNS	O
re	re	VERB	VBD	O
-	-	ADJ	JJ	O
examined	examine	VERB	VBN	O
were	be	VERB	VBD	O
clinically	clinically	ADV	RB	O
cured	cure	VERB	VBN	O
.	.	PUNCT	.	O

Pathologic	pathologic	NOUN	NN	O
findings	finding	NOUN	NNS	O
by	by	ADP	IN	O
light	light	ADJ	JJ	O
microscopy	microscopy	NOUN	NN	O
and	and	CCONJ	CC	O
immunofluorescence	immunofluorescence	NOUN	NN	O
at	at	ADP	IN	O
biopsy	biopsy	NOUN	NN	O
were	be	VERB	VBD	O
scarce	scarce	ADJ	JJ	O
.	.	PUNCT	.	O

Nothing	Nothing	NOUN	NN	O
abnormal	abnormal	ADJ	JJ	O
was	be	VERB	VBD	O
seen	see	VERB	VBN	O
by	by	ADP	IN	O
electron	electron	NOUN	NN	O
microscopy	microscopy	NOUN	NN	O
in	in	ADP	IN	O
two	two	NUM	CD	O
of	of	ADP	IN	O
the	the	DET	DT	O
cases	case	NOUN	NNS	O
studied	study	VERB	VBD	O
.	.	PUNCT	.	O

Renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
was	be	VERB	VBD	O
normal	normal	ADJ	JJ	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
three	three	NUM	CD	O
cases	case	NOUN	NNS	O
the	the	DET	DT	O
excretion	excretion	NOUN	NN	O
at	at	ADP	IN	O
131I	131i	NUM	CD	O
-	-	PUNCT	HYPH	O
hippuran	hippuran	NOUN	NN	O
renography	renography	NOUN	NN	O
was	be	VERB	VBD	O
slightly	slightly	ADV	RB	O
slowed	slow	VERB	VBN	O
.	.	PUNCT	.	O

Although	although	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
acute	acute	ADJ	JJ	O
stage	stage	NOUN	NN	O
the	the	DET	DT	O
renal	renal	ADJ	JJ	B-Disease
lesions	lesion	NOUN	NNS	I-Disease
histologically	histologically	ADV	RB	O
appeared	appear	VERB	VBD	O
toxic	toxic	ADJ	JJ	O
,	,	PUNCT	,	O
evidence	evidence	NOUN	NN	O
suggestive	suggestive	ADJ	JJ	O
of	of	ADP	IN	O
an	an	DET	DT	O
immunological	immunological	ADJ	JJ	O
mechanism	mechanism	NOUN	NN	O
cannot	cannot	NOUN	NN	O
be	be	VERB	VB	O
excluded	exclude	VERB	VBN	O
.	.	PUNCT	.	O

Chronic	chronic	ADJ	JJ	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
a	a	DET	DT	O
novel	novel	ADJ	JJ	O
synthetic	synthetic	ADJ	JJ	O
anthracycline	anthracycline	ADJ	JJ	B-Chemical
derivative	derivative	NOUN	NN	O
(	(	PUNCT	-LRB-	O
SM	SM	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
5887	5887	NUM	CD	I-Chemical
)	)	PUNCT	-RRB-	O
on	on	ADP	IN	O
normal	normal	ADJ	JJ	O
heart	heart	NOUN	NN	O
and	and	CCONJ	CC	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
in	in	ADP	IN	O
beagle	beagle	NOUN	NN	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

This	this	DET	DT	O
study	study	NOUN	NN	O
was	be	VERB	VBD	O
designed	design	VERB	VBN	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
the	the	DET	DT	O
chronic	chronic	ADJ	JJ	O
cardiotoxic	cardiotoxic	ADJ	JJ	B-Disease
potential	potential	NOUN	NN	O
of	of	ADP	IN	O
SM	SM	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
5887	5887	NUM	CD	I-Chemical
and	and	CCONJ	CC	O
a	a	DET	DT	O
possible	possible	ADJ	JJ	O
deteriorating	deteriorate	VERB	VBG	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
SM	sm	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
5887	5887	NUM	CD	I-Chemical
on	on	ADP	IN	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
grade	grade	NOUN	NN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
induced	induced	ADJ	JJ	O
by	by	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
in	in	ADP	IN	O
beagle	beagle	NOUN	NN	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
chronic	chronic	ADJ	JJ	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
beagle	beagle	VERB	VB	O
dogs	dog	NOUN	NNS	O
of	of	ADP	IN	O
each	each	DET	DT	O
sex	sex	NOUN	NN	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
intravenously	intravenously	ADV	RB	O
once	once	ADV	RB	O
every	every	DET	DT	O
3	3	NUM	CD	O
weeks	week	NOUN	NNS	O
,	,	PUNCT	,	O
either	either	CCONJ	CC	O
a	a	DET	DT	O
sublethal	sublethal	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
SM	sm	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
5887	5887	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
experiment	experiment	NOUN	NN	O
was	be	VERB	VBD	O
terminated	terminate	VERB	VBN	O
3	3	NUM	CD	O
weeks	week	NOUN	NNS	O
after	after	ADP	IN	O
the	the	DET	DT	O
ninth	ninth	ADJ	JJ	O
dosing	dosing	NOUN	NN	O
.	.	PUNCT	.	O

Animals	animal	NOUN	NNS	O
which	which	DET	WDT	O
received	receive	VERB	VBD	O
over	over	ADP	IN	O
six	six	NUM	CD	O
courses	course	NOUN	NNS	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
demonstrated	demonstrate	VERB	VBD	O
the	the	DET	DT	O
electrocardiogram	electrocardiogram	NOUN	NN	O
(	(	PUNCT	-LRB-	O
ECG	ECG	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
changes	change	NOUN	NNS	O
,	,	PUNCT	,	O
decrease	decrease	NOUN	NN	O
of	of	ADP	IN	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
high	high	ADJ	JJ	O
-	-	PUNCT	HYPH	O
grade	grade	NOUN	NN	O
histopathological	histopathological	ADJ	JJ	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
while	while	ADP	IN	O
animals	animal	NOUN	NNS	O
which	which	DET	WDT	O
were	be	VERB	VBD	O
terminally	terminally	ADV	RB	O
sacrificed	sacrifice	VERB	VBN	O
after	after	ADP	IN	O
the	the	DET	DT	O
SM	SM	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
5887	5887	NUM	CD	I-Chemical
administration	administration	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
show	show	VERB	VB	O
any	any	DET	DT	O
changes	change	NOUN	NNS	O
in	in	ADP	IN	O
ECG	ECG	PROPN	NNP	O
,	,	PUNCT	,	O
blood	blood	NOUN	NN	O
pressure	pressure	NOUN	NN	O
and	and	CCONJ	CC	O
histopathological	histopathological	ADJ	JJ	O
examinations	examination	NOUN	NNS	O
.	.	PUNCT	.	O

To	to	PART	TO	O
examine	examine	VERB	VB	O
a	a	DET	DT	O
possibly	possibly	ADV	RB	O
deteriorating	deteriorate	VERB	VBG	O
cardiotoxic	cardiotoxic	ADJ	JJ	B-Disease
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
SM	sm	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
5887	5887	NUM	CD	I-Chemical
,	,	PUNCT	,	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
grade	grade	NOUN	NN	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
was	be	VERB	VBD	O
induced	induce	VERB	VBN	O
in	in	ADP	IN	O
dogs	dog	NOUN	NNS	O
by	by	ADP	IN	O
four	four	NUM	CD	O
courses	course	NOUN	NNS	O
of	of	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Nine	nine	NUM	CD	O
weeks	week	NOUN	NNS	O
after	after	ADP	IN	O
pre	pre	ADJ	JJ	O
-	-	ADJ	JJ	O
treatment	treatment	ADJ	JJ	O
,	,	PUNCT	,	O
dogs	dog	NOUN	NNS	O
were	be	VERB	VBD	O
given	give	VERB	VBN	O
four	four	NUM	CD	O
courses	course	NOUN	NNS	O
of	of	ADP	IN	O
either	either	DET	DT	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
or	or	CCONJ	CC	O
SM	sm	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
5887	5887	NUM	CD	I-Chemical
(	(	PUNCT	-LRB-	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
5	5	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
)	)	PUNCT	-RRB-	O
once	once	ADV	RB	O
every	every	DET	DT	O
3	3	NUM	CD	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

The	the	DET	DT	O
low	low	ADJ	JJ	O
-	-	PUNCT	HYPH	O
grade	grade	NOUN	NN	O
cardiotoxic	cardiotoxic	NOUN	NN	B-Disease
changes	change	NOUN	NNS	O
were	be	VERB	VBD	O
enhanced	enhance	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
additional	additional	ADJ	JJ	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

On	on	ADP	IN	O
the	the	DET	DT	O
contrary	contrary	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
SM	SM	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
5887	5887	NUM	CD	I-Chemical
treatment	treatment	NOUN	NN	O
did	do	VERB	VBD	O
not	not	ADV	RB	O
progress	progress	VERB	VB	O
the	the	DET	DT	O
grade	grade	NOUN	NN	O
of	of	ADP	IN	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
conclusion	conclusion	NOUN	NN	O
,	,	PUNCT	,	O
SM	SM	PROPN	NNP	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
5887	5887	PROPN	NNP	I-Chemical
does	do	VERB	VBZ	O
not	not	ADV	RB	O
have	have	VERB	VB	O
any	any	DET	DT	O
potential	potential	NOUN	NN	O
of	of	ADP	IN	O
chronic	chronic	ADJ	JJ	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
and	and	CCONJ	CC	O
deteriorating	deteriorate	VERB	VBG	O
effect	effect	NOUN	NN	O
on	on	ADP	IN	O
doxorubicin	doxorubicin	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
induced	induce	VERB	VBN	O
cardiotoxicity	cardiotoxicity	NOUN	NN	B-Disease
in	in	ADP	IN	O
dogs	dog	NOUN	NNS	O
.	.	PUNCT	.	O

Risk	risk	NOUN	NN	O
for	for	ADP	IN	O
valvular	valvular	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
among	among	ADP	IN	O
users	user	NOUN	NNS	O
of	of	ADP	IN	O
fenfluramine	fenfluramine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
dexfenfluramine	dexfenfluramine	NOUN	NN	B-Chemical
who	who	PRON	WP	O
underwent	undergo	VERB	VBD	O
echocardiography	echocardiography	NOUN	NN	O
before	before	ADP	IN	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
medication	medication	NOUN	NN	O
.	.	PUNCT	.	O

BACKGROUND	BACKGROUND	NOUN	NNS	O
:	:	PUNCT	:	O
Because	because	ADP	IN	O
uncontrolled	uncontrolled	ADJ	JJ	O
echocardiographic	echocardiographic	ADJ	JJ	O
surveys	survey	NOUN	NNS	O
suggested	suggest	VERB	VBD	O
that	that	ADP	IN	O
up	up	ADP	IN	O
to	to	PART	TO	O
30	30	NUM	CD	O
%	%	NOUN	NN	O
to	to	ADP	IN	O
38	38	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
users	user	NOUN	NNS	O
of	of	ADP	IN	O
fenfluramine	fenfluramine	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
dexfenfluramine	dexfenfluramine	NOUN	NN	B-Chemical
had	have	VERB	VBD	O
valvular	valvular	ADJ	JJ	B-Disease
disease	disease	NOUN	NN	I-Disease
,	,	PUNCT	,	O
these	these	DET	DT	O
drugs	drug	NOUN	NNS	O
were	be	VERB	VBD	O
withdrawn	withdraw	VERB	VBN	O
from	from	ADP	IN	O
the	the	DET	DT	O
market	market	NOUN	NN	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
new	new	ADJ	JJ	O
or	or	CCONJ	CC	O
worsening	worsen	VERB	VBG	O
valvular	valvular	ADJ	JJ	B-Disease
abnormalities	abnormality	NOUN	NNS	I-Disease
among	among	ADP	IN	O
users	user	NOUN	NNS	O
of	of	ADP	IN	O
fenfluramine	fenfluramine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
dexfenfluramine	dexfenfluramine	NOUN	NN	B-Chemical
who	who	PRON	WP	O
underwent	undergo	VERB	VBD	O
echocardiography	echocardiography	NOUN	NN	O
before	before	ADP	IN	O
they	-PRON-	PRON	PRP	O
began	begin	VERB	VBD	O
to	to	PART	TO	O
take	take	VERB	VB	O
these	these	DET	DT	O
medications	medication	NOUN	NNS	O
.	.	PUNCT	.	O

DESIGN	design	NOUN	NN	O
:	:	PUNCT	:	O
Cohort	cohort	NOUN	NN	O
study	study	NOUN	NN	O
.	.	PUNCT	.	O

SETTING	set	VERB	VBG	O
:	:	PUNCT	:	O
Academic	academic	ADJ	JJ	O
primary	primary	ADJ	JJ	O
care	care	NOUN	NN	O
practices	practice	NOUN	NNS	O
.	.	PUNCT	.	O

PATIENTS	PATIENTS	PROPN	NNP	O
:	:	PUNCT	:	O
46	46	NUM	CD	O
patients	patient	NOUN	NNS	O
who	who	PRON	WP	O
used	use	VERB	VBD	O
fenfluramine	fenfluramine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
dexfenfluramine	dexfenfluramine	NOUN	NN	B-Chemical
for	for	ADP	IN	O
14	14	NUM	CD	O
days	day	NOUN	NNS	O
or	or	CCONJ	CC	O
more	more	ADJ	JJR	O
and	and	CCONJ	CC	O
had	have	VERB	VBD	O
echocardiograms	echocardiogram	NOUN	NNS	O
obtained	obtain	VERB	VBN	O
before	before	ADP	IN	O
therapy	therapy	NOUN	NN	O
.	.	PUNCT	.	O

MEASUREMENTS	measurement	NOUN	NNS	O
:	:	PUNCT	:	O
Follow	follow	VERB	VB	O
-	-	PUNCT	HYPH	O
up	up	PART	RP	O
echocardiography	echocardiography	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
primary	primary	ADJ	JJ	O
outcome	outcome	NOUN	NN	O
was	be	VERB	VBD	O
new	new	ADJ	JJ	O
or	or	CCONJ	CC	O
worsening	worsen	VERB	VBG	O
valvulopathy	valvulopathy	NOUN	NN	B-Disease
,	,	PUNCT	,	O
defined	define	VERB	VBN	O
as	as	ADP	IN	O
progression	progression	NOUN	NN	O
of	of	ADP	IN	O
either	either	CCONJ	CC	O
aortic	aortic	ADJ	JJ	B-Disease
or	or	CCONJ	CC	I-Disease
mitral	mitral	ADJ	JJ	I-Disease
regurgitation	regurgitation	NOUN	NN	I-Disease
by	by	ADP	IN	O
at	at	ADV	RB	O
least	least	ADV	RBS	O
one	one	NUM	CD	O
degree	degree	NOUN	NN	O
of	of	ADP	IN	O
severity	severity	NOUN	NN	O
and	and	CCONJ	CC	O
disease	disease	NOUN	NN	O
that	that	DET	WDT	O
met	meet	VERB	VBD	O
U	u	PRON	PRP	O
.	.	PUNCT	.	O
S	s	NOUN	NN	O
.	.	PUNCT	.	O

Food	food	NOUN	NN	O
and	and	CCONJ	CC	O
Drug	Drug	PROPN	NNP	O
Administration	Administration	PROPN	NNP	O
criteria	criterion	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
mild	mild	ADJ	JJ	O
aortic	aortic	ADJ	JJ	B-Disease
regurgitation	regurgitation	NOUN	NN	I-Disease
or	or	CCONJ	CC	O
moderate	moderate	ADJ	JJ	O
mitral	mitral	ADJ	JJ	B-Disease
regurgitation	regurgitation	NOUN	NN	I-Disease
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

RESULTS	results	NOUN	NN	O
:	:	PUNCT	:	O
Two	two	NUM	CD	O
patients	patient	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
3	3	NUM	CD	O
%	%	NOUN	NN	O
[	[	PUNCT	-LRB-	O
95	95	NUM	CD	O
%	%	NOUN	NN	O
CI	CI	PROPN	NNP	O
,	,	PUNCT	,	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
%	%	NOUN	NN	O
to	to	ADP	IN	O
14	14	NUM	CD	O
.	.	PUNCT	.	O
8	8	NUM	CD	O
%	%	NOUN	NN	O
]	]	PUNCT	-RRB-	O
)	)	PUNCT	-RRB-	O
receiving	receive	VERB	VBG	O
fenfluramine	fenfluramine	ADJ	JJ	B-Chemical
-	-	PUNCT	HYPH	O
phentermine	phentermine	NOUN	NN	B-Chemical
developed	develop	VERB	VBD	O
valvular	valvular	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

One	one	NUM	CD	O
had	have	VERB	VBD	O
baseline	baseline	NOUN	NN	O
bicuspid	bicuspid	ADP	IN	B-Disease
aortic	aortic	ADJ	JJ	I-Disease
valve	valve	NOUN	NN	I-Disease
and	and	CCONJ	CC	O
mild	mild	ADJ	JJ	O
aortic	aortic	ADJ	JJ	B-Disease
regurgitation	regurgitation	NOUN	NN	I-Disease
that	that	DET	WDT	O
progressed	progress	VERB	VBD	O
to	to	ADP	IN	O
moderate	moderate	ADJ	JJ	O
regurgitation	regurgitation	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
second	second	ADJ	JJ	O
patient	patient	NOUN	NN	O
developed	develop	VERB	VBD	O
new	new	ADJ	JJ	O
moderate	moderate	ADJ	JJ	O
aortic	aortic	ADJ	JJ	B-Disease
insufficiency	insufficiency	NOUN	NN	I-Disease
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
Users	user	NOUN	NNS	O
of	of	ADP	IN	O
diet	diet	NOUN	NN	O
medications	medication	NOUN	NNS	O
are	be	VERB	VBP	O
at	at	ADP	IN	O
risk	risk	NOUN	NN	O
for	for	ADP	IN	O
valvular	valvular	ADJ	JJ	B-Disease
heart	heart	NOUN	NN	I-Disease
disease	disease	NOUN	NN	I-Disease
.	.	PUNCT	.	O

However	however	ADV	RB	O
,	,	PUNCT	,	O
the	the	DET	DT	O
incidence	incidence	NOUN	NN	O
may	may	VERB	MD	O
be	be	VERB	VB	O
lower	low	ADJ	JJR	O
than	than	ADP	IN	O
that	that	DET	DT	O
reported	report	VERB	VBD	O
previously	previously	ADV	RB	O
.	.	PUNCT	.	O

Therapeutic	therapeutic	ADJ	JJ	O
drug	drug	NOUN	NN	O
monitoring	monitoring	NOUN	NN	O
of	of	ADP	IN	O
tobramycin	tobramycin	NOUN	NN	B-Chemical
:	:	PUNCT	:	O
once	once	ADV	RB	O
-	-	PUNCT	HYPH	O
daily	daily	ADV	RB	O
versus	versus	ADP	IN	O
twice	twice	ADV	RB	O
-	-	PUNCT	HYPH	O
daily	daily	ADJ	JJ	O
dosage	dosage	NOUN	NN	O
schedules	schedule	NOUN	NNS	O
.	.	PUNCT	.	O

OBJECTIVE	OBJECTIVE	PROPN	NNP	O
:	:	PUNCT	:	O
To	to	PART	TO	O
evaluate	evaluate	VERB	VB	O
the	the	DET	DT	O
effect	effect	NOUN	NN	O
of	of	ADP	IN	O
dosage	dosage	NOUN	NN	O
regimen	regiman	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
once	once	ADV	RB	O
-	-	PUNCT	HYPH	O
daily	daily	ADV	RB	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
twice	twice	ADV	RB	O
-	-	PUNCT	HYPH	O
daily	daily	ADV	RB	O
)	)	PUNCT	-RRB-	O
of	of	ADP	IN	O
tobramicyn	tobramicyn	NOUN	NN	B-Chemical
on	on	ADP	IN	O
steady	steady	ADJ	JJ	O
-	-	PUNCT	HYPH	O
state	state	NOUN	NN	O
serum	serum	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
and	and	CCONJ	CC	O
toxicity	toxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

MATERIALS	material	NOUN	NNS	O
AND	and	CCONJ	CC	O
METHODS	method	NOUN	NNS	O
:	:	PUNCT	:	O
Patients	patient	NOUN	NNS	O
undergoing	undergo	VERB	VBG	O
treatment	treatment	NOUN	NN	O
with	with	ADP	IN	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
v	v	PUNCT	LS	O
.	.	PUNCT	.	O
tobramycin	tobramycin	ADJ	JJ	B-Chemical
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
/	/	SYM	SYM	O
day	day	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
randomised	randomise	VERB	VBN	O
to	to	ADP	IN	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
.	.	PUNCT	.	O

Group	Group	PROPN	NNP	O
OD	OD	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
n	n	CCONJ	CC	O
=	=	SYM	SYM	O
22	22	NUM	CD	O
)	)	PUNCT	-RRB-	O
received	receive	VERB	VBD	O
a	a	DET	DT	O
once	once	ADV	RB	O
-	-	PUNCT	HYPH	O
daily	daily	ADJ	JJ	O
dose	dose	NOUN	NN	O
of	of	ADP	IN	O
tobramycin	tobramycin	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
group	group	NOUN	NN	O
TD	TD	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
n	n	ADV	RB	O
=	=	SYM	SYM	O
21	21	NUM	CD	O
)	)	PUNCT	-RRB-	O
received	receive	VERB	VBD	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
dose	dose	NOUN	NN	O
divided	divide	VERB	VBD	O
into	into	ADP	IN	O
two	two	NUM	CD	O
doses	dose	NOUN	NNS	O
daily	daily	ADV	RB	O
.	.	PUNCT	.	O

Tobramycin	Tobramycin	PROPN	NNP	B-Chemical
serum	serum	ADJ	JJ	O
concentrations	concentration	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
peak	peak	NOUN	NN	O
and	and	CCONJ	CC	O
trough	trough	NOUN	NN	O
)	)	PUNCT	-RRB-	O
were	be	VERB	VBD	O
measured	measure	VERB	VBN	O
by	by	ADP	IN	O
enzyme	enzyme	ADJ	JJ	O
multiplied	multiply	VERB	VBN	O
immunoassay	immunoassay	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
renal	renal	ADJ	JJ	O
and	and	CCONJ	CC	O
auditory	auditory	NOUN	NN	O
functions	function	NOUN	NNS	O
of	of	ADP	IN	O
the	the	DET	DT	O
patients	patient	NOUN	NNS	O
were	be	VERB	VBD	O
monitored	monitor	VERB	VBN	O
before	before	ADV	RB	O
,	,	PUNCT	,	O
during	during	ADP	IN	O
and	and	CCONJ	CC	O
immediately	immediately	ADV	RB	O
after	after	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

RESULTS	RESULTS	PROPN	NNP	O
:	:	PUNCT	:	O
The	the	DET	DT	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
were	be	VERB	VBD	O
comparable	comparable	ADJ	JJ	O
with	with	ADP	IN	O
respect	respect	NOUN	NN	O
to	to	ADP	IN	O
sex	sex	NOUN	NN	O
,	,	PUNCT	,	O
age	age	NOUN	NN	O
,	,	PUNCT	,	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
and	and	CCONJ	CC	O
renal	renal	ADJ	JJ	O
function	function	NOUN	NN	O
.	.	PUNCT	.	O

No	no	DET	DT	O
statistically	statistically	ADV	RB	O
significant	significant	ADJ	JJ	O
differences	difference	NOUN	NNS	O
were	be	VERB	VBD	O
found	find	VERB	VBN	O
in	in	ADP	IN	O
mean	mean	ADJ	JJ	O
daily	daily	ADJ	JJ	O
dose	dose	NOUN	NN	O
,	,	PUNCT	,	O
duration	duration	NOUN	NN	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
cumulative	cumulative	ADJ	JJ	O
dose	dose	NOUN	NN	O
.	.	PUNCT	.	O

Trough	Trough	PROPN	NNP	O
concentrations	concentration	NOUN	NNS	O
were	be	VERB	VBD	O
<	<	X	XX	O
2	2	NUM	CD	O
g	g	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
in	in	ADP	IN	O
the	the	DET	DT	O
two	two	NUM	CD	O
groups	group	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
100	100	NUM	CD	O
%	%	NOUN	NN	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Peak	peak	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
were	be	VERB	VBD	O
>	>	X	XX	O
6	6	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
in	in	ADP	IN	O
100	100	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
OD	OD	PROPN	NNP	O
group	group	NOUN	NN	O
and	and	CCONJ	CC	O
in	in	ADP	IN	O
67	67	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
TD	TD	PROPN	NNP	O
group	group	NOUN	NN	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Mean	mean	VERB	VB	O
peak	peak	NOUN	NN	O
concentrations	concentration	NOUN	NNS	O
were	be	VERB	VBD	O
markedly	markedly	ADV	RB	O
different	different	ADJ	JJ	O
:	:	PUNCT	:	O
11	11	NUM	CD	O
.	.	PUNCT	.	O
00	00	PUNCT	NFP	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
2	2	NUM	CD	O
.	.	PUNCT	.	O
89	89	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
in	in	ADP	IN	O
OD	OD	PROPN	NNP	O
vs	vs	NOUN	NN	O
.	.	PUNCT	.	O
6	6	NUM	CD	O
.	.	PUNCT	.	O
53	53	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
45	45	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
in	in	ADP	IN	O
TD	TD	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
P	p	NOUN	NN	O
<	<	X	XX	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
01	01	NUM	CD	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

The	the	DET	DT	O
pharmacokinetics	pharmacokinetic	NOUN	NNS	O
parameters	parameter	NOUN	NNS	O
were	be	VERB	VBD	O
:	:	PUNCT	:	O
Ke	Ke	PROPN	NNP	O
,	,	PUNCT	,	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
15	15	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
03	03	NUM	CD	O
/	/	SYM	SYM	O
h	h	NOUN	NN	O
in	in	ADP	IN	O
OD	OD	PROPN	NNP	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
.	.	PUNCT	.	O
24	24	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
06	06	NUM	CD	O
/	/	SYM	SYM	O
h	h	NOUN	NN	O
in	in	ADP	IN	O
TD	TD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
t1	t1	NUM	CD	O
/	/	SYM	SYM	O
2	2	NUM	CD	O
,	,	PUNCT	,	O
(	(	PUNCT	-LRB-	O
4	4	NUM	CD	O
.	.	PUNCT	.	O
95	95	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	PUNCT	HYPH	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
41	41	NUM	CD	O
h	h	NOUN	NN	O
in	in	ADP	IN	O
OD	OD	PROPN	NNP	O
vs	vs	NOUN	NN	O
.	.	PUNCT	.	O
3	3	PUNCT	LS	O
.	.	PUNCT	.	O
07	07	NUM	CD	O
+	+	CCONJ	CC	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
71	71	NUM	CD	O
h	h	NOUN	NN	O
in	in	ADP	IN	O
TD	TD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
Vd	Vd	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
35	35	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
11	11	NUM	CD	O
l	l	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
in	in	ADP	IN	O
OD	OD	PROPN	NNP	O
vs	vs	ADP	IN	O
.	.	PUNCT	.	O
0	0	PUNCT	NFP	O
.	.	PUNCT	.	O
33	33	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
09	09	NUM	CD	O
l	l	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
in	in	ADP	IN	O
TD	TD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
Cl	Cl	PROPN	NNP	O
(	(	PUNCT	-LRB-	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
86	86	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
29	29	NUM	CD	O
ml	ml	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
in	in	ADP	IN	O
OD	OD	PROPN	NNP	O
vs	vs	NOUN	NN	O
.	.	PUNCT	.	O
1	1	NUM	CD	O
.	.	PUNCT	.	O
28	28	NUM	CD	O
+	+	SYM	SYM	O
/	/	SYM	SYM	O
-	-	SYM	SYM	O
0	0	NUM	CD	O
.	.	PUNCT	.	O
33	33	NUM	CD	O
ml	ml	NOUN	NN	O
/	/	SYM	SYM	O
min	min	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	NOUN	NN	O
in	in	ADP	IN	O
TD	TD	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

Increased	increase	VERB	VBN	O
serum	serum	NOUN	NN	O
creatinine	creatinine	NOUN	NN	B-Chemical
was	be	VERB	VBD	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
73	73	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
OD	OD	PROPN	NNP	O
versus	versus	ADP	IN	O
57	57	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
patients	patient	NOUN	NNS	O
in	in	ADP	IN	O
TD	TD	PROPN	NNP	O
,	,	PUNCT	,	O
without	without	ADP	IN	O
evidence	evidence	NOUN	NN	O
of	of	ADP	IN	O
nephrotoxicity	nephrotoxicity	NOUN	NN	B-Disease
.	.	PUNCT	.	O

In	in	ADP	IN	O
TD	TD	PROPN	NNP	O
group	group	NOUN	NN	O
,	,	PUNCT	,	O
three	three	NUM	CD	O
patients	patient	NOUN	NNS	O
developed	develop	VERB	VBD	O
decreased	decrease	VERB	VBN	B-Disease
auditory	auditory	NOUN	NN	I-Disease
function	function	NOUN	NN	I-Disease
,	,	PUNCT	,	O
of	of	ADP	IN	O
which	which	DET	WDT	O
one	one	PRON	PRP	O
presented	present	VERB	VBD	O
with	with	ADP	IN	O
an	an	DET	DT	O
auditory	auditory	ADJ	JJ	B-Disease
loss	loss	NOUN	NN	I-Disease
of	of	ADP	IN	O
-	-	PUNCT	HYPH	O
30	30	NUM	CD	O
dB	db	NOUN	NN	O
,	,	PUNCT	,	O
whereas	whereas	ADP	IN	O
in	in	ADP	IN	O
the	the	DET	DT	O
OD	OD	PROPN	NNP	O
group	group	NOUN	NN	O
only	only	ADV	RB	O
one	one	NUM	CD	O
patient	patient	NOUN	NN	O
presented	present	VERB	VBN	O
decreased	decrease	VERB	VBD	B-Disease
auditory	auditory	NOUN	NN	I-Disease
function	function	NOUN	NN	I-Disease
.	.	PUNCT	.	O

CONCLUSION	conclusion	NOUN	NN	O
:	:	PUNCT	:	O
This	this	DET	DT	O
small	small	ADJ	JJ	O
study	study	NOUN	NN	O
suggests	suggest	VERB	VBZ	O
that	that	ADP	IN	O
a	a	DET	DT	O
once	once	ADV	RB	O
-	-	PUNCT	HYPH	O
daily	daily	ADJ	JJ	O
dosing	dosing	ADJ	JJ	O
regimen	regiman	NOUN	NNS	O
of	of	ADP	IN	O
tobramycin	tobramycin	NOUN	NN	B-Chemical
is	be	VERB	VBZ	O
at	at	ADP	IN	O
least	least	ADJ	JJS	O
as	as	ADV	RB	O
effective	effective	ADJ	JJ	O
as	as	ADP	IN	O
and	and	CCONJ	CC	O
is	be	VERB	VBZ	O
no	no	DET	DT	O
more	more	ADJ	JJR	O
and	and	CCONJ	CC	O
possibly	possibly	ADV	RB	O
less	less	ADV	RBR	O
toxic	toxic	ADJ	JJ	O
than	than	ADP	IN	O
the	the	DET	DT	O
twice	twice	ADV	RB	O
-	-	PUNCT	HYPH	O
daily	daily	ADJ	JJ	O
regimen	regimen	NOUN	NN	O
.	.	PUNCT	.	O

Using	use	VERB	VBG	O
a	a	DET	DT	O
single	single	ADJ	JJ	O
-	-	PUNCT	HYPH	O
dose	dose	NOUN	NN	O
therapy	therapy	NOUN	NN	O
,	,	PUNCT	,	O
peak	peak	NOUN	NN	O
concentration	concentration	NOUN	NN	O
determination	determination	NOUN	NN	O
is	be	VERB	VBZ	O
not	not	ADV	RB	O
necessary	necessary	ADJ	JJ	O
,	,	PUNCT	,	O
only	only	ADV	RB	O
trough	trough	NOUN	NN	O
samples	sample	NOUN	NNS	O
should	should	VERB	MD	O
be	be	VERB	VB	O
monitored	monitor	VERB	VBN	O
to	to	PART	TO	O
ensure	ensure	VERB	VB	O
levels	level	NOUN	NNS	O
below	below	ADP	IN	O
2	2	NUM	CD	O
microg	microg	NOUN	NN	O
/	/	SYM	SYM	O
ml	ml	NOUN	NN	O
.	.	PUNCT	.	O

Enhanced	enhanced	ADJ	JJ	O
bradycardia	bradycardia	NOUN	NNS	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
antagonists	antagonist	NOUN	NNS	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
isoniazid	isoniazid	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

High	high	ADJ	JJ	O
doses	dose	NOUN	NNS	O
of	of	ADP	IN	O
isoniazid	isoniazid	NOUN	NN	B-Chemical
increase	increase	NOUN	NN	O
hypotension	hypotension	NOUN	NN	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
vasodilators	vasodilator	NOUN	NNS	O
and	and	CCONJ	CC	O
change	change	VERB	VB	O
the	the	DET	DT	O
accompanying	accompanying	ADJ	JJ	O
reflex	reflex	ADJ	JJ	O
tachycardia	tachycardia	NOUN	NN	B-Disease
to	to	ADP	IN	O
bradycardia	bradycardia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
an	an	DET	DT	O
interaction	interaction	NOUN	NN	O
attributed	attribute	VERB	VBN	O
to	to	ADP	IN	O
decreased	decrease	VERB	VBN	O
synthesis	synthesis	NOUN	NN	O
of	of	ADP	IN	O
brain	brain	NOUN	NN	O
gamma	gamma	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	I-Chemical
aminobutyric	aminobutyric	ADJ	JJ	I-Chemical
acid	acid	NOUN	NN	I-Chemical
(	(	PUNCT	-LRB-	O
GABA	GABA	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
the	the	DET	DT	O
present	present	ADJ	JJ	O
study	study	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
possible	possible	ADJ	JJ	O
enhancement	enhancement	NOUN	NN	O
by	by	ADP	IN	O
isoniazid	isoniazid	NOUN	NN	B-Chemical
of	of	ADP	IN	O
bradycardia	bradycardia	NOUN	NNS	B-Disease
induced	induce	VERB	VBN	O
by	by	ADP	IN	O
beta	beta	NOUN	NN	O
-	-	PUNCT	HYPH	O
adrenoceptor	adrenoceptor	NOUN	NN	O
antagonists	antagonist	NOUN	NNS	O
was	be	VERB	VBD	O
determined	determine	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
anaesthetised	anaesthetise	VERB	VBN	O
with	with	ADP	IN	O
chloralose	chloralose	NOUN	NN	B-Chemical
-	-	PUNCT	HYPH	O
urethane	urethane	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Isoniazid	Isoniazid	PROPN	NNP	B-Chemical
significantly	significantly	ADV	RB	O
increased	increase	VERB	VBD	O
bradycardia	bradycardia	NOUN	NNS	B-Disease
after	after	ADP	IN	O
propranolol	propranolol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
pindolol	pindolol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
labetalol	labetalol	NOUN	NN	B-Chemical
and	and	CCONJ	CC	O
atenolol	atenolol	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
as	as	ADV	RB	O
well	well	ADV	RB	O
as	as	ADP	IN	O
after	after	ADP	IN	O
clonidine	clonidine	NOUN	NN	B-Chemical
,	,	PUNCT	,	O
but	but	CCONJ	CC	O
not	not	ADV	RB	O
after	after	ADP	IN	O
hexamethonium	hexamethonium	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
carbachol	carbachol	NOUN	NN	B-Chemical
.	.	PUNCT	.	O

Enhancement	enhancement	NOUN	NN	O
was	be	VERB	VBD	O
not	not	ADV	RB	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
rats	rat	NOUN	NNS	O
pretreated	pretreate	VERB	VBN	O
with	with	ADP	IN	O
methylatropine	methylatropine	NOUN	NN	B-Chemical
or	or	CCONJ	CC	O
previously	previously	ADV	RB	O
vagotomised	vagotomise	VERB	VBN	O
.	.	PUNCT	.	O

These	these	DET	DT	O
results	result	NOUN	NNS	O
are	be	VERB	VBP	O
compatible	compatible	ADJ	JJ	O
with	with	ADP	IN	O
interference	interference	NOUN	NN	O
by	by	ADP	IN	O
isoniazid	isoniazid	NOUN	NN	B-Chemical
with	with	ADP	IN	O
GABAergic	GABAergic	PROPN	NNP	O
inhibition	inhibition	NOUN	NN	O
of	of	ADP	IN	O
cardiac	cardiac	ADJ	JJ	O
parasympathetic	parasympathetic	ADJ	JJ	O
tone	tone	NOUN	NN	O
.	.	PUNCT	.	O

Such	such	ADJ	JJ	O
interference	interference	NOUN	NN	O
could	could	VERB	MD	O
be	be	VERB	VB	O
exerted	exert	VERB	VBN	O
centrally	centrally	ADV	RB	O
,	,	PUNCT	,	O
possibly	possibly	ADV	RB	O
at	at	ADP	IN	O
the	the	DET	DT	O
nucleus	nucleus	NOUN	NN	O
ambiguus	ambiguus	NOUN	NN	O
,	,	PUNCT	,	O
or	or	CCONJ	CC	O
peripherally	peripherally	ADV	RB	O
at	at	ADP	IN	O
the	the	DET	DT	O
sinus	sinus	NOUN	NN	O
node	node	NOUN	NN	O
.	.	PUNCT	.	O

Structural	structural	ADJ	JJ	B-Disease
and	and	CCONJ	CC	I-Disease
functional	functional	ADJ	JJ	I-Disease
impairment	impairment	NOUN	NN	I-Disease
of	of	ADP	IN	I-Disease
mitochondria	mitochondria	NOUN	NN	I-Disease
in	in	ADP	IN	O
adriamycin	adriamycin	ADV	RB	B-Chemical
-	-	PUNCT	HYPH	O
induced	induced	ADJ	JJ	O
cardiomyopathy	cardiomyopathy	NOUN	NN	B-Disease
in	in	ADP	IN	O
mice	mouse	NOUN	NNS	O
:	:	PUNCT	:	O
suppression	suppression	NOUN	NN	O
of	of	ADP	IN	O
cytochrome	cytochrome	DET	PDT	O
c	c	DET	DT	O
oxidase	oxidase	NOUN	NN	O
II	II	PROPN	NNP	O
gene	gene	NOUN	NN	O
expression	expression	NOUN	NN	O
.	.	PUNCT	.	O

The	the	DET	DT	O
use	use	NOUN	NN	O
of	of	ADP	IN	O
adriamycin	adriamycin	NOUN	NN	B-Chemical
(	(	PUNCT	-LRB-	O
ADR	ADR	PROPN	NNP	B-Chemical
)	)	PUNCT	-RRB-	O
in	in	ADP	IN	O
cancer	cancer	NOUN	NN	B-Disease
chemotherapy	chemotherapy	NOUN	NN	O
has	have	VERB	VBZ	O
been	be	VERB	VBN	O
limited	limit	VERB	VBN	O
due	due	ADP	IN	O
to	to	ADP	IN	O
its	-PRON-	DET	PRP$	O
cumulative	cumulative	ADJ	JJ	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
toxicity	toxicity	NOUN	NN	I-Disease
.	.	PUNCT	.	O

Earlier	early	ADJ	JJR	O
observations	observation	NOUN	NNS	O
that	that	DET	WDT	O
ADR	ADR	PROPN	NNP	B-Chemical
interacts	interact	VERB	VBZ	O
with	with	ADP	IN	O
mitochondrial	mitochondrial	ADJ	JJ	O
cytochrome	cytochrome	DET	PDT	O
c	c	DET	DT	O
oxidase	oxidase	NOUN	NN	O
(	(	PUNCT	-LRB-	O
COX	COX	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
and	and	CCONJ	CC	O
suppresses	suppress	VERB	VBZ	O
its	-PRON-	DET	PRP$	O
enzyme	enzyme	ADJ	JJ	O
activity	activity	NOUN	NN	O
led	lead	VERB	VBD	O
us	-PRON-	PRON	PRP	O
to	to	PART	TO	O
investigate	investigate	VERB	VB	O
ADR	ADR	PROPN	NNP	B-Chemical
'	'	PUNCT	''	O
s	s	PART	POS	O
action	action	NOUN	NN	O
on	on	ADP	IN	O
the	the	DET	DT	O
cardiovascular	cardiovascular	ADJ	JJ	O
functions	function	NOUN	NNS	O
and	and	CCONJ	CC	O
heart	heart	NOUN	NN	O
mitochondrial	mitochondrial	ADJ	JJ	O
morphology	morphology	NOUN	NN	O
in	in	ADP	IN	O
Balb	Balb	PROPN	NNP	O
-	-	PUNCT	HYPH	O
c	c	PROPN	NNP	O
mice	mouse	NOUN	NNS	O
i	i	PRON	PRP	O
.	.	PUNCT	.	O
p	p	PUNCT	LS	O
.	.	PUNCT	.	O
treated	treat	VERB	VBN	O
with	with	ADP	IN	O
ADR	ADR	PROPN	NNP	B-Chemical
for	for	ADP	IN	O
several	several	ADJ	JJ	O
weeks	week	NOUN	NNS	O
.	.	PUNCT	.	O

At	at	ADP	IN	O
various	various	ADJ	JJ	O
times	time	NOUN	NNS	O
during	during	ADP	IN	O
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
the	the	DET	DT	O
animals	animal	NOUN	NNS	O
were	be	VERB	VBD	O
assessed	assess	VERB	VBN	O
for	for	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	O
functions	function	NOUN	NNS	O
by	by	ADP	IN	O
electrocardiography	electrocardiography	NOUN	NN	O
and	and	CCONJ	CC	O
for	for	ADP	IN	O
heart	heart	NOUN	NN	O
tissue	tissue	NOUN	NN	O
damage	damage	NOUN	NN	O
by	by	ADP	IN	O
electron	electron	NOUN	NN	O
microscopy	microscopy	NOUN	NN	O
.	.	PUNCT	.	O

In	in	ADP	IN	O
parallel	parallel	ADJ	JJ	O
,	,	PUNCT	,	O
total	total	ADJ	JJ	O
RNA	RNA	PROPN	NNP	O
was	be	VERB	VBD	O
extracted	extract	VERB	VBN	O
from	from	ADP	IN	O
samples	sample	NOUN	NNS	O
of	of	ADP	IN	O
dissected	dissect	VERB	VBN	O
heart	heart	NOUN	NN	O
and	and	CCONJ	CC	O
analyzed	analyze	VERB	VBN	O
by	by	ADP	IN	O
Northern	northern	ADJ	JJ	O
blot	blot	NOUN	NN	O
hybridization	hybridization	NOUN	NN	O
to	to	PART	TO	O
determine	determine	VERB	VB	O
the	the	DET	DT	O
steady	steady	ADJ	JJ	O
-	-	PUNCT	HYPH	O
state	state	NOUN	NN	O
level	level	NOUN	NN	O
of	of	ADP	IN	O
three	three	NUM	CD	O
RNA	RNA	PROPN	NNP	O
transcripts	transcript	NOUN	NNS	O
encoded	encode	VERB	VBN	O
by	by	ADP	IN	O
the	the	DET	DT	O
COXII	COXII	PROPN	NNP	O
,	,	PUNCT	,	O
COXIII	COXIII	PROPN	NNP	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
COXIV	coxiv	ADJ	JJ	O
genes	gene	NOUN	NNS	O
.	.	PUNCT	.	O

Similarly	similarly	ADV	RB	O
,	,	PUNCT	,	O
samples	sample	NOUN	NNS	O
obtained	obtain	VERB	VBN	O
from	from	ADP	IN	O
the	the	DET	DT	O
liver	liver	NOUN	NN	O
of	of	ADP	IN	O
the	the	DET	DT	O
same	same	ADJ	JJ	O
animals	animal	NOUN	NNS	O
were	be	VERB	VBD	O
analyzed	analyze	VERB	VBN	O
for	for	ADP	IN	O
comparative	comparative	ADJ	JJ	O
studies	study	NOUN	NNS	O
.	.	PUNCT	.	O

Our	-PRON-	DET	PRP$	O
results	result	NOUN	NNS	O
indicated	indicate	VERB	VBD	O
that	that	ADP	IN	O
1	1	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
treatment	treatment	NOUN	NN	O
of	of	ADP	IN	O
mice	mouse	NOUN	NNS	O
with	with	ADP	IN	O
ADR	ADR	PROPN	NNP	B-Chemical
caused	cause	VERB	VBD	O
cardiovascular	cardiovascular	ADJ	JJ	B-Disease
arrhythmias	arrhythmia	NOUN	NNS	I-Disease
characterized	characterize	VERB	VBN	O
by	by	ADP	IN	O
bradycardia	bradycardia	NOUN	NN	B-Disease
,	,	PUNCT	,	O
extension	extension	NOUN	NN	O
of	of	ADP	IN	O
ventricular	ventricular	ADJ	JJ	O
depolarization	depolarization	NOUN	NN	O
time	time	NOUN	NN	O
(	(	PUNCT	-LRB-	O
tQRS	tQRS	PROPN	NNP	O
)	)	PUNCT	-RRB-	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
failure	failure	NOUN	NN	O
of	of	ADP	IN	O
QRS	QRS	PROPN	NNP	O
at	at	ADP	IN	O
high	high	ADJ	JJ	O
concentrations	concentration	NOUN	NNS	O
(	(	PUNCT	-LRB-	O
10	10	NUM	CD	O
-	-	SYM	SYM	O
14	14	NUM	CD	O
mg	mg	NOUN	NN	O
/	/	SYM	SYM	O
kg	kg	ADP	IN	O
body	body	NOUN	NN	O
weight	weight	NOUN	NN	O
cumulative	cumulative	ADJ	JJ	O
dose	dose	NOUN	NN	O
)	)	PUNCT	-RRB-	O
;	;	PUNCT	:	O
2	2	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
the	the	DET	DT	O
heart	heart	NOUN	NN	O
mitochondria	mitochondria	NOUN	NN	O
underwent	underwent	NOUN	NN	O
swelling	swell	VERB	VBG	B-Disease
,	,	PUNCT	,	O
fusion	fusion	NOUN	NN	O
,	,	PUNCT	,	O
dissolution	dissolution	NOUN	NN	O
,	,	PUNCT	,	O
and	and	CCONJ	CC	O
/	/	SYM	SYM	O
or	or	CCONJ	CC	O
disruption	disruption	NOUN	NN	O
of	of	ADP	IN	O
mitochondrial	mitochondrial	ADJ	JJ	O
cristae	cristae	NOUN	NN	O
after	after	ADP	IN	O
several	several	ADJ	JJ	O
weeks	week	NOUN	NNS	O
of	of	ADP	IN	O
treatment	treatment	NOUN	NN	O
.	.	PUNCT	.	O

Such	such	ADJ	JJ	O
abnormalities	abnormality	NOUN	NNS	O
were	be	VERB	VBD	O
not	not	ADV	RB	O
observed	observe	VERB	VBN	O
in	in	ADP	IN	O
the	the	DET	DT	O
mitochondria	mitochondria	NOUN	NN	O
of	of	ADP	IN	O
liver	liver	ADJ	JJ	O
tissue	tissue	NOUN	NN	O
;	;	PUNCT	:	O
and	and	CCONJ	CC	O
3	3	PUNCT	LS	O
)	)	PUNCT	-RRB-	O
among	among	ADP	IN	O
the	the	DET	DT	O
three	three	NUM	CD	O
genes	gene	NOUN	NNS	O
of	of	ADP	IN	O
COX	COX	PROPN	NNP	O
enzyme	enzyme	NOUN	NN	O
examined	examine	VERB	VBD	O
,	,	PUNCT	,	O
only	only	ADV	RB	O
COXII	COXII	PROPN	NNP	O
gene	gene	NOUN	NN	O
expression	expression	NOUN	NN	O
was	be	VERB	VBD	O
suppressed	suppress	VERB	VBN	O
by	by	ADP	IN	O
ADR	ADR	PROPN	NNP	B-Chemical
treatment	treatment	NOUN	NN	O
,	,	PUNCT	,	O
mainly	mainly	ADV	RB	O
after	after	ADP	IN	O
8	8	NUM	CD	O
weeks	week	NOUN	NNS	O
in	in	ADP	IN	O
both	both	DET	DT	O
heart	heart	NOUN	NN	O
and	and	CCONJ	CC	O
liver	liver	NOUN	NN	O
.	.	PUNCT	.	O

Knowing	know	VERB	VBG	O
that	that	ADP	IN	O
heart	heart	NOUN	NN	O
mitochondria	mitochondria	NOUN	NN	O
represent	represent	VERB	VBP	O
almost	almost	ADV	RB	O
40	40	NUM	CD	O
%	%	NOUN	NN	O
of	of	ADP	IN	O
heart	heart	NOUN	NN	O
muscle	muscle	NOUN	NN	O
by	by	ADP	IN	O
weight	weight	NOUN	NN	O
,	,	PUNCT	,	O
we	-PRON-	PRON	PRP	O
conclude	conclude	VERB	VBP	O
that	that	ADP	IN	O
the	the	DET	DT	O
deteriorating	deteriorate	VERB	VBG	O
effects	effect	NOUN	NNS	O
of	of	ADP	IN	O
ADR	ADR	PROPN	NNP	B-Chemical
on	on	ADP	IN	O
cardiovascular	cardiovascular	ADJ	JJ	O
function	function	NOUN	NN	O
involve	involve	VERB	VBP	O
mitochondrial	mitochondrial	ADJ	JJ	B-Disease
structural	structural	ADJ	JJ	I-Disease
and	and	CCONJ	CC	I-Disease
functional	functional	ADJ	JJ	I-Disease
impairment	impairment	NOUN	NN	I-Disease
.	.	PUNCT	.	O

